Citrus Sinensis ID: 040392

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470
Protein Sequence
VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCKTSNHHTLWKNSLLLRIVLPLSAIFMIVVILLILRYRQKGKRPSNDANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNVGDRCIRQSILN
Secondary Structure (PSIPRED)
cccccccccccccEEccccccccccccHHHHccccccccccccccccccccHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccHHHHHHHHccccccccEEcccccEEEEEEEccccEEEEEEEEcccccccccHHHHHHHHHcccccccccEEEEEccccccEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHHccccccEEEccccccccccccccEEEEcccccccccccccccEEEEEccccccccccccccccccccccccccHHHHHHHHHHccccccccccccccHHHHHHHHcccccccccccccccccccccccHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHccccccccccc
Secondary Structure Prediction (SSPRO)
cccHHccccccccEEEcccccccEEccccccccccccEEEccccccccccHHHHcccccccEEEccccEEEccccccccHHHccHHHcccccEEEccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccEEcHHHHHHHHcccccccEEccccccEEEEEEcccccEEEEEEcccccccccHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEccccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHHcccccEEcccccHHHEEEcccccEEEccccccHHcccccccEEEEEEEcccccccHHHHHcccccccccHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHcccEEEEcHHHcccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHHHHHcccccccccccc
Coil and Loop (DISEMBL)
vipteigglknlEYLFLGynrlqgpipdsfgdlISLKFLNlsnnnlsgaipaslEKLSYLENLNLSFnklegeiprggpfrnfsvesfegnellcgspnlqvppcktsnhhtlwkNSLLLRIVLPLSAIFMIVVILLILRYRqkgkrpsndanmpsiaTWRTFSHLElcratdgfsennligrggfgsvykarlgdgMEVAVKVFNLQcgralkgfDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEymphgslekymyssNYILDIFQRLNIMIDVASALEYlhfgysapiihcdlkpsnvllddnmvahlsdfsiaklltgedqsmtQTQTLATIgymapeygregrvstngdvYSFGIMLMEtftgkkptneifngEMTLKHWvndwlpistMEVVGanllsqedihFVAKEQCVSCVFNLAmectvespeqRINAREIVAKLLKIRDSLLRNvgdrcirqsiln
Flexible Loop (DISEMBL)
vipteigglkNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCKTSNHHTLWKNSLLLRIVLPLSAIFMIVVILLILRYRQkgkrpsndanmpsiATWRTFSHLELCRATDgfsennligrgGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMEctvespeqriNAREIVAKLLKIRDsllrnvgdrcirqsiln
Low Complexity Region (SEG)
VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLIslkflnlsnnnlsGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCKTSNHHTLWKNSLLLRIVLPLSAIFMIVVILLILRYRQKGKRPSNDANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNVGDRCIRQSILN
Disordered region (IsUnstruct)
*****IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCKTSNHHTLWKNSLLLRIVLPLSAIFMIVVILLILRYRQ************SIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNVGDRCIR*****
Disordered Region (DISOPRED)
VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSP*********************LRIVLPLSAIFMIVVILLILR*********************TFSHLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED***TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLR*************
Disordered Region (DISEMBL)
VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCKTSNHHTLWKNSLLLRIVLPLSAIFMIVVILLILRYRQKGKRPSNDANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNVGDRCIRQSILN
Disordered Region (DISPRO)
VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPC********WKNSLLLRIVLPLSAIFMIVVILLILRYRQKG*****DANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNV***********
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCKTSNHHTLWKNSLLLRIVLPLSAIFMIVVILLILRYRQKGKRPSNDANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNVGDRCIRQSILN
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	470	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.970	0.451	0.400	6e-94
C0LGT6	1031	LRR receptor-like serine/	no	no	0.934	0.425	0.401	5e-84
Q9SD62	1025	Putative receptor-like pr	no	no	0.963	0.441	0.404	3e-82
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.944	0.453	0.351	8e-73
Q9FL28	1173	LRR receptor-like serine/	no	no	0.957	0.383	0.353	1e-66
Q9LJF3	1164	Receptor-like protein kin	no	no	0.910	0.367	0.348	5e-66
Q9ZWC8	1166	Serine/threonine-protein	no	no	0.942	0.379	0.327	6e-64
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.921	0.346	0.350	7e-64
O22476	1196	Protein BRASSINOSTEROID I	no	no	0.861	0.338	0.341	1e-62
Q8GUQ5	1207	Brassinosteroid LRR recep	N/A	no	0.821	0.319	0.354	2e-62

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  344 bits (883), Expect = 6e-94,   Method: Compositional matrix adjust.
 Identities = 203/507 (40%), Positives = 289/507 (57%), Gaps = 51/507 (10%)

Query: 2    IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGD-----------------------LISLKF 38
            +P +IG L+NL  L LG N+L G +P + G+                       L+ +K 
Sbjct: 497  LPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKGLVGVKE 556

Query: 39   LNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGS- 97
            ++LSNN+LSG+IP      S LE LNLSFN LEG++P  G F N +  S  GN  LCG  
Sbjct: 557  VDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGI 616

Query: 98   PNLQVPPCKTSNHHTLWKNS-LLLRIVLPLSA-------IFMIVVILLILRYRQKGKRPS 149
               Q+ PC +     + K+S  L ++V+ +S        +FM  V L+ LR R+K K  +
Sbjct: 617  MGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETN 676

Query: 150  NDANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ 208
            N             S+ +L  AT+GFS +N++G G FG+VYKA L  +   VAVKV N+Q
Sbjct: 677  NPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQ 736

Query: 209  CGRALKGFDVECEMMKSIRHRNLIKVISTCSN-----EEFKALVLEYMPHGSLEKYMYSS 263
               A+K F  ECE +K IRHRNL+K+++ CS+      EF+AL+ E+MP+GSL+ +++  
Sbjct: 737  RRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPE 796

Query: 264  --------NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLS 315
                    +  L + +RLNI IDVAS L+YLH     PI HCDLKPSNVLLDD++ AH+S
Sbjct: 797  EVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVS 856

Query: 316  DFSIAKLLTGEDQ-----SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 370
            DF +A+LL   D+      ++      TIGY APEYG  G+ S NGDVYSFGI+L+E FT
Sbjct: 857  DFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFT 916

Query: 371  GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMEC 430
            GK+PTNE+F G  TL  +    LP   +++V  ++L           +C++ VF + + C
Sbjct: 917  GKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFPVVECLTMVFEVGLRC 976

Query: 431  TVESPEQRINAREIVAKLLKIRDSLLR 457
              ESP  R+    +V +L+ IR+   +
Sbjct: 977  CEESPMNRLATSIVVKELISIRERFFK 1003

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  311 bits (798), Expect = 5e-84,   Method: Compositional matrix adjust.
 Identities = 193/481 (40%), Positives = 268/481 (55%), Gaps = 42/481 (8%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           +P  IGG  ++E+LF+  N   G IPD    L+SLK ++ SNNNLSG IP  L  L  L 
Sbjct: 529 MPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSGRIPRYLASLPSLR 587

Query: 62  NLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGS-PNLQVPPCKTSNHHTLWK----- 115
           NLNLS NK EG +P  G FRN +  S  GN  +CG    +Q+ PC         K     
Sbjct: 588 NLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVR 647

Query: 116 NSLLLRIVLPLSAIFMIVVILLILRY-RQKGKRPSNDANMPSIATWRTF----SHLELCR 170
             ++  I + ++++ +I+++  +  + ++K K  ++D N     T   F    S+ EL  
Sbjct: 648 KKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHS 707

Query: 171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHR 229
           AT  FS  NLIG G FG+V+K  LG +   VAVKV NL    A K F  ECE  K IRHR
Sbjct: 708 ATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHR 767

Query: 230 NLIKVISTCSN-----EEFKALVLEYMPHGSLEKYMY--------SSNYILDIFQRLNIM 276
           NL+K+I+ CS+      +F+ALV E+MP GSL+ ++           +  L   ++LNI 
Sbjct: 768 NLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIA 827

Query: 277 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ-----SMT 331
           IDVASALEYLH     P+ HCD+KPSN+LLDD++ AH+SDF +A+LL   D+       +
Sbjct: 828 IDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFS 887

Query: 332 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVND 391
                 TIGY APEYG  G+ S  GDVYSFGI+L+E F+GKKPT+E F G+  L  +   
Sbjct: 888 SAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKS 947

Query: 392 WLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
            L   T    G+N          A ++ +  V  + ++C+ E P  R+   E V +L+ I
Sbjct: 948 ILSGCT-SSGGSN----------AIDEGLRLVLQVGIKCSEEYPRDRMRTDEAVRELISI 996

Query: 452 R 452
           R
Sbjct: 997 R 997

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  305 bits (782), Expect = 3e-82,   Method: Compositional matrix adjust.
 Identities = 198/490 (40%), Positives = 281/490 (57%), Gaps = 37/490 (7%)

Query: 2    IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
            IP  +    +LE+L L  N   GPIPD  G L  L+FL+LS NNLSG IP  +   S L+
Sbjct: 537  IPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFLDLSKNNLSGTIPEYMANFSKLQ 595

Query: 62   NLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGS-PNLQVPPCKTS---NHHTLWKNS 117
            NLNLS N  +G +P  G FRN S  S  GN  LCG  P+LQ+ PC       H ++ K  
Sbjct: 596  NLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRK-- 653

Query: 118  LLLRIVLPLSAIFMIVVILLIL-----RYRQKGKRPSNDANMPSIATWRTF----SHLEL 168
             ++ I +      ++++ L ++     + R K  R +N+ N  S +  ++F    S+ EL
Sbjct: 654  -IITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDEL 712

Query: 169  CRATDGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIR 227
             + T GFS +NLIG G FG+V+K  LG     VA+KV NL    A K F  ECE +  IR
Sbjct: 713  YKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIR 772

Query: 228  HRNLIKVISTCSNEEF-----KALVLEYMPHGSLEKYMY--------SSNYILDIFQRLN 274
            HRNL+K+++ CS+ +F     +ALV E+MP+G+L+ +++        + +  L +F RLN
Sbjct: 773  HRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLN 832

Query: 275  IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ 334
            I IDVASAL YLH     PI HCD+KPSN+LLD ++ AH+SDF +A+LL   D+     Q
Sbjct: 833  IAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQ 892

Query: 335  -----TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWV 389
                    TIGY APEYG  G  S  GDVYSFGI+L+E FTGK+PTN++F   +TL  + 
Sbjct: 893  FSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFT 952

Query: 390  NDWLPI-STMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
               L     +++    +L           +C++ VF + + C+ ESP  RI+  E ++KL
Sbjct: 953  KSALQKRQALDITDETILRGAYAQHFNMVECLTLVFRVGVSCSEESPVNRISMAEAISKL 1012

Query: 449  LKIRDSLLRN 458
            + IR+S  R+
Sbjct: 1013 VSIRESFFRD 1022

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  275 bits (702), Expect = 8e-73,   Method: Compositional matrix adjust.
 Identities = 172/490 (35%), Positives = 267/490 (54%), Gaps = 46/490 (9%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           IP ++G    LE+L L  N     +P S G L  LK L++S N L+GAIP S ++ S L+
Sbjct: 483 IPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLK 542

Query: 62  NLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCKTSNHHTLWKNSLLLR 121
           +LN SFN L G +   G F   ++ESF G+ LLCGS        K   + ++    LL  
Sbjct: 543 HLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQACKKKHKYPSVLLPVLLSL 602

Query: 122 IVLPLSAIFMIVVILLILRYR--------------QKGKRPSNDANMPSIATWRTFSHLE 167
           I  P+  +F      L+ R R               + K+  ND   P I      S+ +
Sbjct: 603 IATPVLCVFGYP---LVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRI------SYQQ 653

Query: 168 LCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKG-FDVECEMMKSI 226
           L  AT GF+ ++LIG G FG VYK  L +  +VAVKV + +      G F  EC+++K  
Sbjct: 654 LIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQILKRT 713

Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYI---LDIFQRLNIMIDVASAL 283
           RHRNLI++I+TCS   F ALVL  MP+GSLE+++Y   Y    LD+ Q +NI  DVA  +
Sbjct: 714 RHRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGI 773

Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA------ 337
            YLH      ++HCDLKPSN+LLDD M A ++DF I++L+ G +++++   +++      
Sbjct: 774 AYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDG 833

Query: 338 ----TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWL 393
               ++GY+APEYG   R ST+GDVYSFG++L+E  +G++PT+ + N   +L  ++    
Sbjct: 834 LLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHY 893

Query: 394 PISTMEVVGANLLSQ-------EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVA 446
           P  ++E +    LS+       E    + +E  +  +  L + CT  +P  R +  ++  
Sbjct: 894 P-DSLEGIIEQALSRWKPQGKPEKCEKLWREVILEMI-ELGLVCTQYNPSTRPDMLDVAH 951

Query: 447 KLLKIRDSLL 456
           ++ ++++ L 
Sbjct: 952 EMGRLKEYLF 961

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  254 bits (648), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 166/470 (35%), Positives = 270/470 (57%), Gaps = 20/470 (4%)

Query: 2    IPTEI-GGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
            IP E+  G+  +  L L  N   G IP SFG++  L  L+LS+NNL+G IP SL  LS L
Sbjct: 689  IPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTL 748

Query: 61   ENLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPC--KTSNHHTLWKNSL 118
            ++L L+ N L+G +P  G F+N +     GN  LCGS    + PC  K  + H   +  +
Sbjct: 749  KHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKK-PLKPCTIKQKSSHFSKRTRV 807

Query: 119  LLRIV---LPLSAIFMIVVILLILRYRQKGKRPSNDANMPSIAT---WRTFSHLELCRAT 172
            +L I+     L  + ++V+IL   + ++K    S+++++P + +    + F   EL +AT
Sbjct: 808  ILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQAT 867

Query: 173  DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRN 230
            D F+  N+IG     +VYK +L DG  +AVKV NL+     + K F  E + +  ++HRN
Sbjct: 868  DSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRN 927

Query: 231  LIKVIS-TCSNEEFKALVLEYMPHGSLEKYMY-SSNYILDIFQRLNIMIDVASALEYLHF 288
            L+K++     + + KALVL +M +G+LE  ++ S+  I  + +++++ + +AS ++YLH 
Sbjct: 928  LVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHS 987

Query: 289  GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA---TIGYMAPE 345
            GY  PI+HCDLKP+N+LLD + VAH+SDF  A++L   +   T   T A   TIGY+APE
Sbjct: 988  GYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPE 1047

Query: 346  YGREGRVSTNGDVYSFGIMLMETFTGKKPT--NEIFNGEMTLKHWVNDWLPISTMEVVGA 403
            +    +V+T  DV+SFGI++ME  T ++PT  N+  + +MTL+  V   +      +V  
Sbjct: 1048 FAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRV 1107

Query: 404  -NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR 452
             ++   + I  + +E+ +     L + CT   PE R +  EI+  L+K+R
Sbjct: 1108 LDMELGDSIVSLKQEEAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLR 1157

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1

 Score =  252 bits (643), Expect = 5e-66,   Method: Compositional matrix adjust.
 Identities = 166/477 (34%), Positives = 246/477 (51%), Gaps = 49/477 (10%)

Query: 2    IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
            IP   G +  L+ L LG+N L G IPDSFG L ++  L+LS+N+L G +P SL  LS+L 
Sbjct: 655  IPLGYGAMGYLQVLNLGHNLLTGTIPDSFGGLKAIGVLDLSHNDLQGFLPGSLGGLSFLS 714

Query: 62   NLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCK-----TSNHHTLWKN 116
            +L++S N L G IP GG    F +  +  N  LCG P   +PPC      T +H    K 
Sbjct: 715  DLDVSNNNLTGPIPFGGQLTTFPLTRYANNSGLCGVP---LPPCSSGSRPTRSHAHPKKQ 771

Query: 117  SLLLRIVLPLSAIFMIVVILLILRYR------QKGKRPSNDANMPS-------------- 156
            S+   +   +   FM +V+L++  YR      ++ +R     ++P+              
Sbjct: 772  SIATGMSAGIVFSFMCIVMLIMALYRARKVQKKEKQREKYIESLPTSGSSSWKLSSVHEP 831

Query: 157  ----IATWR------TFSHLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFN 206
                +AT+       TF+HL    AT+GFS +++IG GGFG VYKA+L DG  VA+K   
Sbjct: 832  LSINVATFEKPLRKLTFAHL--LEATNGFSADSMIGSGGFGDVYKAKLADGSVVAIKKLI 889

Query: 207  LQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMY----S 262
               G+  + F  E E +  I+HRNL+ ++  C   E + LV EYM +GSLE  ++     
Sbjct: 890  QVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHEKTKK 949

Query: 263  SNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 322
                LD   R  I I  A  L +LH      IIH D+K SNVLLD + VA +SDF +A+L
Sbjct: 950  GGIFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMARL 1009

Query: 323  LTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTN-EIFNG 381
            ++  D  ++ +    T GY+ PEY +  R +  GDVYS+G++L+E  +GKKP + E F  
Sbjct: 1010 VSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPEEFGE 1069

Query: 382  EMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQR 438
            +  L  W          E  GA +L  E +   + +  +     +A +C  + P +R
Sbjct: 1070 DNNLVGWAKQLY----REKRGAEILDPELVTDKSGDVELLHYLKIASQCLDDRPFKR 1122

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1

 Score =  245 bits (625), Expect = 6e-64,   Method: Compositional matrix adjust.
 Identities = 161/492 (32%), Positives = 251/492 (51%), Gaps = 49/492 (9%)

Query: 2    IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
            IP   G +  L+ L LG+NR+ G IPDSFG L ++  L+LS+NNL G +P SL  LS+L 
Sbjct: 655  IPPGYGNMGYLQVLNLGHNRITGTIPDSFGGLKAIGVLDLSHNNLQGYLPGSLGSLSFLS 714

Query: 62   NLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCKTSNHHTLW------K 115
            +L++S N L G IP GG    F V  +  N  LCG P   + PC ++    +       K
Sbjct: 715  DLDVSNNNLTGPIPFGGQLTTFPVSRYANNSGLCGVP---LRPCGSAPRRPITSRIHAKK 771

Query: 116  NSLLLRIVLPLSAIFMIVVILLILRYR------QKGKRPSNDANMPSIAT--WR------ 161
             ++   ++  ++  FM  V+L++  YR      ++ KR     ++P+  +  W+      
Sbjct: 772  QTVATAVIAGIAFSFMCFVMLVMALYRVRKVQKKEQKREKYIESLPTSGSCSWKLSSVPE 831

Query: 162  ----------------TFSHLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVF 205
                            TF+HL    AT+GFS   ++G GGFG VYKA+L DG  VA+K  
Sbjct: 832  PLSINVATFEKPLRKLTFAHL--LEATNGFSAETMVGSGGFGEVYKAQLRDGSVVAIKKL 889

Query: 206  NLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSN- 264
                G+  + F  E E +  I+HRNL+ ++  C   E + LV EYM  GSLE  ++  + 
Sbjct: 890  IRITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVLHEKSS 949

Query: 265  ----YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA 320
                  L+   R  I I  A  L +LH      IIH D+K SNVLLD++  A +SDF +A
Sbjct: 950  KKGGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARVSDFGMA 1009

Query: 321  KLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFN 380
            +L++  D  ++ +    T GY+ PEY +  R +  GDVYS+G++L+E  +GKKP +    
Sbjct: 1010 RLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDP--- 1066

Query: 381  GEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRIN 440
            GE    + +  W      E  GA +L  E +   + +  +     +A +C  + P +R  
Sbjct: 1067 GEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELFHYLKIASQCLDDRPFKRPT 1126

Query: 441  AREIVAKLLKIR 452
              +++A   +++
Sbjct: 1127 MIQLMAMFKEMK 1138

Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  245 bits (625), Expect = 7e-64,   Method: Compositional matrix adjust.
 Identities = 174/497 (35%), Positives = 256/497 (51%), Gaps = 64/497 (12%)

Query: 2    IPTEIGGLKNLE-YLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
            IP EIG L++L+  L L YN   G IP + G L  L+ L+LS+N L+G +P S+  +  L
Sbjct: 759  IPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSL 818

Query: 61   ENLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCKTSNHHTLWKNSLLL 120
              LN+SFN L G++ +   F  +  +SF GN  LCGSP  +    +++N     +  L  
Sbjct: 819  GYLNVSFNNLGGKLKK--QFSRWPADSFLGNTGLCGSPLSRCNRVRSNNK----QQGLSA 872

Query: 121  RIVLPLSAI-------FMIVVILLILRYR---------------------QKGKRP--SN 150
            R V+ +SAI        MI+VI L  + R                     Q   +P   N
Sbjct: 873  RSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRN 932

Query: 151  DANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVK-VFNLQC 209
             A+   I  W      ++  AT   SE  +IG GG G VYKA L +G  VAVK +     
Sbjct: 933  GASKSDIR-WE-----DIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDD 986

Query: 210  GRALKGFDVECEMMKSIRHRNLIKVISTCSN--EEFKALVLEYMPHGSLEKYMYSSNYIL 267
              + K F  E + +  IRHR+L+K++  CS+  E    L+ EYM +GS+  +++    +L
Sbjct: 987  LMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVL 1046

Query: 268  -------DIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA 320
                   D   RL I + +A  +EYLH     PI+H D+K SNVLLD NM AHL DF +A
Sbjct: 1047 EKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLA 1106

Query: 321  KLLTGEDQSMTQTQTL--ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEI 378
            K+LT    + T + T    + GY+APEY    + +   DVYS GI+LME  TGK PT+ +
Sbjct: 1107 KVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSV 1166

Query: 379  FNGEMTLKHWVNDWLPISTMEVVGA---NLLSQEDIHFVAKEQCVSC-VFNLAMECTVES 434
            F  EM +  WV      + +EV G+    L+  +    +  E+  +C V  +A++CT  S
Sbjct: 1167 FGAEMDMVRWVE-----THLEVAGSARDKLIDPKLKPLLPFEEDAACQVLEIALQCTKTS 1221

Query: 435  PEQRINAREIVAKLLKI 451
            P++R ++R+    LL +
Sbjct: 1222 PQERPSSRQACDSLLHV 1238

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1

 Score =  240 bits (613), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 155/454 (34%), Positives = 229/454 (50%), Gaps = 49/454 (10%)

Query: 2    IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
            IP EIG +  L  L LG+N + G IPD  GDL  L  L+LS+N L G IP ++  L+ L 
Sbjct: 670  IPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT 729

Query: 62   NLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCKTSN-----HH----- 111
             ++LS N L G IP  G F  F    F  N  LCG P   +P C  SN     HH     
Sbjct: 730  EIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP---LPRCDPSNADGYAHHQRSHG 786

Query: 112  ---TLWKNSLLLRIVLPLSAIFMIVVI----------------LLILRYRQKGKRPSNDA 152
                    S+ + ++     IF ++++                +    +   G R +N+ 
Sbjct: 787  RRPASLAGSVAMGLLFSFVCIFGLILVGREMRKRRRKKEAELEMYAEGHGNSGDRTANNT 846

Query: 153  NMP----------SIATW----RTFSHLELCRATDGFSENNLIGRGGFGSVYKARLGDGM 198
            N            ++A +    R  +  +L +AT+GF  ++LIG GGFG VYKA L DG 
Sbjct: 847  NWKLTGVKEALSINLAAFEKPLRKLTFADLLQATNGFHNDSLIGSGGFGDVYKAILKDGS 906

Query: 199  EVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 258
             VA+K      G+  + F  E E +  I+HRNL+ ++  C   + + LV E+M +GSLE 
Sbjct: 907  AVAIKKLIHVSGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGDERLLVYEFMKYGSLED 966

Query: 259  YMYS---SNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLS 315
             ++    +   L+   R  I I  A  L +LH   S  IIH D+K SNVLLD+N+ A +S
Sbjct: 967  VLHDPKKAGVKLNWSTRRKIAIGSARGLAFLHHNCSPHIIHRDMKSSNVLLDENLEARVS 1026

Query: 316  DFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPT 375
            DF +A+L++  D  ++ +    T GY+ PEY +  R ST GDVYS+G++L+E  TGK+PT
Sbjct: 1027 DFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPT 1086

Query: 376  NEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
            +    G+  L  WV     +   +V    L+ ++
Sbjct: 1087 DSPDFGDNNLVGWVKQHAKLRISDVFDPELMKED 1120

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1

 Score =  240 bits (612), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 152/429 (35%), Positives = 221/429 (51%), Gaps = 43/429 (10%)

Query: 2    IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
            IP E+G +  L  L LG+N L G IP   G L ++  L+LS N  +G IP SL  L+ L 
Sbjct: 679  IPKELGAMYYLSILNLGHNDLSGMIPQQLGGLKNVAILDLSYNRFNGTIPNSLTSLTLLG 738

Query: 62   NLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVP----PCKTSNHH------ 111
             ++LS N L G IP   PF  F    F  N  LCG P L +P    P   +N H      
Sbjct: 739  EIDLSNNNLSGMIPESAPFDTFPDYRFANNS-LCGYP-LPIPCSSGPKSDANQHQKSHRR 796

Query: 112  -TLWKNSLLLRIVLPLSAIFMIVVILLILRYRQKGKRPSNDANM-------PSIATW--- 160
                  S+ + ++  L  IF ++++ +  + R++ K  + +A M        + + W   
Sbjct: 797  QASLAGSVAMGLLFSLFCIFGLIIVAIETKKRRRKKEAALEAYMDGHSHSATANSAWKFT 856

Query: 161  -----------------RTFSHLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVK 203
                             R  +  +L  AT+GF  ++L+G GGFG VYKA+L DG  VA+K
Sbjct: 857  SAREALSINLAAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIK 916

Query: 204  VFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSS 263
                  G+  + F  E E +  I+HRNL+ ++  C   E + LV EYM +GSLE  ++  
Sbjct: 917  KLIHVSGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDR 976

Query: 264  NYI---LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA 320
              I   L+   R  I I  A  L +LH      IIH D+K SNVLLD+N+ A +SDF +A
Sbjct: 977  KKIGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMA 1036

Query: 321  KLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFN 380
            +L++  D  ++ +    T GY+ PEY +  R ST GDVYS+G++L+E  TGK+PT+    
Sbjct: 1037 RLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADF 1096

Query: 381  GEMTLKHWV 389
            G+  L  WV
Sbjct: 1097 GDNNLVGWV 1105

Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants.

Solanum lycopersicum (taxid: 4081)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	470
224116832	1061	predicted protein [Populus trichocarpa]	0.955	0.423	0.570	1e-146
224139658	1019	predicted protein [Populus trichocarpa]	0.978	0.451	0.563	1e-144
359485451	1454	PREDICTED: LRR receptor-like serine/thre	0.959	0.310	0.568	1e-142
359483198	1087	PREDICTED: probable LRR receptor-like se	0.957	0.413	0.553	1e-141
255572272	1089	serine-threonine protein kinase, plant-t	0.972	0.419	0.530	1e-140
359485453	1202	PREDICTED: probable LRR receptor-like se	0.951	0.371	0.565	1e-138
359485449	1583	PREDICTED: LRR receptor-like serine/thre	0.957	0.284	0.577	1e-137
359483677	1229	PREDICTED: LRR receptor-like serine/thre	0.959	0.366	0.557	1e-137
359483683	1228	PREDICTED: LRR receptor-like serine/thre	0.959	0.367	0.559	1e-137
359497186	1140	PREDICTED: LRR receptor-like serine/thre	0.959	0.395	0.557	1e-136

>gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa]

 Score =  525 bits (1352), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 259/454 (57%), Positives = 340/454 (74%), Gaps = 5/454 (1%)

Query: 2    IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
            IPT I  L+NL +  L  NR+QGPIP SFGDL+SL+FL+LS N+LSGAIP SLEKL +L+
Sbjct: 595  IPTSIADLQNLAHFSLSDNRMQGPIPSSFGDLVSLEFLDLSRNSLSGAIPKSLEKLVHLK 654

Query: 62   NLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCKTSNHHTLWKN--SLL 119
              N+SFN+L+GEI  GGPF NFS  SF  NE LCG   +QVPPCK+ + H   K     +
Sbjct: 655  TFNVSFNRLQGEILDGGPFANFSFRSFMDNEALCGPIRMQVPPCKSISTHRQSKRPREFV 714

Query: 120  LRIVLPLSAIFMIVVILLILRYRQKGKRPSNDANMP-SIATWRTFSHLELCRATDGFSEN 178
            +R ++P  A  ++V+ L ++ +R+  KR  +    P   ATWR  S+ EL RAT+GF+E 
Sbjct: 715  IRYIVPAIAFIILVLALAVIIFRRSHKRKLSTQEDPLPPATWRKISYHELYRATEGFNET 774

Query: 179  NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTC 238
            NL+G G  GSVYK  L DG+ +AVKVF+LQ    L  FD ECE+++ +RHRNL+K+IS+C
Sbjct: 775  NLLGTGSCGSVYKGTLSDGLCIAVKVFHLQLEGELMRFDSECEVLRMLRHRNLVKIISSC 834

Query: 239  SNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
             N +FKAL+LE++PHGSLEK++YS NY LDI QRLNIMIDVASALEYLH G + P++HCD
Sbjct: 835  CNLDFKALILEFIPHGSLEKWLYSHNYYLDILQRLNIMIDVASALEYLHHGCTRPVVHCD 894

Query: 299  LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
            LKPSNVL++++MVAH+SDF I++LL GE  ++TQT TLATIGYMAPEYG EG VS  GDV
Sbjct: 895  LKPSNVLINEDMVAHVSDFGISRLL-GEGDAVTQTLTLATIGYMAPEYGLEGIVSVKGDV 953

Query: 359  YSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQ 418
            YS+GI LMETFT KKPT+++F GEM+LK+WV   LP +  EV+ ANLL +E+ HFVAK+ 
Sbjct: 954  YSYGIFLMETFTRKKPTDDMFGGEMSLKNWVKQSLPKAITEVIDANLLIEEE-HFVAKKD 1012

Query: 419  CVSCVFNLAMECTVESPEQRINAREIVAKLLKIR 452
            C++ + NLA+EC+ + P +RI  R+++  L KI+
Sbjct: 1013 CITSILNLALECSADLPGERICMRDVLPALEKIK 1046

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa]

 Score =  519 bits (1336), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 261/463 (56%), Positives = 334/463 (72%), Gaps = 3/463 (0%)

Query: 2    IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
            IP+ IG L+NL    L  N  QG IP++FG L+SL+ L+LS NNLSG IP SLE L YLE
Sbjct: 556  IPSTIGSLQNLIRFSLSKNSFQGSIPEAFGGLVSLELLDLSQNNLSGEIPKSLEALRYLE 615

Query: 62   NLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCKTSNHHTLWKNSLLLR 121
              ++SFN L+GEIPRGGPF NF+  SF  N+ LCG   LQVPPC   +       S LLR
Sbjct: 616  FFSVSFNGLQGEIPRGGPFANFTARSFIMNKGLCGPSRLQVPPCSIESRKDSKTKSRLLR 675

Query: 122  IVLPLSAIFMIVV--ILLILRYRQKGKRPSNDANMPSIATWRTFSHLELCRATDGFSENN 179
              LP  A  ++VV  I L++  R++ ++      +P  A  R  S+LEL  AT+ F E+N
Sbjct: 676  FSLPTVASILLVVAFIFLVMGCRRRYRKDPIPEALPVTAIQRRISYLELLHATNEFHESN 735

Query: 180  LIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
            L+G G FGSVY+ RL DG+ VAVK+FNLQ  RA + FD ECE+M++IRHRNL+K+I +CS
Sbjct: 736  LLGIGSFGSVYQGRLRDGLNVAVKIFNLQLQRAFRSFDTECEIMRNIRHRNLVKIICSCS 795

Query: 240  NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
            N +FKALVLEYMP GSLEK++YS NY LDI QR+NIMIDVASALEYLH GY +P++HCDL
Sbjct: 796  NLDFKALVLEYMPKGSLEKWLYSHNYCLDIIQRVNIMIDVASALEYLHHGYPSPVVHCDL 855

Query: 300  KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVY 359
            KPSNVLLD++MVAH+ DF IAKLL GE++S  QT+TLATIGYMAPEYG +G VST  DVY
Sbjct: 856  KPSNVLLDEDMVAHVCDFGIAKLL-GENESFAQTRTLATIGYMAPEYGLDGLVSTKIDVY 914

Query: 360  SFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQC 419
            SFGIMLME  T K+PT+E+F GEM+LK  V + LP S +++V +N+L++ D + V KE C
Sbjct: 915  SFGIMLMEMLTRKRPTDEMFEGEMSLKRLVKESLPDSVIDIVDSNMLNRGDGYSVKKEHC 974

Query: 420  VSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNVGDR 462
            V+ +  LA++C  ESP +R+   EI+A+L  I+   LR+   R
Sbjct: 975  VTSIMELALQCVNESPGERMAMVEILARLKNIKAEFLRDSERR 1017

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485451|ref|XP_002276944.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  509 bits (1312), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 261/459 (56%), Positives = 337/459 (73%), Gaps = 8/459 (1%)

Query: 2    IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
            IP  +G L+NLE L L  NRLQGPIP  FGDL+SLKFL+LS NNLSG IP SL+ L+YL+
Sbjct: 999  IPRTLGELQNLEDLSLSQNRLQGPIPLEFGDLLSLKFLDLSQNNLSGVIPKSLKALTYLK 1058

Query: 62   NLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCKTSNHHTLWKNSL-LL 120
             LN+SFNKL+GEIP GGPF NF+ ESF  NE LCG+P+ QV  C  S     W+  L +L
Sbjct: 1059 YLNVSFNKLQGEIPDGGPFMNFTAESFIFNEALCGAPHFQVIACDKSTRSRSWRTKLFIL 1118

Query: 121  RIVLP--LSAIFMIVVILLILRYRQKGKRPSN-DANMPSIATWRTFSHLELCRATDGFSE 177
            + +LP  +S I ++V ++L +R R+  + P+  D+ +P   +    SH +L  AT+ F E
Sbjct: 1119 KYILPPVISIITLVVFLVLWIRRRKNLEVPTPIDSWLP--GSHEKISHQQLLYATNYFGE 1176

Query: 178  NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
            +NLIG+G    VYK  L +G+ VAVKVFNL+   A + FD ECE+M+SIRHRNL+K+I+ 
Sbjct: 1177 DNLIGKGSLSMVYKGVLSNGLTVAVKVFNLEFQGAFRSFDSECEVMQSIRHRNLVKIITC 1236

Query: 238  CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
            CSN +FKALVLEYMP GSL+K++YS NY LD+ QRLNIMIDVASALEYLH    + ++HC
Sbjct: 1237 CSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCPSLVVHC 1296

Query: 298  DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 357
            DLKP+N+LLDD+MVAH+ DF IA+LLT E +SM QT+TL TIGYMAPEYG +G VST GD
Sbjct: 1297 DLKPNNILLDDDMVAHVGDFGIARLLT-ETESMQQTKTLGTIGYMAPEYGSDGIVSTKGD 1355

Query: 358  VYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKE 417
            V+S+GIMLME F  KKP +E+FNG++TLK WV + L  S +EVV ANLL +ED  F  K 
Sbjct: 1356 VFSYGIMLMEVFARKKPMDEMFNGDLTLKSWV-ESLADSMIEVVDANLLRREDEDFATKL 1414

Query: 418  QCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL 456
             C+S +  LA+ CT +SPE+RI+ +++V  L KI+  LL
Sbjct: 1415 SCLSSIMALALACTTDSPEERIDMKDVVVGLKKIKIELL 1453

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  508 bits (1307), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 252/455 (55%), Positives = 331/455 (72%), Gaps = 5/455 (1%)

Query: 2    IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
            IP+ IGGL++L  L L +NR +GPI  SF +L SL+F++LS+N L G IP SLE L YL+
Sbjct: 629  IPSNIGGLQDLTSLSLAHNRFEGPILHSFSNLKSLEFMDLSDNALFGEIPKSLEGLVYLK 688

Query: 62   NLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCKTSNHHTLWKNSLLLR 121
             L++SFN L GEIP  GPF NFS ESF  N+ LCGSP L++PPC+T    +   + LLL+
Sbjct: 689  YLDVSFNGLYGEIPPEGPFANFSAESFMMNKALCGSPRLKLPPCRTGTRWSTTISWLLLK 748

Query: 122  IVLP--LSAIFMIVVILLILRYRQKGKRPSNDANMPSIATWRTFSHLELCRATDGFSENN 179
             +LP  LS +  + +I +  R R++       +     ATWR  S+ E+ +AT+GFS  N
Sbjct: 749  YILPAILSTLLFLALIFVWTRCRKRNAVLPTQSESLLTATWRRISYQEIFQATNGFSAGN 808

Query: 180  LIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
            L+GRG  GSVY+  L DG   A+KVFNLQ   A K FD ECE+M  IRHRNLIK++S+CS
Sbjct: 809  LLGRGSLGSVYRGTLSDGKNAAIKVFNLQEEAAFKSFDAECEVMHHIRHRNLIKIVSSCS 868

Query: 240  NE--EFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
            N   +FKALVLEY+P+GSLE+++YS NY LDI QRLNIMIDVA A+EYLH G S P++HC
Sbjct: 869  NSYIDFKALVLEYVPNGSLERWLYSHNYCLDILQRLNIMIDVALAMEYLHHGCSTPVVHC 928

Query: 298  DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 357
            DLKPSN+LLD++   H+ DF IAKLL  E++S+ +TQTLATIGYMAP+Y   G V+T+GD
Sbjct: 929  DLKPSNILLDEDFGGHVGDFGIAKLLR-EEESIRETQTLATIGYMAPKYVSNGIVTTSGD 987

Query: 358  VYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKE 417
            VYS+GI+LMETFT ++PT+EIF+ EM++K+WV DWL  S  EVV ANLL  ED  F+AK+
Sbjct: 988  VYSYGIVLMETFTRRRPTDEIFSEEMSMKNWVWDWLCGSITEVVDANLLRGEDEQFMAKK 1047

Query: 418  QCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR 452
            QC+S +  LAM+C  +SPE+RI  +++V  L KI+
Sbjct: 1048 QCISLILGLAMDCVADSPEERIKMKDVVTTLKKIK 1082

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  503 bits (1295), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 245/462 (53%), Positives = 332/462 (71%), Gaps = 5/462 (1%)

Query: 2    IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
            IP  IGGL++L  L+L  N+LQGPIP S GD+ SL+FL+LS+NNLSG IP SL+ L YL+
Sbjct: 625  IPISIGGLQDLAQLYLSGNKLQGPIPQSVGDIKSLEFLDLSSNNLSGMIPKSLDNLLYLK 684

Query: 62   NLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCKTSNHHTLWK--NSLL 119
              N+SFN L+GEIP GG F NFS +SF GNE LCGS  LQV PCK  N        + ++
Sbjct: 685  YFNVSFNYLQGEIPEGGSFSNFSAQSFIGNEALCGSARLQVSPCKDDNSRATETPGSKIV 744

Query: 120  LRIVLP--LSAIFMIVVILLILRYRQKGKRPSNDANMPSIATWRTFSHLELCRATDGFSE 177
            LR VLP  + A+F++  ++++ RY ++  + S + +  ++ T R  S+ EL  AT+GF E
Sbjct: 745  LRYVLPAIVFAVFVLAFVIMLKRYCERKAKFSIEDDFLALTTIRRISYHELQLATNGFQE 804

Query: 178  NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
            +N +G G FGSVYK  L DG  +A KVFNLQ  RA K FD ECE+++++RHRNL+K+I++
Sbjct: 805  SNFLGMGSFGSVYKGTLSDGTVIAAKVFNLQLERAFKSFDTECEVLRNLRHRNLVKIITS 864

Query: 238  CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
            CS   FKALVLE+MP+ SLEK++YS +Y L+  QRLNIM+DVAS LEYLH GY+ P+ HC
Sbjct: 865  CSGPNFKALVLEFMPNWSLEKWLYSDDYFLNNLQRLNIMLDVASVLEYLHHGYTIPMAHC 924

Query: 298  DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 357
            D+KPSNVLL+++MVA L+DF I+KLL GE+ S+ QT TLATIGYMAPEYG EG VS  GD
Sbjct: 925  DIKPSNVLLNEDMVAFLADFGISKLL-GEEGSVMQTMTLATIGYMAPEYGSEGIVSVRGD 983

Query: 358  VYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKE 417
            VYS+G++LMETFT KKPT+++F  +++LK WV   L     +V+ ANLL  E+ H  AK+
Sbjct: 984  VYSYGVLLMETFTQKKPTDKMFTEQLSLKSWVEQSLSCEVTQVIDANLLGIEEDHLAAKK 1043

Query: 418  QCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNV 459
             C+  +  LA++C+ + P  RI+ + +V  L KI+   LR++
Sbjct: 1044 DCIVSILKLALQCSADLPHDRIDMKHVVTTLQKIKTKFLRDI 1085

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485453|ref|XP_003633276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  496 bits (1278), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 260/460 (56%), Positives = 337/460 (73%), Gaps = 13/460 (2%)

Query: 2    IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
            IP+ I  L+NL  L+L +N+LQG IP +FGDL+SL+ L+LS NNLSG IP SLE L YLE
Sbjct: 744  IPSTISLLQNLLQLYLSHNKLQGHIPPNFGDLVSLESLDLSGNNLSGTIPKSLEHLKYLE 803

Query: 62   NLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPC-KTSNHHTLWKNSLLL 120
             LN+SFNKL+GEIP GGPF NF+ ESF  N  LCG+P  QV  C K S  +T    SLLL
Sbjct: 804  YLNVSFNKLQGEIPNGGPFANFTAESFISNLALCGAPRFQVMACEKDSRKNT---KSLLL 860

Query: 121  RIVLPLS-AIFMIVVILLILRYRQKGKRPSN----DANMPSIATWRTFSHLELCRATDGF 175
            + ++PLS ++  I++++L ++++++  +       D ++P +   R   H EL  AT+ F
Sbjct: 861  KCIVPLSVSLSTIILVVLFVQWKRRQTKSETPIQVDLSLPRMH--RMIPHQELLYATNYF 918

Query: 176  SENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVI 235
             E+NLIG+G  G VYK  L DG+ VAVKVFNL+   A K F+VECE+M++IRHRNL K+I
Sbjct: 919  GEDNLIGKGSLGMVYKGVLSDGLIVAVKVFNLELQGAFKSFEVECEVMRNIRHRNLAKII 978

Query: 236  STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
            S+CSN +FKALVLEYMP+GSLEK++YS NY LD  QRL IMIDVAS LEYLH  YS P++
Sbjct: 979  SSCSNLDFKALVLEYMPNGSLEKWLYSHNYYLDFVQRLKIMIDVASGLEYLHHYYSNPVV 1038

Query: 296  HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 355
            HCDLKPSNVLLDD+MVAH+SDF IAKLL G  + M +T+TL T+GYMAPEYG EG VST 
Sbjct: 1039 HCDLKPSNVLLDDDMVAHISDFGIAKLLMG-SEFMKRTKTLGTVGYMAPEYGSEGIVSTK 1097

Query: 356  GDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVA 415
            GD+YS+GI+LMETF  KKPT+E+F  E+TLK WV      + MEV+ ANLL++ED  F  
Sbjct: 1098 GDIYSYGILLMETFVRKKPTDEMFVEELTLKSWVESSTN-NIMEVIDANLLTEEDESFAL 1156

Query: 416  KEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL 455
            K  C S +  LA++CTVE PE+RIN +++V +L K+ + +
Sbjct: 1157 KRACFSSIMTLALDCTVEPPEKRINTKDVVVRLKKLLNQI 1196

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485449|ref|XP_002276919.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  495 bits (1274), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 265/459 (57%), Positives = 336/459 (73%), Gaps = 9/459 (1%)

Query: 2    IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
            IP+ +G L+NL  L L  N LQGPIP  FGD++SL+ L+LS NNLSG IP SLE L YL+
Sbjct: 1129 IPSSVGQLQNLVELSLSKNNLQGPIPLKFGDVVSLESLDLSWNNLSGTIPQSLEALIYLK 1188

Query: 62   NLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCK-TSNHHTLWKNSLLL 120
            +LN+SFNK +GEI  GGPF NF+ +SF  NE LCG+P  QV  CK  +   +    SLLL
Sbjct: 1189 HLNVSFNKRQGEIRNGGPFVNFTAKSFISNEALCGAPRFQVMACKKVTTRKSTKAKSLLL 1248

Query: 121  RIVLPL--SAIFMIVVILLILRYRQKGKRPSN-DANMPSIATWRTFSHLELCRATDGFSE 177
            + VLP   S I ++ +I+L++R +++   P   D+++P+  T+R  SH EL  AT+ FSE
Sbjct: 1249 KCVLPTIASTIIILALIILLIRRQKRLDIPIQVDSSLPT--TYRKISHQELLHATNYFSE 1306

Query: 178  NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
             NLIG+G  G+VYK  L DG+  A+KVFNL+   + KGF+ ECE+M++IRHRNLIK+IS+
Sbjct: 1307 GNLIGKGSMGTVYKGVLFDGLTAAIKVFNLEFLGSFKGFEAECEVMRNIRHRNLIKIISS 1366

Query: 238  CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
            CSN  FKALVLE+MP+ SLE+++YS NY LD+ QRLNIMIDVASALEYLH  YS P++HC
Sbjct: 1367 CSNLGFKALVLEFMPNRSLERWLYSHNYCLDLIQRLNIMIDVASALEYLHHDYSNPVVHC 1426

Query: 298  DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 357
            DLKP+NVLLD++ VAH+ DF IAKLL G  +S  QT+TL  IGYMAPEYG EG VST+ D
Sbjct: 1427 DLKPNNVLLDEDRVAHVGDFGIAKLLPG-SESRQQTKTLGPIGYMAPEYGSEGIVSTS-D 1484

Query: 358  VYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKE 417
            VYS GIML+E F  KKPT+E+F G+ TLK WV + L  + ME V  NLL +ED HF  KE
Sbjct: 1485 VYSNGIMLLEVFARKKPTDEMFVGDPTLKSWV-ESLASTVMEFVDTNLLDKEDEHFAIKE 1543

Query: 418  QCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL 456
             CV C+  LA+ECT ESPE RIN R++VA+L KIR  LL
Sbjct: 1544 NCVLCIMALALECTAESPEDRINMRDVVARLKKIRIKLL 1582

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483677|ref|XP_003633000.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  493 bits (1270), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 256/459 (55%), Positives = 334/459 (72%), Gaps = 8/459 (1%)

Query: 2    IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
            IP ++G  +NL  L L  N+LQGPIP  FGDL+SL+ L+LS NNLSG IP SLE L YL+
Sbjct: 774  IPRKMGEQQNLAKLSLSQNKLQGPIPIEFGDLVSLESLDLSQNNLSGTIPKSLEALIYLK 833

Query: 62   NLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCKTSNHHTLWKN-SLLL 120
             LN+S NKL+GEIP GGPF NF+ ESF  NE LCG+P+ QV  C  +N    WK  S +L
Sbjct: 834  YLNVSLNKLQGEIPNGGPFINFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFIL 893

Query: 121  R-IVLPLSAIFMIVV-ILLILRYRQKGKRPSN-DANMPSIATWRTFSHLELCRATDGFSE 177
            + I+LP+ +I  +VV I+L +R R   + P+  D+ +P   T    SH +L  AT+ F E
Sbjct: 894  KYILLPVGSIVTLVVFIVLWIRRRDNMEIPTPIDSWLP--GTHEKISHQQLLYATNDFGE 951

Query: 178  NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
            +NLIG+G  G VYK  L +G+ VA+KVFNL+   AL+ FD ECE+M+ IRHRNL+++I+ 
Sbjct: 952  DNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITC 1011

Query: 238  CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
            CSN +FKALVLEYMP+GSLEK++YS NY LD+ QRLNIMIDVASALEYLH   S+ ++HC
Sbjct: 1012 CSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHC 1071

Query: 298  DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 357
            DLKP+NVLLDD+MVAH++DF I KLLT + +SM QT+TL TIGYMAPE+G +G VST  D
Sbjct: 1072 DLKPNNVLLDDDMVAHVADFGITKLLT-KTESMQQTKTLGTIGYMAPEHGSDGIVSTKSD 1130

Query: 358  VYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKE 417
            VYS+GI+LME F+ KKP +E+F G++TLK WV + L  S ++VV ANLL +ED     K 
Sbjct: 1131 VYSYGILLMEVFSRKKPMDEMFTGDLTLKTWV-ESLSNSVIQVVDANLLRREDEDLATKL 1189

Query: 418  QCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL 456
             C+S +  LA+ CT +SPE+R+N ++ V +L K R  LL
Sbjct: 1190 SCLSSIMALALACTTDSPEERLNMKDAVVELKKSRMKLL 1228

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483683|ref|XP_003633001.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  493 bits (1269), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 257/459 (55%), Positives = 334/459 (72%), Gaps = 8/459 (1%)

Query: 2    IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
            IP  +G L+NL  L L  N+LQG IP  FGDL+SL+ ++LS NNL G IP SLE L YL+
Sbjct: 773  IPRRMGELQNLVNLCLSQNKLQGSIPVEFGDLLSLESMDLSQNNLFGTIPKSLEALIYLK 832

Query: 62   NLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCKTSNHHTLWKN-SLLL 120
            +LN+SFNKL+GEIP GGPF NF+ ESF  NE LCG+P+ QV  C  +N    WK  S +L
Sbjct: 833  HLNVSFNKLQGEIPNGGPFVNFTAESFIFNEALCGAPHFQVIACDKNNRTQSWKTKSFIL 892

Query: 121  R-IVLPL-SAIFMIVVILLILRYRQKGKRPSN-DANMPSIATWRTFSHLELCRATDGFSE 177
            + I+LP+ SA+ ++  I+L +R R   + P+  D+ +P        S  +L  AT+GF E
Sbjct: 893  KYILLPVGSAVTLVAFIVLWIRRRDNTEIPAPIDSWLP--GAHEKISQQQLLYATNGFGE 950

Query: 178  NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
            +NLIG+G  G VYK  L +G+ VA+KVFNL+   AL+ FD ECE+M+ I HRNLI++I+ 
Sbjct: 951  DNLIGKGSLGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGICHRNLIRIITC 1010

Query: 238  CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
            CSN +FKALVLEYMP GSL+K++YS NY LD+FQRLNIMIDVASALEYLH   S+ ++HC
Sbjct: 1011 CSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLFQRLNIMIDVASALEYLHHDCSSLVVHC 1070

Query: 298  DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 357
            DLKPSNVLLD+NMVAH++DF IA+LLT E +SM QT+TL TIGYMAPEYG +G VST GD
Sbjct: 1071 DLKPSNVLLDNNMVAHVADFGIARLLT-ETESMQQTKTLGTIGYMAPEYGSDGIVSTKGD 1129

Query: 358  VYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKE 417
            VYS+GI+LME F  KKP +E+F G++TLK WV + L  S +EVV ANLL ++D     K 
Sbjct: 1130 VYSYGILLMEVFARKKPMDEMFTGDVTLKTWV-ESLSSSVIEVVDANLLRRDDEDLATKL 1188

Query: 418  QCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL 456
              +S +  LA+ CT +SPE+RIN +++V +L KI+  LL
Sbjct: 1189 SYLSSLMALALACTADSPEERINMKDVVVELKKIKIKLL 1227

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359497186|ref|XP_003635448.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  492 bits (1267), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 256/459 (55%), Positives = 334/459 (72%), Gaps = 8/459 (1%)

Query: 2    IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
            IP+++G L++L  L L  NRLQGPIP  FGDL+SL+ L+LS NNLSG IP SLE L YL+
Sbjct: 685  IPSKMGKLQSLITLSLSQNRLQGPIPIEFGDLVSLESLDLSQNNLSGTIPKSLEALIYLK 744

Query: 62   NLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCKTSNHHTLWKN-SLLL 120
             LN+S NKL+GEIP GGPF NF+ ESF  NE LCG+P+ QV  C  +N    WK  S +L
Sbjct: 745  YLNVSLNKLQGEIPNGGPFINFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFIL 804

Query: 121  R-IVLPLSAIFMIVV-ILLILRYRQKGKRPSN-DANMPSIATWRTFSHLELCRATDGFSE 177
            + I+LP+ +I  +VV I+L +R R   + P+  D+ +P   T    SH +L  AT+ F E
Sbjct: 805  KYILLPVGSIVTLVVFIVLWIRRRDNMEIPTPIDSWLP--GTHEKISHQQLLYATNDFGE 862

Query: 178  NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
            +NLIG+G  G VYK  L +G+ VA+KVFNL+   AL+ FD ECE+M+ IRHRNL+++I+ 
Sbjct: 863  DNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITC 922

Query: 238  CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
            CSN +FKALVLEYMP+GSLEK++YS NY LD+ QRLNIMIDVASALEYLH   S+ ++HC
Sbjct: 923  CSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHC 982

Query: 298  DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 357
            DLKP+NVLLDD+MVAH++DF I KLLT + +SM QT+TL TIGYMAPE+G +G VST  D
Sbjct: 983  DLKPNNVLLDDDMVAHVADFGITKLLT-KTESMQQTKTLGTIGYMAPEHGSDGIVSTKSD 1041

Query: 358  VYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKE 417
            VYS+GI+LME F+ KKP +E+F G +TLK WV + L  S ++VV ANLL +ED     K 
Sbjct: 1042 VYSYGILLMEVFSRKKPMDEMFTGGLTLKTWV-ESLSNSVIQVVDANLLRREDEDLATKL 1100

Query: 418  QCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL 456
             C+S +  LA+ CT  SPE+R+N ++ V +L K +  LL
Sbjct: 1101 SCLSSIMALALACTTNSPEKRLNMKDAVVELKKSKMKLL 1139

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	470
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.755	0.351	0.389	4.2e-76
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.757	0.352	0.386	1.3e-74
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.851	0.390	0.387	9.3e-71
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.678	0.311	0.411	2.9e-70
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.957	0.383	0.338	2.9e-66
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.948	0.455	0.343	7.6e-65
TAIR|locus:2175703	502	AT5G39390 [Arabidopsis thalian	0.806	0.754	0.375	1.1e-64
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.678	0.309	0.393	5.4e-63
TAIR|locus:2160791	1102	AT5G63930 [Arabidopsis thalian	0.6	0.255	0.342	4.1e-59
TAIR|locus:2092810	1164	BRL3 "BRI1-like 3" [Arabidopsi	0.576	0.232	0.372	8.3e-58

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 674 (242.3 bits), Expect = 4.2e-76, Sum P(2) = 4.2e-76
 Identities = 147/377 (38%), Positives = 223/377 (59%)

Query:   101 QVPPCKTSNHHTLWKNSLLLRIVLPLSAIFMIVVILLILRYRQKGKRPSNDANMPSIATW 160
             Q PP +T +   L K ++ + + + L  + + +V L   + R+  ++ +N A        
Sbjct:   628 QAPPVETRHPSLLKKVAIGVSVGIAL-LLLLFIVSLSWFKKRKNNQKINNSAPFTLEIFH 686

Query:   161 RTFSHLELCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVE 219
                S+ +L  ATDGFS +N++G G FG+V+KA L  +   VAVKV N+Q   A+K F  E
Sbjct:   687 EKLSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAE 746

Query:   220 CEMMKSIRHRNLIKVISTCSN-----EEFKALVLEYMPHGSLEKYMYSSNY--------I 266
             CE +K IRHRNL+K+++ C++      EF+AL+ E+MP+GSL+K+++             
Sbjct:   747 CESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVEEIHRPSRT 806

Query:   267 LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE 326
             L + +RLNI IDVAS L+YLH     PI HCDLKPSN+LLDD++ AH+SDF +A+LL   
Sbjct:   807 LTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDFGLARLLLKF 866

Query:   327 DQS-----MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNG 381
             DQ      ++      TIGY APEYG  G+ S +GDVYSFG++++E FTGK+PTNE+F G
Sbjct:   867 DQESFFNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLVLEMFTGKRPTNELFGG 926

Query:   382 EMTLKHWVNDWLPISTMEVVGANLL-SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRIN 440
               TL  +    LP   +++   ++L S   + F   E C+  + ++ + C  ESP  R+ 
Sbjct:   927 NFTLNSYTKAALPERVLDIADKSILHSGLRVGFPVLE-CLKGILDVGLRCCEESPLNRLA 985

Query:   441 AREIVAKLLKIRDSLLR 457
               E   +L+ IR+   +
Sbjct:   986 TSEAAKELISIRERFFK 1002

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 654 (235.3 bits), Expect = 1.3e-74, Sum P(2) = 1.3e-74
 Identities = 146/378 (38%), Positives = 223/378 (58%)

Query:   101 QVPPCKTSNHHTLWKNSLLLRIVLPLSAIFMIV-VILLILRYRQKGKRPSNDANMPSIAT 159
             Q PP +T +   L K ++L+ I + L  + +I  ++L   R R+K ++ +N         
Sbjct:   628 QEPPVETKHSSHLKKVAILVSIGIALLLLLVIASMVLCWFRKRRKNQQTNNLVPSKLEIF 687

Query:   160 WRTFSHLELCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDV 218
                 S+ +L  AT+GFS +N++G G FG+V+KA L  +   VAVKV N+Q   A+K F  
Sbjct:   688 HEKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFMA 747

Query:   219 ECEMMKSIRHRNLIKVISTCSN-----EEFKALVLEYMPHGSLEKYMYSSNY-------- 265
             ECE +K  RHRNL+K+++ C++      EF+AL+ EY+P+GS++ +++            
Sbjct:   748 ECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLHPEEVEEIRRPPR 807

Query:   266 ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG 325
              L + +RLNI+IDVAS L+YLH     PI HCDLKPSNVLL+D++ AH+SDF +A+LL  
Sbjct:   808 TLTLLERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLLEDDLTAHVSDFGLARLLLK 867

Query:   326 EDQS--MTQTQTLA---TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFN 380
              D+   + Q  +     TIGY APEYG  G+ S +GDVYSFG++L+E FTGK+PT+E+F 
Sbjct:   868 FDKESFLNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLLLEMFTGKRPTDELFG 927

Query:   381 GEMTLKHWVNDWLPISTMEVVGANLLSQE-DIHFVAKEQCVSCVFNLAMECTVESPEQRI 439
             G +TL  +    LP    E+    +L     + F   E C++ V  + + C  E P  R+
Sbjct:   928 GNLTLHSYTKLALPEKVFEIADKAILHIGLRVGFRTAE-CLTLVLEVGLRCCEEYPTNRL 986

Query:   440 NAREIVAKLLKIRDSLLR 457
                E+  +L+ IR+   +
Sbjct:   987 ATSEVAKELISIRERFFK 1004

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 718 (257.8 bits), Expect = 9.3e-71, P = 9.3e-71
 Identities = 164/423 (38%), Positives = 248/423 (58%)

Query:     2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLIXXXXXXXXXXXXXGAIPASLEKLSYLE 61
             IP  +G  + L YL+L  N L G IP + G L              G IP SL  ++ L 
Sbjct:   537 IPNTLGDCQLLRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLADITMLH 596

Query:    62 NLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGS-PNLQVPPCKTSNHHTLWKNSLLL 120
             +LNLSFN   GE+P  G F   S  S +GN  LCG  P+L +P C     +   K+  +L
Sbjct:   597 SLNLSFNSFVGEVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRCCPLLENR--KHFPVL 654

Query:   121 RIVLPLSAIFMIVVIL-LILRYRQKGKRPSNDANMPSIATWRTFSHLELCRATDGFSENN 179
              I + L+A   I+  L L++ + ++ K+ +   +  S+      S+ +L +ATDGF+  N
Sbjct:   655 PISVSLAAALAILSSLYLLITWHKRTKKGA--PSRTSMKGHPLVSYSQLVKATDGFAPTN 712

Query:   180 LIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
             L+G G FGSVYK +L     VAVKV  L+  +ALK F  ECE ++++RHRNL+K+++ CS
Sbjct:   713 LLGSGSFGSVYKGKLNIQDHVAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICS 772

Query:   240 N-----EEFKALVLEYMPHGSLEKYMY------SSNYILDIFQRLNIMIDVASALEYLHF 288
             +      +FKA+V ++MP+GSLE +++      +    L++ +R+ I++DVA AL+YLH 
Sbjct:   773 SIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLHR 832

Query:   289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-----LATIGYMA 343
                 P++HCD+K SNVLLD +MVAH+ DF +A++L  +  S+ Q  T     + TIGY A
Sbjct:   833 HGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARILV-DGTSLIQQSTSSMGFIGTIGYAA 891

Query:   344 PEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA 403
             PEYG     ST+GD+YS+GI+++E  TGK+PT+  F  ++ L+ +V   L     +VV  
Sbjct:   892 PEYGVGLIASTHGDIYSYGILVLEIVTGKRPTDSTFRPDLGLRQYVELGLHGRVTDVVDT 951

Query:   404 NLL 406
              L+
Sbjct:   952 KLI 954

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 619 (223.0 bits), Expect = 2.9e-70, Sum P(2) = 2.9e-70
 Identities = 141/343 (41%), Positives = 202/343 (58%)

Query:   139 LRYRQ-KGKRPSNDANMPSIAT-WRTFSHLELCRATDGFSENNLIGRGGFGSVYKARLGD 196
             LR +  +     ND +   + + +   S+ EL + T GFS +NLIG G FG+V+K  LG 
Sbjct:   681 LRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGS 740

Query:   197 -GMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCSNEEF-----KALVLE 249
                 VA+KV NL C R A K F  ECE +  IRHRNL+K+++ CS+ +F     +ALV E
Sbjct:   741 KNKAVAIKVLNL-CKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYE 799

Query:   250 YMPHGSLEKYMY--------SSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKP 301
             +MP+G+L+ +++        + +  L +F RLNI IDVASAL YLH     PI HCD+KP
Sbjct:   800 FMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKP 859

Query:   302 SNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ-----TLATIGYMAPEYGREGRVSTNG 356
             SN+LLD ++ AH+SDF +A+LL   D+     Q        TIGY APEYG  G  S  G
Sbjct:   860 SNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMG 919

Query:   357 DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPI-STMEVVGANLLSQEDIHFVA 415
             DVYSFGI+L+E FTGK+PTN++F   +TL  +    L     +++    +L         
Sbjct:   920 DVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFN 979

Query:   416 KEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRN 458
               +C++ VF + + C+ ESP  RI+  E ++KL+ IR+S  R+
Sbjct:   980 MVECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIRESFFRD 1022

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 682 (245.1 bits), Expect = 2.9e-66, P = 2.9e-66
 Identities = 159/470 (33%), Positives = 263/470 (55%)

Query:     2 IPTEI-GGLKNLEYLFLGYNRLQGPIPDSFGDLIXXXXXXXXXXXXXGAIPASLEKLSYL 60
             IP E+  G+  +  L L  N   G IP SFG++              G IP SL  LS L
Sbjct:   689 IPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTL 748

Query:    61 ENLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPC--KTSNHHTLWKNSL 118
             ++L L+ N L+G +P  G F+N +     GN  LCGS    + PC  K  + H   +  +
Sbjct:   749 KHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKK-PLKPCTIKQKSSHFSKRTRV 807

Query:   119 LLRIVLPLSAIFMIVVILLIL---RYRQKGKRPSNDANMPSIAT---WRTFSHLELCRAT 172
             +L I+   +A+ ++++++LIL   + ++K    S+++++P + +    + F   EL +AT
Sbjct:   808 ILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQAT 867

Query:   173 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRN 230
             D F+  N+IG     +VYK +L DG  +AVKV NL+     + K F  E + +  ++HRN
Sbjct:   868 DSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRN 927

Query:   231 LIKVISTC-SNEEFKALVLEYMPHGSLEKYMYSSNY-ILDIFQRLNIMIDVASALEYLHF 288
             L+K++     + + KALVL +M +G+LE  ++ S   I  + +++++ + +AS ++YLH 
Sbjct:   928 LVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHS 987

Query:   289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA---TIGYMAPE 345
             GY  PI+HCDLKP+N+LLD + VAH+SDF  A++L   +   T   T A   TIGY+APE
Sbjct:   988 GYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPE 1047

Query:   346 YGREGRVSTNGDVYSFGIMLMETFTGKKPT--NEIFNGEMTLKHWVNDWLPISTMEVVGA 403
             +    +V+T  DV+SFGI++ME  T ++PT  N+  + +MTL+  V   +      +V  
Sbjct:  1048 FAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRV 1107

Query:   404 -NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR 452
              ++   + I  + +E+ +     L + CT   PE R +  EI+  L+K+R
Sbjct:  1108 LDMELGDSIVSLKQEEAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLR 1157

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 664 (238.8 bits), Expect = 7.6e-65, P = 7.6e-65
 Identities = 167/486 (34%), Positives = 262/486 (53%)

Query:     2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLIXXXXXXXXXXXXXGAIPASLEKLSYLE 61
             IP ++G    LE+L L  N     +P S G L              GAIP S ++ S L+
Sbjct:   483 IPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLK 542

Query:    62 NLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGS-PNLQVPPCKTSNHHTLWKNSLLL 120
             +LN SFN L G +   G F   ++ESF G+ LLCGS   +Q   CK  + +     S+LL
Sbjct:   543 HLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQA--CKKKHKYP----SVLL 596

Query:   121 RIVLPLSAIFMIVVILLILRYRQK-GKR---------PSNDANMPSIATWRTFSHLELCR 170
              ++L L A  ++ V    L  R + GK             +    +   +   S+ +L  
Sbjct:   597 PVLLSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRISYQQLIA 656

Query:   171 ATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKG-FDVECEMMKSIRHR 229
             AT GF+ ++LIG G FG VYK  L +  +VAVKV + +      G F  EC+++K  RHR
Sbjct:   657 ATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHR 716

Query:   230 NLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYI---LDIFQRLNIMIDVASALEYL 286
             NLI++I+TCS   F ALVL  MP+GSLE+++Y   Y    LD+ Q +NI  DVA  + YL
Sbjct:   717 NLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYL 776

Query:   287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA--------- 337
             H      ++HCDLKPSN+LLDD M A ++DF I++L+ G +++++   +++         
Sbjct:   777 HHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLC 836

Query:   338 -TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS 396
              ++GY+APEYG   R ST+GDVYSFG++L+E  +G++PT+ + N   +L  ++    P S
Sbjct:   837 GSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDS 896

Query:   397 TMEVVGANLLSQ-------EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLL 449
              +E +    LS+       E    + +E  +  +  L + CT  +P  R +  ++  ++ 
Sbjct:   897 -LEGIIEQALSRWKPQGKPEKCEKLWREVILEMI-ELGLVCTQYNPSTRPDMLDVAHEMG 954

Query:   450 KIRDSL 455
             ++++ L
Sbjct:   955 RLKEYL 960

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2175703 AT5G39390 [Arabidopsis thaliana (taxid:3702)]

 Score = 629 (226.5 bits), Expect = 1.1e-64, Sum P(2) = 1.1e-64
 Identities = 163/434 (37%), Positives = 234/434 (53%)

Query:    48 GAIPASLEKLSYLENLNLSFN--------KLEGEIPRGGPFRNFSVESFEGNELLCGSP- 98
             G+I  S+  LS+L +LNL  N        + EG +P  G F+N +  S  GNE LCG   
Sbjct:    87 GSISPSIGNLSFLRSLNLGDNSFQSNIPQEFEGSVPTKGVFQNGTTVSVFGNENLCGGVI 146

Query:    99 NLQVPPC-KTSNHHTLWKNSLLLRIVLPLSAIFMIVVILLILRYRQKGKRPSNDANMPSI 157
              +Q+ PC ++      +     + + + ++ +F+ +++  +  +++K     ND      
Sbjct:   147 EMQLKPCIESPRQKKPFSLGEKVAVGVGVALLFLFIIVASLSWFKKK-----NDK----- 196

Query:   158 ATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGF 216
                   S+ EL  AT GFS +NLIG G F  V+K  LG +   VAVKV NL    A K F
Sbjct:   197 -----ISYEELYNATSGFSSSNLIGSGNFSDVFKGLLGLEEKLVAVKVLNLLKHGATKSF 251

Query:   217 DVECEMMKSIRHRNLIKVISTCSN-----EEFKALVLEYMPHGSLEKYMY------SSNY 265
               ECE  K IRHRNL K+I+ CS+      +F+ALV E+MP GSL+ ++       ++N+
Sbjct:   252 IAECESFKGIRHRNLAKLITVCSSLDSQGNDFRALVYEFMPKGSLDMWLQPEDLESANNH 311

Query:   266 I--LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 323
                L   +++NI IDVASALEYLH     P+ HCD+KPSNVLLDD++ AH+SDF +A+LL
Sbjct:   312 SRSLTFAEKVNIAIDVASALEYLHVYCHDPVAHCDIKPSNVLLDDDLTAHVSDFGLARLL 371

Query:   324 TGEDQSMTQTQ-----TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEI 378
                D+     Q        TIGY APEYG   + S  GDVYSFG++L+E FTGKKPT+  
Sbjct:   372 YNFDEKTFLNQFSSAGVRGTIGYAAPEYGMGSKPSIQGDVYSFGVLLLEMFTGKKPTDNS 431

Query:   379 FNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQR 438
             F G   L  +    L  ST    G   +  E +  V +         + ++C+ E P  R
Sbjct:   432 FGGGYNLHGYTKSVLSCSTSR--GGRTMVDEWLRLVLE---------VGIKCSEEYPRDR 480

Query:   439 INAREIVAKLLKIR 452
             +   E V +L+ I+
Sbjct:   481 MGMAEAVRELVSIK 494

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 564 (203.6 bits), Expect = 5.4e-63, Sum P(2) = 5.4e-63
 Identities = 138/351 (39%), Positives = 196/351 (55%)

Query:   123 VLPLSAIFMIVVILLILRYRQKGKRPS-NDANMPSIATWRT-FSHLELCRATDGFSENNL 180
             +  L  I ++  +   ++ ++K      N ++  ++  +    S+ EL  AT  FS  NL
Sbjct:   658 IASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNL 717

Query:   181 IGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
             IG G FG+V+K  LG +   VAVKV NL    A K F  ECE  K IRHRNL+K+I+ CS
Sbjct:   718 IGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCS 777

Query:   240 N-----EEFKALVLEYMPHGSLEKYMYSSNY--------ILDIFQRLNIMIDVASALEYL 286
             +      +F+ALV E+MP GSL+ ++   +          L   ++LNI IDVASALEYL
Sbjct:   778 SLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYL 837

Query:   287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ-----TLATIGY 341
             H     P+ HCD+KPSN+LLDD++ AH+SDF +A+LL   D+     Q        TIGY
Sbjct:   838 HVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGY 897

Query:   342 MAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVV 401
              APEYG  G+ S  GDVYSFGI+L+E F+GKKPT+E F G+  L  +    L   T    
Sbjct:   898 AAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKSILSGCTSSG- 956

Query:   402 GANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR 452
             G+N +          ++ +  V  + ++C+ E P  R+   E V +L+ IR
Sbjct:   957 GSNAI----------DEGLRLVLQVGIKCSEEYPRDRMRTDEAVRELISIR 997

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)]

 Score = 415 (151.1 bits), Expect = 4.1e-59, Sum P(2) = 4.1e-59
 Identities = 101/295 (34%), Positives = 158/295 (53%)

Query:   163 FSHLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVF--NLQCGR---ALKGFD 217
             F+  +L  ATD F E+ ++GRG  G+VYKA L  G  +AVK    N + G        F 
Sbjct:   792 FTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFR 851

Query:   218 VECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMI 277
              E   + +IRHRN++K+   C+++    L+ EYMP GSL + ++  +  LD  +R  I +
Sbjct:   852 AEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPSCNLDWSKRFKIAL 911

Query:   278 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA 337
               A  L YLH      I H D+K +N+LLDD   AH+ DF +AK++     S + +    
Sbjct:   912 GAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID-MPHSKSMSAIAG 970

Query:   338 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIST 397
             + GY+APEY    +V+   D+YS+G++L+E  TGK P   I  G   + +WV  ++    
Sbjct:   971 SYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVV-NWVRSYIRRDA 1029

Query:   398 ME--VVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK 450
             +   V+ A L + ED   V+    +  V  +A+ CT  SP  R + R++V  L++
Sbjct:  1030 LSSGVLDARL-TLEDERIVSH---MLTVLKIALLCTSVSPVARPSMRQVVLMLIE 1080

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2092810 BRL3 "BRI1-like 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 437 (158.9 bits), Expect = 8.3e-58, Sum P(2) = 8.3e-58
 Identities = 105/282 (37%), Positives = 153/282 (54%)

Query:   162 TFSHLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECE 221
             TF+HL    AT+GFS +++IG GGFG VYKA+L DG  VA+K      G+  + F  E E
Sbjct:   847 TFAHL--LEATNGFSADSMIGSGGFGDVYKAKLADGSVVAIKKLIQVTGQGDREFMAEME 904

Query:   222 MMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSN----YILDIFQRLNIMI 277
              +  I+HRNL+ ++  C   E + LV EYM +GSLE  ++         LD   R  I I
Sbjct:   905 TIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHEKTKKGGIFLDWSARKKIAI 964

Query:   278 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA 337
               A  L +LH      IIH D+K SNVLLD + VA +SDF +A+L++  D  ++ +    
Sbjct:   965 GAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMARLVSALDTHLSVSTLAG 1024

Query:   338 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTN-EIFNGEMTLKHWVNDWLPIS 396
             T GY+ PEY +  R +  GDVYS+G++L+E  +GKKP + E F  +  L  W        
Sbjct:  1025 TPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPEEFGEDNNLVGWAKQLY--- 1081

Query:   397 TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQR 438
               E  GA +L  E +   + +  +     +A +C  + P +R
Sbjct:  1082 -REKRGAEILDPELVTDKSGDVELLHYLKIASQCLDDRPFKR 1122

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006888 "ER to Golgi vesicle-mediated transport" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0043090 "amino acid import" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	470
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-49
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-47
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-47
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-45
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	7e-44
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-43
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	8e-41
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-40
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-39
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-32
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-32
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-30
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	8e-30
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	9e-30
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-29
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-29
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-27
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-27
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-27
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	7e-27
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-26
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-26
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-26
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-26
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-25
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-25
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-24
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-24
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-24
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	8e-24
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	9e-24
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-23
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-23
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-23
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-23
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	9e-23
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-22
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-22
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-22
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	9e-22
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-22
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-21
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-21
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-21
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	5e-21
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-21
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-20
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-20
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-20
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-20
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-20
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-20
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-20
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-20
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-20
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-20
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-20
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	7e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-19
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-19
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-19
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-19
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-19
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-19
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-18
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-18
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-18
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-18
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-18
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-18
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-18
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-18
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-18
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	7e-18
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	8e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	8e-18
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-17
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-17
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-17
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-17
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-17
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-17
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-17
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-17
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-17
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-17
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-17
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	9e-17
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-16
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-16
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-16
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-16
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-16
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-16
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-16
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-16
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-16
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	9e-16
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-15
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-15
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-15
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-15
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-15
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-15
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-15
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	8e-15
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	8e-15
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	8e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-15
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-14
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-14
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-14
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-14
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-14
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-14
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-14
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-14
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	9e-14
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	9e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-13
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-13
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-13
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-13
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-13
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	7e-13
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	8e-13
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	8e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	8e-13
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	9e-13
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	9e-13
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-12
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-12
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-12
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-12
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-12
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-12
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-12
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-12
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-12
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-12
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-12
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	6e-12
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-12
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-12
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-12
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	7e-12
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	8e-12
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-11
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-11
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-11
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-11
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-11
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-11
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-11
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-11
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-11
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-11
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-11
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	6e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-11
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-11
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	9e-11
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-10
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-10
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	5e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-10
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-10
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	7e-10
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	7e-10
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	7e-10
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	7e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-09
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-09
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-09
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-09
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-09
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-09
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-09
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	6e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	8e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-08
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-08
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-08
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-08
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	5e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-08
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	6e-08
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-08
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	8e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	9e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	9e-08
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	9e-08
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-07
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-07
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	4e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-07
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	5e-07
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-07
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-07
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	9e-07
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	9e-07
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-06
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-06
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-06
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	4e-06
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	5e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	6e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	8e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	8e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-05
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-05
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-05
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	5e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	5e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-05
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	8e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	8e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	8e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	9e-05
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-04
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-04
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-04
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	5e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-04
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	6e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.001
pfam12799	43	pfam12799, LRR_4, Leucine Rich repeats (2 copies)	0.002
pfam12799	43	pfam12799, LRR_4, Leucine Rich repeats (2 copies)	0.002
COG2334	331	COG2334, COG2334, Putative homoserine kinase type	0.003
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  166 bits (422), Expect = 7e-49
 Identities = 70/191 (36%), Positives = 103/191 (53%), Gaps = 9/191 (4%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQ-CGRALKGFDVECEMMKSIRHRNLIKVISTC 238
           +G GGFG+VY AR    G +VA+K+   +     L+    E E++K + H N++K+    
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 239 SNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            +E    LV+EY   GSL+  +  +   L   + L I++ +   LEYLH   S  IIH D
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117

Query: 299 LKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR-EGRVSTNG 356
           LKP N+LLD DN    L+DF ++KLLT +   +       T  YMAPE    +G  S   
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV--GTPAYMAPEVLLGKGYYSEKS 175

Query: 357 DVYSFGIMLME 367
           D++S G++L E
Sbjct: 176 DIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  163 bits (414), Expect = 4e-47
 Identities = 76/270 (28%), Positives = 117/270 (43%), Gaps = 26/270 (9%)

Query: 179 NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ-CGRALKGFDVECEMMKSIRHRNLIKVIS 236
             +G G FG VY AR    G  VA+KV   +   +  +    E +++K ++H N++++  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
              +E+   LV+EY   G L   +      L   +    +  + SALEYLH   S  I+H
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEARFYLRQILSALEYLH---SKGIVH 120

Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 356
            DLKP N+LLD++    L+DF +A+ L   ++  T   T     YMAPE           
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPE---YMAPEVLLGKGYGKAV 177

Query: 357 DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAK 416
           D++S G++L E  TGK P    F G+  L                    +S E    + K
Sbjct: 178 DIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRK 233

Query: 417 EQCVSCVFNLAMECTVESPEQRINAREIVA 446
                          V+ PE+R+ A E + 
Sbjct: 234 -------------LLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  162 bits (413), Expect = 5e-47
 Identities = 82/279 (29%), Positives = 122/279 (43%), Gaps = 44/279 (15%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV----ECEMMKSIRHRNLIKVI 235
           +G G FG+VYKA+  G G  VAVK+   +        D     E  +++ + H N++++I
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKR--SEKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
               +++   LV+EY   G L  Y+      L   +   I + +   LEYLH   S  II
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDLFDYLSRGG-PLSEDEAKKIALQILRGLEYLH---SNGII 120

Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGR-VST 354
           H DLKP N+LLD+N V  ++DF +AK L     S+T T    T  YMAPE    G     
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLT-TFV-GTPWYMAPEVLLGGNGYGP 178

Query: 355 NGDVYSFGIMLMETFTGKKP--------TNEIFNGEMTLKHWVNDWLPISTMEVVGANLL 406
             DV+S G++L E  TGK P          ++    +      ++    S          
Sbjct: 179 KVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSS---------G 229

Query: 407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIV 445
           S+E    + K             C  + P +R  A EI+
Sbjct: 230 SEEAKDLIKK-------------CLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  158 bits (403), Expect = 2e-45
 Identities = 80/278 (28%), Positives = 131/278 (47%), Gaps = 31/278 (11%)

Query: 178 NNLIGRGGFGSVYKARLGD-----GMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNL 231
              +G G FG VYK +L        +EVAVK          ++ F  E  +M+ + H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 232 IKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
           +K++  C+ EE   +V+EYM  G L  Y+  +   L +   L+  + +A  +EYL    S
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---S 120

Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGR 351
              IH DL   N L+ +N+V  +SDF +++ L  +D    +      I +MAPE  +EG+
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYRKRGGKLPIRWMAPESLKEGK 179

Query: 352 VSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED 410
            ++  DV+SFG++L E FT G++P        M+ +  +          +     L Q  
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQP-----YPGMSNEEVLEY--------LKNGYRLPQP- 225

Query: 411 IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
                   C   +++L ++C  E PE R    E+V  L
Sbjct: 226 ------PNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  154 bits (392), Expect = 7e-44
 Identities = 76/282 (26%), Positives = 126/282 (44%), Gaps = 44/282 (15%)

Query: 181 IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKV 234
           +G G FG VYK  L     G   +VAVK           + F  E  +MK + H N++++
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI 294
           +  C+  E   +V EYMP G L  ++      L +   L + + +A  +EYL    S   
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNF 123

Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVST 354
           +H DL   N L+ +N+V  +SDF +++ +  +D    +      I +MAPE  ++G+ ++
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTS 183

Query: 355 NGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF 413
             DV+SFG++L E FT G++P                 +  +S  EV          +  
Sbjct: 184 KSDVWSFGVLLWEIFTLGEQP-----------------YPGMSNEEV----------LEL 216

Query: 414 VAK-------EQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
           +         E C   ++ L ++C    PE R    E+V  L
Sbjct: 217 LEDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  153 bits (389), Expect = 2e-43
 Identities = 80/279 (28%), Positives = 129/279 (46%), Gaps = 32/279 (11%)

Query: 178 NNLIGRGGFGSVYKARLGDG-----MEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNL 231
              +G G FG VYK  L        +EVAVK        + ++ F  E  +M+ + H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 232 IKVISTCSNEEFKALVLEYMPHGSLEKYM-YSSNYILDIFQRLNIMIDVASALEYLHFGY 290
           +K++  C+ EE   +V+EYMP G L  Y+  +    L +   L+  + +A  +EYL    
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--- 120

Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 350
           S   IH DL   N L+ +N+V  +SDF +++ L  +D           I +MAPE  +EG
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYKVKGGKLPIRWMAPESLKEG 179

Query: 351 RVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
           + ++  DV+SFG++L E FT G++P        M+    +          +     L + 
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEP-----YPGMSNAEVLEY--------LKKGYRLPKP 226

Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
                    C   ++ L ++C  E PE R    E+V  L
Sbjct: 227 -------PNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  146 bits (371), Expect = 8e-41
 Identities = 83/292 (28%), Positives = 129/292 (44%), Gaps = 53/292 (18%)

Query: 179 NLIGRGGFGSVYKARL----GDGMEVAVKVFNLQCGRALKGFDV---------ECEMMKS 225
             +G G FG VYK +L    G   EVAVK         LK             E  +MK 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT--------LKEDASEEERKDFLKEARVMKK 52

Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYM--------YSSNYILDIFQRLNIMI 277
           + H N+++++  C+ EE   LVLEYM  G L  Y+              L +   L+  I
Sbjct: 53  LGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112

Query: 278 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA 337
            +A  +EYL    S   +H DL   N L+ +++V  +SDF +++ +  +D    +T    
Sbjct: 113 QIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKL 169

Query: 338 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPIS 396
            I +MAPE  ++G  ++  DV+SFG++L E FT G  P   + N E+ L++         
Sbjct: 170 PIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV-LEY--------- 219

Query: 397 TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
              +     L +        E C   ++ L + C    PE R    E+V +L
Sbjct: 220 ---LRKGYRLPK-------PEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  153 bits (387), Expect = 7e-40
 Identities = 128/474 (27%), Positives = 204/474 (43%), Gaps = 65/474 (13%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
            IP E+   K L  L L +N+L G IP SF ++  L  L+LS N LSG IP +L  +  L
Sbjct: 514 EIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESL 573

Query: 61  ENLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQ-VPPCKTSNHHTLW----K 115
             +N+S N L G +P  G F   +  +  GN  LCG      +PPCK       W     
Sbjct: 574 VQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYIT 633

Query: 116 NSLLLRIVLPLSAIFMIVVILLILRYRQKGKRPSNDANMPSIATWRT-FSHLELCRAT-- 172
            +L   +VL L A      + +  R   + KR  N+       TW   F   ++ ++   
Sbjct: 634 CTLGAFLVLALVAF---GFVFIRGRNNLELKRVENED-----GTWELQFFDSKVSKSITI 685

Query: 173 ----DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEM----M 223
                   E N+I RG  G+ YK + + +GM+  VK         +   +         M
Sbjct: 686 NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVK--------EINDVNSIPSSEIADM 737

Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
             ++H N++K+I  C +E+   L+ EY+   +L + + +    L   +R  I I +A AL
Sbjct: 738 GKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKAL 793

Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
            +LH   S  ++  +L P  +++D     HL   S+  LL       T T+   +  Y+A
Sbjct: 794 RFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC------TDTKCFISSAYVA 846

Query: 344 PEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW---------VNDWLP 394
           PE      ++   D+Y FG++L+E  TGK P +  F    ++  W         ++ W  
Sbjct: 847 PETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMW-- 904

Query: 395 ISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
           I        ++   E +           V NLA+ CT   P  R  A +++  L
Sbjct: 905 IDPSIRGDVSVNQNEIVE----------VMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  141 bits (359), Expect = 4e-39
 Identities = 81/291 (27%), Positives = 124/291 (42%), Gaps = 59/291 (20%)

Query: 179 NLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRA--LKGFDVECEMMKSIRHRNLIKVI 235
            L+GRG FGSVY A   D G  +AVK   L       L+  + E  ++ S++H N+++  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 236 STCSNEEFKAL--VLEYMPHGSLEKYMYSSNYILDIFQRLNI------MIDVASALEYLH 287
            +  +EE   L   LEY+  GSL   +         F +L           +   L YLH
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKK-------FGKLPEPVIRKYTRQILEGLAYLH 118

Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYG 347
              S  I+H D+K +N+L+D + V  L+DF  AK L   +          T  +MAPE  
Sbjct: 119 ---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175

Query: 348 REGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN--- 404
           R        D++S G  ++E  TGK P +E+ N             P++ +  +G++   
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-------------PMAALYKIGSSGEP 222

Query: 405 -----LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK 450
                 LS+E   F+ K             C    P++R  A E    LL+
Sbjct: 223 PEIPEHLSEEAKDFLRK-------------CLRRDPKKRPTADE----LLQ 256

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  127 bits (318), Expect = 2e-32
 Identities = 85/296 (28%), Positives = 127/296 (42%), Gaps = 33/296 (11%)

Query: 180 LIGRGGFGSVYKARLGDGMEVAVKVFNLQ---CGRALKGFDVECEMMKSIRH-RNLIKVI 235
            +G G FG VY AR  D   VA+KV   +     + ++ F  E +++ S+ H  N++K+ 
Sbjct: 7   KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 236 STCSNEEFKALVLEYMPHGSLEKYM--YSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
               +E    LV+EY+  GSLE  +        L   + L I+  + SALEYLH   S  
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121

Query: 294 IIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLA----TIGYMAPEY-- 346
           IIH D+KP N+LLD D  V  L DF +AKLL     + +     +    T GYMAPE   
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 347 -GREGRVSTNGDVYSFGIMLMETFTGKKP---TNEIFNGEMTLKHWVNDWLPISTMEVVG 402
                  S++ D++S GI L E  TG  P            TLK  +    P        
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-------- 233

Query: 403 ANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRN 458
                   +     E       +L  +   + P+ R+++   ++  L     L  +
Sbjct: 234 ---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKES 286

Length = 384

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  123 bits (311), Expect = 4e-32
 Identities = 82/301 (27%), Positives = 128/301 (42%), Gaps = 64/301 (21%)

Query: 181 IGRGGFGSVYKARL------GDGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIK 233
           +G G FG V+           D   VAVK         A K F+ E E++ + +H N++K
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSN-------------YILDIFQRLNIMIDVA 280
               C+  +   +V EYM HG L K++ S                 L + Q L I + +A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 281 SALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA 337
           S + YL   HF      +H DL   N L+  ++V  + DF +++ +   D       T+ 
Sbjct: 133 SGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186

Query: 338 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPIS 396
            I +M PE     + +T  DV+SFG++L E FT GK+P                 W  +S
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP-----------------WYGLS 229

Query: 397 TMEVVGANLLSQEDIHFVAK-------EQCVSCVFNLAMECTVESPEQRINAREIVAKLL 449
             EV          I  + +         C S V+++ + C    P+QRIN ++I  +L 
Sbjct: 230 NEEV----------IECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279

Query: 450 K 450
           K
Sbjct: 280 K 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  117 bits (295), Expect = 4e-30
 Identities = 64/195 (32%), Positives = 98/195 (50%), Gaps = 7/195 (3%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           IG+GGFG VYKAR    G EVA+KV  L+     +    E +++K  +H N++K   +  
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
            ++   +V+E+   GSL+  + S+N  L   Q   +  ++   LEYLH   S  IIH D+
Sbjct: 68  KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDI 124

Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVY 359
           K +N+LL  +    L DF ++  L+      T    + T  +MAPE           D++
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQLSDTKARNT---MVGTPYWMAPEVINGKPYDYKADIW 181

Query: 360 SFGIMLMETFTGKKP 374
           S GI  +E   GK P
Sbjct: 182 SLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  116 bits (292), Expect = 8e-30
 Identities = 83/274 (30%), Positives = 130/274 (47%), Gaps = 38/274 (13%)

Query: 180 LIGRGGFGSVYKARLGD--GMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVIS 236
            IG+G FG V    LGD  G +VAVK   L+    A + F  E  +M ++RH NL++++ 
Sbjct: 13  TIGKGEFGDVM---LGDYRGQKVAVK--CLKDDSTAAQAFLAEASVMTTLRHPNLVQLLG 67

Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYS-SNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
                    +V EYM  GSL  Y+ S    ++ + Q+L   +DV   +EYL        +
Sbjct: 68  VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFV 124

Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 355
           H DL   NVL+ +++VA +SDF +AK     + S  Q      + + APE  RE + ST 
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFSTK 179

Query: 356 GDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFV 414
            DV+SFGI+L E ++ G+ P   I   ++ + H    +     ME               
Sbjct: 180 SDVWSFGILLWEIYSFGRVPYPRIPLKDV-VPHVEKGY----RME--------------- 219

Query: 415 AKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
           A E C   V+ +  +C    P +R   +++  +L
Sbjct: 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  116 bits (292), Expect = 9e-30
 Identities = 66/193 (34%), Positives = 101/193 (52%), Gaps = 4/193 (2%)

Query: 180 LIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALK-GFDVECEMMKSIRHRNLIKVISTC 238
            IG+G FG VYK  L    EVAVK         LK  F  E E++K   H N++K+I  C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 239 SNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
             ++   +V+E +P GSL  ++      L + + L + +D A+ +EYL    S   IH D
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRD 118

Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
           L   N L+ +N V  +SDF +++   G   +++       I + APE    GR ++  DV
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDV 178

Query: 359 YSFGIMLMETFTG 371
           +S+GI+L ETF+ 
Sbjct: 179 WSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  116 bits (292), Expect = 1e-29
 Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 23/214 (10%)

Query: 179 NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCG------RALKGFDVECEMMKSIRHRNL 231
             IG+G FG VY  R   DG    +K  +L          AL     E +++K + H N+
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN----EVKILKKLNHPNI 61

Query: 232 IKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIF---QRLNIMIDVASALEYLHF 288
           IK   +   +    +V+EY   G L + +         F   Q L+  + +  AL+YLH 
Sbjct: 62  IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH- 120

Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  I+H D+KP N+ L  N +  L DF I+K+L+     + +T  + T  Y++PE  +
Sbjct: 121 --SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVDLAKTV-VGTPYYLSPELCQ 176

Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
               +   D++S G +L E  T K P    F GE
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHP----FEGE 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  115 bits (289), Expect = 4e-29
 Identities = 71/293 (24%), Positives = 124/293 (42%), Gaps = 37/293 (12%)

Query: 179 NLIGRGGFGSVYKARL-----GDGMEVAVKVFNLQCGRA-LKGFDVECEMMKSIRHRNLI 232
             +G G FG V   R        G +VAVK  N          F+ E E+++++ H N++
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 233 KVISTCSNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY 290
           K    C     ++  L++EY+P GSL  Y+      +++ + L     +   ++YL    
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG--- 126

Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT-QTQTLATIGYMAPEYGRE 349
           S   IH DL   N+L++   +  +SDF +AK+L  +      +    + I + APE  R 
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186

Query: 350 GRVSTNGDVYSFGIMLMETFTGKKPTNE----------IFNGEMTLKHWVNDWLPISTME 399
            + S+  DV+SFG+ L E FT   P+            I  G+M +   +          
Sbjct: 187 SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE--------- 237

Query: 400 VVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR 452
                 L +E         C   V++L   C    P+ R +  +++  + ++R
Sbjct: 238 ------LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  110 bits (277), Expect = 1e-27
 Identities = 69/276 (25%), Positives = 125/276 (45%), Gaps = 27/276 (9%)

Query: 175 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKV 234
           F+    +G G FG V++    + + VA+K+         + F  E + +K +RH++LI +
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAP 293
            + CS  E   ++ E M  GSL  ++ S    +L +   +++   VA  + YL       
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQN 124

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVS 353
            IH DL   N+L+ +++V  ++DF +A+L+  ++     +       + APE    G  S
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYKWTAPEAASHGTFS 182

Query: 354 TNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIH 412
           T  DV+SFGI+L E FT G+ P   + N E+  +      +P                  
Sbjct: 183 TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMP------------------ 224

Query: 413 FVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
                +C   ++ + +EC    PE R + + +  +L
Sbjct: 225 --CPAKCPQEIYKIMLECWAAEPEDRPSFKALREEL 258

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  109 bits (275), Expect = 3e-27
 Identities = 75/278 (26%), Positives = 117/278 (42%), Gaps = 49/278 (17%)

Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRH--RNLIKVIS- 236
           +G+G  G VYK R    G   A+K  +          D + E  K +    + L    S 
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIH---------VDGDEEFRKQLLRELKTLRSCESP 59

Query: 237 ---TCSNEEFK----ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFG 289
               C    +K    ++VLEYM  GSL   +     I +      I   +   L+YLH  
Sbjct: 60  YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-IARQILKGLDYLH-- 116

Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-LATIGYMAPEYGR 348
               IIH D+KPSN+L++      ++DF I+K+L   + ++ Q  T + T+ YM+PE  +
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL---ENTLDQCNTFVGTVTYMSPERIQ 173

Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE---MTLKHWVNDWLPISTMEVVGANL 405
               S   D++S G+ L+E   GK P   +  G+     L   + D  P S      A  
Sbjct: 174 GESYSYAADIWSLGLTLLECALGKFPF--LPPGQPSFFELMQAICDGPPPSLP----AEE 227

Query: 406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINARE 443
            S E   F++              C  + P++R +A E
Sbjct: 228 FSPEFRDFISA-------------CLQKDPKKRPSAAE 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  109 bits (274), Expect = 3e-27
 Identities = 67/200 (33%), Positives = 104/200 (52%), Gaps = 15/200 (7%)

Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G FG V+        +VAVK   L+ G  + + F  E ++MK +RH  L+++ + CS
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKT--LKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMID----VASALEYLHFGYSAPII 295
            EE   +V EYM  GSL  ++ S         RL  ++D    +A  + YL    S   I
Sbjct: 72  EEEPIYIVTEYMSKGSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLE---SRNYI 125

Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 355
           H DL   N+L+ +N+V  ++DF +A+L+  +D+   +      I + APE    GR +  
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIE-DDEYTAREGAKFPIKWTAPEAANYGRFTIK 184

Query: 356 GDVYSFGIMLMETFT-GKKP 374
            DV+SFGI+L E  T G+ P
Sbjct: 185 SDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  109 bits (274), Expect = 7e-27
 Identities = 74/265 (27%), Positives = 114/265 (43%), Gaps = 25/265 (9%)

Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           IG G  G VYKA     G EVA+K   L+     +    E  +MK  +H N++    +  
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQN-KELIINEILIMKDCKHPNIVDYYDSYL 85

Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
             +   +V+EYM  GSL   +  +   ++  Q   +  +V   LEYLH   S  +IH D+
Sbjct: 86  VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDI 142

Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVY 359
           K  N+LL  +    L+DF  A  LT +++S   +  + T  +MAPE  +        D++
Sbjct: 143 KSDNILLSKDGSVKLADFGFAAQLT-KEKSKRNSV-VGTPYWMAPEVIKRKDYGPKVDIW 200

Query: 360 SFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQC 419
           S GIM +E   G+ P          L       +P     +      S E   F+ K   
Sbjct: 201 SLGIMCIEMAEGEPPYLR-EPPLRALFLITTKGIP----PLKNPEKWSPEFKDFLNK--- 252

Query: 420 VSCVFNLAMECTVESPEQRINAREI 444
                     C V+ PE+R +A E+
Sbjct: 253 ----------CLVKDPEKRPSAEEL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  108 bits (272), Expect = 1e-26
 Identities = 78/300 (26%), Positives = 121/300 (40%), Gaps = 76/300 (25%)

Query: 180 LIGRGGFGSVYKARL-GDGMEVAVKVFN-LQCGRALKGFDVECE---MMKSIRHRNLIKV 234
           +IG G F +V  A+      E A+K+ +  Q  +  K   V+ E   + +   H  +IK+
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67

Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYM--YSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
             T  +EE    VLEY P+G L +Y+  Y S   LD         ++  ALEYLH   S 
Sbjct: 68  YYTFQDEENLYFVLEYAPNGELLQYIRKYGS---LDEKCTRFYAAEILLALEYLH---SK 121

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIG------------ 340
            IIH DLKP N+LLD +M   ++DF  AK+L   + S    +  AT              
Sbjct: 122 GIIHRDLKPENILLDKDMHIKITDFGTAKVL-DPNSSPESNKGDATNIDSQIEKNRRRFA 180

Query: 341 -------YMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWL 393
                  Y++PE   E     + D+++ G ++ +  TGK P    F G        N++L
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP----FRG-------SNEYL 229

Query: 394 PISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRIN--AREIVAKLLKI 451
                                         F   ++     P       A++++ KLL +
Sbjct: 230 -----------------------------TFQKILKLEYSFPP-NFPPDAKDLIEKLLVL 259

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  106 bits (268), Expect = 2e-26
 Identities = 69/212 (32%), Positives = 98/212 (46%), Gaps = 21/212 (9%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEM-----MKSIRHRNLIKV 234
           +G+G FG V   R    G   A+KV   +  + +K  +VE  +     +  I H  ++K+
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKK--KIIKRKEVEHTLTERNILSRINHPFIVKL 58

Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI 294
                 EE   LVLEY P G L  ++       +   R     ++  ALEYLH   S  I
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYLH---SLGI 114

Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVS 353
           I+ DLKP N+LLD +    L+DF +AK L+ E     +T T   T  Y+APE        
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNTFCGTPEYLAPEVLLGKGYG 171

Query: 354 TNGDVYSFGIMLMETFTGKKP-----TNEIFN 380
              D +S G++L E  TGK P       EI+ 
Sbjct: 172 KAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYE 203

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  107 bits (268), Expect = 3e-26
 Identities = 78/286 (27%), Positives = 128/286 (44%), Gaps = 45/286 (15%)

Query: 181 IGRGGFGSVYKAR------LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKV 234
           +G G FG V+ A         D M VAVK        A K F  E E++ +++H +++K 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYS---------------SNYILDIFQRLNIMIDV 279
              C + +   +V EYM HG L K++ +               +   L + Q L+I   +
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
           AS + YL    S   +H DL   N L+  N++  + DF +++ +   D       T+  I
Sbjct: 133 ASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 340 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTM 398
            +M PE     + +T  DV+SFG++L E FT GK+P                 W  +S  
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP-----------------WFQLSNT 232

Query: 399 EVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREI 444
           EV+    ++Q  +       C   V+++ + C    P+QR+N +EI
Sbjct: 233 EVI--ECITQGRV-LERPRVCPKEVYDIMLGCWQREPQQRLNIKEI 275

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  105 bits (265), Expect = 6e-26
 Identities = 64/205 (31%), Positives = 98/205 (47%), Gaps = 21/205 (10%)

Query: 179 NLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVI 235
           +LIGRG FG VYK   L  G  VA+K  +L+     ALK    E +++K+++H N++K I
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLN------IMIDVASALEYLHFG 289
            +    +   ++LEY  +GSL +       I+  F           +  V   L YLH  
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQ-------IIKKFGPFPESLVAVYVYQVLQGLAYLH-- 116

Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 349
               +IH D+K +N+L   + V  L+DF +A  L    +       + T  +MAPE    
Sbjct: 117 -EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--DDASVVGTPYWMAPEVIEM 173

Query: 350 GRVSTNGDVYSFGIMLMETFTGKKP 374
              ST  D++S G  ++E  TG  P
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 2e-25
 Identities = 69/205 (33%), Positives = 106/205 (51%), Gaps = 9/205 (4%)

Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRA-LKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G FG V++    +   VAVK   L+ G    K F  E ++MK +RH  LI++ + C+
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVK--TLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            EE   +V E M +GSL +Y+       L + Q +++   VAS + YL    +   IH D
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRD 128

Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
           L   NVL+ +N +  ++DF +A+++  ED    +      I + APE     R S   DV
Sbjct: 129 LAARNVLVGENNICKVADFGLARVI-KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDV 187

Query: 359 YSFGIMLMETFT-GKKPTNEIFNGE 382
           +SFGI+L E  T G+ P   + N E
Sbjct: 188 WSFGILLTEIVTYGRMPYPGMTNAE 212

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 3e-25
 Identities = 67/216 (31%), Positives = 106/216 (49%), Gaps = 31/216 (14%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV----ECEMMKSIRHRNLIKVI 235
           IG G +G VYKAR    G  VA+K   ++  +  +GF +    E ++++ +RH N++++ 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 236 STCSNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
              +++   +  +V EYM H  L   + S        Q    M  +   L+YLH   S  
Sbjct: 65  EIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNG 120

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE-------Y 346
           I+H D+K SN+L++++ V  L+DF +A+  T    S   T  + T+ Y  PE       Y
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKR-NSADYTNRVITLWYRPPELLLGATRY 179

Query: 347 GREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
           G E  V    D++S G +L E F GK     IF G 
Sbjct: 180 GPE--V----DMWSVGCILAELFLGKP----IFQGS 205

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  102 bits (256), Expect = 1e-24
 Identities = 75/294 (25%), Positives = 124/294 (42%), Gaps = 50/294 (17%)

Query: 181 IGRGGFGSVYKARLG------DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKV 234
           +G G FG V+ A         D M VAVK        A + F  E E++  ++H+++++ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSN---YILD-----------IFQRLNIMIDVA 280
              C+      +V EYM HG L +++ S      IL            + Q L I   +A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 281 SALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA 337
           S + YL   HF      +H DL   N L+   +V  + DF +++ +   D      +T+ 
Sbjct: 133 SGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186

Query: 338 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPIS 396
            I +M PE     + +T  D++SFG++L E FT GK+P                 W  +S
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP-----------------WYQLS 229

Query: 397 TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK 450
             E +      +E         C   V+ +   C    P+QR+  ++I ++L  
Sbjct: 230 NTEAIECITQGRE---LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  101 bits (254), Expect = 1e-24
 Identities = 64/194 (32%), Positives = 98/194 (50%), Gaps = 9/194 (4%)

Query: 180 LIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALK-GFDVECEMMKSIRHRNLIKVISTC 238
           L+G+G FG V+K  L D   VAVK       + LK  F  E  ++K   H N++K+I  C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 239 SNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
           +  +   +V+E +P G    ++      L   Q +   +D A+ + YL    S   IH D
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRD 118

Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGREGRVSTNG 356
           L   N L+ +N V  +SDF +++    ED  +  +  L    I + APE    GR S+  
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175

Query: 357 DVYSFGIMLMETFT 370
           DV+S+GI+L ETF+
Sbjct: 176 DVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  100 bits (250), Expect = 4e-24
 Identities = 72/203 (35%), Positives = 105/203 (51%), Gaps = 18/203 (8%)

Query: 181 IGRGGFGSVYKARLGD--GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTC 238
           IG+G FG V    LGD  G +VAVK   ++     + F  E  +M  +RH NL++++   
Sbjct: 14  IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68

Query: 239 SNEEFKA-LVLEYMPHGSLEKYMYS-SNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
             E+    +V EYM  GSL  Y+ S    +L     L   +DV  A+EYL    +   +H
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVH 125

Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 356
            DL   NVL+ ++ VA +SDF + K     + S TQ      + + APE  RE + ST  
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 180

Query: 357 DVYSFGIMLMETFT-GKKPTNEI 378
           DV+SFGI+L E ++ G+ P   I
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRI 203

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 99.6 bits (248), Expect = 8e-24
 Identities = 59/196 (30%), Positives = 106/196 (54%), Gaps = 14/196 (7%)

Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           IG G FG+V +     G +VAVK  N++C    + F  E  +M  + H+NL++++    +
Sbjct: 14  IGEGEFGAVLQGEY-TGQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 241 EEFKALVLEYMPHGSLEKYMYS-SNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
                +V+E M  G+L  ++ +    ++ + Q L   +DVA  +EYL    S  ++H DL
Sbjct: 71  NGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDL 126

Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVY 359
              N+L+ ++ VA +SDF +A++      SM    +   + + APE  +  + S+  DV+
Sbjct: 127 AARNILVSEDGVAKVSDFGLARV-----GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVW 181

Query: 360 SFGIMLMETFT-GKKP 374
           S+G++L E F+ G+ P
Sbjct: 182 SYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 99.7 bits (249), Expect = 9e-24
 Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 11/205 (5%)

Query: 174 GFSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQ-C--GRALKGFDVECEMMKSIRHR 229
            F    +IG+G FG V   +  D  ++ A+K  N Q C    +++    E  +++ + H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 230 NLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFG 289
            L+ +  +  +EE   LV++ +  G L +Y  S        Q    + ++  ALEYLH  
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDL-RYHLSQKVKFSEEQVKFWICEIVLALEYLH-- 117

Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 349
            S  IIH D+KP N+LLD+    H++DF+IA  +T +  +   T T  T GYMAPE    
Sbjct: 118 -SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPEVLCR 173

Query: 350 GRVSTNGDVYSFGIMLMETFTGKKP 374
              S   D +S G+   E   GK+P
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 98.1 bits (244), Expect = 3e-23
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 6/204 (2%)

Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           IG G FG V+     +  +VA+K    +   + + F  E ++M  + H  L+++   C+ 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 300
                LV E+M HG L  Y+ +          L + +DV   + YL    S+ +IH DL 
Sbjct: 71  RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLA 127

Query: 301 PSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYS 360
             N L+ +N V  +SDF + + +  +DQ  + T T   + + +PE     + S+  DV+S
Sbjct: 128 ARNCLVGENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186

Query: 361 FGIMLMETFT-GKKPTNEIFNGEM 383
           FG+++ E F+ GK P     N E+
Sbjct: 187 FGVLMWEVFSEGKTPYENRSNSEV 210

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 97.9 bits (244), Expect = 4e-23
 Identities = 65/220 (29%), Positives = 95/220 (43%), Gaps = 27/220 (12%)

Query: 174 GFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKGFDV--ECEMMKSIRHRN 230
            F     +G+G +GSVYK  RL D    A+K  +L      +  D   E  ++ S+ H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 231 LIKVISTCSNEEF-----KALVLEYMPHGSLEKYMYSSNYILDIFQR---LNIMIDVASA 282
           +I        E F       +V+EY P G L K +        +        I I +   
Sbjct: 61  II-----SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115

Query: 283 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           L+ LH      I+H DLK +N+LL  N +  + D  I+K+L    ++M +TQ   T  YM
Sbjct: 116 LQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLK---KNMAKTQI-GTPHYM 168

Query: 343 APEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
           APE  +    S   D++S G +L E  T   P    F   
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPP----FEAR 204

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 97.4 bits (242), Expect = 5e-23
 Identities = 74/265 (27%), Positives = 118/265 (44%), Gaps = 30/265 (11%)

Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKG-FDVECEMMKSIRHRNLIKVISTC 238
           IGRG FG V+  RL  D   VAVK         LK  F  E  ++K   H N++++I  C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 239 SNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
           + ++   +V+E +  G    ++ +    L + + + ++ + A+ +EYL    S   IH D
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRD 119

Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI--GYMAPEYGREGRVSTNG 356
           L   N L+ +  V  +SDF +++    ED     T  +  I   + APE    GR S+  
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSES 177

Query: 357 DVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVA 415
           DV+SFGI+L E F+ G  P   + N +              T E +      ++ +    
Sbjct: 178 DVWSFGILLWEAFSLGAVPYANLSNQQ--------------TREAI------EQGVRLPC 217

Query: 416 KEQCVSCVFNLAMECTVESPEQRIN 440
            E C   V+ L   C    P QR +
Sbjct: 218 PELCPDAVYRLMERCWEYDPGQRPS 242

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 97.9 bits (244), Expect = 6e-23
 Identities = 75/291 (25%), Positives = 134/291 (46%), Gaps = 46/291 (15%)

Query: 181 IGRGGFGSVYKARL-GDGME-----VAVKVFNLQCGRALKG-FDVECEMMKSIRHRNLIK 233
           +G G FG VYK  L G         VA+K         ++  F  E E+M  ++H N++ 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSN---------------YILDIFQRLNIMID 278
           ++  C+ E+   ++ EY+ HG L +++  ++                 LD    L+I I 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT 338
           +A+ +EYL    S   +H DL   N L+ + +   +SDF +++ +   D    Q+++L  
Sbjct: 133 IAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 339 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPIST 397
           + +M PE    G+ +T  D++SFG++L E F+ G +P    + G              S 
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP----YYG-------------FSN 232

Query: 398 MEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
            EV+   ++    +     E C + V+ L +EC  E P +R   ++I  +L
Sbjct: 233 QEVI--EMIRSRQL-LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 96.7 bits (241), Expect = 9e-23
 Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 6/203 (2%)

Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           +G G FG V+  +    ++VA+K+   +   +   F  E ++M  + H NL+++   C+ 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 300
           +    +V EYM +G L  Y+      L     L++  DV  A+EYL    S   IH DL 
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLA 127

Query: 301 PSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYS 360
             N L+ ++ V  +SDF +A+ +  +DQ  +   T   + +  PE     R S+  DV+S
Sbjct: 128 ARNCLVGEDNVVKVSDFGLARYVL-DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWS 186

Query: 361 FGIMLMETFT-GKKPTNEIFNGE 382
           FG+++ E F+ GK P     N E
Sbjct: 187 FGVLMWEVFSEGKMPYERFSNSE 209

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 96.3 bits (240), Expect = 2e-22
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 11/201 (5%)

Query: 181 IGRGGFGSVYKAR---LGDG--MEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKV 234
           +G G FG+VYK      G+   + VA+KV   +    A K    E  +M S+ H +++++
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI 294
           +  C + +   L+ + MP G L  Y+ +    +     LN  + +A  + YL       +
Sbjct: 75  LGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRL 130

Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVST 354
           +H DL   NVL+       ++DF +AKLL  +++          I +MA E       + 
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH 190

Query: 355 NGDVYSFGIMLMETFT-GKKP 374
             DV+S+G+ + E  T G KP
Sbjct: 191 KSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 96.1 bits (239), Expect = 2e-22
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 9/206 (4%)

Query: 167 ELCRATDGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKS 225
           E+ R TD   ++ L G G +G VY+       + VAVK    +    ++ F  E  +MK 
Sbjct: 2   EMER-TDITMKHKL-GGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKE 58

Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALE 284
           I+H NL++++  C+ E    ++ E+M +G+L  Y+   N   ++    L +   ++SA+E
Sbjct: 59  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 118

Query: 285 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
           YL        IH DL   N L+ +N +  ++DF +++L+TG D           I + AP
Sbjct: 119 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 174

Query: 345 EYGREGRVSTNGDVYSFGIMLMETFT 370
           E     + S   DV++FG++L E  T
Sbjct: 175 ESLAYNKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 95.7 bits (238), Expect = 3e-22
 Identities = 73/290 (25%), Positives = 125/290 (43%), Gaps = 41/290 (14%)

Query: 180 LIGRGGFGSVYKARL----GDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIK 233
           ++G G FGSV + +L    G  ++VAVK   L       ++ F  E   MK   H N++K
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 234 VISTC----SNEEFKA--LVLEYMPHGSLEKYMYSSN-----YILDIFQRLNIMIDVASA 282
           +I  C    S ++     ++L +M HG L  ++  S        L +   L  M+D+A  
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 283 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           +EYL    +   IH DL   N +L ++M   ++DF ++K +   D           + ++
Sbjct: 126 MEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182

Query: 343 APEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVV 401
           A E   +   ++  DV++FG+ + E  T G+ P   + N E+       D+L        
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY------DYL-------R 229

Query: 402 GANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
             N L Q        E C+  +++L   C    P+ R    ++   L  I
Sbjct: 230 HGNRLKQ-------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 95.5 bits (238), Expect = 3e-22
 Identities = 57/196 (29%), Positives = 88/196 (44%), Gaps = 8/196 (4%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAL-KGFDVECEMMKSIRHRNLIKVISTC 238
           +G G  G V K      G  +AVK   L+   A+ K    E +++       ++      
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 239 SNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            N    ++ +EYM  GSL+K +      +       I + V   L YLH  +   IIH D
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRD 126

Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
           +KPSN+L++      L DF ++  L     S+ +T    T  YMAPE  +    S   D+
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQLV---NSLAKTFV-GTSSYMAPERIQGNDYSVKSDI 182

Query: 359 YSFGIMLMETFTGKKP 374
           +S G+ L+E  TG+ P
Sbjct: 183 WSLGLSLIELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 94.3 bits (235), Expect = 9e-22
 Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 10/201 (4%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCGRALKGFDVECEMMKSIRHRNLIKVISTC 238
           IG G    VY A  L +  +VA+K  +L +C  ++     E + M    H N++K  ++ 
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 239 SNEEFKALVLEYMPHGSLEKYMYSSNY--ILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
              +   LV+ Y+  GSL   M SS     LD      ++ +V   LEYLH   S   IH
Sbjct: 69  VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIH 125

Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLL--TGEDQSMTQTQTLATIGYMAPEYGREGRVST 354
            D+K  N+LL ++    ++DF ++  L   G+     +   + T  +MAPE   +     
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYD 185

Query: 355 NG-DVYSFGIMLMETFTGKKP 374
              D++SFGI  +E  TG  P
Sbjct: 186 FKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 94.3 bits (235), Expect = 9e-22
 Identities = 70/206 (33%), Positives = 105/206 (50%), Gaps = 16/206 (7%)

Query: 179 NLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGR--ALKGFDVECEMMKSIRHRNLIKVI 235
           N IG G FG VY A  L  G  +AVK   +Q      +K    E ++++ ++H NL+K  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILD--IFQRLNIMIDVASALEYLHFGYSAP 293
               + E   + +EY   G+LE+ +     ILD  + +   + +     L YLH   S  
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEE-LLEHGRILDEHVIRVYTLQL--LEGLAYLH---SHG 119

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM-TQTQTLA-TIGYMAPEYGREGR 351
           I+H D+KP+N+ LD N V  L DF  A  L     +M  + Q+LA T  YMAPE    G+
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179

Query: 352 VSTNG---DVYSFGIMLMETFTGKKP 374
              +G   D++S G +++E  TGK+P
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 94.0 bits (233), Expect = 1e-21
 Identities = 66/207 (31%), Positives = 109/207 (52%), Gaps = 12/207 (5%)

Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G+G FG V+         VA+K   L+ G  + + F  E ++MK +RH  L+++ +  S
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 240 NEEFKALVLEYMPHGSLEKYMY-SSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            EE   +V EYM  GSL  ++       L + Q +++   +AS + Y+        +H D
Sbjct: 72  -EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 127

Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGD 357
           L+ +N+L+ +N+V  ++DF +A+L+  ED   T  Q     I + APE    GR +   D
Sbjct: 128 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 358 VYSFGIMLMETFT-GKKPTNEIFNGEM 383
           V+SFGI+L E  T G+ P   + N E+
Sbjct: 186 VWSFGILLTELTTKGRVPYPGMVNREV 212

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 93.3 bits (232), Expect = 2e-21
 Identities = 80/292 (27%), Positives = 128/292 (43%), Gaps = 37/292 (12%)

Query: 180 LIGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKV 234
            +G+G FGSV   R   L D  G  VAVK         L+ F+ E E++KS++H N++K 
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70

Query: 235 ISTCSNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
              C +   +   LV+EY+P+GSL  Y+      LD  + L     +   +EYL    S 
Sbjct: 71  KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SK 127

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREGR 351
             +H DL   N+L++      + DF + K+L   ++    +    + I + APE   E +
Sbjct: 128 RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK 187

Query: 352 VSTNGDVYSFGIMLMETFT----GKKPTNEIF-------NGEMTLKHWVNDWLPISTMEV 400
            S   DV+SFG++L E FT       P  E          G+M + H +           
Sbjct: 188 FSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE---------- 237

Query: 401 VGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR 452
                L + +    A   C + ++ +  EC    P QR +  E+  ++  IR
Sbjct: 238 -----LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 93.4 bits (232), Expect = 3e-21
 Identities = 63/199 (31%), Positives = 97/199 (48%), Gaps = 14/199 (7%)

Query: 181 IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCGRALK-GFDVECEMMKSIRHRNLIKV 234
           +G G FG V          G G  VAVK    +CG+    G+  E  ++K++ H N++K 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 235 ISTCSNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
              CS +  K   L++EY+P GSL  Y+      L++ Q L     +   + YLH   S 
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH---SQ 126

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREGR 351
             IH DL   NVLLD++ +  + DF +AK +  G +    +    + + + A E  +E +
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK 186

Query: 352 VSTNGDVYSFGIMLMETFT 370
            S   DV+SFG+ L E  T
Sbjct: 187 FSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 92.3 bits (229), Expect = 5e-21
 Identities = 68/283 (24%), Positives = 135/283 (47%), Gaps = 30/283 (10%)

Query: 176 SENNLIGRGGFGSVYKA--RLGDGMEVAVKVFNLQCGRALK---GFDVECEMMKSIRHRN 230
           ++  +IG G FG V++   ++    EVAV +  L+ G   K    F  E  +M    H N
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67

Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY 290
           +I++    +  +   ++ EYM +G+L+KY+   +     +Q + ++  +A+ ++YL    
Sbjct: 68  IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS--- 124

Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ-SMTQTQTLATIGYMAPEYGRE 349
               +H DL   N+L++ N+   +SDF ++++L  + + + T +     I + APE    
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184

Query: 350 GRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ 408
            + ++  DV+SFGI++ E  + G++P  ++ N E+              M+ +       
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV--------------MKAI------N 224

Query: 409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
           +     A   C S V+ L ++C  +   +R    +IV  L K+
Sbjct: 225 DGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 92.4 bits (229), Expect = 5e-21
 Identities = 76/283 (26%), Positives = 124/283 (43%), Gaps = 42/283 (14%)

Query: 181 IGRGGFGSVYKARL------GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKV 234
           +G G FG V+ A         D + VAVK        A K F  E E++ +++H +++K 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 235 ISTCSNEEFKALVLEYMPHGSLEKY----------MYSSNYILDIFQR--LNIMIDVASA 282
              C   +   +V EYM HG L K+          M   N   ++ Q   L+I   +A+ 
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 283 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           + YL    S   +H DL   N L+ +N++  + DF +++ +   D       T+  I +M
Sbjct: 133 MVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 343 APEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVV 401
            PE     + +T  DV+S G++L E FT GK+P                 W  +S  EV+
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP-----------------WYQLSNNEVI 232

Query: 402 GANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREI 444
               ++Q  +       C   V++L + C    P  R+N +EI
Sbjct: 233 --ECITQGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEI 272

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 91.4 bits (228), Expect = 1e-20
 Identities = 80/304 (26%), Positives = 122/304 (40%), Gaps = 76/304 (25%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVEC--EM--MKSIRHRNLIKVI 235
           +G G +G VYKAR    G  VA+K   L      +G       E+  +K ++H N++K++
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRL--DNEEEGIPSTALREISLLKELKHPNIVKLL 64

Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
                E    LV EY     L+KY+      L      +IM  +   L Y H   S  I+
Sbjct: 65  DVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRIL 120

Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE-------YGR 348
           H DLKP N+L++ + V  L+DF +A+      ++   T  + T+ Y APE       Y  
Sbjct: 121 HRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--THEVVTLWYRAPEILLGSKHY-- 176

Query: 349 EGRVSTNGDVYSFGIMLMETFTGK--------------------KPTNEIFNGEMTLKHW 388
               ST  D++S G +  E  TGK                     PT E + G   L  +
Sbjct: 177 ----STAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232

Query: 389 VND---WLPISTMEVV------GANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRI 439
                 + P    +V+      G +LLS+               +N         P +RI
Sbjct: 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSK------------MLQYN---------PAKRI 271

Query: 440 NARE 443
           +A+E
Sbjct: 272 SAKE 275

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 90.9 bits (226), Expect = 1e-20
 Identities = 68/219 (31%), Positives = 106/219 (48%), Gaps = 38/219 (17%)

Query: 180 LIGRGGFGSVYKA-RLGDGMEVAVKVFNL----QCGR-ALKGFDVECEMMKSIRHRNLIK 233
           L+G G FGSVY+   L DG   AVK  +L    Q G+ A+K  + E  ++  ++H N+++
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYM--YSS-------NYILDIFQRLNIMIDVASALE 284
            + T   E+   + LE +P GSL K +  Y S        Y   I             LE
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL----------LGLE 116

Query: 285 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIG---Y 341
           YLH       +H D+K +N+L+D N V  L+DF +AK      Q +  +   +  G   +
Sbjct: 117 YLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAK------QVVEFSFAKSFKGSPYW 167

Query: 342 MAPEY-GREGRVSTNGDVYSFGIMLMETFTGKKPTNEIF 379
           MAPE   ++G      D++S G  ++E  TGK P +++ 
Sbjct: 168 MAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 90.3 bits (224), Expect = 2e-20
 Identities = 82/295 (27%), Positives = 129/295 (43%), Gaps = 53/295 (17%)

Query: 179 NLIGRGGFGSVYKAR----LGDGME---VAVKVFNLQCGRAL---KGFDVECEMMKSIRH 228
           N +G G FG VY+      LG G     VAVK   L+ G      K F  E  +M +  H
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVK--TLRKGATDQEKKEFLKEAHLMSNFNH 58

Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNY------ILDIFQRLNIMIDVASA 282
            N++K++  C   E + +++E M  G L  Y+  +        +L + + L+I +DVA  
Sbjct: 59  PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118

Query: 283 LEYL---HFGYSAPIIHCDLKPSNVLL-----DDNMVAHLSDFSIAKLLTGEDQSMTQTQ 334
             YL   HF      IH DL   N L+     D + V  + DF +A+ +   D    + +
Sbjct: 119 CVYLEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGE 172

Query: 335 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWL 393
            L  + +MAPE   +G+ +T  DV+SFG+++ E  T G++P   + N E+ L+H      
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV-LQH------ 225

Query: 394 PISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
                 V     L +        E C   ++ L   C  + P +R     I   L
Sbjct: 226 ------VTAGGRLQK-------PENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 90.0 bits (224), Expect = 3e-20
 Identities = 58/210 (27%), Positives = 89/210 (42%), Gaps = 24/210 (11%)

Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFNL-QCGRALKGFDV-ECEMMKSIRHRNLIKVIST 237
           IG+G FG+V K  R  DG  +  K  +        K   V E  +++ ++H N+++    
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67

Query: 238 CSNEEFKAL--VLEYMPHGSL---------EKYMYSSNYILDIFQRLNIMIDVASALEYL 286
             +   + L  V+EY   G L         E+      +I  I  +L        AL   
Sbjct: 68  IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL------LLALYEC 121

Query: 287 HFGYSAP--IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
           H        ++H DLKP+N+ LD N    L DF +AK+L G D S  +T  + T  YM+P
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL-GHDSSFAKT-YVGTPYYMSP 179

Query: 345 EYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           E           D++S G ++ E      P
Sbjct: 180 EQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 89.8 bits (223), Expect = 3e-20
 Identities = 70/283 (24%), Positives = 120/283 (42%), Gaps = 33/283 (11%)

Query: 178 NNLIGRGGFGSVYKA----RLGDGMEVAVKVFNLQCGRALK-GFDVECEMMKSIRHRNLI 232
              IG G FG VY+        + + VAVK        +++  F  E  +M+   H +++
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
           K+I   + E    +V+E  P G L  Y+  + Y LD+   +     +++AL YL    S 
Sbjct: 71  KLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SK 126

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM-TQTQTLATIGYMAPEYGREGR 351
             +H D+   NVL+       L DF +++ L  ED+S    ++    I +MAPE     R
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL--EDESYYKASKGKLPIKWMAPESINFRR 184

Query: 352 VSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED 410
            ++  DV+ FG+ + E    G KP   + N ++  +    + LP+               
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMP-------------- 230

Query: 411 IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD 453
                   C   +++L  +C    P +R    E+ A+L  I  
Sbjct: 231 ------PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 90.2 bits (224), Expect = 4e-20
 Identities = 78/297 (26%), Positives = 125/297 (42%), Gaps = 49/297 (16%)

Query: 180 LIGRGGFGSVYKARLGD------GMEVAVKVFNLQCG-RALKGFDVECEMMKSI-RHRNL 231
            +G G FG V KA             VAVK+       + L     E EMMK I +H+N+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 232 IKVISTCSNEEFKALVLEYMPHGSLEKYM---------YSSNYILDIFQRL------NIM 276
           I ++  C+ E    +V+EY  HG+L  ++          S +      + L      +  
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 277 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 336
             VA  +E+L    S   IH DL   NVL+ ++ V  ++DF +A+ +   D     T   
Sbjct: 139 YQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195

Query: 337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPI 395
             + +MAPE   +   +   DV+SFG++L E FT G  P                   P 
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP------------------YPG 237

Query: 396 STMEVVGANLLSQEDIHFVAKEQ-CVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
             +E +   L      + + K Q C   +++L  +C  E P QR   +++V  L ++
Sbjct: 238 IPVEELFKLLKEG---YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 90.7 bits (226), Expect = 4e-20
 Identities = 71/261 (27%), Positives = 120/261 (45%), Gaps = 47/261 (18%)

Query: 179 NLIGRGGFGSVYKAR-LGDGMEVAVKVFN------LQCGRALKGFDVECEMMKSIRHRNL 231
             IG G +G V  A     G +VA+K  +      +   R L+    E ++++ +RH N+
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENI 61

Query: 232 IKVISTC---SNEEFKAL--VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           I ++      S E+F  +  V E M    L K + S   + D   +   +  +   L+YL
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY-FLYQILRGLKYL 119

Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ-TQTLATIGYMAPE 345
           H   SA +IH DLKPSN+L++ N    + DF +A+ +  ++      T+ + T  Y APE
Sbjct: 120 H---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPE 176

Query: 346 -------YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTM 398
                  Y      +   D++S G +  E  T  KP   +F G    + +++    I  +
Sbjct: 177 LLLSSSRY------TKAIDIWSVGCIFAELLTR-KP---LFPG----RDYIDQLNLI--V 220

Query: 399 EVVGANLLSQEDIHFVAKEQC 419
           EV+G    S+ED+ F+  E+ 
Sbjct: 221 EVLGT--PSEEDLKFITSEKA 239

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 89.6 bits (222), Expect = 4e-20
 Identities = 77/296 (26%), Positives = 134/296 (45%), Gaps = 41/296 (13%)

Query: 175 FSENNLIGRGGFGSVYKARL----GDGMEVAVKVF--NLQCGRALKGFDVECEMMKSIRH 228
           F+   ++G+G FGSV +A+L    G   +VAVK+   ++     ++ F  E   MK   H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 229 RNLIKVISTCSNEEFKA------LVLEYMPHGSLEKYMYSSN-----YILDIFQRLNIMI 277
            N+IK+I        K       ++L +M HG L  ++  S      + L +   +  MI
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 278 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA 337
           D+AS +EYL    S   IH DL   N +L++NM   ++DF ++K +   D       +  
Sbjct: 121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 338 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPIS 396
            + ++A E   +   +T+ DV++FG+ + E  T G+ P   + N E      + ++L   
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE------IYNYL--- 228

Query: 397 TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR 452
               +  N L Q          C+  V+ L  +C    P+ R + + +  +L  I 
Sbjct: 229 ----IKGNRLKQ-------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 89.2 bits (221), Expect = 5e-20
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 6/207 (2%)

Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           +G G FG V   +     +VA+K+   +   +   F  E ++M  + H  L+++   C+ 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 300
           +    +V EYM +G L  Y+          Q L +  DV   + YL    S   IH DL 
Sbjct: 71  QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLA 127

Query: 301 PSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYS 360
             N L+DD     +SDF +++ +  +D+  +   +   + +  PE     + S+  DV++
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWA 186

Query: 361 FGIMLMETFT-GKKPTNEIFNGEMTLK 386
           FG+++ E ++ GK P     N E   K
Sbjct: 187 FGVLMWEVYSLGKMPYERFNNSETVEK 213

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 88.9 bits (221), Expect = 6e-20
 Identities = 64/208 (30%), Positives = 98/208 (47%), Gaps = 14/208 (6%)

Query: 175 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
           F     +G G +GSVYKA     G  VA+KV  +     L+    E  ++K      ++K
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK 62

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
              +        +V+EY   GS+   M  +N  L   +   I+      LEYLH   S  
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNK 119

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIG---YMAPEYGREG 350
            IH D+K  N+LL++   A L+DF ++  LT    +M +  T+  IG   +MAPE  +E 
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTD---TMAKRNTV--IGTPFWMAPEVIQEI 174

Query: 351 RVSTNGDVYSFGIMLMETFTGKKPTNEI 378
             +   D++S GI  +E   GK P ++I
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDI 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 89.0 bits (220), Expect = 7e-20
 Identities = 66/207 (31%), Positives = 109/207 (52%), Gaps = 12/207 (5%)

Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAL-KGFDVECEMMKSIRHRNLIKVISTCS 239
           +G+G FG V+        +VA+K   L+ G  + + F  E ++MK +RH  L+ + +  S
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIK--TLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 240 NEEFKALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            EE   +V E+M  GSL  ++   +   L + Q +++   +A  + Y+        IH D
Sbjct: 72  -EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRD 127

Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGD 357
           L+ +N+L+ DN+V  ++DF +A+L+  ED   T  Q     I + APE    GR +   D
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 358 VYSFGIMLMETFT-GKKPTNEIFNGEM 383
           V+SFGI+L E  T G+ P   + N E+
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMVNREV 212

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 89.3 bits (221), Expect = 7e-20
 Identities = 72/293 (24%), Positives = 130/293 (44%), Gaps = 50/293 (17%)

Query: 181 IGRGGFGSVYKARLG-DGME----VAVKVF-NLQCGRALKGFDVECEMMKSIRHRNLIKV 234
           +G   FG +YK  L   GM+    VA+K   ++   +    F  E  +M  + H N++ +
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMY----------------SSNYILDIFQRLNIMID 278
           +   + E+   ++ EY+  G L +++                 +    LD    L+I I 
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 279 VASALEYL--HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 336
           +A+ +EYL  HF      +H DL   N+L+ + +   +SD  +++ +   D    Q ++L
Sbjct: 133 IAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPI 395
             I +M PE    G+ S++ D++SFG++L E F+ G +P     N E+            
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV------------ 235

Query: 396 STMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
             +E+V    L          E C   +++L  EC  E P +R   ++I  +L
Sbjct: 236 --IEMVRKRQL------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 59/201 (29%), Positives = 92/201 (45%), Gaps = 20/201 (9%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQ------CGRALKGFDVECEMMKSIRHRNLIK 233
           IG G +G VYKAR    G  VA+K   L+         AL+    E +++K + H N+IK
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIK 62

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
           ++    ++    LV E+M    L K +      L      + +  +   L + H   S  
Sbjct: 63  LLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHG 118

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE--YGREGR 351
           I+H DLKP N+L++   V  L+DF +A+           T  + T  Y APE   G +G 
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGS--PVRPYTHYVVTRWYRAPELLLGDKG- 175

Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            ST  D++S G +  E  + +
Sbjct: 176 YSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 87.8 bits (217), Expect = 1e-19
 Identities = 66/207 (31%), Positives = 106/207 (51%), Gaps = 12/207 (5%)

Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G FG V+        +VAVK   L+ G  + + F  E ++MK +RH  L+++ +  S
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVK--TLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 240 NEEFKALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    +V EYM  GSL  ++       L +   +++   VA+ + Y+        IH D
Sbjct: 72  EEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRD 127

Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGD 357
           L+ +N+L+ D +V  ++DF +A+L+  ED   T  Q     I + APE    GR +   D
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 358 VYSFGIMLMETFT-GKKPTNEIFNGEM 383
           V+SFGI+L E  T G+ P   + N E+
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMNNREV 212

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 87.4 bits (217), Expect = 2e-19
 Identities = 68/216 (31%), Positives = 99/216 (45%), Gaps = 22/216 (10%)

Query: 181 IGRGGFGSVYKA--RLGDGMEVAVKVFNLQCGRALKG---FDVECEMMKSIRHRNLIKVI 235
           +G G FGSV K    +  G EV V V  L+      G   F  E  +M  + H  ++++I
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 236 STCSNEEFKALVLEYMPHGSLEKYM--YSSNYILDIFQRLNIMIDVASALEYL---HFGY 290
             C  E    LV+E  P G L KY+       + D+     +   VA  + YL   HF  
Sbjct: 63  GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDL---KELAHQVAMGMAYLESKHF-- 116

Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-TGEDQSMTQTQTLATIGYMAPEYGRE 349
               +H DL   NVLL +   A +SDF +++ L  G D     T     + + APE    
Sbjct: 117 ----VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172

Query: 350 GRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
           G+ S+  DV+S+G+ L E F+ G KP  E+   E+ 
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI 208

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 11/204 (5%)

Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G FG VYKA+  + G+  A K+  ++    L+ F VE +++   +H N++ +     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
            E    +++E+   G+L+  M      L   Q   +   +  AL +LH   S  +IH DL
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129

Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY-----GREGRVST 354
           K  N+LL  +    L+DF ++       Q   +   + T  +MAPE       ++     
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQK--RDTFIGTPYWMAPEVVACETFKDNPYDY 187

Query: 355 NGDVYSFGIMLMETFTGKKPTNEI 378
             D++S GI L+E    + P +E+
Sbjct: 188 KADIWSLGITLIELAQMEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 86.4 bits (214), Expect = 4e-19
 Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 24/212 (11%)

Query: 180 LIGRGGFGSVYKARLG----DGMEVAVKVFNLQCGRA---------LKGFDVECEMMKSI 226
           LIG G FGSVY   LG     G  +AVK   L    A         L     E  ++K +
Sbjct: 7   LIGSGSFGSVY---LGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63

Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           +H N+++ + +  + +   + LEY+P GS+   + +     +   R N +  +   L YL
Sbjct: 64  QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYL 122

Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT---QTQTL-ATIGYM 342
           H   +  IIH D+K +N+L+D+     +SDF I+K L     S        +L  ++ +M
Sbjct: 123 H---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179

Query: 343 APEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           APE  ++   +   D++S G +++E  TGK P
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 86.4 bits (214), Expect = 6e-19
 Identities = 68/290 (23%), Positives = 123/290 (42%), Gaps = 37/290 (12%)

Query: 174 GFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFN-LQCGRALKGFDVECEMMKSI 226
              E   +GRG FG V+ A+       G    V VK     +       F  E +M + +
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYI--------LDIFQRLNIMID 278
            H+N+++++  C   E   ++LEY   G L++++ ++           L   Q++ +   
Sbjct: 66  SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125

Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT 338
           +A  +++L    +A  +H DL   N L+       +S  S++K      +       L  
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKD-VYNSEYYKLRNALIP 181

Query: 339 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTM 398
           + ++APE  +E   ST  DV+SFG+++ E FT          GE+      ++       
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT---------QGELPFYGLSDE------- 225

Query: 399 EVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
           EV+  N L    +     E C S ++ L   C   +P+ R +  E+V+ L
Sbjct: 226 EVL--NRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 23/206 (11%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-----ECEMMKSIRH---RN 230
           LIGRG +G+VY+ + +  G  VA+K+ NL         DV     E  ++  +R     N
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDT----PDDDVSDIQREVALLSQLRQSQPPN 63

Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY 290
           + K   +        +++EY   GS+   M +   I + +  + I+ +V  AL+Y+H   
Sbjct: 64  ITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP-IAEKYISV-IIREVLVALKYIH--- 118

Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGY-MAPEYGRE 349
              +IH D+K +N+L+ +     L DF +A LL    Q+ ++  T     Y MAPE   E
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN---QNSSKRSTFVGTPYWMAPEVITE 175

Query: 350 GRV-STNGDVYSFGIMLMETFTGKKP 374
           G+   T  D++S GI + E  TG  P
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 66/248 (26%), Positives = 111/248 (44%), Gaps = 33/248 (13%)

Query: 180 LIGRGGFGSVYKARLGD-GMEVAVKVFNL-----QCGRALKGFDVECEMMKSIRHRNLIK 233
           L+G+G FG VY     D G E+AVK         +  + +   + E +++K+++H  +++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
                 ++E  ++ +EYMP GS++  + +   + +   R      +   +EYLH   S  
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLH---SNM 124

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-ATIGYMAPE------Y 346
           I+H D+K +N+L D      L DF  +K L     S T  +++  T  +M+PE      Y
Sbjct: 125 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY 184

Query: 347 GREGRVSTNGDVYSFGIMLMETFTGKKPTNE------IFNGEMTLKHWVNDWLPISTMEV 400
           GR+       DV+S G  ++E  T K P  E      IF          N  LP   +  
Sbjct: 185 GRK------ADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK---IATQPTNPQLPSH-VSP 234

Query: 401 VGANLLSQ 408
              N L +
Sbjct: 235 DARNFLRR 242

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 66/279 (23%), Positives = 111/279 (39%), Gaps = 31/279 (11%)

Query: 180 LIGRGGFGSV----YKARLGDGMEVAVKVF-NLQCGRALKGFDVECEMMKSIRHRNLIKV 234
            +G G FG V    +    G  + VAVK   + +    +  F  E  +M S+ H NLI++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 235 ISTCSNEEFKALVLEYMPHGSL-EKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
                      +V E  P GSL ++    +     I    +  + +A+ + YL    S  
Sbjct: 62  YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKR 117

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAK-LLTGEDQSMTQTQTLATIGYMAPEYGREGRV 352
            IH DL   N+LL  +    + DF + + L   ED  + +        + APE  R    
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177

Query: 353 STNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDI 411
           S   DV+ FG+ L E FT G++P                 W  +S  +++    + +E  
Sbjct: 178 SHASDVWMFGVTLWEMFTYGEEP-----------------WAGLSGSQIL--KKIDKEGE 218

Query: 412 HFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK 450
                E C   ++N+ ++C   +P  R     +   L +
Sbjct: 219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 84.3 bits (208), Expect = 3e-18
 Identities = 75/288 (26%), Positives = 129/288 (44%), Gaps = 40/288 (13%)

Query: 181 IGRGGFGSVYKARLGDG---MEVAVKVFNLQ-CGRA-LKGFDVECEMMKSIRHRNLIKVI 235
           +G G FGSV + +L      ++VAVK   +  C R+ ++ F  E   MK   H N++++I
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 236 STC----SNEEFKA--LVLEYMPHGSLEKYMYSSNY-----ILDIFQRLNIMIDVASALE 284
             C     +E + +  ++L +M HG L  ++  S        L     +  M D+AS +E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 285 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
           YL    S   IH DL   N +L++NM   ++DF ++K +   D           + ++A 
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 345 EYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA 403
           E   +   +T  DV+SFG+ + E  T G+ P   + N E      + D+L          
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE------IYDYLR-------QG 230

Query: 404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
           N L Q          C+  +++L   C + +P+ R +   +  +L K 
Sbjct: 231 NRLKQ-------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 83.9 bits (208), Expect = 3e-18
 Identities = 68/278 (24%), Positives = 128/278 (46%), Gaps = 31/278 (11%)

Query: 178 NNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLI 232
             +IG G FG V + RL       ++VA+K        +    F  E  +M    H N+I
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL-HFGYS 291
           ++    +      ++ EYM +GSL+K++  ++    + Q + ++  +AS ++YL    Y 
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY- 127

Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGR 351
              +H DL   N+L++ N+V  +SDF +++ L   + + T       I + APE     +
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184

Query: 352 VSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED 410
            ++  DV+SFGI++ E  + G++P            +W  D    S  +V+ A    ++ 
Sbjct: 185 FTSASDVWSFGIVMWEVMSYGERP------------YW--DM---SNQDVIKA---VEDG 224

Query: 411 IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
                   C S ++ L ++C  +   +R    +IV+ L
Sbjct: 225 YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 84.3 bits (208), Expect = 4e-18
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 26/209 (12%)

Query: 179 NLIGRGGFGSVYKARL---GDGMEVAVKVFN-LQCGRALKGFDVECEMM-KSIRHRNLIK 233
           ++IG G FG V +A +   G  M  A+K+          + F  E E++ K   H N+I 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYI---------------LDIFQRLNIMID 278
           ++  C N  +  + +EY P+G+L  ++  S  +               L   Q L    D
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT 338
           VA+ ++YL        IH DL   NVL+ +N+ + ++DF +++   GE+  + +T     
Sbjct: 128 VATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLP 181

Query: 339 IGYMAPEYGREGRVSTNGDVYSFGIMLME 367
           + +MA E       +T  DV+SFG++L E
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWE 210

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 83.7 bits (207), Expect = 4e-18
 Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 22/217 (10%)

Query: 175 FSENN---LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRN 230
           + EN    ++G+G +G VY AR L   + +A+K    +  R ++    E  +   ++HRN
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYS------SNYILDIFQRLNIMIDVASALE 284
           +++ + + S   F  + +E +P GSL   + S       N    IF    I+      L+
Sbjct: 67  IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL----EGLK 122

Query: 285 YLHFGYSAPIIHCDLKPSNVLLDD-NMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           YLH      I+H D+K  NVL++  + V  +SDF  +K L G +   T+T T  T+ YMA
Sbjct: 123 YLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN-PCTETFT-GTLQYMA 177

Query: 344 PEYGREGR--VSTNGDVYSFGIMLMETFTGKKPTNEI 378
           PE   +G        D++S G  ++E  TGK P  E+
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 83.5 bits (206), Expect = 4e-18
 Identities = 60/207 (28%), Positives = 108/207 (52%), Gaps = 11/207 (5%)

Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G FG V+     +  +VAVK   L+ G  +++ F  E  +MK+++H  L+++ +  +
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVK--TLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL-NIMIDVASALEYLHFGYSAPIIHCD 298
            EE   ++ EYM  GSL  ++ S      +  +L +    +A  + Y+        IH D
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 128

Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGD 357
           L+ +NVL+ ++++  ++DF +A+++  ED   T  +     I + APE    G  +   D
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 186

Query: 358 VYSFGIMLMETFT-GKKPTNEIFNGEM 383
           V+SFGI+L E  T GK P   + N ++
Sbjct: 187 VWSFGILLYEIVTYGKIPYPGMSNSDV 213

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 83.4 bits (206), Expect = 5e-18
 Identities = 65/261 (24%), Positives = 121/261 (46%), Gaps = 30/261 (11%)

Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G FG V+        +VA+K  +L+ G  + + F  E  +MK ++H  L+++ +  +
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIK--SLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71

Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    ++ EYM +GSL  ++ +   I L I + +++   +A  + ++        IH D
Sbjct: 72  QEPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRD 127

Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
           L+ +N+L+ + +   ++DF +A+L+  +++   +      I + APE    G  +   DV
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186

Query: 359 YSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKE 417
           +SFGI+L E  T G+ P   + N E                  V  NL  +        +
Sbjct: 187 WSFGILLTEIVTYGRIPYPGMTNPE------------------VIQNL--ERGYRMPRPD 226

Query: 418 QCVSCVFNLAMECTVESPEQR 438
            C   ++ L   C  E PE+R
Sbjct: 227 NCPEELYELMRLCWKEKPEER 247

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 83.0 bits (205), Expect = 6e-18
 Identities = 58/209 (27%), Positives = 107/209 (51%), Gaps = 12/209 (5%)

Query: 180 LIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RALKGFDVECEMMKSIRHRNLIKV 234
           +IG G FG V   RL      E+ V +  L+ G   +  + F  E  +M    H N+I +
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLH-FGYSAP 293
               +  +   +V EYM +GSL+ ++   +    + Q + ++  +AS ++YL   GY   
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY--- 127

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQTQTLATIGYMAPEYGREGRV 352
            +H DL   N+L++ N+V  +SDF ++++L  + + + T       I + APE     + 
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186

Query: 353 STNGDVYSFGIMLMETFT-GKKPTNEIFN 380
           ++  DV+S+GI++ E  + G++P  E+ N
Sbjct: 187 TSASDVWSYGIVMWEVMSYGERPYWEMSN 215

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 83.3 bits (206), Expect = 7e-18
 Identities = 73/296 (24%), Positives = 126/296 (42%), Gaps = 58/296 (19%)

Query: 181 IGRGGFGSVYKAR-LG-----DGMEVAVKVFNLQCGRALKG-FDVECEMMKSIRHRNLIK 233
           IG+G FG V++AR  G         VAVK+   +    ++  F  E  +M    H N++K
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYM--------------------YSSNYI-LDIFQR 272
           ++  C+  +   L+ EYM +G L +++                       N + L   ++
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 273 LNIMIDVASALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS 329
           L I   VA+ + YL    F      +H DL   N L+ +NMV  ++DF +++ +   D  
Sbjct: 133 LCIAKQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186

Query: 330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHW 388
                    I +M PE     R +T  DV+++G++L E F+ G +P   + + E+   ++
Sbjct: 187 KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVI--YY 244

Query: 389 VNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREI 444
           V D            N+LS         + C   ++NL   C  + P  R +   I
Sbjct: 245 VRD-----------GNVLS-------CPDNCPLELYNLMRLCWSKLPSDRPSFASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 83.0 bits (205), Expect = 8e-18
 Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 28/214 (13%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIR------HRNLI 232
            +G G F S Y+AR +  G  +AVK        + +  +V   + K IR      H ++I
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 233 KVI-STCSNEEFKALVLEYMPHGS----LEKYMYSSNYILDIFQRLNIMIDVASALEYLH 287
           +++ +TC +  F  L +E+M  GS    L KY      ++     +N    +   L YLH
Sbjct: 67  RMLGATCEDSHFN-LFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLH 120

Query: 288 FGYSAPIIHCDLKPSNVLLDDN-MVAHLSDF-SIAKL---LTGEDQSMTQTQTLATIGYM 342
                 IIH D+K +N+L+D       ++DF + A+L    TG  +   Q Q L TI +M
Sbjct: 121 ---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE--FQGQLLGTIAFM 175

Query: 343 APEYGREGRVSTNGDVYSFGIMLMETFTGKKPTN 376
           APE  R  +   + DV+S G +++E  T K P N
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 82.7 bits (205), Expect = 8e-18
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 35/211 (16%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           IG G +G VYKAR +  G  VA+KV  L+ G   +    E  M+K  RH N++    +  
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLN----------IMIDVASALEYLHFG 289
             +   +V+EY   GSL+          DI+Q             +  +    L YLH  
Sbjct: 71  RRDKLWIVMEYCGGGSLQ----------DIYQVTRGPLSELQIAYVCRETLKGLAYLH-- 118

Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIG---YMAPEY 346
                IH D+K +N+LL ++    L+DF ++  LT    ++ + ++   IG   +MAPE 
Sbjct: 119 -ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLT---ATIAKRKSF--IGTPYWMAPEV 172

Query: 347 G---REGRVSTNGDVYSFGIMLMETFTGKKP 374
               R+G      D+++ GI  +E    + P
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 82.6 bits (204), Expect = 1e-17
 Identities = 65/281 (23%), Positives = 130/281 (46%), Gaps = 32/281 (11%)

Query: 180 LIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RALKGFDVECEMMKSIRHRNLIKV 234
           +IG G FG V + RL      E+ V +  L+ G   +  + F  E  +M    H N+I +
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI 294
               +      ++ E+M +G+L+ ++  ++    + Q + ++  +A+ ++YL        
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNY 127

Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA---TIGYMAPEYGREGR 351
           +H DL   N+L++ N+V  +SDF +++ L  +    T T +L     I + APE     +
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK 187

Query: 352 VSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED 410
            ++  DV+S+GI++ E  + G++P            +W      +S  +V+ A    ++D
Sbjct: 188 FTSASDVWSYGIVMWEVMSYGERP------------YW-----DMSNQDVINA---IEQD 227

Query: 411 IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
                   C + +  L ++C  +    R    +IV+ L K+
Sbjct: 228 YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 82.3 bits (203), Expect = 1e-17
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 26/216 (12%)

Query: 175 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCG------RALKGFDVECEMMKSIRH 228
           +++  ++G+G +G+VY      G  +AVK   L         +  +    E +++KS++H
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMI------DVASA 282
            N+++ + TC ++   ++ +E++P GS+         IL+ F  L   +       +   
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSISS-------ILNRFGPLPEPVFCKYTKQILDG 114

Query: 283 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIG-- 340
           + YLH   +  ++H D+K +NV+L  N +  L DF  A+ L       T +  L ++   
Sbjct: 115 VAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGT 171

Query: 341 --YMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
             +MAPE   E       D++S G  + E  TGK P
Sbjct: 172 PYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 82.9 bits (205), Expect = 1e-17
 Identities = 77/238 (32%), Positives = 112/238 (47%), Gaps = 39/238 (16%)

Query: 170 RATDGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDV----ECEMMK 224
           R  D F     IG G +G VYKAR  D G  VA+K   L   +  +GF +    E ++++
Sbjct: 4   RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILR 61

Query: 225 SIRHRNLIK----VISTCSNEEFKA------LVLEYMPH---GSLEKYM--YSSNYILDI 269
            + HRN++     V       +FK       LV EYM H   G LE  +  +S ++I   
Sbjct: 62  QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF 121

Query: 270 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS 329
            ++L         LE L++ +    +H D+K SN+LL++     L+DF +A+L   E+  
Sbjct: 122 MKQL---------LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172

Query: 330 MTQTQTLATIGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTL 385
              T  + T+ Y  PE   G E R     DV+S G +L E FT KKP   IF     L
Sbjct: 173 P-YTNKVITLWYRPPELLLGEE-RYGPAIDVWSCGCILGELFT-KKP---IFQANQEL 224

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 82.1 bits (203), Expect = 1e-17
 Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 12/203 (5%)

Query: 172 TDGFSENNLIGRGGFGSVYKAR-LGDGMEVA---VKVFNLQCGRALKGFDVECEMMKSIR 227
              F     IG+G F  VYKA  L DG  VA   V++F +   +A +    E +++K + 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 228 HRNLIKVISTCSNEEFKALVLEYMPHGSLE---KYMYSSNYILDIFQRLNIMIDVASALE 284
           H N+IK +++        +VLE    G L    K+      ++         + + SALE
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 285 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
           ++H   S  I+H D+KP+NV +    V  L D  + +  +   ++      + T  YM+P
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSP 175

Query: 345 EYGREGRVSTNGDVYSFGIMLME 367
           E   E   +   D++S G +L E
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYE 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 22/214 (10%)

Query: 181 IGRGGFGSVYKAR---LGDGMEVAVKVFN---LQCGRALKGFDVECEMMKSIRHRNLIKV 234
           I +G +G V+ A+    GD    A+KV     +     +     E +++   +   ++K+
Sbjct: 1   ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI 294
             +   ++   LV+EY+P G L   + +    LD       + ++  ALEYLH   S  I
Sbjct: 59  YYSFQGKKNLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLH---SNGI 114

Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKL------LTGEDQSMTQTQTLATIGYMAPEYGR 348
           IH DLKP N+L+D N    L+DF ++K+      +   D      + + T  Y+APE   
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174

Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
               S   D +S G +L E   G  P    F+GE
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLVGIPP----FHGE 204

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 82.7 bits (204), Expect = 1e-17
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 26/209 (12%)

Query: 179 NLIGRGGFGSVYKARL-GDG--MEVAVKVFNLQCGRA-LKGFDVECEMMKSI-RHRNLIK 233
           ++IG G FG V KAR+  DG  M+ A+K       +   + F  E E++  +  H N+I 
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYI---------------LDIFQRLNIMID 278
           ++  C +  +  L +EY PHG+L  ++  S  +               L   Q L+   D
Sbjct: 73  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT 338
           VA  ++YL        IH DL   N+L+ +N VA ++DF +++   G++  + +T     
Sbjct: 133 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 186

Query: 339 IGYMAPEYGREGRVSTNGDVYSFGIMLME 367
           + +MA E       +TN DV+S+G++L E
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWE 215

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 81.4 bits (201), Expect = 2e-17
 Identities = 53/195 (27%), Positives = 95/195 (48%), Gaps = 6/195 (3%)

Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           +G G FG V+  +    ++VA+K  N +   + + F  E ++M  + H  L+++   C+ 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70

Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 300
           ++   +V E+M +G L  Y+      L     L++  DV   +EYL        IH DL 
Sbjct: 71  QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLA 127

Query: 301 PSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYS 360
             N L+    V  +SDF + + +  +D+  + +     + +  PE     + S+  DV+S
Sbjct: 128 ARNCLVSSTGVVKVSDFGMTRYVL-DDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWS 186

Query: 361 FGIMLMETFT-GKKP 374
           FG+++ E FT GK P
Sbjct: 187 FGVLMWEVFTEGKMP 201

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 81.6 bits (202), Expect = 3e-17
 Identities = 74/232 (31%), Positives = 100/232 (43%), Gaps = 42/232 (18%)

Query: 175 FSENNL-----IGRGGFGSVYKARLGD-GMEVAVK-----VFNLQCGRALKGFDVECEMM 223
           F+  +L     IGRG FG+V K      G  +AVK     V   +  R L   DV   +M
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDV---VM 57

Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK-YMYSSNYILDIFQRLNIMIDVA-- 280
           +S     ++K       E    + +E M   SL+K Y Y    +  +     I+  +A  
Sbjct: 58  RSSDCPYIVKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPE-EILGKIAVA 115

Query: 281 --SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT 338
              AL YL       IIH D+KPSN+LLD N    L DF I+  L     S+ +T+    
Sbjct: 116 TVKALNYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTRDAGC 170

Query: 339 IGYMAPEYGREGRVSTNG--------DVYSFGIMLMETFTGKKPT---NEIF 379
             YMAPE     R+  +         DV+S GI L E  TGK P    N +F
Sbjct: 171 RPYMAPE-----RIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF 217

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 81.7 bits (201), Expect = 3e-17
 Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 16/211 (7%)

Query: 180 LIGRGGFGSVYKA-RLGDG----MEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIK 233
           ++G G FG+VYK   + +G    + VA+K+ N   G +A   F  E  +M S+ H +L++
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
           ++  C +   + LV + MPHG L  Y++     +     LN  + +A  + YL       
Sbjct: 74  LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERR 129

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVS 353
           ++H DL   NVL+       ++DF +A+LL G+++          I +MA E     + +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189

Query: 354 TNGDVYSFGIMLME--TFTGKK----PTNEI 378
              DV+S+G+ + E  TF GK     PT EI
Sbjct: 190 HQSDVWSYGVTIWELMTFGGKPYDGIPTREI 220

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 80.9 bits (200), Expect = 4e-17
 Identities = 64/209 (30%), Positives = 88/209 (42%), Gaps = 14/209 (6%)

Query: 173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAL-KGFDVECEMMKSIRHRN 230
           +   E + +G G  GSV K RL   GM  A+K         L K    E E+ KS +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 231 LIKVISTCSNEEFK--ALVLEYMPHGSLE---KYMYSSNYILDIFQRLNIMIDVASALEY 285
           ++K      +E      + +EY   GSL+   K +      +       I   V   L Y
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120

Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
           LH   S  IIH D+KPSN+LL       L DF ++  L     + T T    T  YMAPE
Sbjct: 121 LH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL-VNSLAGTFT---GTSFYMAPE 173

Query: 346 YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
             +    S   DV+S G+ L+E    + P
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFP 202

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 80.2 bits (198), Expect = 5e-17
 Identities = 60/234 (25%), Positives = 102/234 (43%), Gaps = 21/234 (8%)

Query: 175 FSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKGFDV--ECEMMKSIRHRNL 231
           F   N IG+G FG V+K  R  D    A+K  +L      +  +   E  ++  +    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 232 IKVISTCSNEEFKALVLEYMPHGSLEKYMYS-------SNYILDIFQRLNIMIDVASALE 284
           I+   +  ++    +V+EY  +G L K +          + +   F      I +   L 
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF------IQILLGLA 115

Query: 285 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
           +LH   S  I+H D+K  N+ LD      + D  +AKLL+  D +      + T  Y++P
Sbjct: 116 HLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS--DNTNFANTIVGTPYYLSP 170

Query: 345 EYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTM 398
           E   +   +   DV++ G++L E  TGK P +    G + LK     + P+S M
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQM 224

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 81.8 bits (202), Expect = 5e-17
 Identities = 66/234 (28%), Positives = 110/234 (47%), Gaps = 58/234 (24%)

Query: 170 RATDGFSE---NNLIGRGGFGSVYKAR-LGDGMEVAVKVF--------NLQCGRALKGFD 217
            A    SE    N IG G  G+VYK      G   A+KV           Q  R      
Sbjct: 68  SAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICR------ 121

Query: 218 VECEMMKSIRHRNLIKVISTC-----SNEEFKALVLEYMPHGSLE-KYMYSSNYILDIFQ 271
            E E+++ + H N++K    C      N E + L LE+M  GSLE  ++    ++ D+ +
Sbjct: 122 -EIEILRDVNHPNVVK----CHDMFDHNGEIQVL-LEFMDGGSLEGTHIADEQFLADVAR 175

Query: 272 RLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 331
           +      + S + YLH      I+H D+KPSN+L++      ++DF ++++L    Q+M 
Sbjct: 176 Q------ILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA---QTMD 223

Query: 332 Q-TQTLATIGYMAPEYGREGRVSTN----------GDVYSFGIMLMETFTGKKP 374
               ++ TI YM+PE     R++T+          GD++S G+ ++E + G+ P
Sbjct: 224 PCNSSVGTIAYMSPE-----RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 80.9 bits (200), Expect = 5e-17
 Identities = 68/300 (22%), Positives = 121/300 (40%), Gaps = 45/300 (15%)

Query: 163 FSHLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCG---RALKGFDVE 219
           F  + LC A DG  + +        +     L     VAVKV  L+      A + F  E
Sbjct: 18  FGEVHLCEA-DGLQDFSEKAFAENDNADAPVL-----VAVKV--LRPDASDNAREDFLKE 69

Query: 220 CEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMY--------SSNYILDIFQ 271
            +++  +   N+ +++  C+ +    +++EYM +G L +++          +     +  
Sbjct: 70  VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129

Query: 272 R--LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS 329
              L +   +AS + YL    S   +H DL   N L+  N    ++DF +++ L   D  
Sbjct: 130 STLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYY 186

Query: 330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT--GKKPTNEIFNGEMTLKH 387
             Q +    I +MA E    G+ +T  DV++FG+ L E  T   ++P   + +       
Sbjct: 187 RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD------Q 240

Query: 388 WVNDWLPISTMEVVGANLLSQED---IHFVAKEQCVSCVFNLAMECTVESPEQRINAREI 444
            V        +E   A    ++D   I+      C   ++ L +EC     E R   REI
Sbjct: 241 QV--------IE--NAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 79.8 bits (197), Expect = 9e-17
 Identities = 75/282 (26%), Positives = 125/282 (44%), Gaps = 32/282 (11%)

Query: 179 NLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKGFDVECEMMKSIRHRNLIK 233
            +IG+G FG VY   L    G  +  AVK  N +     ++ F  E  +MK   H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 234 VISTCSNEEFKALV-LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
           ++  C   E   LV L YM HG L  ++ S  +   +   +   + VA  +EYL    S 
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SK 117

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGREG 350
             +H DL   N +LD++    ++DF +A+ +  ++       T A   + +MA E  +  
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177

Query: 351 RVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
           + +T  DV+SFG++L E  T G  P  ++            D   I+   + G  LL   
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRGAPPYPDV------------DSFDITVYLLQGRRLLQ-- 223

Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
                  E C   ++ + + C    PE R    E+V+++ +I
Sbjct: 224 ------PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 80.3 bits (199), Expect = 1e-16
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 25/202 (12%)

Query: 179 NLIGRGGFGSVYKAR-LGDGMEVAVK-VFNLQCGRALKGFDV----ECEMMKSIRHRNLI 232
             +G G +  VYKAR    G  VA+K +   +   A  G +     E ++++ ++H N+I
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
            ++    ++    LV E+M    LEK +   + +L      + M+     LEYLH  +  
Sbjct: 66  GLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW-- 122

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE------- 345
            I+H DLKP+N+L+  + V  L+DF +A+     ++ MT  Q + T  Y APE       
Sbjct: 123 -ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT-HQ-VVTRWYRAPELLFGARH 179

Query: 346 YGREGRVSTNGDVYSFGIMLME 367
           YG         D++S G +  E
Sbjct: 180 YG------VGVDMWSVGCIFAE 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 79.5 bits (196), Expect = 1e-16
 Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 39/219 (17%)

Query: 180 LIGRGGFGSVY---KARLGDGMEVA-VKVFNLQCGR-------ALKGFDVECEMMKSIRH 228
           LIG+G +G VY       G+ M V  V++     GR        +K    E E +K + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGS----LEKYMYSSNYILDIFQRLNIMIDVASALE 284
            N+++ +   + EE+ ++ LEY+P GS    L  Y      ++  F        V   L 
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE-----QVLEGLA 122

Query: 285 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL---LTGEDQSMTQTQTLATIGY 341
           YLH   S  I+H DLK  N+L+D + +  +SDF I+K    +   DQ+M+      ++ +
Sbjct: 123 YLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ---GSVFW 176

Query: 342 MAPE------YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           MAPE       G   +V    D++S G +++E F G++P
Sbjct: 177 MAPEVIHSYSQGYSAKV----DIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 78.8 bits (195), Expect = 2e-16
 Identities = 64/244 (26%), Positives = 100/244 (40%), Gaps = 40/244 (16%)

Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFN---LQCGRALKGFDVECEMMKSIRHRNLIKVIS 236
           +G GGFG V   ++       A+K      +      +    E E+++   H  ++K+  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
           T  ++++  +++EY   G L   +       D +     +  V  A EYLH   +  II+
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGL-FDEYTARFYIACVVLAFEYLH---NRGIIY 116

Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-ATIGYMAPE------YGRE 349
            DLKP N+LLD N    L DF  AK L    +S  +T T   T  Y+APE      Y   
Sbjct: 117 RDLKPENLLLDSNGYVKLVDFGFAKKL----KSGQKTWTFCGTPEYVAPEIILNKGYDF- 171

Query: 350 GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
                + D +S GI+L E  TG+ P    F  +        D  P+     +   L    
Sbjct: 172 -----SVDYWSLGILLYELLTGRPP----FGED--------DEDPMEIYNDI---LKGNG 211

Query: 410 DIHF 413
            + F
Sbjct: 212 KLEF 215

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 33/214 (15%)

Query: 175 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
           F+    IG+G FG VYKA        VA+KV +L+        ++E ++ + I      +
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAED----EIE-DIQQEI------Q 51

Query: 234 VISTCSN-----------EEFK-ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVAS 281
            +S C +           +  K  +++EY   GS    +      LD      I+ +V  
Sbjct: 52  FLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILREVLL 109

Query: 282 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIG 340
            LEYLH       IH D+K +N+LL +     L+DF ++  LT    +M++  T   T  
Sbjct: 110 GLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLT---STMSKRNTFVGTPF 163

Query: 341 YMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           +MAPE  ++       D++S GI  +E   G+ P
Sbjct: 164 WMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 49/206 (23%), Positives = 93/206 (45%), Gaps = 19/206 (9%)

Query: 181 IGRGGFGSVYK---ARLGDG---MEVAVK-VFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
           +G+G FG VY+     +  G     VA+K V      R    F  E  +MK     ++++
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYS--------SNY-ILDIFQRLNIMIDVASALE 284
           ++   S  +   +V+E M  G L+ Y+ S               + + + +  ++A  + 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 285 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
           YL    +   +H DL   N ++ +++   + DF + + +   D      + L  + +MAP
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 345 EYGREGRVSTNGDVYSFGIMLMETFT 370
           E  ++G  +T  DV+SFG++L E  T
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 54/202 (26%), Positives = 100/202 (49%), Gaps = 11/202 (5%)

Query: 180 LIGRGGFGSVYKARL---GDGMEVAVKVFNLQCGRALKGF-DVECEM--MKSIRHRNLIK 233
           L+G G FG+V+K      GD +++ V +  +Q     + F ++   M  M S+ H  +++
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
           ++  C     + LV +  P GSL  ++      LD  + LN  + +A  + YL       
Sbjct: 74  LLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHR 129

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVS 353
           ++H +L   N+LL  + +  ++DF +A LL  +D+    ++    I +MA E    GR +
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYT 189

Query: 354 TNGDVYSFGIMLMETFT-GKKP 374
              DV+S+G+ + E  + G +P
Sbjct: 190 HQSDVWSYGVTVWEMMSYGAEP 211

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 28/205 (13%)

Query: 180 LIGRGGFGSVYKARLGD-GMEVAVKVF-NLQCGRALKGFDV-ECEMMKSIRHRNLIKVIS 236
           L+G G +G V K +  + G  VA+K F   +  + +K   + E  M+K +RH NL+ +I 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 237 TCSNEEFKALVLEYMPH---GSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
               ++   LV E++ H     LEKY       LD  +    +  +   +E+ H   S  
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPNG----LDESRVRKYLFQILRGIEFCH---SHN 120

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE-------Y 346
           IIH D+KP N+L+  + V  L DF  A+ L    +    T  +AT  Y APE       Y
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDYVATRWYRAPELLVGDTKY 178

Query: 347 GREGRVSTNGDVYSFGIMLMETFTG 371
           GR        D+++ G ++ E  TG
Sbjct: 179 GRA------VDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 78.8 bits (194), Expect = 3e-16
 Identities = 58/195 (29%), Positives = 94/195 (48%), Gaps = 8/195 (4%)

Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           IG+G  G+VY A  +  G EVA+K  NLQ     +    E  +M+  +H N++  + +  
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
             +   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH D+
Sbjct: 87  VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 141

Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVY 359
           K  N+LL  +    L+DF     +T E     ++  + T  +MAPE           D++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIW 199

Query: 360 SFGIMLMETFTGKKP 374
           S GIM +E   G+ P
Sbjct: 200 SLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 80.7 bits (199), Expect = 5e-16
 Identities = 38/74 (51%), Positives = 49/74 (66%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           IP E+G +K+L++++LGYN L G IP   G L SL  L+L  NNL+G IP+SL  L  L+
Sbjct: 204 IPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQ 263

Query: 62  NLNLSFNKLEGEIP 75
            L L  NKL G IP
Sbjct: 264 YLFLYQNKLSGPIP 277

Length = 968

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 80.2 bits (198), Expect = 5e-16
 Identities = 42/108 (38%), Positives = 60/108 (55%), Gaps = 6/108 (5%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
            IP +I  L++L+ + L  N ++G IP S G + SL+ L+LS N+ +G+IP SL +L+ L
Sbjct: 433 FIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSL 492

Query: 61  ENLNLSFNKLEGEIPR---GGPFRNFSVESFEGNELLCGSPNLQVPPC 105
             LNL+ N L G +P    G      S  +F  N  LCG P L    C
Sbjct: 493 RILNLNGNSLSGRVPAALGGRLLHRASF-NFTDNAGLCGIPGL--RAC 537

Length = 623

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 77.2 bits (190), Expect = 6e-16
 Identities = 55/193 (28%), Positives = 99/193 (51%), Gaps = 11/193 (5%)

Query: 180 LIGRGGFGSVYKA-RLGDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVIS 236
           ++GRG FG V+   R  D   V +K   ++            EC+++K + H N+I+   
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSS-NYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
               ++   +V+EY P G+L +Y+    N +LD    L+  + +  AL ++H   +  I+
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLIL 123

Query: 296 HCDLKPSNVLLDDN-MVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVST 354
           H DLK  N+LLD + MV  + DF I+K+L+ + ++ T    + T  Y++PE       + 
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYISPELCEGKPYNQ 180

Query: 355 NGDVYSFGIMLME 367
             D+++ G +L E
Sbjct: 181 KSDIWALGCVLYE 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 77.7 bits (191), Expect = 6e-16
 Identities = 66/285 (23%), Positives = 121/285 (42%), Gaps = 37/285 (12%)

Query: 181 IGRGGFGSVYKARL---GD--GMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKV 234
           +G G FG V   R    GD  G +VAVK    +  G  +     E E+++++ H N++K 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 235 ISTCSNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
              C+ +      L++E++P GSL++Y+  +   +++ Q+L   + +   ++YL    S 
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SR 128

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-ATIGYMAPEYGREGR 351
             +H DL   NVL++      + DF + K +  + +  T    L + + + APE   + +
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188

Query: 352 VSTNGDVYSFGIMLMETFT----GKKPTNEIF------NGEMTLKHWVNDWLPISTMEVV 401
                DV+SFG+ L E  T       P           +G+MT+   V            
Sbjct: 189 FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR----------- 237

Query: 402 GANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVA 446
               + +E         C   V+ L  +C    P +R   + ++ 
Sbjct: 238 ----VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 77.4 bits (190), Expect = 9e-16
 Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 29/220 (13%)

Query: 181 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKGFDVECEMMKSI-RHRN 230
           +G G FG V         K +  + + VAVK+       + L     E EMMK I +H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSS-----NYILDI---------FQRL-NI 275
           +I ++  C+ +    +++EY   G+L +Y+ +       Y  DI         F+ L + 
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 276 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 335
              VA  +EYL    S   IH DL   NVL+ +N V  ++DF +A+ +   D     T  
Sbjct: 143 TYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 336 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 374
              + +MAPE   +   +   DV+SFG+++ E FT G  P
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 79.9 bits (197), Expect = 1e-15
 Identities = 41/74 (55%), Positives = 50/74 (67%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           IP EIGGL +L +L L YN L GPIP S G+L +L++L L  N LSG IP S+  L  L 
Sbjct: 228 IPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLI 287

Query: 62  NLNLSFNKLEGEIP 75
           +L+LS N L GEIP
Sbjct: 288 SLDLSDNSLSGEIP 301

Length = 968

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 19/208 (9%)

Query: 179 NLIGRGGFGSVYKA----RLGDG--MEVAVKVFNLQCGRALK-GFDVECEMMKSIRHRNL 231
             +G G FG VY+     R GD   ++VAVK     C    +  F +E  +M    H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 232 IKVISTCSNEEFKALVLEYMPHGSLEKYMYSSN------YILDIFQRLNIMIDVASALEY 285
           +++I        + ++LE M  G L+ ++  +         L +   L    DVA   +Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 286 LHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           L        IH D+   N LL       VA ++DF +A+ +          + +  I +M
Sbjct: 132 LE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188

Query: 343 APEYGREGRVSTNGDVYSFGIMLMETFT 370
            PE   +G  ++  DV+SFG++L E F+
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 64/291 (21%), Positives = 128/291 (43%), Gaps = 46/291 (15%)

Query: 181 IGRGGFGSVYKARL-----GDGME-VAVKVFNLQCGRALKG-FDVECEMMKSIRHRNLIK 233
           +G   FG VYK  L     G+  + VA+K    +    L+  F  E  M   ++H N++ 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMY---------------SSNYILDIFQRLNIMID 278
           ++   + E+  +++  Y  H  L +++                +    L+    ++I+  
Sbjct: 73  LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132

Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT 338
           +A+ +E+L    S  ++H DL   NVL+ D +   +SD  + + +   D       +L  
Sbjct: 133 IAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189

Query: 339 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPIST 397
           I +M+PE    G+ S + D++S+G++L E F+ G +P                 +   S 
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP-----------------YCGYSN 232

Query: 398 MEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
            +V+   ++    +     + C + V+ L +EC  E P +R   ++I ++L
Sbjct: 233 QDVI--EMIRNRQV-LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 75.9 bits (186), Expect = 2e-15
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 26/209 (12%)

Query: 179 NLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCGRA-LKGFDVECEMM-KSIRHRNLIK 233
           ++IG G FG V KAR+   G  M+ A+K       +   + F  E E++ K   H N+I 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYI---------------LDIFQRLNIMID 278
           ++  C +  +  L +EY PHG+L  ++  S  +               L   Q L+   D
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT 338
           VA  ++YL        IH DL   N+L+ +N VA ++DF +++   G++  + +T     
Sbjct: 121 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174

Query: 339 IGYMAPEYGREGRVSTNGDVYSFGIMLME 367
           + +MA E       +TN DV+S+G++L E
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWE 203

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 76.0 bits (188), Expect = 3e-15
 Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 39/211 (18%)

Query: 181 IGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFD---VECEMMKSIRHRNLIKVIS 236
           +G G FG V   R     +  A+K+ +      LK  +    E  +++SIRH  L+ +  
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMI------DVASALEYLHFGY 290
           +  ++    LV+EY+P G L  ++  S        R    +       V  ALEYLH   
Sbjct: 69  SFQDDSNLYLVMEYVPGGELFSHLRKSG-------RFPEPVARFYAAQVVLALEYLH--- 118

Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-ATIGYMAPE---- 345
           S  I++ DLKP N+LLD +    ++DF  AK + G      +T TL  T  Y+APE    
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG------RTYTLCGTPEYLAPEIILS 172

Query: 346 --YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
             YG+        D ++ GI++ E   G  P
Sbjct: 173 KGYGKA------VDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 75.8 bits (187), Expect = 3e-15
 Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 29/206 (14%)

Query: 180 LIGRGGFGSVYKARLGD-GMEVAVKVF------NLQCGRALKGFDVECEMMKSIRHRNLI 232
           ++G G +G V K R    G  VA+K F            AL+    E ++++ +RH N++
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR----EVKVLRQLRHENIV 63

Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
            +      +    LV EY+    LE  + +S   L      + +  +  A+ Y H   S 
Sbjct: 64  NLKEAFRRKGRLYLVFEYVERTLLE-LLEASPGGLPPDAVRSYIWQLLQAIAYCH---SH 119

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE------- 345
            IIH D+KP N+L+ ++ V  L DF  A+ L     S   T  +AT  Y APE       
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAPELLVGDTN 178

Query: 346 YGREGRVSTNGDVYSFGIMLMETFTG 371
           YG+        DV++ G ++ E   G
Sbjct: 179 YGKP------VDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 75.1 bits (184), Expect = 4e-15
 Identities = 72/261 (27%), Positives = 121/261 (46%), Gaps = 30/261 (11%)

Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           +G G FG V+ A      +VAVK        +++ F  E  +MK+++H  L+K+ +  + 
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72

Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL-EYLHFGYSAPIIHCDL 299
           E    ++ E+M  GSL  ++ S        Q L  +ID ++ + E + F      IH DL
Sbjct: 73  EPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 128

Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGDV 358
           + +N+L+  ++V  ++DF +A+++  ED   T  +     I + APE    G  +   DV
Sbjct: 129 RAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 186

Query: 359 YSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKE 417
           +SFGI+LME  T G+ P   + N E+           I  +E                 E
Sbjct: 187 WSFGILLMEIVTYGRIPYPGMSNPEV-----------IRALE---------RGYRMPRPE 226

Query: 418 QCVSCVFNLAMECTVESPEQR 438
            C   ++N+ M C    PE+R
Sbjct: 227 NCPEELYNIMMRCWKNRPEER 247

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 75.4 bits (186), Expect = 4e-15
 Identities = 51/174 (29%), Positives = 85/174 (48%), Gaps = 14/174 (8%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV----ECEMMKSIRHRNLIKVI 235
           IG G  G V+KA+    G  VA+K   L   R   G       E + +++ +H  ++K++
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVAL--RRLEGGIPNQALREIKALQACQHPYVVKLL 65

Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
               +     LV+EYMP   L + +      L   Q  + M  +   + Y+H   +  I+
Sbjct: 66  DVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIM 121

Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE--YG 347
           H DLKP+N+L+  + V  ++DF +A+L + E+     +  +AT  Y APE  YG
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEE-PRLYSHQVATRWYRAPELLYG 174

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 75.2 bits (185), Expect = 4e-15
 Identities = 52/199 (26%), Positives = 88/199 (44%), Gaps = 11/199 (5%)

Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFD---VECEMMKSIRHRNLIKVIS 236
           +G+GGFG V   ++   G   A K  + +  +  KG      E ++++ +  R ++ +  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSAPII 295
               ++   LV+  M  G L+ ++Y+         + +     +   LE+LH      I+
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIV 117

Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 355
           + DLKP NVLLDD+    +SD  +A  L G            T GYMAPE  +      +
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYDFS 174

Query: 356 GDVYSFGIMLMETFTGKKP 374
            D ++ G  L E   G+ P
Sbjct: 175 VDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 73.8 bits (181), Expect = 8e-15
 Identities = 58/202 (28%), Positives = 101/202 (50%), Gaps = 14/202 (6%)

Query: 181 IGRGGFGSV----YKARLGDGMEVAVKVFNLQCGRALKG-FDVECEMMKSIRHRNLIKVI 235
           +G G FG V    YK R    ++VA+KV   +  ++++     E E+M  + +  ++++I
Sbjct: 3   LGSGNFGCVKKGVYKMR-KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
             C  E    LV+E    G L K++      + +   + +M  V+  ++YL        +
Sbjct: 62  GVCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFV 117

Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGREGRVS 353
           H DL   NVLL +   A +SDF ++K L G D S  + ++     + + APE     + S
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKAL-GADDSYYKARSAGKWPLKWYAPECINFRKFS 176

Query: 354 TNGDVYSFGIMLMETFT-GKKP 374
           +  DV+S+GI + E F+ G+KP
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 73.9 bits (181), Expect = 8e-15
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 12/207 (5%)

Query: 175 FSENNLIGRGGFGSVYKAR-LGDGMEVAVK---VFNLQCGRALKGFDVECEMMKSIRHRN 230
           F     IGRG F  VY+A  L DG+ VA+K   +F+L   +A      E +++K + H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLE---KYMYSSNYILDIFQRLNIMIDVASALEYLH 287
           +IK  ++   +    +VLE    G L    K+      ++         + + SALE++H
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123

Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYG 347
              S  ++H D+KP+NV +    V  L D  + +  +   ++      + T  YM+PE  
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSPERI 178

Query: 348 REGRVSTNGDVYSFGIMLMETFTGKKP 374
            E   +   D++S G +L E    + P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 75.1 bits (184), Expect = 8e-15
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 29/220 (13%)

Query: 181 IGRGGFGSVY--------KARLGDGMEVAVKVF-NLQCGRALKGFDVECEMMKSI-RHRN 230
           +G G FG V         K +    + VAVK+  +    + L     E EMMK I +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSS-----NYILD---------IFQRL-NI 275
           +I ++  C+ +    +++EY   G+L +Y+ +      +Y  D          F+ L + 
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 276 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 335
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DF +A+ +   D     T  
Sbjct: 140 AYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 336 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 374
              + +MAPE   +   +   DV+SFG++L E FT G  P
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 76.8 bits (189), Expect = 9e-15
 Identities = 46/117 (39%), Positives = 57/117 (48%), Gaps = 24/117 (20%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           IP+ +G LKNL+YLFL  N+L GPIP S   L  L  L+LS+N+LSG IP  + +L  LE
Sbjct: 252 IPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLE 311

Query: 62  NLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCKTSNHHTLWKNSL 118
            L+L  N   G+IP                  L   P LQV          LW N  
Sbjct: 312 ILHLFSNNFTGKIPVA----------------LTSLPRLQV--------LQLWSNKF 344

Length = 968

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 74.6 bits (183), Expect = 1e-14
 Identities = 69/287 (24%), Positives = 125/287 (43%), Gaps = 32/287 (11%)

Query: 175 FSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKGFDVECEMMKSIRH 228
           F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E  +M S+ +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
            ++ +++  C     + L+ + MP G L  Y+      +     LN  + +A  + YL  
Sbjct: 69  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 126

Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
                ++H DL   NVL+       ++DF +AKLL  +++          I +MA E   
Sbjct: 127 --ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184

Query: 349 EGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS 407
               +   DV+S+G+ + E  T G KP + I   E++           S +E      L 
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SILE--KGERLP 231

Query: 408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI-RD 453
           Q  I       C   V+ + ++C +   + R   RE++ +  K+ RD
Sbjct: 232 QPPI-------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 74.2 bits (182), Expect = 1e-14
 Identities = 64/221 (28%), Positives = 106/221 (47%), Gaps = 31/221 (14%)

Query: 181 IGRGGFGSVYKARLGDGME---------VAVKVF-NLQCGRALKGFDVECEMMKSI-RHR 229
           +G G FG V +A    G++         VAVK+  +    + L     E E+MK I +H+
Sbjct: 20  LGEGCFGQVVRAE-AYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHK 78

Query: 230 NLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSS-----NYILDI---------FQRL-N 274
           N+I ++  C+ E    +++EY   G+L +++ +      +Y  DI         F+ L +
Sbjct: 79  NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138

Query: 275 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ 334
               VA  +EYL    S   IH DL   NVL+ ++ V  ++DF +A+ +   D     + 
Sbjct: 139 CAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195

Query: 335 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 374
               + +MAPE   +   +   DV+SFGI++ E FT G  P
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 70/302 (23%), Positives = 127/302 (42%), Gaps = 54/302 (17%)

Query: 181 IGRGGFGSVYKAR------LGDGMEVAVKVFNLQCGRA-LKGFDVECEMMKSIRHRNLIK 233
           +G G FG V KA             VAVK+       + L+    E  ++K + H ++IK
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSS-----NYILDIFQRLNIMID---------- 278
           +   CS +    L++EY  +GSL  ++  S     +Y+     R +  +D          
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 279 --------VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 330
                   ++  ++YL       ++H DL   NVL+ +     +SDF +++ +  ED  +
Sbjct: 128 DLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWV 389
            +++    + +MA E   +   +T  DV+SFG++L E  T G  P    + G    + + 
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP----YPGIAPERLF- 239

Query: 390 NDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLL 449
                         NLL +        E C   ++NL + C  + P++R    +I  +L 
Sbjct: 240 --------------NLL-KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284

Query: 450 KI 451
           K+
Sbjct: 285 KM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 73.0 bits (179), Expect = 2e-14
 Identities = 70/250 (28%), Positives = 111/250 (44%), Gaps = 31/250 (12%)

Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAL-KGFDVECEMMKSIRHRNLIKVISTC 238
           +G G  G+VYKA  L     +AVKV  L     L K    E E++       +I      
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 239 SNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
             E   ++  E+M  GSL+ Y     ++L       I + V   L YL   +S  I+H D
Sbjct: 69  FVENRISICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYL---WSLKILHRD 120

Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
           +KPSN+L++      L DF ++  L     S+ +T  + T  YMAPE     +   + DV
Sbjct: 121 VKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTY-VGTNAYMAPERISGEQYGIHSDV 176

Query: 359 YSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTME--------VVGANLLSQED 410
           +S GI  ME   G+ P  +I   + +L       +P+  ++        V+     S++ 
Sbjct: 177 WSLGISFMELALGRFPYPQIQKNQGSL-------MPLQLLQCIVDEDPPVLPVGQFSEKF 229

Query: 411 IHFVAKEQCV 420
           +HF+   QC+
Sbjct: 230 VHFIT--QCM 237

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 64/221 (28%), Positives = 100/221 (45%), Gaps = 31/221 (14%)

Query: 181 IGRGGFGSVYKARLGDGME---------VAVKVFNLQCG-RALKGFDVECEMMKSI-RHR 229
           +G G FG V  A    G++         VAVK+       + L     E EMMK I +H+
Sbjct: 26  LGEGCFGQVVMAE-AIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 84

Query: 230 NLIKVISTCSNEEFKALVLEYMPHGSLEKYM---------YSSN------YILDIFQRLN 274
           N+I ++  C+ +    +++EY   G+L +Y+         Y  N        L     ++
Sbjct: 85  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144

Query: 275 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ 334
               VA  +EYL    S   IH DL   NVL+ ++ V  ++DF +A+ +   D     T 
Sbjct: 145 CAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201

Query: 335 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 374
               + +MAPE   +   +   DV+SFG++L E FT G  P
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 73.3 bits (180), Expect = 3e-14
 Identities = 60/240 (25%), Positives = 95/240 (39%), Gaps = 52/240 (21%)

Query: 178 NNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL---------------QCG------RALKG 215
              +G G +G V KA     G  VA+K   +                CG      R LK 
Sbjct: 14  GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK- 72

Query: 216 FDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNI 275
                 +M  I+H N++ ++      +F  LV++ M    L+K +      L   Q   I
Sbjct: 73  ------IMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCI 124

Query: 276 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK-------LLTGEDQ 328
           ++ + + L  LH  Y    +H DL P+N+ ++   +  ++DF +A+         T    
Sbjct: 125 LLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181

Query: 329 SMTQ-----TQTLATIGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTGKK---PTNEI 378
              Q     T  + T+ Y APE   G E +     D++S G +  E  TGK      NEI
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240

Length = 335

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 72.5 bits (178), Expect = 3e-14
 Identities = 61/201 (30%), Positives = 94/201 (46%), Gaps = 17/201 (8%)

Query: 180 LIGRGGFGSVYKARLGDGME-VAVKVFNLQCGRALKGFD---VECEMMKSIRHRNLIKVI 235
            +G G FG V+  R        A+KV  +     LK       E  ++K + H  +I++ 
Sbjct: 8   TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF 67

Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
            T  ++ F  +++EY+P G L  Y+ +S    +         ++  ALEYLH   S  I+
Sbjct: 68  WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALEYLH---SKEIV 123

Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-ATIGYMAPE-YGREGRVS 353
           + DLKP N+LLD      L+DF  AK L        +T TL  T  Y+APE    +G  +
Sbjct: 124 YRDLKPENILLDKEGHIKLTDFGFAKKL------RDRTWTLCGTPEYLAPEVIQSKGH-N 176

Query: 354 TNGDVYSFGIMLMETFTGKKP 374
              D ++ GI++ E   G  P
Sbjct: 177 KAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 72.3 bits (178), Expect = 4e-14
 Identities = 63/225 (28%), Positives = 111/225 (49%), Gaps = 24/225 (10%)

Query: 169 CRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV----ECEMM 223
           CR+ D + + N I  G +G VY+AR    G  VA+K   L+  +  +GF +    E  ++
Sbjct: 1   CRSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALK--KLKMEKEKEGFPITSLREINIL 58

Query: 224 KSIRHRNLIKV--ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVAS 281
             ++H N++ V  +   SN +   +V+EY+ H  L+  M +        +   +M+ + S
Sbjct: 59  LKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLS 117

Query: 282 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGY 341
            + +LH  +   I+H DLK SN+LL++  +  + DF +A+      +    TQ + T+ Y
Sbjct: 118 GVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQLVVTLWY 172

Query: 342 MAPE--YGREGRVSTNGDVYS----FGIMLMET--FTGKKPTNEI 378
            APE   G     ST  D++S    F  +L +   F GK   +++
Sbjct: 173 RAPELLLG-AKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL 216

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 72.3 bits (178), Expect = 6e-14
 Identities = 73/257 (28%), Positives = 118/257 (45%), Gaps = 57/257 (22%)

Query: 179 NLIGRGGFGSVYKA-RLGDGMEVAVKV---FNLQ--CGRALKGFDVECEMMKSIRHRNLI 232
           + IG G +G V  A     G++VA+K    F  Q  C R L+    E ++++  +H N+I
Sbjct: 11  SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR----EIKILRRFKHENII 66

Query: 233 K---VISTCSNEEFKA--LVLEYMPHGSLEKYMYSSNYILD-----IFQRLNIMIDVASA 282
               +I   S E F    +V E M    L K + + +   D     ++Q L         
Sbjct: 67  GILDIIRPPSFESFNDVYIVQELME-TDLYKLIKTQHLSNDHIQYFLYQILR-------G 118

Query: 283 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT-GEDQSMTQTQTLATIGY 341
           L+Y+H   SA ++H DLKPSN+LL+ N    + DF +A++     D +   T+ +AT  Y
Sbjct: 119 LKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWY 175

Query: 342 MAPE-------YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLP 394
            APE       Y      +   D++S G +L E  + +     +F G    K +++    
Sbjct: 176 RAPEIMLNSKGY------TKAIDIWSVGCILAEMLSNRP----LFPG----KDYLHQLNL 221

Query: 395 ISTMEVVGANLLSQEDI 411
           I  + V+G    SQED+
Sbjct: 222 I--LGVLGTP--SQEDL 234

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 71.6 bits (175), Expect = 6e-14
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 19/208 (9%)

Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G FG VYKA+  + G   A KV   +    L+ + VE E++ +  H  ++K++    
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
            +    +++E+ P G+++  M   +  L       I +     LE L + +S  IIH DL
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRGL---TEPQIQVICRQMLEALQYLHSMKIIHRDL 136

Query: 300 KPSNVLLDDNMVAHLSDFSIA----KLLTGEDQSMTQTQTLATIGYMAPEY-----GREG 350
           K  NVLL  +    L+DF ++    K L   D        + T  +MAPE       ++ 
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD------SFIGTPYWMAPEVVMCETMKDT 190

Query: 351 RVSTNGDVYSFGIMLMETFTGKKPTNEI 378
                 D++S GI L+E    + P +E+
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPPHHEL 218

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 71.7 bits (175), Expect = 7e-14
 Identities = 56/195 (28%), Positives = 94/195 (48%), Gaps = 8/195 (4%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           IG+G  G+VY A  +  G EVA++  NLQ     +    E  +M+  ++ N++  + +  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
             +   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142

Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVY 359
           K  N+LL  +    L+DF     +T E     ++  + T  +MAPE           D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIW 200

Query: 360 SFGIMLMETFTGKKP 374
           S GIM +E   G+ P
Sbjct: 201 SLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 71.5 bits (175), Expect = 9e-14
 Identities = 63/245 (25%), Positives = 113/245 (46%), Gaps = 30/245 (12%)

Query: 200 VAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 258
           VAVK+      + A   F  E ++M  +++ N+I+++  C +++   ++ EYM +G L +
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106

Query: 259 YM-----YS----SNYI--LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD 307
           ++      S    +N I  + I   L + + +AS ++YL    S   +H DL   N L+ 
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVG 163

Query: 308 DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 367
           ++    ++DF +++ L   D    Q + +  I +MA E    G+ +T  DV++FG+ L E
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223

Query: 368 TFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ-EDIHFVAKEQCVSCVFN 425
            FT  K+    + + E  +             E  G    +Q   I+      C S VF 
Sbjct: 224 MFTLCKEQPYSLLSDEQVI-------------ENTGEFFRNQGRQIYLSQTPLCPSPVFK 270

Query: 426 LAMEC 430
           L M C
Sbjct: 271 LMMRC 275

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 70.8 bits (173), Expect = 9e-14
 Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 25/213 (11%)

Query: 180 LIGRGGFGSVYKARLGD-GMEVAVKV--FNLQCGRALKGFD-VECE--MMKSIRHRNLIK 233
           L+GRG FG VY     D G E+AVK   F+       K  + +ECE  ++K++RH  +++
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 234 VISTCSNEEFKALVL--EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
                 + E K L +  EYMP GS++  + +   + +   R      +   + YLH   S
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLH---S 124

Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGY-MAPE----- 345
             I+H D+K +N+L D      L DF  +K +     S T  +++    Y M+PE     
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE 184

Query: 346 -YGREGRVSTNGDVYSFGIMLMETFTGKKPTNE 377
            YGR+       DV+S    ++E  T K P  E
Sbjct: 185 GYGRK------ADVWSVACTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 71.3 bits (174), Expect = 1e-13
 Identities = 62/197 (31%), Positives = 98/197 (49%), Gaps = 12/197 (6%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST-- 237
           IG+G  G+V+ A  +  G EVA+K  NLQ     +    E  +MK +++ N++  + +  
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
             +E F  +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   +  +IH 
Sbjct: 87  VGDELF--VVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHR 139

Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 357
           D+K  NVLL  +    L+DF     +T E QS   T  + T  +MAPE           D
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPE-QSKRSTM-VGTPYWMAPEVVTRKAYGPKVD 197

Query: 358 VYSFGIMLMETFTGKKP 374
           ++S GIM +E   G+ P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 70.9 bits (173), Expect = 1e-13
 Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 31/217 (14%)

Query: 175 FSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
           F++   IG+G FG V+K       +V A+K+ +L+        + E E+ + I+    I 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE--------EAEDEI-EDIQQE--IT 54

Query: 234 VISTCSNEEFKA------------LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVAS 281
           V+S C +                 +++EY+  GS    + +  +  D FQ   ++ ++  
Sbjct: 55  VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILK 112

Query: 282 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGY 341
            L+YLH   S   IH D+K +NVLL +     L+DF +A  LT  D  + +   + T  +
Sbjct: 113 GLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFW 167

Query: 342 MAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEI 378
           MAPE  ++    +  D++S GI  +E   G+ P +++
Sbjct: 168 MAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 17/210 (8%)

Query: 175 FSENNL-----IGRGGFGSVYKA------RLGDGMEVAVKVFNLQCGRALK-GFDVECEM 222
           F  NNL     +G G FG V +A      +    M+VAVK+       + +     E ++
Sbjct: 32  FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKI 91

Query: 223 MKSI-RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYS-SNYILDIFQRLNIMIDVA 280
           M  +  H N++ ++  C+      ++ EY  +G L  ++       L +   L+    VA
Sbjct: 92  MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151

Query: 281 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIG 340
             + +L    S   IH DL   NVLL    +  + DF +A+ +  +   + +      + 
Sbjct: 152 KGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK 208

Query: 341 YMAPEYGREGRVSTNGDVYSFGIMLMETFT 370
           +MAPE       +   DV+S+GI+L E F+
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 23/218 (10%)

Query: 181 IGRGGFGSVYKARLGDGME-VAVKVFN---LQCGRALKGFDVECEMMKSIRHRNLIKVIS 236
           +G+GG+G V+ A+  D  E VA+K      L     ++    E +++ + +   L+K++ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLH-FGYSAPII 295
              ++E+  L +EY+P G     + +   + +   R   M ++  A++ LH  GY    I
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARF-YMAEMFEAVDALHELGY----I 123

Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 355
           H DLKP N L+D +    L+DF ++K +     S+     + +  YMAPE  R       
Sbjct: 124 HRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV-----VGSPDYMAPEVLRGKGYDFT 178

Query: 356 GDVYSFGIMLMETFTGKKP-----TNEIFNGEMTLKHW 388
            D +S G ML E   G  P      NE +     LK+W
Sbjct: 179 VDYWSLGCMLYEFLCGFPPFSGSTPNETWE---NLKYW 213

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 12/201 (5%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVK---VFNLQCGRALKGFDVECEMMKSIRHRNLIKVIS 236
           IGRG F  VY+A  L D   VA+K   +F +   +A +    E +++K + H N+IK + 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 237 TCSNEEFKALVLEYMPHGSLE---KYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
           +   +    +VLE    G L    KY      ++         + + SA+E++H   S  
Sbjct: 70  SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRR 126

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVS 353
           ++H D+KP+NV +    V  L D  + +  + +  +      + T  YM+PE   E   +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPERIHENGYN 184

Query: 354 TNGDVYSFGIMLMETFTGKKP 374
              D++S G +L E    + P
Sbjct: 185 FKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 16/212 (7%)

Query: 169 CRATDGFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCGRALKGFDV----ECEMM 223
           CR+   F + N IG G +G VY+AR     E VA+K   +   R   G  +    E  ++
Sbjct: 3   CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER--DGIPISSLREITLL 60

Query: 224 KSIRHRNLIKVISTCSNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVAS 281
            ++RH N++++      +   +  LV+EY     L   + +        Q   +M+ +  
Sbjct: 61  LNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLR 119

Query: 282 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGY 341
            L+YLH  +   IIH DLK SN+LL D     ++DF +A+      + M  T  + T+ Y
Sbjct: 120 GLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM--TPKVVTLWY 174

Query: 342 MAPEYGREGRVSTNG-DVYSFGIMLMETFTGK 372
            APE        T   D+++ G +L E    K
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 56/192 (29%), Positives = 93/192 (48%), Gaps = 12/192 (6%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           IG G +G VYKAR +  G   A+KV  L+ G        E  MMK  +H N++    +  
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
             +   + +E+   GSL+  +Y     L   Q   +  +    L YLH   S   +H D+
Sbjct: 77  RRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDI 132

Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-LATIGYMAPEYG---REGRVSTN 355
           K +N+LL DN    L+DF ++  +T    ++ + ++ + T  +MAPE     R+G  +  
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQITA---TIAKRKSFIGTPYWMAPEVAAVERKGGYNQL 189

Query: 356 GDVYSFGIMLME 367
            D+++ GI  +E
Sbjct: 190 CDIWAVGITAIE 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 70.5 bits (172), Expect = 2e-13
 Identities = 59/195 (30%), Positives = 95/195 (48%), Gaps = 8/195 (4%)

Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           IG+G  G+VY A  +  G EVA+K  NLQ     +    E  +M+  ++ N++  + +  
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
             +   +V+EY+  GSL   +  +   +D  Q   +  +   AL++LH   S  +IH D+
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SNQVIHRDI 141

Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVY 359
           K  N+LL  +    L+DF     +T E QS   T  + T  +MAPE           D++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIW 199

Query: 360 SFGIMLMETFTGKKP 374
           S GIM +E   G+ P
Sbjct: 200 SLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 70.2 bits (172), Expect = 3e-13
 Identities = 70/223 (31%), Positives = 100/223 (44%), Gaps = 24/223 (10%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEM------MKSIRHRNLIK 233
           IG+G FG V  A+   DG   AVKV  LQ    LK  + +  M      +K+++H  L+ 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKV--LQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
           +  +    +    VL+Y+  G L  ++       +   R     ++ASAL YLH   S  
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---SLN 116

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVS 353
           II+ DLKP N+LLD      L+DF + K   G + S T +    T  Y+APE  R+    
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPYD 174

Query: 354 TNGDVYSFGIMLMETFTGKKP-----TNE----IFNGEMTLKH 387
              D +  G +L E   G  P     T E    I N  + LK 
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKP 217

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 69.7 bits (171), Expect = 3e-13
 Identities = 63/213 (29%), Positives = 89/213 (41%), Gaps = 46/213 (21%)

Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVF-----NLQCGR-ALKGFDVECEMMKSIRHRNLIK 233
           IG G +G V+K R  + G  VA+K F     +    + AL+    E  M+K ++H NL+ 
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR----EIRMLKQLKHPNLVN 64

Query: 234 VISTCSNEEFKA-----LVLEYMPH---GSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           +I     E F+      LV EY  H     LEK        +       I+     A+ +
Sbjct: 65  LI-----EVFRRKRKLHLVFEYCDHTVLNELEKNPRG----VPEHLIKKIIWQTLQAVNF 115

Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
            H       IH D+KP N+L+       L DF  A++LTG       T  +AT  Y APE
Sbjct: 116 CH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY--TDYVATRWYRAPE 170

Query: 346 -------YGREGRVSTNGDVYSFGIMLMETFTG 371
                  YG         DV++ G +  E  TG
Sbjct: 171 LLVGDTQYG------PPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 59/195 (30%), Positives = 93/195 (47%), Gaps = 18/195 (9%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G +G VYKAR L  G   AVK+  L+ G        E  M+K  +H N++    +  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
           + E   + +EY   GSL+  +Y     L   Q   +  +    L YLH   S   +H D+
Sbjct: 77  SREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDI 132

Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-LATIGYMAPEYGREGRVSTNG-- 356
           K +N+LL DN    L+DF +A  +T    ++ + ++ + T  +MAPE      V  NG  
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKITA---TIAKRKSFIGTPYWMAPEV---AAVEKNGGY 186

Query: 357 ----DVYSFGIMLME 367
               D+++ GI  +E
Sbjct: 187 NQLCDIWAVGITAIE 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 9/206 (4%)

Query: 175 FSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLI 232
           F++   IG+G FG V+K       +V A+K+ +L+     ++    E  ++       + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
           K   +   +    +++EY+  GS    +      LD  Q   I+ ++   L+YLH   S 
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SE 120

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV 352
             IH D+K +NVLL ++    L+DF +A  LT  D  + +   + T  +MAPE  ++   
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQSAY 178

Query: 353 STNGDVYSFGIMLMETFTGKKPTNEI 378
            +  D++S GI  +E   G+ P +E+
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSEL 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 70.1 bits (172), Expect = 4e-13
 Identities = 63/229 (27%), Positives = 103/229 (44%), Gaps = 51/229 (22%)

Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKGFDV---------ECEMMKSIRHRN 230
           IG G +G V  A     G +VA+K    +   A   FDV         E ++++  +H N
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIK----KIPHA---FDVPTLAKRTLRELKILRHFKHDN 65

Query: 231 L--IKVISTCSNEEFKA--LVLEYMPHGSLEKYMYSS--------NYILDIFQRLNIMID 278
           +  I+ I      +FK   +V++ M    L   ++S          Y L  +Q L     
Sbjct: 66  IIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFL--YQLLR---- 118

Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG--EDQSMTQTQTL 336
               L+Y+H   SA +IH DLKPSN+L++++    + DF +A+ L+    +     T+ +
Sbjct: 119 ---GLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172

Query: 337 ATIGYMAPEYGRE-GRVSTNGDVYS----FGIMLM--ETFTGKKPTNEI 378
           AT  Y APE        +T  D++S    F  ML   + F GK   +++
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL 221

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 69.7 bits (171), Expect = 4e-13
 Identities = 75/263 (28%), Positives = 123/263 (46%), Gaps = 60/263 (22%)

Query: 181 IGRGGFGSVYKARLGD-GMEVAVK----VFN--LQCGRALKGFDVECEMMKSIRHRNLIK 233
           IGRG +G V  A+  +   +VA+K     F+  +   R L+    E ++++ + H N+I 
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR----EIKLLRHLDHENVIA 68

Query: 234 ---VISTCSNEEFKA--LVLEYMPHGSLEKYMYSSNYILD------IFQRLNIMIDVASA 282
              ++     E F    +V E M    L + + SS  + D      ++Q L         
Sbjct: 69  IKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLR-------G 120

Query: 283 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           L+Y+H   SA ++H DLKPSN+LL+ N    + DF +A+  + +   M  T+ + T  Y 
Sbjct: 121 LKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM--TEYVVTRWYR 175

Query: 343 APE-------YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPI 395
           APE       Y       T  DV+S G +  E   G+KP   +F G    K +V+    I
Sbjct: 176 APELLLNCSEYT------TAIDVWSVGCIFAELL-GRKP---LFPG----KDYVHQLKLI 221

Query: 396 STMEVVGANLLSQEDIHFVAKEQ 418
              E++G+   S+ED+ F+  E+
Sbjct: 222 --TELLGSP--SEEDLGFIRNEK 240

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 68.6 bits (167), Expect = 6e-13
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 25/213 (11%)

Query: 180 LIGRGGFGSVYKARLGD-GMEVAVKVFNL-----QCGRALKGFDVECEMMKSIRHRNLIK 233
           L+G+G FG VY     D G E+A K         +  + +   + E +++K+++H  +++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 234 VISTCSNEEFKALV--LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
                 +   K L   +EYMP GS++  + +   + +   R      +   + YLH   S
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLH---S 124

Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGY-MAPE----- 345
             I+H D+K +N+L D      L DF  +K L     S T  +++    Y M+PE     
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184

Query: 346 -YGREGRVSTNGDVYSFGIMLMETFTGKKPTNE 377
            YGR+       DV+S G  ++E  T K P  E
Sbjct: 185 GYGRK------ADVWSLGCTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 68.7 bits (168), Expect = 7e-13
 Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 27/205 (13%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECE-----------MMKSIRH 228
           IG G +G VYKAR    G  VA+K   L         D E E           ++K + H
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRL---------DTETEGVPSTAIREISLLKELNH 58

Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
            N++K++     E    LV E++ H  L+K+M +S  +  I   L I   +   L+ L F
Sbjct: 59  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASP-LSGIPLPL-IKSYLFQLLQGLAF 115

Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
            +S  ++H DLKP N+L++      L+DF +A+      +  T T  + T+ Y APE   
Sbjct: 116 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILL 173

Query: 349 EGRV-STNGDVYSFGIMLMETFTGK 372
             +  ST  D++S G +  E  T +
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 67.9 bits (166), Expect = 8e-13
 Identities = 66/288 (22%), Positives = 122/288 (42%), Gaps = 52/288 (18%)

Query: 181 IGRGGFGSVYKARL---------GDGMEVAVKVFNL-QCGRALKGFDVECEMMKSIRHRN 230
           +G+G F ++YK  L         G G EV+V +  L    R    F     +M  + H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY 290
           L+K+   C  +E   +V EY+  G L+ +++     + +  +L++   +ASAL YL    
Sbjct: 63  LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE--- 118

Query: 291 SAPIIHCDLKPSNVLL---DDNM----VAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
              ++H ++   N+L+     N        LSD  I   +      +++ + +  I ++A
Sbjct: 119 DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV------LSREERVERIPWIA 172

Query: 344 PEYGREGRVSTN--GDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEV 400
           PE  R G+ S     D +SFG  L+E  + G++P + + + E    +     LP+     
Sbjct: 173 PECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPM----- 227

Query: 401 VGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
                    ++             NL  +C    P +R + R I+  L
Sbjct: 228 -----PDCAEL------------ANLINQCWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 68.0 bits (166), Expect = 8e-13
 Identities = 60/229 (26%), Positives = 99/229 (43%), Gaps = 24/229 (10%)

Query: 181 IGRGGFGSVYKARLGDGMEVA-VKVFNLQCGRALKG---FDVECEMMKSIRHRNLIKVIS 236
           IG G FG V       GM  A V V  L+          F  E +  + + H N+++ + 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYIL------DIFQRLNIMIDVASALEYLHFGY 290
            C       LVLE+ P G L+ Y+ S+  ++      D+ QR+    +VAS L +LH   
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLH--- 117

Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE- 349
            A  IH DL   N  L  ++   + D+ +A     ED  +T+      + ++APE     
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 350 ------GRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVND 391
                    +   +++S G+ + E FT   +P  ++ + E  LK  V +
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-EQVLKQVVRE 225

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 68.6 bits (168), Expect = 8e-13
 Identities = 37/109 (33%), Positives = 53/109 (48%), Gaps = 19/109 (17%)

Query: 275 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ 334
           + + +  AL YL   +   +IH D+KPSN+LLD +    L DF I+  L     S  +T+
Sbjct: 119 MTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTR 173

Query: 335 TLATIGYMAPEYGREGRVSTN---------GDVYSFGIMLMETFTGKKP 374
           +     YMAPE     R+             DV+S GI L+E  TG+ P
Sbjct: 174 SAGCAAYMAPE-----RIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 68.4 bits (168), Expect = 9e-13
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 35/215 (16%)

Query: 175 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV----ECEMMKSIR-- 227
           + E   IG G +G+VYKAR L  G  VA+K   +       G  +    E  ++K +   
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE--GIPLSTLREIALLKQLESF 58

Query: 228 -HRNLIKVISTC----SNEEFK-ALVLEYMPHGSLEKYM-------YSSNYILDIFQRLN 274
            H N+++++  C    ++ E K  LV E++    L  Y+            I D+ ++L 
Sbjct: 59  EHPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQL- 116

Query: 275 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ 334
                   +++LH   S  I+H DLKP N+L+  +    ++DF +A++ + E   M  T 
Sbjct: 117 -----LRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE---MALTS 165

Query: 335 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETF 369
            + T+ Y APE   +   +T  D++S G +  E F
Sbjct: 166 VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELF 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 68.0 bits (166), Expect = 9e-13
 Identities = 53/205 (25%), Positives = 100/205 (48%), Gaps = 18/205 (8%)

Query: 180 LIGRGGFGSVYKA--RLGDGMEVAVKVFNLQCGRALK---GFDVECEMMKSIRHRNLIKV 234
           ++G G FG + +   +L    E+ V +  L+ G + K   GF  E   +    H N++++
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL-HFGYSAP 293
               +      +V EYM +G+L+ ++      L   Q + ++  +AS ++YL   GY   
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGY--- 128

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL---ATIGYMAPEYGREG 350
            +H  L    VL++ ++V  +S F   +    ED+S     T+   + + + APE  +  
Sbjct: 129 -VHKGLAAHKVLVNSDLVCKISGFRRLQ----EDKSEAIYTTMSGKSPVLWAAPEAIQYH 183

Query: 351 RVSTNGDVYSFGIMLMETFT-GKKP 374
             S+  DV+SFGI++ E  + G++P
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 70.3 bits (172), Expect = 1e-12
 Identities = 34/74 (45%), Positives = 47/74 (63%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           IP +IG   +L+ L LG N L G IP+S  +L SL+FL L++N L G IP  L ++  L+
Sbjct: 156 IPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLK 215

Query: 62  NLNLSFNKLEGEIP 75
            + L +N L GEIP
Sbjct: 216 WIYLGYNNLSGEIP 229

Length = 968

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 36/214 (16%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV----ECEMMKSIR---HRNLI 232
           IG G +G+VYKAR    G  VA+K   +Q      G  +    E  ++K +    H N++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNE--DGLPLSTVREVALLKRLEAFDHPNIV 65

Query: 233 KVISTC----SNEEFK-ALVLEYMPHGSLEKYM-------YSSNYILDIFQRLNIMIDVA 280
           +++  C    ++ E K  LV E++    L  Y+         +  I D+ ++        
Sbjct: 66  RLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQF------L 118

Query: 281 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIG 340
             L++LH      I+H DLKP N+L+       L+DF +A++ + +   M  T  + T+ 
Sbjct: 119 RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ---MALTPVVVTLW 172

Query: 341 YMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           Y APE   +   +T  D++S G +  E F  +KP
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKP 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 61/213 (28%), Positives = 107/213 (50%), Gaps = 16/213 (7%)

Query: 181 IGRGGFGSV----YKARLGDGMEVAVKVF-NLQCGRALKG-FDVECEMMKSIRHRNLIKV 234
           +G G FG+V    YK +  +   VAVK+  N     ALK     E  +M+ + +  ++++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKT-VAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI 294
           I  C  E +  LV+E    G L K++  + ++ +      ++  V+  ++YL        
Sbjct: 62  IGICEAESW-MLVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLE---ETNF 116

Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGREGRV 352
           +H DL   NVLL     A +SDF ++K L G D++  + +T     + + APE     + 
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKAL-GADENYYKAKTHGKWPVKWYAPECMNYYKF 175

Query: 353 STNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
           S+  DV+SFG+++ E F+ G+KP   +   E+T
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT 208

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 67.1 bits (164), Expect = 1e-12
 Identities = 50/215 (23%), Positives = 91/215 (42%), Gaps = 19/215 (8%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVF---NLQCGRALKGFDVECEMMKSIRHR-NLIKVI 235
           I +G FGSVY A+    G   A+KV    ++     +     E  +M        + K+ 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
            +  ++++  LV+EY+  G     + +   + + + +   + +V   +E LH      II
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-QYIAEVVLGVEDLH---QRGII 119

Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 355
           H D+KP N+L+D      L+DF +++        +   + + T  Y+APE          
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRN------GLENKKFVGTPDYLAPETILGVGDDKM 173

Query: 356 GDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVN 390
            D +S G ++ E   G  P    F+ E     + N
Sbjct: 174 SDWWSLGCVIFEFLFGYPP----FHAETPDAVFDN 204

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 39/104 (37%), Positives = 53/104 (50%), Gaps = 9/104 (8%)

Query: 275 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ 334
           I + +  ALEYLH   S  +IH D+KPSNVL++ N    L DF I+  L     S+ +T 
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLV---DSVAKTI 162

Query: 335 TLATIGYMAPEY----GREGRVSTNGDVYSFGIMLMETFTGKKP 374
                 YMAPE       +       DV+S GI ++E  TG+ P
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 47/192 (24%), Positives = 89/192 (46%), Gaps = 21/192 (10%)

Query: 169 CRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV----ECEMM 223
           C     + +   IG+G FG V+KAR       VA+K   +      +GF +    E +++
Sbjct: 8   CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALK--KVLMENEKEGFPITALREIKIL 65

Query: 224 KSIRHRNLIKVISTCSNE-----EFKA---LVLEYMPHGSLEKYMYSSNYILDIFQRLNI 275
           + ++H N++ +I  C  +      +K    LV E+  H  L   + + N    + +   +
Sbjct: 66  QLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKV 124

Query: 276 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK--LLTGEDQSMTQT 333
           M  + + L Y+H      I+H D+K +N+L+  + +  L+DF +A+   L+   +    T
Sbjct: 125 MKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181

Query: 334 QTLATIGYMAPE 345
             + T+ Y  PE
Sbjct: 182 NRVVTLWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 14/198 (7%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNL--QCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G  G V  A     G +VAVK  +L  Q  R L  F+ E  +M+  +H N++++ S+
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELL-FN-EVVIMRDYQHPNIVEMYSS 84

Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
               +   +V+E++  G+L   +  +   ++  Q   + + V  AL +LH   +  +IH 
Sbjct: 85  YLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLH---AQGVIHR 139

Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGY-MAPEYGREGRVSTNG 356
           D+K  ++LL  +    LSDF     ++ E   + + ++L    Y MAPE        T  
Sbjct: 140 DIKSDSILLTSDGRVKLSDFGFCAQVSKE---VPRRKSLVGTPYWMAPEVISRLPYGTEV 196

Query: 357 DVYSFGIMLMETFTGKKP 374
           D++S GIM++E   G+ P
Sbjct: 197 DIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 67/284 (23%), Positives = 122/284 (42%), Gaps = 38/284 (13%)

Query: 181 IGRGGFGSVY----KARLGDGME--VAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIK 233
           +G+G FG VY    K  + D  E  VA+K  N     R    F  E  +MK     ++++
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYS-----SNYILDIFQRLNIMI----DVASALE 284
           ++   S  +   +++E M  G L+ Y+ S      N  +     L  MI    ++A  + 
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 285 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
           YL+   +   +H DL   N ++ ++    + DF + + +   D      + L  + +M+P
Sbjct: 134 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190

Query: 345 EYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN 404
           E  ++G  +T  DV+SFG++L E  T  +   +  + E  L+             V+   
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF------------VMEGG 238

Query: 405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
           LL + D        C   +F L   C   +P+ R +  EI++ +
Sbjct: 239 LLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 54/205 (26%), Positives = 99/205 (48%), Gaps = 11/205 (5%)

Query: 175 FSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRHRN 230
           F +  ++G+GGFG V   ++   G   A K    +  +  KG  +   E ++++ +  R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFG 289
           ++ +      ++   LVL  M  G L+ ++Y       +  + +    ++   LE LH  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH-- 119

Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 349
               I++ DLKP N+LLDD+    +SD  +A +   E Q++     + T+GYMAPE  + 
Sbjct: 120 -QERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGR--VGTVGYMAPEVVKN 175

Query: 350 GRVSTNGDVYSFGIMLMETFTGKKP 374
            R + + D ++ G +L E   G+ P
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 66/202 (32%), Positives = 93/202 (46%), Gaps = 15/202 (7%)

Query: 180 LIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKGFDVECEM------MKSIRHRNLI 232
           +IG+G FG V  A R  DG   AVKV  LQ    LK  +    M      +K+++H  L+
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKV--LQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
            +  +    E    VL+Y+  G L  ++      L+   R     +VASA+ YLH   S 
Sbjct: 60  GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH---SL 115

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV 352
            II+ DLKP N+LLD      L+DF + K   G +   T +    T  Y+APE  R+   
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPY 173

Query: 353 STNGDVYSFGIMLMETFTGKKP 374
               D +  G +L E   G  P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 17/203 (8%)

Query: 180 LIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMK------SIRHRNLI 232
           ++G+G FG V+ A L G     A+K   L+    L   DVEC M++      +  H  L 
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59

Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
            +  T   +E    V+EY+  G L  +   S +  D+ +      ++   L++LH   S 
Sbjct: 60  HLYCTFQTKENLFFVMEYLNGGDL-MFHIQSCHKFDLPRATFYAAEIICGLQFLH---SK 115

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKL-LTGEDQSMTQTQTLATIGYMAPEYGREGR 351
            I++ DLK  N+LLD +    ++DF + K  + G+ ++ T      T  Y+APE     +
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT---FCGTPDYIAPEILLGQK 172

Query: 352 VSTNGDVYSFGIMLMETFTGKKP 374
            +T+ D +SFG++L E   G+ P
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 66.5 bits (162), Expect = 3e-12
 Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 19/210 (9%)

Query: 181 IGRGGFGSVYKARLGDGM---EVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKVIS 236
           IG G FG V    +  G    +V VK   +    +    F  E +  +S++H NL++ + 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYS----SNYILDIFQRLNIMIDVASALEYLHFGYSA 292
            C+      LV+E+ P G L+ Y+ S         D      +  ++A  L +LH     
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KN 119

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE--G 350
             IH DL   N LL  ++   + D+ ++     ED  +T  Q    + ++APE   E  G
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179

Query: 351 RV-----STNGDVYSFGIMLMETFT-GKKP 374
            +     +   +V+S G+ + E F  G +P
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELFELGSQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 39/221 (17%)

Query: 175 FSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
           F++   IG+G FG VYK       EV A+K+ +L+        + E E+ + I+    I 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE--------EAEDEI-EDIQQE--IT 54

Query: 234 VISTCSNEEFKA------------LVLEYMPHGS----LEKYMYSSNYILDIFQRLNIMI 277
           V+S C +                 +++EY+  GS    L+       YI  I +      
Sbjct: 55  VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR------ 108

Query: 278 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA 337
           ++   L+YLH   S   IH D+K +NVLL +     L+DF +A  LT  D  + +   + 
Sbjct: 109 EILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVG 163

Query: 338 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEI 378
           T  +MAPE  ++       D++S GI  +E   G+ P +++
Sbjct: 164 TPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 67.0 bits (164), Expect = 3e-12
 Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 21/211 (9%)

Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFDVECEMM-KSI-----RHRNLI 232
           ++G+G FG V  A L    E+ AVKV  L+    L+  DVEC M  K +     +H  L 
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKV--LKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59

Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
           ++ S    ++    V+EY+  G L  ++  S    D  +      ++   L++LH     
Sbjct: 60  QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ER 115

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-ATIGYMAPEYGREGR 351
            II+ DLK  NVLLD      ++DF + K       +   T T   T  Y+APE      
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTPDYIAPEILSYQP 172

Query: 352 VSTNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
                D ++ G++L E   G+ P    F G+
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQSP----FEGD 199

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 11/204 (5%)

Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G FG VYKA+  + G+  A KV + +    L+ + VE +++ S  H N++K++    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
            E    +++E+   G+++  M      L   Q   +      AL YLH      IIH DL
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDL 129

Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY-----GREGRVST 354
           K  N+L   +    L+DF ++   T   Q   +   + T  +MAPE       ++     
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPYWMAPEVVMCETSKDRPYDY 187

Query: 355 NGDVYSFGIMLMETFTGKKPTNEI 378
             DV+S GI L+E    + P +E+
Sbjct: 188 KADVWSLGITLIEMAQIEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 66.4 bits (162), Expect = 5e-12
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)

Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFDVECEMMK------SIRHRNLI 232
           ++G+G FG V  A L    E  A+K   L+    L+  DVEC M++      +  H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKA--LKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59

Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
            +  T   +E    V+EY+  G L  ++ SS    D  +      ++   L++LH     
Sbjct: 60  HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR-FDEARARFYAAEIICGLQFLH---KK 115

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKL-LTGEDQSMTQTQTLATIGYMAPEYGREGR 351
            II+ DLK  NVLLD +    ++DF + K  + GE ++ T      T  Y+APE  +  +
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST---FCGTPDYIAPEILKGQK 172

Query: 352 VSTNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
            + + D +SFG++L E   G+ P    F+GE
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSP----FHGE 199

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 66.2 bits (162), Expect = 5e-12
 Identities = 59/231 (25%), Positives = 99/231 (42%), Gaps = 37/231 (16%)

Query: 169 CRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV----ECEMM 223
           C     +     +G G FG VYKAR +  G  VA+K   +   +   GF +    E +++
Sbjct: 4   CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKIL 61

Query: 224 KSIRHRNLIK----VISTCSNEEFKA----LVLEYMPH---GSLEKYMYSSNYILDIFQR 272
           K ++H N++      +      + K     +V  YM H   G LE    + +  L   Q 
Sbjct: 62  KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE----NPSVKLTESQI 117

Query: 273 LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 332
              M+ +   + YLH      I+H D+K +N+L+D+  +  ++DF +A+   G   +   
Sbjct: 118 KCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG 174

Query: 333 ---------TQTLATIGYMAPEY--GREGRVSTNGDVYSFGIMLMETFTGK 372
                    T  + T  Y  PE   G E R +T  D++  G +  E FT +
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPELLLG-ERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 65.9 bits (161), Expect = 6e-12
 Identities = 56/231 (24%), Positives = 101/231 (43%), Gaps = 26/231 (11%)

Query: 173 DGFSENNLIGRGGFGSVYKARLGDGM-----EVAVKVFN-----LQCGRALKGFDVECEM 222
           D  + ++L+  G FG ++   L D       EV VK        +Q    L+    E  +
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQ----ESCL 61

Query: 223 MKSIRHRNLIKVISTCSNEEFKALVLE-YMPHGSLEKYMYSSNYI-------LDIFQRLN 274
           +  + H+N++ ++  C  +     VL  YM  G+L+ ++             L   Q ++
Sbjct: 62  LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVH 121

Query: 275 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ 334
           + I +A  + YLH      +IH D+   N ++D+ +   ++D ++++ L   D       
Sbjct: 122 MAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDN 178

Query: 335 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
               + +MA E       S+  DV+SFG++L E  T G+ P  EI   EM 
Sbjct: 179 ENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA 229

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 65.8 bits (160), Expect = 6e-12
 Identities = 69/284 (24%), Positives = 119/284 (41%), Gaps = 38/284 (13%)

Query: 181 IGRGGFGSVYKARLGDGME------VAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIK 233
           +G+G FG VY+    D ++      VAVK  N     R    F  E  +MK     ++++
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYS-----SNYILDIFQRLNIMI----DVASALE 284
           ++   S  +   +V+E M HG L+ Y+ S      N        L  MI    ++A  + 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 285 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
           YL+   +   +H DL   N ++  +    + DF + + +   D      + L  + +MAP
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 345 EYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN 404
           E  ++G  +T+ D++SFG++L E  +  +   +  + E  LK             V+   
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 238

Query: 405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
            L Q        + C   V +L   C   +P+ R    EIV  L
Sbjct: 239 YLDQ-------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 67.6 bits (165), Expect = 7e-12
 Identities = 33/74 (44%), Positives = 45/74 (60%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           IP  +  L +LE+L L  N+L G IP   G + SLK++ L  NNLSG IP  +  L+ L 
Sbjct: 180 IPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLN 239

Query: 62  NLNLSFNKLEGEIP 75
           +L+L +N L G IP
Sbjct: 240 HLDLVYNNLTGPIP 253

Length = 968

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 65.2 bits (159), Expect = 7e-12
 Identities = 54/198 (27%), Positives = 96/198 (48%), Gaps = 11/198 (5%)

Query: 181 IGRGGFGS--VYKARLGDGMEVAVKVFNLQCGRALKGFDV--ECEMMKSIRHRNLIKVIS 236
           +G+G FG   +Y+ R  D   V  K  NL      +  D   E  ++  ++H N+I   +
Sbjct: 8   LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 237 TCSNEEFKALVLEYMPHGSL-EKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
              ++    + +EY   G+L +K +     + +    L  +  + SA+ Y+H    A I+
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGIL 123

Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 355
           H D+K  N+ L    +  L DF I+K+L G + SM +T  + T  YM+PE  +  + +  
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKIL-GSEYSMAET-VVGTPYYMSPELCQGVKYNFK 181

Query: 356 GDVYSFGIMLMETFTGKK 373
            D+++ G +L E  T K+
Sbjct: 182 SDIWALGCVLYELLTLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 66.1 bits (162), Expect = 7e-12
 Identities = 79/261 (30%), Positives = 116/261 (44%), Gaps = 68/261 (26%)

Query: 181 IGRGGFGSVYKARLGD---GMEVAVKVFNLQCGRALKGFDV------------ECEMMKS 225
           +G+G +G V+KA   D      VA+K          K FD             E   ++ 
Sbjct: 15  LGKGAYGIVWKAI--DRRTKEVVALK----------KIFDAFRNATDAQRTFREIMFLQE 62

Query: 226 IR-HRNLIKVISTCSNEEFKA-------LVLEYMP---HGSLEKYMYSSNYILDIFQRLN 274
           +  H N++K+++       KA       LV EYM    H  +       N + D+ +R  
Sbjct: 63  LGDHPNIVKLLNV-----IKAENDKDIYLVFEYMETDLHAVIRA-----NILEDVHKRY- 111

Query: 275 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT---GEDQSMT 331
           IM  +  AL+Y+H   S  +IH DLKPSN+LL+ +    L+DF +A+ L+      ++  
Sbjct: 112 IMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168

Query: 332 QTQTLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVN 390
            T  +AT  Y APE        T G D++S G +L E   GK     +F G  TL    N
Sbjct: 169 LTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKP----LFPGTSTL----N 220

Query: 391 DWLPISTMEVVGANLLSQEDI 411
               I  +EV+G    S EDI
Sbjct: 221 QLEKI--IEVIGP--PSAEDI 237

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 65.4 bits (159), Expect = 7e-12
 Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 27/214 (12%)

Query: 180 LIGRGGFGSVYKARLGD-GMEVAVKVFNL-----QCGRALKGFDVECEMMKSIRHRNLIK 233
           L+G+G FG VY     D G E+AVK         +  + +   + E +++K++ H  +++
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 234 VISTCSN--EEFKALVLEYMPHGSLEKYMYSSNYILD-IFQRLNIMIDVASALEYLHFGY 290
                 +  E   ++ +E+MP GS++  + S   + + + ++    I     LE + + +
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI-----LEGVSYLH 123

Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGY-MAPE---- 345
           S  I+H D+K +N+L D      L DF  +K L     S T  +++    Y M+PE    
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183

Query: 346 --YGREGRVSTNGDVYSFGIMLMETFTGKKPTNE 377
             YGR+       D++S G  ++E  T K P  E
Sbjct: 184 EGYGRK------ADIWSVGCTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 66.2 bits (162), Expect = 8e-12
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 35/211 (16%)

Query: 179 NLIGRGGFGSVYKARL-GDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVI 235
           + +G G +G V  A     G +VA+K  +   Q     K    E  ++K + H N+I ++
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80

Query: 236 S----TCSNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLN------IMIDVASAL 283
                  S E+F+   LV   M    L   +          Q+L+      ++  +   L
Sbjct: 81  DVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC--------QKLSDDHIQFLVYQILRGL 131

Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           +Y+H   SA IIH DLKPSN+ ++++    + DF +A+     D  M  T  +AT  Y A
Sbjct: 132 KYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT---DDEM--TGYVATRWYRA 183

Query: 344 PE--YGREGRVSTNGDVYSFGIMLMETFTGK 372
           PE         +   D++S G ++ E  TGK
Sbjct: 184 PEIMLNW-MHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 24/206 (11%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G FG +Y A+   D     +K  +L     +  +    E  ++  ++H N++   ++
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67

Query: 238 CSNEEFKALVLEYMPHGSLEK-------YMYSSNYILDIFQRLNIMIDVASALEYLHFGY 290
                   +V+EY   G L K        ++S + IL  F      + ++  L+++H   
Sbjct: 68  FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF------VQISLGLKHIH--- 118

Query: 291 SAPIIHCDLKPSNVLLDDN-MVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGR 348
              I+H D+K  N+ L  N MVA L DF IA+ L   + SM    T   T  Y++PE  +
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL---NDSMELAYTCVGTPYYLSPEICQ 175

Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D++S G +L E  T K P
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 31/209 (14%)

Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFD--------------VECEMMKSI 226
           +G+GGFG V           AV+V N     A K  D              +E E+++ +
Sbjct: 1   LGKGGFGEV----------CAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV 50

Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEY 285
               ++ +     ++    LV+  M  G L+ ++Y+     L++ + ++    +   + +
Sbjct: 51  NSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILH 110

Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
           LH   S  I++ D+KP NVLLDD     LSD  +A  L       T TQ   T GYMAPE
Sbjct: 111 LH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQRAGTNGYMAPE 164

Query: 346 YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
             +E   S   D ++ G  + E   G+ P
Sbjct: 165 ILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 64.9 bits (158), Expect = 1e-11
 Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 16/203 (7%)

Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFD---VECEMMKSIRHRNLIKVIS 236
           +G+GGFG V   ++   G   A K  N +  +  KG++   VE  ++  +  R ++ +  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYS---SNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
               +    LV+  M  G L  ++Y+    N      +       + S LE+LH      
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIA-KLLTGEDQSMTQTQTLA-TIGYMAPEYGREGR 351
           II+ DLKP NVLLD++    +SD  +A +L  G+    ++T+  A T G+MAPE  +   
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ----SKTKGYAGTPGFMAPELLQGEE 173

Query: 352 VSTNGDVYSFGIMLMETFTGKKP 374
              + D ++ G+ L E    + P
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 11/197 (5%)

Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAL-KGFDVECEMMKSIRHRNLIKVISTC 238
           +G G  GSV K   +  G  +A KV ++    ++ K    E ++M   R   ++      
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 239 SNEEFKALVLEYMPHGSLEK-YMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
            NE    + +E+M  GSL++ Y       ++I  +  I + V   L YL+      I+H 
Sbjct: 73  LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLY--NVHRIMHR 128

Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 357
           D+KPSN+L++      L DF ++  L     S+  T  + T  YM+PE  + G+ +   D
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSGELI---NSIADT-FVGTSTYMSPERIQGGKYTVKSD 184

Query: 358 VYSFGIMLMETFTGKKP 374
           V+S GI ++E   GK P
Sbjct: 185 VWSLGISIIELALGKFP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 23/209 (11%)

Query: 173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDV-ECEMMKSIRHRN 230
           D + +   +G G + +VYK +   +G  VA+KV  LQ         + E  ++K ++H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYM-------YSSNYILDIFQRLNIMIDVASAL 283
           ++ +      +E   LV EY+ H  L +YM       +  N  L +FQ L         L
Sbjct: 65  IVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLR-------GL 116

Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
            Y+H  Y   I+H DLKP N+L+ D     L+DF +A+       S T +  + T+ Y  
Sbjct: 117 SYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRP 171

Query: 344 PE-YGREGRVSTNGDVYSFGIMLMETFTG 371
           P+        ST  D++  G + +E   G
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 66.8 bits (163), Expect = 1e-11
 Identities = 52/188 (27%), Positives = 87/188 (46%), Gaps = 16/188 (8%)

Query: 197 GMEVAVKVFNLQCG---RALKGFDVECEMMKSIRHRNLIKVI-STCSNEEFKALVLEYMP 252
           G EVA+K+              F  E  +   + H N++ ++ S  +       V EY+P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 253 HGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDN 309
             +L + + +++  L   +   +M+ V  AL   H   +  I+H DLKP N+++      
Sbjct: 63  GRTLREVL-AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVR 118

Query: 310 MVAHLSDFSIAKLLTGEDQSMTQTQTLAT--IG---YMAPEYGREGRVSTNGDVYSFGIM 364
             A + DF I  LL G   +   T T  T  +G   Y APE  R   V+ N D+Y++G++
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178

Query: 365 LMETFTGK 372
            +E  TG+
Sbjct: 179 FLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 63/218 (28%), Positives = 100/218 (45%), Gaps = 36/218 (16%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC------GRALKGFDVECEMMKSIRHRNLIK 233
           IG G +G VYK R    G  VA+K   L+         A++    E  ++K ++H N++ 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR----EISLLKELQHPNIVC 63

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLH------ 287
           +      E    L+ E++    L+KY+ S              +D      YL+      
Sbjct: 64  LQDVLMQESRLYLIFEFLSM-DLKKYLDSL--------PKGQYMDAELVKSYLYQILQGI 114

Query: 288 -FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE- 345
            F +S  ++H DLKP N+L+D+  V  L+DF +A+      +    T  + T+ Y APE 
Sbjct: 115 LFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--VYTHEVVTLWYRAPEV 172

Query: 346 -YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
             G   R ST  D++S G +  E  T KKP   +F+G+
Sbjct: 173 LLGSP-RYSTPVDIWSIGTIFAEMAT-KKP---LFHGD 205

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 64.9 bits (158), Expect = 1e-11
 Identities = 54/219 (24%), Positives = 98/219 (44%), Gaps = 33/219 (15%)

Query: 181 IGRGGFGSVYKARLGDGME------------------VAVKVFNLQCGR-ALKGFDVECE 221
           +G G FG V+     +GME                  VAVK+      + A   F  E +
Sbjct: 13  LGEGQFGEVHLCEA-EGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 222 MMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYM---------YSSNYILDIFQR 272
           +M  ++  N+I++++ C   +   ++ EYM +G L +++           ++ +   +  
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 273 LNIM-IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 331
           L  M   +AS ++YL    S   +H DL   N L+  N    ++DF +++ L   D    
Sbjct: 132 LIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188

Query: 332 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 370
           Q + +  I +M+ E    G+ +T  DV++FG+ L E  T
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 16/205 (7%)

Query: 181 IGRGGFGSVYKAR-LG---DGMEVAVKVFN----LQCGRALKGFDVECEMMKSIRHRNLI 232
           +G G +G V+  R +G    G   A+KV      +Q  +  +    E ++++++R    +
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 233 KVISTCSNEEFKA-LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
             +      + K  L+L+Y+  G L  ++Y   +  +   R+ I  ++  AL++LH    
Sbjct: 68  VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLH---Q 123

Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGR 351
             II+ D+K  N+LLD      L+DF ++K    E++    +    TI YMAPE  R G 
Sbjct: 124 LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPEVIRGGS 182

Query: 352 VSTNG--DVYSFGIMLMETFTGKKP 374
              +   D +S G++  E  TG  P
Sbjct: 183 GGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 21/211 (9%)

Query: 180 LIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMK----SIRHRN--LI 232
           ++G+G FG V  A L G G   AVK   L+    L   DVEC M++    ++   N  L 
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKA--LKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59

Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
            +  T   +E    V+E++  G L  ++       D+++      ++   L++LH   S 
Sbjct: 60  HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR-FDLYRATFYAAEIVCGLQFLH---SK 115

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKL-LTGEDQSMTQTQTLATIGYMAPEYGREGR 351
            II+ DLK  NV+LD +    ++DF + K  + G++++ T      T  Y+APE  +  +
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST---FCGTPDYIAPEILQGLK 172

Query: 352 VSTNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
            + + D +SFG++L E   G+ P    F+G+
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQSP----FHGD 199

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 13/206 (6%)

Query: 175 FSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRHRN 230
           F +  ++G+GGFG V   ++   G   A K    +  +  KG  +   E ++++ +  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYS-SNYILDIFQRLNIMIDVASALEYLHFG 289
           ++ +      ++   LVL  M  G L+ ++Y+  N   +  + L    ++   LE LH  
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH-- 119

Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA-KLLTGEDQSMTQTQTLATIGYMAPEYGR 348
                ++ DLKP N+LLDD     +SD  +A K+  GE    +    + T+GYMAPE   
Sbjct: 120 -RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE----SIRGRVGTVGYMAPEVLN 174

Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
             R + + D +  G ++ E   G+ P
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 63/200 (31%), Positives = 92/200 (46%), Gaps = 11/200 (5%)

Query: 180 LIGRGGFGSVYKA-RLGDGMEVAVKVFNLQC---GRALKGFDVECE-MMKSIRHRNLIKV 234
           +IG+G FG V  A R  DG   AVKV   +     +  K    E   ++K+++H  L+ +
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI 294
             +    E    VL+++  G L  ++       +   R     ++ASAL YLH   S  I
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SINI 117

Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVST 354
           ++ DLKP N+LLD      L+DF + K   G  QS T T    T  Y+APE  R+     
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175

Query: 355 NGDVYSFGIMLMETFTGKKP 374
             D +  G +L E   G  P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 63.8 bits (155), Expect = 3e-11
 Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 38/214 (17%)

Query: 180 LIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMK-----SIRHRNLIKV 234
           +IGRGGFG VY  R  D      K++ ++C       D +   MK     ++  R ++ +
Sbjct: 1   IIGRGGFGEVYGCRKAD----TGKMYAMKC------LDKKRIKMKQGETLALNERIMLSL 50

Query: 235 IST-------CSNEEFK-----ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASA 282
           +ST       C +  F      + +L+ M  G L  Y  S + +    +      ++   
Sbjct: 51  VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH-YHLSQHGVFSEAEMRFYAAEIILG 109

Query: 283 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ-TLATIGY 341
           LE++H  +   +++ DLKP+N+LLD++    +SD  +A      D S  +   ++ T GY
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVGTHGY 161

Query: 342 MAPEYGREGRV-STNGDVYSFGIMLMETFTGKKP 374
           MAPE  ++G    ++ D +S G ML +   G  P
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 64.1 bits (156), Expect = 3e-11
 Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 30/212 (14%)

Query: 181 IGRGGFGSVYKARLGDGME-VAVKVFNLQCGRAL-KGFDV--ECEMMKSIRHRNLIKVIS 236
           IG G FG+VY AR     E VA+K  +    ++  K  D+  E   ++ +RH N I+   
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDI----FQRLNIMIDVASALEYLHFGYSA 292
               E    LV+EY         + S++ IL++     Q + I      AL+ L + +S 
Sbjct: 83  CYLREHTAWLVMEYC--------LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH 134

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-LATIGYMAPEY---GR 348
             IH D+K  N+LL +     L+DF  A L       ++   + + T  +MAPE      
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFGSASL-------VSPANSFVGTPYWMAPEVILAMD 187

Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFN 380
           EG+     DV+S GI  +E    K P   +FN
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPP---LFN 216

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 66/233 (28%), Positives = 105/233 (45%), Gaps = 43/233 (18%)

Query: 180 LIGRGGFGSVYKARLGDG--------MEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNL 231
           ++G+GG+G V++ R   G        M+V  K   ++  +       E  ++++++H  +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 232 IKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNI-MIDVAS--------A 282
           + +I          L+LEY+  G L  +M+         +R  I M D A         A
Sbjct: 63  VDLIYAFQTGGKLYLILEYLSGGEL--FMH--------LEREGIFMEDTACFYLSEISLA 112

Query: 283 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           LE+LH      II+ DLKP N+LLD      L+DF + K    E  ++T T    TI YM
Sbjct: 113 LEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVTHT-FCGTIEYM 167

Query: 343 APE-YGREGRVSTNGDVYSFGIMLMETFTG---------KKPTNEIFNGEMTL 385
           APE   R G      D +S G ++ +  TG         KK  ++I  G++ L
Sbjct: 168 APEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL 219

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 36/213 (16%)

Query: 180 LIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMK-----SIRHRNLIKV 234
           +IGRGGFG VY  R  D      K++ ++C       D +   MK     ++  R ++ +
Sbjct: 1   IIGRGGFGEVYGCRKAD----TGKMYAMKC------LDKKRIKMKQGETLALNERIMLSL 50

Query: 235 IST-------CSNEEFKA-----LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASA 282
           +ST       C    F        +L+ M  G L  Y  S + +    +      ++   
Sbjct: 51  VSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH-YHLSQHGVFSEKEMRFYATEIILG 109

Query: 283 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           LE++H  +   +++ DLKP+N+LLD++    +SD  +A   + +        ++ T GYM
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGTHGYM 162

Query: 343 APEYGREGRV-STNGDVYSFGIMLMETFTGKKP 374
           APE  ++G    ++ D +S G ML +   G  P
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 55/197 (27%), Positives = 93/197 (47%), Gaps = 11/197 (5%)

Query: 181 IGRGGFGSVYKARLGDGME-VAVKVFNLQCGRALKGFDV-ECEMMKSIRHRNLIKVISTC 238
           +G G + +VYK R     E VA+K  +L          + E  +MK ++H N++++    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 239 SNEEFKALVLEYMPHGSLEKYM--YSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
             E    LV EYM    L+KYM  +     LD     +    +   + + H      ++H
Sbjct: 68  HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLH 123

Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV-STN 355
            DLKP N+L++      L+DF +A+   G   + T +  + T+ Y AP+     R  ST+
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAF-GIPVN-TFSNEVVTLWYRAPDVLLGSRTYSTS 181

Query: 356 GDVYSFGIMLMETFTGK 372
            D++S G ++ E  TG+
Sbjct: 182 IDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 56/196 (28%), Positives = 97/196 (49%), Gaps = 10/196 (5%)

Query: 181 IGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           IG G  G V  AR    G +VAVK+ +L+  +  +    E  +M+  +H+N++++  +  
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
             E   +++E++  G+L   +  S   L+  Q   +   V  AL YLH   S  +IH D+
Sbjct: 89  VGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDI 143

Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGY-MAPEYGREGRVSTNGDV 358
           K  ++LL  +    LSDF     ++   + + + ++L    Y MAPE        T  D+
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQIS---KDVPKRKSLVGTPYWMAPEVISRTPYGTEVDI 200

Query: 359 YSFGIMLMETFTGKKP 374
           +S GIM++E   G+ P
Sbjct: 201 WSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 63.8 bits (155), Expect = 3e-11
 Identities = 55/224 (24%), Positives = 104/224 (46%), Gaps = 41/224 (18%)

Query: 181 IGRGGFGSV-----------------YKARLGDGMEVAVKVFNLQCGR-ALKGFDVECEM 222
           +G G FG V                 +  R G  + VAVK+      + A   F  E ++
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72

Query: 223 MKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQR---------- 272
           +  ++  N+I+++  C +E+   ++ EYM +G L +++ SS+++ D  +           
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL-SSHHLDDKEENGNDAVPPAHC 131

Query: 273 ---------LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 323
                    L++ + +AS ++YL    S   +H DL   N L+ +N+   ++DF +++ L
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188

Query: 324 TGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 367
              D    Q + +  I +MA E    G+ +T  DV++FG+ L E
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWE 232

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 25/206 (12%)

Query: 181 IGRGGFG---SVYKARLGDGMEVAVK----VF-NL-QCGRALKGFDVECEMMKSIRHRN- 230
           IG G FG   SV   R  DG  VA+K    VF NL  C R  +    E +M+   +H N 
Sbjct: 8   IGYGAFGVVWSVTDPR--DGKRVALKKMPNVFQNLVSCKRVFR----ELKMLCFFKHDNV 61

Query: 231 --LIKVISTCSNEEFKAL-VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLH 287
              + ++     + F+ + V+  +    L K + S   +     ++  +  +   L+YLH
Sbjct: 62  LSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKV-FLYQILRGLKYLH 120

Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYG 347
              SA I+H D+KP N+L++ N V  + DF +A+ +   D+S   TQ + T  Y APE  
Sbjct: 121 ---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVTQYYRAPEIL 176

Query: 348 REGRVSTNG-DVYSFGIMLMETFTGK 372
              R  T+  D++S G +  E    +
Sbjct: 177 MGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 64.9 bits (158), Expect = 4e-11
 Identities = 62/219 (28%), Positives = 96/219 (43%), Gaps = 25/219 (11%)

Query: 180 LIGRGGFGSV-YKARLGDGMEVAVKVFNLQ------CGRALKGFD--VECEMMKSIR-HR 229
           ++G G  G+V    R+ DG   AVKV +++        RA       + C+    ++ H 
Sbjct: 39  VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHE 98

Query: 230 NLIKVISTCSNEE---FKALVLEYMPHGSLEKYMYSSNYILDIFQRLN---IMIDVASAL 283
           +  K      N E     ALVL+Y   G L + + S       F+      + I V  A+
Sbjct: 99  DFAK--KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAV 156

Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
            ++H   S  +IH D+K +N+LL  N +  L DF  +K+               T  Y+A
Sbjct: 157 HHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213

Query: 344 PEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
           PE  R    S   D++S G++L E  T K+P    F+GE
Sbjct: 214 PEIWRRKPYSKKADMFSLGVLLYELLTLKRP----FDGE 248

Length = 496

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 62.9 bits (154), Expect = 5e-11
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 37/217 (17%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMM---KSIR----HRNLI 232
           +G G FGSVY AR    G  VA+K       +    ++ EC  +   KS+R    H N++
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWE-ECMNLREVKSLRKLNEHPNIV 61

Query: 233 K---VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLH- 287
           K   V     N+E    V EYM  G+L + M              +I+  +   L ++H 
Sbjct: 62  KLKEVFR--ENDELY-FVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117

Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM-TQTQTLATIGYMAPE- 345
            G+     H DLKP N+L+    V  ++DF +A+    E +S    T  ++T  Y APE 
Sbjct: 118 HGF----FHRDLKPENLLVSGPEVVKIADFGLAR----EIRSRPPYTDYVSTRWYRAPEI 169

Query: 346 YGREGRVSTNGDVYSFGIMLMETFTGKKP----TNEI 378
             R    S+  D+++ G ++ E +T  +P    ++EI
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTL-RPLFPGSSEI 205

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 63.3 bits (154), Expect = 5e-11
 Identities = 42/120 (35%), Positives = 62/120 (51%), Gaps = 19/120 (15%)

Query: 268 DIFQRLN--IMI----------DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLS 315
           D+F RL+  +M           ++A AL++LH   S  II+ DLKP N+LLD+     L+
Sbjct: 84  DLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLT 140

Query: 316 DFSIAKLLTGEDQSMTQTQTLATIGYMAPE-YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           DF ++K     D          T+ YMAPE   R G  + + D +SFG+++ E  TG  P
Sbjct: 141 DFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 6e-11
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 25/214 (11%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC------GRALKGFDVECEMMKSIRHRNLIK 233
           IG G +G VYKAR    G  VA+K   L+         A++    E  ++K + H N+++
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR----EISLLKELNHPNIVR 62

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYS-SNYILDIFQRLNIMIDVASALEYLHFGYSA 292
           ++    +E    LV E++    L+KYM S     LD     + +  +   + Y H   S 
Sbjct: 63  LLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SH 118

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGR- 351
            ++H DLKP N+L+D      L+DF +A+      +  T T  + T+ Y APE     R 
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGSRQ 176

Query: 352 VSTNGDVYSFGIMLMET------FTGKKPTNEIF 379
            ST  D++S G +  E       F G    +++F
Sbjct: 177 YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 62.7 bits (152), Expect = 6e-11
 Identities = 60/255 (23%), Positives = 106/255 (41%), Gaps = 58/255 (22%)

Query: 181 IGRGGFGSVYK--ARLGDGMEVAVKVFNLQCGRALKGFDV-ECEMMKSIRHRNLIKVIST 237
           +G G + +VYK  +R+ +G  VA+KV +++    +    + E  ++K ++H N++ +   
Sbjct: 13  LGEGSYATVYKGISRI-NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71

Query: 238 CSNEEFKALVLEYMPHGSLEKYM-------YSSNYILDIFQRLNIMIDVASALEYLHFGY 290
              +E    V EYM H  L +YM       +  N  L +FQ L         L Y+H  +
Sbjct: 72  IHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLR-------GLAYIHGQH 123

Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP------ 344
              I+H DLKP N+L+       L+DF +A+       S T +  + T+ Y  P      
Sbjct: 124 ---ILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPPDVLLGA 178

Query: 345 -EYGREGRVSTNGDVYSFGIMLMETFTGKK---------------------PTNEIFNGE 382
            +Y      S+  D++  G + +E   G+                      PT + + G 
Sbjct: 179 TDY------SSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGV 232

Query: 383 MTLKHWVNDWLPIST 397
             L ++  +W     
Sbjct: 233 SKLPNYKPEWFLPCK 247

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 64.5 bits (157), Expect = 7e-11
 Identities = 43/100 (43%), Positives = 56/100 (56%), Gaps = 4/100 (4%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDS-FGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
           I + I  L  ++ + L  N+L GPIPD  F    SL++LNLSNNN +G+IP     +  L
Sbjct: 85  ISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRG--SIPNL 142

Query: 61  ENLNLSFNKLEGEIPRG-GPFRNFSVESFEGNELLCGSPN 99
           E L+LS N L GEIP   G F +  V    GN L+   PN
Sbjct: 143 ETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN 182

Length = 968

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 63.0 bits (153), Expect = 8e-11
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)

Query: 180 LIGRGGFGSVYKARLGDG--------MEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNL 231
           ++G G +G V+  R   G        M+V  K   +Q  + ++    E  +++ +R    
Sbjct: 7   VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66

Query: 232 IKVISTCSNEEFKA-LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY 290
           +  +      E K  L+L+Y+  G +  ++Y  +   +   R     ++  ALE+LH   
Sbjct: 67  LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG-EIILALEHLH--- 122

Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR-E 349
              I++ D+K  N+LLD      L+DF ++K    E++  T +    TI YMAPE  R +
Sbjct: 123 KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMAPEIIRGK 181

Query: 350 GRVSTNGDVYSFGIMLMETFTGKKP 374
           G      D +S GI++ E  TG  P
Sbjct: 182 GGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 62.3 bits (151), Expect = 9e-11
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 11/206 (5%)

Query: 180 LIGRGGFGSVYKA-RLGDG----MEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIK 233
           ++G G FG+VYK   + DG    + VA+KV       +A K    E  +M  +    + +
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
           ++  C     + LV + MP+G L  Y+  +   +     LN  + +A  + YL       
Sbjct: 74  LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVR 129

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVS 353
           ++H DL   NVL+       ++DF +A+LL  ++           I +MA E     R +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189

Query: 354 TNGDVYSFGIMLMETFT-GKKPTNEI 378
              DV+S+G+ + E  T G KP + I
Sbjct: 190 HQSDVWSYGVTVWELMTFGAKPYDGI 215

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)

Query: 180 LIGRGGFGSVYKARLGDGME--VAVK---VFNLQCGRALKGFD-------VECEMMK-SI 226
            +G G FG VYK R  +  +  +A+K   V N   G+  +  D        E  ++K  +
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIF--QRL-NIMIDVASAL 283
           RH N+++   T    +   +V++ +    L ++  S       F  +R+ NI + +  AL
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126

Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
            YLH      I+H DL P+N++L ++    ++DF +AK     +  +  T  + TI Y  
Sbjct: 127 RYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKL--TSVVGTILYSC 181

Query: 344 PEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           PE  +        DV++FG +L +  T + P
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 62.2 bits (151), Expect = 1e-10
 Identities = 58/202 (28%), Positives = 92/202 (45%), Gaps = 15/202 (7%)

Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFDVECEMMK------SIRHRNLI 232
           ++G+G FG V  A L    EV A+KV  L+    L+  DV+C M +      + +H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59

Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
            +      ++    V+EY+  G L   +  S    +   R     +V  AL +LH     
Sbjct: 60  ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLH---RH 115

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV 352
            +I+ DLK  N+LLD      L+DF + K   G    +T T    T  Y+APE  +E   
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQELEY 173

Query: 353 STNGDVYSFGIMLMETFTGKKP 374
             + D ++ G+++ E   G+ P
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 63.3 bits (154), Expect = 2e-10
 Identities = 44/113 (38%), Positives = 57/113 (50%), Gaps = 2/113 (1%)

Query: 7   GGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLS 66
           G + NLE L L  N L G IP+  G   SLK L+L  N L G IP SL  L+ LE L L+
Sbjct: 137 GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLA 196

Query: 67  FNKLEGEIPRG-GPFRNFSVESFEGNELLCGSPNLQVPPCKTSNHHTLWKNSL 118
            N+L G+IPR  G  ++        N L    P  ++    + NH  L  N+L
Sbjct: 197 SNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPY-EIGGLTSLNHLDLVYNNL 248

Length = 968

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 67/227 (29%), Positives = 100/227 (44%), Gaps = 24/227 (10%)

Query: 180 LIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMK------SIRHRNLI 232
           ++G+G FG V  ARL   G   AVKV  L+    L+  DVEC M +      +  H  L 
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 59

Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
           ++       +    V+E++  G L  ++  S    +   R     ++ SAL +LH     
Sbjct: 60  QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEITSALMFLH---DK 115

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV 352
            II+ DLK  NVLLD      L+DF + K   G     T +    T  Y+APE  +E   
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEMLY 173

Query: 353 STNGDVYSFGIMLMETFTGKKP---TNE------IFNGEMTLKHWVN 390
             + D ++ G++L E   G  P    NE      I N E+    W++
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLS 220

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 10/201 (4%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G+G +G V   R   DG +  +K  NL+    R  K  + E +++  ++H N++    +
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 238 CSNEE-FKALVLEYMPHGSL-EKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
              E+    +V+ +   G L  K       +L   Q +   + +A AL+YLH      I+
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHIL 124

Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 355
           H DLK  NV L    +  + D  IA++L  E+Q    +  + T  YM+PE       +  
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQCDMASTLIGTPYYMSPELFSNKPYNYK 182

Query: 356 GDVYSFGIMLMETFTGKKPTN 376
            DV++ G  + E  T K   N
Sbjct: 183 SDVWALGCCVYEMATLKHAFN 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 18/207 (8%)

Query: 180 LIGRGGFGSVYKARLGDG--------MEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNL 231
           ++G G +G V+  R   G        M+V  K   +Q  +  +    E ++++ IR    
Sbjct: 7   VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66

Query: 232 IKVISTCSNEEFKA-LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMI-DVASALEYLHFG 289
           +  +      + K  L+L+Y+  G L  ++       +  Q + I   ++  ALE+LH  
Sbjct: 67  LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE--QEVQIYSGEIVLALEHLH-- 122

Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 349
               II+ D+K  N+LLD N    L+DF ++K    ED+         TI YMAP+  R 
Sbjct: 123 -KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH-EDEVERAYSFCGTIEYMAPDIVRG 180

Query: 350 GRVSTNG--DVYSFGIMLMETFTGKKP 374
           G    +   D +S G+++ E  TG  P
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 36/220 (16%)

Query: 181 IGRGGFGSVYKAR--LGDGMEVAVKVFNLQCGRALKGFDVECEM-----MKSIRHRNLIK 233
           IG G +G V+KAR     G  VA+K   +Q G          E+     +++  H N+++
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 234 VISTCS----NEEFK-ALVLEYMPHGSLEKYM-------YSSNYILDIFQRLNIMIDVAS 281
           +   C+    + E K  LV E++    L  Y+         +  I D+      M  +  
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM------MFQLLR 121

Query: 282 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGY 341
            L++LH   S  ++H DLKP N+L+  +    L+DF +A++ + +   M  T  + T+ Y
Sbjct: 122 GLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWY 175

Query: 342 MAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNG 381
            APE   +   +T  D++S G +  E F  +KP   +F G
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP---LFRG 211

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 60.9 bits (148), Expect = 4e-10
 Identities = 63/229 (27%), Positives = 97/229 (42%), Gaps = 52/229 (22%)

Query: 173 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKS------- 225
           + F    +IGRG FG V   R     + + +V+ ++    L  F    EM+K        
Sbjct: 43  EDFDVIKVIGRGAFGEVQLVR----HKSSKQVYAMKL---LSKF----EMIKRSDSAFFW 91

Query: 226 -----IRHRNLIKVISTC---SNEEFKALVLEYMPHGSLEKYMYSSNY-ILDIFQRLNIM 276
                + H N   ++       ++++  +V+EYMP G L   M  SNY I + + R    
Sbjct: 92  EERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNYDIPEKWARFYTA 149

Query: 277 IDVASALEYLH-FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 335
            +V  AL+ +H  G+    IH D+KP N+LLD +    L+DF     +         T  
Sbjct: 150 -EVVLALDAIHSMGF----IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT-A 203

Query: 336 LATIGYMAPE----------YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           + T  Y++PE          YGRE       D +S G+ L E   G  P
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRE------CDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 60.1 bits (146), Expect = 5e-10
 Identities = 44/148 (29%), Positives = 76/148 (51%), Gaps = 15/148 (10%)

Query: 181 IGRGGFGSVYKARLGDGME-VAVKVFNLQC------GRALKGFDVECEMMKSIRHRNLIK 233
           IG G +G+V+KA+  +  E VA+K   L          AL+    E  ++K ++H+N+++
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKELKHKNIVR 63

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
           +     +++   LV EY     L+KY  S N  +D     + M  +   L + H   S  
Sbjct: 64  LYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHN 119

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAK 321
           ++H DLKP N+L++ N    L+DF +A+
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 60.4 bits (146), Expect = 6e-10
 Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 20/206 (9%)

Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKV---FNLQCGRALKGFDVECEMMKSIRHRNLIKVI 235
           +IGRG FG V   R     +V A+K+   F +        F  E ++M       ++++ 
Sbjct: 50  VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLN--IMIDVASALEYLHFGYSAP 293
               ++++  +V+EYMP G L   M  SNY  D+ ++       +V  AL+ +H   S  
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLM--SNY--DVPEKWAKFYTAEVVLALDAIH---SMG 162

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-LATIGYMAPEY----GR 348
           +IH D+KP N+LLD +    L+DF     +  ++  M +  T + T  Y++PE     G 
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRCDTAVGTPDYISPEVLKSQGG 220

Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
           +G      D +S G+ L E   G  P
Sbjct: 221 DGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 60.4 bits (147), Expect = 6e-10
 Identities = 58/229 (25%), Positives = 92/229 (40%), Gaps = 41/229 (17%)

Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKVFN-----LQCGRALKGFDVECEMMKSIRHRNLIK 233
           +IGRG FG V+  R  D  +V A+KV        +   A      E +++       ++K
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH--VRAERDILADADSPWIVK 65

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLH-FGYSA 292
           +  +  +EE   LV+EYMP G L   +   +   +   R  I  ++  AL+ +H  G+  
Sbjct: 66  LYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA-ELVLALDSVHKLGF-- 122

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAK------------LLTGEDQSMTQTQ------ 334
             IH D+KP N+L+D +    L+DF + K              +                
Sbjct: 123 --IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180

Query: 335 ---------TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
                    T+ T  Y+APE  R        D +S G++L E   G  P
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 59.6 bits (144), Expect = 6e-10
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 13/206 (6%)

Query: 175 FSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRHRN 230
           F    ++G+GGFG V   ++   G   A K    +  +  KG  +   E  +++ +  R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYS-SNYILDIFQRLNIMIDVASALEYLHFG 289
           ++ +      ++   LVL  M  G L+ ++Y+  N   D  + +    ++   LE L   
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ-- 119

Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA-KLLTGEDQSMTQTQTLATIGYMAPEYGR 348
               I++ DLKP N+LLDD     +SD  +A ++  GE    T    + T+GYMAPE   
Sbjct: 120 -RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE----TVRGRVGTVGYMAPEVIN 174

Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
             + + + D +  G ++ E   G+ P
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 59.8 bits (145), Expect = 7e-10
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 42/219 (19%)

Query: 172 TDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV---------ECE 221
           T+ + +   +G G FG V  AR    G  VA+K       + +K F           E +
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIK-------KIMKPFSTPVLAKRTYRELK 61

Query: 222 MMKSIRHRNLIKVIST-CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVA 280
           ++K +RH N+I +     S  E    V E +  G+    + +S  +   F +   +  + 
Sbjct: 62  LLKHLRHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQY-FLYQIL 118

Query: 281 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIG 340
             L+Y+H   SA ++H DLKPSN+L+++N    + DF +A++   +D  M  T  ++T  
Sbjct: 119 RGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQM--TGYVSTRY 170

Query: 341 YMAPE-------YGREGRVSTNGDVYSFGIMLMETFTGK 372
           Y APE       Y  E       D++S G +  E   GK
Sbjct: 171 YRAPEIMLTWQKYDVE------VDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 59.4 bits (144), Expect = 7e-10
 Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 26/215 (12%)

Query: 181 IGRGGFGSVYKARLGDGME-VAVKVFNLQ------CGRALKGFDVECEMMKSIRHRNLIK 233
           IG G +G VYKAR     E +A+K   L+         A++    E  ++K ++H N+++
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR----EISLLKEMQHGNIVR 65

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSS-NYILDIFQRLNIMIDVASALEYLHFGYSA 292
           +     +E+   LV EY+    L+K+M SS ++  +       +  +   + Y H   S 
Sbjct: 66  LQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SH 121

Query: 293 PIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGR 351
            ++H DLKP N+L+D    A  L+DF +A+      +  T T  + T+ Y APE     R
Sbjct: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR--TFTHEVVTLWYRAPEILLGSR 179

Query: 352 -VSTNGDVYSFGIMLMET------FTGKKPTNEIF 379
             ST  D++S G +  E       F G    +E+F
Sbjct: 180 HYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF 214

Length = 294

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 59.7 bits (144), Expect = 7e-10
 Identities = 68/267 (25%), Positives = 119/267 (44%), Gaps = 28/267 (10%)

Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           IG G  G V  A     G +VAVK  +L+  +  +    E  +M+   H N++ + ++  
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
             +   +V+E++  G+L   +  +   ++  Q   + + V  AL YLH   +  +IH D+
Sbjct: 90  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDI 144

Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVY 359
           K  ++LL  +    LSDF     ++ E     +   + T  +MAPE        T  D++
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEVDIW 202

Query: 360 SFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ-EDIHFVAKEQ 418
           S GIM++E   G+ P    FN             P+  M  +  NL  + +D H V+   
Sbjct: 203 SLGIMVIEMIDGEPP---YFNEP-----------PLQAMRRIRDNLPPRVKDSHKVS--S 246

Query: 419 CVSCVFNLAMECTVESPEQRINAREIV 445
            +    +L +   V  P QR  A+E++
Sbjct: 247 VLRGFLDLML---VREPSQRATAQELL 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 60.4 bits (146), Expect = 7e-10
 Identities = 69/225 (30%), Positives = 110/225 (48%), Gaps = 29/225 (12%)

Query: 179 NLIGRGGFGSVYKARLGDGME-VAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           N+IG G FG VY+A   D  E VA+K    +  +  +  + E  +MK++ H N+I +   
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIK----KVLQDPQYKNRELLIMKNLNHINIIFLKDY 127

Query: 238 CSNEEFKA--------LVLEYMPHGSLEKYM--YS-SNYILDIFQRLNIMIDVASALEYL 286
              E FK         +V+E++P  ++ KYM  Y+ +N+ L +F        +  AL Y+
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186

Query: 287 HFGYSAPIIHCDLKPSNVLLDDNM-VAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
           H   S  I H DLKP N+L+D N     L DF  AK L    +S++    + +  Y APE
Sbjct: 187 H---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY---ICSRFYRAPE 240

Query: 346 YGR-EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWV 389
                   +T+ D++S G ++ E   G      IF+G+ ++   V
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILGYP----IFSGQSSVDQLV 281

Length = 440

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 59.5 bits (144), Expect = 1e-09
 Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 11/153 (7%)

Query: 218 VECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYI--LDIFQRLNI 275
           +E  +++++ H ++I++  T  +     +VL   PH S + Y Y +     L I Q L I
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMVL---PHYSSDLYTYLTKRSRPLPIDQALII 162

Query: 276 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 335
              +   L YLH   +  IIH D+K  N+ ++D     + D   A+        +    T
Sbjct: 163 EKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGT 219

Query: 336 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMET 368
           + T    APE     + ++  D++S GI+L E 
Sbjct: 220 VET---NAPEVLARDKYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 60/254 (23%), Positives = 105/254 (41%), Gaps = 42/254 (16%)

Query: 155 PSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRAL 213
           P  ++W+  S  E+            +G G FG V  A+  G G   A+K    +    +
Sbjct: 10  PDTSSWK-LSDFEM---------GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKM 59

Query: 214 KGFD---VECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSS----NYI 266
           K       E  ++  + H  ++ ++ +  +E     +LE++  G L  ++  +    N +
Sbjct: 60  KQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDV 119

Query: 267 LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE 326
              +       ++  A EYLH   S  II+ DLKP N+LLD+     ++DF  AK +   
Sbjct: 120 AKFYH-----AELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP-- 169

Query: 327 DQSMTQTQTL-ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP---------TN 376
                +T TL  T  Y+APE  +        D ++ G++L E   G  P           
Sbjct: 170 ----DRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYE 225

Query: 377 EIFNGEMTLKHWVN 390
           +I  G +   +W +
Sbjct: 226 KILAGRLKFPNWFD 239

Length = 329

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 53.7 bits (130), Expect = 1e-09
 Identities = 25/60 (41%), Positives = 33/60 (55%)

Query: 11 NLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKL 70
          NL+ L L  NRL      +F  L +LK L+LS NNL+   P +   L  L +L+LS N L
Sbjct: 1  NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 63/232 (27%), Positives = 100/232 (43%), Gaps = 26/232 (11%)

Query: 175 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL---QCGRALKGFDVECEMMKSIRHRN 230
           FS+   IG G FG+VY AR + +   VA+K  +    Q     +    E   ++ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDI----FQRLNIMIDVASALEYL 286
            I+       E    LV+EY         + S++ +L++     Q + I      AL+ L
Sbjct: 77  TIQYRGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128

Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
            + +S  +IH D+K  N+LL +  +  L DF  A ++   +        + T  +MAPE 
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYWMAPEV 182

Query: 347 ---GREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPI 395
                EG+     DV+S GI  +E    +KP     N    L H   +  P 
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMSALYHIAQNESPA 233

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 13/206 (6%)

Query: 175 FSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
           F    ++G+GGFG V   ++   G   A K    +  +  KG  +     + +   N   
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 234 VISTCSNEEFK---ALVLEYMPHGSLEKYMYS-SNYILDIFQRLNIMIDVASALEYLHFG 289
           V+S     E K    LVL  M  G L+ ++Y+  N   D  + +    ++   LE LH  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH-- 119

Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA-KLLTGEDQSMTQTQTLATIGYMAPEYGR 348
               I++ DLKP N+LLDD     +SD  +A ++  GE    T    + T+GYMAPE  +
Sbjct: 120 -RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE----TIRGRVGTVGYMAPEVVK 174

Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
             R + + D +  G ++ E   GK P
Sbjct: 175 NERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 62/237 (26%), Positives = 94/237 (39%), Gaps = 56/237 (23%)

Query: 171 ATDGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIR-- 227
            T  F    +IG G +G VYKAR    G  VA+K+            D+  +  + I+  
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIM-----------DIIEDEEEEIKEE 52

Query: 228 ---------HRNL-------IKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQ 271
                    H N+       IK     ++++   LV+E    GS+   +     +    +
Sbjct: 53  YNILRKYSNHPNIATFYGAFIKKNPPGNDDQL-WLVMELCGGGSVTDLV---KGLRKKGK 108

Query: 272 RLN------IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG 325
           RL       I+ +    L YLH      +IH D+K  N+LL  N    L DF ++  L  
Sbjct: 109 RLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL-- 163

Query: 326 EDQSMTQTQTLATIG---YMAPE-----YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
            D ++ +  T   IG   +MAPE        +       DV+S GI  +E   GK P
Sbjct: 164 -DSTLGRRNT--FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 58.2 bits (140), Expect = 2e-09
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 28/217 (12%)

Query: 175 FSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNL---QCGRALKGFDVECEMMKSIRHRN 230
           F++   IG G FG+VY AR     EV A+K  +    Q     +    E + ++ I+H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVAS----ALEYL 286
            I+       E    LV+EY         + S++ +L++ ++    +++A+    AL+ L
Sbjct: 87  SIEYKGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAITHGALQGL 138

Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
            + +S  +IH D+K  N+LL +     L+DF  A + +  +        + T  +MAPE 
Sbjct: 139 AYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN------SFVGTPYWMAPEV 192

Query: 347 ---GREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFN 380
                EG+     DV+S GI  +E    K P   +FN
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFN 226

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 15/211 (7%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEM------MKSIRHRNLI 232
           +IG+G FG V  AR   +    AVKV  LQ    LK  + +  M      +K+++H  L+
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59

Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
            +  +    +    VL+Y+  G L  ++      L+   R     ++ASAL YLH   S 
Sbjct: 60  GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SL 115

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV 352
            I++ DLKP N+LLD      L+DF + K     + + T +    T  Y+APE   +   
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPY 173

Query: 353 STNGDVYSFGIMLMETFTGKKPTNEIFNGEM 383
               D +  G +L E   G  P       EM
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 38/127 (29%), Positives = 63/127 (49%), Gaps = 7/127 (5%)

Query: 248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD 307
           +E+M  GSL++ +  +  I +      I I V   L YL   +   I+H D+KPSN+L++
Sbjct: 78  MEHMDGGSLDQVLKKAGRIPENILG-KISIAVLRGLTYLREKHK--IMHRDVKPSNILVN 134

Query: 308 DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 367
                 L DF ++  L     SM  +  + T  YM+PE  +    +   D++S G+ L+E
Sbjct: 135 SRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVE 190

Query: 368 TFTGKKP 374
              G+ P
Sbjct: 191 MAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 62/224 (27%), Positives = 104/224 (46%), Gaps = 40/224 (17%)

Query: 181 IGRGGFGSVYKAR---LGDGMEVAVK----VFN--LQCGRALKGFDVECEMMKSIR-HRN 230
           +G+G +G V  AR     +   VA+K    VF+  +   RAL+    E ++++  R H+N
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR----ELKLLRHFRGHKN 63

Query: 231 LIKVIST--CSNEEFKALVL-EYMPHGSLEKYMYSSNYILD------IFQRLNIMIDVAS 281
           +  +          F  L L E +    L + + S   + D      I+Q L        
Sbjct: 64  ITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQIL-------C 116

Query: 282 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG--EDQSMTQTQTLATI 339
            L+Y+H   SA ++H DLKP N+L++ +    + DF +A+  +    + +   T+ +AT 
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173

Query: 340 GYMAPEYGREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGE 382
            Y APE     +  T   DV+S G +L E   G+KP   +F G+
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAE-LLGRKP---VFKGK 213

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 58.1 bits (140), Expect = 4e-09
 Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 16/204 (7%)

Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKV---FNLQCGRALKGFDVECEMMKSIRHRNLIKVI 235
           +IGRG FG V   R     +V A+K+   F +        F  E ++M       ++++ 
Sbjct: 50  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSAPI 294
               ++ +  +V+EYMP G L   M  SNY + + + R     +V  AL+ +H   S   
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARF-YTAEVVLALDAIH---SMGF 163

Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY----GREG 350
           IH D+KP N+LLD +    L+DF     +  E      T  + T  Y++PE     G +G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDG 222

Query: 351 RVSTNGDVYSFGIMLMETFTGKKP 374
                 D +S G+ L E   G  P
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 56.7 bits (137), Expect = 6e-09
 Identities = 47/224 (20%), Positives = 94/224 (41%), Gaps = 25/224 (11%)

Query: 188 SVYKARLGDGMEVAVKVF---NLQCGRALKGFDVECEMMKSIRHRNLIKV----ISTCSN 240
           S+YK    +  EV ++ F   +      +   + E + ++ I   N++K+    I    +
Sbjct: 35  SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 300
               +L+LEY   G L + +      L    +L++ ID    L  L+   + P  + +L 
Sbjct: 94  LPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150

Query: 301 PSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE--GRVSTNGDV 358
             + L+ +N    +    + K+L     S    + +  + Y + +   +     +   D+
Sbjct: 151 SVSFLVTENYKLKIICHGLEKIL-----SSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDI 205

Query: 359 YSFGIMLMETFTGKKP-----TNEIFNGEMTLKHWVNDWLPIST 397
           YS G++L E FTGK P     T EI++  + +    +  LP+  
Sbjct: 206 YSLGVVLWEIFTGKIPFENLTTKEIYD--LIINKNNSLKLPLDC 247

Length = 283

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 56.7 bits (137), Expect = 8e-09
 Identities = 58/223 (26%), Positives = 100/223 (44%), Gaps = 36/223 (16%)

Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVI---- 235
           +G G  G V+ A   D    VAVK   L   +++K    E ++++ + H N++KV     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 236 --STCSNEEFKAL--------VLEYMP---HGSLEKYMYSSNYI-LDIFQRLNIMIDVAS 281
              +   E+  +L        V EYM       LE+   S  +  L ++Q L        
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR------- 125

Query: 282 ALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGE-DQSMTQTQTLATI 339
            L+Y+H   SA ++H DLKP+NV ++ +++V  + DF +A+++          ++ L T 
Sbjct: 126 GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182

Query: 340 GYMAPEYGREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNG 381
            Y +P         T   D+++ G +  E  TGK     +F G
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP----LFAG 221

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 57.1 bits (138), Expect = 1e-08
 Identities = 24/54 (44%), Positives = 34/54 (62%)

Query: 22  LQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIP 75
           L+G IP+    L  L+ +NLS N++ G IP SL  ++ LE L+LS+N   G IP
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP 483

Length = 623

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 56.1 bits (136), Expect = 1e-08
 Identities = 46/195 (23%), Positives = 79/195 (40%), Gaps = 33/195 (16%)

Query: 174 GFSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCGRALKGFDV----ECEMMKSI 226
            +     IGRG +G VYKA+     DG E A+K F         G       E  +++ +
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFK-GDKEQYTGISQSACREIALLREL 59

Query: 227 RHRNLIKVISTCSNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRL---NIMIDVAS 281
           +H N++ ++        K+  L+ +Y  H   +   +               +++  + +
Sbjct: 60  KHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119

Query: 282 ALEYLHFGYSAPIIHCDLKPSNVLL----DDNMVAHLSDFSIA-------KLLTGEDQSM 330
            + YLH   S  ++H DLKP+N+L+     +  V  + D  +A       K L   D   
Sbjct: 120 GVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD--- 173

Query: 331 TQTQTLATIGYMAPE 345
                + TI Y APE
Sbjct: 174 ---PVVVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 51/199 (25%), Positives = 88/199 (44%), Gaps = 10/199 (5%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRA---LKGFDVECEMMKSIRHRNLIKVI 235
           L+G+G FG V   R    G   A+K+   +   A   +     E  ++K+ RH  L  + 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
            +   ++    V+EY+  G L  ++       +   R     ++ SAL+YLH   S  I+
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLH---SGKIV 117

Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 355
           + DLK  N++LD +    ++DF + K   G   + T      T  Y+APE   +      
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 356 GDVYSFGIMLMETFTGKKP 374
            D +  G+++ E   G+ P
Sbjct: 176 VDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 50/195 (25%), Positives = 92/195 (47%), Gaps = 8/195 (4%)

Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           IG G  G V  A +   G  VAVK  +L+  +  +    E  +M+  +H N++++ ++  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
             +   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLH---AQGVIHRDI 142

Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVY 359
           K  ++LL  +    LSDF     ++ E     +   + T  +MAPE           D++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIW 200

Query: 360 SFGIMLMETFTGKKP 374
           S GIM++E   G+ P
Sbjct: 201 SLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 48/196 (24%), Positives = 94/196 (47%), Gaps = 11/196 (5%)

Query: 181 IGRGGFGSVYKAR--LGDGMEVAVKVFNLQCGRALKGFDV-ECEMMKSIRHRNLIKVIST 237
           +G G + +VYK R  L D + VA+K   L+         + E  ++K ++H N++ +   
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
              E+   LV EY+    L++Y+      +++    N+ + +   L  L++ +   ++H 
Sbjct: 73  IHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMH---NVKLFLFQLLRGLNYCHRRKVLHR 128

Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE-YGREGRVSTNG 356
           DLKP N+L+++     L+DF +A+       + T +  + T+ Y  P+        ST  
Sbjct: 129 DLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQI 186

Query: 357 DVYSFGIMLMETFTGK 372
           D++  G +  E  TG+
Sbjct: 187 DMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 47/196 (23%), Positives = 93/196 (47%), Gaps = 11/196 (5%)

Query: 181 IGRGGFGSVYKAR--LGDGMEVAVKVFNLQCGRALKGFDV-ECEMMKSIRHRNLIKVIST 237
           +G G + +V+K R  L + + VA+K   L+         + E  ++K ++H N++ +   
Sbjct: 14  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
              ++   LV EY+    L++YM     I+ +    N+ I +   L  L + +   ++H 
Sbjct: 73  VHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMH---NVKIFLYQILRGLAYCHRRKVLHR 128

Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR-EGRVSTNG 356
           DLKP N+L+++     L+DF +A+       + T +  + T+ Y  P+        ST  
Sbjct: 129 DLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQI 186

Query: 357 DVYSFGIMLMETFTGK 372
           D++  G +  E  +G+
Sbjct: 187 DMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 24/208 (11%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRA-LKGFDVECEMMKSIRHRNLIKVISTC 238
           +G+G +GSVYK      G+ +A+K   L+   +      +E +++       ++      
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 239 SNEEFKALVLEYMPHGSLEKYMY---SSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
             E    + +EYM  GSL+K +Y    +   +       I   V   L++L   ++  II
Sbjct: 69  FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--II 125

Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIG---YMAPEYGREGRV 352
           H D+KP+NVL++ N    L DF ++  L     S+ +T     IG   YMAPE  + G  
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLV---ASLAKTN----IGCQSYMAPERIKSGGP 178

Query: 353 STNG------DVYSFGIMLMETFTGKKP 374
           + N       DV+S G+ ++E   G+ P
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 55.0 bits (133), Expect = 3e-08
 Identities = 37/148 (25%), Positives = 64/148 (43%), Gaps = 15/148 (10%)

Query: 180 LIGR----GGFGSVYKARLGDGMEVAVKVFNL--QCGRALKGFDVECEMMKSIRHRNLIK 233
           LIG+         + K +  + + VAVK  NL       LK    E    + ++H N++ 
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTL-VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL---NIMIDVASALEYLHFGY 290
            +++   +    +V   M +GS E  +    +  +    L    I+ DV +AL+Y+H   
Sbjct: 64  YVTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNALDYIH--- 118

Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFS 318
           S   IH  +K S++LL  +    LS   
Sbjct: 119 SKGFIHRSVKASHILLSGDGKVVLSGLR 146

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 54.7 bits (131), Expect = 4e-08
 Identities = 52/205 (25%), Positives = 99/205 (48%), Gaps = 11/205 (5%)

Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-ECEMMKSIRHRN 230
           D F   + +G G  G V K +    G+ +A K+ +L+   A++   + E +++       
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFG 289
           ++       ++   ++ +E+M  GSL++ +  +  I  +I  +++I   V   L YL   
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREK 122

Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 349
           +   I+H D+KPSN+L++      L DF ++  L     SM  +  + T  YM+PE  + 
Sbjct: 123 HQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQG 176

Query: 350 GRVSTNGDVYSFGIMLMETFTGKKP 374
              S   D++S G+ L+E   G+ P
Sbjct: 177 THYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 53.7 bits (129), Expect = 5e-08
 Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 21/211 (9%)

Query: 181 IGRGGFGSVYKA---RLGDG-----MEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLI 232
           +G+G F  ++K     +GD       EV +KV +       + F     MM  + H++L+
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                C   +   +V EY+  GSL+ Y+  +  +++I  +L +   +A AL +L      
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DK 119

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT-----QTLATIGYMAPEYG 347
            + H ++   NVLL         +    KL    D  ++ T       L  I ++ PE  
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKL---SDPGISITVLPKEILLERIPWVPPECI 176

Query: 348 REGR-VSTNGDVYSFGIMLMETFTG-KKPTN 376
              + +S   D +SFG  L E F+G  KP +
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSGGDKPLS 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 55.2 bits (133), Expect = 5e-08
 Identities = 60/240 (25%), Positives = 95/240 (39%), Gaps = 63/240 (26%)

Query: 180 LIGRGGFGSVYKARLGDGMEVAVKVFNLQCGR--ALKG--------------FDVECEMM 223
           LIG+GG G VY A            ++  C R  ALK               F  E ++ 
Sbjct: 9   LIGKGGMGEVYLA------------YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIA 56

Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPH--GSLEKYMYSSNYILDIFQR--------- 272
             + H  ++ V S CS+ +    V   MP+  G   K +  S +  +   +         
Sbjct: 57  ADLIHPGIVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVG 113

Query: 273 --LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ-- 328
             L+I   + + +EY+H   S  ++H DLKP N+LL       + D+  A     E++  
Sbjct: 114 AFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDL 170

Query: 329 -------------SMTQT-QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
                        SMT   + + T  YMAPE       S + D+Y+ G++L +  T   P
Sbjct: 171 LDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 54.3 bits (130), Expect = 5e-08
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 31/207 (14%)

Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIS- 236
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 237 ---TCSNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 85  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 139

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV 352
            IIH DLKPSN+ ++++    + DF +A+     D  MT        GY+A  + R   +
Sbjct: 140 DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYRAPEI 188

Query: 353 STNG-------DVYSFGIMLMETFTGK 372
             N        D++S G ++ E  TG+
Sbjct: 189 MLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 53.9 bits (129), Expect = 5e-08
 Identities = 51/202 (25%), Positives = 93/202 (46%), Gaps = 23/202 (11%)

Query: 181 IGRGGFGSVYKAR--LGDGMEVAVKVFNLQCGRALKGFDV-ECEMMKSIRHRNLIKVIST 237
           +G G + +V+K R  L + + VA+K   L+         + E  ++K+++H N++ +   
Sbjct: 13  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
              E    LV EY+    L++Y+ +   ++ +      M  +   L Y H      I+H 
Sbjct: 72  IHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHR 127

Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP-------EYGREG 350
           DLKP N+L+++     L+DF +A+       + T +  + T+ Y  P       EY    
Sbjct: 128 DLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSTEY---- 181

Query: 351 RVSTNGDVYSFGIMLMETFTGK 372
             ST  D++  G +L E  TG+
Sbjct: 182 --STPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 54.1 bits (130), Expect = 6e-08
 Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 16/216 (7%)

Query: 173 DGFSENNLIGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKGFDVECEMMKSIR 227
             F   +L+GRG FG V   R    GD   M+V +K   L     +  F+ E +++    
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKV-MKKSVLLAQETVSFFEEERDILSISN 59

Query: 228 HRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLH 287
              + ++     +++   LV+EY P G L   +   N   D F        +A  +  +H
Sbjct: 60  SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL---NRYEDQFDEDMAQFYLAELVLAIH 116

Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY- 346
             +    +H D+KP NVL+D      L+DF  A  LT  ++ +     + T  Y+APE  
Sbjct: 117 SVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLT-ANKMVNSKLPVGTPDYIAPEVL 175

Query: 347 -----GREGRVSTNGDVYSFGIMLMETFTGKKPTNE 377
                  +G      D +S G++  E   G+ P +E
Sbjct: 176 TTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 53.7 bits (129), Expect = 6e-08
 Identities = 64/283 (22%), Positives = 108/283 (38%), Gaps = 57/283 (20%)

Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGR------ALKGFDVECEMMKS 225
           D + +   IG G +G VYKAR    G  VA+K   L+         AL+    E  +++ 
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR----EISLLQM 56

Query: 226 IRHRNLI-KVISTCSNEEFKA-----LVLEYMPHGSLEKYMYS----SNYILDIFQRLNI 275
           +     I +++     EE        LV EY+    L+K+M S        L      + 
Sbjct: 57  LSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSF 115

Query: 276 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN-MVAHLSDFSIAKLLTGEDQSMTQTQ 334
           M  +   + + H      ++H DLKP N+L+D    +  ++D  + +  +   +S   T 
Sbjct: 116 MYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--TH 170

Query: 335 TLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMETFTGK--------------------K 373
            + T+ Y APE        ST  D++S G +  E    +                     
Sbjct: 171 EIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT 230

Query: 374 PTNEIFNGEMTLKHW--VNDWLPIS------TMEVVGANLLSQ 408
           PT +++ G   L+ W     W P         +   G +LL +
Sbjct: 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQK 273

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 54.9 bits (132), Expect = 7e-08
 Identities = 50/160 (31%), Positives = 73/160 (45%), Gaps = 10/160 (6%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           +P+E   L  + +L +  N LQG I     D+ SL+ L+L+ N   G +P S      LE
Sbjct: 420 LPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLE 478

Query: 62  NLNLSFNKLEGEIPRGGPFRNFSV---ESFEGNELLCGSPNLQVPPCKTSNHHTLWKNSL 118
           NL+LS N+  G +PR     + S         N+L    P+ ++  CK      L  N L
Sbjct: 479 NLDLSRNQFSGAVPRK--LGSLSELMQLKLSENKLSGEIPD-ELSSCKKLVSLDLSHNQL 535

Query: 119 LLRIVLPLSAIFMIVVILLILRYRQ-KGKRPSNDANMPSI 157
             +I  P S   M V+  L L   Q  G+ P N  N+ S+
Sbjct: 536 SGQI--PASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESL 573

Length = 968

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 53.9 bits (129), Expect = 7e-08
 Identities = 52/205 (25%), Positives = 101/205 (49%), Gaps = 11/205 (5%)

Query: 173 DGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQCGRALKGFDV-ECEMMKSIRHRN 230
           D F + + +G G  G V+K +    G+ +A K+ +L+   A++   + E +++       
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILD-IFQRLNIMIDVASALEYLHFG 289
           ++       ++   ++ +E+M  GSL++ +  +  I + I  +++I   V   L YL   
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 122

Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 349
           +   I+H D+KPSN+L++      L DF ++  L     SM  +  + T  YM+PE  + 
Sbjct: 123 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQG 176

Query: 350 GRVSTNGDVYSFGIMLMETFTGKKP 374
              S   D++S G+ L+E   G+ P
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 53.9 bits (129), Expect = 8e-08
 Identities = 31/104 (29%), Positives = 52/104 (50%), Gaps = 3/104 (2%)

Query: 267 LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE 326
           L     L+    VA  +E+L    S   +H DL   NVLL    +  + DF +A+ +  +
Sbjct: 234 LTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290

Query: 327 DQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 370
              +++  T   + +MAPE   +   +T  DV+S+GI+L E F+
Sbjct: 291 SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 53.4 bits (128), Expect = 9e-08
 Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 32/211 (15%)

Query: 181 IGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           IG+G FG VY+ R  D   + A+KV + +   A K      E+  +I  RN++ V +   
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK------EVAHTIGERNIL-VRTLLD 53

Query: 240 NEEFKA-------------LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMI-DVASALEY 285
              F               LV +YM  G L  ++       +   R    I ++  ALE+
Sbjct: 54  ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE--DRAKFYIAELVLALEH 111

Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL-LTGEDQSMTQTQTLATIGYMAP 344
           LH      I++ DLKP N+LLD      L DF ++K  LT    + T      T  Y+AP
Sbjct: 112 LH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT---FCGTTEYLAP 165

Query: 345 EYGREGRVSTNG-DVYSFGIMLMETFTGKKP 374
           E   + +  T   D +S G+++ E   G  P
Sbjct: 166 EVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 12/206 (5%)

Query: 180 LIGRGGFGSVYKARLGDGME-VAVKVF-NLQCGRALKGFDV-ECEMMKSIRHRNLIKVIS 236
           ++G G +G V K R  +  E VA+K F + +    +K   + E +M+++++  N++++  
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
                    LV EY+    LE      N +     R  I       ++ +H+ +   I+H
Sbjct: 68  AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIY----QLIKAIHWCHKNDIVH 123

Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 356
            D+KP N+L+  N V  L DF  A+ L+ E  +   T+ +AT  Y +PE           
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGAPYGKAV 182

Query: 357 DVYSFGIMLMETFTGKKPTNEIFNGE 382
           D++S G +L E   G+     +F GE
Sbjct: 183 DMWSVGCILGELSDGQP----LFPGE 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 51.3 bits (123), Expect = 9e-08
 Identities = 33/150 (22%), Positives = 66/150 (44%), Gaps = 23/150 (15%)

Query: 180 LIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECE--MMKSIRHRNLI--KVI 235
           L+  G    VY     D  +  +K+         KG D E E  +++ +  + L   KV+
Sbjct: 5   LLKGGLTNRVYLLGTKDE-DYVLKINP----SREKGADREREVAILQLLARKGLPVPKVL 59

Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI- 294
           ++  ++ +  L++E++   +L++        +   ++ +I   +A  L  LH     P+ 
Sbjct: 60  ASGESDGWSYLLMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKLH---QLPLL 108

Query: 295 --IHCDLKPSNVLLDDNMVAHLSDFSIAKL 322
              H DL P N+L+DD  +  + D+  A  
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 28/211 (13%)

Query: 181 IGRGGFGSVYKARLGDGME-VAVKVFNL---QCGRALKGFDVECEMMKSIRHRNLIKVIS 236
           IG G FG+VY A      E VAVK  +    Q     +    E + ++ ++H N I+   
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDI----FQRLNIMIDVASALEYLHFGYSA 292
               E    LV+EY         + S++ +L++     Q + I      AL+ L + +S 
Sbjct: 89  CYLKEHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 140

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY---GRE 349
            +IH D+K  N+LL +     L+DF  A   +  +        + T  +MAPE      E
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN------SFVGTPYWMAPEVILAMDE 194

Query: 350 GRVSTNGDVYSFGIMLMETFTGKKPTNEIFN 380
           G+     DV+S GI  +E    K P   +FN
Sbjct: 195 GQYDGKVDVWSLGITCIELAERKPP---LFN 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 34/107 (31%), Positives = 55/107 (51%), Gaps = 9/107 (8%)

Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT 338
           VA+ +E+L    S   +H DL   NVL+ +  +  + DF +A+ +  +   +++  T   
Sbjct: 248 VANGMEFLA---SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 339 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT------GKKPTNEIF 379
           + +MAPE       +T  DV+SFGI+L E FT       + P NE F
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 20/176 (11%)

Query: 219 ECEMMKSIRHRNLIKVISTC----SNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQR 272
           E  ++K + H+N+I +++      S EEF+   LV+E M   +L + ++     LD  + 
Sbjct: 70  ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHME---LDHERM 125

Query: 273 LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 332
             ++  +   +++LH   SA IIH DLKPSN+++  +    + DF +A+       +   
Sbjct: 126 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFMM 179

Query: 333 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW 388
           T  + T  Y APE         N D++S G ++ E   G    + IF G   +  W
Sbjct: 180 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG----SVIFQGTDHIDQW 231

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 4/97 (4%)

Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT 338
           VA  +E+L    S   IH DL   N+LL +N V  + DF +A+ +  +   + +      
Sbjct: 182 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 339 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 374
           + +MAPE   +   +T  DV+SFG++L E F+ G  P
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 45/195 (23%), Positives = 89/195 (45%), Gaps = 13/195 (6%)

Query: 181 IGRGGFGSVY-----KARLGDGMEV--AVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
           +G+G FG+VY     KA   + ++V   + V  L     ++  + E +++  + H  ++K
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAIVK 66

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
             ++    +   ++ EY     L+  +    +         +       L  +H+ +   
Sbjct: 67  FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQTQTLATIGYMAPEYGREGRV 352
           I+H DLK  N+ L +N++  + DF +++LL G  D + T T    T  YM+PE  +    
Sbjct: 127 ILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTFT---GTPYYMSPEALKHQGY 182

Query: 353 STNGDVYSFGIMLME 367
            +  D++S G +L E
Sbjct: 183 DSKSDIWSLGCILYE 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 35/109 (32%), Positives = 55/109 (50%), Gaps = 4/109 (3%)

Query: 267 LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE 326
           LD+   L     VA  +++L    S   IH D+   NVLL D  VA + DF +A+ +  +
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265

Query: 327 DQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 374
              + +      + +MAPE   +   +   DV+S+GI+L E F+ GK P
Sbjct: 266 SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 47/213 (22%)

Query: 181 IGRGGFGSVYKAR--LGDGMEVAVKVFNLQ------CGRALKGFDVECEMMKSIRHRNLI 232
           +G G + +VYK R  L   + VA+K   L+         A++    E  ++K ++H N++
Sbjct: 13  LGEGSYATVYKGRSKLTGQL-VALKEIRLEHEEGAPF-TAIR----EASLLKDLKHANIV 66

Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILD-------IFQRLNIMIDVASALEY 285
            +      ++   LV EY+    L++YM      L        +FQ L         L Y
Sbjct: 67  TLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLLR-------GLAY 118

Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP- 344
            H      ++H DLKP N+L+ +     L+DF +A+       S T +  + T+ Y  P 
Sbjct: 119 CH---QRRVLHRDLKPQNLLISERGELKLADFGLAR--AKSVPSKTYSNEVVTLWYRPPD 173

Query: 345 ------EYGREGRVSTNGDVYSFGIMLMETFTG 371
                 EY      ST+ D++  G +  E  TG
Sbjct: 174 VLLGSTEY------STSLDMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 55/200 (27%), Positives = 87/200 (43%), Gaps = 11/200 (5%)

Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFD-VECE---MMKSIRHRNLIKV 234
           +IGRG +  V   RL     + A+KV   +     +  D V+ E     ++  H  L+ +
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI 294
            S    E     V+EY+  G L  +M     + +   R     +++ AL YLH      I
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGI 117

Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVST 354
           I+ DLK  NVLLD      L+D+ + K   G     T +    T  Y+APE  R      
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 175

Query: 355 NGDVYSFGIMLMETFTGKKP 374
           + D ++ G+++ E   G+ P
Sbjct: 176 SVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 50/217 (23%)

Query: 180 LIGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCGRALKGFDVECEMMKSIRHRNLI 232
            +G G +GSV  A     G +VA+K  +      +   RA +    E  ++K ++H N+I
Sbjct: 22  QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR----ELTLLKHMQHENVI 77

Query: 233 KVI----STCSNEEFKA--LVLEYMPHGSLEKYM---YSSNYI-LDIFQRLNIMIDVASA 282
            ++    S  S +EF+   LV+ YM    L+K M    S + +   ++Q L         
Sbjct: 78  GLLDVFTSAVSGDEFQDFYLVMPYM-QTDLQKIMGHPLSEDKVQYLVYQML-------CG 129

Query: 283 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           L+Y+H   SA IIH DLKP N+ ++++    + DF +A+     D  MT        GY+
Sbjct: 130 LKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMT--------GYV 175

Query: 343 APEYGREGRVSTNG-------DVYSFGIMLMETFTGK 372
              + R   V  N        D++S G ++ E  TGK
Sbjct: 176 VTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 22/203 (10%)

Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDV-----ECEMMKSIRHRNLIKVI 235
           +G G FG V  A   +     V +   +  + +K   V     E +++  I H   + + 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYI---LDIFQRLNIMIDVASALEYLHFGYSA 292
            +  +E +  LVLE++  G    ++  +      +  F    I++      EYL    S 
Sbjct: 98  GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL----IFEYLQ---SL 150

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-ATIGYMAPEYGREGR 351
            I++ DLKP N+LLD +    ++DF  AK++       T+T TL  T  Y+APE      
Sbjct: 151 NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD------TRTYTLCGTPEYIAPEILLNVG 204

Query: 352 VSTNGDVYSFGIMLMETFTGKKP 374
                D ++ GI + E   G  P
Sbjct: 205 HGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 23/212 (10%)

Query: 180 LIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKGFDVECEMMK------SIRHRNLI 232
           ++G+G FG V  A R G     A+K+  L+    ++  DVEC M++      S +   L 
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALSGKPPFLT 64

Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
           ++ S     +    V+EY+  G L   MY    +   F+  + +   A     L F +S 
Sbjct: 65  QLHSCFQTMDRLYFVMEYVNGGDL---MYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAK--LLTGEDQSMTQTQTLATIGYMAPEYGREG 350
            II+ DLK  NV+LD      ++DF + K  +  G    +T      T  Y+APE     
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG----VTTKTFCGTPDYIAPEIIAYQ 176

Query: 351 RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
               + D ++FG++L E   G+ P    F GE
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAP----FEGE 204

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 4/97 (4%)

Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT 338
           VA  +E+L    S   IH DL   N+LL +N V  + DF +A+ +  +   + +      
Sbjct: 188 VAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 339 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 374
           + +MAPE   +   +   DV+SFG++L E F+ G  P
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 53/218 (24%)

Query: 181 IGRGGFGSV---YKARLGDGMEVAVKVFN------LQCGRALKGFDVECEMMKSIRHRNL 231
           +G G +GSV   Y  RL    +VAVK  +      +   R  +    E  ++K ++H N+
Sbjct: 23  VGSGAYGSVCSAYDTRLRQ--KVAVKKLSRPFQSLIHARRTYR----ELRLLKHMKHENV 76

Query: 232 IKVIS----TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLN------IMIDVAS 281
           I ++       S E F  + L     G+        N I+   Q+L+      ++  +  
Sbjct: 77  IGLLDVFTPATSIENFNEVYLVTNLMGA------DLNNIVK-CQKLSDEHVQFLIYQLLR 129

Query: 282 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGY 341
            L+Y+H   SA IIH DLKPSNV ++++    + DF +A+     D  MT        GY
Sbjct: 130 GLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEMT--------GY 175

Query: 342 MAPEYGREGRVSTNG-------DVYSFGIMLMETFTGK 372
           +A  + R   +  N        D++S G ++ E   GK
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 4/97 (4%)

Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT 338
           VA  +E+L    S   IH DL   N+LL +N V  + DF +A+ +  +   + +      
Sbjct: 183 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 339 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 374
           + +MAPE   +   +T  DV+SFG++L E F+ G  P
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 50/226 (22%), Positives = 94/226 (41%), Gaps = 19/226 (8%)

Query: 181 IGRGGFGSVYKARLGDGMEVA-VKVFNLQCGRALK---GFDVECEMMKSIRHRNLIKVIS 236
           IG G FG V  + +     VA V V  L+   + K    F  + +  + ++H N+++ + 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYIL---DIFQRLNIMIDVASALEYLHFGYSAP 293
            C       LV EY   G L+ Y+    +      +     +  ++A+ + ++H      
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHN 119

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY--GREGR 351
            +H DL   N  L  ++   + D+ I      ED   T+      + ++APE      G 
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG 179

Query: 352 VSTN-----GDVYSFGIMLMETF-TGKKPTNEIFNGEMTLKHWVND 391
           + T       +V++ G+ L E F    +P + + + E+ L H + D
Sbjct: 180 LITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV-LNHVIKD 224

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 51.6 bits (124), Expect = 4e-07
 Identities = 48/161 (29%), Positives = 81/161 (50%), Gaps = 18/161 (11%)

Query: 219 ECEMMKSIRHRNLIKVISTC----SNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQR 272
           E  +MK + H+N+I +++      S EEF+   LV+E M   +L + +      LD  +R
Sbjct: 65  ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVI---QMDLD-HER 119

Query: 273 LNIMI-DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 331
           ++ ++  +   +++LH   SA IIH DLKPSN+++  +    + DF +A+   G    M 
Sbjct: 120 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMM- 174

Query: 332 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGK 372
            T  + T  Y APE         N D++S G ++ E   G 
Sbjct: 175 -TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 46.4 bits (111), Expect = 5e-07
 Identities = 22/47 (46%), Positives = 27/47 (57%), Gaps = 1/47 (2%)

Query: 1  VIPTEI-GGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNL 46
          VIP     GL NL+ L L  N L    P++F  L SL+ L+LS NNL
Sbjct: 14 VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 50.8 bits (121), Expect = 5e-07
 Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 34/216 (15%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSI-RHRNLIKVI-- 235
           ++G G +G VYK R +  G   A+KV ++      +   +E  M+K    HRN+      
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIATYYGA 81

Query: 236 ----STCSNEEFKALVLEYMPHGSLEKYM-------YSSNYILDIFQRLNIMIDVASALE 284
               S   +++   LV+E+   GS+   +          ++I  I +      ++   L 
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR------EILRGLA 135

Query: 285 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-LATIGYMA 343
           +LH   +  +IH D+K  NVLL +N    L DF ++  L   D+++ +  T + T  +MA
Sbjct: 136 HLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMA 189

Query: 344 PEY-----GREGRVSTNGDVYSFGIMLMETFTGKKP 374
           PE        +       D++S GI  +E   G  P
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 19/204 (9%)

Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFDVECEMMKSIRH--------RN 230
           +IGRG +  V   RL    ++ A+KV      + L   D + + +++ +H          
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVK----KELVHDDEDIDWVQTEKHVFEQASSNPF 57

Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY 290
           L+ + S         LV+EY+  G L  +M     + +   R     ++  AL +LH   
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLH--- 113

Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 350
              II+ DLK  NVLLD +    L+D+ + K   G     T +    T  Y+APE  R  
Sbjct: 114 ERGIIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGE 171

Query: 351 RVSTNGDVYSFGIMLMETFTGKKP 374
               + D ++ G+++ E   G+ P
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 49/199 (24%), Positives = 84/199 (42%), Gaps = 10/199 (5%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRA---LKGFDVECEMMKSIRHRNLIKVI 235
           L+G+G FG V   R    G   A+K+   +   A   +     E  ++++ RH  L  + 
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
                 +    V+EY   G L  ++       +   R     ++ SALEYLH   S  ++
Sbjct: 62  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH---SRDVV 117

Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 355
           + D+K  N++LD +    ++DF + K   G     T      T  Y+APE   +      
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 356 GDVYSFGIMLMETFTGKKP 374
            D +  G+++ E   G+ P
Sbjct: 176 VDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 50.7 bits (122), Expect = 6e-07
 Identities = 62/237 (26%), Positives = 99/237 (41%), Gaps = 55/237 (23%)

Query: 180 LIGRGGFGSVYKARL-GDGMEVAVKVFNLQC-------GRALKGFDVECEMMKSIRHRNL 231
           L+G+G  G V+  RL G G   A+KV + +         R L     E E++ ++ H  L
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVL----TEQEILATLDHPFL 63

Query: 232 IKVISTCSNEEFKALVLEYMPHGSLEKY--MYSSNYILDIFQRLNIMIDVASALEYLH-F 288
             + ++   E +  LV++Y P G L +         + +   R     +V  ALEYLH  
Sbjct: 64  PTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EVLLALEYLHLL 122

Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ---------------T 333
           G    I++ DLKP N+LL ++    LSDF ++K    E   +++               +
Sbjct: 123 G----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178

Query: 334 QTLATIG------------YMAPE----YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           +T +               Y+APE     G    V    D ++ GI+L E   G  P
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 50.5 bits (120), Expect = 6e-07
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 24/211 (11%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSI-RHRNL------ 231
           L+G G +G VYK R +  G   A+KV ++  G   +    E  M+K    HRN+      
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGA 71

Query: 232 -IKVISTCSNEEFKALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFG 289
            IK      +++   LV+E+   GS+   + ++    L       I  ++   L +LH  
Sbjct: 72  FIKKNPPGMDDQL-WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH-- 128

Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-LATIGYMAPEY-- 346
               +IH D+K  NVLL +N    L DF ++  L   D+++ +  T + T  +MAPE   
Sbjct: 129 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVIA 184

Query: 347 ---GREGRVSTNGDVYSFGIMLMETFTGKKP 374
                +       D++S GI  +E   G  P
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAPP 215

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 51.0 bits (122), Expect = 8e-07
 Identities = 45/168 (26%), Positives = 67/168 (39%), Gaps = 25/168 (14%)

Query: 219 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMY-------SSNYILDIFQ 271
           E +++K+I HR +I +I        K+ V   MP    + + Y            + I +
Sbjct: 136 EIDILKTISHRAIINLIHAYRW---KSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQR 192

Query: 272 RLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 331
           RL        AL YLH      IIH D+K  N+ LD+   A L DF  A  L     +  
Sbjct: 193 RL------LEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243

Query: 332 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME------TFTGKK 373
                 T+   +PE           D++S G++L E      T  GK+
Sbjct: 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291

Length = 392

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 50.7 bits (121), Expect = 9e-07
 Identities = 30/104 (28%), Positives = 49/104 (47%), Gaps = 2/104 (1%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           +P+ +  L NL+ L L +N L   +P    +L +L  L+LS N +S  +P  +E LS LE
Sbjct: 155 LPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALE 212

Query: 62  NLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPC 105
            L+LS N +   +      +N S      N+L     ++     
Sbjct: 213 ELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSN 256

Length = 394

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 50.0 bits (119), Expect = 9e-07
 Identities = 61/225 (27%), Positives = 94/225 (41%), Gaps = 45/225 (20%)

Query: 181 IGRGGFGSVYK-ARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSI-----RHRNLIKV 234
           IG+G +G VYK     DG   AVK+ +      +   D E E   +I      H N++K 
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILD-----PISDVDEEIEAEYNILQSLPNHPNVVKF 84

Query: 235 IST------CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLN------IMIDVASA 282
                        +   LVLE    GS+ + +     +L   QRL+      I+      
Sbjct: 85  YGMFYKADKLVGGQL-WLVLELCNGGSVTELVKG---LLICGQRLDEAMISYILYGALLG 140

Query: 283 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           L++LH   +  IIH D+K +N+LL       L DF ++  LT     + +  ++ T  +M
Sbjct: 141 LQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLRRNTSVGTPFWM 195

Query: 343 APE---------YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEI 378
           APE         Y  + R     DV+S GI  +E   G  P  ++
Sbjct: 196 APEVIACEQQYDYSYDARC----DVWSLGITAIELGDGDPPLFDM 236

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 29/206 (14%)

Query: 181 IGRGGFGSVYKARLG-DGMEVAVKVF------NLQCGRALKGFDVECEMMKSIRHRNLIK 233
           +G G +G+V  A     G +VA+K         L   RA +    E  ++K ++H N+I 
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMKHENVIG 78

Query: 234 VISTCSNEE----FKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLH 287
           ++   + +     F    LV+ +M    L K M       D  Q L  +  +   L+Y+H
Sbjct: 79  LLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFL--VYQMLKGLKYIH 135

Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYG 347
              +A IIH DLKP N+ ++++    + DF +A+     D  M  T  + T  Y APE  
Sbjct: 136 ---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEM--TGYVVTRWYRAPEVI 187

Query: 348 REG-RVSTNGDVYSFGIMLMETFTGK 372
                 +   D++S G ++ E  TGK
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 31/218 (14%)

Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVE---CE-----MMKSIRHRNL 231
           +GRG FG V  A     G   A+K   L+ G  +   +VE   CE        S RH  L
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKA--LKKGDIIARDEVESLMCEKRIFETANSERHPFL 64

Query: 232 IKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVAS---ALEYLHF 288
           + + +    E+    V+EY   G L  ++++     D+F     +   A     L+YLH 
Sbjct: 65  VNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLH- 118

Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-ATIGYMAPEYG 347
                I++ DLK  N+LLD      ++DF + K   G      +T T   T  ++APE  
Sbjct: 119 --ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD---RTSTFCGTPEFLAPEVL 173

Query: 348 REGRVSTNGDVYSFGIMLMETFTGKKP-----TNEIFN 380
            E   +   D +  G+++ E   G+ P       E+F+
Sbjct: 174 TETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD 211

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 50.1 bits (119), Expect = 1e-06
 Identities = 52/210 (24%), Positives = 98/210 (46%), Gaps = 25/210 (11%)

Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFDVEC-----EMMKSIRHRNLIK 233
           +IGRG FG V   +L +  +V A+K+ N      LK  +  C     +++ +  ++ +  
Sbjct: 8   VIGRGAFGEVAVVKLKNADKVFAMKILNKW--EMLKRAETACFREERDVLVNGDNQWITT 65

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYS-SNYILDIFQRLNI--MIDVASALEYLHFGY 290
           +     +E    LV++Y   G L   +    + + +   R  +  M+    ++  LH+  
Sbjct: 66  LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY-- 123

Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDF-SIAKLLTGEDQSMTQTQTLATIGYMAPEYGR- 348
               +H D+KP N+L+D N    L+DF S  KL+  ED ++  +  + T  Y++PE  + 
Sbjct: 124 ----VHRDIKPDNILMDMNGHIRLADFGSCLKLM--EDGTVQSSVAVGTPDYISPEILQA 177

Query: 349 ----EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +G+     D +S G+ + E   G+ P
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 29/209 (13%)

Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTC 238
           +IGRG +  V    L     + A+KV      + L   D + + +++ +H     V  T 
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIK----KELVNDDEDIDWVQTEKH-----VFETA 52

Query: 239 SNEEFKA-------------LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           SN  F                V+E++  G L  +M     + +   R     +++ AL +
Sbjct: 53  SNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARF-YSAEISLALNF 111

Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
           LH      II+ DLK  NVLLD      L+D+ + K   G     T +    T  Y+APE
Sbjct: 112 LH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPE 166

Query: 346 YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
             R      + D ++ G+++ E   G+ P
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 31/109 (28%), Positives = 50/109 (45%), Gaps = 4/109 (3%)

Query: 267 LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE 326
           LD    L+    VA  + +L    S   IH DL   N+LL    +  + DF +A+ +  +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267

Query: 327 DQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 374
              + +      + +MAPE       +   DV+S+GI+L E F+ G  P
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 49.7 bits (118), Expect = 1e-06
 Identities = 46/177 (25%), Positives = 82/177 (46%), Gaps = 22/177 (12%)

Query: 219 ECEMMKSIRHRNLIKVISTC----SNEEFKAL--VLEYMPHGSLEKYMYSSNYILDIFQR 272
           E  +MK + H+N+I +++      S EEF+ +  V+E M     +      ++     +R
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH-----ER 127

Query: 273 LNIMI-DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 331
           ++ ++  +   +++LH   SA IIH DLKPSN+++  +    + DF +A+       S  
Sbjct: 128 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFM 181

Query: 332 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW 388
            T  + T  Y APE         N D++S G ++ E   G      +F G   +  W
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV----LFPGTDHIDQW 234

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 50.6 bits (121), Expect = 2e-06
 Identities = 28/76 (36%), Positives = 35/76 (46%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           IP  +G   NL  L L  N L G IP+      +L  L L +N+L G IP SL     L 
Sbjct: 348 IPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLR 407

Query: 62  NLNLSFNKLEGEIPRG 77
            + L  N   GE+P  
Sbjct: 408 RVRLQDNSFSGELPSE 423

Length = 968

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 33/217 (15%)

Query: 180 LIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKGFDVECEMMK------SIRHRNLI 232
           ++G+G FG V  A R G     A+K+  L+    ++  DVEC M++        +   L 
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVIIQDDDVECTMVEKRVLALPGKPPFLT 64

Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
           ++ S     +    V+EY+  G L   MY     +  F+  + +   A     L F +S 
Sbjct: 65  QLHSCFQTMDRLYFVMEYVNGGDL---MYHIQ-QVGKFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-ATIGYMAPE------ 345
            II+ DLK  NV+LD      ++DF + K      ++   T+T   T  Y+APE      
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDYIAPEIIAYQP 177

Query: 346 YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
           YG+      + D ++FG++L E   G+ P    F+GE
Sbjct: 178 YGK------SVDWWAFGVLLYEMLAGQPP----FDGE 204

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 46/177 (25%), Positives = 82/177 (46%), Gaps = 22/177 (12%)

Query: 219 ECEMMKSIRHRNLIKVISTCSN----EEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQR 272
           E  +MK + H+N+I +++  +     EEF+   LV+E M     +      ++     +R
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDH-----ER 120

Query: 273 LNIMI-DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 331
           ++ ++  +   +++LH   SA IIH DLKPSN+++  +    + DF +A+       S  
Sbjct: 121 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFM 174

Query: 332 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW 388
            T  + T  Y APE         N D++S G ++ E    K     +F G   +  W
Sbjct: 175 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 227

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 41/168 (24%), Positives = 68/168 (40%), Gaps = 24/168 (14%)

Query: 219 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLN---- 274
           E   + +  H  ++K      +++   L++EY   G L K          I QRL     
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNK---------QIKQRLKEHLP 165

Query: 275 --------IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE 326
                   +   +  AL+ +H   S  ++H DLK +N+ L    +  L DF  +K  +  
Sbjct: 166 FQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222

Query: 327 DQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
                 +    T  Y+APE     R S   D++S G++L E  T  +P
Sbjct: 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 49.5 bits (118), Expect = 4e-06
 Identities = 28/73 (38%), Positives = 40/73 (54%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           IP  +    NL  L L  N L+G IP S G   SL+ + L +N+ SG +P+   KL  + 
Sbjct: 372 IPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVY 431

Query: 62  NLNLSFNKLEGEI 74
            L++S N L+G I
Sbjct: 432 FLDISNNNLQGRI 444

Length = 968

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 48.0 bits (114), Expect = 4e-06
 Identities = 40/173 (23%), Positives = 78/173 (45%), Gaps = 26/173 (15%)

Query: 222 MMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVAS 281
           MM+ + H++++ +   C  +    +V E++  G L+ +M+  + +L    +  +   +AS
Sbjct: 57  MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLAS 116

Query: 282 ALEYLHFGYSAPIIHCDLKPSNVLL-------DDNMVAHLSDFSIAKLLTGEDQSMTQTQ 334
           AL YL       ++H ++   N+LL       +      LSD  I   +      +++ +
Sbjct: 117 ALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV------LSRQE 167

Query: 335 TLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLK 386
            +  I ++APE   + +  S   D +SFG  L E           +NGE+ LK
Sbjct: 168 CVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI---------CYNGEIPLK 211

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 47.5 bits (113), Expect = 5e-06
 Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 19/201 (9%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNL--QCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G FG     +   DG +  +K  N+     +  +    E  ++ +++H N+  V   
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI--VQYQ 65

Query: 238 CSNEEFKAL--VLEYMPHGSLEKYMYSSNYILDIFQRLNIM---IDVASALEYLHFGYSA 292
            S EE   L  V++Y   G L K + +   +L  F    I+   + +  AL+++H     
Sbjct: 66  ESFEENGNLYIVMDYCEGGDLYKKINAQRGVL--FPEDQILDWFVQICLALKHVH---DR 120

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-LATIGYMAPEYGREGR 351
            I+H D+K  N+ L  +    L DF IA++L   + ++   +T + T  Y++PE      
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVL---NSTVELARTCIGTPYYLSPEICENRP 177

Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D+++ G +L E  T K
Sbjct: 178 YNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 48.1 bits (114), Expect = 5e-06
 Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 33/221 (14%)

Query: 173 DGFSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFDVECEMMKSIRHRNL 231
           D F    +IGRG FG V   ++     + A+K+ N      LK  +  C      R    
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKW--EMLKRAETAC-----FREERN 53

Query: 232 IKVISTCS----------NEEFKALVLEYMPHGSLEKYMYS-SNYILDIFQRLNI--MID 278
           + V   C           +E +  LV++Y   G L   +    + + +   R  I  M+ 
Sbjct: 54  VLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVL 113

Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT 338
              ++  LH+      +H D+KP NVLLD N    L+DF  + L   +D ++  +  + T
Sbjct: 114 AIHSIHQLHY------VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGT 166

Query: 339 IGYMAPEYGRE-----GRVSTNGDVYSFGIMLMETFTGKKP 374
             Y++PE  +      G+     D +S G+ + E   G+ P
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 47.8 bits (113), Expect = 6e-06
 Identities = 51/208 (24%), Positives = 95/208 (45%), Gaps = 19/208 (9%)

Query: 181 IGRGGFGSVYKARLGDG---MEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLI---KV 234
           +GRG +G VYKA+  DG    E A+K      G ++     E  +++ ++H N+I   KV
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIE-GTGISMSACR-EIALLRELKHPNVIALQKV 66

Query: 235 ISTCSNEEFKALVLEYMPHG--SLEKYMYSSNYILDIFQRLNIMID--VASALEYLHFGY 290
             + S+ +   L+ +Y  H    + K+  +S       Q    M+   +   L+ +H+ +
Sbjct: 67  FLSHSDRKV-WLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 291 SAPIIHCDLKPSNVLL----DDNMVAHLSDFSIAKLLTGEDQSMTQTQ-TLATIGYMAPE 345
           +  ++H DLKP+N+L+     +     ++D   A+L     + +      + T  Y APE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185

Query: 346 YGREGRVSTNG-DVYSFGIMLMETFTGK 372
                R  T   D+++ G +  E  T +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 47.9 bits (114), Expect = 7e-06
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 36/214 (16%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFN------LQCGRALKGFDVECEMMKSIRHRNLI 232
           +IG+G +G V  A     G +VA+K  N          R L+    E ++++ +RH +++
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR----EIKLLRLLRHPDIV 62

Query: 233 KVISTC---SNEEFKAL--VLEYMPHGSLEKYMYSSN------YILDIFQRLNIMIDVAS 281
           ++       S  EFK +  V E M    L + + +++      +   ++Q L        
Sbjct: 63  EIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLR------- 114

Query: 282 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT-QTQTLATIG 340
           AL+Y+H   +A + H DLKP N+L + +    + DF +A++   +  +    T  +AT  
Sbjct: 115 ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171

Query: 341 YMAPEYGRE--GRVSTNGDVYSFGIMLMETFTGK 372
           Y APE       + +   D++S G +  E  TGK
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 47.3 bits (112), Expect = 8e-06
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 37/226 (16%)

Query: 172 TDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKGFDVECEMMK----SI 226
              F    ++G+G FG V  A R G     A+K+  L+    ++  DVEC M++    ++
Sbjct: 1   DFNFL--MVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLAL 56

Query: 227 RHRN--LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYI--LDIFQRLNIMIDVASA 282
           + +   L ++ S     +    V+EY+  G L   MY    +      Q +    +++  
Sbjct: 57  QDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISVG 113

Query: 283 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           L +LH      II+ DLK  NV+LD      ++DF + K    +   +T      T  Y+
Sbjct: 114 LFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD--GVTTRTFCGTPDYI 168

Query: 343 APE------YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
           APE      YG+      + D +++G++L E   G+ P    F+GE
Sbjct: 169 APEIIAYQPYGK------SVDWWAYGVLLYEMLAGQPP----FDGE 204

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 47.5 bits (113), Expect = 8e-06
 Identities = 61/233 (26%), Positives = 96/233 (41%), Gaps = 57/233 (24%)

Query: 173 DGFSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFDVECEMMKSIRHRNL 231
           D F    +IGRG FG V   ++ +  +V A+K+ N            + EM+K       
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILN------------KWEMLK------- 41

Query: 232 IKVISTCSNEEFKALV---------LEYMPHGSLEKYM----YSSNYILDIFQRLNIMI- 277
            +  + C  EE   LV         L Y        Y+    Y    +L +  +    + 
Sbjct: 42  -RAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLP 100

Query: 278 -DVAS--------ALEYLH-FGYSAPIIHCDLKPSNVLLDDNMVAHLSDF-SIAKLLTGE 326
            D+A         A++ +H  GY    +H D+KP NVLLD N    L+DF S  +LL   
Sbjct: 101 EDMARFYLAEMVLAIDSVHQLGY----VHRDIKPDNVLLDKNGHIRLADFGSCLRLLA-- 154

Query: 327 DQSMTQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTGKKP 374
           D ++     + T  Y++PE  +     +GR     D +S G+ + E   G+ P
Sbjct: 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 47.5 bits (113), Expect = 1e-05
 Identities = 25/57 (43%), Positives = 31/57 (54%), Gaps = 1/57 (1%)

Query: 22  LQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSY-LENLNLSFNKLEGEIPRG 77
           + G I  +   L  ++ +NLSNN LSG IP  +   S  L  LNLS N   G IPRG
Sbjct: 81  ISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRG 137

Length = 968

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 34/94 (36%), Positives = 44/94 (46%), Gaps = 3/94 (3%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
            +P EI  L  LE L L  N +   +  S  +L +L  L LSNN L   +P S+  LS L
Sbjct: 200 DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNL 257

Query: 61  ENLNLSFNKLEGEIPRGGPFRNFSVESFEGNELL 94
           E L+LS N++   I   G   N       GN L 
Sbjct: 258 ETLDLSNNQIS-SISSLGSLTNLRELDLSGNSLS 290

Length = 394

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 45.7 bits (109), Expect = 2e-05
 Identities = 44/174 (25%), Positives = 79/174 (45%), Gaps = 21/174 (12%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFN-----LQCGRALKGFDVECEMMKSIR-HRNLIK 233
           IG G F  V KA+    G   A+K        L+    L+    E + ++ +  H N+++
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR----EIQALRRLSPHPNILR 62

Query: 234 VISTCSNEEFK--ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
           +I    + +    ALV E M   +L + +      L   +  + M  +  +L+++H    
Sbjct: 63  LIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---R 118

Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
             I H D+KP N+L+ D+++  L+DF   +   G       T+ ++T  Y APE
Sbjct: 119 NGIFHRDIKPENILIKDDIL-KLADFGSCR---GIYSKPPYTEYISTRWYRAPE 168

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 45.3 bits (107), Expect = 4e-05
 Identities = 36/104 (34%), Positives = 50/104 (48%), Gaps = 12/104 (11%)

Query: 282 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-ATIG 340
           ALE LH      +I+ DLKP N+LLD      L DF + KL   +D    +T T   T  
Sbjct: 105 ALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNTFCGTPE 158

Query: 341 YMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP-----TNEIF 379
           Y+APE       +   D ++ G++L E  TG  P      NE++
Sbjct: 159 YLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY 202

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 44.6 bits (105), Expect = 5e-05
 Identities = 34/126 (26%), Positives = 62/126 (49%), Gaps = 20/126 (15%)

Query: 256 LEKYMYSSNYILDIFQRL---------NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL 306
           LEK + ++    +IF+R+         NIM D+ + LEY+H      I H D+KP N+++
Sbjct: 106 LEKLVENTK---EIFKRIKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMV 159

Query: 307 DDNMVAHLSDFSIAK--LLTGEDQSMTQTQT---LATIGYMAPEYGREGRVSTNGDVYSF 361
           D N   ++ D+ IA   ++ G+    ++ Q      T+ Y   +      V+  GD+ S 
Sbjct: 160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESL 219

Query: 362 GIMLME 367
           G  +++
Sbjct: 220 GYCMLK 225

Length = 294

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 44.6 bits (105), Expect = 5e-05
 Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 35/220 (15%)

Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKGFDVECE----MMKSIR-HRNLIKV 234
           IG+G +G V+K     +G + AVK+ +      +   D E E    ++K++  H N++K 
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILD-----PIHDIDEEIEAEYNILKALSDHPNVVKF 80

Query: 235 ISTCSNEEFKA-----LVLEYMPHGSLEKYMYSSNYILDIFQRLN------IMIDVASAL 283
                 ++ K      LVLE    GS+   +      L   +R+       I+ +    L
Sbjct: 81  YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKG---FLKRGERMEEPIIAYILHEALMGL 137

Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           ++LH   +   IH D+K +N+LL       L DF ++  LT     + +  ++ T  +MA
Sbjct: 138 QHLHVNKT---IHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLRRNTSVGTPFWMA 192

Query: 344 PEY-GREGRVSTN----GDVYSFGIMLMETFTGKKPTNEI 378
           PE    E ++ +      DV+S GI  +E   G  P  ++
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 45.3 bits (107), Expect = 5e-05
 Identities = 52/194 (26%), Positives = 85/194 (43%), Gaps = 33/194 (17%)

Query: 181 IGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFDVECEMMKSIR-HRN-------- 230
           I RG FG VY  R  +  ++ AVKV         K   +   M+  ++  R+        
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVK-------KADMINKNMVHQVQAERDALALSKSP 64

Query: 231 ----LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
               L   + + +N     LV+EY+  G ++  ++   Y  D    +  + +VA AL+YL
Sbjct: 65  FIVHLYYSLQSANN---VYLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYL 120

Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H      IIH DLKP N+L+ +     L+DF ++K+    + +M    T  ++     +Y
Sbjct: 121 H---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKPKNDY 177

Query: 347 GREGRVSTNGDVYS 360
            R     T G V S
Sbjct: 178 SR-----TPGQVLS 186

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 44.2 bits (104), Expect = 8e-05
 Identities = 47/199 (23%), Positives = 84/199 (42%), Gaps = 9/199 (4%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRA---LKGFDVECEMMKSIRHRNLIKVI 235
           L+G+G FG V   +    G   A+K+   +   A   +     E  ++++ RH  L  + 
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61

Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
            +    +    V+EY   G L  ++       +   R     ++ SAL+YLH      ++
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH--SEKNVV 118

Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 355
           + DLK  N++LD +    ++DF + K   G     T      T  Y+APE   +      
Sbjct: 119 YRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA 176

Query: 356 GDVYSFGIMLMETFTGKKP 374
            D +  G+++ E   G+ P
Sbjct: 177 VDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 44.0 bits (104), Expect = 8e-05
 Identities = 36/112 (32%), Positives = 50/112 (44%), Gaps = 28/112 (25%)

Query: 282 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK---------LLTGEDQSMTQ 332
           ALEYLH   +  I+H DLKP N+L+       L+DF ++K         L  G  +  T+
Sbjct: 113 ALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169

Query: 333 ----TQTLATIGYMAPE------YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
                Q   T  Y+APE      YG+        D ++ GI+L E   G  P
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKP------VDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 44.2 bits (104), Expect = 8e-05
 Identities = 69/309 (22%), Positives = 119/309 (38%), Gaps = 50/309 (16%)

Query: 181 IGRG--GFGSVYKAR-LGDGMEVAVKVFNLQ-CGRA-LKGFDVECEMMKSIRHRNLIKVI 235
           IGRG     SVY AR    G  V V++ +L+ C    LK    E  +    RH N++   
Sbjct: 6   IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65

Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL---NIMIDVASALEYLH-FGYS 291
           +  +   +  ++  +M +GS    +    Y  +        NI+      L YLH  GY 
Sbjct: 66  TVFTTGSWLWVISPFMAYGSANSLL--KTYFPEGMSEALIGNILFGALRGLNYLHQNGY- 122

Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ------SMTQTQTLATIGYMAPE 345
              IH ++K S++L+  + +  LS  S    L    Q         Q  T + + +++PE
Sbjct: 123 ---IHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFST-SVLPWLSPE 178

Query: 346 YGREGRVSTN--GDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW--------------- 388
             R+     N   D+YS GI   E  TG+ P  ++   +M L+                 
Sbjct: 179 LLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238

Query: 389 -----------VNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQ 437
                      V+  +  S +       ++ E +   + +       NL   C  + PE+
Sbjct: 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEK 298

Query: 438 RINAREIVA 446
           R +A  +++
Sbjct: 299 RPSASSLLS 307

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 44.3 bits (104), Expect = 9e-05
 Identities = 48/210 (22%), Positives = 96/210 (45%), Gaps = 23/210 (10%)

Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDV------ECEMMKSIRHRNLIKV 234
           +GRG +G VYKA+  DG +   + + L   + ++G  +      E  +++ ++H N+I +
Sbjct: 9   VGRGTYGHVYKAKRKDGKD--DRDYAL---KQIEGTGISMSACREIALLRELKHPNVISL 63

Query: 235 IST-CSNEEFKA-LVLEYMPHG--SLEKYMYSSNYILDIFQRLNIMID--VASALEYLHF 288
                S+ + K  L+ +Y  H    + K+  +S       Q    M+   +   L+ +H+
Sbjct: 64  QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123

Query: 289 GYSAPIIHCDLKPSNVLL----DDNMVAHLSDFSIAKLLTGEDQSMTQTQ-TLATIGYMA 343
            ++  ++H DLKP+N+L+     +     ++D   A+L     + +      + T  Y A
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 344 PEYGREGRVSTNG-DVYSFGIMLMETFTGK 372
           PE     R  T   D+++ G +  E  T +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 44.0 bits (104), Expect = 1e-04
 Identities = 17/37 (45%), Positives = 23/37 (62%)

Query: 39  LNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIP 75
           L L N  L G IP  + KL +L+++NLS N + G IP
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIP 459

Length = 623

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 42/159 (26%), Positives = 68/159 (42%), Gaps = 8/159 (5%)

Query: 215 GFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMY-SSNYILDIFQRL 273
           G   E  ++++I H ++I++  T +  +F  L+L   P    + Y Y ++   + I   L
Sbjct: 129 GTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDIL 185

Query: 274 NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 333
            I   V  A++YLH      IIH D+K  N+ ++      L DF  A      + +    
Sbjct: 186 AIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG 242

Query: 334 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGK 372
               TI   APE           D++S GI+L E  T  
Sbjct: 243 WA-GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 32/71 (45%), Positives = 44/71 (61%), Gaps = 3/71 (4%)

Query: 2   IPTEIGGLK-NLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
           IP  IG LK NL+ L L  N+++  +P    +L +LK L+LS N+LS  +P  L  LS L
Sbjct: 131 IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNL 188

Query: 61  ENLNLSFNKLE 71
            NL+LS NK+ 
Sbjct: 189 NNLDLSGNKIS 199

Length = 394

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 42.2 bits (99), Expect = 3e-04
 Identities = 42/165 (25%), Positives = 76/165 (46%), Gaps = 18/165 (10%)

Query: 222 MMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVAS 281
           +M  + H +L  V   C       +V E++ HG L+  +      + +  ++ +   +AS
Sbjct: 69  LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLAS 128

Query: 282 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH-------LSDFSIAKLLTGEDQSMTQTQ 334
           AL YL       ++H ++   N+LL    +A        LSD  ++   T    ++++ +
Sbjct: 129 ALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FT----ALSREE 179

Query: 335 TLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMET-FTGKKPTNE 377
            +  I ++APE    G  +ST  D +SFG  L+E  F G+ P  E
Sbjct: 180 RVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE 224

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 42.2 bits (100), Expect = 3e-04
 Identities = 42/166 (25%), Positives = 71/166 (42%), Gaps = 13/166 (7%)

Query: 222 MMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVAS 281
           +MK   + N IK+  + +  +   L+++Y+  G L   +      L   +   I+  +  
Sbjct: 64  LMKD--NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK-LSEAEVKKIIRQLVE 120

Query: 282 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMV-AHLSDFSIAKLLTGEDQSMTQTQTLATIG 340
           AL  LH      IIH D+K  NVL D      +L D+ + K+            TL    
Sbjct: 121 ALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI---IGTPSCYDGTLD--- 171

Query: 341 YMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLK 386
           Y +PE  +      + D ++ G++  E  TGK P  E  + E+ L+
Sbjct: 172 YFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLE 217

Length = 267

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 41.7 bits (98), Expect = 4e-04
 Identities = 32/105 (30%), Positives = 49/105 (46%), Gaps = 21/105 (20%)

Query: 278 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL- 336
           ++ SAL YLH   S  +++ DLK  N++LD +    ++DF + K    E  S   T    
Sbjct: 103 EIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTF 155

Query: 337 -ATIGYMAPE------YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
             T  Y+APE      YGR        D +  G+++ E   G+ P
Sbjct: 156 CGTPEYLAPEVLEDNDYGRA------VDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 41.9 bits (98), Expect = 5e-04
 Identities = 55/247 (22%), Positives = 95/247 (38%), Gaps = 57/247 (23%)

Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRN- 230
           D F    +IGRG FG V   +  D G   A+K+         K   +E E +  IR    
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-------KADMLEKEQVAHIRAERD 53

Query: 231 ---------LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVAS 281
                    ++K+  +  ++    L++E++P G +   +   + + +   +  I  +   
Sbjct: 54  ILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVL 112

Query: 282 ALEYLH-FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED------------- 327
           A++ +H  G+    IH D+KP N+LLD      LSDF +   L                 
Sbjct: 113 AIDAIHQLGF----IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPP 168

Query: 328 -----QSMTQTQ---------------TLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 367
                Q+M   +               T+ T  Y+APE   +   +   D +S G+++ E
Sbjct: 169 SDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228

Query: 368 TFTGKKP 374
              G  P
Sbjct: 229 MLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 42.0 bits (98), Expect = 5e-04
 Identities = 45/210 (21%), Positives = 76/210 (36%), Gaps = 70/210 (33%)

Query: 219 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK-----------YMYSSNYIL 267
           +CE + + R +   +      NE    L L  + H ++ K           YM +  Y  
Sbjct: 191 KCERLIAKRVKAGSRAAIQLENE---ILALGRLNHENILKIEEILRSEANTYMITQKYDF 247

Query: 268 DIF-----------------QRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM 310
           D++                 Q   IM  +  A+EY+H      +IH D+K  N+ L+ + 
Sbjct: 248 DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDG 304

Query: 311 VAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG-------------D 357
              L DF  A     E +              A +YG  G V+TN              D
Sbjct: 305 KIVLGDFGTAMPFEKERE--------------AFDYGWVGTVATNSPEILAGDGYCEITD 350

Query: 358 VYSFGIMLMETFT---------GKKPTNEI 378
           ++S G++L++  +         G KP  ++
Sbjct: 351 IWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380

Length = 501

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 42.4 bits (99), Expect = 5e-04
 Identities = 55/238 (23%), Positives = 100/238 (42%), Gaps = 48/238 (20%)

Query: 181 IGRGGFGSVYKARLGDGMEV----AVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIS 236
           IG G FG V+  +     E     A+    L+  R      +E  +M+ ++H+N+++ I 
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYID 79

Query: 237 TCSNEEFKAL--VLEYMPHGSLEKYM---------YSSNYILDIFQRLNIMIDVASALEY 285
              N+  + L  ++E+   G L + +            + I+DI ++L        AL Y
Sbjct: 80  RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQL------LHALAY 133

Query: 286 LHFGYSAP----IIHCDLKPSNVLLDDNM-----------------VAHLSDFSIAKLLT 324
            H     P    ++H DLKP N+ L   +                 +A + DF ++K + 
Sbjct: 134 CHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG 193

Query: 325 GEDQSMTQTQTLATIGYMAPEYGREGRVSTN--GDVYSFGIMLMETFTGKKPTNEIFN 380
            E  SM  +  + T  Y +PE       S +   D+++ G ++ E  +GK P ++  N
Sbjct: 194 IE--SMAHS-CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248

Length = 1021

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 41.1 bits (96), Expect = 6e-04
 Identities = 43/199 (21%), Positives = 81/199 (40%), Gaps = 10/199 (5%)

Query: 180 LIGRGGFGS--VYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           ++G G FG   + +    D      ++   +   A++    E  ++  ++H N++    +
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66

Query: 238 CSNEEFKALVLEYMPHGSL-EKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
              +    +V+EY   G L +K       +      L   + +   ++++H      ++H
Sbjct: 67  FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLH 123

Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-LATIGYMAPEYGREGRVSTN 355
            D+K  N+ L  N    L DF  A+LLT          T + T  Y+ PE       +  
Sbjct: 124 RDIKSKNIFLTQNGKVKLGDFGSARLLT---SPGAYACTYVGTPYYVPPEIWENMPYNNK 180

Query: 356 GDVYSFGIMLMETFTGKKP 374
            D++S G +L E  T K P
Sbjct: 181 SDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 54/247 (21%), Positives = 95/247 (38%), Gaps = 57/247 (23%)

Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRN- 230
           + F    +IGRG FG V   +  D G   A+K+         K   +E E +  IR    
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR-------KADMLEKEQVGHIRAERD 53

Query: 231 ---------LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVAS 281
                    ++K+  +  ++    L++E++P G +   +   + + +   +  I  +   
Sbjct: 54  ILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVL 112

Query: 282 ALEYLH-FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED------------- 327
           A++ +H  G+    IH D+KP N+LLD      LSDF +   L                 
Sbjct: 113 AIDSIHQLGF----IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLP 168

Query: 328 -----QSMTQTQ---------------TLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 367
                Q+M   +               T+ T  Y+APE   +   +   D +S G+++ E
Sbjct: 169 SDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228

Query: 368 TFTGKKP 374
              G  P
Sbjct: 229 MLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies)

 Score = 35.9 bits (84), Expect = 0.002
 Identities = 16/37 (43%), Positives = 24/37 (64%), Gaps = 2/37 (5%)

Query: 35 SLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLE 71
          +L+ L+LSNN ++  +P  L  L  LE L+LS NK+ 
Sbjct: 2  NLETLDLSNNQITD-LPP-LSNLPNLETLDLSGNKIT 36

Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43

>gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies)

 Score = 35.5 bits (83), Expect = 0.002
 Identities = 13/38 (34%), Positives = 22/38 (57%), Gaps = 2/38 (5%)

Query: 10 KNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLS 47
           NLE L L  N++   +P    +L +L+ L+LS N ++
Sbjct: 1  TNLETLDLSNNQITD-LP-PLSNLPNLETLDLSGNKIT 36

Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43

>gnl|CDD|225213 COG2334, COG2334, Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

 Score = 39.6 bits (93), Expect = 0.003
 Identities = 25/111 (22%), Positives = 34/111 (30%), Gaps = 27/111 (24%)

Query: 211 RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIF 270
            AL+GF             N ++              LE+               +    
Sbjct: 136 LALRGF--------PFERPNALRR-------------LEWDILEPRALLRLD--LVEPED 172

Query: 271 QRLNIMIDVASALEYL--HF-GYSAPIIHCDLKPSNVLLD-DNMVAHLSDF 317
            R  ++  +   L  L  H       IIH DL P NVL D D  V+   DF
Sbjct: 173 LRAALLAALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDF 223

Length = 331

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 38.9 bits (91), Expect = 0.004
 Identities = 48/178 (26%), Positives = 75/178 (42%), Gaps = 51/178 (28%)

Query: 180 LIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKS-----IR-HRNL- 231
           +IGRG FG V   +  D G   A+K         L+    + EM++      +R  R++ 
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKK--------LR----KSEMLEKEQVAHVRAERDIL 55

Query: 232 --------IKVISTCSNEEFKALVLEYMPHGS----LEKYMYSSNYILDIF---QRLNIM 276
                   +K+  +  +E +  L++EY+P G     L K         D F   +    +
Sbjct: 56  AEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK--------DTFTEEETRFYI 107

Query: 277 IDVASALEYLH-FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 333
            +   A++ +H  GY    IH D+KP N+LLD      LSDF    L TG  +S    
Sbjct: 108 AETILAIDSIHKLGY----IHRDIKPDNLLLDAKGHIKLSDFG---LCTGLKKSHRTE 158

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	470
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.98
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.89
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.89
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.87
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.87
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.85
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.84
PRK12274	218	serine/threonine protein kinase; Provisional	99.84
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.83
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.83
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.83
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.81
PRK10345	210	hypothetical protein; Provisional	99.81
smart00090	237	RIO RIO-like kinase.	99.77
PRK14879	211	serine/threonine protein kinase; Provisional	99.77
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.76
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.76
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.74
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.74
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.68
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.68
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.67
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.65
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.63
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.57
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.57
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.53
PLN03150	623	hypothetical protein; Provisional	99.52
KOG1243	690	consensus Protein kinase [General function predict	99.43
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.41
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.38
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.31
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.27
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.26
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.22
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.21
KOG3087	229	consensus Serine/threonine protein kinase [General	99.2
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.14
COG4248	637	Uncharacterized protein with protein kinase and he	99.13
PLN03150	623	hypothetical protein; Provisional	99.12
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.06
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.02
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.0
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.97
KOG0617	264	consensus Ras suppressor protein (contains leucine	98.91
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.89
KOG0617	264	consensus Ras suppressor protein (contains leucine	98.88
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.87
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.83
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.82
KOG0472	565	consensus Leucine-rich repeat protein [Function un	98.79
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	98.77
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.72
PRK09902	216	hypothetical protein; Provisional	98.67
KOG0472	565	consensus Leucine-rich repeat protein [Function un	98.63
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.62
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.6
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.59
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	98.58
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.54
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	98.54
KOG4237	498	consensus Extracellular matrix protein slit, conta	98.53
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.51
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	98.5
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.46
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.41
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.4
PF01636	239	APH: Phosphotransferase enzyme family This family	98.35
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.35
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.34
KOG4237	498	consensus Extracellular matrix protein slit, conta	98.28
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.26
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.26
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.22
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	98.2
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.18
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.16
PLN02876	822	acyl-CoA dehydrogenase	98.14
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	98.12
KOG1644	233	consensus U2-associated snRNP A' protein [RNA proc	98.12
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.11
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.08
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	98.08
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.05
PRK10593	297	hypothetical protein; Provisional	98.03
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.01
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	97.98
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.92
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.87

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.8e-55  Score=484.53  Aligned_cols=430  Identities=28%  Similarity=0.464  Sum_probs=277.4

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCCC
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPFR   81 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~   81 (470)
                      |..|.++++|+.|+|++|++++.+|..+.++++|+.|+|++|.++|.+|..+..+++|+.|++++|++++.+|. +..+.
T Consensus       492 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~  571 (968)
T PLN00113        492 PRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVE  571 (968)
T ss_pred             ChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCc
Confidence            44455555555555555555555555555555555555555555555555555555555555555555544433 24444


Q ss_pred             CCccccccCCcc-----------------------ccCCC-CCCCCCCCCCCCCcccccchhhhhHHHHHHHHHHHHHHH
Q 040392           82 NFSVESFEGNEL-----------------------LCGSP-NLQVPPCKTSNHHTLWKNSLLLRIVLPLSAIFMIVVILL  137 (470)
Q Consensus        82 ~l~~l~~~~n~~-----------------------~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  137 (470)
                      +|+.+++++|++                       .|+.+ ....++|........|  ..++.+++++.++++++++++
T Consensus       572 ~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  649 (968)
T PLN00113        572 SLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSW--WFYITCTLGAFLVLALVAFGF  649 (968)
T ss_pred             ccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcccccccee--eeehhHHHHHHHHHHHHHHHH
Confidence            555555555554                       44432 1223455432221111  112222222222222222222


Q ss_pred             H-HhhhccCCCCCCCC-CCCc-cccc--cccCHHHHHHhhCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccch
Q 040392          138 I-LRYRQKGKRPSNDA-NMPS-IATW--RTFSHLELCRATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGR  211 (470)
Q Consensus       138 ~-~~~~~~~~~~~~~~-~~~~-~~~~--~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~  211 (470)
                      + +++|++.+.+.... .... ....  ..............+...+.||+|+||.||+|+. .++..||||.+..... 
T Consensus       650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-  728 (968)
T PLN00113        650 VFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-  728 (968)
T ss_pred             HHHHhhhcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-
Confidence            2 22222111111110 0000 0000  0001122333345678889999999999999986 5789999999864322 


Q ss_pred             hhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 040392          212 ALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS  291 (470)
Q Consensus       212 ~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~  291 (470)
                         ....|++.+++++||||++++++|.+....++||||+++|+|.++++    .++|..+.+++.|+++||+|||+.+.
T Consensus       729 ---~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~  801 (968)
T PLN00113        729 ---IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCS  801 (968)
T ss_pred             ---ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCC
Confidence               22346889999999999999999999999999999999999999995    37899999999999999999997667


Q ss_pred             CCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhC
Q 040392          292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTG  371 (470)
Q Consensus       292 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg  371 (470)
                      .+++||||||+||+++.++..++. ||.+.....      .....++..|+|||++.+..++.++|||||||++|||+||
T Consensus       802 ~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg  874 (968)
T PLN00113        802 PAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTG  874 (968)
T ss_pred             CCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhC
Confidence            899999999999999999988875 665543221      1123578999999999999999999999999999999999


Q ss_pred             CCCCCccccCcchhhHHhhhhcCCc-ccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHH
Q 040392          372 KKPTNEIFNGEMTLKHWVNDWLPIS-TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK  450 (470)
Q Consensus       372 ~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~  450 (470)
                      +.||............|........ .....|+.+.....    .+.....++.+++.+||+.||++||+|.|+++.|++
T Consensus       875 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  950 (968)
T PLN00113        875 KSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS----VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES  950 (968)
T ss_pred             CCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCC----ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHH
Confidence            9999765555556667765443322 22333443322111    122335678899999999999999999999999999


Q ss_pred             HHH
Q 040392          451 IRD  453 (470)
Q Consensus       451 i~~  453 (470)
                      +..
T Consensus       951 ~~~  953 (968)
T PLN00113        951 ASR  953 (968)
T ss_pred             hhc
Confidence            864

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-52  Score=406.96  Aligned_cols=287  Identities=40%  Similarity=0.648  Sum_probs=246.1

Q ss_pred             cccccCHHHHHHhhCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeee
Q 040392          159 TWRTFSHLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTC  238 (470)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~  238 (470)
                      ....|++.++..+|++|...+.||+|+||.||+|...+|+.||||++..........|..|+.++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56679999999999999999999999999999999999999999988755433145599999999999999999999999


Q ss_pred             ccCC-eeeEEEecCCCCChHHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEee
Q 040392          239 SNEE-FKALVLEYMPHGSLEKYMYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSD  316 (470)
Q Consensus       239 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~D  316 (470)
                      .+.+ ..++|+||+++|+|.++++.... .++|.+|++|+.++|+||+|||+.+..+|+||||||+|||+|+++++||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9988 59999999999999999988776 899999999999999999999988888999999999999999999999999


Q ss_pred             eccccccCCCCCccccccc-ccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccc-cCcchhhHHhhhhcC
Q 040392          317 FSIAKLLTGEDQSMTQTQT-LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIF-NGEMTLKHWVNDWLP  394 (470)
Q Consensus       317 fg~a~~~~~~~~~~~~~~~-~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~-~~~~~~~~~~~~~~~  394 (470)
                      ||+|+.....  ....... .||.+|+|||+...+..+.|+|||||||+|+|++||+.|.+... .++..+..|......
T Consensus       221 FGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~  298 (361)
T KOG1187|consen  221 FGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE  298 (361)
T ss_pred             ccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence            9999654321  1111112 79999999999999999999999999999999999999887644 345568888755544


Q ss_pred             C-cccccccccccC-chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHH
Q 040392          395 I-STMEVVGANLLS-QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR  452 (470)
Q Consensus       395 ~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~  452 (470)
                      . ...+++|+.+.. .....     .....+..++..|++.+|..||+|.||++.|+.+.
T Consensus       299 ~~~~~eiiD~~l~~~~~~~~-----~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  299 EGKLREIVDPRLKEGEYPDE-----KEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             CcchhheeCCCccCCCCChH-----HHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            4 688999999863 22111     34666899999999999999999999999997665

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-49  Score=382.44  Aligned_cols=261  Identities=30%  Similarity=0.455  Sum_probs=217.1

Q ss_pred             CCCCCeecccCceEEEEEEeCCCcEEEEEEeecccc--hhhhhHHHHHHHHhcCCCCcceeEEeeeccCC-eeeEEEecC
Q 040392          175 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRNLIKVISTCSNEE-FKALVLEYM  251 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~~~lv~e~~  251 (470)
                      +...+.||+|+||+||+|.+.....||||.+.....  ...+.|.+|+.+|.+++|||||+++|+|.+.. ..++||||+
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~  122 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM  122 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence            344556999999999999996444499999975432  22568999999999999999999999999887 789999999


Q ss_pred             CCCChHHhhhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eeecCCCCCCeeeCCCC-CeEEeeeccccccCCCCC
Q 040392          252 PHGSLEKYMYS-SNYILDIFQRLNIMIDVASALEYLHFGYSAP-IIHCDLKPSNVLLDDNM-VAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       252 ~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-i~H~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~  328 (470)
                      ++|+|.++++. .+..+++..++.++.|||+||.|||   +.+ ||||||||+|||++.++ ++||+|||+++...... 
T Consensus       123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-  198 (362)
T KOG0192|consen  123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-  198 (362)
T ss_pred             CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence            99999999988 3678999999999999999999999   888 99999999999999998 99999999998654321 


Q ss_pred             cccccccccCccccCccccC--CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccccc
Q 040392          329 SMTQTQTLATIGYMAPEYGR--EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL  406 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~--~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (470)
                       ...+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||....... .....+...              
T Consensus       199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~-~~~~v~~~~--------------  262 (362)
T KOG0192|consen  199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ-VASAVVVGG--------------  262 (362)
T ss_pred             -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhcC--------------
Confidence             3444478999999999999  5689999999999999999999999999865521 111111111              


Q ss_pred             CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHhhhc
Q 040392          407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNV  459 (470)
Q Consensus       407 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~~~~  459 (470)
                          .+...+..|+..+..++.+||+.||.+||++.+++..|+.+...+....
T Consensus       263 ----~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~  311 (362)
T KOG0192|consen  263 ----LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAG  311 (362)
T ss_pred             ----CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccC
Confidence                1112233468889999999999999999999999999999987666543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-49  Score=363.90  Aligned_cols=253  Identities=23%  Similarity=0.314  Sum_probs=210.8

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCC-eeeEEEe
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEE-FKALVLE  249 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~~~lv~e  249 (470)
                      ++.+..+.||+|..|+|||++++ +++.+|+|++.... ....+++.+|+++++..+||+||.+||.|.... ...++||
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            34566789999999999999765 68899999996553 445677889999999999999999999999888 5999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      ||++|+|++++... ..+++....+++.++++||.|||+  .++|+||||||+|||++..|++||||||.+..+.+.   
T Consensus       159 YMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---  232 (364)
T KOG0581|consen  159 YMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---  232 (364)
T ss_pred             hcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence            99999999999765 468999999999999999999993  389999999999999999999999999999877543   


Q ss_pred             ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCch
Q 040392          330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE  409 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (470)
                       .....+||..|||||.+.+..|+.++||||||++++|+.+|+.||....+....+...+........     +.     
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp-----P~-----  301 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP-----PR-----  301 (364)
T ss_pred             -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC-----CC-----
Confidence             3456789999999999999999999999999999999999999998752222222222221111100     00     


Q ss_pred             hhhhHhhh-hhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          410 DIHFVAKE-QCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       410 ~~~~~~~~-~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                           .|. .++.++.+++..||++||.+||++.|+++|
T Consensus       302 -----lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  302 -----LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             -----CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                 112 468899999999999999999999999986

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-49  Score=382.40  Aligned_cols=254  Identities=31%  Similarity=0.511  Sum_probs=220.9

Q ss_pred             CCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCCC
Q 040392          175 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHG  254 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g  254 (470)
                      +...+.||+|.||.||.|++.....||+|.++.. ....+.|.+|+++|++|+|+|||+++++|..++..+||||||+.|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            3456789999999999999987789999999754 334567889999999999999999999999988999999999999


Q ss_pred             ChHHhhhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccccc
Q 040392          255 SLEKYMYS-SNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  333 (470)
Q Consensus       255 ~L~~~l~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  333 (470)
                      +|.+++.. .+..+...+.+.++.|||+|++||+   ++++|||||.++|||++++..+||+|||+|+... .+......
T Consensus       287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~-d~~Y~~~~  362 (468)
T KOG0197|consen  287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIG-DDEYTASE  362 (468)
T ss_pred             cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccC-CCceeecC
Confidence            99999987 5577899999999999999999999   9999999999999999999999999999999443 34444455


Q ss_pred             ccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhh
Q 040392          334 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIH  412 (470)
Q Consensus       334 ~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  412 (470)
                      ...-+..|+|||.+..+.++.|||||||||+||||+| |+.|+..+.+.+.  ...                  -..+.+
T Consensus       363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev--~~~------------------le~GyR  422 (468)
T KOG0197|consen  363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV--LEL------------------LERGYR  422 (468)
T ss_pred             CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH--HHH------------------HhccCc
Confidence            5567889999999999999999999999999999999 9999887654432  111                  123455


Q ss_pred             hHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          413 FVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       413 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                      .+.|..||.++.++|..||..+|++|||++.+...|+++..
T Consensus       423 lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  423 LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            66788999999999999999999999999999999988864

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-48  Score=377.44  Aligned_cols=248  Identities=25%  Similarity=0.355  Sum_probs=213.4

Q ss_pred             CCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc---cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      .+|...+.||+|+|+.+|.++. .+|+.||+|++.+.   .....+...+|+++.+.|+|||||+++++|++.++.|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5688999999999999999987 78999999999754   4556677889999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      |+|+.++|..+++ .+..+++.++..++.||+.||.|||   +.+|+|||||..|+|++++.++||+|||+|..+..++ 
T Consensus        98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-  172 (592)
T KOG0575|consen   98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-  172 (592)
T ss_pred             EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCcc-
Confidence            9999999999997 5668999999999999999999999   9999999999999999999999999999999885432 


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                       ......+||+.|.|||++....++..+||||+||+||-|+.|++||+...-.+ .+......                 
T Consensus       173 -Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-ty~~Ik~~-----------------  233 (592)
T KOG0575|consen  173 -ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-TYNKIKLN-----------------  233 (592)
T ss_pred             -cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-HHHHHHhc-----------------
Confidence             34456889999999999999999999999999999999999999998632111 11111100                 


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                         +...|...+.+..+||.++|+.||.+|||+.+|+.+
T Consensus       234 ---~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  234 ---EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             ---CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence               011223346778899999999999999999999976

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-48  Score=357.08  Aligned_cols=202  Identities=30%  Similarity=0.498  Sum_probs=182.7

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ..+|...+.||+|+||+||+|+++ ++..||||.+...  ..+..+.+..|+.+|+.++|||||++++++..+++.++||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            467888999999999999999754 5899999999766  4556677888999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC------CCeEEeeeccccc
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN------MVAHLSDFSIAKL  322 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~------~~~kl~Dfg~a~~  322 (470)
                      |||.||+|.+|++..+ .+++.++..++.|+|.||++||   +++|+||||||.|||++..      -.+||+|||+|+.
T Consensus        89 EyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             EeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            9999999999998765 6899999999999999999999   9999999999999999764      5689999999998


Q ss_pred             cCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccc
Q 040392          323 LTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFN  380 (470)
Q Consensus       323 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~  380 (470)
                      +.+   .......+|++.|||||++...+|+.|+|+||+|+++|+|++|+.||.....
T Consensus       165 L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~  219 (429)
T KOG0595|consen  165 LQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP  219 (429)
T ss_pred             CCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence            863   3444568999999999999999999999999999999999999999986443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-48  Score=360.27  Aligned_cols=254  Identities=25%  Similarity=0.353  Sum_probs=207.8

Q ss_pred             hhCCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccc-------hhhhhHHHHHHHHhcCCCCcceeEEeeeccCC
Q 040392          171 ATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCG-------RALKGFDVECEMMKSIRHRNLIKVISTCSNEE  242 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  242 (470)
                      ..+.|.+.+.||+|+||.|-+|. .++|+.||||++.....       .......+|+++|++|+|||||+++++++.++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            34668888999999999999996 56799999999975521       12233568999999999999999999999999


Q ss_pred             eeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC---CCeEEeeecc
Q 040392          243 FKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN---MVAHLSDFSI  319 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~---~~~kl~Dfg~  319 (470)
                      ..||||||++||+|.+.+-..+ .+.+.....++.|++.|+.|||   +.||+||||||+|||+..+   ..+||+|||+
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccch
Confidence            9999999999999999997665 4677777889999999999999   9999999999999999765   7899999999


Q ss_pred             ccccCCCCCcccccccccCccccCccccCCCC---CCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc
Q 040392          320 AKLLTGEDQSMTQTQTLATIGYMAPEYGREGR---VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS  396 (470)
Q Consensus       320 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  396 (470)
                      |+...   ....+...+||+.|.|||++.+..   +..++|+||+||+||-+++|..||.+...... +.+.+.      
T Consensus       326 AK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-l~eQI~------  395 (475)
T KOG0615|consen  326 AKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-LKEQIL------  395 (475)
T ss_pred             hhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-HHHHHh------
Confidence            99764   334456689999999999998765   33478999999999999999999998554431 222111      


Q ss_pred             ccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          397 TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       397 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                               .+............+.+..+++.+||..||++|||+.|+++|
T Consensus       396 ---------~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  396 ---------KGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             ---------cCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence                     111111222334568889999999999999999999999986

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.4e-47  Score=385.66  Aligned_cols=259  Identities=30%  Similarity=0.530  Sum_probs=226.3

Q ss_pred             CCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccch-hhhhHHHHHHHHhcCCCCcceeEEeeeccCCeee
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKA  245 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  245 (470)
                      .+....+.||+|+||+||+|+..      +...||||.++..+.. ...+|++|++++..++|||||+++|.|.+++..+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            34556678999999999999742      4567999999877655 7889999999999999999999999999999999


Q ss_pred             EEEecCCCCChHHhhhcCC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCe
Q 040392          246 LVLEYMPHGSLEKYMYSSN-------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA  312 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~  312 (470)
                      +|+|||..|||.+||....             .+++..+.+.|+.|||.|++||-   ++.++||||..+|+|++++..|
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEE
Confidence            9999999999999996432             23788899999999999999999   9999999999999999999999


Q ss_pred             EEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhh
Q 040392          313 HLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVND  391 (470)
Q Consensus       313 kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~  391 (470)
                      ||+|||+++...+.++........-+.+|||||.+..+++++++|||||||+|||+++ |+.||.+..+.+.-  +.   
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI--e~---  717 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI--EC---  717 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH--HH---
Confidence            9999999999888787777767778899999999999999999999999999999999 99999987665421  11   


Q ss_pred             hcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          392 WLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                                    +..... +..|++||.++++||..||+.+|.+||++.||-..|+.+...
T Consensus       718 --------------i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  718 --------------IRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             --------------HHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence                          111122 456789999999999999999999999999999999988643

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.9e-48  Score=339.70  Aligned_cols=255  Identities=24%  Similarity=0.347  Sum_probs=204.8

Q ss_pred             CCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEe-eeccCC-eeeEE
Q 040392          173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVIS-TCSNEE-FKALV  247 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~-~~~~~~-~~~lv  247 (470)
                      .+|++.+.||+|+||+||++. ..+|..+|.|.+.-.  +.+..+....|+.+|++|+|||||++++ .+.++. ..++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            458888999999999999995 678999999988643  3456677888999999999999999998 444444 48899


Q ss_pred             EecCCCCChHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeeCCCCCeEEeeeccccc
Q 040392          248 LEYMPHGSLEKYMYS---SNYILDIFQRLNIMIDVASALEYLHFGYSAP--IIHCDLKPSNVLLDDNMVAHLSDFSIAKL  322 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~a~~  322 (470)
                      ||||..|+|.+.++.   .+..+++..+++++.|++.||..+|... +.  |+||||||.||+++.+|.+||+|||+++.
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            999999999998854   3467899999999999999999999322 44  89999999999999999999999999998


Q ss_pred             cCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccc
Q 040392          323 LTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVG  402 (470)
Q Consensus       323 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (470)
                      +.+.  .....+.+|||.||+||.+.+..|+.|+||||+||++|||+.-+.||.+.     .+...-.+......     
T Consensus       178 l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~KI~qgd~-----  245 (375)
T KOG0591|consen  178 LSSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCKKIEQGDY-----  245 (375)
T ss_pred             hcch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHHHHHcCCC-----
Confidence            8543  33445689999999999999999999999999999999999999999863     11111111111000     


Q ss_pred             ccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHH
Q 040392          403 ANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLL  449 (470)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~  449 (470)
                               .....+-.+.++.+|+..|+.+||++||+...++..+.
T Consensus       246 ---------~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  246 ---------PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             ---------CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence                     00112345788999999999999999999655555443

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.4e-46  Score=333.57  Aligned_cols=267  Identities=22%  Similarity=0.318  Sum_probs=208.1

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      +.|+.+.++|+|+||+||+++.+ +|+.||||.+...  +....+-..+|+++|++++|+|+|.++..|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            56888899999999999999866 5999999998533  23345556789999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      ||+. ++.+-+.......+...+.+++.|++.|+.|+|   +.+++||||||+|||++.++.+||||||+|+.+..+  .
T Consensus        82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p--g  155 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP--G  155 (396)
T ss_pred             ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCC--c
Confidence            9987 666667666667899999999999999999999   999999999999999999999999999999988642  3


Q ss_pred             ccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcch--hhHHhhhhcCCcccccccccc-
Q 040392          330 MTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMT--LKHWVNDWLPISTMEVVGANL-  405 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~-  405 (470)
                      ...+..+.|.+|+|||++.+ .+|+..+||||+||++.||++|..-|.+.++-..-  +..-+....| ....++...- 
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~p-rhq~iF~~N~~  234 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIP-RHQSIFSSNPF  234 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCH-HHHHHhccCCc
Confidence            34456789999999999988 68999999999999999999999988764332110  1111111111 1111111111 


Q ss_pred             ---------cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          406 ---------LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       406 ---------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                               ...++.+... ...+.-+.+++..||+.||++|++-+|++.|
T Consensus       235 F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  235 FHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             eeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence                     0011111111 1335568999999999999999999999865

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-45  Score=342.59  Aligned_cols=259  Identities=31%  Similarity=0.464  Sum_probs=209.1

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCC--eeeEEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEE--FKALVL  248 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--~~~lv~  248 (470)
                      ..+|...+.||+|+||.||++... +|...|||.+........+.+..|+++|++++|||||+++|.....+  .+++.|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            345778899999999999999765 48999999987664444667889999999999999999999854444  688999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCCeEEeeeccccccCC-C
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-NMVAHLSDFSIAKLLTG-E  326 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~-~  326 (470)
                      ||+++|+|.+++...+..+++..+..++.|+++||.|||   +++++||||||+|||++. ++.+||+|||+++.... .
T Consensus        96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            999999999999887667899999999999999999999   999999999999999999 79999999999987653 1


Q ss_pred             CCcccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccc-CcchhhHHhhhhcCCccccccccc
Q 040392          327 DQSMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFN-GEMTLKHWVNDWLPISTMEVVGAN  404 (470)
Q Consensus       327 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  404 (470)
                      ..........||+.|||||++..+ ....++|||||||++.||+||+.||..... .+..+........|          
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P----------  242 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP----------  242 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC----------
Confidence            222334457899999999999853 344699999999999999999999987411 11111111111001          


Q ss_pred             ccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHH
Q 040392          405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR  452 (470)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~  452 (470)
                               ..+...+.+..+++..|+..||++||||.+++.|-.--.
T Consensus       243 ---------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~  281 (313)
T KOG0198|consen  243 ---------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ  281 (313)
T ss_pred             ---------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence                     123335777899999999999999999999999875543

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=356.81  Aligned_cols=266  Identities=27%  Similarity=0.439  Sum_probs=216.5

Q ss_pred             HHHHhhCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCee
Q 040392          167 ELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFK  244 (470)
Q Consensus       167 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  244 (470)
                      +.....+.+.+.+.||+|+||+||+|+|-  ..||||++...  .....+.|+.|+..+++-+|.||+-|.|||..+.. 
T Consensus       386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-  462 (678)
T KOG0193|consen  386 EWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-  462 (678)
T ss_pred             ccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence            33444556677899999999999999983  46999999755  44578899999999999999999999999999888 


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccC
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~  324 (470)
                      .||+.+|+|.+|+.+++..+..++..+.+.|+.|+++|+.|||   .++|||+|||..||++.++++|||+|||++..-.
T Consensus       463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~  539 (678)
T KOG0193|consen  463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT  539 (678)
T ss_pred             eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence            8999999999999999988888999999999999999999999   9999999999999999999999999999987543


Q ss_pred             CCCCcccccccccCccccCccccCC---CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccc
Q 040392          325 GEDQSMTQTQTLATIGYMAPEYGRE---GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVV  401 (470)
Q Consensus       325 ~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (470)
                      .-..........|...|||||++..   ..|++.+||||||+|+|||+||..||.. ...+ .+.            -.+
T Consensus       540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~d-qIi------------fmV  605 (678)
T KOG0193|consen  540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRD-QII------------FMV  605 (678)
T ss_pred             eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChh-heE------------EEe
Confidence            2211222234457889999998874   3589999999999999999999999983 2221 111            111


Q ss_pred             cccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          402 GANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                      ........  ......+|+.++.+|+..||..++++||.+.+|+..|+++..+
T Consensus       606 GrG~l~pd--~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  606 GRGYLMPD--LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             cccccCcc--chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            11111100  1122356789999999999999999999999999999998765

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-45  Score=335.85  Aligned_cols=249  Identities=29%  Similarity=0.351  Sum_probs=205.7

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      .++|++++.||+|+||.||.++. .+++-+|+|++++..   ....+....|..+|.+++||.||+++..|++.+..|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            57899999999999999999965 468999999997652   33566778899999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      +||+.||.|...+++.+ .+++..+.-++.+|+.||.|||   +++|+||||||+|||+|.+|+++|+|||+++..... 
T Consensus       104 ld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-  178 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-  178 (357)
T ss_pred             EeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccC-
Confidence            99999999999997555 6888888999999999999999   999999999999999999999999999999854322 


Q ss_pred             CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                       .......+||+.|||||++.+..|+..+|.||+|+++|||++|..||.....     ..+.+.....+.        ..
T Consensus       179 -~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-----~~~~~~I~~~k~--------~~  244 (357)
T KOG0598|consen  179 -GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-----KKMYDKILKGKL--------PL  244 (357)
T ss_pred             -CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-----HHHHHHHhcCcC--------CC
Confidence             2223347999999999999999999999999999999999999999987432     223222222220        00


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCC----CHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRI----NAREIVA  446 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp----s~~el~~  446 (470)
                             .+.-.+.+..+++.+.|+.||++|.    ++.+|.+
T Consensus       245 -------~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~  280 (357)
T KOG0598|consen  245 -------PPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR  280 (357)
T ss_pred             -------CCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence                   0111356688999999999999996    4555443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-45  Score=350.26  Aligned_cols=255  Identities=26%  Similarity=0.407  Sum_probs=213.3

Q ss_pred             HHhhCCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecc---cchhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCe
Q 040392          169 CRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ---CGRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEF  243 (470)
Q Consensus       169 ~~~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~  243 (470)
                      .+...+|.+.+.||+|+|++|++|+ ..+++.||||++.+.   .....+-...|-.+|.+| .||.|++++..|.+...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            4456789999999999999999996 456999999998654   233455667799999999 89999999999999999


Q ss_pred             eeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecccccc
Q 040392          244 KALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  323 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~  323 (470)
                      .|+|+||+++|+|.++|.+.+ .+++.....++.+|+.||+|||   ++|||||||||+|||+|+|+++||+|||.|+.+
T Consensus       149 LYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence            999999999999999998765 7899999999999999999999   999999999999999999999999999999987


Q ss_pred             CCCCCc-----------ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhh
Q 040392          324 TGEDQS-----------MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDW  392 (470)
Q Consensus       324 ~~~~~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  392 (470)
                      .+....           ......+||..|.+||++.....++.+|+|+|||++|+|+.|..||.+..+-- .+...+.  
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl-iFqkI~~--  301 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL-IFQKIQA--  301 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH-HHHHHHH--
Confidence            543222           11245899999999999999999999999999999999999999998742211 1111100  


Q ss_pred             cCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          393 LPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                                        .....++.++..+.+|+.+.|..||.+|++.+||.+|-
T Consensus       302 ------------------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  302 ------------------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             ------------------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence                              01112344567789999999999999999999998873

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=353.33  Aligned_cols=258  Identities=25%  Similarity=0.422  Sum_probs=222.0

Q ss_pred             CCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCCCC
Q 040392          176 SENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGS  255 (470)
Q Consensus       176 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~  255 (470)
                      ..++.||.|+-|.||+|+.. ++.||||.++.-       -..+++.|++|+|+||+.|.|+|.....++||||||+.|-
T Consensus       127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence            44678999999999999984 789999987522       2347889999999999999999999999999999999999


Q ss_pred             hHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccccccc
Q 040392          256 LEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT  335 (470)
Q Consensus       256 L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  335 (470)
                      |...++..+ .++......|..+||.|+.|||   .+.|||||||.-||||+.+..+||+|||-++.....   .++..+
T Consensus       199 L~~VLka~~-~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSF  271 (904)
T KOG4721|consen  199 LYEVLKAGR-PITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSF  271 (904)
T ss_pred             HHHHHhccC-ccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhh
Confidence            999997665 6788888999999999999999   999999999999999999999999999998876432   455678


Q ss_pred             ccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHh
Q 040392          336 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVA  415 (470)
Q Consensus       336 ~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  415 (470)
                      +||..|||||++.....++|+||||||||||||+||..||.+.....+-+-                   ++......+.
T Consensus       272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwG-------------------VGsNsL~Lpv  332 (904)
T KOG4721|consen  272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWG-------------------VGSNSLHLPV  332 (904)
T ss_pred             hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEe-------------------ccCCcccccC
Confidence            999999999999999999999999999999999999999987543321100                   2233455677


Q ss_pred             hhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHhhhccCchhhhc
Q 040392          416 KEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNVGDRCIRQS  467 (470)
Q Consensus       416 ~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~~~~~~~~~~~~  467 (470)
                      |..|+..|.-|++.||+..|..||++.+++.||.-....+.++-.+.+++.|
T Consensus       333 PstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~~tee~yf~sq  384 (904)
T KOG4721|consen  333 PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLSTTEETYFKSQ  384 (904)
T ss_pred             cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhcccHHHHHHHH
Confidence            8899999999999999999999999999999998887777777666666544

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.5e-44  Score=315.40  Aligned_cols=267  Identities=24%  Similarity=0.355  Sum_probs=208.1

Q ss_pred             CCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccch--hhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGR--ALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      ++|...+.+|+|.||.||+|+ ..+|+.||||.++.....  ......+|++.|+.++|+||+.++++|...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            468888999999999999996 567999999999755322  23456789999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      |++. +|+..++++...++..++..++.++++|++|||   .+.|+||||||+|+|++++|.+||+|||+|+.+.+....
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            9975 999999999999999999999999999999999   999999999999999999999999999999988765544


Q ss_pred             ccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhh--------hcCCc-ccc
Q 040392          330 MTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVND--------WLPIS-TME  399 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~~~-~~~  399 (470)
                      ..  ..+.|.+|+|||++.+. .|+..+|+||.||++.||+-|..-|.+..+ -.++....+.        |.... ..+
T Consensus       158 ~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD-idQL~~If~~LGTP~~~~WP~~~~lpd  234 (318)
T KOG0659|consen  158 QT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD-IDQLSKIFRALGTPTPDQWPEMTSLPD  234 (318)
T ss_pred             cc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch-HHHHHHHHHHcCCCCcccCcccccccc
Confidence            33  33789999999998875 599999999999999999988765544221 1111111111        11110 001


Q ss_pred             cccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          400 VVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      .+.-........+. .-..++.++.+|+..++..||.+|+++.|++++
T Consensus       235 Y~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  235 YVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            11101011111111 112346677999999999999999999999875

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-44  Score=340.68  Aligned_cols=268  Identities=27%  Similarity=0.364  Sum_probs=213.0

Q ss_pred             HhhCCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccC--Cee
Q 040392          170 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNE--EFK  244 (470)
Q Consensus       170 ~~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~  244 (470)
                      ...+.|+.++.||+|.||.||+|+ ..+|+.||+|.+..+.  ........+|+.+|++|.||||+++.+...+.  ...
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si  193 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI  193 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence            345678889999999999999996 5679999999987664  34455667899999999999999999998776  689


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccC
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~  324 (470)
                      |+|+|||+. +|..++......+++.++..++.|++.||+|||   .++|+|||||.+|||||.+|.+||+|||+|+++.
T Consensus       194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeecc
Confidence            999999987 999999888888999999999999999999999   9999999999999999999999999999999886


Q ss_pred             CCCCcccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhH-------------Hhh
Q 040392          325 GEDQSMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKH-------------WVN  390 (470)
Q Consensus       325 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~-------------~~~  390 (470)
                      ... ....+..+.|.+|+|||++.+. .|+.++|+||.||+|.||++|+..|.+..+  .....             |..
T Consensus       270 ~~~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE--veQl~kIfklcGSP~e~~W~~  346 (560)
T KOG0600|consen  270 PSG-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE--VEQLHKIFKLCGSPTEDYWPV  346 (560)
T ss_pred             CCC-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH--HHHHHHHHHHhCCCChhcccc
Confidence            543 3346778899999999998875 699999999999999999999998775322  11111             111


Q ss_pred             hhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          391 DWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       391 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ..+|.  ...+.+...-....+. .-..++...++|+..+|..||.+|.||.+++..
T Consensus       347 ~kLP~--~~~~kp~~~y~r~l~E-~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  347 SKLPH--ATIFKPQQPYKRRLRE-TFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             ccCCc--ccccCCCCcccchHHH-HhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            11110  0111111100111111 123457788999999999999999999998753

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.6e-43  Score=346.42  Aligned_cols=260  Identities=24%  Similarity=0.404  Sum_probs=206.0

Q ss_pred             hCCCCCCCeecccCceEEEEEEe------CCCcEEEEEEeeccc-chhhhhHHHHHHHHhcC-CCCcceeEEeeeccC-C
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQC-GRALKGFDVECEMMKSI-RHRNLIKVISTCSNE-E  242 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~-~  242 (470)
                      .++|++.+.||+|+||.||+|.+      .+++.||+|++.... ......+..|+.++..+ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            46799999999999999999963      235689999986442 23456688899999999 899999999988754 4


Q ss_pred             eeeEEEecCCCCChHHhhhcCC----------------------------------------------------------
Q 040392          243 FKALVLEYMPHGSLEKYMYSSN----------------------------------------------------------  264 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  264 (470)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            5789999999999999986532                                                          


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccccccccCccc
Q 040392          265 ---YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGY  341 (470)
Q Consensus       265 ---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y  341 (470)
                         ..+++..+..++.|+++||+|||   +++|+||||||+||+++.++.+||+|||+++...............++..|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence               23677888999999999999999   999999999999999999999999999999865433222223334567889


Q ss_pred             cCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhH
Q 040392          342 MAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCV  420 (470)
Q Consensus       342 ~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (470)
                      +|||++.+..++.++||||||+++|||++ |..||......+. +......   ...               ...+..++
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~~~~~~---~~~---------------~~~~~~~~  303 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FCQRLKD---GTR---------------MRAPENAT  303 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHHHhc---CCC---------------CCCCCCCC
Confidence            99999998899999999999999999997 9999876432221 1111100   000               00122346


Q ss_pred             HHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          421 SCVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       421 ~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                      .++.+++.+||+.||++|||+.|+++.|+++..
T Consensus       304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            678999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-45  Score=343.01  Aligned_cols=266  Identities=23%  Similarity=0.289  Sum_probs=208.7

Q ss_pred             hhCCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccc-hhhhhHHHHHHHHhcCC-CCcceeEEeeeccCC-eeeE
Q 040392          171 ATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCG-RALKGFDVECEMMKSIR-HRNLIKVISTCSNEE-FKAL  246 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~-~~~l  246 (470)
                      ..++|..++.||.|.||.||+|+ ..+|..||||.++.+-. .....-.+|++.|++|. ||||+++.+.+.+.+ ..++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            35678899999999999999997 45689999999875532 22233457999999998 999999999998887 9999


Q ss_pred             EEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCC
Q 040392          247 VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      |||||+. +|.++++.++..+++..+..|+.||++||+|+|   .+|+.|||+||+|||+..+..+||+|||+|+.+.+.
T Consensus        88 VfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk  163 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK  163 (538)
T ss_pred             eHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccC
Confidence            9999976 999999999999999999999999999999999   999999999999999999999999999999987543


Q ss_pred             CCcccccccccCccccCccccC-CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhc--CCc-------
Q 040392          327 DQSMTQTQTLATIGYMAPEYGR-EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWL--PIS-------  396 (470)
Q Consensus       327 ~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~-------  396 (470)
                         ...+..+.|.+|+|||++. .+.|+.+.|+||+||+++|+.+-+.-|.+..+-. .+.. +-..+  |.+       
T Consensus       164 ---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D-qi~K-Ic~VLGtP~~~~~~eg~  238 (538)
T KOG0661|consen  164 ---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID-QIYK-ICEVLGTPDKDSWPEGY  238 (538)
T ss_pred             ---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH-HHHH-HHHHhCCCccccchhHH
Confidence               3345678999999999765 5679999999999999999999988776532211 1100 00000  000       


Q ss_pred             ----ccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          397 ----TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       397 ----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                          .+.+--+... ........+. ++.++.+++.+|+.+||.+||||.|++++
T Consensus       239 ~La~~mnf~~P~~~-~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  239 NLASAMNFRFPQVK-PSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHhccCCCcCC-CCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence                0000000011 1112222233 68889999999999999999999999886

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-44  Score=374.18  Aligned_cols=263  Identities=28%  Similarity=0.487  Sum_probs=225.9

Q ss_pred             CCCCCCCeecccCceEEEEEEeCC--Cc----EEEEEEeecc-cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeee
Q 040392          173 DGFSENNLIGRGGFGSVYKARLGD--GM----EVAVKVFNLQ-CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKA  245 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  245 (470)
                      .+....+.||+|.||.||.|...+  |.    .||||.+... +.+....|.+|..+|+.++|||||+++|.|.+...++
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            345566789999999999997543  33    4899998755 4567788999999999999999999999999999999


Q ss_pred             EEEecCCCCChHHhhhcC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecc
Q 040392          246 LVLEYMPHGSLEKYMYSS------NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSI  319 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  319 (470)
                      +++|||++|+|..|+++.      ...++....+.++.|||+|+.||+   ++++|||||.++|+|+++...+||+|||+
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccch
Confidence            999999999999999988      577899999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCccc
Q 040392          320 AKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTM  398 (470)
Q Consensus       320 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  398 (470)
                      |+.+...+.........-...|||||.+..+.++.|+|||||||++||++| |..||.+..+.+. +..|..        
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v-~~~~~~--------  919 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV-LLDVLE--------  919 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH-HHHHHh--------
Confidence            997766666555555556789999999999999999999999999999999 9999987654432 111111        


Q ss_pred             ccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHhhh
Q 040392          399 EVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRN  458 (470)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~~~  458 (470)
                                 ..+...|..|+..+.++|..||+.+|++||++..|++++..+...+..+
T Consensus       920 -----------ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~  968 (1025)
T KOG1095|consen  920 -----------GGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT  968 (1025)
T ss_pred             -----------CCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence                       1155667899999999999999999999999999999999987655443

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-43  Score=330.64  Aligned_cols=262  Identities=24%  Similarity=0.356  Sum_probs=213.4

Q ss_pred             hCCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecc-cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          172 TDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ-CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      .+.|+..+.||.|..++||+|+ .+.++.||||++..+ +....+.+.+|++.|+.++||||++++..|..+...++||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            5679999999999999999996 567899999999866 34457889999999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          250 YMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||.+|++.+++...- ..+++..+..|++++++||.|||   .+|.||||||+.|||++.+|.|||+|||.+-.+.....
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            999999999997643 45899999999999999999999   99999999999999999999999999998766644332


Q ss_pred             -cccc-cccccCccccCccccCC--CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccc
Q 040392          329 -SMTQ-TQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN  404 (470)
Q Consensus       329 -~~~~-~~~~~t~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (470)
                       .... ...+||+.|||||++..  ..|+.|+||||||++..||.+|..||.....-+.-+... +...|...       
T Consensus       182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL-qn~pp~~~-------  253 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL-QNDPPTLL-------  253 (516)
T ss_pred             eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh-cCCCCCcc-------
Confidence             1222 45689999999998543  359999999999999999999999999865543322221 11111110       


Q ss_pred             ccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                         ...........++..+.+++..||..||++|||+.+++++
T Consensus       254 ---t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  254 ---TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             ---cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence               0111112233446689999999999999999999999875

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-45  Score=360.17  Aligned_cols=270  Identities=24%  Similarity=0.452  Sum_probs=230.4

Q ss_pred             CCCCCCeecccCceEEEEEEeCC----CcEEEEEEeecc-cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          174 GFSENNLIGRGGFGSVYKARLGD----GMEVAVKVFNLQ-CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ...+.+.||.|.||.|++|+++-    ...||||.++.. ..++..+|..|+.||.+..||||+++.|........+||+
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            34567899999999999998642    457999999755 4567788999999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC-
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED-  327 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~-  327 (470)
                      |||++|+|+.||......+++.+...++++|+.|+.||.   ..+++||||.++|||++.+..+|++|||+++.+.+.. 
T Consensus       710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~  786 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  786 (996)
T ss_pred             hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence            999999999999999999999999999999999999999   9999999999999999999999999999999875433 


Q ss_pred             CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCccccccccccc
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL  406 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (470)
                      .........-+.+|.|||.+...+++.++||||||++|||.++ |..||-++.+.+.- ..                   
T Consensus       787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI-ka-------------------  846 (996)
T KOG0196|consen  787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI-KA-------------------  846 (996)
T ss_pred             ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH-HH-------------------
Confidence            2222223345789999999999999999999999999999998 99999887654321 10                   


Q ss_pred             CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH--HHhhhccCchhhh
Q 040392          407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD--SLLRNVGDRCIRQ  466 (470)
Q Consensus       407 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~--~~~~~~~~~~~~~  466 (470)
                      -....+.+.|++||..|.+||..||++|-.+||.+.||+..|.++..  ...+...+.+.|.
T Consensus       847 Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~~~~r~  908 (996)
T KOG0196|consen  847 IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAPESPRP  908 (996)
T ss_pred             HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCCCCCCC
Confidence            02345667789999999999999999999999999999999999863  3555555555543

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-44  Score=345.22  Aligned_cols=250  Identities=26%  Similarity=0.369  Sum_probs=213.0

Q ss_pred             CCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      ..|.....||+|+.|.||.|+ ..+++.||||++........+-+.+|+.+|+..+|+|||++++.|...+...+||||+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            457888899999999999995 5678999999998877777778899999999999999999999998889999999999


Q ss_pred             CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccc
Q 040392          252 PHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  331 (470)
Q Consensus       252 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  331 (470)
                      +||+|.+.+....  +++.++..|+.++++||+|||   .++|+|||||.+|||++.+|.+||+|||++..+.....  .
T Consensus       353 ~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--K  425 (550)
T KOG0578|consen  353 EGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--K  425 (550)
T ss_pred             CCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--c
Confidence            9999999996654  899999999999999999999   99999999999999999999999999999987754332  4


Q ss_pred             ccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhh
Q 040392          332 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDI  411 (470)
Q Consensus       332 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  411 (470)
                      ...-+||+.|||||+.....|++|.||||||++++||+-|+.||-.    +..++......              .....
T Consensus       426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln----E~PlrAlyLIa--------------~ng~P  487 (550)
T KOG0578|consen  426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN----ENPLRALYLIA--------------TNGTP  487 (550)
T ss_pred             cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC----CChHHHHHHHh--------------hcCCC
Confidence            4567899999999999999999999999999999999999999864    11222111100              01111


Q ss_pred             hhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          412 HFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       412 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      +...++..+..|.+++.+||..||++|++|.|+++|
T Consensus       488 ~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  488 KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            222345558889999999999999999999999986

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-43  Score=341.32  Aligned_cols=254  Identities=24%  Similarity=0.335  Sum_probs=208.5

Q ss_pred             hhCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc----cc-hhhhhHHHHHHHHhcCC-CCcceeEEeeeccCCe
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ----CG-RALKGFDVECEMMKSIR-HRNLIKVISTCSNEEF  243 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~  243 (470)
                      ..++|.+.+.||+|+||.|+.|.. .++..||+|+++.+    .. ...+.+.+|+.+++.++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            356899999999999999999964 56899999977654    11 23456668999999999 9999999999999999


Q ss_pred             eeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-CCeEEeeeccccc
Q 040392          244 KALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN-MVAHLSDFSIAKL  322 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~a~~  322 (470)
                      .++||||+.+|+|.+++.+ ...+.+..+..++.|+++|++|||   +++|+||||||+|||++.+ +++||+|||++..
T Consensus        95 ~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~  170 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI  170 (370)
T ss_pred             EEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence            9999999999999999988 667888999999999999999999   9999999999999999999 9999999999987


Q ss_pred             cCCCCCcccccccccCccccCccccCCCC-CC-CccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccc
Q 040392          323 LTGEDQSMTQTQTLATIGYMAPEYGREGR-VS-TNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEV  400 (470)
Q Consensus       323 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~-~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (470)
                      ..  .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++....... ..    ...      
T Consensus       171 ~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~-~k----i~~------  237 (370)
T KOG0583|consen  171 SP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLY-RK----IRK------  237 (370)
T ss_pred             cC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHH-HH----Hhc------
Confidence            63  2233445678999999999999877 75 7899999999999999999999973222111 11    000      


Q ss_pred             ccccccCchhhhhHhhhhh-HHHHHHHHhhccCCCccCCCCHHHHHHHHHHHH
Q 040392          401 VGANLLSQEDIHFVAKEQC-VSCVFNLAMECTVESPEQRINAREIVAKLLKIR  452 (470)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~  452 (470)
                                .....+..+ +.++..++.+|+..||.+|+++.+++ .-.-++
T Consensus       238 ----------~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~  279 (370)
T KOG0583|consen  238 ----------GEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ  279 (370)
T ss_pred             ----------CCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence                      001112223 56688999999999999999999999 433343

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-43  Score=337.02  Aligned_cols=263  Identities=22%  Similarity=0.415  Sum_probs=224.8

Q ss_pred             CCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccc-hhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          173 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      +...+.++||+|-||.|..+....+..||||.++.... .....|..|+++|.+|+||||++++|.|..++.+++|+||+
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            44677889999999999999987789999999987654 44588999999999999999999999999999999999999


Q ss_pred             CCCChHHhhhcCCCCC-CHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          252 PHGSLEKYMYSSNYIL-DIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       252 ~~g~L~~~l~~~~~~~-~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      ++|+|.+|+.+...+. +.....+|+.||+.|++||.   +..++||||.++|+|++.++++||+|||+++.+...+...
T Consensus       618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~  694 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR  694 (807)
T ss_pred             hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence            9999999998876433 56667789999999999999   9999999999999999999999999999999888777777


Q ss_pred             cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh--CCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT--GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                      .....+-+.+|||||.+..+++++++|||+||+++||+++  ...||.+..++.  ..+-.....+...           
T Consensus       695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--vven~~~~~~~~~-----------  761 (807)
T KOG1094|consen  695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--VVENAGEFFRDQG-----------  761 (807)
T ss_pred             eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--HHHhhhhhcCCCC-----------
Confidence            7777888999999999999999999999999999999887  778988765542  2222222222211           


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                      ...-...|.-|+.++.++|.+||+.+-++||+++++..+|.+.
T Consensus       762 ~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  762 RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            1122345678899999999999999999999999999999764

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=345.93  Aligned_cols=260  Identities=28%  Similarity=0.411  Sum_probs=216.1

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCC--C---cEEEEEEeecc---cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGD--G---MEVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEF  243 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~--~---~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  243 (470)
                      .++....+.||+|+||.||+|++..  +   ..||||..+..   .......+..|+++|+.++|||||+++|++.....
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP  235 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            4555666999999999999997542  2   23899998753   35678889999999999999999999999999999


Q ss_pred             eeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecccccc
Q 040392          244 KALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  323 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~  323 (470)
                      .++|||+|+||+|.+++++.+..++..++..++.+.|.||+|||   +++++||||-++|+|++.++.+||+|||+++.-
T Consensus       236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG  312 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence            99999999999999999988878999999999999999999999   999999999999999999999999999998753


Q ss_pred             CCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHh-hhhcCCcccccc
Q 040392          324 TGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWV-NDWLPISTMEVV  401 (470)
Q Consensus       324 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~  401 (470)
                      .  ..........-+.+|+|||.+..+.+++++|||||||++||+++ |..||.+....  ....++ ....+..     
T Consensus       313 ~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI~~~~~r~~-----  383 (474)
T KOG0194|consen  313 S--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKIVKNGYRMP-----  383 (474)
T ss_pred             c--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHHHhcCccCC-----
Confidence            2  12222223356789999999999999999999999999999999 88898875433  233333 2122211     


Q ss_pred             cccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHh
Q 040392          402 GANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL  456 (470)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~  456 (470)
                                   .+...+.++..++.+||..+|+.||+|.++.+.|+.+.....
T Consensus       384 -------------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  384 -------------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             -------------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence                         122447888999999999999999999999999999976544

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-42  Score=325.08  Aligned_cols=288  Identities=24%  Similarity=0.320  Sum_probs=215.6

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhc--CCCCcceeEEeeeccCC----eee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKS--IRHRNLIKVISTCSNEE----FKA  245 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~~~~~~~~~~----~~~  245 (470)
                      ....+..+.||+|.||.||||.+. ++.||||++..   +..+.|..|-+|.+.  ++|+||++|++.-...+    .+.
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            345666789999999999999984 69999999974   455677888888775  47999999999865444    788


Q ss_pred             EEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCCeeecCCCCCCeeeCCCCCeEEeeecc
Q 040392          246 LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFG------YSAPIIHCDLKPSNVLLDDNMVAHLSDFSI  319 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~------~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  319 (470)
                      ||+||.+.|+|.+|+...  .++|....+++..+++||+|||+.      +..+|+|||||.+|||+.+|++..|+|||+
T Consensus       285 LVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             EEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            999999999999999654  589999999999999999999963      456899999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccCccccCccccCCCC-CC-----CccchhhHHHHHHHHHhCCCCCCc--cccCcchhhHHhhh
Q 040392          320 AKLLTGEDQSMTQTQTLATIGYMAPEYGREGR-VS-----TNGDVYSFGIMLMETFTGKKPTNE--IFNGEMTLKHWVND  391 (470)
Q Consensus       320 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~-----~~~DvwslGv~l~el~tg~~p~~~--~~~~~~~~~~~~~~  391 (470)
                      |..+............+||.+|||||++.+.- +.     .+.||||+|.+||||+++..-+..  ..+-+..+..-+..
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~  442 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN  442 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence            99887655555555689999999999997643 22     358999999999999998765432  11111222211111


Q ss_pred             hcCCc-ccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHhhhccCchhh
Q 040392          392 WLPIS-TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNVGDRCIR  465 (470)
Q Consensus       392 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~~~~~~~~~~  465 (470)
                      +.... ..+.+-....+......+.....+.-+.+.+..||+.||+.|.|+.=+.+.+.++...-....++.|.+
T Consensus       443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~~~~~s~~~  517 (534)
T KOG3653|consen  443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWEDSSGESSSS  517 (534)
T ss_pred             CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCccCCccccc
Confidence            11111 111111111222222333334456778999999999999999999999999999875444445555554

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.8e-43  Score=337.03  Aligned_cols=247  Identities=27%  Similarity=0.425  Sum_probs=211.6

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      ++|-+.+.||+|+||.||||+.+ +.+.||+|.+.+.  ..+..+.+.+|+++++.++||||+.++++|+...+.++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            56888899999999999999654 6889999998654  34567789999999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      |+.| +|..++...+ .++++.+..++.+++.||.|||   +.+|+|||+||.|||++.++.+|+||||+|+.+..  ..
T Consensus        82 ~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NT  154 (808)
T ss_pred             hhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc--Cc
Confidence            9977 9999996654 6899999999999999999999   99999999999999999999999999999998753  33


Q ss_pred             ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCch
Q 040392          330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE  409 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (470)
                      ...+...||+-|||||+..+..|+..+|+||+||++||+++|++||...     ++.+.+........            
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~d~v------------  217 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILKDPV------------  217 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhcCCC------------
Confidence            4456678999999999999999999999999999999999999999752     33333333222211            


Q ss_pred             hhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       410 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                        .  .+.+.+.++..++...|.+||.+|.+..+++.|
T Consensus       218 --~--~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  218 --K--PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             --C--CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence              0  112447789999999999999999999998875

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=4.9e-42  Score=339.95  Aligned_cols=258  Identities=22%  Similarity=0.376  Sum_probs=205.7

Q ss_pred             hCCCCCCCeecccCceEEEEEEe------CCCcEEEEEEeeccc-chhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQC-GRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEF  243 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~  243 (470)
                      .++|++.+.||+|+||.||+|++      .++..||||+++... ....+.+.+|+++++.+ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45789999999999999999963      246689999986442 33456678899999999 89999999999999999


Q ss_pred             eeEEEecCCCCChHHhhhcCC-----------------------------------------------------------
Q 040392          244 KALVLEYMPHGSLEKYMYSSN-----------------------------------------------------------  264 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  264 (470)
                      .++||||+++|+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999999986432                                                           


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          265 ---------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       265 ---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                                     ..+++..+..++.|+++||+|||   +.+++||||||+||+++.++.+||+|||++.........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                           14678888999999999999999   999999999999999999999999999999866433222


Q ss_pred             ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |..||....... ....++......             
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~-------------  336 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKMIKEGYRM-------------  336 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHHHHhCccC-------------
Confidence            22223345678999999999999999999999999999998 888887643221 122222111100             


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                           ..+...+.++.+++..||+.||++||++.|+++.|++.
T Consensus       337 -----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         337 -----LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             -----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence                 00112356789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.4e-42  Score=327.54  Aligned_cols=246  Identities=21%  Similarity=0.299  Sum_probs=200.4

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEEeecccch---hhhhHHHHHHHHhcCCCCcceeEEeeecc----CCeeeEEEec
Q 040392          178 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGR---ALKGFDVECEMMKSIRHRNLIKVISTCSN----EEFKALVLEY  250 (470)
Q Consensus       178 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~----~~~~~lv~e~  250 (470)
                      ...||+|++|.||+|.. +|+.||||.+......   ..+.+.+|+.++++++||||+++++++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36799999999999988 6899999998754322   24677899999999999999999999866    3567899999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      +++|+|.+++.+.+ .+++.....++.+++.||.|||   . .+++||||||+||+++.++.+||+|||+++......  
T Consensus       104 ~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        104 CTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            99999999997654 6889999999999999999999   6 488899999999999999999999999988654321  


Q ss_pred             ccccccccCccccCccccCC--CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          330 MTQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                         ....++..|+|||++.+  ..++.++|||||||++|||++|+.||......+. ..........             
T Consensus       178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~-~~~i~~~~~~-------------  240 (283)
T PHA02988        178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI-YDLIINKNNS-------------  240 (283)
T ss_pred             ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhcCCC-------------
Confidence               23457889999999876  6799999999999999999999999986432211 1111110000             


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR  452 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~  452 (470)
                           ...+..++.++.+++.+||+.||++|||+.|+++.|+.++
T Consensus       241 -----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        241 -----LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             -----CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence                 0111235778999999999999999999999999999875

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=8.8e-42  Score=329.12  Aligned_cols=262  Identities=23%  Similarity=0.417  Sum_probs=204.3

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCC-----------------CcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCccee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGD-----------------GMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIK  233 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~  233 (470)
                      .++|.+.+.||+|+||.||+|.+.+                 +..||+|.+.... ......+.+|++++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3578889999999999999997532                 3469999987543 234556889999999999999999


Q ss_pred             EEeeeccCCeeeEEEecCCCCChHHhhhcCC------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 040392          234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSN------------------YILDIFQRLNIMIDVASALEYLHFGYSAPII  295 (470)
Q Consensus       234 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~  295 (470)
                      +++++.+.+..++||||+++|+|.+++....                  ..+++..+..++.|++.||.|||   +.+++
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence            9999999899999999999999999885432                  24677888999999999999999   99999


Q ss_pred             ecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh--CCC
Q 040392          296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT--GKK  373 (470)
Q Consensus       296 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t--g~~  373 (470)
                      ||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            999999999999999999999999986643332222333456788999999988899999999999999999987  556


Q ss_pred             CCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHH
Q 040392          374 PTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLL  449 (470)
Q Consensus       374 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~  449 (470)
                      ||......+  ................           ....+..++..+.+++.+||+.||++|||+.||.+.|+
T Consensus       241 p~~~~~~~~--~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         241 PYGELTDEQ--VIENAGEFFRDQGRQV-----------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCcCCHHH--HHHHHHHHhhhccccc-----------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            776543221  1111111111110000           00112345678999999999999999999999998886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-43  Score=329.38  Aligned_cols=249  Identities=27%  Similarity=0.404  Sum_probs=209.9

Q ss_pred             CCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      ..|...+.||+|+||.||+|.. .+++.||+|+++... ......+++|+.++..++++||.++|+.+..+....++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            4577889999999999999964 568999999998764 45678899999999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      |.||++.+.++... .+++....-++++++.|+.|||   ..+.+|||||+.||++..+|.+|++|||.+..+....  .
T Consensus        93 ~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~--~  166 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV--K  166 (467)
T ss_pred             hcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechh--h
Confidence            99999999997655 4477788889999999999999   9999999999999999999999999999998775322  2


Q ss_pred             cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchh
Q 040392          331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED  410 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (470)
                      .....+||+.|||||++....|+.|+||||||++.+||.+|..|+.+..+...  ...+.+..|        +.+     
T Consensus       167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv--lflIpk~~P--------P~L-----  231 (467)
T KOG0201|consen  167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV--LFLIPKSAP--------PRL-----  231 (467)
T ss_pred             ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE--EEeccCCCC--------Ccc-----
Confidence            33668899999999999988999999999999999999999999987654211  111111111        111     


Q ss_pred             hhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          411 IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       411 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                           ...++..+.+++..||+.||+.||+|.++++|
T Consensus       232 -----~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  232 -----DGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             -----ccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence                 11457779999999999999999999999976

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=9.2e-42  Score=337.74  Aligned_cols=259  Identities=23%  Similarity=0.392  Sum_probs=205.5

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeeccc-chhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-GRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEF  243 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~  243 (470)
                      .++|++.+.||+|+||.||+|...      ++..||+|.+.... ......+..|+++++.+ +|+||+++++++.....
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            457899999999999999998742      24579999987543 23345678899999999 89999999999999999


Q ss_pred             eeEEEecCCCCChHHhhhcCC-----------------------------------------------------------
Q 040392          244 KALVLEYMPHGSLEKYMYSSN-----------------------------------------------------------  264 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  264 (470)
                      .++||||+++|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999999885421                                                           


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccccc
Q 040392          265 ----------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ  334 (470)
Q Consensus       265 ----------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  334 (470)
                                ..+++..+.+++.|++.||+|||   +++++||||||+||+++.++.+||+|||+++.+...........
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                      23678888999999999999999   99999999999999999999999999999976543222222222


Q ss_pred             cccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhh
Q 040392          335 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF  413 (470)
Q Consensus       335 ~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  413 (470)
                      ..++..|+|||++.+..++.++||||||+++|||++ |+.||........ ...........                  
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~~~~~~~~~~~------------------  334 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-FYKMVKRGYQM------------------  334 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-HHHHHHcccCc------------------
Confidence            345678999999988899999999999999999997 9999976433221 11111110000                  


Q ss_pred             HhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHH
Q 040392          414 VAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR  452 (470)
Q Consensus       414 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~  452 (470)
                      ..+...+.++.+++.+||+.||++||++.++++.|+++.
T Consensus       335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            001122567899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.9e-43  Score=301.68  Aligned_cols=249  Identities=24%  Similarity=0.343  Sum_probs=211.8

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc---cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      .++|++.+.||+|-||.||.|+. +++..||+|++.+.   ......++.+|+++-+.|+||||++++++|.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            47899999999999999999974 56888999998644   234456788899999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCC
Q 040392          248 LEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      +||.++|++...+++.. ..+++.....+..|+|.||.|+|   .++++||||||+|+|++.++.+||+|||.+....  
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            99999999999998544 46888999999999999999999   9999999999999999999999999999987532  


Q ss_pred             CCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccccc
Q 040392          327 DQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL  406 (470)
Q Consensus       327 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (470)
                        .......+||..|.+||+..+..++.++|+|++|++.||++.|..||.....++.. .....       .+       
T Consensus       176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etY-krI~k-------~~-------  238 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETY-KRIRK-------VD-------  238 (281)
T ss_pred             --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHH-HHHHH-------cc-------
Confidence              34445678999999999999999999999999999999999999999986533321 11111       11       


Q ss_pred             CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       407 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                            ...|...+.++.+++..|+..+|.+|....|++.|-
T Consensus       239 ------~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp  274 (281)
T KOG0580|consen  239 ------LKFPSTISGGAADLISRLLVKNPIERLALTEVMDHP  274 (281)
T ss_pred             ------ccCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence                  112233466789999999999999999999999874

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.6e-41  Score=323.08  Aligned_cols=269  Identities=20%  Similarity=0.224  Sum_probs=203.8

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46889999999999999999875 58899999986542  2334567789999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      |++++.+..+. .....+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++....... .
T Consensus        81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~  155 (287)
T cd07848          81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-N  155 (287)
T ss_pred             cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-c
Confidence            99987666544 34456889999999999999999999   9999999999999999999999999999998754222 1


Q ss_pred             ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhh--cC---------Cc-c
Q 040392          330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDW--LP---------IS-T  397 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~--~~---------~~-~  397 (470)
                      .......++..|+|||++.+..++.++|||||||++|||++|+.||......+. ........  .+         .. .
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhCCCCHHHHHhhhccchh
Confidence            122335689999999999888899999999999999999999999976432111 10000000  00         00 0


Q ss_pred             cccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          398 MEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      .....+...............++.++.+++.+||+.||++|||+.|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            00000000000111111122356789999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.3e-41  Score=321.56  Aligned_cols=256  Identities=22%  Similarity=0.391  Sum_probs=207.0

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC----CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  246 (470)
                      .++|++.+.||+|+||.||+|.++    .+..||+|.++... ......+.+|+.+++.++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            356888999999999999999753    36789999987553 2334568889999999999999999999999999999


Q ss_pred             EEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCC
Q 040392          247 VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      ||||+++|+|.+++......+++..++.++.|++.||+|||   +.+++||||||+||+++.++.++++|||.+......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            99999999999999876667899999999999999999999   999999999999999999999999999987653221


Q ss_pred             CCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          327 DQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       327 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      .. .......++..|+|||.+.+..++.++||||||+++||+++ |+.||......  .+...+....            
T Consensus       161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~~------------  225 (266)
T cd05064         161 AI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKAVEDGF------------  225 (266)
T ss_pred             ch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHCCC------------
Confidence            11 11112335678999999998999999999999999999875 99998764322  1111111100            


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                            ..+.+..++..+.+++..||+.+|++||++.||.+.|+++
T Consensus       226 ------~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         226 ------RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                  0011234577799999999999999999999999998775

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.7e-41  Score=324.59  Aligned_cols=270  Identities=23%  Similarity=0.297  Sum_probs=203.5

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccc-hhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+++++.++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            478999999999999999999865 689999999864432 233456789999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      |++ ++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++......  .
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~  157 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP--S  157 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC--C
Confidence            996 5888888776667889999999999999999999   999999999999999999999999999998754321  1


Q ss_pred             ccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc--------cccc
Q 040392          330 MTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS--------TMEV  400 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~  400 (470)
                      .......+++.|+|||++.+ ..++.++||||+||++|||++|+.||....+....+...........        ....
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH  237 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence            22234568899999998765 45888999999999999999999999864332222111111000000        0000


Q ss_pred             cccc---ccCchh-hhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          401 VGAN---LLSQED-IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       401 ~~~~---~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ..+.   ...... .........+.++.+++.+||+.||++|||+.|+++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence            0000   000000 0011111234668899999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.6e-41  Score=324.83  Aligned_cols=253  Identities=24%  Similarity=0.344  Sum_probs=206.7

Q ss_pred             hhCCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeE
Q 040392          171 ATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  246 (470)
                      ..++|+.++.||+|+||.||.|+ ..+|..+|+|++++..   ..+.+....|-.+|....+|.||+++..|.+.++.||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            55789999999999999999996 4569999999997652   4456778889999999999999999999999999999


Q ss_pred             EEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC-
Q 040392          247 VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG-  325 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~-  325 (470)
                      ||||++||++..+|...+ .+++..+..++.+++-|++-+|   +.|+|||||||+|+|||..|++||+|||++.-+.. 
T Consensus       219 iMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             EEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence            999999999999997665 6888899999999999999999   99999999999999999999999999999853211 


Q ss_pred             ---------------------CCCcc----c-------------------ccccccCccccCccccCCCCCCCccchhhH
Q 040392          326 ---------------------EDQSM----T-------------------QTQTLATIGYMAPEYGREGRVSTNGDVYSF  361 (470)
Q Consensus       326 ---------------------~~~~~----~-------------------~~~~~~t~~y~aPE~~~~~~~~~~~Dvwsl  361 (470)
                                           .+...    .                   ..+.+|||.|+|||++.+..|+..+|.|||
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence                                 00000    0                   013569999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCccccCcc--hhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCC
Q 040392          362 GIMLMETFTGKKPTNEIFNGEM--TLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRI  439 (470)
Q Consensus       362 Gv~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp  439 (470)
                      ||++|||+.|.+||......+.  .+..|...+.-                   +....++.+..+||.+|+. ||++|.
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f-------------------P~~~~~s~eA~DLI~rll~-d~~~RL  434 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF-------------------PEEVDLSDEAKDLITRLLC-DPENRL  434 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC-------------------CCcCcccHHHHHHHHHHhc-CHHHhc
Confidence            9999999999999987544332  12233222211                   1122335778999999999 999998


Q ss_pred             C---HHHHHHH
Q 040392          440 N---AREIVAK  447 (470)
Q Consensus       440 s---~~el~~~  447 (470)
                      .   +.||.+|
T Consensus       435 G~~G~~EIK~H  445 (550)
T KOG0605|consen  435 GSKGAEEIKKH  445 (550)
T ss_pred             CcccHHHHhcC
Confidence            5   6666543

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-42  Score=336.18  Aligned_cols=248  Identities=25%  Similarity=0.357  Sum_probs=209.4

Q ss_pred             CCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      .-|...+.||.|+.|.|-.|++ .+|+.+|||++.+..   ......+.+|+-+|+.+.|||++++++.+++..+.|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            4577889999999999999974 579999999997552   334566788999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||+++|-|.+++-.++ .+.+..+.+++.||+.|+.|+|   ..+|+|||+||+|+|+|..+++||+|||+|..-.+   
T Consensus        92 Eyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~---  164 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP---  164 (786)
T ss_pred             EecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccC---
Confidence            9999999999997766 5788888999999999999999   99999999999999999999999999999976432   


Q ss_pred             cccccccccCccccCccccCCCCCC-CccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVS-TNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                      ...-...||++.|.|||++.+..|+ .++||||.||+||.|+||+.||++.     .++....+.....           
T Consensus       165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-----Nir~LLlKV~~G~-----------  228 (786)
T KOG0588|consen  165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-----NIRVLLLKVQRGV-----------  228 (786)
T ss_pred             CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-----cHHHHHHHHHcCc-----------
Confidence            2334457899999999999998874 6899999999999999999999852     2222222221111           


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                           +.+|.+.+.++.+|+++|+.+||++|.|++||++|-
T Consensus       229 -----f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  229 -----FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             -----ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence                 223455588899999999999999999999999885

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.7e-42  Score=323.87  Aligned_cols=248  Identities=35%  Similarity=0.578  Sum_probs=197.2

Q ss_pred             CCeecccCceEEEEEEeC-----CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          178 NNLIGRGGFGSVYKARLG-----DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       178 ~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      .+.||.|.||.||+|.+.     .+..|+||.+.... ....+.+.+|++.+++++||||++++|++...+..++|+||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            468999999999999875     36789999996543 334788999999999999999999999999888899999999


Q ss_pred             CCCChHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          252 PHGSLEKYMYSS-NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       252 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      ++|+|.+++... ...+++..+..++.|+++||.|||   +.+++|+||+++||+++.++.+||+|||++..........
T Consensus        84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~  160 (259)
T PF07714_consen   84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK  160 (259)
T ss_dssp             TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred             ccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccc
Confidence            999999999887 567899999999999999999999   8999999999999999999999999999998763333333


Q ss_pred             cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCch
Q 040392          331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE  409 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (470)
                      ..........|+|||.+....++.++||||||+++|||++ |+.||.+....+  +...+....                
T Consensus       161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~--~~~~~~~~~----------------  222 (259)
T PF07714_consen  161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE--IIEKLKQGQ----------------  222 (259)
T ss_dssp             ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH--HHHHHHTTE----------------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccc----------------
Confidence            3344557789999999988889999999999999999999 788887652221  111111100                


Q ss_pred             hhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       410 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                        ....+..++..+.+++..||..||++||++.++++.|
T Consensus       223 --~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  223 --RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             --ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             --cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence              0112234577799999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=7e-42  Score=304.34  Aligned_cols=237  Identities=26%  Similarity=0.340  Sum_probs=200.5

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      .++|+..+.||.|+||.|..++.+ +|..+|+|+++++.   .++.+...+|..+|+.+.||.++++++.+.+....++|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            467899999999999999999865 58899999997653   23455567799999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||++||.|..++++.+ .+++..+.-++.||+.||+|||   +.+|++||+||+|||+|.+|.+||+|||+|+...+. 
T Consensus       123 meyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-  197 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-  197 (355)
T ss_pred             EeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence            99999999999998766 6888999999999999999999   999999999999999999999999999999987532 


Q ss_pred             CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                          .-..+||+.|+|||.+....+..++|-|||||++|||+.|..||.+...  ..+.+  . .        ....   
T Consensus       198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--~~iY~--K-I--------~~~~---  257 (355)
T KOG0616|consen  198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--IQIYE--K-I--------LEGK---  257 (355)
T ss_pred             ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--HHHHH--H-H--------HhCc---
Confidence                3347899999999999999999999999999999999999999987432  11111  1 0        0000   


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCC
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQR  438 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R  438 (470)
                           ...|.-++.++.+|+...|+.|-.+|
T Consensus       258 -----v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  258 -----VKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             -----ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence                 11123346678899999999999998

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-41  Score=317.62  Aligned_cols=257  Identities=26%  Similarity=0.459  Sum_probs=209.9

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCC----CcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGD----GMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  246 (470)
                      .++|++.+.||+|+||.||+|.+..    ...||+|.++... ......+..|+.+++.++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            4578999999999999999998642    4579999986543 3345678889999999999999999999999999999


Q ss_pred             EEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCC
Q 040392          247 VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      +|||+++++|.+++......+++..+..++.|++.||+|||   +.+++|+||||+||++++++.++|+|||++......
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999999776667899999999999999999999   999999999999999999999999999999877522


Q ss_pred             CCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          327 DQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       327 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      ..........++..|+|||.+.+..++.++||||||+++|||++ |..||......+  ....+......          
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~~~~----------  227 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--VIKAVEDGYRL----------  227 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--HHHHHHcCCCC----------
Confidence            22222223345678999999998899999999999999999998 999987643221  11111110000          


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                              ..+..++..+.+++.+||+.+|++||++.|++++|.++
T Consensus       228 --------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 --------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             --------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                    01123466789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-41  Score=326.58  Aligned_cols=245  Identities=25%  Similarity=0.311  Sum_probs=201.9

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   .+....+.+|+++++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46889999999999999999765 68999999986432   234556788999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||+++|+|.+++...+ .+++..+..++.|++.||+|||   +++++||||||+||+++.++.+||+|||++......  
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence            9999999999997654 5788999999999999999999   999999999999999999999999999998865322  


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                         .....|++.|+|||++.+..++.++|||||||++|||++|+.||......+  ....+.   ....           
T Consensus       155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~--~~~~i~---~~~~-----------  215 (291)
T cd05612         155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG--IYEKIL---AGKL-----------  215 (291)
T ss_pred             ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH---hCCc-----------
Confidence               123468999999999998889999999999999999999999997632211  111110   0000           


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCC-----HHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRIN-----AREIVAK  447 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~el~~~  447 (470)
                           ..+...+..+.+++.+||+.||.+||+     +.|+++|
T Consensus       216 -----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         216 -----EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             -----CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence                 001122556889999999999999995     8888877

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.3e-41  Score=321.71  Aligned_cols=267  Identities=21%  Similarity=0.281  Sum_probs=203.3

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|+++++.++||||+++++++......++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            357999999999999999999754 68999999986442 2234467789999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      |+++ +|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......  
T Consensus        84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--  157 (288)
T cd07871          84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--  157 (288)
T ss_pred             CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--
Confidence            9975 999998776666889999999999999999999   9999999999999999999999999999987543221  


Q ss_pred             ccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhc-CC-----------c
Q 040392          330 MTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWL-PI-----------S  396 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~-----------~  396 (470)
                      .......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+. +........ +.           .
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE-LHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhhccccchh
Confidence            12233467899999998865 5689999999999999999999999976432211 111110000 00           0


Q ss_pred             ccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          397 TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       397 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ......+......  ........+.++.+++.+||+.||.+|||+.|+++|
T Consensus       237 ~~~~~~~~~~~~~--~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         237 FRSYLFPQYRAQP--LINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hhccccCccCCCc--hHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0000000000000  001112346678899999999999999999999865

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.8e-41  Score=327.46  Aligned_cols=258  Identities=24%  Similarity=0.400  Sum_probs=207.7

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCc----EEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGM----EVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  246 (470)
                      .+|+..+.||+|+||.||+|++. ++.    .||+|.+.... ......+..|+.+++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46899999999999999999753 333    48999986443 34456788899999999999999999999765 4679


Q ss_pred             EEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCC
Q 040392          247 VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      ++||+++|+|.+++......+++...+.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.+...
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence            99999999999999877767889999999999999999999   999999999999999999999999999999876543


Q ss_pred             CCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          327 DQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       327 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      ..........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+  +........            
T Consensus       163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--~~~~~~~~~------------  228 (316)
T cd05108         163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGE------------  228 (316)
T ss_pred             CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHhCCC------------
Confidence            33222223345678999999999999999999999999999998 999987642221  111111100            


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                            ....+..++.++.+++..||..+|++||++.+++..|.++...
T Consensus       229 ------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         229 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence                  0011223456788999999999999999999999999988643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.3e-41  Score=322.02  Aligned_cols=250  Identities=21%  Similarity=0.299  Sum_probs=201.2

Q ss_pred             CCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          175 FSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      |+..+.||+|+||.||+|.. .+|+.||+|.+....   ......+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            67789999999999999975 579999999986442   22334567899999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          251 MPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       251 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      +++|+|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......  
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--  156 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence            99999988876433 46889999999999999999999   9999999999999999999999999999998653221  


Q ss_pred             ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCch
Q 040392          330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE  409 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (470)
                       ......||..|+|||++.+..++.++|||||||++|||++|+.||........ ........ ....            
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~-~~~~------------  221 (285)
T cd05631         157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-REEVDRRV-KEDQ------------  221 (285)
T ss_pred             -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-HHHHHHHh-hccc------------
Confidence             12335689999999999999999999999999999999999999986432211 11111100 0000            


Q ss_pred             hhhhHhhhhhHHHHHHHHhhccCCCccCCCC-----HHHHHHH
Q 040392          410 DIHFVAKEQCVSCVFNLAMECTVESPEQRIN-----AREIVAK  447 (470)
Q Consensus       410 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~el~~~  447 (470)
                         ...+...+.++.+|+.+||+.||++||+     +.+++++
T Consensus       222 ---~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         222 ---EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             ---ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence               0011234667889999999999999997     8888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.8e-41  Score=322.17  Aligned_cols=256  Identities=28%  Similarity=0.527  Sum_probs=207.9

Q ss_pred             CCCCCCCeecccCceEEEEEEeCC------CcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeee
Q 040392          173 DGFSENNLIGRGGFGSVYKARLGD------GMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKA  245 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  245 (470)
                      ++|++.+.||+|+||.||+|....      ...||+|.+.... ......+.+|+++++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            468889999999999999997543      2579999986443 234556888999999999999999999999888999


Q ss_pred             EEEecCCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC
Q 040392          246 LVLEYMPHGSLEKYMYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM  310 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~  310 (470)
                      ++|||+++|+|.+++....               ..+++.....++.|++.||.|||   +.+++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence            9999999999999986532               35778889999999999999999   99999999999999999999


Q ss_pred             CeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHh
Q 040392          311 VAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWV  389 (470)
Q Consensus       311 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~  389 (470)
                      .+||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||......+  ....+
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~--~~~~i  239 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE--VIEMI  239 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHH
Confidence            999999999986543333233334456888999999988899999999999999999998 999987643221  11111


Q ss_pred             hhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          390 NDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       390 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                      ....   .               ...+..++.++.+|+.+||+.||.+||++.||+++|+++
T Consensus       240 ~~~~---~---------------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         240 RSRQ---L---------------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             HcCC---c---------------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            1100   0               011234578899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.3e-42  Score=316.34  Aligned_cols=249  Identities=23%  Similarity=0.322  Sum_probs=210.2

Q ss_pred             hCCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecc---cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      .-+|++.+.||+|.||.|-+|+ ...|+.||||.+++.   +.+..-.+.+|++||+.|+||||+.++.+|++.+...+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            3468889999999999999996 578999999999755   345566788999999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||..+|.|.+|+.+++ .+++..+.+++.||.+|+.|+|   ..+++|||||.+|||+|.++++||+|||++..+..  
T Consensus       132 MEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~--  205 (668)
T KOG0611|consen  132 MEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD--  205 (668)
T ss_pred             EEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcc--
Confidence            99999999999997665 6899999999999999999999   99999999999999999999999999999987743  


Q ss_pred             CcccccccccCccccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccccc
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL  406 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (470)
                       ......++|++.|.+||+..+..| ++.+|-|||||+||-|+.|..||++.+-.     ..++..-....         
T Consensus       206 -~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-----~lvrQIs~GaY---------  270 (668)
T KOG0611|consen  206 -KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-----RLVRQISRGAY---------  270 (668)
T ss_pred             -ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-----HHHHHhhcccc---------
Confidence             233456899999999999999887 47899999999999999999999874221     11211111110         


Q ss_pred             CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHH
Q 040392          407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLL  449 (470)
Q Consensus       407 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~  449 (470)
                      .        +...+.+..-||++||.+||++|.|..+|..|..
T Consensus       271 r--------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  271 R--------EPETPSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             c--------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence            0        0111455678999999999999999999999873

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=7e-41  Score=314.66  Aligned_cols=251  Identities=24%  Similarity=0.396  Sum_probs=203.7

Q ss_pred             CCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCC
Q 040392          173 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP  252 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~  252 (470)
                      ++|++.+.||+|+||.||+|.++++..+|+|.+.... .....+..|++++++++||||+++++++......++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            4578889999999999999998888899999876432 234568889999999999999999999999999999999999


Q ss_pred             CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccc
Q 040392          253 HGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ  332 (470)
Q Consensus       253 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  332 (470)
                      +|+|.+++......+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||.+........ ...
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~  158 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSS  158 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-ecc
Confidence            99999999766556899999999999999999999   99999999999999999999999999999876532221 111


Q ss_pred             cccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhh
Q 040392          333 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDI  411 (470)
Q Consensus       333 ~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  411 (470)
                      ....++..|+|||.+.+..++.++|+||||+++|||++ |+.||......  .....+......     .          
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--~~~~~i~~~~~~-----~----------  221 (256)
T cd05114         159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--EVVEMISRGFRL-----Y----------  221 (256)
T ss_pred             CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCCCC-----C----------
Confidence            22335668999999988889999999999999999999 89998754321  111111110000     0          


Q ss_pred             hhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          412 HFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       412 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                         .+...+.++.+++.+||+.+|++||++.++++.|
T Consensus       222 ---~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         222 ---RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ---CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence               0111245688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-41  Score=307.44  Aligned_cols=272  Identities=24%  Similarity=0.272  Sum_probs=208.2

Q ss_pred             HHHhhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchh--hhhHHHHHHHHhcCCCCcceeEEeeec--cCC
Q 040392          168 LCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRA--LKGFDVECEMMKSIRHRNLIKVISTCS--NEE  242 (470)
Q Consensus       168 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~--~~~  242 (470)
                      -++..++|+.++.|++|+||.||+|+++ +++.||+|+++.+..+.  .-...+|+.++.+++|||||.+-.+..  +-+
T Consensus        71 gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d  150 (419)
T KOG0663|consen   71 GCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMD  150 (419)
T ss_pred             CcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence            3555678999999999999999999754 68899999997654322  223467999999999999999987763  446


Q ss_pred             eeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccc
Q 040392          243 FKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL  322 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~  322 (470)
                      ..|+|||||+. +|..++......+...++.-++.|+++|++|||   ...|+|||||++|+|+...|.+||+|||+|+.
T Consensus       151 ~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~  226 (419)
T KOG0663|consen  151 KIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLARE  226 (419)
T ss_pred             eeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhh
Confidence            78999999987 999999888878999999999999999999999   99999999999999999999999999999998


Q ss_pred             cCCCCCcccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhc--------
Q 040392          323 LTGEDQSMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWL--------  393 (470)
Q Consensus       323 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--------  393 (470)
                      +..+  ....+..+.|.+|+|||++.+. .|+++.|+||+||++.||++++.-|.+..  +....+.+-..+        
T Consensus       227 ygsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s--E~dQl~~If~llGtPte~iw  302 (419)
T KOG0663|consen  227 YGSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS--EIDQLDKIFKLLGTPSEAIW  302 (419)
T ss_pred             hcCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc--hHHHHHHHHHHhCCCccccC
Confidence            8543  3445667899999999988875 59999999999999999999998776532  222222211111        


Q ss_pred             -CCcccccccccc---cCchhhhhHhhhh-hHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          394 -PISTMEVVGANL---LSQEDIHFVAKEQ-CVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       394 -~~~~~~~~~~~~---~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                       .......+....   ....+.+...+.. .+..-++|+..+|..||.+|.||.|.+.|
T Consensus       303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence             111111000000   0011111111111 34667899999999999999999999876

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1e-40  Score=331.68  Aligned_cols=259  Identities=23%  Similarity=0.402  Sum_probs=206.8

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCC-CCcceeEEeeeccCCe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIR-HRNLIKVISTCSNEEF  243 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~  243 (470)
                      .++|.+.+.||+|+||.||+|+..      .+..||||++.... ....+.+..|+++++++. ||||+++++++.+...
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            567889999999999999999752      23479999986543 334567888999999996 9999999999999999


Q ss_pred             eeEEEecCCCCChHHhhhcCC-----------------------------------------------------------
Q 040392          244 KALVLEYMPHGSLEKYMYSSN-----------------------------------------------------------  264 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  264 (470)
                      .++||||+++|+|.+++....                                                           
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            999999999999999886421                                                           


Q ss_pred             ------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC
Q 040392          265 ------------------------------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD  308 (470)
Q Consensus       265 ------------------------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~  308 (470)
                                                          ..+++..+..++.|+++||+|||   +.+++|+||||+||+++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeC
Confidence                                                13677788899999999999999   999999999999999999


Q ss_pred             CCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhH
Q 040392          309 NMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKH  387 (470)
Q Consensus       309 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~  387 (470)
                      ++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||........... 
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~-  351 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN-  351 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH-
Confidence            99999999999986643322222233456788999999988889999999999999999997 9999876432211111 


Q ss_pred             HhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHH
Q 040392          388 WVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR  452 (470)
Q Consensus       388 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~  452 (470)
                      .+....                  ....+..++.++.+++.+||+.||++||++.+|.+.|+++.
T Consensus       352 ~~~~~~------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         352 KIKSGY------------------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             HHhcCC------------------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            111000                  00112344677899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-41  Score=328.79  Aligned_cols=253  Identities=22%  Similarity=0.344  Sum_probs=204.5

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+..|++++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36889999999999999999865 58999999997542   234456778999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||+++|+|.+++.... .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++.....   
T Consensus        81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence            9999999999996544 5788999999999999999999   99999999999999999999999999999976532   


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ... +..+...  ...  +. ...
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~-i~~~~~~--~~~--~~-~~~  224 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-WEN-LKYWKET--LQR--PV-YDD  224 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-HHH-HHhcccc--ccC--CC-CCc
Confidence              22345689999999999998999999999999999999999999976332211 111 1111000  000  00 000


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                            ....++.++.+++.+||..+|++||++.|++++
T Consensus       225 ------~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         225 ------PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ------cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence                  002336678899999999999999999999987

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.9e-41  Score=327.25  Aligned_cols=242  Identities=22%  Similarity=0.300  Sum_probs=197.4

Q ss_pred             CeecccCceEEEEEEe-CCCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCCC
Q 040392          179 NLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHG  254 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g  254 (470)
                      +.||+|+||.||+|+. .+|+.||+|++....   ......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999975 468999999987542   233456778999999999999999999999999999999999999


Q ss_pred             ChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccccc
Q 040392          255 SLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ  334 (470)
Q Consensus       255 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  334 (470)
                      +|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....  ......
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~~  154 (323)
T cd05571          81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMKT  154 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcccc
Confidence            9999986544 6889999999999999999999   999999999999999999999999999998753221  122234


Q ss_pred             cccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhH
Q 040392          335 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFV  414 (470)
Q Consensus       335 ~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  414 (470)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ....+.   ...                ..
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~~~~~---~~~----------------~~  213 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELIL---MEE----------------IR  213 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH--HHHHHH---cCC----------------CC
Confidence            569999999999999999999999999999999999999997532211  111110   000                00


Q ss_pred             hhhhhHHHHHHHHhhccCCCccCCC-----CHHHHHHH
Q 040392          415 AKEQCVSCVFNLAMECTVESPEQRI-----NAREIVAK  447 (470)
Q Consensus       415 ~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~el~~~  447 (470)
                      .+...+.++.+++.+||+.||++||     ++.++++|
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            1123366788999999999999999     79999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.1e-40  Score=318.98  Aligned_cols=260  Identities=28%  Similarity=0.480  Sum_probs=210.8

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKA  245 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  245 (470)
                      .++|.+.+.||+|+||.||++...      ++..+|+|.+..........+..|++++++++||||+++++++......+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            356888999999999999999742      34568999987655556677889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHhhhcCC------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeE
Q 040392          246 LVLEYMPHGSLEKYMYSSN------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH  313 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~k  313 (470)
                      +||||+++++|.+++....            ..+++..+..++.|++.||+|||   +.+++||||||+||++++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEE
Confidence            9999999999999986432            24899999999999999999999   99999999999999999999999


Q ss_pred             EeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhh
Q 040392          314 LSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDW  392 (470)
Q Consensus       314 l~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~  392 (470)
                      |+|||++................++..|+|||++.+..++.++||||||+++|||++ |..||......+ .......  
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-~~~~i~~--  237 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-VIECITQ--  237 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHc--
Confidence            999999986543332222333445778999999998899999999999999999998 899987643221 1111111  


Q ss_pred             cCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          393 LPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                        ....               ..+..++.++.+++.+||+.||.+||++.|+.+.|+++...
T Consensus       238 --~~~~---------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         238 --GRVL---------------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             --CCcC---------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence              0000               00122356789999999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.2e-41  Score=329.78  Aligned_cols=245  Identities=21%  Similarity=0.266  Sum_probs=201.4

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|++....   ....+.+..|+++++.++||||+++++++.+.+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            57888999999999999999865 58999999987532   234456788999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....... 
T Consensus        98 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-  172 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-  172 (329)
T ss_pred             cCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence            9999999999997654 5788889999999999999999   9999999999999999999999999999998653321 


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                          ....||+.|+|||++.+..++.++|||||||++|||++|+.||......    ..+ ........           
T Consensus       173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~-~~i~~~~~-----------  232 (329)
T PTZ00263        173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF----RIY-EKILAGRL-----------  232 (329)
T ss_pred             ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH----HHH-HHHhcCCc-----------
Confidence                2346899999999999988999999999999999999999999753211    111 10000000           


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCC-----HHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRIN-----AREIVAK  447 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~el~~~  447 (470)
                           ..+..++..+.+++.+||+.||.+||+     +.+++.|
T Consensus       233 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        233 -----KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             -----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                 001123556789999999999999997     6888866

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.5e-40  Score=324.28  Aligned_cols=267  Identities=21%  Similarity=0.277  Sum_probs=205.6

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      .++|++.+.||+|+||.||+++.. +|..+|+|.+.... ......+.+|+++++.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            468999999999999999999765 68899999987553 2345678899999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA-PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      |+++|+|.+++.... .+++..+..++.|++.||.|||   +. +|+||||||+||+++.++.+||+|||++......  
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  157 (331)
T cd06649          84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (331)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence            999999999996544 5789999999999999999999   65 6999999999999999999999999998765322  


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhc-CC------ccc---
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWL-PI------STM---  398 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~------~~~---  398 (470)
                        ......++..|+|||++.+..++.++|||||||++|||++|+.||......+  +........ ..      ...   
T Consensus       158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFGRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccccCCccccCccc
Confidence              1233568999999999999899999999999999999999999996532211  111110000 00      000   


Q ss_pred             ----ccc-----cccccC----------chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          399 ----EVV-----GANLLS----------QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       399 ----~~~-----~~~~~~----------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                          ...     +.....          ...........++.++.+|+.+||+.||++|||+.|++++-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                000     000000          00000000113467899999999999999999999999875

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.7e-41  Score=317.35  Aligned_cols=256  Identities=27%  Similarity=0.486  Sum_probs=211.6

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      ...+|++.+.||.|+||.||+|...++..+|+|.+..........+..|+++++.++|+||+++++++......++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            34578899999999999999999888999999999766555566788999999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          251 MPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       251 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      +++++|.+++.+.. ..+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||.+........ 
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~-  159 (261)
T cd05148          84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY-  159 (261)
T ss_pred             cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence            99999999997643 45799999999999999999999   89999999999999999999999999999976643211 


Q ss_pred             ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                       ......++..|+|||...+..++.++||||||+++|+|++ |+.||......+  ....+.....              
T Consensus       160 -~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~~~--------------  222 (261)
T cd05148         160 -LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE--VYDQITAGYR--------------  222 (261)
T ss_pred             -cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH--HHHHHHhCCc--------------
Confidence             1123345678999999988889999999999999999998 899987643221  1111111000              


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                          ...+..++.++.+++.+||+.||++|||+.++.+.|+.+
T Consensus       223 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         223 ----MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence                011233467789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.4e-40  Score=316.81  Aligned_cols=257  Identities=23%  Similarity=0.377  Sum_probs=205.0

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCc----EEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGM----EVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  246 (470)
                      ++|++.+.||+|+||.||+|.+. +++    .+++|.+.... ......+..|+..++.+.||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            46888899999999999999863 344    47778775332 2334567778889999999999999999864 45678


Q ss_pred             EEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCC
Q 040392          247 VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      ++||+++|+|.+++......+++..+..++.|++.||+|||   +++++|+||||+||++++++.+||+|||+++.....
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            99999999999999877677899999999999999999999   899999999999999999999999999999866433


Q ss_pred             CCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          327 DQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       327 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      ..........++..|+|||.+.++.++.++||||||+++|||++ |..||.+....+  ..+++......          
T Consensus       163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~~~~~~~~~~----------  230 (279)
T cd05111         163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--VPDLLEKGERL----------  230 (279)
T ss_pred             CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHCCCcC----------
Confidence            32223334456778999999988899999999999999999998 999987643221  12222111000          


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                              ..+..++.++.+++.+||..||++|||+.|+++.|..+.+
T Consensus       231 --------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         231 --------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             --------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence                    0112235567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.7e-40  Score=324.34  Aligned_cols=260  Identities=26%  Similarity=0.423  Sum_probs=205.9

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeeccc-chhhhhHHHHHHHHhcC-CCCcceeEEeeecc-CC
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-GRALKGFDVECEMMKSI-RHRNLIKVISTCSN-EE  242 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~-~~  242 (470)
                      .++|++.+.||+|+||.||+|...      +++.||+|++.... ....+.+..|++++.++ +|+||+++++++.. ..
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            357999999999999999999532      35789999986442 23345677899999999 79999999998754 45


Q ss_pred             eeeEEEecCCCCChHHhhhcCC----------------------------------------------------------
Q 040392          243 FKALVLEYMPHGSLEKYMYSSN----------------------------------------------------------  264 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  264 (470)
                      ..+++|||+++++|.+++....                                                          
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            6789999999999999985422                                                          


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccccccccCcccc
Q 040392          265 --YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM  342 (470)
Q Consensus       265 --~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~  342 (470)
                        ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++..+.............++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence              25788899999999999999999   9999999999999999999999999999998764333333333445677899


Q ss_pred             CccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHH
Q 040392          343 APEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVS  421 (470)
Q Consensus       343 aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (470)
                      |||++.+..++.++|||||||++|||++ |..||......+ .+..........                  ..+..++.
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~------------------~~~~~~~~  303 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLKEGTRM------------------RAPEYATP  303 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHhccCCC------------------CCCccCCH
Confidence            9999999999999999999999999998 999987533221 111111111000                  01122356


Q ss_pred             HHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          422 CVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       422 ~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                      ++.+++.+||+.+|++||++.|++++|+++..
T Consensus       304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            78999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.1e-40  Score=312.26  Aligned_cols=255  Identities=24%  Similarity=0.421  Sum_probs=207.5

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      .++|++.+.||+|++|.||+|...++..||+|.+.... ...+.+..|+.+++.++|+||+++++++......+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            45788999999999999999998888899999876432 23567888999999999999999999999999999999999


Q ss_pred             CCCChHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          252 PHGSLEKYMYSS-NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       252 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      ++++|.+++... ...+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++........ .
T Consensus        84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~  159 (261)
T cd05072          84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-T  159 (261)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce-e
Confidence            999999998654 356788899999999999999999   89999999999999999999999999999986543221 1


Q ss_pred             cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCch
Q 040392          331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE  409 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (470)
                      ......++..|+|||+..+..++.++||||||+++|+|++ |..||......  .....+......              
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~~--------------  223 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSALQRGYRM--------------  223 (261)
T ss_pred             ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCCCC--------------
Confidence            1122345678999999988889999999999999999998 99998753222  111111111000              


Q ss_pred             hhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       410 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                          .....++.++.+++.+||..+|++||+++++.+.|+++
T Consensus       224 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         224 ----PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             ----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                01122356788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.4e-40  Score=316.78  Aligned_cols=255  Identities=31%  Similarity=0.508  Sum_probs=206.6

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccch-hhhhHHHHHHHHhcCCCCcceeEEeeeccCCee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCSNEEFK  244 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  244 (470)
                      .++|.+.+.||+|+||.||+|...      ++..||+|.+...... ..+.+.+|+++++.++|+||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            346888899999999999999753      3478999998755433 456788999999999999999999999999999


Q ss_pred             eEEEecCCCCChHHhhhcCC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC
Q 040392          245 ALVLEYMPHGSLEKYMYSSN-------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV  311 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~  311 (470)
                      ++||||+++++|.+++....             ..+++..+..++.|++.|+.|||   +.+++|+||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCe
Confidence            99999999999999996542             34788889999999999999999   999999999999999999999


Q ss_pred             eEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhh
Q 040392          312 AHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVN  390 (470)
Q Consensus       312 ~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~  390 (470)
                      +||+|||++................++..|+|||++.+..++.++||||||+++|||++ |..||......+  ....+.
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~~~~~  238 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VIECIT  238 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHH
Confidence            99999999876543322222333456788999999999999999999999999999998 999987543221  111111


Q ss_pred             hhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHH
Q 040392          391 DWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLL  449 (470)
Q Consensus       391 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~  449 (470)
                         .....               ..+..++..+.+++.+||+.||++||++.|+++.|+
T Consensus       239 ---~~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         239 ---QGRLL---------------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             ---cCCcC---------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence               00000               001234677899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.1e-41  Score=324.63  Aligned_cols=251  Identities=24%  Similarity=0.319  Sum_probs=213.2

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCe-eeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEF-KALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~-~~lv  247 (470)
                      .++|..++.+|+|+||.++.++.+ ++..+++|.+....  ........+|+.++++++|||||.+.+.|.+++. .+||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            467889999999999999999754 57889999987553  3444567889999999999999999999998887 8999


Q ss_pred             EecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCC
Q 040392          248 LEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      |+|++||++.+.+.+.+ ..+++..+..|+.|++.|+.|||   +.+|+|||||+.|||++.++.+||+|||+|+.+.+.
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            99999999999998766 77899999999999999999999   999999999999999999999999999999988654


Q ss_pred             CCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccccc
Q 040392          327 DQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL  406 (470)
Q Consensus       327 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (470)
                      .  ......+||+.|++||++.+.+|..|+|||||||++|||++-+.+|........     +.......          
T Consensus       160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L-----i~ki~~~~----------  222 (426)
T KOG0589|consen  160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL-----ILKINRGL----------  222 (426)
T ss_pred             h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH-----HHHHhhcc----------
Confidence            3  244567899999999999999999999999999999999999999987533221     11111111          


Q ss_pred             CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       407 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                           -.+.+...+.++..++..|+..+|+.||++.+++.+
T Consensus       223 -----~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 -----YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             -----CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                 011233447789999999999999999999999987

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.5e-40  Score=311.56  Aligned_cols=248  Identities=27%  Similarity=0.443  Sum_probs=199.1

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCCCCh
Q 040392          179 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL  256 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L  256 (470)
                      +.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+++++.++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999764 68999999876432 33456788899999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccccccc
Q 040392          257 EKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL  336 (470)
Q Consensus       257 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  336 (470)
                      .+++......+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++................
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            9999766666899999999999999999999   9999999999999999999999999999987653221111111223


Q ss_pred             cCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHh
Q 040392          337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVA  415 (470)
Q Consensus       337 ~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  415 (470)
                      .+..|+|||.+.++.++.++||||||+++|||++ |..||.......  .........+.                  ..
T Consensus       158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--~~~~~~~~~~~------------------~~  217 (252)
T cd05084         158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--TREAIEQGVRL------------------PC  217 (252)
T ss_pred             CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--HHHHHHcCCCC------------------CC
Confidence            3567999999998899999999999999999998 888886533211  11111110000                  01


Q ss_pred             hhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHH
Q 040392          416 KEQCVSCVFNLAMECTVESPEQRINAREIVAKLL  449 (470)
Q Consensus       416 ~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~  449 (470)
                      +..++..+.+++.+||+.+|++||++.++++.|+
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            1234667899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.3e-40  Score=339.66  Aligned_cols=251  Identities=21%  Similarity=0.249  Sum_probs=204.1

Q ss_pred             CCCCCCeecccCceEEEEEEeC-C-CcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-D-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      .|.+.+.||+|++|.||+|... + +..||+|............+..|+.+++.++||||+++++++...+..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4888999999999999999643 3 6788999876555555566788999999999999999999999999999999999


Q ss_pred             CCCChHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          252 PHGSLEKYMYSS---NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       252 ~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ++|+|.+++...   ...+++..+..++.|++.||.|||   +++|+||||||+||+++.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999887542   346889999999999999999999   99999999999999999999999999999987644322


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||......     ............          
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~-----~~~~~~~~~~~~----------  289 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR-----EIMQQVLYGKYD----------  289 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCCCC----------
Confidence            22334457999999999999989999999999999999999999999753221     111111000000          


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                           ..+..++.++.+++.+||..||++||++.+++.+
T Consensus       290 -----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        290 -----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             -----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence                 0112335678999999999999999999998754

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.5e-40  Score=322.98  Aligned_cols=242  Identities=21%  Similarity=0.297  Sum_probs=196.9

Q ss_pred             CeecccCceEEEEEEe-CCCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCCC
Q 040392          179 NLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHG  254 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g  254 (470)
                      +.||+|+||.||+++. .+|..||+|++....   ......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999975 468999999987542   234456678999999999999999999999999999999999999


Q ss_pred             ChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccccc
Q 040392          255 SLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ  334 (470)
Q Consensus       255 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  334 (470)
                      +|..++.... .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.......  .....
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~  154 (323)
T cd05595          81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT  154 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccccc
Confidence            9998886544 6889999999999999999999   9999999999999999999999999999987532211  12234


Q ss_pred             cccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhH
Q 040392          335 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFV  414 (470)
Q Consensus       335 ~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  414 (470)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .......    ...                .
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-~~~~~~~----~~~----------------~  213 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-LFELILM----EEI----------------R  213 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHhc----CCC----------------C
Confidence            568999999999999899999999999999999999999997532221 1111100    000                0


Q ss_pred             hhhhhHHHHHHHHhhccCCCccCCC-----CHHHHHHH
Q 040392          415 AKEQCVSCVFNLAMECTVESPEQRI-----NAREIVAK  447 (470)
Q Consensus       415 ~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~el~~~  447 (470)
                      .+..++.++.+++.+||+.||++||     ++.+++++
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            1123466788999999999999998     89988875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=295.15  Aligned_cols=263  Identities=23%  Similarity=0.303  Sum_probs=212.1

Q ss_pred             HHhhCCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCC-----
Q 040392          169 CRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEE-----  242 (470)
Q Consensus       169 ~~~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-----  242 (470)
                      ....++|++.+.+|+|||+-||.++ ..++..+|+|.+.....+..+...+|++..++++|||+++++++...+.     
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            3345789999999999999999997 6678999999998777778888999999999999999999999875433     


Q ss_pred             eeeEEEecCCCCChHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeeCCCCCeEEeee
Q 040392          243 FKALVLEYMPHGSLEKYMYSS---NYILDIFQRLNIMIDVASALEYLHFGYSAP--IIHCDLKPSNVLLDDNMVAHLSDF  317 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--i~H~dlkp~Nill~~~~~~kl~Df  317 (470)
                      ..|++++|...|+|.+.+...   +..+++.+.++|+.++++||++||   ...  ++||||||.||++++++.++|.||
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH---~~~~~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALH---EKEPPYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHh---ccCCcccccCCCcceeEecCCCceEEEec
Confidence            489999999999999988643   357899999999999999999999   555  999999999999999999999999


Q ss_pred             ccccccCCCCCc-------ccccccccCccccCccccC---CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhH
Q 040392          318 SIAKLLTGEDQS-------MTQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKH  387 (470)
Q Consensus       318 g~a~~~~~~~~~-------~~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~  387 (470)
                      |.+....-.-..       ........|..|+|||++.   +...++++|||||||+||+|+.|..||+.......++.-
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL  253 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL  253 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence            998754321111       1223456899999999885   345789999999999999999999999875543322211


Q ss_pred             HhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          388 WVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       388 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                      -           +..      ....++.....+..+.+++.+|++.||.+||++.+++.++..+
T Consensus       254 A-----------v~n------~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  254 A-----------VQN------AQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             e-----------eec------cccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence            0           011      1111222223577899999999999999999999999998765

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.9e-40  Score=316.54  Aligned_cols=259  Identities=30%  Similarity=0.490  Sum_probs=210.0

Q ss_pred             CCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  246 (470)
                      .+|.+.+.||+|+||.||+|...      ++..+++|.+........+.+.+|++++++++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45778899999999999999742      355689999876555556778899999999999999999999999999999


Q ss_pred             EEecCCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC
Q 040392          247 VLEYMPHGSLEKYMYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV  311 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~  311 (470)
                      ||||+++++|.+++....               ..+++..++.++.|++.||+|||   +++++||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence            999999999999996532               34788999999999999999999   999999999999999999999


Q ss_pred             eEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhh
Q 040392          312 AHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVN  390 (470)
Q Consensus       312 ~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~  390 (470)
                      ++|+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||......+  ..... 
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~-  238 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--VIECI-  238 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH-
Confidence            99999999976543332223334456788999999998899999999999999999999 999987643321  11111 


Q ss_pred             hhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          391 DWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       391 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                        .......               .+..++..+.+++.+||+.+|++||++.++++.|+++...
T Consensus       239 --~~~~~~~---------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         239 --TQGRVLE---------------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             --hCCCCCC---------------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence              1100000               0122366789999999999999999999999999999643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.9e-40  Score=311.73  Aligned_cols=252  Identities=23%  Similarity=0.402  Sum_probs=204.2

Q ss_pred             CCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCC
Q 040392          173 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP  252 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~  252 (470)
                      ++|.+.+.||+|+||.||+|++.++..+|+|.+.... .....+.+|+.+++.++||||+++++++.+....++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4578889999999999999988777789999886432 234568889999999999999999999998888999999999


Q ss_pred             CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccc
Q 040392          253 HGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ  332 (470)
Q Consensus       253 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  332 (470)
                      +|+|.+++......+++..++.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||.++....... ...
T Consensus        83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~  158 (256)
T cd05113          83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSS  158 (256)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-eec
Confidence            99999999776557899999999999999999999   99999999999999999999999999999876543221 111


Q ss_pred             cccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhh
Q 040392          333 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDI  411 (470)
Q Consensus       333 ~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  411 (470)
                      ....++..|+|||...+..++.++||||||+++|||++ |..||......+  ....+......                
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~~~~----------------  220 (256)
T cd05113         159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVEKVSQGLRL----------------  220 (256)
T ss_pred             CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHhcCCCC----------------
Confidence            22335678999999988889999999999999999999 999987543221  11111110000                


Q ss_pred             hhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHH
Q 040392          412 HFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLL  449 (470)
Q Consensus       412 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~  449 (470)
                        ..+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus       221 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         221 --YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             --CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence              001122567899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5.4e-40  Score=310.48  Aligned_cols=258  Identities=23%  Similarity=0.341  Sum_probs=207.6

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.+...   .......+..|+++++.++||||+++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57899999999999999999754 6899999987542   2334456788999999999999999999999889999999


Q ss_pred             ecCCCCChHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC
Q 040392          249 EYMPHGSLEKYMYS---SNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       249 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  325 (470)
                      ||+++|+|.+++..   ....+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988853   2345788999999999999999999   99999999999999999999999999999886543


Q ss_pred             CCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          326 EDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       326 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      ..  .......++..|+|||.+.+..++.++|+||||+++|||++|+.||.............+..   ...     +..
T Consensus       159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~---~~~-----~~~  228 (267)
T cd08228         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ---CDY-----PPL  228 (267)
T ss_pred             hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhc---CCC-----CCC
Confidence            22  11223468889999999988889999999999999999999999986532221111111110   000     000


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR  452 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~  452 (470)
                               .....+..+.+++.+||+.+|++||++.|+++.|++++
T Consensus       229 ---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         229 ---------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             ---------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                     01223567899999999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.9e-41  Score=311.13  Aligned_cols=261  Identities=26%  Similarity=0.334  Sum_probs=197.3

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccC-----CeeeEE
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNE-----EFKALV  247 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-----~~~~lv  247 (470)
                      .|...+++|+|+||.||+|... +++.||||....+..    --..|+++|+.+.|||||++..+|...     -+..+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4677899999999999999754 479999999864432    223599999999999999998887432     144589


Q ss_pred             EecCCCCChHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-CCeEEeeecccccc
Q 040392          248 LEYMPHGSLEKYMYSS---NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN-MVAHLSDFSIAKLL  323 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~a~~~  323 (470)
                      |||+|. +|.+++...   +..++...+.-+..||.+||.|||   +.+|+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999987 999998742   445777778889999999999999   9999999999999999976 99999999999988


Q ss_pred             CCCCCcccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc--cc--
Q 040392          324 TGEDQSMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS--TM--  398 (470)
Q Consensus       324 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~--  398 (470)
                      ......   .+...|..|+|||++.+. .|+.+.||||.||++.||+-|+.-|.+. .+...+...++..-...  ..  
T Consensus       177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~-s~~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD-SSVDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC-CHHHHHHHHHHHhCCCCHHHHhh
Confidence            654433   456788999999988875 6999999999999999999999988763 22233333332221110  00  


Q ss_pred             ------ccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          399 ------EVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       399 ------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                            +...+.+......+ ......+.+..+|+.+++.++|.+|.++.|+++|
T Consensus       253 mn~~y~~~~~p~ik~~~~~~-~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHK-VFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             cCcccccccCccccccccee-ecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence                  11111111111001 1223447789999999999999999999999865

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-41  Score=324.38  Aligned_cols=254  Identities=27%  Similarity=0.461  Sum_probs=218.4

Q ss_pred             CCCCCeecccCceEEEEEEeC---CC--cEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          175 FSENNLIGRGGFGSVYKARLG---DG--MEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~~---~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ....++||.|-||.||+|...   .|  -.||||..+.++ ....+.|..|+.+|+.++||||++++|.|.+.. ..+||
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P-~Wivm  469 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP-MWIVM  469 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-eeEEE
Confidence            344568999999999999643   23  358999987653 455788999999999999999999999998765 46999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      |.++.|.|..|++..+..++......++.||+.||+|||   ++.++||||..+|||+.+...+|++|||+++.+..+..
T Consensus       470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y  546 (974)
T KOG4257|consen  470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY  546 (974)
T ss_pred             ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence            999999999999999999999999999999999999999   99999999999999999999999999999998865544


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                      . ..+...-+..|||||.+.-.+++.++|||.|||++||+++ |..||....+...-                    ..-
T Consensus       547 Y-kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI--------------------~~i  605 (974)
T KOG4257|consen  547 Y-KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI--------------------GHI  605 (974)
T ss_pred             h-hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE--------------------EEe
Confidence            3 3334556788999999999999999999999999999998 99999876544221                    122


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                      ..+.+.+.|++||..+..|+.+||.++|.+||.+.|+...|.++..
T Consensus       606 EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  606 ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            3445667789999999999999999999999999999999999864

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1e-40  Score=325.93  Aligned_cols=246  Identities=21%  Similarity=0.248  Sum_probs=201.2

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCC--CcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGD--GMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  246 (470)
                      .++|.+.+.||+|+||.||+|....  +..||+|++....   ......+..|+++++.++||||+++++++.+....++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            4578999999999999999997543  3689999986432   2345567789999999999999999999999999999


Q ss_pred             EEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCC
Q 040392          247 VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      ||||+++|+|.+++.... .+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++......
T Consensus       109 v~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            999999999999997554 5889999999999999999999   999999999999999999999999999999865321


Q ss_pred             CCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccccc
Q 040392          327 DQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL  406 (470)
Q Consensus       327 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (470)
                           .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......    ...         
T Consensus       185 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-~~~~i~~----~~~---------  245 (340)
T PTZ00426        185 -----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-IYQKILE----GII---------  245 (340)
T ss_pred             -----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-HHHHHhc----CCC---------
Confidence                 123568999999999998889999999999999999999999997632211 1111000    000         


Q ss_pred             CchhhhhHhhhhhHHHHHHHHhhccCCCccCCC-----CHHHHHHH
Q 040392          407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRI-----NAREIVAK  447 (470)
Q Consensus       407 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~el~~~  447 (470)
                             ..+...+..+.+++.+||+.||++|+     +++++++|
T Consensus       246 -------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        246 -------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             -------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                   00122355678999999999999995     89998876

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-40  Score=311.41  Aligned_cols=255  Identities=29%  Similarity=0.451  Sum_probs=206.5

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      .++|++.+.||+|++|.||+|...+++.||+|.++... ...+.+..|++++++++|+||+++++++......++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            45688899999999999999988778899999986443 23456888999999999999999999999999999999999


Q ss_pred             CCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          252 PHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       252 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      ++++|.+++.... ..+++..+..++.|++.|+.|||   +.+++|+||||+||+++.++.+||+|||++........ .
T Consensus        84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~  159 (261)
T cd05068          84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-E  159 (261)
T ss_pred             cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-c
Confidence            9999999996644 46899999999999999999999   99999999999999999999999999999987642211 1


Q ss_pred             cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCch
Q 040392          331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE  409 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (470)
                      .......+..|+|||+..+..++.++||||||+++|||++ |+.||......+  ....+......              
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~~--------------  223 (261)
T cd05068         160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE--VLQQVDQGYRM--------------  223 (261)
T ss_pred             ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHcCCCC--------------
Confidence            1111223457999999998899999999999999999999 999987543211  11111110000              


Q ss_pred             hhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       410 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                          ..+..++..+.+++.+||+.+|++||++.++.+.|+++
T Consensus       224 ----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         224 ----PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             ----CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence                01122356789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.8e-40  Score=320.84  Aligned_cols=266  Identities=20%  Similarity=0.289  Sum_probs=203.0

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      .++|++.+.||+|+||.||++... ++..+|+|.+.... ......+..|+++++.++|+||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            468999999999999999999765 68889999887542 2344668899999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA-PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      |+++|+|.+++.... .+++..+..++.|++.||.|||   +. +++|+||||+||+++.++.+||+|||++..+...  
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--  157 (333)
T cd06650          84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (333)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence            999999999996544 5788899999999999999999   64 7999999999999999999999999998755321  


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccc-cc-------
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTM-EV-------  400 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~-------  400 (470)
                        ......++..|+|||.+.+..++.++|||||||++|||++|+.||......+.  ............. ..       
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  233 (333)
T cd06650         158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL--ELMFGCPVEGDPAESETSPRPRP  233 (333)
T ss_pred             --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH--HHHhcCcccCCccccccCcccCC
Confidence              11234688999999999988899999999999999999999999875332111  1110000000000 00       


Q ss_pred             -------ccccccCc-hhh-------h----hHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          401 -------VGANLLSQ-EDI-------H----FVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       401 -------~~~~~~~~-~~~-------~----~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                             ..+..... ...       .    .......+.++.+|+.+||+.||++||++.|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                   00000000 000       0    00001235678999999999999999999999865

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-40  Score=320.06  Aligned_cols=240  Identities=23%  Similarity=0.273  Sum_probs=194.7

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCCCCh
Q 040392          181 IGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL  256 (470)
Q Consensus       181 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L  256 (470)
                      ||+|+||.||+|+.. +++.||+|++...   .......+..|+.+++.++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999765 5889999998643   233455677899999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccccccc
Q 040392          257 EKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL  336 (470)
Q Consensus       257 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  336 (470)
                      .+++.... .+++..+..++.|++.||.|||   +++|+||||||+||+++.++.+||+|||+++......  .......
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~  154 (312)
T cd05585          81 FHHLQREG-RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFC  154 (312)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccccc
Confidence            99997643 5889999999999999999999   9999999999999999999999999999987542221  1223456


Q ss_pred             cCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhh
Q 040392          337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAK  416 (470)
Q Consensus       337 ~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  416 (470)
                      ||+.|+|||++.+..++.++|||||||++|||++|+.||......     ...........                ..+
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~-----~~~~~~~~~~~----------------~~~  213 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-----EMYRKILQEPL----------------RFP  213 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH-----HHHHHHHcCCC----------------CCC
Confidence            899999999999989999999999999999999999999753221     11111111100                011


Q ss_pred             hhhHHHHHHHHhhccCCCccCCCC---HHHHHHH
Q 040392          417 EQCVSCVFNLAMECTVESPEQRIN---AREIVAK  447 (470)
Q Consensus       417 ~~~~~~l~~l~~~cl~~dP~~Rps---~~el~~~  447 (470)
                      ..++.++.+++.+||+.||++||+   +.|++.|
T Consensus       214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            233567889999999999999974   6777665

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-40  Score=310.45  Aligned_cols=251  Identities=27%  Similarity=0.435  Sum_probs=203.4

Q ss_pred             CCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCC
Q 040392          173 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP  252 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~  252 (470)
                      .+|++.+.||+|+||.||+|.++++..+|+|.+.... .....+.+|+++++.++||||+++++++......++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            3578889999999999999988777889999986432 233467789999999999999999999999999999999999


Q ss_pred             CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccc
Q 040392          253 HGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ  332 (470)
Q Consensus       253 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  332 (470)
                      +++|.+++......+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||+++....... ...
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~~  158 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TSS  158 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccc-ccc
Confidence            99999999776667899999999999999999999   99999999999999999999999999999876532211 111


Q ss_pred             cccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhh
Q 040392          333 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDI  411 (470)
Q Consensus       333 ~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  411 (470)
                      ....++..|+|||.+.+..++.++|+||||+++|||++ |+.||......+.  ...+.....                 
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~~~~~~~~-----------------  219 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV--VESVSAGYR-----------------  219 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH--HHHHHcCCc-----------------
Confidence            11224457999999998899999999999999999999 8999875432211  111110000                 


Q ss_pred             hhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          412 HFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       412 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                       ...+..++.++.+++.+||..+|++||++.|+++.|
T Consensus       220 -~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         220 -LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             -CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence             001123467799999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-41  Score=307.16  Aligned_cols=269  Identities=25%  Similarity=0.290  Sum_probs=206.2

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEee--cccchhhhhHHHHHHHHhcCCCCcceeEEeeecc-----CCe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN-----EEF  243 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-----~~~  243 (470)
                      ...|...+.||+|+||.|..|.. .+|+.||||.+.  .+.....++..+|+++++.++|+||+.+.+.+..     -..
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            45667689999999999999964 468999999986  3445567778899999999999999999998854     356


Q ss_pred             eeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecccccc
Q 040392          244 KALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  323 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~  323 (470)
                      .|+|+|+| +.+|.+.+++.+ .++...+..++.|+++||.|+|   +.+++||||||.|++++.+..+||+|||+|+..
T Consensus       101 vYiV~elM-etDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~  175 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARYL  175 (359)
T ss_pred             eEEehhHH-hhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceeec
Confidence            79999999 559999996554 5899999999999999999999   999999999999999999999999999999987


Q ss_pred             CCCCCcccccccccCccccCccccC-CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc---ccc
Q 040392          324 TGEDQSMTQTQTLATIGYMAPEYGR-EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS---TME  399 (470)
Q Consensus       324 ~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~  399 (470)
                      .........+..+.|.+|+|||++. ...|+.+.||||+||++.||++|+.-|.+...-  .....+-...+..   ...
T Consensus       176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v--~Ql~lI~~~lGtP~~e~l~  253 (359)
T KOG0660|consen  176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV--HQLQLILELLGTPSEEDLQ  253 (359)
T ss_pred             cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH--HHHHHHHHhcCCCCHHHHH
Confidence            6544455567788999999999765 567999999999999999999999887753221  1111111111111   000


Q ss_pred             ccccc--------c-cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          400 VVGAN--------L-LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       400 ~~~~~--------~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      .+...        + ......-...-........+|+.+||..||.+|+|++|+++|
T Consensus       254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            00000        0 000000000112446778999999999999999999999886

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3e-40  Score=321.57  Aligned_cols=242  Identities=23%  Similarity=0.313  Sum_probs=197.3

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCCC
Q 040392          179 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHG  254 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g  254 (470)
                      +.||+|+||.||+++.. +|+.||+|++....   ......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999754 68999999987542   234556778999999999999999999999999999999999999


Q ss_pred             ChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccccc
Q 040392          255 SLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ  334 (470)
Q Consensus       255 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  334 (470)
                      +|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.....  ......
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~  154 (328)
T cd05593          81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKT  154 (328)
T ss_pred             CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccccc
Confidence            9998886543 6889999999999999999999   999999999999999999999999999998753221  112234


Q ss_pred             cccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhH
Q 040392          335 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFV  414 (470)
Q Consensus       335 ~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  414 (470)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||......+     .........                ..
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~-----~~~~~~~~~----------------~~  213 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----LFELILMED----------------IK  213 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH-----HHHHhccCC----------------cc
Confidence            568999999999998899999999999999999999999997532211     111100000                00


Q ss_pred             hhhhhHHHHHHHHhhccCCCccCCC-----CHHHHHHH
Q 040392          415 AKEQCVSCVFNLAMECTVESPEQRI-----NAREIVAK  447 (470)
Q Consensus       415 ~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~el~~~  447 (470)
                      .+..++.++.+++.+||+.||++||     ++.|++++
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            1123366788999999999999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=6.5e-40  Score=312.79  Aligned_cols=255  Identities=26%  Similarity=0.459  Sum_probs=204.8

Q ss_pred             CCCCCCCeecccCceEEEEEEe-----CCCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeE
Q 040392          173 DGFSENNLIGRGGFGSVYKARL-----GDGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  246 (470)
                      ++|++.+.||+|+||.||+|..     .++..|++|.+.... ......+..|+++++.++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4678889999999999999974     246789999986432 3344678889999999999999999999999999999


Q ss_pred             EEecCCCCChHHhhhcCC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC
Q 040392          247 VLEYMPHGSLEKYMYSSN----------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM  310 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~  310 (470)
                      ||||+++++|.+++....                ..+++.+...++.|++.||+|||   +++++|+||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence            999999999999985321                24678889999999999999999   89999999999999999999


Q ss_pred             CeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHh
Q 040392          311 VAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWV  389 (470)
Q Consensus       311 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~  389 (470)
                      .+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||......  .....+
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--~~~~~~  239 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--EVIEMV  239 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH
Confidence            999999999987644333223333446778999999988889999999999999999999 88888653221  111111


Q ss_pred             hhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHH
Q 040392          390 NDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK  450 (470)
Q Consensus       390 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~  450 (470)
                      ....   .               ...+..++.++.+++.+||+.||++||++.++.++|+.
T Consensus       240 ~~~~---~---------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         240 RKRQ---L---------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HcCC---c---------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            1100   0               01122346678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.6e-40  Score=312.84  Aligned_cols=257  Identities=23%  Similarity=0.404  Sum_probs=203.8

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCe
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEF  243 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  243 (470)
                      ..++|++.+.||+|+||.||+|...      ++..||+|.+.... ......+..|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567999999999999999998743      35679999885432 2344567889999999999999999999999999


Q ss_pred             eeEEEecCCCCChHHhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEE
Q 040392          244 KALVLEYMPHGSLEKYMYSSN---------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHL  314 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl  314 (470)
                      .++||||+++|+|.+++.+..         ...++..+..++.|++.||.|||   +.+++|+||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999986532         23577888999999999999999   899999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhc
Q 040392          315 SDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWL  393 (470)
Q Consensus       315 ~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~  393 (470)
                      +|||++................++..|+|||++.+..++.++||||||+++|||++ |..||......  .....+..  
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~~~~~~~~--  236 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--QVLRFVME--  236 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHc--
Confidence            99999876543322222223345788999999998889999999999999999999 78888653221  11111110  


Q ss_pred             CCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHH
Q 040392          394 PISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK  450 (470)
Q Consensus       394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~  450 (470)
                       ....               ..+..++..+.+++.+||+.||++||++.|+++.|++
T Consensus       237 -~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         237 -GGLL---------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             -CCcC---------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence             0000               0012346678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.9e-40  Score=314.45  Aligned_cols=271  Identities=27%  Similarity=0.396  Sum_probs=206.1

Q ss_pred             CCCCCCCeecccCceEEEEEEe-----CCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeecc--CCeee
Q 040392          173 DGFSENNLIGRGGFGSVYKARL-----GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN--EEFKA  245 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~~  245 (470)
                      .+|++.+.||+|+||.||++..     .++..||+|.+........+.+..|+++++.++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4688899999999999999974     3578999999876655666788899999999999999999998643  34678


Q ss_pred             EEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC
Q 040392          246 LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  325 (470)
                      +||||+++|+|.+++......+++..+..++.|++.||+|||   +.+++|+||||+||++++++.+||+|||++.....
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            999999999999999776667899999999999999999999   99999999999999999999999999999987643


Q ss_pred             CCCccc-ccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc-ccccccc
Q 040392          326 EDQSMT-QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS-TMEVVGA  403 (470)
Q Consensus       326 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  403 (470)
                      ...... .....++..|+|||.+.+..++.++||||||+++|||++|..|+......   ............ .......
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhcccccccccchHHHHH
Confidence            222111 11223445699999998888999999999999999999988775432110   000000000000 0000000


Q ss_pred             cccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                      .+  ........+..++.++.+++.+||+.+|++|||+.|+++.|+++
T Consensus       238 ~~--~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         238 LL--KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HH--hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            00  00001112234567899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=6.6e-40  Score=312.05  Aligned_cols=260  Identities=25%  Similarity=0.393  Sum_probs=207.5

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCc----EEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGM----EVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKA  245 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  245 (470)
                      .++|+..+.||+|+||+||+|++ .+|+    .||+|.+.... ......+..|+.+++.+.|+||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            45788899999999999999974 3444    48999986543 33456678899999999999999999998764 467


Q ss_pred             EEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC
Q 040392          246 LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  325 (470)
                      +++||+++|+|.+++......+++..+..++.|++.||+|||   +++++||||||+||+++.++.+||+|||+++....
T Consensus        85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            899999999999999876667899999999999999999999   99999999999999999999999999999987643


Q ss_pred             CCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCccccccccc
Q 040392          326 EDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN  404 (470)
Q Consensus       326 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (470)
                      ...........++..|+|||...+..++.++||||||+++|||++ |..||......  ....++.......        
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~--------  231 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--EIPDLLEKGERLP--------  231 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCCcCC--------
Confidence            322222222345678999999988889999999999999999998 89998754322  1222222111100        


Q ss_pred             ccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHH
Q 040392          405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL  455 (470)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~  455 (470)
                                .+..++.++.+++.+||+.||++||++.++++.|+++....
T Consensus       232 ----------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         232 ----------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             ----------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence                      01234567889999999999999999999999998886443

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-41  Score=329.24  Aligned_cols=253  Identities=25%  Similarity=0.399  Sum_probs=205.2

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|++....   ......+..|++++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46889999999999999999865 68999999987542   234566788999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC-
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED-  327 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~-  327 (470)
                      ||+++++|.+++... ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++....... 
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            999999999999766 46899999999999999999999   9999999999999999999999999999998654322 


Q ss_pred             --------------------------CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccC
Q 040392          328 --------------------------QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNG  381 (470)
Q Consensus       328 --------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~  381 (470)
                                                .........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                      011223456899999999999999999999999999999999999999764321


Q ss_pred             cchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCC-HHHHHHH
Q 040392          382 EMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRIN-AREIVAK  447 (470)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-~~el~~~  447 (470)
                      +. ..... .+..  ...             .+....++.++.+++.+|+. ||.+||+ +.|++++
T Consensus       237 ~~-~~~i~-~~~~--~~~-------------~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         237 ET-YNKII-NWKE--SLR-------------FPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HH-HHHHh-ccCC--ccc-------------CCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            11 11100 0000  000             00001136678899999997 9999999 9999987

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-41  Score=325.66  Aligned_cols=254  Identities=27%  Similarity=0.436  Sum_probs=216.4

Q ss_pred             CCCCCCeecccCceEEEEEEeCC-CcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCC
Q 040392          174 GFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP  252 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~  252 (470)
                      +....++||-|.||.||.|.|+. .-.||||.++.+ ....+.|..|+.+|+.++|||+|+++|+|..+...|||+|||.
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~  346 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC  346 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence            45566789999999999999875 567999999744 4567889999999999999999999999999999999999999


Q ss_pred             CCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccc
Q 040392          253 HGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  331 (470)
Q Consensus       253 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  331 (470)
                      +|+|.+|+.+++ ..++....+.++.||+.|++||.   .+++|||||.++|.|+.++..+|+.|||+++.+....+. .
T Consensus       347 yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT-A  422 (1157)
T KOG4278|consen  347 YGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT-A  422 (1157)
T ss_pred             CccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCcee-c
Confidence            999999998876 44667777899999999999999   999999999999999999999999999999998754432 3


Q ss_pred             ccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCchh
Q 040392          332 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED  410 (470)
Q Consensus       332 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (470)
                      .....-.+.|.|||-+....++.|+|||+|||+|||+.| |..||...+-...  ..            .      -...
T Consensus       423 HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV--Y~------------L------LEkg  482 (1157)
T KOG4278|consen  423 HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--YG------------L------LEKG  482 (1157)
T ss_pred             ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH--HH------------H------Hhcc
Confidence            333445778999999999999999999999999999999 8889876432211  01            0      1122


Q ss_pred             hhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHH
Q 040392          411 IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR  452 (470)
Q Consensus       411 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~  452 (470)
                      .+...++.|+..+++||+.||+++|..||++.|+-+.++.|.
T Consensus       483 yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  483 YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence            344567899999999999999999999999999999999885

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.7e-40  Score=310.32  Aligned_cols=254  Identities=26%  Similarity=0.421  Sum_probs=205.4

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      .+|.+.+.||+|++|.||+|... .++.||+|.+... ......+..|+++++.++|+||+++++++......+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45778899999999999999754 5889999998643 334566888999999999999999999999999999999999


Q ss_pred             CCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          252 PHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       252 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      ++++|.+++.... ..+++..++.++.|+++||+|||   +.+++||||||+||++++++.+||+|||++......... 
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-  160 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-  160 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceee-
Confidence            9999999986543 45889999999999999999999   999999999999999999999999999999876432211 


Q ss_pred             cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCch
Q 040392          331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE  409 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (470)
                      .......+..|+|||.+.+..++.++||||||+++|||++ |..||......     ..........             
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-----~~~~~~~~~~-------------  222 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYELLEKGY-------------  222 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHHCCC-------------
Confidence            1112234568999999988899999999999999999998 89998653221     1111110000             


Q ss_pred             hhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       410 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                        ....+..++.++.+++.+||+.||++||++.++++.|+++
T Consensus       223 --~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         223 --RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             --CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence              0011233467799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5.3e-40  Score=323.31  Aligned_cols=248  Identities=24%  Similarity=0.353  Sum_probs=194.5

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      ++|+..+.||+|+||.||+|+.. +++.||||++.... ......+.+|+++++.++|+||+++++++......++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            45677889999999999999754 68999999986543 23456688899999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      +++|+|.+..     ..++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++..+....  .
T Consensus       154 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~  223 (353)
T PLN00034        154 MDGGSLEGTH-----IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--D  223 (353)
T ss_pred             CCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc--c
Confidence            9999986543     3466778899999999999999   9999999999999999999999999999998653221  1


Q ss_pred             cccccccCccccCccccCC-----CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          331 TQTQTLATIGYMAPEYGRE-----GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~-----~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      ......||..|+|||++..     ...+.++|||||||++|||++|+.||.......  +...........         
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~---------  292 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASLMCAICMSQ---------  292 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHhccC---------
Confidence            1233568999999998743     234568999999999999999999997422211  111111000000         


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                            ....+..++.++.+++.+||+.||++||++.|+++|
T Consensus       293 ------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        293 ------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  000112346678999999999999999999999987

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.2e-40  Score=320.83  Aligned_cols=243  Identities=24%  Similarity=0.331  Sum_probs=195.8

Q ss_pred             CCeecccCceEEEEEEe----CCCcEEEEEEeeccc----chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          178 NNLIGRGGFGSVYKARL----GDGMEVAVKVFNLQC----GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       178 ~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      ++.||+|+||.||+++.    .+++.||+|++....    ......+..|+++++.++||||+++++++..++..++|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            36899999999999975    357899999987432    2234456789999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      |+++|+|.+++.... .+.+..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  154 (323)
T cd05584          81 YLSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--  154 (323)
T ss_pred             CCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--
Confidence            999999999986554 5778888899999999999999   9999999999999999999999999999987543221  


Q ss_pred             ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCch
Q 040392          330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE  409 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (470)
                      .......|++.|+|||++.+..++.++||||||+++|||++|+.||.......     ..........            
T Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-----~~~~~~~~~~------------  217 (323)
T cd05584         155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-----TIDKILKGKL------------  217 (323)
T ss_pred             CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-----HHHHHHcCCC------------
Confidence            12233568999999999998889999999999999999999999997632211     1111111000            


Q ss_pred             hhhhHhhhhhHHHHHHHHhhccCCCccCCC-----CHHHHHHH
Q 040392          410 DIHFVAKEQCVSCVFNLAMECTVESPEQRI-----NAREIVAK  447 (470)
Q Consensus       410 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~el~~~  447 (470)
                          ..+..++.++.+++.+||+.||++||     ++.+++++
T Consensus       218 ----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         218 ----NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             ----CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence                01122356688999999999999999     88888775

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.3e-40  Score=314.36  Aligned_cols=254  Identities=28%  Similarity=0.470  Sum_probs=205.4

Q ss_pred             CCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  246 (470)
                      .+|...+.||+|+||.||++...      ++..+|+|.+..........+..|+++++.++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46778899999999999999632      356899998876655666788999999999999999999999999999999


Q ss_pred             EEecCCCCChHHhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCe
Q 040392          247 VLEYMPHGSLEKYMYSSN--------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA  312 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~  312 (470)
                      +|||+++++|.+++....              ..+++..+..++.|++.|++|||   +.+++|+||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence            999999999999986543              24788999999999999999999   9999999999999999999999


Q ss_pred             EEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhh
Q 040392          313 HLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVND  391 (470)
Q Consensus       313 kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~  391 (470)
                      ||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||......+  .......
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~  239 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--AIECITQ  239 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--HHHHHHc
Confidence            9999999876543222222223345678999999998899999999999999999998 899986543221  1111110


Q ss_pred             hcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHH
Q 040392          392 WLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLL  449 (470)
Q Consensus       392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~  449 (470)
                      ..+                  ...+..++..+.+++.+||+.||++||++.|+.+.|+
T Consensus       240 ~~~------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         240 GRE------------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             Ccc------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            000                  0011234667889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=5.1e-40  Score=314.64  Aligned_cols=257  Identities=26%  Similarity=0.414  Sum_probs=205.7

Q ss_pred             CCCCCCeecccCceEEEEEEeC------CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeE
Q 040392          174 GFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  246 (470)
                      +|++.+.||+|+||.||+|+..      ....+++|.+.... ......+..|+++++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4778899999999999999753      23578999886543 2345678889999999999999999999999999999


Q ss_pred             EEecCCCCChHHhhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCC
Q 040392          247 VLEYMPHGSLEKYMYSSN-----------------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSN  303 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~N  303 (470)
                      ++||+++|+|.+++....                       ..+++..++.++.|++.||.|||   +.+++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence            999999999999886421                       24778899999999999999999   9999999999999


Q ss_pred             eeeCCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCc
Q 040392          304 VLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGE  382 (470)
Q Consensus       304 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~  382 (470)
                      |++++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||...... 
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-  236 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-  236 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence            9999999999999999986543332222233445778999999988889999999999999999999 99998653221 


Q ss_pred             chhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          383 MTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                       .+..+.....                  ....+..++.++.+++.+||+.+|++||++.|+++.|+++..
T Consensus       237 -~~~~~~~~~~------------------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         237 -RLFNLLKTGY------------------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             -HHHHHHhCCC------------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence             1112111100                  001122346678999999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-41  Score=314.26  Aligned_cols=263  Identities=25%  Similarity=0.329  Sum_probs=203.2

Q ss_pred             HHHHHhhCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccc--------------hhhhhHHHHHHHHhcCCCCc
Q 040392          166 LELCRATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCG--------------RALKGFDVECEMMKSIRHRN  230 (470)
Q Consensus       166 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~n  230 (470)
                      .+-....++|++.+.||+|.||.|-+|+. .+++.||||++.+...              ...+...+|+.+|+++.|||
T Consensus        90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n  169 (576)
T KOG0585|consen   90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN  169 (576)
T ss_pred             cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence            33445568899999999999999999975 4699999999864310              12346788999999999999


Q ss_pred             ceeEEeeecc--CCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC
Q 040392          231 LIKVISTCSN--EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD  308 (470)
Q Consensus       231 Iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~  308 (470)
                      ||+++.+..+  .+..|||+|||..|.+...--. ...++..++++++.++..||+|||   ..+|+||||||+|+|+++
T Consensus       170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d-~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPD-KPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSS  245 (576)
T ss_pred             eeEEEEeecCcccCceEEEEEeccCCccccCCCC-cccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcC
Confidence            9999999865  4688999999999887544322 223889999999999999999999   999999999999999999


Q ss_pred             CCCeEEeeeccccccCCC---CCcccccccccCccccCccccCCCC----CCCccchhhHHHHHHHHHhCCCCCCccccC
Q 040392          309 NMVAHLSDFSIAKLLTGE---DQSMTQTQTLATIGYMAPEYGREGR----VSTNGDVYSFGIMLMETFTGKKPTNEIFNG  381 (470)
Q Consensus       309 ~~~~kl~Dfg~a~~~~~~---~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~DvwslGv~l~el~tg~~p~~~~~~~  381 (470)
                      +|++||+|||.+......   +........+||+.|+|||...++.    .+.+.||||+||+||.|+.|+.||.+... 
T Consensus       246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~-  324 (576)
T KOG0585|consen  246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE-  324 (576)
T ss_pred             CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH-
Confidence            999999999998765221   1112223478999999999887743    45789999999999999999999976321 


Q ss_pred             cchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          382 EMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                       ..+.   .+        ++...+..      +...+...++.+|+.++|.+||++|.+..+|..|..--
T Consensus       325 -~~l~---~K--------Ivn~pL~f------P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt  376 (576)
T KOG0585|consen  325 -LELF---DK--------IVNDPLEF------PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT  376 (576)
T ss_pred             -HHHH---HH--------HhcCcccC------CCcccccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence             1111   11        11111111      11113356688999999999999999999999887544

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.8e-40  Score=316.94  Aligned_cols=259  Identities=29%  Similarity=0.466  Sum_probs=207.3

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeeccc-chhhhhHHHHHHHHhcC-CCCcceeEEeeeccCC
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-GRALKGFDVECEMMKSI-RHRNLIKVISTCSNEE  242 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~  242 (470)
                      ..++|+..+.||+|+||.||++...      +...+|+|.+.... .+....+..|+++++.+ +|+||+++++++....
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            4567889999999999999999753      23679999987542 33455688899999999 7999999999999999


Q ss_pred             eeeEEEecCCCCChHHhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC
Q 040392          243 FKALVLEYMPHGSLEKYMYSS---------------NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD  307 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~  307 (470)
                      ..+++|||+++|+|.+++...               ...+++..+..++.|++.||.|||   +.+++|+||||+||+++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEc
Confidence            999999999999999998642               246789999999999999999999   99999999999999999


Q ss_pred             CCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhh
Q 040392          308 DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLK  386 (470)
Q Consensus       308 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~  386 (470)
                      .++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..||......+  ..
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~  244 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--LF  244 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--HH
Confidence            999999999999987644332222222335678999999988889999999999999999998 999987532211  11


Q ss_pred             HHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHH
Q 040392          387 HWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR  452 (470)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~  452 (470)
                      .......                  ....+..++..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       245 ~~~~~~~------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         245 KLLKEGY------------------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHHHcCC------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            1111000                  00011234667899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=5.5e-41  Score=327.37  Aligned_cols=253  Identities=23%  Similarity=0.330  Sum_probs=203.6

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ++|.+.+.||+|+||.||+|+.. +|+.||+|+++...   ......+..|+.+++.++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46889999999999999999754 68999999997542   234556788999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||+++|+|.+++......+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++..+.....
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            999999999999877667899999999999999999999   99999999999999999999999999999987643222


Q ss_pred             cccccccccCccccCccccC------CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccc
Q 040392          329 SMTQTQTLATIGYMAPEYGR------EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVG  402 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~------~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (470)
                       .......+|+.|+|||++.      ...++.++|||||||++|||++|+.||......+ .+......   .....   
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-~~~~i~~~---~~~~~---  229 (330)
T cd05601         158 -VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-TYNNIMNF---QRFLK---  229 (330)
T ss_pred             -eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-HHHHHHcC---CCccC---
Confidence             1223356899999999886      4567899999999999999999999997532211 11111000   00000   


Q ss_pred             ccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          403 ANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                                .+.....+.++.+++..|++ +|.+||++.++++|
T Consensus       230 ----------~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         230 ----------FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             ----------CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence                      00111236678899999998 99999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.5e-40  Score=313.63  Aligned_cols=255  Identities=26%  Similarity=0.424  Sum_probs=203.4

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFK  244 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  244 (470)
                      .++|.+.+.||+|++|.||+|.+.      .+..||+|.+.... ......+..|+.+++.++|+||+++++++.+....
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            467899999999999999999764      35678999876443 33345688899999999999999999999888889


Q ss_pred             eEEEecCCCCChHHhhhcCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC---CeEEe
Q 040392          245 ALVLEYMPHGSLEKYMYSSN------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM---VAHLS  315 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~---~~kl~  315 (470)
                      ++||||+++++|.+++....      ..+++..+..++.||+.||+|||   +++++|+||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEec
Confidence            99999999999999987653      25889999999999999999999   89999999999999998654   69999


Q ss_pred             eeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcC
Q 040392          316 DFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLP  394 (470)
Q Consensus       316 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  394 (470)
                      |||+++................+..|+|||++.+..++.++|||||||++|||++ |..||......+  ....+.....
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~~  239 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VMEFVTGGGR  239 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHcCCc
Confidence            9999987643222222222334568999999988899999999999999999997 999987643221  1111111000


Q ss_pred             CcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHH
Q 040392          395 ISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLL  449 (470)
Q Consensus       395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~  449 (470)
                                        ...+..++..+.+++.+||+.+|++||++.+|+++|.
T Consensus       240 ------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         240 ------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                              0012234667899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-40  Score=334.97  Aligned_cols=258  Identities=24%  Similarity=0.337  Sum_probs=208.4

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCC-cEEEEEEeecccchhhhhHHHHHHHHhcCC-CCcceeEEe-eecc------CC
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDG-MEVAVKVFNLQCGRALKGFDVECEMMKSIR-HRNLIKVIS-TCSN------EE  242 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~-~~~~------~~  242 (470)
                      .-++++.+.|.+|||+.||.|....+ ..||+|++-..+........+|+++|+.|+ |+|||.+++ ....      .-
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            44677889999999999999986655 999999987777888899999999999997 999999999 3321      13


Q ss_pred             eeeEEEecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecccc
Q 040392          243 FKALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK  321 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~  321 (470)
                      ..+|.||||+||.|-+++.... ..+++.++++|+.++++|+++||. +..+|||||||.+||||+.+++.||||||.|.
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            5679999999999999997543 459999999999999999999993 35679999999999999999999999999987


Q ss_pred             ccCCCCCccc-------ccccccCccccCcccc---CCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhh
Q 040392          322 LLTGEDQSMT-------QTQTLATIGYMAPEYG---REGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVND  391 (470)
Q Consensus       322 ~~~~~~~~~~-------~~~~~~t~~y~aPE~~---~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~  391 (470)
                      ..........       .-....|+.|+|||++   .+..+++|+|||||||+||-|+....||++.-.-.+        
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI--------  266 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI--------  266 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE--------
Confidence            5432221100       0123579999999976   466799999999999999999999999987322111        


Q ss_pred             hcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          392 WLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                               +      .....++....++..+.+||+.||++||.+||++.|++.++.++..
T Consensus       267 ---------l------ng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  267 ---------L------NGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             ---------E------eccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                     0      0111122224558889999999999999999999999999999864

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.3e-40  Score=323.01  Aligned_cols=267  Identities=21%  Similarity=0.294  Sum_probs=196.9

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccC-----Ceee
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNE-----EFKA  245 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-----~~~~  245 (470)
                      +|++.+.||+|+||.||+|... ++..||+|.+...  .......+.+|+++++.++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4788899999999999999754 6899999998643  223345678899999999999999999987432     3478


Q ss_pred             EEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC
Q 040392          246 LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  325 (470)
                      +||||+. ++|.+++.... .+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            9999995 68998886544 5889999999999999999999   99999999999999999999999999999976532


Q ss_pred             CCC-cccccccccCccccCccccCC--CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccc-
Q 040392          326 EDQ-SMTQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVV-  401 (470)
Q Consensus       326 ~~~-~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-  401 (470)
                      ... ........+|..|+|||++.+  ..++.++|||||||++|||++|+.||......  .....+.........+.. 
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV--HQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHHhCCCCHHHHH
Confidence            211 122234578999999998865  57899999999999999999999999753221  111111111000000000 


Q ss_pred             ---cc-------cccCchhhh-hHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          402 ---GA-------NLLSQEDIH-FVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       402 ---~~-------~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                         ..       .+....... ...-...+.++.+++.+||+.||++||++.|++++
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence               00       000000000 00001235678899999999999999999999976

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.7e-40  Score=327.67  Aligned_cols=253  Identities=20%  Similarity=0.306  Sum_probs=198.6

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          174 GFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      .|..++.||+|+||+||+|+. .+++.||+|++....   ......+..|+++++.++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            578889999999999999975 468899999997542   2345668889999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC-
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ-  328 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~-  328 (470)
                      |+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++........ 
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence            999999999987654 5788888999999999999999   99999999999999999999999999999754311000 


Q ss_pred             --------------------------------------------cccccccccCccccCccccCCCCCCCccchhhHHHH
Q 040392          329 --------------------------------------------SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIM  364 (470)
Q Consensus       329 --------------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~  364 (470)
                                                                  ........||+.|+|||++.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                        000123469999999999998889999999999999


Q ss_pred             HHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhh--ccCCCccCCCCHH
Q 040392          365 LMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAME--CTVESPEQRINAR  442 (470)
Q Consensus       365 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~dP~~Rps~~  442 (470)
                      +|||++|+.||......+.. .... .+..  ...             ......++.++.+++.+  |+..+|..||++.
T Consensus       238 l~elltG~~Pf~~~~~~~~~-~~i~-~~~~--~~~-------------~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~  300 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQ-LKVI-NWEN--TLH-------------IPPQVKLSPEAVDLITKLCCSAEERLGRNGAD  300 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHH-HHHH-cccc--ccC-------------CCCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence            99999999999764322211 1100 0000  000             00011235667889987  5566777799999


Q ss_pred             HHHHH
Q 040392          443 EIVAK  447 (470)
Q Consensus       443 el~~~  447 (470)
                      |+++|
T Consensus       301 ~~l~h  305 (381)
T cd05626         301 DIKAH  305 (381)
T ss_pred             HHhcC
Confidence            99987

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=6.7e-40  Score=309.90  Aligned_cols=255  Identities=25%  Similarity=0.335  Sum_probs=203.1

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++..........+..|+.+++.++||||+++++++...+..++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            35799999999999999999985 56889999998765545556678899999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      +++++|.+++.... .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.......  .
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~  161 (267)
T cd06646          88 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--A  161 (267)
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccc--c
Confidence            99999999986543 6789999999999999999999   9999999999999999999999999999998653221  1


Q ss_pred             cccccccCccccCccccC---CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          331 TQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                      ......++..|+|||.+.   ...++.++|+||||+++|||++|+.||......+.. ..+......       .+.   
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-~~~~~~~~~-------~~~---  230 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLMSKSNFQ-------PPK---  230 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-eeeecCCCC-------CCC---
Confidence            122346788999999874   345788999999999999999999998653322111 000000000       000   


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                           .......+..+.+++.+||+.+|++||++.+++++|
T Consensus       231 -----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         231 -----LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             -----CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence                 000112356789999999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-39  Score=307.88  Aligned_cols=254  Identities=26%  Similarity=0.453  Sum_probs=202.6

Q ss_pred             CCCCCeecccCceEEEEEEeCC----CcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCe-----
Q 040392          175 FSENNLIGRGGFGSVYKARLGD----GMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEF-----  243 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~-----  243 (470)
                      |.+.+.||+|+||.||+|....    +..||+|.+....  ......+..|+++++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999997542    4679999987542  2345678889999999999999999998865543     


Q ss_pred             -eeEEEecCCCCChHHhhhcCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeee
Q 040392          244 -KALVLEYMPHGSLEKYMYSSN-----YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF  317 (470)
Q Consensus       244 -~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  317 (470)
                       .++++||+++|+|..++....     ..+++..+..++.|++.||.|||   +.+++|+||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence             789999999999998885432     35789999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCc
Q 040392          318 SIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPIS  396 (470)
Q Consensus       318 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  396 (470)
                      |+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.+..+.  ...+++...... 
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~~-  234 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYLRHGNRL-  234 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCC-
Confidence            99987654333222223345678999999988889999999999999999999 88888654322  112222111000 


Q ss_pred             ccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          397 TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       397 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                                       ..+..++.++.+++.+||+.||.+||++.|+++.|+++
T Consensus       235 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         235 -----------------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             -----------------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                             01223467799999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.1e-39  Score=313.98  Aligned_cols=258  Identities=23%  Similarity=0.378  Sum_probs=206.2

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeeccc-chhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-GRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEF  243 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~  243 (470)
                      .++|.+.+.||+|+||.||+|+..      ++..||+|.++... ....+.+.+|+++++++ +|+||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            457899999999999999999641      34579999886542 33456788899999999 79999999999999999


Q ss_pred             eeEEEecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccc
Q 040392          244 KALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL  322 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~  322 (470)
                      .++||||+++|+|.+++.... ..+++.++..++.|++.||+|||   +.+++|+||||+||+++.++.++++|||++..
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence            999999999999999997544 34799999999999999999999   99999999999999999999999999999986


Q ss_pred             cCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccc
Q 040392          323 LTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVV  401 (470)
Q Consensus       323 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (470)
                      ..............++..|+|||.+.+..++.++||||||+++|||++ |..||......+. +..........      
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~------  263 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-FYKLIKEGYRM------  263 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-HHHHHHcCCcC------
Confidence            543322222223345778999999998899999999999999999998 9999876433221 11111100000      


Q ss_pred             cccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          402 GANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                                  ..+...+.++.+++.+||+.+|++||++.|+++.|+++
T Consensus       264 ------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         264 ------------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                        00112255689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.8e-40  Score=311.56  Aligned_cols=268  Identities=26%  Similarity=0.422  Sum_probs=204.6

Q ss_pred             CC-CCCCeecccCceEEEEEEe-----CCCcEEEEEEeecccc-hhhhhHHHHHHHHhcCCCCcceeEEeeeccC--Cee
Q 040392          174 GF-SENNLIGRGGFGSVYKARL-----GDGMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKVISTCSNE--EFK  244 (470)
Q Consensus       174 ~~-~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~  244 (470)
                      +| ...+.||+|+||+||++..     .++..||+|.+..... .....+.+|+++++.++||||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL   83 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence            44 7889999999999988642     3578899999875432 3456678899999999999999999987653  467


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccC
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~  324 (470)
                      ++||||+++++|.+++...  .+++..+..++.|++.||.|||   +.+++|+||||+||++++++.+||+|||++....
T Consensus        84 ~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence            8999999999999999654  4899999999999999999999   9999999999999999999999999999998664


Q ss_pred             CCCCc-ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhh-hcCCccccccc
Q 040392          325 GEDQS-MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVND-WLPISTMEVVG  402 (470)
Q Consensus       325 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  402 (470)
                      ..... .......++..|+|||.+.+..++.++||||||+++|||++|+.||............+... .......+..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence            32211 11122345667999999988889999999999999999999999986543221111111000 00000001111


Q ss_pred             ccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHH
Q 040392          403 ANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR  452 (470)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~  452 (470)
                      ..      .....+..++.++.+++..||+.+|++||++.++++.|+++.
T Consensus       239 ~~------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         239 RG------MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             cC------CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            00      011123445788999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.6e-39  Score=311.13  Aligned_cols=267  Identities=24%  Similarity=0.322  Sum_probs=196.1

Q ss_pred             CCCCCCCeecccCceEEEEEEeC--CCcEEEEEEeecccc--hhhhhHHHHHHHHhcC---CCCcceeEEeeec-----c
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG--RALKGFDVECEMMKSI---RHRNLIKVISTCS-----N  240 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~~~~~~~-----~  240 (470)
                      ++|++.+.||+|+||.||+|+..  +++.||+|.+.....  .....+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36889999999999999999752  468899999865432  2233455677777665   6999999999874     3


Q ss_pred             CCeeeEEEecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecc
Q 040392          241 EEFKALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSI  319 (470)
Q Consensus       241 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  319 (470)
                      ....++||||++ ++|.+++.... ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            456889999996 59999886543 45789999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhh-cCCc--
Q 040392          320 AKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDW-LPIS--  396 (470)
Q Consensus       320 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~--  396 (470)
                      +......   .......+++.|+|||.+.+..++.++|||||||++|||++|+.||......+ .+....... .+..  
T Consensus       157 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~~~~~~~~~  232 (290)
T cd07862         157 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEED  232 (290)
T ss_pred             eEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhh
Confidence            9765322   22234568999999999988889999999999999999999999998643221 111111100 0000  


Q ss_pred             cccc--ccccccCchh--hhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          397 TMEV--VGANLLSQED--IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       397 ~~~~--~~~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ....  ..........  ........++..+.+++.+||+.||++|||+.|+++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            0000  0000000000  0000112346678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.4e-39  Score=310.06  Aligned_cols=260  Identities=23%  Similarity=0.380  Sum_probs=209.6

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCC-----CcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeecc-CCee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGD-----GMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSN-EEFK  244 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~~~~  244 (470)
                      .++|.+.+.||+|+||.||+|.+.+     +..|++|.+.... ......+..|+.+++.++|+||+++++++.. ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            5678899999999999999998755     6889999886442 3445667889999999999999999998765 5678


Q ss_pred             eEEEecCCCCChHHhhhcCC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeee
Q 040392          245 ALVLEYMPHGSLEKYMYSSN-------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF  317 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  317 (470)
                      ++++||+++++|.+++....       ..+++.++..++.|++.||+|||   +.+++|+||||+||+++.++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence            89999999999999986543       35889999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCc
Q 040392          318 SIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPIS  396 (470)
Q Consensus       318 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  396 (470)
                      |+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||.....  ..+..++...... 
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~~-  238 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKDGYRL-  238 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHcCCCC-
Confidence            99986643332222223345678999999988889999999999999999999 9999876422  1222222211100 


Q ss_pred             ccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          397 TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       397 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                                       ..+..++.++.+++.+||..||++|||+.|+++.|+.+..+
T Consensus       239 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         239 -----------------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             -----------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence                             01123466789999999999999999999999999998643

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.1e-40  Score=320.30  Aligned_cols=245  Identities=22%  Similarity=0.299  Sum_probs=195.1

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHH---hcCCCCcceeEEeeeccCCeeeEE
Q 040392          175 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMM---KSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      |++.+.||+|+||.||+|... +++.||||++....   ....+.+..|.+++   +.++||||+++++++......++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567889999999999999754 68999999997542   22344566666654   566899999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||+++|+|..++..  ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++...... 
T Consensus        81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~-  154 (324)
T cd05589          81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-  154 (324)
T ss_pred             EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC-
Confidence            999999999988854  35899999999999999999999   999999999999999999999999999998753221 


Q ss_pred             CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                       ........|++.|+|||.+.+..++.++|||||||++|||++|+.||......+     .........           
T Consensus       155 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~-----~~~~i~~~~-----------  217 (324)
T cd05589         155 -GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE-----VFDSIVNDE-----------  217 (324)
T ss_pred             -CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhCC-----------
Confidence             122234578999999999999899999999999999999999999997532211     111110000           


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCC-----CHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRI-----NAREIVAK  447 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~el~~~  447 (470)
                           ...+..++..+.+++.+||+.||.+||     ++.+++++
T Consensus       218 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         218 -----VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence                 001123466788999999999999999     57777665

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-40  Score=328.51  Aligned_cols=253  Identities=22%  Similarity=0.337  Sum_probs=201.4

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ++|++.+.||+|+||.||+|+.. +|+.||||++....   ......+..|+++++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47889999999999999999764 68999999997532   234456778999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++..+.....
T Consensus        81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence            9999999999997654 5899999999999999999999   99999999999999999999999999999875432110


Q ss_pred             cc------------------------------------cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCC
Q 040392          329 SM------------------------------------TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGK  372 (470)
Q Consensus       329 ~~------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~  372 (470)
                      ..                                    .....+||+.|+|||++....++.++|||||||++|||++|.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence            00                                    011246899999999999889999999999999999999999


Q ss_pred             CCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCC---HHHHHHH
Q 040392          373 KPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRIN---AREIVAK  447 (470)
Q Consensus       373 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps---~~el~~~  447 (470)
                      .||......+.  ...+..+..  ....             +....++.++.+++.+|+. +|.+|++   +.|+++|
T Consensus       237 ~Pf~~~~~~~~--~~~i~~~~~--~~~~-------------~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         237 PPFCSDNPQET--YRKIINWKE--TLQF-------------PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCCHHHH--HHHHHcCCC--ccCC-------------CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            99976432211  111111100  0000             0011235668899999997 9999998   9998875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.1e-40  Score=302.23  Aligned_cols=274  Identities=25%  Similarity=0.309  Sum_probs=206.2

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccc--hhhhhHHHHHHHHhcCCCCc-ceeEEeeeccCC-----
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRN-LIKVISTCSNEE-----  242 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~-----  242 (470)
                      ...|+.+++||+|+||+||+|+. .+|+.||+|+++....  .......+|+.+++.|+|+| |+++++++....     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            34567778899999999999974 4789999999976644  24556678999999999999 999999998766     


Q ss_pred             -eeeEEEecCCCCChHHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeec
Q 040392          243 -FKALVLEYMPHGSLEKYMYSSN---YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFS  318 (470)
Q Consensus       243 -~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  318 (470)
                       ..++|+||++. +|..++....   ..++...+..++.||+.||+|||   +++|+||||||.||+++++|.+||+|||
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccc
Confidence             78899999965 9999998766   35777889999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHh-------h
Q 040392          319 IAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWV-------N  390 (470)
Q Consensus       319 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~-------~  390 (470)
                      +|+...-  .....+..++|.+|+|||++.+. .|+...||||+||++.||++++.-|....+-..-...+.       .
T Consensus       166 lAra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  166 LARAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK  243 (323)
T ss_pred             hHHHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence            9986532  22334567899999999998886 699999999999999999999988776433111111000       0


Q ss_pred             hhcCCcccccccccccCchhhhh--HhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH--HHHH
Q 040392          391 DWLPISTMEVVGANLLSQEDIHF--VAKEQCVSCVFNLAMECTVESPEQRINAREIVAK--LLKI  451 (470)
Q Consensus       391 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~--L~~i  451 (470)
                      .|.........+..-......+.  ...........+++.+|++.+|.+|.|++.++.|  +..+
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence            11111111111110000000000  0011112467899999999999999999999998  6555

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.5e-39  Score=323.17  Aligned_cols=260  Identities=24%  Similarity=0.386  Sum_probs=206.1

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCC-CCcceeEEeeeccCC
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIR-HRNLIKVISTCSNEE  242 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~  242 (470)
                      ..++|.+.+.||+|+||.||+|++.      .+..||+|++.... ....+.+..|++++.++. ||||+++++++....
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            3456888899999999999999853      34689999997543 233456888999999997 999999999999989


Q ss_pred             eeeEEEecCCCCChHHhhhcCC----------------------------------------------------------
Q 040392          243 FKALVLEYMPHGSLEKYMYSSN----------------------------------------------------------  264 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  264 (470)
                      ..++||||+++|+|.+++....                                                          
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            9999999999999999986432                                                          


Q ss_pred             ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCee
Q 040392          265 ---------------------------------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVL  305 (470)
Q Consensus       265 ---------------------------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nil  305 (470)
                                                             ..+++.....++.|++.||+|||   +.+++||||||+||+
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiL  271 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVL  271 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEE
Confidence                                                   13566778889999999999999   999999999999999


Q ss_pred             eCCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcch
Q 040392          306 LDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT  384 (470)
Q Consensus       306 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~  384 (470)
                      ++.++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+..
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~  351 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF  351 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence            99999999999999986533222222233456788999999988889999999999999999998 88998754322211


Q ss_pred             hhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHH
Q 040392          385 LKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR  452 (470)
Q Consensus       385 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~  452 (470)
                       ...+....                  ....+..++.++.+++.+||..+|++||++.||++.|+++.
T Consensus       352 -~~~~~~~~------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         352 -YNAIKRGY------------------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             -HHHHHcCC------------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence             11111000                  00112234677999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.1e-39  Score=318.35  Aligned_cols=252  Identities=23%  Similarity=0.298  Sum_probs=199.1

Q ss_pred             CCCCCCeecccCceEEEEEEe----CCCcEEEEEEeeccc----chhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCee
Q 040392          174 GFSENNLIGRGGFGSVYKARL----GDGMEVAVKVFNLQC----GRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFK  244 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~  244 (470)
                      +|++.+.||+|+||.||+++.    .+++.||+|++....    ....+.+..|+++++.+ .|+||+++++++......
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            478889999999999999975    358899999986432    23345677899999999 499999999999999999


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccC
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~  324 (470)
                      ++||||+++|+|.+++.... .+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            99999999999999986544 5889999999999999999999   9999999999999999999999999999997653


Q ss_pred             CCCCcccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccc
Q 040392          325 GEDQSMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA  403 (470)
Q Consensus       325 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (470)
                      ..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ...........      ++
T Consensus       157 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~~------~~  228 (332)
T cd05614         157 SEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRILKC------DP  228 (332)
T ss_pred             ccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHHhcC------CC
Confidence            32221 22245689999999998765 478899999999999999999999975322211 11111111000      00


Q ss_pred             cccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCC-----CHHHHHHH
Q 040392          404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRI-----NAREIVAK  447 (470)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~el~~~  447 (470)
                                ..+...+..+.+++.+||+.||++||     ++++++++
T Consensus       229 ----------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         229 ----------PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             ----------CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence                      01122356688999999999999999     77888876

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.9e-40  Score=334.49  Aligned_cols=254  Identities=22%  Similarity=0.295  Sum_probs=204.4

Q ss_pred             hhCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCC-----
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEE-----  242 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-----  242 (470)
                      ..++|.+.+.||+|+||+||+|+. .+|+.||||++...  .......+..|+.++..++|+||++++..+...+     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            457899999999999999999974 46999999998654  2344556788999999999999999987764322     


Q ss_pred             ---eeeEEEecCCCCChHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEee
Q 040392          243 ---FKALVLEYMPHGSLEKYMYSS---NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSD  316 (470)
Q Consensus       243 ---~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~D  316 (470)
                         ..++||||+++|+|.+++...   ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEEe
Confidence               367999999999999998653   246889999999999999999999   99999999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc
Q 040392          317 FSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS  396 (470)
Q Consensus       317 fg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  396 (470)
                      ||+++.+.............||+.|+|||++.+..++.++||||||+++|||++|+.||.....     ...........
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-----~~~~~~~~~~~  261 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-----EEVMHKTLAGR  261 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHhcCC
Confidence            9999876433222233446799999999999999999999999999999999999999975321     11211111110


Q ss_pred             ccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          397 TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       397 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ..               ..+..++.++.+++.+||+.||.+||++.+++++
T Consensus       262 ~~---------------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        262 YD---------------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CC---------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            00               0122346778999999999999999999999875

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-40  Score=324.41  Aligned_cols=244  Identities=23%  Similarity=0.309  Sum_probs=202.8

Q ss_pred             HhhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCee
Q 040392          170 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFK  244 (470)
Q Consensus       170 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~  244 (470)
                      ...++|...+.||+|+||+|+++..+ +++.+|||++++..   ....+....|.+++... +||.++.++++|...++.
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            34578999999999999999999754 58899999998763   45566777898888877 599999999999999999


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccC
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~  324 (470)
                      ++||||+.||++..+.  ....+++..+.-++..++.||+|||   +++|||||||.+|||+|.+|++||+|||+++.-.
T Consensus       445 ~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m  519 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM  519 (694)
T ss_pred             EEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccC
Confidence            9999999999954443  3346899999999999999999999   9999999999999999999999999999998643


Q ss_pred             CCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccc
Q 040392          325 GEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN  404 (470)
Q Consensus       325 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (470)
                      .  .....+..+||+.|+|||++.+..|+.++|-|||||+||||+.|..||.+....+ -+...                
T Consensus       520 ~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-~FdsI----------------  580 (694)
T KOG0694|consen  520 G--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-VFDSI----------------  580 (694)
T ss_pred             C--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHH----------------
Confidence            2  2335567899999999999999999999999999999999999999998633222 11111                


Q ss_pred             ccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCH
Q 040392          405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINA  441 (470)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~  441 (470)
                      +..+    ...|..++.+..+++.++|..+|++|..+
T Consensus       581 ~~d~----~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  581 VNDE----VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             hcCC----CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            1110    11234557889999999999999999966

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.5e-39  Score=308.41  Aligned_cols=254  Identities=26%  Similarity=0.449  Sum_probs=198.6

Q ss_pred             CCCCCeecccCceEEEEEEeCC-Cc--EEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccC------Ce
Q 040392          175 FSENNLIGRGGFGSVYKARLGD-GM--EVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNE------EF  243 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~------~~  243 (470)
                      +.+.+.||+|+||.||+|.+.+ +.  .+|+|.++..  .......+..|+++++.++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3467889999999999998654 32  6899988654  234456788899999999999999999987432      24


Q ss_pred             eeEEEecCCCCChHHhhhc-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeec
Q 040392          244 KALVLEYMPHGSLEKYMYS-----SNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFS  318 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  318 (470)
                      .+++|||+++|+|.+++..     ....+++.....++.|++.||+|||   +++|+||||||+||++++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence            6899999999999988742     2245789999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcc
Q 040392          319 IAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPIST  397 (470)
Q Consensus       319 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  397 (470)
                      ++..+.............++..|+|||...+..++.++||||||+++|||++ |+.||......  .+...+...   ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~---~~  232 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYDYLRQG---NR  232 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcC---CC
Confidence            9987643322222223346778999999998899999999999999999999 88888653221  111111110   00


Q ss_pred             cccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          398 MEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                                     ...+..++..+.+++.+||+.||++|||+.++++.|+++
T Consensus       233 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         233 ---------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                           001123466789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.8e-40  Score=314.35  Aligned_cols=254  Identities=24%  Similarity=0.410  Sum_probs=202.9

Q ss_pred             CCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccch-hhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeE
Q 040392          174 GFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  246 (470)
                      +|.+.+.||+|+||.||+|+..      ++..||+|++...... ....+..|+.+++.++||||+++++++......++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4677789999999999999753      2578999998754332 34567889999999999999999999999999999


Q ss_pred             EEecCCCCChHHhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC
Q 040392          247 VLEYMPHGSLEKYMYSS---------------NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV  311 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~  311 (470)
                      ++||+++++|.+++...               ...+++..+..++.|++.||+|||   +++++||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCc
Confidence            99999999999998532               134778888999999999999999   999999999999999999999


Q ss_pred             eEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhh
Q 040392          312 AHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVN  390 (470)
Q Consensus       312 ~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~  390 (470)
                      +||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |..||......     .+..
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~  237 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-----DVIE  237 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHH
Confidence            99999999886543332222233446788999999988889999999999999999998 88887653221     1111


Q ss_pred             hhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHH
Q 040392          391 DWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK  450 (470)
Q Consensus       391 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~  450 (470)
                      .......               ...+..++..+.+++..||+.+|++||++.+|++.|+.
T Consensus       238 ~i~~~~~---------------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         238 MIRNRQV---------------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHcCCc---------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            1111110               01123457779999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.4e-40  Score=320.24  Aligned_cols=242  Identities=22%  Similarity=0.290  Sum_probs=196.1

Q ss_pred             CeecccCceEEEEEEe-CCCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCCC
Q 040392          179 NLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHG  254 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g  254 (470)
                      +.||+|+||.||+++. .+|+.||+|++....   ......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999975 468999999987542   234456678999999999999999999999999999999999999


Q ss_pred             ChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccccc
Q 040392          255 SLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  333 (470)
Q Consensus       255 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  333 (470)
                      +|..++.... .+++..+..++.|++.||+|||   + .+|+||||||+||+++.++.+||+|||++.......  ....
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~  154 (325)
T cd05594          81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMK  154 (325)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cccc
Confidence            9998886544 6889999999999999999999   7 799999999999999999999999999987543221  1223


Q ss_pred             ccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhh
Q 040392          334 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF  413 (470)
Q Consensus       334 ~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  413 (470)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......+  ....+.   ....                
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~--~~~~i~---~~~~----------------  213 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELIL---MEEI----------------  213 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH--HHHHHh---cCCC----------------
Confidence            3568999999999998899999999999999999999999997532211  111100   0000                


Q ss_pred             HhhhhhHHHHHHHHhhccCCCccCCC-----CHHHHHHH
Q 040392          414 VAKEQCVSCVFNLAMECTVESPEQRI-----NAREIVAK  447 (470)
Q Consensus       414 ~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~el~~~  447 (470)
                      ..+...+.++.+++.+||+.||++|+     ++.++++|
T Consensus       214 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         214 RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            00122356788999999999999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=8e-40  Score=323.19  Aligned_cols=254  Identities=22%  Similarity=0.316  Sum_probs=197.0

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ++|++.+.||+|+||+||+|... +++.||+|++....   ......+..|+.++..++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47889999999999999999754 58999999997532   233456778999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence            9999999999997654 6899999999999999999999   99999999999999999999999999999875432110


Q ss_pred             c---------------------------------ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q 040392          329 S---------------------------------MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPT  375 (470)
Q Consensus       329 ~---------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~  375 (470)
                      .                                 ......+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence            0                                 0012347999999999999989999999999999999999999999


Q ss_pred             CccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccC--CCccCCCCHHHHHHH
Q 040392          376 NEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTV--ESPEQRINAREIVAK  447 (470)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~--~dP~~Rps~~el~~~  447 (470)
                      ......+ .... +..+..  ... +            +.....+.++.+++.+++.  .++..||++.|+++|
T Consensus       237 ~~~~~~~-~~~~-i~~~~~--~~~-~------------p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         237 CSETPQE-TYKK-VMNWKE--TLI-F------------PPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCHHH-HHHH-HHcCcC--ccc-C------------CCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            7632211 1111 110000  000 0            0001124556777777543  234456899999987

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-40  Score=306.24  Aligned_cols=270  Identities=26%  Similarity=0.401  Sum_probs=209.3

Q ss_pred             HHhhCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcC--CCCcceeEEeeeccC----C
Q 040392          169 CRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSI--RHRNLIKVISTCSNE----E  242 (470)
Q Consensus       169 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~nIv~~~~~~~~~----~  242 (470)
                      .....+....+.||+|.||.||+|+|. |+.||||+|..   .+.+.+.+|.++.+..  +|+||+.|++.-..+    .
T Consensus       207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T  282 (513)
T KOG2052|consen  207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT  282 (513)
T ss_pred             HhhhheeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence            344566788899999999999999995 99999999974   3445677888888864  999999999875433    3


Q ss_pred             eeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc-----CCCCCeeecCCCCCCeeeCCCCCeEEeee
Q 040392          243 FKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF-----GYSAPIIHCDLKPSNVLLDDNMVAHLSDF  317 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~-----~~~~~i~H~dlkp~Nill~~~~~~kl~Df  317 (470)
                      ..+||++|.+.|||.||+..  ..++....++++..+|.||++||.     .....|.|||||..|||+..++.+.|+|+
T Consensus       283 QLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  283 QLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             EEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence            66899999999999999976  468999999999999999999994     34567999999999999999999999999


Q ss_pred             ccccccCCCC--CcccccccccCccccCccccCCCC------CCCccchhhHHHHHHHHHhCC----------CCCCccc
Q 040392          318 SIAKLLTGED--QSMTQTQTLATIGYMAPEYGREGR------VSTNGDVYSFGIMLMETFTGK----------KPTNEIF  379 (470)
Q Consensus       318 g~a~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~------~~~~~DvwslGv~l~el~tg~----------~p~~~~~  379 (470)
                      |+|.......  ........+||-+|||||++...-      .-..+||||||.++||+..+.          .||.+..
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V  440 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV  440 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence            9998775432  223445678999999999986532      123589999999999998654          4555554


Q ss_pred             cCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          380 NGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                      +...++.++.         +++--+.+.......+....+...+.++|+.||..||..|.||-.+.+.|.++..
T Consensus       441 p~DPs~eeMr---------kVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  441 PSDPSFEEMR---------KVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCCCCHHHHh---------cceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            4433333322         1221122222233334445567789999999999999999999999999999863

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1e-39  Score=315.22  Aligned_cols=260  Identities=27%  Similarity=0.423  Sum_probs=206.4

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC--------CCcEEEEEEeeccc-chhhhhHHHHHHHHhcC-CCCcceeEEeeeccC
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG--------DGMEVAVKVFNLQC-GRALKGFDVECEMMKSI-RHRNLIKVISTCSNE  241 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~  241 (470)
                      .++|.+.+.||+|+||.||+|+..        ++..+|+|.+.... ......+..|+++++.+ +|+||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            357899999999999999999742        23579999987542 33456678899999999 799999999999999


Q ss_pred             CeeeEEEecCCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 040392          242 EFKALVLEYMPHGSLEKYMYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL  306 (470)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill  306 (470)
                      ...++||||+++|+|.+++....               ..+++.+++.++.|++.||+|||   +.+++|+||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEE
Confidence            99999999999999999997542               24788899999999999999999   8999999999999999


Q ss_pred             CCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchh
Q 040392          307 DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTL  385 (470)
Q Consensus       307 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~  385 (470)
                      +.++.+||+|||.+................++..|+|||.+.+..++.++||||||+++|||++ |..||......  .+
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~--~~  251 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--EL  251 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HH
Confidence            9999999999999876532221111122234568999999988889999999999999999998 88888653211  11


Q ss_pred             hHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          386 KHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                      ...+....                  ....+..++.++.+++.+||..+|++||++.++++.|.++...
T Consensus       252 ~~~~~~~~------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         252 FKLLKEGH------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             HHHHHcCC------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence            11111000                  0011223467789999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-39  Score=311.14  Aligned_cols=262  Identities=24%  Similarity=0.385  Sum_probs=202.2

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCC---------------CcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGD---------------GMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVI  235 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~  235 (470)
                      .++|++.+.||+|+||.||++....               ...||+|.+.... ......+.+|++++++++|+|+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3578999999999999999986532               2348999987542 33445688899999999999999999


Q ss_pred             eeeccCCeeeEEEecCCCCChHHhhhcCC-----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 040392          236 STCSNEEFKALVLEYMPHGSLEKYMYSSN-----------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNV  304 (470)
Q Consensus       236 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Ni  304 (470)
                      +++......++||||+++++|.+++....           ..+++..++.++.|++.||+|||   +.+++|+||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhE
Confidence            99999999999999999999999986432           23678889999999999999999   99999999999999


Q ss_pred             eeCCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh--CCCCCCccccCc
Q 040392          305 LLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT--GKKPTNEIFNGE  382 (470)
Q Consensus       305 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t--g~~p~~~~~~~~  382 (470)
                      +++.++.+||+|||++................++..|+|||...++.++.++||||||+++|||++  |..||......+
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            999999999999999876543322222233345778999999988889999999999999999998  566776533221


Q ss_pred             chhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHH
Q 040392          383 MTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLL  449 (470)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~  449 (470)
                       ........+........            ...+..++..+.+++.+||+.||++||++.+|++.|+
T Consensus       241 -~~~~~~~~~~~~~~~~~------------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 -VIENTGEFFRNQGRQIY------------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             -HHHHHHHhhhhcccccc------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence             11111111100000000            0011223567999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-42  Score=298.97  Aligned_cols=252  Identities=22%  Similarity=0.363  Sum_probs=205.3

Q ss_pred             hCCCCCCCeecccCceEEEEE-EeCCCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~-~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      .++|++.+.||+|.|+.||+. ...+|+.+|+|++..+  .....+.+.+|++|-+.|+||||+++...+.+....|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            467888899999999999998 4567999999998644  3446677889999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC---CCCCeEEeeeccccccCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~a~~~~~  325 (470)
                      |+|.|++|..-+-.. ...++..+-+.+.||+++|.|+|   .++|+|||+||+|+++.   ....+||+|||+|..+.+
T Consensus        90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~  165 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND  165 (355)
T ss_pred             ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence            999999996555433 45788888999999999999999   99999999999999994   455799999999998762


Q ss_pred             CCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          326 EDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       326 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                         .......+||++|||||++...+|+..+|||+-||+||-|+.|+.||.+..+... +...+....            
T Consensus       166 ---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl-ye~I~~g~y------------  229 (355)
T KOG0033|consen  166 ---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-YEQIKAGAY------------  229 (355)
T ss_pred             ---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH-HHHHhcccc------------
Confidence               3344567899999999999999999999999999999999999999987433221 111111111            


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                          ..........+++..+|+++||..||.+|.|+.|.++|
T Consensus       230 ----d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  230 ----DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             ----CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence                11111123346678899999999999999999998865

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.6e-40  Score=303.51  Aligned_cols=253  Identities=28%  Similarity=0.378  Sum_probs=207.7

Q ss_pred             CCCCCCCeecccCceEEEEEEeCC-CcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      +.|+.++.||+|.-|+||.++..+ +..+|+|++++..   .+...+...|.+||+.+.||.++.+|+.++.+.+.+++|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            457778999999999999998754 5889999998653   445667888999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC--
Q 040392          249 EYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG--  325 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~--  325 (470)
                      |||+||+|..+.++.. ..+++..+.-++.+++-||+|||   ..|||+|||||+|||+.++|++.|+||.++.....  
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            9999999999987655 56899999999999999999999   99999999999999999999999999998643210  


Q ss_pred             -------------------------------CCC---------------------cccccccccCccccCccccCCCCCC
Q 040392          326 -------------------------------EDQ---------------------SMTQTQTLATIGYMAPEYGREGRVS  353 (470)
Q Consensus       326 -------------------------------~~~---------------------~~~~~~~~~t~~y~aPE~~~~~~~~  353 (470)
                                                     ...                     .....+.+||-.|.|||++.+...+
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg  313 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG  313 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence                                           000                     0111245789999999999999999


Q ss_pred             CccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCC
Q 040392          354 TNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVE  433 (470)
Q Consensus       354 ~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  433 (470)
                      .++|-|+|||++|||+.|..||.+..+.+ .+...+...+                  .++.....+..+.+||++.|.+
T Consensus       314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~-Tl~NIv~~~l------------------~Fp~~~~vs~~akDLIr~LLvK  374 (459)
T KOG0610|consen  314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKE-TLRNIVGQPL------------------KFPEEPEVSSAAKDLIRKLLVK  374 (459)
T ss_pred             chhhHHHHHHHHHHHHhCCCCcCCCCchh-hHHHHhcCCC------------------cCCCCCcchhHHHHHHHHHhcc
Confidence            99999999999999999999999854443 3333222111                  1111123367789999999999


Q ss_pred             CccCCCC----HHHHHHH
Q 040392          434 SPEQRIN----AREIVAK  447 (470)
Q Consensus       434 dP~~Rps----~~el~~~  447 (470)
                      ||.+|..    |.||.+|
T Consensus       375 dP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  375 DPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             ChhhhhccccchHHhhcC
Confidence            9999998    8888765

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=6e-39  Score=303.17  Aligned_cols=258  Identities=23%  Similarity=0.342  Sum_probs=208.7

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ++|++.+.||+|++|.||+|... +|+.||+|.++..   .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57899999999999999999866 7999999988642   2234567888999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC
Q 040392          249 EYMPHGSLEKYMYS---SNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       249 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  325 (470)
                      ||+++|+|.+++..   ....+++.++..++.+++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999998864   2345789999999999999999999   99999999999999999999999999999876533


Q ss_pred             CCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          326 EDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       326 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      ..  .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.....   ....+.........        
T Consensus       159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~--------  225 (267)
T cd08224         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKKIEKCDY--------  225 (267)
T ss_pred             CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc---cHHHHHhhhhcCCC--------
Confidence            21  112234578889999999888899999999999999999999999864321   11111111110000        


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR  452 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~  452 (470)
                       ..     .....++.++.+++.+||..+|++||++.+|++.|+++.
T Consensus       226 -~~-----~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         226 -PP-----LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             -CC-----CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence             00     001134667899999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.3e-39  Score=314.10  Aligned_cols=260  Identities=27%  Similarity=0.419  Sum_probs=207.7

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC--------CCcEEEEEEeeccc-chhhhhHHHHHHHHhcC-CCCcceeEEeeeccC
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG--------DGMEVAVKVFNLQC-GRALKGFDVECEMMKSI-RHRNLIKVISTCSNE  241 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~  241 (470)
                      .++|.+.+.||+|+||.||+|+..        ++..||+|.+.... ......+..|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            467888999999999999999631        24579999986442 34456788999999999 899999999999999


Q ss_pred             CeeeEEEecCCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 040392          242 EFKALVLEYMPHGSLEKYMYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL  306 (470)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill  306 (470)
                      ...++||||+++|+|.+++....               ..+++.++..++.|+++||.|||   +.+++|+||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence            99999999999999999997532               24678889999999999999999   9999999999999999


Q ss_pred             CCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchh
Q 040392          307 DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTL  385 (470)
Q Consensus       307 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~  385 (470)
                      +.++.+||+|||.++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......    
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----  246 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----  246 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH----
Confidence            9999999999999987643332222233445678999999988889999999999999999998 78887653211    


Q ss_pred             hHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          386 KHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                       .+.........               ...+..++.++.+++.+||+.+|.+||++.|+++.|+++...
T Consensus       247 -~~~~~~~~~~~---------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         247 -ELFKLLKEGHR---------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             -HHHHHHHcCCc---------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence             11111100000               001224567799999999999999999999999999998643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=8.4e-40  Score=318.10  Aligned_cols=247  Identities=22%  Similarity=0.255  Sum_probs=197.1

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCC-cceeEEeeeccCCeeeEEE
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHR-NLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~-nIv~~~~~~~~~~~~~lv~  248 (470)
                      +|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+..|.+++..+.|+ +|+++++++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788899999999999999765 57899999987542   23455677899999999765 5888999999899999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||++....... 
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-  155 (324)
T cd05587          81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-  155 (324)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-
Confidence            9999999999986544 5788999999999999999999   9999999999999999999999999999987432111 


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                       .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+  ....+..   ...           
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~~~~i~~---~~~-----------  218 (324)
T cd05587         156 -KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--LFQSIME---HNV-----------  218 (324)
T ss_pred             -CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HHHHHHc---CCC-----------
Confidence             12234568999999999999899999999999999999999999997543211  1111110   000           


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCH-----HHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINA-----REIVAK  447 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~el~~~  447 (470)
                           ..+...+.++.+++.+||..||.+|++.     .+++++
T Consensus       219 -----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         219 -----SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             -----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                 0011235668899999999999999976     666654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.4e-39  Score=304.87  Aligned_cols=253  Identities=27%  Similarity=0.461  Sum_probs=203.7

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      .++|++.+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++.. ...+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEec
Confidence            357889999999999999999988888999999875432 34568899999999999999999998854 4578999999


Q ss_pred             CCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          252 PHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       252 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      ++++|.+++.+.. ..+++.++..++.|++.||.|||   +.+++|+||||+||++++++.++|+|||++..+...... 
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence            9999999997643 45799999999999999999999   899999999999999999999999999999865432211 


Q ss_pred             cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCch
Q 040392          331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE  409 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (470)
                      ......++..|+|||...+..++.++|+||||+++|||++ |..||......+  .........+.              
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~~~~--------------  222 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE--VLEQVERGYRM--------------  222 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHcCCCC--------------
Confidence            1122335668999999988889999999999999999999 888987533221  11111110000              


Q ss_pred             hhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHH
Q 040392          410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK  450 (470)
Q Consensus       410 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~  450 (470)
                          ..+...+..+.+++.+||..+|++|||+.++.+.|++
T Consensus       223 ----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         223 ----PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             ----CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                0112335678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-39  Score=322.28  Aligned_cols=264  Identities=20%  Similarity=0.195  Sum_probs=198.6

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      .++|.+.+.||+|+||.||++.. .+++.||+|...      ...+.+|+++++.++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            35799999999999999999975 468899999753      23467899999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      +. ++|..++.... .+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++....... ..
T Consensus       165 ~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~  238 (391)
T PHA03212        165 YK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-AN  238 (391)
T ss_pred             CC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-cc
Confidence            95 68988886543 5789999999999999999999   8999999999999999999999999999997543211 11


Q ss_pred             cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccC------cchhhHHhhhhc--CCccc----
Q 040392          331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNG------EMTLKHWVNDWL--PISTM----  398 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~------~~~~~~~~~~~~--~~~~~----  398 (470)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||......      ...+...+....  +....    
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~  318 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ  318 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence            223457999999999999889999999999999999999999886542211      111111111100  00000    


Q ss_pred             cccc-------cc--ccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          399 EVVG-------AN--LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       399 ~~~~-------~~--~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ...+       ..  ........+......+.++.+++.+||+.||++|||+.|++++
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            0000       00  0000000011112346678999999999999999999999864

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=8.4e-40  Score=316.82  Aligned_cols=241  Identities=24%  Similarity=0.291  Sum_probs=190.8

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhc-CCCCcceeEEeeeccCCeeeEEEecCCC
Q 040392          179 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKS-IRHRNLIKVISTCSNEEFKALVLEYMPH  253 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~nIv~~~~~~~~~~~~~lv~e~~~~  253 (470)
                      +.||+|+||.||+|+.. +++.||+|+++...   ....+....|..++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999764 57899999987542   2233445556666665 4899999999999999999999999999


Q ss_pred             CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccccc
Q 040392          254 GSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  333 (470)
Q Consensus       254 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  333 (470)
                      |+|.+++.... .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++.......  ....
T Consensus        81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~  154 (316)
T cd05592          81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence            99999986544 5889999999999999999999   8999999999999999999999999999997543222  2223


Q ss_pred             ccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhh
Q 040392          334 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF  413 (470)
Q Consensus       334 ~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  413 (470)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......+  +..-+..   ..                .
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~--~~~~i~~---~~----------------~  213 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE--LFDSILN---DR----------------P  213 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHc---CC----------------C
Confidence            4568999999999998899999999999999999999999997643211  1110000   00                0


Q ss_pred             HhhhhhHHHHHHHHhhccCCCccCCCCHH-HHHH
Q 040392          414 VAKEQCVSCVFNLAMECTVESPEQRINAR-EIVA  446 (470)
Q Consensus       414 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-el~~  446 (470)
                      ..+..++.++.+++.+||+.||++||++. ++++
T Consensus       214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            01122356688999999999999999875 5554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.3e-39  Score=317.49  Aligned_cols=260  Identities=24%  Similarity=0.406  Sum_probs=202.8

Q ss_pred             hCCCCCCCeecccCceEEEEEEe------CCCcEEEEEEeeccc-chhhhhHHHHHHHHhcC-CCCcceeEEeeeccC-C
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQC-GRALKGFDVECEMMKSI-RHRNLIKVISTCSNE-E  242 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~-~  242 (470)
                      .++|++.+.||+|+||.||+|.+      .+++.||||.++... ......+..|+.++.++ +|+||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            46799999999999999999963      347889999987543 23445678899999999 689999999987654 4


Q ss_pred             eeeEEEecCCCCChHHhhhcCC----------------------------------------------------------
Q 040392          243 FKALVLEYMPHGSLEKYMYSSN----------------------------------------------------------  264 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  264 (470)
                      ..+++|||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6789999999999999986432                                                          


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccccccc
Q 040392          265 --------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL  336 (470)
Q Consensus       265 --------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  336 (470)
                              ..+++..+..++.|+++||+|||   +++++||||||+||+++.++.+||+|||++................
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                    13577788899999999999999   9999999999999999999999999999988653322222222334


Q ss_pred             cCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHh
Q 040392          337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVA  415 (470)
Q Consensus       337 ~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  415 (470)
                      ++..|+|||.+.+..++.++||||||+++|||++ |..||......+. ....+......                  ..
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~~~~~------------------~~  303 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLKEGTRM------------------RA  303 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-HHHHHhccCCC------------------CC
Confidence            5678999999988889999999999999999997 8999875432211 11111100000                  00


Q ss_pred             hhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          416 KEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       416 ~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                      +...+.++.+++..||+.+|++||++.|++++|+.+..
T Consensus       304 ~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            11224568899999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-40  Score=327.66  Aligned_cols=253  Identities=22%  Similarity=0.323  Sum_probs=198.5

Q ss_pred             CCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ++|.+.+.||+|+||.||++.. .+++.||+|++....   ......+..|+++++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4688999999999999999975 468999999986432   234556788999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus        81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            9999999999997544 5788899999999999999999   99999999999999999999999999999864321100


Q ss_pred             c---------------------------------------------ccccccccCccccCccccCCCCCCCccchhhHHH
Q 040392          329 S---------------------------------------------MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGI  363 (470)
Q Consensus       329 ~---------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv  363 (470)
                      .                                             ......+||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  236 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence            0                                             0001246899999999999889999999999999


Q ss_pred             HHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCC---CC
Q 040392          364 MLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQR---IN  440 (470)
Q Consensus       364 ~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---ps  440 (470)
                      ++|||++|+.||......+ .+.... .+  .......             ....++.++.+++.+|+. +|.+|   ++
T Consensus       237 il~elltG~~Pf~~~~~~~-~~~~i~-~~--~~~~~~p-------------~~~~~s~~~~dli~~lL~-~~~~r~~r~~  298 (377)
T cd05629         237 IMFECLIGWPPFCSENSHE-TYRKII-NW--RETLYFP-------------DDIHLSVEAEDLIRRLIT-NAENRLGRGG  298 (377)
T ss_pred             hhhhhhcCCCCCCCCCHHH-HHHHHH-cc--CCccCCC-------------CCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence            9999999999997533211 111111 00  0000000             011235668899999997 77765   59


Q ss_pred             HHHHHHH
Q 040392          441 AREIVAK  447 (470)
Q Consensus       441 ~~el~~~  447 (470)
                      +.|++.+
T Consensus       299 ~~~~l~h  305 (377)
T cd05629         299 AHEIKSH  305 (377)
T ss_pred             HHHHhcC
Confidence            9999887

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=7.1e-40  Score=317.93  Aligned_cols=242  Identities=25%  Similarity=0.298  Sum_probs=194.1

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCeeeEEEecCCC
Q 040392          179 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMPH  253 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~  253 (470)
                      +.||+|+||.||+|+.+ +++.||+|++....   ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999865 58899999987532   23445567788888776 699999999999999999999999999


Q ss_pred             CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccccc
Q 040392          254 GSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  333 (470)
Q Consensus       254 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  333 (470)
                      |+|.+++.... .+++..+..++.|++.||+|||   +++++||||||+||+++.++.+||+|||++.......  ....
T Consensus        81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~  154 (320)
T cd05590          81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTS  154 (320)
T ss_pred             chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cccc
Confidence            99999886554 5889999999999999999999   9999999999999999999999999999987542211  2223


Q ss_pred             ccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhh
Q 040392          334 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF  413 (470)
Q Consensus       334 ~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  413 (470)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......+  +...   ......                
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--~~~~---i~~~~~----------------  213 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD--LFEA---ILNDEV----------------  213 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--HHHH---HhcCCC----------------
Confidence            4568999999999998899999999999999999999999997632211  1111   111000                


Q ss_pred             HhhhhhHHHHHHHHhhccCCCccCCCCH------HHHHHH
Q 040392          414 VAKEQCVSCVFNLAMECTVESPEQRINA------REIVAK  447 (470)
Q Consensus       414 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~------~el~~~  447 (470)
                      ..+...+.++.+++.+||+.||++||++      .++++|
T Consensus       214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         214 VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence            0011235678899999999999999998      666554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.7e-39  Score=314.56  Aligned_cols=267  Identities=27%  Similarity=0.417  Sum_probs=209.9

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC--------CCcEEEEEEeeccc-chhhhhHHHHHHHHhcC-CCCcceeEEeeeccC
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG--------DGMEVAVKVFNLQC-GRALKGFDVECEMMKSI-RHRNLIKVISTCSNE  241 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~  241 (470)
                      .++|.+.+.||+|+||.||+|+..        ....+|+|.+.... ......+..|+++++.+ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            457889999999999999999642        24579999986442 33456678899999999 699999999999988


Q ss_pred             CeeeEEEecCCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 040392          242 EFKALVLEYMPHGSLEKYMYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL  306 (470)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill  306 (470)
                      ...+++|||+++|+|.+++....               ..+++.++..++.|++.||.|||   +.+++|+||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEE
Confidence            89999999999999999996532               34788899999999999999999   9999999999999999


Q ss_pred             CCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchh
Q 040392          307 DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTL  385 (470)
Q Consensus       307 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~  385 (470)
                      +.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......  ..
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~~  245 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--EL  245 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--HH
Confidence            9999999999999986643222211222234567999999988889999999999999999999 88888653221  11


Q ss_pred             hHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHhhhccC
Q 040392          386 KHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNVGD  461 (470)
Q Consensus       386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~~~~~~  461 (470)
                      .........                  ...+..++.++.+++.+||+.+|++||++.|+++.|.++......+..+
T Consensus       246 ~~~~~~~~~------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~  303 (314)
T cd05099         246 FKLLREGHR------------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYLD  303 (314)
T ss_pred             HHHHHcCCC------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcCCcee
Confidence            111111000                  0012234667889999999999999999999999999998665544443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.5e-39  Score=309.75  Aligned_cols=245  Identities=24%  Similarity=0.314  Sum_probs=195.1

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCCCCh
Q 040392          181 IGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL  256 (470)
Q Consensus       181 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L  256 (470)
                      ||+|+||+||++... +++.||+|.+....   ....+.+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999754 68999999986432   22335567899999999999999999999999999999999999999


Q ss_pred             HHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccccc
Q 040392          257 EKYMYS---SNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  333 (470)
Q Consensus       257 ~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  333 (470)
                      .+++..   ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++..+.....  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            888743   2346899999999999999999999   99999999999999999999999999999876543221  122


Q ss_pred             ccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhh
Q 040392          334 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF  413 (470)
Q Consensus       334 ~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  413 (470)
                      ...||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ............                .
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~----------------~  218 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRILNDS----------------V  218 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHHHhhcccC----------------C
Confidence            34689999999999999999999999999999999999999975322111 111111000000                0


Q ss_pred             HhhhhhHHHHHHHHhhccCCCccCCC-----CHHHHHHH
Q 040392          414 VAKEQCVSCVFNLAMECTVESPEQRI-----NAREIVAK  447 (470)
Q Consensus       414 ~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~el~~~  447 (470)
                      ..+..++.++.+++.+||+.||++||     ++.++++|
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            01123467789999999999999999     77888775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.1e-39  Score=316.84  Aligned_cols=242  Identities=23%  Similarity=0.282  Sum_probs=194.8

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCeeeEEEecCCC
Q 040392          179 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMPH  253 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~  253 (470)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999765 57899999987542   23345566788888866 799999999999999999999999999


Q ss_pred             CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccccc
Q 040392          254 GSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  333 (470)
Q Consensus       254 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  333 (470)
                      |+|..++.... .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++.......  ....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~  154 (321)
T cd05591          81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTT  154 (321)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCC--cccc
Confidence            99998886554 5788999999999999999999   9999999999999999999999999999987543221  2223


Q ss_pred             ccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhh
Q 040392          334 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF  413 (470)
Q Consensus       334 ~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  413 (470)
                      ...||+.|+|||++.+..++.++||||||+++|||++|+.||......+  ...   .......                
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~--~~~---~i~~~~~----------------  213 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD--LFE---SILHDDV----------------  213 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH--HHH---HHHcCCC----------------
Confidence            4568999999999998899999999999999999999999997643211  111   1110000                


Q ss_pred             HhhhhhHHHHHHHHhhccCCCccCCC-------CHHHHHHH
Q 040392          414 VAKEQCVSCVFNLAMECTVESPEQRI-------NAREIVAK  447 (470)
Q Consensus       414 ~~~~~~~~~l~~l~~~cl~~dP~~Rp-------s~~el~~~  447 (470)
                      ..+..++.++.+++.+||+.||++||       ++.+++++
T Consensus       214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            00112356788999999999999999       88888866

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.1e-39  Score=315.77  Aligned_cols=248  Identities=22%  Similarity=0.275  Sum_probs=194.8

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCeeeEEEecCCC
Q 040392          179 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CGRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMPH  253 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~  253 (470)
                      +.||+|+||.||+|+.. +++.||+|++...   .......+..|..++..+ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999764 5889999998754   223445577788888776 799999999999999999999999999


Q ss_pred             CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccccc
Q 040392          254 GSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  333 (470)
Q Consensus       254 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  333 (470)
                      |+|..++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~  154 (329)
T cd05618          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTS  154 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cccc
Confidence            99998886543 6899999999999999999999   9999999999999999999999999999987532211  1223


Q ss_pred             ccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccC---cchhhHHhhhhcCCcccccccccccCchh
Q 040392          334 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNG---EMTLKHWVNDWLPISTMEVVGANLLSQED  410 (470)
Q Consensus       334 ~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (470)
                      ...||..|+|||++.+..++.++||||||+++|||++|+.||......   ......+.........             
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-------------  221 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-------------  221 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC-------------
Confidence            456899999999999999999999999999999999999999642211   1111111111100000             


Q ss_pred             hhhHhhhhhHHHHHHHHhhccCCCccCCCC------HHHHHHH
Q 040392          411 IHFVAKEQCVSCVFNLAMECTVESPEQRIN------AREIVAK  447 (470)
Q Consensus       411 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps------~~el~~~  447 (470)
                        ...+..++.++.+++.+||+.||++||+      +.++++|
T Consensus       222 --~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         222 --IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             --CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence              0012234667889999999999999998      4677665

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2e-39  Score=306.76  Aligned_cols=257  Identities=26%  Similarity=0.483  Sum_probs=206.3

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CC---cEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DG---MEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  246 (470)
                      .++|+..+.||+|+||.||+|+.. ++   ..+|+|.+.... ....+.+..|+++++.++|+||+++++++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            456888899999999999999864 23   379999986542 3345678889999999999999999999999999999


Q ss_pred             EEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCC
Q 040392          247 VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      ||||+++++|.+++......+++.++..++.|++.|++|||   +.+++|+||||+||+++.++.+||+|||++......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999999776667899999999999999999999   999999999999999999999999999998766432


Q ss_pred             CCcc-cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCccccccccc
Q 040392          327 DQSM-TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN  404 (470)
Q Consensus       327 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (470)
                      .... .......+..|+|||++....++.++||||||+++|||++ |+.||......  .....+....           
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--~~~~~i~~~~-----------  227 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--EVMKAINDGF-----------  227 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHHHHhcCC-----------
Confidence            2111 1111223457999999988889999999999999999998 99998654321  1111111000           


Q ss_pred             ccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                             .......++.++.+++.+||+.+|++||++.++++.|+++
T Consensus       228 -------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 -------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                   0001123466789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3e-39  Score=305.36  Aligned_cols=258  Identities=23%  Similarity=0.343  Sum_probs=207.7

Q ss_pred             CCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc---cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ++|.+.+.||+|++|.||+|.. .+++.+|||.+...   .......+.+|+++++.++|+||+++++++...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688889999999999999975 57899999987643   2234457788999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC
Q 040392          249 EYMPHGSLEKYMYS---SNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       249 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  325 (470)
                      ||+++++|.+++..   ....+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998863   2345789999999999999999999   99999999999999999999999999999876543


Q ss_pred             CCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          326 EDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       326 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      ...  ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.............+...        ..+..
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~  228 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--------DYPPL  228 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC--------CCCCC
Confidence            221  12234688899999999888899999999999999999999999865322211111111100        00000


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR  452 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~  452 (470)
                               ....++.++.+++.+||+.||++|||+.+|++.++++.
T Consensus       229 ---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         229 ---------PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             ---------CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence                     01234667899999999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=5.2e-39  Score=302.13  Aligned_cols=248  Identities=25%  Similarity=0.430  Sum_probs=198.3

Q ss_pred             eecccCceEEEEEEeC---CCcEEEEEEeecccc-hhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCCCC
Q 040392          180 LIGRGGFGSVYKARLG---DGMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGS  255 (470)
Q Consensus       180 ~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~  255 (470)
                      .||+|+||.||+|.+.   ++..||+|++..... ...+.+.+|+.++++++|+||+++++++.. ...++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999999753   356799999865532 334568899999999999999999998864 56789999999999


Q ss_pred             hHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc-ccccc
Q 040392          256 LEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS-MTQTQ  334 (470)
Q Consensus       256 L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~  334 (470)
                      |.+++......+++..+..++.|++.||.|||   +++++|+||||+||+++.++.+||+|||++......... .....
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            99999776667899999999999999999999   899999999999999999999999999998765332221 11122


Q ss_pred             cccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhh
Q 040392          335 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF  413 (470)
Q Consensus       335 ~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  413 (470)
                      ..++..|+|||.+.+..++.++||||||+++||+++ |..||......+  ....+.....                  .
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~------------------~  217 (257)
T cd05115         158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--VMSFIEQGKR------------------L  217 (257)
T ss_pred             CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHHCCCC------------------C
Confidence            234578999999988889999999999999999996 999987643321  1111111100                  0


Q ss_pred             HhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          414 VAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       414 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                      ..+..++.++.+++.+||..+|++||++.+|.+.|+++
T Consensus       218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            01123467789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.9e-39  Score=309.17  Aligned_cols=259  Identities=24%  Similarity=0.387  Sum_probs=204.5

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCe
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEF  243 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  243 (470)
                      ..++|++.+.||+|+||.||+|...      .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3578999999999999999999643      24579999876432 2234457789999999999999999999999899


Q ss_pred             eeEEEecCCCCChHHhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEE
Q 040392          244 KALVLEYMPHGSLEKYMYSSN---------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHL  314 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl  314 (470)
                      .++||||+++|+|.+++....         ...++..+..++.|++.||.|||   +++++||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999996532         23466778899999999999999   999999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhc
Q 040392          315 SDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWL  393 (470)
Q Consensus       315 ~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~  393 (470)
                      +|||+++...............++..|+|||.+.+..++.++|+||||+++|||++ |..||......+  ....+   .
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~--~~~~~---~  235 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ--VLKFV---M  235 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH---H
Confidence            99999886543332222233345778999999998899999999999999999999 788886532211  11111   1


Q ss_pred             CCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHH
Q 040392          394 PISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR  452 (470)
Q Consensus       394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~  452 (470)
                      .....               ..+..++..+.+++.+||+.||++||++.++++.|++..
T Consensus       236 ~~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         236 DGGYL---------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             cCCCC---------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            00000               011233567899999999999999999999999888753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.6e-39  Score=312.68  Aligned_cols=268  Identities=21%  Similarity=0.285  Sum_probs=201.8

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            57889999999999999999764 68889999987543 22334567899999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      +++ +|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......  .
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~  159 (309)
T cd07872          86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT--K  159 (309)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCc--c
Confidence            975 898888776667889999999999999999999   9999999999999999999999999999987543221  1


Q ss_pred             cccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcC--------Cc-cccc
Q 040392          331 TQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLP--------IS-TMEV  400 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--------~~-~~~~  400 (470)
                      ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+. +.........        .. ..+.
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-LHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhhcchhhh
Confidence            2223457889999998765 4588999999999999999999999976432211 1111000000        00 0000


Q ss_pred             ccccccCchh-hhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          401 VGANLLSQED-IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       401 ~~~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      .+........ ........++.++.+++.+||+.||++|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence            0000000000 0001112346678999999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.3e-39  Score=311.25  Aligned_cols=257  Identities=25%  Similarity=0.432  Sum_probs=203.3

Q ss_pred             CCCCCCCeecccCceEEEEEEeCC-Cc--EEEEEEeecc-cchhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCeeeEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLGD-GM--EVAVKVFNLQ-CGRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      ++|++.+.||+|+||.||+|..++ +.  .+++|.++.. .....+.+..|++++.++ +||||+++++++......+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578899999999999999997643 33  4788887642 233456688899999999 799999999999999999999


Q ss_pred             EecCCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCe
Q 040392          248 LEYMPHGSLEKYMYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA  312 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~  312 (470)
                      +||+++++|.+++....               ..+++..+..++.|++.||+|||   +++++||||||+||+++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence            99999999999996532               24788899999999999999999   9999999999999999999999


Q ss_pred             EEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhh
Q 040392          313 HLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVND  391 (470)
Q Consensus       313 kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~  391 (470)
                      ||+|||++.....   .........+..|+|||...+..++.++|||||||++|||++ |..||......+     ....
T Consensus       159 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-----~~~~  230 (297)
T cd05089         159 KIADFGLSRGEEV---YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-----LYEK  230 (297)
T ss_pred             EECCcCCCccccc---eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHH
Confidence            9999999864321   111112223557999999988889999999999999999998 999987543221     1111


Q ss_pred             hcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHH
Q 040392          392 WLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL  455 (470)
Q Consensus       392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~  455 (470)
                      .....               ....+..++.++.+++.+||+.+|.+||++.++++.|+++....
T Consensus       231 ~~~~~---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         231 LPQGY---------------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             HhcCC---------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            11000               00011234667899999999999999999999999999987544

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=7.3e-40  Score=323.84  Aligned_cols=253  Identities=22%  Similarity=0.283  Sum_probs=200.9

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+..|+.+++.++||||+++++++.+....++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            467999999999999999999764 68899999986431   22334567899999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||+++|+|.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++.......
T Consensus       122 ~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~  196 (370)
T cd05596         122 MEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG  196 (370)
T ss_pred             EcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence            9999999999998654  4778888899999999999999   9999999999999999999999999999998654322


Q ss_pred             CcccccccccCccccCccccCCC----CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccc
Q 040392          328 QSMTQTQTLATIGYMAPEYGREG----RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA  403 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (470)
                      . .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||...... ..+.....   .....     
T Consensus       197 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~---~~~~~-----  266 (370)
T cd05596         197 M-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMD---HKNSL-----  266 (370)
T ss_pred             c-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-HHHHHHHc---CCCcC-----
Confidence            1 122345699999999988653    4788999999999999999999999763221 11111110   00000     


Q ss_pred             cccCchhhhhHhhhhhHHHHHHHHhhccCCCccC--CCCHHHHHHH
Q 040392          404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQ--RINAREIVAK  447 (470)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~el~~~  447 (470)
                              ..+.....+.++.+++.+||+.+|.+  |+++.|+++|
T Consensus       267 --------~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         267 --------TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             --------CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence                    00011123667889999999999988  9999999877

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.4e-39  Score=305.50  Aligned_cols=256  Identities=23%  Similarity=0.440  Sum_probs=205.9

Q ss_pred             CCCCCCCeecccCceEEEEEEeCC-C---cEEEEEEeecc-cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLGD-G---MEVAVKVFNLQ-CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      .+|++.+.||+|+||.||+|.... +   ..||+|.+... .......+..|+.+++.++||||+++++++.+....++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            357788999999999999997642 3   36999998654 334456788999999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||+++++|.+++......+++.++..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++.......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            9999999999999876667899999999999999999999   8999999999999999999999999999987654322


Q ss_pred             Ccccccc-c--ccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccc
Q 040392          328 QSMTQTQ-T--LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA  403 (470)
Q Consensus       328 ~~~~~~~-~--~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (470)
                      ....... .  ..+..|+|||.+.+..++.++||||||+++||+++ |..||......  ....++.....         
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i~~~~~---------  229 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAIEQDYR---------  229 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcCCc---------
Confidence            2111111 1  12457999999998899999999999999999887 99998754321  22222211100         


Q ss_pred             cccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                               ...+..++..+.+++.+||..+|.+||++.+++..|+++
T Consensus       230 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         230 ---------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ---------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                     011233466788999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.4e-39  Score=304.28  Aligned_cols=254  Identities=27%  Similarity=0.461  Sum_probs=203.5

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      .++|++.+.||+|+||.||+|++.++..||+|.+..... ..+.+..|+++++.++|+||+++++++.+ ...++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence            356899999999999999999887777899999874322 34568889999999999999999998754 5578999999


Q ss_pred             CCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          252 PHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       252 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      ++|+|.+++.+.. ..+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||.+..+..... .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~  158 (262)
T cd05071          83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T  158 (262)
T ss_pred             CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc-c
Confidence            9999999997543 45789999999999999999999   99999999999999999999999999999976643221 1


Q ss_pred             cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCch
Q 040392          331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE  409 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (470)
                      ......++..|+|||+..+..++.++||||||+++|||++ |..||......+. ... .....+               
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-~~~-~~~~~~---------------  221 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-LDQ-VERGYR---------------  221 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-HHH-HhcCCC---------------
Confidence            1223346678999999988889999999999999999999 8888875432211 110 000000               


Q ss_pred             hhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       410 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                         ......++..+.+++.+||+.+|++||++.++.+.|++.
T Consensus       222 ---~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         222 ---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             ---CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence               000123466789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.7e-39  Score=301.94  Aligned_cols=249  Identities=24%  Similarity=0.331  Sum_probs=204.0

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      +|.+.+.||+|++|.||+|... +++.|++|.+...  .......+..|+++++.++||||+++++++.+....++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4777899999999999999764 6899999998643  234566788899999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          251 MPHGSLEKYMYSS-NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       251 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      +++++|.+++... ...+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++..+..... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence            9999999999765 456889999999999999999999   99999999999999999999999999999886643221 


Q ss_pred             ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCch
Q 040392          330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE  409 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (470)
                       ......+++.|+|||+..+..++.++|+||||+++|||++|+.||......  .......   ....         .  
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~---~~~~---------~--  219 (256)
T cd08529         157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG--ALILKII---RGVF---------P--  219 (256)
T ss_pred             -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH---cCCC---------C--
Confidence             223346788999999999888999999999999999999999999754321  1111110   0000         0  


Q ss_pred             hhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       410 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                          ..+..++..+.+++.+||+.+|++||++.+++++
T Consensus       220 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         220 ----PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ----CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence                0011235678999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-39  Score=302.31  Aligned_cols=248  Identities=32%  Similarity=0.549  Sum_probs=205.0

Q ss_pred             CeecccCceEEEEEEeCC----CcEEEEEEeecccch-hhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCC
Q 040392          179 NLIGRGGFGSVYKARLGD----GMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH  253 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~  253 (470)
                      +.||+|+||.||+|....    +..|++|.+...... ....+..|+++++.++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999997653    888999998765433 367788899999999999999999999999999999999999


Q ss_pred             CChHHhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC
Q 040392          254 GSLEKYMYSS--------NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       254 g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  325 (470)
                      ++|.+++...        ...+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999876        467899999999999999999999   99999999999999999999999999999987654


Q ss_pred             CCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCccccccccc
Q 040392          326 EDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN  404 (470)
Q Consensus       326 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (470)
                      ...........++..|+|||.+....++.++||||+|+++|||++ |..||......  .+...+..   .         
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~---~---------  223 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE--EVLEYLRK---G---------  223 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHc---C---------
Confidence            332233344567889999999988889999999999999999999 69998765221  11111111   0         


Q ss_pred             ccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHH
Q 040392          405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLL  449 (470)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~  449 (470)
                            .....+..++.++.+++.+||+.+|++|||+.|++++|+
T Consensus       224 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         224 ------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                  001112334677999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.6e-39  Score=310.05  Aligned_cols=252  Identities=25%  Similarity=0.329  Sum_probs=204.0

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      +.|++.+.||+|+||.||+|+.. ++..+++|.+........+.+..|+++++.++|+||+++++++..+...++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56899999999999999999865 58999999997766666777888999999999999999999999889999999999


Q ss_pred             CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccc
Q 040392          252 PHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  331 (470)
Q Consensus       252 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  331 (470)
                      ++++|..++.+....+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++......  ...
T Consensus        92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~~  166 (292)
T cd06644          92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQR  166 (292)
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccc--ccc
Confidence            999999888766667899999999999999999999   999999999999999999999999999998754221  122


Q ss_pred             ccccccCccccCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccccc
Q 040392          332 QTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL  406 (470)
Q Consensus       332 ~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (470)
                      .....++..|+|||++.     ...++.++|+||||+++|||++|+.||......+ ....+.....+         .  
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~---------~--  234 (292)
T cd06644         167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSEPP---------T--  234 (292)
T ss_pred             cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-HHHHHhcCCCc---------c--
Confidence            23445788999999874     3457889999999999999999999987532211 11111100000         0  


Q ss_pred             CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       407 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                            ...+..++.++.+++.+||+.+|++||++.|++++
T Consensus       235 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         235 ------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             ------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                  00112335668899999999999999999999874

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.2e-39  Score=305.17  Aligned_cols=253  Identities=24%  Similarity=0.431  Sum_probs=204.7

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      .++|++.+.||+|+||.||+|...+++.||+|.+..... ....+..|+.++++++|+||+++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            467889999999999999999988899999999875432 3457888999999999999999999874 45678999999


Q ss_pred             CCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          252 PHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       252 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      ++++|.+++.... ..+++.++..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++........ .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~  158 (260)
T cd05067          83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-T  158 (260)
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-c
Confidence            9999999986533 46889999999999999999999   99999999999999999999999999999876542221 1


Q ss_pred             cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCch
Q 040392          331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE  409 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (470)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+  ...........              
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~~--------------  222 (260)
T cd05067         159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQNLERGYRM--------------  222 (260)
T ss_pred             cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--HHHHHHcCCCC--------------
Confidence            1122345678999999988889999999999999999999 999997643221  11111110000              


Q ss_pred             hhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHH
Q 040392          410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK  450 (470)
Q Consensus       410 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~  450 (470)
                          ..+..++.++.+++.+||+.+|++||+++++...|+.
T Consensus       223 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         223 ----PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                0112235679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.8e-39  Score=306.18  Aligned_cols=256  Identities=25%  Similarity=0.416  Sum_probs=206.4

Q ss_pred             CCCCCCCeecccCceEEEEEEeCC----CcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLGD----GMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      ++|.+.+.||+|+||.||+|...+    ...|++|...... ....+.+.+|+.+++.++||||+++++++.+. ..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEEE
Confidence            457888999999999999997543    3468999886554 34556788999999999999999999998764 46799


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||+++|+|.+++......+++..+..++.+++.||.|||   +.+++|+||||+||+++.++.+||+|||++.......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  161 (270)
T cd05056          85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES  161 (270)
T ss_pred             EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence            9999999999999876667899999999999999999999   9999999999999999999999999999988664332


Q ss_pred             CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCccccccccccc
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL  406 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (470)
                      .. ......++..|+|||.+....++.++||||||+++||+++ |..||......+.  ..+.....             
T Consensus       162 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~--~~~~~~~~-------------  225 (270)
T cd05056         162 YY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV--IGRIENGE-------------  225 (270)
T ss_pred             ce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHcCC-------------
Confidence            11 1222334568999999988889999999999999999996 9999976543221  11111000             


Q ss_pred             CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       407 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                           ....+..++.++.+++.+||..+|++||++.++++.|.++..
T Consensus       226 -----~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         226 -----RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             -----cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                 001123346778999999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.3e-39  Score=315.63  Aligned_cols=248  Identities=21%  Similarity=0.268  Sum_probs=196.3

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCeeeEEEecCCC
Q 040392          179 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMPH  253 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~  253 (470)
                      +.||+|+||.||+|+.. +++.||+|+++...   ......+..|..++..+ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999764 68899999997542   23345677899999888 699999999999999999999999999


Q ss_pred             CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccccc
Q 040392          254 GSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  333 (470)
Q Consensus       254 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  333 (470)
                      |+|.+++... ..+++..+..++.|++.||.|||   +++++||||||+||+++.++.+||+|||+++.....  .....
T Consensus        81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~  154 (329)
T cd05588          81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTTS  154 (329)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccC--CCccc
Confidence            9999888654 36899999999999999999999   999999999999999999999999999998743211  11223


Q ss_pred             ccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccC---cchhhHHhhhhcCCcccccccccccCchh
Q 040392          334 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNG---EMTLKHWVNDWLPISTMEVVGANLLSQED  410 (470)
Q Consensus       334 ~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (470)
                      ...||+.|+|||++.+..++.++|+|||||++|||++|+.||......   ......+.........             
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-------------  221 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ-------------  221 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC-------------
Confidence            457899999999999999999999999999999999999999743211   1111122111111000             


Q ss_pred             hhhHhhhhhHHHHHHHHhhccCCCccCCCC------HHHHHHH
Q 040392          411 IHFVAKEQCVSCVFNLAMECTVESPEQRIN------AREIVAK  447 (470)
Q Consensus       411 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps------~~el~~~  447 (470)
                        ...+..++.++.+++.+||+.||.+|++      +.++++|
T Consensus       222 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         222 --IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             --CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence              0012234667889999999999999997      6777765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.8e-39  Score=302.54  Aligned_cols=247  Identities=29%  Similarity=0.452  Sum_probs=199.9

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEEeecccc-hhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCCCChH
Q 040392          179 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE  257 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~  257 (470)
                      +.||+|+||.||+|...++..+|+|.+..... .....+.+|+++++.++||||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999988899999999865432 33446788999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccccccccc
Q 040392          258 KYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA  337 (470)
Q Consensus       258 ~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  337 (470)
                      +++......+++..+..++.|++.||.|+|   +.+++|+||+|+||+++.++.+|++|||++........ .......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~  156 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQI  156 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCC
Confidence            999776667899999999999999999999   99999999999999999999999999999875432211 11112234


Q ss_pred             CccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhh
Q 040392          338 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAK  416 (470)
Q Consensus       338 t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  416 (470)
                      +..|+|||++.+..++.++||||||+++|++++ |..||.......  ....+......                  ..+
T Consensus       157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~~~~~~~~~~------------------~~~  216 (250)
T cd05085         157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--AREQVEKGYRM------------------SCP  216 (250)
T ss_pred             cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHHcCCCC------------------CCC
Confidence            567999999988889999999999999999998 999987542221  11111110000                  001


Q ss_pred             hhhHHHHHHHHhhccCCCccCCCCHHHHHHHHH
Q 040392          417 EQCVSCVFNLAMECTVESPEQRINAREIVAKLL  449 (470)
Q Consensus       417 ~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~  449 (470)
                      ..++..+.+++.+||+.+|++||++.|+++.|.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            223667899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.9e-39  Score=309.48  Aligned_cols=251  Identities=24%  Similarity=0.340  Sum_probs=202.0

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCC
Q 040392          175 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH  253 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~  253 (470)
                      |++.+.||+|+||.||+|... ++..+++|.+..........+..|+++++.++||||+++++++......++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            567789999999999999765 4788899998765555667788899999999999999999999999999999999999


Q ss_pred             CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccccc
Q 040392          254 GSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  333 (470)
Q Consensus       254 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  333 (470)
                      ++|..++......+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++......  .....
T Consensus        87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~~  161 (282)
T cd06643          87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRD  161 (282)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccc--ccccc
Confidence            9999988765667899999999999999999999   999999999999999999999999999998765322  11223


Q ss_pred             ccccCccccCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          334 QTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       334 ~~~~t~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                      ...++..|+|||++.     +..++.++|||||||++|||++|+.||......+. ........ +.        .    
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~~-~~--------~----  227 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV-LLKIAKSE-PP--------T----  227 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH-HHHHhhcC-CC--------C----
Confidence            346889999999874     34578899999999999999999999876432211 11111100 00        0    


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                          ...+..++.++.+++.+||+.||.+||++.+++++-
T Consensus       228 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  263 (282)
T cd06643         228 ----LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP  263 (282)
T ss_pred             ----CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence                001122356789999999999999999999988653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-39  Score=304.67  Aligned_cols=252  Identities=24%  Similarity=0.334  Sum_probs=202.6

Q ss_pred             CCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc-----chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeE
Q 040392          173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC-----GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  246 (470)
                      ++|...+.||+|++|.||+|.. .+++.||+|.+....     ......+.+|++++++++||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5789999999999999999975 468999999986432     1234567889999999999999999999999999999


Q ss_pred             EEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCC
Q 040392          247 VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      |+||+++++|.+++.... .+++..+..++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||++......
T Consensus        82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            999999999999986544 5788899999999999999999   999999999999999999999999999998765322


Q ss_pred             CCccc-ccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          327 DQSMT-QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       327 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      ..... .....++..|+|||.+.+..++.++||||||+++|||++|+.||......+. ..........           
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~-----------  225 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA-IFKIATQPTN-----------  225 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH-HHHHhccCCC-----------
Confidence            11111 1234577899999999998899999999999999999999999875322111 1110000000           


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                             ...+..++..+.+++.+||..+|.+||++.|++++
T Consensus       226 -------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         226 -------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             -------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                   00112346678899999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-39  Score=302.16  Aligned_cols=248  Identities=31%  Similarity=0.499  Sum_probs=201.6

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEEeecccch-hhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCCCChH
Q 040392          179 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE  257 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~  257 (470)
                      +.||+|+||.||+|...+++.||+|.+...... ....+..|+++++.++|+||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            469999999999998777999999998755333 4567889999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccccccccc
Q 040392          258 KYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA  337 (470)
Q Consensus       258 ~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  337 (470)
                      +++......+++..+..++.+++.||+|||   +.+++||||+|+||+++.++.+||+|||.+.................
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            999776667889999999999999999999   99999999999999999999999999999876542222111122334


Q ss_pred             CccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhh
Q 040392          338 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAK  416 (470)
Q Consensus       338 t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  416 (470)
                      +..|+|||.+.++.++.++|+||||+++|||++ |..||......  .....+.....                  ...+
T Consensus       158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~~~~~~~------------------~~~~  217 (251)
T cd05041         158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRERIESGYR------------------MPAP  217 (251)
T ss_pred             eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHHHhcCCC------------------CCCC
Confidence            667999999988889999999999999999999 88888654322  11111111000                  0012


Q ss_pred             hhhHHHHHHHHhhccCCCccCCCCHHHHHHHHH
Q 040392          417 EQCVSCVFNLAMECTVESPEQRINAREIVAKLL  449 (470)
Q Consensus       417 ~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~  449 (470)
                      ..++.++.+++.+||..+|++||++.|+++.|.
T Consensus       218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            234667999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2e-39  Score=309.65  Aligned_cols=260  Identities=23%  Similarity=0.425  Sum_probs=204.7

Q ss_pred             CCCCCCeecccCceEEEEEEe-----CCCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccC--Ceee
Q 040392          174 GFSENNLIGRGGFGSVYKARL-----GDGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNE--EFKA  245 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~~  245 (470)
                      -|.+.+.||+|+||.||.++.     .++..||+|.+.... ......+.+|+++++.++||||+++++++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            468889999999999999973     357889999986543 33456788999999999999999999998764  5678


Q ss_pred             EEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC
Q 040392          246 LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  325 (470)
                      +||||+++++|.+++.+....+++..+..++.|++.||+|||   +++++||||||+||+++.++.++|+|||++..+..
T Consensus        85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            999999999999999766556899999999999999999999   99999999999999999999999999999987643


Q ss_pred             CCCc-ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccC----------cchhhHHhhhhcC
Q 040392          326 EDQS-MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNG----------EMTLKHWVNDWLP  394 (470)
Q Consensus       326 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~----------~~~~~~~~~~~~~  394 (470)
                      .... .......++..|+|||.+.+..++.++||||||+++|||++++.|+......          +.....++...  
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  239 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL--  239 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH--
Confidence            3221 1112345677899999998888999999999999999999987764331110          00000000000  


Q ss_pred             CcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          395 ISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                             .      .......+..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus       240 -------~------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         240 -------E------EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             -------H------cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence                   0      0001112234577899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.7e-39  Score=308.86  Aligned_cols=262  Identities=24%  Similarity=0.391  Sum_probs=205.8

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCC-----------------CcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCccee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGD-----------------GMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIK  233 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~  233 (470)
                      ..+|++.+.||+|+||.||+|+..+                 +..||+|.+.... ....+.+..|+++++.++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4578999999999999999987542                 3468999987543 334567888999999999999999


Q ss_pred             EEeeeccCCeeeEEEecCCCCChHHhhhcCC----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCC
Q 040392          234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSN----------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSN  303 (470)
Q Consensus       234 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~N  303 (470)
                      +++++...+..+++|||+++++|.+++....          ..+++..++.++.|++.||+|||   +.+++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence            9999999899999999999999999986544          25889999999999999999999   9999999999999


Q ss_pred             eeeCCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh--CCCCCCccccC
Q 040392          304 VLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT--GKKPTNEIFNG  381 (470)
Q Consensus       304 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t--g~~p~~~~~~~  381 (470)
                      |+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999876543332233334456788999999988889999999999999999998  67777653322


Q ss_pred             cchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHH
Q 040392          382 EMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLL  449 (470)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~  449 (470)
                      +  .............     ....      ...+..++.++.+++.+||+.||++||++.|+++.|+
T Consensus       241 ~--~~~~~~~~~~~~~-----~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 Q--VIENAGHFFRDDG-----RQIY------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             H--HHHHHHhcccccc-----cccc------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            1  1111111100000     0000      0011234567999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.6e-39  Score=305.96  Aligned_cols=256  Identities=25%  Similarity=0.453  Sum_probs=206.3

Q ss_pred             CCCCCCCeecccCceEEEEEEeC----CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      ++|++.+.||+|+||.||+|...    .+..+|+|.++... ....+.+..|+.+++.++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            56888999999999999999753    23479999986542 33456788899999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||+++++|.+++......+++.++..++.|++.||.|||   +.+++|+||||+||+++.++.++++|||++..+....
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            9999999999999876667899999999999999999999   9999999999999999999999999999998764332


Q ss_pred             Ccc-cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          328 QSM-TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       328 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      ... ......++..|+|||.+.+..++.++|+||||+++||+++ |..||......  .....+.....           
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~~~-----------  227 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAIEEGYR-----------  227 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHHhCCCc-----------
Confidence            211 1112233568999999998889999999999999999887 99998764322  11111111100           


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                             ...+..++..+.+++.+||+.+|.+||++.++++.|.++
T Consensus       228 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 -------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                   001122356788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.6e-39  Score=300.76  Aligned_cols=250  Identities=30%  Similarity=0.496  Sum_probs=206.0

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      .++|++.+.||.|+||.||+|... |+.||+|.+..... ..+.+..|+.+++.++|+||+++++++......++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            457888999999999999999874 88999999975543 4567888999999999999999999999889999999999


Q ss_pred             CCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          252 PHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       252 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      ++++|.+++.... ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||.+........  
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--  157 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--  157 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence            9999999997654 36899999999999999999999   99999999999999999999999999999986532111  


Q ss_pred             cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCch
Q 040392          331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE  409 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (470)
                         ....+..|+|||.+.+..++.++||||||+++||+++ |..||......+  ....+.....               
T Consensus       158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~~~---------------  217 (256)
T cd05039         158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPHVEKGYR---------------  217 (256)
T ss_pred             ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHhcCCC---------------
Confidence               2334667999999988889999999999999999998 999987542211  1111111000               


Q ss_pred             hhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       410 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                         ...+..++.++.+++.+||..+|++||++.|+++.|+++
T Consensus       218 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         218 ---MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             ---CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence               001123467789999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-39  Score=310.22  Aligned_cols=253  Identities=25%  Similarity=0.357  Sum_probs=206.8

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      .++|++.+.||.|+||.||+|... ++..+|+|++........+.+..|++++++++|+||+++++++......++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            467899999999999999999764 6899999999766666667788999999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      +++++|.+++.+.+..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++......  ..
T Consensus        84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--~~  158 (280)
T cd06611          84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--LQ  158 (280)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccc--cc
Confidence            9999999999876667899999999999999999999   999999999999999999999999999988754322  12


Q ss_pred             cccccccCccccCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          331 TQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      ......++..|+|||.+.     ...++.++|+||||+++|||++|+.||......+ .+..+.....         +  
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~---------~--  226 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-VLLKILKSEP---------P--  226 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-HHHHHhcCCC---------C--
Confidence            223456888999999874     3447789999999999999999999987642211 1111110000         0  


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                            ....+..++.++.+++..||+.+|.+||++.+++++
T Consensus       227 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         227 ------TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             ------CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                  001122346678899999999999999999999887

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.6e-39  Score=303.76  Aligned_cols=250  Identities=28%  Similarity=0.383  Sum_probs=206.4

Q ss_pred             CCCCCCCeecccCceEEEEEEeCC-CcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      ++|+..+.||+|+||.||+|...+ +..+++|.+.....  .+.+.+|+++++.++|+||+++++++......++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            678999999999999999998764 78999999875432  677889999999999999999999999999999999999


Q ss_pred             CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccc
Q 040392          252 PHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  331 (470)
Q Consensus       252 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  331 (470)
                      ++++|.+++......+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++........  .
T Consensus        81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~  155 (256)
T cd06612          81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--K  155 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--c
Confidence            999999999876777899999999999999999999   89999999999999999999999999999886643221  2


Q ss_pred             ccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhh
Q 040392          332 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDI  411 (470)
Q Consensus       332 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  411 (470)
                      .....++..|+|||++.+..++.++||||||+++|+|++|+.||......+.. .. ......                .
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-~~-~~~~~~----------------~  217 (256)
T cd06612         156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-FM-IPNKPP----------------P  217 (256)
T ss_pred             cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-hh-hccCCC----------------C
Confidence            23345788999999998889999999999999999999999998764322111 00 000000                0


Q ss_pred             hhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          412 HFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       412 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ....+..++.++.+++.+||+.||++||++.|++++
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         218 TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            001122345678999999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.3e-39  Score=305.35  Aligned_cols=256  Identities=26%  Similarity=0.394  Sum_probs=203.5

Q ss_pred             HHhhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          169 CRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       169 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      +.+++++.....||+|+||.||+|+.. ++..|++|.+........+.+.+|+.+++.++|+||+++++++...+..++|
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            345666777789999999999999754 5788999998766666667889999999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCCeEEeeeccccccC
Q 040392          248 LEYMPHGSLEKYMYSSNYIL--DIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-NMVAHLSDFSIAKLLT  324 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~--~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~a~~~~  324 (470)
                      +||+++++|.+++......+  ++..+..++.|++.||+|||   +.+|+|+||||+||+++. ++.++|+|||.+....
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            99999999999997654445  78888899999999999999   999999999999999976 6799999999987653


Q ss_pred             CCCCcccccccccCccccCccccCCCC--CCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccc
Q 040392          325 GEDQSMTQTQTLATIGYMAPEYGREGR--VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVG  402 (470)
Q Consensus       325 ~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (470)
                      ....  ......++..|+|||++.+..  ++.++|+||||+++|+|++|+.||.........  .+......        
T Consensus       161 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~--~~~~~~~~--------  228 (268)
T cd06624         161 GINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA--MFKVGMFK--------  228 (268)
T ss_pred             cCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh--Hhhhhhhc--------
Confidence            2221  122345788999999986543  788999999999999999999998753222111  11000000        


Q ss_pred             ccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          403 ANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                              .....+..++.++.+++.+||+.+|++||++.|++.+
T Consensus       229 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         229 --------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             --------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence                    0000122345678899999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=9.1e-40  Score=325.12  Aligned_cols=252  Identities=21%  Similarity=0.319  Sum_probs=196.7

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          174 GFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      .|+.++.||+|+||.||+|+. .+++.||+|++....   ......+..|+++++.++|+||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            588899999999999999975 468899999987542   2345567889999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC-
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ-  328 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~-  328 (470)
                      |+++|+|.+++...+ .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++..+..... 
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            999999999986654 5788889999999999999999   99999999999999999999999999999753211000 


Q ss_pred             --------------------------------------------cccccccccCccccCccccCCCCCCCccchhhHHHH
Q 040392          329 --------------------------------------------SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIM  364 (470)
Q Consensus       329 --------------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~  364 (470)
                                                                  ........||+.|+|||++.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                        000113468999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCC---H
Q 040392          365 LMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRIN---A  441 (470)
Q Consensus       365 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps---~  441 (470)
                      +|||++|+.||......+. ...... +...  ..             .+.....+.++.+++.+|+ .+|++|++   +
T Consensus       238 l~elltG~~Pf~~~~~~~~-~~~i~~-~~~~--~~-------------~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~  299 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLET-QMKVIN-WQTS--LH-------------IPPQAKLSPEASDLIIKLC-RGPEDRLGKNGA  299 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHH-HHHHHc-cCCC--cC-------------CCCcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence            9999999999976432211 111110 0000  00             0001122556778888876 59999997   8


Q ss_pred             HHHHHH
Q 040392          442 REIVAK  447 (470)
Q Consensus       442 ~el~~~  447 (470)
                      .|+++|
T Consensus       300 ~ei~~h  305 (382)
T cd05625         300 DEIKAH  305 (382)
T ss_pred             HHHhcC
Confidence            888765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-39  Score=308.65  Aligned_cols=255  Identities=24%  Similarity=0.401  Sum_probs=204.8

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFK  244 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  244 (470)
                      .++|.+.+.||+|+||.||+|...      ++..||+|.+.... ......+..|+++++.++|+||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            457888999999999999999754      24689999986442 23345678899999999999999999999999999


Q ss_pred             eEEEecCCCCChHHhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEe
Q 040392          245 ALVLEYMPHGSLEKYMYSSN---------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLS  315 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~  315 (470)
                      ++||||+++|+|.+++....         ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence            99999999999999986432         24678889999999999999999   9999999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcC
Q 040392          316 DFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLP  394 (470)
Q Consensus       316 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  394 (470)
                      |||+++...............++..|+|||.+.+..++.++||||||+++||+++ |..||......  ....+....  
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~~--  237 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--EVLKFVIDG--  237 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--HHHHHHhcC--
Confidence            9999886643332222233456788999999988889999999999999999998 89898653222  111111100  


Q ss_pred             CcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHH
Q 040392          395 ISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLL  449 (470)
Q Consensus       395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~  449 (470)
                       ..               ...+..++.++.+++.+||+.+|++|||+.++++.|+
T Consensus       238 -~~---------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         238 -GH---------------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             -CC---------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence             00               0012233667899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-39  Score=307.82  Aligned_cols=251  Identities=23%  Similarity=0.323  Sum_probs=201.0

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      +|+..+.||+|+||.||++... +++.||+|++....   ......+.+|+++++.++||||+++++++...+..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4778899999999999999754 68999999986432   1223456779999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          250 YMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      |+++|+|.+++.... ..+++..+..++.|++.||.|||   +.+++|+||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence            999999998886543 46899999999999999999999   8999999999999999999999999999987653221 


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                        ......++..|+|||++.+..++.++||||+|+++|||++|+.||...... ..............            
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~------------  221 (285)
T cd05605         157 --TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKREEVERRVKEDQ------------  221 (285)
T ss_pred             --ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHHHHHHHhhhcc------------
Confidence              112346899999999998888999999999999999999999999753221 11111111100000            


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCC-----CHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRI-----NAREIVAK  447 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~el~~~  447 (470)
                          ...+...+..+.+++.+||+.||++||     ++.+++++
T Consensus       222 ----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         222 ----EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             ----cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence                000122366788999999999999999     88898776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.7e-39  Score=309.59  Aligned_cols=251  Identities=26%  Similarity=0.338  Sum_probs=204.2

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      ..+|+..+.||+|++|.||+|.. .+++.||+|.+..........+..|+.+++.+.|+||+++++++......++||||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            35788899999999999999975 46899999998766555567788899999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      +++++|.+++...  .+++.++..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++.......  .
T Consensus        99 ~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~  171 (296)
T cd06654          99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S  171 (296)
T ss_pred             cCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccc--c
Confidence            9999999998643  4788999999999999999999   9999999999999999999999999999987653221  1


Q ss_pred             cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchh
Q 040392          331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED  410 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (470)
                      ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....... ....+..    ......          
T Consensus       172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-~~~~~~~----~~~~~~----------  236 (296)
T cd06654         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIAT----NGTPEL----------  236 (296)
T ss_pred             ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-hHHHHhc----CCCCCC----------
Confidence            1223468889999999988889999999999999999999999997532211 1111110    000000          


Q ss_pred             hhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          411 IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       411 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                         ..+...+..+.+++.+||..+|++||++.|++++
T Consensus       237 ---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         237 ---QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             ---CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence               0012235568899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=5.4e-40  Score=326.14  Aligned_cols=253  Identities=21%  Similarity=0.302  Sum_probs=198.6

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      .+|++.+.||+|+||.||+|+.. +++.||+|++....   ......+..|+++++.++|+||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36889999999999999999754 58999999986432   223456778999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC-
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED-  327 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~-  327 (470)
                      ||+++|+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||++..+.... 
T Consensus        81 E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          81 DYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence            9999999999997654 5788888999999999999999   9999999999999999999999999999975321000 


Q ss_pred             ----------------------------------------CcccccccccCccccCccccCCCCCCCccchhhHHHHHHH
Q 040392          328 ----------------------------------------QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME  367 (470)
Q Consensus       328 ----------------------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~e  367 (470)
                                                              .........||+.|+|||++.+..++.++|||||||++||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence                                                    0001123469999999999999899999999999999999


Q ss_pred             HHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCC---CHHHH
Q 040392          368 TFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRI---NAREI  444 (470)
Q Consensus       368 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp---s~~el  444 (470)
                      |++|+.||......+.. . .+..+...  ...             .....++.++.+++.+|+ .+|.+|+   ++.|+
T Consensus       237 ll~G~~Pf~~~~~~~~~-~-~i~~~~~~--~~~-------------~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el  298 (376)
T cd05598         237 MLVGQPPFLADTPAETQ-L-KVINWETT--LHI-------------PSQAKLSREASDLILRLC-CGAEDRLGKNGADEI  298 (376)
T ss_pred             hhhCCCCCCCCCHHHHH-H-HHhccCcc--ccC-------------CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence            99999999764322111 1 01111000  000             001123556778888876 5999999   89999


Q ss_pred             HHH
Q 040392          445 VAK  447 (470)
Q Consensus       445 ~~~  447 (470)
                      ++|
T Consensus       299 l~h  301 (376)
T cd05598         299 KAH  301 (376)
T ss_pred             hCC
Confidence            987

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.3e-40  Score=319.32  Aligned_cols=238  Identities=25%  Similarity=0.343  Sum_probs=192.4

Q ss_pred             CeecccCceEEEEEEe----CCCcEEEEEEeecccc--hhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCC
Q 040392          179 NLIGRGGFGSVYKARL----GDGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP  252 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~  252 (470)
                      +.||+|+||.||+++.    .+|+.||+|++.....  .....+..|++++++++||||+++++++......++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999864    3589999999975422  233456779999999999999999999999999999999999


Q ss_pred             CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccc
Q 040392          253 HGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ  332 (470)
Q Consensus       253 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  332 (470)
                      +|+|.+++... ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.......  ...
T Consensus        82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~  155 (318)
T cd05582          82 GGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKA  155 (318)
T ss_pred             CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cce
Confidence            99999998654 36899999999999999999999   9999999999999999999999999999987653221  122


Q ss_pred             cccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhh
Q 040392          333 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIH  412 (470)
Q Consensus       333 ~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  412 (470)
                      ....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ ....    .....                
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-~~~~----i~~~~----------------  214 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE-TMTM----ILKAK----------------  214 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH-HHHH----HHcCC----------------
Confidence            34568999999999998889999999999999999999999997532211 1111    00000                


Q ss_pred             hHhhhhhHHHHHHHHhhccCCCccCCCCHHH
Q 040392          413 FVAKEQCVSCVFNLAMECTVESPEQRINARE  443 (470)
Q Consensus       413 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e  443 (470)
                      ...+..++.++.+++.+||+.||++||++.+
T Consensus       215 ~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         215 LGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            0011223567889999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=7.6e-39  Score=303.11  Aligned_cols=252  Identities=25%  Similarity=0.373  Sum_probs=192.3

Q ss_pred             CeecccCceEEEEEEeCC---CcEEEEEEeecccc-hhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCCC
Q 040392          179 NLIGRGGFGSVYKARLGD---GMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHG  254 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g  254 (470)
                      +.||+|+||.||+|.+.+   +..+|+|.++.... .....+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999997643   45799998865432 33456788999999999999999999999988899999999999


Q ss_pred             ChHHhhhcCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          255 SLEKYMYSSN----YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       255 ~L~~~l~~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      +|.+++....    ...++..+..++.|++.|++|||   +.+++|+||||+||+++.++.+||+|||.+..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999996533    24567778889999999999999   9999999999999999999999999999987554333222


Q ss_pred             cccccccCccccCccccCCC-------CCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCccccccc
Q 040392          331 TQTQTLATIGYMAPEYGREG-------RVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVG  402 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~-------~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (470)
                      ......++..|+|||++.+.       .++.++|+||||+++|||++ |+.||......+.....+..  ..   ....+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--~~---~~~~~  232 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVRE--QQ---LKLPK  232 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhc--cc---CCCCC
Confidence            33344577889999987542       35789999999999999997 99999764332211111100  00   00111


Q ss_pred             ccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHH
Q 040392          403 ANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLL  449 (470)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~  449 (470)
                      +..          ....+..+.+++..|| .+|++|||+.||++.|+
T Consensus       233 ~~~----------~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         233 PRL----------KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             Ccc----------CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            111          0112456788999999 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-39  Score=304.33  Aligned_cols=254  Identities=28%  Similarity=0.488  Sum_probs=206.6

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      .++|.+.+.||+|+||.||+|..+++..+|+|.+.... ...+.+..|+.+++.++|+||+++++++......++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            46799999999999999999998888899999987543 23466888999999999999999999999888899999999


Q ss_pred             CCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          252 PHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       252 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      ++++|.+++.+.. ..+++..+..++.+++.|+.|||   +.+++|+||+|+||+++.++.+||+|||.+....... ..
T Consensus        84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~~  159 (261)
T cd05034          84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-YT  159 (261)
T ss_pred             CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchh-hh
Confidence            9999999997644 46899999999999999999999   8999999999999999999999999999987654211 11


Q ss_pred             cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCch
Q 040392          331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE  409 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (470)
                      .......+..|+|||.+.+..++.++|+||||+++|||++ |+.||...... ..+...... ..               
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~~~~~-~~---------------  222 (261)
T cd05034         160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-EVLEQVERG-YR---------------  222 (261)
T ss_pred             hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcC-CC---------------
Confidence            1122234568999999998889999999999999999999 99998653221 111111100 00               


Q ss_pred             hhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHH
Q 040392          410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK  450 (470)
Q Consensus       410 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~  450 (470)
                         ...+..++.++.+++.+||+.+|++||++.++.+.|+.
T Consensus       223 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         223 ---MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence               00112235678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=6.6e-39  Score=304.87  Aligned_cols=247  Identities=24%  Similarity=0.322  Sum_probs=194.1

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCCCCh
Q 040392          181 IGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL  256 (470)
Q Consensus       181 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L  256 (470)
                      ||+|+||.||+++.+ +|+.||+|.+....   ......+..|+++++.++||||+++++++......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999754 58999999986432   12233455699999999999999999999999999999999999999


Q ss_pred             HHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccccccc
Q 040392          257 EKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT  335 (470)
Q Consensus       257 ~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  335 (470)
                      .+++.... ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++.......   .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence            88885543 45888999999999999999999   9999999999999999999999999999987654321   22334


Q ss_pred             ccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHh
Q 040392          336 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVA  415 (470)
Q Consensus       336 ~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  415 (470)
                      .++..|+|||++.+..++.++||||+||++|||++|+.||....... .............. ..              .
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~-~~--------------~  218 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKRRTLEDEV-KF--------------E  218 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHHHhhcccc-cc--------------c
Confidence            68899999999998889999999999999999999999987532211 11111111111000 00              0


Q ss_pred             hhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHH
Q 040392          416 KEQCVSCVFNLAMECTVESPEQRINAREIVAKLL  449 (470)
Q Consensus       416 ~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~  449 (470)
                      ...++.++.+++.+||+.||++||++.|+++...
T Consensus       219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         219 HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             cccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence            0123566899999999999999999977664443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.8e-39  Score=314.94  Aligned_cols=242  Identities=24%  Similarity=0.281  Sum_probs=195.2

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCeeeEEEecCCC
Q 040392          179 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMPH  253 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~  253 (470)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999765 57899999997542   23345567788888887 699999999999999999999999999


Q ss_pred             CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccccc
Q 040392          254 GSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  333 (470)
Q Consensus       254 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  333 (470)
                      |+|..++.... .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++.......  ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (318)
T cd05570          81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTS  154 (318)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cccc
Confidence            99998886554 6899999999999999999999   9999999999999999999999999999987532111  1222


Q ss_pred             ccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhh
Q 040392          334 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF  413 (470)
Q Consensus       334 ~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  413 (470)
                      ...+++.|+|||++.+..++.++|||||||++|||++|+.||......+  ....+   .....                
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~--~~~~i---~~~~~----------------  213 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE--LFQSI---LEDEV----------------  213 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH--HHHHH---HcCCC----------------
Confidence            3468999999999999999999999999999999999999997532211  11111   00000                


Q ss_pred             HhhhhhHHHHHHHHhhccCCCccCCCCH-----HHHHHH
Q 040392          414 VAKEQCVSCVFNLAMECTVESPEQRINA-----REIVAK  447 (470)
Q Consensus       414 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~el~~~  447 (470)
                      ..+..++.++.+++.+||..||.+||++     .+++++
T Consensus       214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            0112235678899999999999999999     888765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.3e-39  Score=310.99  Aligned_cols=257  Identities=28%  Similarity=0.465  Sum_probs=202.1

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCc--EEEEEEeeccc-chhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCeeeE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGM--EVAVKVFNLQC-GRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~l  246 (470)
                      .++|++.+.||+|+||.||+|.+. ++.  .+++|.+.... ......+.+|++++.++ +|+||+++++++...+..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            457888999999999999999864 454  45777765332 33455778899999999 89999999999999999999


Q ss_pred             EEecCCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC
Q 040392          247 VLEYMPHGSLEKYMYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV  311 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~  311 (470)
                      ||||+++|+|.+++....               ..+++.+++.++.|++.|++|||   +++++||||||+||+++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence            999999999999996542               25788999999999999999999   999999999999999999999


Q ss_pred             eEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhh
Q 040392          312 AHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVN  390 (470)
Q Consensus       312 ~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~  390 (470)
                      +||+|||++.....   .........+..|+|||++.+..++.++||||||+++|||+| |..||......+  ......
T Consensus       163 ~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~  237 (303)
T cd05088         163 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKLP  237 (303)
T ss_pred             EEeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--HHHHHh
Confidence            99999999863211   111112234667999999988889999999999999999998 999986532221  111111


Q ss_pred             hhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          391 DWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       391 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                      ....                  ...+..++.++.+++.+||+.+|++||++.+++..|+++...
T Consensus       238 ~~~~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~  283 (303)
T cd05088         238 QGYR------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  283 (303)
T ss_pred             cCCc------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            0000                  000112356688999999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.1e-39  Score=302.09  Aligned_cols=239  Identities=23%  Similarity=0.367  Sum_probs=190.4

Q ss_pred             CeecccCceEEEEEEeCC-------------CcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeee
Q 040392          179 NLIGRGGFGSVYKARLGD-------------GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKA  245 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  245 (470)
                      +.||+|+||.||+|++.+             ...|++|.+..........+..|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999997532             2358999887655555667888999999999999999999999888899


Q ss_pred             EEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC-------eEEeeec
Q 040392          246 LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV-------AHLSDFS  318 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~-------~kl~Dfg  318 (470)
                      +||||+++|+|..++......+++..+..++.|+++||+|||   +++++||||||+||+++.++.       ++++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999998766667899999999999999999999   999999999999999987664       8999999


Q ss_pred             cccccCCCCCcccccccccCccccCccccC-CCCCCCccchhhHHHHHHHHH-hCCCCCCccccCcchhhHHhhhhcCCc
Q 040392          319 IAKLLTGEDQSMTQTQTLATIGYMAPEYGR-EGRVSTNGDVYSFGIMLMETF-TGKKPTNEIFNGEMTLKHWVNDWLPIS  396 (470)
Q Consensus       319 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DvwslGv~l~el~-tg~~p~~~~~~~~~~~~~~~~~~~~~~  396 (470)
                      ++......      ....++..|+|||.+. +..++.++||||||+++|||+ +|..||......+.  .....    ..
T Consensus       158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~~~----~~  225 (262)
T cd05077         158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK--ERFYE----GQ  225 (262)
T ss_pred             CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH--HHHHh----cC
Confidence            98754321      2245778899999886 466899999999999999998 58888765321110  00000    00


Q ss_pred             ccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          397 TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       397 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                      . .     .          ....+.++.+++.+||+.||++||++.+|++++
T Consensus       226 ~-~-----~----------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         226 C-M-----L----------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             c-c-----C----------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            0 0     0          011145688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.1e-39  Score=310.01  Aligned_cols=256  Identities=26%  Similarity=0.425  Sum_probs=204.2

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFK  244 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  244 (470)
                      .++|+..+.||+|+||.||+|...      ++..||+|.+.... ......+..|+.+++.+.||||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467899999999999999999753      46789999987543 23456688899999999999999999999999999


Q ss_pred             eEEEecCCCCChHHhhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCC
Q 040392          245 ALVLEYMPHGSLEKYMYSSN---------------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSN  303 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~N  303 (470)
                      ++||||+++|+|.+++....                     ..+++..++.++.|++.||+|||   +.+++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence            99999999999999996432                     24678888999999999999999   9999999999999


Q ss_pred             eeeCCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCc
Q 040392          304 VLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGE  382 (470)
Q Consensus       304 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~  382 (470)
                      |+++.++.++|+|||++..+..............+..|+|||.+.+..++.++|||||||++|||++ |..||...... 
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~-  239 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE-  239 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            9999999999999999876533222222222345677999999988899999999999999999998 88888653221 


Q ss_pred             chhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHH
Q 040392          383 MTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK  450 (470)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~  450 (470)
                          .+.........        .       ..+..++.++.+++.+||+.+|++||++.|+++.|++
T Consensus       240 ----~~~~~~~~~~~--------~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 ----EVIYYVRDGNV--------L-------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ----HHHHHHhcCCC--------C-------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                11111111100        0       0112346778999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3e-39  Score=312.98  Aligned_cols=241  Identities=23%  Similarity=0.287  Sum_probs=191.6

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCeeeEEEecCCC
Q 040392          179 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMPH  253 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~  253 (470)
                      +.||+|+||.||+|+.. +|+.||+|+++...   .........|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999865 58899999987542   22344556677777754 899999999999999999999999999


Q ss_pred             CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccccc
Q 040392          254 GSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  333 (470)
Q Consensus       254 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  333 (470)
                      |+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++......  .....
T Consensus        81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~  154 (316)
T cd05620          81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRAS  154 (316)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCcee
Confidence            9999988654 35789999999999999999999   999999999999999999999999999998743211  11223


Q ss_pred             ccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhh
Q 040392          334 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF  413 (470)
Q Consensus       334 ~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  413 (470)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......  .....+....+                   
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~~~~~~~~~~-------------------  213 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--ELFESIRVDTP-------------------  213 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCC-------------------
Confidence            456899999999999999999999999999999999999999753221  11111110000                   


Q ss_pred             HhhhhhHHHHHHHHhhccCCCccCCCCHH-HHHH
Q 040392          414 VAKEQCVSCVFNLAMECTVESPEQRINAR-EIVA  446 (470)
Q Consensus       414 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-el~~  446 (470)
                      ..+..++.++.+++.+||+.||++||++. ++++
T Consensus       214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~  247 (316)
T cd05620         214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIRG  247 (316)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            00112356688999999999999999985 5653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.9e-39  Score=302.97  Aligned_cols=247  Identities=23%  Similarity=0.388  Sum_probs=197.4

Q ss_pred             eecccCceEEEEEEe---CCCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCCC
Q 040392          180 LIGRGGFGSVYKARL---GDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHG  254 (470)
Q Consensus       180 ~ig~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g  254 (470)
                      .||+|+||.||+|.+   .++..+|+|+++...  ....+.+..|+.+++.++||||+++++++.. +..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            589999999999964   357889999986443  2345678889999999999999999998864 4668999999999


Q ss_pred             ChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc-ccc
Q 040392          255 SLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM-TQT  333 (470)
Q Consensus       255 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~  333 (470)
                      +|.+++.... .+++..+..++.|++.||+|||   +++++||||||.||+++.++.+||+|||++..+....... ...
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            9999996543 6889999999999999999999   9999999999999999999999999999998764332211 112


Q ss_pred             ccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhh
Q 040392          334 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIH  412 (470)
Q Consensus       334 ~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  412 (470)
                      ...++..|+|||.+....++.++|+||||+++|||++ |..||......  .....+.....                  
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~i~~~~~------------------  216 (257)
T cd05116         157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQMIESGER------------------  216 (257)
T ss_pred             CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHCCCC------------------
Confidence            2334678999999988889999999999999999998 99999764322  12222211100                  


Q ss_pred             hHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          413 FVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       413 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                      ...+..++.++.+++.+||+.||++||++.+|...|++.
T Consensus       217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            011223467789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1e-38  Score=300.74  Aligned_cols=252  Identities=27%  Similarity=0.453  Sum_probs=202.4

Q ss_pred             CCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCC
Q 040392          173 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP  252 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~  252 (470)
                      ++|.+.+.||+|++|.||+|...++..+|+|.+.... ...+.+..|+++++.++|+|++++++++.. ...+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence            4688889999999999999998777789999876432 234567889999999999999999998754 56789999999


Q ss_pred             CCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccc
Q 040392          253 HGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  331 (470)
Q Consensus       253 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  331 (470)
                      +++|.+++.... ..+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.++|+|||.+........ ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~  159 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TA  159 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-cc
Confidence            999999997643 45789999999999999999999   89999999999999999999999999999976533221 11


Q ss_pred             ccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCchh
Q 040392          332 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED  410 (470)
Q Consensus       332 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (470)
                      .....++..|+|||...+..++.++||||||+++|||++ |..||....+.+  ...+.......               
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~~---------------  222 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQVERGYRM---------------  222 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCC---------------
Confidence            122345678999999988889999999999999999999 899987643221  11111111000               


Q ss_pred             hhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHH
Q 040392          411 IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK  450 (470)
Q Consensus       411 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~  450 (470)
                         ..+...+..+.+++.+||..||++||+++++.+.|++
T Consensus       223 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 ---PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence               0012235678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-39  Score=301.38  Aligned_cols=255  Identities=25%  Similarity=0.359  Sum_probs=207.4

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      .++|++.+.||+|+||.||+|... +++.+++|.+........+.+..|+++++.++||||+++++++......+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            367889999999999999999764 5788999999866555667888999999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      +++++|.+++......+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||.+.......  .
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  156 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--A  156 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhh--h
Confidence            9999999999776567899999999999999999999   8999999999999999999999999999987654221  1


Q ss_pred             cccccccCccccCccccCCC---CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          331 TQTQTLATIGYMAPEYGREG---RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~---~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                      ......++..|+|||.+.+.   .++.++|+||||+++|||++|+.||......+.. .........       ...   
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~-~~~~~~~~~-------~~~---  225 (262)
T cd06613         157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL-FLISKSNFP-------PPK---  225 (262)
T ss_pred             ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhccCC-------Ccc---
Confidence            22234678889999998776   7899999999999999999999998764322111 110000000       000   


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                           ...+...+.++.+++.+||..+|.+||++.+++.+
T Consensus       226 -----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         226 -----LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             -----ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                 00112335678999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.1e-39  Score=311.92  Aligned_cols=241  Identities=24%  Similarity=0.323  Sum_probs=191.8

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhc-CCCCcceeEEeeeccCCeeeEEEecCCC
Q 040392          179 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKS-IRHRNLIKVISTCSNEEFKALVLEYMPH  253 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~nIv~~~~~~~~~~~~~lv~e~~~~  253 (470)
                      +.||+|+||.||+|+.. +++.||+|++....   .........|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999865 57899999987542   2234455667777776 4899999999999999999999999999


Q ss_pred             CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccccc
Q 040392          254 GSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  333 (470)
Q Consensus       254 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  333 (470)
                      |+|.+++... ..+++.++..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++.......  ....
T Consensus        81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (316)
T cd05619          81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTC  154 (316)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Ccee
Confidence            9999998654 35788999999999999999999   9999999999999999999999999999987532111  1223


Q ss_pred             ccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhh
Q 040392          334 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF  413 (470)
Q Consensus       334 ~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  413 (470)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||......  .....+....+                   
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~i~~~~~-------------------  213 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQSIRMDNP-------------------  213 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCC-------------------
Confidence            456899999999999889999999999999999999999999763221  11111111000                   


Q ss_pred             HhhhhhHHHHHHHHhhccCCCccCCCCHH-HHHH
Q 040392          414 VAKEQCVSCVFNLAMECTVESPEQRINAR-EIVA  446 (470)
Q Consensus       414 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-el~~  446 (470)
                      ..+..++.++.+++.+||+.||++||++. ++.+
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         214 CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            00112355688999999999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.5e-39  Score=310.82  Aligned_cols=262  Identities=23%  Similarity=0.412  Sum_probs=202.7

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-----------------CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-----------------DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKV  234 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~  234 (470)
                      ++|++.+.||+|+||.||++...                 ++..+|+|.+.... ......+..|+++++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            56899999999999999998532                 23468999987543 3345678899999999999999999


Q ss_pred             EeeeccCCeeeEEEecCCCCChHHhhhcCC----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 040392          235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSN----------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNV  304 (470)
Q Consensus       235 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Ni  304 (470)
                      ++++...+..++||||+++|+|.+++....          ..+++.+...++.|++.||+|||   +.+++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence            999999999999999999999999986543          23667789999999999999999   99999999999999


Q ss_pred             eeCCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh--CCCCCCccccCc
Q 040392          305 LLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT--GKKPTNEIFNGE  382 (470)
Q Consensus       305 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t--g~~p~~~~~~~~  382 (470)
                      +++.++.++|+|||++..+.............++..|+|||...++.++.++||||||+++|||++  |..||......+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999986543322222223345678999998888889999999999999999998  778886543222


Q ss_pred             chhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHH
Q 040392          383 MTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK  450 (470)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~  450 (470)
                      . .. ............           .....+..++..+.+++.+||+.||.+||++.||.+.|++
T Consensus       242 ~-~~-~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         242 V-IE-NTGEFFRDQGRQ-----------VYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             H-HH-HHHHHHhhcccc-----------ccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            1 11 111100000000           0001122346778999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5e-39  Score=305.16  Aligned_cols=239  Identities=24%  Similarity=0.349  Sum_probs=189.7

Q ss_pred             eecccCceEEEEEEeCC-------------------------CcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeE
Q 040392          180 LIGRGGFGSVYKARLGD-------------------------GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKV  234 (470)
Q Consensus       180 ~ig~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~  234 (470)
                      +||+|+||.||+|.+..                         ...|++|.+..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999996421                         23589998875544455678889999999999999999


Q ss_pred             EeeeccCCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC----
Q 040392          235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM----  310 (470)
Q Consensus       235 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~----  310 (470)
                      ++++.+....++||||+++|+|..++......+++..+..++.|+++||+|||   +++++||||||+||+++..+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence            99999999999999999999999999776667899999999999999999999   99999999999999997643    


Q ss_pred             ---CeEEeeeccccccCCCCCcccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHH-hCCCCCCccccCcchh
Q 040392          311 ---VAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETF-TGKKPTNEIFNGEMTL  385 (470)
Q Consensus       311 ---~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~-tg~~p~~~~~~~~~~~  385 (470)
                         .+|++|||.+......      ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......+.  
T Consensus       159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--  230 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK--  230 (274)
T ss_pred             ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH--
Confidence               4899999987643221      12346788999998865 56899999999999999995 69999876433221  


Q ss_pred             hHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHH
Q 040392          386 KHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLL  449 (470)
Q Consensus       386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~  449 (470)
                      ..+......                    .+.....++.+++.+||+.+|++||++.++++.|+
T Consensus       231 ~~~~~~~~~--------------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 ERFYEKKHR--------------------LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHHHHhccC--------------------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            111110000                    00111345889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.3e-39  Score=314.94  Aligned_cols=247  Identities=21%  Similarity=0.265  Sum_probs=196.4

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCeeeEEE
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      +|.+.+.||+|+||.||+|+.. +++.||+|++....   ......+..|..++..+ .|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788899999999999999765 57899999987542   22334456678888777 5899999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++......  
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~--  154 (323)
T cd05616          81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD--  154 (323)
T ss_pred             cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC--
Confidence            9999999999986544 5889999999999999999999   999999999999999999999999999998754221  


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||......  .+...+..   ...           
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~~~~i~~---~~~-----------  218 (323)
T cd05616         155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQSIME---HNV-----------  218 (323)
T ss_pred             CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--HHHHHHHh---CCC-----------
Confidence            12223456899999999999999999999999999999999999999763321  11111110   000           


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCH-----HHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINA-----REIVAK  447 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~el~~~  447 (470)
                           ..+...+.++.+++.+||+.||.+|++.     .++.++
T Consensus       219 -----~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         219 -----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             -----CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence                 0012235678899999999999999984     566544

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.1e-39  Score=322.33  Aligned_cols=254  Identities=22%  Similarity=0.286  Sum_probs=199.5

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeE
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  246 (470)
                      ..++|++.+.||+|+||.||+|+.. +++.+|+|++...   .......+.+|+.+++.++||||+++++++.++...++
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3467999999999999999999865 5889999998642   12234457789999999999999999999999999999


Q ss_pred             EEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCC
Q 040392          247 VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      ||||+++|+|.+++...  .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||++......
T Consensus       121 v~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~  195 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET  195 (370)
T ss_pred             EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence            99999999999999654  4788899999999999999999   999999999999999999999999999999866422


Q ss_pred             CCcccccccccCccccCccccCCC----CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccc
Q 040392          327 DQSMTQTQTLATIGYMAPEYGREG----RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVG  402 (470)
Q Consensus       327 ~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (470)
                      . ........||+.|+|||++.+.    .++.++||||+||++|||++|+.||...... ..........   ...    
T Consensus       196 ~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-~~~~~i~~~~---~~~----  266 (370)
T cd05621         196 G-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-GTYSKIMDHK---NSL----  266 (370)
T ss_pred             C-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-HHHHHHHhCC---ccc----
Confidence            2 1122345799999999988654    3788999999999999999999999753221 1111111100   000    


Q ss_pred             ccccCchhhhhHhhhhhHHHHHHHHhhccCCCccC--CCCHHHHHHH
Q 040392          403 ANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQ--RINAREIVAK  447 (470)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~el~~~  447 (470)
                               ..+.....+..+.+++..|+..+|.+  |+++.|+++|
T Consensus       267 ---------~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         267 ---------NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             ---------CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                     00011123566789999999865543  8899999987

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.9e-39  Score=303.69  Aligned_cols=248  Identities=25%  Similarity=0.396  Sum_probs=200.6

Q ss_pred             CeecccCceEEEEEEeCC--C--cEEEEEEeecccc-hhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCC
Q 040392          179 NLIGRGGFGSVYKARLGD--G--MEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH  253 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~  253 (470)
                      +.||+|++|.||+|.+.+  +  ..||+|.+..... ...+.+..|++++++++||||+++++++.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999997643  3  3699999876655 567788899999999999999999999988 888999999999


Q ss_pred             CChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc-cc
Q 040392          254 GSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS-MT  331 (470)
Q Consensus       254 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~  331 (470)
                      ++|.+++.+.. ..+++.....++.|++.||+|||   +++++|+||+|+||+++.++.+||+|||++..+...... ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999997755 56899999999999999999999   999999999999999999999999999999876442221 11


Q ss_pred             ccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCchh
Q 040392          332 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED  410 (470)
Q Consensus       332 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (470)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+  ....+...  ..              
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~--~~--------------  218 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILKKIDKE--GE--------------  218 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHhc--CC--------------
Confidence            223456788999999988899999999999999999999 999986532221  11111100  00              


Q ss_pred             hhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHH
Q 040392          411 IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLL  449 (470)
Q Consensus       411 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~  449 (470)
                       ....+..++..+.+++.+||+.+|++||++.++++.|.
T Consensus       219 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         219 -RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             -cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence             00011233667899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=7.6e-39  Score=305.31  Aligned_cols=271  Identities=25%  Similarity=0.395  Sum_probs=208.1

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-----CCcEEEEEEeecccch-hhhhHHHHHHHHhcCCCCcceeEEeeecc--CCee
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-----DGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCSN--EEFK  244 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~  244 (470)
                      +.|...+.||+|+||.||+|.+.     ++..+|+|.+...... ....+..|+++++.++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45778899999999999999753     3788999998755443 56778999999999999999999999877  5678


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccC
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~  324 (470)
                      +++|||+++++|.+++......+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||.+....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            9999999999999999876667899999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCCc-ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccc
Q 040392          325 GEDQS-MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA  403 (470)
Q Consensus       325 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (470)
                      ..... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+.........   +...............
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~  237 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIGIAQGQMIVTRLLE  237 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---ccccccccccHHHHHH
Confidence            32221 1111233456799999998888999999999999999999999997653222111   0000000000000000


Q ss_pred             cccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                      .+.  .......+..++.++.+++.+||+.+|++||++.|++++|+++
T Consensus       238 ~~~--~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         238 LLK--EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHH--cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            000  0001111234567899999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.5e-39  Score=304.81  Aligned_cols=257  Identities=25%  Similarity=0.398  Sum_probs=207.3

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCc----EEEEEEeecccc-hhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGM----EVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  246 (470)
                      .+|++.+.||+|+||.||+|.+. +|.    .+|+|....... .....+..|+.+++.++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            56888899999999999999754 233    589998765532 345678889999999999999999999887 77889


Q ss_pred             EEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCC
Q 040392          247 VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      ||||+++|+|.+++......+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||.++.....
T Consensus        86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~  162 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD  162 (279)
T ss_pred             EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence            99999999999999877667899999999999999999999   899999999999999999999999999999876533


Q ss_pred             CCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          327 DQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       327 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      ..........++..|+|||.+....++.++|+||||+++||+++ |+.||......  .+...+.....           
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~-----------  229 (279)
T cd05057         163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--EIPDLLEKGER-----------  229 (279)
T ss_pred             ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhCCCC-----------
Confidence            22222222334568999999988889999999999999999999 99998764322  12222211100           


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                             ...+..++..+.+++.+||..+|.+||++.++++.|+++..
T Consensus       230 -------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         230 -------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             -------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                   01112235568899999999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=9.9e-39  Score=307.70  Aligned_cols=258  Identities=26%  Similarity=0.446  Sum_probs=205.2

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCc----EEEEEEeecccc-hhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGM----EVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  246 (470)
                      ++|+..+.||+|+||.||+|.+. +|.    .+|+|.+..... .....+..|+.+++.++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            56788899999999999999753 343    578888764432 2334678899999999999999999998754 4678


Q ss_pred             EEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCC
Q 040392          247 VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      ++||+++|+|.+++......+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||+++.....
T Consensus        86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~  162 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD  162 (303)
T ss_pred             eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccCc
Confidence            99999999999999877667899999999999999999999   999999999999999999999999999999876433


Q ss_pred             CCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          327 DQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       327 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      ..........++..|+|||.+.+..++.++||||||+++|||++ |+.||......  ....++......          
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~----------  230 (303)
T cd05110         163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--EIPDLLEKGERL----------  230 (303)
T ss_pred             ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHCCCCC----------
Confidence            32222223445778999999988899999999999999999998 89998754221  122222211100          


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                              ..+..++..+.+++..||..+|++||++.++++.|+++...
T Consensus       231 --------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         231 --------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                    01122356688999999999999999999999999998643

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=6.9e-39  Score=308.50  Aligned_cols=268  Identities=23%  Similarity=0.304  Sum_probs=202.5

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      .++|.+.+.||+|+||.||+|+.. +++.||+|.+.... ......+..|+++++.++||||+++++++......++|||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            357899999999999999999764 68899999986443 2334457789999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      |++ ++|.+++......+++..+..++.|+++||+|||   +.+++|+||||+||+++.++.+||+|||++.......  
T Consensus        85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--  158 (301)
T cd07873          85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--  158 (301)
T ss_pred             ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence            997 5999998776667889999999999999999999   9999999999999999999999999999987543221  


Q ss_pred             ccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccc----ccc-
Q 040392          330 MTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEV----VGA-  403 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~-  403 (470)
                      .......++..|+|||.+.+. .++.++||||||+++|||++|+.||......+ .. ..+...........    .+. 
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~  236 (301)
T cd07873         159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE-QL-HFIFRILGTPTEETWPGILSNE  236 (301)
T ss_pred             CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HH-HHHHHHcCCCChhhchhhhccc
Confidence            112234568899999987653 57889999999999999999999997543211 11 11111111000000    000 


Q ss_pred             -----cccCc-hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          404 -----NLLSQ-EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       404 -----~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                           ..... ..........++..+.+++.+||+.||.+|||+.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                 00000 000001122446678999999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-38  Score=297.95  Aligned_cols=249  Identities=28%  Similarity=0.427  Sum_probs=198.8

Q ss_pred             CeecccCceEEEEEEeCC----CcEEEEEEeecccc-hhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCC
Q 040392          179 NLIGRGGFGSVYKARLGD----GMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH  253 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~  253 (470)
                      +.||+|+||.||+|++..    +..+|+|.+..... ...+.+..|+++++.+.|+||+++++++.. +..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence            469999999999996432    36899999875533 345678889999999999999999998764 467899999999


Q ss_pred             CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccc-c
Q 040392          254 GSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT-Q  332 (470)
Q Consensus       254 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~  332 (470)
                      |+|.+++.... .+++..+..++.|++.||+|||   ..+++|+||||+||+++.++.+||+|||++........... .
T Consensus        80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            99999997655 6899999999999999999999   89999999999999999999999999999986643222111 1


Q ss_pred             cccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhh
Q 040392          333 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDI  411 (470)
Q Consensus       333 ~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  411 (470)
                      ....++..|+|||...+..++.++||||||+++|||++ |..||......  ....++....+.                
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~--~~~~~~~~~~~~----------------  217 (257)
T cd05060         156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA--EVIAMLESGERL----------------  217 (257)
T ss_pred             cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHcCCcC----------------
Confidence            11223567999999998899999999999999999998 99998764322  222222211100                


Q ss_pred             hhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHH
Q 040392          412 HFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR  452 (470)
Q Consensus       412 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~  452 (470)
                        ..+..++..+.+++.+||+.+|++||++.++++.|+++.
T Consensus       218 --~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         218 --PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence              112234667899999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4e-39  Score=313.19  Aligned_cols=237  Identities=27%  Similarity=0.320  Sum_probs=188.1

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHH-HHhcCCCCcceeEEeeeccCCeeeEEEecCCC
Q 040392          179 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECE-MMKSIRHRNLIKVISTCSNEEFKALVLEYMPH  253 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~  253 (470)
                      +.||+|+||.||+|+.. +|+.||+|++....   ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999764 68999999987532   122333444444 56789999999999999999999999999999


Q ss_pred             CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccccc
Q 040392          254 GSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  333 (470)
Q Consensus       254 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  333 (470)
                      |+|..++.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||++......  .....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~  154 (323)
T cd05575          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTTS  154 (323)
T ss_pred             CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCccc
Confidence            99999986544 6888999999999999999999   999999999999999999999999999998753221  12233


Q ss_pred             ccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhh
Q 040392          334 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF  413 (470)
Q Consensus       334 ~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  413 (470)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......     ...........                
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-----~~~~~i~~~~~----------------  213 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-----EMYDNILNKPL----------------  213 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH-----HHHHHHHcCCC----------------
Confidence            456899999999999989999999999999999999999999753221     11111111000                


Q ss_pred             HhhhhhHHHHHHHHhhccCCCccCCCCHH
Q 040392          414 VAKEQCVSCVFNLAMECTVESPEQRINAR  442 (470)
Q Consensus       414 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~  442 (470)
                      ..+...+.++.+++.+||+.||.+||++.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         214 RLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            00112356688999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=5.8e-39  Score=323.85  Aligned_cols=263  Identities=26%  Similarity=0.336  Sum_probs=194.6

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeecc--------CC
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN--------EE  242 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--------~~  242 (470)
                      ..+|.+.+.||+|+||.||+|.. .+++.||||++....    ....+|+.+++.++||||+++++++..        ..
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            45799999999999999999976 468899999885332    234569999999999999999887632        12


Q ss_pred             eeeEEEecCCCCChHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-CeEEeeec
Q 040392          243 FKALVLEYMPHGSLEKYMYS---SNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-VAHLSDFS  318 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg  318 (470)
                      ..++||||+++ +|.+++..   ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++ .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence            46789999975 77776643   3456889999999999999999999   99999999999999998665 79999999


Q ss_pred             cccccCCCCCcccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc-
Q 040392          319 IAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS-  396 (470)
Q Consensus       319 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-  396 (470)
                      +++.+....   ......+|+.|+|||++.+. .++.++|||||||++|||++|..||......+ .+...+....... 
T Consensus       217 la~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~~~~p~~  292 (440)
T PTZ00036        217 SAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRIIQVLGTPTE  292 (440)
T ss_pred             cchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCH
Confidence            998664322   12235689999999987654 68999999999999999999999997643211 1111111100000 


Q ss_pred             ---------ccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          397 ---------TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       397 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                               ..+..-+. ..........+...+.++.+|+.+||++||.+|||+.|+++|
T Consensus       293 ~~~~~~~~~~~~~~~~~-~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPD-VKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHHhchhhhcccCCc-cCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence                     00000000 011111222233456789999999999999999999999966

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-40  Score=321.17  Aligned_cols=244  Identities=26%  Similarity=0.420  Sum_probs=208.9

Q ss_pred             eecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCCCChHH
Q 040392          180 LIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK  258 (470)
Q Consensus       180 ~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~  258 (470)
                      .||+|.||+||.|++. +...+|||.+.....+..+.+..|+.+.++|+|.|||+++|.+.+.++.-+.||-++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            6999999999999854 466799999987777888889999999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCCCeEEeeeccccccCCCCCccccccc
Q 040392          259 YMYSSNYIL--DIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQT  335 (470)
Q Consensus       259 ~l~~~~~~~--~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  335 (470)
                      ++.+.=+++  ++.+.-.+.+||++||.|||   ...|+|||||-+|||++ -.|.+||+|||-++.+.+-  .......
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TETF  736 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTETF  736 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccC--Ccccccc
Confidence            998766666  77788889999999999999   99999999999999995 6899999999999987543  2233456


Q ss_pred             ccCccccCccccCCC--CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhh
Q 040392          336 LATIGYMAPEYGREG--RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF  413 (470)
Q Consensus       336 ~~t~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  413 (470)
                      .||..|||||++..+  .|+.++|||||||++.||.||++||.+.-.+...+-+                  .+......
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk------------------VGmyKvHP  798 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK------------------VGMYKVHP  798 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh------------------hcceecCC
Confidence            799999999999765  4899999999999999999999999876544332221                  22233344


Q ss_pred             HhhhhhHHHHHHHHhhccCCCccCCCCHHHHHH
Q 040392          414 VAKEQCVSCVFNLAMECTVESPEQRINAREIVA  446 (470)
Q Consensus       414 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~  446 (470)
                      +.|+..+.+...++.+|+.+||..||+|.+++.
T Consensus       799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            556777899999999999999999999999875

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.7e-38  Score=299.33  Aligned_cols=251  Identities=26%  Similarity=0.446  Sum_probs=195.1

Q ss_pred             CeecccCceEEEEEEeC----CCcEEEEEEeecc-cchhhhhHHHHHHHHhcCCCCcceeEEeeec-cCCeeeEEEecCC
Q 040392          179 NLIGRGGFGSVYKARLG----DGMEVAVKVFNLQ-CGRALKGFDVECEMMKSIRHRNLIKVISTCS-NEEFKALVLEYMP  252 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~-~~~~~~lv~e~~~  252 (470)
                      +.||+|+||.||+|.+.    ++..+|+|.+... .....+.+..|+.+++.++||||+++++++. .+...+++|||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999753    2457999988543 2344567888999999999999999999765 4556789999999


Q ss_pred             CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc--c
Q 040392          253 HGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS--M  330 (470)
Q Consensus       253 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~  330 (470)
                      +|+|.+++.......++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++........  .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            99999999776656778888999999999999999   899999999999999999999999999998765332111  1


Q ss_pred             cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhC-CCCCCccccCcchhhHHhhhhcCCcccccccccccCch
Q 040392          331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTG-KKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE  409 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (470)
                      ......++..|+|||.+.+..++.++||||||+++|||++| ..||.....  ......+.....               
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~~~~~~---------------  220 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDITVYLLQGRR---------------  220 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHhcCCC---------------
Confidence            11223456789999999888899999999999999999995 455543221  111111111000               


Q ss_pred             hhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHH
Q 040392          410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR  452 (470)
Q Consensus       410 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~  452 (470)
                         ...+..++..+.+++.+||..+|++||++.|+++.|+++.
T Consensus       221 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         221 ---LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             ---CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence               0011223567889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=7.7e-39  Score=307.50  Aligned_cols=251  Identities=25%  Similarity=0.336  Sum_probs=204.7

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      ..+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+..|+.+++.++|+||+++++++......++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            46799999999999999999975 47999999999765555556788899999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      +++++|.+++.+.  .+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++........  
T Consensus        98 ~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--  170 (297)
T cd06656          98 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  170 (297)
T ss_pred             cCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--
Confidence            9999999998653  4788899999999999999999   89999999999999999999999999999876533221  


Q ss_pred             cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchh
Q 040392          331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED  410 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (470)
                      ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||............+..     ..     +.      
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~-----~~-----~~------  234 (297)
T cd06656         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-----GT-----PE------  234 (297)
T ss_pred             CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC-----CC-----CC------
Confidence            122346788999999999888999999999999999999999999753221111000000     00     00      


Q ss_pred             hhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          411 IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       411 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                        ...+...+..+.+++.+||..+|++||++.+++++
T Consensus       235 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         235 --LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             --CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              00112235668899999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=5.3e-39  Score=303.78  Aligned_cols=253  Identities=24%  Similarity=0.342  Sum_probs=201.8

Q ss_pred             CCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      ++|.+.+.||+|+||.||+|+. .+++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            4688889999999999999975 468999999987665555566788999999999999999999999999999999999


Q ss_pred             CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccc
Q 040392          252 PHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  331 (470)
Q Consensus       252 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  331 (470)
                      ++++|.+++...+ .+++.++..++.|++.|+.|||   +.+++|+||||+||+++.++.++|+|||++......  ...
T Consensus        89 ~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~~  162 (267)
T cd06645          89 GGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAK  162 (267)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--ccc
Confidence            9999999986544 6889999999999999999999   899999999999999999999999999998765322  122


Q ss_pred             ccccccCccccCccccC---CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          332 QTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       332 ~~~~~~t~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                      .....++..|+|||++.   ...++.++|+|||||++|+|++|..||.......... ..........       ..   
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~-~~~~~~~~~~-------~~---  231 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-LMTKSNFQPP-------KL---  231 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH-hhhccCCCCC-------cc---
Confidence            23456889999999874   4558899999999999999999999986543221111 1000000000       00   


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                           .....++..+.+++.+||..+|++||++.+++++
T Consensus       232 -----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         232 -----KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             -----cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence                 0011234568899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7e-39  Score=322.31  Aligned_cols=266  Identities=20%  Similarity=0.199  Sum_probs=199.4

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      ..+|.+.+.||+|+||.||+|... .++.||||...      ...+.+|++++++++|+||+++++++......++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            447899999999999999999765 47889999643      23456799999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      +. ++|.+++......+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.........
T Consensus       242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            95 6999888766667999999999999999999999   9999999999999999999999999999998664332222


Q ss_pred             cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCc------chhhHHhhhhc-C-Cccccccc
Q 040392          331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE------MTLKHWVNDWL-P-ISTMEVVG  402 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~------~~~~~~~~~~~-~-~~~~~~~~  402 (470)
                      ......||..|+|||++.+..++.++|||||||++|||++|..|+.......      ..+...+.... . ........
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~  397 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG  397 (461)
T ss_pred             cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence            2234569999999999999999999999999999999999887653322110      11111111100 0 00000000


Q ss_pred             ccccCc-------------hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          403 ANLLSQ-------------EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       403 ~~~~~~-------------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ..+...             ....+..-.....++.+|+.+||+.||.+|||+.|++++
T Consensus       398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            000000             000000001224468899999999999999999999986

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=9.4e-39  Score=335.38  Aligned_cols=259  Identities=23%  Similarity=0.305  Sum_probs=203.9

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57899999999999999999864 58999999986432   233557888999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcC----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeec
Q 040392          249 EYMPHGSLEKYMYSS----------NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFS  318 (470)
Q Consensus       249 e~~~~g~L~~~l~~~----------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  318 (470)
                      ||+++|+|.+++...          ....++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999988642          123456778899999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCC----------------cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCc
Q 040392          319 IAKLLTGEDQ----------------SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE  382 (470)
Q Consensus       319 ~a~~~~~~~~----------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~  382 (470)
                      ++........                ........||+.|+|||++.+..++.++|||||||++|||+||+.||......+
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986521110                001123468999999999999999999999999999999999999997632221


Q ss_pred             chhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCC-CHHHHHHHHHHHH
Q 040392          383 MTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRI-NAREIVAKLLKIR  452 (470)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~el~~~L~~i~  452 (470)
                      ......    .       .++.       .......++..+.+++.+||..||++|| +++++.+.|+.+.
T Consensus       239 i~~~~~----i-------~~P~-------~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l  291 (932)
T PRK13184        239 ISYRDV----I-------LSPI-------EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL  291 (932)
T ss_pred             hhhhhh----c-------cChh-------hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            111100    0       0000       0001123466788999999999999996 6677777777764

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2e-38  Score=301.96  Aligned_cols=250  Identities=25%  Similarity=0.328  Sum_probs=199.4

Q ss_pred             CCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      ++|++.+.||+|+||.||+|.. .+++.||+|.+.... ......+..|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3678889999999999999975 568999999986542 33445688899999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      +++++|..+.     .+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++......    
T Consensus        81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----  148 (279)
T cd06619          81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----  148 (279)
T ss_pred             CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence            9999996553     3678888999999999999999   999999999999999999999999999998765322    


Q ss_pred             cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchh--hHHhhhhcCCcccccccccccCc
Q 040392          331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTL--KHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||..........  ..+........     .+..   
T Consensus       149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~---  220 (279)
T cd06619         149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVL---  220 (279)
T ss_pred             cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCC---
Confidence            1233568899999999998899999999999999999999999997643322111  11111000000     0000   


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                            .....+.++.+++.+||+.+|++||++.|++++-
T Consensus       221 ------~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~  254 (279)
T cd06619         221 ------PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP  254 (279)
T ss_pred             ------CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence                  0111245688999999999999999999998873

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5.4e-39  Score=318.43  Aligned_cols=266  Identities=24%  Similarity=0.311  Sum_probs=198.4

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCC-----eee
Q 040392          174 GFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEE-----FKA  245 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-----~~~  245 (470)
                      +|++.+.||+|+||.||+|.. .+|+.||+|.+...  .....+.+.+|+++++.++|+||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478889999999999999975 47899999998643  2234456788999999999999999999997766     789


Q ss_pred             EEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC
Q 040392          246 LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  325 (470)
                      +||||+. ++|.+++... ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++.....
T Consensus        81 lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            9999996 5888887544 36899999999999999999999   99999999999999999999999999999976532


Q ss_pred             CCCcccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccc----
Q 040392          326 EDQSMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEV----  400 (470)
Q Consensus       326 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----  400 (470)
                      .. ........++..|+|||.+.+. .++.++|||||||++|||++|+.||....... .+.. +.........+.    
T Consensus       156 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~-i~~~~g~~~~~~~~~~  232 (372)
T cd07853         156 DE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDL-ITDLLGTPSLEAMRSA  232 (372)
T ss_pred             Cc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHH-HHHHcCCCCHHHHHHh
Confidence            22 1222334678899999988764 47899999999999999999999997643211 1111 100000000000    


Q ss_pred             -------ccccccCch--hhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          401 -------VGANLLSQE--DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       401 -------~~~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                             +........  ..........+.++.+++.+||+.||++|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                   000000000  00000112235678999999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.7e-38  Score=298.35  Aligned_cols=248  Identities=29%  Similarity=0.446  Sum_probs=200.5

Q ss_pred             CCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeee-ccCCeeeEEEecC
Q 040392          173 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTC-SNEEFKALVLEYM  251 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~-~~~~~~~lv~e~~  251 (470)
                      ++|.+.+.||+|+||.||++... |..+|+|.....  ...+.+..|+.++++++|+|++++++++ ......+++|||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46888999999999999999774 888999998643  2345688899999999999999999975 4556789999999


Q ss_pred             CCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          252 PHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       252 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      ++++|.+++.+.. ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.......   
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  156 (256)
T cd05082          83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  156 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence            9999999997654 34789999999999999999999   9999999999999999999999999999987543221   


Q ss_pred             cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCch
Q 040392          331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE  409 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (470)
                        .....+..|+|||++.+..++.++||||||+++|||++ |+.||......  .....+....+.              
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~--------------  218 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYKM--------------  218 (256)
T ss_pred             --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhcCCCC--------------
Confidence              12334568999999988889999999999999999998 99998643211  111111111000              


Q ss_pred             hhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       410 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                          ..+..++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       219 ----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         219 ----DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             ----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                01123467789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.9e-39  Score=319.50  Aligned_cols=266  Identities=21%  Similarity=0.169  Sum_probs=201.2

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC---CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG---DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ..+|.+.+.||+|+||.||++...   .+..||+|.+...     ....+|+++++.++||||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            457999999999999999999643   3678999987532     23467999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      |++. ++|.+++. ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.++|+|||++........
T Consensus       166 e~~~-~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        166 PKYK-CDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             hhcC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            9996 58888884 3456899999999999999999999   99999999999999999999999999999986654333


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCc--chhhHHhhhhcCCc--cccc----
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE--MTLKHWVNDWLPIS--TMEV----  400 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~--~~~~----  400 (470)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ..+...+.......  ....    
T Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  320 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN  320 (392)
T ss_pred             cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence            333334679999999999999999999999999999999999999987643221  11111111100000  0000    


Q ss_pred             -------ccccccCc-hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          401 -------VGANLLSQ-EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       401 -------~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                             ........ ...........+.++.+++.+||..||++||++.|++.+
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                   00000000 000000112235678899999999999999999999986

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=6.1e-39  Score=304.15  Aligned_cols=252  Identities=23%  Similarity=0.323  Sum_probs=198.9

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcC-CCCcceeEEeeeccC------C
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSI-RHRNLIKVISTCSNE------E  242 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~------~  242 (470)
                      +.+.|+..+.||+|+||.||+|... +++.||+|++.... .....+..|+.+++++ +|+||+++++++...      .
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            4567888999999999999999754 58899999986543 3345678899999998 699999999998642      4


Q ss_pred             eeeEEEecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecccc
Q 040392          243 FKALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK  321 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~  321 (470)
                      ..+++|||+++++|.+++.... ..+++..+..++.|++.|++|||   +++++|+||+|+||++++++.++|+|||++.
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~  159 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  159 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence            6789999999999999987643 46889999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCCcccccccccCccccCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc
Q 040392          322 LLTGEDQSMTQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS  396 (470)
Q Consensus       322 ~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  396 (470)
                      .....  ........++..|+|||++.     ...++.++|||||||++|||++|+.||............    ...  
T Consensus       160 ~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~----~~~--  231 (272)
T cd06637         160 QLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI----PRN--  231 (272)
T ss_pred             ecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH----hcC--
Confidence            65321  12223456889999999876     335788999999999999999999998754322111110    000  


Q ss_pred             ccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          397 TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       397 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                          .....         ....++.++.+++.+||..+|.+||++.|++++
T Consensus       232 ----~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         232 ----PAPRL---------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             ----CCCCC---------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence                00000         011235678999999999999999999999864

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.7e-38  Score=299.92  Aligned_cols=252  Identities=22%  Similarity=0.371  Sum_probs=201.8

Q ss_pred             CCCCCCeecccCceEEEEEEeCCCcEEEEEEeeccc------chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          174 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC------GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      +|...+.||+|+||.||+|...+++.+|+|.+....      .+....+.+|+++++.++|+||+++++++.+....+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            477889999999999999988889999999886432      22345678899999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      +||+++++|.+++.+.. .+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            99999999999996544 5788899999999999999999   8999999999999999999999999999987653211


Q ss_pred             C----cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccc
Q 040392          328 Q----SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA  403 (470)
Q Consensus       328 ~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (470)
                      .    ........++..|+|||.+.+..++.++||||||+++|+|++|+.||......+ .... ....  ...    .+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~~~-~~~~--~~~----~~  228 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-AMFY-IGAH--RGL----MP  228 (265)
T ss_pred             ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-HHHH-hhhc--cCC----CC
Confidence            1    111223458889999999998889999999999999999999999997532211 1111 0000  000    00


Q ss_pred             cccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      .          .+..++.++.+++.+||+.+|++||++.|++.+
T Consensus       229 ~----------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         229 R----------LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             C----------CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0          012236678899999999999999999998863

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-40  Score=319.98  Aligned_cols=250  Identities=24%  Similarity=0.393  Sum_probs=210.0

Q ss_pred             CCCCeecccCceEEEEEEeC--CCc--EEEEEEeecccch-hhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          176 SENNLIGRGGFGSVYKARLG--DGM--EVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       176 ~~~~~ig~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      ...++||+|+||.|++|.|.  +|+  .||||+++..... ...+|.+|+.+|.+|+|+|++++||...+ ....+|||.
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            44578999999999999875  343  5899999866543 77899999999999999999999999887 566799999


Q ss_pred             CCCCChHHhhhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          251 MPHGSLEKYMYS-SNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       251 ~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      ++.|+|.+.+.+ .+..+-......++.|||.|+.||.   .+++|||||..+|+++-....+||+|||+++.+...+..
T Consensus       192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~  268 (1039)
T KOG0199|consen  192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM  268 (1039)
T ss_pred             cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence            999999999987 4566778888899999999999999   999999999999999999999999999999988654433


Q ss_pred             -ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          330 -MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       330 -~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                       ...........|+|||.+....++.++|||+|||++|||+| |+.||-+...-  .+.            +.+|     
T Consensus       269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~--qIL------------~~iD-----  329 (1039)
T KOG0199|consen  269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI--QIL------------KNID-----  329 (1039)
T ss_pred             eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--HHH------------Hhcc-----
Confidence             33344556788999999999999999999999999999999 89998764221  111            1122     


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLL  449 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~  449 (470)
                       ...+...+..|+.++++++..||..+|++||++..|.+.+-
T Consensus       330 -~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~  370 (1039)
T KOG0199|consen  330 -AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV  370 (1039)
T ss_pred             -ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence             33455667889999999999999999999999999985443

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=8.3e-39  Score=315.63  Aligned_cols=267  Identities=23%  Similarity=0.230  Sum_probs=197.4

Q ss_pred             hhCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccC------
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNE------  241 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~------  241 (470)
                      ..++|++.+.||+|+||.||++.. .+|..||+|++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            357899999999999999999975 46899999998643  223455677899999999999999999988543      


Q ss_pred             CeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecccc
Q 040392          242 EFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK  321 (470)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~  321 (470)
                      ...++||||+++ +|.+.+..   .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++.
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence            356899999975 66666632   3688888999999999999999   9999999999999999999999999999997


Q ss_pred             ccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc--c--
Q 040392          322 LLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS--T--  397 (470)
Q Consensus       322 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~--  397 (470)
                      .....   .......+|..|+|||.+.+..++.++||||||+++|+|++|+.||....... .+...........  .  
T Consensus       172 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~  247 (359)
T cd07876         172 TACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID-QWNKVIEQLGTPSAEFMN  247 (359)
T ss_pred             ccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCcHHHHH
Confidence            54321   22234568999999999999999999999999999999999999997643211 1110000000000  0  


Q ss_pred             ------cccc--cccccCch----------hhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          398 ------MEVV--GANLLSQE----------DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       398 ------~~~~--~~~~~~~~----------~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                            ....  .+......          ..........+.++.+++.+||+.||++|||+.|+++|-
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  316 (359)
T cd07876         248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP  316 (359)
T ss_pred             HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence                  0000  00000000          000000112356688999999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.7e-39  Score=319.77  Aligned_cols=258  Identities=23%  Similarity=0.285  Sum_probs=201.3

Q ss_pred             HHHhhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCe
Q 040392          168 LCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEF  243 (470)
Q Consensus       168 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  243 (470)
                      .....++|++.+.||+|+||.||+|+.. +++.+|+|++...   .......+.+|+.+++.++||||+++++.+.+...
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  117 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            3445678999999999999999999765 5889999998642   12234457789999999999999999999999999


Q ss_pred             eeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecccccc
Q 040392          244 KALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  323 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~  323 (470)
                      .++||||+++|+|.+++...  .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++...
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~  192 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence            99999999999999998654  3788888899999999999999   999999999999999999999999999999866


Q ss_pred             CCCCCcccccccccCccccCccccCCC----CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccc
Q 040392          324 TGEDQSMTQTQTLATIGYMAPEYGREG----RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTME  399 (470)
Q Consensus       324 ~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  399 (470)
                      ..... .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||...... .........   .....
T Consensus       193 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~---~~~~~  267 (371)
T cd05622         193 NKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMNH---KNSLT  267 (371)
T ss_pred             CcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-HHHHHHHcC---CCccc
Confidence            43221 122345799999999998653    3788999999999999999999999753221 111111110   00000


Q ss_pred             cccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccC--CCCHHHHHHHH
Q 040392          400 VVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQ--RINAREIVAKL  448 (470)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~el~~~L  448 (470)
                                   .+.....+.++.+++..|+..++.+  |+++.|+++|.
T Consensus       268 -------------~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         268 -------------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             -------------CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence                         0111234667889999999844433  78999999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.9e-38  Score=298.00  Aligned_cols=251  Identities=26%  Similarity=0.435  Sum_probs=203.3

Q ss_pred             CCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCC
Q 040392          173 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP  252 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~  252 (470)
                      .+|++.+.||+|+||.||+|.+.++..+|+|.+..... ....+..|++++++++|||++++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            46788899999999999999887788999998864322 33568889999999999999999999999899999999999


Q ss_pred             CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccc
Q 040392          253 HGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ  332 (470)
Q Consensus       253 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  332 (470)
                      +++|.+++......+++..+..++.|++.|++|||   +.+++|+||||+||+++.++.+||+|||.+........ ...
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~  158 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSS  158 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcc-ccc
Confidence            99999999776667889999999999999999999   89999999999999999999999999999876532211 111


Q ss_pred             cccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhh
Q 040392          333 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDI  411 (470)
Q Consensus       333 ~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  411 (470)
                      ....++..|+|||.+.++.++.++||||||+++|||++ |..||......  .+........     ....         
T Consensus       159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~-----~~~~---------  222 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--EVVETINAGF-----RLYK---------  222 (256)
T ss_pred             CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHhCCC-----CCCC---------
Confidence            22335678999999988899999999999999999998 99998753321  1111111000     0000         


Q ss_pred             hhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          412 HFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       412 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                          +...+.++.+++.+||+.+|++||++.|++++|
T Consensus       223 ----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         223 ----PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             ----CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence                111256689999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4.2e-39  Score=302.89  Aligned_cols=253  Identities=30%  Similarity=0.456  Sum_probs=199.8

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhh--hHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          175 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALK--GFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      |++.+.||+|+||+||+++.. +++.||+|++.........  ....|+.+++.++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            456789999999999999865 4668999999866433222  3345999999999999999999999999999999999


Q ss_pred             CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccc
Q 040392          252 PHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  331 (470)
Q Consensus       252 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  331 (470)
                      ++++|.+++.. ...+++..+..++.|+++||.+||   +.+++|+||||+||+++.++.++|+|||.+....  .....
T Consensus        81 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~  154 (260)
T PF00069_consen   81 PGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNEN  154 (260)
T ss_dssp             TTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STTSE
T ss_pred             ccccccccccc-cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--ccccc
Confidence            99999999973 345899999999999999999999   8999999999999999999999999999987641  22233


Q ss_pred             ccccccCccccCccccC-CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchh
Q 040392          332 QTQTLATIGYMAPEYGR-EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED  410 (470)
Q Consensus       332 ~~~~~~t~~y~aPE~~~-~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (470)
                      .....++..|+|||.+. +..++.++||||+|+++|+|++|..||......  ............            ...
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~--~~~~~~~~~~~~------------~~~  220 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD--DQLEIIEKILKR------------PLP  220 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH--HHHHHHHHHHHT------------HHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccch--hhhhhhhhcccc------------ccc
Confidence            44567899999999998 888999999999999999999999999875111  111111100000            000


Q ss_pred             hhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          411 IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       411 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ...........++.+++..||+.||++||++.+++++
T Consensus       221 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  221 SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             ccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000011113679999999999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1e-38  Score=311.83  Aligned_cols=259  Identities=27%  Similarity=0.412  Sum_probs=205.2

Q ss_pred             CCCCCCCeecccCceEEEEEEeC--------CCcEEEEEEeeccc-chhhhhHHHHHHHHhcC-CCCcceeEEeeeccCC
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG--------DGMEVAVKVFNLQC-GRALKGFDVECEMMKSI-RHRNLIKVISTCSNEE  242 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~  242 (470)
                      .+|.+.+.||+|+||.||+|+..        .+..||+|.+.... ....+.+..|+++++++ +||||+++++++....
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            46888999999999999999642        12368999886442 33456788899999999 7999999999999999


Q ss_pred             eeeEEEecCCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC
Q 040392          243 FKALVLEYMPHGSLEKYMYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD  307 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~  307 (470)
                      ..++++||+++|+|.+++....               ..+++.++..++.|++.||+|||   +++++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence            9999999999999999986532               24778889999999999999999   99999999999999999


Q ss_pred             CCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhh
Q 040392          308 DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLK  386 (470)
Q Consensus       308 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~  386 (470)
                      .++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......     
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----  243 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-----  243 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH-----
Confidence            999999999999986543222222222334567999999999899999999999999999998 88888653221     


Q ss_pred             HHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          387 HWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                      .+.........               ...+..++.++.+++.+||+.+|++||++.|+++.|+++...
T Consensus       244 ~~~~~~~~~~~---------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~  296 (334)
T cd05100         244 ELFKLLKEGHR---------------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV  296 (334)
T ss_pred             HHHHHHHcCCC---------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence            11111100000               001123466789999999999999999999999999999743

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-38  Score=309.52  Aligned_cols=255  Identities=21%  Similarity=0.256  Sum_probs=198.6

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ++|++.+.||+|+||.||+++.. +++.||+|++...   .....+.+..|..++..++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47889999999999999999854 5899999998642   2233456788999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||+++|+|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++........
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            999999999999776667899999999999999999999   99999999999999999999999999999876543221


Q ss_pred             cccccccccCccccCccccCC-----CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccc
Q 040392          329 SMTQTQTLATIGYMAPEYGRE-----GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA  403 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (470)
                       .......||+.|+|||++..     ..++.++|||||||++|||++|+.||......+    .+.............  
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~----~~~~i~~~~~~~~~~--  230 (331)
T cd05597         158 -VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE----TYGKIMNHKEHFQFP--  230 (331)
T ss_pred             -ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH----HHHHHHcCCCcccCC--
Confidence             12223468999999998863     457889999999999999999999997532211    111100000000000  


Q ss_pred             cccCchhhhhHhhhhhHHHHHHHHhhccCCCc--cCCCCHHHHHHH
Q 040392          404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESP--EQRINAREIVAK  447 (470)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP--~~Rps~~el~~~  447 (470)
                                .....++.++.+++.+|+..++  ..|+++.+++.|
T Consensus       231 ----------~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         231 ----------PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             ----------CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence                      0011246678899998776543  347899999988

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.7e-38  Score=297.77  Aligned_cols=253  Identities=25%  Similarity=0.440  Sum_probs=204.1

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      .++|++.+.||+|+||.||+|...++..+|+|.+... ....+.+.+|+++++.++|+||+++++++.. ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            4678899999999999999999878888999988643 2345678889999999999999999999887 7789999999


Q ss_pred             CCCChHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          252 PHGSLEKYMYSS-NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       252 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      ++++|.+++... ....++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||.+........ .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~  158 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-T  158 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-c
Confidence            999999999763 345788899999999999999999   89999999999999999999999999999876543221 1


Q ss_pred             cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCch
Q 040392          331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE  409 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (470)
                      ......++..|+|||++....++.++|+||||+++|++++ |..||......  ....+.......              
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~~--------------  222 (260)
T cd05073         159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGYRM--------------  222 (260)
T ss_pred             cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhCCCCC--------------
Confidence            1222345677999999988889999999999999999999 89998754322  112211111000              


Q ss_pred             hhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHH
Q 040392          410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK  450 (470)
Q Consensus       410 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~  450 (470)
                          ......+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus       223 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         223 ----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ----CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                0011235678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.6e-38  Score=300.84  Aligned_cols=247  Identities=23%  Similarity=0.371  Sum_probs=203.1

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      .|+..+.||.|+||.||+|... ++..||+|.+.... ......+..|+++++.+.|+||+++++++.+....++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            4777889999999999999864 58899999987543 345667888999999999999999999999999999999999


Q ss_pred             CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccc
Q 040392          252 PHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  331 (470)
Q Consensus       252 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  331 (470)
                      ++++|.+++...  .+++.....++.|++.||+|||   +.+++|+||+|+||+++.++.++++|||++.......  ..
T Consensus        85 ~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06640          85 GGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--cc
Confidence            999999998653  4788899999999999999999   9999999999999999999999999999997654322  12


Q ss_pred             ccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhh
Q 040392          332 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDI  411 (470)
Q Consensus       332 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  411 (470)
                      .....++..|+|||.+.+..++.++|+||||+++|||++|..||......+..  .......+                 
T Consensus       158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~~~-----------------  218 (277)
T cd06640         158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL--FLIPKNNP-----------------  218 (277)
T ss_pred             cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh--hhhhcCCC-----------------
Confidence            22345788899999998888999999999999999999999998764322111  00000000                 


Q ss_pred             hhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          412 HFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       412 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                       ...+..++..+.+++.+||+.+|++||++.+++++
T Consensus       219 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         219 -PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             -CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence             01122346778999999999999999999999887

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.3e-38  Score=305.86  Aligned_cols=265  Identities=20%  Similarity=0.267  Sum_probs=203.0

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      ++|++.+.||+|+||.||++... ++..+|+|.+.... ......+..|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46889999999999999999754 58889999886543 23345678899999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      +++++|.+++... ..+++..+..++.|+++||.|||   + .+++|+||||+||+++.++.+||+|||++......   
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---  153 (308)
T cd06615          81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  153 (308)
T ss_pred             cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence            9999999999765 45788999999999999999999   6 58999999999999999999999999998755322   


Q ss_pred             ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccc-c-ccccc--
Q 040392          330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTME-V-VGANL--  405 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~--  405 (470)
                       ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||......  ....+........... . .....  
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--ELEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             -ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh--hHHHhhcCccccccccCCcccccCCC
Confidence             123356889999999998888999999999999999999999998653211  1111111100000000 0 00000  


Q ss_pred             ----------------cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          406 ----------------LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       406 ----------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                                      ....... .....++.++.+++.+||..+|++||++.|++++-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEPPPK-LPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             CCccchhhHHHHHHHHhcCCCcc-CcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                            0000000 00112456789999999999999999999999884

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=322.04  Aligned_cols=255  Identities=26%  Similarity=0.439  Sum_probs=221.1

Q ss_pred             CCCCCeecccCceEEEEEEe-CCC----cEEEEEEeecc-cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          175 FSENNLIGRGGFGSVYKARL-GDG----MEVAVKVFNLQ-CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~-~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ....+.||+|+||+||+|.| ++|    -+||+|++... ..+....+.+|+-+|.+++|||+++++++|..+. ..||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            34568999999999999964 444    46899988644 3456778899999999999999999999998776 78999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      +|++.|+|.++++..+..+.....+.|..|||+||.|||   .++++||||-++|||+.+-..+||.|||+++.+...+.
T Consensus       777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            999999999999999999999999999999999999999   99999999999999999999999999999999887766


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                      ..........+.|+|-|.+....++.++|||||||++||++| |..|+......++.  +.                 + 
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~--dl-----------------l-  913 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP--DL-----------------L-  913 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh--HH-----------------H-
Confidence            666666667889999999999999999999999999999999 99998876544321  11                 1 


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                      ..+.+...|..|+.++..++.+||..|+..||+++++...+.++..
T Consensus       914 e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  914 EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence            1223466788899999999999999999999999999999998854

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.3e-38  Score=298.88  Aligned_cols=249  Identities=20%  Similarity=0.270  Sum_probs=201.7

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc-cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ-CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      +|++.+.||+|+||.||++... ++..+|+|.++.. .....+.+..|+.+++.++|+||+++++.+......+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4778899999999999999754 6899999998643 2345567788999999999999999999999999999999999


Q ss_pred             CCCChHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          252 PHGSLEKYMYSS-NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       252 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      ++|+|.+++... ...+++.....++.|++.||.|||   +.+++|+||||+||++++++.++++|||.+.......  .
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--~  155 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--A  155 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccc--c
Confidence            999999988653 345788999999999999999999   9999999999999999999999999999987654322  1


Q ss_pred             cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchh
Q 040392          331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED  410 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (470)
                      ......++..|+|||++.+..++.++|+||||+++|+|++|..||.......     ...........            
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~------------  218 (255)
T cd08219         156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN-----LILKVCQGSYK------------  218 (255)
T ss_pred             ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH-----HHHHHhcCCCC------------
Confidence            2233568889999999998889999999999999999999999997532111     11111000000            


Q ss_pred             hhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          411 IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       411 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                         ..+..++..+.+++.+||+.||++||++.|++..
T Consensus       219 ---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         219 ---PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ---CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence               0011235568899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.1e-38  Score=301.10  Aligned_cols=254  Identities=24%  Similarity=0.307  Sum_probs=206.2

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      ++|+..+.||+|++|.||+|... +++.+|+|.+.... ......+..|+++++.++||||+++++.+......++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            36788899999999999999865 68999999987553 34456788899999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      +++++|.+++......+++.....++.|++.|++|||   + .+++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  156 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-  156 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence            9999999999876567899999999999999999999   8 9999999999999999999999999999875532211 


Q ss_pred             ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCch
Q 040392          330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE  409 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (470)
                         ....++..|+|||.+.+..++.++||||||+++|+|++|+.||......................     +.+.   
T Consensus       157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~---  225 (265)
T cd06605         157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP-----PRLP---  225 (265)
T ss_pred             ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC-----CCCC---
Confidence               11567889999999998899999999999999999999999997653322222222222111110     0000   


Q ss_pred             hhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       410 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                            ...++.++.+++.+||..||++||++.|++.+
T Consensus       226 ------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         226 ------SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             ------hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence                  01146678999999999999999999999865

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-39  Score=311.59  Aligned_cols=254  Identities=23%  Similarity=0.332  Sum_probs=207.5

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeec--ccchhhhhHHHHHHHHhcCC-CCcceeEEeeeccCCeeeEEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNL--QCGRALKGFDVECEMMKSIR-HRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ...|++++.||+||.+.||++...+.+.||+|.+..  .+.+....|..|+.+|.+|+ |.+|+++++|-..++..||||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            356899999999999999999988888888887643  35567888999999999995 999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||-+ .+|.+++.+.........+..++.|++.|+.++|   ..||||.||||.|+|+- .|.+||+|||+|..+.....
T Consensus       440 E~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT  514 (677)
T KOG0596|consen  440 ECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT  514 (677)
T ss_pred             eccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccCcccc
Confidence            9875 4999999888766665688889999999999999   99999999999999885 47999999999999988888


Q ss_pred             cccccccccCccccCccccCCCC-----------CCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcc
Q 040392          329 SMTQTQTLATIGYMAPEYGREGR-----------VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIST  397 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~-----------~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  397 (470)
                      .......+||+.||+||.+....           .++++||||+||+||+|+.|+.||.+..+.      |..      +
T Consensus       515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~------~aK------l  582 (677)
T KOG0596|consen  515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ------IAK------L  582 (677)
T ss_pred             ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH------HHH------H
Confidence            88888899999999999875332           567899999999999999999999874322      111      1


Q ss_pred             cccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          398 MEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ..+.++..--..+.   .+.  ..++.++|..||..||.+||+..|++++
T Consensus       583 ~aI~~P~~~Iefp~---~~~--~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  583 HAITDPNHEIEFPD---IPE--NDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             HhhcCCCccccccC---CCC--chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            11222211000000   001  2338999999999999999999999986

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.3e-38  Score=310.02  Aligned_cols=248  Identities=23%  Similarity=0.292  Sum_probs=195.2

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCeeeEEEecCCC
Q 040392          179 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMPH  253 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~  253 (470)
                      +.||+|+||.||+|+.. +++.||+|++....   ....+.+..|..++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999754 57899999997542   23445677899999888 699999999999999999999999999


Q ss_pred             CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccccc
Q 040392          254 GSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  333 (470)
Q Consensus       254 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  333 (470)
                      |+|..++...+ .+++..+..++.|++.||+|||   +++++||||||+||+++.++.+||+|||++......  .....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~  154 (327)
T cd05617          81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTTS  154 (327)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCcee
Confidence            99998886544 5899999999999999999999   999999999999999999999999999998753221  11223


Q ss_pred             ccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCc-chhhHHhhhhcCCcccccccccccCchhhh
Q 040392          334 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE-MTLKHWVNDWLPISTMEVVGANLLSQEDIH  412 (470)
Q Consensus       334 ~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  412 (470)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....+.........               
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------------  219 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP---------------  219 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC---------------
Confidence            4568999999999999999999999999999999999999997533221 111111111100000               


Q ss_pred             hHhhhhhHHHHHHHHhhccCCCccCCCCH------HHHHHH
Q 040392          413 FVAKEQCVSCVFNLAMECTVESPEQRINA------REIVAK  447 (470)
Q Consensus       413 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~------~el~~~  447 (470)
                      ...+...+..+.+++.+||+.||++|+++      .++++|
T Consensus       220 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         220 IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence            00112235667899999999999999985      566654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.5e-38  Score=305.28  Aligned_cols=251  Identities=25%  Similarity=0.342  Sum_probs=204.8

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      ..+|+..+.||.|++|.||+|.. .+++.|++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            34688899999999999999974 57899999998765555566788899999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      +++++|.+++...  .+++.++..++.|++.|++|||   +.+++|+||+|+||+++.++.+||+|||++........  
T Consensus        98 ~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--  170 (296)
T cd06655          98 LAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--  170 (296)
T ss_pred             cCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--
Confidence            9999999988654  4789999999999999999999   99999999999999999999999999999876543221  


Q ss_pred             cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchh
Q 040392          331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED  410 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (470)
                      ......++..|+|||.+.+..++.++|||||||++|+|++|+.||........ ........ ...              
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~~~~~~~~-~~~--------------  234 (296)
T cd06655         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIATNG-TPE--------------  234 (296)
T ss_pred             cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcC-Ccc--------------
Confidence            12234688899999999888899999999999999999999999876432211 11110000 000              


Q ss_pred             hhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          411 IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       411 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                        ...+..++..+.+++.+||..||++||++.+++.+
T Consensus       235 --~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         235 --LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             --cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence              00112345678899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=8.7e-39  Score=302.59  Aligned_cols=249  Identities=29%  Similarity=0.503  Sum_probs=198.3

Q ss_pred             CeecccCceEEEEEEeCC-------CcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          179 NLIGRGGFGSVYKARLGD-------GMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      +.||+|+||.||+|+..+       +..+|+|.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999997642       2579999876442 23456788899999999999999999999998999999999


Q ss_pred             CCCCChHHhhhcC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-----CeEEeeecc
Q 040392          251 MPHGSLEKYMYSS------NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-----VAHLSDFSI  319 (470)
Q Consensus       251 ~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~-----~~kl~Dfg~  319 (470)
                      +++++|.+++...      ...+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999998653      234788999999999999999999   89999999999999999887     899999999


Q ss_pred             ccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCccc
Q 040392          320 AKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTM  398 (470)
Q Consensus       320 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  398 (470)
                      +................++..|+|||.+.++.++.++||||||+++|||++ |+.||......+  ...++...   .  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~~---~--  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--VLQHVTAG---G--  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH--HHHHHhcC---C--
Confidence            876543322222233446788999999999999999999999999999998 999987532211  11111100   0  


Q ss_pred             ccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHH
Q 040392          399 EVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK  450 (470)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~  450 (470)
                                   ....+..++..+.+++.+||..+|.+||++.++++.|++
T Consensus       231 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         231 -------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             -------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                         001122346778999999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-39  Score=310.74  Aligned_cols=252  Identities=23%  Similarity=0.317  Sum_probs=211.2

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccc---hhhhhHHHHHHHHhcCC-CCcceeEEeeeccCCeee
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG---RALKGFDVECEMMKSIR-HRNLIKVISTCSNEEFKA  245 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~  245 (470)
                      ..+.|++.+.||+|.||.||+++.+ +|+.+|+|.+.+...   .....+.+|+++|+++. ||||+.+++.+++....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            3567888999999999999999765 499999999976543   24468889999999998 999999999999999999


Q ss_pred             EEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC----CCCeEEeeecccc
Q 040392          246 LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD----NMVAHLSDFSIAK  321 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~----~~~~kl~Dfg~a~  321 (470)
                      +|||++.||.|.+.+...  .+++..+..++.|++.++.|||   +.+++|||+||+|+|+..    ++.+|++|||++.
T Consensus       113 lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            999999999999999776  3899999999999999999999   999999999999999953    3579999999999


Q ss_pred             ccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccc
Q 040392          322 LLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVV  401 (470)
Q Consensus       322 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (470)
                      ....   .......+||+.|+|||++....|+..+||||+|+++|.|++|..||......+... .......        
T Consensus       188 ~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-~i~~~~~--------  255 (382)
T KOG0032|consen  188 FIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-AILRGDF--------  255 (382)
T ss_pred             EccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-HHHcCCC--------
Confidence            8754   344566889999999999999999999999999999999999999998754433222 1111100        


Q ss_pred             cccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          402 GANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                              ..........+..+.+++..|+..||.+|+++.++++|
T Consensus       256 --------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  256 --------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             --------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                    00011123346778999999999999999999999997

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=7.7e-39  Score=315.41  Aligned_cols=266  Identities=22%  Similarity=0.230  Sum_probs=197.3

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccC------
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNE------  241 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~------  241 (470)
                      ..++|+..+.||+|+||.||++... .++.||+|.+...  .......+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4578999999999999999999754 6889999998643  233445677899999999999999999987543      


Q ss_pred             CeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecccc
Q 040392          242 EFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK  321 (470)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~  321 (470)
                      ...++||||+++ ++.+.+..   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~  167 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence            356899999975 67766643   4788889999999999999999   9999999999999999999999999999997


Q ss_pred             ccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhh----------
Q 040392          322 LLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVND----------  391 (470)
Q Consensus       322 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~----------  391 (470)
                      .....   .......+|..|+|||++.+..++.++|||||||++|||++|+.||......+ .+...+..          
T Consensus       168 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~  243 (355)
T cd07874         168 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMK  243 (355)
T ss_pred             cCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHH
Confidence            64321   22234568999999999998899999999999999999999999997532111 00000000          


Q ss_pred             --------hcCC--cccccccccccCch--hhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          392 --------WLPI--STMEVVGANLLSQE--DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       392 --------~~~~--~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                              +...  .......+......  ..........+.++.+++.+||+.||++|||+.|++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                    0000  00000000000000  00000111224568899999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-38  Score=300.83  Aligned_cols=248  Identities=28%  Similarity=0.472  Sum_probs=195.2

Q ss_pred             CeecccCceEEEEEEeCC-Cc--EEEEEEeeccc-chhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCeeeEEEecCCC
Q 040392          179 NLIGRGGFGSVYKARLGD-GM--EVAVKVFNLQC-GRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMPH  253 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~  253 (470)
                      +.||+|+||.||+|...+ +.  .+++|.+.... ......+..|++++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999998653 43  46888876432 33456788899999999 799999999999999999999999999


Q ss_pred             CChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeec
Q 040392          254 GSLEKYMYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFS  318 (470)
Q Consensus       254 g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  318 (470)
                      |+|.+++....               ..+++.++..++.|++.||+|||   +.+++|+||||+||++++++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999986532               24788899999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcc
Q 040392          319 IAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPIST  397 (470)
Q Consensus       319 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  397 (470)
                      ++....   ..........+..|+|||++....++.++||||||+++|||++ |..||......+     ..........
T Consensus       158 l~~~~~---~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-----~~~~~~~~~~  229 (270)
T cd05047         158 LSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-----LYEKLPQGYR  229 (270)
T ss_pred             Cccccc---hhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-----HHHHHhCCCC
Confidence            985321   1111112234567999999988889999999999999999997 999986532211     1111100000


Q ss_pred             cccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHH
Q 040392          398 MEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR  452 (470)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~  452 (470)
                      .               ..+..++.++.+++.+||+.+|.+||++.+++..|.++.
T Consensus       230 ~---------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         230 L---------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             C---------------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            0               011223567889999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=7.9e-39  Score=311.39  Aligned_cols=241  Identities=25%  Similarity=0.294  Sum_probs=188.8

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHH-HHHHhcCCCCcceeEEeeeccCCeeeEEEecCCC
Q 040392          179 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVE-CEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH  253 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E-~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~  253 (470)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+..| ..+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999765 57889999987432   1222233334 3456788999999999999999999999999999


Q ss_pred             CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccccc
Q 040392          254 GSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  333 (470)
Q Consensus       254 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  333 (470)
                      |+|.+++.... .+.+.....++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++......  .....
T Consensus        81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~~~  154 (325)
T cd05602          81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGTTS  154 (325)
T ss_pred             CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCCcc
Confidence            99999997544 5778888889999999999999   999999999999999999999999999998754321  12233


Q ss_pred             ccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhh
Q 040392          334 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF  413 (470)
Q Consensus       334 ~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  413 (470)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......+  ....+   .....                
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i---~~~~~----------------  213 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--MYDNI---LNKPL----------------  213 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH--HHHHH---HhCCc----------------
Confidence            4568999999999999999999999999999999999999997532211  11111   00000                


Q ss_pred             HhhhhhHHHHHHHHhhccCCCccCCCCHHHHHH
Q 040392          414 VAKEQCVSCVFNLAMECTVESPEQRINAREIVA  446 (470)
Q Consensus       414 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~  446 (470)
                      ..+...+..+.+++.+||+.||.+||++.+.+.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence            001123566889999999999999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.5e-39  Score=318.34  Aligned_cols=253  Identities=22%  Similarity=0.336  Sum_probs=198.5

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ++|+..+.||+|+||.||+|... +++.||+|++....   ......+..|+.++..++|+||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999764 68999999987432   334556778999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++........
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence            9999999999996544 5889999999999999999999   99999999999999999999999999999875432110


Q ss_pred             c---------------------------------ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q 040392          329 S---------------------------------MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPT  375 (470)
Q Consensus       329 ~---------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~  375 (470)
                      .                                 ......+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence            0                                 0011346899999999999999999999999999999999999999


Q ss_pred             CccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCC---HHHHHHH
Q 040392          376 NEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRIN---AREIVAK  447 (470)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps---~~el~~~  447 (470)
                      ......+. .... ..+  ..... +            +.....+.++.+++.+++ .||.+|++   +.|+++|
T Consensus       237 ~~~~~~~~-~~~i-~~~--~~~~~-~------------p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         237 CSETPQET-YRKV-MNW--KETLV-F------------PPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCHHHH-HHHH-HcC--CCcee-c------------CCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence            76432211 1110 000  00000 0            000113556788888876 49999995   6777776

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2e-38  Score=302.82  Aligned_cols=250  Identities=23%  Similarity=0.339  Sum_probs=199.9

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          175 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      |+..+.||+|+||.||++... +++.||+|.+....   ......+..|+.+++.++|++|+++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            677889999999999999754 68999999986442   22234567799999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          251 MPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       251 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      +++++|.+++.... ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++.......  
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  156 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--  156 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence            99999999886543 45889999999999999999999   9999999999999999999999999999987653221  


Q ss_pred             ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCch
Q 040392          330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE  409 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (470)
                       ......|+..|+|||++.+..++.++||||||+++|+|++|+.||....... ....... ... ..            
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~~~~~-~~~-~~------------  220 (285)
T cd05630         157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEVER-LVK-EV------------  220 (285)
T ss_pred             -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHHHHHh-hhh-hh------------
Confidence             1123468999999999998899999999999999999999999997643211 1111000 000 00            


Q ss_pred             hhhhHhhhhhHHHHHHHHhhccCCCccCCCC-----HHHHHHH
Q 040392          410 DIHFVAKEQCVSCVFNLAMECTVESPEQRIN-----AREIVAK  447 (470)
Q Consensus       410 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~el~~~  447 (470)
                        ....+..++.++.+++.+||+.||++|||     +.|++++
T Consensus       221 --~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         221 --QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             --hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence              00011234667889999999999999999     8898874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.2e-38  Score=302.64  Aligned_cols=254  Identities=25%  Similarity=0.438  Sum_probs=204.4

Q ss_pred             CCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccch-hhhhHHHHHHHHhcCCCCcceeEEeeeccCCeee
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKA  245 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  245 (470)
                      ++|++.+.||+|+||.||+|+.+      +...+++|.+...... ....+..|++++++++|+||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57889999999999999999854      3467999988654433 4567889999999999999999999999989999


Q ss_pred             EEEecCCCCChHHhhhcCC--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeee
Q 040392          246 LVLEYMPHGSLEKYMYSSN--------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF  317 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  317 (470)
                      +||||+++|+|.+++....        ..+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999997544        15899999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCc
Q 040392          318 SIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPIS  396 (470)
Q Consensus       318 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  396 (470)
                      |++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||....+..  ......   ...
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--~~~~~~---~~~  235 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--VLNRLQ---AGK  235 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH--HHHHHH---cCC
Confidence            9987543221 122233456778999999988889999999999999999999 788886543221  111111   000


Q ss_pred             ccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHH
Q 040392          397 TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLL  449 (470)
Q Consensus       397 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~  449 (470)
                      .              ....+..++..+.+++.+||+.+|++||++.|+++.|.
T Consensus       236 ~--------------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         236 L--------------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             c--------------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            0              00011234677899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.2e-38  Score=299.46  Aligned_cols=250  Identities=24%  Similarity=0.393  Sum_probs=200.7

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccc---------hhhhhHHHHHHHHhcCCCCcceeEEeeeccCCe
Q 040392          174 GFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCG---------RALKGFDVECEMMKSIRHRNLIKVISTCSNEEF  243 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  243 (470)
                      +|.+.+.||+|++|.||+|.. .+++.+|+|.+.....         +..+.+..|+.++++++||||+++++++.+...
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            477889999999999999975 4588999998864321         123567789999999999999999999999999


Q ss_pred             eeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecccccc
Q 040392          244 KALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  323 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~  323 (470)
                      .++||||+++++|.+++... ..+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||.++..
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            99999999999999999655 35788899999999999999999   899999999999999999999999999998876


Q ss_pred             CCCCCc----ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccc
Q 040392          324 TGEDQS----MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTME  399 (470)
Q Consensus       324 ~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  399 (470)
                      ......    .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....... .... ....       
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~-~~~~-------  227 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-AIFK-IGEN-------  227 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-HHHH-Hhcc-------
Confidence            432111    11123457889999999988889999999999999999999999997642211 1110 0000       


Q ss_pred             cccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          400 VVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                       ..+          ..+..++..+.+++.+||+.||.+||++.|++++
T Consensus       228 -~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         228 -ASP----------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             -CCC----------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence             000          0112335678899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-38  Score=299.20  Aligned_cols=249  Identities=25%  Similarity=0.353  Sum_probs=203.6

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      ++|+..+.||.|++|.||+|+.. +++.||+|.+.... ......+..|+++++.++|+||+++++++.+....++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            46888899999999999999765 68899999987543 34456678899999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      +++++|.+++...  .+++..+..++.|++.|+.|||   +.+++|+||+|+||++++++.++|+|||++.......  .
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  153 (274)
T cd06609          81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S  153 (274)
T ss_pred             eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence            9999999999765  6899999999999999999999   9999999999999999999999999999998764321  1


Q ss_pred             cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchh
Q 040392          331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED  410 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (470)
                      ......++..|+|||++.+..++.++||||||+++|+|++|+.||......+.  ...+....+.        ...    
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~--------~~~----  219 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV--LFLIPKNNPP--------SLE----  219 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH--HHHhhhcCCC--------CCc----
Confidence            22335678899999999988899999999999999999999999975432111  1100100000        000    


Q ss_pred             hhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          411 IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       411 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                           ...++.++.+++.+||..+|++||++.+++++
T Consensus       220 -----~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         220 -----GNKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             -----ccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence                 00135668899999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.1e-38  Score=301.38  Aligned_cols=267  Identities=23%  Similarity=0.286  Sum_probs=198.7

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      +|.+.+.||+|++|.||+|+.. ++..||+|.+....  ......+..|+.+++.++||||+++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4778899999999999999864 68999999986442  22345678899999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          251 MPHGSLEKYMYSSN--YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       251 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ++ ++|.+++....  ..+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 58988886533  56899999999999999999999   9999999999999999999999999999987543221 


Q ss_pred             cccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCC--------cccc
Q 040392          329 SMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPI--------STME  399 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~  399 (470)
                       .......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||........ ...........        ....
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ-LFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCChhhhhcchhhH
Confidence             122234568899999987654 478899999999999999999999875322111 10100000000        0000


Q ss_pred             cccccccC-chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          400 VVGANLLS-QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       400 ~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ........ ...........++.++.+++.+||+.||++|||+.+++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            00000000 0000001112356778999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.7e-38  Score=308.63  Aligned_cols=241  Identities=20%  Similarity=0.248  Sum_probs=192.5

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCC-CCcceeEEeeeccCCeeeEEE
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIR-HRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      +|+..+.||+|+||.||+|... +|+.||+|++....   ....+.+..|..++..+. |++|+++++++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3677899999999999999754 68999999987542   233455677888888886 577888999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +++++||||||+||+++.++.+||+|||++....... 
T Consensus        81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-  155 (323)
T cd05615          81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-  155 (323)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence            9999999999986544 5889999999999999999999   9999999999999999999999999999987542211 


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                       .......||+.|+|||++.+..++.++||||+||++|||++|+.||......  .....+.   ....           
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~i~---~~~~-----------  218 (323)
T cd05615         156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--ELFQSIM---EHNV-----------  218 (323)
T ss_pred             -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHH---hCCC-----------
Confidence             1223456899999999999888999999999999999999999999764221  1111110   0000           


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINA  441 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~  441 (470)
                           ..+..++.++.+++.+||+.+|.+|++.
T Consensus       219 -----~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 -----SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             -----CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence                 0012235668899999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.1e-38  Score=302.63  Aligned_cols=250  Identities=22%  Similarity=0.322  Sum_probs=199.3

Q ss_pred             CCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          175 FSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      |+..+.||+|+||+||+|.. .+++.||+|.+....   ......+..|+++++.++|+||+++++++...+..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            66778999999999999976 468899999986542   22234567799999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          251 MPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       251 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      +++++|.+++.... ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence            99999998886543 46899999999999999999999   9999999999999999999999999999987653221  


Q ss_pred             ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCch
Q 040392          330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE  409 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (470)
                       ......++..|+|||.+.+..++.++|+||||+++|||++|..||....... ....+........  .          
T Consensus       157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~~~~~~~~~~~--~----------  222 (285)
T cd05632         157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KREEVDRRVLETE--E----------  222 (285)
T ss_pred             -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhhccc--c----------
Confidence             1123468999999999988899999999999999999999999997642211 1111111110000  0          


Q ss_pred             hhhhHhhhhhHHHHHHHHhhccCCCccCCCC-----HHHHHHH
Q 040392          410 DIHFVAKEQCVSCVFNLAMECTVESPEQRIN-----AREIVAK  447 (470)
Q Consensus       410 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~el~~~  447 (470)
                          ..+..++.++.+++..||+.||++||+     +.+++.+
T Consensus       223 ----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         223 ----VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             ----ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence                001223566889999999999999999     6777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.7e-38  Score=301.36  Aligned_cols=265  Identities=24%  Similarity=0.329  Sum_probs=194.6

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccc--hhhhhHHHHHHHHhcC---CCCcceeEEeeecc-----CC
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RALKGFDVECEMMKSI---RHRNLIKVISTCSN-----EE  242 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~-----~~  242 (470)
                      +|++.+.||+|+||.||+|... +++.||+|.+.....  .....+..|+++++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788899999999999999765 689999999865422  1223455677777665   69999999998754     34


Q ss_pred             eeeEEEecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecccc
Q 040392          243 FKALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK  321 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~  321 (470)
                      ..+++|||+++ +|.+++.... ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++.
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            57899999975 8988886543 35899999999999999999999   9999999999999999999999999999997


Q ss_pred             ccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhh-cCC--cc-
Q 040392          322 LLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDW-LPI--ST-  397 (470)
Q Consensus       322 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~--~~-  397 (470)
                      ......   ......++..|+|||++.+..++.++||||+||++|||++|+.||....... .+....... .+.  .. 
T Consensus       157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         157 IYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             cccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHHhCCCChhhCc
Confidence            654221   1223467889999999988899999999999999999999999986532211 111111100 000  00 


Q ss_pred             --ccccccccc--CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          398 --MEVVGANLL--SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       398 --~~~~~~~~~--~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                        .........  ..... ......++.++.+++.+||+.||++|||+.|++.|
T Consensus       233 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPV-QSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             ccccccccccCCCCCCch-HHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence              000000000  00000 01112346678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.8e-39  Score=301.55  Aligned_cols=239  Identities=25%  Similarity=0.375  Sum_probs=190.3

Q ss_pred             CeecccCceEEEEEEeCC--------CcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          179 NLIGRGGFGSVYKARLGD--------GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      +.||+|+||.||+|....        ...+|+|.+........+.+..|+.+++.+.||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999997532        335888888655555566788899999999999999999999988899999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC--------eEEeeeccccc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV--------AHLSDFSIAKL  322 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~--------~kl~Dfg~a~~  322 (470)
                      +++|+|.+++...+..+++..+..++.|++.||+|||   +++++||||||+||+++.++.        ++++|||.+..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            9999999999877667899999999999999999999   999999999999999987765        69999998865


Q ss_pred             cCCCCCcccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCC-CCCCccccCcchhhHHhhhhcCCccccc
Q 040392          323 LTGEDQSMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGK-KPTNEIFNGEMTLKHWVNDWLPISTMEV  400 (470)
Q Consensus       323 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (470)
                      ....      ....++..|+|||.+.+. .++.++||||||+++|||++|. .|+....... . .......        
T Consensus       158 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~-~-~~~~~~~--------  221 (258)
T cd05078         158 VLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-K-LQFYEDR--------  221 (258)
T ss_pred             cCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH-H-HHHHHcc--------
Confidence            4321      224577889999998764 5789999999999999999985 5544322111 0 0000000        


Q ss_pred             ccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          401 VGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                                  ...+.....++.+++.+||+.||++|||++++++.|
T Consensus       222 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         222 ------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             ------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                        000111245688999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.4e-38  Score=303.63  Aligned_cols=268  Identities=23%  Similarity=0.263  Sum_probs=200.1

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      +|+..+.||+|+||.||+|+.. +|+.||+|.+....  ......+..|+++++.++|+||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999764 68999999986442  22335577899999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      ++ ++|.+++......+++..+..++.|+++||.|||   +.+++|+||||+||+++.++.+||+|||++.......  .
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~  154 (284)
T cd07839          81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--R  154 (284)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--C
Confidence            97 5888888766667899999999999999999999   9999999999999999999999999999987553221  1


Q ss_pred             cccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc------ccccccc
Q 040392          331 TQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS------TMEVVGA  403 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~  403 (470)
                      ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+....+.+..+...........      .....+.
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY  234 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence            12234578899999988764 4789999999999999999999986543322211111100000000      0000000


Q ss_pred             cc---cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          404 NL---LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       404 ~~---~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ..   ..............+.++.+++.+||+.||.+|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            00   000000001112346778999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.3e-38  Score=297.90  Aligned_cols=250  Identities=24%  Similarity=0.360  Sum_probs=189.2

Q ss_pred             eecccCceEEEEEEeCC---CcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCCCC
Q 040392          180 LIGRGGFGSVYKARLGD---GMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGS  255 (470)
Q Consensus       180 ~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~  255 (470)
                      .||+|+||.||+|...+   ...+|+|.+.... ......+.+|+++++.++|+||+++++++......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997543   3568888775432 2334567889999999999999999999999999999999999999


Q ss_pred             hHHhhhcCCC----CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccc
Q 040392          256 LEKYMYSSNY----ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  331 (470)
Q Consensus       256 L~~~l~~~~~----~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  331 (470)
                      |.+++.....    ..++.....++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++...........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            9999976442    2457778899999999999999   99999999999999999999999999999875433322222


Q ss_pred             ccccccCccccCccccC-------CCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccc
Q 040392          332 QTQTLATIGYMAPEYGR-------EGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA  403 (470)
Q Consensus       332 ~~~~~~t~~y~aPE~~~-------~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (470)
                      .....++..|+|||+..       ...++.++||||||+++|||++ |..||....+.+ .+...+..    .......+
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~----~~~~~~~~  233 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVRE----QDIKLPKP  233 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhhc----cCccCCCC
Confidence            23345677899999864       2356889999999999999999 788886543221 11111110    00001111


Q ss_pred             cccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                      .          .+..++..+.+++..|| .||++||++.||++.|
T Consensus       234 ~----------~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         234 Q----------LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             c----------ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            0          11234566788999999 5999999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-38  Score=311.63  Aligned_cols=264  Identities=20%  Similarity=0.213  Sum_probs=196.4

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      ...+|.+.+.||+|+||.||+|+.. +++.||+|+....      ....|+.++++++|+||+++++++......++|||
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            3467999999999999999999765 5788999975322      23469999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      ++. ++|.+++......+++..+..++.|++.||.|||   +++|+||||||+||+++.++.+||+|||++......   
T Consensus       138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---  210 (357)
T PHA03209        138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---  210 (357)
T ss_pred             ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccC---
Confidence            995 5899988776677899999999999999999999   999999999999999999999999999998743211   


Q ss_pred             ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCC-CccccC-cc-------hhhHHhhhhc--CCccc
Q 040392          330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPT-NEIFNG-EM-------TLKHWVNDWL--PISTM  398 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~-~~~~~~-~~-------~~~~~~~~~~--~~~~~  398 (470)
                      .......||..|+|||++.+..++.++|||||||++|||+++..|+ ...... +.       .+...+....  +....
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  290 (357)
T PHA03209        211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP  290 (357)
T ss_pred             cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence            1222356899999999999999999999999999999999965554 332111 00       0111111000  00000


Q ss_pred             ccccccc----------cC--chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          399 EVVGANL----------LS--QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       399 ~~~~~~~----------~~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      .......          ..  ...........++.++.+++.+||+.||++|||+.|+++|
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence            0000000          00  0000011112345567789999999999999999999876

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=9.7e-39  Score=310.78  Aligned_cols=240  Identities=27%  Similarity=0.321  Sum_probs=189.0

Q ss_pred             CeecccCceEEEEEEe-CCCcEEEEEEeeccc---chhhhhHHHHHH-HHhcCCCCcceeEEeeeccCCeeeEEEecCCC
Q 040392          179 NLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKGFDVECE-MMKSIRHRNLIKVISTCSNEEFKALVLEYMPH  253 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~  253 (470)
                      +.||+|+||.||+|+. .+|+.||+|++....   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999975 468999999986542   223334445544 57789999999999999999999999999999


Q ss_pred             CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccccc
Q 040392          254 GSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  333 (470)
Q Consensus       254 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  333 (470)
                      |+|..++... ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++......  .....
T Consensus        81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~  154 (325)
T cd05604          81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTTT  154 (325)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCcc
Confidence            9999888654 46889999999999999999999   999999999999999999999999999998753221  12223


Q ss_pred             ccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhh
Q 040392          334 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF  413 (470)
Q Consensus       334 ~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  413 (470)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......+     ..........        .       
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-----~~~~~~~~~~--------~-------  214 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE-----MYDNILHKPL--------V-------  214 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH-----HHHHHHcCCc--------c-------
Confidence            4568999999999999999999999999999999999999997532211     1111111000        0       


Q ss_pred             HhhhhhHHHHHHHHhhccCCCccCCCCHHHHH
Q 040392          414 VAKEQCVSCVFNLAMECTVESPEQRINAREIV  445 (470)
Q Consensus       414 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~  445 (470)
                       .....+..+.+++.+|+..+|.+||++.+.+
T Consensus       215 -~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         215 -LRPGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             -CCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence             0112355678999999999999999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.1e-38  Score=296.07  Aligned_cols=237  Identities=24%  Similarity=0.413  Sum_probs=190.0

Q ss_pred             CeecccCceEEEEEEeCCCc-----------EEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          179 NLIGRGGFGSVYKARLGDGM-----------EVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      +.||+|+||.||+|...+..           .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999875432           5788877644332 6778889999999999999999999887 778999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-------CeEEeeeccc
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-------VAHLSDFSIA  320 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~-------~~kl~Dfg~a  320 (470)
                      |||+++|+|.+++......+++..+..++.|++.||+|||   +.+++|+||||+||+++.++       .+||+|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            9999999999999876657899999999999999999999   99999999999999999888       7999999998


Q ss_pred             cccCCCCCcccccccccCccccCccccCCC--CCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcc
Q 040392          321 KLLTGEDQSMTQTQTLATIGYMAPEYGREG--RVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPIST  397 (470)
Q Consensus       321 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  397 (470)
                      .....      .....++..|+|||++.+.  .++.++||||||+++|||++ |..||...... . ...+..   ....
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-~-~~~~~~---~~~~  224 (259)
T cd05037         156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-E-KERFYQ---DQHR  224 (259)
T ss_pred             ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-h-HHHHHh---cCCC
Confidence            86532      2234466789999998876  78999999999999999999 57777664321 1 111111   0000


Q ss_pred             cccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          398 MEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                              ..         ......+.+++.+||..+|.+||++.++++.|
T Consensus       225 --------~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         225 --------LP---------MPDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             --------CC---------CCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                    00         00025688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6.2e-38  Score=299.42  Aligned_cols=268  Identities=24%  Similarity=0.321  Sum_probs=201.3

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      ++|+..+.||+|++|.||+|+.. +|+.||+|++....  ....+.+..|+++++.++|+|++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888999999999999999865 58999999986432  2233457789999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      |+++++|..++... ..+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07847          81 YCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-  155 (286)
T ss_pred             ccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence            99998888776543 36899999999999999999999   89999999999999999999999999999987643321 


Q ss_pred             ccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchh--hHHhhhhcCC--------ccc
Q 040392          330 MTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTL--KHWVNDWLPI--------STM  398 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~--~~~~~~~~~~--------~~~  398 (470)
                       ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||......+...  ........+.        ...
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07847         156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF  234 (286)
T ss_pred             -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence             1223457788999998865 457899999999999999999999997644322111  0000000000        000


Q ss_pred             -ccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          399 -EVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       399 -~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                       ....+......... ..-...+..+.+++.+||+.+|++||++.|++.+
T Consensus       235 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         235 KGLSIPEPETREPLE-SKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             ccccCCCcccccCHH-HHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence             00000000000000 0011236778999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.6e-38  Score=308.06  Aligned_cols=267  Identities=21%  Similarity=0.274  Sum_probs=196.8

Q ss_pred             CCCeeccc--CceEEEEEEe-CCCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          177 ENNLIGRG--GFGSVYKARL-GDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       177 ~~~~ig~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      +.+.||+|  +|++||+++. .+|+.||+|++....  ......+..|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  7899999965 578999999987542  233456778999999999999999999999999999999999


Q ss_pred             CCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc-
Q 040392          252 PHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS-  329 (470)
Q Consensus       252 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-  329 (470)
                      ++|+|.+++.... ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++++||+.+......... 
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            9999999996542 45889999999999999999999   999999999999999999999999999875543221111 


Q ss_pred             ----ccccccccCccccCccccCC--CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccc-----
Q 040392          330 ----MTQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTM-----  398 (470)
Q Consensus       330 ----~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----  398 (470)
                          .......++..|+|||++.+  ..++.++|||||||++|||++|+.||............ .....+....     
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~  237 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK-LNGTVPCLLDTTTIP  237 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH-hcCCccccccccchh
Confidence                01122346778999999876  45889999999999999999999999764332211111 1100000000     


Q ss_pred             --c--------cccccc-----------cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          399 --E--------VVGANL-----------LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       399 --~--------~~~~~~-----------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                        +        ..+...           ..............+..+.+++.+||+.||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence              0        000000           000000011122346678999999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.6e-38  Score=308.69  Aligned_cols=237  Identities=26%  Similarity=0.300  Sum_probs=186.7

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHH-HHHhcCCCCcceeEEeeeccCCeeeEEEecCCC
Q 040392          179 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVEC-EMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH  253 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~  253 (470)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999864 58899999986432   12233344444 467889999999999999999999999999999


Q ss_pred             CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccccc
Q 040392          254 GSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  333 (470)
Q Consensus       254 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  333 (470)
                      |+|...+... ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++......  .....
T Consensus        81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~  154 (321)
T cd05603          81 GELFFHLQRE-RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETTS  154 (321)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCccc
Confidence            9998888654 35788888999999999999999   999999999999999999999999999998753221  12223


Q ss_pred             ccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhh
Q 040392          334 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF  413 (470)
Q Consensus       334 ~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  413 (470)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||......     ...........                
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~~~~~----------------  213 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS-----QMYDNILHKPL----------------  213 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH-----HHHHHHhcCCC----------------
Confidence            456899999999999888999999999999999999999999763211     11111111100                


Q ss_pred             HhhhhhHHHHHHHHhhccCCCccCCCCHH
Q 040392          414 VAKEQCVSCVFNLAMECTVESPEQRINAR  442 (470)
Q Consensus       414 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~  442 (470)
                      ..+...+.++.+++.+||+.||.+||++.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            00112255688999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.1e-38  Score=309.05  Aligned_cols=255  Identities=20%  Similarity=0.260  Sum_probs=199.3

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ++|.+.+.||+|+||.||+++.. +++.||+|++...   .......+..|..++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47889999999999999999865 5788999998642   1223445778999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||+++|+|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++........
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            999999999999876667899999999999999999999   99999999999999999999999999999976643221


Q ss_pred             cccccccccCccccCccccCC-----CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccc
Q 040392          329 SMTQTQTLATIGYMAPEYGRE-----GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA  403 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (470)
                       .......||+.|+|||++.+     +.++.++||||||+++|||++|+.||......+ .......   ...... ...
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-~~~~i~~---~~~~~~-~p~  231 (331)
T cd05624         158 -VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKIMN---HEERFQ-FPS  231 (331)
T ss_pred             -eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH-HHHHHHc---CCCccc-CCC
Confidence             22233568999999998865     467889999999999999999999997532211 1111100   000000 000


Q ss_pred             cccCchhhhhHhhhhhHHHHHHHHhhccCCCccC--CCCHHHHHHH
Q 040392          404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQ--RINAREIVAK  447 (470)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~el~~~  447 (470)
                      .           ....+.++.+++.+|+..++++  |++++++++|
T Consensus       232 ~-----------~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         232 H-----------ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             c-----------cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            0           0123566889999999876554  4688888876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9.5e-40  Score=287.32  Aligned_cols=252  Identities=26%  Similarity=0.399  Sum_probs=203.4

Q ss_pred             hCCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccc--------hhhhhHHHHHHHHhcC-CCCcceeEEeeeccC
Q 040392          172 TDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCG--------RALKGFDVECEMMKSI-RHRNLIKVISTCSNE  241 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~  241 (470)
                      -++|...+.||.|..++|-+.. ..+|.++|+|++.....        +..+.-..|+.+|+++ .||+|+++.++++.+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            4567888899999999999885 45789999999864321        1233445699999998 599999999999999


Q ss_pred             CeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecccc
Q 040392          242 EFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK  321 (470)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~  321 (470)
                      .+.++|+|.|+.|.|.+++.+. ..+++....+|+.|+.+|++|||   .+.|+||||||+|||++++.++||+|||+|+
T Consensus        96 sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa~  171 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFAC  171 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccceee
Confidence            9999999999999999999544 47899999999999999999999   9999999999999999999999999999999


Q ss_pred             ccCCCCCcccccccccCccccCccccC------CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCC
Q 040392          322 LLTGEDQSMTQTQTLATIGYMAPEYGR------EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPI  395 (470)
Q Consensus       322 ~~~~~~~~~~~~~~~~t~~y~aPE~~~------~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  395 (470)
                      .+.+..   .....+||++|+|||.+.      ...|+..+|+||.||+||-|+.|..||..-  ...-+...+   .. 
T Consensus       172 ~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR--kQmlMLR~I---me-  242 (411)
T KOG0599|consen  172 QLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR--KQMLMLRMI---ME-  242 (411)
T ss_pred             ccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH--HHHHHHHHH---Hh-
Confidence            875432   334578999999999875      235788899999999999999999998652  111111111   11 


Q ss_pred             cccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          396 STMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                                 +......+...+.+.+..+|+.+||++||.+|.|++|+++|
T Consensus       243 -----------GkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  243 -----------GKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             -----------cccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence                       11112222334557788999999999999999999999986

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1e-37  Score=293.00  Aligned_cols=250  Identities=31%  Similarity=0.568  Sum_probs=201.7

Q ss_pred             CCCCCeecccCceEEEEEEeCC-----CcEEEEEEeecccch-hhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          175 FSENNLIGRGGFGSVYKARLGD-----GMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      +++.+.||.|+||.||+++..+     +..||+|.+...... ..+.+..|+++++.++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567899999999999998653     488999999755433 5678889999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      ||+++++|.+++...... +++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            999999999999765544 899999999999999999999   9999999999999999999999999999998665432


Q ss_pred             CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCccccccccccc
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL  406 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (470)
                      .... ....++..|+|||.+.+..++.++|+||+|+++++|++ |+.||......  .........   ...        
T Consensus       158 ~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~--~~~~~~~~~---~~~--------  223 (258)
T smart00219      158 YYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE--EVLEYLKKG---YRL--------  223 (258)
T ss_pred             cccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhcC---CCC--------
Confidence            2211 12336789999999988889999999999999999998 78887652211  111111110   000        


Q ss_pred             CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       407 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                             ..+..++.++.+++.+||+.||++|||+.|+++.|
T Consensus       224 -------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      224 -------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                   00112467789999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.9e-38  Score=300.20  Aligned_cols=259  Identities=22%  Similarity=0.292  Sum_probs=200.8

Q ss_pred             HHHHHhhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcC-CCCcceeEEeeec----
Q 040392          166 LELCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSI-RHRNLIKVISTCS----  239 (470)
Q Consensus       166 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~----  239 (470)
                      ..+....++|++.+.||+|+||.||+|... +++.+|+|++.... .....+..|+.+++.+ +||||+++++++.    
T Consensus        11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   89 (286)
T cd06638          11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV   89 (286)
T ss_pred             ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence            344556789999999999999999999754 58899999876432 2235577899999999 6999999999873    


Q ss_pred             -cCCeeeEEEecCCCCChHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEe
Q 040392          240 -NEEFKALVLEYMPHGSLEKYMYS---SNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLS  315 (470)
Q Consensus       240 -~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~  315 (470)
                       .+...++||||+++++|.+++..   ....+++..+..++.|+++||.|||   +.+++||||||+||+++.++.+||+
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl~  166 (286)
T cd06638          90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLV  166 (286)
T ss_pred             CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEEc
Confidence             44678999999999999988753   2346788899999999999999999   9999999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccCccccCccccCC-----CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhh
Q 040392          316 DFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE-----GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVN  390 (470)
Q Consensus       316 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~  390 (470)
                      |||++..+....  .......++..|+|||++..     ..++.++|||||||++|||++|+.||......+. .... .
T Consensus       167 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-~~~~-~  242 (286)
T cd06638         167 DFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-LFKI-P  242 (286)
T ss_pred             cCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-Hhhc-c
Confidence            999987654321  12233468899999998753     4478899999999999999999999875422111 1100 0


Q ss_pred             hhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          391 DWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       391 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                      ...        .+..        ..+..++.++.+++.+||+.||++||++.|++++.
T Consensus       243 ~~~--------~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         243 RNP--------PPTL--------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             ccC--------CCcc--------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            000        0000        01112345688999999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7.8e-38  Score=293.84  Aligned_cols=250  Identities=22%  Similarity=0.308  Sum_probs=204.5

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          174 GFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      +|+..+.||.|+||.||.++. .+++.+++|.+...  .......+.+|++++++++|+||+++++++.+....+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            478889999999999999974 46889999998654  234556788899999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          251 MPHGSLEKYMYSS-NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       251 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      +++++|.+++... ...+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            9999999999765 356899999999999999999999   89999999999999999999999999999886643221 


Q ss_pred             ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCch
Q 040392          330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE  409 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (470)
                       ......++..|+|||.+.+..++.++|+||||+++|||++|..||......+     ............          
T Consensus       157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-----~~~~~~~~~~~~----------  220 (256)
T cd08221         157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN-----LVVKIVQGNYTP----------  220 (256)
T ss_pred             -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHHHcCCCCC----------
Confidence             2234568899999999988889999999999999999999999986532211     111111110000          


Q ss_pred             hhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       410 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                           .+..++.++.+++.+||..+|++||++.++++++
T Consensus       221 -----~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         221 -----VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             -----CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence                 0123366788999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.1e-38  Score=296.47  Aligned_cols=255  Identities=25%  Similarity=0.380  Sum_probs=199.3

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccc----------hhhhhHHHHHHHHhcCCCCcceeEEeeeccCC
Q 040392          174 GFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCG----------RALKGFDVECEMMKSIRHRNLIKVISTCSNEE  242 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  242 (470)
                      +|...+.||+|++|.||+|.. .+|+.||+|.++....          ...+.+..|+.+++.++|+|++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            467789999999999999975 4689999998753211          12345778999999999999999999999999


Q ss_pred             eeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccc
Q 040392          243 FKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL  322 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~  322 (470)
                      ..++||||+++++|.+++... ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++++|||++..
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            999999999999999999765 46888999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCCCcccccccccCccccCccccCCCC--CCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccc
Q 040392          323 LTGEDQSMTQTQTLATIGYMAPEYGREGR--VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEV  400 (470)
Q Consensus       323 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (470)
                      ..............++..|+|||.+....  ++.++|+||||+++||+++|..||......+    .+.... .......
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~-~~~~~~~  232 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA----AMFKLG-NKRSAPP  232 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH----HHHHhh-ccccCCc
Confidence            53322222223345788999999887654  7899999999999999999999986432211    111100 0000000


Q ss_pred             ccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          401 VGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      +...          ....++.++.+++.+||..+|++||++.+++++
T Consensus       233 ~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         233 IPPD----------VSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             CCcc----------ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            0000          011246678999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.2e-38  Score=312.02  Aligned_cols=266  Identities=22%  Similarity=0.226  Sum_probs=197.4

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccC------
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNE------  241 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~------  241 (470)
                      ..++|.+.+.||+|+||.||+|... .++.||||++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3578999999999999999999754 5889999998643  233455677899999999999999999887543      


Q ss_pred             CeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecccc
Q 040392          242 EFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK  321 (470)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~  321 (470)
                      ...++||||+++ +|.+.+..   .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            357899999975 77777743   3788889999999999999999   9999999999999999999999999999997


Q ss_pred             ccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc--cc-
Q 040392          322 LLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS--TM-  398 (470)
Q Consensus       322 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~-  398 (470)
                      .....   .......+|..|+|||++.+..++.++|||||||++|||++|+.||......+ .+...+.......  .. 
T Consensus       175 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~  250 (364)
T cd07875         175 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEFMK  250 (364)
T ss_pred             ccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHH
Confidence            65321   12234568999999999999999999999999999999999999997643211 1111111000000  00 


Q ss_pred             -------cccc----------ccccCch--hhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          399 -------EVVG----------ANLLSQE--DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       399 -------~~~~----------~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                             ....          .......  ............++.+++.+||+.||.+|||+.|+++|
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                   0000          0000000  00000011124568899999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=5.9e-38  Score=296.51  Aligned_cols=251  Identities=22%  Similarity=0.337  Sum_probs=196.4

Q ss_pred             CCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc-----chhhhhHHHHHHHHhcCCCCcceeEEeeecc--CCee
Q 040392          173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC-----GRALKGFDVECEMMKSIRHRNLIKVISTCSN--EEFK  244 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~  244 (470)
                      .+|+..+.||+|+||.||+|.. .++..||+|.+....     .+....+.+|+.+++.++||||+++++++.+  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4788999999999999999975 458999999886432     2344567889999999999999999998865  3577


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccC
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~  324 (470)
                      ++++||+++++|.+++.... .+++.....++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++....
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            89999999999999996544 4788899999999999999999   9999999999999999999999999999987653


Q ss_pred             CCCCc-ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccc
Q 040392          325 GEDQS-MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA  403 (470)
Q Consensus       325 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (470)
                      ..... .......++..|+|||.+.+..++.++||||||+++|||++|+.||......+ .....    ....    ..+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~-~~~~~----~~~~----~~~  228 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA-AIFKI----ATQP----TNP  228 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH-HHHHH----hcCC----CCC
Confidence            22111 11123457889999999998889999999999999999999999997642211 11110    0000    000


Q ss_pred             cccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      .          .+..++..+.+++ +||..+|++||+++|+++|
T Consensus       229 ~----------~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         229 Q----------LPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             C----------CchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence            0          0122344566777 6888999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.8e-38  Score=307.51  Aligned_cols=255  Identities=19%  Similarity=0.232  Sum_probs=198.6

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ++|.+.+.||+|+||.||+++.+ +++.+|+|++...   .......+..|+.++..++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46888999999999999999865 4788999998642   1223345778999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||+++|+|.+++......+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++....... 
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~-  156 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-  156 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCC-
Confidence            999999999999876667899999999999999999999   9999999999999999999999999999987653222 


Q ss_pred             cccccccccCccccCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccc
Q 040392          329 SMTQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA  403 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (470)
                      ........||+.|+|||++.     ...++.++|||||||++|||++|+.||......+     ..............  
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~-----~~~~i~~~~~~~~~--  229 (332)
T cd05623         157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-----TYGKIMNHKERFQF--  229 (332)
T ss_pred             cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH-----HHHHHhCCCccccC--
Confidence            12223356899999999886     3458899999999999999999999997532211     11111000000000  


Q ss_pred             cccCchhhhhHhhhhhHHHHHHHHhhccCCCccC--CCCHHHHHHH
Q 040392          404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQ--RINAREIVAK  447 (470)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~el~~~  447 (470)
                               ......++.++.+++.+|+..+|.+  |+++.|+++|
T Consensus       230 ---------p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         230 ---------PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ---------CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence                     0001234667889999988654444  7899999988

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=7.8e-38  Score=299.67  Aligned_cols=270  Identities=22%  Similarity=0.282  Sum_probs=200.3

Q ss_pred             hhCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccc-hhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ++++|.+.+.||+|+||.||+|.. .+|+.||+|++..... .....+.+|+++++.++|+||+++++++......++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            357899999999999999999975 4689999999865432 22335678999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||+. +++.+++......+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||+++...... 
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  157 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-  157 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC-
Confidence            9996 6887777665556788888999999999999999   8999999999999999999999999999987543221 


Q ss_pred             cccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhh-cCC-----------
Q 040392          329 SMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDW-LPI-----------  395 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~-----------  395 (470)
                       .......++..|+|||.+.+. .++.++||||||+++|||++|+.||....+....+....... .+.           
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07870         158 -QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP  236 (291)
T ss_pred             -CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence             112334578899999998754 478899999999999999999999976443221111111000 000           


Q ss_pred             -cccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          396 -STMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       396 -~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                       ...+.. .................+.++.+++.+|+..||.+|||+.|++.+
T Consensus       237 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         237 NYKPEWF-LPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             cccchhc-cccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence             000000 000000000000111124568899999999999999999998764

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.1e-38  Score=302.80  Aligned_cols=252  Identities=22%  Similarity=0.325  Sum_probs=200.3

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc-cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ-CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      ++|++.+.||+|+||.||+|... ++..||+|.+... .......+.+|++++++++|+||+++++++......++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            46888999999999999999865 6899999988654 233456788899999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          251 MPHGSLEKYMYSS--NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       251 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      +++++|.+++...  ...+++..+..++.|++.||.|||.  +.+++|+||||+||+++.++.+||+|||++..+...  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  156 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--  156 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence            9999999998764  2368999999999999999999992  258999999999999999999999999998765322  


Q ss_pred             cccccccccCccccCccccCCCC------CCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccc
Q 040392          329 SMTQTQTLATIGYMAPEYGREGR------VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVG  402 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~------~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (470)
                        ......++..|+|||.+.+..      ++.++|+|||||++|+|++|+.||........ . ...........     
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~-~~~~~~~~~~~-----  227 (286)
T cd06622         157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI-F-AQLSAIVDGDP-----  227 (286)
T ss_pred             --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH-H-HHHHHHhhcCC-----
Confidence              112345788999999886543      47899999999999999999999975322111 0 00000000000     


Q ss_pred             ccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          403 ANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                                ...+..++.++.+++.+||..+|++||++.+++.+
T Consensus       228 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         228 ----------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             ----------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence                      00112246778899999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=8.9e-38  Score=295.06  Aligned_cols=257  Identities=26%  Similarity=0.341  Sum_probs=206.3

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      ++|++.+.||.|+||+||+|... ++..+++|++.... ......+..|+++++.++|+||+++++.+......++|||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47889999999999999999754 68899999986442 33567788999999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          251 MPHGSLEKYMYSSN--YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       251 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      +++++|.+++....  ..+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.++|+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            99999999997542  46899999999999999999999   99999999999999999999999999999887654332


Q ss_pred             cc--cccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          329 SM--TQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       329 ~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      ..  ......++..|+|||++... .++.++|+||||+++|||++|+.||......+ ..........+ .        .
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~-~--------~  227 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQNDPP-S--------L  227 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcCCCC-C--------c
Confidence            21  22334688899999998776 78999999999999999999999997643322 11111111000 0        0


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ...     .....++..+.+++.+||..||++||++.+++++
T Consensus       228 ~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         228 ETG-----ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             CCc-----cccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            000     0012346778999999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.8e-38  Score=299.64  Aligned_cols=247  Identities=23%  Similarity=0.358  Sum_probs=200.8

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      .|+..+.||+|+||.||+|... ++..||+|.+.... ....+.+..|+++++.++||||+++++++......++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            3566788999999999999754 57889999987443 344567889999999999999999999999999999999999


Q ss_pred             CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccc
Q 040392          252 PHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  331 (470)
Q Consensus       252 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  331 (470)
                      ++++|.+++..  ..+++..+..++.|+++|+.|||   +.+++|+||+|+||++++++.++++|||++..+....  ..
T Consensus        85 ~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06642          85 GGGSALDLLKP--GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             CCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcc--hh
Confidence            99999998864  35788999999999999999999   8999999999999999999999999999987654321  12


Q ss_pred             ccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhh
Q 040392          332 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDI  411 (470)
Q Consensus       332 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  411 (470)
                      .....++..|+|||.+.+..++.++|+||||+++|||++|+.|+........  ..+.....+        +        
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~--------~--------  219 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LFLIPKNSP--------P--------  219 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--HhhhhcCCC--------C--------
Confidence            2234578899999999988899999999999999999999999875432211  111110000        0        


Q ss_pred             hhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          412 HFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       412 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                        ..+..++.++.+++.+||+.+|++||++.+++++
T Consensus       220 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         220 --TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             --CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence              0012235678899999999999999999999985

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=4e-38  Score=305.52  Aligned_cols=195  Identities=22%  Similarity=0.320  Sum_probs=159.5

Q ss_pred             CCeecccCceEEEEEEeC---CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeecc--CCeeeEEEecCC
Q 040392          178 NNLIGRGGFGSVYKARLG---DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN--EEFKALVLEYMP  252 (470)
Q Consensus       178 ~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~~lv~e~~~  252 (470)
                      .+.||+|+||.||+|+..   +++.||+|.+....  ....+.+|++++++++||||+++++++..  ....+++|||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999854   46789999986432  23446789999999999999999998843  456789999996


Q ss_pred             CCChHHhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee----CCCCCeEEeeeccc
Q 040392          253 HGSLEKYMYSS--------NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL----DDNMVAHLSDFSIA  320 (470)
Q Consensus       253 ~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill----~~~~~~kl~Dfg~a  320 (470)
                      + +|.+++...        ...+++..+..++.|++.||.|||   +.+|+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            4 888877532        135788899999999999999999   9999999999999999    46679999999999


Q ss_pred             cccCCCCCc-ccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcc
Q 040392          321 KLLTGEDQS-MTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEI  378 (470)
Q Consensus       321 ~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~  378 (470)
                      ......... .......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            876432221 22234578999999998876 45899999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1e-37  Score=293.05  Aligned_cols=249  Identities=23%  Similarity=0.358  Sum_probs=200.1

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeecc-CCeeeEEEe
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSN-EEFKALVLE  249 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~~~~~lv~e  249 (470)
                      +|++.+.||+|++|.||++... +++.||+|.+....  ....+.+..|++++++++|+|++++++.+.. ....+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788999999999999999754 57899999986442  3345567889999999999999999988764 446789999


Q ss_pred             cCCCCChHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          250 YMPHGSLEKYMYSS-NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       250 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      |+++++|.+++... ...+++.++..++.+++.|+++||   +.+++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-  156 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-  156 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence            99999999998764 345899999999999999999999   9999999999999999999999999999988664322 


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                       .......+++.|+|||++.+..++.++|+||||+++++|++|+.||........ .........+.             
T Consensus       157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~-------------  221 (257)
T cd08223         157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL-VYRIIEGKLPP-------------  221 (257)
T ss_pred             -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHhcCCCC-------------
Confidence             122335678899999999998999999999999999999999999875322111 11111111000             


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                            .+...+..+.+++.+||+.+|++||++.+++++
T Consensus       222 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         222 ------MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ------CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                  011235678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.5e-37  Score=294.17  Aligned_cols=251  Identities=22%  Similarity=0.363  Sum_probs=187.7

Q ss_pred             eecccCceEEEEEEeCCC---cEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCCCC
Q 040392          180 LIGRGGFGSVYKARLGDG---MEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGS  255 (470)
Q Consensus       180 ~ig~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~  255 (470)
                      .||+|+||.||+|...++   ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            599999999999975433   346677665433 3345678889999999999999999999999999999999999999


Q ss_pred             hHHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccc
Q 040392          256 LEKYMYSSN---YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ  332 (470)
Q Consensus       256 L~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  332 (470)
                      |.+++....   ...+......++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            999997543   34566677889999999999999   899999999999999999999999999998643222222222


Q ss_pred             cccccCccccCccccCC-------CCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCccccccccc
Q 040392          333 TQTLATIGYMAPEYGRE-------GRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN  404 (470)
Q Consensus       333 ~~~~~t~~y~aPE~~~~-------~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (470)
                      ....++..|+|||++..       ..++.++||||||+++|||++ |..||......+ .+.....    .......++.
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~----~~~~~~~~~~  233 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE-VLNHVIK----DQQVKLFKPQ  233 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHh----hcccccCCCc
Confidence            34567889999998743       245789999999999999997 566776432211 1111111    1111111111


Q ss_pred             ccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHH
Q 040392          405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLL  449 (470)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~  449 (470)
                      ..          ...+..+.+++..|| .+|++||++.|+++.|.
T Consensus       234 ~~----------~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         234 LE----------LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             cC----------CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            11          112556788999999 68999999999998773

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=296.68  Aligned_cols=249  Identities=26%  Similarity=0.372  Sum_probs=211.9

Q ss_pred             CCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCC
Q 040392          175 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH  253 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~  253 (470)
                      |.++++||+|+||.||+|. ..+|+.+|||.+..+  ...+.+..|+.+|++++.|++|++||.+.......+|||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            6778999999999999995 457999999998643  4567788899999999999999999998888888999999999


Q ss_pred             CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccccc
Q 040392          254 GSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  333 (470)
Q Consensus       254 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  333 (470)
                      |++.+.+...+..+++..+..++..-+.||+|||   ...-+|||||+.|||++-+|.+||.|||.|..++.  .-....
T Consensus       113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKRN  187 (502)
T KOG0574|consen  113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKRN  187 (502)
T ss_pred             CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhhC
Confidence            9999999999999999999999999999999999   77889999999999999999999999999976642  222334


Q ss_pred             ccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhh
Q 040392          334 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF  413 (470)
Q Consensus       334 ~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  413 (470)
                      ...||+.|||||++..-.|+.++||||+|++..||..|+.||.+...-..              .-.+    .......+
T Consensus       188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA--------------IFMI----PT~PPPTF  249 (502)
T KOG0574|consen  188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA--------------IFMI----PTKPPPTF  249 (502)
T ss_pred             ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce--------------eEec----cCCCCCCC
Confidence            57899999999999988999999999999999999999999987543211              0000    01112223


Q ss_pred             HhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          414 VAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       414 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                      ..|+..+.++.+++++||-+.|++|-++.++++|-
T Consensus       250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~  284 (502)
T KOG0574|consen  250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT  284 (502)
T ss_pred             CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence            34567789999999999999999999999999874

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=302.17  Aligned_cols=249  Identities=24%  Similarity=0.335  Sum_probs=209.8

Q ss_pred             hCCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ..-|...+.||+|.|+.|-.|+ .-+|..||||++++..  .-....+.+|++.|+.++|||||++|.+.......|+|+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            4458888999999999999996 4589999999997653  234456788999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee-CCCCCeEEeeeccccccCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL-DDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill-~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |.-++|+|.+|+.+....+.+....+++.||+.|+.|+|   +..++||||||+||.+ ..-|-+||+|||++..+.+..
T Consensus        97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~  173 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK  173 (864)
T ss_pred             EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence            999999999999998888999999999999999999999   8999999999999765 678899999999998765432


Q ss_pred             CcccccccccCccccCccccCCCCCC-CccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccccc
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRVS-TNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL  406 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (470)
                         .....+|+..|-|||++.+..|+ +++|||||||+||.|++|+.||....+.|. +...++..              
T Consensus       174 ---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-LTmImDCK--------------  235 (864)
T KOG4717|consen  174 ---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-LTMIMDCK--------------  235 (864)
T ss_pred             ---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-hhhhhccc--------------
Confidence               33457899999999999999987 578999999999999999999997655442 22111110              


Q ss_pred             CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       407 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                            ...|...+.+..+||.+||..||.+|.+.+||+.+
T Consensus       236 ------YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  236 ------YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             ------ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence                  11223347778999999999999999999998764

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.2e-37  Score=292.77  Aligned_cols=248  Identities=25%  Similarity=0.336  Sum_probs=201.4

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-----chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-----GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      +|+..+.||+|++|.||+|... +++.|++|.+....     .+..+.+..|+++++.++|+||+++++++......+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4777899999999999999865 78999999986532     23456788899999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      +||+++++|.+++.... .+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||.+.......
T Consensus        81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            99999999999997654 5789999999999999999999   9999999999999999999999999999987653322


Q ss_pred             CcccccccccCccccCccccCCCC-CCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccccc
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL  406 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (470)
                         ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||......... ..+.. ...  .         
T Consensus       157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~-~~~--~---------  220 (258)
T cd06632         157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV-FKIGR-SKE--L---------  220 (258)
T ss_pred             ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH-HHHHh-ccc--C---------
Confidence               223456888999999887766 899999999999999999999999764321111 11000 000  0         


Q ss_pred             CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       407 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                            ...+..++.++.+++.+||+.+|.+||++.+++.+
T Consensus       221 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         221 ------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             ------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence                  00112235668899999999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=8.3e-38  Score=298.53  Aligned_cols=267  Identities=23%  Similarity=0.287  Sum_probs=203.4

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      +|++.+.||+|++|.||+|+.. +|+.||+|++....  ......+..|+.++++++||||+++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4788899999999999999864 68999999987543  33456788899999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      + +++|.+++......+++.++..++.|+++||+|||   +.+++|+||||+||+++.++.++|+|||.+........ .
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~  155 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R  155 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence            9 99999999776677899999999999999999999   99999999999999999999999999999886643321 1


Q ss_pred             cccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcc-------ccc--
Q 040392          331 TQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIST-------MEV--  400 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~~--  400 (470)
                      ......++..|+|||.+.+. .++.++||||+|+++|||++|..||....+. ..+.. .........       .+.  
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAI-VFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHH-HHHHcCCCChHHHhhccCcch
Confidence            22345688899999988654 4689999999999999999998777653221 11111 111100000       000  


Q ss_pred             ccccccC-chhhh-hHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          401 VGANLLS-QEDIH-FVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       401 ~~~~~~~-~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ....... ..... .....+.+.++.+++.+||+.+|++||+++++++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0000000 00000 00112335788999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.8e-38  Score=307.73  Aligned_cols=266  Identities=24%  Similarity=0.253  Sum_probs=196.8

Q ss_pred             HhhCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccC-----
Q 040392          170 RATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNE-----  241 (470)
Q Consensus       170 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-----  241 (470)
                      ...++|++.+.||+|+||.||+|.. .+++.||||.+....  ......+.+|+++++.++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            3467899999999999999999975 468899999986432  22345567899999999999999999887533     


Q ss_pred             -CeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccc
Q 040392          242 -EFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA  320 (470)
Q Consensus       242 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a  320 (470)
                       ...++++|++ +++|.+++...  .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCccc
Confidence             3568999988 67998887543  4889999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCcccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc--c
Q 040392          321 KLLTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS--T  397 (470)
Q Consensus       321 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~  397 (470)
                      ......     .....+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...... ..+..+........  .
T Consensus       166 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~  239 (343)
T cd07878         166 RQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIMEVVGTPSPEV  239 (343)
T ss_pred             eecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCCHHH
Confidence            865322     223468999999999876 56889999999999999999999999753211 11111111000000  0


Q ss_pred             cccccc--------cccCchhhh-hHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          398 MEVVGA--------NLLSQEDIH-FVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       398 ~~~~~~--------~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ...+..        .+....... ..........+.+++.+||..||++|||+.|+++|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000000        000000000 00001224557899999999999999999999976

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5.3e-38  Score=300.82  Aligned_cols=258  Identities=26%  Similarity=0.334  Sum_probs=201.1

Q ss_pred             HHHHHhhCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcC-CCCcceeEEeeeccC--
Q 040392          166 LELCRATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSI-RHRNLIKVISTCSNE--  241 (470)
Q Consensus       166 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~--  241 (470)
                      .++..++++|.+.+.||+|+||.||+|.. .+++.+|+|++.... .....+..|+.+++++ +|||++++++++...  
T Consensus        15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~   93 (291)
T cd06639          15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK   93 (291)
T ss_pred             ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence            44555688999999999999999999976 468899999986432 2345567899999998 799999999998643  


Q ss_pred             ---CeeeEEEecCCCCChHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEe
Q 040392          242 ---EFKALVLEYMPHGSLEKYMYS---SNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLS  315 (470)
Q Consensus       242 ---~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~  315 (470)
                         ...++||||+++++|.+++..   ....+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.+||+
T Consensus        94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~kl~  170 (291)
T cd06639          94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLV  170 (291)
T ss_pred             cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEe
Confidence               357899999999999998853   3356889999999999999999999   8999999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccCccccCccccCCC-----CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhh
Q 040392          316 DFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-----RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVN  390 (470)
Q Consensus       316 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~  390 (470)
                      |||++........  ......++..|+|||.+...     .++.++|||||||++|||++|+.||......+ ....+..
T Consensus       171 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-~~~~~~~  247 (291)
T cd06639         171 DFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-TLFKIPR  247 (291)
T ss_pred             ecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-HHHHHhc
Confidence            9999876542221  12234578899999987543     36889999999999999999999987643221 1111111


Q ss_pred             hhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          391 DWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       391 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      . .+.        ...        .++.....+.+++.+||+.+|++||++.|++++
T Consensus       248 ~-~~~--------~~~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         248 N-PPP--------TLL--------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             C-CCC--------CCC--------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            0 000        000        012234568899999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.2e-37  Score=296.94  Aligned_cols=250  Identities=27%  Similarity=0.360  Sum_probs=193.8

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHH-HhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKGFDVECEM-MKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      ++|++.+.||+|+||.||+|... +|+.||+|+++... ......+..|..+ ++.+.||||+++++++......+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888999999999999999765 69999999987542 2233344555554 666789999999999999999999999


Q ss_pred             cCCCCChHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCCeeeCCCCCeEEeeeccccccCC
Q 040392          250 YMPHGSLEKYMYS---SNYILDIFQRLNIMIDVASALEYLHFGYSA-PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       250 ~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  325 (470)
                      |++ |+|.+++..   ....+++..++.++.|++.||+|||   ++ +++||||||+||+++.++.+||+|||++..+..
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 588887754   2346899999999999999999999   76 999999999999999999999999999876532


Q ss_pred             CCCcccccccccCccccCccccCC----CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccc
Q 040392          326 EDQSMTQTQTLATIGYMAPEYGRE----GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVV  401 (470)
Q Consensus       326 ~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (470)
                      .   .......++..|+|||.+.+    ..++.++|+||||+++|||++|+.||.........+....... .       
T Consensus       157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~-------  225 (283)
T cd06617         157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP-S-------  225 (283)
T ss_pred             c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC-C-------
Confidence            1   11223457889999998865    4468899999999999999999999875332211111111100 0       


Q ss_pred             cccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          402 GANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                       +..         ....++.++.+++.+||..+|++||++.+++.+
T Consensus       226 -~~~---------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         226 -PQL---------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             -CCC---------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             000         011236678999999999999999999999874

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.6e-37  Score=293.99  Aligned_cols=251  Identities=23%  Similarity=0.352  Sum_probs=199.5

Q ss_pred             CCCCCCeecccCceEEEEEEeCC--CcEEEEEEeeccc----------chhhhhHHHHHHHHhc-CCCCcceeEEeeecc
Q 040392          174 GFSENNLIGRGGFGSVYKARLGD--GMEVAVKVFNLQC----------GRALKGFDVECEMMKS-IRHRNLIKVISTCSN  240 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~nIv~~~~~~~~  240 (470)
                      +|++.+.||+|+||.||+|....  ++.+|+|.+....          ......+..|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999998654  7889999875321          2233456678887765 799999999999999


Q ss_pred             CCeeeEEEecCCCCChHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCCeeeCCCCCeEEee
Q 040392          241 EEFKALVLEYMPHGSLEKYMYS---SNYILDIFQRLNIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNMVAHLSD  316 (470)
Q Consensus       241 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~i~H~dlkp~Nill~~~~~~kl~D  316 (470)
                      .+..+++|||+++++|.+++..   ....+++..++.++.|++.||.|||   + .+++|+||+|+||+++.++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEec
Confidence            9999999999999999988743   3456889999999999999999999   5 6899999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc
Q 040392          317 FSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS  396 (470)
Q Consensus       317 fg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  396 (470)
                      ||.+.......   ......++..|+|||.+.+..++.++|+||||+++|||++|+.||......  .....+.   ...
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~--~~~~~~~---~~~  229 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML--SLATKIV---EAV  229 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH--HHHHHHh---hcc
Confidence            99998654322   233456888999999999888999999999999999999999998653211  1111100   000


Q ss_pred             ccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHH
Q 040392          397 TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLL  449 (470)
Q Consensus       397 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~  449 (470)
                      ...              .....++.++.+++.+||+.||++||++.|+.++++
T Consensus       230 ~~~--------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         230 YEP--------------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             CCc--------------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            000              001123567889999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.3e-37  Score=295.21  Aligned_cols=254  Identities=28%  Similarity=0.476  Sum_probs=199.2

Q ss_pred             CCCCCeecccCceEEEEEEeC----CCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCC------
Q 040392          175 FSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEE------  242 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~------  242 (470)
                      |.+.+.||+|+||.||+|.+.    ++..||+|++..+  .....+.+..|+++++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999753    3688999998654  2334567888999999999999999999875432      


Q ss_pred             eeeEEEecCCCCChHHhhhcCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeee
Q 040392          243 FKALVLEYMPHGSLEKYMYSSN-----YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF  317 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  317 (470)
                      ..++++||+++|+|.+++....     ..+++.....++.|++.||+|||   +.+++|+||||+||+++.++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            3478899999999988874321     35788899999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCc
Q 040392          318 SIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPIS  396 (470)
Q Consensus       318 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  396 (470)
                      |+++...............++..|++||.+....++.++||||||+++|||++ |+.||......  ....++.......
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~  235 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--EIYNYLIKGNRLK  235 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--HHHHHHHcCCcCC
Confidence            99986643322222223345678999999988889999999999999999999 88888754321  1222211110000


Q ss_pred             ccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          397 TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       397 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                                        .+..++..+.+++.+||+.+|++||++.|+++.|+++
T Consensus       236 ------------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         236 ------------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             ------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                              0112356789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.2e-37  Score=292.66  Aligned_cols=249  Identities=21%  Similarity=0.306  Sum_probs=202.7

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          174 GFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      +|++.+.||+|+||.||++.. .+|+.||+|.+...  .......+.+|+.+++.++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            478899999999999999975 46899999998643  233455788899999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          251 MPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       251 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      +++++|.+++.... ..+++.++..++.|++.|+.|||   +.+++|+||+|+||+++.++.++++|||++.......  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~--  155 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--  155 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch--
Confidence            99999999986643 35788999999999999999999   8999999999999999999999999999997654321  


Q ss_pred             ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCch
Q 040392          330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE  409 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (470)
                      .......++..|+|||.+.+..++.++|+||||+++++|++|+.||......     ..+.........           
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~-----------  219 (256)
T cd08218         156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-----NLVLKIIRGSYP-----------  219 (256)
T ss_pred             hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH-----HHHHHHhcCCCC-----------
Confidence            1122345788999999998888999999999999999999999998653211     111111111000           


Q ss_pred             hhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       410 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                          ..+..++.++.+++.+||+.+|.+||++.+++++
T Consensus       220 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         220 ----PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             ----CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence                0122346678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5.8e-38  Score=299.14  Aligned_cols=257  Identities=22%  Similarity=0.321  Sum_probs=200.5

Q ss_pred             HHHHHhhCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcC-CCCcceeEEeeecc---
Q 040392          166 LELCRATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSI-RHRNLIKVISTCSN---  240 (470)
Q Consensus       166 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~---  240 (470)
                      .++....+.|++.+.||+|+||.||+|.. .+++.+|+|++.... .....+..|+.+++++ +|+||+++++++..   
T Consensus         9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   87 (282)
T cd06636           9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP   87 (282)
T ss_pred             hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence            34444567899999999999999999976 468899999986543 2345677899999998 69999999999853   


Q ss_pred             ---CCeeeEEEecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEee
Q 040392          241 ---EEFKALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSD  316 (470)
Q Consensus       241 ---~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~D  316 (470)
                         ....+++|||+++|+|.+++.... ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|
T Consensus        88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l~d  164 (282)
T cd06636          88 PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVD  164 (282)
T ss_pred             cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEee
Confidence               457899999999999999987643 45788888999999999999999   99999999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccCccccCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhh
Q 040392          317 FSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVND  391 (470)
Q Consensus       317 fg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~  391 (470)
                      ||++.......  .......++..|+|||.+.     ...++.++|+||||+++|||++|..||....+.+... . ...
T Consensus       165 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-~-~~~  240 (282)
T cd06636         165 FGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-L-IPR  240 (282)
T ss_pred             Ccchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-h-Hhh
Confidence            99987553211  1223356888999999875     3457889999999999999999999997543221110 0 000


Q ss_pred             hcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          392 WLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      .        ....         .....++.++.+++.+||+.||.+||++.|++++
T Consensus       241 ~--------~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         241 N--------PPPK---------LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             C--------CCCC---------CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence            0        0000         0112346679999999999999999999999764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-37  Score=297.15  Aligned_cols=270  Identities=22%  Similarity=0.295  Sum_probs=199.8

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccc-hhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      .++|+..+.||+|++|.||+|+.. +++.||+|.+..... .....+.+|+++++.++|+||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            367889999999999999999865 689999999865432 223456779999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      |+++ +|.+++......+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++.......  
T Consensus        84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--  157 (291)
T cd07844          84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS--  157 (291)
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCC--
Confidence            9985 999998776667899999999999999999999   9999999999999999999999999999987542211  


Q ss_pred             ccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcC--Ccc-c-------
Q 040392          330 MTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLP--IST-M-------  398 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~-~-------  398 (470)
                      .......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||.........+.........  ... .       
T Consensus       158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence            11222346788999998865 458899999999999999999999997543211111111000000  000 0       


Q ss_pred             -ccccccccCchhhhhH-hhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          399 -EVVGANLLSQEDIHFV-AKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       399 -~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                       ................ .......++.+++.+||+.+|++||++.|++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence             0000000000000000 001112667899999999999999999998864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=9.6e-38  Score=299.30  Aligned_cols=251  Identities=25%  Similarity=0.324  Sum_probs=204.1

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      .++|.+.+.||+|+||.||++.. .++..||+|.+........+.+..|+.+++.++||||+++++++...+..++|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            46799999999999999999975 46889999998755445556788899999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      +++++|.+++.+.  .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++........  
T Consensus        98 ~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--  170 (293)
T cd06647          98 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  170 (293)
T ss_pred             CCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--
Confidence            9999999998654  4788899999999999999999   99999999999999999999999999998876543221  


Q ss_pred             cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchh
Q 040392          331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED  410 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (470)
                      ......+++.|+|||.+....++.++|+||||+++|++++|+.||......+.. ... ...  ..              
T Consensus       171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~-~~~-~~~--~~--------------  232 (293)
T cd06647         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLI-ATN--GT--------------  232 (293)
T ss_pred             ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe-eeh-hcC--CC--------------
Confidence            223346888999999998888999999999999999999999999754322110 000 000  00              


Q ss_pred             hhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          411 IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       411 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      .....+...+..+.+++.+||..+|++||++.+++.+
T Consensus       233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         233 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0001112235568899999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.9e-38  Score=298.21  Aligned_cols=256  Identities=23%  Similarity=0.304  Sum_probs=204.3

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      ++|++.+.||+|+||+||++... +|+.||+|++.... ....+.+..|+++++.++||||+++++++......++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            56888899999999999999754 58899999886543 34456788999999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      +++++|.+++... ..+++..+..++.+++.||.|||+  ..+++|+||+|+||+++.++.++|+|||++.......   
T Consensus        85 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---  158 (284)
T cd06620          85 MDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---  158 (284)
T ss_pred             CCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence            9999999988654 358899999999999999999992  2589999999999999999999999999986542211   


Q ss_pred             cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcc------hhhHHhhhhcCCccccccccc
Q 040392          331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEM------TLKHWVNDWLPISTMEVVGAN  404 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~  404 (470)
                       .....++..|+|||++.+..++.++|+|||||++|++++|+.||......+.      ....+........     .+.
T Consensus       159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~  232 (284)
T cd06620         159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-----PPR  232 (284)
T ss_pred             -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-----CCC
Confidence             1234688999999999888999999999999999999999999986433211      1111111111100     000


Q ss_pred             ccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHH
Q 040392          405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLL  449 (470)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~  449 (470)
                      .         ....++.++.+++.+||+.||++||++.|++++..
T Consensus       233 ~---------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~  268 (284)
T cd06620         233 L---------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP  268 (284)
T ss_pred             C---------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence            0         01124667899999999999999999999998753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.3e-38  Score=311.09  Aligned_cols=194  Identities=26%  Similarity=0.383  Sum_probs=168.4

Q ss_pred             CCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccchhhhhHHHHHHHHhcCC-C-----CcceeEEeeeccCCeeeE
Q 040392          174 GFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIR-H-----RNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~nIv~~~~~~~~~~~~~l  246 (470)
                      +|.+++.||+|+||.|.+|. .++++.||||+++.+. .-..+...|+.+|..|+ |     -|+|+++++|...++.||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            78999999999999999995 5579999999997543 33455667999999997 4     489999999999999999


Q ss_pred             EEecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC--CCCeEEeeecccccc
Q 040392          247 VLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD--NMVAHLSDFSIAKLL  323 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~a~~~  323 (470)
                      |+|.+.. +|.++++..+ ..++...+..++.||+.||..||   ..+|||+||||+||||..  ...+||+|||.|...
T Consensus       266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            9999965 9999998766 56889999999999999999999   999999999999999964  347999999999865


Q ss_pred             CCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCc
Q 040392          324 TGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNE  377 (470)
Q Consensus       324 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~  377 (470)
                      ...     ....+-+..|+|||++.+.+|+.+.||||||||+.||++|..-|.+
T Consensus       342 ~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG  390 (586)
T KOG0667|consen  342 SQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG  390 (586)
T ss_pred             CCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence            321     1246678889999999999999999999999999999999776664

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-38  Score=297.12  Aligned_cols=253  Identities=25%  Similarity=0.333  Sum_probs=200.3

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcC-CCCcceeEEeeeccC------C
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSI-RHRNLIKVISTCSNE------E  242 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~------~  242 (470)
                      .+++|++.+.||+|++|.||+|... +++.+++|++..... ..+.+..|+.+++++ .|+||+++++++...      .
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4688999999999999999999864 578999999875433 346788999999999 699999999998654      3


Q ss_pred             eeeEEEecCCCCChHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecc
Q 040392          243 FKALVLEYMPHGSLEKYMYSS---NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSI  319 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  319 (470)
                      ..++||||+++++|.+++...   ...+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence            589999999999999988653   356899999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccCccccCccccCC-----CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcC
Q 040392          320 AKLLTGEDQSMTQTQTLATIGYMAPEYGRE-----GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLP  394 (470)
Q Consensus       320 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  394 (470)
                      +......  ........++..|+|||.+..     ..++.++||||||+++|+|++|+.||....... ........   
T Consensus       160 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~---  233 (275)
T cd06608         160 SAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALFKIPRN---  233 (275)
T ss_pred             ceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HHHHhhcc---
Confidence            8765322  122234568889999998753     346789999999999999999999997532211 11111100   


Q ss_pred             CcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          395 ISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                            ..+.        ...+..++.++.+++.+||..||++|||+.|++++
T Consensus       234 ------~~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         234 ------PPPT--------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             ------CCCC--------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                  0000        01122346678999999999999999999999864

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=7.9e-38  Score=293.51  Aligned_cols=246  Identities=28%  Similarity=0.492  Sum_probs=198.3

Q ss_pred             CCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCC
Q 040392          173 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP  252 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~  252 (470)
                      ++|++.+.||+|+||.||++.. +++.||+|......  ....+..|+.+++.++|||++++++++... ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4588899999999999999975 68889999986432  345688899999999999999999998665 4689999999


Q ss_pred             CCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccc
Q 040392          253 HGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  331 (470)
Q Consensus       253 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  331 (470)
                      +++|.+++.... ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++......     
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----  153 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----  153 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence            999999997654 35789999999999999999999   999999999999999999999999999998754321     


Q ss_pred             ccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCchh
Q 040392          332 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED  410 (470)
Q Consensus       332 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (470)
                      ......+..|+|||.+.+..++.++|+||||+++|||++ |+.||......+  ..........                
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~----------------  215 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--VKECVEKGYR----------------  215 (254)
T ss_pred             CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--HHHHHhCCCC----------------
Confidence            112234567999999988899999999999999999998 999987543221  1111111000                


Q ss_pred             hhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHH
Q 040392          411 IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK  450 (470)
Q Consensus       411 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~  450 (470)
                        ...+..++.++.+++.+||+.+|++||++.+++..|++
T Consensus       216 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         216 --MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             --CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence              00112346678899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.2e-38  Score=329.58  Aligned_cols=254  Identities=20%  Similarity=0.286  Sum_probs=196.7

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeecc--CCeee
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSN--EEFKA  245 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~~  245 (470)
                      ..++|.+.+.||+|+||+||+|+.. ++..||+|.+...  .......+..|+.+++.++||||+++++++..  ....+
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            3578999999999999999999764 5778999998643  23345678889999999999999999998743  45789


Q ss_pred             EEEecCCCCChHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCC----CCCeeecCCCCCCeeeCC----------
Q 040392          246 LVLEYMPHGSLEKYMYSS---NYILDIFQRLNIMIDVASALEYLHFGY----SAPIIHCDLKPSNVLLDD----------  308 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~----~~~i~H~dlkp~Nill~~----------  308 (470)
                      +||||+++|+|.+++...   ...+++..++.|+.||+.||.|||...    ..+|+|+||||+|||++.          
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            999999999999998653   246899999999999999999999321    145999999999999964          


Q ss_pred             -------CCCeEEeeeccccccCCCCCcccccccccCccccCccccCC--CCCCCccchhhHHHHHHHHHhCCCCCCccc
Q 040392          309 -------NMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTGKKPTNEIF  379 (470)
Q Consensus       309 -------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~tg~~p~~~~~  379 (470)
                             .+.+||+|||++..+....   ......+|+.|+|||++.+  ..++.++|||||||++|||++|+.||....
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             cccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                   3358999999998653221   1234568999999998854  458899999999999999999999997532


Q ss_pred             cCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          380 NGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ..    ..++........       +         .....+.++.+|+..||..+|.+||++.|++.+
T Consensus       248 ~~----~qli~~lk~~p~-------l---------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        248 NF----SQLISELKRGPD-------L---------PIKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             cH----HHHHHHHhcCCC-------C---------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            21    111111111000       0         001125668899999999999999999999853

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.4e-37  Score=294.63  Aligned_cols=256  Identities=25%  Similarity=0.277  Sum_probs=200.4

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccc-hhhhhHHHHHHHHhcCCCCcceeEEeeecc--CCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKVISTCSN--EEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~~lv~  248 (470)
                      ++|+..+.||.|++|.||++... +++.+|+|.+..... .....+.+|+++++.++||||+++++++..  ....++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46788899999999999999864 588999999875432 345678889999999999999999998854  34689999


Q ss_pred             ecCCCCChHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC
Q 040392          249 EYMPHGSLEKYMYS---SNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       249 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  325 (470)
                      ||+++++|.+++..   ....++......++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999888653   3345788899999999999999999   99999999999999999999999999999875432


Q ss_pred             CCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccC---cchhhHHhhhhcCCccccccc
Q 040392          326 EDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNG---EMTLKHWVNDWLPISTMEVVG  402 (470)
Q Consensus       326 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  402 (470)
                      ..    .....++..|+|||.+.+..++.++||||||+++|+|++|+.||......   ......+............. 
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  232 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEP-  232 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCC-
Confidence            21    12345788899999999889999999999999999999999999864221   11122222211110000000 


Q ss_pred             ccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          403 ANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                                 ......+.++.+++.+||..+|.+|||+.|++++
T Consensus       233 -----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         233 -----------GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             -----------CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence                       0001235678999999999999999999999984

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.2e-37  Score=288.23  Aligned_cols=250  Identities=28%  Similarity=0.410  Sum_probs=205.8

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCC
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP  252 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~  252 (470)
                      +|+..+.||+|++|.||++... ++..+++|++..........+..|+++++.++|+|++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4777899999999999999875 689999999976655566788899999999999999999999999999999999999


Q ss_pred             CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccc
Q 040392          253 HGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ  332 (470)
Q Consensus       253 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  332 (470)
                      +++|.+++......+++..+..++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||.+........   .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~  154 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R  154 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence            99999999776567899999999999999999999   89999999999999999999999999999887653321   2


Q ss_pred             cccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhh
Q 040392          333 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIH  412 (470)
Q Consensus       333 ~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  412 (470)
                      ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||......+.. .. ...   .......           
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~-~~~---~~~~~~~-----------  218 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL-FK-IAT---NGPPGLR-----------  218 (253)
T ss_pred             cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH-HH-HHh---cCCCCcC-----------
Confidence            3456888999999998888999999999999999999999998764221111 00 000   0000000           


Q ss_pred             hHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          413 FVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       413 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                        ....++..+.+++.+||+.||++|||+.|++++
T Consensus       219 --~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         219 --NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             --cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence              011125668999999999999999999999865

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.7e-37  Score=291.38  Aligned_cols=248  Identities=24%  Similarity=0.380  Sum_probs=201.0

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          174 GFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      +|+..+.||+|++|.||+|.. .+++.+|+|.+...  .......+..|+++++.++||||+++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            478889999999999999975 46889999998654  233456788899999999999999999999989999999999


Q ss_pred             CCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-CCeEEeeeccccccCCCCC
Q 040392          251 MPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN-MVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       251 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~a~~~~~~~~  328 (470)
                      +++++|.+++.... ..+++..+..++.+++.|++|||   +.+++|+||+|+||+++.+ +.+|++|||.+....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-  156 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence            99999999997653 45889999999999999999999   9999999999999999855 468999999998664322 


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                        ......++..|+|||.+.+..++.++||||||+++|+|++|+.||.......  ......   .....          
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~~~~~~---~~~~~----------  219 (256)
T cd08220         157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA--LVLKIM---SGTFA----------  219 (256)
T ss_pred             --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH--HHHHHH---hcCCC----------
Confidence              1123457889999999998889999999999999999999999987532221  111110   00000          


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                           ..+..++.++.+++.+||+.+|++||++.|++++
T Consensus       220 -----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         220 -----PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             -----CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                 0112236678899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-38  Score=308.17  Aligned_cols=241  Identities=22%  Similarity=0.242  Sum_probs=186.3

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcC---CCCcceeEEeeeccCCeeeEEEecCCC
Q 040392          181 IGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSI---RHRNLIKVISTCSNEEFKALVLEYMPH  253 (470)
Q Consensus       181 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~~~~~~lv~e~~~~  253 (470)
                      ||+|+||+||+|+.. +++.||+|++....   .........|..++...   .||||+++++++......++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999764 58999999986432   12233444566666655   699999999999999999999999999


Q ss_pred             CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccccc
Q 040392          254 GSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  333 (470)
Q Consensus       254 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  333 (470)
                      |+|.+++... ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++.......  ....
T Consensus        81 g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~  154 (330)
T cd05586          81 GELFWHLQKE-GRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTN  154 (330)
T ss_pred             ChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCcc
Confidence            9999988654 46889999999999999999999   9999999999999999999999999999987542211  1223


Q ss_pred             ccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhh
Q 040392          334 QTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIH  412 (470)
Q Consensus       334 ~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  412 (470)
                      ...||..|+|||++.+. .++.++|||||||++|||++|+.||......+     ......... ....           
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-----~~~~i~~~~-~~~~-----------  217 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-----MYRNIAFGK-VRFP-----------  217 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-----HHHHHHcCC-CCCC-----------
Confidence            45689999999988754 48999999999999999999999987532211     111110000 0000           


Q ss_pred             hHhhhhhHHHHHHHHhhccCCCccCCC----CHHHHHHH
Q 040392          413 FVAKEQCVSCVFNLAMECTVESPEQRI----NAREIVAK  447 (470)
Q Consensus       413 ~~~~~~~~~~l~~l~~~cl~~dP~~Rp----s~~el~~~  447 (470)
                         ....+.++.+++.+||+.||.+||    ++.++++|
T Consensus       218 ---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         218 ---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             ---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence               011355678999999999999998    56666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.3e-37  Score=290.69  Aligned_cols=251  Identities=25%  Similarity=0.340  Sum_probs=206.2

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccc-hhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      ++|++.+.||+|++|.||+|+.. +++.|++|++..... .....+..|++.+..++|+||+++++++......++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            46888999999999999999865 599999999876543 4567788999999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      +++++|.+++... ..+++..+..++.|+++|++|||   + .+++|+||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence            9999999999765 46899999999999999999999   8 99999999999999999999999999998866432221


Q ss_pred             ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCc-chhhHHhhhhcCCcccccccccccCc
Q 040392          330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE-MTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                        .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||....... .....++.   ....     +.    
T Consensus       157 --~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~~~~-----~~----  222 (264)
T cd06623         157 --CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC---DGPP-----PS----  222 (264)
T ss_pred             --ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh---cCCC-----CC----
Confidence              123457889999999998899999999999999999999999997754211 11111111   0000     00    


Q ss_pred             hhhhhHhhhh-hHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          409 EDIHFVAKEQ-CVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       409 ~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                            .+.. ++..+.+++.+||..+|++||++.|++++
T Consensus       223 ------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         223 ------LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             ------CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                  0111 46678999999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=8.5e-38  Score=298.51  Aligned_cols=267  Identities=25%  Similarity=0.329  Sum_probs=200.8

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccc--hhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      ++|+..+.||+|+||.||+|... +++.||+|++.....  ...+.+.+|+++++.++||||+++++++......++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888999999999999999875 589999999754322  234567789999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      |+++++|..+.... ..+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.++|+|||++.......  
T Consensus        81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--  154 (286)
T cd07846          81 FVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--  154 (286)
T ss_pred             cCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--
Confidence            99998888776543 35899999999999999999999   8999999999999999999999999999988654322  


Q ss_pred             ccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhh--hcCCccccccc----
Q 040392          330 MTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVND--WLPISTMEVVG----  402 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~----  402 (470)
                      .......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+ ........  ..........+    
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07846         155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID-QLYHIIKCLGNLIPRHQEIFQKNPL  233 (286)
T ss_pred             cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHHHhCCCchhhHHHhccchH
Confidence            12223457889999998865 347889999999999999999999886432211 11110000  00000000000    


Q ss_pred             ------ccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          403 ------ANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       403 ------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                            +...... ........++..+.+++.+||+.+|++||++.+++++
T Consensus       234 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         234 FAGMRLPEVKEIE-PLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             hhccccccccCcc-hHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence                  0000000 0001122456779999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.4e-37  Score=291.69  Aligned_cols=253  Identities=29%  Similarity=0.407  Sum_probs=203.0

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccc--hhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      +|...+.||+|+||.||+|... +++.|++|.+.....  .....+..|+++++.++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4788899999999999999754 689999999876543  3667788999999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      +++++|.+++.... .+++..+..++.++++||.|||   +.+++|+||+|+||++++++.+||+|||++..........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            99999999997653 4788899999999999999999   9999999999999999999999999999988764432221


Q ss_pred             c--ccccccCccccCccccCCCC---CCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          331 T--QTQTLATIGYMAPEYGREGR---VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       331 ~--~~~~~~t~~y~aPE~~~~~~---~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      .  .....++..|+|||++.+..   ++.++||||||+++|++++|+.||....+.. .....+.......         
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~---------  226 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-QIMFHVGAGHKPP---------  226 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-HHHHHHhcCCCCC---------
Confidence            1  11345788999999988766   8899999999999999999999997543221 1111111100000         


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                             .+....++..+.+++.+||+.+|++||++.|++.+
T Consensus       227 -------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         227 -------IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             -------CCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                   00011225567899999999999999999998763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.5e-37  Score=298.22  Aligned_cols=254  Identities=22%  Similarity=0.273  Sum_probs=197.7

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ++|++.+.||+|+||.||++... +++.|++|.+....   ......+..|+++++.++||||+++++.+......++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46888999999999999999764 57899999987543   233456778999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||+++++|.+++.... .+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+|++|||+++.......
T Consensus        81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence            9999999999996654 5888999999999999999999   89999999999999999999999999998863211000


Q ss_pred             -------------cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCC
Q 040392          329 -------------SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPI  395 (470)
Q Consensus       329 -------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  395 (470)
                                   ........++..|+|||.+....++.++|+||||+++|||++|..||......+     +.......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-----~~~~~~~~  231 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-----LFGQVISD  231 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhc
Confidence                         001112357888999999988889999999999999999999999987532211     11111100


Q ss_pred             cccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          396 STMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                      ..   ..+.          .+..++.++.+++.+||+.||++||++.++.+.|
T Consensus       232 ~~---~~~~----------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll  271 (305)
T cd05609         232 DI---EWPE----------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVK  271 (305)
T ss_pred             cc---CCCC----------ccccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence            00   0000          0012466789999999999999999854444333

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=9.2e-38  Score=299.98  Aligned_cols=248  Identities=25%  Similarity=0.322  Sum_probs=199.6

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCC
Q 040392          175 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH  253 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~  253 (470)
                      |+....||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            334457999999999999754 6899999998765444556688899999999999999999999999999999999999


Q ss_pred             CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccccc
Q 040392          254 GSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  333 (470)
Q Consensus       254 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  333 (470)
                      ++|.+++..  ..+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++.......  ....
T Consensus       103 ~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~  175 (297)
T cd06659         103 GALTDIVSQ--TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRK  175 (297)
T ss_pred             CCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--cccc
Confidence            999988754  34789999999999999999999   9999999999999999999999999999987553221  1223


Q ss_pred             ccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhh
Q 040392          334 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF  413 (470)
Q Consensus       334 ~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  413 (470)
                      ...++..|+|||++.+..++.++||||||+++|||++|+.||......+ .+. .+........                
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~-~~~~~~~~~~----------------  237 (297)
T cd06659         176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-AMK-RLRDSPPPKL----------------  237 (297)
T ss_pred             ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHH-HHhccCCCCc----------------
Confidence            3568899999999988889999999999999999999999987532211 111 1111000000                


Q ss_pred             HhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          414 VAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       414 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ......+..+.+++.+||+.+|++||++.+++++
T Consensus       238 ~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         238 KNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0011235568899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.4e-37  Score=317.18  Aligned_cols=268  Identities=21%  Similarity=0.250  Sum_probs=192.5

Q ss_pred             HHHhhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCC------CcceeEEeeecc
Q 040392          168 LCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRH------RNLIKVISTCSN  240 (470)
Q Consensus       168 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~nIv~~~~~~~~  240 (470)
                      +....++|++.+.||+|+||+||+|... +++.||||+++... ........|+++++.++|      .+++++++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            3345678999999999999999999754 57889999986421 223345567777777754      458888888865


Q ss_pred             C-CeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCCeeeCCCC--------
Q 040392          241 E-EFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNM--------  310 (470)
Q Consensus       241 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~i~H~dlkp~Nill~~~~--------  310 (470)
                      . .+.++|||++ +++|.+++...+ .+++..+..++.|++.||+|||   . .+|+||||||+|||++.++        
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~  277 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTN  277 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccc
Confidence            4 5788999988 678988886553 6889999999999999999999   7 5999999999999998765        


Q ss_pred             --------CeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCc
Q 040392          311 --------VAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE  382 (470)
Q Consensus       311 --------~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~  382 (470)
                              .+||+|||.+....     .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus       278 ~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~  352 (467)
T PTZ00284        278 RALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE  352 (467)
T ss_pred             cccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence                    49999999875422     12234678999999999999999999999999999999999999997643211


Q ss_pred             chhh-----------HHhhhhcCCccccccc------ccccCchh-----hhhHhhhhhHHHHHHHHhhccCCCccCCCC
Q 040392          383 MTLK-----------HWVNDWLPISTMEVVG------ANLLSQED-----IHFVAKEQCVSCVFNLAMECTVESPEQRIN  440 (470)
Q Consensus       383 ~~~~-----------~~~~~~~~~~~~~~~~------~~~~~~~~-----~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps  440 (470)
                       .+.           .|..........+..+      +.......     ............+.+|+.+||++||++|||
T Consensus       353 -~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t  431 (467)
T PTZ00284        353 -HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN  431 (467)
T ss_pred             -HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence             111           1110000000000000      00000000     000000111355789999999999999999


Q ss_pred             HHHHHHH
Q 040392          441 AREIVAK  447 (470)
Q Consensus       441 ~~el~~~  447 (470)
                      +.|+++|
T Consensus       432 a~e~L~H  438 (467)
T PTZ00284        432 ARQMTTH  438 (467)
T ss_pred             HHHHhcC
Confidence            9999985

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=6.3e-38  Score=300.37  Aligned_cols=248  Identities=25%  Similarity=0.328  Sum_probs=199.7

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCC
Q 040392          175 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH  253 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~  253 (470)
                      |.....||+|+||.||++... ++..||||.+........+.+..|+.+++.++|+||+++++.+...+..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            444567999999999999754 6889999998765555566788999999999999999999999999999999999999


Q ss_pred             CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccccc
Q 040392          254 GSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  333 (470)
Q Consensus       254 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  333 (470)
                      ++|.+++...  .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++.......  ....
T Consensus       104 ~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~  176 (292)
T cd06658         104 GALTDIVTHT--RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRK  176 (292)
T ss_pred             CcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCc
Confidence            9999988543  4788999999999999999999   8999999999999999999999999999987553222  1122


Q ss_pred             ccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhh
Q 040392          334 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF  413 (470)
Q Consensus       334 ~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  413 (470)
                      ...++..|+|||.+.+..++.++||||||+++|||++|+.||....... .+... ....+..        ..       
T Consensus       177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~-~~~~~~~--------~~-------  239 (292)
T cd06658         177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-AMRRI-RDNLPPR--------VK-------  239 (292)
T ss_pred             eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH-HhcCCCc--------cc-------
Confidence            3468889999999988889999999999999999999999987532211 11111 1000100        00       


Q ss_pred             HhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          414 VAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       414 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                       .....+..+.+++..||..||.+|||+.|++++
T Consensus       240 -~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         240 -DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             -cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence             011225568899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.2e-37  Score=297.60  Aligned_cols=266  Identities=24%  Similarity=0.293  Sum_probs=199.7

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccch-----hhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGR-----ALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      +|...+.||+|++|.||+|... +++.||+|.+......     ....+..|+++++.++|+||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778889999999999999864 6899999998754322     234566799999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||+ +|+|.+++......+++..+..++.|+++||.|||   +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            9999 88999999765557899999999999999999999   9999999999999999999999999999998664322


Q ss_pred             CcccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCC---------cc
Q 040392          328 QSMTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPI---------ST  397 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---------~~  397 (470)
                      .  ......++..|+|||.+.+ ..++.++|+||||+++|||++|..||....+ ...+..........         ..
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  233 (298)
T cd07841         157 R--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-IDQLGKIFEALGTPTEENWPGVTSL  233 (298)
T ss_pred             c--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc-HHHHHHHHHHcCCCchhhhhhcccc
Confidence            1  1222346788999998754 4578999999999999999999777664322 11111111100000         00


Q ss_pred             cccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          398 MEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      .............. .......+..+.+++.+||+.||++|||+.|++.+
T Consensus       234 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         234 PDYVEFKPFPPTPL-KQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccCCcch-hhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            00000000000000 01112336778999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.5e-37  Score=297.48  Aligned_cols=245  Identities=25%  Similarity=0.284  Sum_probs=201.0

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ++|++.+.||+|++|.||++... +++.+|+|++....   ....+.+..|++++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888999999999999999765 58999999986432   234566888999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||+++++|.+++... ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||++......  
T Consensus        81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            999999999999765 46889999999999999999999   899999999999999999999999999998865432  


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                         .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||......  .......   ...            
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~---~~~------------  214 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI--QIYEKIL---EGK------------  214 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHh---cCC------------
Confidence               22346889999999998888899999999999999999999998753311  1111000   000            


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCC-----CHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRI-----NAREIVAK  447 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~el~~~  447 (470)
                          ...+...+..+.+++.+||..||.+|+     +++|++++
T Consensus       215 ----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         215 ----VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             ----ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence                000112255688999999999999999     77787755

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-37  Score=294.93  Aligned_cols=248  Identities=26%  Similarity=0.396  Sum_probs=199.6

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc-chhhhhHHHHHHHHhcCC---CCcceeEEeeeccCCeeeEEE
Q 040392          174 GFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC-GRALKGFDVECEMMKSIR---HRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      .|+..+.||+|+||.||+|.+ .+++.||+|.+.... ......+..|+.+++.++   |||++++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            477789999999999999975 568999999986542 344566788999999986   999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||+++++|.+++...  .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++....... 
T Consensus        82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06917          82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-  155 (277)
T ss_pred             ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-
Confidence            999999999998654  5889999999999999999999   9999999999999999999999999999998764332 


Q ss_pred             cccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          329 SMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                       .......++..|+|||.+.++ .++.++|+||||+++|+|++|+.||.......     +.......     ..+.+. 
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-----~~~~~~~~-----~~~~~~-  223 (277)
T cd06917         156 -SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-----AMMLIPKS-----KPPRLE-  223 (277)
T ss_pred             -cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-----hhhccccC-----CCCCCC-
Confidence             222334688899999987654 46899999999999999999999997532211     11000000     000000 


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                              ....+.++.+++.+||+.||++||++.|++.+
T Consensus       224 --------~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         224 --------DNGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             --------cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence                    01135678999999999999999999999874

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.1e-37  Score=292.48  Aligned_cols=251  Identities=23%  Similarity=0.298  Sum_probs=196.9

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-----chhhhhHHHHHHHHhcCCCCcceeEEeeeccC--Cee
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-----GRALKGFDVECEMMKSIRHRNLIKVISTCSNE--EFK  244 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~  244 (470)
                      .+|.+.+.||+|+||.||+|... ++..||+|.+....     ......+..|++++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            47888999999999999999764 58999999875331     22345778899999999999999999988663  467


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccC
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~  324 (470)
                      +++|||+++++|.+++.... .+++.....++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++....
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            89999999999999986553 5788889999999999999999   9999999999999999999999999999987653


Q ss_pred             CCCCc-ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccc
Q 040392          325 GEDQS-MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA  403 (470)
Q Consensus       325 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (470)
                      ..... .......++..|+|||.+.+..++.++||||||+++|||++|+.||....... .....   .... .    . 
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~~~---~~~~-~----~-  227 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-AIFKI---ATQP-T----N-  227 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-HHHHH---hcCC-C----C-
Confidence            22111 11223458889999999988889999999999999999999999987532211 11110   0000 0    0 


Q ss_pred             cccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                               ...+...+..+.+++.+|+. +|++||++.|++++
T Consensus       228 ---------~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         228 ---------PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             ---------CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence                     00112235567889999995 99999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.7e-37  Score=289.56  Aligned_cols=252  Identities=21%  Similarity=0.305  Sum_probs=201.9

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeecc--CCeeeEEE
Q 040392          174 GFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSN--EEFKALVL  248 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~~lv~  248 (470)
                      +|++.+.||.|+||.||+|.. .++..+|+|.+...  .....+.+..|+++++.++|+||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            478889999999999999975 46889999998643  23345667889999999999999999997753  45678999


Q ss_pred             ecCCCCChHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeeecCCCCCCeeeCCCCCeEEeeecccccc
Q 040392          249 EYMPHGSLEKYMYSS---NYILDIFQRLNIMIDVASALEYLHFGY--SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  323 (470)
Q Consensus       249 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~--~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~  323 (470)
                      ||+++++|.+++...   ...+++..++.++.|++.||.|||..+  +.+++|+||+|+||+++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998654   456899999999999999999999543  678999999999999999999999999999876


Q ss_pred             CCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccc
Q 040392          324 TGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA  403 (470)
Q Consensus       324 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (470)
                      .....  ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.....  ..+...+......        
T Consensus       161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~--------  228 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--LQLASKIKEGKFR--------  228 (265)
T ss_pred             cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--HHHHHHHhcCCCC--------
Confidence            43221  12234688999999999988899999999999999999999999976431  1112211110000        


Q ss_pred             cccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                                ..+...+..+.+++.+||+.+|++||++.+|+++
T Consensus       229 ----------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         229 ----------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ----------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                      0112335678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-37  Score=300.00  Aligned_cols=253  Identities=27%  Similarity=0.376  Sum_probs=202.2

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccc---hhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG---RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ++|+..+.||+|++|.||+|... +++.||+|.+.....   ...+.+..|+++++.++|+||+++++.+......++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888899999999999999765 489999999875432   24556888999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          249 EYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      ||+.+++|.+++.... ..+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            9999999999987543 56889999999999999999999   9999999999999999999999999999987543211


Q ss_pred             Cc---------------------------ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccc
Q 040392          328 QS---------------------------MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFN  380 (470)
Q Consensus       328 ~~---------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~  380 (470)
                      ..                           .......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            10                           011123578899999999988899999999999999999999999975432


Q ss_pred             CcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCC----HHHHHHH
Q 040392          381 GEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRIN----AREIVAK  447 (470)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps----~~el~~~  447 (470)
                      .+ .+.........                  .......+..+.+++.+||..||++||+    ++|++++
T Consensus       238 ~~-~~~~~~~~~~~------------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         238 DE-TFSNILKKEVT------------------FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             HH-HHHHHhcCCcc------------------CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            21 11111100000                  0000113667899999999999999999    7777775

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.2e-37  Score=294.69  Aligned_cols=253  Identities=28%  Similarity=0.361  Sum_probs=206.4

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      ..+.|+..+.||+|++|.||+|... ++..+++|++..... ....+..|+++++.++|+|++++++++......++|+|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4567888899999999999999876 689999999975543 45677889999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      |+++++|.+++......+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++........ 
T Consensus        96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  171 (286)
T cd06614          96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-  171 (286)
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence            99999999999876557899999999999999999999   89999999999999999999999999999876543221 


Q ss_pred             ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCch
Q 040392          330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE  409 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (470)
                       ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ...........+               
T Consensus       172 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-~~~~~~~~~~~~---------------  234 (286)
T cd06614         172 -KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-RALFLITTKGIP---------------  234 (286)
T ss_pred             -hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCC---------------
Confidence             122345778999999998888999999999999999999999998753221 111111110000               


Q ss_pred             hhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       410 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                        ....+..++..+.+++.+||+.+|.+||++.+++.+
T Consensus       235 --~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         235 --PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             --CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence              001112246678999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.3e-37  Score=290.71  Aligned_cols=254  Identities=26%  Similarity=0.375  Sum_probs=201.2

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc------chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeE
Q 040392          174 GFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC------GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  246 (470)
                      +|+..+.||+|++|.||+|.. .+++.||+|++....      ....+.+..|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999975 568999999986432      1235678889999999999999999999999999999


Q ss_pred             EEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-CeEEeeeccccccCC
Q 040392          247 VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-VAHLSDFSIAKLLTG  325 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~  325 (470)
                      |+||+++++|.+++.... .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++ .+||+|||.+..+..
T Consensus        81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            999999999999996544 6788999999999999999999   99999999999999998776 599999999887654


Q ss_pred             CCCc--ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccc
Q 040392          326 EDQS--MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA  403 (470)
Q Consensus       326 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (470)
                      ....  .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||....... ....+ ........      
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~-~~~~~~~~------  228 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN-HLALI-FKIASATT------  228 (268)
T ss_pred             ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc-hHHHH-HHHhccCC------
Confidence            3211  11223457889999999988889999999999999999999999986432211 11111 10000000      


Q ss_pred             cccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                              ....+...+.++.+++.+||..+|++||++.|++.+
T Consensus       229 --------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         229 --------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             --------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence                    001112335678899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4.4e-37  Score=298.15  Aligned_cols=194  Identities=22%  Similarity=0.326  Sum_probs=158.6

Q ss_pred             CeecccCceEEEEEEeC---CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeec--cCCeeeEEEecCCC
Q 040392          179 NLIGRGGFGSVYKARLG---DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS--NEEFKALVLEYMPH  253 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~--~~~~~~lv~e~~~~  253 (470)
                      ..||+|+||.||+|+..   ++..||+|.+....  ....+.+|+++++.++||||+++++++.  .....++||||+++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            57999999999999864   35789999886432  2345678999999999999999999884  35677899999975


Q ss_pred             CChHHhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee----CCCCCeEEeeecccc
Q 040392          254 GSLEKYMYSS--------NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL----DDNMVAHLSDFSIAK  321 (470)
Q Consensus       254 g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill----~~~~~~kl~Dfg~a~  321 (470)
                       +|.+++...        ...+++..+..++.|++.||.|||   +.+++||||||+||++    +.++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             787776422        135788899999999999999999   9999999999999999    567799999999998


Q ss_pred             ccCCCCCc-ccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcc
Q 040392          322 LLTGEDQS-MTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEI  378 (470)
Q Consensus       322 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~  378 (470)
                      ........ .......+|..|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            66433221 12234568999999998876 45899999999999999999999999753

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-37  Score=295.09  Aligned_cols=269  Identities=24%  Similarity=0.300  Sum_probs=202.9

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      ++|++.+.||+|++|.||+|... +++.||+|.++..  .....+.+..|+++++.++|+||+++++++...+..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999865 5889999998643  23345678889999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      |++++.+..+.. ....+++..+..++.|++.||.|||   ..+++|+||+|+||++++++.+||+|||++........ 
T Consensus        81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-  155 (288)
T cd07833          81 YVERTLLELLEA-SPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-  155 (288)
T ss_pred             cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence            999866665554 3446899999999999999999999   89999999999999999999999999999887654322 


Q ss_pred             ccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhh--cCCccccc--ccc-
Q 040392          330 MTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDW--LPISTMEV--VGA-  403 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~--~~~-  403 (470)
                      .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+. ........  .+......  .+. 
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ-LYLIQKCLGPLPPSHQELFSSNPR  234 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHhhhcccCcc
Confidence            122335678889999999888 789999999999999999999999875322111 10000000  00000000  000 


Q ss_pred             -------cccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          404 -------NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       404 -------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                             ............+..++.++.+++.+||..+|++||++.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence                   00000111111223347889999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.8e-37  Score=298.13  Aligned_cols=247  Identities=26%  Similarity=0.323  Sum_probs=198.1

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ..|...+.||+|+||.||+|+.. +++.||+|++....   ......+..|+++++.++||||+++++++......++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45888999999999999999764 68999999986432   233456788999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||++ |++.+++......+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++......  
T Consensus        95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--  168 (307)
T cd06607          95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--  168 (307)
T ss_pred             HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence            9997 5887877665567899999999999999999999   999999999999999999999999999998754322  


Q ss_pred             cccccccccCccccCccccC---CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          329 SMTQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                          ....++..|+|||.+.   ...++.++||||||+++|||++|+.||........  ........+        +. 
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~--~~~~~~~~~--------~~-  233 (307)
T cd06607         169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQNDS--------PT-  233 (307)
T ss_pred             ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH--HHHHhcCCC--------CC-
Confidence                1245778899999874   45688999999999999999999999865322111  000000000        00 


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                              ..+..++..+.+++.+||..+|++||++.+++.+.
T Consensus       234 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         234 --------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             --------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence                    00122466789999999999999999999998863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-39  Score=307.91  Aligned_cols=245  Identities=27%  Similarity=0.354  Sum_probs=202.7

Q ss_pred             CCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc---cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          175 FSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      |..++.||+|+||.||.|+. .+.+.||||.....   +.+.+.++..|+++|++++|||++.+-|+|-.+...++||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            66678899999999999974 46788999997533   445678889999999999999999999999988888999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      |- |+-.+++.-.+.++.+..+..|+.+.+.||+|||   +.+.||||||+.|||+++.|.|||+|||.|....+.    
T Consensus       108 Cl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA----  179 (948)
T KOG0577|consen  108 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA----  179 (948)
T ss_pred             Hh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCch----
Confidence            95 5888998877888999999999999999999999   999999999999999999999999999999876432    


Q ss_pred             cccccccCccccCccccC---CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          331 TQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                        .+++|||.|||||++.   .++|+-++||||||++..||..+++|.-.+.    .+.......      +.-.+.+. 
T Consensus       180 --nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN----AMSALYHIA------QNesPtLq-  246 (948)
T KOG0577|consen  180 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----AMSALYHIA------QNESPTLQ-  246 (948)
T ss_pred             --hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch----HHHHHHHHH------hcCCCCCC-
Confidence              3478999999999875   5789999999999999999999999965421    111111100      01111111 


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                              ....+..|..++..||++-|++|||..++++|-
T Consensus       247 --------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~  279 (948)
T KOG0577|consen  247 --------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR  279 (948)
T ss_pred             --------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence                    123477899999999999999999999998874

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-38  Score=309.66  Aligned_cols=246  Identities=26%  Similarity=0.410  Sum_probs=202.0

Q ss_pred             CCCCeecccCceEEEEEEeC-CCcEEEEEEeec----ccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCe--eeEEE
Q 040392          176 SENNLIGRGGFGSVYKARLG-DGMEVAVKVFNL----QCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEF--KALVL  248 (470)
Q Consensus       176 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~--~~lv~  248 (470)
                      .....||+|+|-+||||.+. +|.+||--.++.    ++....++|..|+.+|+.|+||||++++.+|.+...  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            34568999999999999754 477776443322    245566889999999999999999999999977654  77899


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCCCeEEeeeccccccCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |.+..|+|..|+.+.+ ..+......|++||++||.|||+. ..+|+|||||.+||+++ ..|.|||+|+|+|.......
T Consensus       123 EL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~  200 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH  200 (632)
T ss_pred             ecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence            9999999999998776 578889999999999999999954 68999999999999996 56899999999999764322


Q ss_pred             CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                          ....+|||.|||||+.. ..|++.+||||||++++||+|+.+||.+..+...-++.......|..+..+-      
T Consensus       201 ----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~------  269 (632)
T KOG0584|consen  201 ----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVK------  269 (632)
T ss_pred             ----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccC------
Confidence                23378999999999886 7899999999999999999999999998766654445544444454444333      


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                                  .+++.++|.+|+.. ..+|||+.|++.+
T Consensus       270 ------------dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  270 ------------DPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             ------------CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence                        34578999999999 9999999999864

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=6.4e-37  Score=287.42  Aligned_cols=252  Identities=28%  Similarity=0.374  Sum_probs=206.1

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccc--hhhhhHHHHHHHHhcCCCCcceeEEeeeccC--CeeeEEE
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRNLIKVISTCSNE--EFKALVL  248 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~~lv~  248 (470)
                      +|...+.||+|++|.||+|... +++.|++|++.....  ...+.+..|++++++++|+||+++++.+...  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677899999999999999865 689999999875542  4567788999999999999999999999888  8899999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||+++++|.+++.... .+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            9999999999997665 7899999999999999999999   89999999999999999999999999999887654332


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                      ........++..|+|||...+...+.++||||||+++++|++|..||....+.......    .....            
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~------------  220 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYK----IGSSG------------  220 (260)
T ss_pred             cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHh----ccccC------------
Confidence            11233456888999999998888999999999999999999999999765411111100    00000            


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                        .....+...+.++.+++.+|+..+|++||++.|++.+
T Consensus       221 --~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         221 --EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             --CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence              0001122336678999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.9e-37  Score=296.04  Aligned_cols=269  Identities=23%  Similarity=0.252  Sum_probs=200.3

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccc--hhhhhHHHHHHHHhcCCCCcceeEEeeeccC--CeeeE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRNLIKVISTCSNE--EFKAL  246 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~~l  246 (470)
                      .++|+..+.||+|+||.||+|... +++.+|+|.++....  .....+.+|+.++++++||||+++++++...  ...++
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            357889999999999999999865 588999999865432  2233466799999999999999999998776  88999


Q ss_pred             EEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCC
Q 040392          247 VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      ||||+++ +|.+++......+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++......
T Consensus        84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            9999975 999998776667899999999999999999999   899999999999999999999999999998866432


Q ss_pred             CCcccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhc-----------C
Q 040392          327 DQSMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWL-----------P  394 (470)
Q Consensus       327 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-----------~  394 (470)
                      .  .......++..|+|||.+.+. .++.++|+||||+++|||++|..||....... ..........           .
T Consensus       160 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         160 L--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID-QLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             c--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchHHHHHhhc
Confidence            2  122234578889999988654 46899999999999999999999987543211 1111100000           0


Q ss_pred             CcccccccccccCchhhhhHhhhh-hHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          395 ISTMEVVGANLLSQEDIHFVAKEQ-CVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       395 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      .....................+.. .+..+.+++.+||+.+|++|||+.|++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence            000000000000000000011111 36668899999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1e-36  Score=289.88  Aligned_cols=247  Identities=24%  Similarity=0.372  Sum_probs=201.1

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          174 GFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      -|+..+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.++++++||||+++++++......++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            377789999999999999975 468899999986432 334567888999999999999999999999999999999999


Q ss_pred             CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccc
Q 040392          252 PHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  331 (470)
Q Consensus       252 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  331 (470)
                      ++++|.+++...  .+++..+..++.|++.|+.|||   ..+++|+||+|+||+++.++.++|+|||++.......  ..
T Consensus        85 ~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06641          85 GGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hh
Confidence            999999998643  5789999999999999999999   9999999999999999999999999999987654322  12


Q ss_pred             ccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhh
Q 040392          332 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDI  411 (470)
Q Consensus       332 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  411 (470)
                      .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.......  ....+...   .. .            
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~---~~-~------------  219 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--VLFLIPKN---NP-P------------  219 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--HHHHHhcC---CC-C------------
Confidence            223457889999999988889999999999999999999999987532211  11111100   00 0            


Q ss_pred             hhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          412 HFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       412 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                        ..+..++.++.+++.+||+.+|.+||++.+++++
T Consensus       220 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         220 --TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             --CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence              0012235678899999999999999999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2e-37  Score=291.37  Aligned_cols=248  Identities=25%  Similarity=0.334  Sum_probs=202.7

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      +|++.+.||.|+||.||+|+.. +++.||+|.+....   ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788899999999999999865 58999999987542   2456778889999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      |+++++|.+++... ..+++..+..++.|+++||.|||   +.+++|+||+|+||++++++.++|+|||.+.......  
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  154 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--  154 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence            99999999999765 46889999999999999999999   8999999999999999999999999999987654322  


Q ss_pred             ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCch
Q 040392          330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE  409 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (470)
                       ......++..|+|||.+.+..++.++|+||||+++|+|++|..||......  ........... .             
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~-~-------------  217 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQET-A-------------  217 (258)
T ss_pred             -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhcc-c-------------
Confidence             223355788999999998888999999999999999999999998864332  11111111100 0             


Q ss_pred             hhhhHhhhhhHHHHHHHHhhccCCCccCCCCH--HHHHH
Q 040392          410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINA--REIVA  446 (470)
Q Consensus       410 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~--~el~~  446 (470)
                        ....+...+..+.+++.+||+.||.+||++  +|+++
T Consensus       218 --~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         218 --DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             --cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence              001112335778899999999999999999  66653

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.8e-37  Score=293.78  Aligned_cols=265  Identities=24%  Similarity=0.291  Sum_probs=198.0

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      +|+..+.||.|++|.||+|+.. +|+.||||.+....  ......+..|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999764 68999999886442  22335678899999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          251 MPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       251 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      +. ++|.+++.... ..+++..+..++.|++.||+|||   ..+++|+||+|+||+++.++.+||+|||++.......  
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--  154 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--  154 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc--
Confidence            96 58988886543 56889999999999999999999   9999999999999999999999999999987553221  


Q ss_pred             ccccccccCccccCccccCCCC-CCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc--cc----ccc-
Q 040392          330 MTQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS--TM----EVV-  401 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~----~~~-  401 (470)
                      .......++..|+|||...+.. ++.++||||||+++|||+||+.||....... .............  ..    ... 
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhhhhHHHH
Confidence            1122335678899999876644 6889999999999999999999987532211 1111111100000  00    000 


Q ss_pred             ----cccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          402 ----GANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       402 ----~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                          -+.... ... .......+.++.+++.+||+.||++||++.|++.+
T Consensus       234 ~~~~~~~~~~-~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         234 YKPSFPKWAR-QDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HHhhcccccc-cCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence                000000 000 00012245678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=6.5e-37  Score=292.38  Aligned_cols=249  Identities=25%  Similarity=0.311  Sum_probs=200.3

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCC
Q 040392          174 GFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP  252 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~  252 (470)
                      .|...+.||+|++|.||++.. .+++.+++|.+........+.+.+|+.+++.+.||||+++++++...+..++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            355568999999999999975 4689999999875544455667889999999999999999999999999999999999


Q ss_pred             CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccc
Q 040392          253 HGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ  332 (470)
Q Consensus       253 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  332 (470)
                      +++|.+++..  ..+++..+..++.|++.||+|||   +.+++||||+|+||+++.++.++|+|||.+.......  ...
T Consensus       100 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~  172 (285)
T cd06648         100 GGALTDIVTH--TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRR  172 (285)
T ss_pred             CCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC--ccc
Confidence            9999999876  35889999999999999999999   9999999999999999999999999999887543221  122


Q ss_pred             cccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhh
Q 040392          333 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIH  412 (470)
Q Consensus       333 ~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  412 (470)
                      ....++..|+|||.+.+..++.++||||||+++|||++|+.||...... ..... .....+...        .      
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-~~~~~-~~~~~~~~~--------~------  236 (285)
T cd06648         173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-QAMKR-IRDNLPPKL--------K------  236 (285)
T ss_pred             ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-HHHHH-HHhcCCCCC--------c------
Confidence            2346889999999998888999999999999999999999998652211 11111 110000000        0      


Q ss_pred             hHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          413 FVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       413 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                        .+..++..+.+++.+||+.+|++||++.+++++
T Consensus       237 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         237 --NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             --ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence              011235678999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-37  Score=296.55  Aligned_cols=270  Identities=21%  Similarity=0.273  Sum_probs=198.7

Q ss_pred             CCCCCCeecccCceEEEEEEeC---CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccC--Ceee
Q 040392          174 GFSENNLIGRGGFGSVYKARLG---DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNE--EFKA  245 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~~  245 (470)
                      +|++.+.||+|++|.||+|...   +++.||+|.+....   ......+.+|+.+++.++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4778899999999999999864   47899999987632   33345677899999999999999999999887  8899


Q ss_pred             EEEecCCCCChHHhhhcCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC----CCCeEEeee
Q 040392          246 LVLEYMPHGSLEKYMYSSN----YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD----NMVAHLSDF  317 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~----~~~~kl~Df  317 (470)
                      +||||+++ +|.+++....    ..+++..+..++.|++.||+|||   +.+++||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 7776664322    36788999999999999999999   999999999999999999    999999999


Q ss_pred             ccccccCCCCC-cccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCc--------chhhH
Q 040392          318 SIAKLLTGEDQ-SMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE--------MTLKH  387 (470)
Q Consensus       318 g~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~--------~~~~~  387 (470)
                      |++........ ........++..|+|||.+.+. .++.++||||||+++|+|++|+.||.......        ..+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99886643222 1222344678899999987664 57899999999999999999999997643322        00111


Q ss_pred             HhhhhcC-----------C-cccc---cccccccCchhhhhHhhh--hhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          388 WVNDWLP-----------I-STME---VVGANLLSQEDIHFVAKE--QCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       388 ~~~~~~~-----------~-~~~~---~~~~~~~~~~~~~~~~~~--~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      .+.....           . ....   ................+.  ..+.++.+++.+||+.||++|||+.|++.+
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            1000000           0 0000   000000000011111111  345678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-39  Score=310.35  Aligned_cols=251  Identities=24%  Similarity=0.346  Sum_probs=209.2

Q ss_pred             CCCCCCeecccCceEEEEEEeCC-CcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCC
Q 040392          174 GFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP  252 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~  252 (470)
                      -|.++..||.|+||.||+|..++ +-..|.|++........+++.-|++||..+.||+||++++.|...+...++.|||.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            36677889999999999997664 44567888888888889999999999999999999999999988889999999999


Q ss_pred             CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccc
Q 040392          253 HGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ  332 (470)
Q Consensus       253 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  332 (470)
                      ||-+...+-.-+..+++.++..++.|++.||.|||   +..|||||||+.|||++-+|.++|+|||.+-...  ......
T Consensus       113 GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qkR  187 (1187)
T KOG0579|consen  113 GGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQKR  187 (1187)
T ss_pred             CchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccch--hHHhhh
Confidence            99999999888889999999999999999999999   9999999999999999999999999999875332  223344


Q ss_pred             cccccCccccCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          333 TQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       333 ~~~~~t~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                      ..+.||+.|||||+..     ..+|+.++||||||++|.||.-+.+|-.+...    ++-.+...              .
T Consensus       188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp----MRVllKia--------------K  249 (1187)
T KOG0579|consen  188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP----MRVLLKIA--------------K  249 (1187)
T ss_pred             ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch----HHHHHHHh--------------h
Confidence            5688999999999754     56799999999999999999999999765422    12111111              0


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ..+.....|...+..+.+++..||..||..||++.++++|
T Consensus       250 SePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  250 SEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             cCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            1111123345557889999999999999999999999875

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-37  Score=291.66  Aligned_cols=266  Identities=25%  Similarity=0.298  Sum_probs=198.0

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          175 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      |++.+.||.|++|.||+|... +|..||+|++....  ......+.+|+++++.++|||++++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567889999999999999764 69999999987543  223356778999999999999999999999999999999999


Q ss_pred             CCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          252 PHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       252 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      + ++|.+++.... ..+++..+..++.|+++||+|||   +.+++|+||+|+||+++.++.++|+|||++.......  .
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~  154 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--R  154 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--c
Confidence            5 68999886544 46899999999999999999999   8999999999999999999999999999987553221  1


Q ss_pred             cccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhc-CCcc-----cccc--
Q 040392          331 TQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWL-PIST-----MEVV--  401 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~-----~~~~--  401 (470)
                      ......++..|+|||++.+. .++.++|+||||+++|+|++|+.||....... .......... +...     ....  
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhhhhhchhh
Confidence            12233568889999987654 47889999999999999999999987533211 1111111100 0000     0000  


Q ss_pred             cccccC-chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          402 GANLLS-QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       402 ~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ...... ............+..+.+++.+||+.||++||++.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            000000 0000001122345678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=286.55  Aligned_cols=267  Identities=24%  Similarity=0.335  Sum_probs=226.1

Q ss_pred             HHHhhCCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccc-hhhhhHHHHHHHHhcCCCCcceeEEeeecc
Q 040392          168 LCRATDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKVISTCSN  240 (470)
Q Consensus       168 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  240 (470)
                      +.....+++...++-+|.||.||+|.|.      +.+.|.+|.++...+ -+...+..|.-++..+.|||+..+.+.+.+
T Consensus       279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie  358 (563)
T KOG1024|consen  279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE  358 (563)
T ss_pred             hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence            3444566777788999999999999543      345678888765533 345667889999999999999999998854


Q ss_pred             -CCeeeEEEecCCCCChHHhhhcCC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCe
Q 040392          241 -EEFKALVLEYMPHGSLEKYMYSSN-------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA  312 (470)
Q Consensus       241 -~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~  312 (470)
                       .+.++.++.++.-|+|..++..++       ..++..+...++.|++.|++|||   +.+++|.||.++|.++|+..++
T Consensus       359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqV  435 (563)
T KOG1024|consen  359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQV  435 (563)
T ss_pred             ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeE
Confidence             567889999999999999997332       34666777889999999999999   9999999999999999999999


Q ss_pred             EEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhh
Q 040392          313 HLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVND  391 (470)
Q Consensus       313 kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~  391 (470)
                      ||+|=.+++.+.+.+..........+..||+||.+....|+.++|+|||||+||||+| |+.|+.+.++.|+  ..++. 
T Consensus       436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm--~~ylk-  512 (563)
T KOG1024|consen  436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM--EHYLK-  512 (563)
T ss_pred             EeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH--HHHHh-
Confidence            9999999999998888888777888999999999999999999999999999999999 9999987655432  23322 


Q ss_pred             hcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHhh
Q 040392          392 WLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLR  457 (470)
Q Consensus       392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~~  457 (470)
                                       .+.+..+|-+||.+++.+|.-||..+|++||+++|++.-|.++..++.+
T Consensus       513 -----------------dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt~  561 (563)
T KOG1024|consen  513 -----------------DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLTR  561 (563)
T ss_pred             -----------------ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHhh
Confidence                             2345566789999999999999999999999999999999999887754

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.3e-36  Score=293.15  Aligned_cols=248  Identities=26%  Similarity=0.340  Sum_probs=199.0

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      .|...+.||+|+||.||+|+.. ++..||+|.+....   ......+..|+++++.++|+|++++++++.+....++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3777889999999999999754 68899999986432   2334567889999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      |+++ +|.+.+......+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++......   
T Consensus       106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---  178 (317)
T cd06635         106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---  178 (317)
T ss_pred             CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence            9975 888887666667899999999999999999999   999999999999999999999999999998754321   


Q ss_pred             ccccccccCccccCccccC---CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccccc
Q 040392          330 MTQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL  406 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (470)
                         ....++..|+|||++.   .+.++.++||||||+++|||++|+.||....... ....+.....+.           
T Consensus       179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~~~~-----------  243 (317)
T cd06635         179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPT-----------  243 (317)
T ss_pred             ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHhccCCC-----------
Confidence               2345788999999873   4568899999999999999999999987532211 111111111000           


Q ss_pred             CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHH
Q 040392          407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK  450 (470)
Q Consensus       407 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~  450 (470)
                             .....++..+.+++.+||+.+|.+||++.+++++...
T Consensus       244 -------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~  280 (317)
T cd06635         244 -------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV  280 (317)
T ss_pred             -------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence                   0012235668999999999999999999999997543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.6e-36  Score=289.35  Aligned_cols=267  Identities=24%  Similarity=0.306  Sum_probs=200.3

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccc-hhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      +|+..+.||.|++|.||+|+.. +|+.||+|++..... .....+..|+++++.++|+||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4788999999999999999875 689999999875432 23456678999999999999999999999999999999999


Q ss_pred             CCCChHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          252 PHGSLEKYMYSSN--YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       252 ~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      ++ +|.+++....  ..+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.++++|||++.......  
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--  154 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--  154 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence            85 8988886544  46899999999999999999999   8999999999999999999999999999987553221  


Q ss_pred             ccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhc-CCc-------cccc
Q 040392          330 MTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWL-PIS-------TMEV  400 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~-------~~~~  400 (470)
                      .......++..|++||.+.+. .++.++|+||||+++|+|++|+.||......+ .......... +..       ....
T Consensus       155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhHHHHhcCch
Confidence            112234568889999987654 57889999999999999999999997643321 1111111000 000       0000


Q ss_pred             ccccccC-chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          401 VGANLLS-QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       401 ~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ....... ...........++..+.+++.+||+.||.+||++.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0000000 0000011112346778999999999999999999999864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.5e-36  Score=289.26  Aligned_cols=261  Identities=20%  Similarity=0.234  Sum_probs=195.1

Q ss_pred             CCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc-chhhhhHHHHHHHHhcCC-CCcceeEEeeeccC--CeeeEEEe
Q 040392          175 FSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC-GRALKGFDVECEMMKSIR-HRNLIKVISTCSNE--EFKALVLE  249 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~--~~~~lv~e  249 (470)
                      |.+.+.||+|+||.||+|.. .+++.||+|.+.... .........|+.++.++. |+|++++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            56778999999999999975 468999999986532 222233456888888885 99999999999877  88999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      |++ |+|.+++......+++..+..++.|++.||+|||   +.+++|+||+|+||+++. +.+||+|||++........ 
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-  154 (282)
T cd07831          81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-  154 (282)
T ss_pred             cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence            997 5888888766667899999999999999999999   999999999999999999 9999999999986643221 


Q ss_pred             ccccccccCccccCccccC-CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCC------------c
Q 040392          330 MTQTQTLATIGYMAPEYGR-EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPI------------S  396 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~-~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------------~  396 (470)
                        .....++..|+|||.+. +..++.++|||||||++|||++|..||......  ....+.......            .
T Consensus       155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL--DQIAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH--HHHHHHHHHcCCCCHHHHHhhcccc
Confidence              12245788999999764 455788999999999999999999999753221  111111111110            0


Q ss_pred             ccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          397 TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       397 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ......+...... . .......+.++.+++.+||+.+|++||++.+++++
T Consensus       231 ~~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         231 HMNYNFPSKKGTG-L-RKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cccccCccccccc-H-HHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            0000000000000 0 01112457889999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.2e-36  Score=293.97  Aligned_cols=268  Identities=24%  Similarity=0.275  Sum_probs=199.4

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccch--hhhhHHHHHHHHhcCCCCcceeEEeeeccC--Ceee
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGR--ALKGFDVECEMMKSIRHRNLIKVISTCSNE--EFKA  245 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~~  245 (470)
                      ..++|++.+.||+|+||.||+|... +|+.||+|.+......  ....+.+|+.++++++|+||+++++++...  +..+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            4578999999999999999999764 6899999998654322  223456799999999999999999998654  5679


Q ss_pred             EEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC
Q 040392          246 LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  325 (470)
                      +||||+.+ +|.+++......+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++.....
T Consensus        85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            99999975 898888766667899999999999999999999   99999999999999999999999999999987643


Q ss_pred             CCCcccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccc-----
Q 040392          326 EDQSMTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTME-----  399 (470)
Q Consensus       326 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----  399 (470)
                      ...  ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||......+ .+.... .........     
T Consensus       161 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~-~~~~~~-~~~~~~~~~~~~~~  236 (309)
T cd07845         161 PAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE-QLDLII-QLLGTPNESIWPGF  236 (309)
T ss_pred             ccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH-HhcCCCChhhchhh
Confidence            221  1223345788999998865 457899999999999999999999997543211 111111 100000000     


Q ss_pred             -------cccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          400 -------VVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       400 -------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                             ............. ......+.++.+++.+||+.||++|||+.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         237 SDLPLVGKFTLPKQPYNNLK-HKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hcccccccccccCCCCCchH-HhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                   0000000000000 0011235678899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-36  Score=290.25  Aligned_cols=267  Identities=24%  Similarity=0.312  Sum_probs=200.4

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccC--CeeeEEEe
Q 040392          175 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNE--EFKALVLE  249 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~~lv~e  249 (470)
                      |++.+.||+|++|.||+|+.. +++.+|+|.+....  ......+..|+++++.++|+|++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567889999999999999865 48899999997653  33345677899999999999999999999887  88999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      |+++ +|.+++......+++..+..++.|+++||+|||   +.+++|+||+|+||++++++.+||+|||++........ 
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-  155 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-  155 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence            9975 899988776567899999999999999999999   89999999999999999999999999999987643321 


Q ss_pred             ccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc------ccc---
Q 040392          330 MTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS------TME---  399 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~---  399 (470)
                      .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..............      ...   
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07840         156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGSPTDENWPGVSKLPW  234 (287)
T ss_pred             ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchhhccccccchh
Confidence            11223456788999997764 45789999999999999999999998754321 11111111000000      000   


Q ss_pred             --cccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          400 --VVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       400 --~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                        ...................++.++.+++.+||+.+|++||++.+++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence              000000000001111111236789999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=8.4e-37  Score=286.82  Aligned_cols=249  Identities=22%  Similarity=0.317  Sum_probs=200.0

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      +|...+.||+|+||.||+|... +|..+|+|.+....  ....+.+.+|+++++.++|+||+++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778899999999999999765 58899999986542  23445677899999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-CeEEeeeccccccCCCCC
Q 040392          251 MPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-VAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       251 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~  328 (470)
                      +++++|.+++.... ..+++..+..++.|+++||.|||   +.+++|+||+|+||++++++ .+|++|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999986543 35789999999999999999999   89999999999999999886 469999999876643221


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                        ......++..|+|||...+..++.++|+||||+++|||++|+.||.....     ..++...........        
T Consensus       158 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~--------  222 (257)
T cd08225         158 --LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-----HQLVLKICQGYFAPI--------  222 (257)
T ss_pred             --cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHhcccCCCC--------
Confidence              11234578899999999888899999999999999999999999865322     112211111110000        


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                             ....+.++.+++.+||..+|++||++.|++++
T Consensus       223 -------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         223 -------SPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             -------CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                   11235568899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.6e-36  Score=287.32  Aligned_cols=242  Identities=21%  Similarity=0.295  Sum_probs=187.0

Q ss_pred             eecccCceEEEEEEeC-CCcEEEEEEeecccc---hhhhhHHHHHHHH---hcCCCCcceeEEeeeccCCeeeEEEecCC
Q 040392          180 LIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG---RALKGFDVECEMM---KSIRHRNLIKVISTCSNEEFKALVLEYMP  252 (470)
Q Consensus       180 ~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l---~~l~h~nIv~~~~~~~~~~~~~lv~e~~~  252 (470)
                      .||+|+||.||++... +++.+|+|.+.....   .....+..|..++   ....||||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999764 589999999864321   1122233444333   34479999999999998899999999999


Q ss_pred             CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccc
Q 040392          253 HGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ  332 (470)
Q Consensus       253 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  332 (470)
                      +|+|.+++.... .+++..+..++.|++.||+|||   +.+++|+||||+||++++++.++|+|||++.......    .
T Consensus        81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~  152 (279)
T cd05633          81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P  152 (279)
T ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----c
Confidence            999999886544 5899999999999999999999   9999999999999999999999999999987543221    1


Q ss_pred             cccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhh
Q 040392          333 TQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDI  411 (470)
Q Consensus       333 ~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  411 (470)
                      ....++..|+|||.+.+ ..++.++||||+|+++|||++|..||..........   .......     ..         
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~~-----~~---------  215 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---IDRMTLT-----VN---------  215 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH---HHHHhhc-----CC---------
Confidence            23468999999998864 558899999999999999999999997643321111   1100000     00         


Q ss_pred             hhHhhhhhHHHHHHHHhhccCCCccCCC-----CHHHHHHH
Q 040392          412 HFVAKEQCVSCVFNLAMECTVESPEQRI-----NAREIVAK  447 (470)
Q Consensus       412 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~el~~~  447 (470)
                       ...+..++.++.+++.+||+.||++||     +++|+++|
T Consensus       216 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         216 -VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             -cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence             001223466789999999999999999     69999886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.8e-36  Score=283.04  Aligned_cols=249  Identities=27%  Similarity=0.349  Sum_probs=204.6

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccc--hhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      +|.+.+.||.|++|.||++... ++..+++|++.....  .....+..|+++++.++|+|++++++.+......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4778899999999999999765 689999999875432  4566788899999999999999999999988999999999


Q ss_pred             CCCCChHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          251 MPHGSLEKYMYSS---NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       251 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      +++++|.+++...   ...+++..+..++.+++.||.|||   +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            9999999999765   367899999999999999999999   8999999999999999999999999999988654322


Q ss_pred             CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                        .......+++.|+|||...+..++.++|+||+|+++++|++|+.||......     .............        
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~--------  222 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL-----ELALKILKGQYPP--------  222 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH-----HHHHHHhcCCCCC--------
Confidence              1223346888999999998888999999999999999999999998654321     1111111110000        


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                             .+..++.++.+++.+||..+|++||++.|++++
T Consensus       223 -------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         223 -------IPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             -------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                   011336678999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.3e-36  Score=294.47  Aligned_cols=267  Identities=23%  Similarity=0.331  Sum_probs=195.4

Q ss_pred             Ceeccc--CceEEEEEEe-CCCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCC
Q 040392          179 NLIGRG--GFGSVYKARL-GDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH  253 (470)
Q Consensus       179 ~~ig~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~  253 (470)
                      ..||+|  +||+||+|+. .+|+.||+|++....  ....+.+..|+.+++.++||||+++++++...+..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  9999999976 479999999986542  23456788899999999999999999999999999999999999


Q ss_pred             CChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc--
Q 040392          254 GSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM--  330 (470)
Q Consensus       254 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--  330 (470)
                      ++|.+++.... ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++++||+.+..........  
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            99999987643 35788999999999999999999   9999999999999999999999999998654332211110  


Q ss_pred             ---cccccccCccccCccccCCC--CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhh--------cCCcc
Q 040392          331 ---TQTQTLATIGYMAPEYGREG--RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDW--------LPIST  397 (470)
Q Consensus       331 ---~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~--------~~~~~  397 (470)
                         ......++..|+|||++.+.  .++.++||||||+++|||++|+.||......+..........        .+...
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE  240 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence               01112345679999998764  478999999999999999999999986543221111100000        00000


Q ss_pred             ccc-----------cccc-------ccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          398 MEV-----------VGAN-------LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       398 ~~~-----------~~~~-------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                      ...           .+..       ...........+..++..+.+++.+||+.||++|||+.|++++-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~  309 (328)
T cd08226         241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA  309 (328)
T ss_pred             hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence            000           0000       00001112222345678899999999999999999999998653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.6e-36  Score=283.56  Aligned_cols=242  Identities=27%  Similarity=0.348  Sum_probs=195.3

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCCCCh
Q 040392          181 IGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL  256 (470)
Q Consensus       181 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L  256 (470)
                      ||.|++|.||+|+.. +++.+|+|++....   ....+.+..|+++++.++||||+++++++.++...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999865 48999999986542   23456788899999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccccccc
Q 040392          257 EKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL  336 (470)
Q Consensus       257 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  336 (470)
                      .+++.... .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.......   ......
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~  153 (262)
T cd05572          81 WTILRDRG-LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC  153 (262)
T ss_pred             HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence            99997653 5789999999999999999999   9999999999999999999999999999998764322   122346


Q ss_pred             cCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhh
Q 040392          337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAK  416 (470)
Q Consensus       337 ~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  416 (470)
                      ++..|+|||.+.+..++.++|+||||+++|+|++|..||.........   .........              .....+
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~--------------~~~~~~  216 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME---IYNDILKGN--------------GKLEFP  216 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH---HHHHHhccC--------------CCCCCC
Confidence            788999999998888999999999999999999999999765421111   111111000              000111


Q ss_pred             hhhHHHHHHHHhhccCCCccCCCC-----HHHHHH
Q 040392          417 EQCVSCVFNLAMECTVESPEQRIN-----AREIVA  446 (470)
Q Consensus       417 ~~~~~~l~~l~~~cl~~dP~~Rps-----~~el~~  446 (470)
                      ..++.++.+++.+||..+|++||+     +.|+++
T Consensus       217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            222567899999999999999999     677665

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.4e-36  Score=289.85  Aligned_cols=267  Identities=22%  Similarity=0.272  Sum_probs=195.9

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccc--hhhhhHHHHHHHHhcCC-CCcceeEEeeeccCCe-----
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RALKGFDVECEMMKSIR-HRNLIKVISTCSNEEF-----  243 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~-----  243 (470)
                      ++|++.+.||+|+||.||+|... +++.||+|.......  .....+.+|+.+++.+. |+||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888999999999999999764 689999999765422  23456778999999995 6999999999876555     


Q ss_pred             eeEEEecCCCCChHHhhhcCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCCeEEeeec
Q 040392          244 KALVLEYMPHGSLEKYMYSSN----YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-NMVAHLSDFS  318 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg  318 (470)
                      .++||||+++ +|.+++....    ..+++..+..++.|++.||.|||   +++++||||+|+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999985 8988876432    35799999999999999999999   999999999999999998 8999999999


Q ss_pred             cccccCCCCCcccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhc-CCc
Q 040392          319 IAKLLTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWL-PIS  396 (470)
Q Consensus       319 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~  396 (470)
                      ++..+.....  ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||....+.+... ....... +..
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~  233 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL-HIFKLLGTPTE  233 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH-HHHHHhCCCCh
Confidence            9876532211  1122356788999998765 457899999999999999999999987533221111 1111000 000


Q ss_pred             -c----cccccc---cccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          397 -T----MEVVGA---NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       397 -~----~~~~~~---~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                       .    ....+.   ......... ......+.++.+++.+||..||.+||++.|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         234 QVWPGVSKLRDWHEFPQWKPQDLS-RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             hhCcchhhccchhhcCcccchhHH-HhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence             0    000000   000000000 0112356778999999999999999999999864

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.9e-36  Score=292.51  Aligned_cols=272  Identities=21%  Similarity=0.284  Sum_probs=196.5

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccc--hhhhhHHHHHHHHhcCCCCcceeEEeeeccCC------
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRNLIKVISTCSNEE------  242 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~------  242 (470)
                      .++|++.+.||+|+||.||+|... +++.||+|.+.....  .....+..|++++++++||||+++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            467999999999999999999764 689999999864422  22334567999999999999999999886543      


Q ss_pred             --eeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccc
Q 040392          243 --FKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA  320 (470)
Q Consensus       243 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a  320 (470)
                        ..++||||+.+ +|.+++......+++.++..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence              45899999965 888888766667899999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCCc--ccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcc-hhhHHhhhhcCCc
Q 040392          321 KLLTGEDQS--MTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEM-TLKHWVNDWLPIS  396 (470)
Q Consensus       321 ~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~  396 (470)
                      .........  .......++..|+|||.+.+. .++.++||||||+++|||++|+.||........ .....+....+..
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE  246 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            866432211  112234578889999987664 378899999999999999999999875332110 0000000000000


Q ss_pred             c------cccccccccCchh----hhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          397 T------MEVVGANLLSQED----IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       397 ~------~~~~~~~~~~~~~----~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      .      ....+........    ............+.+++.+||..||++||++.|++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            0      0000000000000    0000011124567899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-36  Score=280.54  Aligned_cols=248  Identities=27%  Similarity=0.383  Sum_probs=203.0

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccc--hhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      +|++.+.||+|++|.||+++.. +++.|++|.+.....  .....+..|++++++++|+|++++++++.+....+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999765 578999999875543  4566788999999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      +++++|.+++... ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  155 (254)
T cd06627          81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-  155 (254)
T ss_pred             CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence            9999999998765 46899999999999999999999   999999999999999999999999999999876433221 


Q ss_pred             cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchh
Q 040392          331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED  410 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (470)
                       .....++..|+|||...+..++.++|+||+|+++|+|++|+.||......    ....... ....             
T Consensus       156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~----~~~~~~~-~~~~-------------  216 (254)
T cd06627         156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM----AALFRIV-QDDH-------------  216 (254)
T ss_pred             -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH----HHHHHHh-ccCC-------------
Confidence             23346788999999998888899999999999999999999998754321    1111100 0000             


Q ss_pred             hhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          411 IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       411 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                        ...+...+..+.+++.+||..+|++||++.+++.+
T Consensus       217 --~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         217 --PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             --CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence              00112235678899999999999999999999853

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-36  Score=287.00  Aligned_cols=266  Identities=24%  Similarity=0.251  Sum_probs=202.4

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccc--hhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          175 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      |...+.||+|++|.||+|... +++.+++|.+.....  .....+..|+++++.++|+||+++++++......++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567789999999999999764 688999999865432  24566778999999999999999999999999999999999


Q ss_pred             CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccc
Q 040392          252 PHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  331 (470)
Q Consensus       252 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  331 (470)
                      ++ +|.+++......+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||.+.......  ..
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~  154 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP  154 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence            75 898888776667899999999999999999999   9999999999999999999999999999988764332  12


Q ss_pred             ccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCC------cccc---cc
Q 040392          332 QTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPI------STME---VV  401 (470)
Q Consensus       332 ~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------~~~~---~~  401 (470)
                      .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+ .+..........      ...+   ..
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFKIFRTLGTPDPEVWPKFTSLARNY  233 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCchHhcccchhhhhhh
Confidence            2234577889999998776 78999999999999999999999986533211 111111000000      0000   00


Q ss_pred             ccccc-CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          402 GANLL-SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       402 ~~~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ..... ............++.++.+++.+||+.||.+||++.+++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            00000 00000011223457889999999999999999999999864

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.9e-37  Score=319.13  Aligned_cols=256  Identities=25%  Similarity=0.383  Sum_probs=193.2

Q ss_pred             HHhhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc-cchhhhhHHHHHHHHhcCCCCcceeEEeeecc------
Q 040392          169 CRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ-CGRALKGFDVECEMMKSIRHRNLIKVISTCSN------  240 (470)
Q Consensus       169 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~------  240 (470)
                      .+...+|+.++.||+||||.||+++.+ ||+.||||++... +.+....+.+|+.++++|+|||||+++..|.+      
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            455678999999999999999999865 8999999998755 44556778889999999999999999831100      


Q ss_pred             --------------------------------------------------------------------------------
Q 040392          241 --------------------------------------------------------------------------------  240 (470)
Q Consensus       241 --------------------------------------------------------------------------------  240 (470)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -------------------------C--------CeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHh
Q 040392          241 -------------------------E--------EFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLH  287 (470)
Q Consensus       241 -------------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH  287 (470)
                                               .        ...||-||||+..++.+++......-.....++++++|++||.|+|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence                                     0        1346789999987777777655533357788999999999999999


Q ss_pred             cCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccC----C------------CCCcccccccccCccccCccccCCCC
Q 040392          288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT----G------------EDQSMTQTQTLATIGYMAPEYGREGR  351 (470)
Q Consensus       288 ~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~----~------------~~~~~~~~~~~~t~~y~aPE~~~~~~  351 (470)
                         +.|||||||||.||++++++.|||+|||+|+...    .            .......+..+||..|+|||++.+..
T Consensus       715 ---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  715 ---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             ---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence               9999999999999999999999999999998721    0            11122445678999999999987654


Q ss_pred             ---CCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHh
Q 040392          352 ---VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAM  428 (470)
Q Consensus       352 ---~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  428 (470)
                         |+.|+|+||+||+++||+.   ||.....+...+........|.. ....++               ...+-..+++
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~~~---------------~~~~e~slI~  852 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFFDP---------------EHPEEASLIR  852 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-cccccc---------------cchHHHHHHH
Confidence               9999999999999999996   56543222222222111111111 111111               1333468999


Q ss_pred             hccCCCccCCCCHHHHHH
Q 040392          429 ECTVESPEQRINAREIVA  446 (470)
Q Consensus       429 ~cl~~dP~~Rps~~el~~  446 (470)
                      ++++.||.+||||.|++.
T Consensus       853 ~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  853 WLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHhcCCCccCCCHHHHhh
Confidence            999999999999999875

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3e-36  Score=289.43  Aligned_cols=253  Identities=24%  Similarity=0.304  Sum_probs=197.0

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCC-CcEEEEEEeeccc-chhhhhHHHHHHHHhcCC-CCcceeEEeeeccCCeeeEEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQC-GRALKGFDVECEMMKSIR-HRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      .++|++.+.||+|++|.||+|...+ ++.||||.+.... ......+..|+.++.... |+||+++++++.+....+++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            4678899999999999999998764 8999999987542 223445566777666664 999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      ||++ +++.+++......+++..+..++.|++.|++|||   + .+++||||+|+||++++++.+||+|||++..+....
T Consensus        94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            9985 4888887665567899999999999999999999   6 589999999999999999999999999987654322


Q ss_pred             CcccccccccCccccCccccCCCC----CCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccc
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGR----VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA  403 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (470)
                      .   .....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||.........+........+    ..   
T Consensus       170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~----~~---  239 (296)
T cd06618         170 A---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP----SL---  239 (296)
T ss_pred             c---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCC----CC---
Confidence            1   12234778899999987553    7889999999999999999999986532221111111111000    00   


Q ss_pred             cccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                                .....++.++.+++.+||..||++||++.+++++-
T Consensus       240 ----------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         240 ----------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             ----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence                      00112466789999999999999999999998774

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=7.8e-36  Score=282.14  Aligned_cols=247  Identities=20%  Similarity=0.239  Sum_probs=194.4

Q ss_pred             HHhhCCCCCCCee--cccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCee
Q 040392          169 CRATDGFSENNLI--GRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFK  244 (470)
Q Consensus       169 ~~~~~~~~~~~~i--g~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~  244 (470)
                      ....++|++.+.+  |+|+||.||++.. .++..+|+|.+........     |......+ +||||+++++++...+..
T Consensus        10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~   84 (267)
T PHA03390         10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGH   84 (267)
T ss_pred             HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence            3445677777776  9999999999975 4688899999864322111     22222222 699999999999999999


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-CeEEeeecccccc
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-VAHLSDFSIAKLL  323 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~a~~~  323 (470)
                      ++||||+++++|.+++.... .+++..+..++.|+++||.|||   +.+++|+||+|+||+++.++ .++|+|||++...
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~  160 (267)
T PHA03390         85 VLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII  160 (267)
T ss_pred             EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence            99999999999999997654 7899999999999999999999   99999999999999999998 9999999998765


Q ss_pred             CCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccc
Q 040392          324 TGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA  403 (470)
Q Consensus       324 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (470)
                      ...      ....++..|+|||++.+..++.++||||||+++|||++|+.||............+.... ....      
T Consensus       161 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~------  227 (267)
T PHA03390        161 GTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKL------  227 (267)
T ss_pred             CCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccC------
Confidence            322      123578899999999988899999999999999999999999985544333333333221 1000      


Q ss_pred             cccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCC-HHHHHHH
Q 040392          404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRIN-AREIVAK  447 (470)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-~~el~~~  447 (470)
                                ......+..+.+++.+||+.+|.+||+ ++|++++
T Consensus       228 ----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        228 ----------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             ----------CcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence                      001134667899999999999999996 5888754

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.3e-36  Score=288.86  Aligned_cols=268  Identities=25%  Similarity=0.276  Sum_probs=195.8

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      ++|++.+.||+|++|.||+|... +|+.||+|.+....  ......+..|+++++.++||||+++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            56888999999999999999865 68999999986432  2234567789999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCCeEEeeeccccccCCCC
Q 040392          250 YMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-NMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |++ ++|.+++.... ...++..+..++.|++.||+|||   +++++|+||+|+||+++. ++.+||+|||++.......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            996 48877775443 33678888899999999999999   899999999999999985 5679999999997543211


Q ss_pred             CcccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhh-hcCCc-c-ccc---
Q 040392          328 QSMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVND-WLPIS-T-MEV---  400 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~-~-~~~---  400 (470)
                        .......++..|+|||.+.+. .++.++||||||+++|+|+||+.||......+. ....... ..+.. . ...   
T Consensus       158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  234 (294)
T PLN00009        158 --RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE-LFKIFRILGTPNEETWPGVTSL  234 (294)
T ss_pred             --cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChhhccccccc
Confidence              111234568899999987664 578999999999999999999999975432211 1111000 00000 0 000   


Q ss_pred             cccc-ccC--chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          401 VGAN-LLS--QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       401 ~~~~-~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      .+.. ...  ............+.++.+++.+|++.+|++||++.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000 000  0000000112335668899999999999999999999874

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.5e-36  Score=289.77  Aligned_cols=271  Identities=25%  Similarity=0.288  Sum_probs=200.8

Q ss_pred             HhhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCC----
Q 040392          170 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEE----  242 (470)
Q Consensus       170 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~----  242 (470)
                      ...++|++.+.||+|+||.||+|..+ +|+.||+|.++...  ......+..|++++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999865 58899999987543  223345677999999999999999999886654    


Q ss_pred             ------eeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEee
Q 040392          243 ------FKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSD  316 (470)
Q Consensus       243 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~D  316 (470)
                            ..++|+||+++ ++.+++......+++..+..++.|++.||+|||   +.+|+|+||+|+||++++++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence                  78999999976 787877766567899999999999999999999   89999999999999999999999999


Q ss_pred             eccccccCCCCCcccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhc--
Q 040392          317 FSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWL--  393 (470)
Q Consensus       317 fg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--  393 (470)
                      ||++........ .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..+........  
T Consensus       160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-~~~~~~~~~~~~~  237 (302)
T cd07864         160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-AQLELISRLCGSP  237 (302)
T ss_pred             ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCC
Confidence            999986643321 11122345778999998764 35788999999999999999999998753221 11111111100  


Q ss_pred             -CCccccc--------ccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          394 -PISTMEV--------VGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       394 -~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                       +......        .+......... ......++..+.+++..||+.||.+||++.+++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         238 CPAVWPDVIKLPYFNTMKPKKQYRRRL-REEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             Chhhcccccccccccccccccccccch-hhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence             0000000        00000000000 01112346779999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=274.24  Aligned_cols=252  Identities=22%  Similarity=0.279  Sum_probs=201.1

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc-cchhhhhHHHHHHHHhcCC-CCcceeEEeeeccCCeeeEEEe
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ-CGRALKGFDVECEMMKSIR-HRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      ++...+..||.|+.|.|++++.. +|..+|||..... ..+..+++...+.++.... +|.||+.+|||.......+.||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            44566778999999999999754 5899999998654 4456677777777766654 8999999999998888889999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      .|. ..++.++.....++++.-.-++...++.||.||-+  .++|+|||+||+|||+|+.|++|+||||++-++....  
T Consensus       172 lMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--  246 (391)
T KOG0983|consen  172 LMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--  246 (391)
T ss_pred             HHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc--
Confidence            984 36777777777788998899999999999999996  6799999999999999999999999999998775432  


Q ss_pred             ccccccccCccccCccccCC---CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccccc
Q 040392          330 MTQTQTLATIGYMAPEYGRE---GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL  406 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (470)
                       ..+...|-+.|||||.+.-   ..|+.++||||||++++||.||+.||.....+=..+....+ ..|            
T Consensus       247 -AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~eP------------  312 (391)
T KOG0983|consen  247 -AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEP------------  312 (391)
T ss_pred             -ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCC------------
Confidence             3344568889999998864   46899999999999999999999999874333222222222 111            


Q ss_pred             CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       407 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                          ......+.++..+.+++..||+.|+.+||...++++|
T Consensus       313 ----P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  313 ----PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             ----CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence                1111223357889999999999999999999999876

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.2e-36  Score=286.37  Aligned_cols=244  Identities=23%  Similarity=0.313  Sum_probs=192.7

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCCCCh
Q 040392          181 IGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL  256 (470)
Q Consensus       181 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L  256 (470)
                      ||+|+||+||++... +|+.||+|.+....   ......+..|+++++.++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999754 68999999986432   22344567899999999999999999999999999999999999999


Q ss_pred             HHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccccccc
Q 040392          257 EKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT  335 (470)
Q Consensus       257 ~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  335 (470)
                      .+++.... ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||.+.....   .......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccc
Confidence            99987644 35899999999999999999999   99999999999999999999999999999876532   1122234


Q ss_pred             ccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHh
Q 040392          336 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVA  415 (470)
Q Consensus       336 ~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  415 (470)
                      .++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ............                ....
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~----------------~~~~  217 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-EKEELKRRTLEM----------------AVEY  217 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-cHHHHHhccccc----------------cccC
Confidence            57889999999988889999999999999999999999997543211 111110000000                0001


Q ss_pred             hhhhHHHHHHHHhhccCCCccCCC-----CHHHHHHH
Q 040392          416 KEQCVSCVFNLAMECTVESPEQRI-----NAREIVAK  447 (470)
Q Consensus       416 ~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~el~~~  447 (470)
                      +..++..+.+++.+||+.||++||     ++.+++.+
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence            122366788999999999999999     66666653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=315.98  Aligned_cols=260  Identities=28%  Similarity=0.457  Sum_probs=214.0

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC----C----CcEEEEEEeecc-cchhhhhHHHHHHHHhcC-CCCcceeEEeeecc
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG----D----GMEVAVKVFNLQ-CGRALKGFDVECEMMKSI-RHRNLIKVISTCSN  240 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~----~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~  240 (470)
                      ..++..+.+.+|+|.||.|++|...    .    ...||||.++.. ...+.+.+..|+++|+.+ .|+||+.++|+|..
T Consensus       294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~  373 (609)
T KOG0200|consen  294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ  373 (609)
T ss_pred             chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence            3445566679999999999999632    1    456999998644 335677889999999999 59999999999999


Q ss_pred             CCeeeEEEecCCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCee
Q 040392          241 EEFKALVLEYMPHGSLEKYMYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVL  305 (470)
Q Consensus       241 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nil  305 (470)
                      +...++|+||+..|+|.+++..++               ..++....+.++.|||.|++||+   +++++||||.++|||
T Consensus       374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVL  450 (609)
T KOG0200|consen  374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVL  450 (609)
T ss_pred             CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEE
Confidence            999999999999999999998877               45888999999999999999999   999999999999999


Q ss_pred             eCCCCCeEEeeeccccccCCCCCcccc-cccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcc
Q 040392          306 LDDNMVAHLSDFSIAKLLTGEDQSMTQ-TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEM  383 (470)
Q Consensus       306 l~~~~~~kl~Dfg~a~~~~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~  383 (470)
                      ++++..+||+|||+|+.....+..... +...-...|||||.+....++.++|||||||+|||++| |..||.+....+ 
T Consensus       451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~-  529 (609)
T KOG0200|consen  451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE-  529 (609)
T ss_pred             ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH-
Confidence            999999999999999976554443322 11114567999999999999999999999999999999 899987632121 


Q ss_pred             hhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHH
Q 040392          384 TLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR  452 (470)
Q Consensus       384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~  452 (470)
                      .+.+++.                  .+.+...|..|+.++.++|..||+.+|++||++.|+...+....
T Consensus       530 ~l~~~l~------------------~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  530 ELLEFLK------------------EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             HHHHHHh------------------cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence            1122222                  12333456778999999999999999999999999999999964

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=4.3e-36  Score=287.94  Aligned_cols=259  Identities=20%  Similarity=0.249  Sum_probs=186.5

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCC----CcEEEEEEeecccchhh-----------hhHHHHHHHHhcCCCCcceeEEe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGD----GMEVAVKVFNLQCGRAL-----------KGFDVECEMMKSIRHRNLIKVIS  236 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~nIv~~~~  236 (470)
                      .++|.+.+.||+|+||.||+|...+    +..+|+|..........           .....+...+..+.|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3679999999999999999998654    45667776433221110           01122334456678999999998


Q ss_pred             eeccCC----eeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCe
Q 040392          237 TCSNEE----FKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA  312 (470)
Q Consensus       237 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~  312 (470)
                      ++....    ..++++|++.. ++.+.+... ...++..+..++.|++.||+|||   +.+++||||||+|||++.++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcE
Confidence            765433    44678888744 676666443 23577888999999999999999   9999999999999999999999


Q ss_pred             EEeeeccccccCCCCCc-----ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhH
Q 040392          313 HLSDFSIAKLLTGEDQS-----MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKH  387 (470)
Q Consensus       313 kl~Dfg~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~  387 (470)
                      +|+|||+|+.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||............
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~  245 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA  245 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence            99999999866432211     1122346999999999999999999999999999999999999999875332211111


Q ss_pred             HhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          388 WVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       388 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                      ...+....         +.. .   ......++.++.+++..||+.+|++||++.++++.|
T Consensus       246 ~~~~~~~~---------~~~-~---~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        246 AKCDFIKR---------LHE-G---KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             hHHHHHHH---------hhh-h---hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            10000000         000 0   001123467799999999999999999999999876

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.9e-36  Score=295.88  Aligned_cols=264  Identities=23%  Similarity=0.244  Sum_probs=197.5

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccC------
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNE------  241 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~------  241 (470)
                      ..++|+..+.||+|+||.||+|+.. +++.||+|.+...  .......+..|+.+++.++|+||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            3578999999999999999999754 6899999998643  223345677899999999999999999987543      


Q ss_pred             CeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecccc
Q 040392          242 EFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK  321 (470)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~  321 (470)
                      ...++||||+.+ +|.+.+...   ++...+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~  166 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  166 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence            357899999964 888887543   788899999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhh---------
Q 040392          322 LLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDW---------  392 (470)
Q Consensus       322 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~---------  392 (470)
                      ......   ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ..+.......         
T Consensus       167 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~  242 (353)
T cd07850         167 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIEQLGTPSDEFMS  242 (353)
T ss_pred             eCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHH
Confidence            653221   122345788999999999999999999999999999999999998753211 1111100000         


Q ss_pred             ---------cCCc-------ccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          393 ---------LPIS-------TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       393 ---------~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                               ....       ..+...........  ...+...+.++.+++.+||+.||++||++.|++.+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDS--ESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HhhhhhhHHhhcCCCCCCcchhhhCcccccCccc--ccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                     0000       00000000000000  00011235678899999999999999999999976

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.9e-36  Score=288.81  Aligned_cols=245  Identities=24%  Similarity=0.301  Sum_probs=198.0

Q ss_pred             CCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCCCCh
Q 040392          178 NNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL  256 (470)
Q Consensus       178 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L  256 (470)
                      ...||+|+||.||++.. .++..||+|.+..........+..|+.+++.++|+||+++++++...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            46799999999999976 46899999998655555566788899999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccccccc
Q 040392          257 EKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL  336 (470)
Q Consensus       257 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  336 (470)
                      .+++...  .+++.....++.|++.|++|||   +.+++|+||+|+||+++.++.++|+|||++.......  .......
T Consensus       105 ~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~  177 (292)
T cd06657         105 TDIVTHT--RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLV  177 (292)
T ss_pred             HHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccccc
Confidence            9987543  4788999999999999999999   8999999999999999999999999999987654322  1223356


Q ss_pred             cCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhh
Q 040392          337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAK  416 (470)
Q Consensus       337 ~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  416 (470)
                      ++..|+|||.+.+..++.++|+||+|+++|+|++|..||......  ..........+....                ..
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~----------------~~  239 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLPPKLK----------------NL  239 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhhCCcccC----------------Cc
Confidence            788999999998888999999999999999999999998753221  111111111111100                00


Q ss_pred             hhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          417 EQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       417 ~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ...+..+.+++.+||+.+|.+||++.+++++
T Consensus       240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         240 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             ccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            1225567899999999999999999999885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.6e-36  Score=295.35  Aligned_cols=268  Identities=25%  Similarity=0.316  Sum_probs=199.4

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHhcC-CCCcceeEEeeecc--CCee
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRALKGFDVECEMMKSI-RHRNLIKVISTCSN--EEFK  244 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~--~~~~  244 (470)
                      ..++|++.+.||+|+||.||+|... +++.+|+|++...  .......+..|+.+++++ +||||+++++++..  ....
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3567899999999999999999865 5889999988542  223345567899999999 99999999998854  3467


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccC
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~  324 (470)
                      ++||||++ ++|.+++...  .+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++....
T Consensus        85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            99999997 5999988654  6788899999999999999999   9999999999999999999999999999998664


Q ss_pred             CCCCc---ccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc----
Q 040392          325 GEDQS---MTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS----  396 (470)
Q Consensus       325 ~~~~~---~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----  396 (470)
                      .....   .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+. ....... ....    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~-~~~~~~~~  236 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEV-IGPPSAED  236 (337)
T ss_pred             cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHH-hCCCCHHH
Confidence            33221   12233467889999998754 4578899999999999999999999875432211 1111000 0000    


Q ss_pred             --------ccccccccccCchh-hhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          397 --------TMEVVGANLLSQED-IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       397 --------~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                              .....+ ....... ........++.++.+++.+||+.||++|||+.+++++
T Consensus       237 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         237 IESIKSPFAATMLD-SLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHhhhHHHhhh-hcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                    000000 0000000 0000111257789999999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4e-36  Score=291.08  Aligned_cols=263  Identities=21%  Similarity=0.260  Sum_probs=193.9

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCCCCh
Q 040392          179 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL  256 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L  256 (470)
                      +.+|.|+++.||++.. +++.||+|++...  .....+.+..|+++++.++|+||+++++++.+.+..+++|||+++|+|
T Consensus         8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l   86 (314)
T cd08216           8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC   86 (314)
T ss_pred             HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence            3445555555555544 6999999998754  344567788999999999999999999999999999999999999999


Q ss_pred             HHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc-----c
Q 040392          257 EKYMYSS-NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS-----M  330 (470)
Q Consensus       257 ~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-----~  330 (470)
                      .+++... ...+++.....++.|++.||+|||   +.+|+|+||||+||+++.++.+||+|||.+..+......     .
T Consensus        87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~  163 (314)
T cd08216          87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD  163 (314)
T ss_pred             HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence            9999754 345788899999999999999999   999999999999999999999999999988755322211     1


Q ss_pred             cccccccCccccCccccCCC--CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCC----cc-----cc
Q 040392          331 TQTQTLATIGYMAPEYGREG--RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPI----ST-----ME  399 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~-----~~  399 (470)
                      ......++..|+|||++...  .++.++|+||||+++|||++|+.||............ .....+.    ..     ..
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  242 (314)
T cd08216         164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK-VRGTVPCLLDKSTYPLYEDS  242 (314)
T ss_pred             ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhccCccccccCchhhhcCC
Confidence            11234567789999998653  5889999999999999999999999864332221111 1100000    00     00


Q ss_pred             -------cccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          400 -------VVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       400 -------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                             ..+...  ............+.++.+++.+||+.||++|||+.|++++-
T Consensus       243 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p  296 (314)
T cd08216         243 MSQSRSSNEHPNN--RDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS  296 (314)
T ss_pred             cCcccccccccch--hhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence                   000000  00011112233456789999999999999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.4e-36  Score=290.54  Aligned_cols=254  Identities=26%  Similarity=0.323  Sum_probs=194.4

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCC-CCcceeEEeeeccCCeeeEEEe
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIR-HRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      ++|...+.||+|+||.||++... +++.+|+|.+.... ......+..|+.++.++. |+||+++++++..+...+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            35666788999999999999754 58999999986543 234556788999999996 9999999999988888999999


Q ss_pred             cCCCCChHHhh---hc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC
Q 040392          250 YMPHGSLEKYM---YS-SNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       250 ~~~~g~L~~~l---~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  325 (470)
                      |+.. ++.++.   .. ....+++..+..++.+++.||+|||+  +.+++||||||+||+++.++.+||+|||++.....
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            9864 655543   22 23568999999999999999999992  25999999999999999999999999999876543


Q ss_pred             CCCcccccccccCccccCccccCCC---CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccc
Q 040392          326 EDQSMTQTQTLATIGYMAPEYGREG---RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVG  402 (470)
Q Consensus       326 ~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (470)
                      ..   ......++..|+|||.+.+.   .++.++||||||+++|||++|+.||.....    ............     .
T Consensus       161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~~-----~  228 (288)
T cd06616         161 SI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQLTQVVKGD-----P  228 (288)
T ss_pred             CC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHHHHhhhcCCC-----C
Confidence            21   11233578899999998776   689999999999999999999999875421    111111111000     0


Q ss_pred             ccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          403 ANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      +.+..      ..+..++.++.+++.+||+.+|++||++.+++++
T Consensus       229 ~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         229 PILSN------SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CcCCC------cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00000      0112346778999999999999999999999886

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.1e-36  Score=285.09  Aligned_cols=244  Identities=27%  Similarity=0.356  Sum_probs=194.2

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEeecccc---hhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCCCCh
Q 040392          181 IGRGGFGSVYKARLG-DGMEVAVKVFNLQCG---RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL  256 (470)
Q Consensus       181 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L  256 (470)
                      ||.|+||.||++... +|+.+++|.+.....   .....+..|++++++++|+||+++++.+......++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999876 499999999865432   3456788899999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC------cc
Q 040392          257 EKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ------SM  330 (470)
Q Consensus       257 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~------~~  330 (470)
                      .+++.... .+++..+..++.|+++||+|||   +.+++|+||+|+||+++.++.++|+|||++........      ..
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            99997655 6899999999999999999999   99999999999999999999999999999875432211      11


Q ss_pred             cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchh
Q 040392          331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED  410 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (470)
                      ......++..|+|||.......+.++|+||||+++|++++|..||......+     ..........             
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~~~~~~-------------  218 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE-----IFQNILNGKI-------------  218 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHhcCCc-------------
Confidence            2234457889999999988889999999999999999999999987543211     1111100000             


Q ss_pred             hhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          411 IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       411 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                       ........+..+.+++.+||+.+|++||++.++.+.
T Consensus       219 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~  254 (265)
T cd05579         219 -EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEI  254 (265)
T ss_pred             -CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHH
Confidence             000001125678999999999999999999444443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-36  Score=310.29  Aligned_cols=272  Identities=17%  Similarity=0.179  Sum_probs=190.3

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeCC--CcEEEEEEe--------------e---cccchhhhhHHHHHHHHhcCCCCcc
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLGD--GMEVAVKVF--------------N---LQCGRALKGFDVECEMMKSIRHRNL  231 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~--------------~---~~~~~~~~~~~~E~~~l~~l~h~nI  231 (470)
                      ..++|++.+.||+|+||.||++..+.  +...++|.+              .   .........+.+|+.++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            35789999999999999999986432  222222211              0   0112234557789999999999999


Q ss_pred             eeEEeeeccCCeeeEEEecCCCCChHHhhhcCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC
Q 040392          232 IKVISTCSNEEFKALVLEYMPHGSLEKYMYSSN----YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD  307 (470)
Q Consensus       232 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~  307 (470)
                      +++++++...+..++|+|++. ++|.+++....    ..........++.|++.||.|||   +++|+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence            999999999999999999995 47777765432    22335567789999999999999   99999999999999999


Q ss_pred             CCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCC-CCccccC-cchh
Q 040392          308 DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP-TNEIFNG-EMTL  385 (470)
Q Consensus       308 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p-~~~~~~~-~~~~  385 (470)
                      .++.+||+|||++..+..... .......||..|+|||++.+..++.++|||||||++|||++|..+ +...... ...+
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             CCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            999999999999987643221 122335789999999999999999999999999999999998764 4332111 1111


Q ss_pred             hHHhhhh------cCCc---cccccccccc---CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          386 KHWVNDW------LPIS---TMEVVGANLL---SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       386 ~~~~~~~------~~~~---~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ...+...      .+..   ..+.++....   .............+.++.+++.+||+.||.+|||+.|++++
T Consensus       381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            1111110      0000   0000000000   00000111112245668889999999999999999999875

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-36  Score=295.67  Aligned_cols=273  Identities=23%  Similarity=0.270  Sum_probs=199.7

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc-cchhhhhHHHHHHHHhcCCCCcceeEEeeeccC-----Cee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ-CGRALKGFDVECEMMKSIRHRNLIKVISTCSNE-----EFK  244 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-----~~~  244 (470)
                      +++|.+.+.||+|+||.||+|.. .+|+.||+|++... .......+..|+.+++.++|+||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            57899999999999999999975 46899999998643 233455677899999999999999999876543     357


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccC
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~  324 (470)
                      ++|+||+++ +|.+++...  .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++....
T Consensus        84 ~lv~e~~~~-~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          84 YIVQELMET-DLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEEehhccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            899999965 888887543  5889999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCCCc-ccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccc--
Q 040392          325 GEDQS-MTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEV--  400 (470)
Q Consensus       325 ~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--  400 (470)
                      ..... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ..+. .+.........+.  
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~-~~~~-~~~~~~~~~~~~~~~  235 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL-HQLN-LILGVLGTPSQEDLN  235 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHH-HHHHHcCCCCHHHHH
Confidence            32211 12233467899999998654 46889999999999999999999999653211 1111 1111111000000  


Q ss_pred             --cccc-------ccCchhhh-hHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH--HHHHH
Q 040392          401 --VGAN-------LLSQEDIH-FVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK--LLKIR  452 (470)
Q Consensus       401 --~~~~-------~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~--L~~i~  452 (470)
                        .+..       ........ .......+.++.+++.+||+.+|++||++.|++++  ++...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence              0000       00000000 00011235678999999999999999999999998  55543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-38  Score=326.94  Aligned_cols=256  Identities=27%  Similarity=0.374  Sum_probs=208.1

Q ss_pred             HHhhCCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeee
Q 040392          169 CRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKA  245 (470)
Q Consensus       169 ~~~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  245 (470)
                      ...+-+|+...+||.|.||.||-|. ..+|...|+|.+....  .+..+.+.+|..++..++|||+|+++|+-.+++..+
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence            3445678888999999999999996 5579999999886543  445677889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC
Q 040392          246 LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  325 (470)
                      |.||||++|+|.+.+...+ ..++.....+..|++.|++|||   +.|||||||||.||+++.+|.+|++|||.|..+.+
T Consensus      1311 IFMEyC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHHHHhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecC
Confidence            9999999999999996554 4677777789999999999999   99999999999999999999999999999998876


Q ss_pred             CCCc--ccccccccCccccCccccCCCC---CCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccc
Q 040392          326 EDQS--MTQTQTLATIGYMAPEYGREGR---VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEV  400 (470)
Q Consensus       326 ~~~~--~~~~~~~~t~~y~aPE~~~~~~---~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (470)
                      ....  ..-....||+.|||||++.+..   ...+.||||+|||+.||+||+.||...++.=.-+....-.+        
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh-------- 1458 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGH-------- 1458 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccC--------
Confidence            5322  2223568999999999987643   56789999999999999999999998654311111111111        


Q ss_pred             ccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          401 VGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                                 ....|+..+.+-.+++..||..||++|.++.|++++
T Consensus      1459 -----------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 -----------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             -----------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                       112234457778899999999999999998877664

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3.4e-36  Score=282.42  Aligned_cols=247  Identities=26%  Similarity=0.338  Sum_probs=201.7

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      +|++.+.||+|++|.||++... +++.+|+|.+....  ......+..|+++++.++|+||+++++++......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4778899999999999999654 68899999986542  23455677899999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          251 MPHGSLEKYMYSS---NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       251 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      +++++|.+++...   ...+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+|++|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999998652   246889999999999999999999   999999999999999999999999999999876433 


Q ss_pred             CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                         ......++..|+|||.+.+..++.++|+||||+++|||++|+.||......+  +...+.   ....         .
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--~~~~~~---~~~~---------~  219 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD--LRYKVQ---RGKY---------P  219 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHh---cCCC---------C
Confidence               1223457889999999998889999999999999999999999997643211  111111   0000         0


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                            ..+...+.++.+++.+||..+|++||++.|++++
T Consensus       220 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         220 ------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             ------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                  0111336678999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.5e-36  Score=294.96  Aligned_cols=270  Identities=22%  Similarity=0.275  Sum_probs=199.5

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeecc----CCee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSN----EEFK  244 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~----~~~~  244 (470)
                      .++|++.+.||+|++|.||+|... +|+.||+|++....  ......+..|+.+++.++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            368999999999999999999754 69999999986542  2345567789999999999999999988753    3567


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccC
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~  324 (470)
                      ++||||+. ++|.+++.... .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++....
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            89999996 58999886544 5899999999999999999999   8999999999999999999999999999987654


Q ss_pred             CCCCc--ccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCC---ccc
Q 040392          325 GEDQS--MTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPI---STM  398 (470)
Q Consensus       325 ~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~  398 (470)
                      .....  .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .+ ..+......   ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~-~~-~~~~~~~g~~~~~~~  236 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH-QL-KLILSVLGSPSEEVL  236 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH-HH-HHHHHHhCCChhHhh
Confidence            32211  11123468889999998765 458899999999999999999999997532211 11 110000000   000


Q ss_pred             cccc-c-------cccCchhhh-hHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          399 EVVG-A-------NLLSQEDIH-FVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       399 ~~~~-~-------~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                      +... .       ......... .......+.++.+++.+||+.+|++||++.+++.+-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~  295 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP  295 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence            0000 0       000000000 001123467799999999999999999999998853

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-35  Score=280.83  Aligned_cols=251  Identities=22%  Similarity=0.301  Sum_probs=198.3

Q ss_pred             CCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc-----cchhhhhHHHHHHHHhcCCCCcceeEEeeeccC--Cee
Q 040392          173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ-----CGRALKGFDVECEMMKSIRHRNLIKVISTCSNE--EFK  244 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~  244 (470)
                      .+|++.+.||+|+||.||+|.. .++..||+|.+...     .......+.+|++++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4788999999999999999975 45899999987532     223456788899999999999999999998654  467


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccC
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~  324 (470)
                      ++++||+++++|.+++.... .+++.....++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++....
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            89999999999999986544 4788889999999999999999   9999999999999999999999999999998653


Q ss_pred             CCCC-cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccc
Q 040392          325 GEDQ-SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA  403 (470)
Q Consensus       325 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (470)
                      .... ........++..|+|||.+.+..++.++|+||||+++|+|++|+.||......+ ....   .. .....     
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~---~~-~~~~~-----  227 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-AIFK---IA-TQPTK-----  227 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-HHHH---HH-cCCCC-----
Confidence            2111 111123458889999999988889999999999999999999999997532211 1111   00 00000     


Q ss_pred             cccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                               ...+...+.++.+++.+||+ +|..||++.+++.|
T Consensus       228 ---------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         228 ---------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             ---------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence                     01122335678999999999 57999999998865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=6e-37  Score=302.08  Aligned_cols=274  Identities=26%  Similarity=0.354  Sum_probs=205.6

Q ss_pred             CCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecc-cchhhhhHHHHHHHHhcCCCCcceeEEeeeccC------Ceee
Q 040392          174 GFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ-CGRALKGFDVECEMMKSIRHRNLIKVISTCSNE------EFKA  245 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~------~~~~  245 (470)
                      .|...+.||+|+||.||+|+ ..+|+.||||.++.. ..+..+.+-.|++++++++|+|||++++.-++.      ....
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            35667899999999999998 457999999999754 345567788899999999999999999876543      3567


Q ss_pred             EEEecCCCCChHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee--CCCC--CeEEeeecc
Q 040392          246 LVLEYMPHGSLEKYMYSSN--YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL--DDNM--VAHLSDFSI  319 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill--~~~~--~~kl~Dfg~  319 (470)
                      +|||||.+|||...+.+-.  ..+++.+.+.++.+++.||.|||   ..+|+||||||.||++  +++|  .-||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            9999999999999997543  56899999999999999999999   9999999999999998  3334  469999999


Q ss_pred             ccccCCCCCcccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchh-hHHhhhhc-CCc
Q 040392          320 AKLLTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTL-KHWVNDWL-PIS  396 (470)
Q Consensus       320 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~-~~~~~~~~-~~~  396 (470)
                      |+.+..+.   ...+.+||..|++||+... +.|+..+|.|||||++|+++||..||.....+.... ..|..... +..
T Consensus       171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~  247 (732)
T KOG4250|consen  171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG  247 (732)
T ss_pred             cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence            99875433   5567899999999999984 789999999999999999999999999865543211 12221111 111


Q ss_pred             ccccccccccCchh--hhhHhh----hhhHHHHHHHHhhccCCCccCCC--CHHHHHHHHHHHHH
Q 040392          397 TMEVVGANLLSQED--IHFVAK----EQCVSCVFNLAMECTVESPEQRI--NAREIVAKLLKIRD  453 (470)
Q Consensus       397 ~~~~~~~~~~~~~~--~~~~~~----~~~~~~l~~l~~~cl~~dP~~Rp--s~~el~~~L~~i~~  453 (470)
                      ..-...+...+.-.  ...+.+    ......+..++..+|..+|++|.  ...+....+..|..
T Consensus       248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~  312 (732)
T KOG4250|consen  248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN  312 (732)
T ss_pred             eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence            11111111100000  000111    11133466788899999999999  88887777777654

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=7.8e-36  Score=288.15  Aligned_cols=248  Identities=26%  Similarity=0.347  Sum_probs=197.7

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      .|...+.||+|+||.||+|+.. ++..+|+|.+...   .......+..|+++++.++|+|++++++++......++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            4677789999999999999864 5788999998642   22344567789999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      |+. |++.+++......+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++|+|||++......   
T Consensus        96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---  168 (308)
T cd06634          96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  168 (308)
T ss_pred             ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence            996 5888877665666899999999999999999999   999999999999999999999999999998765321   


Q ss_pred             ccccccccCccccCccccC---CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccccc
Q 040392          330 MTQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL  406 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (470)
                         ....++..|+|||.+.   ...++.++||||||+++|+|++|+.||......+ ....+.....+.           
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~~-----------  233 (308)
T cd06634         169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPA-----------  233 (308)
T ss_pred             ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHHHhhcCCCC-----------
Confidence               2245788999999874   3567889999999999999999999986532211 111111111000           


Q ss_pred             CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHH
Q 040392          407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK  450 (470)
Q Consensus       407 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~  450 (470)
                             .....++..+.+++.+||+.+|++||++.+++.+-.-
T Consensus       234 -------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~  270 (308)
T cd06634         234 -------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV  270 (308)
T ss_pred             -------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence                   0012235668899999999999999999999987543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2e-35  Score=285.89  Aligned_cols=244  Identities=27%  Similarity=0.337  Sum_probs=194.7

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          175 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      |...+.||+|+||+||+|+.. +++.|++|.+....   ......+..|+++++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            666788999999999999764 68899999986432   23345677899999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      +. |++.+++......+++.++..++.|++.|+.|||   +.+++|+||+|+||+++.++.+||+|||++.....     
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----  173 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----  173 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence            96 5888888766667899999999999999999999   99999999999999999999999999998864321     


Q ss_pred             cccccccCccccCccccC---CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          331 TQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                       .....++..|+|||++.   ...++.++||||||+++|||++|..||........ .........+         ..  
T Consensus       174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~~~~---------~~--  240 (313)
T cd06633         174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNDSP---------TL--  240 (313)
T ss_pred             -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhcCCC---------CC--
Confidence             12346788999999874   45688899999999999999999999876422111 1110000000         00  


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                             .....+..+.+++.+||+.+|.+||++.+++++
T Consensus       241 -------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         241 -------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             -------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                   011224568899999999999999999999976

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.2e-35  Score=280.83  Aligned_cols=242  Identities=21%  Similarity=0.289  Sum_probs=187.1

Q ss_pred             eecccCceEEEEEEe-CCCcEEEEEEeecccc---hhhhhHHHHH---HHHhcCCCCcceeEEeeeccCCeeeEEEecCC
Q 040392          180 LIGRGGFGSVYKARL-GDGMEVAVKVFNLQCG---RALKGFDVEC---EMMKSIRHRNLIKVISTCSNEEFKALVLEYMP  252 (470)
Q Consensus       180 ~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~  252 (470)
                      .||+|+||.||+|.. .+++.||+|.+.....   .....+..|.   ++++...||+|+++++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999975 4588999999865421   1112233343   34455679999999999999999999999999


Q ss_pred             CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccc
Q 040392          253 HGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ  332 (470)
Q Consensus       253 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  332 (470)
                      +|+|.+++... ..+++..+..++.|++.|+.|||   +.+++|+||||+||+++.++.+||+|||++.......    .
T Consensus        81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~  152 (278)
T cd05606          81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P  152 (278)
T ss_pred             CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----C
Confidence            99999888654 46899999999999999999999   8999999999999999999999999999987553221    1


Q ss_pred             cccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhh
Q 040392          333 TQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDI  411 (470)
Q Consensus       333 ~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  411 (470)
                      ....++..|+|||.+.++ .++.++||||+|+++|||++|+.||..................        .         
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~---------  215 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--------A---------  215 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhcc--------C---------
Confidence            234689999999998754 5899999999999999999999999764322111100000000        0         


Q ss_pred             hhHhhhhhHHHHHHHHhhccCCCccCCC-----CHHHHHHH
Q 040392          412 HFVAKEQCVSCVFNLAMECTVESPEQRI-----NAREIVAK  447 (470)
Q Consensus       412 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~el~~~  447 (470)
                       ...+..++.++.+++.+|+..+|.+||     ++.+++++
T Consensus       216 -~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         216 -VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             -CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence             001122356789999999999999999     99999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.1e-36  Score=292.39  Aligned_cols=274  Identities=24%  Similarity=0.256  Sum_probs=206.4

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCC-----eee
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEE-----FKA  245 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-----~~~  245 (470)
                      +|++.+.||.|++|.||+|+.. +++.||+|.+....  ....+.+..|+.+++.++|+||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5788899999999999999865 48999999987543  344567888999999999999999999987765     789


Q ss_pred             EEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC
Q 040392          246 LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  325 (470)
                      ++|||++ ++|.+++.... .+++..+..++.|++.||+|||   +.+++|+||||.||+++.++.++|+|||++.....
T Consensus        81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            9999997 48998886554 7899999999999999999999   99999999999999999999999999999987644


Q ss_pred             CCCc-ccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhc----------
Q 040392          326 EDQS-MTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWL----------  393 (470)
Q Consensus       326 ~~~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~----------  393 (470)
                      .... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+ .+........          
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID-QLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHhcCCCChhHhhhc
Confidence            3210 122334678899999999887 78999999999999999999999997643211 1111111000          


Q ss_pred             -CCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH--HHHHHH
Q 040392          394 -PISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK--LLKIRD  453 (470)
Q Consensus       394 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~--L~~i~~  453 (470)
                       .......+..................+.++.+++.+||+.+|++||++.+++.+  ++++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence             000000000000000000001112246778999999999999999999999986  666654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.8e-36  Score=294.05  Aligned_cols=273  Identities=23%  Similarity=0.240  Sum_probs=202.3

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccC-----Ce
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNE-----EF  243 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-----~~  243 (470)
                      .++|.+.+.||+|+||.||+|+. .+++.||+|.+...  .......+..|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            46789999999999999999975 46899999998643  233345667899999999999999999987543     35


Q ss_pred             eeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecccccc
Q 040392          244 KALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  323 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~  323 (470)
                      .++|+||+. ++|.+++... ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++...
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            799999996 6898888654 46899999999999999999999   999999999999999999999999999999865


Q ss_pred             CCCCCcccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcC--C-----
Q 040392          324 TGEDQSMTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLP--I-----  395 (470)
Q Consensus       324 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~-----  395 (470)
                      ....  .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||...... ............  .     
T Consensus       159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07858         159 SEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV-HQLKLITELLGSPSEEDLGF  235 (337)
T ss_pred             CCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCCChHHhhh
Confidence            4322  12233457889999998764 46889999999999999999999998653211 111100000000  0     


Q ss_pred             ----cccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH--HHHHH
Q 040392          396 ----STMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK--LLKIR  452 (470)
Q Consensus       396 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~--L~~i~  452 (470)
                          .......................++.++.+++.+||+.+|++||++.|++++  ++.+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~  298 (337)
T cd07858         236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH  298 (337)
T ss_pred             cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence                0000000000000000001122457788999999999999999999999998  76654

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=4.6e-36  Score=285.42  Aligned_cols=250  Identities=29%  Similarity=0.434  Sum_probs=202.6

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHhcCC-CCcceeEEeeeccCCeeeEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CGRALKGFDVECEMMKSIR-HRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv  247 (470)
                      ++|.+.+.||+|++|.||+|... ++..||+|++...   .......+..|.+++++++ |+||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888999999999999999764 6899999998653   2233466788999999998 99999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||+++++|.+++.+.. .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++++|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            99999999999997654 6899999999999999999999   9999999999999999999999999999988664322


Q ss_pred             Cc------------------ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHh
Q 040392          328 QS------------------MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWV  389 (470)
Q Consensus       328 ~~------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~  389 (470)
                      ..                  .......++..|+|||......++.++|+||||++++++++|+.||....... ......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~  235 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL-TFQKIL  235 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHH
Confidence            11                  12233457889999999888889999999999999999999999988643211 111100


Q ss_pred             hhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCH----HHHHHH
Q 040392          390 NDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINA----REIVAK  447 (470)
Q Consensus       390 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~----~el~~~  447 (470)
                      .    .                ....+...+..+.+++.+||+.+|.+||++    .+++++
T Consensus       236 ~----~----------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         236 K----L----------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             h----c----------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence            0    0                000112225668899999999999999999    777754

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.4e-35  Score=289.87  Aligned_cols=269  Identities=21%  Similarity=0.259  Sum_probs=197.1

Q ss_pred             hCCCCC-CCeecccCceEEEEEEeC-CCcEEEEEEeecccchh--------------hhhHHHHHHHHhcCCCCcceeEE
Q 040392          172 TDGFSE-NNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRA--------------LKGFDVECEMMKSIRHRNLIKVI  235 (470)
Q Consensus       172 ~~~~~~-~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~nIv~~~  235 (470)
                      .++|.. .+.||+|+||+||+|... +++.||+|.+.......              ...+.+|+++++.++|+||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            456654 477999999999999754 68999999986432211              12467899999999999999999


Q ss_pred             eeeccCCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEe
Q 040392          236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLS  315 (470)
Q Consensus       236 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~  315 (470)
                      +++...+..++||||++ |+|.+++... ..+++.....++.|++.||+|||   +.+++|+||+|+||+++.++.++|+
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEEC
Confidence            99999999999999997 5999988643 45889999999999999999999   9999999999999999999999999


Q ss_pred             eeccccccCCCC------------CcccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCc
Q 040392          316 DFSIAKLLTGED------------QSMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE  382 (470)
Q Consensus       316 Dfg~a~~~~~~~------------~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~  382 (470)
                      |||.+.......            .........++..|+|||.+.+. .++.++|+||||+++|||++|..||....+.+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            999987654111            01111233467889999988764 46899999999999999999999987643221


Q ss_pred             chhhHHhhhhcCCcccc----c-----ccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          383 MTLKHWVNDWLPISTME----V-----VGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       383 ~~~~~~~~~~~~~~~~~----~-----~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                       .+. .+..........    .     ..+...............++.++.+++.+||+.+|++||++.|++.+
T Consensus       242 -~~~-~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        242 -QLG-RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             -HHH-HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence             111 111000000000    0     00000000000011112346678999999999999999999999874

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-36  Score=281.91  Aligned_cols=239  Identities=23%  Similarity=0.290  Sum_probs=185.5

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHH-hcCCCCcceeEEeeeccCCeeeEEEecCCC
Q 040392          179 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMM-KSIRHRNLIKVISTCSNEEFKALVLEYMPH  253 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l-~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~  253 (470)
                      +.||+|+||.||+|... +|+.||+|++....   ......+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57999999999999764 58999999986432   12223344454443 455899999999999999999999999999


Q ss_pred             CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccccc
Q 040392          254 GSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  333 (470)
Q Consensus       254 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  333 (470)
                      ++|.+++.... .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.....      ..
T Consensus        82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~  151 (260)
T cd05611          82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK  151 (260)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence            99999996544 5788999999999999999999   89999999999999999999999999999875432      22


Q ss_pred             ccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhh
Q 040392          334 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF  413 (470)
Q Consensus       334 ~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  413 (470)
                      ...++..|+|||.+.+..++.++||||||+++|||++|..||......+ .......    ....  .          ..
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~----~~~~--~----------~~  214 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-VFDNILS----RRIN--W----------PE  214 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHh----cccC--C----------CC
Confidence            3457889999999988888999999999999999999999997532211 1111100    0000  0          00


Q ss_pred             HhhhhhHHHHHHHHhhccCCCccCCCCHHHH
Q 040392          414 VAKEQCVSCVFNLAMECTVESPEQRINAREI  444 (470)
Q Consensus       414 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el  444 (470)
                      .....++.++.+++.+||+.+|++||++.++
T Consensus       215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~  245 (260)
T cd05611         215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGY  245 (260)
T ss_pred             cccccCCHHHHHHHHHHccCCHHHccCCCcH
Confidence            0112346778999999999999999977544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-35  Score=281.08  Aligned_cols=265  Identities=23%  Similarity=0.289  Sum_probs=195.5

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccc--hhhhhHHHHHHHHhcC---CCCcceeEEeeeccCCe-----
Q 040392          175 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RALKGFDVECEMMKSI---RHRNLIKVISTCSNEEF-----  243 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~~~~-----  243 (470)
                      |++.+.||+|+||.||+|+.. +++.||+|.+.....  .....+..|+.+++++   .|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567789999999999999876 489999999874422  2233455677777665   59999999999987766     


Q ss_pred             eeEEEecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccc
Q 040392          244 KALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL  322 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~  322 (470)
                      .+++|||+++ +|.+++.... ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||++..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            8999999975 8988886543 35899999999999999999999   89999999999999999999999999999877


Q ss_pred             cCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccc
Q 040392          323 LTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVG  402 (470)
Q Consensus       323 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (470)
                      +.....   .....++..|+|||.+.+..++.++|+||||+++|||++|+.||...... ..+..+..............
T Consensus       157 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         157 YSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             ccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHcCCCChHhcCC
Confidence            643221   12234788899999999889999999999999999999999988753322 22222221111000000000


Q ss_pred             -----ccccCchh--hhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          403 -----ANLLSQED--IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       403 -----~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                           ........  .........+..+.+++.+||+.||.+||++.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence                 00000000  0001111335678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-37  Score=274.47  Aligned_cols=250  Identities=22%  Similarity=0.285  Sum_probs=204.7

Q ss_pred             hhCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeE
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  246 (470)
                      ..++|+.++.||+|.||.|..++- .+|+.+|+|++++..   ......-..|-++|+..+||.+..+-..|...+..++
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            457899999999999999999974 479999999998663   2333445569999999999999999888999999999


Q ss_pred             EEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCC
Q 040392          247 VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      ||||+.||.|.-.+...+ .+++.....+...|+.||.|||   +++|++||+|.+|.++|.+|++||+|||+++.-.  
T Consensus       246 VMeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I--  319 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI--  319 (516)
T ss_pred             EEEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcc--
Confidence            999999999988886544 5778888889999999999999   9999999999999999999999999999998532  


Q ss_pred             CCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccccc
Q 040392          327 DQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL  406 (470)
Q Consensus       327 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (470)
                      .........+||+.|+|||++....|+.++|-|.+||++|||++|+.||...+.+...-...                  
T Consensus       320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl------------------  381 (516)
T KOG0690|consen  320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL------------------  381 (516)
T ss_pred             cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH------------------
Confidence            23345567899999999999999999999999999999999999999998644332110000                  


Q ss_pred             CchhhhhHhhhhhHHHHHHHHhhccCCCccCCC-----CHHHHHHH
Q 040392          407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRI-----NAREIVAK  447 (470)
Q Consensus       407 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~el~~~  447 (470)
                       ..  ....|...+++...|+...|..||.+|.     .+.||.++
T Consensus       382 -~e--d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  382 -ME--DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             -hh--hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence             00  1112344467788999999999999998     45666554

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.6e-35  Score=288.39  Aligned_cols=265  Identities=25%  Similarity=0.317  Sum_probs=197.6

Q ss_pred             HhhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeecc-CCeee
Q 040392          170 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSN-EEFKA  245 (470)
Q Consensus       170 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~~~~~  245 (470)
                      ..+++|++.+.||.|+||.||+|... +++.||+|++....  ....+.+..|+++++.++||||+++++++.. ....+
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            35788999999999999999999754 78999999875432  2334667789999999999999999998865 56788


Q ss_pred             EEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC
Q 040392          246 LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  325 (470)
                      +++||+ +++|.+++...  .+++.....++.|+++||.|||   +.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus        87 lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~  160 (328)
T cd07856          87 FVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDP  160 (328)
T ss_pred             EEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence            999998 56898888643  4678888899999999999999   99999999999999999999999999999875422


Q ss_pred             CCCcccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhh-----------HHhhhhc
Q 040392          326 EDQSMTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLK-----------HWVNDWL  393 (470)
Q Consensus       326 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~-----------~~~~~~~  393 (470)
                      .     .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ....           ++.....
T Consensus       161 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  234 (328)
T cd07856         161 Q-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV-NQFSIITDLLGTPPDDVINTIC  234 (328)
T ss_pred             C-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHhcc
Confidence            1     122456788999998765 56899999999999999999999998753221 0110           1111110


Q ss_pred             CCcccccccccccCchhhh-hHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          394 PISTMEVVGANLLSQEDIH-FVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       394 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      .....+... .+....... ......++.++.+++.+||+.+|++||++.+++.+
T Consensus       235 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         235 SENTLRFVQ-SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             chhhHHHHh-hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000000000 000000000 00112346778999999999999999999999877

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-35  Score=280.36  Aligned_cols=264  Identities=21%  Similarity=0.285  Sum_probs=195.6

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccc-hhhhhHHHHHHHHhcCC-CCcceeEEeeeccCCeeeEEEecC
Q 040392          175 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-RALKGFDVECEMMKSIR-HRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      |.+.+.||+|++|.||+|+.. +++.|++|.+..... .......+|+..+++++ |+||+++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567889999999999999875 478899999864422 22233456899999999 999999999999999999999999


Q ss_pred             CCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          252 PHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       252 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                       +|+|.+++.... ..+++..+..++.|++.+|.|||   +.+++|+||+|+||+++.++.++|+|||.+........  
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--  154 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence             779988887654 46899999999999999999999   89999999999999999999999999999986543221  


Q ss_pred             cccccccCccccCccccC-CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchh-----------hHHhhhhcCCccc
Q 040392          331 TQTQTLATIGYMAPEYGR-EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTL-----------KHWVNDWLPISTM  398 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~-~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~-----------~~~~~~~~~~~~~  398 (470)
                       .....++..|+|||.+. ...++.++|+||||+++|||++|+.||......+...           ..|..........
T Consensus       155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07830         155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL  233 (283)
T ss_pred             -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence             12345788999999874 4457899999999999999999999986542211100           0011000000000


Q ss_pred             ccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          399 EVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ...-+..... ......+ ..+.++.+++.+||+.+|++||++.|++.+
T Consensus       234 ~~~~~~~~~~-~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         234 GFRFPQFAPT-SLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             cccccccccc-cHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            0000000000 0000111 115678999999999999999999999864

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.8e-35  Score=285.97  Aligned_cols=271  Identities=21%  Similarity=0.266  Sum_probs=196.6

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccch--hhhhHHHHHHHHhcCCCCcceeEEeeeccC-------
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGR--ALKGFDVECEMMKSIRHRNLIKVISTCSNE-------  241 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-------  241 (470)
                      .++|++.+.||+|+||.||+|... +++.+|+|++......  ....+.+|+++++.++||||+++++++.+.       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            578999999999999999999764 6899999998644322  234567899999999999999999887443       


Q ss_pred             -CeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccc
Q 040392          242 -EFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA  320 (470)
Q Consensus       242 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a  320 (470)
                       ...++|+||+.+ ++...+......+++..+..++.|+++||+|||   +.+++|+||||+||++++++.++|+|||++
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence             346899999965 787777665667999999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCcc---------cccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhh
Q 040392          321 KLLTGEDQSM---------TQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVN  390 (470)
Q Consensus       321 ~~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~  390 (470)
                      ..........         ......++..|+|||.+.+. .++.++||||||+++|||++|+.||....... .......
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~-~~~~~~~  241 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID-QLHLIFK  241 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence            7654322111         11233567889999987654 58899999999999999999999987533211 1111111


Q ss_pred             hhcCCc---------ccccccccccC-chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          391 DWLPIS---------TMEVVGANLLS-QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       391 ~~~~~~---------~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ......         .....+..... ...............+.+++.+||+.||++|||+.|++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            000000         00000000000 0000000111234678899999999999999999999864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=6.3e-35  Score=279.39  Aligned_cols=252  Identities=23%  Similarity=0.302  Sum_probs=196.8

Q ss_pred             CCCCCCeecccCceEEEEEEe----CCCcEEEEEEeeccc----chhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCee
Q 040392          174 GFSENNLIGRGGFGSVYKARL----GDGMEVAVKVFNLQC----GRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFK  244 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~  244 (470)
                      +|++.+.||+|+||.||.|+.    .+|..||+|++....    ....+.+..|+++++.+ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999975    368999999986432    22345677899999999 599999999999988899


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccC
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~  324 (470)
                      ++||||+++++|.+++.... .+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.+||+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            99999999999999987654 5788899999999999999999   9999999999999999999999999999987653


Q ss_pred             CCCCcccccccccCccccCccccCCC--CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccc
Q 040392          325 GEDQSMTQTQTLATIGYMAPEYGREG--RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVG  402 (470)
Q Consensus       325 ~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (470)
                      .... .......++..|+|||.+...  .++.++||||||+++|+|++|..||..... ......+........      
T Consensus       157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~------  228 (290)
T cd05613         157 EDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILKSE------  228 (290)
T ss_pred             cccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhhccC------
Confidence            3221 122234588899999998753  467899999999999999999999864211 111122111110000      


Q ss_pred             ccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCC-----CHHHHHHH
Q 040392          403 ANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRI-----NAREIVAK  447 (470)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~el~~~  447 (470)
                                ...+..++..+.+++.+||+.||++||     ++.+++.+
T Consensus       229 ----------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         229 ----------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             ----------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence                      000122356688999999999999997     77777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-35  Score=289.04  Aligned_cols=267  Identities=23%  Similarity=0.295  Sum_probs=196.5

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccC------C
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNE------E  242 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~------~  242 (470)
                      .++|...+.||+|+||.||+|.. .+|+.||+|.+....  ......+..|+++++.++||||+++++++...      .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            47899999999999999999975 468999999986432  22334577899999999999999999988644      3


Q ss_pred             eeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccc
Q 040392          243 FKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL  322 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~  322 (470)
                      ..++|+||+.. +|.++..   ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++..
T Consensus        94 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             eEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            46899999964 7776652   35788999999999999999999   99999999999999999999999999999875


Q ss_pred             cCCCCCcccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc---cc
Q 040392          323 LTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS---TM  398 (470)
Q Consensus       323 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~  398 (470)
                      ....     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .+..... .....   ..
T Consensus       167 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~-~~~~~~~~~~  239 (342)
T cd07879         167 ADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILK-VTGVPGPEFV  239 (342)
T ss_pred             CCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-hcCCCCHHHH
Confidence            4221     123457888999998876 468899999999999999999999997532111 1110000 00000   00


Q ss_pred             ccccc----------cccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH--HHHHHH
Q 040392          399 EVVGA----------NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK--LLKIRD  453 (470)
Q Consensus       399 ~~~~~----------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~--L~~i~~  453 (470)
                      +....          ........ .......+.++.+++.+||+.||++||++.|++.+  ++.+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         240 QKLEDKAAKSYIKSLPKYPRKDF-STLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HHhcccchHHHHhhcCCcccchH-HHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            00000          00000000 00001235668899999999999999999999976  777653

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-35  Score=288.55  Aligned_cols=268  Identities=23%  Similarity=0.265  Sum_probs=197.9

Q ss_pred             HHHhhCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCC--
Q 040392          168 LCRATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEE--  242 (470)
Q Consensus       168 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--  242 (470)
                      +....++|++.+.||+|+||.||+|.. .++..||+|++...  .......+..|+++++.++||||+++++++....  
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            334567899999999999999999974 47899999998543  2223456778999999999999999999886543  


Q ss_pred             ----eeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeec
Q 040392          243 ----FKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFS  318 (470)
Q Consensus       243 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  318 (470)
                          ..++||||+ +++|.+++..  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++++|||
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence                458999999 6799888864  35889999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCC--
Q 040392          319 IAKLLTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPI--  395 (470)
Q Consensus       319 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--  395 (470)
                      ++......     .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||....... ............  
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~  237 (343)
T cd07880         164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-QLMEIMKVTGTPSK  237 (343)
T ss_pred             cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCH
Confidence            98765321     123456889999998865 458899999999999999999999997532211 111111100000  


Q ss_pred             ccccccccc--------ccCc-hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          396 STMEVVGAN--------LLSQ-EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       396 ~~~~~~~~~--------~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ...+.....        +... ..........++..+.+++.+|++.||++||++.+++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000000000        0000 000001112446678999999999999999999999943

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4e-35  Score=279.31  Aligned_cols=264  Identities=27%  Similarity=0.328  Sum_probs=199.2

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          175 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      |+..+.||+|++|.||+|+.. +++.+|+|.+....  ....+.+..|+.+++.++|+|++++++++......++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            556788999999999999765 58999999987653  333456778999999999999999999999999999999999


Q ss_pred             CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccc
Q 040392          252 PHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  331 (470)
Q Consensus       252 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  331 (470)
                      + ++|.+++......+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||.+........  .
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~  154 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T  154 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence            7 5999999876557899999999999999999999   89999999999999999999999999999876543221  2


Q ss_pred             ccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc----c---ccc--c
Q 040392          332 QTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS----T---MEV--V  401 (470)
Q Consensus       332 ~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~---~~~--~  401 (470)
                      .....++..|+|||.+.+. .++.++||||||+++|||++|+.||......+ .+ ..+.......    .   ...  .
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID-QL-FKIFQILGTPTEESWPGVTKLPDY  232 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HH-HHHHHHhCCCcHHHHHhhcccccc
Confidence            2233457789999988766 78999999999999999999999986532211 00 0000000000    0   000  0


Q ss_pred             cccccC--chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          402 GANLLS--QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       402 ~~~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      +.....  ...... .....+..+.+++.+||..||++||++.+++.+
T Consensus       233 ~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         233 KPTFPKFPPKDLEK-VLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cccccccCccchHH-hcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            000000  000000 011225678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.5e-35  Score=290.39  Aligned_cols=268  Identities=21%  Similarity=0.277  Sum_probs=195.7

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccC---------
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNE---------  241 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~---------  241 (470)
                      ..+|.+.+.||.|+||.||+|.. .+|+.||+|.+........+.+.+|+++++.++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            36789999999999999999975 46899999998766555667788899999999999999999776543         


Q ss_pred             -----CeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCCCeEEe
Q 040392          242 -----EFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLS  315 (470)
Q Consensus       242 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~-~~~~~kl~  315 (470)
                           ...++||||++ ++|.+++...  .+++..+..++.|++.||.|||   +.+++||||||+||+++ .++.+|++
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEEC
Confidence                 35789999997 5998888543  4789999999999999999999   89999999999999997 45678999


Q ss_pred             eeccccccCCCCCc-ccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhc
Q 040392          316 DFSIAKLLTGEDQS-MTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWL  393 (470)
Q Consensus       316 Dfg~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  393 (470)
                      |||.+......... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||......+. ....... .
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~~-~  235 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILES-V  235 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHh-c
Confidence            99998765322111 11123357888999997654 5688899999999999999999999975432111 1111110 0


Q ss_pred             CCccc-------cccccccc----CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          394 PISTM-------EVVGANLL----SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       394 ~~~~~-------~~~~~~~~----~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      +....       ........    .............+.++.+++.+||+.||++||++.|++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            00000       00000000    00000000011345678899999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.6e-35  Score=280.02  Aligned_cols=255  Identities=22%  Similarity=0.284  Sum_probs=198.0

Q ss_pred             CCCCCCeecccCceEEEEEEe----CCCcEEEEEEeeccc----chhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCee
Q 040392          174 GFSENNLIGRGGFGSVYKARL----GDGMEVAVKVFNLQC----GRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFK  244 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~  244 (470)
                      +|++.+.||+|++|.||+++.    .+++.||||++....    ....+.+..|++++.++ .||||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            477789999999999999974    357889999986432    22345677899999999 599999999999999999


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccC
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~  324 (470)
                      ++||||+++|+|.+++.... .+++.....++.|+++||.|||   +.+++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            99999999999999986543 5788899999999999999999   8999999999999999999999999999987654


Q ss_pred             CCCCcccccccccCccccCccccCCCC--CCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccc
Q 040392          325 GEDQSMTQTQTLATIGYMAPEYGREGR--VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVG  402 (470)
Q Consensus       325 ~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (470)
                      .... .......++..|+|||...+..  .+.++|+||||+++|||++|..||...... ..............      
T Consensus       157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~------  228 (288)
T cd05583         157 AEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISRRILKSK------  228 (288)
T ss_pred             cccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHHHHHHHccC------
Confidence            3221 1122345788999999987655  788999999999999999999998642111 11111111110000      


Q ss_pred             ccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHH
Q 040392          403 ANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK  450 (470)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~  450 (470)
                                ...+..++..+.+++.+||+.||++|||+.++...|..
T Consensus       229 ----------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         229 ----------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             ----------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                      00112235668899999999999999998877665543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-36  Score=271.74  Aligned_cols=259  Identities=23%  Similarity=0.322  Sum_probs=201.3

Q ss_pred             CeecccCceEEEEEE-eCCCcEEEEEEeecccchhhhhHHHHHHHHhcCC-CCcceeEEeeeccCCeeeEEEecCCCCCh
Q 040392          179 NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIR-HRNLIKVISTCSNEEFKALVLEYMPHGSL  256 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e~~~~g~L  256 (470)
                      +.||+|+|+.|--+. ..+|.+||||++.+.......+..+|++++.+.+ |+||++++++|++++..|+|||-|.||+|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            689999999999884 7789999999999887888889999999999995 99999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC---CeEEeeeccccccCC-----CCC
Q 040392          257 EKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM---VAHLSDFSIAKLLTG-----EDQ  328 (470)
Q Consensus       257 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~---~~kl~Dfg~a~~~~~-----~~~  328 (470)
                      ...+++.. .+++.++.++..+|+.||.+||   .+||.|||+||+|||.....   -+|||||.++.-+.-     ...
T Consensus       164 LshI~~~~-~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas  239 (463)
T KOG0607|consen  164 LSHIQKRK-HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS  239 (463)
T ss_pred             HHHHHHhh-hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence            99997766 5889999999999999999999   99999999999999996554   479999998754321     111


Q ss_pred             cccccccccCccccCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc----ccc
Q 040392          329 SMTQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS----TME  399 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~  399 (470)
                      .......+|+..|||||+..     ...|+.+.|.|||||++|-|++|..||.+.-...-   -|-+......    ..+
T Consensus       240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC---GWdrGe~Cr~CQ~~LFe  316 (463)
T KOG0607|consen  240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC---GWDRGEVCRVCQNKLFE  316 (463)
T ss_pred             CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC---CccCCCccHHHHHHHHH
Confidence            22234567999999999753     23488999999999999999999999987533211   1111100000    001


Q ss_pred             cccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          400 VVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      .+-......+..   .....+.+..+++...+..|+.+|.++.+++++
T Consensus       317 sIQEGkYeFPdk---dWahIS~eakdlisnLlvrda~~rlsa~~vlnh  361 (463)
T KOG0607|consen  317 SIQEGKYEFPDK---DWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH  361 (463)
T ss_pred             HHhccCCcCChh---hhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence            111111111111   123457788999999999999999999998873

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.3e-36  Score=289.86  Aligned_cols=250  Identities=26%  Similarity=0.342  Sum_probs=206.3

Q ss_pred             hhCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccc--hhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      ....|.+.+.||+|.|+.|..|++ .++..||+|.+++..-  .....+.+|+++|..++|||||+++.+.+.....|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            356799999999999999999974 4699999999976532  2334578899999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||+.+|.+.+++.+.+ ...+..+..+..|+.+|++|||   ++.|+|||||++|||++.+.++||+|||++..+..  
T Consensus       134 ~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~--  207 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY--  207 (596)
T ss_pred             EEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeecc--
Confidence            99999999999997766 4555888899999999999999   99999999999999999999999999999988753  


Q ss_pred             CcccccccccCccccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccccc
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL  406 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (470)
                       .......+|++.|.|||++.+..+ ++.+|+||+|+++|-|+.|..||++..-.+..                 +..+.
T Consensus       208 -~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-----------------~rvl~  269 (596)
T KOG0586|consen  208 -GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-----------------PRVLR  269 (596)
T ss_pred             -cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-----------------chhee
Confidence             333455789999999999998775 57899999999999999999999863222111                 11111


Q ss_pred             CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       407 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                      .....    +.-++.+..+++++++-.+|.+|++.+++.++-
T Consensus       270 gk~rI----p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~  307 (596)
T KOG0586|consen  270 GKYRI----PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR  307 (596)
T ss_pred             eeecc----cceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence            11111    122245567999999999999999999998764

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.8e-36  Score=271.22  Aligned_cols=203  Identities=24%  Similarity=0.336  Sum_probs=170.0

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC---C--CcEEEEEEeecccc--hhhhhHHHHHHHHhcCCCCcceeEEeeecc-CC
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG---D--GMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRNLIKVISTCSN-EE  242 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~~  242 (470)
                      ....|+....||+|.||.||+|.-+   +  ...+|+|.++....  ......-+|+.+++.++|||++.+..++.+ +.
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            3467899999999999999999532   2  23799999975532  223445679999999999999999998866 78


Q ss_pred             eeeEEEecCCCCChHHhhhcCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC----CCeEE
Q 040392          243 FKALVLEYMPHGSLEKYMYSSN----YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN----MVAHL  314 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~----~~~kl  314 (470)
                      ..++++||.+. +|.+.++-.+    ..++...+..++.||+.|+.|||   +.-|+||||||.|||+..+    |.|||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEe
Confidence            88999999987 9988886432    56888899999999999999999   8999999999999999877    99999


Q ss_pred             eeeccccccCCCCCcc-cccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCc
Q 040392          315 SDFSIAKLLTGEDQSM-TQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNE  377 (470)
Q Consensus       315 ~Dfg~a~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~  377 (470)
                      +|||+++.+.++-... .....+.|.+|+|||++.+. .||.+.||||+||++.||+|-++-|..
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence            9999999886654433 44456789999999998875 599999999999999999998877664

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-35  Score=289.86  Aligned_cols=264  Identities=25%  Similarity=0.315  Sum_probs=197.0

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCe----
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEF----  243 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~----  243 (470)
                      ..++|++.+.||+|++|.||+|+.. ++..||+|++...  .......+..|+.+++.++|+||+++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4678999999999999999999865 5889999998643  22334556789999999999999999988765544    


Q ss_pred             --eeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecccc
Q 040392          244 --KALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK  321 (470)
Q Consensus       244 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~  321 (470)
                        .++|+||+ +++|.+++..  ..+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++.
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~  166 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR  166 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence              88999999 5699999865  35899999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCCcccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccc
Q 040392          322 LLTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEV  400 (470)
Q Consensus       322 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (470)
                      .....     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+ .+..... .........
T Consensus       167 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~~-~~~~~~~~~  239 (343)
T cd07851         167 HTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRIMN-LVGTPDEEL  239 (343)
T ss_pred             ccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHH-hcCCCCHHH
Confidence            65322     223457888999998765 367889999999999999999999997532211 1111111 000000000


Q ss_pred             cc----c-------cccCchhhhh-HhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          401 VG----A-------NLLSQEDIHF-VAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       401 ~~----~-------~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ..    .       .+........ ......+.++.+++.+||+.||++|||+.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            00    0       0000000000 0111236779999999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.8e-35  Score=277.15  Aligned_cols=248  Identities=20%  Similarity=0.269  Sum_probs=193.1

Q ss_pred             CCCCCCeecccCceEEEEEEeCC-CcEEEEEEeecc-----cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          174 GFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQ-----CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      +|.+.+.||+|+||.||+++... +..+++|..+..     .......+..|+.+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47888999999999999997643 455666665421     112233466789999999999999999999998999999


Q ss_pred             EecCCCCChHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccC
Q 040392          248 LEYMPHGSLEKYMYS---SNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~  324 (470)
                      |||+++++|.+++..   ....+++..+..++.|++.||.|||   +.+++|+||+|+||+++. +.++|+|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999988864   3356899999999999999999999   999999999999999975 569999999987664


Q ss_pred             CCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccc
Q 040392          325 GEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN  404 (470)
Q Consensus       325 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (470)
                      ....  ......++..|+|||...+..++.++|+||||+++|+|++|..||......     ..........     .+ 
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~~~~~-----~~-  223 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL-----SVVLRIVEGP-----TP-  223 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHHcCC-----CC-
Confidence            3221  222345788999999988888899999999999999999999998642211     1111110000     00 


Q ss_pred             ccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                               ..+..++.++.+++.+||+.+|++||++.|++++
T Consensus       224 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         224 ---------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             ---------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence                     0112346678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.8e-35  Score=287.08  Aligned_cols=271  Identities=23%  Similarity=0.263  Sum_probs=198.9

Q ss_pred             HHHHHHhhCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccC
Q 040392          165 HLELCRATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNE  241 (470)
Q Consensus       165 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  241 (470)
                      ..++....++|.+.+.||+|+||.||+|.. .+++.||+|++....  ....+.+.+|++++++++||||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            345666789999999999999999999974 568999999986432  22345677899999999999999999987532


Q ss_pred             ------CeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEe
Q 040392          242 ------EFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLS  315 (470)
Q Consensus       242 ------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~  315 (470)
                            ...+++++++ +++|.+++...  .+++..+..++.|+++||+|||   +.+++||||||+||+++.++.+||+
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~  162 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL  162 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEEe
Confidence                  3467888877 77998888543  4889999999999999999999   9999999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhc-
Q 040392          316 DFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWL-  393 (470)
Q Consensus       316 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-  393 (470)
                      |||++.....     ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ........... 
T Consensus       163 dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~  236 (345)
T cd07877         163 DFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGT  236 (345)
T ss_pred             cccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCC
Confidence            9999875422     1223457889999998765 46888999999999999999999998653221 11111111000 


Q ss_pred             -CCcccccccccc--------cCchhhhh-HhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          394 -PISTMEVVGANL--------LSQEDIHF-VAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       394 -~~~~~~~~~~~~--------~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                       +......+....        ........ ......+.++.+++.+|++.||.+||++.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence             000000000000        00000000 0001235678899999999999999999999876

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=9.6e-35  Score=283.59  Aligned_cols=268  Identities=21%  Similarity=0.202  Sum_probs=192.0

Q ss_pred             CCCCCCeecccCceEEEEEEeC-C--CcEEEEEEeeccc--chhhhhHHHHHHHHhcC-CCCcceeEEeeecc----CCe
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-D--GMEVAVKVFNLQC--GRALKGFDVECEMMKSI-RHRNLIKVISTCSN----EEF  243 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~----~~~  243 (470)
                      +|.+.+.||+|+||.||+++.. +  +..||+|.+....  ....+.+..|+++++++ .||||+++++.+..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4777889999999999999754 3  7789999986432  22345677899999999 59999999987532    245


Q ss_pred             eeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecccccc
Q 040392          244 KALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  323 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~  323 (470)
                      .++++||+. ++|.+++... ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++...
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            678899986 5899888654 46889999999999999999999   999999999999999999999999999999865


Q ss_pred             CCCCCc--ccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhc-C-Cc-c
Q 040392          324 TGEDQS--MTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWL-P-IS-T  397 (470)
Q Consensus       324 ~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~-~~-~  397 (470)
                      ......  .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...... ..+...+.... + .. .
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~  234 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQVLGTPDEETL  234 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence            432211  11223468899999998765 46899999999999999999999998753211 01110000000 0 00 0


Q ss_pred             cccccc-------cccCchhhh-hHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          398 MEVVGA-------NLLSQEDIH-FVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       398 ~~~~~~-------~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      .....+       ......... .......+..+.+++.+||+.||++||++.|++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            000000       000000000 00111235678999999999999999999998765

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-35  Score=272.61  Aligned_cols=239  Identities=29%  Similarity=0.338  Sum_probs=194.0

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEeecccc---hhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCCCCh
Q 040392          181 IGRGGFGSVYKARLG-DGMEVAVKVFNLQCG---RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL  256 (470)
Q Consensus       181 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L  256 (470)
                      ||.|+||.||++... +++.+|+|++.....   .....+..|+++++.++|+||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999765 589999999875432   2455788899999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccccccc
Q 040392          257 EKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL  336 (470)
Q Consensus       257 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  336 (470)
                      .+++.... .+++.....++.|++.|+.|||   +.+++|+||+|+||+++.++.++|+|||.+.......  .......
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~  154 (250)
T cd05123          81 FSHLSKEG-RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC  154 (250)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCc
Confidence            99997654 5899999999999999999999   8999999999999999999999999999987654321  1223456


Q ss_pred             cCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhh
Q 040392          337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAK  416 (470)
Q Consensus       337 ~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  416 (470)
                      ++..|+|||...+...+.++|+||||+++|++++|..||......  .....+..   ..                ...+
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~---~~----------------~~~~  213 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK--EIYEKILK---DP----------------LRFP  213 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHhc---CC----------------CCCC
Confidence            788999999998888999999999999999999999999754321  11111100   00                0111


Q ss_pred             hhhHHHHHHHHhhccCCCccCCCCH---HHHHH
Q 040392          417 EQCVSCVFNLAMECTVESPEQRINA---REIVA  446 (470)
Q Consensus       417 ~~~~~~l~~l~~~cl~~dP~~Rps~---~el~~  446 (470)
                      ...+.++.+++.+||..||++||++   .+++.
T Consensus       214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~  246 (250)
T cd05123         214 EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA  246 (250)
T ss_pred             CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence            2225668899999999999999999   55544

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-36  Score=280.84  Aligned_cols=247  Identities=23%  Similarity=0.336  Sum_probs=202.6

Q ss_pred             CCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc---cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      +.|..-+.||+|+||.||-+.. .+|+-+|.|.+.++   ..+.......|-+++.++..+.||.+-..|+..+..++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            5678889999999999999864 46999999998644   2233445677999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          249 EYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      ..|+||+|.=.|...+ ..+++..+.-++.+|+.||++||   +.+|++||+||+|||+|+.|+++|+|+|+|..+....
T Consensus       265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~  341 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK  341 (591)
T ss_pred             EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence            9999999987776654 56899999999999999999999   9999999999999999999999999999999875432


Q ss_pred             CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                         .....+||.+|||||++.+..|+...|-||+||++|||+.|+.||.......              ..+.+|.+...
T Consensus       342 ---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv--------------k~eEvdrr~~~  404 (591)
T KOG0986|consen  342 ---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV--------------KREEVDRRTLE  404 (591)
T ss_pred             ---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh--------------hHHHHHHHHhc
Confidence               2234589999999999999999999999999999999999999997532110              11223333322


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAR  442 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~  442 (470)
                      +..   .-++.++.++.++.+..|..||++|..-.
T Consensus       405 ~~~---ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  405 DPE---EYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             chh---hcccccCHHHHHHHHHHHccCHHHhccCC
Confidence            221   12356688899999999999999998543

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-35  Score=242.63  Aligned_cols=267  Identities=24%  Similarity=0.268  Sum_probs=201.9

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          174 GFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      +|...++||+|.||+||+|+. .+++.||+|.++.+.  ........+|+-+++.++|.|||++++....+...-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            567778999999999999974 468889999987553  33455678899999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      |.. +|..+..+.+..++.+.+..++.|+++||.++|   ++.+.|||+||.|.++..+|++|+.|||+++.+.-+  -.
T Consensus        83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgip--vr  156 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP--VR  156 (292)
T ss_pred             hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCc--eE
Confidence            965 999999998889999999999999999999999   999999999999999999999999999999865321  12


Q ss_pred             cccccccCccccCccccCCCC-CCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhh-hcC-----Cccccccc
Q 040392          331 TQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVND-WLP-----ISTMEVVG  402 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~-~~~-----~~~~~~~~  402 (470)
                      -.+..+.|.+|.+|.++.+.+ |++..|+||-||++.|+.. |+.-|.+.+-.. .+...... ..+     .......|
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd-qlkrif~~lg~p~ed~wps~t~lpd  235 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEDQWPSMTKLPD  235 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH-HHHHHHHHhCCCccccCCccccCCC
Confidence            233456899999999998865 8999999999999999998 665555432211 11111100 000     01111122


Q ss_pred             ccccCchh--hh-hHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          403 ANLLSQED--IH-FVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       403 ~~~~~~~~--~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      -.......  .. ...-......=.+++...+.-+|.+|.++++.+++
T Consensus       236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            11111111  00 11112223345688999999999999999998875

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-35  Score=286.24  Aligned_cols=242  Identities=23%  Similarity=0.276  Sum_probs=196.9

Q ss_pred             hCCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccchhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCeeeEEEe
Q 040392          172 TDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      ++.|.....+|.|+|+.|-++. ..+++..++|++....    ..-.+|+.++... +||||+++.+.+.+..+.++|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            5678888899999999999885 4568899999997542    2234466665555 69999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee-CCCCCeEEeeeccccccCCCCC
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL-DDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill-~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      .+.++-+.+.+..... .. ..+..|+.+|+.|+.|||   .+|++||||||+|||+ ++.++++|+|||.++...+.  
T Consensus       397 ~l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--  469 (612)
T ss_pred             hccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence            9999988888765542 22 667789999999999999   9999999999999999 69999999999999876433  


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                         ....+-|..|.|||++....+++++|+||||++||+|++|+.||.....+ ..+...   ....+.           
T Consensus       470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~---i~~~~~-----------  531 (612)
T KOG0603|consen  470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTR---IQMPKF-----------  531 (612)
T ss_pred             ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHh---hcCCcc-----------
Confidence               33456789999999999999999999999999999999999999876555 111111   111111           


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLL  449 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~  449 (470)
                             .+..+.+..+|+..||+.||.+||+|.++..+=.
T Consensus       532 -------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w  565 (612)
T KOG0603|consen  532 -------SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPW  565 (612)
T ss_pred             -------ccccCHHHHHHHHHhccCChhhCcChhhhccCcc
Confidence                   1344777899999999999999999999987643

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-35  Score=263.79  Aligned_cols=253  Identities=22%  Similarity=0.260  Sum_probs=198.8

Q ss_pred             hhCCCCCC-CeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcC-CCCcceeEEeeecc----CCe
Q 040392          171 ATDGFSEN-NLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSI-RHRNLIKVISTCSN----EEF  243 (470)
Q Consensus       171 ~~~~~~~~-~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~----~~~  243 (470)
                      .+++|.+. +.||-|-.|.|..+.. .+|+.+|+|++.     +....++|+++.-.. .|||||.+++++++    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            35666653 5799999999999864 479999999985     233456688875555 69999999998865    356


Q ss_pred             eeEEEecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC---CCCCeEEeeecc
Q 040392          244 KALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSI  319 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~  319 (470)
                      ..+|||.++||.|.+.+++.+ ..+++.++..|+.||+.|+.|||   +..|.||||||+|+|..   .|..+||+|||+
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccccc
Confidence            779999999999999998776 46899999999999999999999   99999999999999995   466899999999


Q ss_pred             ccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccc
Q 040392          320 AKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTME  399 (470)
Q Consensus       320 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  399 (470)
                      |+.-..   .......+.|+.|.|||++...+|+...|+||+||++|-|++|..||........+- .+...        
T Consensus       211 AK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aisp-gMk~r--------  278 (400)
T KOG0604|consen  211 AKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-GMKRR--------  278 (400)
T ss_pred             ccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCCh-hHHhH--------
Confidence            986432   344456788999999999999999999999999999999999999998754322110 00000        


Q ss_pred             cccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          400 VVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                       +..   +.+........+.+.+..++++.+|+.+|.+|.|..|++++
T Consensus       279 -I~~---gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  279 -IRT---GQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             -hhc---cCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence             000   00111112234557888999999999999999999999875

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.8e-34  Score=302.01  Aligned_cols=146  Identities=27%  Similarity=0.400  Sum_probs=130.7

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      .++|.+.+.||+|+||.||+|... +++.||+|++....   ......+..|+.+++.++|+||+++++++......++|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            367889999999999999999865 68999999986432   22346678899999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecccc
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK  321 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~  321 (470)
                      |||+++++|.+++...+ .+++..++.++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999996544 5788899999999999999999   8999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=4.9e-34  Score=264.97  Aligned_cols=219  Identities=21%  Similarity=0.154  Sum_probs=175.3

Q ss_pred             cCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCCCChHHhhhc
Q 040392          184 GGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYS  262 (470)
Q Consensus       184 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~  262 (470)
                      |.+|.||++.. .+++.||+|.+....     ....|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            89999999975 468999999986542     223455555566799999999999999999999999999999999865


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccccccccCcccc
Q 040392          263 SNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM  342 (470)
Q Consensus       263 ~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~  342 (470)
                      .. .+++..+..++.|+++||+|||   +++++|+||||+||+++.++.++++|||.+......     .....++..|+
T Consensus        79 ~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~  149 (237)
T cd05576          79 FL-NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYC  149 (237)
T ss_pred             hc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcccc
Confidence            44 5899999999999999999999   999999999999999999999999999987655321     12234567799


Q ss_pred             CccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHH
Q 040392          343 APEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSC  422 (470)
Q Consensus       343 aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (470)
                      |||...+..++.++|+||+|+++|||++|+.|+........               ....          ...+..++..
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~---------------~~~~----------~~~~~~~~~~  204 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN---------------THTT----------LNIPEWVSEE  204 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc---------------cccc----------cCCcccCCHH
Confidence            99999888899999999999999999999988653211100               0000          0011223566


Q ss_pred             HHHHHhhccCCCccCCCCH
Q 040392          423 VFNLAMECTVESPEQRINA  441 (470)
Q Consensus       423 l~~l~~~cl~~dP~~Rps~  441 (470)
                      +.+++.+||+.||++||++
T Consensus       205 ~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         205 ARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHHHHHccCCHHHhcCC
Confidence            8899999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-35  Score=278.33  Aligned_cols=245  Identities=23%  Similarity=0.343  Sum_probs=199.4

Q ss_pred             CCeecccCceEEEEEE-eCCCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCCC
Q 040392          178 NNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHG  254 (470)
Q Consensus       178 ~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g  254 (470)
                      .+.||+|.||+||-|+ .++|+.||||++++-  ..+....+++|+.||+.+.||.||.+-..|+..+..++|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            4789999999999996 457999999998754  2334477889999999999999999999999999999999999775


Q ss_pred             ChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC---CCeEEeeeccccccCCCCCccc
Q 040392          255 SLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN---MVAHLSDFSIAKLLTGEDQSMT  331 (470)
Q Consensus       255 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~---~~~kl~Dfg~a~~~~~~~~~~~  331 (470)
                      -|+-.+.+....+++.....++.||+.||.|||   -++|+|+||||+|||+.+.   .++||||||+|+.+..   ...
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE---ksF  722 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE---KSF  722 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecch---hhh
Confidence            566666667788999999999999999999999   9999999999999999643   4799999999998743   233


Q ss_pred             ccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhh
Q 040392          332 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDI  411 (470)
Q Consensus       332 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  411 (470)
                      ....+||+.|+|||++....|...-|+||+||++|--++|..||.+..    ++.+.++..   .+       +.   ..
T Consensus       723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE----dIndQIQNA---aF-------My---Pp  785 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE----DINDQIQNA---AF-------MY---PP  785 (888)
T ss_pred             hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc----chhHHhhcc---cc-------cc---CC
Confidence            345789999999999999999999999999999999999999998632    222222110   00       00   00


Q ss_pred             hhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          412 HFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       412 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                        ....+.+.+..+||...|++.-++|-|...-+.|
T Consensus       786 --~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  786 --NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             --CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence              1123446778999999999999999998876554

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=5e-36  Score=263.05  Aligned_cols=254  Identities=26%  Similarity=0.272  Sum_probs=194.3

Q ss_pred             CCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccc-hhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCeeeEEEec
Q 040392          174 GFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCG-RALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      +.+.+..||.|+||+|+|-. .++|+.+|||+++.... ...+++..|.+...+- ++||||+++|.+..++...+.||.
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL  144 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL  144 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence            34445789999999999985 45799999999986643 5667788888765544 799999999998888888899999


Q ss_pred             CCCCChHHhhh---c-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCC
Q 040392          251 MPHGSLEKYMY---S-SNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       251 ~~~g~L~~~l~---~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      |+ .+|..+..   + .+..+++.-.-+|....+.||.||-+  ...|+|||+||+|||++..|.+||||||++-.+.. 
T Consensus       145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~-  220 (361)
T KOG1006|consen  145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD-  220 (361)
T ss_pred             Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH-
Confidence            95 47655432   2 23567888888899999999999996  67899999999999999999999999999876532 


Q ss_pred             CCcccccccccCccccCccccCC--CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccc
Q 040392          327 DQSMTQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN  404 (470)
Q Consensus       327 ~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (470)
                        ....+...|-..|||||.+..  ..|+.++||||||++|+|+.||..|+..+..--..+.+.+....|.-        
T Consensus       221 --SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l--------  290 (361)
T KOG1006|consen  221 --SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPIL--------  290 (361)
T ss_pred             --HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCee--------
Confidence              233445567888999998864  34899999999999999999999999876442222333333222211        


Q ss_pred             ccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                       .....     ....+..+..++..|+.+|-..||+..+++.+
T Consensus       291 -~~~~~-----~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  291 -LFDKE-----CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             -cCccc-----ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence             11000     01235668899999999999999999988754

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-35  Score=298.46  Aligned_cols=259  Identities=22%  Similarity=0.291  Sum_probs=208.4

Q ss_pred             HHHHhhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCC
Q 040392          167 ELCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEE  242 (470)
Q Consensus       167 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  242 (470)
                      ++....++|.+++.||+|+||.|..++++ +++.||.|++.+.   ......-|..|-.+|..-..+=|+.++..|.+..
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER  148 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence            34455688999999999999999999864 5888999998753   2334556888999999999999999999999999


Q ss_pred             eeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccc
Q 040392          243 FKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL  322 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~  322 (470)
                      +.|+||||++||+|..++.+.. .+++..+..++..|+-||.-||   +.|+|||||||+|||+|..|++||+|||.+-.
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClk  224 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLK  224 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHh
Confidence            9999999999999999998777 7899999999999999999999   99999999999999999999999999999887


Q ss_pred             cCCCCCcccccccccCccccCccccC----C-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcc
Q 040392          323 LTGEDQSMTQTQTLATIGYMAPEYGR----E-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIST  397 (470)
Q Consensus       323 ~~~~~~~~~~~~~~~t~~y~aPE~~~----~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  397 (470)
                      +... ........+|||-|.+||++.    + +.|++.+|-||+||++|||+.|..||....-    ...|-..-.+...
T Consensus       225 m~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl----veTY~KIm~hk~~  299 (1317)
T KOG0612|consen  225 MDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL----VETYGKIMNHKES  299 (1317)
T ss_pred             cCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH----HHHHHHHhchhhh
Confidence            7543 344556678999999999875    2 5689999999999999999999999986211    1122111111111


Q ss_pred             cccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCC---HHHHHHHH
Q 040392          398 MEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRIN---AREIVAKL  448 (470)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps---~~el~~~L  448 (470)
                      ..+             +.....+.+..+||.+.+. +|+.|..   +.++..|-
T Consensus       300 l~F-------------P~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp  339 (1317)
T KOG0612|consen  300 LSF-------------PDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP  339 (1317)
T ss_pred             cCC-------------CcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence            111             1112246678888888776 6788887   88887763

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-34  Score=265.55  Aligned_cols=264  Identities=21%  Similarity=0.266  Sum_probs=200.2

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcCC-C-C----cceeEEeeeccCCee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIR-H-R----NLIKVISTCSNEEFK  244 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----nIv~~~~~~~~~~~~  244 (470)
                      +++|.+...+|+|.||.|..+.+ ..+..||||+++. ..+..+....|+++++++. + |    -++.+.+||...++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            78899999999999999999954 3578999999863 2334455677999999994 2 2    278888999999999


Q ss_pred             eEEEecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC----------------
Q 040392          245 ALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD----------------  307 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~----------------  307 (470)
                      ++|+|.+ |-|+.+++.+.+ .+++..++..++.|+++++++||   +.+++|-||||+|||+.                
T Consensus       167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~  242 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF  242 (415)
T ss_pred             EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccce
Confidence            9999998 559999998755 56889999999999999999999   99999999999999983                


Q ss_pred             ----CCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcc
Q 040392          308 ----DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEM  383 (470)
Q Consensus       308 ----~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~  383 (470)
                          .+..++++|||.|+.....     .+..+.|..|+|||++.+-.++.++||||+||+|+|++||..-|...++.|.
T Consensus       243 ~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH  317 (415)
T KOG0671|consen  243 IRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH  317 (415)
T ss_pred             eccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence                1346899999999864322     2556789999999999999999999999999999999999999887664431


Q ss_pred             -hhhHHhhhhcCCcccc--------------------------cccccccCchhhhhHhhhhhHHHHHHHHhhccCCCcc
Q 040392          384 -TLKHWVNDWLPISTME--------------------------VVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPE  436 (470)
Q Consensus       384 -~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~  436 (470)
                       .+-+.+-.-.|.....                          +.++........  .........|++|+++||.+||.
T Consensus       318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~--~~~d~e~~~LfDLl~~mL~fDP~  395 (415)
T KOG0671|consen  318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYM--LQDDLEHVQLFDLLRRMLEFDPA  395 (415)
T ss_pred             HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHh--ccCcHHHhHHHHHHHHHHccCcc
Confidence             1111111111110000                          000000000001  11122256699999999999999


Q ss_pred             CCCCHHHHHHH
Q 040392          437 QRINAREIVAK  447 (470)
Q Consensus       437 ~Rps~~el~~~  447 (470)
                      +|+|+.|++.|
T Consensus       396 ~RiTl~EAL~H  406 (415)
T KOG0671|consen  396 RRITLREALSH  406 (415)
T ss_pred             ccccHHHHhcC
Confidence            99999999875

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3.8e-33  Score=287.48  Aligned_cols=260  Identities=21%  Similarity=0.229  Sum_probs=170.3

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC-C----CcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEee------ec
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG-D----GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST------CS  239 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~------~~  239 (470)
                      ..++|.+.+.||+|+||.||+|+.. +    +..||+|++......  +.+..|  .+....+.++..++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            4678999999999999999999864 4    689999987532211  111111  1122222222222211      24


Q ss_pred             cCCeeeEEEecCCCCChHHhhhcCCCCC-------------------CHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 040392          240 NEEFKALVLEYMPHGSLEKYMYSSNYIL-------------------DIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK  300 (470)
Q Consensus       240 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~-------------------~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlk  300 (470)
                      .....++||||+++++|.+++.......                   ....+..++.|++.||+|||   +++|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence            5567899999999999999987543211                   12345679999999999999   9999999999


Q ss_pred             CCCeeeCC-CCCeEEeeeccccccCCCCCcccccccccCccccCccccCCC----------------------CCCCccc
Q 040392          301 PSNVLLDD-NMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG----------------------RVSTNGD  357 (470)
Q Consensus       301 p~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----------------------~~~~~~D  357 (470)
                      |+|||++. ++.+||+|||+|+.+.... ........+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999986 6799999999998653222 2223346789999999965322                      2345679


Q ss_pred             hhhHHHHHHHHHhCCCCCCccc--------cCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhh
Q 040392          358 VYSFGIMLMETFTGKKPTNEIF--------NGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAME  429 (470)
Q Consensus       358 vwslGv~l~el~tg~~p~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  429 (470)
                      ||||||++|||+++..|++...        ........|.....+...         ..................+|+.+
T Consensus       362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~d~~~~~~~dLi~~  432 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRAS---------PDLRRGFEVLDLDGGAGWELLKS  432 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccc---------hhhhhhhhhccccchHHHHHHHH
Confidence            9999999999999877654310        001112222211111100         00000000001113345689999


Q ss_pred             ccCCCccCCCCHHHHHHH
Q 040392          430 CTVESPEQRINAREIVAK  447 (470)
Q Consensus       430 cl~~dP~~Rps~~el~~~  447 (470)
                      ||+.||++|||+.|+++|
T Consensus       433 mL~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        433 MMRFKGRQRISAKAALAH  450 (566)
T ss_pred             HccCCcccCCCHHHHhCC
Confidence            999999999999999987

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-35  Score=258.72  Aligned_cols=273  Identities=19%  Similarity=0.284  Sum_probs=198.5

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeecc--------
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSN--------  240 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--------  240 (470)
                      ...|+...+||+|.||.||+|+.+ +|+.||+|..-.+.  ..-.....+|++++..|+|+|++.++..|..        
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            455777789999999999999754 57888988754322  2223445679999999999999999988743        


Q ss_pred             CCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccc
Q 040392          241 EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA  320 (470)
Q Consensus       241 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a  320 (470)
                      ....|+||.+|+. +|..++......++..++.+++.++..||.|+|   ...|+|||+||.|+|++.++.+||+|||++
T Consensus        96 r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   96 RATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             cceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence            2357899999976 999999877778999999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCC--cccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcc-h-hhHHhhhhcCC
Q 040392          321 KLLTGEDQ--SMTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEM-T-LKHWVNDWLPI  395 (470)
Q Consensus       321 ~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~-~-~~~~~~~~~~~  395 (470)
                      +.+.....  ....+..+.|.+|++||.+.+ ..++++.|||+.||++.||+||.+-+....+... . +........+.
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE  251 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence            76643222  233455677999999998876 4699999999999999999999987665322110 0 11111111111


Q ss_pred             c--------ccccccccccCchhhhh----HhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          396 S--------TMEVVGANLLSQEDIHF----VAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       396 ~--------~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                      .        ..+.+...-+.....+-    ..+---..+..+|+..++..||.+|+++.+++.|-
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD  316 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence            0        11111000001000000    00011134678999999999999999999998764

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=6.3e-33  Score=257.41  Aligned_cols=238  Identities=31%  Similarity=0.366  Sum_probs=193.6

Q ss_pred             CceEEEEEEeC-CCcEEEEEEeecccchh-hhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCCCChHHhhhc
Q 040392          185 GFGSVYKARLG-DGMEVAVKVFNLQCGRA-LKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYS  262 (470)
Q Consensus       185 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~  262 (470)
                      +||.||+|... +|+.+|+|++....... .+.+..|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999876 48999999997654443 67889999999999999999999999998999999999999999999876


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccccccccCcccc
Q 040392          263 SNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM  342 (470)
Q Consensus       263 ~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~  342 (470)
                      ... +++..+..++.+++.++.|||   +.+++|+||+|+||+++.++.++++|||.+.......   ......++..|+
T Consensus        81 ~~~-~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~  153 (244)
T smart00220       81 RGR-LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM  153 (244)
T ss_pred             ccC-CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence            543 789999999999999999999   8999999999999999999999999999998764332   223455788999


Q ss_pred             CccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHH
Q 040392          343 APEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSC  422 (470)
Q Consensus       343 aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  422 (470)
                      +||...+..++.++||||||++++++++|..||....+.+ ....+..........                ....++.+
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~----------------~~~~~~~~  216 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-ELFKKIGKPKPPFPP----------------PEWKISPE  216 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHhccCCCCcc----------------ccccCCHH
Confidence            9999988889999999999999999999999987632221 122211111000000                00003567


Q ss_pred             HHHHHhhccCCCccCCCCHHHHHH
Q 040392          423 VFNLAMECTVESPEQRINAREIVA  446 (470)
Q Consensus       423 l~~l~~~cl~~dP~~Rps~~el~~  446 (470)
                      +.+++.+||..+|++||++.++++
T Consensus       217 ~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      217 AKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHHccCCchhccCHHHHhh
Confidence            899999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-33  Score=280.23  Aligned_cols=255  Identities=24%  Similarity=0.328  Sum_probs=208.3

Q ss_pred             HHhhCCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccchhhhhHHHHHHHHhcC-CCCcceeEEeeec-----cC
Q 040392          169 CRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSI-RHRNLIKVISTCS-----NE  241 (470)
Q Consensus       169 ~~~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~-----~~  241 (470)
                      ...++.|++.+.||.|.+|.||+++ .++++..|+|+...... ..+.+..|.++++.+ .|||++.++|++.     .+
T Consensus        15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~   93 (953)
T KOG0587|consen   15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG   93 (953)
T ss_pred             CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence            3456789999999999999999997 45689999999875533 345577789999988 5999999999984     45


Q ss_pred             CeeeEEEecCCCCChHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccc
Q 040392          242 EFKALVLEYMPHGSLEKYMYSS-NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA  320 (470)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a  320 (470)
                      +...+|||||.+||..++++.. +..+.|.....|+..++.|+.+||   ...++|||||-.|||++.++.||++|||.+
T Consensus        94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGvS  170 (953)
T KOG0587|consen   94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGVS  170 (953)
T ss_pred             CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeeee
Confidence            7889999999999999998654 356889999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCCCCcccccccccCccccCccccCCC-----CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCC
Q 040392          321 KLLTGEDQSMTQTQTLATIGYMAPEYGREG-----RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPI  395 (470)
Q Consensus       321 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  395 (470)
                      ..+.  .+.......+||+.|||||++...     .|+..+|+||||++..||-.|.+|+.++..-..-+.         
T Consensus       171 aQld--sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~---------  239 (953)
T KOG0587|consen  171 AQLD--STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL---------  239 (953)
T ss_pred             eeee--cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc---------
Confidence            7653  233444567899999999988643     377889999999999999999999887543211100         


Q ss_pred             cccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          396 STMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                               +...+......+.....++.+++..||.+|-++||++.++++|
T Consensus       240 ---------IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  240 ---------IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             ---------CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence                     0112233344456678999999999999999999999998864

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-34  Score=268.00  Aligned_cols=257  Identities=27%  Similarity=0.418  Sum_probs=198.2

Q ss_pred             CCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccc-------hhhhhHHHHHHHHhcCCCCcceeEEeeec-cCCe
Q 040392          173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCG-------RALKGFDVECEMMKSIRHRNLIKVISTCS-NEEF  243 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~-~~~~  243 (470)
                      ++|-.+.+||+|+|+.||+|. ....+.||||+-..+..       .-.+..-+|.+|.+.|.||.||++|+|+. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            446667789999999999996 55678899998644321       11233556999999999999999999995 4567


Q ss_pred             eeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC---CCCCeEEeeeccc
Q 040392          244 KALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIA  320 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~a  320 (470)
                      .+-|+|||+|.+|.=|++..+ .+++..+..|+.||+.||.||.+. ..+|||-||||.|||+-   .-|.+||+|||++
T Consensus       543 FCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            789999999999988886655 689999999999999999999943 78999999999999994   4678999999999


Q ss_pred             cccCCCCCc-----ccccccccCccccCccccCCC----CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhh
Q 040392          321 KLLTGEDQS-----MTQTQTLATIGYMAPEYGREG----RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVND  391 (470)
Q Consensus       321 ~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~----~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~  391 (470)
                      +.+.+....     ...+...||.+|++||.+.-+    .++.|+||||+||++|.++.|+.||+..-.. ..+.+.   
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ-QdILqe---  696 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ-QDILQE---  696 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH-HHHHhh---
Confidence            988765443     223456899999999987543    4788999999999999999999999863221 111111   


Q ss_pred             hcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHH
Q 040392          392 WLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVA  446 (470)
Q Consensus       392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~  446 (470)
                      ..           ++......++...-.+.+..++|++||.+--+.|....++..
T Consensus       697 NT-----------IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  697 NT-----------ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             hc-----------hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            10           111222223333344677889999999999999998888754

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-33  Score=260.76  Aligned_cols=243  Identities=22%  Similarity=0.276  Sum_probs=193.2

Q ss_pred             hhCCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccc---hhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCeee
Q 040392          171 ATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCG---RALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFKA  245 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~  245 (470)
                      ...+|..+..||+|+||.|-.|. ..+.+.+|||+++++.-   ...+--..|-++|... +-|.+++++.++..-+..|
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy  426 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY  426 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence            34578999999999999999995 44578899999976521   2222234467777666 4678899999999999999


Q ss_pred             EEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC
Q 040392          246 LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  325 (470)
                      +||||+.||+|--.+++-+ .+.+..+.-++.+||-||-+||   +++|++||||.+||+++.+|++||+|||+++.-. 
T Consensus       427 FVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni-  501 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI-  501 (683)
T ss_pred             eEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccc-
Confidence            9999999999977776655 4677788889999999999999   9999999999999999999999999999998432 


Q ss_pred             CCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          326 EDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       326 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                       -...+....+||+.|+|||++....|+.++|-|||||+||||+.|+.||+..+..+. +......            ..
T Consensus       502 -~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el-F~aI~eh------------nv  567 (683)
T KOG0696|consen  502 -FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-FQAIMEH------------NV  567 (683)
T ss_pred             -cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHc------------cC
Confidence             122334568999999999999999999999999999999999999999987543322 1111111            00


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCC
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRIN  440 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps  440 (470)
                              ..|...+.+..++....+.+.|.+|..
T Consensus       568 --------syPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  568 --------SYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             --------cCcccccHHHHHHHHHHhhcCCccccC
Confidence                    112233677889999999999999974

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-34  Score=273.18  Aligned_cols=250  Identities=22%  Similarity=0.273  Sum_probs=203.9

Q ss_pred             CCCCCCCeecccCceEEEEEEeCCCc-EEEEEEeecc---cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLGDGM-EVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      .++..+..||-|+||.|=.++.++.. .+|+|++++.   ..+..+.+..|-++|...+.|.||++|..|.+..+.|++|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            45566778999999999999875433 4888888654   3455667788999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      |.|-||.|...+.+.+ .++..+...++..+++|++|||   .++||+|||||+|.+++.+|-+||.|||+|+.+.... 
T Consensus       500 EaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~-  574 (732)
T KOG0614|consen  500 EACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR-  574 (732)
T ss_pred             HhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCC-
Confidence            9999999999997665 6788888889999999999999   9999999999999999999999999999999875432 


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                        ..-..+||+.|.|||++.+...+.++|.||||+++|||++|.+||...++-    ..|-...             .  
T Consensus       575 --KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm----ktYn~IL-------------k--  633 (732)
T KOG0614|consen  575 --KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM----KTYNLIL-------------K--  633 (732)
T ss_pred             --ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH----HHHHHHH-------------h--
Confidence              223478999999999999999999999999999999999999999875432    2211110             0  


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCC-----HHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRIN-----AREIVAKL  448 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~el~~~L  448 (470)
                      .......|........+++++.+..+|.+|..     ..+|.+|-
T Consensus       634 Gid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~  678 (732)
T KOG0614|consen  634 GIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR  678 (732)
T ss_pred             hhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence            00111223444667889999999999999986     56666553

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.2e-32  Score=275.00  Aligned_cols=258  Identities=19%  Similarity=0.227  Sum_probs=181.2

Q ss_pred             hhCCCCCCCeecccCceEEEEEEe-----------------CCCcEEEEEEeecccchhh--------------hhHHHH
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARL-----------------GDGMEVAVKVFNLQCGRAL--------------KGFDVE  219 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~--------------~~~~~E  219 (470)
                      ..++|.+.++||+|+||.||+|..                 .+++.||||.+........              +....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999953                 2356899999864432222              223346


Q ss_pred             HHHHhcCCCCcc-----eeEEeeecc--------CCeeeEEEecCCCCChHHhhhcCC----------------------
Q 040392          220 CEMMKSIRHRNL-----IKVISTCSN--------EEFKALVLEYMPHGSLEKYMYSSN----------------------  264 (470)
Q Consensus       220 ~~~l~~l~h~nI-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~----------------------  264 (470)
                      +.++.+++|.++     ++++++|..        ....++||||+++++|.++++...                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766554     677777643        346789999999999999986432                      


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccccccccCccccC
Q 040392          265 -YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA  343 (470)
Q Consensus       265 -~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~a  343 (470)
                       ..+++..+..++.|++.+|.|||   +.+|+||||||+||+++.++.+||+|||++..+.... ........+++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeC
Confidence             12356678889999999999999   8999999999999999999999999999997653221 112222345789999


Q ss_pred             ccccCCCCC----------------------CCccchhhHHHHHHHHHhCCC-CCCccccCcc-------hhhHHhhhhc
Q 040392          344 PEYGREGRV----------------------STNGDVYSFGIMLMETFTGKK-PTNEIFNGEM-------TLKHWVNDWL  393 (470)
Q Consensus       344 PE~~~~~~~----------------------~~~~DvwslGv~l~el~tg~~-p~~~~~~~~~-------~~~~~~~~~~  393 (470)
                      ||.+.....                      ..+.||||+||++++|++|.. |+........       ....|... .
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~-~  457 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY-K  457 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh-c
Confidence            998754321                      124699999999999999886 6653211111       11112110 0


Q ss_pred             CCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCc---cCCCCHHHHHHH
Q 040392          394 PISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESP---EQRINAREIVAK  447 (470)
Q Consensus       394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~Rps~~el~~~  447 (470)
                      ...    .+          .......+....+++.++|..+|   .+|+|+.|+++|
T Consensus       458 ~~~----~~----------~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        458 GQK----YD----------FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             ccC----CC----------cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            000    00          00112235668899999999866   689999999976

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-34  Score=283.88  Aligned_cols=255  Identities=25%  Similarity=0.400  Sum_probs=195.6

Q ss_pred             CCCeecccCceE-EEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCeeeEEEecCCCC
Q 040392          177 ENNLIGRGGFGS-VYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMPHG  254 (470)
Q Consensus       177 ~~~~ig~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~g  254 (470)
                      ..+.+|.|+.|+ ||+|.. +|+.||||++-..   -.....+|++.++.- +|||||++++.-.++.+.|+..|.|.. 
T Consensus       513 ~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-  587 (903)
T KOG1027|consen  513 PKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-  587 (903)
T ss_pred             cHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-
Confidence            335688999875 689988 5899999998532   334567899999988 599999999999999999999999965 


Q ss_pred             ChHHhhhcCC--C-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---C--CCeEEeeeccccccCCC
Q 040392          255 SLEKYMYSSN--Y-ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD---N--MVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       255 ~L~~~l~~~~--~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~---~--~~~kl~Dfg~a~~~~~~  326 (470)
                      +|++++....  . .........++.|+++||++||   +.+|+||||||.||||+.   +  .+++|+|||+++.+...
T Consensus       588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~  664 (903)
T KOG1027|consen  588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG  664 (903)
T ss_pred             hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence            9999998741  1 1111445789999999999999   999999999999999975   2  47899999999988765


Q ss_pred             CCc-ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCccccccccc
Q 040392          327 DQS-MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN  404 (470)
Q Consensus       327 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (470)
                      ... .......||.+|+|||++....-+.++||||+||++|+.++ |.+||++...++..+..      ...  .     
T Consensus       665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~------~~~--~-----  731 (903)
T KOG1027|consen  665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT------GNY--T-----  731 (903)
T ss_pred             cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc------Ccc--c-----
Confidence            443 23456679999999999999888899999999999999999 59999985444332211      000  0     


Q ss_pred             ccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHH------------HHHHHHHHHhhhc
Q 040392          405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVA------------KLLKIRDSLLRNV  459 (470)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~------------~L~~i~~~~~~~~  459 (470)
                      +..     .....+|  +..+||.+|++++|..||+|.+|+.            .|+++.|+...++
T Consensus       732 L~~-----L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSDRvE~e~  791 (903)
T KOG1027|consen  732 LVH-----LEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVSDRVEKEN  791 (903)
T ss_pred             eee-----eccCchH--HHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhhhhhhhhhh
Confidence            000     0001112  6789999999999999999999975            4555655554444

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.9e-32  Score=247.63  Aligned_cols=247  Identities=22%  Similarity=0.278  Sum_probs=199.2

Q ss_pred             CCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc---cchhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCeeeEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ---CGRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      ++|+.++.||+|+|+.|..+++ ++.+.+|+|++++.   ..+.++..+.|-.+..+- +||.+|-++.+|..+...++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            5789999999999999999975 45788999998765   345566677788887776 699999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      .||++||+|-=.++..+ .++++.+..+...|+-||.|||   ++||++||||.+|||+|..|++|++|+|+++.--  .
T Consensus       330 ieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l--~  403 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL--G  403 (593)
T ss_pred             EEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCC--C
Confidence            99999999966665444 5888899999999999999999   9999999999999999999999999999998532  2


Q ss_pred             CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCc--cccCcchhhHHhhhhcCCcccccccccc
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNE--IFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      .....+..+||+.|.|||++.+..|...+|-|++||+++||+.|+.||+-  +.+.+..-.+|.-...-.+..       
T Consensus       404 ~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi-------  476 (593)
T KOG0695|consen  404 PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI-------  476 (593)
T ss_pred             CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc-------
Confidence            23344568999999999999999999999999999999999999999984  333343333433221111100       


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCC
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRIN  440 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps  440 (470)
                              ..|...+.....++..-|++||.+|..
T Consensus       477 --------riprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  477 --------RIPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             --------cccceeehhhHHHHHHhhcCCcHHhcC
Confidence                    112233555678899999999999974

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=1.5e-32  Score=236.18  Aligned_cols=263  Identities=20%  Similarity=0.328  Sum_probs=197.7

Q ss_pred             hhCCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccchhhhhHHHHHHHHhcCC-CCcceeEEeeeccC--CeeeE
Q 040392          171 ATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIR-HRNLIKVISTCSNE--EFKAL  246 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~--~~~~l  246 (470)
                      ..++|++.+++|+|.|+.||.|. ..+.+.++||++++-   ..+.+.+|+.+|+.|+ ||||+++++...++  ..+.+
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            45789999999999999999995 567889999999743   4456788999999997 99999999998664  57789


Q ss_pred             EEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCCeEEeeeccccccCC
Q 040392          247 VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-NMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~  325 (470)
                      |+||+++.+...+..    .++...+..++.+++.||.|+|   +.||.|||+||.|+++|. .-.++|+|+|+|.++.+
T Consensus       113 iFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             HhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            999999987766653    4677788889999999999999   999999999999999985 55799999999998865


Q ss_pred             CCCcccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhh------------HHhhhh
Q 040392          326 EDQSMTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLK------------HWVNDW  392 (470)
Q Consensus       326 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~------------~~~~~~  392 (470)
                      ....   ...+.+..|.-||++.. ..|+.+-|+|||||++..|+..+.||-...+...++.            .++...
T Consensus       186 ~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY  262 (338)
T KOG0668|consen  186 GKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY  262 (338)
T ss_pred             Ccee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence            3322   23456667889998865 4589999999999999999999999876544433322            222221


Q ss_pred             ---cCCcccccccccccCchhhhhHhh---hhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          393 ---LPISTMEVVGANLLSQEDIHFVAK---EQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       393 ---~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                         ++.....+....- ...=.++...   .-.+++..+++...|..|-++||||+|.++|
T Consensus       263 ~i~Ldp~~~~i~~~~~-rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  263 QIDLDPQFEDILGRHS-RKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             ccCCChhHhhHhhccc-cccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence               1111111110000 0000001111   1124678999999999999999999999876

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.3e-31  Score=259.81  Aligned_cols=208  Identities=22%  Similarity=0.345  Sum_probs=176.4

Q ss_pred             CCCCCCeecccCceEEEEEE-eCCCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          174 GFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      -|..++.||-|+||.|.+++ ..+...||.|.+++.+   .......+.|-.||..-..+=||+++..|.+.+..|+|||
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            47778899999999999995 4557779999987653   3445567789999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC----
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG----  325 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~----  325 (470)
                      |++||++-.+|...+ .+.+..+..++.++..|+++.|   ..|+|||||||+|||||.+|++||+|||++.-+..    
T Consensus       710 YIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds  785 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  785 (1034)
T ss_pred             ccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceecccc
Confidence            999999999887665 5778888889999999999999   99999999999999999999999999999863211    


Q ss_pred             -----CCCc-------------------------------ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHH
Q 040392          326 -----EDQS-------------------------------MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETF  369 (470)
Q Consensus       326 -----~~~~-------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~  369 (470)
                           .+..                               ......+||+.|+|||++....++..+|.||.||+||||+
T Consensus       786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence                 0000                               0012456999999999999999999999999999999999


Q ss_pred             hCCCCCCccccCcchh
Q 040392          370 TGKKPTNEIFNGEMTL  385 (470)
Q Consensus       370 tg~~p~~~~~~~~~~~  385 (470)
                      .|+.||.+...++...
T Consensus       866 ~g~~pf~~~tp~~tq~  881 (1034)
T KOG0608|consen  866 VGQPPFLADTPGETQY  881 (1034)
T ss_pred             hCCCCccCCCCCccee
Confidence            9999999876665543

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-31  Score=226.57  Aligned_cols=216  Identities=25%  Similarity=0.315  Sum_probs=172.3

Q ss_pred             HHHhhCCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecc-cchhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCee
Q 040392          168 LCRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ-CGRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFK  244 (470)
Q Consensus       168 ~~~~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~  244 (470)
                      ++...+.......||+|++|.|=+.+ ..+|+..|+|.+... ..+..++...|+.+..+. .+|.+|.++|........
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            33444556667789999999998886 457999999998654 345566677788775554 699999999998888888


Q ss_pred             eEEEecCCCCChHHhhh---cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecccc
Q 040392          245 ALVLEYMPHGSLEKYMY---SSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK  321 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~  321 (470)
                      .+.||.|. .+|..+-.   +.+..+++...-+|+..+.+||.|||.  ...++|||+||+|||++.+|++|+||||.+-
T Consensus       121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccce
Confidence            99999995 48766643   345678899999999999999999996  6789999999999999999999999999988


Q ss_pred             ccCCCCCcccccccccCccccCccccCC----CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHh
Q 040392          322 LLTGEDQSMTQTQTLATIGYMAPEYGRE----GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWV  389 (470)
Q Consensus       322 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~  389 (470)
                      .+.+.   ...+...|-..|+|||.+..    ..|+.++||||||+++.||.+++.||+.+..+=..+.+.+
T Consensus       198 ~L~dS---iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV  266 (282)
T KOG0984|consen  198 YLVDS---IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV  266 (282)
T ss_pred             eehhh---hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh
Confidence            76432   22333456778999998754    3689999999999999999999999988665544444433

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.5e-33  Score=244.73  Aligned_cols=266  Identities=23%  Similarity=0.313  Sum_probs=197.9

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccC-----CeeeE
Q 040392          175 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNE-----EFKAL  246 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-----~~~~l  246 (470)
                      .+..+.||-|+||.||.+++. +|+.||+|.+..-  .-...+++.+|++++...+|.|++..++.....     ...|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            455688999999999999754 7999999987532  234567888999999999999999888766433     24567


Q ss_pred             EEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCC
Q 040392          247 VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      ++|.+.. +|...+-+-. .++...+.-++.||++||.|||   +.+|.||||||.|.|++++..+||||||+++... .
T Consensus       135 ~TELmQS-DLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee-~  208 (449)
T KOG0664|consen  135 LTELMQS-DLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWD-Q  208 (449)
T ss_pred             HHHHHHh-hhhheeccCC-CCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccc-h
Confidence            8888854 8888775544 5788888899999999999999   9999999999999999999999999999998654 3


Q ss_pred             CCcccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          327 DQSMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       327 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      +....++..+.|..|+|||++.+. .|+.+.||||+||++.||+.++.-|...  +.....+.+.+.+.-...+.....+
T Consensus       209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq--~PiqQL~lItdLLGTPs~EaMr~AC  286 (449)
T KOG0664|consen  209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA--GPIEQLQMIIDLLGTPSQEAMKYAC  286 (449)
T ss_pred             hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc--ChHHHHHHHHHHhCCCcHHHHHHHh
Confidence            444566677889999999999875 5999999999999999999999887652  2222223333222222111111100


Q ss_pred             cCchh---------------hhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          406 LSQED---------------IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       406 ~~~~~---------------~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                      -+...               .....+..-..+...+...++..||++|.+..+.+.++
T Consensus       287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            00000               00111122245577889999999999999999988876

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=5.9e-30  Score=231.74  Aligned_cols=211  Identities=36%  Similarity=0.555  Sum_probs=183.7

Q ss_pred             ecccCceEEEEEEeCC-CcEEEEEEeecccch-hhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCCCChHH
Q 040392          181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK  258 (470)
Q Consensus       181 ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~  258 (470)
                      ||+|++|.||++...+ ++.+++|++...... ....+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999998754 899999998755332 34678899999999999999999999999899999999999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCCeEEeeeccccccCCCCCccccccccc
Q 040392          259 YMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-NMVAHLSDFSIAKLLTGEDQSMTQTQTLA  337 (470)
Q Consensus       259 ~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  337 (470)
                      ++......+++..+..++.++++++.+||   +.+++|+||+|.||+++. ++.++|+|||.+........  ......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~  155 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG  155 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence            99766456899999999999999999999   899999999999999999 89999999999986643221  2233557


Q ss_pred             CccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhh
Q 040392          338 TIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAK  416 (470)
Q Consensus       338 t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  416 (470)
                      ...|++||..... .++.++|+|++|+++++|                                                
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------  187 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------  187 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence            8889999998877 788999999999999999                                                


Q ss_pred             hhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          417 EQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       417 ~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                          ..+.+++..|++.+|++||++.++++++
T Consensus       188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ----PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                2367899999999999999999998764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=6.3e-31  Score=236.96  Aligned_cols=258  Identities=25%  Similarity=0.286  Sum_probs=197.8

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccC------C
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNE------E  242 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~------~  242 (470)
                      ..+|..++.+|.|.- .|..|.+ -.+++||+|.....  .....++..+|..++..+.|+||++++.++...      .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            456788889999998 6666643 35899999987533  345567788899999999999999999998543      3


Q ss_pred             eeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccc
Q 040392          243 FKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL  322 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~  322 (470)
                      ..|+|||+|.. +|.+.+.   ..++..+...+..|++.|+.|||   +.+|+||||||+||++..+..+||.|||+|+.
T Consensus        95 e~y~v~e~m~~-nl~~vi~---~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   95 EVYLVMELMDA-NLCQVIL---MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             hHHHHHHhhhh-HHHHHHH---HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcc
Confidence            56899999965 9988887   34688889999999999999999   99999999999999999999999999999985


Q ss_pred             cCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCC-------
Q 040392          323 LTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPI-------  395 (470)
Q Consensus       323 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------  395 (470)
                      .   +.....+..+.|..|.|||++.+..+.+.+||||+||++.||++|+.-|.    ++..+.+|.+.....       
T Consensus       168 e---~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~----g~d~idQ~~ki~~~lgtpd~~F  240 (369)
T KOG0665|consen  168 E---DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP----GKDHIDQWNKIIEQLGTPDPSF  240 (369)
T ss_pred             c---CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec----CchHHHHHHHHHHHhcCCCHHH
Confidence            4   33356677889999999999999889999999999999999999998765    344444553321100       


Q ss_pred             ---------------------cccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          396 ---------------------STMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       396 ---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                                           .+.+.+...+......   .+..-..-+.+++.+||..||++|.|++++++|
T Consensus       241 ~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e---~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  241 MKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLE---GSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHhhHHHHHHhhcChHhhccchhhhCCccccccccc---CCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                                 0000000000000000   010113447899999999999999999999876

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=5e-31  Score=257.68  Aligned_cols=254  Identities=25%  Similarity=0.371  Sum_probs=207.8

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      .++|+.+..+|.|.||.||||+. .+++..|+|+++.......+..++|+-+++..+||||+.++|.+...+...+.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            56899999999999999999975 46899999999988888888899999999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      |.+|+|++.-+-.+ .+++.+...+++..++|++|||   +.+-+|||||-.||++++.|.+|+.|||.+-.+..  .-.
T Consensus        94 cgggslQdiy~~Tg-plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti~  167 (829)
T KOG0576|consen   94 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TIA  167 (829)
T ss_pred             cCCCcccceeeecc-cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhh--hhh
Confidence            99999998876544 6889999999999999999999   99999999999999999999999999998866532  233


Q ss_pred             cccccccCccccCcccc---CCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          331 TQTQTLATIGYMAPEYG---REGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~---~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                      ......||+.|||||+.   ..+.|...+|||++|++..|+---+.|..+..+-...+.  +.            .+...
T Consensus       168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L--mT------------kS~~q  233 (829)
T KOG0576|consen  168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL--MT------------KSGFQ  233 (829)
T ss_pred             hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH--hh------------ccCCC
Confidence            44568899999999975   356789999999999999999988877544322111111  00            00000


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                        ......+......|-++++.|+..+|++||+++.++.|
T Consensus       234 --pp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  234 --PPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             --CCcccCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence              01111233447778999999999999999999987753

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=8.3e-29  Score=227.25  Aligned_cols=199  Identities=31%  Similarity=0.443  Sum_probs=173.0

Q ss_pred             CCCCCeecccCceEEEEEEeCC-CcEEEEEEeecccch-hhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCC
Q 040392          175 FSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP  252 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~  252 (470)
                      |...+.||.|++|.||++...+ ++.+++|.+...... ..+.+..|++.++.++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567899999999999998764 899999999765544 66788889999999999999999999998899999999999


Q ss_pred             CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccc
Q 040392          253 HGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ  332 (470)
Q Consensus       253 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  332 (470)
                      +++|.+++......+++.....++.+++.++.+||   +.+++|+|++|.||+++.++.++|+|||.+......... ..
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~  156 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LL  156 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cc
Confidence            99999999765533789999999999999999999   889999999999999999999999999998876543211 22


Q ss_pred             cccccCccccCcccc-CCCCCCCccchhhHHHHHHHHHhCCCCCCc
Q 040392          333 TQTLATIGYMAPEYG-REGRVSTNGDVYSFGIMLMETFTGKKPTNE  377 (470)
Q Consensus       333 ~~~~~t~~y~aPE~~-~~~~~~~~~DvwslGv~l~el~tg~~p~~~  377 (470)
                      ....++..|++||.. ....++.++|+|+||++++||++|+.||..
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            334577889999998 666788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=9.3e-29  Score=234.08  Aligned_cols=130  Identities=28%  Similarity=0.378  Sum_probs=110.1

Q ss_pred             CCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccchhhhhHHHHHHHHhcCC-----C---CcceeEEeeec----
Q 040392          173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIR-----H---RNLIKVISTCS----  239 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~nIv~~~~~~~----  239 (470)
                      .+|-+.++||.|.|++||++. ..+.+.||+|+.+.. ..-.+....|+++|++++     |   .+||++++.|.    
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            578889999999999999996 456788999998743 233455677999999884     2   46999999985    


Q ss_pred             cCCeeeEEEecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 040392          240 NEEFKALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL  306 (470)
Q Consensus       240 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill  306 (470)
                      ++.+.+||+|++ |.+|..+|.... ..++...+.+|+.|++.||.|||.  ..+|||-||||+|||+
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence            467999999999 569999997766 458899999999999999999997  5699999999999998

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-29  Score=244.07  Aligned_cols=196  Identities=22%  Similarity=0.339  Sum_probs=167.1

Q ss_pred             CCCCCCCeecccCceEEEEEEeCC-CcEEEEEEeeccc--------chhhhhHHHHHHHHhcCC---CCcceeEEeeecc
Q 040392          173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQC--------GRALKGFDVECEMMKSIR---HRNLIKVISTCSN  240 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~  240 (470)
                      .+|...+.+|.|+||.|+.|.++. ...|+||.+.+..        .+..-....|++||..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            358889999999999999997654 6678999876431        112233556999999997   9999999999999


Q ss_pred             CCeeeEEEecC-CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecc
Q 040392          241 EEFKALVLEYM-PHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSI  319 (470)
Q Consensus       241 ~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  319 (470)
                      .+++|++||-. ++-+|.+++.-+ ..+++..+..|..|++.|+++||   ..+|+|||||-+||.++.+|-+||+|||.
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeeccc
Confidence            99999999985 455899999544 47899999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccCccccCccccCCCCCC-CccchhhHHHHHHHHHhCCCCCC
Q 040392          320 AKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVS-TNGDVYSFGIMLMETFTGKKPTN  376 (470)
Q Consensus       320 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslGv~l~el~tg~~p~~  376 (470)
                      |....+.    .....+||..|.|||++.+..|- ...|||++|++||-++....||.
T Consensus       717 aa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  717 AAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            8765433    23457899999999999998874 55899999999999999999875

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=9.8e-30  Score=242.00  Aligned_cols=269  Identities=23%  Similarity=0.262  Sum_probs=201.8

Q ss_pred             HhhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCC------CCcceeEEeeeccCC
Q 040392          170 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIR------HRNLIKVISTCSNEE  242 (470)
Q Consensus       170 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~nIv~~~~~~~~~~  242 (470)
                      ..-.+|.+....|+|-|++|.+|... .|..||||++..+ ....+.=..|+++|++|+      --|+++++..|....
T Consensus       429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn  507 (752)
T KOG0670|consen  429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN  507 (752)
T ss_pred             hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence            34567888899999999999999754 4889999999754 223344567999999996      347899999999999


Q ss_pred             eeeEEEecCCCCChHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-CCeEEeeecc
Q 040392          243 FKALVLEYMPHGSLEKYMYSSN--YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN-MVAHLSDFSI  319 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~  319 (470)
                      +.|||+|.+.. +|.+++.+.+  ..+....+..++.|+.-||..|-   ..+|+|.||||.|||+.+. ..+||||||.
T Consensus       508 HLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS  583 (752)
T KOG0670|consen  508 HLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGS  583 (752)
T ss_pred             eeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCcc
Confidence            99999999854 9999998765  45677788899999999999999   9999999999999999864 5689999999


Q ss_pred             ccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchh--------------
Q 040392          320 AKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTL--------------  385 (470)
Q Consensus       320 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~--------------  385 (470)
                      |.......    .+.+..+..|.|||++.+-.|+...|+||+||+||||.||+..|.+..+..+--              
T Consensus       584 A~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml  659 (752)
T KOG0670|consen  584 ASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML  659 (752)
T ss_pred             cccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence            98764332    233456778999999999999999999999999999999999988755543210              


Q ss_pred             --hHHhhhhcCCc------------------ccccccc-cccCchhh----hhHhhhhhHHHHHHHHhhccCCCccCCCC
Q 040392          386 --KHWVNDWLPIS------------------TMEVVGA-NLLSQEDI----HFVAKEQCVSCVFNLAMECTVESPEQRIN  440 (470)
Q Consensus       386 --~~~~~~~~~~~------------------~~~~~~~-~~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~Rps  440 (470)
                        .++...++...                  .+..+.| .-+.....    ...........|.+|+..|+..||++|.+
T Consensus       660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit  739 (752)
T KOG0670|consen  660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT  739 (752)
T ss_pred             hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence              01111111111                  0000000 00000000    00112244677999999999999999999


Q ss_pred             HHHHHHH
Q 040392          441 AREIVAK  447 (470)
Q Consensus       441 ~~el~~~  447 (470)
                      ..++++|
T Consensus       740 ~nqAL~H  746 (752)
T KOG0670|consen  740 VNQALKH  746 (752)
T ss_pred             HHHHhcC
Confidence            9999876

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=7.3e-29  Score=218.67  Aligned_cols=256  Identities=20%  Similarity=0.303  Sum_probs=189.5

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcC-CCCcceeEEee-eccCCeeeEE
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSI-RHRNLIKVIST-CSNEEFKALV  247 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~-~~~~~~~~lv  247 (470)
                      ..+.|.+.+.+|+|.||.+-.+.++ +.+.+++|-+.... ...++|.+|...--.| -|.||+.-++. |+..+.+.++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            3467999999999999999999754 67889999886443 3456788888765556 48999987764 5677888999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee-C-CCCCeEEeeeccccccCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL-D-DNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill-~-~~~~~kl~Dfg~a~~~~~  325 (470)
                      +||+|.|+|.+-+...+  +.+.....++.|+++|+.|+|   ++.++|||||.+|||+ + +..++|+||||..+... 
T Consensus       101 qE~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g-  174 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG-  174 (378)
T ss_pred             eccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccC-
Confidence            99999999998886644  678888999999999999999   9999999999999999 2 34489999999987532 


Q ss_pred             CCCcccccccccCccccCccccCCC-----CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccc
Q 040392          326 EDQSMTQTQTLATIGYMAPEYGREG-----RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEV  400 (470)
Q Consensus       326 ~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (470)
                          ......-.+..|.+||.....     ...+.+|+|.||++++.++||..||....-.......|.. |...+....
T Consensus       175 ----~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~-w~~rk~~~~  249 (378)
T KOG1345|consen  175 ----TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQ-WLKRKNPAL  249 (378)
T ss_pred             ----ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHH-HhcccCccC
Confidence                111223345679999976532     3577899999999999999999999864433333334432 111111111


Q ss_pred             ccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHH
Q 040392          401 VGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK  450 (470)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~  450 (470)
                      .  +..          ..++..+..+.++-+..+|++|-...++.+..+.
T Consensus       250 P--~~F----------~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~  287 (378)
T KOG1345|consen  250 P--KKF----------NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC  287 (378)
T ss_pred             c--hhh----------cccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence            1  111          1125567789999999999999666666555544

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=2.7e-27  Score=209.23  Aligned_cols=170  Identities=21%  Similarity=0.202  Sum_probs=131.6

Q ss_pred             CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccccc
Q 040392          254 GSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  333 (470)
Q Consensus       254 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  333 (470)
                      |+|.+++...+..+++.+++.++.|++.||+|||   +.+      ||+||+++.++.+|+  ||.+.......      
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc------
Confidence            6899999876667999999999999999999999   666      999999999999999  99987654321      


Q ss_pred             ccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhh
Q 040392          334 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF  413 (470)
Q Consensus       334 ~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  413 (470)
                       ..||+.|+|||++.+..++.++|||||||++|||++|+.||.........+..+.....+.....             .
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------------~  129 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRD-------------R  129 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccc-------------c
Confidence             25889999999999999999999999999999999999998764332222222222111110000             0


Q ss_pred             HhhhhhHH--HHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          414 VAKEQCVS--CVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       414 ~~~~~~~~--~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                      ..+.....  ++.+++.+||..+|++||++.|+++++..+...
T Consensus       130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence            00111222  689999999999999999999999999888654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=7.8e-28  Score=224.90  Aligned_cols=270  Identities=24%  Similarity=0.328  Sum_probs=200.2

Q ss_pred             HHhhCCCCCCCeecccCceEEEEEEeC----CCcEEEEEEeecccchhhhhHHHHHHHHhcCC-CCcceeEEeeeccCCe
Q 040392          169 CRATDGFSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQCGRALKGFDVECEMMKSIR-HRNLIKVISTCSNEEF  243 (470)
Q Consensus       169 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~  243 (470)
                      ....+.|..+++||.|.|++||++...    ..+.||+|.+...  ....++..|+++|..+. +.||+++.+++...+.
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~  109 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ  109 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence            344567899999999999999999643    4678999998643  34456889999999994 9999999999999999


Q ss_pred             eeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCCCeEEeeeccccc
Q 040392          244 KALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKL  322 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~a~~  322 (470)
                      ..+|+||++..+-.++...    ++...+..+++.++.||.++|   ..||+||||||.|++.+ .-+.-.|.|||+|..
T Consensus       110 v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~  182 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR  182 (418)
T ss_pred             eEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHH
Confidence            9999999999888888853    567888899999999999999   99999999999999997 456789999999872


Q ss_pred             cCCCC--------------C----------------------------cccccccccCccccCccccCC-CCCCCccchh
Q 040392          323 LTGED--------------Q----------------------------SMTQTQTLATIGYMAPEYGRE-GRVSTNGDVY  359 (470)
Q Consensus       323 ~~~~~--------------~----------------------------~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvw  359 (470)
                      .....              .                            ........||++|.|||++.. ...++++|||
T Consensus       183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw  262 (418)
T KOG1167|consen  183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW  262 (418)
T ss_pred             HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence            11000              0                            000113469999999998765 5688999999


Q ss_pred             hHHHHHHHHHhCCCCCCccccCcchhhHHhhhh----------cCCc--ccc---------------ccc-ccccCchh-
Q 040392          360 SFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDW----------LPIS--TME---------------VVG-ANLLSQED-  410 (470)
Q Consensus       360 slGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~----------~~~~--~~~---------------~~~-~~~~~~~~-  410 (470)
                      |.||+++-+++++.||-...++-..+.+.+..+          .+..  ..+               .++ ..+..... 
T Consensus       263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~  342 (418)
T KOG1167|consen  263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP  342 (418)
T ss_pred             eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence            999999999999999887655544333322111          1111  000               010 00111000 


Q ss_pred             -hh-hHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          411 -IH-FVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       411 -~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                       .. ....+..+..+++++.+|+..||.+|.||++.+.|
T Consensus       343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence             01 11112334578999999999999999999999876

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=1.2e-27  Score=258.76  Aligned_cols=197  Identities=16%  Similarity=0.234  Sum_probs=140.2

Q ss_pred             cCCC-CcceeEEeee-------ccCCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeee
Q 040392          225 SIRH-RNLIKVISTC-------SNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH  296 (470)
Q Consensus       225 ~l~h-~nIv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H  296 (470)
                      .++| +||+++++++       ......+.++||+ +++|.+++......+++.+++.++.||++||+|||   +++|+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeee
Confidence            4456 6888888877       2334567788988 55999999765666899999999999999999999   999999


Q ss_pred             cCCCCCCeeeCCC-------------------CCeEEeeeccccccCCCCC--------------cccccccccCccccC
Q 040392          297 CDLKPSNVLLDDN-------------------MVAHLSDFSIAKLLTGEDQ--------------SMTQTQTLATIGYMA  343 (470)
Q Consensus       297 ~dlkp~Nill~~~-------------------~~~kl~Dfg~a~~~~~~~~--------------~~~~~~~~~t~~y~a  343 (470)
                      |||||+|||++..                   +.+|++|||+++.......              ........+|+.|+|
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            9999999999654                   4455666666543211000              000112357888999


Q ss_pred             ccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHH
Q 040392          344 PEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCV  423 (470)
Q Consensus       344 PE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  423 (470)
                      ||++.+..++.++|||||||+||||++|..|+....   ..+..+.....+.        ..           .......
T Consensus       184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~~~~~~--------~~-----------~~~~~~~  241 (793)
T PLN00181        184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRHRVLPP--------QI-----------LLNWPKE  241 (793)
T ss_pred             hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHHhhcCh--------hh-----------hhcCHHH
Confidence            999999999999999999999999999888765311   1111111100000        00           0012235


Q ss_pred             HHHHhhccCCCccCCCCHHHHHHH
Q 040392          424 FNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       424 ~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      .+++.+||+++|.+||++.|++++
T Consensus       242 ~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        242 ASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHHHHhCCCChhhCcChHHHhhc
Confidence            678899999999999999999875

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.5e-27  Score=210.49  Aligned_cols=248  Identities=22%  Similarity=0.344  Sum_probs=195.7

Q ss_pred             CCCCCeecccCceEEEEEEeCCCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCC
Q 040392          175 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP  252 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~  252 (470)
                      .....+|.+...|..|+|+|+ |..+++|++...  ..+....|..|.-.++-..||||..+++.|..+....++..||+
T Consensus       192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp  270 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP  270 (448)
T ss_pred             hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence            344567889999999999996 677778887543  34556778999999999999999999999999999999999999


Q ss_pred             CCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEe--eeccccccCCCCCc
Q 040392          253 HGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLS--DFSIAKLLTGEDQS  329 (470)
Q Consensus       253 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~--Dfg~a~~~~~~~~~  329 (470)
                      .|+|...+++.. ...+..++.+++.++++|++|||+. ..-|.---+....+++|++.+.+|+  |-.++.        
T Consensus       271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf--------  341 (448)
T KOG0195|consen  271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--------  341 (448)
T ss_pred             chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee--------
Confidence            999999998765 4467788999999999999999942 2334445688999999999988875  222221        


Q ss_pred             ccccccccCccccCccccCCCCC---CCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccccc
Q 040392          330 MTQTQTLATIGYMAPEYGREGRV---STNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL  406 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~---~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (470)
                       ........+.|++||.+...+-   -.++|+|||++++|||.|+..||.+..+-+..+..-                  
T Consensus       342 -qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia------------------  402 (448)
T KOG0195|consen  342 -QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA------------------  402 (448)
T ss_pred             -eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh------------------
Confidence             1122345788999999876653   457999999999999999999999887665544421                  


Q ss_pred             CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHH
Q 040392          407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR  452 (470)
Q Consensus       407 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~  452 (470)
                       -++.+...|...+..+..|+.-|++.||.+||.+.+++-.|+++.
T Consensus       403 -leglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  403 -LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             -hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence             122233334445777889999999999999999999999999885

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=1.6e-24  Score=209.82  Aligned_cols=262  Identities=21%  Similarity=0.249  Sum_probs=201.3

Q ss_pred             CCCCCCeecccCceEEEEEEeCCC--cEEEEEEeecccchhhhhHHHHHHHHhcCCC----CcceeEEeee-ccCCeeeE
Q 040392          174 GFSENNLIGRGGFGSVYKARLGDG--MEVAVKVFNLQCGRALKGFDVECEMMKSIRH----RNLIKVISTC-SNEEFKAL  246 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~nIv~~~~~~-~~~~~~~l  246 (470)
                      +|.+.+.||+|+||.||.|...+.  ..+|+|............+..|+.++..+..    +++..+++.. ....+.++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999986543  5789998765433333367889999999873    6899999998 57788999


Q ss_pred             EEecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-----CCeEEeeeccc
Q 040392          247 VLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN-----MVAHLSDFSIA  320 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~-----~~~kl~Dfg~a  320 (470)
                      ||+.+ |.+|.++..... ..++..+..+++.|++.+|+++|   +.|++||||||.|+.++..     ..+.+.|||++
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99998 679999886555 67999999999999999999999   9999999999999999865     46999999999


Q ss_pred             c--ccCCCCCc----c-c-ccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhh
Q 040392          321 K--LLTGEDQS----M-T-QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDW  392 (470)
Q Consensus       321 ~--~~~~~~~~----~-~-~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  392 (470)
                      +  .+......    . . .....||.+|+++..+.+...+.+.|+||++.++.|++.|..||........ ........
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~~~  253 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEKDP  253 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHHHh
Confidence            8  43222211    1 1 2345699999999999999999999999999999999999999976543221 11110000


Q ss_pred             cCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHH
Q 040392          393 LPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL  455 (470)
Q Consensus       393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~  455 (470)
                      ...    ....           .....+.++.+++..+-..+...+|....+...|++.....
T Consensus       254 ~~~----~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  254 RKL----LTDR-----------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             hhh----cccc-----------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            000    0000           11123566777887788899999999999999988876543

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=1.4e-24  Score=196.94  Aligned_cols=270  Identities=18%  Similarity=0.186  Sum_probs=214.0

Q ss_pred             hCCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccchhhhhHHHHHHHHhcCC-CCcceeEEeeeccCCeeeEEEe
Q 040392          172 TDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIR-HRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      .-.|.+.++||+|+||.++.|+ +-++++||||.-..+  .....+..|.+..+.|. .++|..++.+..++.+..+|+|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            3579999999999999999996 557999999975433  23456778999999885 7999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-----CCCeEEeeeccccccC
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-----NMVAHLSDFSIAKLLT  324 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~-----~~~~kl~Dfg~a~~~~  324 (470)
                      .+ |.+|+|+..=++..++..++..+|.|++.-++|+|   ++.+|.|||||+|+||+.     ...+.|+|||+|+.+.
T Consensus       105 LL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  105 LL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             hh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence            98 67999999888889999999999999999999999   999999999999999974     3468999999999886


Q ss_pred             CCCCc-----ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccc
Q 040392          325 GEDQS-----MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTME  399 (470)
Q Consensus       325 ~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  399 (470)
                      ++.+.     ....+..||.+||+-..+.+.+.+.+.|+-|+|-++++.+.|..||.+......- ..|          +
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK-~kY----------e  249 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK-EKY----------E  249 (449)
T ss_pred             CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH-HHH----------H
Confidence            65432     3345677999999999999999999999999999999999999999975432110 011          0


Q ss_pred             cccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHhhhcc
Q 040392          400 VVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNVG  460 (470)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~~~~~  460 (470)
                      -+............  -+.+|.++..-+.-.-..+=++-|..+-+...+..+.++...+.+
T Consensus       250 KIGe~Kr~T~i~~L--c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~D  308 (449)
T KOG1165|consen  250 KIGETKRSTPIEVL--CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDD  308 (449)
T ss_pred             HhccccccCCHHHH--HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccc
Confidence            01100011111111  123577888888888888888889999888888888877666553

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=9.3e-25  Score=211.01  Aligned_cols=165  Identities=22%  Similarity=0.207  Sum_probs=129.2

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC--CCcEEEEEEeecc-----cchhhhhHHHHHHHHhcCCCCccee-EEeeeccCC
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQ-----CGRALKGFDVECEMMKSIRHRNLIK-VISTCSNEE  242 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~-~~~~~~~~~  242 (470)
                      ..++|.+.+.||+|+||+||+|++.  +++.+|||+....     .......+.+|+++++.++|+|+++ ++++    +
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~   91 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G   91 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence            4678999999999999999999764  5777899986533     1223456889999999999999985 4432    3


Q ss_pred             eeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC-CCCCeeeCCCCCeEEeeecccc
Q 040392          243 FKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL-KPSNVLLDDNMVAHLSDFSIAK  321 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dl-kp~Nill~~~~~~kl~Dfg~a~  321 (470)
                      ..++||||++|++|... ...    .   ...++.+++++|.|||   +.+|+|||| ||+|||++.++.+||+|||+|+
T Consensus        92 ~~~LVmE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~  160 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS  160 (365)
T ss_pred             CcEEEEEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence            57899999999999632 111    1   1467899999999999   999999999 9999999999999999999999


Q ss_pred             ccCCCCCccc------ccccccCccccCccccCCC
Q 040392          322 LLTGEDQSMT------QTQTLATIGYMAPEYGREG  350 (470)
Q Consensus       322 ~~~~~~~~~~------~~~~~~t~~y~aPE~~~~~  350 (470)
                      .+........      -....+++.|+|||++...
T Consensus       161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            7754332111      1345678889999988644

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=3.3e-24  Score=186.36  Aligned_cols=264  Identities=18%  Similarity=0.173  Sum_probs=202.8

Q ss_pred             hhCCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCC-CcceeEEeeeccCCeeeEEE
Q 040392          171 ATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRH-RNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ...+|..+++||.|+||.+|.|. ..+|.+||||+-.....  ...+.-|.++.+.|++ ..|..+..|..+..+..+||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            35689999999999999999995 67899999998764432  2446679999999975 67777788888999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCCeEEeeeccccccCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~a~~~~~  325 (470)
                      |.+ |.+|++++.-+...++..+++-++.|++.-++|+|   .++++||||||+|+|++-   ...+.++|||+|+.+.+
T Consensus        91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            998 67999999888888999999999999999999999   999999999999999963   45789999999998754


Q ss_pred             CCCc-----ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccc
Q 040392          326 EDQS-----MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEV  400 (470)
Q Consensus       326 ~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (470)
                      ....     .......||.+|.+-..+.+...+.+.|+-|+|.+|...-.|..||.+........ .+ ......+    
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q-Ky-EkI~EkK----  240 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ-KY-EKISEKK----  240 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH-HH-HHHHHhh----
Confidence            3322     33345679999999888888888999999999999999999999999754321110 00 0000001    


Q ss_pred             ccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          401 VGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                           .+.....  -=..+|.++.-.+.-|-..-=++-|...-+.+.++-+..
T Consensus       241 -----~s~~ie~--LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr  286 (341)
T KOG1163|consen  241 -----MSTPIEV--LCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR  286 (341)
T ss_pred             -----cCCCHHH--HhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence                 0000000  012337778888888888888888988877666655543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=6.7e-24  Score=218.31  Aligned_cols=253  Identities=20%  Similarity=0.227  Sum_probs=186.4

Q ss_pred             CCCeecccCceEEEEEEe-CCCcEEEEEEee-----cccchh-hhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          177 ENNLIGRGGFGSVYKARL-GDGMEVAVKVFN-----LQCGRA-LKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       177 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~-----~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      ....+|.|++|.|+.+.. ......+.|.+.     ...... ...+..|+-+-..+.|+|++..+..+.+.....-.||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            457899999997777753 334444444432     111111 1225567778888999999888777766655555699


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      ||++ +|..++... ..++...+-.++.|++.|+.|+|   ..|+.|||+|++|++++.+|.+||+|||.+....-....
T Consensus       402 ~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~  476 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK  476 (601)
T ss_pred             cccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence            9999 999998655 35778888889999999999999   999999999999999999999999999998766444333


Q ss_pred             --ccccccccCccccCccccCCCCCCCc-cchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccccc
Q 040392          330 --MTQTQTLATIGYMAPEYGREGRVSTN-GDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL  406 (470)
Q Consensus       330 --~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (470)
                        ......+|+..|+|||.+.+..|++. .||||.|+++..|++|+.||.........+..          ....+.  .
T Consensus       477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~----------~~~~~~--~  544 (601)
T KOG0590|consen  477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT----------NNYSDQ--R  544 (601)
T ss_pred             hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh----------hccccc--c
Confidence              45566789999999999999998865 89999999999999999999865443322100          000000  0


Q ss_pred             CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHH
Q 040392          407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVA  446 (470)
Q Consensus       407 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~  446 (470)
                      .............+.+...++.++|++||.+|.++.+|++
T Consensus       545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            0111111122344667789999999999999999999976

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.89  E-value=7e-22  Score=191.47  Aligned_cols=258  Identities=31%  Similarity=0.418  Sum_probs=198.1

Q ss_pred             CCCCCeecccCceEEEEEEeCCCcEEEEEEeecccch---hhhhHHHHHHHHhcCCCC-cceeEEeeeccCCeeeEEEec
Q 040392          175 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGR---ALKGFDVECEMMKSIRHR-NLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      |...+.||.|+||.||++...  ..+++|.+......   ....+.+|+.+++.+.|+ +|+++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            567788999999999999876  88999998655322   467788999999999988 799999999777778999999


Q ss_pred             CCCCChHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-CeEEeeeccccccCCCC
Q 040392          251 MPHGSLEKYMYSSN--YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-VAHLSDFSIAKLLTGED  327 (470)
Q Consensus       251 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~  327 (470)
                      +.++++.+++....  ..++......++.|++.++.|+|   ..+++|||+||+||+++..+ .++++|||.+.......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999997776544  26889999999999999999999   89999999999999999988 79999999998654433


Q ss_pred             Ccc----cccccccCccccCccccCC---CCCCCccchhhHHHHHHHHHhCCCCCCccccC--cchhhHHhhhhcCCccc
Q 040392          328 QSM----TQTQTLATIGYMAPEYGRE---GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNG--EMTLKHWVNDWLPISTM  398 (470)
Q Consensus       328 ~~~----~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~  398 (470)
                      ...    ......++..|+|||.+.+   ..+....|+|++|++++++++|..||......  .......+.........
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA  236 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence            221    3456789999999999987   57889999999999999999999996654321  11111111111110000


Q ss_pred             ccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          399 EVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ..    ......      ......+.+++..|+..+|..|.++.+....
T Consensus       237 ~~----~~~~~~------~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         237 SP----LSPSNP------ELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cc----cCcccc------chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            00    000000      1123467899999999999999999988776

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.87  E-value=1.3e-22  Score=182.49  Aligned_cols=174  Identities=13%  Similarity=0.120  Sum_probs=134.1

Q ss_pred             HHhhCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhh---h------HHHHHHHHhcCCCCcceeEEeeec
Q 040392          169 CRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALK---G------FDVECEMMKSIRHRNLIKVISTCS  239 (470)
Q Consensus       169 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~h~nIv~~~~~~~  239 (470)
                      ....++|...+.+|.|+||.||.+.. ++..+|+|++.........   .      +.+|++.+.++.|++|..+..++.
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            34568899999999999999999866 5778999999755332222   2      578999999999999999988865


Q ss_pred             cC--------CeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC
Q 040392          240 NE--------EFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV  311 (470)
Q Consensus       240 ~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~  311 (470)
                      ..        ...+++|||++|.+|.++..     .+.    ....+++.++..+|   ..+++|||++|+||+++.++ 
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-
Confidence            33        35789999999999988742     222    34669999999999   99999999999999999988 


Q ss_pred             eEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh
Q 040392          312 AHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT  370 (470)
Q Consensus       312 ~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t  370 (470)
                      ++++|||....... ....             ..+.....+..++|+|+||+++.....
T Consensus       173 i~liDfg~~~~~~e-~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        173 LRIIDLSGKRCTAQ-RKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             EEEEECCCcccccc-hhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence            99999998764421 1110             012334456679999999999876543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.87  E-value=8.9e-22  Score=175.10  Aligned_cols=139  Identities=18%  Similarity=0.187  Sum_probs=108.0

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEEeecccch--h-------hhh-----------------HHHHHHHHhcCCCCcc
Q 040392          178 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGR--A-------LKG-----------------FDVECEMMKSIRHRNL  231 (470)
Q Consensus       178 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~h~nI  231 (470)
                      ...||+|++|.||+|...+|+.||||+++.....  .       ...                 ...|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4689999999999998878999999998754211  1       111                 2349999999987776


Q ss_pred             eeEEeeeccCCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeeecCCCCCCeeeCCCC
Q 040392          232 IKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL-HFGYSAPIIHCDLKPSNVLLDDNM  310 (470)
Q Consensus       232 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~L-H~~~~~~i~H~dlkp~Nill~~~~  310 (470)
                      .....+..  ...++||||++++++...... ...++......++.|++.+|.|+ |   ..+|+||||||+||+++ ++
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~  154 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DG  154 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CC
Confidence            43332221  223799999998877655332 23578889999999999999999 7   88999999999999998 47


Q ss_pred             CeEEeeecccccc
Q 040392          311 VAHLSDFSIAKLL  323 (470)
Q Consensus       311 ~~kl~Dfg~a~~~  323 (470)
                      .++|+|||+|...
T Consensus       155 ~v~LiDFG~a~~~  167 (190)
T cd05147         155 KLYIIDVSQSVEH  167 (190)
T ss_pred             cEEEEEccccccC
Confidence            8999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.87  E-value=8e-22  Score=193.94  Aligned_cols=216  Identities=28%  Similarity=0.397  Sum_probs=167.0

Q ss_pred             HhcCCCCcceeEEeeeccCCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe-eecCCCC
Q 040392          223 MKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI-IHCDLKP  301 (470)
Q Consensus       223 l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i-~H~dlkp  301 (470)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+....-.+++.....+.++++.||+|+|   ..+| .|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeecc
Confidence            45789999999999999999999999999999999999887778999999999999999999999   4444 9999999


Q ss_pred             CCeeeCCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCC-------CCCccchhhHHHHHHHHHhCCCC
Q 040392          302 SNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGR-------VSTNGDVYSFGIMLMETFTGKKP  374 (470)
Q Consensus       302 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-------~~~~~DvwslGv~l~el~tg~~p  374 (470)
                      .|.+++..+.+|++|||+.................-...|.|||.+....       .+.+.|+||||++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            99999999999999999987664311112222233456799999987642       46679999999999999999999


Q ss_pred             CCccccCcc--hhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHH
Q 040392          375 TNEIFNGEM--TLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR  452 (470)
Q Consensus       375 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~  452 (470)
                      |+.....+.  .+..++....    ...+.+.+...        .+.+.++..++..||..+|++||++.++-..++.+.
T Consensus       158 ~~~~~~~~~~~eii~~~~~~~----~~~~rP~i~~~--------~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~  225 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKKGG----SNPFRPSIELL--------NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN  225 (484)
T ss_pred             cccccccCChHHHHHHHHhcC----CCCcCcchhhh--------hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence            987544332  2222222200    11111111111        033457899999999999999999999999998876


Q ss_pred             H
Q 040392          453 D  453 (470)
Q Consensus       453 ~  453 (470)
                      .
T Consensus       226 ~  226 (484)
T KOG1023|consen  226 K  226 (484)
T ss_pred             c
Confidence            4

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.85  E-value=8.6e-21  Score=169.41  Aligned_cols=139  Identities=23%  Similarity=0.243  Sum_probs=110.0

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEEeecccchh--------------------------hhhHHHHHHHHhcCCCCcc
Q 040392          178 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRA--------------------------LKGFDVECEMMKSIRHRNL  231 (470)
Q Consensus       178 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~nI  231 (470)
                      ...||+|++|.||+|...+|+.||||+++......                          ......|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            57899999999999987789999999987542110                          1123568899999999987


Q ss_pred             eeEEeeeccCCeeeEEEecCCCCChHHh-hhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCCeeeCCC
Q 040392          232 IKVISTCSNEEFKALVLEYMPHGSLEKY-MYSSNYILDIFQRLNIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDN  309 (470)
Q Consensus       232 v~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~i~H~dlkp~Nill~~~  309 (470)
                      .....+...  ..++||||++++++... +..  ..++......++.|++.++.++|   . .+|+||||||+||+++ +
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~  153 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-C
Confidence            544433322  24799999998865433 332  34678888999999999999999   7 9999999999999999 8


Q ss_pred             CCeEEeeeccccccC
Q 040392          310 MVAHLSDFSIAKLLT  324 (470)
Q Consensus       310 ~~~kl~Dfg~a~~~~  324 (470)
                      +.++|+|||++....
T Consensus       154 ~~~~liDFG~a~~~~  168 (190)
T cd05145         154 GKPYIIDVSQAVELD  168 (190)
T ss_pred             CCEEEEEcccceecC
Confidence            999999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.84  E-value=5.7e-22  Score=204.34  Aligned_cols=248  Identities=22%  Similarity=0.262  Sum_probs=181.1

Q ss_pred             CCCCCCeecccCceEEEEEEeCCCcEEEEEEeeccc-chhhhhHH---HHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          174 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC-GRALKGFD---VECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~---~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      ++...+.||++.|=.|.+|++..|. |+||++-++. .-....+.   .|++ ...++|||++++.-+-......|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5777889999999999999998777 9999986554 22333333   3444 555689999999888777778889999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecccccc-CCCCC
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-TGEDQ  328 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~-~~~~~  328 (470)
                      |+.. +|.|.+..+ ..+...+...|+.|++.||..+|   ..+|+|||||.+|||++.=+.+.|+||..=+.. -+++.
T Consensus       102 yvkh-nLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             HHhh-hhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            9976 999999544 46778888899999999999999   999999999999999999999999999754321 11121


Q ss_pred             cccc----cccccCccccCccccCCC-----------CCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhh
Q 040392          329 SMTQ----TQTLATIGYMAPEYGREG-----------RVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDW  392 (470)
Q Consensus       329 ~~~~----~~~~~t~~y~aPE~~~~~-----------~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~  392 (470)
                      ....    .....-..|.|||.+...           ..+++-||||+||++.||++ |++||.-.     ++..|....
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr~~~  251 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYRSGN  251 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHhccC
Confidence            1111    122234469999976541           15678899999999999999 88888641     222222211


Q ss_pred             --cCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHH
Q 040392          393 --LPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK  450 (470)
Q Consensus       393 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~  450 (470)
                        .+....+.              .+   ...+..++..|++.||.+|.+|++.++.-+.
T Consensus       252 ~~~~e~~Le~--------------Ie---d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  252 ADDPEQLLEK--------------IE---DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             ccCHHHHHHh--------------Cc---CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence              00000000              00   2247789999999999999999999998443

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=4.5e-20  Score=162.42  Aligned_cols=186  Identities=15%  Similarity=0.102  Sum_probs=137.7

Q ss_pred             CCCCeecccCceEEEEEEeCCCcEEEEEEeecccch----hhhhHHHHHHHHhcCC-CCcceeEEeeeccCCeeeEEEec
Q 040392          176 SENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGR----ALKGFDVECEMMKSIR-HRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       176 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      .....|++|+||+||.+.. .+.+++.+.+......    ....+.+|+++|++|. |+++++++++    ...+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            4567899999999998866 6888888877543221    1225788999999995 5889999886    346899999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC-CCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL-KPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dl-kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      +.|.+|.+....        ....++.|++++|.++|   ..||+|||| ||+||+++.++.++|+|||+|.........
T Consensus        80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             ecCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            999998654421        12357889999999999   999999999 799999999999999999999855432211


Q ss_pred             ----cc-------ccccccCccccCccccCCC-CCC-CccchhhHHHHHHHHHhCCCCCCc
Q 040392          330 ----MT-------QTQTLATIGYMAPEYGREG-RVS-TNGDVYSFGIMLMETFTGKKPTNE  377 (470)
Q Consensus       330 ----~~-------~~~~~~t~~y~aPE~~~~~-~~~-~~~DvwslGv~l~el~tg~~p~~~  377 (470)
                          ..       ......++.|++|+...-. ..+ ...+.++-|.-+|.++|++.+.-+
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence                00       1122356677777643221 222 467888999999999999988543

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=1.8e-20  Score=174.17  Aligned_cols=195  Identities=19%  Similarity=0.294  Sum_probs=142.1

Q ss_pred             CCCcceeEEeeecc---------------------------CCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHH
Q 040392          227 RHRNLIKVISTCSN---------------------------EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV  279 (470)
Q Consensus       227 ~h~nIv~~~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i  279 (470)
                      +|||||++.++|.+                           ....|+||...+. +|.+++....  .+.....-++.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence            59999999887633                           2366789988865 9999996554  4666777799999


Q ss_pred             HHHHHHHhcCCCCCeeecCCCCCCeee--CCCC--CeEEeeeccccccCCCC----CcccccccccCccccCccccCCCC
Q 040392          280 ASALEYLHFGYSAPIIHCDLKPSNVLL--DDNM--VAHLSDFSIAKLLTGED----QSMTQTQTLATIGYMAPEYGREGR  351 (470)
Q Consensus       280 ~~~L~~LH~~~~~~i~H~dlkp~Nill--~~~~--~~kl~Dfg~a~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~  351 (470)
                      ++|+.|||   .+|+.|||+|.+|||+  |+|+  .+.++|||.+-.-....    .........|...-||||+.....
T Consensus       351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            99999999   9999999999999998  3333  57889999864322111    111122345777889999876432


Q ss_pred             ------CCCccchhhHHHHHHHHHhCCCCCCccccCcch--hhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHH
Q 040392          352 ------VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMT--LKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCV  423 (470)
Q Consensus       352 ------~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  423 (470)
                            .-.|+|.|+.|.+.||+++...||..  .++..  .+.|-+..+                   ...++.++..+
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~--rGem~L~~r~Yqe~qL-------------------Palp~~vpp~~  486 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYK--RGEMLLDTRTYQESQL-------------------PALPSRVPPVA  486 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccc--cchheechhhhhhhhC-------------------CCCcccCChHH
Confidence                  23589999999999999999999986  33322  222222111                   12345668889


Q ss_pred             HHHHhhccCCCccCCCCHHHHHHHH
Q 040392          424 FNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       424 ~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                      .+++...|+.||.+|+++.-....|
T Consensus       487 rqlV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  487 RQLVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHHHHHHhcCCccccCCccHHHhHH
Confidence            9999999999999999987655554

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.83  E-value=4.5e-20  Score=171.03  Aligned_cols=230  Identities=22%  Similarity=0.302  Sum_probs=144.6

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCC----------CcceeEEeee--
Q 040392          175 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRH----------RNLIKVISTC--  238 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~nIv~~~~~~--  238 (470)
                      +...+.||.|+++.||.+++. +|+++|+|++....   ....+.+.+|.-....+.+          -.++..++..  
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            345678999999999999875 58999999985442   3345556666554444322          1121111111  


Q ss_pred             -------ccC---C-----eeeEEEecCCCCChHHhhhc---CC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 040392          239 -------SNE---E-----FKALVLEYMPHGSLEKYMYS---SN---YILDIFQRLNIMIDVASALEYLHFGYSAPIIHC  297 (470)
Q Consensus       239 -------~~~---~-----~~~lv~e~~~~g~L~~~l~~---~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~  297 (470)
                             ...   .     ..+++|+-+. ++|.+++..   ..   ..+....+..+..|+++.+++||   ..|++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEec
Confidence                   111   1     2357788774 588887642   22   12334556778899999999999   9999999


Q ss_pred             CCCCCCeeeCCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCC--------CCCCCccchhhHHHHHHHHH
Q 040392          298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE--------GRVSTNGDVYSFGIMLMETF  369 (470)
Q Consensus       298 dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DvwslGv~l~el~  369 (470)
                      ||+|+|++++.+|.++|+||+.......   ... . ...+..|.+||....        -.++.+.|.|++|+++|.|.
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~---~~~-~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGT---RYR-C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTE---EEE-G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCc---eee-c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            9999999999999999999988765321   111 1 335577999996643        24788999999999999999


Q ss_pred             hCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCC
Q 040392          370 TGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQR  438 (470)
Q Consensus       370 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R  438 (470)
                      +|+.||+........  .|           .+. .+           .+.+..+..|+..+|+.||++|
T Consensus       245 C~~lPf~~~~~~~~~--~~-----------~f~-~C-----------~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADP--EW-----------DFS-RC-----------RDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTS--GG-----------GGT-TS-----------S---HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccc--cc-----------cch-hc-----------CCcCHHHHHHHHHHccCCcccC
Confidence            999999864322111  00           000 00           0236778999999999999998

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=5.6e-20  Score=193.13  Aligned_cols=251  Identities=22%  Similarity=0.238  Sum_probs=184.8

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCC---CCcceeEEeeeccCCeeeEE
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIR---HRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~~lv  247 (470)
                      ..+.|.+.+.||+|+||.||+|...+|+.||+|+-++.+..   .|..-.+++.+|+   -+.|..+...+.-.+..++|
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv  772 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV  772 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence            34567788899999999999999888999999998765443   2334456666666   23344555555556677899


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-------CCCCeEEeeeccc
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-------DNMVAHLSDFSIA  320 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~-------~~~~~kl~Dfg~a  320 (470)
                      +||.+.|+|.+++. ....+++..+..++.|+++.++.||   ..+||||||||+|.+|.       ...-++|+|||.+
T Consensus       773 ~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s  848 (974)
T KOG1166|consen  773 SEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS  848 (974)
T ss_pred             eeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence            99999999999997 4457899999999999999999999   99999999999999994       3456899999999


Q ss_pred             cccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccc
Q 040392          321 KLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEV  400 (470)
Q Consensus       321 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (470)
                      ..+.--.....-...+.|-.+-.+|+..+..+++.+|.|+++-+++-|+.|++-=  ..++.    .           ..
T Consensus       849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--~~~g~----~-----------~~  911 (974)
T KOG1166|consen  849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--VKNGS----S-----------WM  911 (974)
T ss_pred             eeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--hcCCc----c-----------ee
Confidence            8765433334445667899999999999999999999999999999999998531  11110    0           00


Q ss_pred             ccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          401 VGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                      ++..+     .+.+..    .-..+++..+|+.|=..=|...++...|+++...
T Consensus       912 ~~~~~-----~Ry~~~----~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~  956 (974)
T KOG1166|consen  912 VKTNF-----PRYWKR----DMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE  956 (974)
T ss_pred             ccccc-----hhhhhH----HHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence            11110     011111    1134666777776666667778888888777543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.81  E-value=4.1e-21  Score=188.91  Aligned_cols=224  Identities=25%  Similarity=0.294  Sum_probs=179.5

Q ss_pred             ecccCceEEEEEE----eCCCcEEEEEEeecccc--hhhhhHHHHHHHHhcCC-CCcceeEEeeeccCCeeeEEEecCCC
Q 040392          181 IGRGGFGSVYKAR----LGDGMEVAVKVFNLQCG--RALKGFDVECEMMKSIR-HRNLIKVISTCSNEEFKALVLEYMPH  253 (470)
Q Consensus       181 ig~G~~g~Vy~~~----~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e~~~~  253 (470)
                      +|+|+||.|+.++    ...|..+|.|+.++...  ........|..++..++ ||.+++++..+..+...+++++|..+
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            7899999999874    23477899998865532  12224556888899887 99999999999999999999999999


Q ss_pred             CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccccc
Q 040392          254 GSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT  333 (470)
Q Consensus       254 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  333 (470)
                      |.|...+.+.. .++......+...++-+++++|   +.+++|+|+|++||+++.+|++++.|||+++.......     
T Consensus        82 g~lft~l~~~~-~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-----  152 (612)
T KOG0603|consen   82 GDLFTRLSKEV-MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-----  152 (612)
T ss_pred             chhhhccccCC-chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh-----
Confidence            99988886555 4566667778889999999999   99999999999999999999999999999986643322     


Q ss_pred             ccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhh
Q 040392          334 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF  413 (470)
Q Consensus       334 ~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  413 (470)
                       .+||..|||||++.  ....++|-||||++++||+||..||..     ..+...                    .....
T Consensus       153 -~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~I--------------------l~~~~  204 (612)
T KOG0603|consen  153 -ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRI--------------------LKAEL  204 (612)
T ss_pred             -cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHH--------------------hhhcc
Confidence             28999999999988  567789999999999999999999876     111110                    01122


Q ss_pred             HhhhhhHHHHHHHHhhccCCCccCCCCH
Q 040392          414 VAKEQCVSCVFNLAMECTVESPEQRINA  441 (470)
Q Consensus       414 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~  441 (470)
                      ..+......+.+++..++..+|..|...
T Consensus       205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  205 EMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            3345557778899999999999999866

>PRK10345 hypothetical protein; Provisional

Probab=99.81  E-value=4.5e-19  Score=159.16  Aligned_cols=136  Identities=15%  Similarity=0.257  Sum_probs=106.2

Q ss_pred             CCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcC-----CCCcceeEEeeeccCC---eee-E
Q 040392          176 SENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSI-----RHRNLIKVISTCSNEE---FKA-L  246 (470)
Q Consensus       176 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~~~~~~~~~~---~~~-l  246 (470)
                      ...+.||+|+||.||.  +++....+||+.........+.+.+|+++++.+     .||||++++++++++.   ..+ +
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            4457899999999996  433333479988765444566789999999999     5799999999998763   323 7


Q ss_pred             EEec--CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCeeecCCCCCCeeeCC----CCCeEEeeecc
Q 040392          247 VLEY--MPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL-EYLHFGYSAPIIHCDLKPSNVLLDD----NMVAHLSDFSI  319 (470)
Q Consensus       247 v~e~--~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L-~~LH~~~~~~i~H~dlkp~Nill~~----~~~~kl~Dfg~  319 (470)
                      |+||  +++|+|.+++.+..  +++.  ..++.+++.++ +|||   +.+|+||||||+||+++.    ++.++|+||+-
T Consensus        83 I~e~~G~~~~tL~~~l~~~~--~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQCR--YEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EecCCCCcchhHHHHHHccc--ccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            8999  55799999996643  4444  35677888777 9999   999999999999999974    34899999544


Q ss_pred             c
Q 040392          320 A  320 (470)
Q Consensus       320 a  320 (470)
                      +
T Consensus       156 ~  156 (210)
T PRK10345        156 E  156 (210)
T ss_pred             C
Confidence            3

>smart00090 RIO RIO-like kinase

Probab=99.77  E-value=2.1e-18  Score=158.69  Aligned_cols=141  Identities=20%  Similarity=0.184  Sum_probs=110.8

Q ss_pred             CCCCCCeecccCceEEEEEE--eCCCcEEEEEEeecccch------------------------hhhhHHHHHHHHhcCC
Q 040392          174 GFSENNLIGRGGFGSVYKAR--LGDGMEVAVKVFNLQCGR------------------------ALKGFDVECEMMKSIR  227 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  227 (470)
                      -|.+.+.||+|++|.||+|.  ..+|+.||+|+++.....                        ....+..|++.+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47888999999999999998  568999999998743210                        0123467999999997


Q ss_pred             CC--cceeEEeeeccCCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eeecCCCCCCe
Q 040392          228 HR--NLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP-IIHCDLKPSNV  304 (470)
Q Consensus       228 h~--nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-i~H~dlkp~Ni  304 (470)
                      +.  .+.+++++    ...++||||+++++|....... ..........++.|++.++++||   ..+ ++|+||||+||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NI  180 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNI  180 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhE
Confidence            53  34455543    2347999999998887665332 24556667889999999999999   899 99999999999


Q ss_pred             eeCCCCCeEEeeecccccc
Q 040392          305 LLDDNMVAHLSDFSIAKLL  323 (470)
Q Consensus       305 ll~~~~~~kl~Dfg~a~~~  323 (470)
                      +++ ++.++|+|||.+...
T Consensus       181 li~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      181 LVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EEE-CCCEEEEEChhhhcc
Confidence            999 889999999998754

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=3.3e-18  Score=155.65  Aligned_cols=134  Identities=25%  Similarity=0.331  Sum_probs=112.5

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEEeecccch--------hhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          179 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGR--------ALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      +.||+|++|.||+|.. .|..+++|........        ....+..|++++..+.|+++.....++......+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 6788999986533211        123567799999999999987777776666778899999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL  322 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~  322 (470)
                      ++|++|.+++....    . .+..++.+++.+|.++|   +.+++|+|++|.||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999986432    2 77889999999999999   99999999999999999 78999999998763

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.76  E-value=9e-18  Score=151.14  Aligned_cols=138  Identities=24%  Similarity=0.192  Sum_probs=109.2

Q ss_pred             CCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccch----------------------hhhhHHHHHHHHhcCCCC-
Q 040392          173 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGR----------------------ALKGFDVECEMMKSIRHR-  229 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~h~-  229 (470)
                      ..|.+.+.||+|+||.||++...+|+.||||++......                      .......|..++..+.|+ 
T Consensus        15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            347788999999999999998888999999987643210                      111256688888888777 


Q ss_pred             -cceeEEeeeccCCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC
Q 040392          230 -NLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD  308 (470)
Q Consensus       230 -nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~  308 (470)
                       .+...++.    ...++||||+++++|......       .....++.+++.++.++|   ..+++|+||+|+||++++
T Consensus        95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~  160 (198)
T cd05144          95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDD  160 (198)
T ss_pred             CCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcC
Confidence             44455443    345899999999999766431       234678899999999999   899999999999999999


Q ss_pred             CCCeEEeeeccccccC
Q 040392          309 NMVAHLSDFSIAKLLT  324 (470)
Q Consensus       309 ~~~~kl~Dfg~a~~~~  324 (470)
                      ++.++|+|||.+....
T Consensus       161 ~~~~~liDfg~~~~~~  176 (198)
T cd05144         161 DEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CCcEEEEECCccccCC
Confidence            9999999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.76  E-value=2.3e-19  Score=173.36  Aligned_cols=241  Identities=22%  Similarity=0.277  Sum_probs=157.1

Q ss_pred             CCCCCeecccCceEEEEEEeCC----CcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEe-------ee-----
Q 040392          175 FSENNLIGRGGFGSVYKARLGD----GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIS-------TC-----  238 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~-------~~-----  238 (470)
                      ..+.+..+..+++.++..+...    ...++.+..+............++-.+....|.+..-+.+       .+     
T Consensus       246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v  325 (516)
T KOG1033|consen  246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKV  325 (516)
T ss_pred             ccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccc
Confidence            4444556666666666654322    2334444443332122222333444444444433322222       11     


Q ss_pred             ccCCeeeEEEecCCCCChHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEee
Q 040392          239 SNEEFKALVLEYMPHGSLEKYMYSSN--YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSD  316 (470)
Q Consensus       239 ~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~D  316 (470)
                      ....+.|+.|++|...+|.+|+...+  ...++...+.++.|++.|+.|      ++.+|+|+||.||+...+..+||+|
T Consensus       326 ~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgD  399 (516)
T KOG1033|consen  326 GKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGD  399 (516)
T ss_pred             ccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhh
Confidence            11235789999999999999996433  567788889999999999998      6889999999999999999999999


Q ss_pred             eccccccCCCC----CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhh
Q 040392          317 FSIAKLLTGED----QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVND  391 (470)
Q Consensus       317 fg~a~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~  391 (470)
                      ||+........    .....+...||..||+||.+.+..|+.++||||||++|+|+++ -..+++    ....+.+....
T Consensus       400 Fgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----r~~t~~d~r~g  475 (516)
T KOG1033|consen  400 FGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----RIATLTDIRDG  475 (516)
T ss_pred             hhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----HHHhhhhhhcC
Confidence            99988765433    2344566789999999999999999999999999999999998 222222    11111111111


Q ss_pred             hcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHH
Q 040392          392 WLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREI  444 (470)
Q Consensus       392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el  444 (470)
                      ..|..        ..          .+ .++-..|+.+++.+.|.+||++.+.
T Consensus       476 ~ip~~--------~~----------~d-~p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  476 IIPPE--------FL----------QD-YPEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             CCChH--------Hh----------hc-CcHHHHHHHHhcCCCcccCchHHHH
Confidence            11100        00          00 1123579999999999999954443

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.74  E-value=2.7e-17  Score=170.15  Aligned_cols=137  Identities=20%  Similarity=0.258  Sum_probs=111.1

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeeccc--c------hhhhhHHHHHHHHhcCCCCcceeEEeeeccCCe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--G------RALKGFDVECEMMKSIRHRNLIKVISTCSNEEF  243 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  243 (470)
                      ...|...+.||+|+||.||+|.+.+. .+++|+.....  .      .....+..|+++++.++|++++....++.....
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            34456788999999999999987544 44444432111  1      123457789999999999999888777777677


Q ss_pred             eeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccc
Q 040392          244 KALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL  322 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~  322 (470)
                      .++||||+++++|.+++.         ....++.+++++|.+||   +.+++|||+||+||++ .++.++|+|||+++.
T Consensus       411 ~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             CEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            789999999999998884         35678999999999999   9999999999999999 678999999999874

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.74  E-value=1.1e-17  Score=150.66  Aligned_cols=130  Identities=21%  Similarity=0.313  Sum_probs=105.3

Q ss_pred             eecccCceEEEEEEeCCCcEEEEEEeecccc--------hhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          180 LIGRGGFGSVYKARLGDGMEVAVKVFNLQCG--------RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       180 ~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      .||+|++|.||+|.+ +|..+++|.......        .....+..|++++..++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999986 578899998653211        11355678999999999887655444444555678999999


Q ss_pred             CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccc
Q 040392          252 PHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL  322 (470)
Q Consensus       252 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~  322 (470)
                      +|++|.+++.....        .++.+++.+|.+||   +.+++|+|++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999988754321        78999999999999   99999999999999999 89999999998864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.68  E-value=2.1e-17  Score=170.90  Aligned_cols=213  Identities=24%  Similarity=0.304  Sum_probs=146.4

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeCC-CcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      ..++|+.+++|..|+||.||.++++. .+++|.|+=+ +.  .+  .++   ++.....|.+|                 
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~--li--lRn---ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN--LI--LRN---ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhcccc-cc--hh--hhc---cccccCCccee-----------------
Confidence            34689999999999999999998764 6778884322 11  00  000   22222233222                 


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC--
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED--  327 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~--  327 (470)
                          |+-...++..+ .++.        +++.+++|+|   +.+|+|||+||+|.+++.-|++|++|||+++......  
T Consensus       136 ----gDc~tllk~~g-~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 ----GDCATLLKNIG-PLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             ----chhhhhcccCC-CCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence                34444443322 2222        2277899999   9999999999999999999999999999876421110  


Q ss_pred             -----------CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc
Q 040392          328 -----------QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS  396 (470)
Q Consensus       328 -----------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  396 (470)
                                 ........+||+.|.|||++....|...+|.|++|+++||.+-|+.||... ..|+-+...+.+.... 
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd-tpeelfg~visd~i~w-  277 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD-TPEELFGQVISDDIEW-  277 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC-CHHHHHhhhhhhhccc-
Confidence                       011223468999999999999999999999999999999999999999873 2333333333322111 


Q ss_pred             ccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHH
Q 040392          397 TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAR  442 (470)
Q Consensus       397 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~  442 (470)
                                      ....+..+.++.+++...|+.+|..|.-..
T Consensus       278 ----------------pE~dea~p~Ea~dli~~LL~qnp~~Rlgt~  307 (1205)
T KOG0606|consen  278 ----------------PEEDEALPPEAQDLIEQLLRQNPLCRLGTG  307 (1205)
T ss_pred             ----------------cccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence                            111233467789999999999999998443

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.68  E-value=3.3e-16  Score=139.61  Aligned_cols=136  Identities=24%  Similarity=0.261  Sum_probs=97.6

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEEeecccch--hhhh----------------------HHHHHHHHhcCCCC--cc
Q 040392          178 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGR--ALKG----------------------FDVECEMMKSIRHR--NL  231 (470)
Q Consensus       178 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~--nI  231 (470)
                      .+.||+|+||.||+|...+++.||||++......  ....                      ...|.+.+..+.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4689999999999998878999999998653211  1111                      12455555555433  24


Q ss_pred             eeEEeeeccCCeeeEEEecCCCCChHH-hhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCCeeeCCC
Q 040392          232 IKVISTCSNEEFKALVLEYMPHGSLEK-YMYSSNYILDIFQRLNIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDN  309 (470)
Q Consensus       232 v~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~i~H~dlkp~Nill~~~  309 (470)
                      .+.+++    ...++||||++++++.. .+....  .. .....++.+++.++.++|   . .+++|+||||+||+++ +
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-D  150 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-C
Confidence            444443    23589999999954321 111111  11 566789999999999999   7 9999999999999999 9


Q ss_pred             CCeEEeeeccccccC
Q 040392          310 MVAHLSDFSIAKLLT  324 (470)
Q Consensus       310 ~~~kl~Dfg~a~~~~  324 (470)
                      +.++++|||.+....
T Consensus       151 ~~~~liDfg~a~~~~  165 (187)
T cd05119         151 GKVYIIDVPQAVEID  165 (187)
T ss_pred             CcEEEEECccccccc
Confidence            999999999997553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.67  E-value=6.4e-16  Score=132.32  Aligned_cols=135  Identities=20%  Similarity=0.259  Sum_probs=113.3

Q ss_pred             CCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCC--CcceeEEeeeccCCeeeEEEecCCCC
Q 040392          177 ENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRH--RNLIKVISTCSNEEFKALVLEYMPHG  254 (470)
Q Consensus       177 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~~~~~lv~e~~~~g  254 (470)
                      +.+.||+|.++.||++...+ ..+++|.......  ...+..|+.+++.++|  .++++++++....+..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            45789999999999998854 7899999865433  4568889999999976  58999999888878899999999987


Q ss_pred             ChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccc
Q 040392          255 SLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL  322 (470)
Q Consensus       255 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~  322 (470)
                      .+..+        +......++.++++++.++|.....+++|+|++|+||+++.++.++++|||.+..
T Consensus        79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77544        4556678899999999999943335799999999999999999999999998863

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.65  E-value=2.5e-17  Score=169.82  Aligned_cols=257  Identities=22%  Similarity=0.277  Sum_probs=196.2

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCC--CcEEEEEEeeccc--chhhhhHHHHHHHHhcCC-CCcceeEEeeeccCCeeeE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGD--GMEVAVKVFNLQC--GRALKGFDVECEMMKSIR-HRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~l  246 (470)
                      ...|...+.||+|+|+.|-......  ...+|+|.+....  .........|..+-..+. |+|++.+++...+.+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            4567888889999999998886543  3445666554332  233444455777777776 9999999999999999999


Q ss_pred             EEecCCCCChHHhh-hcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-CeEEeeeccccccC
Q 040392          247 VLEYMPHGSLEKYM-YSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-VAHLSDFSIAKLLT  324 (470)
Q Consensus       247 v~e~~~~g~L~~~l-~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~a~~~~  324 (470)
                      +++|..++++.+.+ .......+......+..|+..++.|+|.  ..++.|+|+||+|.+++..+ ..++.|||+|..+.
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            99999999998888 4433356667778899999999999995  67899999999999999999 99999999999887


Q ss_pred             C-CCCccccccccc-CccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccc
Q 040392          325 G-EDQSMTQTQTLA-TIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVV  401 (470)
Q Consensus       325 ~-~~~~~~~~~~~~-t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (470)
                      . ..........+| ++.|.|||...+. ...+..|+||.|+++.-+++|..||............|........     
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----  251 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFT-----  251 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccc-----
Confidence            6 455555566778 9999999998874 4567899999999999999999999876555444444433210000     


Q ss_pred             cccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHH
Q 040392          402 GANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVA  446 (470)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~  446 (470)
                                 ............++..+++..+|..|.+.+++..
T Consensus       252 -----------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  252 -----------QLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             -----------cCccccCChhhhhcccccccCCchhccccccccc
Confidence                       0001112444678889999999999999888654

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.63  E-value=3.1e-15  Score=137.96  Aligned_cols=135  Identities=18%  Similarity=0.244  Sum_probs=105.2

Q ss_pred             CCeec-ccCceEEEEEEeCCCcEEEEEEeeccc-------------chhhhhHHHHHHHHhcCCCCcc--eeEEeeeccC
Q 040392          178 NNLIG-RGGFGSVYKARLGDGMEVAVKVFNLQC-------------GRALKGFDVECEMMKSIRHRNL--IKVISTCSNE  241 (470)
Q Consensus       178 ~~~ig-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~nI--v~~~~~~~~~  241 (470)
                      ...|| .|+.|+||+++.. +..++||.+....             ......+.+|++++..++|++|  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35787 8999999999884 7789999885321             1223456789999999998875  6677664332


Q ss_pred             -C---eeeEEEecCCC-CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEee
Q 040392          242 -E---FKALVLEYMPH-GSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSD  316 (470)
Q Consensus       242 -~---~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~D  316 (470)
                       .   ..++|||++++ .+|.+++...  .++..    .+.+++.++.+||   ..||+|+||||.|||++.++.++|+|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEE
Confidence             2   23599999997 6898888543  24433    3678999999999   99999999999999999999999999


Q ss_pred             eccccc
Q 040392          317 FSIAKL  322 (470)
Q Consensus       317 fg~a~~  322 (470)
                      ||.+..
T Consensus       186 fg~~~~  191 (239)
T PRK01723        186 FDRGEL  191 (239)
T ss_pred             CCCccc
Confidence            998875

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.57  E-value=9.8e-14  Score=139.02  Aligned_cols=140  Identities=21%  Similarity=0.248  Sum_probs=98.9

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEEeecccchhh----------------------------------------hhHH
Q 040392          178 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAL----------------------------------------KGFD  217 (470)
Q Consensus       178 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~  217 (470)
                      .+.||.|++|.||+|+..+|+.||||+.++...+..                                        -++.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            368999999999999999999999999865421110                                        0234


Q ss_pred             HHHHHHhcCC----CCcceeEEeee-ccCCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHH-HHHHHhcCCC
Q 040392          218 VECEMMKSIR----HRNLIKVISTC-SNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVAS-ALEYLHFGYS  291 (470)
Q Consensus       218 ~E~~~l~~l~----h~nIv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~-~L~~LH~~~~  291 (470)
                      .|++.+.+++    |.+-+.+-..+ ......++||||++|++|.++........   ....++..++. .+..+|   .
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~---~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVL---R  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHH---h
Confidence            4555555442    32223322222 22345689999999999988765322222   23456666666 467888   8


Q ss_pred             CCeeecCCCCCCeeeCCCCCeEEeeecccccc
Q 040392          292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  323 (470)
Q Consensus       292 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~  323 (470)
                      .|++|+|++|.||+++.++.++++|||++..+
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l  307 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRL  307 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence            99999999999999999999999999998755

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.57  E-value=2e-15  Score=137.71  Aligned_cols=216  Identities=20%  Similarity=0.309  Sum_probs=148.8

Q ss_pred             HhcCCCCcceeEEeeeccC-----CeeeEEEecCCCCChHHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 040392          223 MKSIRHRNLIKVISTCSNE-----EFKALVLEYMPHGSLEKYMYSSN---YILDIFQRLNIMIDVASALEYLHFGYSAPI  294 (470)
Q Consensus       223 l~~l~h~nIv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i  294 (470)
                      +-.+-|.||++++.|+.+.     ....+++||+..|++.+++++..   ..+......+|+.||..||.||| .+..+|
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh-s~~Ppi  199 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH-SCDPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh-ccCCcc
Confidence            4445699999999998653     35678999999999999997543   45666777889999999999999 568999


Q ss_pred             eecCCCCCCeeeCCCCCeEEeeecccccc--CCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCC
Q 040392          295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLL--TGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGK  372 (470)
Q Consensus       295 ~H~dlkp~Nill~~~~~~kl~Dfg~a~~~--~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~  372 (470)
                      +|+++..+-|++..++-+|++--.-....  .............+-++|.+||.-...+.+.++|||+||+..+||..+.
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE  279 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE  279 (458)
T ss_pred             ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence            99999999999999999988532111100  0001111122334678899999988888899999999999999999987


Q ss_pred             CCCCc-cccCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          373 KPTNE-IFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       373 ~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                      .-... ...-+.  .            +.+....+..++.          .-.+++..|++..|..||+|++++.|.-.+
T Consensus       280 iq~tnseS~~~~--e------------e~ia~~i~~len~----------lqr~~i~kcl~~eP~~rp~ar~llfHpllf  335 (458)
T KOG1266|consen  280 IQSTNSESKVEV--E------------ENIANVIIGLENG----------LQRGSITKCLEGEPNGRPDARLLLFHPLLF  335 (458)
T ss_pred             eccCCCcceeeh--h------------hhhhhheeeccCc----------cccCcCcccccCCCCCCcchhhhhcCceee
Confidence            64221 111000  0            0000001111100          013678899999999999999999887665


Q ss_pred             HHHHhhhccCch
Q 040392          452 RDSLLRNVGDRC  463 (470)
Q Consensus       452 ~~~~~~~~~~~~  463 (470)
                      .-...+.-..-|
T Consensus       336 eVhslkll~ahc  347 (458)
T KOG1266|consen  336 EVHSLKLLMAHC  347 (458)
T ss_pred             ecchHHHHhhHh
Confidence            544444444444

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.53  E-value=1.6e-14  Score=142.67  Aligned_cols=250  Identities=23%  Similarity=0.247  Sum_probs=186.8

Q ss_pred             CCCCCCCeecc--cCceEEEEEEe---CCCcEEEEEEeeccc--chhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCee
Q 040392          173 DGFSENNLIGR--GGFGSVYKARL---GDGMEVAVKVFNLQC--GRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFK  244 (470)
Q Consensus       173 ~~~~~~~~ig~--G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~  244 (470)
                      ..|.+.+.+|.  |.+|.||.+..   .++..+|+|.-+...  ......-.+|+...+.+ .|+|.++.+..++..+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            35677888999  99999999975   358889999854332  23333445577777777 499999999999999999


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCeeecCCCCCCeeeCCC-CCeEEeeecc
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVAS----ALEYLHFGYSAPIIHCDLKPSNVLLDDN-MVAHLSDFSI  319 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~----~L~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~  319 (470)
                      ++-+|++. .+|.++.......++....+....+..+    ||.++|   +..++|-|+||.||++..+ ...+++|||+
T Consensus       194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcce
Confidence            99999995 6999999877777888899999999999    999999   9999999999999999999 8899999999


Q ss_pred             ccccCCCCCcccc---cccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc
Q 040392          320 AKLLTGEDQSMTQ---TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS  396 (470)
Q Consensus       320 a~~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  396 (470)
                      ...+.........   ....+...|++||... +.++.+.|+|++|.++.+..++..+......     ..|    .+..
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-----~~W----~~~r  339 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN-----SSW----SQLR  339 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC-----CCc----cccc
Confidence            9887655432211   1225778899999875 4678899999999999999998776443110     111    1111


Q ss_pred             ccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          397 TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       397 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ...+.+.-+           +....++...+..+++.+|..|++++.+.++
T Consensus       340 ~~~ip~e~~-----------~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  340 QGYIPLEFC-----------EGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             cccCchhhh-----------cCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence            000000000           0114445568899999999999999877653

>PLN03150 hypothetical protein; Provisional

Probab=99.52  E-value=1.8e-14  Score=150.81  Aligned_cols=103  Identities=40%  Similarity=0.672  Sum_probs=91.4

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCC-C-C
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-G-P   79 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~-~   79 (470)
                      +|.+|++|++|+.|+|++|+|+|.+|+.+..+++|+.|+|++|+++|.+|+.++.|++|+.|+|++|.++|.+|.. . .
T Consensus       434 ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~  513 (623)
T PLN03150        434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR  513 (623)
T ss_pred             CCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhc
Confidence            6788999999999999999999999999999999999999999999999999999999999999999999888864 2 2


Q ss_pred             CCCCccccccCCccccCCCCCCCCCCC
Q 040392           80 FRNFSVESFEGNELLCGSPNLQVPPCK  106 (470)
Q Consensus        80 l~~l~~l~~~~n~~~~~~~~~~~~~~~  106 (470)
                      +.++..+++.+|+.+|+.|..  ++|.
T Consensus       514 ~~~~~~l~~~~N~~lc~~p~l--~~C~  538 (623)
T PLN03150        514 LLHRASFNFTDNAGLCGIPGL--RACG  538 (623)
T ss_pred             cccCceEEecCCccccCCCCC--CCCc
Confidence            346678899999999987743  4664

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.43  E-value=2.5e-12  Score=128.45  Aligned_cols=169  Identities=19%  Similarity=0.250  Sum_probs=129.8

Q ss_pred             EeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCCCChHHhhhcCCCCCCHHHH
Q 040392          193 RLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQR  272 (470)
Q Consensus       193 ~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~  272 (470)
                      +..++.+|.|...+...........+-++.++.++||||+++++.++.++..|+|+|.+.  .|..++.+.    .....
T Consensus        33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l----~~~~v  106 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL----GKEEV  106 (690)
T ss_pred             eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh----HHHHH
Confidence            455788999988876655445556777889999999999999999999999999999984  677777543    35566


Q ss_pred             HHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCC
Q 040392          273 LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV  352 (470)
Q Consensus       273 ~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  352 (470)
                      ..-+.||+.||.+||+  ..+++|++|.-..|++++.|..||++|.++........  .......-..|..|+.+.... 
T Consensus       107 ~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~-  181 (690)
T KOG1243|consen  107 CLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE-  181 (690)
T ss_pred             HHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc-
Confidence            6788999999999985  67899999999999999999999999998865432221  112222233466676543222 


Q ss_pred             CCccchhhHHHHHHHHHhCCC
Q 040392          353 STNGDVYSFGIMLMETFTGKK  373 (470)
Q Consensus       353 ~~~~DvwslGv~l~el~tg~~  373 (470)
                       -..|.|.||++++|++.|..
T Consensus       182 -~s~D~~~Lg~li~el~ng~~  201 (690)
T KOG1243|consen  182 -WSIDSWGLGCLIEELFNGSL  201 (690)
T ss_pred             -cchhhhhHHHHHHHHhCccc
Confidence             24699999999999999943

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.41  E-value=1.2e-12  Score=114.53  Aligned_cols=127  Identities=24%  Similarity=0.237  Sum_probs=96.1

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcc-eeEEeeeccCCeeeEEEecCCCCCh
Q 040392          178 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNL-IKVISTCSNEEFKALVLEYMPHGSL  256 (470)
Q Consensus       178 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv~e~~~~g~L  256 (470)
                      .+.|+.|.++.||+++.. +..+++|....... ....+..|+.+++.+.+.++ .+++.+..  ...++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            367899999999999875 78899999754422 23356789999998865554 44555433  235799999999887


Q ss_pred             HHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eeecCCCCCCeeeCCCCCeEEeeecccc
Q 040392          257 EKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP-----IIHCDLKPSNVLLDDNMVAHLSDFSIAK  321 (470)
Q Consensus       257 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-----i~H~dlkp~Nill~~~~~~kl~Dfg~a~  321 (470)
                      .+..         ......+.+++++|..||   ..+     ++|+|++|.||+++ ++.++++|||.+.
T Consensus        79 ~~~~---------~~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          79 LTED---------FSDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cccc---------ccCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            5431         111345778999999999   666     59999999999999 6789999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.38  E-value=1.1e-12  Score=132.97  Aligned_cols=146  Identities=20%  Similarity=0.177  Sum_probs=92.4

Q ss_pred             CCCCCCCeecccCceEEEEEEeCC-CcEEEEEEeecccchh----------------------------------hh---
Q 040392          173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRA----------------------------------LK---  214 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~---  214 (470)
                      ..|+. +.||.|++|.||+|+.++ |+.||||+.++...+.                                  .+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45776 789999999999999887 9999999997542110                                  01   


Q ss_pred             ---hHHHHHHHHhcCC----CCcceeEEeeec-cCCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHH-HHH
Q 040392          215 ---GFDVECEMMKSIR----HRNLIKVISTCS-NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASA-LEY  285 (470)
Q Consensus       215 ---~~~~E~~~l~~l~----h~nIv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~-L~~  285 (470)
                         ++..|+.-+.+++    +.+.+.+-..+. -....++||||++|+.+.++..-.....+...   ++...+.. +.-
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~---la~~~v~~~~~Q  275 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKL---LAERGVEVFFTQ  275 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHH---HHHHHHHHHHHH
Confidence               1233443333332    333333322222 23456799999999999775321111122211   22222221 222


Q ss_pred             HhcCCCCCeeecCCCCCCeeeCCCC----CeEEeeeccccccCC
Q 040392          286 LHFGYSAPIIHCDLKPSNVLLDDNM----VAHLSDFSIAKLLTG  325 (470)
Q Consensus       286 LH~~~~~~i~H~dlkp~Nill~~~~----~~kl~Dfg~a~~~~~  325 (470)
                      +.   ..|++|+|+||.||+++.++    +++++|||++..+..
T Consensus       276 if---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        276 VF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            33   67999999999999999888    999999999987643

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.31  E-value=4.5e-11  Score=105.54  Aligned_cols=137  Identities=22%  Similarity=0.218  Sum_probs=98.8

Q ss_pred             CCeecccCceEEEEEEeCC-------CcEEEEEEeeccc------------c----------hhhhhHH----HHHHHHh
Q 040392          178 NNLIGRGGFGSVYKARLGD-------GMEVAVKVFNLQC------------G----------RALKGFD----VECEMMK  224 (470)
Q Consensus       178 ~~~ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~------------~----------~~~~~~~----~E~~~l~  224 (470)
                      ...||.|--+.||.|...+       +..+|||+.+...            .          ...+.+.    .|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3578999999999997543       5799999975321            0          0111222    6899999


Q ss_pred             cCCC--CcceeEEeeeccCCeeeEEEecCCCCChHH-hhhcCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeeecCCC
Q 040392          225 SIRH--RNLIKVISTCSNEEFKALVLEYMPHGSLEK-YMYSSNYILDIFQRLNIMIDVASALEYL-HFGYSAPIIHCDLK  300 (470)
Q Consensus       225 ~l~h--~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~~i~~~L~~L-H~~~~~~i~H~dlk  300 (470)
                      ++..  -++.+++++    ...++||||+.++.+.. .+.+  ..++......+..+++.+|..+ |   ..+++||||+
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs  152 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLS  152 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence            8853  456667765    34579999997654321 2222  1244556677889999999998 8   8899999999


Q ss_pred             CCCeeeCCCCCeEEeeeccccccC
Q 040392          301 PSNVLLDDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       301 p~Nill~~~~~~kl~Dfg~a~~~~  324 (470)
                      +.||+++ ++.++|+|||.+....
T Consensus       153 ~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         153 EYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHHEEEE-CCcEEEEECCCceeCC
Confidence            9999997 4689999999887553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.27  E-value=6.2e-11  Score=108.47  Aligned_cols=141  Identities=18%  Similarity=0.214  Sum_probs=110.1

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEEeecccc-hhhhhHHHHHHHHhcCCC--CcceeEEeeeccCC---eeeEEEecCC
Q 040392          179 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCG-RALKGFDVECEMMKSIRH--RNLIKVISTCSNEE---FKALVLEYMP  252 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~~---~~~lv~e~~~  252 (470)
                      +.|+.|..+.||++...+|..+++|....... .....+..|+++++.+.+  .++.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            57899999999999887678999999754322 245578889999999975  44677788776542   5689999999


Q ss_pred             CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 040392          253 HGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFG-------------------------------------------  289 (470)
Q Consensus       253 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-------------------------------------------  289 (470)
                      |.++.+.+..  ..++......++.+++++|..||..                                           
T Consensus        84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            9988776532  2467777778888888888888842                                           


Q ss_pred             ----------CCCCeeecCCCCCCeeeCC--CCCeEEeeecccc
Q 040392          290 ----------YSAPIIHCDLKPSNVLLDD--NMVAHLSDFSIAK  321 (470)
Q Consensus       290 ----------~~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~a~  321 (470)
                                ....++|+|+++.||+++.  ++.+.|+||+.+.
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                      1245799999999999998  6678999999875

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.26  E-value=1.3e-11  Score=137.61  Aligned_cols=91  Identities=38%  Similarity=0.527  Sum_probs=83.8

Q ss_pred             CCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCCCCCccc
Q 040392            8 GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPFRNFSVE   86 (470)
Q Consensus         8 ~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l   86 (470)
                      .+++|+.|+|++|++++.+|..+.++++|+.|+|++|.+++.+|..+..+++|+.|++++|.+++.+|. +..+++|+.|
T Consensus       473 ~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  552 (968)
T PLN00113        473 GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQL  552 (968)
T ss_pred             ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEE
Confidence            458899999999999999999999999999999999999999999999999999999999999988776 4789999999


Q ss_pred             cccCCccccCCC
Q 040392           87 SFEGNELLCGSP   98 (470)
Q Consensus        87 ~~~~n~~~~~~~   98 (470)
                      ++++|++....|
T Consensus       553 ~Ls~N~l~~~~p  564 (968)
T PLN00113        553 DLSQNQLSGEIP  564 (968)
T ss_pred             ECCCCcccccCC
Confidence            999999865444

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.22  E-value=1.2e-10  Score=99.35  Aligned_cols=131  Identities=21%  Similarity=0.301  Sum_probs=98.1

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEEeeccc---ch-----hhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          179 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQC---GR-----ALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~-----~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      ..+++|+-+.+|.+.+. |.++++|.-.++.   ++     ...+-..|++++.+++--.|...+=+..+++...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            46789999999999774 5557777643321   11     123455699999988655544444445566667799999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL  322 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~  322 (470)
                      ++|..|.+.+...        ...++..+-.-+.-||   ..+|+|+||.++||++..++ +.++|||++..
T Consensus        81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA--------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999898655        2456777777788999   99999999999999998765 99999999874

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.21  E-value=8.4e-12  Score=123.61  Aligned_cols=251  Identities=20%  Similarity=0.159  Sum_probs=175.9

Q ss_pred             HhhCCCCCCCeecccCceEEEEEEe--CCCcEEEEEEeecccchhhh--hHHHHHHHHhcC-CCCcceeEEeeeccCCee
Q 040392          170 RATDGFSENNLIGRGGFGSVYKARL--GDGMEVAVKVFNLQCGRALK--GFDVECEMMKSI-RHRNLIKVISTCSNEEFK  244 (470)
Q Consensus       170 ~~~~~~~~~~~ig~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~  244 (470)
                      ....+|..+..||.|.|+.|++...  .++..|++|.+.........  .-..|+.+...+ .|.++++....+..-...
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            3456788899999999999999853  35788999987544222211  123466666666 488888887777777777


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-CCeEEeeecccccc
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN-MVAHLSDFSIAKLL  323 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~a~~~  323 (470)
                      ++--||++++++..... ....+++..++++..|++.++.++|   ++.++|+|++|+||++..+ +..+++|||.+..+
T Consensus       342 ~ip~e~~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~  417 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL  417 (524)
T ss_pred             cCchhhhcCcchhhhhH-HHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccccc
Confidence            78999999998866652 2234677788899999999999999   9999999999999999886 88899999998642


Q ss_pred             CCCCCcccccccccCcccc--CccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccc
Q 040392          324 TGEDQSMTQTQTLATIGYM--APEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVV  401 (470)
Q Consensus       324 ~~~~~~~~~~~~~~t~~y~--aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (470)
                      .     ..........++.  +|+......+..+.|+++||..+.+..++..--....       .|..         +.
T Consensus       418 ~-----~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-------~~~~---------i~  476 (524)
T KOG0601|consen  418 A-----FSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-------QSLT---------IR  476 (524)
T ss_pred             c-----eecccccccccccccchhhccccccccccccccccccccccccCcccCcccc-------ccee---------ee
Confidence            1     1111122333344  5555666678889999999999999999875422211       1100         00


Q ss_pred             cccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          402 GANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                      ...+...        ......+..+...+...++..||.+.++..+.+-.++
T Consensus       477 ~~~~p~~--------~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~  520 (524)
T KOG0601|consen  477 SGDTPNL--------PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD  520 (524)
T ss_pred             cccccCC--------CchHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence            0000000        0112446778889999999999999998887766543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.20  E-value=1.5e-10  Score=98.16  Aligned_cols=142  Identities=18%  Similarity=0.187  Sum_probs=104.1

Q ss_pred             CCCeecccCceEEEEEEeCCCcEEEEEEeeccc--------chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          177 ENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--------GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       177 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ....|-+|+-+.|+++.+ .|+..+||.-..+.        .-..++..+|++++.++.--.|.-..-++.+.....++|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            567899999999999988 47887777632221        112445667999999886444443333455555567999


Q ss_pred             ecCCC-CChHHhhhcCCCCCCH-HHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC---CeEEeeeccccc
Q 040392          249 EYMPH-GSLEKYMYSSNYILDI-FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM---VAHLSDFSIAKL  322 (470)
Q Consensus       249 e~~~~-g~L~~~l~~~~~~~~~-~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~---~~kl~Dfg~a~~  322 (470)
                      ||++| .++.+++.+....... .....++..|-+.+.-||   ..+|+||||..+||++..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99976 4788888765433333 333788999999999999   99999999999999996544   458999999863

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.14  E-value=1.5e-11  Score=128.17  Aligned_cols=251  Identities=22%  Similarity=0.278  Sum_probs=172.5

Q ss_pred             HhhCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc---cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeee
Q 040392          170 RATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKA  245 (470)
Q Consensus       170 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  245 (470)
                      ...+.+.+.+.+-+|+++.++.++- ..|...++|+....   .....+....+-.++-...+|-+++....+.-....+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            3557788888899999999998853 33544455543321   1112222333333333345566666555555667778


Q ss_pred             EEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccC-
Q 040392          246 LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT-  324 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~-  324 (470)
                      ++++|..+++|...++... ..+..-.......+..+++|||   ...+.|+|++|.|.+...+++.++.|||...... 
T Consensus       881 L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~  956 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL  956 (1205)
T ss_pred             hhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCcccccccccc
Confidence            9999999999999987766 3444455567777889999999   7879999999999999999999999998332110 


Q ss_pred             -----CC---------------C--------CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 040392          325 -----GE---------------D--------QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTN  376 (470)
Q Consensus       325 -----~~---------------~--------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~  376 (470)
                           +.               .        .........+|+.|.+||...+......+|.|++|++++|.++|..||.
T Consensus       957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen  957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred             ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence                 00               0        0011234568999999999999999999999999999999999999998


Q ss_pred             ccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHH
Q 040392          377 EIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAR  442 (470)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~  442 (470)
                      ........ .....                 ........+...+.+..+++...+..+|.+|..|.
T Consensus      1037 a~tpq~~f-~ni~~-----------------~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQIF-ENILN-----------------RDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             Ccchhhhh-hcccc-----------------CCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            74433211 11111                 01111112233456678899999999999998876

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.13  E-value=3.8e-09  Score=100.38  Aligned_cols=267  Identities=14%  Similarity=0.112  Sum_probs=164.8

Q ss_pred             CCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcC-CCCcceeEEee------ecc-CCeeeEE
Q 040392          176 SENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSI-RHRNLIKVIST------CSN-EEFKALV  247 (470)
Q Consensus       176 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~------~~~-~~~~~lv  247 (470)
                      ...+.||+|+-+.+|-.--  -..-+.|++........   .+.+..|... .||-+-.=+.+      ..+ .....++
T Consensus        14 ~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQ---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecch--hhchhheeecCCCchHH---HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            3457799999999997521  11234566653322111   1123333333 46543221111      112 2236678


Q ss_pred             EecCCCCC-hHHhhh-----cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecccc
Q 040392          248 LEYMPHGS-LEKYMY-----SSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK  321 (470)
Q Consensus       248 ~e~~~~g~-L~~~l~-----~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~  321 (470)
                      |..+++.. ...+..     .+-...+|...++++..++.+.+.||   ..|.+-||+.++|+|+++++.+.|.|-..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEccccee
Confidence            88877642 222221     11245789999999999999999999   8999999999999999999999999754322


Q ss_pred             ccCCCCCcccccccccCccccCccccC-----CCCCCCccchhhHHHHHHHHHhC-CCCCCccccCc---chhh-HHhhh
Q 040392          322 LLTGEDQSMTQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTG-KKPTNEIFNGE---MTLK-HWVND  391 (470)
Q Consensus       322 ~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~tg-~~p~~~~~~~~---~~~~-~~~~~  391 (470)
                      .   ..........+|...|++||...     +-.-+...|.|.+|+++++++.| ++||.+.....   .... +....
T Consensus       166 i---~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         166 I---NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             e---ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence            1   12334445677899999999765     33456789999999999999985 99998753221   0111 00000


Q ss_pred             hcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCC--CccCCCCHHHHHHHHHHHHHHHhh
Q 040392          392 WLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVE--SPEQRINAREIVAKLLKIRDSLLR  457 (470)
Q Consensus       392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~--dP~~Rps~~el~~~L~~i~~~~~~  457 (470)
                      .    .....+...-.......+.-.-.+.++..++.+|+..  ++.-||+++-++..|-++.+++..
T Consensus       243 ~----f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~  306 (637)
T COG4248         243 R----FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK  306 (637)
T ss_pred             e----eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence            0    0000010000001111112233467788899999886  467899999999999999887654

>PLN03150 hypothetical protein; Provisional

Probab=99.12  E-value=1.3e-10  Score=121.84  Aligned_cols=88  Identities=35%  Similarity=0.569  Sum_probs=82.5

Q ss_pred             CCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCCCCCcccccc
Q 040392           11 NLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPFRNFSVESFE   89 (470)
Q Consensus        11 ~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~   89 (470)
                      .++.|+|++|.++|.+|..+..+++|+.|+|++|.++|.+|..+..+++|+.|||++|.|++.+|. +..+++|+.|+++
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            378899999999999999999999999999999999999999999999999999999999987776 5889999999999


Q ss_pred             CCccccCCC
Q 040392           90 GNELLCGSP   98 (470)
Q Consensus        90 ~n~~~~~~~   98 (470)
                      +|++.+..|
T Consensus       499 ~N~l~g~iP  507 (623)
T PLN03150        499 GNSLSGRVP  507 (623)
T ss_pred             CCcccccCC
Confidence            999887766

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.06  E-value=2e-09  Score=94.67  Aligned_cols=125  Identities=26%  Similarity=0.281  Sum_probs=82.4

Q ss_pred             EEEEEEeCCCcEEEEEEeeccc-------------ch-------------hhhhHHHHHHHHhcCCCC--cceeEEeeec
Q 040392          188 SVYKARLGDGMEVAVKVFNLQC-------------GR-------------ALKGFDVECEMMKSIRHR--NLIKVISTCS  239 (470)
Q Consensus       188 ~Vy~~~~~~~~~vavK~~~~~~-------------~~-------------~~~~~~~E~~~l~~l~h~--nIv~~~~~~~  239 (470)
                      .||.|...+|..+|+|..+...             ..             .......|++.|.++...  ++.+++.+. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899998899999999975320             00             122355699999999755  566777553 


Q ss_pred             cCCeeeEEEecCC--CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCeeecCCCCCCeeeCCCCCeEEee
Q 040392          240 NEEFKALVLEYMP--HGSLEKYMYSSNYILDIFQRLNIMIDVASALEY-LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSD  316 (470)
Q Consensus       240 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~-LH~~~~~~i~H~dlkp~Nill~~~~~~kl~D  316 (470)
                         ...+||||++  |..+..+.. ..  ++......++.+++..+.. +|   ..|++|||+++.||+++++ .+.|+|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~-~~--~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iID  149 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKD-VD--LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIID  149 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHH-CG--GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--
T ss_pred             ---CCEEEEEecCCCccchhhHHh-cc--ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEe
Confidence               2469999998  545544332 21  1133455677788785555 68   8999999999999999987 999999


Q ss_pred             ecccccc
Q 040392          317 FSIAKLL  323 (470)
Q Consensus       317 fg~a~~~  323 (470)
                      ||.+...
T Consensus       150 f~qav~~  156 (188)
T PF01163_consen  150 FGQAVDS  156 (188)
T ss_dssp             GTTEEET
T ss_pred             cCcceec
Confidence            9988754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.02  E-value=1.5e-08  Score=98.82  Aligned_cols=168  Identities=19%  Similarity=0.210  Sum_probs=128.3

Q ss_pred             CceEEEEEE-eCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeec----cCCeeeEEEecCCC-CChHH
Q 040392          185 GFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS----NEEFKALVLEYMPH-GSLEK  258 (470)
Q Consensus       185 ~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~----~~~~~~lv~e~~~~-g~L~~  258 (470)
                      ...+.||+. ..||..|++|+++............-+++++++.|.|+|++.+.+.    .+...++|++|.|+ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            446789996 4589999999996543333333445688999999999999988775    34567899999886 46666


Q ss_pred             hhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccC
Q 040392          259 YMYSS--------------NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       259 ~l~~~--------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~  324 (470)
                      +....              +...++...|.++.|+..||.++|   +.|+..+-|.+.+|+++.+.+++|+..|....+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            54321              134567889999999999999999   9999999999999999999999999988877664


Q ss_pred             CCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q 040392          325 GEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP  374 (470)
Q Consensus       325 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p  374 (470)
                      .+..                |.+.   --.+.|.=.||.+++.|.||..-
T Consensus       445 ~d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDPT----------------EPLE---SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCC----------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence            3321                1111   12367999999999999999753

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.00  E-value=5.8e-09  Score=97.37  Aligned_cols=139  Identities=17%  Similarity=0.109  Sum_probs=100.8

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEEeecccc-----------hhhhhHHHHHHHHhcCCCCc--ceeEEeeecc-----
Q 040392          179 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCG-----------RALKGFDVECEMMKSIRHRN--LIKVISTCSN-----  240 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~n--Iv~~~~~~~~-----  240 (470)
                      +.+-......|++..+ +|+.|.||.......           .....+.+|++.+.++...+  .++++++.+.     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4555555556778776 578999997743321           11113678999888885333  3444555532     


Q ss_pred             CCeeeEEEecCCCC-ChHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-------CCC
Q 040392          241 EEFKALVLEYMPHG-SLEKYMYSS-NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-------NMV  311 (470)
Q Consensus       241 ~~~~~lv~e~~~~g-~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~-------~~~  311 (470)
                      ....++|||++++. +|.+++... ....+...+..++.+++..+.-||   ..||+|+|++++|||++.       +..
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence            23467999999886 798888532 233456677789999999999999   999999999999999975       568


Q ss_pred             eEEeeecccc
Q 040392          312 AHLSDFSIAK  321 (470)
Q Consensus       312 ~kl~Dfg~a~  321 (470)
                      +.++||+.+.
T Consensus       184 ~~LIDl~r~~  193 (268)
T PRK15123        184 LSVIDLHRAQ  193 (268)
T ss_pred             EEEEECCccc
Confidence            9999999875

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.97  E-value=2.2e-10  Score=81.58  Aligned_cols=61  Identities=46%  Similarity=0.585  Sum_probs=54.7

Q ss_pred             CCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccc
Q 040392           10 KNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKL   70 (470)
Q Consensus        10 ~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l   70 (470)
                      ++|+.|+|++|+|+...+..|.++++|++|+|++|.|++..|..|..+++|+.|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            5789999999999966667889999999999999999977778899999999999999986

...

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=98.91  E-value=1.4e-10  Score=96.81  Aligned_cols=90  Identities=29%  Similarity=0.435  Sum_probs=57.4

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccc--cCCCCCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEG--EIPRGGP   79 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~--~~~~~~~   79 (470)
                      +|..|..|++|+.|++++|+|+ .+|.++..+++|+.|+++-|++. .+|..|+.++.|+.||+++|.++.  .+-++..
T Consensus        48 vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~  125 (264)
T KOG0617|consen   48 VPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFY  125 (264)
T ss_pred             cCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhH
Confidence            5666777777777777777777 66777777777777777777776 667777777777777776666642  2222334


Q ss_pred             CCCCccccccCCcc
Q 040392           80 FRNFSVESFEGNEL   93 (470)
Q Consensus        80 l~~l~~l~~~~n~~   93 (470)
                      +..|..|++.+|.+
T Consensus       126 m~tlralyl~dndf  139 (264)
T KOG0617|consen  126 MTTLRALYLGDNDF  139 (264)
T ss_pred             HHHHHHHHhcCCCc
Confidence            44444555554443

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.89  E-value=1.5e-08  Score=91.78  Aligned_cols=135  Identities=24%  Similarity=0.214  Sum_probs=98.8

Q ss_pred             CCCCCeecccCceEEEEEEeCCCcEEEEEEeeccc----------------------chhhhhHHHHHHHHhcCCCC--c
Q 040392          175 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC----------------------GRALKGFDVECEMMKSIRHR--N  230 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~--n  230 (470)
                      ..+...||-|--+.||.|..++|.++|||.-+...                      .-......+|.++|..|.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            34568899999999999999999999999743210                      00122356799999998644  6


Q ss_pred             ceeEEeeeccCCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC
Q 040392          231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM  310 (470)
Q Consensus       231 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~  310 (470)
                      +.+.+++    +...+|||+++|-.|...-      ++....-.++..|++-+.-+-   ..|++|||+++-||+++++|
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg  239 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDG  239 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCC
Confidence            7776665    4457999999986654332      123334455666666666665   68899999999999999999


Q ss_pred             CeEEeeeccccc
Q 040392          311 VAHLSDFSIAKL  322 (470)
Q Consensus       311 ~~kl~Dfg~a~~  322 (470)
                      .+.++||--+..
T Consensus       240 ~~~vIDwPQ~v~  251 (304)
T COG0478         240 DIVVIDWPQAVP  251 (304)
T ss_pred             CEEEEeCccccc
Confidence            999999976653

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=98.88  E-value=3.6e-10  Score=94.30  Aligned_cols=89  Identities=30%  Similarity=0.409  Sum_probs=82.5

Q ss_pred             ccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCCc
Q 040392            5 EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFS   84 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~   84 (470)
                      .+.++.+++.|.||+|+++ ..|+.++.|.+|+.|++++|+|+ .+|..++.++.|+.|+++-|++...+.+++.++-|+
T Consensus        28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~~lprgfgs~p~le  105 (264)
T KOG0617|consen   28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLNILPRGFGSFPALE  105 (264)
T ss_pred             cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhhcCccccCCCchhh
Confidence            3456788899999999999 88999999999999999999999 999999999999999999999998888899999999


Q ss_pred             cccccCCcccc
Q 040392           85 VESFEGNELLC   95 (470)
Q Consensus        85 ~l~~~~n~~~~   95 (470)
                      +|++.-|++.-
T Consensus       106 vldltynnl~e  116 (264)
T KOG0617|consen  106 VLDLTYNNLNE  116 (264)
T ss_pred             hhhcccccccc
Confidence            99999999853

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.87  E-value=1.1e-09  Score=94.73  Aligned_cols=86  Identities=36%  Similarity=0.488  Sum_probs=40.4

Q ss_pred             ccC-CCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccc-cCCCCCCceecCCccccc--cCCCCCCC
Q 040392            5 EIG-GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYLENLNLSFNKLEG--EIPRGGPF   80 (470)
Q Consensus         5 ~~~-~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~-~~l~~L~~l~l~~N~l~~--~~~~~~~l   80 (470)
                      .++ .+.+|+.|+|++|.|+..  +.+..+++|++|+|++|+|+ .+++.+ ..+++|+.|++++|+|..  .+..+..+
T Consensus        36 ~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l  112 (175)
T PF14580_consen   36 NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSL  112 (175)
T ss_dssp             S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-
T ss_pred             chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcC
Confidence            344 467899999999999954  46888999999999999999 555445 468999999999999973  33344678


Q ss_pred             CCCccccccCCcc
Q 040392           81 RNFSVESFEGNEL   93 (470)
Q Consensus        81 ~~l~~l~~~~n~~   93 (470)
                      ++|+.|++.+||+
T Consensus       113 ~~L~~L~L~~NPv  125 (175)
T PF14580_consen  113 PKLRVLSLEGNPV  125 (175)
T ss_dssp             TT--EEE-TT-GG
T ss_pred             CCcceeeccCCcc
Confidence            8999999999998

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.83  E-value=1.6e-08  Score=102.14  Aligned_cols=141  Identities=21%  Similarity=0.201  Sum_probs=92.9

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEEeecccchhh----------------------------------------hhHHH
Q 040392          179 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRAL----------------------------------------KGFDV  218 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~~  218 (470)
                      +.|+.++-|.||+|++++|+.||||+.++...+..                                        -++..
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            67999999999999999999999999876421110                                        01333


Q ss_pred             HHHHHhcCC-----CCcceeEEeeeccCCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHH-HHHHhcCCCC
Q 040392          219 ECEMMKSIR-----HRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASA-LEYLHFGYSA  292 (470)
Q Consensus       219 E~~~l~~l~-----h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~-L~~LH~~~~~  292 (470)
                      |+.-+.+++     .+++.-..=|++-.....++|||++|-.+.+...-.....+...   ++..++++ +..+-   ..
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~q~~---~d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLRQLL---RD  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHHHHH---hc
Confidence            444444442     23332222233334556799999999988887433333345333   33333332 12222   56


Q ss_pred             CeeecCCCCCCeeeCCCCCeEEeeeccccccCC
Q 040392          293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       293 ~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  325 (470)
                      |++|.|.+|.||+++.++++.+.|||+...+..
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            899999999999999999999999999876643

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.82  E-value=2.3e-09  Score=108.06  Aligned_cols=153  Identities=18%  Similarity=0.273  Sum_probs=105.5

Q ss_pred             HHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc-------ccccccccCccccCccccC
Q 040392          276 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS-------MTQTQTLATIGYMAPEYGR  348 (470)
Q Consensus       276 ~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-------~~~~~~~~t~~y~aPE~~~  348 (470)
                      +.+++.|+.|+|.  +.+++|++|.|++|.++.++..||+.|+++....+....       .......-...|.|||++.
T Consensus       105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            3345599999996  688999999999999999999999999988765442211       1111223466799999999


Q ss_pred             CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHh
Q 040392          349 EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAM  428 (470)
Q Consensus       349 ~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  428 (470)
                      ....+.++|+||+|+++|-+..|..+--...........-.         ...+.....       ...+.+.++.+=+.
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~---------~~~~~~~~~-------~s~~~p~el~~~l~  246 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR---------NLLNAGAFG-------YSNNLPSELRESLK  246 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh---------ccccccccc-------ccccCcHHHHHHHH
Confidence            98899999999999999999965555332222211111000         000111111       11345788899999


Q ss_pred             hccCCCccCCCCHHHHHH
Q 040392          429 ECTVESPEQRINAREIVA  446 (470)
Q Consensus       429 ~cl~~dP~~Rps~~el~~  446 (470)
                      +++..++..||++.++..
T Consensus       247 k~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  247 KLLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             HHhcCCcccCcchhhhhc
Confidence            999999999998776654

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=98.79  E-value=9e-10  Score=103.60  Aligned_cols=92  Identities=29%  Similarity=0.435  Sum_probs=58.6

Q ss_pred             CCCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCccccc-CCCCCCceecCCccccccCCCCCC
Q 040392            1 VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLE-KLSYLENLNLSFNKLEGEIPRGGP   79 (470)
Q Consensus         1 ~~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~-~l~~L~~l~l~~N~l~~~~~~~~~   79 (470)
                      ++|.+++.|.+|+.|||..|+|. .+| .|.++..|..|+++.|+|+ .+|.+.. .+.+|..||+..|+++..|..+.-
T Consensus       197 tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklke~Pde~cl  273 (565)
T KOG0472|consen  197 TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLKEVPDEICL  273 (565)
T ss_pred             cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccccCchHHHH
Confidence            36777777777777777777776 555 5666666666666666666 5555544 566666666666666655555556


Q ss_pred             CCCCccccccCCcccc
Q 040392           80 FRNFSVESFEGNELLC   95 (470)
Q Consensus        80 l~~l~~l~~~~n~~~~   95 (470)
                      +++|+.||+++|.+..
T Consensus       274 LrsL~rLDlSNN~is~  289 (565)
T KOG0472|consen  274 LRSLERLDLSNNDISS  289 (565)
T ss_pred             hhhhhhhcccCCcccc
Confidence            6666666666666543

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=98.77  E-value=1.2e-09  Score=108.01  Aligned_cols=91  Identities=32%  Similarity=0.319  Sum_probs=82.8

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFR   81 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~   81 (470)
                      +|.+|.+|+.|+.||||+|+|. ..|..+..-+++-.|+||+|+|.+.....|-+|+.|-.||||+|++...||.+..|.
T Consensus        95 iP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~  173 (1255)
T KOG0444|consen   95 IPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLS  173 (1255)
T ss_pred             CCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhhcCHHHHHHh
Confidence            7899999999999999999999 889999999999999999999995554667799999999999999999999999999


Q ss_pred             CCccccccCCcc
Q 040392           82 NFSVESFEGNEL   93 (470)
Q Consensus        82 ~l~~l~~~~n~~   93 (470)
                      .|+.|.+++|++
T Consensus       174 ~LqtL~Ls~NPL  185 (1255)
T KOG0444|consen  174 MLQTLKLSNNPL  185 (1255)
T ss_pred             hhhhhhcCCChh
Confidence            999999999986

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.72  E-value=1.1e-07  Score=85.93  Aligned_cols=106  Identities=24%  Similarity=0.274  Sum_probs=83.1

Q ss_pred             hhhHHHHHHHHhcCCCC--cceeEEeeeccC----CeeeEEEecCCCC-ChHHhhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 040392          213 LKGFDVECEMMKSIRHR--NLIKVISTCSNE----EFKALVLEYMPHG-SLEKYMYSSNYILDIFQRLNIMIDVASALEY  285 (470)
Q Consensus       213 ~~~~~~E~~~l~~l~h~--nIv~~~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~  285 (470)
                      .....+|...+..|...  .+.+.+++.+..    ...++|+|++++. +|.+++..... .+......++.+++..+.-
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAK  133 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHH
Confidence            34567788888777533  345566665542    2447999999874 79998875332 5666778899999999999


Q ss_pred             HhcCCCCCeeecCCCCCCeeeCCCC---CeEEeeeccccc
Q 040392          286 LHFGYSAPIIHCDLKPSNVLLDDNM---VAHLSDFSIAKL  322 (470)
Q Consensus       286 LH~~~~~~i~H~dlkp~Nill~~~~---~~kl~Dfg~a~~  322 (470)
                      ||   ..|++|+|+++.|||++.++   .+.++||+-++.
T Consensus       134 lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  134 LH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99   99999999999999999887   899999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.67  E-value=5.2e-07  Score=80.00  Aligned_cols=136  Identities=18%  Similarity=0.100  Sum_probs=101.0

Q ss_pred             ecccCceEEEEEEeCCCcEEEEEEeeccc------chhhhhHHHHHHHHhcCCC--CcceeEEeeec---c--CCeeeEE
Q 040392          181 IGRGGFGSVYKARLGDGMEVAVKVFNLQC------GRALKGFDVECEMMKSIRH--RNLIKVISTCS---N--EEFKALV  247 (470)
Q Consensus       181 ig~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~---~--~~~~~lv  247 (470)
                      -|+||.+.|++.... |..+-+|.-....      .-....|.+|+..+.+|..  -++.++. ++.   .  .-..+||
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            466899999998774 5578888754221      2245678899999998853  2244444 332   1  1234699


Q ss_pred             EecCCC-CChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC--eEEeeecccc
Q 040392          248 LEYMPH-GSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV--AHLSDFSIAK  321 (470)
Q Consensus       248 ~e~~~~-g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~a~  321 (470)
                      +|-+++ .+|.+++.+.. ...+...+..++.+++..+.-||   ..|+.|+|+.+.||+++.++.  ++++||.-++
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            997753 48888886543 34577778899999999999999   999999999999999986666  9999998665

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=98.63  E-value=2.4e-09  Score=100.83  Aligned_cols=88  Identities=32%  Similarity=0.450  Sum_probs=79.1

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCcccc-CCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFG-DLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPF   80 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~-~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l   80 (470)
                      +| +|+.+..|.+|+++.|+|+ .+|.... ++.+|..|||..|+++ .+|+.+.-+.+|..||+|+|.|++.++.++.+
T Consensus       221 lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl  297 (565)
T KOG0472|consen  221 LP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNL  297 (565)
T ss_pred             CC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCcccccc
Confidence            56 8899999999999999999 8888775 7999999999999999 89999999999999999999999999988888


Q ss_pred             CCCccccccCCcc
Q 040392           81 RNFSVESFEGNEL   93 (470)
Q Consensus        81 ~~l~~l~~~~n~~   93 (470)
                       .|..|.+.|||+
T Consensus       298 -hL~~L~leGNPl  309 (565)
T KOG0472|consen  298 -HLKFLALEGNPL  309 (565)
T ss_pred             -eeeehhhcCCch
Confidence             899999999987

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.62  E-value=4.5e-07  Score=81.53  Aligned_cols=152  Identities=22%  Similarity=0.211  Sum_probs=97.6

Q ss_pred             CHHHHHHhhCCCCCCC---eecccCceEEEEEEeCCCcEEEEEEeecccchh------------------------hhhH
Q 040392          164 SHLELCRATDGFSENN---LIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRA------------------------LKGF  216 (470)
Q Consensus       164 ~~~~~~~~~~~~~~~~---~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------~~~~  216 (470)
                      +...+....++..+..   .|..|--+.||+|...++..+|||++......-                        ....
T Consensus        36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~  115 (268)
T COG1718          36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA  115 (268)
T ss_pred             HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence            3344445555555544   455777889999988889999999986432110                        0012


Q ss_pred             HHHHHHHhcCC--CCcceeEEeeeccCCeeeEEEecCCCCCh-HHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 040392          217 DVECEMMKSIR--HRNLIKVISTCSNEEFKALVLEYMPHGSL-EKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP  293 (470)
Q Consensus       217 ~~E~~~l~~l~--h~nIv~~~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~  293 (470)
                      ..|..-|+++.  +-.+.+.+++.    ...+||||+..... .-.|.+  ..+.......+..++++.+.-|-.  ..+
T Consensus       116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~--~a~  187 (268)
T COG1718         116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYK--EAG  187 (268)
T ss_pred             HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHH--hcC
Confidence            23555566553  33344444443    23699999965311 111211  122333566677888888887772  389


Q ss_pred             eeecCCCCCCeeeCCCCCeEEeeeccccccC
Q 040392          294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       294 i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~  324 (470)
                      ++|+||+.-|||+. ++.+.|+|||-|....
T Consensus       188 LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         188 LVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             cccccchhhheEEE-CCeEEEEECccccccC
Confidence            99999999999999 8899999999887553

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.60  E-value=7.5e-07  Score=81.49  Aligned_cols=132  Identities=12%  Similarity=0.120  Sum_probs=85.2

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCC--cceeEEeeeccCCeeeEEEecCCCCC-
Q 040392          179 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHR--NLIKVISTCSNEEFKALVLEYMPHGS-  255 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~~~~~~~~~~~~~lv~e~~~~g~-  255 (470)
                      ..||+|..+.||+.   .|..+++|......  ......+|.++++.+..-  .+.+++++....+...+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            57899999999984   35568889876432  234567899999988643  34677888877777889999999863 


Q ss_pred             hHHhhhcCCCCCCHHHHHHHHHHHHHHH---------------------------------------HHHhc-CCCCCee
Q 040392          256 LEKYMYSSNYILDIFQRLNIMIDVASAL---------------------------------------EYLHF-GYSAPII  295 (470)
Q Consensus       256 L~~~l~~~~~~~~~~~~~~i~~~i~~~L---------------------------------------~~LH~-~~~~~i~  295 (470)
                      +...+..     +......++..+++.+                                       .+|.. .....++
T Consensus        82 ~~~~~~~-----~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~  156 (226)
T TIGR02172        82 FSRIISD-----NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL  156 (226)
T ss_pred             hhhhhcC-----CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence            2111110     0011111111111111                                       11111 1134578


Q ss_pred             ecCCCCCCeeeCCCCCeEEeeecccc
Q 040392          296 HCDLKPSNVLLDDNMVAHLSDFSIAK  321 (470)
Q Consensus       296 H~dlkp~Nill~~~~~~kl~Dfg~a~  321 (470)
                      |+|+.|.||++++++ +.++||+.+.
T Consensus       157 HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       157 HGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             ecCCCCCcEEEcCCC-cEEEechhcC
Confidence            999999999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.59  E-value=2.5e-08  Score=70.86  Aligned_cols=60  Identities=35%  Similarity=0.452  Sum_probs=53.7

Q ss_pred             CCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCC-CCCCCCccccccCCcc
Q 040392           34 ISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GPFRNFSVESFEGNEL   93 (470)
Q Consensus        34 ~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~~~~n~~   93 (470)
                      ++|++|+|++|+|+...+..|..+++|+.|++++|.|+...+.. ..+++|+.+++++|++
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            57899999999999666678999999999999999999777755 7899999999999975

...

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=98.58  E-value=6.2e-09  Score=103.17  Aligned_cols=90  Identities=30%  Similarity=0.339  Sum_probs=59.2

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFR   81 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~   81 (470)
                      +|.++..|.+|..+|||.|+|+ ..|+.+-++.+|..|+||+|+|+ .+......-.+|++|+||+|+++..|..+..|+
T Consensus       214 ~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt~LP~avcKL~  291 (1255)
T KOG0444|consen  214 IPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLTVLPDAVCKLT  291 (1255)
T ss_pred             CCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhccchHHHhhhH
Confidence            5667777777777777777777 66777777777777777777776 555555555566666666666665555555666


Q ss_pred             CCccccccCCcc
Q 040392           82 NFSVESFEGNEL   93 (470)
Q Consensus        82 ~l~~l~~~~n~~   93 (470)
                      +|+.|+..+|++
T Consensus       292 kL~kLy~n~NkL  303 (1255)
T KOG0444|consen  292 KLTKLYANNNKL  303 (1255)
T ss_pred             HHHHHHhccCcc
Confidence            666666655554

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.54  E-value=4.5e-07  Score=91.51  Aligned_cols=139  Identities=22%  Similarity=0.290  Sum_probs=90.5

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEEeecccchh-------------------------------hh------hHHHHHH
Q 040392          179 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRA-------------------------------LK------GFDVECE  221 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------~~------~~~~E~~  221 (470)
                      +.||..+.|.||+|+.++|+.||||+-++.-...                               .+      +|..|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            6799999999999999999999999976532111                               01      1333433


Q ss_pred             HHhc----CCCCc------ceeEEeeeccCCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 040392          222 MMKS----IRHRN------LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS  291 (470)
Q Consensus       222 ~l~~----l~h~n------Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~  291 (470)
                      -..+    ++|-+      |.+++-  .-.....|+||||+|..+.+.-.-....++...+..-+.++     |+++...
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~-----~~~qIf~  319 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEA-----YLEQIFK  319 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHH-----HHHHHHh
Confidence            3222    23444      333332  22345689999999998766543333345555444333332     2222235


Q ss_pred             CCeeecCCCCCCeeeC----CCCCeEEeeeccccccC
Q 040392          292 APIIHCDLKPSNVLLD----DNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       292 ~~i~H~dlkp~Nill~----~~~~~kl~Dfg~a~~~~  324 (470)
                      .|++|+|=+|.||+++    .++.+.+.|||+...+.
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            6899999999999998    47789999999987654

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=98.54  E-value=8.3e-09  Score=101.54  Aligned_cols=89  Identities=28%  Similarity=0.265  Sum_probs=45.1

Q ss_pred             ccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCC----CCC
Q 040392            5 EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG----GPF   80 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~----~~l   80 (470)
                      +++...+|++|+|++|+|+...+..|..|.+|++|+|++|.|+-.-...|..+++|+.|||++|.|+..+.+.    ..|
T Consensus       312 ~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl  391 (873)
T KOG4194|consen  312 SWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGL  391 (873)
T ss_pred             hhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccc
Confidence            3444444555555555555444444444455555555555544333344555556666666666655444432    335


Q ss_pred             CCCccccccCCcc
Q 040392           81 RNFSVESFEGNEL   93 (470)
Q Consensus        81 ~~l~~l~~~~n~~   93 (470)
                      ++|+.|+|.+|++
T Consensus       392 ~~LrkL~l~gNql  404 (873)
T KOG4194|consen  392 PSLRKLRLTGNQL  404 (873)
T ss_pred             hhhhheeecCcee
Confidence            5566666666654

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=98.53  E-value=2e-08  Score=94.50  Aligned_cols=92  Identities=24%  Similarity=0.247  Sum_probs=83.1

Q ss_pred             ccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCC-CCCCCC
Q 040392            5 EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GPFRNF   83 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l   83 (470)
                      .|..|++|+.|+|++|+|+.+-+..|.++..|+.|.|..|+|...-...|.++.+|++|+|.+|+|+..-|.. ..+-.|
T Consensus       269 cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l  348 (498)
T KOG4237|consen  269 CFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSL  348 (498)
T ss_pred             HHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEeccccccccee
Confidence            3678999999999999999999999999999999999999999666678999999999999999999777765 567889


Q ss_pred             ccccccCCccccC
Q 040392           84 SVESFEGNELLCG   96 (470)
Q Consensus        84 ~~l~~~~n~~~~~   96 (470)
                      ..+.+-.|++.|.
T Consensus       349 ~~l~l~~Np~~Cn  361 (498)
T KOG4237|consen  349 STLNLLSNPFNCN  361 (498)
T ss_pred             eeeehccCcccCc
Confidence            9999999999883

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.51  E-value=2.5e-08  Score=86.44  Aligned_cols=85  Identities=25%  Similarity=0.294  Sum_probs=28.7

Q ss_pred             cCCCCCCcEeeCcCCcCCCCCCcccc-CCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCC-CCCCCC
Q 040392            6 IGGLKNLEYLFLGYNRLQGPIPDSFG-DLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GPFRNF   83 (470)
Q Consensus         6 ~~~l~~l~~l~l~~n~l~~~~p~~~~-~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l   83 (470)
                      +.+..+++.|+|++|.|+.+  ..++ .+.+|+.|||++|.|+ .++ .+..+++|+.|++++|.|+...+.+ ..+++|
T Consensus        15 ~~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L   90 (175)
T PF14580_consen   15 YNNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNL   90 (175)
T ss_dssp             -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT-
T ss_pred             cccccccccccccccccccc--cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCccccchHHhCCcC
Confidence            34566789999999999944  4676 5899999999999999 664 4888999999999999999553333 358999


Q ss_pred             ccccccCCccc
Q 040392           84 SVESFEGNELL   94 (470)
Q Consensus        84 ~~l~~~~n~~~   94 (470)
                      +.|++++|.+.
T Consensus        91 ~~L~L~~N~I~  101 (175)
T PF14580_consen   91 QELYLSNNKIS  101 (175)
T ss_dssp             -EEE-TTS---
T ss_pred             CEEECcCCcCC
Confidence            99999999984

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=98.50  E-value=1.3e-08  Score=100.30  Aligned_cols=91  Identities=33%  Similarity=0.312  Sum_probs=76.9

Q ss_pred             cccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCC-CCCCC
Q 040392            4 TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GPFRN   82 (470)
Q Consensus         4 ~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~   82 (470)
                      +++.+|+.|+.|+||.|.|..+-++.+.-..+|++|+|++|+|+...++.|..|..|+.|+|++|.|+..-... ..+++
T Consensus       287 g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lss  366 (873)
T KOG4194|consen  287 GWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSS  366 (873)
T ss_pred             ccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhh
Confidence            56778899999999999998888888888899999999999999666788889999999999999988444432 57899


Q ss_pred             CccccccCCccc
Q 040392           83 FSVESFEGNELL   94 (470)
Q Consensus        83 l~~l~~~~n~~~   94 (470)
                      |+.|++.+|.+.
T Consensus       367 L~~LdLr~N~ls  378 (873)
T KOG4194|consen  367 LHKLDLRSNELS  378 (873)
T ss_pred             hhhhcCcCCeEE
Confidence            999999999874

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.46  E-value=2.1e-06  Score=76.48  Aligned_cols=138  Identities=17%  Similarity=0.175  Sum_probs=91.4

Q ss_pred             HhhCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHH---------HHHHHHhcCC---CCcceeEEee
Q 040392          170 RATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFD---------VECEMMKSIR---HRNLIKVIST  237 (470)
Q Consensus       170 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~---------~E~~~l~~l~---h~nIv~~~~~  237 (470)
                      ....+|...+.+-.....-|.+-.. +|..+++|..+.......+.+.         +++..+.+++   .-....++..
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            3556788888888777777777766 5789999998765433333222         2233233332   2222332222


Q ss_pred             e-----ccCCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCe
Q 040392          238 C-----SNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA  312 (470)
Q Consensus       238 ~-----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~  312 (470)
                      .     ......+++|||++|..|.+...     +++    .++..+.+++.-+|   ..|++|||.+|.|++++.+ .+
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~-~i  173 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNN-GI  173 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECC-cE
Confidence            2     22344568999999988766542     222    25566778899999   9999999999999999855 49


Q ss_pred             EEeeecccc
Q 040392          313 HLSDFSIAK  321 (470)
Q Consensus       313 kl~Dfg~a~  321 (470)
                      +++||+..+
T Consensus       174 ~iID~~~k~  182 (229)
T PF06176_consen  174 RIIDTQGKR  182 (229)
T ss_pred             EEEECcccc
Confidence            999997654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.41  E-value=8.4e-06  Score=72.11  Aligned_cols=101  Identities=23%  Similarity=0.281  Sum_probs=82.4

Q ss_pred             HHHHHHhcCCC-CcceeEEeeeccCCeeeEEEecCCCCChHHh---hhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 040392          218 VECEMMKSIRH-RNLIKVISTCSNEEFKALVLEYMPHGSLEKY---MYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP  293 (470)
Q Consensus       218 ~E~~~l~~l~h-~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~---l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~  293 (470)
                      .|.-+++.+++ +++++++|+|..    ++|.||.+.+++...   +.. -...+|..+.+++.++++.+.+++++....
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            48888888876 699999999954    689999987755321   111 124689999999999999999999766677


Q ss_pred             eeecCCCCCCeeeCCCCCeEEeeecccccc
Q 040392          294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  323 (470)
Q Consensus       294 i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~  323 (470)
                      +.-.|++++|+-+++++++|++|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            888999999999999999999999977644

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.40  E-value=4.2e-06  Score=77.80  Aligned_cols=138  Identities=14%  Similarity=0.083  Sum_probs=85.7

Q ss_pred             eecccCc-eEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCC-CCcceeEEeeeccCCeeeEEEecCCCCChH
Q 040392          180 LIGRGGF-GSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIR-HRNLIKVISTCSNEEFKALVLEYMPHGSLE  257 (470)
Q Consensus       180 ~ig~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~  257 (470)
                      .|..|.. +.||+.... +..+++|......   ......|+++++.+. +-.+.+++++....+..++|||+++|.++.
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            3555555 789999764 4788899875432   345667999888884 444667888877666788999999998776


Q ss_pred             Hhhh-------------------cCC---CCCCH--HHHHHHHH--------------------HHHHHHHHHh----cC
Q 040392          258 KYMY-------------------SSN---YILDI--FQRLNIMI--------------------DVASALEYLH----FG  289 (470)
Q Consensus       258 ~~l~-------------------~~~---~~~~~--~~~~~i~~--------------------~i~~~L~~LH----~~  289 (470)
                      ....                   ...   .....  ........                    .+...+..|-    ..
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            4321                   000   00000  00000000                    0111122221    01


Q ss_pred             CCCCeeecCCCCCCeeeCCCCCeEEeeecccc
Q 040392          290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK  321 (470)
Q Consensus       290 ~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~  321 (470)
                      ....++|+|+.|.||+++++..+.|+||+.+.
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            13558999999999999998888999998774

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.35  E-value=3.8e-06  Score=77.27  Aligned_cols=141  Identities=19%  Similarity=0.282  Sum_probs=84.1

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCC--cceeEEeeec---cCCeeeEEEecCC
Q 040392          178 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHR--NLIKVISTCS---NEEFKALVLEYMP  252 (470)
Q Consensus       178 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~~~~~~~---~~~~~~lv~e~~~  252 (470)
                      ++.++.|..+.||++...+ ..+++|.....  .....+..|..+++.+...  .+.+++.+..   .....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            3578999999999999876 69999997644  4456677888888887532  3566666442   2345689999999


Q ss_pred             CCChHH----------------hh---hcC---CCCCCHHHH---------HHH------------HHHHHH-HHHHHhc
Q 040392          253 HGSLEK----------------YM---YSS---NYILDIFQR---------LNI------------MIDVAS-ALEYLHF  288 (470)
Q Consensus       253 ~g~L~~----------------~l---~~~---~~~~~~~~~---------~~i------------~~~i~~-~L~~LH~  288 (470)
                      +.++..                .+   +..   .........         ...            ...+.+ .+..++.
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            987777                11   111   000111000         000            111222 2333331


Q ss_pred             ----CCCCCeeecCCCCCCeeeC-CCCCeEEeeecccc
Q 040392          289 ----GYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAK  321 (470)
Q Consensus       289 ----~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~a~  321 (470)
                          .....++|+|+.|.||+++ +++.+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence                1356799999999999999 66667899998775

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.35  E-value=7.8e-08  Score=87.49  Aligned_cols=85  Identities=24%  Similarity=0.305  Sum_probs=54.1

Q ss_pred             ccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCCc
Q 040392            5 EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFS   84 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~   84 (470)
                      +..-++.++.|++|.|.|.-.  +++..|++|+.||||+|.++ .+.+.-..+.+.+.|.|+.|.|. ..+++..|-+|.
T Consensus       302 SvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE-~LSGL~KLYSLv  377 (490)
T KOG1259|consen  302 SVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIE-TLSGLRKLYSLV  377 (490)
T ss_pred             hhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHh-hhhhhHhhhhhe
Confidence            334456677777777777622  44666777777777777776 55455555666666666666655 445555666777


Q ss_pred             cccccCCcc
Q 040392           85 VESFEGNEL   93 (470)
Q Consensus        85 ~l~~~~n~~   93 (470)
                      .|++.+|+|
T Consensus       378 nLDl~~N~I  386 (490)
T KOG1259|consen  378 NLDLSSNQI  386 (490)
T ss_pred             eccccccch
Confidence            777777776

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.34  E-value=7.4e-08  Score=96.37  Aligned_cols=185  Identities=18%  Similarity=0.195  Sum_probs=133.0

Q ss_pred             CCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCc-ceeEEeeeccCCeeeEEEecCCC
Q 040392          175 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRN-LIKVISTCSNEEFKALVLEYMPH  253 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~~lv~e~~~~  253 (470)
                      +...+-+++|+++.++|.+-...+....+.+...     ....-++++|.+++||| .+..++-+..++...++++++..
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~  318 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST  318 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence            3334567899999999987543444445554422     34456899999999999 66667777777888899999988


Q ss_pred             C-ChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccc
Q 040392          254 G-SLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ  332 (470)
Q Consensus       254 g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  332 (470)
                      + +...........+...+...+...-+++++++|   +-.-+|+|    ||+..+ +..|..||+.+..+.+..   ..
T Consensus       319 ~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~  387 (829)
T KOG0576|consen  319 GRSSALEMTVSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KP  387 (829)
T ss_pred             CccccccCChhhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCccc---cc
Confidence            7 333222222223444455567777888999999   55457888    776655 688999999887664322   34


Q ss_pred             cccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q 040392          333 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPT  375 (470)
Q Consensus       333 ~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~  375 (470)
                      ....+++.|+|||+...+.+..+.|+|+.|+-..++--|-.|-
T Consensus       388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            4567999999999999999999999999998766777666653

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=98.28  E-value=1.1e-07  Score=89.66  Aligned_cols=89  Identities=24%  Similarity=0.278  Sum_probs=75.8

Q ss_pred             CCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCcee-cCCccccccCCCC-CCCCCCcccc
Q 040392           10 KNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLN-LSFNKLEGEIPRG-GPFRNFSVES   87 (470)
Q Consensus        10 ~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~-l~~N~l~~~~~~~-~~l~~l~~l~   87 (470)
                      +....|+|..|+|+.+.|.+|..+++|+.||||+|+|+..-|++|..+++|..|- .++|+|+..+.+. +.|..++.|.
T Consensus        67 ~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLl  146 (498)
T KOG4237|consen   67 PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLL  146 (498)
T ss_pred             CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHh
Confidence            4567899999999988888999999999999999999999999999999996665 4559999666654 7788899999


Q ss_pred             ccCCccccCCC
Q 040392           88 FEGNELLCGSP   98 (470)
Q Consensus        88 ~~~n~~~~~~~   98 (470)
                      +..|.+.|-..
T Consensus       147 lNan~i~Cir~  157 (498)
T KOG4237|consen  147 LNANHINCIRQ  157 (498)
T ss_pred             cChhhhcchhH
Confidence            98888887443

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.26  E-value=7.4e-07  Score=58.22  Aligned_cols=36  Identities=44%  Similarity=0.594  Sum_probs=17.0

Q ss_pred             CCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCC
Q 040392           11 NLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLS   47 (470)
Q Consensus        11 ~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~   47 (470)
                      +|++|+|++|+|+ .+|+.+.+|++|+.|+|++|+|+
T Consensus         2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~   37 (44)
T PF12799_consen    2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS   37 (44)
T ss_dssp             T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred             cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence            4455555555555 33444555555555555555554

...

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.26  E-value=6.9e-07  Score=58.35  Aligned_cols=38  Identities=42%  Similarity=0.606  Sum_probs=33.2

Q ss_pred             CCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccc
Q 040392           34 ISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEG   72 (470)
Q Consensus        34 ~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~   72 (470)
                      ++|+.|+|++|+|+ .+|+.+.+|++|+.|++++|+|+.
T Consensus         1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~~   38 (44)
T PF12799_consen    1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPISD   38 (44)
T ss_dssp             TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCSB
T ss_pred             CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCCC
Confidence            57999999999999 788889999999999999999983

...

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.22  E-value=1.1e-05  Score=68.66  Aligned_cols=129  Identities=20%  Similarity=0.256  Sum_probs=90.7

Q ss_pred             CCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcce-eEEeeeccCCeeeEEEecCCCC
Q 040392          176 SENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLI-KVISTCSNEEFKALVLEYMPHG  254 (470)
Q Consensus       176 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~~~~~~~~~~~~~lv~e~~~~g  254 (470)
                      +..+.|++|.+|.||++.+. |..+|+|+-+.++  ....+..|++++..++-.++. +++.|..+    .+.|||+.|-
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~   97 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCc
Confidence            34578999999999999995 6689999876543  346688899999999877664 45555333    3559999998


Q ss_pred             ChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC-CCCeeeCCCCCeEEeeeccccc
Q 040392          255 SLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK-PSNVLLDDNMVAHLSDFSIAKL  322 (470)
Q Consensus       255 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlk-p~Nill~~~~~~kl~Dfg~a~~  322 (470)
                      .|.+.-...    +..+    ...+++.---|.   ..||-|+.|+ |...++..++.+.|+||..|+.
T Consensus        98 ~L~~~~~~~----~rk~----l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          98 PLGKLEIGG----DRKH----LLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             chhhhhhcc----cHHH----HHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            887665321    2222    334445544455   7788898886 4445555566999999998873

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=98.20  E-value=1.6e-07  Score=97.42  Aligned_cols=85  Identities=38%  Similarity=0.548  Sum_probs=50.3

Q ss_pred             CCCCCCcEeeCcCCcCCCCCCcc-ccCCCCCCEEeccCCcCCC----------------------CCcccccCCCCCCce
Q 040392            7 GGLKNLEYLFLGYNRLQGPIPDS-FGDLISLKFLNLSNNNLSG----------------------AIPASLEKLSYLENL   63 (470)
Q Consensus         7 ~~l~~l~~l~l~~n~l~~~~p~~-~~~l~~L~~l~l~~n~i~~----------------------~~~~~~~~l~~L~~l   63 (470)
                      .++++|+.|+|++|+|. .+|++ +.++..|+.|+||+|+++.                      .+| .+..+++|+.+
T Consensus       380 ~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~~fP-e~~~l~qL~~l  457 (1081)
T KOG0618|consen  380 VNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLLSFP-ELAQLPQLKVL  457 (1081)
T ss_pred             ccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCceeech-hhhhcCcceEE
Confidence            34455555555555555 33432 3455555555555555551                      344 56677777788


Q ss_pred             ecCCccccc-cCCCCCCCCCCccccccCCcc
Q 040392           64 NLSFNKLEG-EIPRGGPFRNFSVESFEGNEL   93 (470)
Q Consensus        64 ~l~~N~l~~-~~~~~~~l~~l~~l~~~~n~~   93 (470)
                      |+|+|+|+- .++....-++|+.|+++||..
T Consensus       458 DlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  458 DLSCNNLSEVTLPEALPSPNLKYLDLSGNTR  488 (1081)
T ss_pred             ecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence            888888762 333333447888888888873

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.18  E-value=1.4e-07  Score=76.21  Aligned_cols=84  Identities=27%  Similarity=0.346  Sum_probs=72.4

Q ss_pred             CCCCCcEeeCcCCcCCCCCCccccC-CCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCCccc
Q 040392            8 GLKNLEYLFLGYNRLQGPIPDSFGD-LISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSVE   86 (470)
Q Consensus         8 ~l~~l~~l~l~~n~l~~~~p~~~~~-l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l   86 (470)
                      ...+|+.++|++|.+. .+|+.|.. .+.+++|+|++|.|+ .+|+++..++.|+.|+++.|.|...+.-+.+|.+|..|
T Consensus        51 ~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~~~p~vi~~L~~l~~L  128 (177)
T KOG4579|consen   51 KGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLNAEPRVIAPLIKLDML  128 (177)
T ss_pred             CCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccccchHHHHHHHhHHHh
Confidence            4466777899999999 66777754 568999999999999 89999999999999999999999888777788888888


Q ss_pred             cccCCcc
Q 040392           87 SFEGNEL   93 (470)
Q Consensus        87 ~~~~n~~   93 (470)
                      +..+|.+
T Consensus       129 ds~~na~  135 (177)
T KOG4579|consen  129 DSPENAR  135 (177)
T ss_pred             cCCCCcc
Confidence            8888776

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.16  E-value=2.7e-05  Score=68.65  Aligned_cols=125  Identities=26%  Similarity=0.443  Sum_probs=91.5

Q ss_pred             CCCCCCCeecccCc-eEEEEEEeCCCcEEEEEEeec---cc--------c----------hhhhhHHHHHHHHhcCC---
Q 040392          173 DGFSENNLIGRGGF-GSVYKARLGDGMEVAVKVFNL---QC--------G----------RALKGFDVECEMMKSIR---  227 (470)
Q Consensus       173 ~~~~~~~~ig~G~~-g~Vy~~~~~~~~~vavK~~~~---~~--------~----------~~~~~~~~E~~~l~~l~---  227 (470)
                      .+++.++.||.|.- |.||+++. +|+.+|+|.+..   ..        .          .....|..|++...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67889999999999 99999999 588999999421   10        0          12345778999988885   


Q ss_pred             CCcc--eeEEeeeccC------------------CeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHh
Q 040392          228 HRNL--IKVISTCSNE------------------EFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLH  287 (470)
Q Consensus       228 h~nI--v~~~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH  287 (470)
                      +.++  |+.+||..-.                  ....||.||++...          .++.    +-+.+|.+-+..+|
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~----~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQI----RDIPQMLRDLKILH  181 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccch----hHHHHHHHHHHHHH
Confidence            4455  8999987211                  13457888886633          1222    23556667788899


Q ss_pred             cCCCCCeeecCCCCCCeeeCCCCCeEEeeeccc
Q 040392          288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA  320 (470)
Q Consensus       288 ~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a  320 (470)
                         ..||+-+|+++.|..     .-||+|||.+
T Consensus       182 ---k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  182 ---KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             ---HCCeeeccCcccccc-----CCEEEecccC
Confidence               999999999999986     2389999864

>PLN02876 acyl-CoA dehydrogenase

Probab=98.14  E-value=3.5e-05  Score=84.18  Aligned_cols=79  Identities=14%  Similarity=0.302  Sum_probs=57.5

Q ss_pred             CCeecccCceEEEEEEeCCC---cEEEEEEeeccc-chhhhhHHHHHHHHhcCC-CCcc--eeEEeeeccC---CeeeEE
Q 040392          178 NNLIGRGGFGSVYKARLGDG---MEVAVKVFNLQC-GRALKGFDVECEMMKSIR-HRNL--IKVISTCSNE---EFKALV  247 (470)
Q Consensus       178 ~~~ig~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nI--v~~~~~~~~~---~~~~lv  247 (470)
                      .+.++.|.++.+|+....++   ..+++|+..... ......+.+|+++++.+. |.++  .+++.+|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46789999999999877654   467788754322 122346788999999995 6654  7888888664   467899


Q ss_pred             EecCCCCCh
Q 040392          248 LEYMPHGSL  256 (470)
Q Consensus       248 ~e~~~~g~L  256 (470)
                      |||++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999988643

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=98.12  E-value=3e-07  Score=95.41  Aligned_cols=84  Identities=31%  Similarity=0.332  Sum_probs=65.1

Q ss_pred             CCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCc-ccccCCCCCCceecCCccccccCCCCCCCCCCccc
Q 040392            8 GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIP-ASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSVE   86 (470)
Q Consensus         8 ~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~-~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l   86 (470)
                      .++.|+.|+|.+|.|+...-+.+.+.+.|+.|+|++|+|. .+| ..+.++..|+.|+||+|+|+..+..+..++.|.+|
T Consensus       357 ~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL  435 (1081)
T KOG0618|consen  357 NHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTL  435 (1081)
T ss_pred             hhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHH
Confidence            4678899999999999877788999999999999999999 555 56788999999999999998555433333334444


Q ss_pred             cccCCc
Q 040392           87 SFEGNE   92 (470)
Q Consensus        87 ~~~~n~   92 (470)
                      ...+|+
T Consensus       436 ~ahsN~  441 (1081)
T KOG0618|consen  436 RAHSNQ  441 (1081)
T ss_pred             hhcCCc
Confidence            333333

>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification]

Probab=98.12  E-value=2.6e-06  Score=73.55  Aligned_cols=83  Identities=24%  Similarity=0.281  Sum_probs=70.4

Q ss_pred             CCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCcccc--ccCCCCCCCCCCccc
Q 040392            9 LKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLE--GEIPRGGPFRNFSVE   86 (470)
Q Consensus         9 l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~--~~~~~~~~l~~l~~l   86 (470)
                      +.+...+||++|.+...  +.|..+++|.+|.|++|+|+..-|..-.-+++|+.|.+.+|.|.  |.+..+..+++|+.|
T Consensus        41 ~d~~d~iDLtdNdl~~l--~~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~LtnNsi~~l~dl~pLa~~p~L~~L  118 (233)
T KOG1644|consen   41 LDQFDAIDLTDNDLRKL--DNLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTNNSIQELGDLDPLASCPKLEYL  118 (233)
T ss_pred             ccccceecccccchhhc--ccCCCccccceEEecCCcceeeccchhhhccccceEEecCcchhhhhhcchhccCCcccee
Confidence            35677899999999855  67889999999999999999666555555778999999999997  566667888999999


Q ss_pred             cccCCcc
Q 040392           87 SFEGNEL   93 (470)
Q Consensus        87 ~~~~n~~   93 (470)
                      .+-+|++
T Consensus       119 tll~Npv  125 (233)
T KOG1644|consen  119 TLLGNPV  125 (233)
T ss_pred             eecCCch
Confidence            9999996

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.11  E-value=7.1e-05  Score=66.53  Aligned_cols=129  Identities=21%  Similarity=0.284  Sum_probs=90.2

Q ss_pred             CCCeecccCceEEEEEEeCCCcEEEEEEeeccc----------------chhhhhHHHHHHHHhcCC------CCcceeE
Q 040392          177 ENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC----------------GRALKGFDVECEMMKSIR------HRNLIKV  234 (470)
Q Consensus       177 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~nIv~~  234 (470)
                      ....||+|+.-.||.  +++.....||+.....                ....+...+|+.....+.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            346899999999986  4455667888876554                122445566766666555      8899999


Q ss_pred             EeeeccCCeeeEEEecCCC------CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC
Q 040392          235 ISTCSNEEFKALVLEYMPH------GSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD  308 (470)
Q Consensus       235 ~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~  308 (470)
                      +|+.+.+....+|+|.+.+      -+|.+++.+..  ++. ...+.+.++   ..||-   ..+|+.+|++|.||++..
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~--~~~-~~~~~L~~f---~~~l~---~~~Iv~~dl~~~NIv~~~  153 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG--LTE-ELRQALDEF---KRYLL---DHHIVIRDLNPHNIVVQR  153 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC--ccH-HHHHHHHHH---HHHHH---HcCCeecCCCcccEEEEe
Confidence            9999999999999998643      26888885544  444 334444444   45566   677999999999999953


Q ss_pred             CC----CeEEee
Q 040392          309 NM----VAHLSD  316 (470)
Q Consensus       309 ~~----~~kl~D  316 (470)
                      +.    .+.|+|
T Consensus       154 ~~~~~~~lvlID  165 (199)
T PF10707_consen  154 RDSGEFRLVLID  165 (199)
T ss_pred             cCCCceEEEEEe
Confidence            22    466665

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.08  E-value=2.8e-05  Score=71.81  Aligned_cols=74  Identities=8%  Similarity=0.131  Sum_probs=47.4

Q ss_pred             CCeecccCce-EEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCC---cceeEEeeeccC---CeeeEEEec
Q 040392          178 NNLIGRGGFG-SVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHR---NLIKVISTCSNE---EFKALVLEY  250 (470)
Q Consensus       178 ~~~ig~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~~~~~~~~~---~~~~lv~e~  250 (470)
                      ++.|+.|+.. .||+.    +..+++|.....  .....+..|.+++..+...   .+.++++.....   ...+++|++
T Consensus         2 ~~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           2 IEPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             ceeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            3567767766 58876    235778875532  2344678899999887532   345555554432   244789999


Q ss_pred             CCCCChH
Q 040392          251 MPHGSLE  257 (470)
Q Consensus       251 ~~~g~L~  257 (470)
                      ++|.++.
T Consensus        76 i~G~~l~   82 (235)
T cd05155          76 LEGETAT   82 (235)
T ss_pred             ecCCCCC
Confidence            9987764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=98.08  E-value=3.3e-07  Score=90.36  Aligned_cols=90  Identities=33%  Similarity=0.410  Sum_probs=70.0

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFR   81 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~   81 (470)
                      +|.+|+.+.+|..||.+.|.+. .+|..++++.+|..|.+..|++. .+|+.+.. -.|..||+|+|+|+..|-.+..++
T Consensus       158 lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~-LpLi~lDfScNkis~iPv~fr~m~  234 (722)
T KOG0532|consen  158 LPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCS-LPLIRLDFSCNKISYLPVDFRKMR  234 (722)
T ss_pred             CCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhC-CceeeeecccCceeecchhhhhhh
Confidence            5777777777777777777777 67777777777777777777777 67777773 357888999999886666678888


Q ss_pred             CCccccccCCccc
Q 040392           82 NFSVESFEGNELL   94 (470)
Q Consensus        82 ~l~~l~~~~n~~~   94 (470)
                      .|+.|.+++|++.
T Consensus       235 ~Lq~l~LenNPLq  247 (722)
T KOG0532|consen  235 HLQVLQLENNPLQ  247 (722)
T ss_pred             hheeeeeccCCCC
Confidence            8999999999874

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.05  E-value=6.4e-07  Score=81.68  Aligned_cols=87  Identities=30%  Similarity=0.347  Sum_probs=73.8

Q ss_pred             ccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCcccc--ccCCCCCCCCC
Q 040392            5 EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLE--GEIPRGGPFRN   82 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~--~~~~~~~~l~~   82 (470)
                      .+..|++|+.||||+|.|+ .+-.--..|-++++|.|+.|.|. .+. .+..+.+|..||+++|+|.  ..+..++.|+.
T Consensus       324 nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE-~LS-GL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPC  400 (490)
T KOG1259|consen  324 NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIE-TLS-GLRKLYSLVNLDLSSNQIEELDEVNHIGNLPC  400 (490)
T ss_pred             hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHh-hhh-hhHhhhhheeccccccchhhHHHhcccccccH
Confidence            3567899999999999999 44444456889999999999998 563 4888999999999999997  46677899999


Q ss_pred             CccccccCCccc
Q 040392           83 FSVESFEGNELL   94 (470)
Q Consensus        83 l~~l~~~~n~~~   94 (470)
                      |+.+.+.+||+.
T Consensus       401 LE~l~L~~NPl~  412 (490)
T KOG1259|consen  401 LETLRLTGNPLA  412 (490)
T ss_pred             HHHHhhcCCCcc
Confidence            999999999983

>PRK10593 hypothetical protein; Provisional

Probab=98.03  E-value=0.00011  Score=70.13  Aligned_cols=78  Identities=12%  Similarity=0.033  Sum_probs=57.6

Q ss_pred             CCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCC---CcceeEEeeecc---CCeeeEEEe
Q 040392          176 SENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRH---RNLIKVISTCSN---EEFKALVLE  249 (470)
Q Consensus       176 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~nIv~~~~~~~~---~~~~~lv~e  249 (470)
                      ...+.||.|..+.||+....++ .+++|..+.  ......+..|++.++.|.-   -.+.++++++..   .+..++|||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             heeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            3456799999999999977655 477777532  1133578889999998853   367888887754   356899999


Q ss_pred             cCCCCCh
Q 040392          250 YMPHGSL  256 (470)
Q Consensus       250 ~~~~g~L  256 (470)
                      +++++++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998765

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.01  E-value=8e-05  Score=68.70  Aligned_cols=73  Identities=18%  Similarity=0.233  Sum_probs=49.5

Q ss_pred             CeecccCceEEEEEEeCC--CcEEEEEEeecccchhhhhHHHHHHHHhcCCCCc-ceeEEeeeccCCeeeEEEecCCCCC
Q 040392          179 NLIGRGGFGSVYKARLGD--GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRN-LIKVISTCSNEEFKALVLEYMPHGS  255 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~~lv~e~~~~g~  255 (470)
                      +.|..|-...+|+....+  +..|++|+...... .......|+.+++.+...+ .+++++...    ..++|||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            567888889999998764  67899998764322 2233456888888885333 345554433    248999999876


Q ss_pred             h
Q 040392          256 L  256 (470)
Q Consensus       256 L  256 (470)
                      +
T Consensus        79 l   79 (235)
T cd05157          79 L   79 (235)
T ss_pred             C
Confidence            5

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=97.98  E-value=6.2e-07  Score=88.45  Aligned_cols=88  Identities=32%  Similarity=0.460  Sum_probs=69.1

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFR   81 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~   81 (470)
                      +|..+.+|..|++|||+.|+++ .+|..+..|+ |+.|-+++|+++ .+|+.++.+..|..||++.|.|...++.++.+.
T Consensus       113 ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~  189 (722)
T KOG0532|consen  113 IPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLT  189 (722)
T ss_pred             cchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHH
Confidence            6778888999999999999998 7788777664 788888999998 888888888888888888888887777666555


Q ss_pred             CCccccccCCc
Q 040392           82 NFSVESFEGNE   92 (470)
Q Consensus        82 ~l~~l~~~~n~   92 (470)
                      +|+.|....|.
T Consensus       190 slr~l~vrRn~  200 (722)
T KOG0532|consen  190 SLRDLNVRRNH  200 (722)
T ss_pred             HHHHHHHhhhh
Confidence            55554444444

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.97  E-value=6.4e-05  Score=70.39  Aligned_cols=136  Identities=14%  Similarity=0.168  Sum_probs=79.0

Q ss_pred             eecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcc-eeEEeeeccCCeeeEEEecCCCCChHH
Q 040392          180 LIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNL-IKVISTCSNEEFKALVLEYMPHGSLEK  258 (470)
Q Consensus       180 ~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv~e~~~~g~L~~  258 (470)
                      .+..|-.+.+|+... ++..+++|..........-....|.++++.+....+ .+++....    .++||||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            356688889999874 577888987654322221245779999998864333 34444432    368999999876532


Q ss_pred             h-----------------hhcCC---CCCCHHHH-HHHHHH---------HHHHHHHHhc-----CCCCCeeecCCCCCC
Q 040392          259 Y-----------------MYSSN---YILDIFQR-LNIMID---------VASALEYLHF-----GYSAPIIHCDLKPSN  303 (470)
Q Consensus       259 ~-----------------l~~~~---~~~~~~~~-~~i~~~---------i~~~L~~LH~-----~~~~~i~H~dlkp~N  303 (470)
                      .                 ++...   ...+.... ..+..+         +...+..+..     .....++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 11111   11111111 111111         1111222210     112458999999999


Q ss_pred             eeeCCCCCeEEeeecccc
Q 040392          304 VLLDDNMVAHLSDFSIAK  321 (470)
Q Consensus       304 ill~~~~~~kl~Dfg~a~  321 (470)
                      |++++++ +.++||..+.
T Consensus       158 il~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             EEEeCCC-CEEEeccccC
Confidence            9999877 7899999875

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.92  E-value=4.5e-05  Score=81.93  Aligned_cols=197  Identities=21%  Similarity=0.258  Sum_probs=136.1

Q ss_pred             HHHHHHHHhcCCCCcceeEEeeeccCCeee----EEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 040392          216 FDVECEMMKSIRHRNLIKVISTCSNEEFKA----LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS  291 (470)
Q Consensus       216 ~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~----lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~  291 (470)
                      ...|...+....|+|++.++.|..+.....    +..|++..-++...++... ..+..+.+.+..++..||.|+|   .
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~-~i~~~~~r~~~~~~~~GL~~~h---~  304 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG-SIPLETLRILHQKLLEGLAYLH---S  304 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc-ccCHHHHHHHHHHHhhhHHHHH---H
Confidence            344666778889999999999876654443    3457788888888776554 5788888899999999999999   5


Q ss_pred             CCeeecCCCCC---CeeeCCCCCeEEe--eeccccccCCCCCcccccccccCccccCccccCCCCCCCc--cchhhHHHH
Q 040392          292 APIIHCDLKPS---NVLLDDNMVAHLS--DFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTN--GDVYSFGIM  364 (470)
Q Consensus       292 ~~i~H~dlkp~---Nill~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~--~DvwslGv~  364 (470)
                      ....|.-+..+   +.-.+.++.+.++  ||+.+..+......   .....+..+.+||......+..+  .|+|.+|..
T Consensus       305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll  381 (1351)
T KOG1035|consen  305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL  381 (1351)
T ss_pred             hccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence            55555545444   4445667777777  88888765433222   22345566788887776655444  799999999


Q ss_pred             HHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHH
Q 040392          365 LMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREI  444 (470)
Q Consensus       365 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el  444 (470)
                      ...+..|..+-.......                ..              .+..+.....+....|+..++++|+++.++
T Consensus       382 ~~~~~~~~~i~~~~~~~~----------------~~--------------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~l  431 (1351)
T KOG1035|consen  382 LLQLSQGEDISEKSAVPV----------------SL--------------LDVLSTSELLDALPKCLDEDSEERLSALEL  431 (1351)
T ss_pred             HhhhhhcCcccccccchh----------------hh--------------hccccchhhhhhhhhhcchhhhhccchhhh
Confidence            999998776532211000                00              001112246688889999999999999999


Q ss_pred             HHHHH
Q 040392          445 VAKLL  449 (470)
Q Consensus       445 ~~~L~  449 (470)
                      +.+.-
T Consensus       432 l~~~f  436 (1351)
T KOG1035|consen  432 LTHPF  436 (1351)
T ss_pred             hhchh
Confidence            98764

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.87  E-value=0.00036  Score=68.88  Aligned_cols=76  Identities=24%  Similarity=0.241  Sum_probs=54.8

Q ss_pred             CCeecccCceEEEEEEeCCC-cEEEEEEeeccc-------chhhhhHHHHHHHHhcCC---CCcceeEEeeeccCCeeeE
Q 040392          178 NNLIGRGGFGSVYKARLGDG-MEVAVKVFNLQC-------GRALKGFDVECEMMKSIR---HRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       178 ~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~~l  246 (470)
                      .+.||.|.+..||++...+| +.++||.-.+..       .....+...|.+.|+.+.   -.++++++.+  +.+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            35799999999999998777 589999854221       123456677888888763   2457777777  3355689


Q ss_pred             EEecCCCCC
Q 040392          247 VLEYMPHGS  255 (470)
Q Consensus       247 v~e~~~~g~  255 (470)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998643

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	470
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-37
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-36
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-31
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-30
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-24
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		6e-24
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-23
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-23
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-22
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		9e-22
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-21
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-21
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-21
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-21
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-21
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-21
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-21
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-21
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-21
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-21
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-21
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-21
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-21
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-21
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-21
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-21
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-21
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		5e-21
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		6e-21
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-20
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-20
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-20
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		6e-20
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		7e-20
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		7e-20
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		8e-20
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-19
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-19
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-19
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-19
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-19
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-19
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-19
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-19
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-19
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-19
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-19
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-19
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-19
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-19
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-19
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-19
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-19
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-19
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-19
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-19
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-19
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-19
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-19
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-19
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-19
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-19
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-19
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-19
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-19
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-19
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-19
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-19
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-19
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-19
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-19
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		5e-19
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-19
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-19
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-19
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-19
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-19
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		6e-19
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		7e-19
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		7e-19
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-19
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		9e-19
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-19
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		9e-19
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-18
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-18
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-18
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-18
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-18
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-18
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-18
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-18
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-18
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		5e-18
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		7e-18
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		7e-18
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		7e-18
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-18
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		8e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		8e-18
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		8e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		8e-18
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		8e-18
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		8e-18
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		8e-18
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		9e-18
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-17
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-17
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-17
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-17
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-17
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-17
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-17
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-17
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-17
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-17
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-17
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-17
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-17
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-17
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-17
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-17
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-17
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-17
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-17
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-17
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-17
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-17
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-17
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-17
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-17
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-17
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-17
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		6e-17
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		6e-17
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-17
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-17
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		6e-17
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-17
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		7e-17
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		7e-17
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		8e-17
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		8e-17
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		8e-17
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		9e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-16
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-16
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-16
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-16
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-16
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-16
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-16
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-16
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-16
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-16
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-16
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-16
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-16
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-16
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-16
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-16
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-16
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-16
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-16
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-16
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-16
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-16
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-16
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-16
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-16
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-16
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-16
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-16
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-16
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-16
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-16
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-16
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-16
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-16
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-16
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-16
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-16
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		6e-16
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		6e-16
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		7e-16
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-16
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-15
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-15
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-15
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-15
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-15
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-15
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-15
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-15
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-15
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-15
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		6e-15
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		6e-15
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		6e-15
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-15
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		7e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-15
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-15
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		8e-15
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-15
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-15
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-14
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-14
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-14
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-14
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-14
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-14
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-14
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-14
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		4e-14
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		4e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-14
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-14
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-14
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		7e-14
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		8e-14
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		8e-14
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		8e-14
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		9e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-13
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-13
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-13
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-13
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-13
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-13
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-13
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-13
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-13
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		6e-13
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		6e-13
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		7e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		7e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-13
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		7e-13
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		8e-13
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		8e-13
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-13
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		8e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		9e-13
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		9e-13
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		9e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		9e-13
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		9e-13
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-12
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-12
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-12
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-12
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-12
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-12
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-12
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-12
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-12
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-12
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-12
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-12
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-12
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-12
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-12
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-12
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-12
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-12
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-12
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-12
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-12
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-12
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-12
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-12
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-12
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-12
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-12
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-12
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-12
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-12
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		5e-12
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		5e-12
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-12
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		6e-12
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-12
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		6e-12
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		7e-12
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-12
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		7e-12
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		7e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-12
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		7e-12
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-12
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		8e-12
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		8e-12
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		8e-12
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-12
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-12
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		9e-12
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		9e-12
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		9e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		9e-12
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-11
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-11
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-11
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-11
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		1e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-11
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-11
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-11
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-11
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-11
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-11
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-11
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-11
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-11
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-11
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		2e-11
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-11
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-11
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-11
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-11
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-11
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		5e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-11
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		6e-11
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		7e-11
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		7e-11
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-11
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		7e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		7e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		7e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-11
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-11
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		7e-11
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		7e-11
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		7e-11
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-11
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		7e-11
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		7e-11
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		8e-11
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		8e-11
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		8e-11
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		8e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		9e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		9e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-11
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		9e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-10
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-10
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-10
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-10
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-10
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-10
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-10
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-10
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-10
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-10
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		7e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		7e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		7e-10
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		7e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		8e-10
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		8e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		8e-10
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		8e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		9e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		9e-10
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-09
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-09
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-09
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-09
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-09
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		5e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		5e-09
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-09
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-09
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		5e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-09
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-09
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-09
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-09
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-09
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		7e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		7e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-09
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		7e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		7e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		7e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		8e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		8e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		8e-09
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		8e-09
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		8e-09
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		9e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		9e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		9e-09
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-08
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-08
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-08
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-08
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-08
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-08
3soa_A	444	Full-Length Human Camkii Length = 444		2e-08
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-08
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-08
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-08
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-08
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-08
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-08
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-08
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-08
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-08
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		5e-08
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		5e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-08
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		6e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		6e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-08
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		6e-08
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		6e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		6e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		7e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		7e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		7e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		7e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		7e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		8e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		8e-08
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		8e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		8e-08
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		8e-08
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		8e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		9e-08
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		9e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		9e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		9e-08
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		9e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-07
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-07
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-07
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-07
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-07
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-07
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-07
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-07
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-07
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-07
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-07
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-07
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-07
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-07
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-07
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-07
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-07
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-07
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-07
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-07
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		4e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		6e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-07
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		7e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-07
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		8e-07
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-07
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-07
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		9e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		9e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-06
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-06
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-06
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-06
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-06
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-06
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-06
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-06
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-06
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-06
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-06
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-06
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		5e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		5e-06
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		5e-06
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		5e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-06
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-06
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		5e-06
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		5e-06
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		5e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		6e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		8e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		8e-06
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-05
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-05
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-05
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-05
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-05
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-05
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-05
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-05
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-05
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-05
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-05
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-05
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-05
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-05
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-05
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-05
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-05
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-05
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-05
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-05
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-05
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-05
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-05
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-05
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-05
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-05
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-05
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-05
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-05
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-05
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-05
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-05
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-05
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-05
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-05
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-05
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-05
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		5e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 106/310 (34%), Positives = 155/310 (50%), Gaps = 17/310 (5%)
Query: 148 PSNDANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNL 207
           P+ +     +   + FS  EL  A+D FS  N++GRGGFG VYK RL DG  VAVK   L
Sbjct: 13  PAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK--RL 70
Query: 208 QCGRALKG---FDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMY--- 261
           +  R   G   F  E EM+    HRNL+++   C     + LV  YM +GS+   +    
Sbjct: 71  KEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 130
Query: 262 SSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 321
            S   LD  +R  I +  A  L YLH      IIH D+K +N+LLD+   A + DF +AK
Sbjct: 131 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 190
Query: 322 LLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIF-- 379
           L+  +D  +       TIG++APEY   G+ S   DV+ +G+ML+E  TG++  +     
Sbjct: 191 LMDYKDXHVXXA-VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 249
Query: 380 -NGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQR 438
            + ++ L  WV   L    +E      L   D+    K++ V  +  +A+ CT  SP +R
Sbjct: 250 NDDDVMLLDWVKGLLKEKKLEA-----LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMER 304
Query: 439 INAREIVAKL 448
               E+V  L
Sbjct: 305 PKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 104/310 (33%), Positives = 153/310 (49%), Gaps = 17/310 (5%)
Query: 148 PSNDANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNL 207
           P+ +     +   + FS  EL  A+D F   N++GRGGFG VYK RL DG  VAVK   L
Sbjct: 5   PAEEDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVK--RL 62
Query: 208 QCGRALKG---FDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMY--- 261
           +  R   G   F  E EM+    HRNL+++   C     + LV  YM +GS+   +    
Sbjct: 63  KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 122
Query: 262 SSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 321
            S   LD  +R  I +  A  L YLH      IIH D+K +N+LLD+   A + DF +AK
Sbjct: 123 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182
Query: 322 LLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIF-- 379
           L+  +D  +        IG++APEY   G+ S   DV+ +G+ML+E  TG++  +     
Sbjct: 183 LMDYKDXHVXXA-VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 241
Query: 380 -NGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQR 438
            + ++ L  WV   L    +E      L   D+    K++ V  +  +A+ CT  SP +R
Sbjct: 242 NDDDVMLLDWVKGLLKEKKLEA-----LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMER 296
Query: 439 INAREIVAKL 448
               E+V  L
Sbjct: 297 PKMSEVVRML 306

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 95/299 (31%), Positives = 156/299 (52%), Gaps = 17/299 (5%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKS 225
           ++L  AT+ F    LIG G FG VYK  L DG +VA+K    +  + ++ F+ E E +  
Sbjct: 32  VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSF 91
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSN---YILDIFQRLNIMIDVASA 282
            RH +L+ +I  C       L+ +YM +G+L++++Y S+     +   QRL I I  A  
Sbjct: 92  CRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARG 151
Query: 283 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           L YLH   +  IIH D+K  N+LLD+N V  ++DF I+K  T  DQ+        T+GY+
Sbjct: 152 LHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYI 208
Query: 343 APEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMT-LKHWVNDWLPISTME-V 400
            PEY  +GR++   DVYSFG++L E    +    +    EM  L  W  +      +E +
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268
Query: 401 VGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL---LKIRDSLL 456
           V  NL  +       + + +    + A++C   S E R +  +++ KL   L++++S++
Sbjct: 269 VDPNLADK------IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQESVI 321

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 94/299 (31%), Positives = 155/299 (51%), Gaps = 17/299 (5%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKS 225
           ++L  AT+ F    LIG G FG VYK  L DG +VA+K    +  + ++ F+ E E +  
Sbjct: 32  VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSF 91
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSN---YILDIFQRLNIMIDVASA 282
            RH +L+ +I  C       L+ +YM +G+L++++Y S+     +   QRL I I  A  
Sbjct: 92  CRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARG 151
Query: 283 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           L YLH   +  IIH D+K  N+LLD+N V  ++DF I+K  T   Q+        T+GY+
Sbjct: 152 LHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYI 208
Query: 343 APEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMT-LKHWVNDWLPISTME-V 400
            PEY  +GR++   DVYSFG++L E    +    +    EM  L  W  +      +E +
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268
Query: 401 VGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL---LKIRDSLL 456
           V  NL  +       + + +    + A++C   S E R +  +++ KL   L++++S++
Sbjct: 269 VDPNLADK------IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQESVI 321

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 119/234 (50%), Gaps = 17/234 (7%)
Query: 156 SIATWRTFSHLELCRATDGFSEN------NLIGRGGFGSVYKARLGDGMEVAVK----VF 205
           S   + +FS  EL   T+ F E       N +G GGFG VYK  + +   VAVK    + 
Sbjct: 8   SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMV 66
Query: 206 NLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYM--YSS 263
           ++      + FD E ++M   +H NL++++   S+ +   LV  YMP+GSL   +     
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 126
Query: 264 NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 323
              L    R  I    A+ + +LH  +    IH D+K +N+LLD+   A +SDF +A+  
Sbjct: 127 TPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARAS 183
Query: 324 TGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNE 377
               Q++  ++ + T  YMAPE  R G ++   D+YSFG++L+E  TG    +E
Sbjct: 184 EKFAQTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 236

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 119/234 (50%), Gaps = 17/234 (7%)
Query: 156 SIATWRTFSHLELCRATDGFSEN------NLIGRGGFGSVYKARLGDGMEVAVK----VF 205
           S   + +FS  EL   T+ F E       N +G GGFG VYK  + +   VAVK    + 
Sbjct: 8   SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMV 66
Query: 206 NLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNY 265
           ++      + FD E ++M   +H NL++++   S+ +   LV  YMP+GSL   +   + 
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 126
Query: 266 I--LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 323
              L    R  I    A+ + +LH  +    IH D+K +N+LLD+   A +SDF +A+  
Sbjct: 127 TPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARAS 183
Query: 324 TGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNE 377
               Q++   + + T  YMAPE  R G ++   D+YSFG++L+E  TG    +E
Sbjct: 184 EKFAQTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 236

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 118/234 (50%), Gaps = 17/234 (7%)
Query: 156 SIATWRTFSHLELCRATDGFSEN------NLIGRGGFGSVYKARLGDGMEVAVK----VF 205
           S   + +FS  EL   T+ F E       N +G GGFG VYK  + +   VAVK    + 
Sbjct: 2   SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMV 60
Query: 206 NLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNY 265
           ++      + FD E ++M   +H NL++++   S+ +   LV  YMP+GSL   +   + 
Sbjct: 61  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 120
Query: 266 I--LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 323
              L    R  I    A+ + +LH  +    IH D+K +N+LLD+   A +SDF +A+  
Sbjct: 121 TPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARAS 177
Query: 324 TGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNE 377
               Q +   + + T  YMAPE  R G ++   D+YSFG++L+E  TG    +E
Sbjct: 178 EKFAQXVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 230

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 128/286 (44%), Gaps = 45/286 (15%)
Query: 181 IGRGGFGSVYKAR------LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKV 234
           +G G FG V+ A         D M VAVK        A K F  E E++ +++H +++K 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYS---------------SNYILDIFQRLNIMIDV 279
              C + +   +V EYM HG L K++ +               +   L + Q L+I   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
           AS + YL    S   +H DL   N L+  N++  + DF +++ +   D       T+  I
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 340 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTM 398
            +M PE     + +T  DV+SFG++L E FT GK+P                 W  +S  
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP-----------------WFQLSNT 242
Query: 399 EVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREI 444
           EV+    ++Q  +       C   V+++ + C    P+QR+N +EI
Sbjct: 243 EVI--ECITQGRV-LERPRVCPKEVYDVMLGCWQREPQQRLNIKEI 285

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 104/198 (52%), Gaps = 8/198 (4%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRA--LKGFDVECEMMKSIRHRNLIKVISTC 238
           IG G FG+V++A    G +VAVK+   Q   A  +  F  E  +MK +RH N++  +   
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 239 SNEEFKALVLEYMPHGSLEKYMYSSNY--ILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
           +     ++V EY+  GSL + ++ S     LD  +RL++  DVA  + YLH   + PI+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 356
            DLK  N+L+D      + DF +++L       +       T  +MAPE  R+   +   
Sbjct: 163 RDLKSPNLLVDKKYTVKVCDFGLSRLKAS--XFLXSKXAAGTPEWMAPEVLRDEPSNEKS 220
Query: 357 DVYSFGIMLMETFTGKKP 374
           DVYSFG++L E  T ++P
Sbjct: 221 DVYSFGVILWELATLQQP 238

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 105/198 (53%), Gaps = 8/198 (4%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRA--LKGFDVECEMMKSIRHRNLIKVISTC 238
           IG G FG+V++A    G +VAVK+   Q   A  +  F  E  +MK +RH N++  +   
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 239 SNEEFKALVLEYMPHGSLEKYMYSSNY--ILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
           +     ++V EY+  GSL + ++ S     LD  +RL++  DVA  + YLH   + PI+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 356
            +LK  N+L+D      + DF +++L       ++      T  +MAPE  R+   +   
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGTPEWMAPEVLRDEPSNEKS 220
Query: 357 DVYSFGIMLMETFTGKKP 374
           DVYSFG++L E  T ++P
Sbjct: 221 DVYSFGVILWELATLQQP 238

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 148/305 (48%), Gaps = 37/305 (12%)
Query: 176 SENNLIGRGGFGSVYKARLGDG---MEVAVKVFNLQCGRALK---GFDVECEMMKSIRHR 229
           +   +IG G FG VYK  L       EV V +  L+ G   K    F  E  +M    H 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 230 NLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL-HF 288
           N+I++    S  +   ++ EYM +G+L+K++   +    + Q + ++  +A+ ++YL + 
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQTQTLATIGYMAPEYG 347
            Y    +H DL   N+L++ N+V  +SDF ++++L  + + + T +     I + APE  
Sbjct: 167 NY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 348 REGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL 406
              + ++  DV+SFGI++ E  T G++P  E+ N E+     +ND          G  L 
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA--IND----------GFRLP 270
Query: 407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVA---KLLKIRDSLLRNVGDRC 463
           +  D        C S ++ L M+C  +   +R    +IV+   KL++  DS L+ + D  
Sbjct: 271 TPMD--------CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS-LKTLADFD 321
Query: 464 IRQSI 468
            R SI
Sbjct: 322 PRVSI 326

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 71/230 (30%), Positives = 113/230 (49%), Gaps = 17/230 (7%)
Query: 160 WRTFSHLELCRATDGFSE------NNLIGRGGFGSVYKARLGDGMEVAVK----VFNLQC 209
           + +FS  EL   T+ F E       N  G GGFG VYK  + +   VAVK    + ++  
Sbjct: 3   FHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITT 61
Query: 210 GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYM--YSSNYIL 267
               + FD E ++    +H NL++++   S+ +   LV  Y P+GSL   +        L
Sbjct: 62  EELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPL 121
Query: 268 DIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 327
               R  I    A+ + +LH  +    IH D+K +N+LLD+   A +SDF +A+      
Sbjct: 122 SWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFA 178
Query: 328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNE 377
           Q +  ++ + T  Y APE  R G ++   D+YSFG++L+E  TG    +E
Sbjct: 179 QXVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 227

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 139/310 (44%), Gaps = 42/310 (13%)
Query: 170 RATDGFSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKGFDVE 219
           R    F E +L     +G+G FGSV   R   L D  G  VAVK         L+ F+ E
Sbjct: 6   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 65
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFK--ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMI 277
            E++KS++H N++K    C +   +   L++EY+P+GSL  Y+      +D  + L    
Sbjct: 66  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 125
Query: 278 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-L 336
            +   +EYL    +   IH DL   N+L+++     + DF + K+L  + +     +   
Sbjct: 126 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 182
Query: 337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT----GKKPTNEIF-------NGEMTL 385
           + I + APE   E + S   DV+SFG++L E FT     K P  E          G+M +
Sbjct: 183 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 242
Query: 386 KHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIV 445
            H +                L + +      + C   ++ +  EC   +  QR + R++ 
Sbjct: 243 FHLIE---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 287
Query: 446 AKLLKIRDSL 455
            ++ +IRD++
Sbjct: 288 LRVDQIRDNM 297

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 139/310 (44%), Gaps = 42/310 (13%)
Query: 170 RATDGFSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKGFDVE 219
           R    F E +L     +G+G FGSV   R   L D  G  VAVK         L+ F+ E
Sbjct: 1   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 60
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFK--ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMI 277
            E++KS++H N++K    C +   +   L++EY+P+GSL  Y+      +D  + L    
Sbjct: 61  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 120
Query: 278 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-L 336
            +   +EYL    +   IH DL   N+L+++     + DF + K+L  + +     +   
Sbjct: 121 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 177
Query: 337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT----GKKPTNEIF-------NGEMTL 385
           + I + APE   E + S   DV+SFG++L E FT     K P  E          G+M +
Sbjct: 178 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 237
Query: 386 KHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIV 445
            H +                L + +      + C   ++ +  EC   +  QR + R++ 
Sbjct: 238 FHLIE---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 282
Query: 446 AKLLKIRDSL 455
            ++ +IRD++
Sbjct: 283 LRVDQIRDNM 292

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 139/310 (44%), Gaps = 42/310 (13%)
Query: 170 RATDGFSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKGFDVE 219
           R    F E +L     +G+G FGSV   R   L D  G  VAVK         L+ F+ E
Sbjct: 2   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 61
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFK--ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMI 277
            E++KS++H N++K    C +   +   L++EY+P+GSL  Y+      +D  + L    
Sbjct: 62  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 121
Query: 278 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-L 336
            +   +EYL    +   IH DL   N+L+++     + DF + K+L  + +     +   
Sbjct: 122 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 178
Query: 337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT----GKKPTNEIF-------NGEMTL 385
           + I + APE   E + S   DV+SFG++L E FT     K P  E          G+M +
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238
Query: 386 KHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIV 445
            H +                L + +      + C   ++ +  EC   +  QR + R++ 
Sbjct: 239 FHLIE---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 283
Query: 446 AKLLKIRDSL 455
            ++ +IRD++
Sbjct: 284 LRVDQIRDNM 293

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 139/310 (44%), Gaps = 42/310 (13%)
Query: 170 RATDGFSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKGFDVE 219
           R    F E +L     +G+G FGSV   R   L D  G  VAVK         L+ F+ E
Sbjct: 8   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 67
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFK--ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMI 277
            E++KS++H N++K    C +   +   L++EY+P+GSL  Y+      +D  + L    
Sbjct: 68  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 127
Query: 278 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM-TQTQTL 336
            +   +EYL    +   IH DL   N+L+++     + DF + K+L  + +    +    
Sbjct: 128 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 184
Query: 337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT----GKKPTNEIF-------NGEMTL 385
           + I + APE   E + S   DV+SFG++L E FT     K P  E          G+M +
Sbjct: 185 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 244
Query: 386 KHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIV 445
            H +                L + +      + C   ++ +  EC   +  QR + R++ 
Sbjct: 245 FHLIE---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 289
Query: 446 AKLLKIRDSL 455
            ++ +IRD++
Sbjct: 290 LRVDQIRDNM 299

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 134/294 (45%), Gaps = 37/294 (12%)
Query: 181 IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVI 235
           +G+G FGSV   R   L D  G  VAVK         L+ F+ E E++KS++H N++K  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 236 STCSNEEFK--ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
             C +   +   L++EY+P+GSL  Y+      +D  + L     +   +EYL    +  
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 152
Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM-TQTQTLATIGYMAPEYGREGRV 352
            IH DL   N+L+++     + DF + K+L  + +    +    + I + APE   E + 
Sbjct: 153 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 212
Query: 353 STNGDVYSFGIMLMETFT----GKKPTNEIF-------NGEMTLKHWVNDWLPISTMEVV 401
           S   DV+SFG++L E FT     K P  E          G+M + H +            
Sbjct: 213 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE----------- 261
Query: 402 GANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL 455
               L + +      + C   ++ +  EC   +  QR + R++  ++ +IRD++
Sbjct: 262 ----LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 311

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 134/294 (45%), Gaps = 37/294 (12%)
Query: 181 IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVI 235
           +G+G FGSV   R   L D  G  VAVK         L+ F+ E E++KS++H N++K  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 236 STCSNEEFK--ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
             C +   +   L++EY+P+GSL  Y+      +D  + L     +   +EYL    +  
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134
Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-LATIGYMAPEYGREGRV 352
            IH DL   N+L+++     + DF + K+L  + +     +   + I + APE   E + 
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 194
Query: 353 STNGDVYSFGIMLMETFT----GKKPTNEIF-------NGEMTLKHWVNDWLPISTMEVV 401
           S   DV+SFG++L E FT     K P  E          G+M + H +            
Sbjct: 195 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE----------- 243
Query: 402 GANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL 455
               L + +      + C   ++ +  EC   +  QR + R++  ++ +IRD++
Sbjct: 244 ----LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 139/310 (44%), Gaps = 42/310 (13%)
Query: 170 RATDGFSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKGFDVE 219
           R    F E +L     +G+G FGSV   R   L D  G  VAVK         L+ F+ E
Sbjct: 7   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 66
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFK--ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMI 277
            E++KS++H N++K    C +   +   L++EY+P+GSL  Y+      +D  + L    
Sbjct: 67  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 126
Query: 278 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-L 336
            +   +EYL    +   IH DL   N+L+++     + DF + K+L  + +     +   
Sbjct: 127 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 183
Query: 337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT----GKKPTNEIF-------NGEMTL 385
           + I + APE   E + S   DV+SFG++L E FT     K P  E          G+M +
Sbjct: 184 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 243
Query: 386 KHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIV 445
            H +                L + +      + C   ++ +  EC   +  QR + R++ 
Sbjct: 244 FHLIE---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 288
Query: 446 AKLLKIRDSL 455
            ++ +IRD++
Sbjct: 289 LRVDQIRDNM 298

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 139/310 (44%), Gaps = 42/310 (13%)
Query: 170 RATDGFSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKGFDVE 219
           R    F E +L     +G+G FGSV   R   L D  G  VAVK         L+ F+ E
Sbjct: 9   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 68
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFK--ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMI 277
            E++KS++H N++K    C +   +   L++EY+P+GSL  Y+      +D  + L    
Sbjct: 69  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 128
Query: 278 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-L 336
            +   +EYL    +   IH DL   N+L+++     + DF + K+L  + +     +   
Sbjct: 129 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 185
Query: 337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT----GKKPTNEIF-------NGEMTL 385
           + I + APE   E + S   DV+SFG++L E FT     K P  E          G+M +
Sbjct: 186 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 245
Query: 386 KHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIV 445
            H +                L + +      + C   ++ +  EC   +  QR + R++ 
Sbjct: 246 FHLIE---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 290
Query: 446 AKLLKIRDSL 455
            ++ +IRD++
Sbjct: 291 LRVDQIRDNM 300

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 140/310 (45%), Gaps = 42/310 (13%)
Query: 170 RATDGFSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKGFDVE 219
           R    F E +L     +G+G FGSV   R   L D  G  VAVK         L+ F+ E
Sbjct: 5   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFK--ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMI 277
            E++KS++H N++K    C +   +   L++EY+P+GSL  Y+ +    +D  + L    
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTS 124
Query: 278 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-L 336
            +   +EYL    +   IH DL   N+L+++     + DF + K+L  + +     +   
Sbjct: 125 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 181
Query: 337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT----GKKPTNEIF-------NGEMTL 385
           + I + APE   E + S   DV+SFG++L E FT     K P  E          G+M +
Sbjct: 182 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 241
Query: 386 KHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIV 445
            H +                L + +      + C   ++ +  EC   +  QR + R++ 
Sbjct: 242 FHLIE---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 286
Query: 446 AKLLKIRDSL 455
            ++ +IRD++
Sbjct: 287 LRVDQIRDNM 296

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 138/310 (44%), Gaps = 42/310 (13%)
Query: 170 RATDGFSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKGFDVE 219
           R    F E +L     +G+G FGSV   R   L D  G  VAVK         L+ F+ E
Sbjct: 33  RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 92
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFK--ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMI 277
            E++KS++H N++K    C +   +   L++EY+P+GSL  Y+      +D  + L    
Sbjct: 93  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 152
Query: 278 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-L 336
            +   +EYL    +   IH DL   N+L+++     + DF + K+L  + +     +   
Sbjct: 153 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 209
Query: 337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT----GKKPTNEIF-------NGEMTL 385
           + I + APE   E + S   DV+SFG++L E FT     K P  E          G+M +
Sbjct: 210 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 269
Query: 386 KHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIV 445
            H +                L + +      + C   ++ +  EC   +  QR + R++ 
Sbjct: 270 FHLIE---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 314
Query: 446 AKLLKIRDSL 455
            ++ +IRD +
Sbjct: 315 LRVDQIRDQM 324

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 139/310 (44%), Gaps = 42/310 (13%)
Query: 170 RATDGFSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKGFDVE 219
           R    F E +L     +G+G FGSV   R   L D  G  VAVK         L+ F+ E
Sbjct: 5   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFK--ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMI 277
            E++KS++H N++K    C +   +   L++EY+P+GSL  Y+      +D  + L    
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 124
Query: 278 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-L 336
            +   +EYL    +   IH DL   N+L+++     + DF + K+L  + +     +   
Sbjct: 125 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 181
Query: 337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT----GKKPTNEIF-------NGEMTL 385
           + I + APE   E + S   DV+SFG++L E FT     K P  E          G+M +
Sbjct: 182 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 241
Query: 386 KHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIV 445
            H +                L + +      + C   ++ +  EC   +  QR + R++ 
Sbjct: 242 FHLIE---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 286
Query: 446 AKLLKIRDSL 455
            ++ +IRD++
Sbjct: 287 LRVDQIRDNM 296

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 134/294 (45%), Gaps = 37/294 (12%)
Query: 181 IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVI 235
           +G+G FGSV   R   L D  G  VAVK         L+ F+ E E++KS++H N++K  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 236 STCSNEEFK--ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
             C +   +   L++EY+P+GSL  Y+      +D  + L     +   +EYL    +  
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 152
Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM-TQTQTLATIGYMAPEYGREGRV 352
            IH DL   N+L+++     + DF + K+L  + +    +    + I + APE   E + 
Sbjct: 153 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 212
Query: 353 STNGDVYSFGIMLMETFT----GKKPTNEIF-------NGEMTLKHWVNDWLPISTMEVV 401
           S   DV+SFG++L E FT     K P  E          G+M + H +            
Sbjct: 213 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE----------- 261
Query: 402 GANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL 455
               L + +      + C   ++ +  EC   +  QR + R++  ++ +IRD++
Sbjct: 262 ----LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 311

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 133/294 (45%), Gaps = 37/294 (12%)
Query: 181 IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVI 235
           +G+G FGSV   R   L D  G  VAVK         L+ F+ E E++KS++H N++K  
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 236 STCSNEEFK--ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
             C +   +   L++EY+P+GSL  Y+      +D  + L     +   +EYL    +  
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 132
Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-LATIGYMAPEYGREGRV 352
            IH DL   N+L+++     + DF + K+L  + +     +   + I + APE   E + 
Sbjct: 133 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 192
Query: 353 STNGDVYSFGIMLMETFT----GKKPTNEIF-------NGEMTLKHWVNDWLPISTMEVV 401
           S   DV+SFG++L E FT     K P  E          G+M + H +            
Sbjct: 193 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE----------- 241
Query: 402 GANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL 455
               L + +      + C   ++ +  EC   +  QR + R++  ++ +IRD +
Sbjct: 242 ----LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 291

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 134/294 (45%), Gaps = 37/294 (12%)
Query: 181 IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVI 235
           +G+G FGSV   R   L D  G  VAVK         L+ F+ E E++KS++H N++K  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 236 STCSNEEFK--ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
             C +   +   L++EY+P+GSL  Y+      +D  + L     +   +EYL    +  
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134
Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-LATIGYMAPEYGREGRV 352
            IH DL   N+L+++     + DF + K+L  + +     +   + I + APE   E + 
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF 194
Query: 353 STNGDVYSFGIMLMETFT----GKKPTNEIF-------NGEMTLKHWVNDWLPISTMEVV 401
           S   DV+SFG++L E FT     K P  E          G+M + H +            
Sbjct: 195 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE----------- 243
Query: 402 GANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL 455
               L + +      + C   ++ +  EC   +  QR + R++  ++ +IRD++
Sbjct: 244 ----LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 81/282 (28%), Positives = 121/282 (42%), Gaps = 40/282 (14%)
Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKG-FDVECEMMKSIRHRNLIKVISTC 238
           IGRG FG V+  RL  D   VAVK         LK  F  E  ++K   H N++++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 239 SNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
           + ++   +V+E +  G    ++ +    L +   L ++ D A+ +EYL    S   IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
           L   N L+ +  V  +SDF +++       + +       + + APE    GR S+  DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 359 YSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAK- 416
           +SFGI+L ETF+ G  P                             NL +Q+   FV K 
Sbjct: 299 WSFGILLWETFSLGASPY---------------------------PNLSNQQTREFVEKG 331
Query: 417 ------EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR 452
                 E C   VF L  +C    P QR +   I  +L  IR
Sbjct: 332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 140/310 (45%), Gaps = 42/310 (13%)
Query: 170 RATDGFSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKGFDVE 219
           R    F E +L     +G+G FGSV   R   L D  G  VAVK         L+ F+ E
Sbjct: 5   RDPTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFK--ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMI 277
            E++KS++H N++K    C +   +   L++E++P+GSL +Y+      +D  + L    
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTS 124
Query: 278 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-L 336
            +   +EYL    +   IH DL   N+L+++     + DF + K+L  + +     +   
Sbjct: 125 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 181
Query: 337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT----GKKPTNEIF-------NGEMTL 385
           + I + APE   E + S   DV+SFG++L E FT     K P  E          G+M +
Sbjct: 182 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 241
Query: 386 KHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIV 445
            H +                L + +      + C   ++ +  EC   +  QR + R++ 
Sbjct: 242 FHLIE---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 286
Query: 446 AKLLKIRDSL 455
            ++ +IRD++
Sbjct: 287 LRVDQIRDNM 296

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 81/282 (28%), Positives = 121/282 (42%), Gaps = 40/282 (14%)
Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKG-FDVECEMMKSIRHRNLIKVISTC 238
           IGRG FG V+  RL  D   VAVK         LK  F  E  ++K   H N++++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 239 SNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
           + ++   +V+E +  G    ++ +    L +   L ++ D A+ +EYL    S   IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
           L   N L+ +  V  +SDF +++       + +       + + APE    GR S+  DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 359 YSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAK- 416
           +SFGI+L ETF+ G  P                             NL +Q+   FV K 
Sbjct: 299 WSFGILLWETFSLGASPY---------------------------PNLSNQQTREFVEKG 331
Query: 417 ------EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR 452
                 E C   VF L  +C    P QR +   I  +L  IR
Sbjct: 332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 139/310 (44%), Gaps = 42/310 (13%)
Query: 170 RATDGFSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKGFDVE 219
           R    F E +L     +G+G FGSV   R   L D  G  VAVK         L+ F+ E
Sbjct: 3   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 62
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFK--ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMI 277
            E++KS++H N++K    C +   +   L++EY+P+GSL  Y+      +D  + L    
Sbjct: 63  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 122
Query: 278 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-L 336
            +   +EYL    +   IH +L   N+L+++     + DF + K+L  + +     +   
Sbjct: 123 QICKGMEYLG---TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGE 179
Query: 337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT----GKKPTNEIF-------NGEMTL 385
           + I + APE   E + S   DV+SFG++L E FT     K P  E          G+M +
Sbjct: 180 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 239
Query: 386 KHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIV 445
            H +                L + +      + C   ++ +  EC   +  QR + R++ 
Sbjct: 240 FHLIE---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 284
Query: 446 AKLLKIRDSL 455
            ++ +IRD++
Sbjct: 285 LRVDQIRDNM 294

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 100/208 (48%), Gaps = 21/208 (10%)
Query: 180 LIGRGGFGSVYKA-RLGDGMEVAVKVF----NLQCGRALKGFDVECEMMKSIRHRNLIKV 234
           +IG GGFG VY+A  +GD  EVAVK      +    + ++    E ++   ++H N+I +
Sbjct: 14  IIGIGGFGKVYRAFWIGD--EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI 294
              C  E    LV+E+   G L + +       DI   +N  + +A  + YLH     PI
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL--VNWAVQIARGMNYLHDEAIVPI 129
Query: 295 IHCDLKPSNVLLDD--------NMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           IH DLK SN+L+          N +  ++DF +A+    E    T+        +MAPE 
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGAYAWMAPEV 185
Query: 347 GREGRVSTNGDVYSFGIMLMETFTGKKP 374
            R    S   DV+S+G++L E  TG+ P
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 134/274 (48%), Gaps = 28/274 (10%)
Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G FG+VYK +  GD   VAVK+ N+     + L+ F  E  +++  RH N++  +  
Sbjct: 20  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
            +  +  A+V ++    SL  ++++S    ++ + ++I    A  ++YLH   +  IIH 
Sbjct: 77  STKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHR 132
Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR---EGRVST 354
           DLK +N+ L ++    + DF +A + +    S    Q   +I +MAPE  R       S 
Sbjct: 133 DLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 192
Query: 355 NGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFV 414
             DVY+FGI+L E  TG+ P + I N +  +             E+VG   LS  D+  V
Sbjct: 193 QSDVYAFGIVLYELMTGQLPYSNINNRDQII-------------EMVGRGSLS-PDLSKV 238
Query: 415 AKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
            +  C   +  L  EC  +  ++R +   I+A++
Sbjct: 239 -RSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 271

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 124/292 (42%), Gaps = 50/292 (17%)
Query: 181 IGRGGFGSVYKARL------GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKV 234
           +G G FG V+ A         D M VAVK        A + F  E E++  ++H+++++ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYS--------------SNYILDIFQRLNIMIDVA 280
              C+      +V EYM HG L +++ S              +   L + Q L +   VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 281 SALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA 337
           + + YL   HF      +H DL   N L+   +V  + DF +++ +   D      +T+ 
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 338 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPIS 396
            I +M PE     + +T  DV+SFG++L E FT GK+P                 W  +S
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP-----------------WYQLS 265
Query: 397 TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
             E +      +E         C   V+ +   C    P+QR + +++ A+L
Sbjct: 266 NTEAIDCITQGRE---LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 314

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 124/292 (42%), Gaps = 50/292 (17%)
Query: 181 IGRGGFGSVYKARL------GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKV 234
           +G G FG V+ A         D M VAVK        A + F  E E++  ++H+++++ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYS--------------SNYILDIFQRLNIMIDVA 280
              C+      +V EYM HG L +++ S              +   L + Q L +   VA
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 281 SALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA 337
           + + YL   HF      +H DL   N L+   +V  + DF +++ +   D      +T+ 
Sbjct: 140 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 193
Query: 338 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPIS 396
            I +M PE     + +T  DV+SFG++L E FT GK+P                 W  +S
Sbjct: 194 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP-----------------WYQLS 236
Query: 397 TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
             E +      +E         C   V+ +   C    P+QR + +++ A+L
Sbjct: 237 NTEAIDCITQGRE---LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 285

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 124/292 (42%), Gaps = 50/292 (17%)
Query: 181 IGRGGFGSVYKARL------GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKV 234
           +G G FG V+ A         D M VAVK        A + F  E E++  ++H+++++ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYS--------------SNYILDIFQRLNIMIDVA 280
              C+      +V EYM HG L +++ S              +   L + Q L +   VA
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 281 SALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA 337
           + + YL   HF      +H DL   N L+   +V  + DF +++ +   D      +T+ 
Sbjct: 146 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 199
Query: 338 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPIS 396
            I +M PE     + +T  DV+SFG++L E FT GK+P                 W  +S
Sbjct: 200 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP-----------------WYQLS 242
Query: 397 TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
             E +      +E         C   V+ +   C    P+QR + +++ A+L
Sbjct: 243 NTEAIDCITQGRE---LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 291

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 6/205 (2%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           IG G FG V+     +  +VA+K    +   + + F  E E+M  + H  L+++   C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 300
           +    LV E+M HG L  Y+ +   +      L + +DV   + YL     A +IH DL 
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EASVIHRDLA 130
Query: 301 PSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYS 360
             N L+ +N V  +SDF + + +  +DQ  + T T   + + +PE     R S+  DV+S
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 361 FGIMLMETFT-GKKPTNEIFNGEMT 384
           FG+++ E F+ GK P     N E+ 
Sbjct: 190 FGVLMWEVFSEGKIPYENRSNSEVV 214

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 125/278 (44%), Gaps = 28/278 (10%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           IG G FG V+     +  +VA+K    +   + + F  E E+M  + H  L+++   C  
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 300
           +    LV E+M HG L  Y+ +   +      L + +DV   + YL     A +IH DL 
Sbjct: 77  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 133
Query: 301 PSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYS 360
             N L+ +N V  +SDF + + +  +DQ  + T T   + + +PE     R S+  DV+S
Sbjct: 134 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 192
Query: 361 FGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPIST-MEVVGANLLSQEDIHFVAKEQ 418
           FG+++ E F+ GK P     N E+     V D   IST   +    L S           
Sbjct: 193 FGVLMWEVFSEGKIPYENRSNSEV-----VED---ISTGFRLYKPRLASTH--------- 235
Query: 419 CVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL 456
               V+ +   C  E PE R     ++ +L +I +S L
Sbjct: 236 ----VYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 269

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 125/278 (44%), Gaps = 28/278 (10%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           IG G FG V+     +  +VA+K    +   + + F  E E+M  + H  L+++   C  
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 300
           +    LV E+M HG L  Y+ +   +      L + +DV   + YL     A +IH DL 
Sbjct: 72  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 128
Query: 301 PSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYS 360
             N L+ +N V  +SDF + + +  +DQ  + T T   + + +PE     R S+  DV+S
Sbjct: 129 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 187
Query: 361 FGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPIST-MEVVGANLLSQEDIHFVAKEQ 418
           FG+++ E F+ GK P     N E+     V D   IST   +    L S           
Sbjct: 188 FGVLMWEVFSEGKIPYENRSNSEV-----VED---ISTGFRLYKPRLASTH--------- 230
Query: 419 CVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL 456
               V+ +   C  E PE R     ++ +L +I +S L
Sbjct: 231 ----VYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL 264

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 125/278 (44%), Gaps = 28/278 (10%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           IG G FG V+     +  +VA+K    +   + + F  E E+M  + H  L+++   C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 300
           +    LV E+M HG L  Y+ +   +      L + +DV   + YL     A +IH DL 
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 130
Query: 301 PSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYS 360
             N L+ +N V  +SDF + + +  +DQ  + T T   + + +PE     R S+  DV+S
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 361 FGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPIST-MEVVGANLLSQEDIHFVAKEQ 418
           FG+++ E F+ GK P     N E+     V D   IST   +    L S           
Sbjct: 190 FGVLMWEVFSEGKIPYENRSNSEV-----VED---ISTGFRLYKPRLASTH--------- 232
Query: 419 CVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL 456
               V+ +   C  E PE R     ++ +L +I +S L
Sbjct: 233 ----VYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL 266

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 133/274 (48%), Gaps = 28/274 (10%)
Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G FG+VYK +  GD   VAVK+ N+     + L+ F  E  +++  RH N++  +  
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
            +  +  A+V ++    SL  ++++S    ++ + ++I    A  ++YLH   +  IIH 
Sbjct: 89  STKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHR 144
Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR---EGRVST 354
           DLK +N+ L ++    + DF +A   +    S    Q   +I +MAPE  R       S 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 355 NGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFV 414
             DVY+FGI+L E  TG+ P + I N +  +             E+VG   LS  D+  V
Sbjct: 205 QSDVYAFGIVLYELMTGQLPYSNINNRDQII-------------EMVGRGSLS-PDLSKV 250
Query: 415 AKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
            +  C   +  L  EC  +  ++R +   I+A++
Sbjct: 251 -RSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 120/283 (42%), Gaps = 42/283 (14%)
Query: 181 IGRGGFGSVYKARL------GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKV 234
           +G G FG V+ A         D + VAVK        A K F  E E++ +++H +++K 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSN------------YILDIFQRLNIMIDVASA 282
              C   +   +V EYM HG L K++ +                L   Q L+I   +A+ 
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 283 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           + YL    S   +H DL   N L+ +N++  + DF +++ +   D       T+  I +M
Sbjct: 141 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 343 APEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVV 401
            PE     + +T  DV+S G++L E FT GK+P                 W  +S  EV+
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP-----------------WYQLSNNEVI 240
Query: 402 GANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREI 444
               ++Q  +       C   V+ L + C    P  R N + I
Sbjct: 241 --ECITQGRV-LQRPRTCPQEVYELMLGCWQREPHMRKNIKGI 280

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 139/293 (47%), Gaps = 36/293 (12%)
Query: 176 SENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RALKGFDVECEMMKSIRHRN 230
           S + ++G G FG V   RL      E++V +  L+ G   +  + F  E  +M    H N
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL-HFG 289
           +I++    +  +   +V EYM +GSL+ ++   +    + Q + ++  +AS ++YL   G
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ-TLATIGYMAPEYGR 348
           Y    +H DL   N+L++ N+V  +SDF +A++L  + ++   T+     I + +PE   
Sbjct: 168 Y----VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 349 EGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS 407
             + ++  DV+S+GI+L E  + G++P            +W      +S  +V+ A    
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP------------YW-----EMSNQDVIKA---V 263
Query: 408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNVG 460
            E         C + ++ L ++C  +    R    +IV+    I D L+RN G
Sbjct: 264 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRNPG 312

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 12/207 (5%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G+G FG V+         VA+K   L+ G  + + F  E ++MK +RH  L+++ +  S
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 240 NEEFKALVLEYMPHGSLEKYMY-SSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    +V EYM  GSL  ++   +   L + Q +++   +AS + Y+        +H D
Sbjct: 74  EEPI-XIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 129
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGD 357
           L+ +N+L+ +N+V  ++DF +A+L+  ED   T  Q     I + APE    GR +   D
Sbjct: 130 LRAANILVGENLVCKVADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 187
Query: 358 VYSFGIMLME-TFTGKKPTNEIFNGEM 383
           V+SFGI+L E T  G+ P   + N E+
Sbjct: 188 VWSFGILLTELTTKGRVPYPGMVNREV 214

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 125/278 (44%), Gaps = 28/278 (10%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           IG G FG V+     +  +VA+K    +   + + F  E E+M  + H  L+++   C  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 300
           +    LV E+M HG L  Y+ +   +      L + +DV   + YL     A +IH DL 
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 131
Query: 301 PSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYS 360
             N L+ +N V  +SDF + + +  +DQ  + T T   + + +PE     R S+  DV+S
Sbjct: 132 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190
Query: 361 FGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPIST-MEVVGANLLSQEDIHFVAKEQ 418
           FG+++ E F+ GK P     N E+     V D   IST   +    L S           
Sbjct: 191 FGVLMWEVFSEGKIPYENRSNSEV-----VED---ISTGFRLYKPRLASTH--------- 233
Query: 419 CVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL 456
               V+ +   C  E PE R     ++ +L +I +S L
Sbjct: 234 ----VYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 124/278 (44%), Gaps = 28/278 (10%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           IG G FG V+     +  +VA+K    +   +   F  E E+M  + H  L+++   C  
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIK-EGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 300
           +    LV E+M HG L  Y+ +   +      L + +DV   + YL     A +IH DL 
Sbjct: 94  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 150
Query: 301 PSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYS 360
             N L+ +N V  +SDF + + +  +DQ  + T T   + + +PE     R S+  DV+S
Sbjct: 151 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 209
Query: 361 FGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPIST-MEVVGANLLSQEDIHFVAKEQ 418
           FG+++ E F+ GK P     N E+     V D   IST   +    L S           
Sbjct: 210 FGVLMWEVFSEGKIPYENRSNSEV-----VED---ISTGFRLYKPRLASTH--------- 252
Query: 419 CVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL 456
               V+ +   C  E PE R     ++ +L +I +S L
Sbjct: 253 ----VYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL 286

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 104/203 (51%), Gaps = 18/203 (8%)
Query: 181 IGRGGFGSVYKARLGD--GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTC 238
           IG+G FG V    LGD  G +VAVK   ++     + F  E  +M  +RH NL++++   
Sbjct: 14  IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 239 SNEEFK-ALVLEYMPHGSLEKYMYS-SNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
             E+    +V EYM  GSL  Y+ S    +L     L   +DV  A+EYL        +H
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 125
Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 356
            DL   NVL+ ++ VA +SDF + K     + S TQ      + + APE  RE + ST  
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 180
Query: 357 DVYSFGIMLMETFT-GKKPTNEI 378
           DV+SFGI+L E ++ G+ P   I
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRI 203

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 104/203 (51%), Gaps = 18/203 (8%)
Query: 181 IGRGGFGSVYKARLGD--GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTC 238
           IG+G FG V    LGD  G +VAVK   ++     + F  E  +M  +RH NL++++   
Sbjct: 29  IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 239 SNEEFK-ALVLEYMPHGSLEKYMYS-SNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
             E+    +V EYM  GSL  Y+ S    +L     L   +DV  A+EYL        +H
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 140
Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 356
            DL   NVL+ ++ VA +SDF + K     + S TQ      + + APE  RE + ST  
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 195
Query: 357 DVYSFGIMLMETFT-GKKPTNEI 378
           DV+SFGI+L E ++ G+ P   I
Sbjct: 196 DVWSFGILLWEIYSFGRVPYPRI 218

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 133/274 (48%), Gaps = 28/274 (10%)
Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G FG+VYK +  GD   VAVK+ N+     + L+ F  E  +++  RH N++  +  
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
            +  +  A+V ++    SL  ++++S    ++ + ++I    A  ++YLH   +  IIH 
Sbjct: 89  STAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHR 144
Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR---EGRVST 354
           DLK +N+ L ++    + DF +A   +    S    Q   +I +MAPE  R       S 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 355 NGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFV 414
             DVY+FGI+L E  TG+ P + I N +  +             E+VG   LS  D+  V
Sbjct: 205 QSDVYAFGIVLYELMTGQLPYSNINNRDQII-------------EMVGRGSLS-PDLSKV 250
Query: 415 AKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
            +  C   +  L  EC  +  ++R +   I+A++
Sbjct: 251 -RSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 13/211 (6%)
Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNL--QCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G FG+VYK +  GD   VAVK+  +        + F  E  +++  RH N++  +  
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
            + +   A+V ++    SL K+++       +FQ ++I    A  ++YLH   +  IIH 
Sbjct: 101 MTKDNL-AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHR 156
Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR---EGRVST 354
           D+K +N+ L + +   + DF +A + +    S    Q   ++ +MAPE  R       S 
Sbjct: 157 DMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSF 216
Query: 355 NGDVYSFGIMLMETFTGKKPTNEIFNGEMTL 385
             DVYS+GI+L E  TG+ P + I N +  +
Sbjct: 217 QSDVYSYGIVLYELMTGELPYSHINNRDQII 247

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 12/207 (5%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G+G FG V+         VA+K   L+ G  + + F  E ++MK +RH  L+++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 240 NEEFKALVLEYMPHGSLEKYMYSS-NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    +V+EYM  GSL  ++       L + Q +++   +AS + Y+        +H D
Sbjct: 84  EEPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGD 357
           L+ +N+L+ +N+V  ++DF +A+L+  ED   T  Q     I + APE    GR +   D
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 358 VYSFGIMLME-TFTGKKPTNEIFNGEM 383
           V+SFGI+L E T  G+ P   + N E+
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREV 224

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 103/203 (50%), Gaps = 18/203 (8%)
Query: 181 IGRGGFGSVYKARLGD--GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTC 238
           IG+G FG V    LGD  G +VAVK   ++     + F  E  +M  +RH NL++++   
Sbjct: 20  IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 239 SNEEFK-ALVLEYMPHGSLEKYMYS-SNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
             E+    +V EYM  GSL  Y+ S    +L     L   +DV  A+EYL        +H
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 131
Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 356
            DL   NVL+ ++ VA +SDF + K     + S TQ      + + APE  RE   ST  
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREAAFSTKS 186
Query: 357 DVYSFGIMLMETFT-GKKPTNEI 378
           DV+SFGI+L E ++ G+ P   I
Sbjct: 187 DVWSFGILLWEIYSFGRVPYPRI 209

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 104/203 (51%), Gaps = 18/203 (8%)
Query: 181 IGRGGFGSVYKARLGD--GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTC 238
           IG+G FG V    LGD  G +VAVK   ++     + F  E  +M  +RH NL++++   
Sbjct: 201 IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 239 SNEEFK-ALVLEYMPHGSLEKYMYS-SNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
             E+    +V EYM  GSL  Y+ S    +L     L   +DV  A+EYL        +H
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 312
Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 356
            DL   NVL+ ++ VA +SDF + K     + S TQ      + + APE  RE + ST  
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 367
Query: 357 DVYSFGIMLMETFT-GKKPTNEI 378
           DV+SFGI+L E ++ G+ P   I
Sbjct: 368 DVWSFGILLWEIYSFGRVPYPRI 390

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 12/207 (5%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G+G FG V+         VA+K   L+ G  + + F  E ++MK IRH  L+++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 240 NEEFKALVLEYMPHGSLEKYMYSS-NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    +V EYM  GSL  ++       L + Q +++   +AS + Y+        +H D
Sbjct: 84  EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGD 357
           L+ +N+L+ +N+V  ++DF +A+L+  ED   T  Q     I + APE    GR +   D
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 358 VYSFGIMLME-TFTGKKPTNEIFNGEM 383
           V+SFGI+L E T  G+ P   + N E+
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREV 224

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 135/281 (48%), Gaps = 28/281 (9%)
Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G FG+VYK +  GD   VAVK+ N+     + L+ F  E  +++  RH N++  +  
Sbjct: 21  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
            +  +  A+V ++    SL  +++      ++ + ++I    A  ++YLH   +  IIH 
Sbjct: 78  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 133
Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR---EGRVST 354
           DLK +N+ L +++   + DF +A + +    S    Q   +I +MAPE  R   +   S 
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 355 NGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFV 414
             DVY+FGI+L E  TG+ P + I N +  +              +VG   LS  D+  V
Sbjct: 194 QSDVYAFGIVLYELMTGQLPYSNINNRDQII-------------FMVGRGYLS-PDLSKV 239
Query: 415 AKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL 455
            +  C   +  L  EC  +  ++R    +I+A +  +  SL
Sbjct: 240 -RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 279

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 135/281 (48%), Gaps = 28/281 (9%)
Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G FG+VYK +  GD   VAVK+ N+     + L+ F  E  +++  RH N++  +  
Sbjct: 18  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
            +  +  A+V ++    SL  +++      ++ + ++I    A  ++YLH   +  IIH 
Sbjct: 75  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 130
Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR---EGRVST 354
           DLK +N+ L +++   + DF +A + +    S    Q   +I +MAPE  R   +   S 
Sbjct: 131 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 190
Query: 355 NGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFV 414
             DVY+FGI+L E  TG+ P + I N +  +              +VG   LS  D+  V
Sbjct: 191 QSDVYAFGIVLYELMTGQLPYSNINNRDQII-------------FMVGRGYLS-PDLSKV 236
Query: 415 AKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL 455
            +  C   +  L  EC  +  ++R    +I+A +  +  SL
Sbjct: 237 -RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 276

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 135/281 (48%), Gaps = 28/281 (9%)
Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G FG+VYK +  GD   VAVK+ N+     + L+ F  E  +++  RH N++  +  
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
            +  +  A+V ++    SL  +++      ++ + ++I    A  ++YLH   +  IIH 
Sbjct: 73  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 128
Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR---EGRVST 354
           DLK +N+ L +++   + DF +A + +    S    Q   +I +MAPE  R   +   S 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 355 NGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFV 414
             DVY+FGI+L E  TG+ P + I N +  +              +VG   LS  D+  V
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNINNRDQII-------------FMVGRGYLS-PDLSKV 234
Query: 415 AKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL 455
            +  C   +  L  EC  +  ++R    +I+A +  +  SL
Sbjct: 235 -RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 12/207 (5%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G+G FG V+         VA+K   L+ G  + + F  E ++MK +RH  L+++ +  S
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 240 NEEFKALVLEYMPHGSLEKYMY-SSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    +V EYM  GSL  ++   +   L + Q +++   +AS + Y+        +H D
Sbjct: 77  EEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 132
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGD 357
           L+ +N+L+ +N+V  ++DF +A+L+  ED   T  Q     I + APE    GR +   D
Sbjct: 133 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 190
Query: 358 VYSFGIMLME-TFTGKKPTNEIFNGEM 383
           V+SFGI+L E T  G+ P   + N E+
Sbjct: 191 VWSFGILLTELTTKGRVPYPGMVNREV 217

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 12/207 (5%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G+G FG V+         VA+K   L+ G  + + F  E ++MK +RH  L+++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 240 NEEFKALVLEYMPHGSLEKYMYSS-NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    +V+EYM  GSL  ++       L + Q +++   +AS + Y+        +H D
Sbjct: 84  EEPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGD 357
           L+ +N+L+ +N+V  ++DF +A+L+  ED   T  Q     I + APE    GR +   D
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 358 VYSFGIMLME-TFTGKKPTNEIFNGEM 383
           V+SFGI+L E T  G+ P   + N E+
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREV 224

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 115/229 (50%), Gaps = 20/229 (8%)
Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNL---QCGRALKGFDVECEMMKSIRHRNLIKVIS 236
           +G GG  +VY A      ++VA+K   +   +    LK F+ E      + H+N++ +I 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
               ++   LV+EY+   +L +Y+  S+  L +   +N    +   +++ H      I+H
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAH---DMRIVH 134
Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT-QTLATIGYMAPEYGREGRVSTN 355
            D+KP N+L+D N    + DF IAK L+  + S+TQT   L T+ Y +PE  +       
Sbjct: 135 RDIKPQNILIDSNKTLKIFDFGIAKALS--ETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 356 GDVYSFGIMLMETFTGKKPTNEIFNGE----MTLKHWVNDWLPISTMEV 400
            D+YS GI+L E   G+ P    FNGE    + +KH + D +P  T +V
Sbjct: 193 TDIYSIGIVLYEMLVGEPP----FNGETAVSIAIKH-IQDSVPNVTTDV 236

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 139/294 (47%), Gaps = 36/294 (12%)
Query: 175 FSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RALKGFDVECEMMKSIRHR 229
            S + ++G G FG V   RL      E++V +  L+ G   +  + F  E  +M    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 230 NLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL-HF 288
           N+I++    +  +   +V EYM +GSL+ ++   +    + Q + ++  +AS ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ-TLATIGYMAPEYG 347
           GY    +H DL   N+L++ N+V  +SDF ++++L  + ++   T+     I + +PE  
Sbjct: 167 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 348 REGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL 406
              + ++  DV+S+GI+L E  + G++P            +W      +S  +V+ A   
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERP------------YW-----EMSNQDVIKA--- 262
Query: 407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNVG 460
             E         C + ++ L ++C  +    R    +IV+    I D L+RN G
Sbjct: 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRNPG 312

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 139/294 (47%), Gaps = 36/294 (12%)
Query: 175 FSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RALKGFDVECEMMKSIRHR 229
            S + ++G G FG V   RL      E++V +  L+ G   +  + F  E  +M    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 230 NLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL-HF 288
           N+I++    +  +   +V EYM +GSL+ ++   +    + Q + ++  +AS ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ-TLATIGYMAPEYG 347
           GY    +H DL   N+L++ N+V  +SDF ++++L  + ++   T+     I + +PE  
Sbjct: 167 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 348 REGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL 406
              + ++  DV+S+GI+L E  + G++P            +W      +S  +V+ A   
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERP------------YW-----EMSNQDVIKA--- 262
Query: 407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNVG 460
             E         C + ++ L ++C  +    R    +IV+    I D L+RN G
Sbjct: 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRNPG 312

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 139/293 (47%), Gaps = 36/293 (12%)
Query: 176 SENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RALKGFDVECEMMKSIRHRN 230
           S + ++G G FG V   RL      E++V +  L+ G   +  + F  E  +M    H N
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL-HFG 289
           +I++    +  +   +V EYM +GSL+ ++   +    + Q + ++  +AS ++YL   G
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ-TLATIGYMAPEYGR 348
           Y    +H DL   N+L++ N+V  +SDF ++++L  + ++   T+     I + +PE   
Sbjct: 168 Y----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 349 EGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS 407
             + ++  DV+S+GI+L E  + G++P            +W      +S  +V+ A    
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP------------YW-----EMSNQDVIKA---V 263
Query: 408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNVG 460
            E         C + ++ L ++C  +    R    +IV+    I D L+RN G
Sbjct: 264 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRNPG 312

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 135/281 (48%), Gaps = 28/281 (9%)
Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G FG+VYK +  GD   VAVK+ N+     + L+ F  E  +++  RH N++  +  
Sbjct: 21  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
            +  +  A+V ++    SL  +++      ++ + ++I    A  ++YLH   +  IIH 
Sbjct: 78  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 133
Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR---EGRVST 354
           DLK +N+ L +++   + DF +A + +    S    Q   +I +MAPE  R   +   S 
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 355 NGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFV 414
             DVY+FGI+L E  TG+ P + I N +  +              +VG   LS  D+  V
Sbjct: 194 QSDVYAFGIVLYELMTGQLPYSNINNRDQII-------------FMVGRGYLS-PDLSKV 239
Query: 415 AKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL 455
            +  C   +  L  EC  +  ++R    +I+A +  +  SL
Sbjct: 240 -RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 279

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 139/294 (47%), Gaps = 36/294 (12%)
Query: 175 FSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RALKGFDVECEMMKSIRHR 229
            S + ++G G FG V   RL      E++V +  L+ G   +  + F  E  +M    H 
Sbjct: 45  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 104
Query: 230 NLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL-HF 288
           N+I++    +  +   +V EYM +GSL+ ++   +    + Q + ++  +AS ++YL   
Sbjct: 105 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 164
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ-TLATIGYMAPEYG 347
           GY    +H DL   N+L++ N+V  +SDF ++++L  + ++   T+     I + +PE  
Sbjct: 165 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 220
Query: 348 REGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL 406
              + ++  DV+S+GI+L E  + G++P            +W      +S  +V+ A   
Sbjct: 221 AYRKFTSASDVWSYGIVLWEVMSYGERP------------YW-----EMSNQDVIKA--- 260
Query: 407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNVG 460
             E         C + ++ L ++C  +    R    +IV+    I D L+RN G
Sbjct: 261 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRNPG 310

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 132/274 (48%), Gaps = 28/274 (10%)
Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G FG+VYK +  GD   VAVK+ N+     + L+ F  E  +++  RH N++  +  
Sbjct: 43  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
            +  +  A+V ++    SL  +++      ++ + ++I    A  ++YLH   +  IIH 
Sbjct: 100 STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 155
Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR---EGRVST 354
           DLK +N+ L +++   + DF +A + +    S    Q   +I +MAPE  R   +   S 
Sbjct: 156 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 215
Query: 355 NGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFV 414
             DVY+FGI+L E  TG+ P + I N +  +              +VG   LS  D+  V
Sbjct: 216 QSDVYAFGIVLYELMTGQLPYSNINNRDQII-------------FMVGRGYLS-PDLSKV 261
Query: 415 AKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
            +  C   +  L  EC  +  ++R    +I+A +
Sbjct: 262 -RSNCPKAMKRLMAECLKKKRDERPLFPQILASI 294

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 139/294 (47%), Gaps = 36/294 (12%)
Query: 175 FSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RALKGFDVECEMMKSIRHR 229
            S + ++G G FG V   RL      E++V +  L+ G   +  + F  E  +M    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 230 NLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL-HF 288
           N+I++    +  +   +V EYM +GSL+ ++   +    + Q + ++  +AS ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ-TLATIGYMAPEYG 347
           GY    +H DL   N+L++ N+V  +SDF ++++L  + ++   T+     I + +PE  
Sbjct: 167 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 348 REGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL 406
              + ++  DV+S+GI+L E  + G++P            +W      +S  +V+ A   
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERP------------YW-----EMSNQDVIKA--- 262
Query: 407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNVG 460
             E         C + ++ L ++C  +    R    +IV+    I D L+RN G
Sbjct: 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRNPG 312

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 132/274 (48%), Gaps = 28/274 (10%)
Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G FG+VYK +  GD   VAVK+ N+     + L+ F  E  +++  RH N++  +  
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
            +  +  A+V ++    SL  +++      ++ + ++I    A  ++YLH   +  IIH 
Sbjct: 101 STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 156
Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR---EGRVST 354
           DLK +N+ L +++   + DF +A + +    S    Q   +I +MAPE  R   +   S 
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 355 NGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFV 414
             DVY+FGI+L E  TG+ P + I N +  +              +VG   LS  D+  V
Sbjct: 217 QSDVYAFGIVLYELMTGQLPYSNINNRDQII-------------FMVGRGYLS-PDLSKV 262
Query: 415 AKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
            +  C   +  L  EC  +  ++R    +I+A +
Sbjct: 263 -RSNCPKAMKRLMAECLKKKRDERPLFPQILASI 295

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 12/207 (5%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G+G FG V+         VA+K   L+ G  + + F  E ++MK +RH  L+++ +  S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 240 NEEFKALVLEYMPHGSLEKYMY-SSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    +V EYM  GSL  ++   +   L + Q +++   +AS + Y+        +H D
Sbjct: 250 EEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGD 357
           L+ +N+L+ +N+V  ++DF +A+L+  ED   T  Q     I + APE    GR +   D
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 358 VYSFGIMLME-TFTGKKPTNEIFNGEM 383
           V+SFGI+L E T  G+ P   + N E+
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNREV 390

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 139/294 (47%), Gaps = 36/294 (12%)
Query: 175 FSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RALKGFDVECEMMKSIRHR 229
            S + ++G G FG V   RL      E++V +  L+ G   +  + F  E  +M    H 
Sbjct: 18  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 77
Query: 230 NLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL-HF 288
           N+I++    +  +   +V EYM +GSL+ ++   +    + Q + ++  +AS ++YL   
Sbjct: 78  NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 137
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ-TLATIGYMAPEYG 347
           GY    +H DL   N+L++ N+V  +SDF ++++L  + ++   T+     I + +PE  
Sbjct: 138 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 193
Query: 348 REGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL 406
              + ++  DV+S+GI+L E  + G++P            +W      +S  +V+ A   
Sbjct: 194 AYRKFTSASDVWSYGIVLWEVMSYGERP------------YW-----EMSNQDVIKA--- 233
Query: 407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNVG 460
             E         C + ++ L ++C  +    R    +IV+    I D L+RN G
Sbjct: 234 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRNPG 283

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 12/207 (5%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G+G FG V+         VA+K   L+ G  + + F  E ++MK +RH  L+++ +  S
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 240 NEEFKALVLEYMPHGSLEKYMY-SSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    +V EYM  GSL  ++   +   L + Q +++   +AS + Y+        +H D
Sbjct: 81  EEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRD 136
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGD 357
           L+ +N+L+ +N+V  ++DF +A+L+  ED   T  Q     I + APE    GR +   D
Sbjct: 137 LRAANILVGENLVCKVADFGLARLI--EDNEWTARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 358 VYSFGIMLME-TFTGKKPTNEIFNGEM 383
           V+SFGI+L E T  G+ P   + N E+
Sbjct: 195 VWSFGILLTELTTKGRVPYPGMVNREV 221

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 139/294 (47%), Gaps = 36/294 (12%)
Query: 175 FSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RALKGFDVECEMMKSIRHR 229
            S + ++G G FG V   RL      E++V +  L+ G   +  + F  E  +M    H 
Sbjct: 35  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 94
Query: 230 NLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL-HF 288
           N+I++    +  +   +V EYM +GSL+ ++   +    + Q + ++  +AS ++YL   
Sbjct: 95  NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 154
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ-TLATIGYMAPEYG 347
           GY    +H DL   N+L++ N+V  +SDF ++++L  + ++   T+     I + +PE  
Sbjct: 155 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 210
Query: 348 REGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL 406
              + ++  DV+S+GI+L E  + G++P            +W      +S  +V+ A   
Sbjct: 211 AYRKFTSASDVWSYGIVLWEVMSYGERP------------YW-----EMSNQDVIKA--- 250
Query: 407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNVG 460
             E         C + ++ L ++C  +    R    +IV+    I D L+RN G
Sbjct: 251 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRNPG 300

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 138/293 (47%), Gaps = 36/293 (12%)
Query: 176 SENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RALKGFDVECEMMKSIRHRN 230
           S + ++G G FG V   RL      E++V +  L+ G   +  + F  E  +M    H N
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL-HFG 289
           +I++    +  +   +V EYM +GSL+ ++   +    + Q + ++  +AS ++YL   G
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ-TLATIGYMAPEYGR 348
           Y    +H DL   N+L++ N+V  +SDF + ++L  + ++   T+     I + +PE   
Sbjct: 168 Y----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 349 EGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS 407
             + ++  DV+S+GI+L E  + G++P            +W      +S  +V+ A    
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP------------YW-----EMSNQDVIKA---V 263
Query: 408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNVG 460
            E         C + ++ L ++C  +    R    +IV+    I D L+RN G
Sbjct: 264 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRNPG 312

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 12/207 (5%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G+G FG V+         VA+K   L+ G  + + F  E ++MK +RH  L+++ +  S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 240 NEEFKALVLEYMPHGSLEKYMY-SSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    +V EYM  GSL  ++   +   L + Q +++   +AS + Y+        +H D
Sbjct: 250 EEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGD 357
           L+ +N+L+ +N+V  ++DF +A+L+  ED   T  Q     I + APE    GR +   D
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 358 VYSFGIMLME-TFTGKKPTNEIFNGEM 383
           V+SFGI+L E T  G+ P   + N E+
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNREV 390

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 135/281 (48%), Gaps = 28/281 (9%)
Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G FG+VYK +  GD   VAVK+ N+     + L+ F  E  +++  RH N++  +  
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
            +  +  A+V ++    SL  +++      ++ + ++I    A  ++YLH   +  IIH 
Sbjct: 73  STAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 128
Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR---EGRVST 354
           DLK +N+ L +++   + DF +A + +    S    Q   +I +MAPE  R   +   S 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 355 NGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFV 414
             DVY+FGI+L E  TG+ P + I N +  +              +VG   LS  D+  V
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNINNRDQII-------------FMVGRGYLS-PDLSKV 234
Query: 415 AKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL 455
            +  C   +  L  EC  +  ++R    +I+A +  +  SL
Sbjct: 235 -RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 108/207 (52%), Gaps = 12/207 (5%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G+G FG V+         VA+K   L+ G  + + F  E ++MK +RH  L+++ +  S
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 240 NEEFKALVLEYMPHGSLEKYMYSS-NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    +V EYM  GSL  ++       L + Q +++   +AS + Y+        +H D
Sbjct: 73  EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 128
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGD 357
           L+ +N+L+ +N+V  ++DF +A+L+  ED   T  Q     I + APE    GR +   D
Sbjct: 129 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 186
Query: 358 VYSFGIMLME-TFTGKKPTNEIFNGEM 383
           V+SFGI+L E T  G+ P   + N E+
Sbjct: 187 VWSFGILLTELTTKGRVPYPGMVNREV 213

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 108/207 (52%), Gaps = 12/207 (5%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G+G FG V+         VA+K   L+ G  + + F  E ++MK +RH  L+++ +  S
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 240 NEEFKALVLEYMPHGSLEKYMYSS-NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    +V EYM  GSL  ++       L + Q +++   +AS + Y+        +H D
Sbjct: 75  EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 130
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGD 357
           L+ +N+L+ +N+V  ++DF +A+L+  ED   T  Q     I + APE    GR +   D
Sbjct: 131 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 188
Query: 358 VYSFGIMLME-TFTGKKPTNEIFNGEM 383
           V+SFGI+L E T  G+ P   + N E+
Sbjct: 189 VWSFGILLTELTTKGRVPYPGMVNREV 215

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 12/207 (5%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G+G FG V+         VA+K   L+ G  + + F  E ++MK +RH  L+++ +  S
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 240 NEEFKALVLEYMPHGSLEKYMYS-SNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    +V EYM  GSL  ++   +   L + Q +++   +AS + Y+        +H D
Sbjct: 333 EEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 388
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGD 357
           L+ +N+L+ +N+V  ++DF +A+L+  ED   T  Q     I + APE    GR +   D
Sbjct: 389 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 358 VYSFGIMLME-TFTGKKPTNEIFNGEM 383
           V+SFGI+L E T  G+ P   + N E+
Sbjct: 447 VWSFGILLTELTTKGRVPYPGMVNREV 473

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 108/207 (52%), Gaps = 12/207 (5%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G+G FG V+         VA+K   L+ G  + + F  E ++MK +RH  L+++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 240 NEEFKALVLEYMPHGSLEKYMYSS-NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    +V EYM  GSL  ++       L + Q +++   +AS + Y+        +H D
Sbjct: 84  EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGD 357
           L+ +N+L+ +N+V  ++DF +A+L+  ED   T  Q     I + APE    GR +   D
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 358 VYSFGIMLME-TFTGKKPTNEIFNGEM 383
           V+SFGI+L E T  G+ P   + N E+
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREV 224

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 12/207 (5%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G+G FG V+         VA+K   L+ G  + + F  E ++MK +RH  L+++ +  S
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 240 NEEFKALVLEYMPHGSLEKYMY-SSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    +V EYM  GSL  ++   +   L + Q +++   +AS + Y+        +H D
Sbjct: 81  EEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRD 136
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGD 357
           L+ +N+L+ +N+V  ++DF +A+L+  ED   T  Q     I + APE    GR +   D
Sbjct: 137 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 358 VYSFGIMLME-TFTGKKPTNEIFNGEM 383
           V+SFGI+L E T  G+ P   + N E+
Sbjct: 195 VWSFGILLTELTTKGRVPYPGMVNREV 221

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 108/207 (52%), Gaps = 12/207 (5%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G+G FG V+         VA+K   L+ G  + + F  E ++MK +RH  L+++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 240 NEEFKALVLEYMPHGSLEKYMYSS-NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    +V EYM  GSL  ++       L + Q +++   +AS + Y+        +H D
Sbjct: 84  EEPI-YIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGD 357
           L+ +N+L+ +N+V  ++DF +A+L+  ED   T  Q     I + APE    GR +   D
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 358 VYSFGIMLME-TFTGKKPTNEIFNGEM 383
           V+SFGI+L E T  G+ P   + N E+
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREV 224

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 132/291 (45%), Gaps = 30/291 (10%)
Query: 165 HLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMK 224
           H+EL R      +   +G G FG V   +     +VAVK+   +   +   F  E + M 
Sbjct: 2   HMELKREEITLLKE--LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMM 58
Query: 225 SIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALE 284
            + H  L+K    CS E    +V EY+ +G L  Y+ S    L+  Q L +  DV   + 
Sbjct: 59  KLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMA 118
Query: 285 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
           +L    S   IH DL   N L+D ++   +SDF + + +  +DQ ++   T   + + AP
Sbjct: 119 FLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAP 174
Query: 345 EYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA 403
           E     + S+  DV++FGI++ E F+ GK P +   N E+ LK                 
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK----------------- 217
Query: 404 NLLSQEDIHFVAKEQCVS-CVFNLAMECTVESPEQRINAREIVAKLLKIRD 453
             +SQ   H + +    S  ++ +   C  E PE+R   +++++ +  +R+
Sbjct: 218 --VSQG--HRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 132/289 (45%), Gaps = 36/289 (12%)
Query: 178 NNLIGRGGFGSVYKARL--GDGMEVAVKVFNLQCG---RALKGFDVECEMMKSIRHRNLI 232
             +IG G  G V   RL      +V V +  L+ G   R  + F  E  +M    H N+I
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL-HFGYS 291
           ++    +      +V EYM +GSL+ ++ + +    I Q + ++  V + + YL   GY 
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY- 172
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQTQTLATIGYMAPEYGREG 350
              +H DL   NVL+D N+V  +SDF ++++L  + D + T T     I + APE     
Sbjct: 173 ---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFR 229
Query: 351 RVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
             S+  DV+SFG+++ E    G++P   + N ++           IS++E         E
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV-----------ISSVE---------E 269
Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRN 458
                A   C   +  L ++C  +   QR    +IV+ L    D+L+R+
Sbjct: 270 GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL----DALIRS 314

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 12/207 (5%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G+G FG V+         VA+K   L+ G  + + F  E ++MK +RH  L+++ +  S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 240 NEEFKALVLEYMPHGSLEKYMY-SSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    +V EYM  GSL  ++   +   L + Q +++   +AS + Y+        +H D
Sbjct: 250 EEPI-YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGD 357
           L+ +N+L+ +N+V  ++DF +A+L+  ED   T  Q     I + APE    GR +   D
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 358 VYSFGIMLME-TFTGKKPTNEIFNGEM 383
           V+SFGI+L E T  G+ P   + N E+
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNREV 390

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 132/289 (45%), Gaps = 36/289 (12%)
Query: 178 NNLIGRGGFGSVYKARL--GDGMEVAVKVFNLQCG---RALKGFDVECEMMKSIRHRNLI 232
             +IG G  G V   RL      +V V +  L+ G   R  + F  E  +M    H N+I
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL-HFGYS 291
           ++    +      +V EYM +GSL+ ++ + +    I Q + ++  V + + YL   GY 
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY- 172
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQTQTLATIGYMAPEYGREG 350
              +H DL   NVL+D N+V  +SDF ++++L  + D + T T     I + APE     
Sbjct: 173 ---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229
Query: 351 RVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
             S+  DV+SFG+++ E    G++P   + N ++           IS++E         E
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV-----------ISSVE---------E 269
Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRN 458
                A   C   +  L ++C  +   QR    +IV+ L    D+L+R+
Sbjct: 270 GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL----DALIRS 314

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 134/281 (47%), Gaps = 28/281 (9%)
Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G FG+VYK +  GD   VAVK+ N+     + L+ F  E  +++  RH N++  +  
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
            +  +  A+V ++    SL  +++      ++ + ++I    A  ++YLH   +  IIH 
Sbjct: 73  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 128
Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR---EGRVST 354
           DLK +N+ L +++   + DF +A   +    S    Q   +I +MAPE  R   +   S 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 355 NGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFV 414
             DVY+FGI+L E  TG+ P + I N +  +              +VG   LS  D+  V
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNINNRDQII-------------FMVGRGYLS-PDLSKV 234
Query: 415 AKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL 455
            +  C   +  L  EC  +  ++R    +I+A +  +  SL
Sbjct: 235 -RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 131/274 (47%), Gaps = 28/274 (10%)
Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G FG+VYK +  GD   VAVK+ N+     + L+ F  E  +++  RH N++  +  
Sbjct: 36  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
            +  +  A+V ++    SL  +++      ++ + ++I    A  ++YLH   +  IIH 
Sbjct: 93  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 148
Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR---EGRVST 354
           DLK +N+ L +++   + DF +A   +    S    Q   +I +MAPE  R   +   S 
Sbjct: 149 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 208
Query: 355 NGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFV 414
             DVY+FGI+L E  TG+ P + I N +  +              +VG   LS  D+  V
Sbjct: 209 QSDVYAFGIVLYELMTGQLPYSNINNRDQII-------------FMVGRGYLS-PDLSKV 254
Query: 415 AKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
            +  C   +  L  EC  +  ++R    +I+A +
Sbjct: 255 -RSNCPKAMKRLMAECLKKKRDERPLFPQILASI 287

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/293 (24%), Positives = 139/293 (47%), Gaps = 36/293 (12%)
Query: 176 SENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RALKGFDVECEMMKSIRHRN 230
           S + ++G G FG V   RL      E++V +  L+ G   +  + F  E  +M    H N
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL-HFG 289
           +I++    +  +   +V EYM +GSL+ ++   +    + Q + ++  +AS ++YL   G
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ-TLATIGYMAPEYGR 348
           +    +H DL   N+L++ N+V  +SDF ++++L  + ++   T+     I + +PE   
Sbjct: 168 F----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 349 EGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS 407
             + ++  DV+S+GI+L E  + G++P            +W      +S  +V+ A    
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP------------YW-----EMSNQDVIKA---V 263
Query: 408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNVG 460
            E         C + ++ L ++C  +    R    +IV+    I D L+RN G
Sbjct: 264 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRNPG 312

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 108/207 (52%), Gaps = 12/207 (5%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G+G FG V+         VA+K   L+ G  + + F  E ++MK +RH  L+++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 240 NEEFKALVLEYMPHGSLEKYMYSS-NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    +V+EYM  G L  ++       L + Q +++   +AS + Y+        +H D
Sbjct: 84  EEPI-YIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGD 357
           L+ +N+L+ +N+V  ++DF +A+L+  ED   T  Q     I + APE    GR +   D
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 358 VYSFGIMLME-TFTGKKPTNEIFNGEM 383
           V+SFGI+L E T  G+ P   + N E+
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREV 224

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 131/274 (47%), Gaps = 28/274 (10%)
Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G FG+VYK +  GD   VAVK+ N+     + L+ F  E  +++  RH N++  +  
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
            +  +  A+V ++    SL  +++      ++ + ++I    A  ++YLH   +  IIH 
Sbjct: 101 STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 156
Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR---EGRVST 354
           DLK +N+ L +++   + DF +A   +    S    Q   +I +MAPE  R   +   S 
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 355 NGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFV 414
             DVY+FGI+L E  TG+ P + I N +  +              +VG   LS  D+  V
Sbjct: 217 QSDVYAFGIVLYELMTGQLPYSNINNRDQII-------------FMVGRGYLS-PDLSKV 262
Query: 415 AKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
            +  C   +  L  EC  +  ++R    +I+A +
Sbjct: 263 -RSNCPKAMKRLMAECLKKKRDERPLFPQILASI 295

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 12/207 (5%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G+G FG V+         VA+K   L+ G  + + F  E ++MK +RH  L+++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 240 NEEFKALVLEYMPHGSLEKYMYSS-NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    +V EYM  GSL  ++       L + Q +++   +AS + Y+        +H D
Sbjct: 84  EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGD 357
           L  +N+L+ +N+V  ++DF +A+L+  ED   T  Q     I + APE    GR +   D
Sbjct: 140 LAAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 358 VYSFGIMLME-TFTGKKPTNEIFNGEM 383
           V+SFGI+L E T  G+ P   + N E+
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREV 224

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 107/207 (51%), Gaps = 12/207 (5%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G+G FG V+         VA+K   L+ G  + + F  E ++MK +RH  L+++ +  S
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 240 NEEFKALVLEYMPHGSLEKYMYSS-NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    +V EYM  GSL  ++       L + Q +++   +AS + Y+        +H D
Sbjct: 251 EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 306
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGD 357
           L+ +N+L+ +N+V  ++DF + +L+  ED   T  Q     I + APE    GR +   D
Sbjct: 307 LRAANILVGENLVCKVADFGLGRLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 364
Query: 358 VYSFGIMLME-TFTGKKPTNEIFNGEM 383
           V+SFGI+L E T  G+ P   + N E+
Sbjct: 365 VWSFGILLTELTTKGRVPYPGMVNREV 391

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/303 (25%), Positives = 134/303 (44%), Gaps = 38/303 (12%)
Query: 162 TFSHLELCRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALK---GFD 217
           T SHL     +D +    ++G GG   V+ AR L D  +VAVKV      R       F 
Sbjct: 6   TPSHL-----SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR 60
Query: 218 VECEMMKSIRHRNLIKVISTCSNE----EFKALVLEYMPHGSLEKYMYSSNYILDIFQRL 273
            E +   ++ H  ++ V  T   E        +V+EY+   +L   +++      +  + 
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKR 117
Query: 274 NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 333
            I + +A A + L+F +   IIH D+KP+N+++       + DF IA+ +     S+TQT
Sbjct: 118 AIEV-IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 334 QT-LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDW 392
              + T  Y++PE  R   V    DVYS G +L E  TG+ P        +  +H   D 
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVREDP 236
Query: 393 LPISTMEVVGANLLSQEDIHFVAKEQCVSCVFN-LAMECTVESPEQRIN-AREIVAKLLK 450
           +P S                  A+ + +S   + + ++   ++PE R   A E+ A L++
Sbjct: 237 IPPS------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278
Query: 451 IRD 453
           + +
Sbjct: 279 VHN 281

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 107/207 (51%), Gaps = 12/207 (5%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G+G FG V+         VA+K   L+ G  + + F  E ++MK +RH  L+++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 240 NEEFKALVLEYMPHGSLEKYMYSS-NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    +V EYM  G L  ++       L + Q +++   +AS + Y+        +H D
Sbjct: 84  EEPI-YIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGD 357
           L+ +N+L+ +N+V  ++DF +A+L+  ED   T  Q     I + APE    GR +   D
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 358 VYSFGIMLME-TFTGKKPTNEIFNGEM 383
           V+SFGI+L E T  G+ P   + N E+
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREV 224

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 138/294 (46%), Gaps = 36/294 (12%)
Query: 175 FSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RALKGFDVECEMMKSIRHR 229
            S + ++G G FG V   RL      E++V +  L+ G   +  + F  E  +M    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 230 NLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL-HF 288
           N+I++    +  +   +V E M +GSL+ ++   +    + Q + ++  +AS ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ-TLATIGYMAPEYG 347
           GY    +H DL   N+L++ N+V  +SDF ++++L  + ++   T+     I + +PE  
Sbjct: 167 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 348 REGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL 406
              + ++  DV+S+GI+L E  + G++P            +W      +S  +V+ A   
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERP------------YW-----EMSNQDVIKA--- 262
Query: 407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNVG 460
             E         C + ++ L ++C  +    R    +IV+    I D L+RN G
Sbjct: 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRNPG 312

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 138/294 (46%), Gaps = 36/294 (12%)
Query: 175 FSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RALKGFDVECEMMKSIRHR 229
            S + ++G G FG V   RL      E++V +  L+ G   +  + F  E  +M    H 
Sbjct: 18  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 77
Query: 230 NLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL-HF 288
           N+I++    +  +   +V E M +GSL+ ++   +    + Q + ++  +AS ++YL   
Sbjct: 78  NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 137
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ-TLATIGYMAPEYG 347
           GY    +H DL   N+L++ N+V  +SDF ++++L  + ++   T+     I + +PE  
Sbjct: 138 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 193
Query: 348 REGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL 406
              + ++  DV+S+GI+L E  + G++P            +W      +S  +V+ A   
Sbjct: 194 AYRKFTSASDVWSYGIVLWEVMSYGERP------------YW-----EMSNQDVIKA--- 233
Query: 407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNVG 460
             E         C + ++ L ++C  +    R    +IV+    I D L+RN G
Sbjct: 234 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRNPG 283

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 137/307 (44%), Gaps = 46/307 (14%)
Query: 162 TFSHLELCRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALK---GFD 217
           T SHL     +D +    ++G GG   V+ AR L D  +VAVKV      R       F 
Sbjct: 6   TPSHL-----SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR 60
Query: 218 VECEMMKSIRHRNLIKVISTCSNE----EFKALVLEYMPHGSLEKYMYSSNYILDIFQRL 273
            E +   ++ H  ++ V  T   E        +V+EY+   +L   +++      +  + 
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKR 117
Query: 274 NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 333
            I + +A A + L+F +   IIH D+KP+N+++       + DF IA+ +     S+TQT
Sbjct: 118 AIEV-IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 334 QT-LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE----MTLKHW 388
              + T  Y++PE  R   V    DVYS G +L E  TG+ P    F G+    +  +H 
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHV 232
Query: 389 VNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFN-LAMECTVESPEQRIN-AREIVA 446
             D +P S                  A+ + +S   + + ++   ++PE R   A E+ A
Sbjct: 233 REDPIPPS------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274
Query: 447 KLLKIRD 453
            L+++ +
Sbjct: 275 DLVRVHN 281

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 124/287 (43%), Gaps = 30/287 (10%)
Query: 178 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKGFDVECEMMKSIRHRNLI 232
           N +IGRG FG VY   L    G  +  AVK  N +     +  F  E  +MK   H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 233 KVISTCSNEEFKALV-LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  ++YL    S
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 150
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGRE 349
              +H DL   N +LD+     ++DF +A+ +  ++      +T A   + +MA E  + 
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQT 210
Query: 350 GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
            + +T  DV+SFG++L E  T   P     N              I+   + G  LL   
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----------FDITVYLLQGRRLLQ-- 257
Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL 456
                  E C   ++ + ++C     E R +  E+V+++  I  + +
Sbjct: 258 ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 298

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 124/287 (43%), Gaps = 30/287 (10%)
Query: 178 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKGFDVECEMMKSIRHRNLI 232
           N +IGRG FG VY   L    G  +  AVK  N +     +  F  E  +MK   H N++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 233 KVISTCSNEEFKALV-LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  ++YL    S
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 149
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGRE 349
              +H DL   N +LD+     ++DF +A+ +  ++      +T A   + +MA E  + 
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 209
Query: 350 GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
            + +T  DV+SFG++L E  T   P     N              I+   + G  LL   
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----------FDITVYLLQGRRLLQ-- 256
Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL 456
                  E C   ++ + ++C     E R +  E+V+++  I  + +
Sbjct: 257 ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 297

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 124/287 (43%), Gaps = 30/287 (10%)
Query: 178 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKGFDVECEMMKSIRHRNLI 232
           N +IGRG FG VY   L    G  +  AVK  N +     +  F  E  +MK   H N++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 233 KVISTCSNEEFKALV-LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  ++YL    S
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 146
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGRE 349
              +H DL   N +LD+     ++DF +A+ +  ++      +T A   + +MA E  + 
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 350 GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
            + +T  DV+SFG++L E  T   P     N              I+   + G  LL   
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----------FDITVYLLQGRRLLQ-- 253
Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL 456
                  E C   ++ + ++C     E R +  E+V+++  I  + +
Sbjct: 254 ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 124/287 (43%), Gaps = 30/287 (10%)
Query: 178 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKGFDVECEMMKSIRHRNLI 232
           N +IGRG FG VY   L    G  +  AVK  N +     +  F  E  +MK   H N++
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 233 KVISTCSNEEFKALV-LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  ++YL    S
Sbjct: 87  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 143
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGRE 349
              +H DL   N +LD+     ++DF +A+ +  ++      +T A   + +MA E  + 
Sbjct: 144 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 203
Query: 350 GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
            + +T  DV+SFG++L E  T   P     N              I+   + G  LL   
Sbjct: 204 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----------FDITVYLLQGRRLLQ-- 250
Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL 456
                  E C   ++ + ++C     E R +  E+V+++  I  + +
Sbjct: 251 ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 291

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 131/284 (46%), Gaps = 42/284 (14%)
Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNL-------QCGRALKGFDVECEMMKSIRHRNLI 232
           IG+GGFG V+K RL  D   VA+K   L       +     + F  E  +M ++ H N++
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
           K+     N     +V+E++P G L   +    + +    +L +M+D+A  +EY+    + 
Sbjct: 87  KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143
Query: 293 PIIHCDLKPSNVL---LDDN--MVAHLSDFSIAKLLTGEDQSM-TQTQTLATIGYMAPEY 346
           PI+H DL+  N+    LD+N  + A ++DFS+++      QS+ + +  L    +MAPE 
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ------QSVHSVSGLLGNFQWMAPET 197
Query: 347 --GREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN 404
               E   +   D YSF ++L    TG+ P +E   G++                    N
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF-----------------IN 240
Query: 405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
           ++ +E +     E C   + N+   C    P++R +   IV +L
Sbjct: 241 MIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 124/287 (43%), Gaps = 30/287 (10%)
Query: 178 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKGFDVECEMMKSIRHRNLI 232
           N +IGRG FG VY   L    G  +  AVK  N +     +  F  E  +MK   H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 233 KVISTCSNEEFKALV-LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  ++YL    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 151
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGRE 349
              +H DL   N +LD+     ++DF +A+ +  ++      +T A   + +MA E  + 
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 350 GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
            + +T  DV+SFG++L E  T   P     N              I+   + G  LL   
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----------FDITVYLLQGRRLLQ-- 258
Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL 456
                  E C   ++ + ++C     E R +  E+V+++  I  + +
Sbjct: 259 ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 299

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 94/203 (46%), Gaps = 11/203 (5%)
Query: 178 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
             ++GRG FG V KA+     +VA+K    +  R  K F VE   +  + H N++K+   
Sbjct: 14  EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGA 70
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYI--LDIFQRLNIMIDVASALEYLHFGYSAPII 295
           C N     LV+EY   GSL   ++ +  +        ++  +  +  + YLH      +I
Sbjct: 71  CLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 128
Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 355
           H DLKP N+LL    VA  +   I    T  D     T    +  +MAPE       S  
Sbjct: 129 HRDLKPPNLLL----VAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEK 184
Query: 356 GDVYSFGIMLMETFTGKKPTNEI 378
            DV+S+GI+L E  T +KP +EI
Sbjct: 185 CDVFSWGIILWEVITRRKPFDEI 207

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 113/249 (45%), Gaps = 26/249 (10%)
Query: 162 TFSHLELCRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALK---GFD 217
           T SHL     +D +    ++G GG   V+ AR L D  +VAVKV      R       F 
Sbjct: 6   TPSHL-----SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR 60
Query: 218 VECEMMKSIRHRNLIKVISTCSNE----EFKALVLEYMPHGSLEKYMYSSNYILDIFQRL 273
            E +   ++ H  ++ V  T   E        +V+EY+   +L   +++      +  + 
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKR 117
Query: 274 NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 333
            I + +A A + L+F +   IIH D+KP+N+L+       + DF IA+ +     S+ QT
Sbjct: 118 AIEV-IADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQT 176
Query: 334 QT-LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE----MTLKHW 388
              + T  Y++PE  R   V    DVYS G +L E  TG+ P    F G+    +  +H 
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHV 232
Query: 389 VNDWLPIST 397
             D +P S 
Sbjct: 233 REDPIPPSA 241

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 94/203 (46%), Gaps = 11/203 (5%)
Query: 178 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
             ++GRG FG V KA+     +VA+K    +  R  K F VE   +  + H N++K+   
Sbjct: 13  EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGA 69
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYI--LDIFQRLNIMIDVASALEYLHFGYSAPII 295
           C N     LV+EY   GSL   ++ +  +        ++  +  +  + YLH      +I
Sbjct: 70  CLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 355
           H DLKP N+LL    VA  +   I    T  D     T    +  +MAPE       S  
Sbjct: 128 HRDLKPPNLLL----VAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 356 GDVYSFGIMLMETFTGKKPTNEI 378
            DV+S+GI+L E  T +KP +EI
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEI 206

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 124/287 (43%), Gaps = 30/287 (10%)
Query: 178 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKGFDVECEMMKSIRHRNLI 232
           N +IGRG FG VY   L    G  +  AVK  N +     +  F  E  +MK   H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 233 KVISTCSNEEFKALV-LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  ++YL    S
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 148
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGRE 349
              +H DL   N +LD+     ++DF +A+ +  ++      +T A   + +MA E  + 
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 208
Query: 350 GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
            + +T  DV+SFG++L E  T   P     N              I+   + G  LL   
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----------FDITVYLLQGRRLLQ-- 255
Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL 456
                  E C   ++ + ++C     E R +  E+V+++  I  + +
Sbjct: 256 ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 124/287 (43%), Gaps = 30/287 (10%)
Query: 178 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKGFDVECEMMKSIRHRNLI 232
           N +IGRG FG VY   L    G  +  AVK  N +     +  F  E  +MK   H N++
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 233 KVISTCSNEEFKALV-LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  ++YL    S
Sbjct: 114 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 170
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGRE 349
              +H DL   N +LD+     ++DF +A+ +  ++      +T A   + +MA E  + 
Sbjct: 171 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 230
Query: 350 GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
            + +T  DV+SFG++L E  T   P     N              I+   + G  LL   
Sbjct: 231 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----------FDITVYLLQGRRLLQ-- 277
Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL 456
                  E C   ++ + ++C     E R +  E+V+++  I  + +
Sbjct: 278 ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 318

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 124/287 (43%), Gaps = 30/287 (10%)
Query: 178 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKGFDVECEMMKSIRHRNLI 232
           N +IGRG FG VY   L    G  +  AVK  N +     +  F  E  +MK   H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 233 KVISTCSNEEFKALV-LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  ++YL    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 151
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGRE 349
              +H DL   N +LD+     ++DF +A+ +  ++      +T A   + +MA E  + 
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 350 GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
            + +T  DV+SFG++L E  T   P     N              I+   + G  LL   
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----------FDITVYLLQGRRLLQ-- 258
Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL 456
                  E C   ++ + ++C     E R +  E+V+++  I  + +
Sbjct: 259 ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 299

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 124/287 (43%), Gaps = 30/287 (10%)
Query: 178 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKGFDVECEMMKSIRHRNLI 232
           N +IGRG FG VY   L    G  +  AVK  N +     +  F  E  +MK   H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 233 KVISTCSNEEFKALV-LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  ++YL    S
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 150
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGRE 349
              +H DL   N +LD+     ++DF +A+ +  ++      +T A   + +MA E  + 
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 210
Query: 350 GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
            + +T  DV+SFG++L E  T   P     N              I+   + G  LL   
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----------FDITVYLLQGRRLLQ-- 257
Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL 456
                  E C   ++ + ++C     E R +  E+V+++  I  + +
Sbjct: 258 ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 298

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 124/287 (43%), Gaps = 30/287 (10%)
Query: 178 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKGFDVECEMMKSIRHRNLI 232
           N +IGRG FG VY   L    G  +  AVK  N +     +  F  E  +MK   H N++
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 233 KVISTCSNEEFKALV-LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  ++YL    S
Sbjct: 113 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 169
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGRE 349
              +H DL   N +LD+     ++DF +A+ +  ++      +T A   + +MA E  + 
Sbjct: 170 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 229
Query: 350 GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
            + +T  DV+SFG++L E  T   P     N              I+   + G  LL   
Sbjct: 230 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----------FDITVYLLQGRRLLQ-- 276
Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL 456
                  E C   ++ + ++C     E R +  E+V+++  I  + +
Sbjct: 277 ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 317

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 136/293 (46%), Gaps = 34/293 (11%)
Query: 175 FSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RALKGFDVECEMMKSIRHR 229
            S + ++G G FG V   RL      E++V +  L+ G   +  + F  E  +M    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 230 NLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFG 289
           N+I++    +  +   +V E M +GSL+ ++   +    + Q + ++  +AS ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS-- 164
Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ-TLATIGYMAPEYGR 348
                +H DL   N+L++ N+V  +SDF ++++L  + ++   T+     I + +PE   
Sbjct: 165 -DMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 349 EGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS 407
             + ++  DV+S+GI+L E  + G++P            +W      +S  +V+ A    
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP------------YW-----EMSNQDVIKA---V 263
Query: 408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNVG 460
            E         C + ++ L ++C  +    R    +IV+    I D L+RN G
Sbjct: 264 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRNPG 312

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 119/261 (45%), Gaps = 30/261 (11%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           +G G FG V+        +VAVK    Q   +   F  E  +MK ++H+ L+++ +  + 
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 81
Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
           E    ++ EYM +GSL  ++ + + I L I + L++   +A  + ++        IH DL
Sbjct: 82  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 137
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGDV 358
           + +N+L+ D +   ++DF +A+L+  ED   T  +     I + APE    G  +   DV
Sbjct: 138 RAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 195
Query: 359 YSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKE 417
           +SFGI+L E  T G+ P   + N E                  V  NL  +     V  +
Sbjct: 196 WSFGILLTEIVTHGRIPYPGMTNPE------------------VIQNL--ERGYRMVRPD 235
Query: 418 QCVSCVFNLAMECTVESPEQR 438
            C   ++ L   C  E PE R
Sbjct: 236 NCPEELYQLMRLCWKERPEDR 256

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 119/261 (45%), Gaps = 30/261 (11%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           +G G FG V+        +VAVK    Q   +   F  E  +MK ++H+ L+++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
           E    ++ EYM +GSL  ++ + + I L I + L++   +A  + ++        IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGDV 358
           + +N+L+ D +   ++DF +A+L+  ED   T  +     I + APE    G  +   DV
Sbjct: 136 RAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 359 YSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKE 417
           +SFGI+L E  T G+ P   + N E+           I  +E              V  +
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPEV-----------IQNLE---------RGYRMVRPD 233
Query: 418 QCVSCVFNLAMECTVESPEQR 438
            C   ++ L   C  E PE R
Sbjct: 234 NCPEELYQLMRLCWKERPEDR 254

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 119/261 (45%), Gaps = 30/261 (11%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           +G G FG V+        +VAVK    Q   +   F  E  +MK ++H+ L+++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
           E    ++ EYM +GSL  ++ + + I L I + L++   +A  + ++        IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGDV 358
           + +N+L+ D +   ++DF +A+L+  ED   T  +     I + APE    G  +   DV
Sbjct: 136 RAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 359 YSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKE 417
           +SFGI+L E  T G+ P   + N E                  V  NL  +     V  +
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPE------------------VIQNL--ERGYRMVRPD 233
Query: 418 QCVSCVFNLAMECTVESPEQR 438
            C   ++ L   C  E PE R
Sbjct: 234 NCPEELYQLMRLCWKERPEDR 254

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 119/261 (45%), Gaps = 30/261 (11%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           +G G FG V+        +VAVK    Q   +   F  E  +MK ++H+ L+++ +  + 
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 80
Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
           E    ++ EYM +GSL  ++ + + I L I + L++   +A  + ++        IH DL
Sbjct: 81  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 136
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGDV 358
           + +N+L+ D +   ++DF +A+L+  ED   T  +     I + APE    G  +   DV
Sbjct: 137 RAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 194
Query: 359 YSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKE 417
           +SFGI+L E  T G+ P   + N E                  V  NL  +     V  +
Sbjct: 195 WSFGILLTEIVTHGRIPYPGMTNPE------------------VIQNL--ERGYRMVRPD 234
Query: 418 QCVSCVFNLAMECTVESPEQR 438
            C   ++ L   C  E PE R
Sbjct: 235 NCPEELYQLMRLCWKERPEDR 255

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 119/261 (45%), Gaps = 30/261 (11%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           +G G FG V+        +VAVK    Q   +   F  E  +MK ++H+ L+++ +  + 
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 88
Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
           E    ++ EYM +GSL  ++ + + I L I + L++   +A  + ++        IH DL
Sbjct: 89  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 144
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGDV 358
           + +N+L+ D +   ++DF +A+L+  ED   T  +     I + APE    G  +   DV
Sbjct: 145 RAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 202
Query: 359 YSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKE 417
           +SFGI+L E  T G+ P   + N E                  V  NL  +     V  +
Sbjct: 203 WSFGILLTEIVTHGRIPYPGMTNPE------------------VIQNL--ERGYRMVRPD 242
Query: 418 QCVSCVFNLAMECTVESPEQR 438
            C   ++ L   C  E PE R
Sbjct: 243 NCPEELYQLMRLCWKERPEDR 263

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 119/261 (45%), Gaps = 30/261 (11%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           +G G FG V+        +VAVK    Q   +   F  E  +MK ++H+ L+++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
           E    ++ EYM +GSL  ++ + + I L I + L++   +A  + ++        IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGDV 358
           + +N+L+ D +   ++DF +A+L+  ED   T  +     I + APE    G  +   DV
Sbjct: 136 RAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 359 YSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKE 417
           +SFGI+L E  T G+ P   + N E                  V  NL  +     V  +
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPE------------------VIQNL--ERGYRMVRPD 233
Query: 418 QCVSCVFNLAMECTVESPEQR 438
            C   ++ L   C  E PE R
Sbjct: 234 NCPEELYQLMRLCWKERPEDR 254

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 119/261 (45%), Gaps = 30/261 (11%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           +G G FG V+        +VAVK    Q   +   F  E  +MK ++H+ L+++ +  + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
           E    ++ EYM +GSL  ++ + + I L I + L++   +A  + ++        IH DL
Sbjct: 86  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 141
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGDV 358
           + +N+L+ D +   ++DF +A+L+  ED   T  +     I + APE    G  +   DV
Sbjct: 142 RAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 199
Query: 359 YSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKE 417
           +SFGI+L E  T G+ P   + N E+           I  +E              V  +
Sbjct: 200 WSFGILLTEIVTHGRIPYPGMTNPEV-----------IQNLE---------RGYRMVRPD 239
Query: 418 QCVSCVFNLAMECTVESPEQR 438
            C   ++ L   C  E PE R
Sbjct: 240 NCPEELYQLMRLCWKERPEDR 260

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 119/261 (45%), Gaps = 30/261 (11%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           +G G FG V+        +VAVK    Q   +   F  E  +MK ++H+ L+++ +  + 
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 87
Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
           E    ++ EYM +GSL  ++ + + I L I + L++   +A  + ++        IH DL
Sbjct: 88  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 143
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGDV 358
           + +N+L+ D +   ++DF +A+L+  ED   T  +     I + APE    G  +   DV
Sbjct: 144 RAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 201
Query: 359 YSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKE 417
           +SFGI+L E  T G+ P   + N E+           I  +E              V  +
Sbjct: 202 WSFGILLTEIVTHGRIPYPGMTNPEV-----------IQNLE---------RGYRMVRPD 241
Query: 418 QCVSCVFNLAMECTVESPEQR 438
            C   ++ L   C  E PE R
Sbjct: 242 NCPEELYQLMRLCWKERPEDR 262

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 119/261 (45%), Gaps = 30/261 (11%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           +G G FG V+        +VAVK    Q   +   F  E  +MK ++H+ L+++ +  + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
           E    ++ EYM +GSL  ++ + + I L I + L++   +A  + ++        IH DL
Sbjct: 86  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 141
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGDV 358
           + +N+L+ D +   ++DF +A+L+  ED   T  +     I + APE    G  +   DV
Sbjct: 142 RAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 199
Query: 359 YSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKE 417
           +SFGI+L E  T G+ P   + N E                  V  NL  +     V  +
Sbjct: 200 WSFGILLTEIVTHGRIPYPGMTNPE------------------VIQNL--ERGYRMVRPD 239
Query: 418 QCVSCVFNLAMECTVESPEQR 438
            C   ++ L   C  E PE R
Sbjct: 240 NCPEELYQLMRLCWKERPEDR 260

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 119/261 (45%), Gaps = 30/261 (11%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           +G G FG V+        +VAVK    Q   +   F  E  +MK ++H+ L+++ +  + 
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 84
Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
           E    ++ EYM +GSL  ++ + + I L I + L++   +A  + ++        IH DL
Sbjct: 85  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 140
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGDV 358
           + +N+L+ D +   ++DF +A+L+  ED   T  +     I + APE    G  +   DV
Sbjct: 141 RAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 198
Query: 359 YSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKE 417
           +SFGI+L E  T G+ P   + N E                  V  NL  +     V  +
Sbjct: 199 WSFGILLTEIVTHGRIPYPGMTNPE------------------VIQNL--ERGYRMVRPD 238
Query: 418 QCVSCVFNLAMECTVESPEQR 438
            C   ++ L   C  E PE R
Sbjct: 239 NCPEELYQLMRLCWKERPEDR 259

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 123/261 (47%), Gaps = 30/261 (11%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           +G G FG V+ A      +VAVK        +++ F  E  +MK+++H  L+K+ +  + 
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 81
Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL-EYLHFGYSAPIIHCDL 299
           E    ++ E+M  GSL  ++ S        Q L  +ID ++ + E + F      IH DL
Sbjct: 82  EPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 137
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGDV 358
           + +N+L+  ++V  ++DF +A+++  ED   T  +     I + APE    G  +   DV
Sbjct: 138 RAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 195
Query: 359 YSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKE 417
           +SFGI+LME  T G+ P    + G             +S  EV+ A    +        E
Sbjct: 196 WSFGILLMEIVTYGRIP----YPG-------------MSNPEVIRA---LERGYRMPRPE 235
Query: 418 QCVSCVFNLAMECTVESPEQR 438
            C   ++N+ M C    PE+R
Sbjct: 236 NCPEELYNIMMRCWKNRPEER 256

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 133/288 (46%), Gaps = 36/288 (12%)
Query: 180 LIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RALKGFDVECEMMKSIRHRNLIKV 234
           +IG G FG V + RL      E  V +  L+ G   R  + F  E  +M    H N+I++
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI 294
               +N     ++ E+M +G+L+ ++  ++    + Q + ++  +AS + YL        
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLA---EMSY 139
Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA---TIGYMAPEYGREGR 351
           +H DL   N+L++ N+V  +SDF +++ L       T+T +L     I + APE     +
Sbjct: 140 VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRK 199
Query: 352 VSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED 410
            ++  D +S+GI++ E  + G++P            +W      +S  +V+ A    ++D
Sbjct: 200 FTSASDAWSYGIVMWEVMSFGERP------------YW-----DMSNQDVINA---IEQD 239
Query: 411 IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRN 458
                   C + +  L ++C     ++  NAR    +++   D ++RN
Sbjct: 240 YRLPPPPDCPTSLHQLMLDCW----QKDRNARPRFPQVVSALDKMIRN 283

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 126/283 (44%), Gaps = 40/283 (14%)
Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNL-------QCGRALKGFDVECEMMKSIRHRNLI 232
           IG+GGFG V+K RL  D   VA+K   L       +     + F  E  +M ++ H N++
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
           K+     N     +V+E++P G L   +    + +    +L +M+D+A  +EY+    + 
Sbjct: 87  KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143
Query: 293 PIIHCDLKPSNVL---LDDN--MVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY- 346
           PI+H DL+  N+    LD+N  + A ++DF      T +    + +  L    +MAPE  
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFG-----TSQQSVHSVSGLLGNFQWMAPETI 198
Query: 347 -GREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL 405
              E   +   D YSF ++L    TG+ P +E   G++                    N+
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF-----------------INM 241
Query: 406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
           + +E +     E C   + N+   C    P++R +   IV +L
Sbjct: 242 IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 124/287 (43%), Gaps = 30/287 (10%)
Query: 178 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKGFDVECEMMKSIRHRNLI 232
           N +IGRG FG VY   L    G  +  AVK  N +     +  F  E  +MK   H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 233 KVISTCSNEEFKALV-LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  +++L    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 151
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGRE 349
              +H DL   N +LD+     ++DF +A+ +  ++      +T A   + +MA E  + 
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 350 GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
            + +T  DV+SFG++L E  T   P     N              I+   + G  LL   
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----------FDITVYLLQGRRLLQ-- 258
Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL 456
                  E C   ++ + ++C     E R +  E+V+++  I  + +
Sbjct: 259 ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 299

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 130/284 (45%), Gaps = 42/284 (14%)
Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNL-------QCGRALKGFDVECEMMKSIRHRNLI 232
           IG+GGFG V+K RL  D   VA+K   L       +     + F  E  +M ++ H N++
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
           K+     N     +V+E++P G L   +    + +    +L +M+D+A  +EY+    + 
Sbjct: 87  KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143
Query: 293 PIIHCDLKPSNVL---LDDN--MVAHLSDFSIAKLLTGEDQSM-TQTQTLATIGYMAPEY 346
           PI+H DL+  N+    LD+N  + A ++DF +++      QS+ + +  L    +MAPE 
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ------QSVHSVSGLLGNFQWMAPET 197
Query: 347 --GREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN 404
               E   +   D YSF ++L    TG+ P +E   G++                    N
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF-----------------IN 240
Query: 405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
           ++ +E +     E C   + N+   C    P++R +   IV +L
Sbjct: 241 MIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 119/261 (45%), Gaps = 30/261 (11%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           +G G FG V+        +VAVK    Q   +   F  E  +MK ++H+ L+++ +  + 
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 89
Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
           E    ++ EYM +GSL  ++ + + I L I + L++   +A  + ++        IH DL
Sbjct: 90  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 145
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGDV 358
           + +N+L+ D +   ++DF +A+L+  ED   T  +     I + APE    G  +   DV
Sbjct: 146 RAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 203
Query: 359 YSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKE 417
           +SFGI+L E  T G+ P   + N E+           I  +E              V  +
Sbjct: 204 WSFGILLTEIVTHGRIPYPGMTNPEV-----------IQNLE---------RGYRMVRPD 243
Query: 418 QCVSCVFNLAMECTVESPEQR 438
            C   ++ L   C  E PE R
Sbjct: 244 NCPEELYQLMRLCWKERPEDR 264

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 124/287 (43%), Gaps = 30/287 (10%)
Query: 178 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKGFDVECEMMKSIRHRNLI 232
           N +IGRG FG VY   L    G  +  AVK  N +     +  F  E  +MK   H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 233 KVISTCSNEEFKALV-LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  +++L    S
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 152
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGRE 349
              +H DL   N +LD+     ++DF +A+ +  ++      +T A   + +MA E  + 
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 350 GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
            + +T  DV+SFG++L E  T   P     N              I+   + G  LL   
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----------FDITVYLLQGRRLLQ-- 259
Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL 456
                  E C   ++ + ++C     E R +  E+V+++  I  + +
Sbjct: 260 ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 300

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 124/287 (43%), Gaps = 30/287 (10%)
Query: 178 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKGFDVECEMMKSIRHRNLI 232
           N +IGRG FG VY   L    G  +  AVK  N +     +  F  E  +MK   H N++
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 233 KVISTCSNEEFKALV-LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  +++L    S
Sbjct: 100 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 156
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGRE 349
              +H DL   N +LD+     ++DF +A+ +  ++      +T A   + +MA E  + 
Sbjct: 157 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 216
Query: 350 GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
            + +T  DV+SFG++L E  T   P     N              I+   + G  LL   
Sbjct: 217 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----------FDITVYLLQGRRLLQ-- 263
Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL 456
                  E C   ++ + ++C     E R +  E+V+++  I  + +
Sbjct: 264 ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 304

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 124/287 (43%), Gaps = 30/287 (10%)
Query: 178 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKGFDVECEMMKSIRHRNLI 232
           N +IGRG FG VY   L    G  +  AVK  N +     +  F  E  +MK   H N++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 233 KVISTCSNEEFKALV-LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  +++L    S
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 149
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGRE 349
              +H DL   N +LD+     ++DF +A+ +  ++      +T A   + +MA E  + 
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 209
Query: 350 GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
            + +T  DV+SFG++L E  T   P     N              I+   + G  LL   
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----------FDITVYLLQGRRLLQ-- 256
Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL 456
                  E C   ++ + ++C     E R +  E+V+++  I  + +
Sbjct: 257 ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 297

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 119/261 (45%), Gaps = 30/261 (11%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           +G G FG V+        +VAVK    Q   +   F  E  +MK ++H+ L+++ +  + 
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 74
Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
           E    ++ EYM +GSL  ++ + + I L I + L++   +A  + ++        IH DL
Sbjct: 75  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 130
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGDV 358
           + +N+L+ D +   ++DF +A+L+  ED   T  +     I + APE    G  +   DV
Sbjct: 131 RAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 188
Query: 359 YSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKE 417
           +SFGI+L E  T G+ P   + N E                  V  NL  +     V  +
Sbjct: 189 WSFGILLTEIVTHGRIPYPGMTNPE------------------VIQNL--ERGYRMVRPD 228
Query: 418 QCVSCVFNLAMECTVESPEQR 438
            C   ++ L   C  E PE R
Sbjct: 229 NCPEELYQLMRLCWKERPEDR 249

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 124/287 (43%), Gaps = 30/287 (10%)
Query: 178 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKGFDVECEMMKSIRHRNLI 232
           N +IGRG FG VY   L    G  +  AVK  N +     +  F  E  +MK   H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 233 KVISTCSNEEFKALV-LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  +++L    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 151
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGRE 349
              +H DL   N +LD+     ++DF +A+ +  ++      +T A   + +MA E  + 
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 350 GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
            + +T  DV+SFG++L E  T   P     N              I+   + G  LL   
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----------FDITVYLLQGRRLLQ-- 258
Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL 456
                  E C   ++ + ++C     E R +  E+V+++  I  + +
Sbjct: 259 ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 299

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 124/287 (43%), Gaps = 30/287 (10%)
Query: 178 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKGFDVECEMMKSIRHRNLI 232
           N +IGRG FG VY   L    G  +  AVK  N +     +  F  E  +MK   H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 233 KVISTCSNEEFKALV-LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  +++L    S
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 152
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGRE 349
              +H DL   N +LD+     ++DF +A+ +  ++      +T A   + +MA E  + 
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 350 GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
            + +T  DV+SFG++L E  T   P     N              I+   + G  LL   
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----------FDITVYLLQGRRLLQ-- 259
Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL 456
                  E C   ++ + ++C     E R +  E+V+++  I  + +
Sbjct: 260 ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 300

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 116/243 (47%), Gaps = 25/243 (10%)
Query: 148 PSNDANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKA-RLGDG----MEVAV 202
           PS  A  P+ A  R     EL R         ++G G FG+VYK   + +G    + VA+
Sbjct: 22  PSGTA--PNQAQLRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAI 72
Query: 203 KVFNLQCG-RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMY 261
           K+ N   G +A   F  E  +M S+ H +L++++  C +   + LV + MPHG L +Y++
Sbjct: 73  KILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVH 131
Query: 262 SSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 321
                +     LN  + +A  + YL       ++H DL   NVL+       ++DF +A+
Sbjct: 132 EHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLAR 188
Query: 322 LLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME--TFTGKK----PT 375
           LL G+++          I +MA E     + +   DV+S+G+ + E  TF GK     PT
Sbjct: 189 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT 248
Query: 376 NEI 378
            EI
Sbjct: 249 REI 251

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 124/287 (43%), Gaps = 30/287 (10%)
Query: 178 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKGFDVECEMMKSIRHRNLI 232
           N +IGRG FG VY   L    G  +  AVK  N +     +  F  E  +MK   H N++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 233 KVISTCSNEEFKALV-LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  +++L    S
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 210
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGRE 349
              +H DL   N +LD+     ++DF +A+ +  ++      +T A   + +MA E  + 
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 350 GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
            + +T  DV+SFG++L E  T   P     N              I+   + G  LL   
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----------FDITVYLLQGRRLLQ-- 317
Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL 456
                  E C   ++ + ++C     E R +  E+V+++  I  + +
Sbjct: 318 ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 140/287 (48%), Gaps = 36/287 (12%)
Query: 180 LIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RALKGFDVECEMMKSIRHRNLIKV 234
           +IG G FG V   RL      E+ V +  L+ G   +  + F  E  +M    H N+I +
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL-HFGYSAP 293
               +  +   +V EYM +GSL+ ++  ++    + Q + ++  +++ ++YL   GY   
Sbjct: 89  EGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGY--- 145
Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ-TLATIGYMAPEYGREGRV 352
            +H DL   N+L++ N+V  +SDF ++++L  + ++   T+     I + APE     + 
Sbjct: 146 -VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKF 204
Query: 353 STNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDI 411
           ++  DV+S+GI++ E  + G++P  E+ N ++           I  +E  G  L S  D 
Sbjct: 205 TSASDVWSYGIVMWEVVSYGERPYWEMTNQDV-----------IKAVE-EGYRLPSPMD- 251
Query: 412 HFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRN 458
                  C + ++ L ++C     ++  N+R    +++ + D L+RN
Sbjct: 252 -------CPAALYQLMLDCW----QKERNSRPKFDEIVNMLDKLIRN 287

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 114/249 (45%), Gaps = 26/249 (10%)
Query: 162 TFSHLELCRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALK---GFD 217
           T SHL     +D +    ++G GG   V+ AR L    +VAVKV      R       F 
Sbjct: 6   TPSHL-----SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR 60
Query: 218 VECEMMKSIRHRNLIKVISTCSNE----EFKALVLEYMPHGSLEKYMYSSNYILDIFQRL 273
            E +   ++ H  ++ V +T   E        +V+EY+   +L   +++      +  + 
Sbjct: 61  REAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKR 117
Query: 274 NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 333
            I + +A A + L+F +   IIH D+KP+N+++       + DF IA+ +     S+TQT
Sbjct: 118 AIEV-IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 334 QT-LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE----MTLKHW 388
              + T  Y++PE  R   V    DVYS G +L E  TG+ P    F G+    +  +H 
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHV 232
Query: 389 VNDWLPIST 397
             D +P S 
Sbjct: 233 REDPIPPSA 241

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 121/261 (46%), Gaps = 30/261 (11%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           +G G FG V+ A      +VAVK        +++ F  E  +MK+++H  L+K+ +  + 
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL-EYLHFGYSAPIIHCDL 299
           E    ++ E+M  GSL  ++ S        Q L  +ID ++ + E + F      IH DL
Sbjct: 255 EPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 310
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGDV 358
           + +N+L+  ++V  ++DF +A+++  ED   T  +     I + APE    G  +   DV
Sbjct: 311 RAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 368
Query: 359 YSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKE 417
           +SFGI+LME  T G+ P   + N E+           I  +E                 E
Sbjct: 369 WSFGILLMEIVTYGRIPYPGMSNPEV-----------IRALE---------RGYRMPRPE 408
Query: 418 QCVSCVFNLAMECTVESPEQR 438
            C   ++N+ M C    PE+R
Sbjct: 409 NCPEELYNIMMRCWKNRPEER 429

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/289 (23%), Positives = 138/289 (47%), Gaps = 36/289 (12%)
Query: 178 NNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RALKGFDVECEMMKSIRHRNLI 232
             +IG G FG V   RL      +VAV +  L+ G   +  + F  E  +M    H N++
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL-HFGYS 291
            +    +  +   +V+E+M +G+L+ ++   +    + Q + ++  +A+ + YL   GY 
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGY- 166
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM-TQTQTLATIGYMAPEYGREG 350
              +H DL   N+L++ N+V  +SDF +++++  + +++ T T     + + APE  +  
Sbjct: 167 ---VHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYR 223
Query: 351 RVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
           + ++  DV+S+GI++ E  + G++P            +W      +S  +V+ A    +E
Sbjct: 224 KFTSASDVWSYGIVMWEVMSYGERP------------YW-----DMSNQDVIKA---IEE 263
Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRN 458
                A   C + +  L ++C  +   +R    +IV     I D ++RN
Sbjct: 264 GYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVG----ILDKMIRN 308

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 132/288 (45%), Gaps = 36/288 (12%)
Query: 180 LIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RALKGFDVECEMMKSIRHRNLIKV 234
           +IG G FG V + RL      E  V +  L+ G   R  + F  E  +M    H N+I++
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 80
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI 294
               +N     ++ E+M +G+L+ ++  ++    + Q + ++  +AS + YL        
Sbjct: 81  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLA---EMSY 137
Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA---TIGYMAPEYGREGR 351
           +H DL   N+L++ N+V  +SDF +++ L       T T +L     I + APE     +
Sbjct: 138 VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRK 197
Query: 352 VSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED 410
            ++  D +S+GI++ E  + G++P            +W      +S  +V+ A    ++D
Sbjct: 198 FTSASDAWSYGIVMWEVMSFGERP------------YW-----DMSNQDVINA---IEQD 237
Query: 411 IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRN 458
                   C + +  L ++C     ++  NAR    +++   D ++RN
Sbjct: 238 YRLPPPPDCPTSLHQLMLDCW----QKDRNARPRFPQVVSALDKMIRN 281

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 130/282 (46%), Gaps = 41/282 (14%)
Query: 175 FSENNLIGRGGFGSVYKARL----GDGMEVAVKVF--NLQCGRALKGFDVECEMMKSIRH 228
           F+   ++G+G FGSV +A+L    G  ++VAVK+   ++     ++ F  E   MK   H
Sbjct: 25  FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84
Query: 229 RNLIKVISTCSNEEFKA------LVLEYMPHGSLEKYMYSSN-----YILDIFQRLNIMI 277
            ++ K++        K       ++L +M HG L  ++ +S      + L +   +  M+
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 278 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA 337
           D+A  +EYL    S   IH DL   N +L ++M   ++DF +++ +   D       +  
Sbjct: 145 DIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201
Query: 338 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPIS 396
            + ++A E   +   + + DV++FG+ + E  T G+ P   I N E      + ++L   
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE------IYNYL--- 252
Query: 397 TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQR 438
               +G N L Q         +C+  V++L  +C    P+QR
Sbjct: 253 ----IGGNRLKQ-------PPECMEEVYDLMYQCWSADPKQR 283

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 181 IGRGGFGSVY-----KARLGDGMEVAVKVFNLQCGRALK-GFDVECEMMKSIRHRNLIKV 234
           +G G FG V          G G  VAVK     CG  L+ G+  E E+++++ H +++K 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 235 ISTCSNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
              C ++  K+  LV+EY+P GSL  Y+    + + + Q L     +   + YLH   + 
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYL--PRHCVGLAQLLLFAQQICEGMAYLH---AQ 131
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREGR 351
             IH  L   NVLLD++ +  + DF +AK +  G +    +    + + + APE  +E +
Sbjct: 132 HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECK 191
Query: 352 VSTNGDVYSFGIMLMETFT 370
                DV+SFG+ L E  T
Sbjct: 192 FYYASDVWSFGVTLYELLT 210

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 80/315 (25%), Positives = 139/315 (44%), Gaps = 46/315 (14%)
Query: 154 MPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRA 212
           +P  +   T SHL     +D +    ++G GG   V+ AR L    +VAVKV      R 
Sbjct: 15  VPRGSHMTTPSHL-----SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARD 69
Query: 213 LK---GFDVECEMMKSIRHRNLIKVISTCSNE----EFKALVLEYMPHGSLEKYMYSSNY 265
                 F  E +   ++ H  ++ V  T   E        +V+EY+   +L   +++   
Sbjct: 70  PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG- 128
Query: 266 ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG 325
              +  +  I + +A A + L+F +   IIH D+KP+N+++       + DF IA+ +  
Sbjct: 129 --PMTPKRAIEV-IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 185
Query: 326 EDQSMTQTQT-LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE-- 382
              S+TQT   + T  Y++PE  R   V    DVYS G +L E  TG+ P    F G+  
Sbjct: 186 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSP 241
Query: 383 --MTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFN-LAMECTVESPEQRI 439
             +  +H   D +P S                  A+ + +S   + + ++   ++PE R 
Sbjct: 242 VSVAYQHVREDPIPPS------------------ARHEGLSADLDAVVLKALAKNPENRY 283
Query: 440 N-AREIVAKLLKIRD 453
             A E+ A L+++ +
Sbjct: 284 QTAAEMRADLVRVHN 298

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 118/266 (44%), Gaps = 26/266 (9%)
Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G +G VY+       + VAVK    +    ++ F  E  +MK I+H NL++++  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    +++E+M +G+L  Y+   N   ++    L +   ++SA+EYL        IH D
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 137
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
           L   N L+ +N +  ++DF +++L+TG D           I + APE     + S   DV
Sbjct: 138 LAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 196
Query: 359 YSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQ 418
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 197 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 237
Query: 419 CVSCVFNLAMECTVESPEQRINAREI 444
           C   V+ L   C   +P  R +  EI
Sbjct: 238 CPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 181 IGRGGFGSVY-----KARLGDGMEVAVKVFNLQCGRALK-GFDVECEMMKSIRHRNLIKV 234
           +G G FG V          G G  VAVK     CG  L+ G+  E E+++++ H +++K 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 235 ISTCSNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
              C ++  K+  LV+EY+P GSL  Y+    + + + Q L     +   + YLH   + 
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYL--PRHCVGLAQLLLFAQQICEGMAYLH---AQ 130
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREGR 351
             IH  L   NVLLD++ +  + DF +AK +  G +    +    + + + APE  +E +
Sbjct: 131 HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECK 190
Query: 352 VSTNGDVYSFGIMLMETFT 370
                DV+SFG+ L E  T
Sbjct: 191 FYYASDVWSFGVTLYELLT 209

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 113/236 (47%), Gaps = 23/236 (9%)
Query: 155 PSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKA-RLGDG----MEVAVKVFNLQC 209
           P+ A  R     EL R         ++G G FG+VYK   + +G    + VA+K+ N   
Sbjct: 4   PNQAQLRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT 56
Query: 210 G-RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILD 268
           G +A   F  E  +M S+ H +L++++  C +   + LV + MPHG L +Y++     + 
Sbjct: 57  GPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIG 115
Query: 269 IFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ 328
               LN  + +A  + YL       ++H DL   NVL+       ++DF +A+LL G+++
Sbjct: 116 SQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 172
Query: 329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME--TFTGKK----PTNEI 378
                     I +MA E     + +   DV+S+G+ + E  TF GK     PT EI
Sbjct: 173 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 228

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 113/249 (45%), Gaps = 26/249 (10%)
Query: 162 TFSHLELCRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALK---GFD 217
           T SHL     +D +    ++G GG   V+ AR L    +VAVKV      R       F 
Sbjct: 6   TPSHL-----SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR 60
Query: 218 VECEMMKSIRHRNLIKVISTCSNE----EFKALVLEYMPHGSLEKYMYSSNYILDIFQRL 273
            E +   ++ H  ++ V  T   E        +V+EY+   +L   +++      +  + 
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKR 117
Query: 274 NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 333
            I + +A A + L+F +   IIH D+KP+N+++       + DF IA+ +     S+TQT
Sbjct: 118 AIEV-IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 334 QT-LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE----MTLKHW 388
              + T  Y++PE  R   V    DVYS G +L E  TG+ P    F G+    +  +H 
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHV 232
Query: 389 VNDWLPIST 397
             D +P S 
Sbjct: 233 REDPIPPSA 241

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 181 IGRGGFGSVY-----KARLGDGMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKV 234
           +G G FG V          G G  VAVK     CG +   G+  E ++++++ H ++IK 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 235 ISTCSNEEFKAL--VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
              C ++  K+L  V+EY+P GSL  Y+    + + + Q L     +   + YLH   S 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLH---SQ 136
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREGR 351
             IH +L   NVLLD++ +  + DF +AK +  G +    +    + + + APE  +E +
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 196
Query: 352 VSTNGDVYSFGIMLMETFT 370
                DV+SFG+ L E  T
Sbjct: 197 FYYASDVWSFGVTLYELLT 215

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 118/266 (44%), Gaps = 26/266 (9%)
Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G +G VY+       + VAVK    +    ++ F  E  +MK I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    +++E+M +G+L  Y+   N   ++    L +   ++SA+EYL        IH D
Sbjct: 85  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
           L   N L+ +N +  ++DF +++L+TG D           I + APE     + S   DV
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 359 YSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQ 418
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 201 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 241
Query: 419 CVSCVFNLAMECTVESPEQRINAREI 444
           C   V+ L   C   +P  R +  EI
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 95/192 (49%), Gaps = 7/192 (3%)
Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G +G VY        + VAVK    +    ++ F  E  +MK I+H NL++++  C+
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    +V EYMP+G+L  Y+   N   +     L +   ++SA+EYL        IH D
Sbjct: 99  LEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE---KKNFIHRD 155
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
           L   N L+ +N V  ++DF +++L+TG D           I + APE       S   DV
Sbjct: 156 LAARNCLVGENHVVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDV 214
Query: 359 YSFGIMLMETFT 370
           ++FG++L E  T
Sbjct: 215 WAFGVLLWEIAT 226

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 119/261 (45%), Gaps = 30/261 (11%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           +G G FG V+        +VAVK    Q   +   F  E  +MK ++H+ L+++ +  + 
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 75
Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
           E    ++ EYM +GSL  ++ + + I L I + L++   +A  + ++        IH +L
Sbjct: 76  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRNL 131
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGDV 358
           + +N+L+ D +   ++DF +A+L+  ED   T  +     I + APE    G  +   DV
Sbjct: 132 RAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 189
Query: 359 YSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKE 417
           +SFGI+L E  T G+ P   + N E                  V  NL  +     V  +
Sbjct: 190 WSFGILLTEIVTHGRIPYPGMTNPE------------------VIQNL--ERGYRMVRPD 229
Query: 418 QCVSCVFNLAMECTVESPEQR 438
            C   ++ L   C  E PE R
Sbjct: 230 NCPEELYQLMRLCWKERPEDR 250

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 127/291 (43%), Gaps = 34/291 (11%)
Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G FG VY+       + VAVK    +    ++ F  E  +MK I+H NL++++  C+
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    ++ E+M +G+L  Y+   N   +     L +   ++SA+EYL        IH D
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
           L   N L+ +N +  ++DF +++L+TG D           I + APE     + S   DV
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 359 YSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKE 417
           ++FG++L E  T G  P   I               P    E++      ++D      E
Sbjct: 194 WAFGVLLWEIATYGMSPYPGI--------------DPSQVYELL------EKDYRMERPE 233
Query: 418 QCVSCVFNLAMECTVESPEQRIN------AREIVAKLLKIRDSLLRNVGDR 462
            C   V+ L   C   +P  R +      A E + +   I D + + +G R
Sbjct: 234 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKR 284

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 119/267 (44%), Gaps = 28/267 (10%)
Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G +G VY+       + VAVK    +    ++ F  E  +MK I+H NL++++  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    +++E+M +G+L  Y+   N   +     L +   ++SA+EYL        IH D
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
           L   N L+ +N +  ++DF +++L+TG D           I + APE     + S   DV
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 359 YSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKE 417
           ++FG++L E  T G  P   I               P    E++      ++D      E
Sbjct: 194 WAFGVLLWEIATYGMSPYPGI--------------DPSQVYELL------EKDYRMERPE 233
Query: 418 QCVSCVFNLAMECTVESPEQRINAREI 444
            C   V+ L   C   +P  R +  EI
Sbjct: 234 GCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 106/207 (51%), Gaps = 12/207 (5%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G FG V+        +VA+K   L+ G  + + F  E ++MK ++H  L+++ +  S
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKT--LKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    +V EYM  GSL  ++       L +   +++   VA+ + Y+        IH D
Sbjct: 75  EEPI-YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRD 130
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGD 357
           L+ +N+L+ + ++  ++DF +A+L+  ED   T  Q     I + APE    GR +   D
Sbjct: 131 LRSANILVGNGLICKIADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 188
Query: 358 VYSFGIMLMETFT-GKKPTNEIFNGEM 383
           V+SFGI+L E  T G+ P   + N E+
Sbjct: 189 VWSFGILLTELVTKGRVPYPGMNNREV 215

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 126/290 (43%), Gaps = 32/290 (11%)
Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G +G VY+       + VAVK    +    ++ F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    +++E+M +G+L  Y+   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
           L   N L+ +N +  ++DF +++L+TG D           I + APE     + S   DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 359 YSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQ 418
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 196 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 236
Query: 419 CVSCVFNLAMECTVESPEQRIN------AREIVAKLLKIRDSLLRNVGDR 462
           C   V+ L   C   +P  R +      A E + +   I D + + +G R
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKR 286

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 117/266 (43%), Gaps = 26/266 (9%)
Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G +G VY+       + VAVK    +    ++ F  E  +MK I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    ++ E+M +G+L  Y+   N   ++    L +   ++SA+EYL        IH D
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
           L   N L+ +N +  ++DF +++L+TG D           I + APE     + S   DV
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 359 YSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQ 418
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 201 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 241
Query: 419 CVSCVFNLAMECTVESPEQRINAREI 444
           C   V+ L   C   +P  R +  EI
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 129/292 (44%), Gaps = 47/292 (16%)
Query: 178 NNLIGRGGFGSVYKARLG-DG--MEVAVKVFNLQCGRA-LKGFDVECEMM-KSIRHRNLI 232
            ++IG G FG V KAR+  DG  M+ A+K       +   + F  E E++ K   H N+I
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYI---------------LDIFQRLNIMI 277
            ++  C +  +  L +EY PHG+L  ++  S  +               L   Q L+   
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 278 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA 337
           DVA  ++YL        IH DL   N+L+ +N VA ++DF +++   G++  + +T    
Sbjct: 150 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 203
Query: 338 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPIS 396
            + +MA E       +TN DV+S+G++L E  + G  P   +   E+  K      LP  
Sbjct: 204 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK------LP-- 255
Query: 397 TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
                       +         C   V++L  +C  E P +R +  +I+  L
Sbjct: 256 ------------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 295

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 117/266 (43%), Gaps = 26/266 (9%)
Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G +G VY+       + VAVK    +    ++ F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    +++E+M +G+L  Y+   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
           L   N L+ +N +  ++DF +++L+TG D           I + APE     + S   DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 359 YSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQ 418
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 196 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 236
Query: 419 CVSCVFNLAMECTVESPEQRINAREI 444
           C   V+ L   C   +P  R +  EI
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 102/208 (49%), Gaps = 7/208 (3%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 300
           +    ++ EYM +G L  Y+    +     Q L +  DV  A+EYL    S   +H DL 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 147
Query: 301 PSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYS 360
             N L++D  V  +SDF +++ +  +D+  +   +   + +  PE     + S+  D+++
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVL-DDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 206
Query: 361 FGIMLMETFT-GKKPTNEIFNGEMTLKH 387
           FG+++ E ++ GK P     N E T +H
Sbjct: 207 FGVLMWEIYSLGKMPYERFTNSE-TAEH 233

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 129/292 (44%), Gaps = 47/292 (16%)
Query: 178 NNLIGRGGFGSVYKARLG-DG--MEVAVKVFNLQCGRA-LKGFDVECEMM-KSIRHRNLI 232
            ++IG G FG V KAR+  DG  M+ A+K       +   + F  E E++ K   H N+I
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYI---------------LDIFQRLNIMI 277
            ++  C +  +  L +EY PHG+L  ++  S  +               L   Q L+   
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 278 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA 337
           DVA  ++YL        IH DL   N+L+ +N VA ++DF +++   G++  + +T    
Sbjct: 140 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 193
Query: 338 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPIS 396
            + +MA E       +TN DV+S+G++L E  + G  P   +   E+  K      LP  
Sbjct: 194 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK------LP-- 245
Query: 397 TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
                       +         C   V++L  +C  E P +R +  +I+  L
Sbjct: 246 ------------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 285

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 117/266 (43%), Gaps = 26/266 (9%)
Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G +G VY+       + VAVK    +    ++ F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    ++ E+M +G+L  Y+   N   ++    L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
           L   N L+ +N +  ++DF +++L+TG D           I + APE     + S   DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 359 YSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQ 418
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 196 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 236
Query: 419 CVSCVFNLAMECTVESPEQRINAREI 444
           C   V+ L   C   +P  R +  EI
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 12/208 (5%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-----ECEMMKSI 226
           + F    ++G G F +V  AR L    E A+K+  L+    +K   V     E ++M  +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 89
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
            H   +K+  T  ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRF-YTAEIVSALEYL 148
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H      IIH DLKP N+LL+++M   ++DF  AK+L+ E +       + T  Y++PE 
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 205
Query: 347 GREGRVSTNGDVYSFGIMLMETFTGKKP 374
             E   S + D+++ G ++ +   G  P
Sbjct: 206 LTEKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 117/266 (43%), Gaps = 26/266 (9%)
Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G +G VY+       + VAVK    +    ++ F  E  +MK I+H NL++++  C+
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    ++ E+M +G+L  Y+   N   ++    L +   ++SA+EYL        IH D
Sbjct: 84  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 140
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
           L   N L+ +N +  ++DF +++L+TG D           I + APE     + S   DV
Sbjct: 141 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 199
Query: 359 YSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQ 418
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 200 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 240
Query: 419 CVSCVFNLAMECTVESPEQRINAREI 444
           C   V+ L   C   +P  R +  EI
Sbjct: 241 CPEKVYELMRACWQWNPSDRPSFAEI 266

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 181 IGRGGFGSVY-----KARLGDGMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKV 234
           +G G FG V          G G  VAVK     CG +   G+  E ++++++ H ++IK 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 235 ISTCSNEEFKAL--VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
              C ++  K+L  V+EY+P GSL  Y+    + + + Q L     +   + YLH   + 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLH---AQ 136
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREGR 351
             IH +L   NVLLD++ +  + DF +AK +  G +    +    + + + APE  +E +
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 196
Query: 352 VSTNGDVYSFGIMLMETFT 370
                DV+SFG+ L E  T
Sbjct: 197 FYYASDVWSFGVTLYELLT 215

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 117/266 (43%), Gaps = 26/266 (9%)
Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G +G VY+       + VAVK    +    ++ F  E  +MK I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    ++ E+M +G+L  Y+   N   ++    L +   ++SA+EYL        IH D
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
           L   N L+ +N +  ++DF +++L+TG D           I + APE     + S   DV
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 359 YSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQ 418
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 201 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 241
Query: 419 CVSCVFNLAMECTVESPEQRINAREI 444
           C   V+ L   C   +P  R +  EI
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 118/261 (45%), Gaps = 30/261 (11%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           +G G  G V+        +VAVK    Q   +   F  E  +MK ++H+ L+++ +  + 
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
           E    ++ EYM +GSL  ++ + + I L I + L++   +A  + ++        IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGDV 358
           + +N+L+ D +   ++DF +A+L+  ED   T  +     I + APE    G  +   DV
Sbjct: 136 RAANILVSDTLSCKIADFGLARLI--EDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 359 YSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKE 417
           +SFGI+L E  T G+ P   + N E+           I  +E              V  +
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPEV-----------IQNLE---------RGYRMVRPD 233
Query: 418 QCVSCVFNLAMECTVESPEQR 438
            C   ++ L   C  E PE R
Sbjct: 234 NCPEELYQLMRLCWKERPEDR 254

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 117/266 (43%), Gaps = 26/266 (9%)
Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G +G VY+       + VAVK    +    ++ F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    ++ E+M +G+L  Y+   N   ++    L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
           L   N L+ +N +  ++DF +++L+TG D           I + APE     + S   DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 359 YSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQ 418
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 196 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 236
Query: 419 CVSCVFNLAMECTVESPEQRINAREI 444
           C   V+ L   C   +P  R +  EI
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 102/208 (49%), Gaps = 7/208 (3%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++   C+ 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 300
           +    ++ EYM +G L  Y+    +     Q L +  DV  A+EYL    S   +H DL 
Sbjct: 75  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 131
Query: 301 PSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYS 360
             N L++D  V  +SDF +++ +  +D+  +   +   + +  PE     + S+  D+++
Sbjct: 132 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 190
Query: 361 FGIMLMETFT-GKKPTNEIFNGEMTLKH 387
           FG+++ E ++ GK P     N E T +H
Sbjct: 191 FGVLMWEIYSLGKMPYERFTNSE-TAEH 217

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 102/208 (49%), Gaps = 7/208 (3%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 300
           +    ++ EYM +G L  Y+    +     Q L +  DV  A+EYL    S   +H DL 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 147
Query: 301 PSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYS 360
             N L++D  V  +SDF +++ +  +D+  +   +   + +  PE     + S+  D+++
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 206
Query: 361 FGIMLMETFT-GKKPTNEIFNGEMTLKH 387
           FG+++ E ++ GK P     N E T +H
Sbjct: 207 FGVLMWEIYSLGKMPYERFTNSE-TAEH 233

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 117/266 (43%), Gaps = 26/266 (9%)
Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G +G VY+       + VAVK    +    ++ F  E  +MK I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    ++ E+M +G+L  Y+   N   ++    L +   ++SA+EYL        IH D
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
           L   N L+ +N +  ++DF +++L+TG D           I + APE     + S   DV
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 359 YSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQ 418
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 201 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 241
Query: 419 CVSCVFNLAMECTVESPEQRINAREI 444
           C   V+ L   C   +P  R +  EI
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 117/266 (43%), Gaps = 26/266 (9%)
Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G +G VY+       + VAVK    +    ++ F  E  +MK I+H NL++++  C+
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    ++ E+M +G+L  Y+   N   ++    L +   ++SA+EYL        IH D
Sbjct: 93  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 149
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
           L   N L+ +N +  ++DF +++L+TG D           I + APE     + S   DV
Sbjct: 150 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 208
Query: 359 YSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQ 418
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 209 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 249
Query: 419 CVSCVFNLAMECTVESPEQRINAREI 444
           C   V+ L   C   +P  R +  EI
Sbjct: 250 CPEKVYELMRACWQWNPSDRPSFAEI 275

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 102/208 (49%), Gaps = 7/208 (3%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++   C+ 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 300
           +    ++ EYM +G L  Y+    +     Q L +  DV  A+EYL    S   +H DL 
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 132
Query: 301 PSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYS 360
             N L++D  V  +SDF +++ +  +D+  +   +   + +  PE     + S+  D+++
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 191
Query: 361 FGIMLMETFT-GKKPTNEIFNGEMTLKH 387
           FG+++ E ++ GK P     N E T +H
Sbjct: 192 FGVLMWEIYSLGKMPYERFTNSE-TAEH 218

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 117/266 (43%), Gaps = 26/266 (9%)
Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G +G VY+       + VAVK    +    ++ F  E  +MK I+H NL++++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    ++ E+M +G+L  Y+   N   ++    L +   ++SA+EYL        IH D
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 138
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
           L   N L+ +N +  ++DF +++L+TG D           I + APE     + S   DV
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 359 YSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQ 418
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 198 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 238
Query: 419 CVSCVFNLAMECTVESPEQRINAREI 444
           C   V+ L   C   +P  R +  EI
Sbjct: 239 CPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 117/266 (43%), Gaps = 26/266 (9%)
Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G +G VY+       + VAVK    +    ++ F  E  +MK I+H NL++++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    ++ E+M +G+L  Y+   N   ++    L +   ++SA+EYL        IH D
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 138
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
           L   N L+ +N +  ++DF +++L+TG D           I + APE     + S   DV
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 359 YSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQ 418
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 198 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 238
Query: 419 CVSCVFNLAMECTVESPEQRINAREI 444
           C   V+ L   C   +P  R +  EI
Sbjct: 239 CPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 131/289 (45%), Gaps = 36/289 (12%)
Query: 179 NLIGRGGFGSVYKA--RLGDGMEVAVKVFNLQCG---RALKGFDVECEMMKSIRHRNLIK 233
            +IG G FG V     +L    E+ V +  L+ G   +  + F  E  +M    H N+I 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
           +    +      ++ E+M +GSL+ ++  ++    + Q + ++  +A+ ++YL       
Sbjct: 99  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMN 155
Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA---TIGYMAPEYGREG 350
            +H DL   N+L++ N+V  +SDF +++ L  +    T T  L     I + APE  +  
Sbjct: 156 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 215
Query: 351 RVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
           + ++  DV+S+GI++ E  + G++P            +W      ++  +V+ A    ++
Sbjct: 216 KFTSASDVWSYGIVMWEVMSYGERP------------YW-----DMTNQDVINA---IEQ 255
Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRN 458
           D        C S +  L ++C  +    R    +IV  L    D ++RN
Sbjct: 256 DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL----DKMIRN 300

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 102/208 (49%), Gaps = 7/208 (3%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++   C+ 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 300
           +    ++ EYM +G L  Y+    +     Q L +  DV  A+EYL    S   +H DL 
Sbjct: 71  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 127
Query: 301 PSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYS 360
             N L++D  V  +SDF +++ +  +D+  +   +   + +  PE     + S+  D+++
Sbjct: 128 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 186
Query: 361 FGIMLMETFT-GKKPTNEIFNGEMTLKH 387
           FG+++ E ++ GK P     N E T +H
Sbjct: 187 FGVLMWEIYSLGKMPYERFTNSE-TAEH 213

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 102/208 (49%), Gaps = 7/208 (3%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++   C+ 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 300
           +    ++ EYM +G L  Y+    +     Q L +  DV  A+EYL    S   +H DL 
Sbjct: 82  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 138
Query: 301 PSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYS 360
             N L++D  V  +SDF +++ +  +D+  +   +   + +  PE     + S+  D+++
Sbjct: 139 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 197
Query: 361 FGIMLMETFT-GKKPTNEIFNGEMTLKH 387
           FG+++ E ++ GK P     N E T +H
Sbjct: 198 FGVLMWEIYSLGKMPYERFTNSE-TAEH 224

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 125/290 (43%), Gaps = 32/290 (11%)
Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G +G VY+       + VAVK    +    ++ F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    ++ E+M +G+L  Y+   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
           L   N L+ +N +  ++DF +++L+TG D           I + APE     + S   DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 359 YSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQ 418
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 196 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 236
Query: 419 CVSCVFNLAMECTVESPEQRIN------AREIVAKLLKIRDSLLRNVGDR 462
           C   V+ L   C   +P  R +      A E + +   I D + + +G R
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKR 286

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 125/290 (43%), Gaps = 32/290 (11%)
Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G +G VY+       + VAVK    +    ++ F  E  +MK I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    ++ E+M +G+L  Y+   N   +     L +   ++SA+EYL        IH D
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
           L   N L+ +N +  ++DF +++L+TG D           I + APE     + S   DV
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 359 YSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQ 418
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 201 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 241
Query: 419 CVSCVFNLAMECTVESPEQRIN------AREIVAKLLKIRDSLLRNVGDR 462
           C   V+ L   C   +P  R +      A E + +   I D + + +G R
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKR 291

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 116/266 (43%), Gaps = 26/266 (9%)
Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G +G VY+       + VAVK    +    ++ F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    ++ E+M +G+L  Y+   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
           L   N L+ +N +  ++DF +++L+TG D           I + APE     + S   DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 359 YSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQ 418
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 196 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 236
Query: 419 CVSCVFNLAMECTVESPEQRINAREI 444
           C   V+ L   C   +P  R +  EI
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 102/208 (49%), Gaps = 7/208 (3%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++   C+ 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 300
           +    ++ EYM +G L  Y+    +     Q L +  DV  A+EYL    S   +H DL 
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 132
Query: 301 PSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYS 360
             N L++D  V  +SDF +++ +  +D+  +   +   + +  PE     + S+  D+++
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIWA 191
Query: 361 FGIMLMETFT-GKKPTNEIFNGEMTLKH 387
           FG+++ E ++ GK P     N E T +H
Sbjct: 192 FGVLMWEIYSLGKMPYERFTNSE-TAEH 218

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 117/266 (43%), Gaps = 26/266 (9%)
Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G +G VY+       + VAVK    +    ++ F  E  +MK I+H NL++++  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    ++ E+M +G+L  Y+   N   ++    L +   ++SA+EYL        IH D
Sbjct: 81  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 137
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
           L   N L+ +N +  ++DF +++L+TG D           I + APE     + S   DV
Sbjct: 138 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAPAGAKFPIKWTAPESLAYNKFSIKSDV 196
Query: 359 YSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQ 418
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 197 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 237
Query: 419 CVSCVFNLAMECTVESPEQRINAREI 444
           C   V+ L   C   +P  R +  EI
Sbjct: 238 CPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 12/211 (5%)
Query: 170 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-----ECEMM 223
           +  + F    ++G G F +V  AR L    E A+K+  L+    +K   V     E ++M
Sbjct: 6   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVM 63
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
             + H   +K+  T  ++E     L Y  +G L KY+       +   R     ++ SAL
Sbjct: 64  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSAL 122
Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           EYLH      IIH DLKP N+LL+++M   ++DF  AK+L+ E +       + T  Y++
Sbjct: 123 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 179
Query: 344 PEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           PE   E     + D+++ G ++ +   G  P
Sbjct: 180 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 12/211 (5%)
Query: 170 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-----ECEMM 223
           +  + F    ++G G F +V  AR L    E A+K+  L+    +K   V     E ++M
Sbjct: 7   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVM 64
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
             + H   +K+  T  ++E     L Y  +G L KY+       +   R     ++ SAL
Sbjct: 65  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSAL 123
Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           EYLH      IIH DLKP N+LL+++M   ++DF  AK+L+ E +       + T  Y++
Sbjct: 124 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 180
Query: 344 PEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           PE   E     + D+++ G ++ +   G  P
Sbjct: 181 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 117/266 (43%), Gaps = 26/266 (9%)
Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G +G VY+       + VAVK    +    ++ F  E  +MK I+H NL++++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    ++ E+M +G+L  Y+   N   ++    L +   ++SA+EYL        IH D
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 138
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
           L   N L+ +N +  ++DF +++L+TG D           I + APE     + S   DV
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAPAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 359 YSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQ 418
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 198 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 238
Query: 419 CVSCVFNLAMECTVESPEQRINAREI 444
           C   V+ L   C   +P  R +  EI
Sbjct: 239 CPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 12/211 (5%)
Query: 170 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-----ECEMM 223
           +  + F    ++G G F +V  AR L    E A+K+  L+    +K   V     E ++M
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVM 62
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
             + H   +K+  T  ++E     L Y  +G L KY+       +   R     ++ SAL
Sbjct: 63  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSAL 121
Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           EYLH      IIH DLKP N+LL+++M   ++DF  AK+L+ E +       + T  Y++
Sbjct: 122 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 178
Query: 344 PEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           PE   E     + D+++ G ++ +   G  P
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 12/211 (5%)
Query: 170 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-----ECEMM 223
           +  + F    ++G G F +V  AR L    E A+K+  L+    +K   V     E ++M
Sbjct: 4   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVM 61
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
             + H   +K+  T  ++E     L Y  +G L KY+       +   R     ++ SAL
Sbjct: 62  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSAL 120
Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           EYLH      IIH DLKP N+LL+++M   ++DF  AK+L+ E +       + T  Y++
Sbjct: 121 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 177
Query: 344 PEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           PE   E     + D+++ G ++ +   G  P
Sbjct: 178 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 127/291 (43%), Gaps = 34/291 (11%)
Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G +G VY+       + VAVK    +    ++ F  E  +MK I+H NL++++  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    ++ E+M +G+L  Y+   N   +     L +   ++SA+EYL        IH D
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
           L   N L+ +N +  ++DF +++L+TG D           I + APE     + S   DV
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTG-DTFTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 359 YSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKE 417
           ++FG++L E  T G  P   I               P    E++      ++D      E
Sbjct: 194 WAFGVLLWEIATYGMSPYPGI--------------DPSQVYELL------EKDYRMERPE 233
Query: 418 QCVSCVFNLAMECTVESPEQRIN------AREIVAKLLKIRDSLLRNVGDR 462
            C   V+ L   C   +P  R +      A E + +   I D + + +G R
Sbjct: 234 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKR 284

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-----ECEMMKSI 226
           + F    ++G G F +V  AR L    E A+K+  L+    +K   V     E ++M  +
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 86
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
            H   +K+  T  ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 87  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 145
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H      IIH DLKP N+LL+++M   ++DF  AK+L+ E +       + T  Y++PE 
Sbjct: 146 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 202
Query: 347 GREGRVSTNGDVYSFGIMLMETFTGKKP 374
             E     + D+++ G ++ +   G  P
Sbjct: 203 LTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-----ECEMMKSI 226
           + F    ++G G F +V  AR L    E A+K+  L+    +K   V     E ++M  +
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 71
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
            H   +K+  T  ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 72  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 130
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H      IIH DLKP N+LL+++M   ++DF  AK+L+ E +       + T  Y++PE 
Sbjct: 131 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 187
Query: 347 GREGRVSTNGDVYSFGIMLMETFTGKKP 374
             E     + D+++ G ++ +   G  P
Sbjct: 188 LTEKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-----ECEMMKSI 226
           + F    ++G G F +V  AR L    E A+K+  L+    +K   V     E ++M  +
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 90
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
            H   +K+  T  ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 91  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 149
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H      IIH DLKP N+LL+++M   ++DF  AK+L+ E +       + T  Y++PE 
Sbjct: 150 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 206
Query: 347 GREGRVSTNGDVYSFGIMLMETFTGKKP 374
             E     + D+++ G ++ +   G  P
Sbjct: 207 LTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-----ECEMMKSI 226
           + F    ++G G F +V  AR L    E A+K+  L+    +K   V     E ++M  +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 89
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
            H   +K+  T  ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 148
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H      IIH DLKP N+LL+++M   ++DF  AK+L+ E +       + T  Y++PE 
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 347 GREGRVSTNGDVYSFGIMLMETFTGKKP 374
             E     + D+++ G ++ +   G  P
Sbjct: 206 LTEKSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-----ECEMMKSI 226
           + F    ++G G F +V  AR L    E A+K+  L+    +K   V     E ++M  +
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 86
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
            H   +K+  T  ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 87  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 145
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H      IIH DLKP N+LL+++M   ++DF  AK+L+ E +       + T  Y++PE 
Sbjct: 146 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 202
Query: 347 GREGRVSTNGDVYSFGIMLMETFTGKKP 374
             E     + D+++ G ++ +   G  P
Sbjct: 203 LTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 104/198 (52%), Gaps = 11/198 (5%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G FG V+     +  +VAVK   L+ G  +++ F  E  +MK+++H  L+++ +  +
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVK--TLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL-NIMIDVASALEYLHFGYSAPIIHCD 298
            EE   ++ EYM  GSL  ++ S      +  +L +    +A  + Y+        IH D
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 135
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGD 357
           L+ +NVL+ ++++  ++DF +A+++  ED   T  +     I + APE    G  +   D
Sbjct: 136 LRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGCFTIKSD 193
Query: 358 VYSFGIMLMETFT-GKKP 374
           V+SFGI+L E  T GK P
Sbjct: 194 VWSFGILLYEIVTYGKIP 211

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-----ECEMMKSI 226
           + F    ++G G F +V  AR L    E A+K+  L+    +K   V     E ++M  +
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 90
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
            H   +K+  T  ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 91  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 149
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H      IIH DLKP N+LL+++M   ++DF  AK+L+ E +       + T  Y++PE 
Sbjct: 150 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 206
Query: 347 GREGRVSTNGDVYSFGIMLMETFTGKKP 374
             E     + D+++ G ++ +   G  P
Sbjct: 207 LTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-----ECEMMKSI 226
           + F    ++G G F +V  AR L    E A+K+  L+    +K   V     E ++M  +
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 87
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
            H   +K+  T  ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 146
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H      IIH DLKP N+LL+++M   ++DF  AK+L+ E +       + T  Y++PE 
Sbjct: 147 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 203
Query: 347 GREGRVSTNGDVYSFGIMLMETFTGKKP 374
             E     + D+++ G ++ +   G  P
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-----ECEMMKSI 226
           + F    ++G G F +V  AR L    E A+K+  L+    +K   V     E ++M  +
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 87
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
            H   +K+  T  ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 146
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H      IIH DLKP N+LL+++M   ++DF  AK+L+ E +       + T  Y++PE 
Sbjct: 147 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 203
Query: 347 GREGRVSTNGDVYSFGIMLMETFTGKKP 374
             E     + D+++ G ++ +   G  P
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-----ECEMMKSI 226
           + F    ++G G F +V  AR L    E A+K+  L+    +K   V     E ++M  +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 89
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
            H   +K+  T  ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 148
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H      IIH DLKP N+LL+++M   ++DF  AK+L+ E +       + T  Y++PE 
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 347 GREGRVSTNGDVYSFGIMLMETFTGKKP 374
             E     + D+++ G ++ +   G  P
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-----ECEMMKSI 226
           + F    ++G G F +V  AR L    E A+K+  L+    +K   V     E ++M  +
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 87
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
            H   +K+  T  ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 146
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H      IIH DLKP N+LL+++M   ++DF  AK+L+ E +       + T  Y++PE 
Sbjct: 147 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPEL 203
Query: 347 GREGRVSTNGDVYSFGIMLMETFTGKKP 374
             E     + D+++ G ++ +   G  P
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-----ECEMMKSI 226
           + F    ++G G F +V  AR L    E A+K+  L+    +K   V     E ++M  +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 89
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
            H   +K+  T  ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 148
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H      IIH DLKP N+LL+++M   ++DF  AK+L+ E +       + T  Y++PE 
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 347 GREGRVSTNGDVYSFGIMLMETFTGKKP 374
             E     + D+++ G ++ +   G  P
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-----ECEMMKSI 226
           + F    ++G G F +V  AR L    E A+K+  L+    +K   V     E ++M  +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 89
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
            H   +K+  T  ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 148
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H      IIH DLKP N+LL+++M   ++DF  AK+L+ E +       + T  Y++PE 
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 347 GREGRVSTNGDVYSFGIMLMETFTGKKP 374
             E     + D+++ G ++ +   G  P
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-----ECEMMKSI 226
           + F    ++G G F +V  AR L    E A+K+  L+    +K   V     E ++M  +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 89
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
            H   +K+  T  ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 148
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H      IIH DLKP N+LL+++M   ++DF  AK+L+ E +       + T  Y++PE 
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 347 GREGRVSTNGDVYSFGIMLMETFTGKKP 374
             E     + D+++ G ++ +   G  P
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 129/292 (44%), Gaps = 47/292 (16%)
Query: 178 NNLIGRGGFGSVYKARLG-DG--MEVAVKVFNLQCGRA-LKGFDVECEMM-KSIRHRNLI 232
            ++IG G FG V KAR+  DG  M+ A+K       +   + F  E E++ K   H N+I
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYI---------------LDIFQRLNIMI 277
            ++  C +  +  L +EY PHG+L  ++  S  +               L   Q L+   
Sbjct: 87  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 278 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA 337
           DVA  ++YL        IH +L   N+L+ +N VA ++DF +++   G++  + +T    
Sbjct: 147 DVARGMDYLS---QKQFIHRNLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 200
Query: 338 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPIS 396
            + +MA E       +TN DV+S+G++L E  + G  P   +   E+  K      LP  
Sbjct: 201 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK------LP-- 252
Query: 397 TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
                       +         C   V++L  +C  E P +R +  +I+  L
Sbjct: 253 ------------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 292

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-----ECEMMKSI 226
           + F    ++G G F +V  AR L    E A+K+  L+    +K   V     E ++M  +
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 92
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
            H   +K+  T  ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 93  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 151
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H      IIH DLKP N+LL+++M   ++DF  AK+L+ E +       + T  Y++PE 
Sbjct: 152 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 208
Query: 347 GREGRVSTNGDVYSFGIMLMETFTGKKP 374
             E     + D+++ G ++ +   G  P
Sbjct: 209 LTEKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 117/266 (43%), Gaps = 26/266 (9%)
Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G +G VY+       + VAVK    +    ++ F  E  +MK I+H NL++++  C+
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    ++ E+M +G+L  Y+   N   ++    L +   ++SA+EYL        IH +
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRN 382
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
           L   N L+ +N +  ++DF +++L+TG D           I + APE     + S   DV
Sbjct: 383 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 441
Query: 359 YSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQ 418
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 442 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 482
Query: 419 CVSCVFNLAMECTVESPEQRINAREI 444
           C   V+ L   C   +P  R +  EI
Sbjct: 483 CPEKVYELMRACWQWNPSDRPSFAEI 508

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 79/324 (24%), Positives = 139/324 (42%), Gaps = 35/324 (10%)
Query: 148 PSNDANMPSI-ATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVF 205
           P+   N P+I      +   E+ R TD  +  + +G G +G VY+       + VAVK  
Sbjct: 196 PAPKRNKPTIYGVSPNYDKWEMER-TD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL 253
Query: 206 NLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNY 265
             +    ++ F  E  +MK I+H NL++++  C+ E    ++ E+M +G+L  Y+   N 
Sbjct: 254 K-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR 312
Query: 266 I-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT 324
             +     L +   ++SA+EYL        IH +L   N L+ +N +  ++DF +++L+T
Sbjct: 313 QEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369
Query: 325 GEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMT 384
           G D           I + APE     + S   DV++FG++L E  T              
Sbjct: 370 G-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------- 418
Query: 385 LKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRIN---- 440
                    P   +++     L ++D      E C   V+ L   C   +P  R +    
Sbjct: 419 ---------PYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 469
Query: 441 --AREIVAKLLKIRDSLLRNVGDR 462
             A E + +   I D + + +G R
Sbjct: 470 HQAFETMFQESSISDEVEKELGKR 493

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 12/208 (5%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-----ECEMMKSI 226
           + F    ++G G F +   AR L    E A+K+  L+    +K   V     E ++M  +
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 87
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
            H   +K+  T  ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 146
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H      IIH DLKP N+LL+++M   ++DF  AK+L+ E +       + T  Y++PE 
Sbjct: 147 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 203
Query: 347 GREGRVSTNGDVYSFGIMLMETFTGKKP 374
             E     + D+++ G ++ +   G  P
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 16/220 (7%)
Query: 164 SHLELCRATDGFSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRAL 213
           + L  C+    F E +L     +G+G FGSV   R   LGD  G  VAVK          
Sbjct: 9   AQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ 68
Query: 214 KGFDVECEMMKSIRHRNLIKV--ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQ 271
           + F  E +++K++    ++K   +S     +   LV+EY+P G L  ++      LD  +
Sbjct: 69  RDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASR 128
Query: 272 RLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT-GEDQSM 330
            L     +   +EYL    S   +H DL   N+L++      ++DF +AKLL   +D  +
Sbjct: 129 LLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV 185
Query: 331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 370
            +    + I + APE   +   S   DV+SFG++L E FT
Sbjct: 186 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/289 (22%), Positives = 130/289 (44%), Gaps = 36/289 (12%)
Query: 179 NLIGRGGFGSVYKA--RLGDGMEVAVKVFNLQCG---RALKGFDVECEMMKSIRHRNLIK 233
            +IG G FG V     +L    E+ V +  L+ G   +  + F  E  +M    H N+I 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
           +    +      ++ E+M +GSL+ ++  ++    + Q + ++  +A+ ++YL       
Sbjct: 73  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMN 129
Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA---TIGYMAPEYGREG 350
            +H  L   N+L++ N+V  +SDF +++ L  +    T T  L     I + APE  +  
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 189
Query: 351 RVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
           + ++  DV+S+GI++ E  + G++P            +W      ++  +V+ A    ++
Sbjct: 190 KFTSASDVWSYGIVMWEVMSYGERP------------YW-----DMTNQDVINA---IEQ 229
Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRN 458
           D        C S +  L ++C  +    R    +IV  L    D ++RN
Sbjct: 230 DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL----DKMIRN 274

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 12/208 (5%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-----ECEMMKSI 226
           + F    ++G G F +V  AR L    E A+K+  L+    +K   V     E ++M  +
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 94
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
            H   +K+     ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 95  DHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 153
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H      IIH DLKP N+LL+++M   ++DF  AK+L+ E +       + T  Y++PE 
Sbjct: 154 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 210
Query: 347 GREGRVSTNGDVYSFGIMLMETFTGKKP 374
             E     + D+++ G ++ +   G  P
Sbjct: 211 LTEKSACKSSDLWALGCIIYQLVAGLPP 238

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 181 IGRGGFGSVY-----KARLGDGMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKV 234
           +G G FG V          G G  VAVK      G +   G+  E ++++++ H ++IK 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 235 ISTCSNEEFKAL--VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
              C +    +L  V+EY+P GSL  Y+    + + + Q L     +   + YLH   + 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLH---AQ 153
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT-GEDQSMTQTQTLATIGYMAPEYGREGR 351
             IH DL   NVLLD++ +  + DF +AK +  G +    +    + + + APE  +E +
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYK 213
Query: 352 VSTNGDVYSFGIMLMETFT 370
                DV+SFG+ L E  T
Sbjct: 214 FYYASDVWSFGVTLYELLT 232

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 98/199 (49%), Gaps = 12/199 (6%)
Query: 181 IGRGGFGSVYKARL---GD--GMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKV 234
           +G G FG V   R    GD  G +VAVK    + G   +     E E+++++ H N++K 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 235 ISTCSNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
              C+ +      L++E++P GSL++Y+  +   +++ Q+L   + +   ++YL    S 
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 133
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREGR 351
             +H DL   NVL++      + DF + K + T ++    +    + + + APE   + +
Sbjct: 134 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSK 193
Query: 352 VSTNGDVYSFGIMLMETFT 370
                DV+SFG+ L E  T
Sbjct: 194 FYIASDVWSFGVTLHELLT 212

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 112/220 (50%), Gaps = 25/220 (11%)
Query: 163 FSHLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQ-C--GRALKGFDV 218
           F H E+ RA         IG+G FG V   +  D  ++ A+K  N Q C     ++    
Sbjct: 14  FDHFEILRA---------IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK 64
Query: 219 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMID 278
           E ++M+ + H  L+ +  +  +EE   +V++ +  G L  ++  + +  +   +L  + +
Sbjct: 65  ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL-FICE 123
Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA- 337
           +  AL+YL    +  IIH D+KP N+LLD++   H++DF+IA +L  E    TQ  T+A 
Sbjct: 124 LVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMAG 176
Query: 338 TIGYMAPEY--GREGR-VSTNGDVYSFGIMLMETFTGKKP 374
           T  YMAPE    R+G   S   D +S G+   E   G++P
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 116/260 (44%), Gaps = 38/260 (14%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           +G G FG V+ A      +VAVK        +++ F  E  +MK+++H  L+K+ +  + 
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 248
Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL-EYLHFGYSAPIIHCDL 299
           E    ++ E+M  GSL  ++ S        Q L  +ID ++ + E + F      IH DL
Sbjct: 249 EPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 304
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVY 359
           + +N+L+  ++V  ++DF +A++                I + APE    G  +   DV+
Sbjct: 305 RAANILVSASLVCKIADFGLARV-----------GAKFPIKWTAPEAINFGSFTIKSDVW 353
Query: 360 SFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQ 418
           SFGI+LME  T G+ P   + N E+           I  +E                 E 
Sbjct: 354 SFGILLMEIVTYGRIPYPGMSNPEV-----------IRALE---------RGYRMPRPEN 393
Query: 419 CVSCVFNLAMECTVESPEQR 438
           C   ++N+ M C    PE+R
Sbjct: 394 CPEELYNIMMRCWKNRPEER 413

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 108/212 (50%), Gaps = 10/212 (4%)
Query: 179 NLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RALKGFDVECEMMKSIRHRNLIK 233
            +IG G FG V   RL      E+ V +  L+ G   +  + F  E  +M    H N+I 
Sbjct: 35  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 94
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
           +    +  +   ++ EYM +GSL+ ++  ++    + Q + ++  + S ++YL       
Sbjct: 95  LEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DMS 151
Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ-TLATIGYMAPEYGREGRV 352
            +H DL   N+L++ N+V  +SDF ++++L  + ++   T+     I + APE     + 
Sbjct: 152 AVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 211
Query: 353 STNGDVYSFGIMLMETFT-GKKPTNEIFNGEM 383
           ++  DV+S+GI++ E  + G++P  ++ N ++
Sbjct: 212 TSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 243

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 16/215 (7%)
Query: 169 CRATDGFSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKGFDV 218
           C+    F E +L     +G+G FGSV   R   LGD  G  VAVK          + F  
Sbjct: 1   CQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR 60
Query: 219 ECEMMKSIRHRNLIKV--ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIM 276
           E +++K++    ++K   +S     +   LV+EY+P G L  ++      LD  + L   
Sbjct: 61  EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 120
Query: 277 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT-GEDQSMTQTQT 335
             +   +EYL    S   +H DL   N+L++      ++DF +AKLL   +D  + +   
Sbjct: 121 SQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG 177
Query: 336 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 370
            + I + APE   +   S   DV+SFG++L E FT
Sbjct: 178 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 98/199 (49%), Gaps = 12/199 (6%)
Query: 181 IGRGGFGSVYKARL---GD--GMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKV 234
           +G G FG V   R    GD  G +VAVK    + G   +     E E+++++ H N++K 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 235 ISTCSNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
              C+ +      L++E++P GSL++Y+  +   +++ Q+L   + +   ++YL    S 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 145
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREGR 351
             +H DL   NVL++      + DF + K + T ++    +    + + + APE   + +
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSK 205
Query: 352 VSTNGDVYSFGIMLMETFT 370
                DV+SFG+ L E  T
Sbjct: 206 FYIASDVWSFGVTLHELLT 224

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 108/212 (50%), Gaps = 10/212 (4%)
Query: 179 NLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RALKGFDVECEMMKSIRHRNLIK 233
            +IG G FG V   RL      E+ V +  L+ G   +  + F  E  +M    H N+I 
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 73
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
           +    +  +   ++ EYM +GSL+ ++  ++    + Q + ++  + S ++YL       
Sbjct: 74  LEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DMS 130
Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ-TLATIGYMAPEYGREGRV 352
            +H DL   N+L++ N+V  +SDF ++++L  + ++   T+     I + APE     + 
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 190
Query: 353 STNGDVYSFGIMLMETFT-GKKPTNEIFNGEM 383
           ++  DV+S+GI++ E  + G++P  ++ N ++
Sbjct: 191 TSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 222

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 27/211 (12%)
Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAL-----KGFDVECEMMKSIRHRNLIKV 234
           +G GGFG V +    D G +VA+K    QC + L     + + +E ++MK + H N++  
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIK----QCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 78
Query: 235 ------ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQR--LNIMIDVASALEYL 286
                 +   +  +   L +EY   G L KY+        + +     ++ D++SAL YL
Sbjct: 79  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 138
Query: 287 HFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           H      IIH DLKP N++L      ++  + D   AK L   DQ    T+ + T+ Y+A
Sbjct: 139 HENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQYLA 192
Query: 344 PEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           PE   + + +   D +SFG +  E  TG +P
Sbjct: 193 PELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 27/211 (12%)
Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRAL-----KGFDVECEMMKSIRHRNLIKV 234
           +G GGFG V +    D G +VA+K    QC + L     + + +E ++MK + H N++  
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIK----QCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 235 ------ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQR--LNIMIDVASALEYL 286
                 +   +  +   L +EY   G L KY+        + +     ++ D++SAL YL
Sbjct: 78  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 287 HFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           H      IIH DLKP N++L      ++  + D   AK L   DQ    T+ + T+ Y+A
Sbjct: 138 HENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQYLA 191
Query: 344 PEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           PE   + + +   D +SFG +  E  TG +P
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 108/212 (50%), Gaps = 10/212 (4%)
Query: 179 NLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCG---RALKGFDVECEMMKSIRHRNLIK 233
            +IG G FG V   RL      E+ V +  L+ G   +  + F  E  +M    H N+I 
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 79
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
           +    +  +   ++ EYM +GSL+ ++  ++    + Q + ++  + S ++YL       
Sbjct: 80  LEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DMS 136
Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ-TLATIGYMAPEYGREGRV 352
            +H DL   N+L++ N+V  +SDF ++++L  + ++   T+     I + APE     + 
Sbjct: 137 YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 196
Query: 353 STNGDVYSFGIMLMETFT-GKKPTNEIFNGEM 383
           ++  DV+S+GI++ E  + G++P  ++ N ++
Sbjct: 197 TSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 228

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 122/292 (41%), Gaps = 36/292 (12%)
Query: 181 IGRGGFGSV----YKARLGDGMEVAVKVFN---LQCGRALKGFDVECEMMKSIRHRNLIK 233
           +G G FG V    + A  G  + VAVK      L    A+  F  E   M S+ HRNLI+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYM--YSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
           +         K +V E  P GSL   +  +  +++L    R    + VA  + YL    S
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 133
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREG 350
              IH DL   N+LL    +  + DF + + L   +D  + Q        + APE  +  
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 351 RVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
             S   D + FG+ L E FT G++P                 W+ ++  +++  + + +E
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQEP-----------------WIGLNGSQIL--HKIDKE 234
Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNVGD 461
                  E C   ++N+ ++C    PE R     +   LL+ + + +R + D
Sbjct: 235 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRALQD 286

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 28/223 (12%)
Query: 173 DGFSENNLIGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKGFDVECEMM 223
           D  +    +G G FG V         K +  + + VAVK+       + L     E EMM
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 224 KSI-RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSS-----NYILDI-------- 269
           K I +H+N+I ++  C+ +    +++EY   G+L +Y+ +       Y  DI        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 270 -FQRL-NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 327
            F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DF +A+ +   D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 370
                T     + +MAPE   +   +   DV+SFG+++ E FT
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 175 FSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKGFDVECEMMK 224
           F E +L     +G+G FGSV   R   LGD  G  VAVK          + F  E +++K
Sbjct: 8   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 67
Query: 225 SIRHRNLIKV--ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASA 282
           ++    ++K   +S     +   LV+EY+P G L  ++      LD  + L     +   
Sbjct: 68  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 127
Query: 283 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT-GEDQSMTQTQTLATIGY 341
           +EYL    S   +H DL   N+L++      ++DF +AKLL   +D  + +    + I +
Sbjct: 128 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 184
Query: 342 MAPEYGREGRVSTNGDVYSFGIMLMETFT 370
            APE   +   S   DV+SFG++L E FT
Sbjct: 185 YAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 104/198 (52%), Gaps = 11/198 (5%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G FG V+     +  +VAVK   L+ G  +++ F  E  +MK+++H  L+++ +  +
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVK--TLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL-NIMIDVASALEYLHFGYSAPIIHCD 298
            EE   ++ E+M  GSL  ++ S      +  +L +    +A  + Y+        IH D
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 134
Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGD 357
           L+ +NVL+ ++++  ++DF +A+++  ED   T  +     I + APE    G  +   +
Sbjct: 135 LRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGCFTIKSN 192
Query: 358 VYSFGIMLMETFT-GKKP 374
           V+SFGI+L E  T GK P
Sbjct: 193 VWSFGILLYEIVTYGKIP 210

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 16/209 (7%)
Query: 175 FSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKGFDVECEMMK 224
           F E +L     +G+G FGSV   R   LGD  G  VAVK          + F  E +++K
Sbjct: 4   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 63
Query: 225 SIRHRNLIKV--ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASA 282
           ++    ++K   +S         LV+EY+P G L  ++      LD  + L     +   
Sbjct: 64  ALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 123
Query: 283 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT-GEDQSMTQTQTLATIGY 341
           +EYL    S   +H DL   N+L++      ++DF +AKLL   +D  + +    + I +
Sbjct: 124 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFW 180
Query: 342 MAPEYGREGRVSTNGDVYSFGIMLMETFT 370
            APE   +   S   DV+SFG++L E FT
Sbjct: 181 YAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 112/269 (41%), Gaps = 36/269 (13%)
Query: 181 IGRGGFGSV----YKARLGDGMEVAVKVFN---LQCGRALKGFDVECEMMKSIRHRNLIK 233
           +G G FG V    + A  G  + VAVK      L    A+  F  E   M S+ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYM--YSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
           +         K +V E  P GSL   +  +  +++L    R    + VA  + YL    S
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 129
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREG 350
              IH DL   N+LL    +  + DF + + L   +D  + Q        + APE  +  
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 189
Query: 351 RVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
             S   D + FG+ L E FT G++P                 W+ ++  +++  + + +E
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEP-----------------WIGLNGSQIL--HKIDKE 230
Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQR 438
                  E C   ++N+ ++C    PE R
Sbjct: 231 GERLPRPEDCPQDIYNVMVQCWAHKPEDR 259

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 28/223 (12%)
Query: 173 DGFSENNLIGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKGFDVECEMM 223
           D  +    +G G FG V         K +  + + VAVK+       + L     E EMM
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 224 KSI-RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSS-----NYILDI-------- 269
           K I +H+N+I ++  C+ +    +++EY   G+L +Y+ +       Y  DI        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 270 -FQRL-NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 327
            F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DF +A+ +   D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMRIADFGLARDINNID 211
Query: 328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 370
                T     + +MAPE   +   +   DV+SFG+++ E FT
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 112/269 (41%), Gaps = 36/269 (13%)
Query: 181 IGRGGFGSV----YKARLGDGMEVAVKVFN---LQCGRALKGFDVECEMMKSIRHRNLIK 233
           +G G FG V    + A  G  + VAVK      L    A+  F  E   M S+ HRNLI+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYM--YSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
           +         K +V E  P GSL   +  +  +++L    R    + VA  + YL    S
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 139
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREG 350
              IH DL   N+LL    +  + DF + + L   +D  + Q        + APE  +  
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 199
Query: 351 RVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
             S   D + FG+ L E FT G++P                 W+ ++  +++  + + +E
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEP-----------------WIGLNGSQIL--HKIDKE 240
Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQR 438
                  E C   ++N+ ++C    PE R
Sbjct: 241 GERLPRPEDCPQDIYNVMVQCWAHKPEDR 269

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 28/223 (12%)
Query: 173 DGFSENNLIGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKGFDVECEMM 223
           D  +    +G G FG V         K +  + + VAVK+       + L     E EMM
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 224 KSI-RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSS-----NYILDI-------- 269
           K I +H+N+I ++  C+ +    +++EY   G+L +Y+ +       Y  DI        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 270 -FQRL-NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 327
            F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DF +A+ +   D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 370
                T     + +MAPE   +   +   DV+SFG+++ E FT
Sbjct: 212 YYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 114/266 (42%), Gaps = 26/266 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G +GSVYKA     G  VA+K   ++    L+    E  +M+     +++K   +  
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
                 +V+EY   GS+   +   N  L   +   I+      LEYLHF      IH D+
Sbjct: 95  KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK---IHRDI 151
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVY 359
           K  N+LL+    A L+DF +A  LT  D    +   + T  +MAPE  +E   +   D++
Sbjct: 152 KAGNILLNTEGHAKLADFGVAGQLT--DXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIW 209
Query: 360 SFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQC 419
           S GI  +E   GK P  +I               P+  + ++  N        F   E  
Sbjct: 210 SLGITAIEMAEGKPPYADIH--------------PMRAIFMIPTNPPPT----FRKPELW 251
Query: 420 VSCVFNLAMECTVESPEQRINAREIV 445
                +   +C V+SPEQR  A +++
Sbjct: 252 SDNFTDFVKQCLVKSPEQRATATQLL 277

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 28/223 (12%)
Query: 173 DGFSENNLIGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKGFDVECEMM 223
           D  +    +G G FG V         K +  + + VAVK+       + L     E EMM
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 224 KSI-RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSS-----NYILDI-------- 269
           K I +H+N+I ++  C+ +    +++EY   G+L +Y+ +       Y  DI        
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 270 -FQRL-NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 327
            F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DF +A+ +   D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 370
                T     + +MAPE   +   +   DV+SFG+++ E FT
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 28/223 (12%)
Query: 173 DGFSENNLIGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKGFDVECEMM 223
           D  +    +G G FG V         K +  + + VAVK+       + L     E EMM
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 224 KSI-RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSS-----NYILDI-------- 269
           K I +H+N+I ++  C+ +    +++EY   G+L +Y+ +       Y  DI        
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 270 -FQRL-NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 327
            F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DF +A+ +   D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 370
                T     + +MAPE   +   +   DV+SFG+++ E FT
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 112/269 (41%), Gaps = 36/269 (13%)
Query: 181 IGRGGFGSV----YKARLGDGMEVAVKVFN---LQCGRALKGFDVECEMMKSIRHRNLIK 233
           +G G FG V    + A  G  + VAVK      L    A+  F  E   M S+ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYM--YSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
           +         K +V E  P GSL   +  +  +++L    R    + VA  + YL    S
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 129
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREG 350
              IH DL   N+LL    +  + DF + + L   +D  + Q        + APE  +  
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 351 RVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
             S   D + FG+ L E FT G++P                 W+ ++  +++  + + +E
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEP-----------------WIGLNGSQIL--HKIDKE 230
Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQR 438
                  E C   ++N+ ++C    PE R
Sbjct: 231 GERLPRPEDCPQDIYNVMVQCWAHKPEDR 259

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 103/223 (46%), Gaps = 28/223 (12%)
Query: 173 DGFSENNLIGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKGFDVECEMM 223
           D  +    +G G FG V         K +  + + VAVK+       + L     E EMM
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 224 KSI-RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYM-----------YSSNYILD--- 268
           K I +H+N+I ++  C+ +    +++EY   G+L +Y+           Y  N + +   
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 269 IFQRL-NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 327
            F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DF +A+ +   D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 370
                T     + +MAPE   +   +   DV+SFG+++ E FT
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 112/269 (41%), Gaps = 36/269 (13%)
Query: 181 IGRGGFGSV----YKARLGDGMEVAVKVFN---LQCGRALKGFDVECEMMKSIRHRNLIK 233
           +G G FG V    + A  G  + VAVK      L    A+  F  E   M S+ HRNLI+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYM--YSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
           +         K +V E  P GSL   +  +  +++L    R    + VA  + YL    S
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 139
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREG 350
              IH DL   N+LL    +  + DF + + L   +D  + Q        + APE  +  
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 351 RVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
             S   D + FG+ L E FT G++P                 W+ ++  +++  + + +E
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEP-----------------WIGLNGSQIL--HKIDKE 240
Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQR 438
                  E C   ++N+ ++C    PE R
Sbjct: 241 GERLPRPEDCPQDIYNVMVQCWAHKPEDR 269

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 112/269 (41%), Gaps = 36/269 (13%)
Query: 181 IGRGGFGSV----YKARLGDGMEVAVKVFN---LQCGRALKGFDVECEMMKSIRHRNLIK 233
           +G G FG V    + A  G  + VAVK      L    A+  F  E   M S+ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYM--YSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
           +         K +V E  P GSL   +  +  +++L    R    + VA  + YL    S
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 129
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREG 350
              IH DL   N+LL    +  + DF + + L   +D  + Q        + APE  +  
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 351 RVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
             S   D + FG+ L E FT G++P                 W+ ++  +++  + + +E
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEP-----------------WIGLNGSQIL--HKIDKE 230
Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQR 438
                  E C   ++N+ ++C    PE R
Sbjct: 231 GERLPRPEDCPQDIYNVMVQCWAHKPEDR 259

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 112/269 (41%), Gaps = 36/269 (13%)
Query: 181 IGRGGFGSV----YKARLGDGMEVAVKVFN---LQCGRALKGFDVECEMMKSIRHRNLIK 233
           +G G FG V    + A  G  + VAVK      L    A+  F  E   M S+ HRNLI+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYM--YSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
           +         K +V E  P GSL   +  +  +++L    R    + VA  + YL    S
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 133
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREG 350
              IH DL   N+LL    +  + DF + + L   +D  + Q        + APE  +  
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 351 RVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
             S   D + FG+ L E FT G++P                 W+ ++  +++  + + +E
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQEP-----------------WIGLNGSQIL--HKIDKE 234
Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQR 438
                  E C   ++N+ ++C    PE R
Sbjct: 235 GERLPRPEDCPQDIYNVMVQCWAHKPEDR 263

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 28/223 (12%)
Query: 173 DGFSENNLIGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKGFDVECEMM 223
           D  +    +G G FG V         K +  + + VAVK+       + L     E EMM
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 224 KSI-RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSS-----NYILDI-------- 269
           K I +H+N+I ++  C+ +    +++EY   G+L +Y+ +       Y  DI        
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 270 -FQRL-NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 327
            F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DF +A+ +   D
Sbjct: 201 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 370
                T     + +MAPE   +   +   DV+SFG+++ E FT
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 28/223 (12%)
Query: 173 DGFSENNLIGRGGFGSVY--------KARLGDGMEVAVKVFNLQCGRA-LKGFDVECEMM 223
           D  +    +G G FG V         K +  + + VAVK+         L     E EMM
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 224 KSI-RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSS-----NYILDI-------- 269
           K I +H+N+I ++  C+ +    +++EY   G+L +Y+ +       Y  DI        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 270 -FQRL-NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 327
            F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DF +A+ +   D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 370
                T     + +MAPE   +   +   DV+SFG+++ E FT
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 28/223 (12%)
Query: 173 DGFSENNLIGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKGFDVECEMM 223
           D  +    +G G FG V         K +  + + VAVK+       + L     E EMM
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 224 KSI-RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSS-----NYILDI-------- 269
           K I +H+N+I ++  C+ +    +++EY   G+L +Y+ +       Y  DI        
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 270 -FQRL-NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 327
            F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DF +A+ +   D
Sbjct: 142 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLTARNVLVTENNVMKIADFGLARDINNID 198
Query: 328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 370
                T     + +MAPE   +   +   DV+SFG+++ E FT
Sbjct: 199 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 28/223 (12%)
Query: 173 DGFSENNLIGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKGFDVECEMM 223
           D  +    +G G FG V         K +  + + VAVK+       + L     E EMM
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 224 KSI-RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSS-----NYILDI-------- 269
           K I +H+N+I ++  C+ +    +++EY   G+L +Y+ +       Y  DI        
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 270 -FQRL-NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 327
            F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DF +A+ +   D
Sbjct: 147 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 203
Query: 328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 370
                T     + +MAPE   +   +   DV+SFG+++ E FT
Sbjct: 204 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 28/223 (12%)
Query: 173 DGFSENNLIGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKGFDVECEMM 223
           D  +    +G G FG V         K +  + + VAVK+       + L     E EMM
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 224 KSI-RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSS-----NYILDI-------- 269
           K I +H+N+I ++  C+ +    +++EY   G+L +Y+ +       Y  DI        
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 270 -FQRL-NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 327
            F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DF +A+ +   D
Sbjct: 144 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 200
Query: 328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 370
                T     + +MAPE   +   +   DV+SFG+++ E FT
Sbjct: 201 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 11/219 (5%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMK 224
           LE     D   +  ++G+G +G VY  R L + + +A+K    +  R  +    E  + K
Sbjct: 1   LEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHK 60
Query: 225 SIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSS-NYILDIFQRLNIMI-DVASA 282
            ++H+N+++ + + S   F  + +E +P GSL   + S    + D  Q +      +   
Sbjct: 61  HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG 120
Query: 283 LEYLHFGYSAPIIHCDLKPSNVLLDD-NMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGY 341
           L+YLH      I+H D+K  NVL++  + V  +SDF  +K L G +   T+T T  T+ Y
Sbjct: 121 LKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETFT-GTLQY 175
Query: 342 MAPEYGREGR--VSTNGDVYSFGIMLMETFTGKKPTNEI 378
           MAPE   +G        D++S G  ++E  TGK P  E+
Sbjct: 176 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 214

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/304 (23%), Positives = 130/304 (42%), Gaps = 49/304 (16%)
Query: 178 NNLIGRGGFGSVYKARLGDG----MEVAVKVFN-LQCGRALKGFDVECEMMKSIRHRNLI 232
           + +IG+G FG VY     D     ++ A+K  + +   + ++ F  E  +M+ + H N++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 233 KVIST-CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            +I      E    ++L YM HG L +++ S      +   ++  + VA  +EYL     
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL---AE 142
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA--TIGYMAPEYGRE 349
              +H DL   N +LD++    ++DF +A+ +   +    Q    A   + + A E  + 
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT 202
Query: 350 GRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ 408
            R +T  DV+SFG++L E  T G  P   I   ++T                        
Sbjct: 203 YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT------------------------ 238
Query: 409 EDIHFVAK-------EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNVGD 461
              HF+A+       E C   ++ +  +C    P  R   R +V ++ +I  +LL   GD
Sbjct: 239 ---HFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL---GD 292
Query: 462 RCIR 465
             ++
Sbjct: 293 HYVQ 296

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 11/219 (5%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMK 224
           LE     D   +  ++G+G +G VY  R L + + +A+K    +  R  +    E  + K
Sbjct: 15  LEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHK 74
Query: 225 SIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSS-NYILDIFQRLNIMI-DVASA 282
            ++H+N+++ + + S   F  + +E +P GSL   + S    + D  Q +      +   
Sbjct: 75  HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG 134
Query: 283 LEYLHFGYSAPIIHCDLKPSNVLLDD-NMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGY 341
           L+YLH      I+H D+K  NVL++  + V  +SDF  +K L G +   T+T T  T+ Y
Sbjct: 135 LKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETFT-GTLQY 189
Query: 342 MAPEYGREGR--VSTNGDVYSFGIMLMETFTGKKPTNEI 378
           MAPE   +G        D++S G  ++E  TGK P  E+
Sbjct: 190 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 28/223 (12%)
Query: 173 DGFSENNLIGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKGFDVECEMM 223
           D  +    +G G FG V         K +  + + VAVK+       + L     E EMM
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 224 KSI-RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSS-----NYILDI-------- 269
           K I +H+N+I ++  C+ +    +++ Y   G+L +Y+ +       Y  DI        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 270 -FQRL-NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 327
            F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DF +A+ +   D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 370
                T     + +MAPE   +   +   DV+SFG+++ E FT
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 117/277 (42%), Gaps = 31/277 (11%)
Query: 178 NNLIGRGGFGSVYKA----RLGDGMEVAVKVFNLQCGRALK-GFDVECEMMKSIRHRNLI 232
           N ++G G FG VY+       G+ + VAVK     C    K  F  E  +MK++ H +++
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
           K+I     EE   +++E  P+G L  Y+  +   L +   +   + +  A+ YL    S 
Sbjct: 89  KLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SI 144
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV 352
             +H D+   N+L+       L DF +++ +  ED        L  I +M+PE     R 
Sbjct: 145 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSPESINFRRF 203
Query: 353 STNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDI 411
           +T  DV+ F + + E  + GK+P             W+ +   I  +E    + L + D+
Sbjct: 204 TTASDVWMFAVCMWEILSFGKQPF-----------FWLENKDVIGVLE--KGDRLPKPDL 250
Query: 412 HFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
                  C   ++ L   C    P  R    E+V  L
Sbjct: 251 -------CPPVLYTLMTRCWDYDPSDRPRFTELVCSL 280

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 117/277 (42%), Gaps = 31/277 (11%)
Query: 178 NNLIGRGGFGSVYKA----RLGDGMEVAVKVFNLQCGRALK-GFDVECEMMKSIRHRNLI 232
           N ++G G FG VY+       G+ + VAVK     C    K  F  E  +MK++ H +++
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
           K+I     EE   +++E  P+G L  Y+  +   L +   +   + +  A+ YL    S 
Sbjct: 73  KLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SI 128
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV 352
             +H D+   N+L+       L DF +++ +  ED        L  I +M+PE     R 
Sbjct: 129 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSPESINFRRF 187
Query: 353 STNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDI 411
           +T  DV+ F + + E  + GK+P             W+ +   I  +E    + L + D+
Sbjct: 188 TTASDVWMFAVCMWEILSFGKQPF-----------FWLENKDVIGVLE--KGDRLPKPDL 234
Query: 412 HFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
                  C   ++ L   C    P  R    E+V  L
Sbjct: 235 -------CPPVLYTLMTRCWDYDPSDRPRFTELVCSL 264

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 12/201 (5%)
Query: 181 IGRGGFGSVYKAR-LGDGMEVAVK---VFNLQCGRALKGFDVECEMMKSIRHRNLIKVIS 236
           IGRG F  VY+A  L DG+ VA+K   +F+L   +A      E +++K + H N+IK  +
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 237 TCSNEEFKALVLEYMPHGSLE---KYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
           +   +    +VLE    G L    K+      ++         + + SALE++H   S  
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRR 156
Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVS 353
           ++H D+KP+NV +    V  L D  + +  +   ++      + T  YM+PE   E   +
Sbjct: 157 VMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIHENGYN 214
Query: 354 TNGDVYSFGIMLMETFTGKKP 374
              D++S G +L E    + P
Sbjct: 215 FKSDIWSLGCLLYEMAALQSP 235

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 117/277 (42%), Gaps = 31/277 (11%)
Query: 178 NNLIGRGGFGSVYKA----RLGDGMEVAVKVFNLQCGRALK-GFDVECEMMKSIRHRNLI 232
           N ++G G FG VY+       G+ + VAVK     C    K  F  E  +MK++ H +++
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
           K+I     EE   +++E  P+G L  Y+  +   L +   +   + +  A+ YL    S 
Sbjct: 77  KLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SI 132
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV 352
             +H D+   N+L+       L DF +++ +  ED        L  I +M+PE     R 
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSPESINFRRF 191
Query: 353 STNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDI 411
           +T  DV+ F + + E  + GK+P             W+ +   I  +E    + L + D+
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQPF-----------FWLENKDVIGVLE--KGDRLPKPDL 238
Query: 412 HFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
                  C   ++ L   C    P  R    E+V  L
Sbjct: 239 -------CPPVLYTLMTRCWDYDPSDRPRFTELVCSL 268

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 104/236 (44%), Gaps = 39/236 (16%)
Query: 175 FSENNL-----IGRGGFGSVYKARLGDGME------VAVKVFNLQCGRALKG-FDVECEM 222
           +  NN+     IG G FG V++AR    +       VAVK+   +    ++  F  E  +
Sbjct: 44  YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 103
Query: 223 MKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNY----------------- 265
           M    + N++K++  C+  +   L+ EYM +G L +++ S +                  
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 266 ------ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSI 319
                  L   ++L I   VA+ + YL        +H DL   N L+ +NMV  ++DF +
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGL 220
Query: 320 AKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 374
           ++ +   D           I +M PE     R +T  DV+++G++L E F+ G +P
Sbjct: 221 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 76/305 (24%), Positives = 130/305 (42%), Gaps = 49/305 (16%)
Query: 173 DGFSENNLIGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKGFDVECEMM 223
           D  +    +G G FG V         K +  + + VAVK+       + L     E EMM
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 224 KSI-RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSS-----NYILDI-------- 269
           K I +H+N+I ++  C+ +    +++ Y   G+L +Y+ +       Y  DI        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 270 -FQRL-NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 327
            F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DF +A+ +   D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLK 386
                T     + +MAPE   +   +   DV+SFG+++ E FT G  P    + G     
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP----YPG----- 262
Query: 387 HWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVA 446
                 +P+  +       L +E         C + ++ +  +C    P QR   +++V 
Sbjct: 263 ------IPVEEL-----FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311
Query: 447 KLLKI 451
            L +I
Sbjct: 312 DLDRI 316

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 125/294 (42%), Gaps = 40/294 (13%)
Query: 179 NLIGRGGFGSVYKARL----GDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLI 232
            ++G G FGSV +  L    G  ++VAVK   L     R ++ F  E   MK   H N+I
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 233 KVISTCSNEEFKAL-----VLEYMPHGSLEKYMYSSNY-----ILDIFQRLNIMIDVASA 282
           +++  C     + +     +L +M +G L  Y+  S        + +   L  M+D+A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 283 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           +EYL    +   +H DL   N +L D+M   ++DF ++K +   D           + ++
Sbjct: 160 MEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 343 APEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVV 401
           A E   +   ++  DV++FG+ + E  T G  P   + N EM       D+L      + 
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY------DYL------LH 264
Query: 402 GANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL 455
           G  L   ED        C+  ++ +   C    P  R     +  +L K+ +SL
Sbjct: 265 GHRLKQPED--------CLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/291 (22%), Positives = 129/291 (44%), Gaps = 46/291 (15%)
Query: 181 IGRGGFGSVYKARL-----GDGME-VAVKVFNLQCGRALKG-FDVECEMMKSIRHRNLIK 233
           +G   FG VYK  L     G+  + VA+K    +    L+  F  E  +   ++H N++ 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQR---------------LNIMID 278
           ++   + ++  +++  Y  HG L +++   +   D+                  ++++  
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT 338
           +A+ +EYL    S  ++H DL   NVL+ D +   +SD  + + +   D       +L  
Sbjct: 154 IAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 210
Query: 339 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPIST 397
           I +MAPE    G+ S + D++S+G++L E F+ G +P                 +   S 
Sbjct: 211 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP-----------------YCGYSN 253
Query: 398 MEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
            +VV   ++    +     + C + V+ L +EC  E P +R   ++I ++L
Sbjct: 254 QDVV--EMIRNRQV-LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 301

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 124/302 (41%), Gaps = 59/302 (19%)
Query: 181 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKGFDVECEMMKSI-RHRN 230
           +G G FG V         K +     +VAVK+       + L     E EMMK I +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYM---------YSSNYILDIFQRLN------I 275
           +I ++  C+ +    +++EY   G+L +Y+         YS N   +  ++L+       
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 276 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 335
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DF +A+ +   D     T  
Sbjct: 197 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 336 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT------GKKPTNEIFNGEMTLKHWV 389
              + +MAPE   +   +   DV+SFG++L E FT         P  E+F          
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK--------- 304
Query: 390 NDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLL 449
                           L +E         C + ++ +  +C    P QR   +++V  L 
Sbjct: 305 ----------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 348
Query: 450 KI 451
           +I
Sbjct: 349 RI 350

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/291 (22%), Positives = 129/291 (44%), Gaps = 46/291 (15%)
Query: 181 IGRGGFGSVYKARL-----GDGME-VAVKVFNLQCGRALKG-FDVECEMMKSIRHRNLIK 233
           +G   FG VYK  L     G+  + VA+K    +    L+  F  E  +   ++H N++ 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQR---------------LNIMID 278
           ++   + ++  +++  Y  HG L +++   +   D+                  ++++  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT 338
           +A+ +EYL    S  ++H DL   NVL+ D +   +SD  + + +   D       +L  
Sbjct: 137 IAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 339 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPIST 397
           I +MAPE    G+ S + D++S+G++L E F+ G +P                 +   S 
Sbjct: 194 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP-----------------YCGYSN 236
Query: 398 MEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
            +VV   ++    +     + C + V+ L +EC  E P +R   ++I ++L
Sbjct: 237 QDVV--EMIRNRQV-LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 124/302 (41%), Gaps = 59/302 (19%)
Query: 181 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKGFDVECEMMKSI-RHRN 230
           +G G FG V         K +     +VAVK+       + L     E EMMK I +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYM---------YSSNYILDIFQRLN------I 275
           +I ++  C+ +    +++EY   G+L +Y+         YS N   +  ++L+       
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 276 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 335
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DF +A+ +   D     T  
Sbjct: 145 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 336 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT------GKKPTNEIFNGEMTLKHWV 389
              + +MAPE   +   +   DV+SFG++L E FT         P  E+F          
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK--------- 252
Query: 390 NDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLL 449
                           L +E         C + ++ +  +C    P QR   +++V  L 
Sbjct: 253 ----------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 296
Query: 450 KI 451
           +I
Sbjct: 297 RI 298

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 124/302 (41%), Gaps = 59/302 (19%)
Query: 181 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKGFDVECEMMKSI-RHRN 230
           +G G FG V         K +     +VAVK+       + L     E EMMK I +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYM---------YSSNYILDIFQRLN------I 275
           +I ++  C+ +    +++EY   G+L +Y+         YS N   +  ++L+       
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 276 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 335
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DF +A+ +   D     T  
Sbjct: 148 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 336 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT------GKKPTNEIFNGEMTLKHWV 389
              + +MAPE   +   +   DV+SFG++L E FT         P  E+F          
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK--------- 255
Query: 390 NDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLL 449
                           L +E         C + ++ +  +C    P QR   +++V  L 
Sbjct: 256 ----------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 299
Query: 450 KI 451
           +I
Sbjct: 300 RI 301

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 124/302 (41%), Gaps = 59/302 (19%)
Query: 181 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKGFDVECEMMKSI-RHRN 230
           +G G FG V         K +     +VAVK+       + L     E EMMK I +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYM---------YSSNYILDIFQRLN------I 275
           +I ++  C+ +    +++EY   G+L +Y+         YS N   +  ++L+       
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 276 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 335
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DF +A+ +   D     T  
Sbjct: 149 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 336 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT------GKKPTNEIFNGEMTLKHWV 389
              + +MAPE   +   +   DV+SFG++L E FT         P  E+F          
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK--------- 256
Query: 390 NDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLL 449
                           L +E         C + ++ +  +C    P QR   +++V  L 
Sbjct: 257 ----------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 300
Query: 450 KI 451
           +I
Sbjct: 301 RI 302

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 124/302 (41%), Gaps = 59/302 (19%)
Query: 181 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKGFDVECEMMKSI-RHRN 230
           +G G FG V         K +     +VAVK+       + L     E EMMK I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYM---------YSSNYILDIFQRLN------I 275
           +I ++  C+ +    +++EY   G+L +Y+         YS N   +  ++L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 276 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 335
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DF +A+ +   D     T  
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 336 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT------GKKPTNEIFNGEMTLKHWV 389
              + +MAPE   +   +   DV+SFG++L E FT         P  E+F          
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK--------- 263
Query: 390 NDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLL 449
                           L +E         C + ++ +  +C    P QR   +++V  L 
Sbjct: 264 ----------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 307
Query: 450 KI 451
           +I
Sbjct: 308 RI 309

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 124/302 (41%), Gaps = 59/302 (19%)
Query: 181 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKGFDVECEMMKSI-RHRN 230
           +G G FG V         K +     +VAVK+       + L     E EMMK I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYM---------YSSNYILDIFQRLN------I 275
           +I ++  C+ +    +++EY   G+L +Y+         YS N   +  ++L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 276 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 335
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DF +A+ +   D     T  
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 336 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT------GKKPTNEIFNGEMTLKHWV 389
              + +MAPE   +   +   DV+SFG++L E FT         P  E+F          
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK--------- 263
Query: 390 NDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLL 449
                           L +E         C + ++ +  +C    P QR   +++V  L 
Sbjct: 264 ----------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 307
Query: 450 KI 451
           +I
Sbjct: 308 RI 309

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 95/195 (48%), Gaps = 8/195 (4%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           IG+G  G+VY A  +  G EVA++  NLQ     +    E  +M+  ++ N++  + +  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
             +   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVY 359
           K  N+LL  +    L+DF     +T E     +++ + T  +MAPE           D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSEMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 360 SFGIMLMETFTGKKP 374
           S GIM +E   G+ P
Sbjct: 201 SLGIMAIEMIEGEPP 215

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 87/309 (28%), Positives = 132/309 (42%), Gaps = 46/309 (14%)
Query: 180 LIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKS--IRHRNLIKVIST 237
           LIGRG +G+VYK  L D   VAVKVF+       + F  E  + +   + H N+ + I  
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFI-- 73
Query: 238 CSNEEFKA-------LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF-- 288
             +E   A       LV+EY P+GSL KY+  S +  D      +   V   L YLH   
Sbjct: 74  VGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRLAHSVTRGLAYLHTEL 131
Query: 289 ----GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE------DQSMTQTQTLAT 338
                Y   I H DL   NVL+ ++    +SDF ++  LTG       ++       + T
Sbjct: 132 PRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGT 191
Query: 339 IGYMAPEYGREGRVSTNG--------DVYSFGIMLMETF---TGKKPTNEIFNGEMTLKH 387
           I YMAPE   EG V+           D+Y+ G++  E F   T   P   +   +M  + 
Sbjct: 192 IRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQT 250
Query: 388 WVNDWLPISTMEVVGANLLSQEDIHFVAKEQ--CVSCVFNLAMECTVESPEQRINAR--- 442
            V +      M+V+ +    +       KE    V  +     +C  +  E R+ A+   
Sbjct: 251 EVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAE 310
Query: 443 EIVAKLLKI 451
           E +A+L+ I
Sbjct: 311 ERMAELMMI 319

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 109/236 (46%), Gaps = 25/236 (10%)
Query: 148 PSNDANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKARL---GDGMEVAV-- 202
           PS  AN       R F   EL +         ++G G FG+V+K      G+ +++ V  
Sbjct: 16  PSEKANK---VLARIFKETELRKL-------KVLGSGVFGTVHKGVWIPEGESIKIPVCI 65
Query: 203 KVFNLQCGRALKGFDVECEMM---KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKY 259
           KV   + GR  + F    + M    S+ H ++++++  C     + LV +Y+P GSL  +
Sbjct: 66  KVIEDKSGR--QSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDH 122
Query: 260 MYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSI 319
           +      L     LN  + +A  + YL       ++H +L   NVLL       ++DF +
Sbjct: 123 VRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGV 179
Query: 320 AKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 374
           A LL  +D+ +  ++    I +MA E    G+ +   DV+S+G+ + E  T G +P
Sbjct: 180 ADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 235

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 100/205 (48%), Gaps = 15/205 (7%)
Query: 179 NLIGRGGFGSVYKARL---GDGMEVAV--KVFNLQCGRALKGFDVECEMM---KSIRHRN 230
            ++G G FG+V+K      G+ +++ V  KV   + GR  + F    + M    S+ H +
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAH 76
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY 290
           +++++  C     + LV +Y+P GSL  ++      L     LN  + +A  + YL    
Sbjct: 77  IVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE--- 132
Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 350
              ++H +L   NVLL       ++DF +A LL  +D+ +  ++    I +MA E    G
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192
Query: 351 RVSTNGDVYSFGIMLMETFT-GKKP 374
           + +   DV+S+G+ + E  T G +P
Sbjct: 193 KYTHQSDVWSYGVTVWELMTFGAEP 217

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 124/302 (41%), Gaps = 59/302 (19%)
Query: 181 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKGFDVECEMMKSI-RHRN 230
           +G G FG V         K +     +VAVK+       + L     E EMMK I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYM---------YSSNYILDIFQRLN------I 275
           +I ++  C+ +    +++EY   G+L +Y+         +S N   +  ++L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 276 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 335
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DF +A+ +   D     T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 336 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT------GKKPTNEIFNGEMTLKHWV 389
              + +MAPE   +   +   DV+SFG++L E FT         P  E+F          
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK--------- 263
Query: 390 NDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLL 449
                           L +E         C + ++ +  +C    P QR   +++V  L 
Sbjct: 264 ----------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 307
Query: 450 KI 451
           +I
Sbjct: 308 RI 309

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 102/202 (50%), Gaps = 17/202 (8%)
Query: 185 GFGSVYKARLGD----GMEVAVKVFNLQCGRALK---GFDVECEMMKSIRHRNLIKVIST 237
           G G+  K ++G+    G +VAVK+ N Q  R+L        E + +K  RH ++IK+   
Sbjct: 20  GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV 79
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
            S      +V+EY+  G L  Y+     + ++  R  +   + SA++Y H      ++H 
Sbjct: 80  ISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCH---RHMVVHR 135
Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG- 356
           DLKP NVLLD +M A ++DF ++ +++  D    +T +  +  Y APE    GR+     
Sbjct: 136 DLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRT-SCGSPNYAAPEV-ISGRLYAGPE 191
Query: 357 -DVYSFGIMLMETFTGKKPTNE 377
            D++S G++L     G  P ++
Sbjct: 192 VDIWSCGVILYALLCGTLPFDD 213

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 175 FSENNL-----IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIR- 227
           F  NNL     +G G FG V +A   G G E AV    ++  ++    D +  +M  ++ 
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 228 ------HRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVAS 281
                 H N++ ++  C++     ++ EY  +G L  ++   + +L+      I    AS
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 282 ALEYLHFG----------YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 331
             + LHF            S   IH D+   NVLL +  VA + DF +A+ +  +   + 
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 332 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 370
           +      + +MAPE   +   +   DV+S+GI+L E F+
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           IG+G  G+VY A  +  G EVA++  NLQ     +    E  +M+  ++ N++  + +  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
             +   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH D+
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 143
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVY 359
           K  N+LL  +    L+DF     +T E     ++  + T  +MAPE           D++
Sbjct: 144 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAPEVVTRKAYGPKVDIW 201
Query: 360 SFGIMLMETFTGKKP 374
           S GIM +E   G+ P
Sbjct: 202 SLGIMAIEMIEGEPP 216

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 95/195 (48%), Gaps = 8/195 (4%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           IG+G  G+VY A  +  G EVA++  NLQ     +    E  +M+  ++ N++  + +  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
             +   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVY 359
           K  N+LL  +    L+DF     +T E QS   T  + T  +MAPE           D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPE-QSKRST-MVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 360 SFGIMLMETFTGKKP 374
           S GIM +E   G+ P
Sbjct: 201 SLGIMAIEMIEGEPP 215

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 187 GSVYKARLGDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNE--E 242
           G ++K R   G ++ VKV  ++    R  + F+ EC  ++   H N++ V+  C +    
Sbjct: 24  GELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 243 FKALVLEYMPHGSLEKYMYS-SNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKP 301
              L+  +MP+GSL   ++  +N+++D  Q +   +D+A  + +LH      I    L  
Sbjct: 83  HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIPRHALNS 141
Query: 302 SNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTN---GDV 358
            +V++D++M A +S       +     S      +    ++APE  ++    TN    D+
Sbjct: 142 RSVMIDEDMTARIS-------MADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADM 194
Query: 359 YSFGIMLMETFTGKKPTNEIFNGEMTLK 386
           +SF ++L E  T + P  ++ N E+ +K
Sbjct: 195 WSFAVLLWELVTREVPFADLSNMEIGMK 222

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           IG+G  G+VY A  +  G EVA++  NLQ     +    E  +M+  ++ N++  + +  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
             +   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVY 359
           K  N+LL  +    L+DF     +T E     ++  + T  +MAPE           D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 360 SFGIMLMETFTGKKP 374
           S GIM +E   G+ P
Sbjct: 201 SLGIMAIEMIEGEPP 215

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 181 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKGFDVECEMMKSI-RHRN 230
           +G G FG V         K +     +VAVK+       + L     E EMMK I +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYM---------YSSNYILDIFQRLN------I 275
           +I ++  C+ +    +++EY   G+L +Y+         Y  N   +  ++L+       
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 276 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 335
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DF +A+ +   D     T  
Sbjct: 141 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 336 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 370
              + +MAPE   +   +   DV+SFG++L E FT
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/286 (23%), Positives = 122/286 (42%), Gaps = 39/286 (13%)
Query: 181 IGRGGFGSVYKARLGDGME------VAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIK 233
           +G+G FG VY+    D ++      VAVK  N     R    F  E  +MK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILD---------IFQRLNIMIDVASALE 284
           ++   S  +   +V+E M HG L+ Y+ S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 285 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
           YL+   +   +H DL   N ++  +    + DF + + +   D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 345 EYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN 404
           E  ++G  +T+ D++SFG++L E  +  +   +  + E  LK             V+   
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 249
Query: 405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK 450
            L Q D        C   V +L   C   +P+ R    EIV  LLK
Sbjct: 250 YLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIV-NLLK 287

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 123/302 (40%), Gaps = 59/302 (19%)
Query: 181 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKGFDVECEMMKSI-RHRN 230
           +G G FG V         K +     +VAVK+       + L     E EMMK I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYM---------YSSNYILDIFQRLN------I 275
           +I ++  C+ +    +++EY   G+L +Y+         Y  N   +  ++L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 276 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 335
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DF +A+ +   D     T  
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 336 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT------GKKPTNEIFNGEMTLKHWV 389
              + +MAPE   +   +   DV+SFG++L E FT         P  E+F          
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK--------- 263
Query: 390 NDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLL 449
                           L +E         C + ++ +  +C    P QR   +++V  L 
Sbjct: 264 ----------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 307
Query: 450 KI 451
           +I
Sbjct: 308 RI 309

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/286 (23%), Positives = 122/286 (42%), Gaps = 39/286 (13%)
Query: 181 IGRGGFGSVYKARLGDGME------VAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIK 233
           +G+G FG VY+    D ++      VAVK  N     R    F  E  +MK     ++++
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILD---------IFQRLNIMIDVASALE 284
           ++   S  +   +V+E M HG L+ Y+ S     +         + + + +  ++A  + 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 285 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
           YL+   +   +H DL   N ++  +    + DF + + +   D      + L  + +MAP
Sbjct: 142 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 345 EYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN 404
           E  ++G  +T+ D++SFG++L E  +  +   +  + E  LK             V+   
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 246
Query: 405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK 450
            L Q D        C   V +L   C   +P+ R    EIV  LLK
Sbjct: 247 YLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIV-NLLK 284

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/286 (23%), Positives = 121/286 (42%), Gaps = 39/286 (13%)
Query: 181 IGRGGFGSVYKARLGDGME------VAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIK 233
           +G+G FG VY+    D ++      VAVK  N     R    F  E  +MK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILD---------IFQRLNIMIDVASALE 284
           ++   S  +   +V+E M HG L+ Y+ S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 285 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
           YL+   +   +H DL   N ++  +    + DF + + +   D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 345 EYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN 404
           E  ++G  +T+ D++SFG++L E  +  +   +  + E  LK             V+   
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 249
Query: 405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK 450
            L Q D        C   V +L   C   +P  R    EIV  LLK
Sbjct: 250 YLDQPD-------NCPERVTDLMRMCWQFNPNMRPTFLEIV-NLLK 287

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRH 228
           + F   NL+G+G F  VY+A  +  G+EVA+K+ + +       ++    E ++   ++H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
            +++++ +   +  +  LVLE   +G + +Y+ +        +  + M  + + + YLH 
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH- 129
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  I+H DL  SN+LL  NM   ++DF +A  L    +         T  Y++PE   
Sbjct: 130 --SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK--HYTLCGTPNYISPEIAT 185
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
                   DV+S G M      G+ P
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGRPP 211

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 114/229 (49%), Gaps = 29/229 (12%)
Query: 174 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
            +++  +IG G FG VY+A+L D  E+ V +  +  G+A K  + E ++M+ + H N+++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQGKAFK--NRELQIMRKLDHCNIVR 77
Query: 234 V------ISTCSNEEFKALVLEYMP---HGSLEKYMYSSNYILDIFQRLNIMIDVASALE 284
           +           +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 136
Query: 285 YLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           Y+H FG    I H D+KP N+LLD D  V  L DF  AK L   + +++    + +  Y 
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYR 189
Query: 343 APE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWV 389
           APE  +G     S+  DV+S G +L E   G+     IF G+  +   V
Sbjct: 190 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 233

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 109/244 (44%), Gaps = 20/244 (8%)
Query: 148 PSNDANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKARL---GDGMEVAVKV 204
           PS +A  P+ A  R     E       F +  ++G G FG+VYK      G+ +++ V +
Sbjct: 33  PSGEA--PNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAI 83
Query: 205 FNLQ---CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMY 261
             L+     +A K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+ 
Sbjct: 84  MELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR 142
Query: 262 SSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 321
                +     LN  + +A  + YL       ++H DL   NVL+       ++DF +AK
Sbjct: 143 EHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAK 199
Query: 322 LLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFN 380
           LL  E++          I +MA E       +   DV+S+G+ + E  T G KP + I  
Sbjct: 200 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 259
Query: 381 GEMT 384
            E++
Sbjct: 260 SEIS 263

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 135/314 (42%), Gaps = 41/314 (13%)
Query: 148 PSNDANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKARL---GDGMEVAVKV 204
           PS +A  P+ A  R     E       F +  ++G G FG+VYK      G+ +++ V +
Sbjct: 3   PSGEA--PNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAI 53
Query: 205 FNLQ---CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMY 261
             L+     +A K    E  +M S+ + ++ +++  C     + L+++ MP G L  Y+ 
Sbjct: 54  KELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR 112
Query: 262 SSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 321
                +     LN  + +A  + YL       ++H DL   NVL+       ++DF +AK
Sbjct: 113 EHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAK 169
Query: 322 LLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFN 380
           LL  E++          I +MA E       +   DV+S+G+ + E  T G KP + I  
Sbjct: 170 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 229
Query: 381 GEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRIN 440
            E++           S +E      L Q  I       C   V+ + ++C +   + R  
Sbjct: 230 SEIS-----------SILE--KGERLPQPPI-------CTIDVYMIMVKCWMIDADSRPK 269
Query: 441 AREIVAKLLKI-RD 453
            RE++ +  K+ RD
Sbjct: 270 FRELIIEFSKMARD 283

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKGFDVECEMMKSI 226
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           RH N++++     +     L+LEY P G + K +   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK-FDEQRTATYITELANALSYC 129
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H   S  +IH D+KP N+LL       ++DF      +    S  +T    T+ Y+ PE 
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 182
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKP 374
             EGR+     D++S G++  E   GK P
Sbjct: 183 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/296 (24%), Positives = 131/296 (44%), Gaps = 33/296 (11%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKGFDVE 219
           L + + T+ F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E
Sbjct: 10  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 68
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV 279
             +M S+ + ++ +++  C     + L+++ MP G L  Y+      +     LN  + +
Sbjct: 69  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI 127
Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
           A  + YL       ++H DL   NVL+       ++DF +AKLL  E++          I
Sbjct: 128 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 340 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTM 398
            +MA E       +   DV+S+G+ + E  T G KP + I   E++           S +
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SIL 233
Query: 399 EVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI-RD 453
           E      L Q  I       C   V+ + ++C +   + R   RE++ +  K+ RD
Sbjct: 234 E--KGERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 280

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 114/229 (49%), Gaps = 29/229 (12%)
Query: 174 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
            +++  +IG G FG VY+A+L D  E+ V +  +  G+A K  + E ++M+ + H N+++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQGKAFK--NRELQIMRKLDHCNIVR 77
Query: 234 V------ISTCSNEEFKALVLEYMP---HGSLEKYMYSSNYILDIFQRLNIMIDVASALE 284
           +           +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 136
Query: 285 YLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           Y+H FG    I H D+KP N+LLD D  V  L DF  AK L   + +++    + +  Y 
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYR 189
Query: 343 APE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWV 389
           APE  +G     S+  DV+S G +L E   G+     IF G+  +   V
Sbjct: 190 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 233

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 114/229 (49%), Gaps = 29/229 (12%)
Query: 174 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
            +++  +IG G FG VY+A+L D  E+ V +  +  G+A K  + E ++M+ + H N+++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQGKAFK--NRELQIMRKLDHCNIVR 77
Query: 234 V------ISTCSNEEFKALVLEYMP---HGSLEKYMYSSNYILDIFQRLNIMIDVASALE 284
           +           +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 136
Query: 285 YLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           Y+H FG    I H D+KP N+LLD D  V  L DF  AK L   + +++    + +  Y 
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYR 189
Query: 343 APE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWV 389
           APE  +G     S+  DV+S G +L E   G+     IF G+  +   V
Sbjct: 190 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 233

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/296 (24%), Positives = 131/296 (44%), Gaps = 33/296 (11%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKGFDVE 219
           L + + T+ F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV 279
             +M S+ + ++ +++  C     + L+++ MP G L  Y+      +     LN  + +
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
           A  + YL       ++H DL   NVL+       ++DF +AKLL  E++          I
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 340 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTM 398
            +MA E       +   DV+S+G+ + E  T G KP + I   E++           S +
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SIL 234
Query: 399 EVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI-RD 453
           E      L Q  I       C   V+ + ++C +   + R   RE++ +  K+ RD
Sbjct: 235 E--KGERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 281

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 106/226 (46%), Gaps = 12/226 (5%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKGFDVE 219
           L + + T+ F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E
Sbjct: 10  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 68
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV 279
             +M S+ + ++ +++  C     + L+++ MP G L  Y+      +     LN  + +
Sbjct: 69  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 127
Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
           A  + YL       ++H DL   NVL+       ++DF +AKLL  E++          I
Sbjct: 128 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 340 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
            +MA E       +   DV+S+G+ + E  T G KP + I   E++
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 230

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/296 (24%), Positives = 131/296 (44%), Gaps = 33/296 (11%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKGFDVE 219
           L + + T+ F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E
Sbjct: 9   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV 279
             +M S+ + ++ +++  C     + L+++ MP G L  Y+      +     LN  + +
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
           A  + YL       ++H DL   NVL+       ++DF +AKLL  E++          I
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 340 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTM 398
            +MA E       +   DV+S+G+ + E  T G KP + I   E++           S +
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SIL 232
Query: 399 EVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI-RD 453
           E      L Q  I       C   V+ + ++C +   + R   RE++ +  K+ RD
Sbjct: 233 E--KGERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKGFDVECEMMKSI 226
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           RH N++++     +     L+LEY P G++ + +   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H   S  +IH D+KP N+LL       ++DF      +    S  +T+   T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTELCGTLDYLPPEM 177
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKP 374
             EGR+     D++S G++  E   GK P
Sbjct: 178 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 118/275 (42%), Gaps = 40/275 (14%)
Query: 180 LIGRGGFGSVYKARLGDGMEVAVKV----FNLQCGRALKGFDVECEMMKSIRHRNLIKVI 235
           ++G+G FG   K    +  EV V      F+ +  R    F  E ++M+ + H N++K I
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRT---FLKEVKVMRCLEHPNVLKFI 73
Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
                ++    + EY+  G+L   + S +      QR++   D+AS + YLH   S  II
Sbjct: 74  GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNII 130
Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL---------ATIG---YMA 343
           H DL   N L+ +N    ++DF +A+L+  E       ++L           +G   +MA
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 344 PEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA 403
           PE           DV+SFGI+L E   G+   +              D+LP  TM+  G 
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCE-IIGRVNADP-------------DYLP-RTMD-FGL 234
Query: 404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQR 438
           N+    D +      C    F + + C    PE+R
Sbjct: 235 NVRGFLDRY--CPPNCPPSFFPITVRCCDLDPEKR 267

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 129/295 (43%), Gaps = 38/295 (12%)
Query: 181 IGRGGFGSVY----KARLGDGME--VAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIK 233
           +G+G FG VY    K  + D  E  VA+K  N     R    F  E  +MK     ++++
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYS------SNYIL---DIFQRLNIMIDVASALE 284
           ++   S  +   +++E M  G L+ Y+ S      +N +L    + + + +  ++A  + 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 285 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
           YL+   +   +H DL   N ++ ++    + DF + + +   D      + L  + +M+P
Sbjct: 147 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSP 203
Query: 345 EYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN 404
           E  ++G  +T  DV+SFG++L E  T  +   +  + E  L+             V+   
Sbjct: 204 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGG 251
Query: 405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNV 459
           LL + D        C   +F L   C   +P+ R +  EI++ + +  +   R V
Sbjct: 252 LLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 299

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 106/226 (46%), Gaps = 12/226 (5%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKGFDVE 219
           L + + T+ F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E
Sbjct: 12  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 70
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV 279
             +M S+ + ++ +++  C     + L+++ MP G L  Y+      +     LN  + +
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 129
Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
           A  + YL       ++H DL   NVL+       ++DF +AKLL  E++          I
Sbjct: 130 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 340 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
            +MA E       +   DV+S+G+ + E  T G KP + I   E++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 12/208 (5%)
Query: 170 RATDGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVF-NLQCGRALKGFDV-ECEMMKSI 226
           ++ + +    L+G G +G V K R  D G  VA+K F      + +K   + E +++K +
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKY-MYSSNYILDIFQRLNIMIDVASALEY 285
           RH NL+ ++  C  ++   LV E++ H  L+   ++ +     + Q+    I     +  
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQI-----ING 136
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
           + F +S  IIH D+KP N+L+  + V  L DF  A+ L    +       +AT  Y APE
Sbjct: 137 IGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAPE 194
Query: 346 -YGREGRVSTNGDVYSFGIMLMETFTGK 372
               + +     DV++ G ++ E F G+
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 12/215 (5%)
Query: 177 ENNLIGRGGFGSV----YKARLGDGMEVAVKVFNLQCGRALKG-FDVECEMMKSIRHRNL 231
           E+  +G G FG+V    Y+ +          + N     ALK     E  +M+ + +  +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 232 IKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
           +++I  C  E +  LV+E    G L KY+  + ++ D    + ++  V+  ++YL     
Sbjct: 75  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---E 129
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG-EDQSMTQTQTLATIGYMAPEYGREG 350
           +  +H DL   NVLL     A +SDF ++K L   E+    QT     + + APE     
Sbjct: 130 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYY 189
Query: 351 RVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
           + S+  DV+SFG+++ E F+ G+KP   +   E+T
Sbjct: 190 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 224

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 185 GFGSVYKARLGD----GMEVAVKVFNLQCGRALK---GFDVECEMMKSIRHRNLIKVIST 237
           G G+  K ++G+    G +VAVK+ N Q  R+L        E + +K  RH ++IK+   
Sbjct: 20  GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV 79
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
            S      +V+EY+  G L  Y+     + ++  R  +   + SA++Y H      ++H 
Sbjct: 80  ISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCH---RHMVVHR 135
Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG- 356
           DLKP NVLLD +M A ++DF ++ +++  D    +  +  +  Y APE    GR+     
Sbjct: 136 DLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLR-DSCGSPNYAAPEV-ISGRLYAGPE 191
Query: 357 -DVYSFGIMLMETFTGKKPTNE 377
            D++S G++L     G  P ++
Sbjct: 192 VDIWSCGVILYALLCGTLPFDD 213

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/286 (23%), Positives = 122/286 (42%), Gaps = 39/286 (13%)
Query: 181 IGRGGFGSVYKARLGDGME------VAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIK 233
           +G+G FG VY+    D ++      VAVK  N     R    F  E  +MK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILD---------IFQRLNIMIDVASALE 284
           ++   S  +   +V+E M HG L+ Y+ S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 285 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
           YL+   +   +H DL   N ++  +    + DF + + +   D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 345 EYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN 404
           E  ++G  +T+ D++SFG++L E  +  +   +  + E  LK             V+   
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 249
Query: 405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK 450
            L Q D        C   V +L   C   +P+ R    EIV  LLK
Sbjct: 250 YLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIV-NLLK 287

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 101/201 (50%), Gaps = 15/201 (7%)
Query: 175 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFD-------VECEMMKSIR 227
           + + + +G G F +VYKAR  +  ++ V +  ++ G   +  D        E ++++ + 
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQI-VAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70
Query: 228 HRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLH 287
           H N+I ++    ++   +LV ++M    LE  +  ++ +L        M+     LEYLH
Sbjct: 71  HPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYG 347
             +   I+H DLKP+N+LLD+N V  L+DF +AK     +++      + T  Y APE  
Sbjct: 130 QHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--XHQVVTRWYRAPELL 184
Query: 348 REGRVSTNG-DVYSFGIMLME 367
              R+   G D+++ G +L E
Sbjct: 185 FGARMYGVGVDMWAVGCILAE 205

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 12/215 (5%)
Query: 177 ENNLIGRGGFGSV----YKARLGDGMEVAVKVFNLQCGRALKG-FDVECEMMKSIRHRNL 231
           E+  +G G FG+V    Y+ +          + N     ALK     E  +M+ + +  +
Sbjct: 29  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 88
Query: 232 IKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
           +++I  C  E +  LV+E    G L KY+  + ++ D    + ++  V+  ++YL     
Sbjct: 89  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---E 143
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG-EDQSMTQTQTLATIGYMAPEYGREG 350
           +  +H DL   NVLL     A +SDF ++K L   E+    QT     + + APE     
Sbjct: 144 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 203
Query: 351 RVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
           + S+  DV+SFG+++ E F+ G+KP   +   E+T
Sbjct: 204 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 238

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 12/215 (5%)
Query: 177 ENNLIGRGGFGSV----YKARLGDGMEVAVKVFNLQCGRALKG-FDVECEMMKSIRHRNL 231
           E+  +G G FG+V    Y+ +          + N     ALK     E  +M+ + +  +
Sbjct: 373 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 432
Query: 232 IKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
           +++I  C  E +  LV+E    G L KY+  + ++ D    + ++  V+  ++YL     
Sbjct: 433 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---E 487
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG-EDQSMTQTQTLATIGYMAPEYGREG 350
           +  +H DL   NVLL     A +SDF ++K L   E+    QT     + + APE     
Sbjct: 488 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 547
Query: 351 RVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
           + S+  DV+SFG+++ E F+ G+KP   +   E+T
Sbjct: 548 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 582

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 12/215 (5%)
Query: 177 ENNLIGRGGFGSV----YKARLGDGMEVAVKVFNLQCGRALKG-FDVECEMMKSIRHRNL 231
           E+  +G G FG+V    Y+ +          + N     ALK     E  +M+ + +  +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 232 IKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
           +++I  C  E +  LV+E    G L KY+  + ++ D    + ++  V+  ++YL     
Sbjct: 75  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---E 129
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG-EDQSMTQTQTLATIGYMAPEYGREG 350
           +  +H DL   NVLL     A +SDF ++K L   E+    QT     + + APE     
Sbjct: 130 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 189
Query: 351 RVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
           + S+  DV+SFG+++ E F+ G+KP   +   E+T
Sbjct: 190 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 224

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 12/215 (5%)
Query: 177 ENNLIGRGGFGSV----YKARLGDGMEVAVKVFNLQCGRALKG-FDVECEMMKSIRHRNL 231
           E+  +G G FG+V    Y+ +          + N     ALK     E  +M+ + +  +
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 232 IKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
           +++I  C  E +  LV+E    G L KY+  + ++ D    + ++  V+  ++YL     
Sbjct: 91  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---E 145
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG-EDQSMTQTQTLATIGYMAPEYGREG 350
           +  +H DL   NVLL     A +SDF ++K L   E+    QT     + + APE     
Sbjct: 146 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 205
Query: 351 RVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
           + S+  DV+SFG+++ E F+ G+KP   +   E+T
Sbjct: 206 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 240

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 12/215 (5%)
Query: 177 ENNLIGRGGFGSV----YKARLGDGMEVAVKVFNLQCGRALKG-FDVECEMMKSIRHRNL 231
           E+  +G G FG+V    Y+ +          + N     ALK     E  +M+ + +  +
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 232 IKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
           +++I  C  E +  LV+E    G L KY+  + ++ D    + ++  V+  ++YL     
Sbjct: 91  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---E 145
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG-EDQSMTQTQTLATIGYMAPEYGREG 350
           +  +H DL   NVLL     A +SDF ++K L   E+    QT     + + APE     
Sbjct: 146 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 205
Query: 351 RVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
           + S+  DV+SFG+++ E F+ G+KP   +   E+T
Sbjct: 206 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 240

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 12/215 (5%)
Query: 177 ENNLIGRGGFGSV----YKARLGDGMEVAVKVFNLQCGRALKG-FDVECEMMKSIRHRNL 231
           E+  +G G FG+V    Y+ +          + N     ALK     E  +M+ + +  +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 232 IKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
           +++I  C  E +  LV+E    G L KY+  + ++ D    + ++  V+  ++YL     
Sbjct: 81  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---E 135
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG-EDQSMTQTQTLATIGYMAPEYGREG 350
           +  +H DL   NVLL     A +SDF ++K L   E+    QT     + + APE     
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 351 RVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
           + S+  DV+SFG+++ E F+ G+KP   +   E+T
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 230

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 12/215 (5%)
Query: 177 ENNLIGRGGFGSV----YKARLGDGMEVAVKVFNLQCGRALKG-FDVECEMMKSIRHRNL 231
           E+  +G G FG+V    Y+ +          + N     ALK     E  +M+ + +  +
Sbjct: 9   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 68
Query: 232 IKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
           +++I  C  E +  LV+E    G L KY+  + ++ D    + ++  V+  ++YL     
Sbjct: 69  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---E 123
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG-EDQSMTQTQTLATIGYMAPEYGREG 350
           +  +H DL   NVLL     A +SDF ++K L   E+    QT     + + APE     
Sbjct: 124 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 183
Query: 351 RVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
           + S+  DV+SFG+++ E F+ G+KP   +   E+T
Sbjct: 184 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 218

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 164 SHLELCR--ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKGFD 217
           SH+   R  A + F     +G+G FG+VY AR      + A+KV F  Q  +A       
Sbjct: 2   SHMSKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 218 VECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMI 277
            E E+   +RH N++++     +     L+LEY P G++ + +   +   D  +    + 
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYIT 120
Query: 278 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA 337
           ++A+AL Y H   S  +IH D+KP N+LL       ++DF      +    S  +T    
Sbjct: 121 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCG 173
Query: 338 TIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTGKKP 374
           T+ Y+ PE   EGR+     D++S G++  E   GK P
Sbjct: 174 TLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 12/215 (5%)
Query: 177 ENNLIGRGGFGSV----YKARLGDGMEVAVKVFNLQCGRALKG-FDVECEMMKSIRHRNL 231
           E+  +G G FG+V    Y+ +          + N     ALK     E  +M+ + +  +
Sbjct: 374 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 433
Query: 232 IKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
           +++I  C  E +  LV+E    G L KY+  + ++ D    + ++  V+  ++YL     
Sbjct: 434 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---E 488
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG-EDQSMTQTQTLATIGYMAPEYGREG 350
           +  +H DL   NVLL     A +SDF ++K L   E+    QT     + + APE     
Sbjct: 489 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 548
Query: 351 RVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
           + S+  DV+SFG+++ E F+ G+KP   +   E+T
Sbjct: 549 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 583

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 29/216 (13%)
Query: 175 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKV 234
           F++   IG+G FG V+K       +V           A+K  D+E    +    +  I V
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVV----------AIKIIDLEEAEDEIEDIQQEITV 74
Query: 235 ISTCSNEEFKA------------LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASA 282
           +S C +                 +++EY+  GS    + +  +  D FQ   ++ ++   
Sbjct: 75  LSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKG 132
Query: 283 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           L+YLH   S   IH D+K +NVLL +     L+DF +A  LT  D  + +   + T  +M
Sbjct: 133 LDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWM 187
Query: 343 APEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEI 378
           APE  ++    +  D++S GI  +E   G+ P +++
Sbjct: 188 APEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 223

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 12/215 (5%)
Query: 177 ENNLIGRGGFGSV----YKARLGDGMEVAVKVFNLQCGRALKG-FDVECEMMKSIRHRNL 231
           E+  +G G FG+V    Y+ +          + N     ALK     E  +M+ + +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 232 IKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
           +++I  C  E +  LV+E    G L KY+  + ++ D    + ++  V+  ++YL     
Sbjct: 71  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---E 125
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG-EDQSMTQTQTLATIGYMAPEYGREG 350
           +  +H DL   NVLL     A +SDF ++K L   E+    QT     + + APE     
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 351 RVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
           + S+  DV+SFG+++ E F+ G+KP   +   E+T
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 220

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           IG+G  G+VY A  +  G EVA++  NLQ     +    E  +M+  ++ N++  + +  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
             +   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  +IH ++
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRNI 143
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVY 359
           K  N+LL  +    L+DF     +T E     ++  + T  +MAPE           D++
Sbjct: 144 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIW 201
Query: 360 SFGIMLMETFTGKKP 374
           S GIM +E   G+ P
Sbjct: 202 SLGIMAIEMIEGEPP 216

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVIST 237
           IG+G F  V  AR +  G EVAVK+ +       +L+    E  +MK + H N++K+   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
              E+   LV+EY   G +  Y+ +  ++ +   R      + SA++Y H  +   I+H 
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 130
Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVS-TNG 356
           DLK  N+LLD +M   ++DF  +   T  ++  T      +  Y APE  +  +      
Sbjct: 131 DLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEV 187
Query: 357 DVYSFGIMLMETFTGKKPTNEIFNGE 382
           DV+S G++L    +G  P    F+G+
Sbjct: 188 DVWSLGVILYTLVSGSLP----FDGQ 209

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/286 (23%), Positives = 122/286 (42%), Gaps = 39/286 (13%)
Query: 181 IGRGGFGSVYKARLGDGME------VAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIK 233
           +G+G FG VY+    D ++      VAVK  N     R    F  E  +MK     ++++
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILD---------IFQRLNIMIDVASALE 284
           ++   S  +   +V+E M HG L+ Y+ S     +         + + + +  ++A  + 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 285 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
           YL+   +   +H DL   N ++  +    + DF + + +   D      + L  + +MAP
Sbjct: 144 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 345 EYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN 404
           E  ++G  +T+ D++SFG++L E  +  +   +  + E  LK             V+   
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 248
Query: 405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK 450
            L Q D        C   V +L   C   +P+ R    EIV  LLK
Sbjct: 249 YLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIV-NLLK 286

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKGFDVECEMMKSI 226
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           RH N++++     +     L+LEY P G++ + +   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H   S  +IH D+KP N+LL       ++DF      +    S  +T    T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPPEM 177
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKP 374
             EGR+     D++S G++  E   GK P
Sbjct: 178 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/296 (24%), Positives = 130/296 (43%), Gaps = 33/296 (11%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKGFDVE 219
           L + + T+ F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E
Sbjct: 9   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV 279
             +M S+ + ++ +++  C     + L+ + MP G L  Y+      +     LN  + +
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
           A  + YL       ++H DL   NVL+       ++DF +AKLL  E++          I
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 340 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTM 398
            +MA E       +   DV+S+G+ + E  T G KP + I   E++           S +
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SIL 232
Query: 399 EVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI-RD 453
           E      L Q  I       C   V+ + ++C +   + R   RE++ +  K+ RD
Sbjct: 233 E--KGERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 23/219 (10%)
Query: 175 FSENNL-----IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIR- 227
           F  NNL     +G G FG V +A   G G E AV    ++  ++    D +  +M  ++ 
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 228 ------HRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVAS 281
                 H N++ ++  C++     ++ EY  +G L  ++   + +L+      I     S
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLS 162
Query: 282 ALEYLHFG----------YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 331
             + LHF            S   IH D+   NVLL +  VA + DF +A+ +  +   + 
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 332 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 370
           +      + +MAPE   +   +   DV+S+GI+L E F+
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 105/226 (46%), Gaps = 12/226 (5%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKGFDVE 219
           L + + T+ F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E
Sbjct: 9   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV 279
             +M S+ + ++ +++  C     + L+ + MP G L  Y+      +     LN  + +
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
           A  + YL       ++H DL   NVL+       ++DF +AKLL  E++          I
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 340 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
            +MA E       +   DV+S+G+ + E  T G KP + I   E++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKGFDVECEMMKSI 226
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           RH N++++     +     L+LEY P G++ + +   +   D  +    + ++A+AL Y 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 123
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H   S  +IH D+KP N+LL       ++DF      +    S  +T    T+ Y+ PE 
Sbjct: 124 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 176
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKP 374
             EGR+     D++S G++  E   GK P
Sbjct: 177 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 204

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKGFDVECEMMKSI 226
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           RH N++++     +     L+LEY P G++ + +   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H   S  +IH D+KP N+LL       ++DF      +    S  +T    T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTXLCGTLDYLPPEM 177
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKP 374
             EGR+     D++S G++  E   GK P
Sbjct: 178 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKGFDVECEMMKSI 226
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           RH N++++     +     L+LEY P G++ + +   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H   S  +IH D+KP N+LL       ++DF      +    S  +T    T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPPEM 177
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKP 374
             EGR+     D++S G++  E   GK P
Sbjct: 178 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQC------GRALKGFDVECEMMKSIRHRNLIKV 234
           +G G +G VYKA+   G  VA+K   L          A++    E  ++K + H N++ +
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR----EISLLKELHHPNIVSL 84
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI 294
           I    +E    LV E+M    L+K +  +   L   Q   I I +   L  +   +   I
Sbjct: 85  IDVIHSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCHQHRI 140
Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY-GREGRVS 353
           +H DLKP N+L++ +    L+DF +A+      +S   T  + T+ Y AP+      + S
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVLMGSKKYS 198
Query: 354 TNGDVYSFGIMLMETFTGK 372
           T+ D++S G +  E  TGK
Sbjct: 199 TSVDIWSIGCIFAEMITGK 217

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKGFDVECEMMKSI 226
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           RH N++++     +     L+LEY P G++ + +   +   D  +    + ++A+AL Y 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 125
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H   S  +IH D+KP N+LL       ++DF      +    S  +T    T+ Y+ PE 
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPPEM 178
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKP 374
             EGR+     D++S G++  E   GK P
Sbjct: 179 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/296 (24%), Positives = 130/296 (43%), Gaps = 33/296 (11%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKGFDVE 219
           L + + T+ F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E
Sbjct: 9   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV 279
             +M S+ + ++ +++  C     + L+ + MP G L  Y+      +     LN  + +
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
           A  + YL       ++H DL   NVL+       ++DF +AKLL  E++          I
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 340 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTM 398
            +MA E       +   DV+S+G+ + E  T G KP + I   E++           S +
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SIL 232
Query: 399 EVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI-RD 453
           E      L Q  I       C   V+ + ++C +   + R   RE++ +  K+ RD
Sbjct: 233 E--KGERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKGFDVECEMMKSI 226
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           RH N++++     +     L+LEY P G++ + +   +   D  +    + ++A+AL Y 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 150
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H   S  +IH D+KP N+LL       ++DF      +    S  +T    T+ Y+ PE 
Sbjct: 151 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 203
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKP 374
             EGR+     D++S G++  E   GK P
Sbjct: 204 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKGFDVECEMMKSI 226
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           RH N++++     +     L+LEY P G++ + +   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H   S  +IH D+KP N+LL       ++DF      +    S  +T    T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 177
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKP 374
             EGR+     D++S G++  E   GK P
Sbjct: 178 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/296 (24%), Positives = 130/296 (43%), Gaps = 33/296 (11%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKGFDVE 219
           L + + T+ F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E
Sbjct: 16  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 74
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV 279
             +M S+ + ++ +++  C     + L+ + MP G L  Y+      +     LN  + +
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 133
Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
           A  + YL       ++H DL   NVL+       ++DF +AKLL  E++          I
Sbjct: 134 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 340 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTM 398
            +MA E       +   DV+S+G+ + E  T G KP + I   E++           S +
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SIL 239
Query: 399 EVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI-RD 453
           E      L Q  I       C   V+ + ++C +   + R   RE++ +  K+ RD
Sbjct: 240 E--KGERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 286

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKGFDVECEMMKSI 226
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           RH N++++     +     L+LEY P G++ + +   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H   S  +IH D+KP N+LL       ++DF      +    S  +T    T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 180
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKP 374
             EGR+     D++S G++  E   GK P
Sbjct: 181 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 129/295 (43%), Gaps = 38/295 (12%)
Query: 181 IGRGGFGSVY----KARLGDGME--VAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIK 233
           +G+G FG VY    K  + D  E  VA+K  N     R    F  E  +MK     ++++
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYS------SNYIL---DIFQRLNIMIDVASALE 284
           ++   S  +   +++E M  G L+ Y+ S      +N +L    + + + +  ++A  + 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 285 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
           YL+   +   +H DL   N ++ ++    + DF + + +   D      + L  + +M+P
Sbjct: 147 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 203
Query: 345 EYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN 404
           E  ++G  +T  DV+SFG++L E  T  +   +  + E  L+             V+   
Sbjct: 204 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGG 251
Query: 405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNV 459
           LL + D        C   +F L   C   +P+ R +  EI++ + +  +   R V
Sbjct: 252 LLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 299

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 105/226 (46%), Gaps = 12/226 (5%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKGFDVE 219
           L + + T+ F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E
Sbjct: 19  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 77
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV 279
             +M S+ + ++ +++  C     + L+ + MP G L  Y+      +     LN  + +
Sbjct: 78  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 136
Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
           A  + YL       ++H DL   NVL+       ++DF +AKLL  E++          I
Sbjct: 137 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 193
Query: 340 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
            +MA E       +   DV+S+G+ + E  T G KP + I   E++
Sbjct: 194 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 239

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/305 (22%), Positives = 133/305 (43%), Gaps = 38/305 (12%)
Query: 171 ATDGFSENNLIGRGGFGSVY----KARLGDGME--VAVKVFNLQCG-RALKGFDVECEMM 223
           A +  + +  +G+G FG VY    K  + D  E  VA+K  N     R    F  E  +M
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYS------SNYIL---DIFQRLN 274
           K     ++++++   S  +   +++E M  G L+ Y+ S      +N +L    + + + 
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 275 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ 334
           +  ++A  + YL+   +   +H DL   N ++ ++    + DF + + +   D      +
Sbjct: 130 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 186
Query: 335 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLP 394
            L  + +M+PE  ++G  +T  DV+SFG++L E  T  +   +  + E  L+        
Sbjct: 187 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 239
Query: 395 ISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS 454
                V+   LL + D        C   +F L   C   +P+ R +  EI++ + +  + 
Sbjct: 240 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 287
Query: 455 LLRNV 459
             R V
Sbjct: 288 GFREV 292

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQC------GRALKGFDVECEMMKSIRHRNLIKV 234
           +G G +G VYKA+   G  VA+K   L          A++    E  ++K + H N++ +
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR----EISLLKELHHPNIVSL 84
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI 294
           I    +E    LV E+M    L+K +  +   L   Q   I I +   L  +   +   I
Sbjct: 85  IDVIHSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCHQHRI 140
Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY-GREGRVS 353
           +H DLKP N+L++ +    L+DF +A+      +S   T  + T+ Y AP+      + S
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVLMGSKKYS 198
Query: 354 TNGDVYSFGIMLMETFTGK 372
           T+ D++S G +  E  TGK
Sbjct: 199 TSVDIWSIGCIFAEMITGK 217

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 105/226 (46%), Gaps = 12/226 (5%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKGFDVE 219
           L + + T+ F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV 279
             +M S+ + ++ +++  C     + L+ + MP G L  Y+      +     LN  + +
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
           A  + YL       ++H DL   NVL+       ++DF +AKLL  E++          I
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 340 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
            +MA E       +   DV+S+G+ + E  T G KP + I   E++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 105/226 (46%), Gaps = 12/226 (5%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKGFDVE 219
           L + + T+ F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E
Sbjct: 12  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 70
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV 279
             +M S+ + ++ +++  C     + L+ + MP G L  Y+      +     LN  + +
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 129
Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
           A  + YL       ++H DL   NVL+       ++DF +AKLL  E++          I
Sbjct: 130 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 340 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
            +MA E       +   DV+S+G+ + E  T G KP + I   E++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 129/295 (43%), Gaps = 38/295 (12%)
Query: 181 IGRGGFGSVY----KARLGDGME--VAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIK 233
           +G+G FG VY    K  + D  E  VA+K  N     R    F  E  +MK     ++++
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYS------SNYIL---DIFQRLNIMIDVASALE 284
           ++   S  +   +++E M  G L+ Y+ S      +N +L    + + + +  ++A  + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 285 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
           YL+   +   +H DL   N ++ ++    + DF + + +   D      + L  + +M+P
Sbjct: 153 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 345 EYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN 404
           E  ++G  +T  DV+SFG++L E  T  +   +  + E  L+             V+   
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGG 257
Query: 405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNV 459
           LL + D        C   +F L   C   +P+ R +  EI++ + +  +   R V
Sbjct: 258 LLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 305

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKGFDVECEMMKSI 226
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           RH N++++     +     L+LEY P G++ + +   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H   S  +IH D+KP N+LL       ++DF      +    S  +T    T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 180
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKP 374
             EGR+     D++S G++  E   GK P
Sbjct: 181 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 129/295 (43%), Gaps = 38/295 (12%)
Query: 181 IGRGGFGSVY----KARLGDGME--VAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIK 233
           +G+G FG VY    K  + D  E  VA+K  N     R    F  E  +MK     ++++
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYS------SNYIL---DIFQRLNIMIDVASALE 284
           ++   S  +   +++E M  G L+ Y+ S      +N +L    + + + +  ++A  + 
Sbjct: 115 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 174
Query: 285 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
           YL+   +   +H DL   N ++ ++    + DF + + +   D      + L  + +M+P
Sbjct: 175 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 231
Query: 345 EYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN 404
           E  ++G  +T  DV+SFG++L E  T  +   +  + E  L+             V+   
Sbjct: 232 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGG 279
Query: 405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNV 459
           LL + D        C   +F L   C   +P+ R +  EI++ + +  +   R V
Sbjct: 280 LLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 327

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 129/295 (43%), Gaps = 38/295 (12%)
Query: 181 IGRGGFGSVY----KARLGDGME--VAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIK 233
           +G+G FG VY    K  + D  E  VA+K  N     R    F  E  +MK     ++++
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYS------SNYIL---DIFQRLNIMIDVASALE 284
           ++   S  +   +++E M  G L+ Y+ S      +N +L    + + + +  ++A  + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 285 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
           YL+   +   +H DL   N ++ ++    + DF + + +   D      + L  + +M+P
Sbjct: 153 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 345 EYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN 404
           E  ++G  +T  DV+SFG++L E  T  +   +  + E  L+             V+   
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGG 257
Query: 405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNV 459
           LL + D        C   +F L   C   +P+ R +  EI++ + +  +   R V
Sbjct: 258 LLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 305

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 105/226 (46%), Gaps = 12/226 (5%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKGFDVE 219
           L + + T+ F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E
Sbjct: 12  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 70
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV 279
             +M S+ + ++ +++  C     + L+ + MP G L  Y+      +     LN  + +
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 129
Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
           A  + YL       ++H DL   NVL+       ++DF +AKLL  E++          I
Sbjct: 130 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 340 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
            +MA E       +   DV+S+G+ + E  T G KP + I   E++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 105/226 (46%), Gaps = 12/226 (5%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKGFDVE 219
           L + + T+ F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E
Sbjct: 12  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 70
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV 279
             +M S+ + ++ +++  C     + L+ + MP G L  Y+      +     LN  + +
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 129
Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
           A  + YL       ++H DL   NVL+       ++DF +AKLL  E++          I
Sbjct: 130 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 340 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
            +MA E       +   DV+S+G+ + E  T G KP + I   E++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKGFDVECEMMKSI 226
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           RH N++++     +     L+LEY P G++ + +   +   D  +    + ++A+AL Y 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 128
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H   S  +IH D+KP N+LL       ++DF      +    S  +T    T+ Y+ PE 
Sbjct: 129 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 181
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKP 374
             EGR+     D++S G++  E   GK P
Sbjct: 182 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 209

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKGFDVECEMMKSI 226
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           RH N++++     +     L+LEY P G++ + +   +   D  +    + ++A+AL Y 
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 141
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H   S  +IH D+KP N+LL       ++DF      +    S  +T    T+ Y+ PE 
Sbjct: 142 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 194
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKP 374
             EGR+     D++S G++  E   GK P
Sbjct: 195 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 222

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKGFDVECEMMKSI 226
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           RH N++++     +     L+LEY P G++ + +   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 129
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H   S  +IH D+KP N+LL       ++DF      +    S  +T    T+ Y+ PE 
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 182
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKP 374
             EGR+     D++S G++  E   GK P
Sbjct: 183 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/305 (22%), Positives = 133/305 (43%), Gaps = 38/305 (12%)
Query: 171 ATDGFSENNLIGRGGFGSVY----KARLGDGME--VAVKVFNLQCG-RALKGFDVECEMM 223
           A +  + +  +G+G FG VY    K  + D  E  VA+K  N     R    F  E  +M
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 72
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYS------SNYIL---DIFQRLN 274
           K     ++++++   S  +   +++E M  G L+ Y+ S      +N +L    + + + 
Sbjct: 73  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 132
Query: 275 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ 334
           +  ++A  + YL+   +   +H DL   N ++ ++    + DF + + +   D      +
Sbjct: 133 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 189
Query: 335 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLP 394
            L  + +M+PE  ++G  +T  DV+SFG++L E  T  +   +  + E  L+        
Sbjct: 190 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 242
Query: 395 ISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS 454
                V+   LL + D        C   +F L   C   +P+ R +  EI++ + +  + 
Sbjct: 243 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 290
Query: 455 LLRNV 459
             R V
Sbjct: 291 GFREV 295

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 105/226 (46%), Gaps = 12/226 (5%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKGFDVE 219
           L + + T+ F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E
Sbjct: 15  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 73
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV 279
             +M S+ + ++ +++  C     + L+ + MP G L  Y+      +     LN  + +
Sbjct: 74  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 132
Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
           A  + YL       ++H DL   NVL+       ++DF +AKLL  E++          I
Sbjct: 133 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 189
Query: 340 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
            +MA E       +   DV+S+G+ + E  T G KP + I   E++
Sbjct: 190 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 235

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/305 (22%), Positives = 133/305 (43%), Gaps = 38/305 (12%)
Query: 171 ATDGFSENNLIGRGGFGSVY----KARLGDGME--VAVKVFNLQCG-RALKGFDVECEMM 223
           A +  + +  +G+G FG VY    K  + D  E  VA+K  N     R    F  E  +M
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYS------SNYIL---DIFQRLN 274
           K     ++++++   S  +   +++E M  G L+ Y+ S      +N +L    + + + 
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 275 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ 334
           +  ++A  + YL+   +   +H DL   N ++ ++    + DF + + +   D      +
Sbjct: 136 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 192
Query: 335 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLP 394
            L  + +M+PE  ++G  +T  DV+SFG++L E  T  +   +  + E  L+        
Sbjct: 193 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 245
Query: 395 ISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS 454
                V+   LL + D        C   +F L   C   +P+ R +  EI++ + +  + 
Sbjct: 246 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 293
Query: 455 LLRNV 459
             R V
Sbjct: 294 GFREV 298

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 105/226 (46%), Gaps = 12/226 (5%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKGFDVE 219
           L + + T+ F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E
Sbjct: 6   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 64
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV 279
             +M S+ + ++ +++  C     + L+ + MP G L  Y+      +     LN  + +
Sbjct: 65  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 123
Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
           A  + YL       ++H DL   NVL+       ++DF +AKLL  E++          I
Sbjct: 124 AEGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 180
Query: 340 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
            +MA E       +   DV+S+G+ + E  T G KP + I   E++
Sbjct: 181 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 226

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/305 (22%), Positives = 133/305 (43%), Gaps = 38/305 (12%)
Query: 171 ATDGFSENNLIGRGGFGSVY----KARLGDGME--VAVKVFNLQCG-RALKGFDVECEMM 223
           A +  + +  +G+G FG VY    K  + D  E  VA+K  N     R    F  E  +M
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYS------SNYIL---DIFQRLN 274
           K     ++++++   S  +   +++E M  G L+ Y+ S      +N +L    + + + 
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 275 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ 334
           +  ++A  + YL+   +   +H DL   N ++ ++    + DF + + +   D      +
Sbjct: 136 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 192
Query: 335 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLP 394
            L  + +M+PE  ++G  +T  DV+SFG++L E  T  +   +  + E  L+        
Sbjct: 193 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 245
Query: 395 ISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS 454
                V+   LL + D        C   +F L   C   +P+ R +  EI++ + +  + 
Sbjct: 246 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 293
Query: 455 LLRNV 459
             R V
Sbjct: 294 GFREV 298

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 129/295 (43%), Gaps = 38/295 (12%)
Query: 181 IGRGGFGSVY----KARLGDGME--VAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIK 233
           +G+G FG VY    K  + D  E  VA+K  N     R    F  E  +MK     ++++
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYS------SNYIL---DIFQRLNIMIDVASALE 284
           ++   S  +   +++E M  G L+ Y+ S      +N +L    + + + +  ++A  + 
Sbjct: 84  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 143
Query: 285 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
           YL+   +   +H DL   N ++ ++    + DF + + +   D      + L  + +M+P
Sbjct: 144 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 200
Query: 345 EYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN 404
           E  ++G  +T  DV+SFG++L E  T  +   +  + E  L+             V+   
Sbjct: 201 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGG 248
Query: 405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNV 459
           LL + D        C   +F L   C   +P+ R +  EI++ + +  +   R V
Sbjct: 249 LLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 296

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 105/226 (46%), Gaps = 12/226 (5%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKGFDVE 219
           L + + T+ F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E
Sbjct: 3   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV 279
             +M S+ + ++ +++  C     + L+ + MP G L  Y+      +     LN  + +
Sbjct: 62  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120
Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
           A  + YL       ++H DL   NVL+       ++DF +AKLL  E++          I
Sbjct: 121 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 340 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
            +MA E       +   DV+S+G+ + E  T G KP + I   E++
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 223

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 14/209 (6%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKGFDVECEMMKSI 226
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           RH N++++     +     L+LEY P G + K +   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK-FDEQRTATYITELANALSYC 129
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H   S  +IH D+KP N+LL       ++DF      +    S  +     T+ Y+ PE 
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLXGTLDYLPPEM 182
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKP 374
             EGR+     D++S G++  E   GK P
Sbjct: 183 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 105/226 (46%), Gaps = 12/226 (5%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKGFDVE 219
           L + + T+ F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E
Sbjct: 13  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 71
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV 279
             +M S+ + ++ +++  C     + L+++ MP G L  Y+      +     LN  + +
Sbjct: 72  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 130
Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
           A  + YL       ++H DL   NVL+       ++DF  AKLL  E++          I
Sbjct: 131 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 187
Query: 340 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
            +MA E       +   DV+S+G+ + E  T G KP + I   E++
Sbjct: 188 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 233

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 105/226 (46%), Gaps = 12/226 (5%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKGFDVE 219
           L + + T+ F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV 279
             +M S+ + ++ +++  C     + L+++ MP G L  Y+      +     LN  + +
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
           A  + YL       ++H DL   NVL+       ++DF  AKLL  E++          I
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 340 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
            +MA E       +   DV+S+G+ + E  T G KP + I   E++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKGFDVECEMMKSI 226
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           RH N++++     +     L+LEY P G++ + +   +   D  +    + ++A+AL Y 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 125
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H   S  +IH D+KP N+LL       ++DF      +    S  +T    T+ Y+ PE 
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSCHAPSSRRTTLSGTLDYLPPEM 178
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKP 374
             EGR+     D++S G++  E   GK P
Sbjct: 179 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKGFDVECEMMKSI 226
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           RH N++++     +     L+LEY P G++ + +   +   D  +    + ++A+AL Y 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 121
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H   S  +IH D+KP N+LL       ++DF      +    S  +T    T+ Y+ PE 
Sbjct: 122 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 174
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKP 374
             EGR+     D++S G++  E   GK P
Sbjct: 175 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 202

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/296 (24%), Positives = 130/296 (43%), Gaps = 33/296 (11%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKGFDVE 219
           L + + T+ F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E
Sbjct: 34  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 92
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV 279
             +M S+ + ++ +++  C     + L+ + MP G L  Y+      +     LN  + +
Sbjct: 93  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 151
Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
           A  + YL       ++H DL   NVL+       ++DF +AKLL  E++          I
Sbjct: 152 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 208
Query: 340 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTM 398
            +MA E       +   DV+S+G+ + E  T G KP + I   E++           S +
Sbjct: 209 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SIL 257
Query: 399 EVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI-RD 453
           E      L Q  I       C   V+ + ++C +   + R   RE++ +  K+ RD
Sbjct: 258 E--KGERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 304

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G FG VYKA+  + G   A KV   +    L+ + VE E++ +  H  ++K++    
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
           ++    +++E+ P G+++  M   +  L   Q   I +     LE L+F +S  IIH DL
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHSKRIIHRDL 135
Query: 300 KPSNVLLDDNMVAHLSDFSIA----KLLTGEDQSMTQTQTLATIGYMAPEY-----GREG 350
           K  NVL+       L+DF ++    K L   D        + T  +MAPE       ++ 
Sbjct: 136 KAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD------SFIGTPYWMAPEVVMCETMKDT 189
Query: 351 RVSTNGDVYSFGIMLMETFTGKKPTNEI 378
                 D++S GI L+E    + P +E+
Sbjct: 190 PYDYKADIWSLGITLIEMAQIEPPHHEL 217

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 105/226 (46%), Gaps = 12/226 (5%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKGFDVE 219
           L + + T+ F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV 279
             +M S+ + ++ +++  C     + L+++ MP G L  Y+      +     LN  + +
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
           A  + YL       ++H DL   NVL+       ++DF  AKLL  E++          I
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 340 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
            +MA E       +   DV+S+G+ + E  T G KP + I   E++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKGFDVECEMMKSI 226
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           RH N++++     +     L+LEY P G++ + +   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 129
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H   S  +IH D+KP N+LL       ++DF      +    S  +T    T+ Y+ PE 
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEX 182
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKP 374
             EGR      D++S G++  E   GK P
Sbjct: 183 I-EGRXHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 33/222 (14%)
Query: 179 NLIGRGGFGSVYKA------RLGDGMEVAVKVFNLQCGRALK-GFDVECEMMKSI-RHRN 230
            ++G G FG V  A      + G  ++VAVK+   +   + +     E +MM  +  H N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYM-------------YSSNYILDIFQRLNIMI 277
           ++ ++  C+      L+ EY  +G L  Y+             Y +   L+  + LN++ 
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 278 ---------DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ 328
                     VA  +E+L F      +H DL   NVL+    V  + DF +A+ +  +  
Sbjct: 171 FEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 370
            + +      + +MAPE   EG  +   DV+S+GI+L E F+
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKGFDVECEMMKSI 226
           A + F     +G+G FG+VY AR  +   + A+KV F  Q  +A        E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           RH N++++     +     L+LEY P G++ + +   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H   S  +IH D+KP N+LL       ++DF      +    S  +     T+ Y+ PE 
Sbjct: 125 H---SKKVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPPEM 177
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKP 374
             EGR+     D++S G++  E   GK P
Sbjct: 178 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G FG VYKA+  + G   A KV   +    L+ + VE E++ +  H  ++K++    
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
           ++    +++E+ P G+++  M   +  L   Q   I +     LE L+F +S  IIH DL
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHSKRIIHRDL 143
Query: 300 KPSNVLLDDNMVAHLSDFSIA----KLLTGEDQSMTQTQTLATIGYMAPEY-----GREG 350
           K  NVL+       L+DF ++    K L   D        + T  +MAPE       ++ 
Sbjct: 144 KAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD------SFIGTPYWMAPEVVMCETMKDT 197
Query: 351 RVSTNGDVYSFGIMLMETFTGKKPTNEI 378
                 D++S GI L+E    + P +E+
Sbjct: 198 PYDYKADIWSLGITLIEMAQIEPPHHEL 225

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 107/233 (45%), Gaps = 36/233 (15%)
Query: 168 LCRATDGFSENNLIGRGGFGSVYKAR--LGDGMEVAVKVFNLQCGRALKGFDVECEM--- 222
           LCRA   +     IG G +G V+KAR     G  VA+K   +Q G          E+   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 223 --MKSIRHRNLIKVISTCS----NEEFK-ALVLEYMPHGSLEKYM-------YSSNYILD 268
             +++  H N++++   C+    + E K  LV E++    L  Y+         +  I D
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124
Query: 269 IFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ 328
           +      M  +   L++LH   S  ++H DLKP N+L+  +    L+DF +A++ + +  
Sbjct: 125 M------MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-- 173
Query: 329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNG 381
            M  T  + T+ Y APE   +   +T  D++S G +  E F  +KP   +F G
Sbjct: 174 -MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP---LFRG 221

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 14/205 (6%)
Query: 179 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALK---GFDVECEMMKSIRHRNLIKV 234
           + +G G FG V   +    G +VAVK+ N Q  R+L        E + +K  RH ++IK+
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI 294
               S      +V+EY+  G L  Y+   N  LD  +   +   + S ++Y H      +
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCH---RHMV 137
Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVST 354
           +H DLKP NVLLD +M A ++DF ++ +++  D    +  +  +  Y APE    GR+  
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRX-SCGSPNYAAPEVI-SGRLYA 193
Query: 355 NG--DVYSFGIMLMETFTGKKPTNE 377
               D++S G++L     G  P ++
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDD 218

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 107/233 (45%), Gaps = 36/233 (15%)
Query: 168 LCRATDGFSENNLIGRGGFGSVYKAR--LGDGMEVAVKVFNLQCGRALKGFDVECEM--- 222
           LCRA   +     IG G +G V+KAR     G  VA+K   +Q G          E+   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 223 --MKSIRHRNLIKVISTCS----NEEFK-ALVLEYMPHGSLEKYM-------YSSNYILD 268
             +++  H N++++   C+    + E K  LV E++    L  Y+         +  I D
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124
Query: 269 IFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ 328
           +      M  +   L++LH   S  ++H DLKP N+L+  +    L+DF +A++ + +  
Sbjct: 125 M------MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-- 173
Query: 329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNG 381
            M  T  + T+ Y APE   +   +T  D++S G +  E F  +KP   +F G
Sbjct: 174 -MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP---LFRG 221

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 29/216 (13%)
Query: 175 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKV 234
           F++   IG+G FG V+K       +V           A+K  D+E    +    +  I V
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVV----------AIKIIDLEEAEDEIEDIQQEITV 58
Query: 235 ISTCSNEEFKA------------LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASA 282
           +S C +                 +++EY+  GS    +      LD  Q   I+ ++   
Sbjct: 59  LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKG 116
Query: 283 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           L+YLH   S   IH D+K +NVLL ++    L+DF +A  LT  D  + +   + T  +M
Sbjct: 117 LDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWM 171
Query: 343 APEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEI 378
           APE  ++    +  D++S GI  +E   G+ P +E+
Sbjct: 172 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 207

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 107/233 (45%), Gaps = 36/233 (15%)
Query: 168 LCRATDGFSENNLIGRGGFGSVYKAR--LGDGMEVAVKVFNLQCGRALKGFDVECEM--- 222
           LCRA   +     IG G +G V+KAR     G  VA+K   +Q G          E+   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 223 --MKSIRHRNLIKVISTCS----NEEFK-ALVLEYMPHGSLEKYM-------YSSNYILD 268
             +++  H N++++   C+    + E K  LV E++    L  Y+         +  I D
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124
Query: 269 IFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ 328
           +      M  +   L++LH   S  ++H DLKP N+L+  +    L+DF +A++ + +  
Sbjct: 125 M------MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-- 173
Query: 329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNG 381
            M  T  + T+ Y APE   +   +T  D++S G +  E F  +KP   +F G
Sbjct: 174 -MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP---LFRG 221

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVIST 237
           IG+G F  V  AR +  G EVAVK+ +       +L+    E  +MK + H N++K+   
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
              E+   LV+EY   G +  Y+ +   + +   R      + SA++Y H  Y   I+H 
Sbjct: 83  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKY---IVHR 138
Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVS-TNG 356
           DLK  N+LLD +M   ++DF  +   T  ++  T      +  Y APE  +  +      
Sbjct: 139 DLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT---FCGSPPYAAPELFQGKKYDGPEV 195
Query: 357 DVYSFGIMLMETFTGKKPTNEIFNGE 382
           DV+S G++L    +G  P    F+G+
Sbjct: 196 DVWSLGVILYTLVSGSLP----FDGQ 217

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 114/231 (49%), Gaps = 34/231 (14%)
Query: 174 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
            ++   +IG G FG V++A+L +  EVA+K   LQ  R     + E ++M+ ++H N++ 
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-LQDKRFK---NRELQIMRIVKHPNVVD 96
Query: 234 VIS------TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNI------MIDVAS 281
           + +         +E F  LVLEY+P    E    +S +   + Q + +      M  +  
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 282 ALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIG 340
           +L Y+H   S  I H D+KP N+LLD  + V  L DF  AK+L   + +++    + +  
Sbjct: 153 SLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS---XICSRY 206
Query: 341 YMAPE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWV 389
           Y APE  +G     +TN D++S G ++ E   G+     +F GE  +   V
Sbjct: 207 YRAPELIFGATN-YTTNIDIWSTGCVMAELMQGQP----LFPGESGIDQLV 252

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/305 (21%), Positives = 132/305 (43%), Gaps = 38/305 (12%)
Query: 171 ATDGFSENNLIGRGGFGSVY----KARLGDGME--VAVKVFNLQCG-RALKGFDVECEMM 223
           A +  + +  +G+G FG VY    K  + D  E  VA+K  N     R    F  E  +M
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 67
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYS------SNYIL---DIFQRLN 274
           K     ++++++   S  +   +++E M  G L+ Y+ S      +N +L    + + + 
Sbjct: 68  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 127
Query: 275 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ 334
           +  ++A  + YL+   +   +H DL   N ++ ++    + DF + + +   D      +
Sbjct: 128 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGK 184
Query: 335 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLP 394
            L  + +M+PE  ++G  +T  DV+SFG++L E  T  +   +  + E  L+        
Sbjct: 185 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 237
Query: 395 ISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS 454
                V+   LL + D        C   +  L   C   +P+ R +  EI++ + +  + 
Sbjct: 238 -----VMEGGLLDKPD-------NCPDMLLELMRMCWQYNPKMRPSFLEIISSIKEEMEP 285
Query: 455 LLRNV 459
             R V
Sbjct: 286 GFREV 290

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 29/216 (13%)
Query: 175 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKV 234
           F++   IG+G FG V+K       +V           A+K  D+E    +    +  I V
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVV----------AIKIIDLEEAEDEIEDIQQEITV 58
Query: 235 ISTCSNEEFKA------------LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASA 282
           +S C +                 +++EY+  GS    +      LD  Q   I+ ++   
Sbjct: 59  LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKG 116
Query: 283 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           L+YLH   S   IH D+K +NVLL ++    L+DF +A  LT  D  + +   + T  +M
Sbjct: 117 LDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWM 171
Query: 343 APEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEI 378
           APE  ++    +  D++S GI  +E   G+ P +E+
Sbjct: 172 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 207

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVIST 237
           IG+G F  V  AR +  G EVAVK+ +       +L+    E  +MK + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
              E+   LV+EY   G +  Y+ +   + +   R      + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVS-TNG 356
           DLK  N+LLD +M   ++DF  +   T  ++  T      +  Y APE  +  +      
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEV 194
Query: 357 DVYSFGIMLMETFTGKKPTNEIFNGE 382
           DV+S G++L    +G  P    F+G+
Sbjct: 195 DVWSLGVILYTLVSGSLP----FDGQ 216

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 105/226 (46%), Gaps = 12/226 (5%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKGFDVE 219
           L + + T+ F +  ++  G FG+VYK      G+ +++ V +  L+     +A K    E
Sbjct: 16  LRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 74
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV 279
             +M S+ + ++ +++  C     + L+++ MP G L  Y+      +     LN  + +
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 133
Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
           A  + YL       ++H DL   NVL+       ++DF +AKLL  E++          I
Sbjct: 134 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 340 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
            +MA E       +   DV+S+G+ + E  T G KP + I   E++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKGFDVECEMMKSIRH 228
           + F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +RH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
            N++++     +     L+LEY P G++ + +   +   D  +    + ++A+AL Y H 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR-FDEQRTATYITELANALSYCH- 129
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +IH D+KP N+LL  N    ++DF      +    S  +T    T+ Y+ PE   
Sbjct: 130 --SKRVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMI- 182
Query: 349 EGRVSTNG-DVYSFGIMLMETFTGKKP 374
           EGR+     D++S G++  E   G  P
Sbjct: 183 EGRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVIST 237
           IG+G F  V  AR +  G EVAVK+ +       +L+    E  +MK + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
              E+   LV+EY   G +  Y+ +   + +   R      + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVS-TNG 356
           DLK  N+LLD +M   ++DF  +   T  ++  T      +  Y APE  +  +      
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEV 194
Query: 357 DVYSFGIMLMETFTGKKPTNEIFNGE 382
           DV+S G++L    +G  P    F+G+
Sbjct: 195 DVWSLGVILYTLVSGSLP----FDGQ 216

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 29/216 (13%)
Query: 175 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKV 234
           F++   IG+G FG V+K       +V           A+K  D+E    +    +  I V
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVV----------AIKIIDLEEAEDEIEDIQQEITV 73
Query: 235 ISTCSNEEFKA------------LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASA 282
           +S C +                 +++EY+  GS    +      LD  Q   I+ ++   
Sbjct: 74  LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKG 131
Query: 283 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           L+YLH   S   IH D+K +NVLL ++    L+DF +A  LT  D  + +   + T  +M
Sbjct: 132 LDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWM 186
Query: 343 APEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEI 378
           APE  ++    +  D++S GI  +E   G+ P +E+
Sbjct: 187 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/286 (23%), Positives = 121/286 (42%), Gaps = 39/286 (13%)
Query: 181 IGRGGFGSVYKARLGDGME------VAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIK 233
           +G+G FG VY+    D ++      VAVK  N     R    F  E  +MK     ++++
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILD---------IFQRLNIMIDVASALE 284
           ++   S  +   +V+E M HG L+ Y+ S     +         + + + +  ++A  + 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 285 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
           YL+   +   +H +L   N ++  +    + DF + + +   D      + L  + +MAP
Sbjct: 146 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202
Query: 345 EYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN 404
           E  ++G  +T+ D++SFG++L E  +  +   +  + E  LK             V+   
Sbjct: 203 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 250
Query: 405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK 450
            L Q D        C   V +L   C   +P  R    EIV  LLK
Sbjct: 251 YLDQPD-------NCPERVTDLMRMCWQFNPNMRPTFLEIV-NLLK 288

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/286 (23%), Positives = 121/286 (42%), Gaps = 39/286 (13%)
Query: 181 IGRGGFGSVYKARLGDGME------VAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIK 233
           +G+G FG VY+    D ++      VAVK  N     R    F  E  +MK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILD---------IFQRLNIMIDVASALE 284
           ++   S  +   +V+E M HG L+ Y+ S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 285 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
           YL+   +   +H +L   N ++  +    + DF + + +   D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 345 EYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN 404
           E  ++G  +T+ D++SFG++L E  +  +   +  + E  LK             V+   
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 249
Query: 405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK 450
            L Q D        C   V +L   C   +P  R    EIV  LLK
Sbjct: 250 YLDQPD-------NCPERVTDLMRMCWQFNPNMRPTFLEIV-NLLK 287

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKGFDVECEMMKSI 226
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           RH N++++     +     L+LEY P G++ + +   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H   S  +IH D+KP N+LL       ++DF      +    S  +     T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPPEM 177
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKP 374
             EGR+     D++S G++  E   GK P
Sbjct: 178 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 29/216 (13%)
Query: 175 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKV 234
           F++   IG+G FG V+K       +V           A+K  D+E    +    +  I V
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVV----------AIKIIDLEEAEDEIEDIQQEITV 78
Query: 235 ISTCSNEEFKA------------LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASA 282
           +S C +                 +++EY+  GS    +      LD  Q   I+ ++   
Sbjct: 79  LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKG 136
Query: 283 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           L+YLH   S   IH D+K +NVLL ++    L+DF +A  LT  D  + +   + T  +M
Sbjct: 137 LDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWM 191
Query: 343 APEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEI 378
           APE  ++    +  D++S GI  +E   G+ P +E+
Sbjct: 192 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 227

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 104/226 (46%), Gaps = 12/226 (5%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKGFDVE 219
           L + + T+ F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E
Sbjct: 9   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV 279
             +M S+ + ++ +++  C     + L+ + MP G L  Y+      +     LN  + +
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
           A  + YL       ++H DL   NVL+       ++DF  AKLL  E++          I
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 183
Query: 340 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
            +MA E       +   DV+S+G+ + E  T G KP + I   E++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 93/199 (46%), Gaps = 18/199 (9%)
Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVF-NLQCGRALKGFDV-ECEMMKSIRHRNLIKVIST 237
           IG G +G V+K R  D G  VA+K F   +    +K   + E  M+K ++H NL+ ++  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVAS----ALEYLHFGYSAP 293
              +    LV EY  H  L +        LD +QR      V S     L+ ++F +   
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHE--------LDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE-YGREGRV 352
            IH D+KP N+L+  + V  L DF  A+LLTG   S      +AT  Y +PE    + + 
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGP--SDYYDDEVATRWYRSPELLVGDTQY 180
Query: 353 STNGDVYSFGIMLMETFTG 371
               DV++ G +  E  +G
Sbjct: 181 GPPVDVWAIGCVFAELLSG 199

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 11/204 (5%)
Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G FG VYKA+  +  +  A KV + +    L+ + VE +++ S  H N++K++    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
            E    +++E+   G+++  M      L   Q   +      AL YLH      IIH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 161
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY-----GREGRVST 354
           K  N+L   +    L+DF ++   T   Q   +   + T  +MAPE       ++     
Sbjct: 162 KAGNILFTLDGDIKLADFGVSAKNTRXIQR--RDSFIGTPYWMAPEVVMCETSKDRPYDY 219
Query: 355 NGDVYSFGIMLMETFTGKKPTNEI 378
             DV+S GI L+E    + P +E+
Sbjct: 220 KADVWSLGITLIEMAEIEPPHHEL 243

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 104/226 (46%), Gaps = 12/226 (5%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKGFDVE 219
           L + + T+ F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV 279
             +M S+ + ++ +++  C     + L+ + MP G L  Y+      +     LN  + +
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
           A  + YL       ++H DL   NVL+       ++DF  AKLL  E++          I
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 340 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
            +MA E       +   DV+S+G+ + E  T G KP + I   E++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKGFDVECEMMKSI 226
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           RH N++++     +     L+LEY P G++ + +   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H   S  +IH D+KP N+LL       ++DF      +    S  +     T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPPEM 177
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKP 374
             EGR+     D++S G++  E   GK P
Sbjct: 178 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKGFDVECEMMKSI 226
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           RH N++++     +     L+LEY P G++ + +   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H   S  +IH D+KP N+LL       ++DF      +    S  +     T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPPEM 180
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKP 374
             EGR+     D++S G++  E   GK P
Sbjct: 181 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKGFDVECEMMKSI 226
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           RH N++++     +     L+LEY P G++ + +   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H   S  +IH D+KP N+LL       ++DF      +    S  +     T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDYLPPEM 180
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKP 374
             EGR+     D++S G++  E   GK P
Sbjct: 181 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKGFDVECEMMKSI 226
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           RH N++++     +     L+LEY P G++ + +   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H   S  +IH D+KP N+LL       +++F      +    S  +T    T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPPEM 180
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKP 374
             EGR+     D++S G++  E   GK P
Sbjct: 181 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 11/204 (5%)
Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G FG VYKA+  +  +  A KV + +    L+ + VE +++ S  H N++K++    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
            E    +++E+   G+++  M      L   Q   +      AL YLH      IIH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 161
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY-----GREGRVST 354
           K  N+L   +    L+DF ++   T   Q   +   + T  +MAPE       ++     
Sbjct: 162 KAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPYWMAPEVVMCETSKDRPYDY 219
Query: 355 NGDVYSFGIMLMETFTGKKPTNEI 378
             DV+S GI L+E    + P +E+
Sbjct: 220 KADVWSLGITLIEMAEIEPPHHEL 243

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 104/226 (46%), Gaps = 12/226 (5%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKGFDVE 219
           L + + T+ F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E
Sbjct: 16  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 74
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV 279
             +M S+ + ++ +++  C     + L+ + MP G L  Y+      +     LN  + +
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 133
Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
           A  + YL       ++H DL   NVL+       ++DF  AKLL  E++          I
Sbjct: 134 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 190
Query: 340 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
            +MA E       +   DV+S+G+ + E  T G KP + I   E++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKGFDVECEMMKSI 226
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           RH N++++     +     L+LEY P G++ + +   +   D  +    + ++A+AL Y 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 126
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H   S  +IH D+KP N+LL       +++F      +    S  +T    T+ Y+ PE 
Sbjct: 127 H---SKRVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPPEM 179
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKP 374
             EGR+     D++S G++  E   GK P
Sbjct: 180 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 11/204 (5%)
Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G FG VYKA+  +  +  A KV + +    L+ + VE +++ S  H N++K++    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
            E    +++E+   G+++  M      L   Q   +      AL YLH      IIH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 161
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY-----GREGRVST 354
           K  N+L   +    L+DF ++   T   Q   +   + T  +MAPE       ++     
Sbjct: 162 KAGNILFTLDGDIKLADFGVSAKNTRXIQR--RDXFIGTPYWMAPEVVMCETSKDRPYDY 219
Query: 355 NGDVYSFGIMLMETFTGKKPTNEI 378
             DV+S GI L+E    + P +E+
Sbjct: 220 KADVWSLGITLIEMAEIEPPHHEL 243

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKGFDVECEMMKSI 226
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           RH N++++     +     L+LEY P G++ + +   +   D  +    + ++A+AL Y 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 126
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H   S  +IH D+KP N+LL       ++DF      +    S  +     T+ Y+ PE 
Sbjct: 127 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPPEM 179
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKP 374
             EGR+     D++S G++  E   GK P
Sbjct: 180 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKGFDVECEMMKSI 226
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           RH N++++     +     L+LEY P G++ + +   +   D  +    + ++A+AL Y 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 150
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H   S  +IH D+KP N+LL       ++DF      +    S  +     T+ Y+ PE 
Sbjct: 151 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDYLPPEM 203
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKP 374
             EGR+     D++S G++  E   GK P
Sbjct: 204 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/286 (23%), Positives = 121/286 (42%), Gaps = 39/286 (13%)
Query: 181 IGRGGFGSVYKARLGDGME------VAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIK 233
           +G+G FG VY+    D ++      VAVK  N     R    F  E  +MK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILD---------IFQRLNIMIDVASALE 284
           ++   S  +   +V+E M HG L+ Y+ S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 285 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
           YL+   +   +H DL   N ++  +    + DF + + +          + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 345 EYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN 404
           E  ++G  +T+ D++SFG++L E  +  +   +  + E  LK             V+   
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 249
Query: 405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK 450
            L Q D        C   V +L   C   +P+ R    EIV  LLK
Sbjct: 250 YLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIV-NLLK 287

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKGFDVECEMMKSI 226
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           RH N++++     +     L+LEY P G++ + +   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H   S  +IH D+KP N+LL       ++DF      +    S  +     T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPPEM 180
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKP 374
             EGR+     D++S G++  E   GK P
Sbjct: 181 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVIST 237
           IG+G F  V  AR +  G EVAV++ +       +L+    E  +MK + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
              E+   LV+EY   G +  Y+ +   + +   R      + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVS-TNG 356
           DLK  N+LLD +M   ++DF  +   T  ++  T      +  Y APE  +  +      
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEV 194
Query: 357 DVYSFGIMLMETFTGKKPTNEIFNGE 382
           DV+S G++L    +G  P    F+G+
Sbjct: 195 DVWSLGVILYTLVSGSLP----FDGQ 216

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 29/229 (12%)
Query: 174 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
            +++  +IG G FG VY+A+L D  E+      LQ  R     + E ++M+ + H N+++
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVR 85
Query: 234 V------ISTCSNEEFKALVLEYMP---HGSLEKYMYSSNYILDIFQRLNIMIDVASALE 284
           +           +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L 
Sbjct: 86  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 144
Query: 285 YLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           Y+H FG    I H D+KP N+LLD D  V  L DF  AK L   + +++    + +  Y 
Sbjct: 145 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYR 197
Query: 343 APE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWV 389
           APE  +G     S+  DV+S G +L E   G+     IF G+  +   V
Sbjct: 198 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 241

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKGFDVECEMMKSI 226
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           RH N++++     +     L+LEY P G++ + +   +   D  +    + ++A+AL Y 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 125
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
           H   S  +IH D+KP N+LL       ++DF      +    S  +     T+ Y+ PE 
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDTLCGTLDYLPPEM 178
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKP 374
             EGR+     D++S G++  E   GK P
Sbjct: 179 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 29/229 (12%)
Query: 174 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
            +++  +IG G FG VY+A+L D  E+      LQ  R     + E ++M+ + H N+++
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVR 96
Query: 234 V------ISTCSNEEFKALVLEYMP---HGSLEKYMYSSNYILDIFQRLNIMIDVASALE 284
           +           +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L 
Sbjct: 97  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 155
Query: 285 YLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           Y+H FG    I H D+KP N+LLD D  V  L DF  AK L   + +++    + +  Y 
Sbjct: 156 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYR 208
Query: 343 APE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWV 389
           APE  +G     S+  DV+S G +L E   G+     IF G+  +   V
Sbjct: 209 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 252

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 37/223 (16%)
Query: 175 FSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQCGR--------ALKGFDVECEMMKS 225
           +   ++IGRG    V +      G E AVK+  +   R          +    E  +++ 
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 226 IR-HRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALE 284
           +  H ++I +I +  +  F  LV + M  G L  Y+ +    L   +  +IM  +  A+ 
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-TEKVALSEKETRSIMRSLLEAVS 214
Query: 285 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA-KLLTGEDQSMTQTQTLATIGYMA 343
           +LH   +  I+H DLKP N+LLDDNM   LSDF  +  L  GE       +   T GY+A
Sbjct: 215 FLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE----KLRELCGTPGYLA 267
Query: 344 PE------------YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           PE            YG+E       D+++ G++L     G  P
Sbjct: 268 PEILKCSMDETHPGYGKE------VDLWACGVILFTLLAGSPP 304

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 29/229 (12%)
Query: 174 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
            +++  +IG G FG VY+A+L D  E+      LQ  R     + E ++M+ + H N+++
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVR 78
Query: 234 V------ISTCSNEEFKALVLEYMP---HGSLEKYMYSSNYILDIFQRLNIMIDVASALE 284
           +           +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L 
Sbjct: 79  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 137
Query: 285 YLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           Y+H FG    I H D+KP N+LLD D  V  L DF  AK L   + +++    + +  Y 
Sbjct: 138 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYR 190
Query: 343 APE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWV 389
           APE  +G     S+  DV+S G +L E   G+     IF G+  +   V
Sbjct: 191 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 234

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 12/226 (5%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKGFDVE 219
           L + + T+ F +  ++  G FG+VYK      G+ +++ V +  L+     +A K    E
Sbjct: 9   LRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV 279
             +M S+ + ++ +++  C     + L+ + MP G L  Y+      +     LN  + +
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
           A  + YL       ++H DL   NVL+       ++DF +AKLL  E++          I
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 340 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
            +MA E       +   DV+S+G+ + E  T G KP + I   E++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 116/285 (40%), Gaps = 40/285 (14%)
Query: 181 IGRGGFGSVYKARLG------DGMEVAVKVFNLQCGRALK-GFDVECEMMKSIRHRNLIK 233
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++  + H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMY------SSNYILDIFQRLNIMIDVASALEYLH 287
            I        + ++LE M  G L+ ++       S    L +   L++  D+A   +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 288 FGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
             +    IH D+   N LL       VA + DF +A+ +            +  + +M P
Sbjct: 159 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 345 EYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA 403
           E   EG  ++  D +SFG++L E F+ G  P     N E+              +E V +
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------LEFVTS 261
Query: 404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
                        + C   V+ +  +C    PE R N   I+ ++
Sbjct: 262 GG------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 29/229 (12%)
Query: 174 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
            +++  +IG G FG VY+A+L D  E+      LQ  R     + E ++M+ + H N+++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVR 77
Query: 234 V------ISTCSNEEFKALVLEYMP---HGSLEKYMYSSNYILDIFQRLNIMIDVASALE 284
           +           +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 136
Query: 285 YLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           Y+H FG    I H D+KP N+LLD D  V  L DF  AK L   + +++    + +  Y 
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYR 189
Query: 343 APE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWV 389
           APE  +G     S+  DV+S G +L E   G+     IF G+  +   V
Sbjct: 190 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 233

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 29/229 (12%)
Query: 174 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
            +++  +IG G FG VY+A+L D  E+      LQ  R     + E ++M+ + H N+++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVR 77
Query: 234 V------ISTCSNEEFKALVLEYMP---HGSLEKYMYSSNYILDIFQRLNIMIDVASALE 284
           +           +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 136
Query: 285 YLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           Y+H FG    I H D+KP N+LLD D  V  L DF  AK L   + +++    + +  Y 
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYR 189
Query: 343 APE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWV 389
           APE  +G     S+  DV+S G +L E   G+     IF G+  +   V
Sbjct: 190 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 233

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 12/226 (5%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKGFDVE 219
           L + + T+ F +  ++  G FG+VYK      G+ +++ V +  L+     +A K    E
Sbjct: 16  LRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 74
Query: 220 CEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV 279
             +M S+ + ++ +++  C     + L+ + MP G L  Y+      +     LN  + +
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 133
Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
           A  + YL       ++H DL   NVL+       ++DF +AKLL  E++          I
Sbjct: 134 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 340 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
            +MA E       +   DV+S+G+ + E  T G KP + I   E++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 116/285 (40%), Gaps = 40/285 (14%)
Query: 181 IGRGGFGSVYKARLG------DGMEVAVKVFNLQCGRALK-GFDVECEMMKSIRHRNLIK 233
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++  + H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMY------SSNYILDIFQRLNIMIDVASALEYLH 287
            I        + ++LE M  G L+ ++       S    L +   L++  D+A   +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 288 FGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
             +    IH D+   N LL       VA + DF +A+ +            +  + +M P
Sbjct: 173 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 345 EYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA 403
           E   EG  ++  D +SFG++L E F+ G  P     N E+              +E V +
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------LEFVTS 275
Query: 404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
                        + C   V+ +  +C    PE R N   I+ ++
Sbjct: 276 GG------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 29/229 (12%)
Query: 174 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
            +++  +IG G FG VY+A+L D  E+      LQ  R     + E ++M+ + H N+++
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVR 89
Query: 234 V------ISTCSNEEFKALVLEYMP---HGSLEKYMYSSNYILDIFQRLNIMIDVASALE 284
           +           +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L 
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 148
Query: 285 YLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           Y+H FG    I H D+KP N+LLD D  V  L DF  AK L   + +++    + +  Y 
Sbjct: 149 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYR 201
Query: 343 APE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWV 389
           APE  +G     S+  DV+S G +L E   G+     IF G+  +   V
Sbjct: 202 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 245

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 116/278 (41%), Gaps = 33/278 (11%)
Query: 181 IGRGGFGSV----YKARLGDGMEVAVKVF-NLQCGRALKGFDVECEMMKSIRHRNLIKVI 235
           IG G FG V    Y +     M VA+K   N       + F  E   M+   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
              + E    +++E    G L  ++    Y LD+   +     +++AL YL    S   +
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ-TQTLATIGYMAPEYGREGRVST 354
           H D+   NVL+  N    L DF +++ +  ED +  + ++    I +MAPE     R ++
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 191
Query: 355 NGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF 413
             DV+ FG+ + E    G KP   + N ++  +    + LP+                  
Sbjct: 192 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------- 235
Query: 414 VAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
                C   +++L  +C    P +R    E+ A+L  I
Sbjct: 236 ----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 29/229 (12%)
Query: 174 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
            +++  +IG G FG VY+A+L D  E+      LQ  R     + E ++M+ + H N+++
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVR 111
Query: 234 V------ISTCSNEEFKALVLEYMP---HGSLEKYMYSSNYILDIFQRLNIMIDVASALE 284
           +           +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L 
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 170
Query: 285 YLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           Y+H FG    I H D+KP N+LLD D  V  L DF  AK L   + +++    + +  Y 
Sbjct: 171 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYR 223
Query: 343 APE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWV 389
           APE  +G     S+  DV+S G +L E   G+     IF G+  +   V
Sbjct: 224 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 267

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVIST 237
           IG+G F  V  AR +  G EVAV++ +       +L+    E  +MK + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
              E+   LV+EY   G +  Y+ +   + +   R      + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVS-TNG 356
           DLK  N+LLD +M   ++DF  +   T  ++     +   +  Y APE  +  +      
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKL---DEFCGSPPYAAPELFQGKKYDGPEV 194
Query: 357 DVYSFGIMLMETFTGKKPTNEIFNGE 382
           DV+S G++L    +G  P    F+G+
Sbjct: 195 DVWSLGVILYTLVSGSLP----FDGQ 216

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 29/229 (12%)
Query: 174 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
            +++  +IG G FG VY+A+L D  E+      LQ  R     + E ++M+ + H N+++
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVR 89
Query: 234 V------ISTCSNEEFKALVLEYMP---HGSLEKYMYSSNYILDIFQRLNIMIDVASALE 284
           +           +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L 
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 148
Query: 285 YLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           Y+H FG    I H D+KP N+LLD D  V  L DF  AK L   + +++    + +  Y 
Sbjct: 149 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYR 201
Query: 343 APE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWV 389
           APE  +G     S+  DV+S G +L E   G+     IF G+  +   V
Sbjct: 202 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 245

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 115/285 (40%), Gaps = 40/285 (14%)
Query: 181 IGRGGFGSVYKARLG------DGMEVAVKVFNLQCGRALK-GFDVECEMMKSIRHRNLIK 233
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++    H+N+++
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMY------SSNYILDIFQRLNIMIDVASALEYLH 287
            I        + ++LE M  G L+ ++       S    L +   L++  D+A   +YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 288 FGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
             +    IH D+   N LL       VA + DF +A+ +            +  + +M P
Sbjct: 150 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 206
Query: 345 EYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA 403
           E   EG  ++  D +SFG++L E F+ G  P     N E+              +E V +
Sbjct: 207 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------LEFVTS 252
Query: 404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
                        + C   V+ +  +C    PE R N   I+ ++
Sbjct: 253 GG------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 291

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 29/229 (12%)
Query: 174 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
            +++  +IG G FG VY+A+L D  E+      LQ  R     + E ++M+ + H N+++
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVR 81
Query: 234 V------ISTCSNEEFKALVLEYMP---HGSLEKYMYSSNYILDIFQRLNIMIDVASALE 284
           +           +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L 
Sbjct: 82  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 140
Query: 285 YLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           Y+H FG    I H D+KP N+LLD D  V  L DF  AK L   + +++    + +  Y 
Sbjct: 141 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYR 193
Query: 343 APE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWV 389
           APE  +G     S+  DV+S G +L E   G+     IF G+  +   V
Sbjct: 194 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 237

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRALKGFDVECEMMKS 225
           + F +   IG G +G VYKAR    G  VA+K   L          A++    E  ++K 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKE 65
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           + H N++K++     E    LV E++ H  L+K+M +S   L       I   +   L+ 
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQG 122
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
           L F +S  ++H DLKP N+L++      L+DF +A+      +  T T  + T+ Y APE
Sbjct: 123 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPE 180
Query: 346 YGREGR-VSTNGDVYSFGIMLMETFTGK 372
                +  ST  D++S G +  E  T +
Sbjct: 181 ILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 29/229 (12%)
Query: 174 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
            +++  +IG G FG VY+A+L D  E+      LQ  R     + E ++M+ + H N+++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVR 77
Query: 234 V------ISTCSNEEFKALVLEYMP---HGSLEKYMYSSNYILDIFQRLNIMIDVASALE 284
           +           +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 136
Query: 285 YLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           Y+H FG    I H D+KP N+LLD D  V  L DF  AK L   + +++    + +  Y 
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYR 189
Query: 343 APE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWV 389
           APE  +G     S+  DV+S G +L E   G+     IF G+  +   V
Sbjct: 190 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 233

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRALKGFDVECEMMKS 225
           + F +   IG G +G VYKAR    G  VA+K   L          A++    E  ++K 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKE 58
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           + H N++K++     E    LV E++ H  L+K+M +S   L       I   +   L+ 
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQG 115
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
           L F +S  ++H DLKP N+L++      L+DF +A+      +  T T  + T+ Y APE
Sbjct: 116 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPE 173
Query: 346 YGREGR-VSTNGDVYSFGIMLMETFTGK 372
                +  ST  D++S G +  E  T +
Sbjct: 174 ILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/115 (38%), Positives = 53/115 (46%), Gaps = 8/115 (6%)
Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLIXXXXXXXXXXXXXGAIPASLEKLSYLE 61
           IP EIG +  L  L LG+N + G IPD  GDL              G IP ++  L+ L 
Sbjct: 645 IPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT 704
Query: 62  NLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCKTSN-----HH 111
            ++LS N L G IP  G F  F    F  N  LCG P   +P C  SN     HH
Sbjct: 705 EIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP---LPRCDPSNADGYAHH 756

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 29/229 (12%)
Query: 174 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
            +++  +IG G FG VY+A+L D  E+      LQ  R     + E ++M+ + H N+++
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVR 90
Query: 234 V------ISTCSNEEFKALVLEYMP---HGSLEKYMYSSNYILDIFQRLNIMIDVASALE 284
           +           +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L 
Sbjct: 91  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 149
Query: 285 YLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           Y+H FG    I H D+KP N+LLD D  V  L DF  AK L   + +++    + +  Y 
Sbjct: 150 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYR 202
Query: 343 APE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWV 389
           APE  +G     S+  DV+S G +L E   G+     IF G+  +   V
Sbjct: 203 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 246

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRALKGFDVECEMMKS 225
           + F +   IG G +G VYKAR    G  VA+K   L          A++    E  ++K 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKE 58
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           + H N++K++     E    LV E++ H  L+K+M +S   L       I   +   L+ 
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQG 115
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
           L F +S  ++H DLKP N+L++      L+DF +A+      +  T T  + T+ Y APE
Sbjct: 116 LSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPE 173
Query: 346 YGREGR-VSTNGDVYSFGIMLMETFTGK 372
                +  ST  D++S G +  E  T +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 17/217 (7%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFDVECEMMK 224
           L++    + F  + ++G+G FG V+ A      +  A+K   L+    L   DVEC M++
Sbjct: 11  LQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVE 68
Query: 225 ------SIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMID 278
                 +  H  L  +  T   +E    V+EY+  G L  Y   S +  D+ +      +
Sbjct: 69  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL-MYHIQSCHKFDLSRATFYAAE 127
Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL-LTGEDQSMTQTQTLA 337
           +   L++LH   S  I++ DLK  N+LLD +    ++DF + K  + G+ ++    +   
Sbjct: 128 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT---NEFCG 181
Query: 338 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           T  Y+APE     + + + D +SFG++L E   G+ P
Sbjct: 182 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 101/232 (43%), Gaps = 40/232 (17%)
Query: 175 FSENNLI-----GRGGFGSVYKA-------RLGDGMEVAVKVFNLQCGRA-LKGFDVECE 221
           F   NL+     G G FG V KA       R G    VAVK+       + L+    E  
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAG-YTTVAVKMLKENASPSELRDLLSEFN 78
Query: 222 MMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYI--------------- 266
           ++K + H ++IK+   CS +    L++EY  +GSL  ++  S  +               
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 267 --------LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFS 318
                   L +   ++    ++  ++YL       ++H DL   N+L+ +     +SDF 
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 319 IAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 370
           +++ +  ED  + ++Q    + +MA E   +   +T  DV+SFG++L E  T
Sbjct: 196 LSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 115/285 (40%), Gaps = 40/285 (14%)
Query: 181 IGRGGFGSVYKARLG------DGMEVAVKVFNLQCGRALK-GFDVECEMMKSIRHRNLIK 233
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++    H+N+++
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMY------SSNYILDIFQRLNIMIDVASALEYLH 287
            I        + ++LE M  G L+ ++       S    L +   L++  D+A   +YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 288 FGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
             +    IH D+   N LL       VA + DF +A+ +            +  + +M P
Sbjct: 165 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 221
Query: 345 EYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA 403
           E   EG  ++  D +SFG++L E F+ G  P     N E+              +E V +
Sbjct: 222 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------LEFVTS 267
Query: 404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
                        + C   V+ +  +C    PE R N   I+ ++
Sbjct: 268 GG------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 306

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 101/232 (43%), Gaps = 40/232 (17%)
Query: 175 FSENNLI-----GRGGFGSVYKA-------RLGDGMEVAVKVFNLQCGRA-LKGFDVECE 221
           F   NL+     G G FG V KA       R G    VAVK+       + L+    E  
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAG-YTTVAVKMLKENASPSELRDLLSEFN 78
Query: 222 MMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYI--------------- 266
           ++K + H ++IK+   CS +    L++EY  +GSL  ++  S  +               
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 267 --------LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFS 318
                   L +   ++    ++  ++YL       ++H DL   N+L+ +     +SDF 
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLA---EMSLVHRDLAARNILVAEGRKMKISDFG 195
Query: 319 IAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 370
           +++ +  ED  + ++Q    + +MA E   +   +T  DV+SFG++L E  T
Sbjct: 196 LSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 115/285 (40%), Gaps = 40/285 (14%)
Query: 181 IGRGGFGSVYKARLG------DGMEVAVKVFNLQCGRALK-GFDVECEMMKSIRHRNLIK 233
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++    H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMY------SSNYILDIFQRLNIMIDVASALEYLH 287
            I        + ++LE M  G L+ ++       S    L +   L++  D+A   +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 288 FGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
             +    IH D+   N LL       VA + DF +A+ +            +  + +M P
Sbjct: 159 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 345 EYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA 403
           E   EG  ++  D +SFG++L E F+ G  P     N E+              +E V +
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------LEFVTS 261
Query: 404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
                        + C   V+ +  +C    PE R N   I+ ++
Sbjct: 262 GG------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 12/210 (5%)
Query: 181 IGRGGFGSV----YKARLGDGMEVAVKVFNLQCGRA-LKGFDVECEMMKSIRHRNLIKVI 235
           +G G FGSV    Y+ R    ++VA+KV      +A  +    E ++M  + +  ++++I
Sbjct: 18  LGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
             C  E    LV+E    G L K++      + +     ++  V+  ++YL        +
Sbjct: 77  GVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFV 132
Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT-QTQTLATIGYMAPEYGREGRVST 354
           H DL   NVLL +   A +SDF ++K L  +D   T ++     + + APE     + S+
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 355 NGDVYSFGIMLMETFT-GKKPTNEIFNGEM 383
             DV+S+G+ + E  + G+KP  ++   E+
Sbjct: 193 RSDVWSYGVTMWEALSYGQKPYKKMKGPEV 222

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 15/210 (7%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRA-LKGFDVECEMMKSIRHRN 230
           D F     +G G FG V+       G+E  +K  N    +  ++  + E E++KS+ H N
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNY---ILDIFQRLNIMIDVASALEYLH 287
           +IK+     +     +V+E    G L + + S+      L       +M  + +AL Y H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 288 FGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
              S  ++H DLKP N+L  D   +    + DF +A+L   ++ S   T    T  YMAP
Sbjct: 142 ---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTALYMAP 195
Query: 345 EYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           E  +   V+   D++S G+++    TG  P
Sbjct: 196 EVFKRD-VTFKCDIWSAGVVMYFLLTGCLP 224

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 115/285 (40%), Gaps = 40/285 (14%)
Query: 181 IGRGGFGSVYKARLG------DGMEVAVKVFNLQCGRALK-GFDVECEMMKSIRHRNLIK 233
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++    H+N+++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMY------SSNYILDIFQRLNIMIDVASALEYLH 287
            I        + ++LE M  G L+ ++       S    L +   L++  D+A   +YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 288 FGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
             +    IH D+   N LL       VA + DF +A+ +            +  + +M P
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 345 EYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA 403
           E   EG  ++  D +SFG++L E F+ G  P     N E+              +E V +
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------LEFVTS 260
Query: 404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
                        + C   V+ +  +C    PE R N   I+ ++
Sbjct: 261 GG------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 95/209 (45%), Gaps = 12/209 (5%)
Query: 172 TDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRH 228
           TD +     IG+G F  V +  +L  G E A K+ N +    R  +  + E  + + ++H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
            N++++  + S E F  LV + +  G L + + +  Y    +   +    +   LE +  
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILEAVLH 118
Query: 289 GYSAPIIHCDLKPSNVLLDDN---MVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
            +   ++H DLKP N+LL          L+DF +A  + G+ Q+        T GY++PE
Sbjct: 119 CHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPE 176
Query: 346 YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
             R+       D+++ G++L     G  P
Sbjct: 177 VLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRALKGFDVECEMMKS 225
           + F +   IG G +G VYKAR    G  VA+K   L          A++    E  ++K 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKE 58
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           + H N++K++     E    LV E++ H  L+K+M +S   L       I   +   L+ 
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQG 115
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
           L F +S  ++H DLKP N+L++      L+DF +A+      +  T T  + T+ Y APE
Sbjct: 116 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPE 173
Query: 346 YGREGR-VSTNGDVYSFGIMLMETFTGK 372
                +  ST  D++S G +  E  T +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRALKGFDVECEMMKS 225
           + F +   IG G +G VYKAR    G  VA+K   L          A++    E  ++K 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKE 57
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           + H N++K++     E    LV E++ H  L+K+M +S   L       I   +   L+ 
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQG 114
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
           L F +S  ++H DLKP N+L++      L+DF +A+      +  T T  + T+ Y APE
Sbjct: 115 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPE 172
Query: 346 YGREGR-VSTNGDVYSFGIMLMETFTGK 372
                +  ST  D++S G +  E  T +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 29/229 (12%)
Query: 174 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
            +++  +IG G FG VY+A+L D  E+      LQ  R     + E ++M+ + H N+++
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVR 82
Query: 234 V------ISTCSNEEFKALVLEYMP---HGSLEKYMYSSNYILDIFQRLNIMIDVASALE 284
           +           +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L 
Sbjct: 83  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 141
Query: 285 YLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           Y+H FG    I H D+KP N+LLD D  V  L DF  AK L   + +++    + +  Y 
Sbjct: 142 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYR 194
Query: 343 APE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWV 389
           APE  +G     S+  DV+S G +L E   G+     IF G+  +   V
Sbjct: 195 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 238

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRALKGFDVECEMMKS 225
           + F +   IG G +G VYKAR    G  VA+K   L          A++    E  ++K 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKE 57
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           + H N++K++     E    LV E++ H  L+K+M +S   L       I   +   L+ 
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQG 114
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
           L F +S  ++H DLKP N+L++      L+DF +A+      +  T T  + T+ Y APE
Sbjct: 115 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPE 172
Query: 346 YGREGR-VSTNGDVYSFGIMLMETFTGK 372
                +  ST  D++S G +  E  T +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 29/229 (12%)
Query: 174 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
            +++  +IG G FG VY+A+L D  E+      LQ  R     + E ++M+ + H N+++
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVR 111
Query: 234 V------ISTCSNEEFKALVLEYMP---HGSLEKYMYSSNYILDIFQRLNIMIDVASALE 284
           +           +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L 
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 170
Query: 285 YLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           Y+H FG    I H D+KP N+LLD D  V  L DF  AK L   + +++    + +  Y 
Sbjct: 171 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYR 223
Query: 343 APE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWV 389
           APE  +G     S+  DV+S G +L E   G+     IF G+  +   V
Sbjct: 224 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 267

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 29/229 (12%)
Query: 174 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
            +++  +IG G FG VY+A+L D  E+      LQ  R     + E ++M+ + H N+++
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVR 105
Query: 234 V------ISTCSNEEFKALVLEYMP---HGSLEKYMYSSNYILDIFQRLNIMIDVASALE 284
           +           +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L 
Sbjct: 106 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 164
Query: 285 YLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           Y+H FG    I H D+KP N+LLD D  V  L DF  AK L   + +++    + +  Y 
Sbjct: 165 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYR 217
Query: 343 APE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWV 389
           APE  +G     S+  DV+S G +L E   G+     IF G+  +   V
Sbjct: 218 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 261

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 110/228 (48%), Gaps = 29/228 (12%)
Query: 175 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKV 234
           +++  +IG G FG VY+A+L D  E+      LQ  R     + E ++M+ + H N++++
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRL 116
Query: 235 ------ISTCSNEEFKALVLEYMP---HGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
                      +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L Y
Sbjct: 117 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 175
Query: 286 LH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           +H FG    I H D+KP N+LLD D  V  L DF  AK L   + +++    + +  Y A
Sbjct: 176 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 228
Query: 344 PE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWV 389
           PE  +G     S+  DV+S G +L E   G+     IF G+  +   V
Sbjct: 229 PELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 271

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVIST 237
           IG+G F  V  AR +  G EVAVK+ +       +L+    E  +MK + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
              E+   LV+EY   G +  Y+ +   + +   R      + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVS-TNG 356
           DLK  N+LLD +M   ++DF  +   T  ++            Y APE  +  +      
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKL---DAFCGAPPYAAPELFQGKKYDGPEV 194
Query: 357 DVYSFGIMLMETFTGKKPTNEIFNGE 382
           DV+S G++L    +G  P    F+G+
Sbjct: 195 DVWSLGVILYTLVSGSLP----FDGQ 216

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 99/224 (44%), Gaps = 22/224 (9%)
Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFD---VECEMMKSIRHRNLIKVIS 236
           +G G FG V+  R   +G   A+KV   +    LK  +    E  M+  + H  +I++  
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
           T  + +   ++++Y+  G L   +  S    +   +     +V  ALEYLH   S  II+
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYLH---SKDIIY 129
Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 356
            DLKP N+LLD N    ++DF  AK +      +       T  Y+APE       + + 
Sbjct: 130 RDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLC-----GTPDYIAPEVVSTKPYNKSI 184
Query: 357 DVYSFGIMLMETFTGKKP---------TNEIFNGEMTLKHWVND 391
           D +SFGI++ E   G  P           +I N E+    + N+
Sbjct: 185 DWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNE 228

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRALKGFDVECEMMKS 225
           + F +   IG G +G VYKAR    G  VA+K   L          A++    E  ++K 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKE 62
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           + H N++K++     E    LV E++ H  L+K+M +S   L       I   +   L+ 
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQG 119
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
           L F +S  ++H DLKP N+L++      L+DF +A+      +  T T  + T+ Y APE
Sbjct: 120 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPE 177
Query: 346 YGREGR-VSTNGDVYSFGIMLMETFTGK 372
                +  ST  D++S G +  E  T +
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRALKGFDVECEMMKS 225
           + F +   IG G +G VYKAR    G  VA+K   L          A++    E  ++K 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKE 58
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           + H N++K++     E    LV E++ H  L+K+M +S   L       I   +   L+ 
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQG 115
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
           L F +S  ++H DLKP N+L++      L+DF +A+      +  T T  + T+ Y APE
Sbjct: 116 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPE 173
Query: 346 YGREGR-VSTNGDVYSFGIMLMETFTGK 372
                +  ST  D++S G +  E  T +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 110/228 (48%), Gaps = 29/228 (12%)
Query: 175 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKV 234
           +++  +IG G FG VY+A+L D  E+      LQ  R     + E ++M+ + H N++++
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRL 114
Query: 235 ------ISTCSNEEFKALVLEYMP---HGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
                      +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L Y
Sbjct: 115 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 173
Query: 286 LH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           +H FG    I H D+KP N+LLD D  V  L DF  AK L   + +++    + +  Y A
Sbjct: 174 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 226
Query: 344 PE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWV 389
           PE  +G     S+  DV+S G +L E   G+     IF G+  +   V
Sbjct: 227 PELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 269

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/108 (38%), Positives = 51/108 (47%), Gaps = 3/108 (2%)
Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLIXXXXXXXXXXXXXGAIPASLEKLSYLE 61
           IP EIG +  L  L LG+N + G IPD  GDL              G IP ++  L+ L 
Sbjct: 648 IPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT 707
Query: 62  NLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCKTSN 109
            ++LS N L G IP  G F  F    F  N  LCG P   +P C  SN
Sbjct: 708 EIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP---LPRCDPSN 752

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRALKGFDVECEMMKS 225
           + F +   IG G +G VYKAR    G  VA+K   L          A++    E  ++K 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKE 65
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           + H N++K++     E    LV E++ H  L+K+M +S   L       I   +   L+ 
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQG 122
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
           L F +S  ++H DLKP N+L++      L+DF +A+      +  T T  + T+ Y APE
Sbjct: 123 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPE 180
Query: 346 YGREGR-VSTNGDVYSFGIMLMETFTGK 372
                +  ST  D++S G +  E  T +
Sbjct: 181 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRALKGFDVECEMM 223
           + + F +   IG G +G VYKAR    G  VA+K   L          A++    E  ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLL 57
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
           K + H N++K++     E    LV E++ H  L+K+M +S   L       I   +   L
Sbjct: 58  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLL 114
Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           + L F +S  ++H DLKP N+L++      L+DF +A+      +  T T  + T+ Y A
Sbjct: 115 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRA 172
Query: 344 PEYGREGR-VSTNGDVYSFGIMLMETFTGK 372
           PE     +  ST  D++S G +  E  T +
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 101/232 (43%), Gaps = 40/232 (17%)
Query: 175 FSENNLI-----GRGGFGSVYKA-------RLGDGMEVAVKVFNLQCGRA-LKGFDVECE 221
           F   NL+     G G FG V KA       R G    VAVK+       + L+    E  
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAG-YTTVAVKMLKENASPSELRDLLSEFN 78
Query: 222 MMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYI--------------- 266
           ++K + H ++IK+   CS +    L++EY  +GSL  ++  S  +               
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 267 --------LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFS 318
                   L +   ++    ++  ++YL       ++H DL   N+L+ +     +SDF 
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 319 IAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 370
           +++ +  ED  + ++Q    + +MA E   +   +T  DV+SFG++L E  T
Sbjct: 196 LSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 115/285 (40%), Gaps = 40/285 (14%)
Query: 181 IGRGGFGSVYKARLG------DGMEVAVKVFNLQCGRALK-GFDVECEMMKSIRHRNLIK 233
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++    H+N+++
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMY------SSNYILDIFQRLNIMIDVASALEYLH 287
            I        + ++LE M  G L+ ++       S    L +   L++  D+A   +YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 288 FGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
             +    IH D+   N LL       VA + DF +A+ +            +  + +M P
Sbjct: 175 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 231
Query: 345 EYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA 403
           E   EG  ++  D +SFG++L E F+ G  P     N E+              +E V +
Sbjct: 232 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------LEFVTS 277
Query: 404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
                        + C   V+ +  +C    PE R N   I+ ++
Sbjct: 278 GG------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 316

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 115/285 (40%), Gaps = 40/285 (14%)
Query: 181 IGRGGFGSVYKARLG------DGMEVAVKVFNLQCGRALK-GFDVECEMMKSIRHRNLIK 233
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++    H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMY------SSNYILDIFQRLNIMIDVASALEYLH 287
            I        + ++LE M  G L+ ++       S    L +   L++  D+A   +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 288 FGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
             +    IH D+   N LL       VA + DF +A+ +            +  + +M P
Sbjct: 159 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPP 215
Query: 345 EYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA 403
           E   EG  ++  D +SFG++L E F+ G  P     N E+              +E V +
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------LEFVTS 261
Query: 404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
                        + C   V+ +  +C    PE R N   I+ ++
Sbjct: 262 GG------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 110/228 (48%), Gaps = 29/228 (12%)
Query: 175 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKV 234
           +++  +IG G FG VY+A+L D  E+      LQ  R     + E ++M+ + H N++++
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRL 157
Query: 235 ------ISTCSNEEFKALVLEYMP---HGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
                      +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L Y
Sbjct: 158 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 216
Query: 286 LH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           +H FG    I H D+KP N+LLD D  V  L DF  AK L   + +++    + +  Y A
Sbjct: 217 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 269
Query: 344 PE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWV 389
           PE  +G     S+  DV+S G +L E   G+     IF G+  +   V
Sbjct: 270 PELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 312

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKGFDVECEMMKSIRH 228
           + F     +G+G FG+VY AR      + A+KV F  Q  +A        E E+   +RH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
            N++++     +     L+LEY P G++ + +   +   D  +    + ++A+AL Y H 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR-FDEQRTATYITELANALSYCH- 129
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +IH D+KP N+LL  N    ++DF      +    S  +     T+ Y+ PE   
Sbjct: 130 --SKRVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRDTLCGTLDYLPPEMI- 182
Query: 349 EGRVSTNG-DVYSFGIMLMETFTGKKP 374
           EGR+     D++S G++  E   G  P
Sbjct: 183 EGRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 115/285 (40%), Gaps = 40/285 (14%)
Query: 181 IGRGGFGSVYKARLG------DGMEVAVKVFNLQCGRALK-GFDVECEMMKSIRHRNLIK 233
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++    H+N+++
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMY------SSNYILDIFQRLNIMIDVASALEYLH 287
            I        + ++LE M  G L+ ++       S    L +   L++  D+A   +YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 288 FGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
             +    IH D+   N LL       VA + DF +A+ +            +  + +M P
Sbjct: 185 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 241
Query: 345 EYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA 403
           E   EG  ++  D +SFG++L E F+ G  P     N E+              +E V +
Sbjct: 242 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------LEFVTS 287
Query: 404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
                        + C   V+ +  +C    PE R N   I+ ++
Sbjct: 288 G------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 326

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 115/285 (40%), Gaps = 40/285 (14%)
Query: 181 IGRGGFGSVYKARLG------DGMEVAVKVFNLQCGRALK-GFDVECEMMKSIRHRNLIK 233
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++    H+N+++
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMY------SSNYILDIFQRLNIMIDVASALEYLH 287
            I        + ++LE M  G L+ ++       S    L +   L++  D+A   +YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 288 FGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
             +    IH D+   N LL       VA + DF +A+ +            +  + +M P
Sbjct: 176 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 232
Query: 345 EYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA 403
           E   EG  ++  D +SFG++L E F+ G  P     N E+              +E V +
Sbjct: 233 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------LEFVTS 278
Query: 404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
                        + C   V+ +  +C    PE R N   I+ ++
Sbjct: 279 GG------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 317

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 11/205 (5%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDV----ECEMMKSIRH 228
           + F +   IG G +G VYKAR     EV V +  ++     +G       E  ++K + H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALXKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
            N++K++     E    LV E++ H  L+K+M +S   L       I   +   L+ L F
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAF 118
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
            +S  ++H DLKP N+L++      L+DF +A+      +  T T  + T+ Y APE   
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILL 176
Query: 349 EGR-VSTNGDVYSFGIMLMETFTGK 372
             +  ST  D++S G +  E  T +
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 11/205 (5%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDV----ECEMMKSIRH 228
           + F +   IG G +G VYKAR     EV V +  ++     +G       E  ++K + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALXKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
            N++K++     E    LV E++ H  L+K+M +S   L       I   +   L+ L F
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAF 117
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
            +S  ++H DLKP N+L++      L+DF +A+      +  T T  + T+ Y APE   
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILL 175
Query: 349 EGR-VSTNGDVYSFGIMLMETFTGK 372
             +  ST  D++S G +  E  T +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 18/212 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFD---VECEMMKSIRH 228
           D F +  ++GRGGFG V+  ++   G   A K  N +  +  KG+    VE +++  +  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMI---DVASALEY 285
           R ++ +      +    LV+  M  G +  ++Y+ +     FQ    +     + S LE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAP 344
           LH      II+ DLKP NVLLDD+    +SD  +A  L       T+T+  A T G+MAP
Sbjct: 305 LH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA---GQTKTKGYAGTPGFMAP 358
Query: 345 E--YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           E   G E   S   D ++ G+ L E    + P
Sbjct: 359 ELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 115/285 (40%), Gaps = 40/285 (14%)
Query: 181 IGRGGFGSVYKARLG------DGMEVAVKVFNLQCGRALK-GFDVECEMMKSIRHRNLIK 233
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++    H+N+++
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMY------SSNYILDIFQRLNIMIDVASALEYLH 287
            I        + ++LE M  G L+ ++       S    L +   L++  D+A   +YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 288 FGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
             +    IH D+   N LL       VA + DF +A+ +            +  + +M P
Sbjct: 199 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 345 EYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA 403
           E   EG  ++  D +SFG++L E F+ G  P     N E+              +E V +
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------LEFVTS 301
Query: 404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
                        + C   V+ +  +C    PE R N   I+ ++
Sbjct: 302 GG------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 340

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 116/278 (41%), Gaps = 33/278 (11%)
Query: 181 IGRGGFGSV----YKARLGDGMEVAVKVF-NLQCGRALKGFDVECEMMKSIRHRNLIKVI 235
           IG G FG V    Y +     M VA+K   N       + F  E   M+   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
              + E    +++E    G L  ++    + LD+   +     +++AL YL    S   +
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ-TQTLATIGYMAPEYGREGRVST 354
           H D+   NVL+  N    L DF +++ +  ED +  + ++    I +MAPE     R ++
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTXXKASKGKLPIKWMAPESINFRRFTS 191
Query: 355 NGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF 413
             DV+ FG+ + E    G KP   + N ++  +    + LP+                  
Sbjct: 192 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------- 235
Query: 414 VAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
                C   +++L  +C    P +R    E+ A+L  I
Sbjct: 236 ----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/305 (21%), Positives = 131/305 (42%), Gaps = 38/305 (12%)
Query: 171 ATDGFSENNLIGRGGFGSVY----KARLGDGME--VAVKVFNLQCG-RALKGFDVECEMM 223
           A +  + +  +G+G FG VY    K  + D  E  VA+K  N     R    F  E  +M
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYS------SNYIL---DIFQRLN 274
           K     ++++++   S  +   +++E M  G L+ Y+ S      +N +L    + + + 
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 275 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ 334
           +  ++A  + YL+   +   +H DL   N  + ++    + DF + + +   D      +
Sbjct: 130 MAGEIADGMAYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGK 186
Query: 335 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLP 394
            L  + +M+PE  ++G  +T  DV+SFG++L E  T  +   +  + E  L+        
Sbjct: 187 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 239
Query: 395 ISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS 454
                V+   LL + D        C   +  L   C   +P+ R +  EI++ + +  + 
Sbjct: 240 -----VMEGGLLDKPD-------NCPDMLLELMRMCWQYNPKMRPSFLEIISSIKEEMEP 287
Query: 455 LLRNV 459
             R V
Sbjct: 288 GFREV 292

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 37/220 (16%)
Query: 175 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKV 234
           F++ + IG+G FG VYK       EV           A+K  D+E    +    +  I V
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVV----------AIKIIDLEEAEDEIEDIQQEITV 70
Query: 235 ISTCSNEEFKA------------LVLEYMPHGS----LEKYMYSSNYILDIFQRLNIMID 278
           +S C +                 +++EY+  GS    L+       YI  I +      +
Sbjct: 71  LSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR------E 124
Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT 338
           +   L+YLH   S   IH D+K +NVLL +     L+DF +A  LT  D  + +   + T
Sbjct: 125 ILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNXFVGT 179
Query: 339 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEI 378
             +MAPE  ++       D++S GI  +E   G+ P +++
Sbjct: 180 PFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 219

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 18/212 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFD---VECEMMKSIRH 228
           D F +  ++GRGGFG V+  ++   G   A K  N +  +  KG+    VE +++  +  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMI---DVASALEY 285
           R ++ +      +    LV+  M  G +  ++Y+ +     FQ    +     + S LE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAP 344
           LH      II+ DLKP NVLLDD+    +SD  +A  L       T+T+  A T G+MAP
Sbjct: 305 LH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA---GQTKTKGYAGTPGFMAP 358
Query: 345 E--YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           E   G E   S   D ++ G+ L E    + P
Sbjct: 359 ELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 115/285 (40%), Gaps = 40/285 (14%)
Query: 181 IGRGGFGSVYKARLG------DGMEVAVKVFNLQCGRALK-GFDVECEMMKSIRHRNLIK 233
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++    H+N+++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMY------SSNYILDIFQRLNIMIDVASALEYLH 287
            I        + +++E M  G L+ ++       S    L +   L++  D+A   +YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 288 FGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
             +    IH D+   N LL       VA + DF +A+ +            +  + +M P
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 345 EYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA 403
           E   EG  ++  D +SFG++L E F+ G  P     N E+              +E V +
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------LEFVTS 260
Query: 404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
                        + C   V+ +  +C    PE R N   I+ ++
Sbjct: 261 GG------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 28/216 (12%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNL 231
           + FS + +IGRGGFG VY  R  D G   A+K  + +  +  +G  +      ++  R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL------ALNERIM 242
Query: 232 IKVIST-------CSNEEFK-----ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV 279
           + ++ST       C +  F      + +L+ M  G L  ++       +   R     ++
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEI 301
Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
              LE++H  +   +++ DLKP+N+LLD++    +SD  +A   + +        ++ T 
Sbjct: 302 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTH 354
Query: 340 GYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKP 374
           GYMAPE  ++G    ++ D +S G ML +   G  P
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 28/216 (12%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNL 231
           + FS + +IGRGGFG VY  R  D G   A+K  + +  +  +G  +      ++  R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL------ALNERIM 242
Query: 232 IKVIST-------CSNEEFK-----ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV 279
           + ++ST       C +  F      + +L+ M  G L  ++       +   R     ++
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEI 301
Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
              LE++H  +   +++ DLKP+N+LLD++    +SD  +A   + +        ++ T 
Sbjct: 302 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTH 354
Query: 340 GYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKP 374
           GYMAPE  ++G    ++ D +S G ML +   G  P
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 18/212 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFD---VECEMMKSIRH 228
           D F +  ++GRGGFG V+  ++   G   A K  N +  +  KG+    VE +++  +  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMI---DVASALEY 285
           R ++ +      +    LV+  M  G +  ++Y+ +     FQ    +     + S LE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAP 344
           LH      II+ DLKP NVLLDD+    +SD  +A  L       T+T+  A T G+MAP
Sbjct: 305 LH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA---GQTKTKGYAGTPGFMAP 358
Query: 345 E--YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           E   G E   S   D ++ G+ L E    + P
Sbjct: 359 ELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 18/212 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFD---VECEMMKSIRH 228
           D F +  ++GRGGFG V+  ++   G   A K  N +  +  KG+    VE +++  +  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMI---DVASALEY 285
           R ++ +      +    LV+  M  G +  ++Y+ +     FQ    +     + S LE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAP 344
           LH      II+ DLKP NVLLDD+    +SD  +A  L       T+T+  A T G+MAP
Sbjct: 305 LH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA---GQTKTKGYAGTPGFMAP 358
Query: 345 E--YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           E   G E   S   D ++ G+ L E    + P
Sbjct: 359 ELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 24/215 (11%)
Query: 171 ATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKGFDV-ECEMMKSIRH 228
           ++  F +   +G G + +VYK      G+ VA+K   L          + E  +MK ++H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNY----------ILDIFQRLNIMID 278
            N++++      E    LV E+M    L+KYM S             ++  FQ       
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQ------- 114
Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT 338
               L+ L F +   I+H DLKP N+L++      L DF +A+       +   +  + T
Sbjct: 115 -WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEVVT 171
Query: 339 IGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGK 372
           + Y AP+     R  ST+ D++S G +L E  TGK
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 111/229 (48%), Gaps = 29/229 (12%)
Query: 174 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
            +++  +IG G FG VY+A+L D  E+      LQ  R     + E ++M+ + H N+++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVR 77
Query: 234 V--ISTCSNEE----FKALVLEYMP---HGSLEKYMYSSNYILDIFQRLNIMIDVASALE 284
           +      S E+    +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  +L 
Sbjct: 78  LRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 136
Query: 285 YLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           Y+H FG    I H D+KP N+LLD D  V  L DF  AK L   + +++    + +  Y 
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYR 189
Query: 343 APE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWV 389
           APE  +G     S+  DV+S G +L E   G+     IF G+  +   V
Sbjct: 190 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 233

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 98/219 (44%), Gaps = 13/219 (5%)
Query: 163 FSHLELC-RATDGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQ--CGRALKGFDV 218
           F  +  C R TD +     +G+G F  V +  +     E A K+ N +    R  +  + 
Sbjct: 20  FQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLER 79
Query: 219 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMID 278
           E  + + ++H N++++  + S E F  LV + +  G L + + +  Y    +   +    
Sbjct: 80  EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHC 135
Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLLDDN---MVAHLSDFSIAKLLTGEDQSMTQTQT 335
           +   LE ++  +   I+H DLKP N+LL          L+DF +A  + GE Q+      
Sbjct: 136 IHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFA- 194
Query: 336 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
             T GY++PE  R+       D+++ G++L     G  P
Sbjct: 195 -GTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 115/285 (40%), Gaps = 40/285 (14%)
Query: 181 IGRGGFGSVYKARLG------DGMEVAVKVFNLQCGRALK-GFDVECEMMKSIRHRNLIK 233
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++    H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMY------SSNYILDIFQRLNIMIDVASALEYLH 287
            I        + +++E M  G L+ ++       S    L +   L++  D+A   +YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 288 FGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
             +    IH D+   N LL       VA + DF +A+ +            +  + +M P
Sbjct: 173 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 345 EYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA 403
           E   EG  ++  D +SFG++L E F+ G  P     N E+              +E V +
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------LEFVTS 275
Query: 404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
                        + C   V+ +  +C    PE R N   I+ ++
Sbjct: 276 GG------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 116/278 (41%), Gaps = 33/278 (11%)
Query: 181 IGRGGFGSV----YKARLGDGMEVAVKVF-NLQCGRALKGFDVECEMMKSIRHRNLIKVI 235
           IG G FG V    Y +     + VA+K   N       + F  E   M+   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
              + E    +++E    G L  ++    Y LD+   +     +++AL YL    S   +
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ-TQTLATIGYMAPEYGREGRVST 354
           H D+   NVL+  N    L DF +++ +  ED +  + ++    I +MAPE     R ++
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 191
Query: 355 NGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF 413
             DV+ FG+ + E    G KP   + N ++  +    + LP+                  
Sbjct: 192 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------- 235
Query: 414 VAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
                C   +++L  +C    P +R    E+ A+L  I
Sbjct: 236 ----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 101/230 (43%), Gaps = 22/230 (9%)
Query: 150 NDANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKARLGDG-MEVAVKV-FNL 207
           N +  P I T R F+        D F     +G+G FG+VY AR       VA+KV F  
Sbjct: 8   NSSGTPDILT-RHFT-------IDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKS 59
Query: 208 QCGR--ALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNY 265
           Q  +         E E+   + H N++++ +   +     L+LEY P G L K +  S  
Sbjct: 60  QIEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSC- 118
Query: 266 ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG 325
             D  +   IM ++A AL Y H      +IH D+KP N+LL       ++DF      + 
Sbjct: 119 TFDEQRTATIMEELADALMYCH---GKKVIHRDIKPENLLLGLKGELKIADFG----WSV 171
Query: 326 EDQSMTQTQTLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTGKKP 374
              S+ +     T+ Y+ PE   EGR+     D++  G++  E   G  P
Sbjct: 172 HAPSLRRKTMCGTLDYLPPEMI-EGRMHNEKVDLWCIGVLCYELLVGNPP 220

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 28/214 (13%)
Query: 175 FSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
           FS + +IGRGGFG VY  R  D G   A+K  + +  +  +G  +      ++  R ++ 
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL------ALNERIMLS 243
Query: 234 VIST-------CSNEEFK-----ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVAS 281
           ++ST       C +  F      + +L+ M  G L  ++       +   R     ++  
Sbjct: 244 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIIL 302
Query: 282 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGY 341
            LE++H  +   +++ DLKP+N+LLD++    +SD  +A   + +        ++ T GY
Sbjct: 303 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGY 355
Query: 342 MAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKP 374
           MAPE  ++G    ++ D +S G ML +   G  P
Sbjct: 356 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 116/278 (41%), Gaps = 33/278 (11%)
Query: 181 IGRGGFGSV----YKARLGDGMEVAVKVF-NLQCGRALKGFDVECEMMKSIRHRNLIKVI 235
           IG G FG V    Y +     + VA+K   N       + F  E   M+   H +++K+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
              + E    +++E    G L  ++    Y LD+   +     +++AL YL    S   +
Sbjct: 83  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 138
Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ-TQTLATIGYMAPEYGREGRVST 354
           H D+   NVL+  N    L DF +++ +  ED +  + ++    I +MAPE     R ++
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 196
Query: 355 NGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF 413
             DV+ FG+ + E    G KP   + N ++  +    + LP+                  
Sbjct: 197 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------- 240
Query: 414 VAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
                C   +++L  +C    P +R    E+ A+L  I
Sbjct: 241 ----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 116/278 (41%), Gaps = 33/278 (11%)
Query: 181 IGRGGFGSV----YKARLGDGMEVAVKVF-NLQCGRALKGFDVECEMMKSIRHRNLIKVI 235
           IG G FG V    Y +     + VA+K   N       + F  E   M+   H +++K+I
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
              + E    +++E    G L  ++    Y LD+   +     +++AL YL    S   +
Sbjct: 106 GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 161
Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ-TQTLATIGYMAPEYGREGRVST 354
           H D+   NVL+  N    L DF +++ +  ED +  + ++    I +MAPE     R ++
Sbjct: 162 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 219
Query: 355 NGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF 413
             DV+ FG+ + E    G KP   + N ++  +    + LP+                  
Sbjct: 220 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------- 263
Query: 414 VAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
                C   +++L  +C    P +R    E+ A+L  I
Sbjct: 264 ----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 297

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 28/214 (13%)
Query: 175 FSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
           FS + +IGRGGFG VY  R  D G   A+K  + +  +  +G  +      ++  R ++ 
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL------ALNERIMLS 244
Query: 234 VIST-------CSNEEFK-----ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVAS 281
           ++ST       C +  F      + +L+ M  G L  ++       +   R     ++  
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIIL 303
Query: 282 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGY 341
            LE++H  +   +++ DLKP+N+LLD++    +SD  +A   + +        ++ T GY
Sbjct: 304 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGY 356
Query: 342 MAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKP 374
           MAPE  ++G    ++ D +S G ML +   G  P
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 116/278 (41%), Gaps = 33/278 (11%)
Query: 181 IGRGGFGSV----YKARLGDGMEVAVKVF-NLQCGRALKGFDVECEMMKSIRHRNLIKVI 235
           IG G FG V    Y +     + VA+K   N       + F  E   M+   H +++K+I
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
              + E    +++E    G L  ++    Y LD+   +     +++AL YL    S   +
Sbjct: 75  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 130
Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ-TQTLATIGYMAPEYGREGRVST 354
           H D+   NVL+  N    L DF +++ +  ED +  + ++    I +MAPE     R ++
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 355 NGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF 413
             DV+ FG+ + E    G KP   + N ++  +    + LP+                  
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------- 232
Query: 414 VAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
                C   +++L  +C    P +R    E+ A+L  I
Sbjct: 233 ----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 116/278 (41%), Gaps = 33/278 (11%)
Query: 181 IGRGGFGSV----YKARLGDGMEVAVKVF-NLQCGRALKGFDVECEMMKSIRHRNLIKVI 235
           IG G FG V    Y +     + VA+K   N       + F  E   M+   H +++K+I
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
              + E    +++E    G L  ++    Y LD+   +     +++AL YL    S   +
Sbjct: 81  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 136
Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ-TQTLATIGYMAPEYGREGRVST 354
           H D+   NVL+  N    L DF +++ +  ED +  + ++    I +MAPE     R ++
Sbjct: 137 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 194
Query: 355 NGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF 413
             DV+ FG+ + E    G KP   + N ++  +    + LP+                  
Sbjct: 195 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------- 238
Query: 414 VAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
                C   +++L  +C    P +R    E+ A+L  I
Sbjct: 239 ----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 272

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 116/278 (41%), Gaps = 33/278 (11%)
Query: 181 IGRGGFGSV----YKARLGDGMEVAVKVF-NLQCGRALKGFDVECEMMKSIRHRNLIKVI 235
           IG G FG V    Y +     + VA+K   N       + F  E   M+   H +++K+I
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
              + E    +++E    G L  ++    Y LD+   +     +++AL YL    S   +
Sbjct: 80  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 135
Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ-TQTLATIGYMAPEYGREGRVST 354
           H D+   NVL+  N    L DF +++ +  ED +  + ++    I +MAPE     R ++
Sbjct: 136 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 193
Query: 355 NGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF 413
             DV+ FG+ + E    G KP   + N ++  +    + LP+                  
Sbjct: 194 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------- 237
Query: 414 VAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
                C   +++L  +C    P +R    E+ A+L  I
Sbjct: 238 ----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 271

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 182 GRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST---C 238
            RG FG V+KA+L +   VAVK+F LQ  ++ +  + E      ++H NL++ I+     
Sbjct: 24  ARGRFGCVWKAQLMNDF-VAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKRG 81
Query: 239 SNEEFK-ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF--------G 289
           SN E +  L+  +   GSL  Y+  +  I+   +  ++   ++  L YLH         G
Sbjct: 82  SNLEVELWLITAFHDKGSLTDYLKGN--IITWNELCHVAETMSRGLSYLHEDVPWCRGEG 139
Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA-KLLTGEDQSMTQTQTLATIGYMAPEYGR 348
           +   I H D K  NVLL  ++ A L+DF +A +   G+    T  Q + T  YMAPE   
Sbjct: 140 HKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQ-VGTRRYMAPEV-L 197
Query: 349 EGRVSTNG------DVYSFGIMLMETFTGKKPTN 376
           EG ++         D+Y+ G++L E  +  K  +
Sbjct: 198 EGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 102/217 (47%), Gaps = 17/217 (7%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFDVECEMMK 224
           L++    + F  + ++G+G FG V+ A      +  A+K   L+    L   DVEC M++
Sbjct: 10  LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVE 67
Query: 225 ------SIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMID 278
                 +  H  L  +  T   +E    V+EY+  G L  Y   S +  D+ +      +
Sbjct: 68  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL-MYHIQSCHKFDLSRATFYAAE 126
Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL-LTGEDQSMTQTQTLA 337
           +   L++LH   S  I++ DLK  N+LLD +    ++DF + K  + G+ ++        
Sbjct: 127 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT---NXFCG 180
Query: 338 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           T  Y+APE     + + + D +SFG++L E   G+ P
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 96/209 (45%), Gaps = 12/209 (5%)
Query: 172 TDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRH 228
           TD +     +G+G F  V +  ++  G E A K+ N +    R  +  + E  + + ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
            N++++  + S E F  LV + +  G L + + +  Y    +   +    +   LE ++ 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILESVNH 118
Query: 289 GYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
            +   I+H DLKP N+LL          L+DF +A  + G+ Q+        T GY++PE
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPE 176
Query: 346 YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
             R+       D+++ G++L     G  P
Sbjct: 177 VLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 116/278 (41%), Gaps = 33/278 (11%)
Query: 181 IGRGGFGSV----YKARLGDGMEVAVKVF-NLQCGRALKGFDVECEMMKSIRHRNLIKVI 235
           IG G FG V    Y +     M VA+K   N       + F  E   M+   H +++K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
              + E    +++E    G L  ++    + LD+   +     +++AL YL    S   +
Sbjct: 458 GVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ-TQTLATIGYMAPEYGREGRVST 354
           H D+   NVL+  N    L DF +++ +  ED +  + ++    I +MAPE     R ++
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 355 NGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF 413
             DV+ FG+ + E    G KP   + N ++  +    + LP+                  
Sbjct: 572 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------- 615
Query: 414 VAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
                C   +++L  +C    P +R    E+ A+L  I
Sbjct: 616 ----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 103/235 (43%), Gaps = 24/235 (10%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMK------S 225
           D F    ++G+G FG V  AR+ + G   AVKV  L+    L+  DVEC M +      +
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLA 80
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
             H  L ++       +    V+E++  G L  ++  S    +   R     ++ SAL +
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISALMF 139
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
           LH      II+ DLK  NVLLD      L+DF + K   G    +T      T  Y+APE
Sbjct: 140 LH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPE 194
Query: 346 YGREGRVSTNGDVYSFGIMLMETFTGKKP---TNE------IFNGEMTLKHWVND 391
             +E       D ++ G++L E   G  P    NE      I N E+    W+++
Sbjct: 195 ILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHE 249

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 24/204 (11%)
Query: 182 GRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST---- 237
            RG FG V+KA+L +   VAVK+F +Q  ++ +  + E   +  ++H N+++ I      
Sbjct: 33  ARGRFGCVWKAQLLNEY-VAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAEKRG 90
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF-------GY 290
            S +    L+  +   GSL  ++ ++  ++   +  +I   +A  L YLH        G+
Sbjct: 91  TSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGH 148
Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIA-KLLTGEDQSMTQTQTLATIGYMAPEYGRE 349
              I H D+K  NVLL +N+ A ++DF +A K   G+    T  Q + T  YMAPE   E
Sbjct: 149 KPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ-VGTRRYMAPEV-LE 206
Query: 350 GRVSTNG------DVYSFGIMLME 367
           G ++         D+Y+ G++L E
Sbjct: 207 GAINFQRDAFLRIDMYAMGLVLWE 230

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 17/208 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRALKGFDVECEMMKS 225
           + F +   IG G +G VYKAR    G  VA+K   L          A++    E  ++K 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKE 57
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           + H N++K++     E    LV E++ H  L+K+M +S   L       I   +   L+ 
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQG 114
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
           L F +S  ++H DLKP N+L++      L+DF +A+      +  T    + T+ Y APE
Sbjct: 115 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPE 172
Query: 346 YGREGR-VSTNGDVYSFGIMLMETFTGK 372
                +  ST  D++S G +  E  T +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 17/210 (8%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRALKGFDVECEMM 223
           + + F +   IG G +G VYKAR    G  VA+K   L          A++    E  ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLL 56
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
           K + H N++K++     E    LV E++ H  L+K+M +S   L       I   +   L
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLL 113
Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           + L F +S  ++H DLKP N+L++      L+DF +A+      +  T    + T+ Y A
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRA 171
Query: 344 PEYGREGR-VSTNGDVYSFGIMLMETFTGK 372
           PE     +  ST  D++S G +  E  T +
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 17/210 (8%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRALKGFDVECEMM 223
           + + F +   IG G +G VYKAR    G  VA+K   L          A++    E  ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLL 58
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
           K + H N++K++     E    LV E++ H  L+K+M +S   L       I   +   L
Sbjct: 59  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLL 115
Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           + L F +S  ++H DLKP N+L++      L+DF +A+      +  T    + T+ Y A
Sbjct: 116 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRA 173
Query: 344 PEYGREGR-VSTNGDVYSFGIMLMETFTGK 372
           PE     +  ST  D++S G +  E  T +
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 17/210 (8%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRALKGFDVECEMM 223
           + + F +   IG G +G VYKAR    G  VA+K   L          A++    E  ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLL 56
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
           K + H N++K++     E    LV E++ H  L+K+M +S   L       I   +   L
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLL 113
Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           + L F +S  ++H DLKP N+L++      L+DF +A+      +  T    + T+ Y A
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRA 171
Query: 344 PEYGREGR-VSTNGDVYSFGIMLMETFTGK 372
           PE     +  ST  D++S G +  E  T +
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 132/308 (42%), Gaps = 54/308 (17%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSI--RHRNLIKVIS-- 236
           +G+G +G V++  L  G  VAVK+F+    R  + +  E E+  ++  RH N++  I+  
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFS---SRDEQSWFRETEIYNTVLLRHDNILGFIASD 71
Query: 237 -TCSNEEFK-ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLH---FGYS 291
            T  N   +  L+  Y  HGSL  Y +     L+    L + +  A  L +LH   FG  
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSL--YDFLQRQTLEPHLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 292 A--PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT-GEDQ-SMTQTQTLATIGYMAPEYG 347
               I H D K  NVL+  N+   ++D  +A + + G D   +     + T  YMAPE  
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVL 189
Query: 348 REGRVSTN-------GDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEV 400
            E ++ T+        D+++FG++L E          I NG       V D+ P      
Sbjct: 190 DE-QIRTDCFESYKWTDIWAFGLVLWEI-----ARRTIVNGI------VEDYRP--PFYD 235
Query: 401 VGANLLSQEDIHFV--------------AKEQCVSCVFNLAMECTVESPEQRINAREIVA 446
           V  N  S ED+  V              A +  +S +  +  EC   +P  R+ A  I  
Sbjct: 236 VVPNDPSFEDMKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRIKK 295
Query: 447 KLLKIRDS 454
            L KI +S
Sbjct: 296 TLQKISNS 303

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 101/210 (48%), Gaps = 12/210 (5%)
Query: 181 IGRGGFGSV----YKARLGDGMEVAVKVFNLQCGRA-LKGFDVECEMMKSIRHRNLIKVI 235
           +G G FGSV    Y+ R    ++VA+KV      +A  +    E ++M  + +  ++++I
Sbjct: 344 LGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
             C  E    LV+E    G L K++      + +     ++  V+  ++YL        +
Sbjct: 403 GVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFV 458
Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT-QTQTLATIGYMAPEYGREGRVST 354
           H +L   NVLL +   A +SDF ++K L  +D   T ++     + + APE     + S+
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 355 NGDVYSFGIMLMETFT-GKKPTNEIFNGEM 383
             DV+S+G+ + E  + G+KP  ++   E+
Sbjct: 519 RSDVWSYGVTMWEALSYGQKPYKKMKGPEV 548

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVIST 237
           IG+G F  V  AR +  G EVA+K+ +       +L+    E  +MK + H N++K+   
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
              E+   L++EY   G +  Y+ +   + +   R      + SA++Y H      I+H 
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH---QKRIVHR 135
Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVS-TNG 356
           DLK  N+LLD +M   ++DF  +   T   +  T      +  Y APE  +  +      
Sbjct: 136 DLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT---FCGSPPYAAPELFQGKKYDGPEV 192
Query: 357 DVYSFGIMLMETFTGKKPTNEIFNGE 382
           DV+S G++L    +G  P    F+G+
Sbjct: 193 DVWSLGVILYTLVSGSLP----FDGQ 214

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 17/210 (8%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRALKGFDVECEMM 223
           + + F +   IG G +G VYKAR    G  VA+K   L          A++    E  ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLL 59
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
           K + H N++K++     E    LV E++ H  L+K+M +S   L       I   +   L
Sbjct: 60  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLL 116
Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           + L F +S  ++H DLKP N+L++      L+DF +A+      +  T    + T+ Y A
Sbjct: 117 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRA 174
Query: 344 PEYGREGR-VSTNGDVYSFGIMLMETFTGK 372
           PE     +  ST  D++S G +  E  T +
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 17/210 (8%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRALKGFDVECEMM 223
           + + F +   IG G +G VYKAR    G  VA+K   L          A++    E  ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLL 58
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
           K + H N++K++     E    LV E++ H  L+K+M +S   L       I   +   L
Sbjct: 59  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLL 115
Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           + L F +S  ++H DLKP N+L++      L+DF +A+      +  T    + T+ Y A
Sbjct: 116 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRA 173
Query: 344 PEYGREGR-VSTNGDVYSFGIMLMETFTGK 372
           PE     +  ST  D++S G +  E  T +
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 175 FSENNL-----IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIR- 227
           F  NNL     +G G FG V +A   G G E AV    ++  ++    D +  +M  ++ 
Sbjct: 35  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 94
Query: 228 ------HRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMY---------SSNYILDIFQR 272
                 H N++ ++  C++     ++ EY  +G L  ++               L++   
Sbjct: 95  MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDL 154
Query: 273 LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 332
           L+    VA  + +L    S   IH D+   NVLL +  VA + DF +A+ +  +   + +
Sbjct: 155 LHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 211
Query: 333 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 370
                 + +MAPE   +   +   DV+S+GI+L E F+
Sbjct: 212 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 96/209 (45%), Gaps = 12/209 (5%)
Query: 172 TDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRH 228
           TD +     +G+G F  V +  ++  G E A K+ N +    R  +  + E  + + ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
            N++++  + S E F  LV + +  G L + + +  Y    +   +    +   LE ++ 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILESVNH 118
Query: 289 GYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
            +   I+H DLKP N+LL          L+DF +A  + G+ Q+        T GY++PE
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPE 176
Query: 346 YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
             R+       D+++ G++L     G  P
Sbjct: 177 VLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 17/210 (8%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRALKGFDVECEMM 223
           + + F +   IG G +G VYKAR    G  VA+K   L          A++    E  ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLL 56
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
           K + H N++K++     E    LV E++ H  L+K+M +S   L       I   +   L
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLL 113
Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           + L F +S  ++H DLKP N+L++      L+DF +A+      +  T    + T+ Y A
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRA 171
Query: 344 PEYGREGR-VSTNGDVYSFGIMLMETFTGK 372
           PE     +  ST  D++S G +  E  T +
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 17/210 (8%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRALKGFDVECEMM 223
           + + F +   IG G +G VYKAR    G  VA+K   L          A++    E  ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLL 58
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
           K + H N++K++     E    LV E++ H  L+K+M +S   L       I   +   L
Sbjct: 59  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLL 115
Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           + L F +S  ++H DLKP N+L++      L+DF +A+      +  T    + T+ Y A
Sbjct: 116 QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRA 173
Query: 344 PEYGREGR-VSTNGDVYSFGIMLMETFTGK 372
           PE     +  ST  D++S G +  E  T +
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 17/210 (8%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRALKGFDVECEMM 223
           + + F +   IG G +G VYKAR    G  VA+K   L          A++    E  ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLL 57
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
           K + H N++K++     E    LV E++ H  L+K+M +S   L       I   +   L
Sbjct: 58  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLL 114
Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           + L F +S  ++H DLKP N+L++      L+DF +A+      +  T    + T+ Y A
Sbjct: 115 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRA 172
Query: 344 PEYGREGR-VSTNGDVYSFGIMLMETFTGK 372
           PE     +  ST  D++S G +  E  T +
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 17/208 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRALKGFDVECEMMKS 225
           + F +   IG G +G VYKAR    G  VA+K   L          A++    E  ++K 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKE 57
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           + H N++K++     E    LV E++ H  L+K+M +S   L       I   +   L+ 
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQG 114
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
           L F +S  ++H DLKP N+L++      L+DF +A+      +  T    + T+ Y APE
Sbjct: 115 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPE 172
Query: 346 YGREGR-VSTNGDVYSFGIMLMETFTGK 372
                +  ST  D++S G +  E  T +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 17/210 (8%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRALKGFDVECEMM 223
           + + F +   IG G +G VYKAR    G  VA+K   L          A++    E  ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLL 59
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
           K + H N++K++     E    LV E++ H  L+K+M +S   L       I   +   L
Sbjct: 60  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLL 116
Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           + L F +S  ++H DLKP N+L++      L+DF +A+      +  T    + T+ Y A
Sbjct: 117 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRA 174
Query: 344 PEYGREGR-VSTNGDVYSFGIMLMETFTGK 372
           PE     +  ST  D++S G +  E  T +
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 17/210 (8%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRALKGFDVECEMM 223
           + + F +   IG G +G VYKAR    G  VA+K   L          A++    E  ++
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLL 60
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
           K + H N++K++     E    LV E++ H  L+K+M +S   L       I   +   L
Sbjct: 61  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLL 117
Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           + L F +S  ++H DLKP N+L++      L+DF +A+      +  T    + T+ Y A
Sbjct: 118 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRA 175
Query: 344 PEYGREGR-VSTNGDVYSFGIMLMETFTGK 372
           PE     +  ST  D++S G +  E  T +
Sbjct: 176 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 17/210 (8%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRALKGFDVECEMM 223
           + + F +   IG G +G VYKAR    G  VA+K   L          A++    E  ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLL 57
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
           K + H N++K++     E    LV E++ H  L+K+M +S   L       I   +   L
Sbjct: 58  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLL 114
Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           + L F +S  ++H DLKP N+L++      L+DF +A+      +  T    + T+ Y A
Sbjct: 115 QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRA 172
Query: 344 PEYGREGR-VSTNGDVYSFGIMLMETFTGK 372
           PE     +  ST  D++S G +  E  T +
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 17/208 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRALKGFDVECEMMKS 225
           + F +   IG G +G VYKAR    G  VA+K   L          A++    E  ++K 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKE 59
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           + H N++K++     E    LV E++ H  L+K+M +S   L       I   +   L+ 
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQG 116
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
           L F +S  ++H DLKP N+L++      L+DF +A+      +  T    + T+ Y APE
Sbjct: 117 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPE 174
Query: 346 YGREGR-VSTNGDVYSFGIMLMETFTGK 372
                +  ST  D++S G +  E  T +
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 82/311 (26%), Positives = 129/311 (41%), Gaps = 66/311 (21%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSI--RHRNLIKVISTC 238
           +G+G +G V++     G  VAVK+F+    R  K +  E E+  ++  RH N++  I++ 
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 100
Query: 239 SNEEFKA----LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLH---FGYS 291
                 +    L+  Y   GSL  Y+  +   LD    L I++ +AS L +LH   FG  
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 292 A--PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-----LATIGYMAP 344
               I H DLK  N+L+  N    ++D  +A +     QS  Q        + T  YMAP
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM---HSQSTNQLDVGNNPRVGTKRYMAP 215
Query: 345 E----------YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLP 394
           E          +    RV    D+++FG++L E    +  +N I          V D+ P
Sbjct: 216 EVLDETIQVDCFDSYKRV----DIWAFGLVLWEV-ARRMVSNGI----------VEDYKP 260
Query: 395 ISTMEVVGANLLSQEDIHFVA--------------KEQCVSCVFNLAMECTVESPEQRIN 440
                 V  N  S ED+  V                +  ++ +  L  EC  ++P  R+ 
Sbjct: 261 --PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT 318
Query: 441 AREIVAKLLKI 451
           A  I   L KI
Sbjct: 319 ALRIKKTLTKI 329

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 179 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGR--ALKGFDVECEMMKSIRHRNLIKVIS 236
            LIG+G FG VY  R     EVA+++ +++      LK F  E    +  RH N++  + 
Sbjct: 39  ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
            C +    A++       +L   +  +  +LD+ +   I  ++   + YLH   +  I+H
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153
Query: 297 CDLKPSNVLLDDNMVAHLSD---FSIAKLLTG---EDQSMTQTQTLATIGYMAPEYGREG 350
            DLK  NV  D+  V  ++D   FSI+ +L     ED+   Q   L    ++APE  R+ 
Sbjct: 154 KDLKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQNGWLC---HLAPEIIRQL 209
Query: 351 R---------VSTNGDVYSFGIMLMETFTGKKP 374
                      S + DV++ G +  E    + P
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 33/220 (15%)
Query: 175 FSENNLIGRGGFGSVYKARLG-DGMEVA---VKVFNLQCGRALK---------------- 214
           F E  LIG GGFG V+KA+   DG       VK  N +  R +K                
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKLDHVNIVHYNGC 73
Query: 215 --GFDVECEM----MKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSN-YIL 267
             GFD + E     ++S  +       S+ S  +   + +E+   G+LE+++       L
Sbjct: 74  WDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 133
Query: 268 DIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 327
           D    L +   +   ++Y+H   S  +IH DLKPSN+ L D     + DF +   L  + 
Sbjct: 134 DKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 190
Query: 328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 367
           +   +T++  T+ YM+PE           D+Y+ G++L E
Sbjct: 191 K---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE 227

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 16/218 (7%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQ-CGRALKGFDVECEMMKSIRHRN 230
           D +    +IG G    V  A      E VA+K  NL+ C  ++     E + M    H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 231 LIKVISTCSNEEFKALVLEYMPHGS---LEKYMYSSNY----ILDIFQRLNIMIDVASAL 283
           ++   ++   ++   LV++ +  GS   + K++ +       +LD      I+ +V   L
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-TGEDQSMTQTQT--LATIG 340
           EYLH       IH D+K  N+LL ++    ++DF ++  L TG D +  + +   + T  
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 341 YMAPEYGREGR-VSTNGDVYSFGIMLMETFTGKKPTNE 377
           +MAPE   + R      D++SFGI  +E  TG  P ++
Sbjct: 187 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK 224

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 17/210 (8%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRALKGFDVECEMM 223
           + + F +   IG G +G VYKAR    G  VA+K   L          A++    E  ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLL 56
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
           K + H N++K++     E    LV E++ H  L+K+M +S   L       I   +   L
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLL 113
Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           + L F +S  ++H DLKP N+L++      L+DF +A+      +  T    + T+ Y A
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRA 171
Query: 344 PEYGREGR-VSTNGDVYSFGIMLMETFTGK 372
           PE     +  ST  D++S G +  E  T +
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 101/231 (43%), Gaps = 18/231 (7%)
Query: 155 PSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKA-RLGDG----MEVAVKVFNLQC 209
           P+ A  R     EL +         ++G G FG+VYK   + DG    + VA+KV     
Sbjct: 6   PNQALLRILKETELRKV-------KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT 58
Query: 210 G-RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILD 268
             +A K    E  +M  +    + +++  C     + LV + MP+G L  ++  +   L 
Sbjct: 59  SPKANKEILDEAYVMAGVGSPYVSRLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLG 117
Query: 269 IFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ 328
               LN  + +A  + YL       ++H DL   NVL+       ++DF +A+LL  ++ 
Sbjct: 118 SQDLLNWCMQIAKGMSYLE---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 174
Query: 329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEI 378
                     I +MA E     R +   DV+S+G+ + E  T G KP + I
Sbjct: 175 EYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 225

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 175 FSENNL-----IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIR- 227
           F  NNL     +G G FG V +A   G G E AV    ++  ++    D +  +M  ++ 
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 228 ------HRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMY---------SSNYILDIFQR 272
                 H N++ ++  C++     ++ EY  +G L  ++               L++   
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDL 162
Query: 273 LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 332
           L+    VA  + +L    S   IH D+   NVLL +  VA + DF +A+ +  +   + +
Sbjct: 163 LHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 219
Query: 333 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 370
                 + +MAPE   +   +   DV+S+GI+L E F+
Sbjct: 220 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 187 GSVYKARLGDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNE--E 242
           G ++K R   G ++ VKV  ++    R  + F+ EC  ++   H N++ V+  C +    
Sbjct: 24  GELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 243 FKALVLEYMPHGSLEKYMYS-SNYILDIFQRLNIMIDVASALEYLHFGYSAPII--HCDL 299
              L+  + P+GSL   ++  +N+++D  Q +   +D A    +LH     P+I  H  L
Sbjct: 83  HPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLH--TLEPLIPRHA-L 139
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTN---G 356
              +V +D++  A +S   +         S           ++APE  ++    TN    
Sbjct: 140 NSRSVXIDEDXTARISXADVK-------FSFQSPGRXYAPAWVAPEALQKKPEDTNRRSA 192
Query: 357 DVYSFGIMLMETFTGKKPTNEIFNGEMTLK 386
           D +SF ++L E  T + P  ++ N E+  K
Sbjct: 193 DXWSFAVLLWELVTREVPFADLSNXEIGXK 222

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 82/311 (26%), Positives = 129/311 (41%), Gaps = 66/311 (21%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSI--RHRNLIKVISTC 238
           +G+G +G V++     G  VAVK+F+    R  K +  E E+  ++  RH N++  I++ 
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 239 SNEEFKA----LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLH---FGYS 291
                 +    L+  Y   GSL  Y+  +   LD    L I++ +AS L +LH   FG  
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 292 A--PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-----LATIGYMAP 344
               I H DLK  N+L+  N    ++D  +A +     QS  Q        + T  YMAP
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM---HSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 345 E----------YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLP 394
           E          +    RV    D+++FG++L E    +  +N I          V D+ P
Sbjct: 187 EVLDETIQVDCFDSYKRV----DIWAFGLVLWEV-ARRMVSNGI----------VEDYKP 231
Query: 395 ISTMEVVGANLLSQEDIHFVA--------------KEQCVSCVFNLAMECTVESPEQRIN 440
                 V  N  S ED+  V                +  ++ +  L  EC  ++P  R+ 
Sbjct: 232 --PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT 289
Query: 441 AREIVAKLLKI 451
           A  I   L KI
Sbjct: 290 ALRIKKTLTKI 300

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 82/311 (26%), Positives = 129/311 (41%), Gaps = 66/311 (21%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSI--RHRNLIKVISTC 238
           +G+G +G V++     G  VAVK+F+    R  K +  E E+  ++  RH N++  I++ 
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 239 SNEEFKA----LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLH---FGYS 291
                 +    L+  Y   GSL  Y+  +   LD    L I++ +AS L +LH   FG  
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 292 A--PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-----LATIGYMAP 344
               I H DLK  N+L+  N    ++D  +A +     QS  Q        + T  YMAP
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM---HSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 345 E----------YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLP 394
           E          +    RV    D+++FG++L E    +  +N I          V D+ P
Sbjct: 187 EVLDETIQVDCFDSYKRV----DIWAFGLVLWEV-ARRMVSNGI----------VEDYKP 231
Query: 395 ISTMEVVGANLLSQEDIHFVA--------------KEQCVSCVFNLAMECTVESPEQRIN 440
                 V  N  S ED+  V                +  ++ +  L  EC  ++P  R+ 
Sbjct: 232 --PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT 289
Query: 441 AREIVAKLLKI 451
           A  I   L KI
Sbjct: 290 ALRIKKTLTKI 300

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 16/215 (7%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQ-CGRALKGFDVECEMMKSIRHRN 230
           D +    +IG G    V  A      E VA+K  NL+ C  ++     E + M    H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 231 LIKVISTCSNEEFKALVLEYMPHGS---LEKYMYSSNY----ILDIFQRLNIMIDVASAL 283
           ++   ++   ++   LV++ +  GS   + K++ +       +LD      I+ +V   L
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-TGEDQSMTQTQT--LATIG 340
           EYLH       IH D+K  N+LL ++    ++DF ++  L TG D +  + +   + T  
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 341 YMAPEYGREGR-VSTNGDVYSFGIMLMETFTGKKP 374
           +MAPE   + R      D++SFGI  +E  TG  P
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 31/226 (13%)
Query: 169 CRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIR 227
            R    F E  ++G+G FG V KAR   D    A+K         L     E  ++ S+ 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLN 60
Query: 228 H-------------RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLN 274
           H             RN +K ++    +    + +EY  +G+L   ++S N      +   
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 275 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK-------LLTGED 327
           +   +  AL Y+H   S  IIH DLKP N+ +D++    + DF +AK       +L  + 
Sbjct: 121 LFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 328 QSM-----TQTQTLATIGYMAPEY-GREGRVSTNGDVYSFGIMLME 367
           Q++       T  + T  Y+A E     G  +   D+YS GI+  E
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 17/208 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRALKGFDVECEMMKS 225
           + F +   IG G +G VYKAR    G  VA+K   L          A++    E  ++K 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKE 57
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           + H N++K++     E    LV E++ H  L+ +M +S   L       I   +   L+ 
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASA--LTGIPLPLIKSYLFQLLQG 114
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
           L F +S  ++H DLKP N+L++      L+DF +A+      +  T T  + T+ Y APE
Sbjct: 115 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPE 172
Query: 346 YGREGR-VSTNGDVYSFGIMLMETFTGK 372
                +  ST  D++S G +  E  T +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 21/209 (10%)
Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVIST 237
           IG+G F  V  AR +  G EVA+K+ +       +L+    E  +MK + H N++K+   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
              E+   L++EY   G +  Y+ +   + +   R      + SA++Y H      I+H 
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH---QKRIVHR 138
Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIG---YMAPEYGREGRVS- 353
           DLK  N+LLD +M   ++DF  +   T         +  A  G   Y APE  +  +   
Sbjct: 139 DLKAENLLLDADMNIKIADFGFSNEFT------VGGKLDAFCGAPPYAAPELFQGKKYDG 192
Query: 354 TNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
              DV+S G++L    +G  P    F+G+
Sbjct: 193 PEVDVWSLGVILYTLVSGSLP----FDGQ 217

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 31/222 (13%)
Query: 164 SHLELCRATDGFSENNLIGRGGFGSVYKARL----GDGMEVAVKVFNLQCGRALKGFD-- 217
           SH EL +         ++G+G FG V+  R       G   A+KV        LK  D  
Sbjct: 28  SHFELLK---------VLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKAT---LKVRDRV 75
Query: 218 ---VECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLN 274
              +E +++  + H  ++K+      E    L+L+++  G L  +   S  ++   + + 
Sbjct: 76  RTKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVK 133
Query: 275 I-MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 333
             + ++A  L++LH   S  II+ DLKP N+LLD+     L+DF ++K     D      
Sbjct: 134 FYLAELALGLDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--EAIDHEKKAY 188
Query: 334 QTLATIGYMAPE-YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
               T+ YMAPE   R+G  S + D +S+G+++ E  TG  P
Sbjct: 189 SFCGTVEYMAPEVVNRQGH-SHSADWWSYGVLMFEMLTGSLP 229

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 101/204 (49%), Gaps = 16/204 (7%)
Query: 179 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGR--ALKGFD-----VECEMMKSIRHRNL 231
            ++G+G FG V+  +   G + A +++ ++  +   LK  D     +E +++  + H  +
Sbjct: 30  KVLGQGSFGKVFLVKKISGSD-ARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFI 88
Query: 232 IKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNI-MIDVASALEYLHFGY 290
           +K+      E    L+L+++  G L  +   S  ++   + +   + ++A AL++LH   
Sbjct: 89  VKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLAELALALDHLH--- 143
Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 350
           S  II+ DLKP N+LLD+     L+DF ++K     D          T+ YMAPE     
Sbjct: 144 SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRR 201
Query: 351 RVSTNGDVYSFGIMLMETFTGKKP 374
             + + D +SFG+++ E  TG  P
Sbjct: 202 GHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 101/204 (49%), Gaps = 16/204 (7%)
Query: 179 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGR--ALKGFD-----VECEMMKSIRHRNL 231
            ++G+G FG V+  +   G + A +++ ++  +   LK  D     +E +++  + H  +
Sbjct: 31  KVLGQGSFGKVFLVKKISGSD-ARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFI 89
Query: 232 IKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNI-MIDVASALEYLHFGY 290
           +K+      E    L+L+++  G L  +   S  ++   + +   + ++A AL++LH   
Sbjct: 90  VKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLAELALALDHLH--- 144
Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 350
           S  II+ DLKP N+LLD+     L+DF ++K     D          T+ YMAPE     
Sbjct: 145 SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRR 202
Query: 351 RVSTNGDVYSFGIMLMETFTGKKP 374
             + + D +SFG+++ E  TG  P
Sbjct: 203 GHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 90/202 (44%), Gaps = 9/202 (4%)
Query: 176 SENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKV 234
           S+  ++G G FG V+K      G+++A K+   +  +  +    E  +M  + H NLI++
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI 294
                ++    LV+EY+  G L   +   +Y L     +  M  +   + ++H  Y   I
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---I 208
Query: 295 IHCDLKPSNVLL--DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV 352
           +H DLKP N+L    D     + DF +A+     ++         T  ++APE      V
Sbjct: 209 LHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---NFGTPEFLAPEVVNYDFV 265
Query: 353 STNGDVYSFGIMLMETFTGKKP 374
           S   D++S G++     +G  P
Sbjct: 266 SFPTDMWSVGVIAYMLLSGLSP 287

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 115/285 (40%), Gaps = 40/285 (14%)
Query: 181 IGRGGFGSVYKARLG------DGMEVAVKVF-NLQCGRALKGFDVECEMMKSIRHRNLIK 233
           +G G FG VY+ ++         ++VAVK    +   +    F +E  ++    H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMY------SSNYILDIFQRLNIMIDVASALEYLH 287
            I        + ++LE M  G L+ ++       S    L +   L++  D+A   +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 288 FGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
             +    IH D+   N LL       VA + DF +A+ +            +  + +M P
Sbjct: 173 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 345 EYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA 403
           E   EG  ++  D +SFG++L E F+ G  P     N E+              +E V +
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------LEFVTS 275
Query: 404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
                        + C   V+ +  +C    PE R N   I+ ++
Sbjct: 276 GG------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 101/204 (49%), Gaps = 16/204 (7%)
Query: 179 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGR--ALKGFD-----VECEMMKSIRHRNL 231
            ++G+G FG V+  +   G + A +++ ++  +   LK  D     +E +++  + H  +
Sbjct: 30  KVLGQGSFGKVFLVKKISGSD-ARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFI 88
Query: 232 IKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNI-MIDVASALEYLHFGY 290
           +K+      E    L+L+++  G L  +   S  ++   + +   + ++A AL++LH   
Sbjct: 89  VKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLAELALALDHLH--- 143
Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 350
           S  II+ DLKP N+LLD+     L+DF ++K     D          T+ YMAPE     
Sbjct: 144 SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRR 201
Query: 351 RVSTNGDVYSFGIMLMETFTGKKP 374
             + + D +SFG+++ E  TG  P
Sbjct: 202 GHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 33/210 (15%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSI--RHRNLIKVISTC 238
           IG+G FG V++ +   G EVAVK+F+    R  + +  E E+ +++  RH N++  I+  
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 69
Query: 239 SNEEFKA----LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY---- 290
           + +        LV +Y  HGSL  Y+  + Y + +   + + +  AS L +LH       
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 127
Query: 291 -SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA------TIGYMA 343
               I H DLK  N+L+  N    ++D  +A        S T T  +A      T  YMA
Sbjct: 128 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAV----RHDSATDTIDIAPNHRVGTKRYMA 183
Query: 344 PEY------GREGRVSTNGDVYSFGIMLME 367
           PE        +        D+Y+ G++  E
Sbjct: 184 PEVLDDSINMKHFESFKRADIYAMGLVFWE 213

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 25/206 (12%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSI--RHRNLIKVISTC 238
           IG+G FG V++ +   G EVAVK+F+    R  + +  E E+ +++  RH N++  I+  
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 67
Query: 239 SNEEFKA----LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY---- 290
           + +        LV +Y  HGSL  Y+  + Y + +   + + +  AS L +LH       
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 125
Query: 291 -SAPIIHCDLKPSNVLLDDNMVAHLSDFSIA-KLLTGEDQ-SMTQTQTLATIGYMAPEY- 346
               I H DLK  N+L+  N    ++D  +A +  +  D   +     + T  YMAPE  
Sbjct: 126 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 185
Query: 347 -----GREGRVSTNGDVYSFGIMLME 367
                 +        D+Y+ G++  E
Sbjct: 186 DDSINMKHFESFKRADIYAMGLVFWE 211

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 102/223 (45%), Gaps = 13/223 (5%)
Query: 160 WRTFSHLELCRATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDV 218
           W+      + + T  F +  ++G+GGFG V   ++   G   A K    +  +  KG  +
Sbjct: 173 WKWLERQPVTKNT--FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM 230
Query: 219 ---ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLN 274
              E ++++ +  R ++ +      ++   LVL  M  G L+ ++Y          + + 
Sbjct: 231 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF 290
Query: 275 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ 334
              ++   LE LH      I++ DLKP N+LLDD+    +SD  +A  +    +  T   
Sbjct: 291 YAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKG 344
Query: 335 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNE 377
            + T+GYMAPE  +  R + + D ++ G +L E   G+ P  +
Sbjct: 345 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 101/220 (45%), Gaps = 13/220 (5%)
Query: 160 WRTFSHLELCRATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDV 218
           W+      + + T  F +  ++G+GGFG V   ++   G   A K    +  +  KG  +
Sbjct: 173 WKWLERQPVTKNT--FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM 230
Query: 219 ---ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLN 274
              E ++++ +  R ++ +      ++   LVL  M  G L+ ++Y          + + 
Sbjct: 231 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF 290
Query: 275 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ 334
              ++   LE LH      I++ DLKP N+LLDD+    +SD  +A  +    +  T   
Sbjct: 291 YAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKG 344
Query: 335 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
            + T+GYMAPE  +  R + + D ++ G +L E   G+ P
Sbjct: 345 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 25/206 (12%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSI--RHRNLIKVISTC 238
           IG+G FG V++ +   G EVAVK+F+    R  + +  E E+ +++  RH N++  I+  
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 239 SNEEFKA----LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY---- 290
           + +        LV +Y  HGSL  Y+  + Y + +   + + +  AS L +LH       
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 291 -SAPIIHCDLKPSNVLLDDNMVAHLSDFSIA-KLLTGEDQ-SMTQTQTLATIGYMAPEY- 346
               I H DLK  N+L+  N    ++D  +A +  +  D   +     + T  YMAPE  
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 347 -----GREGRVSTNGDVYSFGIMLME 367
                 +        D+Y+ G++  E
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWE 210

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 33/210 (15%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSI--RHRNLIKVISTC 238
           IG+G FG V++ +   G EVAVK+F+    R  + +  E E+ +++  RH N++  I+  
Sbjct: 37  IGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 92
Query: 239 SNEEFKA----LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY---- 290
           + +        LV +Y  HGSL  Y+  + Y + +   + + +  AS L +LH       
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 150
Query: 291 -SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA------TIGYMA 343
               I H DLK  N+L+  N    ++D  +A        S T T  +A      T  YMA
Sbjct: 151 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAV----RHDSATDTIDIAPNHRVGTKRYMA 206
Query: 344 PEY------GREGRVSTNGDVYSFGIMLME 367
           PE        +        D+Y+ G++  E
Sbjct: 207 PEVLDDSINMKHFESFKRADIYAMGLVFWE 236

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKGFDV------ECEMMKSIRHRNLIK 233
           +G G FG V  A       +VA+K  + Q    LK  D+      E   +K +RH ++IK
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQL---LKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
           +    +      +V+EY   G L  Y+     + +   R      +  A+EY H      
Sbjct: 74  LYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGR-RFFQQIICAIEYCH---RHK 128
Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVS 353
           I+H DLKP N+LLDDN+   ++DF ++ ++T  D +  +T +  +  Y APE    G++ 
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAPEVI-NGKLY 184
Query: 354 TNG--DVYSFGIMLMETFTGKKPTNEIF 379
                DV+S GI+L     G+ P ++ F
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPFDDEF 212

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 33/210 (15%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSI--RHRNLIKVISTC 238
           IG+G FG V++ +   G EVAVK+F+    R  + +  E E+ +++  RH N++  I+  
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 72
Query: 239 SNEEFKA----LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY---- 290
           + +        LV +Y  HGSL  Y+  + Y + +   + + +  AS L +LH       
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 130
Query: 291 -SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA------TIGYMA 343
               I H DLK  N+L+  N    ++D  +A        S T T  +A      T  YMA
Sbjct: 131 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAV----RHDSATDTIDIAPNHRVGTKRYMA 186
Query: 344 PEY------GREGRVSTNGDVYSFGIMLME 367
           PE        +        D+Y+ G++  E
Sbjct: 187 PEVLDDSINMKHFESFKRADIYAMGLVFWE 216

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 33/210 (15%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSI--RHRNLIKVISTC 238
           IG+G FG V++ +   G EVAVK+F+    R  + +  E E+ +++  RH N++  I+  
Sbjct: 50  IGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 239 SNEEFKA----LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY---- 290
           + +        LV +Y  HGSL  Y+  + Y + +   + + +  AS L +LH       
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 291 -SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA------TIGYMA 343
               I H DLK  N+L+  N    ++D  +A        S T T  +A      T  YMA
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAV----RHDSATDTIDIAPNHRVGTKRYMA 219
Query: 344 PEY------GREGRVSTNGDVYSFGIMLME 367
           PE        +        D+Y+ G++  E
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWE 249

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/278 (23%), Positives = 115/278 (41%), Gaps = 33/278 (11%)
Query: 181 IGRGGFGSV----YKARLGDGMEVAVKVF-NLQCGRALKGFDVECEMMKSIRHRNLIKVI 235
           IG G FG V    Y +     M VA+K   N       + F  E   M+   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
              + E    +++E    G L  ++    + LD+   +     +++AL YL    S   +
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ-TQTLATIGYMAPEYGREGRVST 354
           H D+   NVL+       L DF +++ +  ED +  + ++    I +MAPE     R ++
Sbjct: 134 HRDIAARNVLVSATDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 191
Query: 355 NGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF 413
             DV+ FG+ + E    G KP   + N ++  +    + LP+                  
Sbjct: 192 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------- 235
Query: 414 VAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
                C   +++L  +C    P +R    E+ A+L  I
Sbjct: 236 ----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 28/211 (13%)
Query: 175 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
           F E  LIG GGFG V+KA+   DG    +K       +A    + E + +  + H N++ 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA----EREVKALAKLDHVNIVH 68
Query: 234 V--------------ISTCSNEEFKALV--LEYMPHGSLEKYMYSSN-YILDIFQRLNIM 276
                              S  + K L   +E+   G+LE+++       LD    L + 
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 277 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 336
             +   ++Y+H   S  +I+ DLKPSN+ L D     + DF +   L  + +   + ++ 
Sbjct: 129 EQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RXRSK 182
Query: 337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLME 367
            T+ YM+PE           D+Y+ G++L E
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAE 213

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 171 ATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVEC-------EM 222
           AT  +     IG G +G+VYKAR    G  VA+K   +  G   +G  +           
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGE--EGLPISTVREVALLRR 59
Query: 223 MKSIRHRNLIKVISTC----SNEEFK-ALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIM 276
           +++  H N+++++  C    ++ E K  LV E++    L  Y+  +    L      ++M
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLM 118
Query: 277 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 336
                 L++LH      I+H DLKP N+L+       L+DF +A++ + +   M     +
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALAPVV 172
Query: 337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGK 372
            T+ Y APE   +   +T  D++S G +  E F  K
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 25/211 (11%)
Query: 175 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL---QCGRALKGFDVECEMMKSIRHRN 230
           FS+   IG G FG+VY AR + +   VA+K  +    Q     +    E   ++ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVAS----ALEYL 286
            I+       E    LV+EY         + S++ +L++ ++    +++A+    AL+ L
Sbjct: 77  TIQYRGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
            + +S  +IH D+K  N+LL +  +  L DF  A ++            + T  +MAPE 
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANXFVGTPYWMAPEV 182
Query: 347 ---GREGRVSTNGDVYSFGIMLMETFTGKKP 374
                EG+     DV+S GI  +E    K P
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 17/210 (8%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRALKGFDVECEMM 223
           + + F +   IG G +G VYKAR    G  VA+K   L          A++    E  ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLL 56
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
           K + H N++K++     E    LV E++ H  L+ +M +S   L       I   +   L
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASA--LTGIPLPLIKSYLFQLL 113
Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           + L F +S  ++H DLKP N+L++      L+DF +A+      +  T    + T+ Y A
Sbjct: 114 QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRA 171
Query: 344 PEYGREGR-VSTNGDVYSFGIMLMETFTGK 372
           PE     +  ST  D++S G +  E  T +
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 28/217 (12%)
Query: 175 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL---QCGRALKGFDVECEMMKSIRHRN 230
           FS+   IG G FG+VY AR + +   VA+K  +    Q     +    E   ++ +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVAS----ALEYL 286
            I+       E    LV+EY         + S++ +L++ ++    +++A+    AL+ L
Sbjct: 116 TIQYRGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAVTHGALQGL 167
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
            + +S  +IH D+K  N+LL +  +  L DF  A ++            + T  +MAPE 
Sbjct: 168 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANXFVGTPYWMAPEV 221
Query: 347 ---GREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFN 380
                EG+     DV+S GI  +E    K P   +FN
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFN 255

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/277 (22%), Positives = 113/277 (40%), Gaps = 20/277 (7%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGDGMEV-AVKVF---NLQCGRALKGFDVECEMMKSIRH 228
           D F     +G+G FG+VY AR      + A+KV     L+          E E+   +RH
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
            N++++ +   + +   L+LE+ P G L K +       D  +    M ++A AL Y H 
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR-FDEQRSATFMEELADALHYCH- 132
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
                +IH D+KP N+L+       ++DF      +    S+ +     T+ Y+ PE   
Sbjct: 133 --ERKVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPPEMIE 186
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ 408
                   D++  G++  E   G  P +   + E   +        I  +++     LS 
Sbjct: 187 GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR--------IVNVDLKFPPFLSD 238
Query: 409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIV 445
                ++K         L ++  +E P  + N+R ++
Sbjct: 239 GSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVL 275

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 17/210 (8%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRALKGFDVECEMM 223
           + + F +   IG G +G VYKAR    G  VA+K   L          A++    E  ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLL 59
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
           K + H N++K++     E    LV E++ H  L+ +M +S   L       I   +   L
Sbjct: 60  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASA--LTGIPLPLIKSYLFQLL 116
Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           + L F +S  ++H DLKP N+L++      L+DF +A+      +  T    + T+ Y A
Sbjct: 117 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRA 174
Query: 344 PEYGREGR-VSTNGDVYSFGIMLMETFTGK 372
           PE     +  ST  D++S G +  E  T +
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/278 (23%), Positives = 115/278 (41%), Gaps = 33/278 (11%)
Query: 181 IGRGGFGSV----YKARLGDGMEVAVKVF-NLQCGRALKGFDVECEMMKSIRHRNLIKVI 235
           IG G FG V    Y +     M VA+K   N       + F  E   M+   H +++K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
              + E    +++E    G L  ++    + LD+   +     +++AL YL    S   +
Sbjct: 458 GVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ-TQTLATIGYMAPEYGREGRVST 354
           H D+   NVL+       L DF +++ +  ED +  + ++    I +MAPE     R ++
Sbjct: 514 HRDIAARNVLVSATDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 355 NGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF 413
             DV+ FG+ + E    G KP   + N ++  +    + LP+                  
Sbjct: 572 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------- 615
Query: 414 VAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
                C   +++L  +C    P +R    E+ A+L  I
Sbjct: 616 ----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 101/221 (45%), Gaps = 25/221 (11%)
Query: 175 FSENNL-----IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIR- 227
           F  NNL     +G G FG V +A   G G E AV    ++  ++    D +  +M  ++ 
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 228 ------HRNLIKVISTCSNEEFKALVLEYMPHGSLEKYM---------YSSNYILDIFQR 272
                 H N++ ++  C++     ++ EY  +G L  ++         YS N   +  ++
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQ 162
Query: 273 L---NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS 329
           L   +++   +   + + F  S   IH D+   NVLL +  VA + DF +A+ +  +   
Sbjct: 163 LSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 222
Query: 330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 370
           + +      + +MAPE   +   +   DV+S+GI+L E F+
Sbjct: 223 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 94/209 (44%), Gaps = 13/209 (6%)
Query: 172 TDGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRH 228
           +D +     +G+G F  V +      G+E A K+ N +    R  +  + E  + + ++H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
            N++++  +   E F  LV + +  G L + + +  +    +   +    +   LE + +
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESIAY 119
Query: 289 GYSAPIIHCDLKPSNVLLDDN---MVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
            +S  I+H +LKP N+LL          L+DF +A  +   + S        T GY++PE
Sbjct: 120 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAGTPGYLSPE 176
Query: 346 YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
             ++   S   D+++ G++L     G  P
Sbjct: 177 VLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 16/204 (7%)
Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKV---FNLQCGRALKGFDVECEMMKSIRHRNLIKVI 235
           +IGRG FG V   R     +V A+K+   F +        F  E ++M       ++++ 
Sbjct: 82  VIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 141
Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
               ++++  +V+EYMP G L   M  SNY +          +V  AL+ +H   S  +I
Sbjct: 142 CAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFYTAEVVLALDAIH---SMGLI 196
Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-LATIGYMAPEY----GREG 350
           H D+KP N+LLD +    L+DF     +  ++  M    T + T  Y++PE     G +G
Sbjct: 197 HRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVHCDTAVGTPDYISPEVLKSQGGDG 254
Query: 351 RVSTNGDVYSFGIMLMETFTGKKP 374
                 D +S G+ L E   G  P
Sbjct: 255 YYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 94/209 (44%), Gaps = 13/209 (6%)
Query: 172 TDGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRH 228
           +D +     +G+G F  V +      G+E A K+ N +    R  +  + E  + + ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
            N++++  +   E F  LV + +  G L + + +  +    +   +    +   LE + +
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESIAY 120
Query: 289 GYSAPIIHCDLKPSNVLLDDN---MVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
            +S  I+H +LKP N+LL          L+DF +A  +   + S        T GY++PE
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAGTPGYLSPE 177
Query: 346 YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
             ++   S   D+++ G++L     G  P
Sbjct: 178 VLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 94/209 (44%), Gaps = 13/209 (6%)
Query: 172 TDGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRH 228
           +D +     +G+G F  V +      G+E A K+ N +    R  +  + E  + + ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
            N++++  +   E F  LV + +  G L + + +  +    +   +    +   LE + +
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESIAY 120
Query: 289 GYSAPIIHCDLKPSNVLLDDN---MVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
            +S  I+H +LKP N+LL          L+DF +A  +   + S        T GY++PE
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAGTPGYLSPE 177
Query: 346 YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
             ++   S   D+++ G++L     G  P
Sbjct: 178 VLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 171 ATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVEC-------EM 222
           AT  +     IG G +G+VYKAR    G  VA+K   +  G   +G  +           
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGE--EGLPISTVREVALLRR 59
Query: 223 MKSIRHRNLIKVISTC----SNEEFK-ALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIM 276
           +++  H N+++++  C    ++ E K  LV E++    L  Y+  +    L      ++M
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLM 118
Query: 277 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 336
                 L++LH      I+H DLKP N+L+       L+DF +A++ + +   M     +
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALDPVV 172
Query: 337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGK 372
            T+ Y APE   +   +T  D++S G +  E F  K
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 18/208 (8%)
Query: 179 NLIGRGGFGSVYKARLGDG--------MEVAVKVFNLQCGRALKGFDVECEMMKSIRHRN 230
            ++G G +G V+  R   G        M+V  K   +Q  +  +    E ++++ IR   
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 231 LIKVISTCSNEEFK-ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMI-DVASALEYLHF 288
            +  +      E K  L+L+Y+  G L  ++       +    + I + ++  ALE+LH 
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE--HEVQIYVGEIVLALEHLH- 176
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
                II+ D+K  N+LLD N    L+DF ++K     D++        TI YMAP+  R
Sbjct: 177 --KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA-DETERAYDFCGTIEYMAPDIVR 233
Query: 349 EGRVSTNG--DVYSFGIMLMETFTGKKP 374
            G    +   D +S G+++ E  TG  P
Sbjct: 234 GGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 171 ATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVEC-------EM 222
           AT  +     IG G +G+VYKAR    G  VA+K   +  G   +G  +           
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGE--EGLPISTVREVALLRR 59
Query: 223 MKSIRHRNLIKVISTC----SNEEFK-ALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIM 276
           +++  H N+++++  C    ++ E K  LV E++    L  Y+  +    L      ++M
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLM 118
Query: 277 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 336
                 L++LH      I+H DLKP N+L+       L+DF +A++ + +   M     +
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALFPVV 172
Query: 337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGK 372
            T+ Y APE   +   +T  D++S G +  E F  K
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/277 (22%), Positives = 113/277 (40%), Gaps = 20/277 (7%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGDGMEV-AVKVF---NLQCGRALKGFDVECEMMKSIRH 228
           D F     +G+G FG+VY AR      + A+KV     L+          E E+   +RH
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
            N++++ +   + +   L+LE+ P G L K +       D  +    M ++A AL Y H 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR-FDEQRSATFMEELADALHYCH- 131
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
                +IH D+KP N+L+       ++DF      +    S+ +     T+ Y+ PE   
Sbjct: 132 --ERKVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPPEMIE 185
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ 408
                   D++  G++  E   G  P +   + E   +        I  +++     LS 
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR--------IVNVDLKFPPFLSD 237
Query: 409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIV 445
                ++K         L ++  +E P  + N+R ++
Sbjct: 238 GSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVL 274

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 78/303 (25%), Positives = 134/303 (44%), Gaps = 46/303 (15%)
Query: 175 FSENNLIGRGGFGSVYKARLG-DGMEVAVK---VFNLQ--CGRALKGFDVECEMMKSIRH 228
           +++   IG G +G V  A        VA+K    F  Q  C R L+    E +++   RH
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLR----EIQILLRFRH 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLN-----IMIDVASAL 283
            N+I +         +A+   Y+    +E  +Y    +L   Q  N      +  +   L
Sbjct: 101 ENVIGIRDILRASTLEAMRDVYIVQDLMETDLYK---LLKSQQLSNDHICYFLYQILRGL 157
Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQTQTLATIGYM 342
           +Y+H   SA ++H DLKPSN+L++      + DF +A++   E D +   T+ +AT  Y 
Sbjct: 158 KYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYR 214
Query: 343 APEYGREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVV 401
           APE     +  T   D++S G +L E  + +     IF G    KH+++    I  + ++
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQLNHI--LGIL 264
Query: 402 GANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNVGD 461
           G+   SQED+         +C+ N+     ++S   +       AKL    DS   ++ D
Sbjct: 265 GSP--SQEDL---------NCIINMKARNYLQSLPSKTKV--AWAKLFPKSDSKALDLLD 311
Query: 462 RCI 464
           R +
Sbjct: 312 RML 314

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 92/210 (43%), Gaps = 13/210 (6%)
Query: 180 LIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEM------MKSIRHRNLIK 233
           +IG+G FG V  AR     EV   V  LQ    LK  + +  M      +K+++H  L+ 
Sbjct: 45  VIGKGSFGKVLLAR-HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
           +  +    +    VL+Y+  G L  ++      L+   R     ++ASAL YLH   S  
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SLN 159
Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVS 353
           I++ DLKP N+LLD      L+DF + K     + + T +    T  Y+APE   +    
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVLHKQPYD 217
Query: 354 TNGDVYSFGIMLMETFTGKKPTNEIFNGEM 383
              D +  G +L E   G  P       EM
Sbjct: 218 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 247

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 16/204 (7%)
Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKV---FNLQCGRALKGFDVECEMMKSIRHRNLIKVI 235
           +IGRG FG V   R     +V A+K+   F +        F  E ++M       ++++ 
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSAPI 294
               ++ +  +V+EYMP G L   M  SNY + + + R     +V  AL+ +H   S   
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARF-YTAEVVLALDAIH---SMGF 189
Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE----YGREG 350
           IH D+KP N+LLD +    L+DF     +  E      T  + T  Y++PE     G +G
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDG 248
Query: 351 RVSTNGDVYSFGIMLMETFTGKKP 374
                 D +S G+ L E   G  P
Sbjct: 249 YYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 101/233 (43%), Gaps = 44/233 (18%)
Query: 171 ATDGFSEN----NLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKGFDV------- 218
           +T GF EN     ++GRG    V +        E AVK+ ++  G +    +V       
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 219 --ECEMMKSIR-HRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQR--L 273
             E ++++ +  H N+I++  T     F  LV + M  G L  Y+     + +   R  +
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM 130
Query: 274 NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 333
             +++V  AL  L+      I+H DLKP N+LLDD+M   L+DF  +  L   D      
Sbjct: 131 RALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLR 181
Query: 334 QTLATIGYMAPE------------YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           +   T  Y+APE            YG+E       D++S G+++     G  P
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIMYTLLAGSPP 228

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 16/204 (7%)
Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKV---FNLQCGRALKGFDVECEMMKSIRHRNLIKVI 235
           +IGRG FG V   R     +V A+K+   F +        F  E ++M       ++++ 
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 140
Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSAPI 294
               ++ +  +V+EYMP G L   M  SNY + + + R     +V  AL+ +H   S   
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARF-YTAEVVLALDAIH---SMGF 194
Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE----YGREG 350
           IH D+KP N+LLD +    L+DF     +  E      T  + T  Y++PE     G +G
Sbjct: 195 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDG 253
Query: 351 RVSTNGDVYSFGIMLMETFTGKKP 374
                 D +S G+ L E   G  P
Sbjct: 254 YYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 94/209 (44%), Gaps = 13/209 (6%)
Query: 172 TDGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRH 228
           +D +     +G+G F  V +      G+E A K+ N +    R  +  + E  + + ++H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
            N++++  +   E F  LV + +  G L + + +  +    +   +    +   LE + +
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESIAY 143
Query: 289 GYSAPIIHCDLKPSNVLLDDN---MVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
            +S  I+H +LKP N+LL          L+DF +A  +   + S        T GY++PE
Sbjct: 144 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAGTPGYLSPE 200
Query: 346 YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
             ++   S   D+++ G++L     G  P
Sbjct: 201 VLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 16/204 (7%)
Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKV---FNLQCGRALKGFDVECEMMKSIRHRNLIKVI 235
           +IGRG FG V   R     +V A+K+   F +        F  E ++M       ++++ 
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 140
Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSAPI 294
               ++ +  +V+EYMP G L   M  SNY + + + R     +V  AL+ +H   S   
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARF-YTAEVVLALDAIH---SMGF 194
Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE----YGREG 350
           IH D+KP N+LLD +    L+DF     +  E      T  + T  Y++PE     G +G
Sbjct: 195 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDG 253
Query: 351 RVSTNGDVYSFGIMLMETFTGKKP 374
                 D +S G+ L E   G  P
Sbjct: 254 YYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 95/195 (48%), Gaps = 8/195 (4%)
Query: 181 IGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           IG G  G V  AR    G +VAVK+ +L+  +  +    E  +M+  +H N++++  +  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
             E   +++E++  G+L   +  S   L+  Q   +   V  AL YLH   +  +IH D+
Sbjct: 113 VGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDI 167
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVY 359
           K  ++LL  +    LSDF     ++ +     +   + T  +MAPE       +T  D++
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKXLVGTPYWMAPEVISRSLYATEVDIW 225
Query: 360 SFGIMLMETFTGKKP 374
           S GIM++E   G+ P
Sbjct: 226 SLGIMVIEMVDGEPP 240

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 18/211 (8%)
Query: 180 LIGRGGFGSVYKARLGDG--------MEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNL 231
           ++G+GG+G V++ R   G        M+V  K   ++  +       E  +++ ++H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 232 IKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
           + +I          L+LEY+  G L   +      ++       + +++ AL +LH    
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHLH---Q 139
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGR 351
             II+ DLKP N++L+      L+DF + K  +  D ++T T    TI YMAPE      
Sbjct: 140 KGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHT-FCGTIEYMAPEILMRSG 197
Query: 352 VSTNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
            +   D +S G ++ +  TG  P    F GE
Sbjct: 198 HNRAVDWWSLGALMYDMLTGAPP----FTGE 224

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 120/268 (44%), Gaps = 28/268 (10%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           IG G  G V  A     G +VAVK  +L+  +  +    E  +M+   H N++ + S+  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
             +   +V+E++  G+L   +  +   ++  Q   + + V  AL YLH   +  +IH D+
Sbjct: 113 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDI 167
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVY 359
           K  ++LL  +    LSDF     ++ E     +   + T  +MAPE        T  D++
Sbjct: 168 KSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKXLVGTPYWMAPEVISRLPYGTEVDIW 225
Query: 360 SFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ-EDIHFVAKEQ 418
           S GIM++E   G+ P    FN             P+  M  +  +L  + +D+H V+   
Sbjct: 226 SLGIMVIEMIDGEPP---YFNEP-----------PLQAMRRIRDSLPPRVKDLHKVSS-- 269
Query: 419 CVSCVFNLAMECTVESPEQRINAREIVA 446
            +    +L +   V  P QR  A+E++ 
Sbjct: 270 VLRGFLDLML---VREPSQRATAQELLG 294

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 94/226 (41%), Gaps = 31/226 (13%)
Query: 169 CRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIR 227
            R    F E  ++G+G FG V KAR   D    A+K         L     E  ++ S+ 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLN 60
Query: 228 H-------------RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLN 274
           H             RN +K ++    +    + +EY  + +L   ++S N      +   
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWR 120
Query: 275 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK-------LLTGED 327
           +   +  AL Y+H   S  IIH DLKP N+ +D++    + DF +AK       +L  + 
Sbjct: 121 LFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 328 QSM-----TQTQTLATIGYMAPEY-GREGRVSTNGDVYSFGIMLME 367
           Q++       T  + T  Y+A E     G  +   D+YS GI+  E
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 17/210 (8%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRALKGFDVECEMM 223
           + + F +   IG G +G VYKAR    G  VA+K   L          A++    E  ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLL 59
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
           K + H N++K++     E    LV E++    L+K+M +S   L       I   +   L
Sbjct: 60  KELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASA--LTGIPLPLIKSYLFQLL 116
Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           + L F +S  ++H DLKP N+L++      L+DF +A+      +  T    + T+ Y A
Sbjct: 117 QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRA 174
Query: 344 PEYGREGR-VSTNGDVYSFGIMLMETFTGK 372
           PE     +  ST  D++S G +  E  T +
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 17/210 (8%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRALKGFDVECEMM 223
           + + F +   IG G +G VYKAR    G  VA+K   L          A++    E  ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLL 57
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
           K + H N++K++     E    LV E++    L+K+M +S   L       I   +   L
Sbjct: 58  KELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASA--LTGIPLPLIKSYLFQLL 114
Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           + L F +S  ++H DLKP N+L++      L+DF +A+      +  T    + T+ Y A
Sbjct: 115 QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRA 172
Query: 344 PEYGREGR-VSTNGDVYSFGIMLMETFTGK 372
           PE     +  ST  D++S G +  E  T +
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 181 IGRGGFGSVYK-ARLGDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G+G F  V +  ++  G E A K+ N +    R  +  + E  + + ++H N++++  +
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
            S E    L+ + +  G L + + +  Y    +   +    +   LE +   +   ++H 
Sbjct: 90  ISEEGHHYLIFDLVTGGELFEDIVAREY----YSEADASHCIQQILEAVLHCHQMGVVHR 145
Query: 298 DLKPSNVLLDDNM---VAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVST 354
           DLKP N+LL   +      L+DF +A  + GE Q+        T GY++PE  R+     
Sbjct: 146 DLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYLSPEVLRKDPYGK 203
Query: 355 NGDVYSFGIMLMETFTGKKP 374
             D+++ G++L     G  P
Sbjct: 204 PVDLWACGVILYILLVGYPP 223

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 22/217 (10%)
Query: 171 ATDGFSENNLIGRGGFGSVYKAR-LGDGMEVA---VKVFNLQCGRALKGFDVECEM---- 222
           AT  +     IG G +G+VYKAR    G  VA   V+V N   G          E+    
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 223 -MKSIRHRNLIKVISTC----SNEEFK-ALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNI 275
            +++  H N+++++  C    ++ E K  LV E++    L  Y+  +    L      ++
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDL 125
Query: 276 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 335
           M      L++LH      I+H DLKP N+L+       L+DF +A++ + +   M  T  
Sbjct: 126 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALTPV 179
Query: 336 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGK 372
           + T+ Y APE   +   +T  D++S G +  E F  K
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 44/233 (18%)
Query: 171 ATDGFSEN----NLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKGFDV------- 218
           +T GF EN     ++GRG    V +        E AVK+ ++  G +    +V       
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 219 --ECEMMKSIR-HRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQR--L 273
             E ++++ +  H N+I++  T     F  LV + M  G L  Y+     + +   R  +
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM 130
Query: 274 NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 333
             +++V  AL  L+      I+H DLKP N+LLDD+M   L+DF  +  L   D      
Sbjct: 131 RALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLR 181
Query: 334 QTLATIGYMAPE------------YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
               T  Y+APE            YG+E       D++S G+++     G  P
Sbjct: 182 SVCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIMYTLLAGSPP 228

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 17/210 (8%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRALKGFDVECEMM 223
           + + F +   IG G +G VYKAR    G  VA+K   L          A++    E  ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLL 59
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
           K + H N++K++     E    LV E++    L+K+M +S   L       I   +   L
Sbjct: 60  KELNHPNIVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDASA--LTGIPLPLIKSYLFQLL 116
Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           + L F +S  ++H DLKP N+L++      L+DF +A+      +  T    + T+ Y A
Sbjct: 117 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRA 174
Query: 344 PEYGREGR-VSTNGDVYSFGIMLMETFTGK 372
           PE     +  ST  D++S G +  E  T +
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 126/267 (47%), Gaps = 48/267 (17%)
Query: 175 FSENNLIGRGGFGSVYKARLG-DGMEVAVK---VFNLQ--CGRALKGFDVECEMMKSIRH 228
           ++  + IG G +G V  A    + + VA+K    F  Q  C R L+    E +++   RH
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRH 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSN-YILDIFQRLN------IMIDVAS 281
            N+I +     N+  +A  +E M    L  ++  ++ Y L   Q L+       +  +  
Sbjct: 101 ENIIGI-----NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILR 155
Query: 282 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQTQTLATIG 340
            L+Y+H   SA ++H DLKPSN+LL+      + DF +A++   + D +   T+ +AT  
Sbjct: 156 GLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 341 YMAPEYGREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTME 399
           Y APE     +  T   D++S G +L E  + +     IF G    KH+++    I  + 
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQLNHI--LG 262
Query: 400 VVGANLLSQEDIHFVAKEQCVSCVFNL 426
           ++G+   SQED+         +C+ NL
Sbjct: 263 ILGSP--SQEDL---------NCIINL 278

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     IG G FG V   + +  G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EYMP G +  ++       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     IG G FG V   + +  G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EYMP G +  ++       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVIST 237
           IG+G F  V  AR +  G EVAVK+ +       +L+    E  + K + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
              E+   LV EY   G +  Y+ +     +   R      + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVS-TNG 356
           DLK  N+LLD +    ++DF  +   T  ++            Y APE  +  +      
Sbjct: 138 DLKAENLLLDADXNIKIADFGFSNEFTFGNKL---DAFCGAPPYAAPELFQGKKYDGPEV 194
Query: 357 DVYSFGIMLMETFTGKKPTNEIFNGE 382
           DV+S G++L    +G  P    F+G+
Sbjct: 195 DVWSLGVILYTLVSGSLP----FDGQ 216

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 97/231 (41%), Gaps = 38/231 (16%)
Query: 175 FSENNL-----IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIR- 227
           F  NNL     +G G FG V +A   G G E AV    ++  ++    D +  +M  ++ 
Sbjct: 28  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 87
Query: 228 ------HRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMY-------------------- 261
                 H N++ ++  C++     ++ EY  +G L  ++                     
Sbjct: 88  MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGL 147
Query: 262 --SSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSI 319
                  L++   L+    VA  + +L    S   IH D+   NVLL +  VA + DF +
Sbjct: 148 DKEDGRPLELRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGL 204
Query: 320 AKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 370
           A+ +  +   + +      + +MAPE   +   +   DV+S+GI+L E F+
Sbjct: 205 ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 15/207 (7%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   + +  G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+P G +  ++       +   R      +    EYLH 
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 144
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-ATIGYMAPEYG 347
             S  +I+ DLKP N+L+D      ++DF  AK + G      +T TL  T  Y+APE  
Sbjct: 145 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEYLAPEII 196
Query: 348 REGRVSTNGDVYSFGIMLMETFTGKKP 374
                +   D ++ G+++ E   G  P
Sbjct: 197 LSKGYNKAVDWWALGVLIYEMAAGYPP 223

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/286 (23%), Positives = 133/286 (46%), Gaps = 31/286 (10%)
Query: 173 DGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQCGRALKGFDV-ECEMMKSIRHRN 230
           D F + + +G G  G V+K +    G+ +A K+ +L+   A++   + E +++       
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILD-IFQRLNIMIDVASALEYLHFG 289
           ++       ++   ++ +E+M  GSL++ +  +  I + I  +++I   V   L YL   
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 126
Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 349
           +   I+H D+KPSN+L++      L DF ++  L  E       + + T  YM+PE  + 
Sbjct: 127 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE----MANEFVGTRSYMSPERLQG 180
Query: 350 GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
              S   D++S G+ L+E   G+ P   +   E+ L + VN+  P      + + + S E
Sbjct: 181 THYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFEL-LDYIVNEPPP-----KLPSAVFSLE 234
Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREI-VAKLLKIRDS 454
              FV K             C +++P +R + +++ V   +K  D+
Sbjct: 235 FQDFVNK-------------CLIKNPAERADLKQLMVHAFIKRSDA 267

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 25/209 (11%)
Query: 181 IGRGGFGSVYKARLG-DGMEVAVK----VFNL--QCGRALKGFDVECEMMKSIRHRNLIK 233
           IG G +G V  AR    G +VA+K     F++     R L+    E +++K  +H N+I 
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR----ELKILKHFKHDNIIA 117
Query: 234 VIS----TCSNEEFKAL--VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLH 287
           +      T    EFK++  VL+ M    L + ++SS   L +      +  +   L+Y+H
Sbjct: 118 IKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH 175
Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL--TGEDQSMTQTQTLATIGYMAPE 345
              SA +IH DLKPSN+L+++N    + DF +A+ L  +  +     T+ +AT  Y APE
Sbjct: 176 ---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 232
Query: 346 YGREGRVSTNG-DVYSFGIMLMETFTGKK 373
                   T   D++S G +  E    ++
Sbjct: 233 LMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 123/261 (47%), Gaps = 48/261 (18%)
Query: 181 IGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CGRALKGFDVECEMMKSIRHRNLIKV 234
           IG G +G V  A    + + VA+K    F  Q  C R L+    E +++ + RH N+I +
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLAFRHENIIGI 88
Query: 235 ISTCSNEEFKALVLEYMPHGSL-EKYMYSSNYILDIFQRLN------IMIDVASALEYLH 287
                N+  +A  +E M    + +  M +  Y L   Q L+       +  +   L+Y+H
Sbjct: 89  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 143
Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQTQTLATIGYMAPEY 346
              SA ++H DLKPSN+LL+      + DF +A++   + D +   T+ +AT  Y APE 
Sbjct: 144 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL 405
               +  T   D++S G +L E  + +     IF G    KH+++    I  + ++G+  
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQLNHI--LGILGSP- 249
Query: 406 LSQEDIHFVAKEQCVSCVFNL 426
            SQED+         +C+ NL
Sbjct: 250 -SQEDL---------NCIINL 260

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 15/207 (7%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   + +  G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+P G +  ++       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-ATIGYMAPEYG 347
             S  +I+ DLKP N+L+D      ++DF  AK + G      +T TL  T  Y+APE  
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEYLAPEII 211
Query: 348 REGRVSTNGDVYSFGIMLMETFTGKKP 374
                +   D ++ G+++ E   G  P
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 25/209 (11%)
Query: 181 IGRGGFGSVYKARLG-DGMEVAVK----VFNL--QCGRALKGFDVECEMMKSIRHRNLIK 233
           IG G +G V  AR    G +VA+K     F++     R L+    E +++K  +H N+I 
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR----ELKILKHFKHDNIIA 118
Query: 234 VIS----TCSNEEFKAL--VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLH 287
           +      T    EFK++  VL+ M    L + ++SS   L +      +  +   L+Y+H
Sbjct: 119 IKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH 176
Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL--TGEDQSMTQTQTLATIGYMAPE 345
              SA +IH DLKPSN+L+++N    + DF +A+ L  +  +     T+ +AT  Y APE
Sbjct: 177 ---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 233
Query: 346 YGREGRVSTNG-DVYSFGIMLMETFTGKK 373
                   T   D++S G +  E    ++
Sbjct: 234 LMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 98/218 (44%), Gaps = 28/218 (12%)
Query: 181 IGRGGFGSVYK-ARLGDGMEVAVK-----VFNLQCGRALKGFDVECEMMKSIRHRNLIKV 234
           IGRG +GSV K      G  +AVK     V   +  + L   DV   +M+S     +++ 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDV---VMRSSDCPYIVQF 86
Query: 235 ISTCSNEEFKALVLEYMPHG--SLEKYMYSSNYILD--IFQRLNIMIDVASALEYLHFGY 290
                 E    + +E M        KY+YS   +LD  I + +   I +A+     H   
Sbjct: 87  YGALFREGDCWICMELMSTSFDKFYKYVYS---VLDDVIPEEILGKITLATVKALNHLKE 143
Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY---- 346
           +  IIH D+KPSN+LLD +    L DF I+  L     S+ +T+      YMAPE     
Sbjct: 144 NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDAGCRPYMAPERIDPS 200
Query: 347 -GREGRVSTNGDVYSFGIMLMETFTGKKPT---NEIFN 380
             R+G      DV+S GI L E  TG+ P    N +F+
Sbjct: 201 ASRQG-YDVRSDVWSLGITLYELATGRFPYPKWNSVFD 237

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 99/230 (43%), Gaps = 44/230 (19%)
Query: 174 GFSEN----NLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKGFDV---------E 219
           GF EN     ++GRG    V +        E AVK+ ++  G +    +V         E
Sbjct: 1   GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 60
Query: 220 CEMMKSIR-HRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQR--LNIM 276
            ++++ +  H N+I++  T     F  LV + M  G L  Y+     + +   R  +  +
Sbjct: 61  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 120
Query: 277 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 336
           ++V  AL  L+      I+H DLKP N+LLDD+M   L+DF  +  L   D      +  
Sbjct: 121 LEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVC 171
Query: 337 ATIGYMAPE------------YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
            T  Y+APE            YG+E       D++S G+++     G  P
Sbjct: 172 GTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIMYTLLAGSPP 215

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 122/261 (46%), Gaps = 48/261 (18%)
Query: 181 IGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CGRALKGFDVECEMMKSIRHRNLIKV 234
           IG G +G V  A    + + VA+K    F  Q  C R L+    E +++   RH N+I +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 235 ISTCSNEEFKALVLEYMPHGSL-EKYMYSSNYILDIFQRLN------IMIDVASALEYLH 287
                N+  +A  +E M    + +  M +  Y L   Q L+       +  +   L+Y+H
Sbjct: 91  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQTQTLATIGYMAPEY 346
              SA ++H DLKPSN+LL+      + DF +A++   + D +   T+ +AT  Y APE 
Sbjct: 146 ---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL 405
               +  T   D++S G +L E  + +     IF G    KH+++    I  + ++G+  
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQLNHI--LGILGSP- 251
Query: 406 LSQEDIHFVAKEQCVSCVFNL 426
            SQED+         +C+ NL
Sbjct: 252 -SQEDL---------NCIINL 262

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 105/234 (44%), Gaps = 21/234 (8%)
Query: 175 FSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
           ++  N IGRG +G V  A + G  +  A K         +  F  E E+MKS+ H N+I+
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 234 VISTCSNEEFKALVLEYMPHGSL-EKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
           +  T  +     LV+E    G L E+ ++   +      R  IM DV SA+ Y H     
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR--IMKDVLSAVAYCH---KL 125
Query: 293 PIIHCDLKPSNVL-LDDNMVAHLS--DFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 349
            + H DLKP N L L D+  + L   DF +A     +   M +T+ + T  Y++P+   E
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMMRTK-VGTPYYVSPQV-LE 181
Query: 350 GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLK-------HWVNDWLPIS 396
           G      D +S G+M+     G  P +   + E+ LK           DWL +S
Sbjct: 182 GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVS 235

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 122/252 (48%), Gaps = 24/252 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQ--CGRALKG-FDVECEMMKSIRHRNLIKVIS 236
           +G G FG V  A     G +VA+K+ N +      ++G  + E   ++ +RH ++IK+  
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
              +++   +V+EY  +  L  Y+   + + +   R      + SA+EY H      I+H
Sbjct: 76  VIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCH---RHKIVH 130
Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 356
            DLKP N+LLD+++   ++DF ++ ++T  D +  +T +  +  Y APE    G++    
Sbjct: 131 RDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAPEV-ISGKLYAGP 186
Query: 357 --DVYSFGIMLMETFTGKKPTNE---------IFNGEMTLKHWVNDWLPISTMEVVGANL 405
             DV+S G++L      + P ++         I NG  TL  +++         ++  N 
Sbjct: 187 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNP 246
Query: 406 LSQEDIHFVAKE 417
           L++  IH + ++
Sbjct: 247 LNRISIHEIMQD 258

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 122/252 (48%), Gaps = 24/252 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQ--CGRALKG-FDVECEMMKSIRHRNLIKVIS 236
           +G G FG V  A     G +VA+K+ N +      ++G  + E   ++ +RH ++IK+  
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
              +++   +V+EY  +  L  Y+   + + +   R      + SA+EY H      I+H
Sbjct: 72  VIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCH---RHKIVH 126
Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 356
            DLKP N+LLD+++   ++DF ++ ++T  D +  +T +  +  Y APE    G++    
Sbjct: 127 RDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAPEV-ISGKLYAGP 182
Query: 357 --DVYSFGIMLMETFTGKKPTNE---------IFNGEMTLKHWVNDWLPISTMEVVGANL 405
             DV+S G++L      + P ++         I NG  TL  +++         ++  N 
Sbjct: 183 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNP 242
Query: 406 LSQEDIHFVAKE 417
           L++  IH + ++
Sbjct: 243 LNRISIHEIMQD 254

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 180 LIGRGGFGSVYKARLGDG--------MEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNL 231
           ++G+GG+G V++ R   G        M+V  K   ++  +       E  +++ ++H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 232 IKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
           + +I          L+LEY+  G L   +      ++       + +++ AL +LH    
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHLH---Q 139
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGR 351
             II+ DLKP N++L+      L+DF + K  +  D ++T      TI YMAPE      
Sbjct: 140 KGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHX-FCGTIEYMAPEILMRSG 197
Query: 352 VSTNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
            +   D +S G ++ +  TG  P    F GE
Sbjct: 198 HNRAVDWWSLGALMYDMLTGAPP----FTGE 224

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 122/261 (46%), Gaps = 48/261 (18%)
Query: 181 IGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CGRALKGFDVECEMMKSIRHRNLIKV 234
           IG G +G V  A    + + VA+K    F  Q  C R L+    E +++   RH N+I +
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 86
Query: 235 ISTCSNEEFKALVLEYMPHGSL-EKYMYSSNYILDIFQRLN------IMIDVASALEYLH 287
                N+  +A  +E M    + +  M +  Y L   Q L+       +  +   L+Y+H
Sbjct: 87  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQTQTLATIGYMAPEY 346
              SA ++H DLKPSN+LL+      + DF +A++   + D +   T+ +AT  Y APE 
Sbjct: 142 ---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL 405
               +  T   D++S G +L E  + +     IF G    KH+++    I  + ++G+  
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQLNHI--LGILGSP- 247
Query: 406 LSQEDIHFVAKEQCVSCVFNL 426
            SQED+         +C+ NL
Sbjct: 248 -SQEDL---------NCIINL 258

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 122/261 (46%), Gaps = 48/261 (18%)
Query: 181 IGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CGRALKGFDVECEMMKSIRHRNLIKV 234
           IG G +G V  A    + + VA+K    F  Q  C R L+    E +++   RH N+I +
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 91
Query: 235 ISTCSNEEFKALVLEYMPHGSL-EKYMYSSNYILDIFQRLN------IMIDVASALEYLH 287
                N+  +A  +E M    + +  M +  Y L   Q L+       +  +   L+Y+H
Sbjct: 92  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 146
Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQTQTLATIGYMAPEY 346
              SA ++H DLKPSN+LL+      + DF +A++   + D +   T+ +AT  Y APE 
Sbjct: 147 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 203
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL 405
               +  T   D++S G +L E  + +     IF G    KH+++    I  + ++G+  
Sbjct: 204 MLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQLNHI--LGILGSP- 252
Query: 406 LSQEDIHFVAKEQCVSCVFNL 426
            SQED+         +C+ NL
Sbjct: 253 -SQEDL---------NCIINL 263

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 122/261 (46%), Gaps = 48/261 (18%)
Query: 181 IGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CGRALKGFDVECEMMKSIRHRNLIKV 234
           IG G +G V  A    + + VA+K    F  Q  C R L+    E +++   RH N+I +
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 92
Query: 235 ISTCSNEEFKALVLEYMPHGSL-EKYMYSSNYILDIFQRLN------IMIDVASALEYLH 287
                N+  +A  +E M    + +  M +  Y L   Q L+       +  +   L+Y+H
Sbjct: 93  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 147
Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQTQTLATIGYMAPEY 346
              SA ++H DLKPSN+LL+      + DF +A++   + D +   T+ +AT  Y APE 
Sbjct: 148 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 204
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL 405
               +  T   D++S G +L E  + +     IF G    KH+++    I  + ++G+  
Sbjct: 205 MLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQLNHI--LGILGSP- 253
Query: 406 LSQEDIHFVAKEQCVSCVFNL 426
            SQED+         +C+ NL
Sbjct: 254 -SQEDL---------NCIINL 264

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 122/261 (46%), Gaps = 48/261 (18%)
Query: 181 IGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CGRALKGFDVECEMMKSIRHRNLIKV 234
           IG G +G V  A    + + VA+K    F  Q  C R L+    E +++   RH N+I +
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 83
Query: 235 ISTCSNEEFKALVLEYMPHGSL-EKYMYSSNYILDIFQRLN------IMIDVASALEYLH 287
                N+  +A  +E M    + +  M +  Y L   Q L+       +  +   L+Y+H
Sbjct: 84  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 138
Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQTQTLATIGYMAPEY 346
              SA ++H DLKPSN+LL+      + DF +A++   + D +   T+ +AT  Y APE 
Sbjct: 139 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 195
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL 405
               +  T   D++S G +L E  + +     IF G    KH+++    I  + ++G+  
Sbjct: 196 MLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQLNHI--LGILGSP- 244
Query: 406 LSQEDIHFVAKEQCVSCVFNL 426
            SQED+         +C+ NL
Sbjct: 245 -SQEDL---------NCIINL 255

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 34/213 (15%)
Query: 180 LIGRGGFGSVY--KARLGDGMEVAVKVFNLQCGRALKGF-----DVECEMMKSIRHRNLI 232
           ++G G F  V+  K RL        K+F L+C +    F     + E  ++K I+H N++
Sbjct: 16  VLGSGAFSEVFLVKQRLTG------KLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIV 69
Query: 233 KVISTCSNEEFKALVLEYMPHGSL-----EKYMYSSNYILDIFQRLNIMIDVASALEYLH 287
            +     +     LV++ +  G L     E+ +Y+      + Q+      V SA++YLH
Sbjct: 70  TLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ------VLSAVKYLH 123
Query: 288 FGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
                 I+H DLKP N+L    ++N    ++DF ++K+    +Q+   +    T GY+AP
Sbjct: 124 ---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAP 176
Query: 345 EYGREGRVSTNGDVYSFGIMLMETFTGKKPTNE 377
           E   +   S   D +S G++      G  P  E
Sbjct: 177 EVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE 209

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 122/261 (46%), Gaps = 48/261 (18%)
Query: 181 IGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CGRALKGFDVECEMMKSIRHRNLIKV 234
           IG G +G V  A    + + VA+K    F  Q  C R L+    E +++   RH N+I +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 235 ISTCSNEEFKALVLEYMPHGSL-EKYMYSSNYILDIFQRLN------IMIDVASALEYLH 287
                N+  +A  +E M    + +  M +  Y L   Q L+       +  +   L+Y+H
Sbjct: 91  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQTQTLATIGYMAPEY 346
              SA ++H DLKPSN+LL+      + DF +A++   + D +   T+ +AT  Y APE 
Sbjct: 146 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL 405
               +  T   D++S G +L E  + +     IF G    KH+++    I  + ++G+  
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQLNHI--LGILGSP- 251
Query: 406 LSQEDIHFVAKEQCVSCVFNL 426
            SQED+         +C+ NL
Sbjct: 252 -SQEDL---------NCIINL 262

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQ--CGRALKG-FDVECEMMKSIRHRNLIKVIS 236
           +G G FG V  A     G +VA+K+ N +      ++G  + E   ++ +RH ++IK+  
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
              +++   +V+EY  +  L  Y+   + + +   R      + SA+EY H      I+H
Sbjct: 81  VIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCH---RHKIVH 135
Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 356
            DLKP N+LLD+++   ++DF ++ ++T  D +  +T +  +  Y APE    G++    
Sbjct: 136 RDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAPEV-ISGKLYAGP 191
Query: 357 --DVYSFGIMLMETFTGKKPTNE 377
             DV+S G++L      + P ++
Sbjct: 192 EVDVWSCGVILYVMLCRRLPFDD 214

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 96/231 (41%), Gaps = 29/231 (12%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKG----FDVECEMMKSIRHRNLIKVI- 235
           IGRG F +VYK  L     V V    LQ  +  K     F  E E +K ++H N+++   
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 236 ---STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMI------DVASALEYL 286
              ST   ++   LV E    G+L+ Y       L  F+   I +       +   L++L
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTY-------LKRFKVXKIKVLRSWCRQILKGLQFL 145
Query: 287 HFGYSAPIIHCDLKPSNVLLDD-NMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
           H   + PIIH DLK  N+ +        + D  +A L     ++      + T  + APE
Sbjct: 146 H-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFXAPE 200
Query: 346 YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS 396
              E +   + DVY+FG   +E  T + P +E  N     +   +   P S
Sbjct: 201 XYEE-KYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPAS 250

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 122/261 (46%), Gaps = 48/261 (18%)
Query: 181 IGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CGRALKGFDVECEMMKSIRHRNLIKV 234
           IG G +G V  A    + + VA+K    F  Q  C R L+    E +++   RH N+I +
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 84
Query: 235 ISTCSNEEFKALVLEYMPHGSL-EKYMYSSNYILDIFQRLN------IMIDVASALEYLH 287
                N+  +A  +E M    + +  M +  Y L   Q L+       +  +   L+Y+H
Sbjct: 85  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 139
Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQTQTLATIGYMAPEY 346
              SA ++H DLKPSN+LL+      + DF +A++   + D +   T+ +AT  Y APE 
Sbjct: 140 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 196
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL 405
               +  T   D++S G +L E  + +     IF G    KH+++    I  + ++G+  
Sbjct: 197 MLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQLNHI--LGILGSP- 245
Query: 406 LSQEDIHFVAKEQCVSCVFNL 426
            SQED+         +C+ NL
Sbjct: 246 -SQEDL---------NCIINL 256

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQ--CGRALKG-FDVECEMMKSIRHRNLIKVIS 236
           +G G FG V  A     G +VA+K+ N +      ++G  + E   ++ +RH ++IK+  
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
              +++   +V+EY  +  L  Y+   + + +   R      + SA+EY H      I+H
Sbjct: 82  VIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCH---RHKIVH 136
Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 356
            DLKP N+LLD+++   ++DF ++ ++T  D +  +T +  +  Y APE    G++    
Sbjct: 137 RDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAPEV-ISGKLYAGP 192
Query: 357 --DVYSFGIMLMETFTGKKPTNE 377
             DV+S G++L      + P ++
Sbjct: 193 EVDVWSCGVILYVMLCRRLPFDD 215

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 105/234 (44%), Gaps = 21/234 (8%)
Query: 175 FSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
           ++  N IGRG +G V  A + G  +  A K         +  F  E E+MKS+ H N+I+
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 234 VISTCSNEEFKALVLEYMPHGSL-EKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
           +  T  +     LV+E    G L E+ ++   +      R  IM DV SA+ Y H     
Sbjct: 88  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR--IMKDVLSAVAYCH---KL 142
Query: 293 PIIHCDLKPSNVL-LDDNMVAHLS--DFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 349
            + H DLKP N L L D+  + L   DF +A     +   M +T+ + T  Y++P+   E
Sbjct: 143 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMMRTK-VGTPYYVSPQV-LE 198
Query: 350 GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLK-------HWVNDWLPIS 396
           G      D +S G+M+     G  P +   + E+ LK           DWL +S
Sbjct: 199 GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVS 252

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 125/267 (46%), Gaps = 48/267 (17%)
Query: 175 FSENNLIGRGGFGSVYKARLG-DGMEVAVK---VFNLQ--CGRALKGFDVECEMMKSIRH 228
           ++  + IG G +G V  A    + + VA+K    F  Q  C R L+    E +++   RH
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRH 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSL-EKYMYSSNYILDIFQRLN------IMIDVAS 281
            N+I +     N+  +A  +E M    + +  M +  Y L   Q L+       +  +  
Sbjct: 101 ENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR 155
Query: 282 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQTQTLATIG 340
            L+Y+H   SA ++H DLKPSN+LL+      + DF +A++   + D +   T+ +AT  
Sbjct: 156 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 341 YMAPEYGREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTME 399
           Y APE     +  T   D++S G +L E  + +     IF G    KH+++    I  + 
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQLNHI--LG 262
Query: 400 VVGANLLSQEDIHFVAKEQCVSCVFNL 426
           ++G+   SQED+         +C+ NL
Sbjct: 263 ILGSP--SQEDL---------NCIINL 278

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 126/267 (47%), Gaps = 39/267 (14%)
Query: 181 IGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CGRALKGFDVECEMMKSIRHRNLIKV 234
           IG G +G V  A    + + VA+K    F  Q  C R L+    E +++   RH N+I +
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 86
Query: 235 ISTCSNEEFKALVLEYMPHGSL-EKYMYSSNYILDIFQRLN------IMIDVASALEYLH 287
                N+  +A  +E M    + +  M +  Y L   Q L+       +  +   L+Y+H
Sbjct: 87  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQTQTLATIGYMAPEY 346
              SA ++H DLKPSN+LL+      + DF +A++   + D +   T+ +AT  Y APE 
Sbjct: 142 ---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL 405
               +  T   D++S G +L E  + +     IF G    KH+++    I  + ++G+  
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQLNHI--LGILGSP- 247
Query: 406 LSQEDIHFVAKEQCVSCVFNLAMECTV 432
            SQED++ +   +  + + +L  +  V
Sbjct: 248 -SQEDLNXIINLKARNYLLSLPHKNKV 273

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 122/261 (46%), Gaps = 48/261 (18%)
Query: 181 IGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CGRALKGFDVECEMMKSIRHRNLIKV 234
           IG G +G V  A    + + VA+K    F  Q  C R L+    E +++   RH N+I +
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 86
Query: 235 ISTCSNEEFKALVLEYMPHGSL-EKYMYSSNYILDIFQRLN------IMIDVASALEYLH 287
                N+  +A  +E M    + +  M +  Y L   Q L+       +  +   L+Y+H
Sbjct: 87  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQTQTLATIGYMAPEY 346
              SA ++H DLKPSN+LL+      + DF +A++   + D +   T+ +AT  Y APE 
Sbjct: 142 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL 405
               +  T   D++S G +L E  + +     IF G    KH+++    I  + ++G+  
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQLNHI--LGILGSP- 247
Query: 406 LSQEDIHFVAKEQCVSCVFNL 426
            SQED+         +C+ NL
Sbjct: 248 -SQEDL---------NCIINL 258

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 125/267 (46%), Gaps = 48/267 (17%)
Query: 175 FSENNLIGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CGRALKGFDVECEMMKSIRH 228
           ++  + IG G +G V  A    + + VA+K    F  Q  C R L+    E +++   RH
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRH 84
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSL-EKYMYSSNYILDIFQRLN------IMIDVAS 281
            N+I +     N+  +A  +E M    + +  M +  Y L   Q L+       +  +  
Sbjct: 85  ENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILR 139
Query: 282 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQTQTLATIG 340
            L+Y+H   SA ++H DLKPSN+LL+      + DF +A++   + D +   T+ +AT  
Sbjct: 140 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 341 YMAPEYGREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTME 399
           Y APE     +  T   D++S G +L E  + +     IF G    KH+++    I  + 
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQLNHI--LG 246
Query: 400 VVGANLLSQEDIHFVAKEQCVSCVFNL 426
           ++G+   SQED+         +C+ NL
Sbjct: 247 ILGSP--SQEDL---------NCIINL 262

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 122/261 (46%), Gaps = 48/261 (18%)
Query: 181 IGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CGRALKGFDVECEMMKSIRHRNLIKV 234
           IG G +G V  A    + + VA+K    F  Q  C R L+    E +++   RH N+I +
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 88
Query: 235 ISTCSNEEFKALVLEYMPHGSL-EKYMYSSNYILDIFQRLN------IMIDVASALEYLH 287
                N+  +A  +E M    + +  M +  Y L   Q L+       +  +   L+Y+H
Sbjct: 89  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 143
Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQTQTLATIGYMAPEY 346
              SA ++H DLKPSN+LL+      + DF +A++   + D +   T+ +AT  Y APE 
Sbjct: 144 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL 405
               +  T   D++S G +L E  + +     IF G    KH+++    I  + ++G+  
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQLNHI--LGILGSP- 249
Query: 406 LSQEDIHFVAKEQCVSCVFNL 426
            SQED+         +C+ NL
Sbjct: 250 -SQEDL---------NCIINL 260

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 25/212 (11%)
Query: 181 IGRGGFGSVYKA------RLGDGMEVAVKVFNLQCGRA-LKGFDVECEMMKSIRHR-NLI 232
           +GRG FG V +A      +      VAVK+       +  +    E +++  I H  N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 233 KVISTCSNEEFKALVL-EYMPHGSLEKYM---------YSSNYILDIFQRLNIMI----D 278
            ++  C+      +V+ E+   G+L  Y+         Y    +   F  L  +I     
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT 338
           VA  +E+L    S   IH DL   N+LL +  V  + DF +A+ +  +   + +      
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 339 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 370
           + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 122/261 (46%), Gaps = 48/261 (18%)
Query: 181 IGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CGRALKGFDVECEMMKSIRHRNLIKV 234
           IG G +G V  A    + + VA+K    F  Q  C R L+    E +++   RH N+I +
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 94
Query: 235 ISTCSNEEFKALVLEYMPHGSL-EKYMYSSNYILDIFQRLN------IMIDVASALEYLH 287
                N+  +A  +E M    + +  M +  Y L   Q L+       +  +   L+Y+H
Sbjct: 95  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 149
Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQTQTLATIGYMAPEY 346
              SA ++H DLKPSN+LL+      + DF +A++   + D +   T+ +AT  Y APE 
Sbjct: 150 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 206
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL 405
               +  T   D++S G +L E  + +     IF G    KH+++    I  + ++G+  
Sbjct: 207 MLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQLNHI--LGILGSP- 255
Query: 406 LSQEDIHFVAKEQCVSCVFNL 426
            SQED+         +C+ NL
Sbjct: 256 -SQEDL---------NCIINL 266

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 122/261 (46%), Gaps = 48/261 (18%)
Query: 181 IGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CGRALKGFDVECEMMKSIRHRNLIKV 234
           IG G +G V  A    + + VA+K    F  Q  C R L+    E +++   RH N+I +
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 86
Query: 235 ISTCSNEEFKALVLEYMPHGSL-EKYMYSSNYILDIFQRLN------IMIDVASALEYLH 287
                N+  +A  +E M    + +  M +  Y L   Q L+       +  +   L+Y+H
Sbjct: 87  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQTQTLATIGYMAPEY 346
              SA ++H DLKPSN+LL+      + DF +A++   + D +   T+ +AT  Y APE 
Sbjct: 142 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL 405
               +  T   D++S G +L E  + +     IF G    KH+++    I  + ++G+  
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQLNHI--LGILGSP- 247
Query: 406 LSQEDIHFVAKEQCVSCVFNL 426
            SQED+         +C+ NL
Sbjct: 248 -SQEDL---------NCIINL 258

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRALKGFDVECEMM 223
           + + F +   IG G +G VYKAR    G  VA+K   L          A++    E  ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLL 59
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
           K + H N++K++     E    LV E++    L+ +M +S   L       I   +   L
Sbjct: 60  KELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASA--LTGIPLPLIKSYLFQLL 116
Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           + L F +S  ++H DLKP N+L++      L+DF +A+      +  T    + T+ Y A
Sbjct: 117 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRA 174
Query: 344 PEYGREGR-VSTNGDVYSFGIMLMETFTGK 372
           PE     +  ST  D++S G +  E  T +
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 87/178 (48%), Gaps = 14/178 (7%)
Query: 175 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMK-SIRHRNLIK 233
           F   +++G G  G++    + D  +VAVK    +C       D E ++++ S  H N+I+
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIR 82
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
              T  + +F+ + +E +   +L++Y+   ++     + + ++    S L +LH   S  
Sbjct: 83  YFCTEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLN 138
Query: 294 IIHCDLKPSNVLLD-----DNMVAHLSDFSIA-KLLTGEDQSMTQTQTLATIGYMAPE 345
           I+H DLKP N+L+        + A +SDF +  KL  G      ++    T G++APE
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 126/267 (47%), Gaps = 39/267 (14%)
Query: 181 IGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CGRALKGFDVECEMMKSIRHRNLIKV 234
           IG G +G V  A    + + VA+K    F  Q  C R L+    E +++   RH N+I +
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 86
Query: 235 ISTCSNEEFKALVLEYMPHGSL-EKYMYSSNYILDIFQRLN------IMIDVASALEYLH 287
                N+  +A  +E M    + +  M +  Y L   Q L+       +  +   L+Y+H
Sbjct: 87  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQTQTLATIGYMAPEY 346
              SA ++H DLKPSN+LL+      + DF +A++   + D +   T+ +AT  Y APE 
Sbjct: 142 ---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL 405
               +  T   D++S G +L E  + +     IF G    KH+++    I  + ++G+  
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQLNHI--LGILGSP- 247
Query: 406 LSQEDIHFVAKEQCVSCVFNLAMECTV 432
            SQED++ +   +  + + +L  +  V
Sbjct: 248 -SQEDLNXIINLKARNYLLSLPHKNKV 273

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 181 IGRGGFGSVYKARLGDGME-VAVKVFNLQ------CGRALKGFDVECEMMKSIRHRNLIK 233
           IG G +G+V+KA+  +  E VA+K   L          AL+    E  ++K ++H+N+++
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKELKHKNIVR 65
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
           +     +++   LV E+     L+KY  S N  LD     + +  +   L + H   S  
Sbjct: 66  LHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRN 121
Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV- 352
           ++H DLKP N+L++ N    L+DF +A+      +    +  + T+ Y  P+     ++ 
Sbjct: 122 VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLY 179
Query: 353 STNGDVYSFGIMLMETFTGKKP 374
           ST+ D++S G +  E     +P
Sbjct: 180 STSIDMWSAGCIFAELANAARP 201

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 127/297 (42%), Gaps = 32/297 (10%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIS---- 236
           IG+G +G V+  +   G +VAVKVF      A    + E      +RH N++  I+    
Sbjct: 45  IGKGRYGEVWMGKW-RGEKVAVKVF-FTTEEASWFRETEIYQTVLMRHENILGFIAADIK 102
Query: 237 -TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLH---FGYSA 292
            T S  +   L+ +Y  +GSL  Y+ S+   LD    L +     S L +LH   F    
Sbjct: 103 GTGSWTQL-YLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFSTQG 159
Query: 293 --PIIHCDLKPSNVLLDDNMVAHLSDFSIA-KLLTGEDQ-SMTQTQTLATIGYMAPEYGR 348
              I H DLK  N+L+  N    ++D  +A K ++  ++  +     + T  YM PE   
Sbjct: 160 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLD 219
Query: 349 EG------RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS-----T 397
           E       +     D+YSFG++L E    ++  +     E  L +  +D +P        
Sbjct: 220 ESLNRNHFQSYIMADMYSFGLILWEV--ARRCVSGGIVEEYQLPY--HDLVPSDPSYEDM 275
Query: 398 MEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS 454
            E+V    L     +  + ++C+  +  L  EC   +P  R+ A  +   L K+ +S
Sbjct: 276 REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   + +  G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+P G +  ++       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 159
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 118/246 (47%), Gaps = 39/246 (15%)
Query: 181 IGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CGRALKGFDVECEMMKSIRHRNLIKV 234
           IG G +G V  A    + + VA+K    F  Q  C R L+    E +++ + RH N+I +
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLAFRHENIIGI 88
Query: 235 ISTCSNEEFKALVLEYMPHGSL-EKYMYSSNYILDIFQRLN------IMIDVASALEYLH 287
                N+  +A  +E M    + +  M +  Y L   Q L+       +  +   L+Y+H
Sbjct: 89  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 143
Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQTQTLATIGYMAPEY 346
              SA ++H DLKPSN+LL+      + DF +A++   + D +   T+ +AT  Y APE 
Sbjct: 144 ---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL 405
               +  T   D++S G +L E  + +     IF G    KH+++    I  + ++G+  
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQLNHI--LGILGSP- 249
Query: 406 LSQEDI 411
            SQED+
Sbjct: 250 -SQEDL 254

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   + +  G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+P G +  ++       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------GRALKGFDVECEMM 223
           + + F +   IG G +G VYKAR    G  VA+K   L          A++    E  ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLL 58
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
           K + H N++K++     E    LV E++    L+ +M +S   L       I   +   L
Sbjct: 59  KELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASA--LTGIPLPLIKSYLFQLL 115
Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           + L F +S  ++H DLKP N+L++      L+DF +A+      +  T    + T+ Y A
Sbjct: 116 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRA 173
Query: 344 PEYGREGR-VSTNGDVYSFGIMLMETFTGK 372
           PE     +  ST  D++S G +  E  T +
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 28/228 (12%)
Query: 171 ATDGFS---------ENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKGFDVEC 220
           +TD FS         + +++G G    V     L    E AVK+   Q G        E 
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 221 EMMKSIR-HRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV 279
           EM+   + HRN++++I     E+   LV E M  GS+  +++   +  ++   + ++ DV
Sbjct: 62  EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-VVQDV 120
Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDD-NMVA--HLSDFSIAK--LLTGEDQSMTQTQ 334
           ASAL++LH   +  I H DLKP N+L +  N V+   + DF +     L G+   ++  +
Sbjct: 121 ASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 335 TLATIG---YMAPE----YGREGRV-STNGDVYSFGIMLMETFTGKKP 374
            L   G   YMAPE    +  E  +     D++S G++L    +G  P
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   + +  G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+P G +  ++       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     IG G FG V   + +  G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+P G +  ++       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 28/228 (12%)
Query: 171 ATDGFS---------ENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKGFDVEC 220
           +TD FS         + +++G G    V     L    E AVK+   Q G        E 
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 221 EMMKSIR-HRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV 279
           EM+   + HRN++++I     E+   LV E M  GS+  +++   +  ++   + ++ DV
Sbjct: 62  EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-VVQDV 120
Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDD-NMVA--HLSDFSIAK--LLTGEDQSMTQTQ 334
           ASAL++LH   +  I H DLKP N+L +  N V+   + DF +     L G+   ++  +
Sbjct: 121 ASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPE 177
Query: 335 TLATIG---YMAPE----YGREGRV-STNGDVYSFGIMLMETFTGKKP 374
            L   G   YMAPE    +  E  +     D++S G++L    +G  P
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 91/225 (40%), Gaps = 31/225 (13%)
Query: 170 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRH 228
           R    F E  ++G+G FG V KAR   D    A+K         L     E  ++ S+ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVXLLASLNH 61
Query: 229 -------------RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNI 275
                        RN +K  +    +    +  EY  + +L   ++S N      +   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRL 121
Query: 276 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK-------LLTGEDQ 328
              +  AL Y+H   S  IIH +LKP N+ +D++    + DF +AK       +L  + Q
Sbjct: 122 FRQILEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 329 SM-----TQTQTLATIGYMAPEY-GREGRVSTNGDVYSFGIMLME 367
           ++       T  + T  Y+A E     G  +   D YS GI+  E
Sbjct: 179 NLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   +  + G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+P G +  ++       +   R      +    EYLH 
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 151
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 204
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 125/281 (44%), Gaps = 39/281 (13%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRN--LIKVIS 236
           IG GG   V++         A+K  NL+    + L  +  E   +  ++  +  +I++  
Sbjct: 20  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 79
Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
               +++  +V+E   +  L  ++     I D ++R +      + LE +H  +   I+H
Sbjct: 80  YEITDQYIYMVME-CGNIDLNSWLKKKKSI-DPWERKSYW---KNMLEAVHTIHQHGIVH 134
Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVS-TN 355
            DLKP+N L+ D M+  L DF IA  +  +  S+ +   + T+ YM PE  ++   S  N
Sbjct: 135 SDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 193
Query: 356 G----------DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL 405
           G          DV+S G +L     GK P  +I N +++  H + D  P   +E      
Sbjct: 194 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIID--PNHEIEFPD--- 247
Query: 406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVA 446
           + ++D+  V K  C          C    P+QRI+  E++A
Sbjct: 248 IPEKDLQDVLK--C----------CLKRDPKQRISIPELLA 276

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   + +  G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+P G +  ++       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 122/261 (46%), Gaps = 48/261 (18%)
Query: 181 IGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CGRALKGFDVECEMMKSIRHRNLIKV 234
           IG G +G V  A    + + VA++    F  Q  C R L+    E +++   RH N+I +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 235 ISTCSNEEFKALVLEYMPHGSL-EKYMYSSNYILDIFQRLN------IMIDVASALEYLH 287
                N+  +A  +E M    + +  M +  Y L   Q L+       +  +   L+Y+H
Sbjct: 91  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQTQTLATIGYMAPEY 346
              SA ++H DLKPSN+LL+      + DF +A++   + D +   T+ +AT  Y APE 
Sbjct: 146 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL 405
               +  T   D++S G +L E  + +     IF G    KH+++    I  + ++G+  
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQLNHI--LGILGSP- 251
Query: 406 LSQEDIHFVAKEQCVSCVFNL 426
            SQED+         +C+ NL
Sbjct: 252 -SQEDL---------NCIINL 262

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 27/58 (46%), Positives = 38/58 (65%), Gaps = 3/58 (5%)
Query: 48  GAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPC 105
           G +P  L +L +L +LN+SFN L GEIP+GG  + F V ++  N+ LCGSP   +P C
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   + +  G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+P G +  ++       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 24/215 (11%)
Query: 181 IGRGGFGSVYKA------RLGDGMEVAVKVFNLQCGRA-LKGFDVECEMMKSIRHR-NLI 232
           +GRG FG V +A      +      VAVK+       +  +    E +++  I H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 233 KVISTCSNEEFKALVL-EYMPHGSLEKYMYSSNY-----------ILDIFQRLNIMIDVA 280
            ++  C+      +V+ E+   G+L  Y+ S               L +   +     VA
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 281 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIG 340
             +E+L    S   IH DL   N+LL +  V  + DF +A+ +  +   + +      + 
Sbjct: 155 KGMEFLA---SRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 341 YMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 374
           +MAPE   +   +   DV+SFG++L E F+ G  P
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 246

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   +  + G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+P G +  ++       +   R      +    EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   +  + G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+P G +  ++       +   R      +    EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   +  + G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+P G +  ++       +   R      +    EYLH 
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 151
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 204
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   + +  G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+P G +  ++       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   +  + G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+P G +  ++       +   R      +    EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 125/281 (44%), Gaps = 39/281 (13%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRN--LIKVIS 236
           IG GG   V++         A+K  NL+    + L  +  E   +  ++  +  +I++  
Sbjct: 16  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 75
Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
               +++  +V+E   +  L  ++     I D ++R +      + LE +H  +   I+H
Sbjct: 76  YEITDQYIYMVME-CGNIDLNSWLKKKKSI-DPWERKSYW---KNMLEAVHTIHQHGIVH 130
Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVS-TN 355
            DLKP+N L+ D M+  L DF IA  +  +  S+ +   + T+ YM PE  ++   S  N
Sbjct: 131 SDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 189
Query: 356 G----------DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL 405
           G          DV+S G +L     GK P  +I N +++  H + D  P   +E      
Sbjct: 190 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIID--PNHEIEFPD--- 243
Query: 406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVA 446
           + ++D+  V K  C          C    P+QRI+  E++A
Sbjct: 244 IPEKDLQDVLK--C----------CLKRDPKQRISIPELLA 272

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   + +  G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+P G +  ++       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 173 DGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQCGRALKGFDV-ECEMMKSIRHRN 230
           D F + + +G G  G V+K +    G+ +A K+ +L+   A++   + E +++       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILD-IFQRLNIMIDVASALEYLHFG 289
           ++       ++   ++ +E+M  GSL++ +  +  I + I  +++I   V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 123
Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 349
           +   I+H D+KPSN+L++      L DF ++  L     SM  +  + T  YM+PE  + 
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQG 177
Query: 350 GRVSTNGDVYSFGIMLMETFTGKKP 374
              S   D++S G+ L+E   G+ P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 173 DGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQCGRALKGFDV-ECEMMKSIRHRN 230
           D F + + +G G  G V+K +    G+ +A K+ +L+   A++   + E +++       
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILD-IFQRLNIMIDVASALEYLHFG 289
           ++       ++   ++ +E+M  GSL++ +  +  I + I  +++I   V   L YL   
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 185
Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 349
           +   I+H D+KPSN+L++      L DF ++  L     SM  +  + T  YM+PE  + 
Sbjct: 186 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQG 239
Query: 350 GRVSTNGDVYSFGIMLMETFTGKKP 374
              S   D++S G+ L+E   G+ P
Sbjct: 240 THYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   +  + G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+P G +  ++       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 106/225 (47%), Gaps = 35/225 (15%)
Query: 181 IGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CGRALKGFDVECEMMKSIRHRNLIKV 234
           IG G +G V  A    + + VA+K    F  Q  C R L+    E +++   RH N+I +
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 84
Query: 235 ISTCSNEEFKALVLEYMPHGSL-EKYMYSSNYILDIFQRLN------IMIDVASALEYLH 287
                N+  +A  +E M    + +  M +  Y L   Q L+       +  +   L+Y+H
Sbjct: 85  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 139
Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQTQTLATIGYMAPEY 346
              SA ++H DLKPSN+LL+      + DF +A++   + D +   T+ +AT  Y APE 
Sbjct: 140 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 196
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVN 390
               +  T   D++S G +L E  + +     IF G    KH+++
Sbjct: 197 MLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 233

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   +  + G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+P G +  ++       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 173 DGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQCGRALKGFDV-ECEMMKSIRHRN 230
           D F + + +G G  G V+K +    G+ +A K+ +L+   A++   + E +++       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILD-IFQRLNIMIDVASALEYLHFG 289
           ++       ++   ++ +E+M  GSL++ +  +  I + I  +++I   V   L YL   
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 150
Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 349
           +   I+H D+KPSN+L++      L DF ++  L     SM  +  + T  YM+PE  + 
Sbjct: 151 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQG 204
Query: 350 GRVSTNGDVYSFGIMLMETFTGKKP 374
              S   D++S G+ L+E   G+ P
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   +  + G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+P G +  ++       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 78/161 (48%), Gaps = 12/161 (7%)
Query: 219 ECEMMKSIRHRNLIKVISTCS--NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIM 276
           E  ++K + H N++K++      NE+   +V E +  G + +         D  Q     
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED--QARFYF 143
Query: 277 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 336
            D+   +EYLH+     IIH D+KPSN+L+ ++    ++DF ++    G D  +  + T+
Sbjct: 144 QDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL--SNTV 198
Query: 337 ATIGYMAPEYGREGRVSTNG---DVYSFGIMLMETFTGKKP 374
            T  +MAPE   E R   +G   DV++ G+ L     G+ P
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 173 DGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQCGRALKGFDV-ECEMMKSIRHRN 230
           D F + + +G G  G V+K +    G+ +A K+ +L+   A++   + E +++       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILD-IFQRLNIMIDVASALEYLHFG 289
           ++       ++   ++ +E+M  GSL++ +  +  I + I  +++I   V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 123
Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 349
           +   I+H D+KPSN+L++      L DF ++  L     SM  +  + T  YM+PE  + 
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQG 177
Query: 350 GRVSTNGDVYSFGIMLMETFTGKKP 374
              S   D++S G+ L+E   G+ P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 173 DGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQCGRALKGFDV-ECEMMKSIRHRN 230
           D F + + +G G  G V+K +    G+ +A K+ +L+   A++   + E +++       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILD-IFQRLNIMIDVASALEYLHFG 289
           ++       ++   ++ +E+M  GSL++ +  +  I + I  +++I   V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 123
Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 349
           +   I+H D+KPSN+L++      L DF ++  L     SM  +  + T  YM+PE  + 
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQG 177
Query: 350 GRVSTNGDVYSFGIMLMETFTGKKP 374
              S   D++S G+ L+E   G+ P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 76/171 (44%), Gaps = 23/171 (13%)
Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT 338
           VA  +E+L    S   IH DL   N+LL +N V  + DF +A+ +      + +  T   
Sbjct: 208 VARGMEFLS---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 339 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPIST 397
           + +MAPE   +   ST  DV+S+G++L E F+ G  P                   P   
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSP------------------YPGVQ 306
Query: 398 MEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
           M+    + L +E +   A E     ++ + ++C    P++R    E+V KL
Sbjct: 307 MDEDFCSRL-REGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 95/215 (44%), Gaps = 24/215 (11%)
Query: 181 IGRGGFGSVYKA------RLGDGMEVAVKVFNLQCGRA-LKGFDVECEMMKSIRHR-NLI 232
           +GRG FG V +A      +      VAVK+       +  +    E +++  I H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 233 KVISTCSNEEFKALVL-EYMPHGSLEKYMYSSNY-------ILDIFQRLNIMI----DVA 280
            ++  C+      +V+ E+   G+L  Y+ S          +   F  L  +I     VA
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 281 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIG 340
             +E+L    S   IH DL   N+LL +  V  + DF +A+ +  +   + +      + 
Sbjct: 155 KGMEFLA---SRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 341 YMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 374
           +MAPE   +   +   DV+SFG++L E F+ G  P
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 246

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 125/281 (44%), Gaps = 39/281 (13%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRN--LIKVIS 236
           IG GG   V++         A+K  NL+    + L  +  E   +  ++  +  +I++  
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
               +++  +V+E   +  L  ++     I D ++R +      + LE +H  +   I+H
Sbjct: 96  YEITDQYIYMVME-CGNIDLNSWLKKKKSI-DPWERKSYW---KNMLEAVHTIHQHGIVH 150
Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVS-TN 355
            DLKP+N L+ D M+  L DF IA  +  +  S+ +   + T+ YM PE  ++   S  N
Sbjct: 151 SDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 209
Query: 356 G----------DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL 405
           G          DV+S G +L     GK P  +I N +++  H + D  P   +E      
Sbjct: 210 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIID--PNHEIEFPD--- 263
Query: 406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVA 446
           + ++D+  V K  C          C    P+QRI+  E++A
Sbjct: 264 IPEKDLQDVLK--C----------CLKRDPKQRISIPELLA 292

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   +  + G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+P G +  ++       +   R      +    EYLH 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 179
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 232
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 173 DGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQCGRALKGFDV-ECEMMKSIRHRN 230
           D F + + +G G  G V+K +    G+ +A K+ +L+   A++   + E +++       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILD-IFQRLNIMIDVASALEYLHFG 289
           ++       ++   ++ +E+M  GSL++ +  +  I + I  +++I   V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 123
Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 349
           +   I+H D+KPSN+L++      L DF ++  L     SM  +  + T  YM+PE  + 
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQG 177
Query: 350 GRVSTNGDVYSFGIMLMETFTGKKP 374
              S   D++S G+ L+E   G+ P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 173 DGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQCGRALKGFDV-ECEMMKSIRHRN 230
           D F + + +G G  G V+K +    G+ +A K+ +L+   A++   + E +++       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILD-IFQRLNIMIDVASALEYLHFG 289
           ++       ++   ++ +E+M  GSL++ +  +  I + I  +++I   V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 123
Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 349
           +   I+H D+KPSN+L++      L DF ++  L     SM  +  + T  YM+PE  + 
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQG 177
Query: 350 GRVSTNGDVYSFGIMLMETFTGKKP 374
              S   D++S G+ L+E   G+ P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 91/196 (46%), Gaps = 13/196 (6%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDV----ECEMMKSIRHRNLIKVIS 236
           IG G +G VYKA+   G   A+K   L+  +  +G       E  ++K ++H N++K+  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLE--KEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
               ++   LV E++    L+K +      L+     + ++ + + + Y H      ++H
Sbjct: 68  VIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123
Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY-GREGRVSTN 355
            DLKP N+L++      ++DF +A+      +    T  + T+ Y AP+      + ST 
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAPDVLMGSKKYSTT 181
Query: 356 GDVYSFGIMLMETFTG 371
            D++S G +  E   G
Sbjct: 182 IDIWSVGCIFAEMVNG 197

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 48/227 (21%)
Query: 172 TDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVK--------VFNLQCGRALKGFDVECEM 222
           +  F   +L+G G +G V  A     G  VA+K        +F L+  R +K       +
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK-------I 62
Query: 223 MKSIRHRNLIKVISTCSNEEFK-----ALVLEYMP---HGSLEKYMYSSNYI-LDIFQRL 273
           +K  +H N+I + +    + F+      ++ E M    H  +   M S ++I   I+Q L
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 274 NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL---------- 323
                   A++ LH    + +IH DLKPSN+L++ N    + DF +A+++          
Sbjct: 123 R-------AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 324 TGEDQSMTQTQTLATIGYMAPEYG-REGRVSTNGDVYSFGIMLMETF 369
           TG+   M  T+ +AT  Y APE      + S   DV+S G +L E F
Sbjct: 173 TGQQSGM--TEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 125/281 (44%), Gaps = 39/281 (13%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRN--LIKVIS 236
           IG GG   V++         A+K  NL+    + L  +  E   +  ++  +  +I++  
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
               +++  +V+E   +  L  ++     I D ++R +      + LE +H  +   I+H
Sbjct: 77  YEITDQYIYMVME-CGNIDLNSWLKKKKSI-DPWERKSYW---KNMLEAVHTIHQHGIVH 131
Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVS-TN 355
            DLKP+N L+ D M+  L DF IA  +  +  S+ +   + T+ YM PE  ++   S  N
Sbjct: 132 SDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 190
Query: 356 G----------DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL 405
           G          DV+S G +L     GK P  +I N +++  H + D  P   +E      
Sbjct: 191 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIID--PNHEIEFPD--- 244
Query: 406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVA 446
           + ++D+  V K  C          C    P+QRI+  E++A
Sbjct: 245 IPEKDLQDVLK--C----------CLKRDPKQRISIPELLA 273

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 121/261 (46%), Gaps = 48/261 (18%)
Query: 181 IGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CGRALKGFDVECEMMKSIRHRNLIKV 234
           IG G +G V  A    + + VA+K    F  Q  C R L+    E +++   RH N+I +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 235 ISTCSNEEFKALVLEYMPHGSL-EKYMYSSNYILDIFQRLN------IMIDVASALEYLH 287
                N+  +A  +E M    + +  M +  Y L   Q L+       +  +   L+Y+H
Sbjct: 91  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQTQTLATIGYMAPEY 346
              SA ++H DLKPSN+LL+      + DF +A++   + D +    + +AT  Y APE 
Sbjct: 146 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEI 202
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL 405
               +  T   D++S G +L E  + +     IF G    KH+++    I  + ++G+  
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQLNHI--LGILGSP- 251
Query: 406 LSQEDIHFVAKEQCVSCVFNL 426
            SQED+         +C+ NL
Sbjct: 252 -SQEDL---------NCIINL 262

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 121/261 (46%), Gaps = 48/261 (18%)
Query: 181 IGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CGRALKGFDVECEMMKSIRHRNLIKV 234
           IG G +G V  A    + + VA+K    F  Q  C R L+    E +++   RH N+I +
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 91
Query: 235 ISTCSNEEFKALVLEYMPHGSL-EKYMYSSNYILDIFQRLN------IMIDVASALEYLH 287
                N+  +A  +E M    + +  M +  Y L   Q L+       +  +   L+Y+H
Sbjct: 92  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 146
Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQTQTLATIGYMAPEY 346
              SA ++H DLKPSN+LL+      + DF +A++   + D +    + +AT  Y APE 
Sbjct: 147 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEI 203
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL 405
               +  T   D++S G +L E  + +     IF G    KH+++    I  + ++G+  
Sbjct: 204 MLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQLNHI--LGILGSP- 252
Query: 406 LSQEDIHFVAKEQCVSCVFNL 426
            SQED+         +C+ NL
Sbjct: 253 -SQEDL---------NCIINL 263

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/280 (23%), Positives = 130/280 (46%), Gaps = 34/280 (12%)
Query: 173 DGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQCGRALKGFDV-ECEMMKSIRHRN 230
           D F + + +G G  G V+K +    G+ +A K+ +L+   A++   + E +++       
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILD-IFQRLNIMIDVASALEYLHFG 289
           ++       ++   ++ +E+M  GSL++ +  +  I + I  +++I   V   L YL   
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 142
Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 349
           +   I+H D+KPSN+L++      L DF ++  L     SM  +  + T  YM+PE  + 
Sbjct: 143 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQG 196
Query: 350 GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMT----LKHWVNDWLPISTMEVVGANL 405
              S   D++S G+ L+E   G+ P     +G M     L + VN+  P      + + +
Sbjct: 197 THYSVQSDIWSMGLSLVEMAVGRYPIGS-GSGSMAIFELLDYIVNEPPP-----KLPSGV 250
Query: 406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIV 445
            S E   FV K             C +++P +R + ++++
Sbjct: 251 FSLEFQDFVNK-------------CLIKNPAERADLKQLM 277

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 95/197 (48%), Gaps = 13/197 (6%)
Query: 181 IGRGGFGSVYK--ARLGDGMEVAVKVFNLQCGRALKGFDV-ECEMMKSIRHRNLIKVIST 237
           +G G + +VYK  ++L D + VA+K   L+         + E  ++K ++H N++ +   
Sbjct: 10  LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
              E+   LV EY+    L++Y+     I+++    N+ + +   L  L + +   ++H 
Sbjct: 69  IHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMH---NVKLFLFQLLRGLAYCHRQKVLHR 124
Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE--YGREGRVSTN 355
           DLKP N+L+++     L+DF +A+       + T    + T+ Y  P+   G     ST 
Sbjct: 125 DLKPQNLLINERGELKLADFGLAR--AKSIPTKTYDNEVVTLWYRPPDILLGSTD-YSTQ 181
Query: 356 GDVYSFGIMLMETFTGK 372
            D++  G +  E  TG+
Sbjct: 182 IDMWGVGCIFYEMATGR 198

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 91/196 (46%), Gaps = 13/196 (6%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDV----ECEMMKSIRHRNLIKVIS 236
           IG G +G VYKA+   G   A+K   L+  +  +G       E  ++K ++H N++K+  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLE--KEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
               ++   LV E++    L+K +      L+     + ++ + + + Y H      ++H
Sbjct: 68  VIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123
Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY-GREGRVSTN 355
            DLKP N+L++      ++DF +A+      +    T  + T+ Y AP+      + ST 
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAPDVLMGSKKYSTT 181
Query: 356 GDVYSFGIMLMETFTG 371
            D++S G +  E   G
Sbjct: 182 IDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 91/196 (46%), Gaps = 13/196 (6%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDV----ECEMMKSIRHRNLIKVIS 236
           IG G +G VYKA+   G   A+K   L+  +  +G       E  ++K ++H N++K+  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLE--KEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
               ++   LV E++    L+K +      L+     + ++ + + + Y H      ++H
Sbjct: 68  VIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123
Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY-GREGRVSTN 355
            DLKP N+L++      ++DF +A+      +    T  + T+ Y AP+      + ST 
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAPDVLMGSKKYSTT 181
Query: 356 GDVYSFGIMLMETFTG 371
            D++S G +  E   G
Sbjct: 182 IDIWSVGCIFAEMVNG 197

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 27/218 (12%)
Query: 181 IGRGGFGSVYKA------RLGDGMEVAVKVFNLQCGRA-LKGFDVECEMMKSIRHR-NLI 232
           +GRG FG V +A      +      VAVK+       +  +    E +++  I H  N++
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 233 KVISTCSNEEFKALVL-EYMPHGSLEKYMYSSNY----------ILDIFQRLNIMI---- 277
            ++  C+      +V+ E+   G+L  Y+ S             +   F  L  +I    
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 278 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA 337
            VA  +E+L    S   IH DL   N+LL +  V  + DF +A+ +  +   + +     
Sbjct: 156 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 338 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 374
            + +MAPE   +   +   DV+SFG++L E F+ G  P
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/211 (22%), Positives = 95/211 (45%), Gaps = 12/211 (5%)
Query: 170 RATDGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSI 226
           R T+ +     +G+G F  V +  ++  G E A  + N +    R  +  + E  + + +
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           +H N++++  + S E    L+ + +  G L + + +  Y    +   +    +   LE +
Sbjct: 68  KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY----YSEADASHCIQQILEAV 123
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNM---VAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
              +   ++H +LKP N+LL   +      L+DF +A  + GE Q+        T GY++
Sbjct: 124 LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYLS 181
Query: 344 PEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           PE  R+       D+++ G++L     G  P
Sbjct: 182 PEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 11/205 (5%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-ECEMMKSIRHRN 230
           D F   + +G G  G V K +    G+ +A K+ +L+   A++   + E +++       
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILD-IFQRLNIMIDVASALEYLHFG 289
           ++       ++   ++ +E+M  GSL++ +  +  I + I  +++I   V   L YL   
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREK 133
Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 349
           +   I+H D+KPSN+L++      L DF ++  L     SM  +  + T  YMAPE  + 
Sbjct: 134 HQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMAPERLQG 187
Query: 350 GRVSTNGDVYSFGIMLMETFTGKKP 374
              S   D++S G+ L+E   G+ P
Sbjct: 188 THYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 48/227 (21%)
Query: 172 TDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVK--------VFNLQCGRALKGFDVECEM 222
           +  F   +L+G G +G V  A     G  VA+K        +F L+  R +K       +
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK-------I 62
Query: 223 MKSIRHRNLIKVISTCSNEEFK-----ALVLEYMP---HGSLEKYMYSSNYI-LDIFQRL 273
           +K  +H N+I + +    + F+      ++ E M    H  +   M S ++I   I+Q L
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 274 NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL---------- 323
                   A++ LH    + +IH DLKPSN+L++ N    + DF +A+++          
Sbjct: 123 R-------AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 324 TGEDQSMTQTQTLATIGYMAPEYG-REGRVSTNGDVYSFGIMLMETF 369
           TG+   M  T+ +AT  Y APE      + S   DV+S G +L E F
Sbjct: 173 TGQQSGM--TEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 149
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 150 DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 204
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 205 YNQTVDIWSVGCIMAELLTGR 225

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   + +  G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY P G +  ++       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+++D      ++DF +AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 125/281 (44%), Gaps = 39/281 (13%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRN--LIKVIS 236
           IG GG   V++         A+K  NL+    + L  +  E   +  ++  +  +I++  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
               +++  +V+E   +  L  ++     I D ++R +      + LE +H  +   I+H
Sbjct: 124 YEITDQYIYMVME-CGNIDLNSWLKKKKSI-DPWERKSYW---KNMLEAVHTIHQHGIVH 178
Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVS-TN 355
            DLKP+N L+ D M+  L DF IA  +  +  S+ +   + T+ YM PE  ++   S  N
Sbjct: 179 SDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 237
Query: 356 G----------DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL 405
           G          DV+S G +L     GK P  +I N +++  H + D  P   +E      
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIID--PNHEIEFPD--- 291
Query: 406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVA 446
           + ++D+  V K  C          C    P+QRI+  E++A
Sbjct: 292 IPEKDLQDVLK--C----------CLKRDPKQRISIPELLA 320

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 28/219 (12%)
Query: 181 IGRGGFGSVYKA------RLGDGMEVAVKVFNLQCGRA-LKGFDVECEMMKSIRHR-NLI 232
           +GRG FG V +A      +      VAVK+       +  +    E +++  I H  N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 233 KVISTCSNEEFKALVL-EYMPHGSLEKYMYSSNY-----------ILDIFQRLNIMI--- 277
            ++  C+      +V+ E+   G+L  Y+ S              +   F  L  +I   
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 278 -DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 336
             VA  +E+L    S   IH DL   N+LL +  V  + DF +A+ +  +   + +    
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 374
             + +MAPE   +   +   DV+SFG++L E F+ G  P
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 39/239 (16%)
Query: 181 IGRGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKGFDVECEMMKSIRHRNLIKV 234
           +G G +G V  A  R+ +   VAVK+ +++    C   +K    E  + K + H N++K 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EIXINKMLNHENVVKF 70
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL--NIMIDVASALEYLH----- 287
                    + L LEY   G L             F R+  +I +    A  + H     
Sbjct: 71  YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 288 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
             + +   I H D+KP N+LLD+     +SDF +A +    ++     +   T+ Y+APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 177
Query: 346 YGREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW------VNDWLPIST 397
             +         DV+S GI+L     G+ P ++  +       W      +N W  I +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 93/218 (42%), Gaps = 20/218 (9%)
Query: 165 HLELCRATDGFSENNLIGRGGFG----SVYKARLGDGMEVAVKVFNLQCGRALKGFDVEC 220
           H    + TDG+     IG G +      ++KA     ME AVK+ +       +  ++  
Sbjct: 14  HRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKAT---NMEFAVKIIDKSKRDPTEEIEI-- 68
Query: 221 EMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVA 280
            +++  +H N+I +     + ++  +V E M  G L   +    +  +  +   ++  + 
Sbjct: 69  -LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE-REASAVLFTIT 126
Query: 281 SALEYLHFGYSAPIIHCDLKPSNVLLDDNM----VAHLSDFSIAKLLTGEDQSMTQTQTL 336
             +EYLH   +  ++H DLKPSN+L  D         + DF  AK L  E+  +      
Sbjct: 127 KTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL--MTPC 181
Query: 337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
            T  ++APE           D++S G++L    TG  P
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 28/219 (12%)
Query: 181 IGRGGFGSVYKA------RLGDGMEVAVKVFNLQCGRA-LKGFDVECEMMKSIRHR-NLI 232
           +GRG FG V +A      +      VAVK+       +  +    E +++  I H  N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 233 KVISTCSNEEFKALVL-EYMPHGSLEKYMYSSNY-----------ILDIFQRLNIMI--- 277
            ++  C+      +V+ E+   G+L  Y+ S              +   F  L  +I   
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 278 -DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 336
             VA  +E+L    S   IH DL   N+LL +  V  + DF +A+ +  +   + +    
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 374
             + +MAPE   +   +   DV+SFG++L E F+ G  P
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 25/221 (11%)
Query: 180 LIGRGGFGSVYKA-RLGDGMEVAVKVF--NLQCGRALKGFDVECEMMKSI--------RH 228
           L+G+GGFG+V+   RL D ++VA+KV   N   G +     V C +  ++         H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 229 RNLIKVISTCSNEEFKALVLEY-MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLH 287
             +I+++     +E   LVLE  +P   L  Y+     + +   R      V +A+++ H
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRC-FFGQVVAAIQHCH 156
Query: 288 FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY 346
              S  ++H D+K  N+L+D     A L DF    LL  E      T    T  Y  PE+
Sbjct: 157 ---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE----PYTDFDGTRVYSPPEW 209
Query: 347 -GREGRVSTNGDVYSFGIMLMETFTGKKP---TNEIFNGEM 383
             R    +    V+S GI+L +   G  P     EI   E+
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAEL 250

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 126/281 (44%), Gaps = 39/281 (13%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRN--LIKVIS 236
           IG GG   V++         A+K  NL+    + L  +  E   +  ++  +  +I++  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
               +++  +V+E   +  L  ++     I D ++R +   ++   LE +H  +   I+H
Sbjct: 124 YEITDQYIYMVME-CGNIDLNSWLKKKKSI-DPWERKSYWKNM---LEAVHTIHQHGIVH 178
Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVS-TN 355
            DLKP+N L+ D M+  L DF IA  +  +  S+ +   + T+ YM PE  ++   S  N
Sbjct: 179 SDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 237
Query: 356 G----------DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL 405
           G          DV+S G +L     GK P  +I N +++  H + D  P   +E      
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIID--PNHEIEFPD--- 291
Query: 406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVA 446
           + ++D+  V K  C          C    P+QRI+  E++A
Sbjct: 292 IPEKDLQDVLK--C----------CLKRDPKQRISIPELLA 320

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 28/219 (12%)
Query: 181 IGRGGFGSVYKA------RLGDGMEVAVKVFNLQCGRA-LKGFDVECEMMKSIRHR-NLI 232
           +GRG FG V +A      +      VAVK+       +  +    E +++  I H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 233 KVISTCSNEEFKALVL-EYMPHGSLEKYMYSSNYIL--------DIFQRLNIM------- 276
            ++  C+      +V+ E+   G+L  Y+ S             D+++    +       
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 277 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 336
             VA  +E+L    S   IH DL   N+LL +  V  + DF +A+ +  +   + +    
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 374
             + +MAPE   +   +   DV+SFG++L E F+ G  P
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   + +  G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY P G +  ++       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+++D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   + +  G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY P G +  ++       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+++D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 39/239 (16%)
Query: 181 IGRGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKGFDVECEMMKSIRHRNLIKV 234
           +G G +G V  A  R+ +   VAVK+ +++    C   +K    E  + K + H N++K 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EIXINKMLNHENVVKF 69
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL--NIMIDVASALEYLH----- 287
                    + L LEY   G L             F R+  +I +    A  + H     
Sbjct: 70  YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 288 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
             + +   I H D+KP N+LLD+     +SDF +A +    ++     +   T+ Y+APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 346 YGREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW------VNDWLPIST 397
             +         DV+S GI+L     G+ P ++  +       W      +N W  I +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 235

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 39/229 (17%)
Query: 170 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDV--ECEMMKSI 226
           R    F     +GRGGFG V++A+   D    A+K   L   R L    V  E + +  +
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP-NRELAREKVMREVKALAKL 60
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSS-------------NYILDIFQR- 272
            H  +++      N   +    E +   S + Y+Y               N    I +R 
Sbjct: 61  EHPGIVRYF----NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116
Query: 273 ----LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ 328
               L+I + +A A+E+LH   S  ++H DLKPSN+    + V  + DF +   +  +++
Sbjct: 117 RSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 173
Query: 329 SMT----------QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 367
             T           T  + T  YM+PE       S   D++S G++L E
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   +  + G   A+K+ + Q    LK  +    E  + +++  
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +VLEY P G +  ++       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 23/220 (10%)
Query: 164 SHLELCRATDGFSENNLIGRGGFGS----VYKARLGDGMEVAVKVFNLQCGRALKGFDVE 219
           SH+ L   +DG+     IG G +      V+KA     ME AVKV +    ++ +    E
Sbjct: 19  SHMNLV-FSDGYVVKETIGVGSYSECKRCVHKA---TNMEYAVKVID----KSKRDPSEE 70
Query: 220 CE-MMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMID 278
            E +++  +H N+I +     + +   LV E M  G L   +    +  +      ++  
Sbjct: 71  IEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-VLHT 129
Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNM----VAHLSDFSIAKLLTGEDQSMTQTQ 334
           +   +EYLH   S  ++H DLKPSN+L  D         + DF  AK L  E+  +    
Sbjct: 130 IGKTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLL--MT 184
Query: 335 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
              T  ++APE  +        D++S GI+L     G  P
Sbjct: 185 PCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 39/239 (16%)
Query: 181 IGRGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKGFDVECEMMKSIRHRNLIKV 234
           +G G +G V  A  R+ +   VAVK+ +++    C   +K    E  + K + H N++K 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL--NIMIDVASALEYLH----- 287
                    + L LEY   G L             F R+  +I +    A  + H     
Sbjct: 70  YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 288 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
             + +   I H D+KP N+LLD+     +SDF +A +    ++     +   T+ Y+APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 346 YGREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW------VNDWLPIST 397
             +         DV+S GI+L     G+ P ++  +       W      +N W  I +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPWKKIDS 235

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 39/239 (16%)
Query: 181 IGRGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKGFDVECEMMKSIRHRNLIKV 234
           +G G +G V  A  R+ +   VAVK+ +++    C   +K    E  + K + H N++K 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EIXINKMLNHENVVKF 69
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL--NIMIDVASALEYLH----- 287
                    + L LEY   G L             F R+  +I +    A  + H     
Sbjct: 70  YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 288 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
             + +   I H D+KP N+LLD+     +SDF +A +    ++     +   T+ Y+APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 346 YGREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW------VNDWLPIST 397
             +         DV+S GI+L     G+ P ++  +       W      +N W  I +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 235

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   + +  G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY P G +  ++       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+++D      ++DF +AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 181 IGRGGFGSVYKARLGDGME-VAVKVFNLQ------CGRALKGFDVECEMMKSIRHRNLIK 233
           IG G +G+V+KA+  +  E VA+K   L          AL+    E  ++K ++H+N+++
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKELKHKNIVR 65
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
           +     +++   LV E+     L+KY  S N  LD     + +  +   L + H   S  
Sbjct: 66  LHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRN 121
Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV- 352
           ++H DLKP N+L++ N    L++F +A+      +    +  + T+ Y  P+     ++ 
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLY 179
Query: 353 STNGDVYSFGIMLMETFTGKKP 374
           ST+ D++S G +  E     +P
Sbjct: 180 STSIDMWSAGCIFAELANAGRP 201

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNAMH 199
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGXVATRWYRAPEIMLNWMH 199
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 149
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 150 DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 204
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 205 YNQTVDIWSVGCIMAELLTGR 225

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 88/188 (46%), Gaps = 18/188 (9%)
Query: 219 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMID 278
           E  ++KS+ H N+IK+     ++++  LV E+   G L + + +  +  D     NIM  
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQ 154
Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLLDDN---MVAHLSDFSIAKLLTGEDQSMTQTQT 335
           + S + YLH      I+H D+KP N+LL++    +   + DF ++   +   +       
Sbjct: 155 ILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS---KDYKLRDR 208
Query: 336 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP-----TNEIFNGEMTLKHW-- 388
           L T  Y+APE  ++ + +   DV+S G+++     G  P       +I       K++  
Sbjct: 209 LGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD 267
Query: 389 VNDWLPIS 396
            NDW  IS
Sbjct: 268 FNDWKNIS 275

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 124/281 (44%), Gaps = 39/281 (13%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRN--LIKVIS 236
           IG GG   V++         A+K  NL+    + L  +  E   +  ++  +  +I++  
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
               +++  +V+E   +  L  ++     I D ++R +      + LE +H  +   I+H
Sbjct: 96  YEITDQYIYMVME-CGNIDLNSWLKKKKSI-DPWERKSYW---KNMLEAVHTIHQHGIVH 150
Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVS-TN 355
            DLKP+N L+ D M+  L DF IA  +  +   + +   + T+ YM PE  ++   S  N
Sbjct: 151 SDLKPANFLIVDGMLK-LIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSREN 209
Query: 356 G----------DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL 405
           G          DV+S G +L     GK P  +I N +++  H + D  P   +E      
Sbjct: 210 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIID--PNHEIEFPD--- 263
Query: 406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVA 446
           + ++D+  V K  C          C    P+QRI+  E++A
Sbjct: 264 IPEKDLQDVLK--C----------CLKRDPKQRISIPELLA 292

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 18/213 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVF------NLQCGRALKGFDVECEMMKS 225
           D +     +G G F  V K R  G G E A K        + + G + +  + E  +++ 
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           IRH N+I +     N+    L+LE +  G L  ++     + +  +    +  +   + Y
Sbjct: 72  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-EATQFLKQILDGVHY 130
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAH----LSDFSIAKLLTGEDQSMTQTQTLATIGY 341
           LH   S  I H DLKP N++L D  V +    L DF IA  +   ++         T  +
Sbjct: 131 LH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEF 184
Query: 342 MAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           +APE      +    D++S G++     +G  P
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 28/219 (12%)
Query: 181 IGRGGFGSVYKA------RLGDGMEVAVKVFNLQCGRA-LKGFDVECEMMKSIRHR-NLI 232
           +GRG FG V +A      +      VAVK+       +  +    E +++  I H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 233 KVISTCSNEEFKALVL-EYMPHGSLEKYMYSSNY-----------ILDIFQRLNIMI--- 277
            ++  C+      +V+ E+   G+L  Y+ S              +   F  L  +I   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 278 -DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 336
             VA  +E+L    S   IH DL   N+LL +  V  + DF +A+ +  +   + +    
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 374
             + +MAPE   +   +   DV+SFG++L E F+ G  P
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 18/213 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVF------NLQCGRALKGFDVECEMMKS 225
           D +     +G G F  V K R  G G E A K        + + G + +  + E  +++ 
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           IRH N+I +     N+    L+LE +  G L  ++     + +  +    +  +   + Y
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-EATQFLKQILDGVHY 123
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAH----LSDFSIAKLLTGEDQSMTQTQTLATIGY 341
           LH   S  I H DLKP N++L D  V +    L DF IA  +   ++         T  +
Sbjct: 124 LH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEF 177
Query: 342 MAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           +APE      +    D++S G++     +G  P
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 18/213 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVK------VFNLQCGRALKGFDVECEMMKS 225
           D +     +G G F  V K R  G G E A K      + + + G + +  + E  +++ 
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           IRH N+I +     N+    L+LE +  G L  ++     + +  +    +  +   + Y
Sbjct: 86  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-EATQFLKQILDGVHY 144
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAH----LSDFSIAKLLTGEDQSMTQTQTLATIGY 341
           LH   S  I H DLKP N++L D  V +    L DF IA  +   ++         T  +
Sbjct: 145 LH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEF 198
Query: 342 MAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           +APE      +    D++S G++     +G  P
Sbjct: 199 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 231

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 151
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMH 206
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 207 YNQTVDIWSVGCIMAELLTGR 227

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   + +  G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY P G +  ++       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+++D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 151
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMH 206
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 207 YNQTVDIWSVGCIMAELLTGR 227

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 155
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 156 DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 210
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 211 YNQTVDIWSVGCIMAELLTGR 231

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 151
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMH 206
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 207 YNQTVDIWSVGCIMAELLTGR 227

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 106/229 (46%), Gaps = 30/229 (13%)
Query: 171 ATDGFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQ------CGRALKGFDVECEMM 223
           + D +     +G G +G VYKA      E VA+K   L+       G A++    E  ++
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----EVSLL 87
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
           K ++HRN+I++ S   +     L+ EY     L+KYM  +    D+  R+ I   +   +
Sbjct: 88  KELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYMDKNP---DVSMRV-IKSFLYQLI 142
Query: 284 EYLHFGYSAPIIHCDLKPSNVLL-----DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT 338
             ++F +S   +H DLKP N+LL      +  V  + DF +A+      +    T  + T
Sbjct: 143 NGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF--THEIIT 200
Query: 339 IGYMAPEYGREGR-VSTNGDVYS----FGIMLMET--FTGKKPTNEIFN 380
           + Y  PE     R  ST+ D++S    +  MLM+T  F G    +++F 
Sbjct: 201 LWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFK 249

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 141
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 142 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 196
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 197 YNQTVDIWSVGCIMAELLTGR 217

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 41/212 (19%)
Query: 181 IGRGGFGSV---YKARLGDGMEVAVKVFN------LQCGRALKGFDVECEMMKSIRHRNL 231
           +G G +GSV   Y ARL    +VAVK  +      +   R  +    E  ++K ++H N+
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYR----ELRLLKHLKHENV 89
Query: 232 IKVIS----TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLH 287
           I ++       S E+F  + L     G+    +  S  + D   +  ++  +   L+Y+H
Sbjct: 90  IGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQF-LVYQLLRGLKYIH 148
Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYG 347
              SA IIH DLKPSNV ++++    + DF +A+     D+ MT        GY+A  + 
Sbjct: 149 ---SAGIIHRDLKPSNVAVNEDSELRILDFGLAR---QADEEMT--------GYVATRWY 194
Query: 348 REGRVSTNG-------DVYSFGIMLMETFTGK 372
           R   +  N        D++S G ++ E   GK
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   + S     D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF + +    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 88  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 142
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 143 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 197
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 198 YNQTVDIWSVGCIMAELLTGR 218

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 163
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 164 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 218
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 219 YNQTVDIWSVGCIMAELLTGR 239

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 141
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 142 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 196
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 197 YNQTVDIWSVGCIMAELLTGR 217

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 140
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 195
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 196 YNQTVDIWSVGCIMAELLTGR 216

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 149
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 150 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 204
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 205 YNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 89  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 143
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 144 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 198
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 199 YNQTVDIWSVGCIMAELLTGR 219

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 150
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 151 DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 205
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 206 YNQTVDIWSVGCIMAELLTGR 226

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 164
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 165 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 219
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 220 YNQTVDIWSVGCIMAELLTGR 240

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 28/219 (12%)
Query: 181 IGRGGFGSVYKA------RLGDGMEVAVKVFNLQCGRA-LKGFDVECEMMKSIRHR-NLI 232
           +GRG FG V +A      +      VAVK+       +  +    E +++  I H  N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 233 KVISTCSNEEFKALVL-EYMPHGSLEKYMYSSNY-----------ILDIFQRLNIMI--- 277
            ++  C+      +V+ E+   G+L  Y+ S              +   F  L  +I   
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 278 -DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 336
             VA  +E+L    S   IH DL   N+LL +  V  + DF +A+ +  +   + +    
Sbjct: 146 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 374
             + +MAPE   +   +   DV+SFG++L E F+ G  P
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 146
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 147 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 201
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 202 YNQTVDIWSVGCIMAELLTGR 222

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 146
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 147 DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 201
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 202 YNQTVDIWSVGCIMAELLTGR 222

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 151
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 206
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 207 YNQTVDIWSVGCIMAELLTGR 227

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 150
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 151 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 205
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 206 YNQTVDIWSVGCIMAELLTGR 226

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 167
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 168 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 222
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 223 YNQTVDIWSVGCIMAELLTGR 243

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 146
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 147 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 201
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 202 YNQTVDIWSVGCIMAELLTGR 222

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 28/219 (12%)
Query: 181 IGRGGFGSVYKA------RLGDGMEVAVKVFNLQCGRA-LKGFDVECEMMKSIRHR-NLI 232
           +GRG FG V +A      +      VAVK+       +  +    E +++  I H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 233 KVISTCSNEEFKALVL-EYMPHGSLEKYMYSSNYIL--------DIFQRLNIM------- 276
            ++  C+      +V+ E+   G+L  Y+ S             D+++    +       
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 277 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 336
             VA  +E+L    S   IH DL   N+LL +  V  + DF +A+ +  +   + +    
Sbjct: 155 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 374
             + +MAPE   +   +   DV+SFG++L E F+ G  P
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   +  + G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY P G +  ++       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+++D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 156
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 157 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 211
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 212 YNQTVDIWSVGCIMAELLTGR 232

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 39/239 (16%)
Query: 181 IGRGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKGFDVECEMMKSIRHRNLIKV 234
           +G G +G V  A  R+ +   VAVK+ +++    C   +K    E  + K + H N++K 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL--NIMIDVASALEYLH----- 287
                    + L LEY   G L             F R+  +I +    A  + H     
Sbjct: 70  YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 288 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
             + +   I H D+KP N+LLD+     +SDF +A +    ++     +   T+ Y+APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 346 YGREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW------VNDWLPIST 397
             +         DV+S GI+L     G+ P ++  +       W      +N W  I +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 235

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 156
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 157 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 211
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 212 YNQTVDIWSVGCIMAELLTGR 232

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 149
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 150 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 204
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 205 YNQTVDIWSVGCIMAELLTGR 225

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 146
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 147 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 201
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 202 YNQTVDIWSVGCIMAELLTGR 222

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 150
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 151 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 205
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 206 YNQTVDIWSVGCIMAELLTGR 226

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 39/239 (16%)
Query: 181 IGRGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKGFDVECEMMKSIRHRNLIKV 234
           +G G +G V  A  R+ +   VAVK+ +++    C   +K    E  + K + H N++K 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL--NIMIDVASALEYLH----- 287
                    + L LEY   G L             F R+  +I +    A  + H     
Sbjct: 70  YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 288 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
             + +   I H D+KP N+LLD+     +SDF +A +    ++     +   T+ Y+APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 346 YGREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW------VNDWLPIST 397
             +         DV+S GI+L     G+ P ++  +       W      +N W  I +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 235

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 87/201 (43%), Gaps = 14/201 (6%)
Query: 180 LIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDV--ECEMMKSIRHRNLIKVIS 236
           ++G+G FG V K +      E AVKV N    +      +  E E++K + H N++K+  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
              +     +V E    G L   +       +      I+  V S + Y+H      I+H
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-HDAARIIKQVFSGITYMH---KHNIVH 144
Query: 297 CDLKPSNVLLDD---NMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVS 353
            DLKP N+LL+    +    + DF ++   T   Q+      + T  Y+APE  R G   
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTAYYIAPEVLR-GTYD 200
Query: 354 TNGDVYSFGIMLMETFTGKKP 374
              DV+S G++L    +G  P
Sbjct: 201 EKCDVWSAGVILYILLSGTPP 221

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 28/219 (12%)
Query: 181 IGRGGFGSVYKA------RLGDGMEVAVKVFNLQCGRA-LKGFDVECEMMKSIRHR-NLI 232
           +GRG FG V +A      +      VAVK+       +  +    E +++  I H  N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 233 KVISTCSNEEFKALVL-EYMPHGSLEKYMYSSNYIL--------DIFQRLNIM------- 276
            ++  C+      +V+ E+   G+L  Y+ S             D+++    +       
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 277 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 336
             VA  +E+L    S   IH DL   N+LL +  V  + DF +A+ +  +   + +    
Sbjct: 146 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 374
             + +MAPE   +   +   DV+SFG++L E F+ G  P
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 39/239 (16%)
Query: 181 IGRGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKGFDVECEMMKSIRHRNLIKV 234
           +G G +G V  A  R+ +   VAVK+ +++    C   +K    E  + K + H N++K 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL--NIMIDVASALEYLH----- 287
                    + L LEY   G L             F R+  +I +    A  + H     
Sbjct: 70  YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 288 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
             + +   I H D+KP N+LLD+     +SDF +A +    ++     +   T+ Y+APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 346 YGREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW------VNDWLPIST 397
             +         DV+S GI+L     G+ P ++  +       W      +N W  I +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 235

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 39/239 (16%)
Query: 181 IGRGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKGFDVECEMMKSIRHRNLIKV 234
           +G G +G V  A  R+ +   VAVK+ +++    C   +K    E  + K + H N++K 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL--NIMIDVASALEYLH----- 287
                    + L LEY   G L             F R+  +I +    A  + H     
Sbjct: 70  YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 288 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
             + +   I H D+KP N+LLD+     +SDF +A +    ++     +   T+ Y+APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 346 YGREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW------VNDWLPIST 397
             +         DV+S GI+L     G+ P ++  +       W      +N W  I +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 235

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 155
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 156 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 210
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 211 YNQTVDIWSVGCIMAELLTGR 231

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 39/239 (16%)
Query: 181 IGRGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKGFDVECEMMKSIRHRNLIKV 234
           +G G +G V  A  R+ +   VAVK+ +++    C   +K    E  + K + H N++K 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 70
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL--NIMIDVASALEYLH----- 287
                    + L LEY   G L             F R+  +I +    A  + H     
Sbjct: 71  YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 288 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
             + +   I H D+KP N+LLD+     +SDF +A +    ++     +   T+ Y+APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 346 YGREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW------VNDWLPIST 397
             +         DV+S GI+L     G+ P ++  +       W      +N W  I +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 28/219 (12%)
Query: 181 IGRGGFGSVYKA------RLGDGMEVAVKVFNLQCGRA-LKGFDVECEMMKSIRHR-NLI 232
           +GRG FG V +A      +      VAVK+       +  +    E +++  I H  N++
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 233 KVISTCSNEEFKALVL-EYMPHGSLEKYMYSSNY-----------ILDIFQRLNIMI--- 277
            ++  C+      +V+ E+   G+L  Y+ S              +   F  L  +I   
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 278 -DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 336
             VA  +E+L    S   IH DL   N+LL +  V  + DF +A+ +  +   + +    
Sbjct: 192 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248
Query: 337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 374
             + +MAPE   +   +   DV+SFG++L E F+ G  P
Sbjct: 249 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 287

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 39/239 (16%)
Query: 181 IGRGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKGFDVECEMMKSIRHRNLIKV 234
           +G G +G V  A  R+ +   VAVK+ +++    C   +K    E  + K + H N++K 
Sbjct: 13  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 68
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL--NIMIDVASALEYLH----- 287
                    + L LEY   G L             F R+  +I +    A  + H     
Sbjct: 69  YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 115
Query: 288 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
             + +   I H D+KP N+LLD+     +SDF +A +    ++     +   T+ Y+APE
Sbjct: 116 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 346 YGREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW------VNDWLPIST 397
             +         DV+S GI+L     G+ P ++  +       W      +N W  I +
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 234

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 156
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 157 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 211
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 212 YNQTVDIWSVGCIMAELLTGR 232

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 121/261 (46%), Gaps = 48/261 (18%)
Query: 181 IGRGGFGSVYKARLG-DGMEVAVKV---FNLQC--GRALKGFDVECEMMKSIRHRNLIKV 234
           IG G +G V  A    + + VA+K    F  Q    R L+    E +++   RH N+I +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLR----EIKILLRFRHENIIGI 90
Query: 235 ISTCSNEEFKALVLEYMPHGSL-EKYMYSSNYILDIFQRLN------IMIDVASALEYLH 287
                N+  +A  +E M    + +  M +  Y L   Q L+       +  +   L+Y+H
Sbjct: 91  -----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE-DQSMTQTQTLATIGYMAPEY 346
              SA ++H DLKPSN+LL+      + DF +A++   + D +   T+ +AT  Y APE 
Sbjct: 146 ---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 347 GREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL 405
               +  T   D++S G +L E  + +     IF G    KH+++    I  + ++G+  
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQLNHI--LGILGSP- 251
Query: 406 LSQEDIHFVAKEQCVSCVFNL 426
            SQED+         +C+ NL
Sbjct: 252 -SQEDL---------NCIINL 262

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 39/239 (16%)
Query: 181 IGRGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKGFDVECEMMKSIRHRNLIKV 234
           +G G +G V  A  R+ +   VAVK+ +++    C   +K    E  + K + H N++K 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL--NIMIDVASALEYLH----- 287
                    + L LEY   G L             F R+  +I +    A  + H     
Sbjct: 70  YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 288 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
             + +   I H D+KP N+LLD+     +SDF +A +    ++     +   T+ Y+APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 346 YGREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW------VNDWLPIST 397
             +         DV+S GI+L     G+ P ++  +       W      +N W  I +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 235

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 87/206 (42%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   + +  G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L K+  +  +     +V+EY P G +  ++       +   R      +    EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 159
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+++D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 93/220 (42%), Gaps = 32/220 (14%)
Query: 181 IGRGGFGSVYKARLGD---GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +GRG FG V+  R+ D   G + AVK   L+  RA +   + C  + S R   ++ +   
Sbjct: 101 LGRGSFGEVH--RMEDKQTGFQCAVKKVRLEVFRAEE--LMACAGLTSPR---IVPLYGA 153
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
                +  + +E +  GSL + +      L   + L  +      LEYLH   S  I+H 
Sbjct: 154 VREGPWVNIFMELLEGGSLGQ-LVKEQGCLPEDRALYYLGQALEGLEYLH---SRRILHG 209
Query: 298 DLKPSNVLL-DDNMVAHLSDFSIA----------KLLTGEDQSMTQTQTLATIGYMAPEY 346
           D+K  NVLL  D   A L DF  A           LLTG+    T+T       +MAPE 
Sbjct: 210 DVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTET-------HMAPEV 262
Query: 347 GREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLK 386
                     DV+S   M++    G  P  + F G + LK
Sbjct: 263 VLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK 302

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 87/201 (43%), Gaps = 14/201 (6%)
Query: 180 LIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDV--ECEMMKSIRHRNLIKVIS 236
           ++G+G FG V K +      E AVKV N    +      +  E E++K + H N++K+  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
              +     +V E    G L   +       +      I+  V S + Y+H      I+H
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-HDAARIIKQVFSGITYMH---KHNIVH 144
Query: 297 CDLKPSNVLLDD---NMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVS 353
            DLKP N+LL+    +    + DF ++   T   Q+      + T  Y+APE  R G   
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTAYYIAPEVLR-GTYD 200
Query: 354 TNGDVYSFGIMLMETFTGKKP 374
              DV+S G++L    +G  P
Sbjct: 201 EKCDVWSAGVILYILLSGTPP 221

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 39/239 (16%)
Query: 181 IGRGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKGFDVECEMMKSIRHRNLIKV 234
           +G G +G V  A  R+ +   VAVK+ +++    C   +K    E  + K + H N++K 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL--NIMIDVASALEYLH----- 287
                    + L LEY   G L             F R+  +I +    A  + H     
Sbjct: 70  YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 288 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
             + +   I H D+KP N+LLD+     +SDF +A +    ++     +   T+ Y+APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 346 YGREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW------VNDWLPIST 397
             +         DV+S GI+L     G+ P ++  +       W      +N W  I +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 235

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 39/239 (16%)
Query: 181 IGRGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKGFDVECEMMKSIRHRNLIKV 234
           +G G +G V  A  R+ +   VAVK+ +++    C   +K    E  + K + H N++K 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL--NIMIDVASALEYLH----- 287
                    + L LEY   G L             F R+  +I +    A  + H     
Sbjct: 70  YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 288 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
             + +   I H D+KP N+LLD+     +SDF +A +    ++     +   T+ Y+APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 346 YGREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW------VNDWLPIST 397
             +         DV+S GI+L     G+ P ++  +       W      +N W  I +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 235

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 28/219 (12%)
Query: 181 IGRGGFGSVYKA------RLGDGMEVAVKVFNLQCGRA-LKGFDVECEMMKSIRHR-NLI 232
           +GRG FG V +A      +      VAVK+       +  +    E +++  I H  N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 233 KVISTCSNEEFKALVL-EYMPHGSLEKYMYSSNY-----------ILDIFQRLNIMI--- 277
            ++  C+      +V+ E+   G+L  Y+ S              +   F  L  +I   
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 278 -DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 336
             VA  +E+L    S   IH DL   N+LL +  V  + DF +A+ +  +   + +    
Sbjct: 157 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 374
             + +MAPE   +   +   DV+SFG++L E F+ G  P
Sbjct: 214 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 252

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 39/239 (16%)
Query: 181 IGRGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKGFDVECEMMKSIRHRNLIKV 234
           +G G +G V  A  R+ +   VAVK+ +++    C   +K    E  + K + H N++K 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 70
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL--NIMIDVASALEYLH----- 287
                    + L LEY   G L             F R+  +I +    A  + H     
Sbjct: 71  YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 288 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
             + +   I H D+KP N+LLD+     +SDF +A +    ++     +   T+ Y+APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 346 YGREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW------VNDWLPIST 397
             +         DV+S GI+L     G+ P ++  +       W      +N W  I +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIS- 236
           +G G +GSV  +  +  G+++AVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 237 ---TCSNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 119 FTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 173
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 174 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 228
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 229 YNMTVDIWSVGCIMAELLTGR 249

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 17/213 (7%)
Query: 172 TDGFSENNLIGRGGFGSVY--KARLGDGMEVAVKVFNLQCGRALKGFDV---ECEMMKSI 226
           +D +    ++G+G FG V   K ++  G E AVKV + +  +     +    E +++K +
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 89
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
            H N++K+     ++ +  LV E    G L   + S     ++     I+  V S + Y+
Sbjct: 90  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 148
Query: 287 HFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           H      I+H DLKP N+LL+    +    + DF ++   T  + S      + T  Y+A
Sbjct: 149 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMKDKIGTAYYIA 202
Query: 344 PEYGREGRVSTNGDVYSFGIMLMETFTGKKPTN 376
           PE    G      DV+S G++L    +G  P N
Sbjct: 203 PEV-LHGTYDEKCDVWSTGVILYILLSGCPPFN 234

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 93/220 (42%), Gaps = 32/220 (14%)
Query: 181 IGRGGFGSVYKARLGD---GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +GRG FG V+  R+ D   G + AVK   L+  RA +   + C  + S R   ++ +   
Sbjct: 82  LGRGSFGEVH--RMEDKQTGFQCAVKKVRLEVFRAEE--LMACAGLTSPR---IVPLYGA 134
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
                +  + +E +  GSL + +      L   + L  +      LEYLH   S  I+H 
Sbjct: 135 VREGPWVNIFMELLEGGSLGQ-LVKEQGCLPEDRALYYLGQALEGLEYLH---SRRILHG 190
Query: 298 DLKPSNVLL-DDNMVAHLSDFSIA----------KLLTGEDQSMTQTQTLATIGYMAPEY 346
           D+K  NVLL  D   A L DF  A           LLTG+    T+T       +MAPE 
Sbjct: 191 DVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTET-------HMAPEV 243
Query: 347 GREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLK 386
                     DV+S   M++    G  P  + F G + LK
Sbjct: 244 VLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK 283

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   +  + G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+  G +  ++       +   R      +    EYLH 
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 145
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D+     ++DF  AK + G    +       T  Y+APE   
Sbjct: 146 --SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 198
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 199 SKGYNKAVDWWALGVLIYEMAAGYPP 224

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   +  + G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+  G +  ++       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   +  + G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+  G +  ++       +   R      +    EYLH 
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 153
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 154 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 206
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 207 SKGYNKAVDWWALGVLIYEMAAGYPP 232

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 22/212 (10%)
Query: 172 TDGFSENNLIGRGGFGS----VYKARLGDGMEVAVKVFNLQCGRALKGFDVECE-MMKSI 226
           +DG+     IG G +      V+KA     ME AVKV +    ++ +    E E +++  
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKAT---NMEYAVKVID----KSKRDPSEEIEILLRYG 78
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           +H N+I +     + +   LV E M  G L   +    +  +      ++  +   +EYL
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-VLHTIGKTVEYL 137
Query: 287 HFGYSAPIIHCDLKPSNVLLDDNM----VAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           H   S  ++H DLKPSN+L  D         + DF  AK L  E+  +       T  ++
Sbjct: 138 H---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLL--MTPCYTANFV 192
Query: 343 APEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           APE  +        D++S GI+L     G  P
Sbjct: 193 APEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 87/198 (43%), Gaps = 14/198 (7%)
Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNL-QCGRALKGFDV-ECEMMKSIRHRNLIKVIST 237
           IG G +G   K R   DG  +  K  +      A K   V E  +++ ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 238 CSNEEFKAL--VLEYMPHGSLE----KYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
             +     L  V+EY   G L     K      Y+ + F  L +M  +  AL+  H    
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV-LRVMTQLTLALKECHRRSD 132
Query: 292 A--PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 349
               ++H DLKP+NV LD      L DF +A++L   D S  +T  + T  YM+PE    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKT-FVGTPYYMSPEQMNR 190
Query: 350 GRVSTNGDVYSFGIMLME 367
              +   D++S G +L E
Sbjct: 191 MSYNEKSDIWSLGCLLYE 208

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 39/239 (16%)
Query: 181 IGRGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKGFDVECEMMKSIRHRNLIKV 234
           +G G +G V  A  R+ +   VAVK+ +++    C   +K    E  + K + H N++K 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 70
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL--NIMIDVASALEYLH----- 287
                    + L LEY   G L             F R+  +I +    A  + H     
Sbjct: 71  YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 288 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
             + +   I H D+KP N+LLD+     +SDF +A +    ++     +   T+ Y+APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 346 YGREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW------VNDWLPIST 397
             +         DV+S GI+L     G+ P ++  +       W      +N W  I +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 39/239 (16%)
Query: 181 IGRGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKGFDVECEMMKSIRHRNLIKV 234
           +G G +G V  A  R+ +   VAVK+ +++    C   +K    E  + K + H N++K 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 70
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL--NIMIDVASALEYLH----- 287
                    + L LEY   G L             F R+  +I +    A  + H     
Sbjct: 71  YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 288 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
             + +   I H D+KP N+LLD+     +SDF +A +    ++     +   T+ Y+APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 346 YGREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW------VNDWLPIST 397
             +         DV+S GI+L     G+ P ++  +       W      +N W  I +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 39/239 (16%)
Query: 181 IGRGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKGFDVECEMMKSIRHRNLIKV 234
           +G G +G V  A  R+ +   VAVK+ +++    C   +K    E  + K + H N++K 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 70
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL--NIMIDVASALEYLH----- 287
                    + L LEY   G L             F R+  +I +    A  + H     
Sbjct: 71  YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 288 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
             + +   I H D+KP N+LLD+     +SDF +A +    ++     +   T+ Y+APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 346 YGREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW------VNDWLPIST 397
             +         DV+S GI+L     G+ P ++  +       W      +N W  I +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   +  + G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+  G +  ++       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 39/239 (16%)
Query: 181 IGRGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKGFDVECEMMKSIRHRNLIKV 234
           +G G +G V  A  R+ +   VAVK+ +++    C   +K    E  + K + H N++K 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL--NIMIDVASALEYLH----- 287
                    + L LEY   G L             F R+  +I +    A  + H     
Sbjct: 70  YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 288 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
             + +   I H D+KP N+LLD+     +SDF +A +    ++     +   T+ Y+APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 346 YGREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW------VNDWLPIST 397
             +         DV+S GI+L     G+ P ++  +       W      +N W  I +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 235

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   +  + G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+  G +  ++       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYG 347
             S  +I+ DLKP N+L+D      ++DF  AK + G      +T  LA T  Y+APE  
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLAGTPEYLAPEII 210
Query: 348 REGRVSTNGDVYSFGIMLMETFTGKKP 374
                +   D ++ G+++ E   G  P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 87/206 (42%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   + +  G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L K+  +  +     +V+EY P G +  ++       +   R      +    EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+++D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 15/207 (7%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   +  + G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+  G +  ++       +   R      +    EYLH 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 179
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-ATIGYMAPEYG 347
             S  +I+ DLKP N+L+D      ++DF  AK + G       T TL  T  Y+APE  
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------ATWTLCGTPEYLAPEII 231
Query: 348 REGRVSTNGDVYSFGIMLMETFTGKKP 374
                +   D ++ G+++ E   G  P
Sbjct: 232 LSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 87/206 (42%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   + +  G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L K+  +  +     +V+EY P G +  ++       +   R      +    EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+++D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 39/239 (16%)
Query: 181 IGRGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKGFDVECEMMKSIRHRNLIKV 234
           +G G +G V  A  R+ +   VAVK+ +++    C   +K    E  + K + H N++K 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 70
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL--NIMIDVASALEYLH----- 287
                    + L LEY   G L             F R+  +I +    A  + H     
Sbjct: 71  YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 288 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
             + +   I H D+KP N+LLD+     +SDF +A +    ++     +   T+ Y+APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 346 YGREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW------VNDWLPIST 397
             +         DV+S GI+L     G+ P ++  +       W      +N W  I +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   +  + G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+  G +  ++       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G  VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +  +    D  Q L  +  +   L+Y+H   SA
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFL--IYQILRGLKYIH---SA 140
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 195
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 196 YNQTVDIWSVGCIMAELLTGR 216

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   +  + G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+  G +  ++       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARF-YAAQIVLTFEYLH- 158
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   +  + G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+  G +  ++       +   R      +    EYLH 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 179
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 232
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 76/176 (43%), Gaps = 11/176 (6%)
Query: 219 ECEMMKSIRHRNLIKVISTCSNEEFKAL--VLEYMPHGSLEKYMYSSNYILDIFQRLNIM 276
           E ++++ +RH+N+I+++    NEE + +  V+EY   G  E           + Q     
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF 115
Query: 277 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 336
             +   LEYLH   S  I+H D+KP N+LL       +S   +A+ L       T   + 
Sbjct: 116 CQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 337 ATIGYMAPEY--GREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVN 390
            +  +  PE   G +       D++S G+ L    TG  P    F G+   K + N
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP----FEGDNIYKLFEN 224

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 48/227 (21%)
Query: 172 TDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVK--------VFNLQCGRALKGFDVECEM 222
           +  F   +L+G G +G V  A     G  VA+K        +F L+  R +K       +
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK-------I 62
Query: 223 MKSIRHRNLIKVISTCSNEEFK-----ALVLEYMP---HGSLEKYMYSSNYI-LDIFQRL 273
           +K  +H N+I + +    + F+      ++ E M    H  +   M S ++I   I+Q L
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 274 NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL---------- 323
                   A++ LH    + +IH DLKPSN+L++ N    + DF +A+++          
Sbjct: 123 R-------AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 324 TGEDQSMTQTQTLATIGYMAPEYG-REGRVSTNGDVYSFGIMLMETF 369
           TG+   M   + +AT  Y APE      + S   DV+S G +L E F
Sbjct: 173 TGQQSGM--VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 125/281 (44%), Gaps = 39/281 (13%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRN--LIKVIS 236
           IG GG   V++         A+K  NL+    + L  +  E   +  ++  +  +I++  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
               +++  +V+E   +  L  ++     I D ++R +   ++   LE +H  +   I+H
Sbjct: 124 YEITDQYIYMVME-CGNIDLNSWLKKKKSI-DPWERKSYWKNM---LEAVHTIHQHGIVH 178
Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVS-TN 355
            DLKP+N L+ D M+  L DF IA  +  +  S+ +   +  + YM PE  ++   S  N
Sbjct: 179 SDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSREN 237
Query: 356 G----------DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL 405
           G          DV+S G +L     GK P  +I N +++  H + D  P   +E      
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIID--PNHEIEFPD--- 291
Query: 406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVA 446
           + ++D+  V K  C          C    P+QRI+  E++A
Sbjct: 292 IPEKDLQDVLK--C----------CLKRDPKQRISIPELLA 320

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 118/267 (44%), Gaps = 28/267 (10%)
Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           IG G  G V  A +   G  VAVK  +L+  +  +    E  +M+  +H N++++ ++  
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
             +   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 97  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 151
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVY 359
           K  ++LL  +    LSDF     ++ E     +   + T  +MAPE           D++
Sbjct: 152 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEVDIW 209
Query: 360 SFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ-EDIHFVAKEQ 418
           S GIM++E   G+ P    FN             P+  M+++  NL  + +++H V+   
Sbjct: 210 SLGIMVIEMVDGEPP---YFNEP-----------PLKAMKMIRDNLPPRLKNLHKVS--- 252
Query: 419 CVSCVFNLAMECTVESPEQRINAREIV 445
               +        V  P QR  A E++
Sbjct: 253 --PSLKGFLDRLLVRDPAQRATAAELL 277

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G  VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 140
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 195
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 196 YNQTVDIWSVGCIMAELLTGR 216

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 87/201 (43%), Gaps = 14/201 (6%)
Query: 180 LIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDV--ECEMMKSIRHRNLIKVIS 236
           ++G+G FG V K +      E AVKV N    +      +  E E++K + H N++K+  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
              +     +V E    G L   +       +      I+  V S + Y+H      I+H
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-HDAARIIKQVFSGITYMH---KHNIVH 144
Query: 297 CDLKPSNVLLDD---NMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVS 353
            DLKP N+LL+    +    + DF ++   T   Q+      + T  Y+APE  R G   
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTAYYIAPEVLR-GTYD 200
Query: 354 TNGDVYSFGIMLMETFTGKKP 374
              DV+S G++L    +G  P
Sbjct: 201 EKCDVWSAGVILYILLSGTPP 221

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   + +  G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+  G +  ++       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + D+ +A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDYGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   +  + G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+  G +  ++       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLX-----GTPEYLAPEIIL 211
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 118/267 (44%), Gaps = 28/267 (10%)
Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           IG G  G V  A +   G  VAVK  +L+  +  +    E  +M+  +H N++++ ++  
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
             +   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 99  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 153
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVY 359
           K  ++LL  +    LSDF     ++ E     +   + T  +MAPE           D++
Sbjct: 154 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEVDIW 211
Query: 360 SFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ-EDIHFVAKEQ 418
           S GIM++E   G+ P    FN             P+  M+++  NL  + +++H V+   
Sbjct: 212 SLGIMVIEMVDGEPP---YFNEP-----------PLKAMKMIRDNLPPRLKNLHKVS--- 254
Query: 419 CVSCVFNLAMECTVESPEQRINAREIV 445
               +        V  P QR  A E++
Sbjct: 255 --PSLKGFLDRLLVRDPAQRATAAELL 279

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G  VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 97/225 (43%), Gaps = 19/225 (8%)
Query: 181 IGRGGFG-SVYKARLGDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G FG ++      DG +  +K  N+     +  +    E  ++ +++H N+++   +
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQR---LNIMIDVASALEYLHFGYSAPI 294
                   +V++Y   G L K + +   +L  FQ    L+  + +  AL+++H      I
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVL--FQEDQILDWFVQICLALKHVH---DRKI 146
Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIG---YMAPEYGREGR 351
           +H D+K  N+ L  +    L DF IA++L       T     A IG   Y++PE      
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNS-----TVELARACIGTPYYLSPEICENKP 201
Query: 352 VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS 396
            +   D+++ G +L E  T K          + LK     + P+S
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVS 246

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G  VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 100 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 154
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 155 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 209
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 210 YNQTVDIWSVGCIMAELLTGR 230

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 118/267 (44%), Gaps = 28/267 (10%)
Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           IG G  G V  A +   G  VAVK  +L+  +  +    E  +M+  +H N++++ ++  
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
             +   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 142
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVY 359
           K  ++LL  +    LSDF     ++ E     +   + T  +MAPE           D++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 360 SFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ-EDIHFVAKEQ 418
           S GIM++E   G+ P    FN             P+  M+++  NL  + +++H V+   
Sbjct: 201 SLGIMVIEMVDGEPP---YFNEP-----------PLKAMKMIRDNLPPRLKNLHKVS--- 243
Query: 419 CVSCVFNLAMECTVESPEQRINAREIV 445
               +        V  P QR  A E++
Sbjct: 244 --PSLKGFLDRLLVRDPAQRATAAELL 268

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 109/244 (44%), Gaps = 31/244 (12%)
Query: 148 PSNDANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFN 206
           PS D   PS       ++L+  + TD F+   ++G+G FG V  A R G     A+K+  
Sbjct: 2   PSEDRKQPS-------NNLDRVKLTD-FNFLMVLGKGSFGKVMLADRKGTEELYAIKI-- 51
Query: 207 LQCGRALKGFDVECEMMKS------IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYM 260
           L+    ++  DVEC M++        +   L ++ S     +    V+EY+  G L   M
Sbjct: 52  LKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL---M 108
Query: 261 YSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA 320
           Y    +   F+    +   A     L F +   II+ DLK  NV+LD      ++DF + 
Sbjct: 109 YHIQQV-GKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMC 167
Query: 321 K--LLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEI 378
           K  ++ G    +T  +   T  Y+APE         + D +++G++L E   G+ P    
Sbjct: 168 KEHMMDG----VTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP---- 219
Query: 379 FNGE 382
           F+GE
Sbjct: 220 FDGE 223

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 118/267 (44%), Gaps = 28/267 (10%)
Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           IG G  G V  A +   G  VAVK  +L+  +  +    E  +M+  +H N++++ ++  
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
             +   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 92  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 146
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVY 359
           K  ++LL  +    LSDF     ++ E     +   + T  +MAPE           D++
Sbjct: 147 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEVDIW 204
Query: 360 SFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ-EDIHFVAKEQ 418
           S GIM++E   G+ P    FN             P+  M+++  NL  + +++H V+   
Sbjct: 205 SLGIMVIEMVDGEPP---YFNEP-----------PLKAMKMIRDNLPPRLKNLHKVS--- 247
Query: 419 CVSCVFNLAMECTVESPEQRINAREIV 445
               +        V  P QR  A E++
Sbjct: 248 --PSLKGFLDRLLVRDPAQRATAAELL 272

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G  VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 150
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 151 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 205
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 206 YNQTVDIWSVGCIMAELLTGR 226

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   +  + G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+  G +  ++       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   +  + G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+  G +  ++       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G  VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 164
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 165 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 219
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 220 YNQTVDIWSVGCIMAELLTGR 240

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G  VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 163
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 164 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 218
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 219 YNQTVDIWSVGCIMAELLTGR 239

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 118/267 (44%), Gaps = 28/267 (10%)
Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           IG G  G V  A +   G  VAVK  +L+  +  +    E  +M+  +H N++++ ++  
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
             +   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 142 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 196
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVY 359
           K  ++LL  +    LSDF     ++ E     +   + T  +MAPE           D++
Sbjct: 197 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEVDIW 254
Query: 360 SFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ-EDIHFVAKEQ 418
           S GIM++E   G+ P    FN             P+  M+++  NL  + +++H V+   
Sbjct: 255 SLGIMVIEMVDGEPP---YFNEP-----------PLKAMKMIRDNLPPRLKNLHKVS--- 297
Query: 419 CVSCVFNLAMECTVESPEQRINAREIV 445
               +        V  P QR  A E++
Sbjct: 298 --PSLKGFLDRLLVRDPAQRATAAELL 322

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 23/212 (10%)
Query: 172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRN 230
           +D F   + +GRG    VY+ +  G     A+KV      + +     E  ++  + H N
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI--VRTEIGVLLRLSHPN 109
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSL-----EKYMYSSNYILDIFQRLNIMIDVASALEY 285
           +IK+          +LVLE +  G L     EK  YS     D  ++      +  A+ Y
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ------ILEAVAY 163
Query: 286 LHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           LH      I+H DLKP N+L      +    ++DF ++K++  E Q + +T    T GY 
Sbjct: 164 LH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKT-VCGTPGYC 217
Query: 343 APEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           APE  R        D++S GI+      G +P
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   +  + G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+  G +  ++       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   +  + G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+  G +  ++       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   +  + G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+  G +  ++       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 21/218 (9%)
Query: 172 TDGFSENNLIGRGGFGSVY--KARLGDGMEVAVKVFNLQCGRALKGFDV---ECEMMKSI 226
           +D +    ++G+G FG V   K ++  G E AVKV + +  +     +    E +++K +
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
            H N++K+     ++ +  LV E    G L   + S     ++     I+  V S + Y+
Sbjct: 84  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 142
Query: 287 HFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           H      I+H DLKP N+LL+    +    + DF ++   T  + S      + T  Y+A
Sbjct: 143 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMKDKIGTAYYIA 196
Query: 344 PEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNG 381
           PE    G      DV+S G++L    +G  P    FNG
Sbjct: 197 PEV-LHGTYDEKCDVWSTGVILYILLSGCPP----FNG 229

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   +  + G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+  G +  ++       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G  VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFYLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 41/212 (19%)
Query: 181 IGRGGFGSV---YKARLGDGMEVAVKVFN------LQCGRALKGFDVECEMMKSIRHRNL 231
           +G G +GSV   Y ARL    +VAVK  +      +   R  +    E  ++K ++H N+
Sbjct: 28  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYR----ELRLLKHLKHENV 81
Query: 232 IKVIS----TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLH 287
           I ++       S E+F  + L     G+    +     + D   +  ++  +   L+Y+H
Sbjct: 82  IGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-LVYQLLRGLKYIH 140
Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYG 347
              SA IIH DLKPSNV ++++    + DF +A+     D+ MT        GY+A  + 
Sbjct: 141 ---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADEEMT--------GYVATRWY 186
Query: 348 REGRVSTNG-------DVYSFGIMLMETFTGK 372
           R   +  N        D++S G ++ E   GK
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 41/212 (19%)
Query: 181 IGRGGFGSV---YKARLGDGMEVAVKVFN------LQCGRALKGFDVECEMMKSIRHRNL 231
           +G G +GSV   Y ARL    +VAVK  +      +   R  +    E  ++K ++H N+
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYR----ELRLLKHLKHENV 89
Query: 232 IKVIS----TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLH 287
           I ++       S E+F  + L     G+    +     + D   +  ++  +   L+Y+H
Sbjct: 90  IGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-LVYQLLRGLKYIH 148
Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYG 347
              SA IIH DLKPSNV ++++    + DF +A+     D+ MT        GY+A  + 
Sbjct: 149 ---SAGIIHRDLKPSNVAVNEDSELRILDFGLAR---QADEEMT--------GYVATRWY 194
Query: 348 REGRVSTNG-------DVYSFGIMLMETFTGK 372
           R   +  N        D++S G ++ E   GK
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 19/220 (8%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDV--ECEMMKSIRHRNLIKVISTC 238
           +G G FG V++        V V  F +     L  + V  E  +M  + H  LI +    
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKF-INTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 239 SNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            ++    L+LE++  G L   + + +Y +   + +N M      L+++H      I+H D
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLD 174
Query: 299 LKPSNVLLDDNMVAHLS--DFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 356
           +KP N++ +    + +   DF +A  L  ++       T AT  + APE      V    
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAPEIVDREPVGFYT 231
Query: 357 DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVN----DW 392
           D+++ G++     +G  P    F GE  L+   N    DW
Sbjct: 232 DMWAIGVLGYVLLSGLSP----FAGEDDLETLQNVKRCDW 267

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 118/267 (44%), Gaps = 28/267 (10%)
Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           IG G  G V  A +   G  VAVK  +L+  +  +    E  +M+  +H N++++ ++  
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
             +   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 219 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 273
Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVY 359
           K  ++LL  +    LSDF     ++ E     +   + T  +MAPE           D++
Sbjct: 274 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEVDIW 331
Query: 360 SFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ-EDIHFVAKEQ 418
           S GIM++E   G+ P    FN             P+  M+++  NL  + +++H V+   
Sbjct: 332 SLGIMVIEMVDGEPP---YFNEP-----------PLKAMKMIRDNLPPRLKNLHKVS--- 374
Query: 419 CVSCVFNLAMECTVESPEQRINAREIV 445
               +        V  P QR  A E++
Sbjct: 375 --PSLKGFLDRLLVRDPAQRATAAELL 399

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 105/241 (43%), Gaps = 27/241 (11%)
Query: 153 NMPSIATWRTFSHLELCRATDG---FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ 208
           +M S +  R+   ++L    D    F    L+G G +G VYK R +  G   A+KV ++ 
Sbjct: 1   SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV- 59
Query: 209 CGRALKGFDVECEMMKSI-RHRNL-------IKVISTCSNEEFKALVLEYMPHGSLEKYM 260
            G   +    E  M+K    HRN+       IK      +++   LV+E+   GS+   +
Sbjct: 60  TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL-WLVMEFCGAGSVTDLI 118
Query: 261 YSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSI 319
            ++    L       I  ++   L +LH      +IH D+K  NVLL +N    L DF +
Sbjct: 119 KNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGV 175
Query: 320 AKLLTGEDQSMTQTQT-LATIGYMAPEY-----GREGRVSTNGDVYSFGIMLMETFTGKK 373
           +  L   D+++ +  T + T  +MAPE        +       D++S GI  +E   G  
Sbjct: 176 SAQL---DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
Query: 374 P 374
           P
Sbjct: 233 P 233

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 91/218 (41%), Gaps = 28/218 (12%)
Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +GRG FG V++ +    G + AVK   L+  R  +   V C  + S R   ++ +     
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE--LVACAGLSSPR---IVPLYGAVR 120
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
              +  + +E +  GSL + +      +        +  +  ALE L + ++  I+H D+
Sbjct: 121 EGPWVNIFMELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 176
Query: 300 KPSNVLL-DDNMVAHLSDFSIA----------KLLTGEDQSMTQTQTLATIGYMAPEYGR 348
           K  NVLL  D   A L DF  A           LLTG+    T+T       +MAPE   
Sbjct: 177 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET-------HMAPEVVM 229
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLK 386
                   D++S   M++    G  P  + F G + LK
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 267

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 87/198 (43%), Gaps = 14/198 (7%)
Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNL-QCGRALKGFDV-ECEMMKSIRHRNLIKVIST 237
           IG G +G   K R   DG  +  K  +      A K   V E  +++ ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 238 CSNEEFKAL--VLEYMPHGSLE----KYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
             +     L  V+EY   G L     K      Y+ + F  L +M  +  AL+  H    
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV-LRVMTQLTLALKECHRRSD 132
Query: 292 A--PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 349
               ++H DLKP+NV LD      L DF +A++L   D+   + + + T  YM+PE    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDEDFAK-EFVGTPYYMSPEQMNR 190
Query: 350 GRVSTNGDVYSFGIMLME 367
              +   D++S G +L E
Sbjct: 191 MSYNEKSDIWSLGCLLYE 208

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 21/218 (9%)
Query: 172 TDGFSENNLIGRGGFGSVY--KARLGDGMEVAVKVFNLQCGRALKGFDV---ECEMMKSI 226
           +D +    ++G+G FG V   K ++  G E AVKV + +  +     +    E +++K +
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 107
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
            H N++K+     ++ +  LV E    G L   + S     ++     I+  V S + Y+
Sbjct: 108 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 166
Query: 287 HFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           H      I+H DLKP N+LL+    +    + DF ++   T  + S      + T  Y+A
Sbjct: 167 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMKDKIGTAYYIA 220
Query: 344 PEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNG 381
           PE    G      DV+S G++L    +G  P    FNG
Sbjct: 221 PEV-LHGTYDEKCDVWSTGVILYILLSGCPP----FNG 253

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 167
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E         +AT  Y APE       
Sbjct: 168 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MXGYVATRWYRAPEIMLNWMH 222
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 223 YNQTVDIWSVGCIMAELLTGR 243

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/80 (37%), Positives = 43/80 (53%), Gaps = 3/80 (3%)
Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ-TQTLATIGYMAPEYGREGRVST 354
           H D+KP N+L+  +  A+L DF IA   T  D+ +TQ   T+ T+ Y APE   E   + 
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYXAPERFSESHATY 214
Query: 355 NGDVYSFGIMLMETFTGKKP 374
             D+Y+   +L E  TG  P
Sbjct: 215 RADIYALTCVLYECLTGSPP 234

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 87/200 (43%), Gaps = 11/200 (5%)
Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFD-VECE---MMKSIRHRNLIKV 234
           +IGRG +  V   RL     + A+KV   +     +  D V+ E     ++  H  L+ +
Sbjct: 12  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 71
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI 294
            S    E     V+EY+  G L  +M     + +   R     +++ AL YLH      I
Sbjct: 72  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGI 127
Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVST 354
           I+ DLK  NVLLD      L+D+ + K   G     T +    T  Y+APE  R      
Sbjct: 128 IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYGF 185
Query: 355 NGDVYSFGIMLMETFTGKKP 374
           + D ++ G+++ E   G+ P
Sbjct: 186 SVDWWALGVLMFEMMAGRSP 205

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 21/218 (9%)
Query: 172 TDGFSENNLIGRGGFGSVY--KARLGDGMEVAVKVFNLQCGRALKGFDV---ECEMMKSI 226
           +D +    ++G+G FG V   K ++  G E AVKV + +  +     +    E +++K +
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 106
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
            H N++K+     ++ +  LV E    G L   + S     ++     I+  V S + Y+
Sbjct: 107 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 165
Query: 287 HFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           H      I+H DLKP N+LL+    +    + DF ++   T  + S      + T  Y+A
Sbjct: 166 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMKDKIGTAYYIA 219
Query: 344 PEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNG 381
           PE    G      DV+S G++L    +G  P    FNG
Sbjct: 220 PEV-LHGTYDEKCDVWSTGVILYILLSGCPP----FNG 252

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 91/218 (41%), Gaps = 28/218 (12%)
Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +GRG FG V++ +    G + AVK   L+  R  +   V C  + S R   ++ +     
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE--LVACAGLSSPR---IVPLYGAVR 136
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
              +  + +E +  GSL + +      +        +  +  ALE L + ++  I+H D+
Sbjct: 137 EGPWVNIFMELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 192
Query: 300 KPSNVLL-DDNMVAHLSDFSIA----------KLLTGEDQSMTQTQTLATIGYMAPEYGR 348
           K  NVLL  D   A L DF  A           LLTG+    T+T       +MAPE   
Sbjct: 193 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET-------HMAPEVVM 245
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLK 386
                   D++S   M++    G  P  + F G + LK
Sbjct: 246 GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 283

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 97/239 (40%), Gaps = 39/239 (16%)
Query: 181 IGRGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKGFDVECEMMKSIRHRNLIKV 234
           +G G  G V  A  R+ +   VAVK+ +++    C   +K    E  + K + H N++K 
Sbjct: 14  LGEGAAGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL--NIMIDVASALEYLH----- 287
                    + L LEY   G L             F R+  +I +    A  + H     
Sbjct: 70  YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 288 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
             + +   I H D+KP N+LLD+     +SDF +A +    ++     +   T+ Y+APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 346 YGREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW------VNDWLPIST 397
             +         DV+S GI+L     G+ P ++  +       W      +N W  I +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 235

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 87/200 (43%), Gaps = 11/200 (5%)
Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFD-VECE---MMKSIRHRNLIKV 234
           +IGRG +  V   RL     + A+KV   +     +  D V+ E     ++  H  L+ +
Sbjct: 27  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 86
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI 294
            S    E     V+EY+  G L  +M     + +   R     +++ AL YLH      I
Sbjct: 87  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGI 142
Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVST 354
           I+ DLK  NVLLD      L+D+ + K   G     T +    T  Y+APE  R      
Sbjct: 143 IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYGF 200
Query: 355 NGDVYSFGIMLMETFTGKKP 374
           + D ++ G+++ E   G+ P
Sbjct: 201 SVDWWALGVLMFEMMAGRSP 220

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 25/220 (11%)
Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G GGF  V     L DG   A+K       +  +    E +M +   H N++++++ C 
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 240 NEEFKA----LVLEYMPHGSL----EKYMYSSNYILDIFQRLNIMIDVASALEYLHF-GY 290
            E        L+L +   G+L    E+     N++ +  Q L +++ +   LE +H  GY
Sbjct: 97  RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTED-QILWLLLGICRGLEAIHAKGY 155
Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL----LTGEDQSMTQTQTLA---TIGYMA 343
           +    H DLKP+N+LL D     L D          + G  Q++T     A   TI Y A
Sbjct: 156 A----HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 344 PE---YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFN 380
           PE         +    DV+S G +L     G+ P + +F 
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ 251

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 11/202 (5%)
Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFD-VECE---MMKSIRHRNLIKV 234
           +IGRG +  V   RL     + A+KV   +     +  D V+ E     ++  H  L+ +
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI 294
            S    E     V+EY+  G L  +M     + +   R     +++ AL YLH      I
Sbjct: 76  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGI 131
Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVST 354
           I+ DLK  NVLLD      L+D+ + K   G     T +    T  Y+APE  R      
Sbjct: 132 IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYGF 189
Query: 355 NGDVYSFGIMLMETFTGKKPTN 376
           + D ++ G+++ E   G+ P +
Sbjct: 190 SVDWWALGVLMFEMMAGRSPFD 211

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 86/198 (43%), Gaps = 14/198 (7%)
Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNL-QCGRALKGFDV-ECEMMKSIRHRNLIKVIST 237
           IG G +G   K R   DG  +  K  +      A K   V E  +++ ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 238 CSNEEFKAL--VLEYMPHGSLE----KYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
             +     L  V+EY   G L     K      Y+ + F  L +M  +  AL+  H    
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV-LRVMTQLTLALKECHRRSD 132
Query: 292 A--PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 349
               ++H DLKP+NV LD      L DF +A++L   D S  +   + T  YM+PE    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKA-FVGTPYYMSPEQMNR 190
Query: 350 GRVSTNGDVYSFGIMLME 367
              +   D++S G +L E
Sbjct: 191 MSYNEKSDIWSLGCLLYE 208

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/242 (23%), Positives = 102/242 (42%), Gaps = 35/242 (14%)
Query: 179 NLIGRGGFGSVYKA-RLGDGMEVAVKV-----FNLQCGRALKGFDVECEMMKSIRHRNLI 232
            +IG+G F  V +      G + AVK+     F    G + +    E  +   ++H +++
Sbjct: 30  EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASA---------L 283
           +++ T S++    +V E+M    L           +I +R +     + A         L
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADL---------CFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 284 EYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIG 340
           E L + +   IIH D+KP NVLL   +++    L DF +A  L   +  +     + T  
Sbjct: 141 EALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLG--ESGLVAGGRVGTPH 198
Query: 341 YMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP----TNEIFNGEMTLKHWVN--DWLP 394
           +MAPE  +        DV+  G++L    +G  P       +F G +  K+ +N   W  
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSH 258
Query: 395 IS 396
           IS
Sbjct: 259 IS 260

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 97/239 (40%), Gaps = 39/239 (16%)
Query: 181 IGRGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKGFDVECEMMKSIRHRNLIKV 234
           +G G +G V  A  R+ +   VAVK+ +++    C   +K    E  +   + H N++K 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINAMLNHENVVKF 70
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL--NIMIDVASALEYLH----- 287
                    + L LEY   G L             F R+  +I +    A  + H     
Sbjct: 71  YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 288 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
             + +   I H D+KP N+LLD+     +SDF +A +    ++     +   T+ Y+APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 346 YGREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW------VNDWLPIST 397
             +         DV+S GI+L     G+ P ++  +       W      +N W  I +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 88/206 (42%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   +  + G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+  G +  ++       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ +   G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYQMAAGYPP 237

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 112/257 (43%), Gaps = 37/257 (14%)
Query: 181 IGRGGFGSVYKAR-LGDGMEVAVK-----VFNLQCGRALKGFDVECEMMKSIRHRNLIKV 234
           +GRG +G V K R +  G  +AVK     V + +  R L   D+    M+++     +  
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS---MRTVDCPFTVTF 115
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL------NIMIDVASALEYLHF 288
                 E    + +E M   SL+K+      ++D  Q +       I + +  ALE+LH 
Sbjct: 116 YGALFREGDVWICMELM-DTSLDKFY---KQVIDKGQTIPEDILGKIAVSIVKALEHLHS 171
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA----- 343
             S  +IH D+KPSNVL++      + DF I+  L     S+ +T       YMA     
Sbjct: 172 KLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV---DSVAKTIDAGCKPYMAPERIN 226
Query: 344 PEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA 403
           PE  ++G  S   D++S GI ++E    + P +        LK  V +  P      + A
Sbjct: 227 PELNQKG-YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP-----QLPA 280
Query: 404 NLLSQEDIHFVAKEQCV 420
           +  S E + F +  QC+
Sbjct: 281 DKFSAEFVDFTS--QCL 295

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 102/222 (45%), Gaps = 28/222 (12%)
Query: 168 LCRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV----ECEM 222
            C     + +   IG+G FG V+KAR    G +VA+K   ++  +  +GF +    E ++
Sbjct: 13  FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKI 70
Query: 223 MKSIRHRNLIKVISTCSNE-----EFKA---LVLEYMPH---GSLEKYMYSSNYILDIFQ 271
           ++ ++H N++ +I  C  +       KA   LV ++  H   G L   +    + L   +
Sbjct: 71  LQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK--FTLSEIK 128
Query: 272 RLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL--LTGEDQS 329
           R+  M+     L  L++ +   I+H D+K +NVL+  + V  L+DF +A+   L    Q 
Sbjct: 129 RVMQML-----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 330 MTQTQTLATIGYMAPEYGR-EGRVSTNGDVYSFGIMLMETFT 370
                 + T+ Y  PE    E       D++  G ++ E +T
Sbjct: 184 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 92/212 (43%), Gaps = 22/212 (10%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCGRALKG-FDVECEMMKSIRHRN 230
           D +   +++G G F  V  A      + VA+K    +     +G  + E  ++  I+H N
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSL-----EKYMYSSNYILDIFQRLNIMIDVASALEY 285
           ++ +     +     L+++ +  G L     EK  Y+            ++  V  A++Y
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER------DASRLIFQVLDAVKY 131
Query: 286 LHFGYSAPIIHCDLKPSNVL---LDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           LH      I+H DLKP N+L   LD++    +SDF ++K+   ED     +    T GY+
Sbjct: 132 LH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYV 185
Query: 343 APEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           APE   +   S   D +S G++      G  P
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 100/235 (42%), Gaps = 32/235 (13%)
Query: 154 MPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--GR 211
           MP       +   E  R  D +   +++G G F  V  A      +   K+  ++C   +
Sbjct: 1   MPGAVEGPRWKQAEDIR--DIYDFRDVLGTGAFSEVILAE----DKRTQKLVAIKCIAKK 54
Query: 212 ALKG----FDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL-----EKYMYS 262
           AL+G     + E  ++  I+H N++ +     +     L+++ +  G L     EK  Y+
Sbjct: 55  ALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYT 114
Query: 263 SNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVL---LDDNMVAHLSDFSI 319
                       ++  V  A++YLH      I+H DLKP N+L   LD++    +SDF +
Sbjct: 115 ER------DASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGL 165
Query: 320 AKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           +K+   ED     +    T GY+APE   +   S   D +S G++      G  P
Sbjct: 166 SKM---EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 92/212 (43%), Gaps = 22/212 (10%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCGRALKG-FDVECEMMKSIRHRN 230
           D +   +++G G F  V  A      + VA+K    +     +G  + E  ++  I+H N
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSL-----EKYMYSSNYILDIFQRLNIMIDVASALEY 285
           ++ +     +     L+++ +  G L     EK  Y+            ++  V  A++Y
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER------DASRLIFQVLDAVKY 131
Query: 286 LHFGYSAPIIHCDLKPSNVL---LDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           LH      I+H DLKP N+L   LD++    +SDF ++K+   ED     +    T GY+
Sbjct: 132 LH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYV 185
Query: 343 APEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           APE   +   S   D +S G++      G  P
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 91/218 (41%), Gaps = 28/218 (12%)
Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +GRG FG V++ +    G + AVK   L+  R  +   V C  + S R   ++ +     
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE--LVACAGLSSPR---IVPLYGAVR 134
Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
              +  + +E +  GSL + +      +        +  +  ALE L + ++  I+H D+
Sbjct: 135 EGPWVNIFMELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 190
Query: 300 KPSNVLL-DDNMVAHLSDFSIA----------KLLTGEDQSMTQTQTLATIGYMAPEYGR 348
           K  NVLL  D   A L DF  A           LLTG+    T+T       +MAPE   
Sbjct: 191 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET-------HMAPEVVM 243
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLK 386
                   D++S   M++    G  P  + F G + LK
Sbjct: 244 GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 281

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 88/206 (42%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   +  + G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+  G +  ++       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+++D      ++DF  AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIII 211
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 92/212 (43%), Gaps = 22/212 (10%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCGRALKG-FDVECEMMKSIRHRN 230
           D +   +++G G F  V  A      + VA+K    +     +G  + E  ++  I+H N
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSL-----EKYMYSSNYILDIFQRLNIMIDVASALEY 285
           ++ +     +     L+++ +  G L     EK  Y+            ++  V  A++Y
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER------DASRLIFQVLDAVKY 131
Query: 286 LHFGYSAPIIHCDLKPSNVL---LDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           LH      I+H DLKP N+L   LD++    +SDF ++K+   ED     +    T GY+
Sbjct: 132 LH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYV 185
Query: 343 APEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           APE   +   S   D +S G++      G  P
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 91/218 (41%), Gaps = 20/218 (9%)
Query: 165 HLELCRATDGFSENNLIGRGGFG----SVYKARLGDGMEVAVKVFNLQCGRALKGFDVEC 220
           H    + TDG+     IG G +      ++KA      E AVK+ +       +  ++  
Sbjct: 14  HRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKAT---NXEFAVKIIDKSKRDPTEEIEI-- 68
Query: 221 EMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVA 280
            +++  +H N+I +     + ++  +V E    G L   +    +  +  +   ++  + 
Sbjct: 69  -LLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSE-REASAVLFTIT 126
Query: 281 SALEYLHFGYSAPIIHCDLKPSNVLLDDNM----VAHLSDFSIAKLLTGEDQSMTQTQTL 336
             +EYLH   +  ++H DLKPSN+L  D         + DF  AK L  E+  +      
Sbjct: 127 KTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL--XTPC 181
Query: 337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
            T  ++APE           D++S G++L    TG  P
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 30/214 (14%)
Query: 175 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKG----FDVECEMMKSIRH 228
           F     +G G F  V  A      +   K+F ++C   +ALKG     + E  +++ I+H
Sbjct: 24  FEFKETLGTGAFSEVVLAE----EKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKH 79
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSL-----EKYMYSSNYILDIFQRLNIMIDVASAL 283
            N++ +     +     LV++ +  G L     EK  Y+      + ++      V  A+
Sbjct: 80  ENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQ------VLDAV 133
Query: 284 EYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIG 340
            YLH      I+H DLKP N+L    D+     +SDF ++K+   E +    +    T G
Sbjct: 134 YYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM---EGKGDVMSTACGTPG 187
Query: 341 YMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           Y+APE   +   S   D +S G++      G  P
Sbjct: 188 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 92/206 (44%), Gaps = 29/206 (14%)
Query: 181 IGRGGFGSVYKARLG-DGMEVAVKVF------NLQCGRALKGFDVECEMMKSIRHRNLIK 233
           +G G +G+V  A  G  G +VA+K         L   RA +    E  ++K +RH N+I 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMRHENVIG 88
Query: 234 VISTCSNEEFKA------LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLH 287
           ++   + +E         LV+ +M    L K M       D  Q L     V   L+ L 
Sbjct: 89  LLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFL-----VYQMLKGLR 142
Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYG 347
           + ++A IIH DLKP N+ ++++    + DF +A+    E         + T  Y APE  
Sbjct: 143 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MXGXVVTRWYRAPEVI 197
Query: 348 REG-RVSTNGDVYSFGIMLMETFTGK 372
               R +   D++S G ++ E  TGK
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G  VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 164
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E         +AT  Y APE       
Sbjct: 165 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MXGXVATRWYRAPEIMLNWMH 219
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 220 YNQTVDIWSVGCIMAELLTGR 240

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 172 TDGFSENNLIGRGGFGSVY--KARLGDGMEVAVKVFNLQCGRALKGFDV---ECEMMKSI 226
           +D +    ++G+G FG V   K ++  G E AVKV + +  +     +    E +++K +
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL 286
            H N+ K+     ++ +  LV E    G L   + S     ++     I+  V S + Y 
Sbjct: 84  DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYX 142
Query: 287 HFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           H      I+H DLKP N+LL+    +    + DF ++   T  + S      + T  Y+A
Sbjct: 143 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKXKDKIGTAYYIA 196
Query: 344 PEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNG 381
           PE    G      DV+S G++L    +G  P    FNG
Sbjct: 197 PEV-LHGTYDEKCDVWSTGVILYILLSGCPP----FNG 229

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 84/204 (41%), Gaps = 10/204 (4%)
Query: 175 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRN 230
           F    L+G+G FG V   R    G   A+K+   +       +     E  ++++ RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY 290
           L  +       +    V+EY   G L  ++       +   R     ++ SALEYLH   
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH--- 122
Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 350
           S  +++ D+K  N++LD +    ++DF + K   G     T      T  Y+APE   + 
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDN 180
Query: 351 RVSTNGDVYSFGIMLMETFTGKKP 374
                 D +  G+++ E   G+ P
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G  VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 140
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E         +AT  Y APE       
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWYRAPEIMLNWMH 195
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 196 YNQTVDIWSVGCIMAELLTGR 216

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 84/204 (41%), Gaps = 10/204 (4%)
Query: 175 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRN 230
           F    L+G+G FG V   R    G   A+K+   +       +     E  ++++ RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY 290
           L  +       +    V+EY   G L  ++       +   R     ++ SALEYLH   
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH--- 122
Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 350
           S  +++ D+K  N++LD +    ++DF + K   G     T      T  Y+APE   + 
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDN 180
Query: 351 RVSTNGDVYSFGIMLMETFTGKKP 374
                 D +  G+++ E   G+ P
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 84/204 (41%), Gaps = 10/204 (4%)
Query: 175 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRN 230
           F    L+G+G FG V   R    G   A+K+   +       +     E  ++++ RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY 290
           L  +       +    V+EY   G L  ++       +   R     ++ SALEYLH   
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH--- 122
Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 350
           S  +++ D+K  N++LD +    ++DF + K   G     T      T  Y+APE   + 
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 351 RVSTNGDVYSFGIMLMETFTGKKP 374
                 D +  G+++ E   G+ P
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    +  F +A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILGFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 73/150 (48%), Gaps = 9/150 (6%)
Query: 228 HRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLH 287
           H N++K+     ++    LV+E +  G L + +    +  +  +   IM  + SA+ ++H
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSET-EASYIMRKLVSAVSHMH 123
Query: 288 FGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
                 ++H DLKP N+L    +DN+   + DF  A+L   ++Q +       T+ Y AP
Sbjct: 124 ---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCFTLHYAAP 178
Query: 345 EYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           E   +     + D++S G++L    +G+ P
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 90/196 (45%), Gaps = 27/196 (13%)
Query: 168 LCRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV----ECEM 222
            C     + +   IG+G FG V+KAR    G +VA+K   ++  +  +GF +    E ++
Sbjct: 13  FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKI 70
Query: 223 MKSIRHRNLIKVISTCSNEEFKA--------LVLEYMPH---GSLEKYMYSSNYILDIFQ 271
           ++ ++H N++ +I  C  +            LV ++  H   G L   +    + L   +
Sbjct: 71  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIK 128
Query: 272 RLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL--LTGEDQS 329
           R+  M+     L  L++ +   I+H D+K +NVL+  + V  L+DF +A+   L    Q 
Sbjct: 129 RVMQML-----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 330 MTQTQTLATIGYMAPE 345
                 + T+ Y  PE
Sbjct: 184 NRYXNRVVTLWYRPPE 199

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 84/204 (41%), Gaps = 10/204 (4%)
Query: 175 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRN 230
           F    L+G+G FG V   R    G   A+K+   +       +     E  ++++ RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY 290
           L  +       +    V+EY   G L  ++       +   R     ++ SALEYLH   
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH--- 122
Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 350
           S  +++ D+K  N++LD +    ++DF + K   G     T      T  Y+APE   + 
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 351 RVSTNGDVYSFGIMLMETFTGKKP 374
                 D +  G+++ E   G+ P
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/263 (23%), Positives = 104/263 (39%), Gaps = 47/263 (17%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDV-----ECEMMKSIRHRNLIKVI 235
           +GRG FG V++      +E + K   +     +KG D      E  ++   RHRN++ + 
Sbjct: 13  LGRGEFGIVHRC-----VETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLH 67
Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLN----------IMIDVASALEY 285
            +  + E   ++ E++               LDIF+R+N          I+  V    E 
Sbjct: 68  ESFESMEELVMIFEFISG-------------LDIFERINTSAFELNEREIVSYVHQVCEA 114
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLS--DFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           L F +S  I H D++P N++      + +   +F  A+ L   D             Y A
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYA 171
Query: 344 PEYGREGRVSTNGDVYSFGIMLMETFTGKKP----TNE-----IFNGEMTLKHWVNDWLP 394
           PE  +   VST  D++S G ++    +G  P    TN+     I N E T        + 
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS 231
Query: 395 ISTMEVVGANLLSQEDIHFVAKE 417
           I  M+ V   L+ +      A E
Sbjct: 232 IEAMDFVDRLLVKERKSRMTASE 254

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 84/204 (41%), Gaps = 10/204 (4%)
Query: 175 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRN 230
           F    L+G+G FG V   R    G   A+K+   +       +     E  ++++ RH  
Sbjct: 12  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 71
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY 290
           L  +       +    V+EY   G L  ++       +   R     ++ SALEYLH   
Sbjct: 72  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH--- 127
Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 350
           S  +++ D+K  N++LD +    ++DF + K   G     T      T  Y+APE   + 
Sbjct: 128 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDN 185
Query: 351 RVSTNGDVYSFGIMLMETFTGKKP 374
                 D +  G+++ E   G+ P
Sbjct: 186 DYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + D  +A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDAGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G  VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E         +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWYRAPEIMLNWMH 199
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 84/204 (41%), Gaps = 10/204 (4%)
Query: 175 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRN 230
           F    L+G+G FG V   R    G   A+K+   +       +     E  ++++ RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY 290
           L  +       +    V+EY   G L  ++       +   R     ++ SALEYLH   
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH--- 122
Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 350
           S  +++ D+K  N++LD +    ++DF + K   G     T      T  Y+APE   + 
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDN 180
Query: 351 RVSTNGDVYSFGIMLMETFTGKKP 374
                 D +  G+++ E   G+ P
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 168 LCRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV----ECEM 222
            C     + +   IG+G FG V+KAR    G +VA+K   ++  +  +GF +    E ++
Sbjct: 12  FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKI 69
Query: 223 MKSIRHRNLIKVISTCSNEEFKA--------LVLEYMPH---GSLEKYMYSSNYILDIFQ 271
           ++ ++H N++ +I  C  +            LV ++  H   G L   +    + L   +
Sbjct: 70  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIK 127
Query: 272 RLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL--LTGEDQS 329
           R+  M+     L  L++ +   I+H D+K +NVL+  + V  L+DF +A+   L    Q 
Sbjct: 128 RVMQML-----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182
Query: 330 MTQTQTLATIGYMAPEYGR-EGRVSTNGDVYSFGIMLMETFT 370
                 + T+ Y  PE    E       D++  G ++ E +T
Sbjct: 183 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 168 LCRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV----ECEM 222
            C     + +   IG+G FG V+KAR    G +VA+K   ++  +  +GF +    E ++
Sbjct: 13  FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKI 70
Query: 223 MKSIRHRNLIKVISTCSNEEFKA--------LVLEYMPH---GSLEKYMYSSNYILDIFQ 271
           ++ ++H N++ +I  C  +            LV ++  H   G L   +    + L   +
Sbjct: 71  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIK 128
Query: 272 RLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL--LTGEDQS 329
           R+  M+     L  L++ +   I+H D+K +NVL+  + V  L+DF +A+   L    Q 
Sbjct: 129 RVMQML-----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 330 MTQTQTLATIGYMAPEYGR-EGRVSTNGDVYSFGIMLMETFT 370
                 + T+ Y  PE    E       D++  G ++ E +T
Sbjct: 184 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G  VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + DF +A+    E         +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWYRAPEIMLNWMH 199
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 10/209 (4%)
Query: 170 RATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKVFN---LQCGRALKGFDVECEMMKS 225
           R    +     +G+GGF   Y+    D  EV A KV     L      +    E  + KS
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 82
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           + + +++       +++F  +VLE     SL +       + +   R   M      ++Y
Sbjct: 83  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTIQGVQY 141
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
           LH   +  +IH DLK  N+ L+D+M   + DF +A  +  E     +     T  Y+APE
Sbjct: 142 LH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKDLCGTPNYIAPE 196
Query: 346 YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
              +   S   D++S G +L     GK P
Sbjct: 197 VLCKKGHSFEVDIWSLGCILYTLLVGKPP 225

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 84/204 (41%), Gaps = 10/204 (4%)
Query: 175 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRN 230
           F    L+G+G FG V   R    G   A+K+   +       +     E  ++++ RH  
Sbjct: 10  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 69
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY 290
           L  +       +    V+EY   G L  ++       +   R     ++ SALEYLH   
Sbjct: 70  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH--- 125
Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 350
           S  +++ D+K  N++LD +    ++DF + K   G     T      T  Y+APE   + 
Sbjct: 126 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDN 183
Query: 351 RVSTNGDVYSFGIMLMETFTGKKP 374
                 D +  G+++ E   G+ P
Sbjct: 184 DYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + D  +A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDRGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 87/200 (43%), Gaps = 11/200 (5%)
Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFD-VECE---MMKSIRHRNLIKV 234
           +IGRG +  V   RL     + A++V   +     +  D V+ E     ++  H  L+ +
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI 294
            S    E     V+EY+  G L  +M     + +   R     +++ AL YLH      I
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGI 174
Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVST 354
           I+ DLK  NVLLD      L+D+ + K   G     T +    T  Y+APE  R      
Sbjct: 175 IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 232
Query: 355 NGDVYSFGIMLMETFTGKKP 374
           + D ++ G+++ E   G+ P
Sbjct: 233 SVDWWALGVLMFEMMAGRSP 252

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFDVEC-----EMMKSIRHRNLIK 233
           +IGRG FG V   +L +  +V A+K+ N      LK  +  C     +++ +   + +  
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKILNKW--EMLKRAETACFREERDVLVNGDSKWITT 138
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYS-SNYILDIFQRLNI--MIDVASALEYLHFGY 290
           +     ++    LV++Y   G L   +    + + +   R  +  M+    ++  LH+  
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHY-- 196
Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDF-SIAKLLTGEDQSMTQTQTLATIGYMAPEY--- 346
               +H D+KP N+L+D N    L+DF S  KL+  ED ++  +  + T  Y++PE    
Sbjct: 197 ----VHRDIKPDNILMDMNGHIRLADFGSCLKLM--EDGTVQSSVAVGTPDYISPEILQA 250
Query: 347 --GREGRVSTNGDVYSFGIMLMETFTGKKP 374
             G +GR     D +S G+ + E   G+ P
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 91/216 (42%), Gaps = 18/216 (8%)
Query: 170 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALK------GFDVECEM 222
           +  D +     +G G F  V K R    G+E A K    +  RA +        + E  +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 223 MKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASA 282
           ++ + H N+I +     N     L+LE +  G L  ++ +    L   +  + +  +   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDG 127
Query: 283 LEYLHFGYSAPIIHCDLKPSNV-LLDDNM-VAHLS--DFSIAKLLTGEDQSMTQTQTLAT 338
           + YLH   +  I H DLKP N+ LLD N+ + H+   DF +A  +   +  +       T
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGT 181
Query: 339 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
             ++APE      +    D++S G++     +G  P
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 87/206 (42%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   +  + G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+  G +  ++       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +       T  Y+AP    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPAIIL 211
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 19/212 (8%)
Query: 178 NNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIR-HRNLIKVI 235
           + L+G G +  V  A  L +G E AVK+   Q G +      E E +   + ++N++++I
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
               ++    LV E +  GS+  ++    +  +  +   ++ DVA+AL++LH   +  I 
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHIQKQKH-FNEREASRVVRDVAAALDFLH---TKGIA 133
Query: 296 HCDLKPSNVLLDDN---MVAHLSDFSIAK--LLTGEDQSMTQTQTLATIG---YMAPEY- 346
           H DLKP N+L +         + DF +     L      +T  +     G   YMAPE  
Sbjct: 134 HRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVV 193
Query: 347 ----GREGRVSTNGDVYSFGIMLMETFTGKKP 374
                +        D++S G++L    +G  P
Sbjct: 194 EVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 91/216 (42%), Gaps = 18/216 (8%)
Query: 170 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALK------GFDVECEM 222
           +  D +     +G G F  V K R    G+E A K    +  RA +        + E  +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 223 MKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASA 282
           ++ + H N+I +     N     L+LE +  G L  ++ +    L   +  + +  +   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDG 127
Query: 283 LEYLHFGYSAPIIHCDLKPSNV-LLDDNM-VAHLS--DFSIAKLLTGEDQSMTQTQTLAT 338
           + YLH   +  I H DLKP N+ LLD N+ + H+   DF +A  +   +  +       T
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGT 181
Query: 339 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
             ++APE      +    D++S G++     +G  P
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           +G G +GSV  A     G+ VAVK  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 238 C----SNEEFKALVL-EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
                S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-R 351
            IIH DLKPSN+ ++++    + D  +A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDGGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 352 VSTNGDVYSFGIMLMETFTGK 372
            +   D++S G ++ E  TG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 12/210 (5%)
Query: 170 RATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKVFN---LQCGRALKGFDVECEMMKS 225
           R    +     +G+GGF   Y+    D  EV A KV     L      +    E  + KS
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           + + +++       +++F  +VLE     SL +       + +   R   M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTIQGVQY 157
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-ATIGYMAP 344
           LH   +  +IH DLK  N+ L+D+M   + DF +A  +  + +   + +TL  T  Y+AP
Sbjct: 158 LH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE---RKKTLCGTPNYIAP 211
Query: 345 EYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           E   +   S   D++S G +L     GK P
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 91/216 (42%), Gaps = 18/216 (8%)
Query: 170 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALK------GFDVECEM 222
           +  D +     +G G F  V K R    G+E A K    +  RA +        + E  +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 223 MKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASA 282
           ++ + H N+I +     N     L+LE +  G L  ++ +    L   +  + +  +   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDG 127
Query: 283 LEYLHFGYSAPIIHCDLKPSNV-LLDDNM-VAHLS--DFSIAKLLTGEDQSMTQTQTLAT 338
           + YLH   +  I H DLKP N+ LLD N+ + H+   DF +A  +   +  +       T
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGT 181
Query: 339 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
             ++APE      +    D++S G++     +G  P
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 10/209 (4%)
Query: 170 RATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKVFN---LQCGRALKGFDVECEMMKS 225
           R    +     +G+GGF   Y+    D  EV A KV     L      +    E  + KS
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           + + +++       +++F  +VLE     SL +       + +   R   M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTIQGVQY 157
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
           LH   +  +IH DLK  N+ L+D+M   + DF +A  +  E     +     T  Y+APE
Sbjct: 158 LH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKDLCGTPNYIAPE 212
Query: 346 YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
              +   S   D++S G +L     GK P
Sbjct: 213 VLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 91/216 (42%), Gaps = 18/216 (8%)
Query: 170 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALK------GFDVECEM 222
           +  D +     +G G F  V K R    G+E A K    +  RA +        + E  +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 223 MKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASA 282
           ++ + H N+I +     N     L+LE +  G L  ++ +    L   +  + +  +   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDG 127
Query: 283 LEYLHFGYSAPIIHCDLKPSNV-LLDDNM-VAHLS--DFSIAKLLTGEDQSMTQTQTLAT 338
           + YLH   +  I H DLKP N+ LLD N+ + H+   DF +A  +   +  +       T
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGT 181
Query: 339 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
             ++APE      +    D++S G++     +G  P
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 91/216 (42%), Gaps = 18/216 (8%)
Query: 170 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALK------GFDVECEM 222
           +  D +     +G G F  V K R    G+E A K    +  RA +        + E  +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 223 MKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASA 282
           ++ + H N+I +     N     L+LE +  G L  ++ +    L   +  + +  +   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDG 127
Query: 283 LEYLHFGYSAPIIHCDLKPSNV-LLDDNM-VAHLS--DFSIAKLLTGEDQSMTQTQTLAT 338
           + YLH   +  I H DLKP N+ LLD N+ + H+   DF +A  +   +  +       T
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGT 181
Query: 339 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
             ++APE      +    D++S G++     +G  P
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 10/209 (4%)
Query: 170 RATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKVFN---LQCGRALKGFDVECEMMKS 225
           R    +     +G+GGF   Y+    D  EV A KV     L      +    E  + KS
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           + + +++       +++F  +VLE     SL +       + +   R   M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTIQGVQY 157
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
           LH   +  +IH DLK  N+ L+D+M   + DF +A  +  E     +     T  Y+APE
Sbjct: 158 LH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKXLCGTPNYIAPE 212
Query: 346 YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
              +   S   D++S G +L     GK P
Sbjct: 213 VLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 101/234 (43%), Gaps = 12/234 (5%)
Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKVFN---LQCGRALKGFDVECEMMKSIRHRNLIKVI 235
            +G+GGF   ++    D  EV A K+     L      +   +E  + +S+ H++++   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
               + +F  +VLE     SL +       + +   R  +   +    +YLH      +I
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLHRNR---VI 139
Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-ATIGYMAPEYGREGRVST 354
           H DLK  N+ L++++   + DF +A   T  +    + +TL  T  Y+APE   +   S 
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERKKTLCGTPNYIAPEVLSKKGHSF 196
Query: 355 NGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ 408
             DV+S G ++     GK P       E  L+   N++     +  V A+L+ +
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 250

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 101/234 (43%), Gaps = 12/234 (5%)
Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKVFN---LQCGRALKGFDVECEMMKSIRHRNLIKVI 235
            +G+GGF   ++    D  EV A K+     L      +   +E  + +S+ H++++   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
               + +F  +VLE     SL +       + +   R  +   +    +YLH      +I
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLHRNR---VI 139
Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-ATIGYMAPEYGREGRVST 354
           H DLK  N+ L++++   + DF +A   T  +    + +TL  T  Y+APE   +   S 
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERKKTLCGTPNYIAPEVLSKKGHSF 196
Query: 355 NGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ 408
             DV+S G ++     GK P       E  L+   N++     +  V A+L+ +
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 250

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 101/234 (43%), Gaps = 12/234 (5%)
Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKVFN---LQCGRALKGFDVECEMMKSIRHRNLIKVI 235
            +G+GGF   ++    D  EV A K+     L      +   +E  + +S+ H++++   
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 87
Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
               + +F  +VLE     SL +       + +   R  +   +    +YLH      +I
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLHRNR---VI 143
Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-ATIGYMAPEYGREGRVST 354
           H DLK  N+ L++++   + DF +A   T  +    + +TL  T  Y+APE   +   S 
Sbjct: 144 HRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERKKTLCGTPNYIAPEVLSKKGHSF 200
Query: 355 NGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ 408
             DV+S G ++     GK P       E  L+   N++     +  V A+L+ +
Sbjct: 201 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 254

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 86/170 (50%), Gaps = 20/170 (11%)
Query: 217 DVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIM 276
           + E E++K + H  +IK+ +    E++  +VLE M  G L   +  +  + +   +L   
Sbjct: 188 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YF 245
Query: 277 IDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQT 333
             +  A++YLH      IIH DLKP NVLL   +++ +  ++DF  +K+L GE   M   
Sbjct: 246 YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLM--- 298
Query: 334 QTL-ATIGYMAPEYGREGRVSTNG-----DVYSFGIMLMETFTGKKPTNE 377
           +TL  T  Y+APE      V T G     D +S G++L    +G  P +E
Sbjct: 299 RTLCGTPTYLAPEVLVS--VGTAGYNRAVDCWSLGVILFICLSGYPPFSE 346

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 86/170 (50%), Gaps = 20/170 (11%)
Query: 217 DVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIM 276
           + E E++K + H  +IK+ +    E++  +VLE M  G L   +  +  + +   +L   
Sbjct: 202 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YF 259
Query: 277 IDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQT 333
             +  A++YLH      IIH DLKP NVLL   +++ +  ++DF  +K+L GE   M   
Sbjct: 260 YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLM--- 312
Query: 334 QTL-ATIGYMAPEYGREGRVSTNG-----DVYSFGIMLMETFTGKKPTNE 377
           +TL  T  Y+APE      V T G     D +S G++L    +G  P +E
Sbjct: 313 RTLCGTPTYLAPEVLVS--VGTAGYNRAVDCWSLGVILFICLSGYPPFSE 360

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 87/206 (42%), Gaps = 13/206 (6%)
Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRH 228
           D F     +G G FG V   +  + G   A+K+ + Q    LK  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+  G +  ++       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G    +  T        +APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEA-----LAPEIIL 211
Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   D ++ G+++ E   G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 29/223 (13%)
Query: 173 DGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFN---LQCGRALKG-----FDVECEMM 223
           D +  +  +G G  G V  A       +VA+K+ +      G A +       + E E++
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
           K + H  +IK+ +    E++  +VLE M  G L   +  +  + +   +L     +  A+
Sbjct: 70  KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLAV 127
Query: 284 EYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-ATI 339
           +YLH      IIH DLKP NVLL   +++ +  ++DF  +K+L GE   M   +TL  T 
Sbjct: 128 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLM---RTLCGTP 180
Query: 340 GYMAPEYGREGRVSTNG-----DVYSFGIMLMETFTGKKPTNE 377
            Y+APE      V T G     D +S G++L    +G  P +E
Sbjct: 181 TYLAPEVLVS--VGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 29/223 (13%)
Query: 173 DGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFN---LQCGRALKG-----FDVECEMM 223
           D +  +  +G G  G V  A       +VA+K+ +      G A +       + E E++
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
           K + H  +IK+ +    E++  +VLE M  G L   +  +  + +   +L     +  A+
Sbjct: 70  KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLAV 127
Query: 284 EYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-ATI 339
           +YLH      IIH DLKP NVLL   +++ +  ++DF  +K+L GE   M   +TL  T 
Sbjct: 128 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLM---RTLCGTP 180
Query: 340 GYMAPEYGREGRVSTNG-----DVYSFGIMLMETFTGKKPTNE 377
            Y+APE      V T G     D +S G++L    +G  P +E
Sbjct: 181 TYLAPEVLVS--VGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 29/223 (13%)
Query: 173 DGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFN---LQCGRALKG-----FDVECEMM 223
           D +  +  +G G  G V  A       +VA+K+ +      G A +       + E E++
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
           K + H  +IK+ +    E++  +VLE M  G L   +  +  + +   +L     +  A+
Sbjct: 69  KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLAV 126
Query: 284 EYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-ATI 339
           +YLH      IIH DLKP NVLL   +++ +  ++DF  +K+L GE   M   +TL  T 
Sbjct: 127 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLM---RTLCGTP 179
Query: 340 GYMAPEYGREGRVSTNG-----DVYSFGIMLMETFTGKKPTNE 377
            Y+APE      V T G     D +S G++L    +G  P +E
Sbjct: 180 TYLAPEVLVS--VGTAGYNRAVDCWSLGVILFICLSGYPPFSE 220

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 29/223 (13%)
Query: 173 DGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFN---LQCGRALKG-----FDVECEMM 223
           D +  +  +G G  G V  A       +VA+K+ +      G A +       + E E++
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
           K + H  +IK+ +    E++  +VLE M  G L   +  +  + +   +L     +  A+
Sbjct: 70  KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLAV 127
Query: 284 EYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-ATI 339
           +YLH      IIH DLKP NVLL   +++ +  ++DF  +K+L GE   M   +TL  T 
Sbjct: 128 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLM---RTLCGTP 180
Query: 340 GYMAPEYGREGRVSTNG-----DVYSFGIMLMETFTGKKPTNE 377
            Y+APE      V T G     D +S G++L    +G  P +E
Sbjct: 181 TYLAPEVLVS--VGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 102/235 (43%), Gaps = 44/235 (18%)
Query: 181 IGRGGFGSVYKA---RLGDGMEVAVKVFN-----LQCGRALKGFDVECEMMKSIRHRNLI 232
           +G+G +G V+K+   R G+ + V  K+F+         R  +   +  E+     H N++
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVK-KIFDAFQNSTDAQRTFREIMILTELSG---HENIV 72
Query: 233 KVIST--CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY 290
            +++     N+    LV +YM    L   + ++  IL+   +  ++  +   ++YLH   
Sbjct: 73  NLLNVLRADNDRDVYLVFDYM-ETDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH--- 126
Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG-------------------EDQSMT 331
           S  ++H D+KPSN+LL+      ++DF +++                       +D    
Sbjct: 127 SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 332 QTQTLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTL 385
            T  +AT  Y APE        T G D++S G +L E   GK     IF G  T+
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP----IFPGSSTM 237

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 29/223 (13%)
Query: 173 DGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFN---LQCGRALKG-----FDVECEMM 223
           D +  +  +G G  G V  A       +VA+K+ +      G A +       + E E++
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
           K + H  +IK+ +    E++  +VLE M  G L   +  +  + +   +L     +  A+
Sbjct: 76  KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLAV 133
Query: 284 EYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-ATI 339
           +YLH      IIH DLKP NVLL   +++ +  ++DF  +K+L GE   M   +TL  T 
Sbjct: 134 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLM---RTLCGTP 186
Query: 340 GYMAPEYGREGRVSTNG-----DVYSFGIMLMETFTGKKPTNE 377
            Y+APE      V T G     D +S G++L    +G  P +E
Sbjct: 187 TYLAPEVLVS--VGTAGYNRAVDCWSLGVILFICLSGYPPFSE 227

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 273 LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM-- 330
           L+I I +A A+E+LH   S  ++H DLKPSN+    + V  + DF +   +  +++    
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 331 --------TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 367
                   T    + T  YM+PE       S   D++S G++L E
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 180 LIGRGGFGSVY-KARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSI------RHRNLI 232
           ++G+G FG V    R G     AVK+  L+    ++  DVEC M++        +   L 
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
           ++ S     +    V+EY+  G L   MY    +   F+  + +   A     L F  S 
Sbjct: 85  QLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSK 140
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV 352
            II+ DLK  NV+LD      ++DF + K    +   +T      T  Y+APE       
Sbjct: 141 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--GVTTKXFCGTPDYIAPEIIAYQPY 198
Query: 353 STNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
             + D ++FG++L E   G+ P    F GE
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQAP----FEGE 224

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 88/205 (42%), Gaps = 18/205 (8%)
Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALK------GFDVECEMMKSIRHRNLIK 233
           +G G F  V K R    G+E A K    +  RA +        + E  +++ + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
           +     N     L+LE +  G L  ++ +    L   +  + +  +   + YLH   +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 294 IIHCDLKPSNV-LLDDNM-VAHLS--DFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 349
           I H DLKP N+ LLD N+ + H+   DF +A  +   +  +       T  ++APE    
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 350 GRVSTNGDVYSFGIMLMETFTGKKP 374
             +    D++S G++     +G  P
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASP 217

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ----CGRALKGFDVECE--MMKS 225
           D +     +G G F  V K R    G++ A K    +      R +   D+E E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           I+H N+I +     N+    L+LE +  G L  ++     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVA----HLSDFSIAKLLTGEDQSMTQTQTLATIGY 341
           LH   S  I H DLKP N++L D  V      + DF +A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPAF 183
Query: 342 MAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           +APE      +    D++S G++     +G  P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 180 LIGRGGFGSVY-KARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSI------RHRNLI 232
           ++G+G FG V    R G     AVK+  L+    ++  DVEC M++        +   L 
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
           ++ S     +    V+EY+  G L   MY    +   F+  + +   A     L F  S 
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV 352
            II+ DLK  NV+LD      ++DF + K    +   +T      T  Y+APE       
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--GVTTKXFCGTPDYIAPEIIAYQPY 519
Query: 353 STNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
             + D ++FG++L E   G+ P    F GE
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAP----FEGE 545

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 54/106 (50%), Gaps = 10/106 (9%)
Query: 274 NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 333
            + + +  AL YL   +   +IH D+KPSN+LLD+     L DF I+  L  +D++  ++
Sbjct: 128 KMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLV-DDKAKDRS 184
Query: 334 QTLATIGYMAPEY-----GREGRVSTNGDVYSFGIMLMETFTGKKP 374
              A   YMAPE        +       DV+S GI L+E  TG+ P
Sbjct: 185 AGCAA--YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ----CGRALKGFDVECE--MMKS 225
           D +     +G G F  V K R    G++ A K    +      R +   D+E E  ++K 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           I+H N+I +     N+    L+LE +  G L  ++     + +  +    +  + + + Y
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 128
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVA----HLSDFSIAKLLTGEDQSMTQTQTLATIGY 341
           LH   S  I H DLKP N++L D  V      + DF +A  +   D          T  +
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 182
Query: 342 MAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           +APE      +    D++S G++     +G  P
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 23/217 (10%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G  G V  A     G+ VAVK  +   Q     K    E  ++K + H+N+I +++ 
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 89
Query: 238 CSN----EEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            +     EEF+   LV+E M   +L + ++     LD  +   ++  +   +++LH   S
Sbjct: 90  FTPQKTLEEFQDVYLVMELM-DANLCQVIHME---LDHERMSYLLYQMLCGIKHLH---S 142
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGR 351
           A IIH DLKPSN+++  +    + DF +A+  +    +   T  + T  Y APE      
Sbjct: 143 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAST---NFMMTPYVVTRYYRAPEVILGMG 199
Query: 352 VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW 388
              N D++S G ++ E   G    + IF G   +  W
Sbjct: 200 YKENVDIWSVGCIMGELVKG----SVIFQGTDHIDQW 232

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ----CGRALKGFDVECE--MMKS 225
           D +     +G G F  V K R    G++ A K    +      R +   D+E E  ++K 
Sbjct: 11  DYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           I+H N+I +     N+    L+LE +  G L  ++     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVA----HLSDFSIAKLLTGEDQSMTQTQTLATIGY 341
           LH   S  I H DLKP N++L D  V      + DF +A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 342 MAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           +APE      +    D++S G++     +G  P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ----CGRALKGFDVECE--MMKS 225
           D +     +G G F  V K R    G++ A K    +      R +   D+E E  ++K 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           I+H N+I +     N+    L+LE +  G L  ++     + +  +    +  + + + Y
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 128
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVA----HLSDFSIAKLLTGEDQSMTQTQTLATIGY 341
           LH   S  I H DLKP N++L D  V      + DF +A  +   D          T  +
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 182
Query: 342 MAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           +APE      +    D++S G++     +G  P
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ----CGRALKGFDVECE--MMKS 225
           D +     +G G F  V K R    G++ A K    +      R +   D+E E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           I+H N+I +     N+    L+LE +  G L  ++     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVA----HLSDFSIAKLLTGEDQSMTQTQTLATIGY 341
           LH   S  I H DLKP N++L D  V      + DF +A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 342 MAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           +APE      +    D++S G++     +G  P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ----CGRALKGFDVECE--MMKS 225
           D +     +G G F  V K R    G++ A K    +      R +   D+E E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           I+H N+I +     N+    L+LE +  G L  ++     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVA----HLSDFSIAKLLTGEDQSMTQTQTLATIGY 341
           LH   S  I H DLKP N++L D  V      + DF +A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 342 MAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           +APE      +    D++S G++     +G  P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/233 (22%), Positives = 98/233 (42%), Gaps = 10/233 (4%)
Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKVFN---LQCGRALKGFDVECEMMKSIRHRNLIKVI 235
            +G+GGF   ++    D  EV A K+     L      +   +E  + +S+ H++++   
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 105
Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
               + +F  +VLE     SL +       + +   R  +   +    +YLH      +I
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLHRNR---VI 161
Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 355
           H DLK  N+ L++++   + DF +A  +  E     +     T  Y+APE   +   S  
Sbjct: 162 HRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAPEVLSKKGHSFE 219
Query: 356 GDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ 408
            DV+S G ++     GK P       E  L+   N++     +  V A+L+ +
Sbjct: 220 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 272

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ----CGRALKGFDVECE--MMKS 225
           D +     +G G F  V K R    G++ A K    +      R +   D+E E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           I+H N+I +     N+    L+LE +  G L  ++     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVA----HLSDFSIAKLLTGEDQSMTQTQTLATIGY 341
           LH   S  I H DLKP N++L D  V      + DF +A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 342 MAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           +APE      +    D++S G++     +G  P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/233 (22%), Positives = 98/233 (42%), Gaps = 10/233 (4%)
Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKVFN---LQCGRALKGFDVECEMMKSIRHRNLIKVI 235
            +G+GGF   ++    D  EV A K+     L      +   +E  + +S+ H++++   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
               + +F  +VLE     SL +       + +   R  +   +    +YLH      +I
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLHRNR---VI 163
Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 355
           H DLK  N+ L++++   + DF +A  +  E     +     T  Y+APE   +   S  
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAPEVLSKKGHSFE 221
Query: 356 GDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ 408
            DV+S G ++     GK P       E  L+   N++     +  V A+L+ +
Sbjct: 222 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 274

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ----CGRALKGFDVECE--MMKS 225
           D +     +G G F  V K R    G++ A K    +      R +   D+E E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           I+H N+I +     N+    L+LE +  G L  ++     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVA----HLSDFSIAKLLTGEDQSMTQTQTLATIGY 341
           LH   S  I H DLKP N++L D  V      + DF +A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 342 MAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           +APE      +    D++S G++     +G  P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ----CGRALKGFDVECE--MMKS 225
           D +     +G G F  V K R    G++ A K    +      R +   D+E E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           I+H N+I +     N+    L+LE +  G L  ++     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVA----HLSDFSIAKLLTGEDQSMTQTQTLATIGY 341
           LH   S  I H DLKP N++L D  V      + DF +A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 342 MAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           +APE      +    D++S G++     +G  P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 98/229 (42%), Gaps = 41/229 (17%)
Query: 215 GFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKY-----MYSSNYILDI 269
            F  E +++  I++   +      +N +   ++ EYM + S+ K+     +   NY   I
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 270 -FQRLNIMI-DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 327
             Q +  +I  V ++  Y+H      I H D+KPSN+L+D N    LSDF       GE 
Sbjct: 149 PIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDF-------GES 199
Query: 328 QSMTQTQ---TLATIGYMAPEYGREGRVSTNG---DVYSFGIMLMETFTGKKPTN----- 376
           + M   +   +  T  +M PE+      S NG   D++S GI L   F    P +     
Sbjct: 200 EYMVDKKIKGSRGTYEFMPPEFF-SNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258
Query: 377 -EIFNGEMT--------LKHWVNDWLPISTME-VVGANLLSQEDIHFVA 415
            E+FN   T          H++    P++  +     N LS EDI F+ 
Sbjct: 259 VELFNNIRTKNIEYPLDRNHFL---YPLTNKKSTCSNNFLSNEDIDFLK 304

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 49/97 (50%), Gaps = 4/97 (4%)
Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT 338
           VA  +E+L    S   IH DL   N+LL +  V  + DF +A+ +  +   + +      
Sbjct: 200 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 339 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 374
           + +MAPE   +   +   DV+SFG++L E F+ G  P
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 293

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ----CGRALKGFDVECE--MMKS 225
           D +     +G G F  V K R    G++ A K    +      R +   D+E E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           I+H N+I +     N+    L+LE +  G L  ++     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVA----HLSDFSIAKLLTGEDQSMTQTQTLATIGY 341
           LH   S  I H DLKP N++L D  V      + DF +A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 342 MAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           +APE      +    D++S G++     +G  P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 49/97 (50%), Gaps = 4/97 (4%)
Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT 338
           VA  +E+L    S   IH DL   N+LL +  V  + DF +A+ +  +   + +      
Sbjct: 202 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 339 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 374
           + +MAPE   +   +   DV+SFG++L E F+ G  P
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ----CGRALKGFDVECE--MMKS 225
           D +     +G G F  V K R    G++ A K    +      R +   D+E E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           I+H N+I +     N+    L+LE +  G L  ++     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVA----HLSDFSIAKLLTGEDQSMTQTQTLATIGY 341
           LH   S  I H DLKP N++L D  V      + DF +A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 342 MAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           +APE      +    D++S G++     +G  P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/233 (22%), Positives = 98/233 (42%), Gaps = 10/233 (4%)
Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKVFN---LQCGRALKGFDVECEMMKSIRHRNLIKVI 235
            +G+GGF   ++    D  EV A K+     L      +   +E  + +S+ H++++   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
               + +F  +VLE     SL +       + +   R  +   +    +YLH      +I
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLHRNR---VI 137
Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 355
           H DLK  N+ L++++   + DF +A  +  E     +     T  Y+APE   +   S  
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAPEVLSKKGHSFE 195
Query: 356 GDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ 408
            DV+S G ++     GK P       E  L+   N++     +  V A+L+ +
Sbjct: 196 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 248

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 47/92 (51%), Gaps = 3/92 (3%)
Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT 338
           VA  +E+L    S   IH DL   N+LL +  V  + DF +A+ +  +   + +      
Sbjct: 207 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 339 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 370
           + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ----CGRALKGFDVECE--MMKS 225
           D +     +G G F  V K R    G++ A K    +      R +   D+E E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           I+H N+I +     N+    L+LE +  G L  ++     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVA----HLSDFSIAKLLTGEDQSMTQTQTLATIGY 341
           LH   S  I H DLKP N++L D  V      + DF +A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 342 MAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           +APE      +    D++S G++     +G  P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 23/217 (10%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G  G V  A     G+ VAVK  +   Q     K    E  ++K + H+N+I +++ 
Sbjct: 32  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 91
Query: 238 CSN----EEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            +     EEF+   LV+E M   +L + ++     LD  +   ++  +   +++LH   S
Sbjct: 92  FTPQKTLEEFQDVYLVMELM-DANLCQVIHME---LDHERMSYLLYQMLCGIKHLH---S 144
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGR 351
           A IIH DLKPSN+++  +    + DF +A+       +   T  + T  Y APE      
Sbjct: 145 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT---NFMMTPYVVTRYYRAPEVILGMG 201
Query: 352 VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW 388
            + N D++S G ++ E   G      IF G   +  W
Sbjct: 202 YAANVDIWSVGCIMGELVKG----CVIFQGTDHIDQW 234

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 26/211 (12%)
Query: 178 NNLIGRGGFGSVYKA---RLGD-----GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHR 229
           N  +G+G F  ++K     +GD       EV +KV +       + F     MM  + H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 230 NLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFG 289
           +L+     C   +   LV E++  GSL+ Y+  +   ++I  +L +   +A+A   +HF 
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA---MHFL 129
Query: 290 YSAPIIHCDLKPSNVLL---DDNMVAH-----LSDFSIAKLLTGEDQSMTQTQTLATIGY 341
               +IH ++   N+LL   +D    +     LSD  I+  +  +D  + Q +    I +
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD--ILQER----IPW 183
Query: 342 MAPEYGREGR-VSTNGDVYSFGIMLMETFTG 371
           + PE     + ++   D +SFG  L E  +G
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 47/92 (51%), Gaps = 3/92 (3%)
Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT 338
           VA  +E+L    S   IH DL   N+LL +  V  + DF +A+ +  +   + +      
Sbjct: 209 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 339 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 370
           + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ----CGRALKGFDVECE--MMKS 225
           D +     +G G F  V K R    G++ A K    +      R +   D+E E  ++K 
Sbjct: 11  DYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           I+H N+I +     N+    L+LE +  G L  ++     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVA----HLSDFSIAKLLTGEDQSMTQTQTLATIGY 341
           LH   S  I H DLKP N++L D  V      + DF +A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 342 MAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           +APE      +    D++S G++     +G  P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 111/257 (43%), Gaps = 37/257 (14%)
Query: 181 IGRGGFGSVYKAR-LGDGMEVAVK-----VFNLQCGRALKGFDVECEMMKSIRHRNLIKV 234
           +GRG +G V K R +  G  +AVK     V + +  R L   D+    M+++     +  
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS---MRTVDCPFTVTF 71
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL------NIMIDVASALEYLHF 288
                 E    + +E M   SL+K+      ++D  Q +       I + +  ALE+LH 
Sbjct: 72  YGALFREGDVWICMELM-DTSLDKFY---KQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA----- 343
             S  +IH D+KPSNVL++      + DF I+  L  +   + +        YMA     
Sbjct: 128 KLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDIDAGCKPYMAPERIN 182
Query: 344 PEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA 403
           PE  ++G  S   D++S GI ++E    + P +        LK  V +  P      + A
Sbjct: 183 PELNQKG-YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP-----QLPA 236
Query: 404 NLLSQEDIHFVAKEQCV 420
           +  S E + F +  QC+
Sbjct: 237 DKFSAEFVDFTS--QCL 251

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 96/226 (42%), Gaps = 23/226 (10%)
Query: 180 LIGRGGFGSVYKA-RLGDGMEVAVKVFNL----QCGRALKGFDVECE--MMKSIRH--RN 230
           L+G GGFGSVY   R+ D + VA+K          G    G  V  E  ++K +      
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 231 LIKVISTCSNEEFKALVLEYM-PHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFG 289
           +I+++      +   L+LE M P   L  ++     + +   R +    V  A+ + H  
Sbjct: 75  VIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH-- 131
Query: 290 YSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
            +  ++H D+K  N+L+D N     L DF    LL    +    T    T  Y  PE+ R
Sbjct: 132 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 186
Query: 349 EGRV-STNGDVYSFGIMLMETFTGKKP---TNEIFNGEMTLKHWVN 390
             R    +  V+S GI+L +   G  P     EI  G++  +  V+
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 232

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 106/261 (40%), Gaps = 28/261 (10%)
Query: 145 GKRPSNDANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVK 203
           G  P ND +   +A  +    LE       +    L+G GGFGSVY   R+ D + VA+K
Sbjct: 1   GAAPCNDLHATKLAPGKEKEPLE-----SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK 55
Query: 204 VFNL----QCGRALKGFDVECE--MMKSIRH--RNLIKVISTCSNEEFKALVLEY-MPHG 254
                     G    G  V  E  ++K +      +I+++      +   L+LE   P  
Sbjct: 56  HVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQ 115
Query: 255 SLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-H 313
            L  ++     + +   R +    V  A+ + H   +  ++H D+K  N+L+D N     
Sbjct: 116 DLFDFITERGALQEELAR-SFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELK 171
Query: 314 LSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGK 372
           L DF    LL    +    T    T  Y  PE+ R  R    +  V+S GI+L +   G 
Sbjct: 172 LIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 227
Query: 373 KP---TNEIFNGEMTLKHWVN 390
            P     EI  G++  +  V+
Sbjct: 228 IPFEHDEEIIRGQVFFRQRVS 248

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 83/176 (47%), Gaps = 20/176 (11%)
Query: 219 ECEMMKSIRHRNLIKVISTC----SNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQR 272
           E  +MK + H+N+I +++      S EEF+   +V+E M   +L + +      LD  + 
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME---LDHERM 128
Query: 273 LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 332
             ++  +   +++LH   SA IIH DLKPSN+++  +    + DF +A+       S   
Sbjct: 129 SYLLYQMLVGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMM 182
Query: 333 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW 388
           T  + T  Y APE         N D++S G+++ E   G      +F G   +  W
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG----GVLFPGTDHIDQW 234

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 23/217 (10%)
Query: 181 IGRGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G  G V   Y A L   + +       Q     K    E  +MK + H+N+I +++ 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 238 CSN----EEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            +     EEF+   LV+E M   +L + +      LD  +   ++  +   +++LH   S
Sbjct: 92  FTPQKTLEEFQDVYLVMELM-DANLXQVIQME---LDHERMSYLLYQMLXGIKHLH---S 144
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGR 351
           A IIH DLKPSN+++  +    + DF +A+       S   T  + T  Y APE      
Sbjct: 145 AGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 352 VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW 388
              N D++S G ++ E    K     +F G   +  W
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 23/217 (10%)
Query: 181 IGRGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G  G V   Y A L   + +       Q     K    E  +MK + H+N+I +++ 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 238 CSN----EEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            +     EEF+   LV+E M   +L + +      LD  +   ++  +   +++LH   S
Sbjct: 85  FTPQKTLEEFQDVYLVMELM-DANLXQVIQME---LDHERMSYLLYQMLXGIKHLH---S 137
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGR 351
           A IIH DLKPSN+++  +    + DF +A+       S   T  + T  Y APE      
Sbjct: 138 AGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 352 VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW 388
              N D++S G ++ E    K     +F G   +  W
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 227

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 71/150 (47%), Gaps = 20/150 (13%)
Query: 169 CRATDGFSENNLIGRGGFGSVYK--ARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSI 226
            R T  F E   IG G FGSV+K   RL DG   A+K    +  + L G   E   ++ +
Sbjct: 3   SRYTTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIK----RSKKPLAGSVDEQNALREV 57
Query: 227 -------RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL---NIM 276
                  +H ++++  S  + ++   +  EY   GSL   +  +  I+  F+     +++
Sbjct: 58  YAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 117
Query: 277 IDVASALEYLHFGYSAPIIHCDLKPSNVLL 306
           + V   L Y+H   S  ++H D+KPSN+ +
Sbjct: 118 LQVGRGLRYIH---SMSLVHMDIKPSNIFI 144

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 20/149 (13%)
Query: 170 RATDGFSENNLIGRGGFGSVYK--ARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSI- 226
           R T  F E   IG G FGSV+K   RL DG   A+K    +  + L G   E   ++ + 
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIK----RSKKPLAGSVDEQNALREVY 60
Query: 227 ------RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL---NIMI 277
                 +H ++++  S  + ++   +  EY   GSL   +  +  I+  F+     ++++
Sbjct: 61  AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 120
Query: 278 DVASALEYLHFGYSAPIIHCDLKPSNVLL 306
            V   L Y+H   S  ++H D+KPSN+ +
Sbjct: 121 QVGRGLRYIH---SMSLVHMDIKPSNIFI 146

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 83/176 (47%), Gaps = 20/176 (11%)
Query: 219 ECEMMKSIRHRNLIKVISTC----SNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQR 272
           E  +MK + H+N+I +++      S EEF+   +V+E M   +L + +      LD  + 
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME---LDHERM 128
Query: 273 LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 332
             ++  +   +++LH   SA IIH DLKPSN+++  +    + DF +A+       S   
Sbjct: 129 SYLLYQMLVGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMM 182
Query: 333 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW 388
           T  + T  Y APE         N D++S G+++ E   G      +F G   +  W
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG----GVLFPGTDHIDQW 234

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 106/261 (40%), Gaps = 28/261 (10%)
Query: 145 GKRPSNDANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVK 203
           G  P ND +   +A  +    LE       +    L+G GGFGSVY   R+ D + VA+K
Sbjct: 1   GAAPCNDLHATKLAPGKEKEPLE-----SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK 55
Query: 204 VFNL----QCGRALKGFDVECE--MMKSIRH--RNLIKVISTCSNEEFKALVLEY-MPHG 254
                     G    G  V  E  ++K +      +I+++      +   L+LE   P  
Sbjct: 56  HVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQ 115
Query: 255 SLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-H 313
            L  ++     + +   R +    V  A+ + H   +  ++H D+K  N+L+D N     
Sbjct: 116 DLFDFITERGALQEELAR-SFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELK 171
Query: 314 LSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGK 372
           L DF    LL    +    T    T  Y  PE+ R  R    +  V+S GI+L +   G 
Sbjct: 172 LIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 227
Query: 373 KP---TNEIFNGEMTLKHWVN 390
            P     EI  G++  +  V+
Sbjct: 228 IPFEHDEEIIRGQVFFRQRVS 248

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 20/149 (13%)
Query: 170 RATDGFSENNLIGRGGFGSVYK--ARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSI- 226
           R T  F E   IG G FGSV+K   RL DG   A+K    +  + L G   E   ++ + 
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIK----RSKKPLAGSVDEQNALREVY 62
Query: 227 ------RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL---NIMI 277
                 +H ++++  S  + ++   +  EY   GSL   +  +  I+  F+     ++++
Sbjct: 63  AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 122
Query: 278 DVASALEYLHFGYSAPIIHCDLKPSNVLL 306
            V   L Y+H   S  ++H D+KPSN+ +
Sbjct: 123 QVGRGLRYIH---SMSLVHMDIKPSNIFI 148

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 106/261 (40%), Gaps = 28/261 (10%)
Query: 145 GKRPSNDANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVK 203
           G  P ND +   +A  +    LE       +    L+G GGFGSVY   R+ D + VA+K
Sbjct: 1   GAAPCNDLHATKLAPGKEKEPLE-----SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK 55
Query: 204 VFNL----QCGRALKGFDVECE--MMKSIRH--RNLIKVISTCSNEEFKALVLEY-MPHG 254
                     G    G  V  E  ++K +      +I+++      +   L+LE   P  
Sbjct: 56  HVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQ 115
Query: 255 SLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-H 313
            L  ++     + +   R +    V  A+ + H   +  ++H D+K  N+L+D N     
Sbjct: 116 DLFDFITERGALQEELAR-SFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELK 171
Query: 314 LSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGK 372
           L DF    LL    +    T    T  Y  PE+ R  R    +  V+S GI+L +   G 
Sbjct: 172 LIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 227
Query: 373 KP---TNEIFNGEMTLKHWVN 390
            P     EI  G++  +  V+
Sbjct: 228 IPFEHDEEIIRGQVFFRQRVS 248

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 20/149 (13%)
Query: 170 RATDGFSENNLIGRGGFGSVYK--ARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSI- 226
           R T  F E   IG G FGSV+K   RL DG   A+K    +  + L G   E   ++ + 
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIK----RSKKPLAGSVDEQNALREVY 60
Query: 227 ------RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL---NIMI 277
                 +H ++++  S  + ++   +  EY   GSL   +  +  I+  F+     ++++
Sbjct: 61  AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 120
Query: 278 DVASALEYLHFGYSAPIIHCDLKPSNVLL 306
            V   L Y+H   S  ++H D+KPSN+ +
Sbjct: 121 QVGRGLRYIH---SMSLVHMDIKPSNIFI 146

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 23/217 (10%)
Query: 181 IGRGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G  G V   Y A L   + +       Q     K    E  +MK + H+N+I +++ 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 238 CSN----EEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            +     EEF+   LV+E M   +L + +      LD  +   ++  +   +++LH   S
Sbjct: 92  FTPQKTLEEFQDVYLVMELM-DANLXQVIQME---LDHERMSYLLYQMLXGIKHLH---S 144
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGR 351
           A IIH DLKPSN+++  +    + DF +A+       S   T  + T  Y APE      
Sbjct: 145 AGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 352 VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW 388
              N D++S G ++ E    K     +F G   +  W
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 101/246 (41%), Gaps = 36/246 (14%)
Query: 151 DANMPSIATW-RTFSHL--ELCRATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKVFN 206
           D  +     W + F+ L  E+    + F    +IGRG FG V   ++ +   + A+K+ N
Sbjct: 49  DKYVAEFLEWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILN 108
Query: 207 LQCGRALKGFDVECEMMKSIRHRNLIKVISTCS----------NEEFKALVLEYMPHGSL 256
                 LK  +  C      R    + V   C           +E    LV++Y   G L
Sbjct: 109 KW--EMLKRAETAC-----FREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDL 161
Query: 257 EKYMYS-SNYILDIFQRLNI--MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH 313
              +    + + +   R  I  M+    ++  LH+      +H D+KP NVLLD N    
Sbjct: 162 LTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHY------VHRDIKPDNVLLDVNGHIR 215
Query: 314 LSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE-----GRVSTNGDVYSFGIMLMET 368
           L+DF  + L   +D ++  +  + T  Y++PE  +      G+     D +S G+ + E 
Sbjct: 216 LADFG-SCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEM 274
Query: 369 FTGKKP 374
             G+ P
Sbjct: 275 LYGETP 280

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 23/217 (10%)
Query: 181 IGRGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G  G V   Y A L   + +       Q     K    E  +MK + H+N+I +++ 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 238 CSN----EEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            +     EEF+   LV+E M   +L + +      LD  +   ++  +   +++LH   S
Sbjct: 92  FTPQKTLEEFQDVYLVMELM-DANLXQVIQME---LDHERMSYLLYQMLCGIKHLH---S 144
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGR 351
           A IIH DLKPSN+++  +    + DF +A+       S   T  + T  Y APE      
Sbjct: 145 AGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 352 VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW 388
              N D++S G ++ E    K     +F G   +  W
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 101/246 (41%), Gaps = 36/246 (14%)
Query: 151 DANMPSIATW-RTFSHL--ELCRATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKVFN 206
           D  +     W + F+ L  E+    + F    +IGRG FG V   ++ +   + A+K+ N
Sbjct: 65  DKYVAEFLEWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILN 124
Query: 207 LQCGRALKGFDVECEMMKSIRHRNLIKVISTCS----------NEEFKALVLEYMPHGSL 256
                 LK  +  C      R    + V   C           +E    LV++Y   G L
Sbjct: 125 KW--EMLKRAETAC-----FREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDL 177
Query: 257 EKYMYS-SNYILDIFQRLNI--MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH 313
              +    + + +   R  I  M+    ++  LH+      +H D+KP NVLLD N    
Sbjct: 178 LTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHY------VHRDIKPDNVLLDVNGHIR 231
Query: 314 LSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE-----GRVSTNGDVYSFGIMLMET 368
           L+DF  + L   +D ++  +  + T  Y++PE  +      G+     D +S G+ + E 
Sbjct: 232 LADFG-SCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEM 290
Query: 369 FTGKKP 374
             G+ P
Sbjct: 291 LYGETP 296

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 94/211 (44%), Gaps = 26/211 (12%)
Query: 178 NNLIGRGGFGSVYKA---RLGD-----GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHR 229
           N  +G+G F  ++K     +GD       EV +KV +       + F     MM  + H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 230 NLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFG 289
           +L+     C   +   LV E++  GSL+ Y+  +   ++I  +L +   +A A   +HF 
Sbjct: 73  HLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWA---MHFL 129
Query: 290 YSAPIIHCDLKPSNVLL---DDNMVAH-----LSDFSIAKLLTGEDQSMTQTQTLATIGY 341
               +IH ++   N+LL   +D    +     LSD  I+  +  +D  + Q +    I +
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD--ILQER----IPW 183
Query: 342 MAPEYGREGR-VSTNGDVYSFGIMLMETFTG 371
           + PE     + ++   D +SFG  L E  +G
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 22/202 (10%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVI-- 235
           +G G +GSV  A     G +VA+K  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 236 ----STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
               S+  N     LV+ +M    L+K M         F    I   V   L+ L + +S
Sbjct: 110 FTPASSLRNFYDFYLVMPFM-QTDLQKIMGME------FSEEKIQYLVYQMLKGLKYIHS 162
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG- 350
           A ++H DLKP N+ ++++    + DF +A+    E      T  + T  Y APE      
Sbjct: 163 AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWM 217
Query: 351 RVSTNGDVYSFGIMLMETFTGK 372
             +   D++S G ++ E  TGK
Sbjct: 218 HYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 103/206 (50%), Gaps = 29/206 (14%)
Query: 142 RQKGK-RPSNDANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKARLGDGME- 199
           +Q+G+ R  + ++ P+ +  R  S  ++    D +   +LIG G +G V +A   D +E 
Sbjct: 24  QQEGQQRKQHHSSKPTASMPRPHSDWQI---PDRYEIRHLIGTGSYGHVCEAY--DKLEK 78
Query: 200 --VAVK----VFN--LQCGRALKGFDVECEMMKSIRHRNLIKVISTC---SNEEFKAL-- 246
             VA+K    VF   + C R L+    E  ++  + H +++KV+        E+F  L  
Sbjct: 79  RVVAIKKILRVFEDLIDCKRILR----EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV 134
Query: 247 VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL 306
           VLE +     +K   +  Y+ ++  +  ++ ++   ++Y+H   SA I+H DLKP+N L+
Sbjct: 135 VLE-IADSDFKKLFRTPVYLTELHIK-TLLYNLLVGVKYVH---SAGILHRDLKPANCLV 189
Query: 307 DDNMVAHLSDFSIAKLLTGEDQSMTQ 332
           + +    + DF +A+ +   +   +Q
Sbjct: 190 NQDCSVKVCDFGLARTVDYPENGNSQ 215

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 23/217 (10%)
Query: 181 IGRGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G  G V   Y A L   + +       Q     K    E  +MK + H+N+I +++ 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 238 CSN----EEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            +     EEF+   LV+E M     +         LD  +   ++  +   +++LH   S
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCGIKHLH---S 137
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGR 351
           A IIH DLKPSN+++  +    + DF +A+       S   T  + T  Y APE      
Sbjct: 138 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 352 VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW 388
              N D++S G ++ E    K     +F G   +  W
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 227

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 23/217 (10%)
Query: 181 IGRGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G  G V   Y A L   + +       Q     K    E  +MK + H+N+I +++ 
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 85
Query: 238 CSN----EEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            +     EEF+   LV+E M     +         LD  +   ++  +   +++LH   S
Sbjct: 86  FTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCGIKHLH---S 138
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGR 351
           A IIH DLKPSN+++  +    + DF +A+       S   T  + T  Y APE      
Sbjct: 139 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 195
Query: 352 VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW 388
              N D++S G ++ E    K     +F G   +  W
Sbjct: 196 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 228

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 22/202 (10%)
Query: 181 IGRGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVI-- 235
           +G G +GSV  A     G +VA+K  +   Q     K    E  ++K ++H N+I ++  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 236 ----STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
               S+  N     LV+ +M    L+K M         F    I   V   L+ L + +S
Sbjct: 92  FTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK------FSEEKIQYLVYQMLKGLKYIHS 144
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG- 350
           A ++H DLKP N+ ++++    + DF +A+    E      T  + T  Y APE      
Sbjct: 145 AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWM 199
Query: 351 RVSTNGDVYSFGIMLMETFTGK 372
             +   D++S G ++ E  TGK
Sbjct: 200 HYNQTVDIWSVGCIMAEMLTGK 221

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 23/217 (10%)
Query: 181 IGRGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G  G V   Y A L   + +       Q     K    E  +MK + H+N+I +++ 
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 85
Query: 238 CSN----EEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            +     EEF+   LV+E M     +         LD  +   ++  +   +++LH   S
Sbjct: 86  FTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCGIKHLH---S 138
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGR 351
           A IIH DLKPSN+++  +    + DF +A+       S   T  + T  Y APE      
Sbjct: 139 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 195
Query: 352 VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW 388
              N D++S G ++ E    K     +F G   +  W
Sbjct: 196 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 228

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 23/217 (10%)
Query: 181 IGRGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G  G V   Y A L   + +       Q     K    E  +MK + H+N+I +++ 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 238 CSN----EEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            +     EEF+   LV+E M     +         LD  +   ++  +   +++LH   S
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCGIKHLH---S 144
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGR 351
           A IIH DLKPSN+++  +    + DF +A+       S   T  + T  Y APE      
Sbjct: 145 AGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 352 VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW 388
              N D++S G ++ E    K     +F G   +  W
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 105/258 (40%), Gaps = 28/258 (10%)
Query: 148 PSNDANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFN 206
           P ND +   +A  +    LE       +    L+G GGFGSVY   R+ D + VA+K   
Sbjct: 31  PCNDLHATKLAPGKEKEPLE-----SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE 85
Query: 207 L----QCGRALKGFDVECE--MMKSIRH--RNLIKVISTCSNEEFKALVLEY-MPHGSLE 257
                  G    G  V  E  ++K +      +I+++      +   L+LE   P   L 
Sbjct: 86  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 145
Query: 258 KYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSD 316
            ++     + +   R +    V  A+ + H   +  ++H D+K  N+L+D N     L D
Sbjct: 146 DFITERGALQEELAR-SFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLID 201
Query: 317 FSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGKKP- 374
           F    LL    +    T    T  Y  PE+ R  R    +  V+S GI+L +   G  P 
Sbjct: 202 FGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 257
Query: 375 --TNEIFNGEMTLKHWVN 390
               EI  G++  +  V+
Sbjct: 258 EHDEEIIRGQVFFRQRVS 275

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 105/258 (40%), Gaps = 28/258 (10%)
Query: 148 PSNDANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFN 206
           P ND +   +A  +    LE       +    L+G GGFGSVY   R+ D + VA+K   
Sbjct: 16  PCNDLHATKLAPGKEKEPLE-----SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE 70
Query: 207 L----QCGRALKGFDVECE--MMKSIRH--RNLIKVISTCSNEEFKALVLEY-MPHGSLE 257
                  G    G  V  E  ++K +      +I+++      +   L+LE   P   L 
Sbjct: 71  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 130
Query: 258 KYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSD 316
            ++     + +   R +    V  A+ + H   +  ++H D+K  N+L+D N     L D
Sbjct: 131 DFITERGALQEELAR-SFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLID 186
Query: 317 FSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGKKP- 374
           F    LL    +    T    T  Y  PE+ R  R    +  V+S GI+L +   G  P 
Sbjct: 187 FGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242
Query: 375 --TNEIFNGEMTLKHWVN 390
               EI  G++  +  V+
Sbjct: 243 EHDEEIIGGQVFFRQRVS 260

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 105/258 (40%), Gaps = 28/258 (10%)
Query: 148 PSNDANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFN 206
           P ND +   +A  +    LE       +    L+G GGFGSVY   R+ D + VA+K   
Sbjct: 17  PCNDLHATKLAPGKEKEPLE-----SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE 71
Query: 207 L----QCGRALKGFDVECE--MMKSIRH--RNLIKVISTCSNEEFKALVLEY-MPHGSLE 257
                  G    G  V  E  ++K +      +I+++      +   L+LE   P   L 
Sbjct: 72  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 131
Query: 258 KYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSD 316
            ++     + +   R +    V  A+ + H   +  ++H D+K  N+L+D N     L D
Sbjct: 132 DFITERGALQEELAR-SFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLID 187
Query: 317 FSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGKKP- 374
           F    LL    +    T    T  Y  PE+ R  R    +  V+S GI+L +   G  P 
Sbjct: 188 FGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243
Query: 375 --TNEIFNGEMTLKHWVN 390
               EI  G++  +  V+
Sbjct: 244 EHDEEIIGGQVFFRQRVS 261

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 105/258 (40%), Gaps = 28/258 (10%)
Query: 148 PSNDANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFN 206
           P ND +   +A  +    LE       +    L+G GGFGSVY   R+ D + VA+K   
Sbjct: 3   PCNDLHATKLAPGKEKEPLE-----SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE 57
Query: 207 L----QCGRALKGFDVECE--MMKSIRH--RNLIKVISTCSNEEFKALVLEY-MPHGSLE 257
                  G    G  V  E  ++K +      +I+++      +   L+LE   P   L 
Sbjct: 58  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 117
Query: 258 KYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSD 316
            ++     + +   R +    V  A+ + H   +  ++H D+K  N+L+D N     L D
Sbjct: 118 DFITERGALQEELAR-SFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLID 173
Query: 317 FSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGKKP- 374
           F    LL    +    T    T  Y  PE+ R  R    +  V+S GI+L +   G  P 
Sbjct: 174 FGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 229
Query: 375 --TNEIFNGEMTLKHWVN 390
               EI  G++  +  V+
Sbjct: 230 EHDEEIIRGQVFFRQRVS 247

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 105/258 (40%), Gaps = 28/258 (10%)
Query: 148 PSNDANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFN 206
           P ND +   +A  +    LE       +    L+G GGFGSVY   R+ D + VA+K   
Sbjct: 17  PCNDLHATKLAPGKEKEPLE-----SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE 71
Query: 207 L----QCGRALKGFDVECE--MMKSIRH--RNLIKVISTCSNEEFKALVLEY-MPHGSLE 257
                  G    G  V  E  ++K +      +I+++      +   L+LE   P   L 
Sbjct: 72  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 131
Query: 258 KYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSD 316
            ++     + +   R +    V  A+ + H   +  ++H D+K  N+L+D N     L D
Sbjct: 132 DFITERGALQEELAR-SFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLID 187
Query: 317 FSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGKKP- 374
           F    LL    +    T    T  Y  PE+ R  R    +  V+S GI+L +   G  P 
Sbjct: 188 FGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243
Query: 375 --TNEIFNGEMTLKHWVN 390
               EI  G++  +  V+
Sbjct: 244 EHDEEIIGGQVFFRQRVS 261

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 105/258 (40%), Gaps = 28/258 (10%)
Query: 148 PSNDANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFN 206
           P ND +   +A  +    LE       +    L+G GGFGSVY   R+ D + VA+K   
Sbjct: 23  PCNDLHATKLAPGKEKEPLE-----SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE 77
Query: 207 L----QCGRALKGFDVECE--MMKSIRH--RNLIKVISTCSNEEFKALVLEY-MPHGSLE 257
                  G    G  V  E  ++K +      +I+++      +   L+LE   P   L 
Sbjct: 78  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 137
Query: 258 KYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSD 316
            ++     + +   R +    V  A+ + H   +  ++H D+K  N+L+D N     L D
Sbjct: 138 DFITERGALQEELAR-SFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLID 193
Query: 317 FSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGKKP- 374
           F    LL    +    T    T  Y  PE+ R  R    +  V+S GI+L +   G  P 
Sbjct: 194 FGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 249
Query: 375 --TNEIFNGEMTLKHWVN 390
               EI  G++  +  V+
Sbjct: 250 EHDEEIIRGQVFFRQRVS 267

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 23/217 (10%)
Query: 181 IGRGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G  G V   Y A L   + +       Q     K    E  +MK + H+N+I +++ 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 238 CSN----EEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            +     EEF+   LV+E M     +         LD  +   ++  +   +++LH   S
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCGIKHLH---S 144
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGR 351
           A IIH DLKPSN+++  +    + DF +A+       S   T  + T  Y APE      
Sbjct: 145 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 352 VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW 388
              N D++S G ++ E    K     +F G   +  W
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 105/258 (40%), Gaps = 28/258 (10%)
Query: 148 PSNDANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFN 206
           P ND +   +A  +    LE       +    L+G GGFGSVY   R+ D + VA+K   
Sbjct: 16  PCNDLHATKLAPGKEKEPLE-----SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE 70
Query: 207 L----QCGRALKGFDVECE--MMKSIRH--RNLIKVISTCSNEEFKALVLEY-MPHGSLE 257
                  G    G  V  E  ++K +      +I+++      +   L+LE   P   L 
Sbjct: 71  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 130
Query: 258 KYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSD 316
            ++     + +   R +    V  A+ + H   +  ++H D+K  N+L+D N     L D
Sbjct: 131 DFITERGALQEELAR-SFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLID 186
Query: 317 FSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGKKP- 374
           F    LL    +    T    T  Y  PE+ R  R    +  V+S GI+L +   G  P 
Sbjct: 187 FGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242
Query: 375 --TNEIFNGEMTLKHWVN 390
               EI  G++  +  V+
Sbjct: 243 EHDEEIIRGQVFFRQRVS 260

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 105/258 (40%), Gaps = 28/258 (10%)
Query: 148 PSNDANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFN 206
           P ND +   +A  +    LE       +    L+G GGFGSVY   R+ D + VA+K   
Sbjct: 3   PCNDLHATKLAPGKEKEPLE-----SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE 57
Query: 207 L----QCGRALKGFDVECE--MMKSIRH--RNLIKVISTCSNEEFKALVLEY-MPHGSLE 257
                  G    G  V  E  ++K +      +I+++      +   L+LE   P   L 
Sbjct: 58  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 117
Query: 258 KYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSD 316
            ++     + +   R +    V  A+ + H   +  ++H D+K  N+L+D N     L D
Sbjct: 118 DFITERGALQEELAR-SFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLID 173
Query: 317 FSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGKKP- 374
           F    LL    +    T    T  Y  PE+ R  R    +  V+S GI+L +   G  P 
Sbjct: 174 FGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 229
Query: 375 --TNEIFNGEMTLKHWVN 390
               EI  G++  +  V+
Sbjct: 230 EHDEEIIRGQVFFRQRVS 247

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 105/258 (40%), Gaps = 28/258 (10%)
Query: 148 PSNDANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFN 206
           P ND +   +A  +    LE       +    L+G GGFGSVY   R+ D + VA+K   
Sbjct: 17  PCNDLHATKLAPGKEKEPLE-----SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE 71
Query: 207 L----QCGRALKGFDVECE--MMKSIRH--RNLIKVISTCSNEEFKALVLEY-MPHGSLE 257
                  G    G  V  E  ++K +      +I+++      +   L+LE   P   L 
Sbjct: 72  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 131
Query: 258 KYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSD 316
            ++     + +   R +    V  A+ + H   +  ++H D+K  N+L+D N     L D
Sbjct: 132 DFITERGALQEELAR-SFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLID 187
Query: 317 FSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGKKP- 374
           F    LL    +    T    T  Y  PE+ R  R    +  V+S GI+L +   G  P 
Sbjct: 188 FGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243
Query: 375 --TNEIFNGEMTLKHWVN 390
               EI  G++  +  V+
Sbjct: 244 EHDEEIIGGQVFFRQRVS 261

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 105/258 (40%), Gaps = 28/258 (10%)
Query: 148 PSNDANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFN 206
           P ND +   +A  +    LE       +    L+G GGFGSVY   R+ D + VA+K   
Sbjct: 17  PCNDLHATKLAPGKEKEPLE-----SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE 71
Query: 207 L----QCGRALKGFDVECE--MMKSIRH--RNLIKVISTCSNEEFKALVLEY-MPHGSLE 257
                  G    G  V  E  ++K +      +I+++      +   L+LE   P   L 
Sbjct: 72  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 131
Query: 258 KYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSD 316
            ++     + +   R +    V  A+ + H   +  ++H D+K  N+L+D N     L D
Sbjct: 132 DFITERGALQEELAR-SFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLID 187
Query: 317 FSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGKKP- 374
           F    LL    +    T    T  Y  PE+ R  R    +  V+S GI+L +   G  P 
Sbjct: 188 FGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243
Query: 375 --TNEIFNGEMTLKHWVN 390
               EI  G++  +  V+
Sbjct: 244 EHDEEIIGGQVFFRQRVS 261

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 23/217 (10%)
Query: 181 IGRGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G  G V   Y A L   + +       Q     K    E  +MK + H+N+I +++ 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 238 CSN----EEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            +     EEF+   LV+E M     +         LD  +   ++  +   +++LH   S
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCGIKHLH---S 144
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGR 351
           A IIH DLKPSN+++  +    + DF +A+       S   T  + T  Y APE      
Sbjct: 145 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 352 VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW 388
              N D++S G ++ E    K     +F G   +  W
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 105/258 (40%), Gaps = 28/258 (10%)
Query: 148 PSNDANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFN 206
           P ND +   +A  +    LE       +    L+G GGFGSVY   R+ D + VA+K   
Sbjct: 16  PCNDLHATKLAPGKEKEPLE-----SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE 70
Query: 207 L----QCGRALKGFDVECE--MMKSIRH--RNLIKVISTCSNEEFKALVLEY-MPHGSLE 257
                  G    G  V  E  ++K +      +I+++      +   L+LE   P   L 
Sbjct: 71  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 130
Query: 258 KYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSD 316
            ++     + +   R +    V  A+ + H   +  ++H D+K  N+L+D N     L D
Sbjct: 131 DFITERGALQEELAR-SFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLID 186
Query: 317 FSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGKKP- 374
           F    LL    +    T    T  Y  PE+ R  R    +  V+S GI+L +   G  P 
Sbjct: 187 FGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242
Query: 375 --TNEIFNGEMTLKHWVN 390
               EI  G++  +  V+
Sbjct: 243 EHDEEIIGGQVFFRQRVS 260

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 23/217 (10%)
Query: 181 IGRGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G  G V   Y A L   + +       Q     K    E  +MK + H+N+I +++ 
Sbjct: 31  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 90
Query: 238 CSN----EEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            +     EEF+   LV+E M     +         LD  +   ++  +   +++LH   S
Sbjct: 91  FTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCGIKHLH---S 143
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGR 351
           A IIH DLKPSN+++  +    + DF +A+       S   T  + T  Y APE      
Sbjct: 144 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 200
Query: 352 VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW 388
              N D++S G ++ E    K     +F G   +  W
Sbjct: 201 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 233

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 20/176 (11%)
Query: 219 ECEMMKSIRHRNLIKVISTC----SNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQR 272
           E  +MK + H+N+I +++      S EEF+   +V+E M   +L + +      LD  + 
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME---LDHERM 128
Query: 273 LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 332
             ++  +   +++LH   SA IIH DLKPSN+++  +    + DF +A+       S   
Sbjct: 129 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMM 182
Query: 333 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW 388
           T  + T  Y APE         N D++S G ++ E   G      +F G   +  W
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG----GVLFPGTDHIDQW 234

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 92/227 (40%), Gaps = 32/227 (14%)
Query: 167 ELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVK-VFN--------------LQCGR 211
           EL      ++    I  G +G+V      +G+ VA+K VFN                C R
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 212 ALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKA-----LVLEYMPHGSLEKYMYSSNYI 266
            L+    E  ++    H N++ +     + E  A     LV E M    L + ++    +
Sbjct: 76  VLR----EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIV 130
Query: 267 LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE 326
           +        M  +   L  LH    A ++H DL P N+LL DN    + DF++A+  T +
Sbjct: 131 ISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD 187
Query: 327 DQSMTQTQTLATIGYMAPEYGREGRVSTN-GDVYSFGIMLMETFTGK 372
                +T  +    Y APE   + +  T   D++S G ++ E F  K
Sbjct: 188 ---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 105/258 (40%), Gaps = 28/258 (10%)
Query: 148 PSNDANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFN 206
           P ND +   +A  +    LE       +    L+G GGFGSVY   R+ D + VA+K   
Sbjct: 16  PCNDLHATKLAPGKEKEPLE-----SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE 70
Query: 207 L----QCGRALKGFDVECE--MMKSIRH--RNLIKVISTCSNEEFKALVLEY-MPHGSLE 257
                  G    G  V  E  ++K +      +I+++      +   L+LE   P   L 
Sbjct: 71  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 130
Query: 258 KYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSD 316
            ++     + +   R +    V  A+ + H   +  ++H D+K  N+L+D N     L D
Sbjct: 131 DFITERGALQEELAR-SFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLID 186
Query: 317 FSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGKKP- 374
           F    LL    +    T    T  Y  PE+ R  R    +  V+S GI+L +   G  P 
Sbjct: 187 FGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242
Query: 375 --TNEIFNGEMTLKHWVN 390
               EI  G++  +  V+
Sbjct: 243 EHDEEIIGGQVFFRQRVS 260

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 23/217 (10%)
Query: 181 IGRGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G  G V   Y A L   + +       Q     K    E  +MK + H+N+I +++ 
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 92
Query: 238 CSN----EEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            +     EEF+   LV+E M     +         LD  +   ++  +   +++LH   S
Sbjct: 93  FTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCGIKHLH---S 145
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGR 351
           A IIH DLKPSN+++  +    + DF +A+       S   T  + T  Y APE      
Sbjct: 146 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 202
Query: 352 VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW 388
              N D++S G ++ E    K     +F G   +  W
Sbjct: 203 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 235

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 105/258 (40%), Gaps = 28/258 (10%)
Query: 148 PSNDANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFN 206
           P ND +   +A  +    LE       +    L+G GGFGSVY   R+ D + VA+K   
Sbjct: 36  PCNDLHATKLAPGKEKEPLE-----SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE 90
Query: 207 L----QCGRALKGFDVECE--MMKSIRH--RNLIKVISTCSNEEFKALVLEY-MPHGSLE 257
                  G    G  V  E  ++K +      +I+++      +   L+LE   P   L 
Sbjct: 91  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 150
Query: 258 KYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSD 316
            ++     + +   R +    V  A+ + H   +  ++H D+K  N+L+D N     L D
Sbjct: 151 DFITERGALQEELAR-SFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLID 206
Query: 317 FSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGKKP- 374
           F    LL    +    T    T  Y  PE+ R  R    +  V+S GI+L +   G  P 
Sbjct: 207 FGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 262
Query: 375 --TNEIFNGEMTLKHWVN 390
               EI  G++  +  V+
Sbjct: 263 EHDEEIIRGQVFFRQRVS 280

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 105/258 (40%), Gaps = 28/258 (10%)
Query: 148 PSNDANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFN 206
           P ND +   +A  +    LE       +    L+G GGFGSVY   R+ D + VA+K   
Sbjct: 31  PCNDLHATKLAPGKEKEPLE-----SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE 85
Query: 207 L----QCGRALKGFDVECE--MMKSIRH--RNLIKVISTCSNEEFKALVLEY-MPHGSLE 257
                  G    G  V  E  ++K +      +I+++      +   L+LE   P   L 
Sbjct: 86  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 145
Query: 258 KYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSD 316
            ++     + +   R +    V  A+ + H   +  ++H D+K  N+L+D N     L D
Sbjct: 146 DFITERGALQEELAR-SFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLID 201
Query: 317 FSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGKKP- 374
           F    LL    +    T    T  Y  PE+ R  R    +  V+S GI+L +   G  P 
Sbjct: 202 FGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 257
Query: 375 --TNEIFNGEMTLKHWVN 390
               EI  G++  +  V+
Sbjct: 258 EHDEEIIRGQVFFRQRVS 275

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 23/217 (10%)
Query: 181 IGRGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G  G V   Y A L   + +       Q     K    E  +MK + H+N+I +++ 
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 92
Query: 238 CSN----EEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            +     EEF+   LV+E M     +         LD  +   ++  +   +++LH   S
Sbjct: 93  FTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCGIKHLH---S 145
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGR 351
           A IIH DLKPSN+++  +    + DF +A+       S   T  + T  Y APE      
Sbjct: 146 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 202
Query: 352 VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW 388
              N D++S G ++ E    K     +F G   +  W
Sbjct: 203 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 235

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 92/227 (40%), Gaps = 32/227 (14%)
Query: 167 ELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVK-VFN--------------LQCGR 211
           EL      ++    I  G +G+V      +G+ VA+K VFN                C R
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 212 ALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKA-----LVLEYMPHGSLEKYMYSSNYI 266
            L+    E  ++    H N++ +     + E  A     LV E M    L + ++    +
Sbjct: 76  VLR----EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIV 130
Query: 267 LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE 326
           +        M  +   L  LH    A ++H DL P N+LL DN    + DF++A+  T +
Sbjct: 131 ISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD 187
Query: 327 DQSMTQTQTLATIGYMAPEYGREGRVSTN-GDVYSFGIMLMETFTGK 372
                +T  +    Y APE   + +  T   D++S G ++ E F  K
Sbjct: 188 ---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 83/200 (41%), Gaps = 9/200 (4%)
Query: 179 NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFD---VECEMMKSIRHRNLIKV 234
            L+G+G FG V   +    G   A+K+   +   A         E  ++++ RH  L  +
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI 294
             +    +    V+EY   G L  ++       +   R     ++ SAL+YLH      +
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH--SEKNV 270
Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVST 354
           ++ DLK  N++LD +    ++DF + K   G     T      T  Y+APE   +     
Sbjct: 271 VYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 328
Query: 355 NGDVYSFGIMLMETFTGKKP 374
             D +  G+++ E   G+ P
Sbjct: 329 AVDWWGLGVVMYEMMCGRLP 348

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 20/176 (11%)
Query: 219 ECEMMKSIRHRNLIKVISTC----SNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQR 272
           E  +MK + H+N+I +++      S EEF+   +V+E M   +L + +      LD  + 
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME---LDHERM 128
Query: 273 LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 332
             ++  +   +++LH   SA IIH DLKPSN+++  +    + DF +A+       S   
Sbjct: 129 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMM 182
Query: 333 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW 388
           T  + T  Y APE         N D++S G ++ E   G      +F G   +  W
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG----GVLFPGTDHIDQW 234

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 81/213 (38%), Gaps = 13/213 (6%)
Query: 173 DGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNL 231
           D +  +  +G G FG V++      G   A K          +    E + M  +RH  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 232 IKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
           + +     ++    ++ E+M  G L + +   +  +   + +  M  V   L ++H    
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---E 273
Query: 292 APIIHCDLKPSNVLLDDNMVAHLS--DFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 349
              +H DLKP N++        L   DF +   L   D   +   T  T  + APE    
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVAEG 330
Query: 350 GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
             V    D++S G++     +G  P    F GE
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSGLSP----FGGE 359

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 83/200 (41%), Gaps = 9/200 (4%)
Query: 179 NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFD---VECEMMKSIRHRNLIKV 234
            L+G+G FG V   +    G   A+K+   +   A         E  ++++ RH  L  +
Sbjct: 157 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 216
Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI 294
             +    +    V+EY   G L  ++       +   R     ++ SAL+YLH      +
Sbjct: 217 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH--SEKNV 273
Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVST 354
           ++ DLK  N++LD +    ++DF + K   G     T      T  Y+APE   +     
Sbjct: 274 VYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 331
Query: 355 NGDVYSFGIMLMETFTGKKP 374
             D +  G+++ E   G+ P
Sbjct: 332 AVDWWGLGVVMYEMMCGRLP 351

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 20/176 (11%)
Query: 219 ECEMMKSIRHRNLIKVISTC----SNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQR 272
           E  +MK + H+N+I +++      S EEF+   +V+E M   +L + +      LD  + 
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME---LDHERM 128
Query: 273 LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 332
             ++  +   +++LH   SA IIH DLKPSN+++  +    + DF +A+       S   
Sbjct: 129 SYLLYQMLVGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMM 182
Query: 333 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW 388
           T  + T  Y APE         N D++S G ++ E   G      +F G   +  W
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG----GVLFPGTDHIDQW 234

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 23/217 (10%)
Query: 181 IGRGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G  G V   Y A L   + +       Q     K    E  +MK + H+N+I +++ 
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 238 CSN----EEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            +     EEF+   LV+E M     +         LD  +   ++  +   +++LH   S
Sbjct: 130 FTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCGIKHLH---S 182
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGR 351
           A IIH DLKPSN+++  +    + DF +A+       S   T  + T  Y APE      
Sbjct: 183 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 239
Query: 352 VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW 388
              N D++S G ++ E    K     +F G   +  W
Sbjct: 240 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 272

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 23/217 (10%)
Query: 181 IGRGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G  G V   Y A L   + +       Q     K    E  +MK + H+N+I +++ 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 238 C----SNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
                S EEF+   +V+E M     +         LD  +   ++  +   +++LH   S
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLCQVIQME----LDHERMSYLLYQMLCGIKHLH---S 144
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGR 351
           A IIH DLKPSN+++  +    + DF +A+       S   T  + T  Y APE      
Sbjct: 145 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPEVVTRYYRAPEVILGMG 201
Query: 352 VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW 388
              N D++S G ++ E   G      +F G   +  W
Sbjct: 202 YKENVDIWSVGCIMGEMIKG----GVLFPGTDHIDQW 234

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 20/176 (11%)
Query: 219 ECEMMKSIRHRNLIKVISTC----SNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQR 272
           E  +MK + H+N+I +++      S EEF+   +V+E M   +L + +      LD  + 
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME---LDHERM 128
Query: 273 LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 332
             ++  +   +++LH   SA IIH DLKPSN+++  +    + DF +A+       S   
Sbjct: 129 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 182
Query: 333 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW 388
           T  + T  Y APE         N D++S G ++ E   G      +F G   +  W
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG----GVLFPGTDHIDQW 234

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 90/214 (42%), Gaps = 23/214 (10%)
Query: 172 TDGFSENNLIGRGGFGSVY--KARLGDGMEVAVKVFNLQCGRALKGFDV---ECEMMKSI 226
           +D +     +G G +G V   K +L  G E A+K+                 E  ++K +
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 78
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLN---IMIDVASAL 283
            H N++K+     ++    LV+E    G L    +    +   F  ++   IM  V S  
Sbjct: 79  DHPNIMKLYEFFEDKRNYYLVMEVYRGGEL----FDEIILRQKFSEVDAAVIMKQVLSGT 134
Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFSIAKLLTGEDQSMTQTQTLATIG 340
            YLH      I+H DLKP N+LL+    + +  + DF ++      +      + L T  
Sbjct: 135 TYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKMKERLGTAY 188
Query: 341 YMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           Y+APE  R+ +     DV+S G++L     G  P
Sbjct: 189 YIAPEVLRK-KYDEKCDVWSCGVILYILLCGYPP 221

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 91/207 (43%), Gaps = 30/207 (14%)
Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMM--KSIRHRNLIKVISTC 238
           IG G FG     R     E+ V V  ++ G A+   +V+ E++  +S+RH N+++     
Sbjct: 28  IGSGNFGVARLMRDKLTKEL-VAVKYIERGAAIDE-NVQREIINHRSLRHPNIVRFKEVI 85
Query: 239 SNEEFKALVLEYMPHGSLEKYM-----YSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
                 A+++EY   G L + +     +S +     FQ+L       S + Y H   S  
Sbjct: 86  LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL------LSGVSYCH---SMQ 136
Query: 294 IIHCDLKPSNVLLDDNMVAHLS--DFSIAKLLTGEDQSMTQTQTLATIG---YMAPEY-G 347
           I H DLK  N LLD +    L   DF  +K       S+  +Q  +T+G   Y+APE   
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVLL 190
Query: 348 REGRVSTNGDVYSFGIMLMETFTGKKP 374
           R+       DV+S G+ L     G  P
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYP 217

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 23/217 (10%)
Query: 181 IGRGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           IG G  G V   Y A L   + +       Q     K    E  +MK + H+N+I +++ 
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 238 CSN----EEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            +     EEF+   LV+E M     +         LD  +   ++  +   +++LH   S
Sbjct: 130 FTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCGIKHLH---S 182
Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGR 351
           A IIH DLKPSN+++  +    + DF +A+       S   T  + T  Y APE      
Sbjct: 183 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 239
Query: 352 VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW 388
              N D++S G ++ E    K     +F G   +  W
Sbjct: 240 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 272

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 18/213 (8%)
Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ----CGRALKGFDVECE--MMKS 225
           D +     +G G F  V K R    G++ A K    +      R +   D+E E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           I+H N+I +     N+    L+ E +  G L  ++     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVA----HLSDFSIAKLLTGEDQSMTQTQTLATIGY 341
           LH   S  I H DLKP N++L D  V      + DF +A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 342 MAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           +APE      +    D++S G++     +G  P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 81/213 (38%), Gaps = 13/213 (6%)
Query: 173 DGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNL 231
           D +  +  +G G FG V++      G   A K          +    E + M  +RH  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 232 IKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
           + +     ++    ++ E+M  G L + +   +  +   + +  M  V   L ++H    
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---E 167
Query: 292 APIIHCDLKPSNVLLDDNMVAHLS--DFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 349
              +H DLKP N++        L   DF +   L   D   +   T  T  + APE    
Sbjct: 168 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVAEG 224
Query: 350 GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
             V    D++S G++     +G  P    F GE
Sbjct: 225 KPVGYYTDMWSVGVLSYILLSGLSP----FGGE 253

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 99/226 (43%), Gaps = 38/226 (16%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCGRALKGFDVECEMM- 223
           L +   +D +     IG G FG     R     E VAVK   ++ G  +   +V+ E++ 
Sbjct: 12  LPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKY--IERGEKIAA-NVKREIIN 68
Query: 224 -KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYM-----YSSNYILDIFQRLNIMI 277
            +S+RH N+++           A+V+EY   G L + +     +S +     FQ+L    
Sbjct: 69  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL---- 124
Query: 278 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLS--DFSIAKLLTGEDQSMTQTQT 335
              S + Y H   +  + H DLK  N LLD +    L   DF  +K       S+  +Q 
Sbjct: 125 --ISGVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQP 173
Query: 336 LATIG---YMAPEY----GREGRVSTNGDVYSFGIMLMETFTGKKP 374
            +T+G   Y+APE       +G+V+   DV+S G+ L     G  P
Sbjct: 174 KSTVGTPAYIAPEVLLKKEYDGKVA---DVWSCGVTLYVMLVGAYP 216

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 84/199 (42%), Gaps = 16/199 (8%)
Query: 175 FSENNLIGRGGFGSVYKARLG-DGMEVAVK----VFNLQCGRALKGFDVECEMMKSIRHR 229
           F   + +G G +G V+K R   DG   AVK     F     RA K  +V     K  +H 
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHE-KVGQHP 117
Query: 230 NLIKVISTCSNEEFKALVLEYMPHG-SLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             +++      EE   L L+    G SL+++  +    L   Q    + D   AL +LH 
Sbjct: 118 CCVRLEQAW--EEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH- 174
Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  ++H D+KP+N+ L       L DF +   L        Q        YMAPE   
Sbjct: 175 --SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMAPEL-L 228
Query: 349 EGRVSTNGDVYSFGIMLME 367
           +G   T  DV+S G+ ++E
Sbjct: 229 QGSYGTAADVFSLGLTILE 247

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 102/248 (41%), Gaps = 35/248 (14%)
Query: 173 DGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKV-----FNLQCGRALKGFDVECEMMKSI 226
           D +    +IG+G F  V +      G + AVK+     F    G + +    E  +   +
Sbjct: 26  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 85
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASA---- 282
           +H ++++++ T S++    +V E+M    L           +I +R +     + A    
Sbjct: 86  KHPHIVELLETYSSDGMLYMVFEFMDGADL---------CFEIVKRADAGFVYSEAVASH 136
Query: 283 -----LEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQTQ 334
                LE L + +   IIH D+KP  VLL   +++    L  F +A  L   +  +    
Sbjct: 137 YMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--ESGLVAGG 194
Query: 335 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP----TNEIFNGEMTLKHWVN 390
            + T  +MAPE  +        DV+  G++L    +G  P       +F G +  K+ +N
Sbjct: 195 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMN 254
Query: 391 --DWLPIS 396
              W  IS
Sbjct: 255 PRQWSHIS 262

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 79/176 (44%), Gaps = 20/176 (11%)
Query: 219 ECEMMKSIRHRNLIKVISTC----SNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQR 272
           E  +MK + H+N+I +++      S EEF+   +V+E M     +         LD  + 
Sbjct: 74  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME----LDHERM 129
Query: 273 LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 332
             ++  +   +++LH   SA IIH DLKPSN+++  +    + DF +A+       S   
Sbjct: 130 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 183
Query: 333 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW 388
           T  + T  Y APE         N D++S G ++ E   G      +F G   +  W
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG----GVLFPGTDHIDQW 235

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 82/187 (43%), Gaps = 29/187 (15%)
Query: 175 FSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQ-----C---GRALKGFDVECEMMKS 225
           +S  + +G G FG V+ A   +   EV VK    +     C      L    +E  ++  
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGS-LEKYMYSSNYILDIFQRLN------IMID 278
           + H N+IKV+    N+ F  LV+E   HGS L+ + +     +D   RL+      I   
Sbjct: 86  VEHANIIKVLDIFENQGFFQLVME--KHGSGLDLFAF-----IDRHPRLDEPLASYIFRQ 138
Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT 338
           + SA+ YL       IIH D+K  N+++ ++    L DF  A  L   ++         T
Sbjct: 139 LVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYTFCGT 192
Query: 339 IGYMAPE 345
           I Y APE
Sbjct: 193 IEYCAPE 199

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 79/176 (44%), Gaps = 20/176 (11%)
Query: 219 ECEMMKSIRHRNLIKVISTC----SNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQR 272
           E  +MK + H+N+I +++      S EEF+   +V+E M     +         LD  + 
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME----LDHERM 128
Query: 273 LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 332
             ++  +   +++LH   SA IIH DLKPSN+++  +    + DF +A+       S   
Sbjct: 129 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 182
Query: 333 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW 388
           T  + T  Y APE         N D++S G ++ E   G      +F G   +  W
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG----GVLFPGTDHIDQW 234

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 84/204 (41%), Gaps = 9/204 (4%)
Query: 175 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFD---VECEMMKSIRHRN 230
           F    L+G+G FG V   +    G   A+K+   +   A         E  ++++ RH  
Sbjct: 10  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 69
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY 290
           L  +  +    +    V+EY   G L  ++       +   R     ++ SAL+YLH   
Sbjct: 70  LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH--S 126
Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 350
              +++ DLK  N++LD +    ++DF + K   G     T      T  Y+APE   + 
Sbjct: 127 EKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLEDN 184
Query: 351 RVSTNGDVYSFGIMLMETFTGKKP 374
                 D +  G+++ E   G+ P
Sbjct: 185 DYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 23/226 (10%)
Query: 180 LIGRGGFGSVYKA-RLGDGMEVAVKVFNL----QCGRALKGFDVECE--MMKSIRH--RN 230
           L+G GGFGSVY   R+ D + VA+K          G    G  V  E  ++K +      
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 231 LIKVISTCSNEEFKALVLEY-MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFG 289
           +I+++      +   L+LE   P   L  ++     + +   R +    V  A+ + H  
Sbjct: 75  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH-- 131
Query: 290 YSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
            +  ++H D+K  N+L+D N     L DF    LL    +    T    T  Y  PE+ R
Sbjct: 132 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 186
Query: 349 EGRV-STNGDVYSFGIMLMETFTGKKP---TNEIFNGEMTLKHWVN 390
             R    +  V+S GI+L +   G  P     EI  G++  +  V+
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 232

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 84/204 (41%), Gaps = 9/204 (4%)
Query: 175 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFD---VECEMMKSIRHRN 230
           F    L+G+G FG V   +    G   A+K+   +   A         E  ++++ RH  
Sbjct: 12  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 71
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY 290
           L  +  +    +    V+EY   G L  ++       +   R     ++ SAL+YLH   
Sbjct: 72  LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH--S 128
Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 350
              +++ DLK  N++LD +    ++DF + K   G     T      T  Y+APE   + 
Sbjct: 129 EKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLEDN 186
Query: 351 RVSTNGDVYSFGIMLMETFTGKKP 374
                 D +  G+++ E   G+ P
Sbjct: 187 DYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 23/226 (10%)
Query: 180 LIGRGGFGSVYKA-RLGDGMEVAVKVFNL----QCGRALKGFDVECE--MMKSIRH--RN 230
           L+G GGFGSVY   R+ D + VA+K          G    G  V  E  ++K +      
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 231 LIKVISTCSNEEFKALVLEY-MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFG 289
           +I+++      +   L+LE   P   L  ++     + +   R +    V  A+ + H  
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH-- 132
Query: 290 YSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
            +  ++H D+K  N+L+D N     L DF    LL    +    T    T  Y  PE+ R
Sbjct: 133 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 187
Query: 349 EGRV-STNGDVYSFGIMLMETFTGKKP---TNEIFNGEMTLKHWVN 390
             R    +  V+S GI+L +   G  P     EI  G++  +  V+
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 233

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 23/226 (10%)
Query: 180 LIGRGGFGSVYKA-RLGDGMEVAVKVFNL----QCGRALKGFDVECE--MMKSIRH--RN 230
           L+G GGFGSVY   R+ D + VA+K          G    G  V  E  ++K +      
Sbjct: 38  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 97
Query: 231 LIKVISTCSNEEFKALVLEY-MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFG 289
           +I+++      +   L+LE   P   L  ++     + +   R +    V  A+ + H  
Sbjct: 98  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH-- 154
Query: 290 YSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
            +  ++H D+K  N+L+D N     L DF    LL    +    T    T  Y  PE+ R
Sbjct: 155 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 209
Query: 349 EGRV-STNGDVYSFGIMLMETFTGKKP---TNEIFNGEMTLKHWVN 390
             R    +  V+S GI+L +   G  P     EI  G++  +  V+
Sbjct: 210 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 255

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 23/226 (10%)
Query: 180 LIGRGGFGSVYKA-RLGDGMEVAVKVFNL----QCGRALKGFDVECE--MMKSIRH--RN 230
           L+G GGFGSVY   R+ D + VA+K          G    G  V  E  ++K +      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 231 LIKVISTCSNEEFKALVLEY-MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFG 289
           +I+++      +   L+LE   P   L  ++     + +   R +    V  A+ + H  
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH-- 127
Query: 290 YSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
            +  ++H D+K  N+L+D N     L DF    LL    +    T    T  Y  PE+ R
Sbjct: 128 -NXGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 182
Query: 349 EGRV-STNGDVYSFGIMLMETFTGKKP---TNEIFNGEMTLKHWVN 390
             R    +  V+S GI+L +   G  P     EI  G++  +  V+
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 228

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 23/226 (10%)
Query: 180 LIGRGGFGSVYKA-RLGDGMEVAVKVFNL----QCGRALKGFDVECE--MMKSIRH--RN 230
           L+G GGFGSVY   R+ D + VA+K          G    G  V  E  ++K +      
Sbjct: 14  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 73
Query: 231 LIKVISTCSNEEFKALVLEY-MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFG 289
           +I+++      +   L+LE   P   L  ++     + +   R +    V  A+ + H  
Sbjct: 74  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH-- 130
Query: 290 YSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
            +  ++H D+K  N+L+D N     L DF    LL    +    T    T  Y  PE+ R
Sbjct: 131 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 185
Query: 349 EGRV-STNGDVYSFGIMLMETFTGKKP---TNEIFNGEMTLKHWVN 390
             R    +  V+S GI+L +   G  P     EI  G++  +  V+
Sbjct: 186 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 231

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 84/204 (41%), Gaps = 9/204 (4%)
Query: 175 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFD---VECEMMKSIRHRN 230
           F    L+G+G FG V   +    G   A+K+   +   A         E  ++++ RH  
Sbjct: 11  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 70
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY 290
           L  +  +    +    V+EY   G L  ++       +   R     ++ SAL+YLH   
Sbjct: 71  LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH--S 127
Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 350
              +++ DLK  N++LD +    ++DF + K   G     T      T  Y+APE   + 
Sbjct: 128 EKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLEDN 185
Query: 351 RVSTNGDVYSFGIMLMETFTGKKP 374
                 D +  G+++ E   G+ P
Sbjct: 186 DYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 102/248 (41%), Gaps = 35/248 (14%)
Query: 173 DGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKV-----FNLQCGRALKGFDVECEMMKSI 226
           D +    +IG+G F  V +      G + AVK+     F    G + +    E  +   +
Sbjct: 24  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASA---- 282
           +H ++++++ T S++    +V E+M    L           +I +R +     + A    
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADL---------CFEIVKRADAGFVYSEAVASH 134
Query: 283 -----LEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQTQ 334
                LE L + +   IIH D+KP  VLL   +++    L  F +A  L   +  +    
Sbjct: 135 YMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--ESGLVAGG 192
Query: 335 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP----TNEIFNGEMTLKHWVN 390
            + T  +MAPE  +        DV+  G++L    +G  P       +F G +  K+ +N
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMN 252
Query: 391 --DWLPIS 396
              W  IS
Sbjct: 253 PRQWSHIS 260

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 23/226 (10%)
Query: 180 LIGRGGFGSVYKA-RLGDGMEVAVKVFNL----QCGRALKGFDVECE--MMKSIRH--RN 230
           L+G GGFGSVY   R+ D + VA+K          G    G  V  E  ++K +      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 231 LIKVISTCSNEEFKALVLEY-MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFG 289
           +I+++      +   L+LE   P   L  ++     + +   R +    V  A+ + H  
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH-- 127
Query: 290 YSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
            +  ++H D+K  N+L+D N     L DF    LL    +    T    T  Y  PE+ R
Sbjct: 128 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 182
Query: 349 EGRV-STNGDVYSFGIMLMETFTGKKP---TNEIFNGEMTLKHWVN 390
             R    +  V+S GI+L +   G  P     EI  G++  +  V+
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 228

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 79/176 (44%), Gaps = 20/176 (11%)
Query: 219 ECEMMKSIRHRNLIKVISTC----SNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQR 272
           E  +MK + H+N+I +++      S EEF+   +V+E M     +         LD  + 
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME----LDHERM 128
Query: 273 LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 332
             ++  +   +++LH   SA IIH DLKPSN+++  +    + DF +A+       S   
Sbjct: 129 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 182
Query: 333 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW 388
           T  + T  Y APE         N D++S G ++ E   G      +F G   +  W
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG----GVLFPGTDHIDQW 234

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 23/226 (10%)
Query: 180 LIGRGGFGSVYKA-RLGDGMEVAVKVFNL----QCGRALKGFDVECE--MMKSIRH--RN 230
           L+G GGFGSVY   R+ D + VA+K          G    G  V  E  ++K +      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 231 LIKVISTCSNEEFKALVLEY-MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFG 289
           +I+++      +   L+LE   P   L  ++     + +   R +    V  A+ + H  
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH-- 127
Query: 290 YSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
            +  ++H D+K  N+L+D N     L DF    LL    +    T    T  Y  PE+ R
Sbjct: 128 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 182
Query: 349 EGRV-STNGDVYSFGIMLMETFTGKKP---TNEIFNGEMTLKHWVN 390
             R    +  V+S GI+L +   G  P     EI  G++  +  V+
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVS 228

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 23/226 (10%)
Query: 180 LIGRGGFGSVYKA-RLGDGMEVAVKVFNL----QCGRALKGFDVECE--MMKSIRH--RN 230
           L+G GGFGSVY   R+ D + VA+K          G    G  V  E  ++K +      
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 231 LIKVISTCSNEEFKALVLEY-MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFG 289
           +I+++      +   L+LE   P   L  ++     + +   R +    V  A+ + H  
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH-- 132
Query: 290 YSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
            +  ++H D+K  N+L+D N     L DF    LL    +    T    T  Y  PE+ R
Sbjct: 133 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 187
Query: 349 EGRV-STNGDVYSFGIMLMETFTGKKP---TNEIFNGEMTLKHWVN 390
             R    +  V+S GI+L +   G  P     EI  G++  +  V+
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 233

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 23/226 (10%)
Query: 180 LIGRGGFGSVYKA-RLGDGMEVAVKVFNL----QCGRALKGFDVECE--MMKSIRH--RN 230
           L+G GGFGSVY   R+ D + VA+K          G    G  V  E  ++K +      
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 231 LIKVISTCSNEEFKALVLEY-MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFG 289
           +I+++      +   L+LE   P   L  ++     + +   R +    V  A+ + H  
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH-- 132
Query: 290 YSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
            +  ++H D+K  N+L+D N     L DF    LL    +    T    T  Y  PE+ R
Sbjct: 133 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 187
Query: 349 EGRV-STNGDVYSFGIMLMETFTGKKP---TNEIFNGEMTLKHWVN 390
             R    +  V+S GI+L +   G  P     EI  G++  +  V+
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 233

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 50/103 (48%), Gaps = 9/103 (8%)
Query: 275 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFSIAKLLTGEDQSMT 331
           IM  +  A++YLH   S  I H D+KP N+L      N +  L+DF  AK  T  +   +
Sbjct: 120 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---S 173
Query: 332 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
            T+   T  Y+APE     +   + D++S G+++     G  P
Sbjct: 174 LTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 216

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 89/222 (40%), Gaps = 33/222 (14%)
Query: 181 IGRGGFGSVYKA------RLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSI----RHRN 230
           +G G FG V +A      +    M VAVK+  L+    L   +     +K +     H N
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKM--LKPSAHLTEREALMSELKVLSYLGNHMN 104
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKY-----------------MYSSNYILDIFQRL 273
           ++ ++  C+      ++ EY  +G L  +                 M      LD+   L
Sbjct: 105 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 164
Query: 274 NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 333
           +    VA  + +L    S   IH DL   N+LL    +  + DF +A+ +  +   + + 
Sbjct: 165 SFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 221
Query: 334 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 374
                + +MAPE       +   DV+S+GI L E F+ G  P
Sbjct: 222 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 263

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 89/222 (40%), Gaps = 33/222 (14%)
Query: 181 IGRGGFGSVYKA------RLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSI----RHRN 230
           +G G FG V +A      +    M VAVK+  L+    L   +     +K +     H N
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKM--LKPSAHLTEREALMSELKVLSYLGNHMN 111
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKY-----------------MYSSNYILDIFQRL 273
           ++ ++  C+      ++ EY  +G L  +                 M      LD+   L
Sbjct: 112 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 171
Query: 274 NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 333
           +    VA  + +L    S   IH DL   N+LL    +  + DF +A+ +  +   + + 
Sbjct: 172 SFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKG 228
Query: 334 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 374
                + +MAPE       +   DV+S+GI L E F+ G  P
Sbjct: 229 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 270

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 89/222 (40%), Gaps = 33/222 (14%)
Query: 181 IGRGGFGSVYKA------RLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSI----RHRN 230
           +G G FG V +A      +    M VAVK+  L+    L   +     +K +     H N
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKM--LKPSAHLTEREALMSELKVLSYLGNHMN 106
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKY-----------------MYSSNYILDIFQRL 273
           ++ ++  C+      ++ EY  +G L  +                 M      LD+   L
Sbjct: 107 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 166
Query: 274 NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 333
           +    VA  + +L    S   IH DL   N+LL    +  + DF +A+ +  +   + + 
Sbjct: 167 SFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 223
Query: 334 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 374
                + +MAPE       +   DV+S+GI L E F+ G  P
Sbjct: 224 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 265

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 100/228 (43%), Gaps = 38/228 (16%)
Query: 164 SHLELCRATDGFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCGRALKGFDVECEM 222
           + L +   +D +     IG G FG     R     E VAVK   ++ G  +   +V+ E+
Sbjct: 9   ADLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKY--IERGEKIDE-NVKREI 65
Query: 223 M--KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYM-----YSSNYILDIFQRLNI 275
           +  +S+RH N+++           A+V+EY   G L + +     +S +     FQ+L  
Sbjct: 66  INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL-- 123
Query: 276 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLS--DFSIAKLLTGEDQSMTQT 333
                S + Y H   +  + H DLK  N LLD +    L   DF  +K       S+  +
Sbjct: 124 ----ISGVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHS 170
Query: 334 QTLATIG---YMAPEY----GREGRVSTNGDVYSFGIMLMETFTGKKP 374
           Q  +T+G   Y+APE       +G+V+   DV+S G+ L     G  P
Sbjct: 171 QPKSTVGTPAYIAPEVLLKKEYDGKVA---DVWSCGVTLYVMLVGAYP 215

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 89/222 (40%), Gaps = 33/222 (14%)
Query: 181 IGRGGFGSVYKA------RLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSI----RHRN 230
           +G G FG V +A      +    M VAVK+  L+    L   +     +K +     H N
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKM--LKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKY-----------------MYSSNYILDIFQRL 273
           ++ ++  C+      ++ EY  +G L  +                 M      LD+   L
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 274 NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 333
           +    VA  + +L    S   IH DL   N+LL    +  + DF +A+ +  +   + + 
Sbjct: 149 SFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 334 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 374
                + +MAPE       +   DV+S+GI L E F+ G  P
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 32/223 (14%)
Query: 166 LELCRATDGFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCGRALKGFDVECEMM- 223
           L +   +D +     IG G FG     R     E VAVK   ++ G  +   +V+ E++ 
Sbjct: 12  LPIMHDSDRYELVKDIGAGNFGVARLMRDKQANELVAVKY--IERGEKIDE-NVKREIIN 68
Query: 224 -KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYM-----YSSNYILDIFQRLNIMI 277
            +S+RH N+++           A+V+EY   G L + +     +S +     FQ+L    
Sbjct: 69  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL---- 124
Query: 278 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHL--SDFSIAKLLTGEDQSMTQTQT 335
              S + Y H   +  + H DLK  N LLD +    L  +DF  +K      Q  +    
Sbjct: 125 --ISGVSYAH---AMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKS---A 176
Query: 336 LATIGYMAPEY----GREGRVSTNGDVYSFGIMLMETFTGKKP 374
           + T  Y+APE       +G+V+   DV+S G+ L     G  P
Sbjct: 177 VGTPAYIAPEVLLKKEYDGKVA---DVWSCGVTLYVMLVGAYP 216

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 90/214 (42%), Gaps = 23/214 (10%)
Query: 172 TDGFSENNLIGRGGFGSVY--KARLGDGMEVAVKVFNLQCGRALKGFDV---ECEMMKSI 226
           +D +     +G G +G V   K +L  G E A+K+                 E  ++K +
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLN---IMIDVASAL 283
            H N++K+     ++    LV+E    G L    +    +   F  ++   IM  V S  
Sbjct: 62  DHPNIMKLYEFFEDKRNYYLVMEVYRGGEL----FDEIILRQKFSEVDAAVIMKQVLSGT 117
Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFSIAKLLTGEDQSMTQTQTLATIG 340
            YLH      I+H DLKP N+LL+    + +  + DF ++      +      + L T  
Sbjct: 118 TYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKMKERLGTAY 171
Query: 341 YMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           Y+APE  R+ +     DV+S G++L     G  P
Sbjct: 172 YIAPEVLRK-KYDEKCDVWSCGVILYILLCGYPP 204

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 89/222 (40%), Gaps = 33/222 (14%)
Query: 181 IGRGGFGSVYKA------RLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSI----RHRN 230
           +G G FG V +A      +    M VAVK+  L+    L   +     +K +     H N
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKM--LKPSAHLTEREALMSELKVLSYLGNHMN 111
Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKY-----------------MYSSNYILDIFQRL 273
           ++ ++  C+      ++ EY  +G L  +                 M      LD+   L
Sbjct: 112 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 171
Query: 274 NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 333
           +    VA  + +L    S   IH DL   N+LL    +  + DF +A+ +  +   + + 
Sbjct: 172 SFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 228
Query: 334 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 374
                + +MAPE       +   DV+S+GI L E F+ G  P
Sbjct: 229 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 270

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 94/248 (37%), Gaps = 60/248 (24%)
Query: 181 IGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFDVE-----CEMMKSIRHRNLIKV 234
           IG+G +G V  A       + A+K+ N    R +   DVE       +MK + H N+ ++
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 235 ISTCSNEEFKALVLEYMPHG------------------------------------SLEK 258
                +E++  LV+E + HG                                    ++  
Sbjct: 94  YEVYEDEQYICLVME-LCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 259 YMYSSNYILDIFQR----LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN--MVA 312
            ++     LD  QR     NIM  + SAL YLH   +  I H D+KP N L   N     
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEI 209
Query: 313 HLSDFSIA----KLLTGEDQSMTQTQTLATIGYMAPEYGREGRVS--TNGDVYSFGIMLM 366
            L DF ++    KL  GE   MT      T  ++APE       S     D +S G++L 
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKA--GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLH 267
Query: 367 ETFTGKKP 374
               G  P
Sbjct: 268 LLLMGAVP 275
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	470
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-83
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-79
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	6e-70
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-64
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-58
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-57
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-57
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-56
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-56
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-55
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-54
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-54
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-53
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-52
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-51
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-50
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-49
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-47
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-42
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-26
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-25
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	7e-25
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-19
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	7e-10
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-41
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-41
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-40
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	9e-24
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-23
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-23
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-22
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-21
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-20
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-20
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	9e-19
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-17
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-17
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-17
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-16
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-13
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-12
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-06
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	8e-40
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-39
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-39
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-39
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-38
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-38
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-38
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-38
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	8e-38
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-37
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-37
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-37
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-37
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-37
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-37
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-37
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-37
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-37
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-37
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-37
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-37
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	9e-37
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-36
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-36
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	5e-36
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-36
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-36
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-36
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-35
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-35
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-35
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-35
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-35
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-35
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-35
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-35
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-35
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-35
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-35
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-35
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	8e-35
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-34
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-34
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-34
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-34
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-34
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	9e-34
4aoj_A	329	High affinity nerve growth factor receptor; transf	9e-34
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-33
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-33
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-33
2a19_B	284	Interferon-induced, double-stranded RNA-activated	9e-33
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-32
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-32
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-32
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-32
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-32
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	6e-32
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	9e-32
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-31
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-31
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-31
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	7e-31
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	8e-31
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-30
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-30
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-30
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	8e-30
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	9e-30
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-29
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-29
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-29
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-29
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	9e-29
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-28
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-28
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-27
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-27
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-27
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	6e-27
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	6e-27
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	8e-27
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-26
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-26
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	5e-26
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	8e-26
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-25
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-25
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-25
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-25
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-25
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-25
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-25
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	8e-25
3fme_A	290	Dual specificity mitogen-activated protein kinase;	9e-25
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-24
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-24
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-24
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-24
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	8e-24
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-23
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-23
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	6e-23
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	8e-23
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-22
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-22
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-22
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-22
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-22
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-22
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-22
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-22
3o0g_A	292	Cell division protein kinase 5; kinase activator c	6e-22
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	7e-22
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	8e-22
3uqc_A	286	Probable conserved transmembrane protein; structur	9e-22
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-21
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-21
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-21
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-21
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-21
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-21
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-21
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-21
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	7e-21
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	8e-21
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-20
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-20
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-20
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-20
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-06
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-20
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-20
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-20
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-20
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-20
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-20
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-20
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	9e-18
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-17
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-17
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-17
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-16
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-14
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-14
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-13
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-13
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-13
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-13
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-12
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-04
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	8e-20
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	8e-20
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-19
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-19
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-19
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-19
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-19
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-19
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-19
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-19
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-19
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-19
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-18
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-17
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-16
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-16
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-15
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-14
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-11
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-08
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-08
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-08
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-06
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-19
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-19
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-19
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-19
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-19
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	6e-19
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	8e-19
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-18
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-18
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-18
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-18
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-18
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-18
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-18
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-18
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-18
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-17
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-17
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	7e-15
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-18
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-18
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-18
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	6e-18
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	7e-18
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	7e-18
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	7e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	8e-18
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	9e-18
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	9e-18
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-17
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-17
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-17
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-17
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-17
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-16
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-16
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-15
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-15
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-15
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	8e-15
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-14
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-13
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-12
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-11
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	6e-17
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-17
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-15
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-14
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-14
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-14
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-12
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-12
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-12
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-11
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-11
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-08
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-06
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-16
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-16
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-16
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-16
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-16
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-16
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-16
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-16
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-14
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-14
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-14
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-13
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-12
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-12
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-12
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-11
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-08
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-07
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-07
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-06
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-15
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-15
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-15
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-14
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-14
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-13
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-13
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-13
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-13
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-13
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-13
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-13
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-13
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-12
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-12
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	9e-12
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-09
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	9e-06
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-15
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	8e-15
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-14
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-14
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-14
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-13
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-13
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-12
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-11
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-08
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-06
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-14
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	8e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-13
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-13
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-12
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-12
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-12
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-12
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	8e-12
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-10
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-10
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-09
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-07
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-13
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-13
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-12
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-11
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-10
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-10
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-09
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-07
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-07
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-05
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-12
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-12
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-12
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	7e-12
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	9e-12
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-11
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-10
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-10
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-12
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	9e-10
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-09
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-09
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	8e-09
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-07
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	8e-07
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-12
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-12
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-12
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-11
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-11
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-11
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-11
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	8e-11
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-10
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-10
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-08
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-08
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	8e-06
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-11
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-09
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-04
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-12
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-07
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-07
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-04
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-12
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-11
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-11
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-11
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-10
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-09
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-08
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-04
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-12
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	7e-12
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-10
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-10
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-09
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-08
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-08
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-11
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-11
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-11
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-10
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-09
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-09
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-11
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	8e-11
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-10
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-10
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	9e-10
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-09
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-09
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-08
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-08
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-07
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-07
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-05
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-11
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-11
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-10
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-10
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-09
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	7e-07
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-06
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-04
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	7e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	5e-09
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-11
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	5e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	7e-07
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-11
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-10
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-09
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-09
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-07
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-07
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-07
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-11
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-10
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-10
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-09
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-08
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-11
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-10
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-09
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-09
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-09
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-09
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-09
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-09
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-11
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-11
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-11
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-11
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-10
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-10
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-09
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-09
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-09
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-08
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-08
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-07
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-06
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-11
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	6e-11
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	5e-10
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-09
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	9e-09
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	7e-11
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-10
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	8e-08
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	8e-08
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-07
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	7e-07
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-04
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-10
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-10
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-09
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	7e-09
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	6e-07
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-10
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-09
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-06
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-05
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-05
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-04
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-04
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-10
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-10
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-09
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-08
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-08
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-04
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-10
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	5e-07
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-06
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-04
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	8e-10
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	9e-09
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-08
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-07
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-07
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-07
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-06
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	6e-07
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-06
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-09
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-09
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-09
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-07
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-07
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-07
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-06
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-09
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-09
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-09
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-05
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-09
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-09
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	8e-09
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-08
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-07
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	6e-07
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	9e-09
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-08
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-08
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-07
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-06
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-08
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-08
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-08
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-08
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-07
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-06
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-06
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-05
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-04
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-08
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-08
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-07
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-07
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-06
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-06
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-08
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-08
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-07
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-06
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-06
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-05
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-04
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	5e-08
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-04
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	5e-08
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	7e-08
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	7e-08
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-07
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	9e-07
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	7e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	9e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-04
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-07
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-06
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-05
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-05
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-04
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	5e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-07
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	3e-07
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	4e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	5e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	8e-05
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	5e-07
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-05
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	5e-07
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-07
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-06
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-06
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-06
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-06
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-05
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-05
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-05
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-04
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-04
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	5e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-04
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-07
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-06
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-05
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-04
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	6e-07
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	8e-06
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-05
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	8e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-06
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-06
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	7e-06
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	8e-06
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	9e-06
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-05
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	5e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-04
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	4e-04

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  258 bits (662), Expect = 3e-83
 Identities = 99/326 (30%), Positives = 158/326 (48%), Gaps = 20/326 (6%)

Query: 142 RQKGKRPSNDANMPSIATW---RTFSHLELCRATDGFSENNLIGRGGFGSVYKARLGDGM 198
             K     NDA   S            ++L  AT+ F    LIG G FG VYK  L DG 
Sbjct: 5   YSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGA 64

Query: 199 EVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 258
           +VA+K    +  + ++ F+ E E +   RH +L+ +I  C       L+ +YM +G+L++
Sbjct: 65  KVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKR 124

Query: 259 YMYSSN---YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLS 315
           ++Y S+     +   QRL I I  A  L YLH      IIH D+K  N+LLD+N V  ++
Sbjct: 125 HLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKIT 181

Query: 316 DFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPT 375
           DF I+K  T  DQ+   T    T+GY+ PEY  +GR++   DVYSFG++L E    +   
Sbjct: 182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241

Query: 376 NEIF-NGEMTLKHWVNDWLPIST-MEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVE 433
            +      + L  W  +        ++V  NL  +     + K        + A++C   
Sbjct: 242 VQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRK------FGDTAVKCLAL 295

Query: 434 SPEQRINAREIVAKL---LKIRDSLL 456
           S E R +  +++ KL   L++++S++
Sbjct: 296 SSEDRPSMGDVLWKLEYALRLQESVI 321

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  248 bits (636), Expect = 3e-79
 Identities = 103/311 (33%), Positives = 156/311 (50%), Gaps = 19/311 (6%)

Query: 148 PSNDANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNL 207
           P+ +     +   + FS  EL  A+D FS  N++GRGGFG VYK RL DG  VAVK    
Sbjct: 5   PAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKE 64

Query: 208 QCGRALKG-FDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMY---SS 263
           +  +  +  F  E EM+    HRNL+++   C     + LV  YM +GS+   +     S
Sbjct: 65  ERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPES 124

Query: 264 NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 323
              LD  +R  I +  A  L YLH      IIH D+K +N+LLD+   A + DF +AKL+
Sbjct: 125 QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184

Query: 324 TGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIF---N 380
             +D  +T T    TIG++APEY   G+ S   DV+ +G+ML+E  TG++  +      +
Sbjct: 185 DYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243

Query: 381 GEMTLKHWVNDWLPIST---MEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQ 437
            ++ L  WV     +       +V  +L      ++  +E  V  +  +A+ CT  SP +
Sbjct: 244 DDVMLLDWV--KGLLKEKKLEALVDVDLQG----NYKDEE--VEQLIQVALLCTQSSPME 295

Query: 438 RINAREIVAKL 448
           R    E+V  L
Sbjct: 296 RPKMSEVVRML 306

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  223 bits (572), Expect = 6e-70
 Identities = 82/308 (26%), Positives = 140/308 (45%), Gaps = 27/308 (8%)

Query: 161 RTFSHLELCRATDGFSE------NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRA-- 212
            +FS  EL   T+ F E       N +G GGFG VYK  + +   VAVK           
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71

Query: 213 --LKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNY--ILD 268
              + FD E ++M   +H NL++++   S+ +   LV  YMP+GSL   +   +    L 
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131

Query: 269 IFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ 328
              R  I    A+ + +LH       IH D+K +N+LLD+   A +SDF +A+      Q
Sbjct: 132 WHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188

Query: 329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW 388
           ++  ++ + T  YMAPE  R G ++   D+YSFG++L+E  TG    +E       L   
Sbjct: 189 TVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEH-REPQLLLDI 246

Query: 389 VNDWL--PISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVA 446
             +      +  + +   +         +    V  ++++A +C  E   +R + +++  
Sbjct: 247 KEEIEDEEKTIEDYIDKKMND-----ADSTS--VEAMYSVASQCLHEKKNKRPDIKKVQQ 299

Query: 447 KLLKIRDS 454
            L ++  S
Sbjct: 300 LLQEMTAS 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  210 bits (537), Expect = 1e-64
 Identities = 65/307 (21%), Positives = 120/307 (39%), Gaps = 22/307 (7%)

Query: 163 FSHLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEM 222
                L   +       +  RG FG V+KA+L     VAVK+F +Q  ++ +  + E   
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQ-NEYEVYS 71

Query: 223 MKSIRHRNLIKVISTCSNEEFKA----LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMID 278
           +  ++H N+++ I              L+  +   GSL  ++     ++   +  +I   
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAET 129

Query: 279 VASALEYLH-------FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 331
           +A  L YLH        G+   I H D+K  NVLL +N+ A ++DF +A        +  
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189

Query: 332 QTQTLATIGYMAPEYGREGRVSTNG-----DVYSFGIMLMETFTGKKPTNEIFNGEMT-L 385
               + T  YMAPE                D+Y+ G++L E  +     +   +  M   
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249

Query: 386 KHWVNDWLPISTM-EVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREI 444
           +  +     +  M EVV           +  K   ++ +     EC     E R++A  +
Sbjct: 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309

Query: 445 VAKLLKI 451
             ++ ++
Sbjct: 310 GERITQM 316

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  194 bits (494), Expect = 2e-58
 Identities = 75/280 (26%), Positives = 125/280 (44%), Gaps = 27/280 (9%)

Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTC 238
           IG G FG+V++A    G +VAVK+   Q      +  F  E  +MK +RH N++  +   
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103

Query: 239 SNEEFKALVLEYMPHGSLEKYMYSSN--YILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
           +     ++V EY+  GSL + ++ S     LD  +RL++  DVA  + YLH   + PI+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162

Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 356
            +LK  N+L+D      + DF +++L      S        T  +MAPE  R+   +   
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS--KSAAGTPEWMAPEVLRDEPSNEKS 220

Query: 357 DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAK 416
           DVYSFG++L E  T ++P    +               ++  +VV A  +  +       
Sbjct: 221 DVYSFGVILWELATLQQP----WGN-------------LNPAQVVAA--VGFKCKRLEIP 261

Query: 417 EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL 456
                 V  +   C    P +R +   I+  L  +  S +
Sbjct: 262 RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  190 bits (485), Expect = 2e-57
 Identities = 68/289 (23%), Positives = 123/289 (42%), Gaps = 46/289 (15%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRA-------LKGFDVECEMMKSIRHRNLI 232
           IG+GGFG V+K R + D   VA+K   L             + F  E  +M ++ H N++
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86

Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
           K+     N     +V+E++P G L   +    + +    +L +M+D+A  +EY+    + 
Sbjct: 87  KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143

Query: 293 PIIHCDLKPSNVLLD-----DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE-- 345
           PI+H DL+  N+ L        + A ++DF +++         + +  L    +MAPE  
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAPETI 198

Query: 346 YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDW---LPISTMEVVG 402
              E   +   D YSF ++L    TG+ P +E   G++   + + +      I       
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP------ 252

Query: 403 ANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
                         E C   + N+   C    P++R +   IV +L ++
Sbjct: 253 --------------EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  189 bits (483), Expect = 4e-57
 Identities = 76/312 (24%), Positives = 139/312 (44%), Gaps = 36/312 (11%)

Query: 143 QKGKRPSNDANMPSIATWR-TFSHLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVA 201
           +KG    +  +  +   W      + + +          IG G FG+VYK +     +VA
Sbjct: 2   KKGHHHHHHGSRDAADDWEIPDGQITVGQ---------RIGSGSFGTVYKGKWHG--DVA 50

Query: 202 VKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKY 259
           VK+ N+     + L+ F  E  +++  RH N++  +   +  +  A+V ++    SL  +
Sbjct: 51  VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHH 109

Query: 260 MYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSI 319
           +++S    ++ + ++I    A  ++YLH   +  IIH DLK +N+ L ++    + DF +
Sbjct: 110 LHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGL 166

Query: 320 AKLLTGEDQSMTQTQTLATIGYMAPE---YGREGRVSTNGDVYSFGIMLMETFTGKKPTN 376
           A   +    S    Q   +I +MAPE          S   DVY+FGI+L E  TG+ P +
Sbjct: 167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 226

Query: 377 EIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPE 436
            I N +  +             E+VG   LS +      +  C   +  L  EC  +  +
Sbjct: 227 NINNRDQII-------------EMVGRGSLSPDLS--KVRSNCPKRMKRLMAECLKKKRD 271

Query: 437 QRINAREIVAKL 448
           +R +   I+A++
Sbjct: 272 ERPSFPRILAEI 283

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  188 bits (480), Expect = 2e-56
 Identities = 72/280 (25%), Positives = 112/280 (40%), Gaps = 35/280 (12%)

Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           +GRG FG V KA+     +VA+K    +     K F VE   +  + H N++K+   C N
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN 72

Query: 241 EEFKALVLEYMPHGSLEKYMYSSN--YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
                LV+EY   GSL   ++ +           ++  +  +  + YLH      +IH D
Sbjct: 73  P--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130

Query: 299 LKPSNVLLDDNM-VAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 357
           LKP N+LL     V  + DF  A      D     T    +  +MAPE       S   D
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 185

Query: 358 VYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWL--PISTMEVVGANLLSQEDIHFVA 415
           V+S+GI+L E  T +KP +EI      +   V++    P+                    
Sbjct: 186 VFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI------------------- 226

Query: 416 KEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL 455
            +     + +L   C  + P QR +  EIV  +  +    
Sbjct: 227 -KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  187 bits (476), Expect = 3e-56
 Identities = 64/281 (22%), Positives = 118/281 (41%), Gaps = 36/281 (12%)

Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTC 238
           +     G ++K R   G ++ VKV  ++    R  + F+ EC  ++   H N++ V+  C
Sbjct: 18  LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76

Query: 239 SNEEFK--ALVLEYMPHGSLEKYMYS-SNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
            +       L+  +MP+GSL   ++  +N+++D  Q +   +D+A  + +LH      I 
Sbjct: 77  QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIP 135

Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 355
              L   +V++D++M A +S   +         S      +    ++APE  ++    TN
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQKKPEDTN 188

Query: 356 G---DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIH 412
               D++SF ++L E  T + P    F               +S ME+     ++ E + 
Sbjct: 189 RRSADMWSFAVLLWELVTREVP----FAD-------------LSNMEIGMK--VALEGLR 229

Query: 413 FVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD 453
                     V  L   C  E P +R     IV  L K++D
Sbjct: 230 PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  186 bits (475), Expect = 2e-55
 Identities = 79/329 (24%), Positives = 121/329 (36%), Gaps = 41/329 (12%)

Query: 163 FSHLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEM 222
            +  E     D      LIGRG +G+VYK  L D   VAVKVF+       + F  E  +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNI 58

Query: 223 MK--SIRHRNLIKVISTC-----SNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNI 275
            +   + H N+ + I               LV+EY P+GSL KY+  S +  D      +
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRL 116

Query: 276 MIDVASALEYLH------FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS 329
              V   L YLH        Y   I H DL   NVL+ ++    +SDF ++  LTG    
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176

Query: 330 MTQTQTLA------TIGYMAPEYGRE-------GRVSTNGDVYSFGIMLMETFTGKKPTN 376
               +  A      TI YMAPE                  D+Y+ G++  E F     T+
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC--TD 234

Query: 377 EIFNGEMT-----LKHWVNDWLPISTME--VVGANLLSQEDIHFVAKEQCVSCVFNLAME 429
                 +       +  V +      M+  V       +    +      V  +     +
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294

Query: 430 CTVESPEQRINAREIVAKLLKIRDSLLRN 458
           C  +  E R+ A+    ++ ++     RN
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWERN 323

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  180 bits (460), Expect = 6e-54
 Identities = 73/283 (25%), Positives = 114/283 (40%), Gaps = 38/283 (13%)

Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQC----GRALKGFDVECEMMKSIRHRNLIKVIS 236
           IG GGFG VY+A    G EVAVK           + ++    E ++   ++H N+I +  
Sbjct: 15  IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73

Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
            C  E    LV+E+   G L + +      +     +N  + +A  + YLH     PIIH
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPIIH 131

Query: 297 CDLKPSNVLLD--------DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
            DLK SN+L+          N +  ++DF +A+        M+         +MAPE  R
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWH-RTTKMSAA---GAYAWMAPEVIR 187

Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ 408
               S   DV+S+G++L E  TG+ P    F G             I  + V     ++ 
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVP----FRG-------------IDGLAVAYG--VAM 228

Query: 409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
             +       C      L  +C    P  R +   I+ +L  I
Sbjct: 229 NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  180 bits (459), Expect = 3e-53
 Identities = 56/287 (19%), Positives = 112/287 (39%), Gaps = 39/287 (13%)

Query: 179 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVIS 236
            LIG+G FG VY  R     EVA+++ +++      LK F  E    +  RH N++  + 
Sbjct: 39  ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
            C +    A++       +L   +  +  +LD+ +   I  ++   + YLH   +  I+H
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153

Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA---TIGYMAPEYGREGRVS 353
            DLK  NV  D+  V  ++DF +  +         + +       + ++APE  R+    
Sbjct: 154 KDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212

Query: 354 TNG---------DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN 404
           T           DV++ G +  E    + P    F                + +  +G  
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAREWP----FKT-QP---------AEAIIWQMGTG 258

Query: 405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
           +        +++      + ++ + C     E+R    +++  L K+
Sbjct: 259 MKPN-----LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  178 bits (454), Expect = 3e-52
 Identities = 65/295 (22%), Positives = 109/295 (36%), Gaps = 22/295 (7%)

Query: 179 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTC 238
             IG+G +G V+  +   G +VAVKVF      A    + E      +RH N++  I+  
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE-EASWFRETEIYQTVLMRHENILGFIAAD 100

Query: 239 SNEEFK----ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLH-----FG 289
                      L+ +Y  +GSL  Y+   +  LD    L +     S L +LH       
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158

Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA--TIGYMAPE-- 345
               I H DLK  N+L+  N    ++D  +A     +   +         T  YM PE  
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218

Query: 346 ----YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVV 401
                    +     D+YSFG++L E          +   ++     V        M  +
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREI 278

Query: 402 GANLLSQEDI-HFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL 455
                 +    +  + ++C+  +  L  EC   +P  R+ A  +   L K+ +S 
Sbjct: 279 VCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  174 bits (443), Expect = 5e-51
 Identities = 69/288 (23%), Positives = 114/288 (39%), Gaps = 34/288 (11%)

Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G+G FG   K      G  + +K          + F  E ++M+ + H N++K I    
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77

Query: 240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
            ++    + EY+  G+L   + S +      QR++   D+AS + YLH   S  IIH DL
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDL 134

Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA------------TIGYMAPEYG 347
              N L+ +N    ++DF +A+L+  E       ++L                +MAPE  
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194

Query: 348 REGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS 407
                    DV+SFGI+L E                       D+LP  TM+     L  
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRVNAD--------------PDYLP-RTMDFG---LNV 236

Query: 408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL 455
           +  +       C    F + + C    PE+R +  ++   L  +R  L
Sbjct: 237 RGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  172 bits (438), Expect = 2e-50
 Identities = 68/293 (23%), Positives = 116/293 (39%), Gaps = 26/293 (8%)

Query: 179 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEM--MKSIRHRNLIKVIS 236
             +G+G +G V++     G  VAVK+F+ +     K +  E E+     +RH N++  I+
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIA 69

Query: 237 TCSNEEFKA----LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLH----- 287
           +       +    L+  Y   GSL  Y Y     LD    L I++ +AS L +LH     
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSL--YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127

Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA--TIGYMAPE 345
                 I H DLK  N+L+  N    ++D  +A + +     +         T  YMAPE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187

Query: 346 ------YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTM- 398
                            D+++FG++L E          + + +      V +      M 
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247

Query: 399 EVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
           +VV  +       +    +  ++ +  L  EC  ++P  R+ A  I   L KI
Sbjct: 248 KVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  166 bits (421), Expect = 2e-47
 Identities = 64/294 (21%), Positives = 114/294 (38%), Gaps = 22/294 (7%)

Query: 179 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTC 238
             IG+G FG V++ +   G EVAVK+F+ +  R+    + E      +RH N++  I+  
Sbjct: 48  ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAAD 105

Query: 239 SNEEFKA----LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLH-----FG 289
           + +        LV +Y  HGSL  Y+  + Y + +   + + +  AS L +LH       
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163

Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA--TIGYMAPE-- 345
               I H DLK  N+L+  N    ++D  +A        ++         T  YMAPE  
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223

Query: 346 ----YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTM-EV 400
                 +        D+Y+ G++  E            + ++     V     +  M +V
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 283

Query: 401 VGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS 454
           V    L     +     + +  +  +  EC   +   R+ A  I   L ++   
Sbjct: 284 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  151 bits (383), Expect = 3e-42
 Identities = 39/104 (37%), Positives = 56/104 (53%), Gaps = 4/104 (3%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
                G  KN + + L  N L   +    G   +L  L+L NN + G +P  L +L +L 
Sbjct: 213 ASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLH 271

Query: 62  NLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPC 105
           +LN+SFN L GEIP+GG  + F V ++  N+ LCGSP   +P C
Sbjct: 272 SLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  108 bits (271), Expect = 2e-26
 Identities = 26/75 (34%), Positives = 38/75 (50%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           IP  I  L  L YL++ +  + G IPD    + +L  L+ S N LSG +P S+  L  L 
Sbjct: 93  IPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLV 152

Query: 62  NLNLSFNKLEGEIPR 76
            +    N++ G IP 
Sbjct: 153 GITFDGNRISGAIPD 167

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  104 bits (262), Expect = 3e-25
 Identities = 28/76 (36%), Positives = 39/76 (51%), Gaps = 1/76 (1%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL- 60
           IP  +  +K L  L   YN L G +P S   L +L  +    N +SGAIP S    S L 
Sbjct: 117 IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLF 176

Query: 61  ENLNLSFNKLEGEIPR 76
            ++ +S N+L G+IP 
Sbjct: 177 TSMTISRNRLTGKIPP 192

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  103 bits (259), Expect = 7e-25
 Identities = 29/75 (38%), Positives = 45/75 (60%), Gaps = 1/75 (1%)

Query: 2   IPTEIGGLKNLEYLFL-GYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
           IP+ +  L  L +L++ G N L GPIP +   L  L +L +++ N+SGAIP  L ++  L
Sbjct: 68  IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127

Query: 61  ENLNLSFNKLEGEIP 75
             L+ S+N L G +P
Sbjct: 128 VTLDFSYNALSGTLP 142

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 87.2 bits (217), Expect = 3e-19
 Identities = 25/78 (32%), Positives = 35/78 (44%), Gaps = 3/78 (3%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQG--PIPDSFGDLISLKFLNLSN-NNLSGAIPASLEKL 57
           V+         +  L L    L    PIP S  +L  L FL +   NNL G IP ++ KL
Sbjct: 41  VLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKL 100

Query: 58  SYLENLNLSFNKLEGEIP 75
           + L  L ++   + G IP
Sbjct: 101 TQLHYLYITHTNVSGAIP 118

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 59.1 bits (144), Expect = 7e-10
 Identities = 20/59 (33%), Positives = 26/59 (44%), Gaps = 3/59 (5%)

Query: 20 NRLQGPIPDSFGDLISLKFLNLSNNNLSG--AIPASLEKLSYLENLNLS-FNKLEGEIP 75
              G + D+      +  L+LS  NL     IP+SL  L YL  L +   N L G IP
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  149 bits (379), Expect = 5e-41
 Identities = 77/282 (27%), Positives = 118/282 (41%), Gaps = 40/282 (14%)

Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKVISTC 238
           IGRG FG V+  RL  D   VAVK             F  E  ++K   H N++++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 239 SNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
           + ++   +V+E +  G    ++ +    L +   L ++ D A+ +EYL    S   IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238

Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
           L   N L+ +  V  +SDF +++       + +       + + APE    GR S+  DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298

Query: 359 YSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAK- 416
           +SFGI+L ETF+ G  P    +               +S  +             FV K 
Sbjct: 299 WSFGILLWETFSLGASP----YPN-------------LSNQQT----------REFVEKG 331

Query: 417 ------EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR 452
                 E C   VF L  +C    P QR +   I  +L  IR
Sbjct: 332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  147 bits (373), Expect = 6e-41
 Identities = 77/291 (26%), Positives = 130/291 (44%), Gaps = 40/291 (13%)

Query: 180 LIGRGGFGSVYKA---RLGDGMEVAVKVFNLQCGR---ALKGFDVECEMMKSIRHRNLIK 233
            +G GG  +VY A    L   ++VA+K   +        LK F+ E      + H+N++ 
Sbjct: 18  KLGGGGMSTVYLAEDTILN--IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
           +I     ++   LV+EY+   +L +Y+  S+  L +   +N    +   +++ H      
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAH---DMR 131

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-LATIGYMAPEYGREGRV 352
           I+H D+KP N+L+D N    + DF IAK L+  + S+TQT   L T+ Y +PE  +    
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALS--ETSLTQTNHVLGTVQYFSPEQAKGEAT 189

Query: 353 STNGDVYSFGIMLMETFTGKKPTNEIFNGE----MTLKHWVNDWLPISTMEVVGANLLSQ 408
               D+YS GI+L E   G+ P    FNGE    + +KH + D +P  T +V     + Q
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPP----FNGETAVSIAIKH-IQDSVPNVTTDVRKD--IPQ 242

Query: 409 EDIHFVAKEQCVSCVFNLAMECTVESPEQR-INAREIVAKLLKIRDSLLRN 458
                         + N+ +  T +    R    +E+   L  +      N
Sbjct: 243 S-------------LSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRAN 280

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  152 bits (387), Expect = 4e-40
 Identities = 48/111 (43%), Positives = 59/111 (53%), Gaps = 3/111 (2%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           IP EIG +  L  L LG+N + G IPD  GDL  L  L+LS+N L G IP ++  L+ L 
Sbjct: 648 IPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT 707

Query: 62  NLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCKTSNHHT 112
            ++LS N L G IP  G F  F    F  N  LCG P   +P C  SN   
Sbjct: 708 EIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP---LPRCDPSNADG 755

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  103 bits (260), Expect = 9e-24
 Identities = 33/75 (44%), Positives = 37/75 (49%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           IP  +     L  L L +N L G IP S G L  L+ L L  N L G IP  L  +  LE
Sbjct: 410 IPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLE 469

Query: 62  NLNLSFNKLEGEIPR 76
            L L FN L GEIP 
Sbjct: 470 TLILDFNDLTGEIPS 484

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  101 bits (254), Expect = 5e-23
 Identities = 32/76 (42%), Positives = 40/76 (52%), Gaps = 2/76 (2%)

Query: 2   IPTEIGG--LKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSY 59
           I   +       L+ L+L  N   G IP +  +   L  L+LS N LSG IP+SL  LS 
Sbjct: 384 ILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSK 443

Query: 60  LENLNLSFNKLEGEIP 75
           L +L L  N LEGEIP
Sbjct: 444 LRDLKLWLNMLEGEIP 459

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  100 bits (252), Expect = 8e-23
 Identities = 31/75 (41%), Positives = 42/75 (56%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           IP E+  +K LE L L +N L G IP    +  +L +++LSNN L+G IP  + +L  L 
Sbjct: 458 IPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLA 517

Query: 62  NLNLSFNKLEGEIPR 76
            L LS N   G IP 
Sbjct: 518 ILKLSNNSFSGNIPA 532

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 98.4 bits (246), Expect = 5e-22
 Identities = 31/76 (40%), Positives = 42/76 (55%), Gaps = 2/76 (2%)

Query: 2   IPTEIGG-LKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPA-SLEKLSY 59
           IP  + G    L  L L  N   G +P  FG    L+ L LS+NN SG +P  +L K+  
Sbjct: 285 IPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRG 344

Query: 60  LENLNLSFNKLEGEIP 75
           L+ L+LSFN+  GE+P
Sbjct: 345 LKVLDLSFNEFSGELP 360

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 95.4 bits (238), Expect = 5e-21
 Identities = 33/113 (29%), Positives = 43/113 (38%), Gaps = 12/113 (10%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIP-DSFGDLISLKFLNLSNNNLSGAIPASLEKLSY- 59
           +P   G    LE L L  N   G +P D+   +  LK L+LS N  SG +P SL  LS  
Sbjct: 310 VPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSAS 369

Query: 60  LENLNLSFNKLEGEIPRG-GPFRNFSVESFE--GNEL-------LCGSPNLQV 102
           L  L+LS N   G I          +++      N         L     L  
Sbjct: 370 LLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVS 422

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 94.6 bits (236), Expect = 1e-20
 Identities = 27/74 (36%), Positives = 38/74 (51%), Gaps = 3/74 (4%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           IP  +G    L++L +  N+L G    +      LK LN+S+N   G IP     L  L+
Sbjct: 216 IP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQ 272

Query: 62  NLNLSFNKLEGEIP 75
            L+L+ NK  GEIP
Sbjct: 273 YLSLAENKFTGEIP 286

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 92.7 bits (231), Expect = 3e-20
 Identities = 25/75 (33%), Positives = 35/75 (46%), Gaps = 3/75 (4%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLE-KLSYL 60
               I     L+ L +  N+  GPIP     L SL++L+L+ N  +G IP  L      L
Sbjct: 239 FSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTL 296

Query: 61  ENLNLSFNKLEGEIP 75
             L+LS N   G +P
Sbjct: 297 TGLDLSGNHFYGAVP 311

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 88.4 bits (220), Expect = 9e-19
 Identities = 24/78 (30%), Positives = 41/78 (52%), Gaps = 6/78 (7%)

Query: 2   IPTEI---GGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLS 58
                    G   L++L +  N++ G +       ++L+FL++S+NN S  IP  L   S
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCS 223

Query: 59  YLENLNLSFNKLEGEIPR 76
            L++L++S NKL G+  R
Sbjct: 224 ALQHLDISGNKLSGDFSR 241

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 84.6 bits (210), Expect = 1e-17
 Identities = 24/77 (31%), Positives = 38/77 (49%), Gaps = 4/77 (5%)

Query: 3   PTEIGGLKNLEYLFLGYNRLQGPIPDS-FGDLISLKFLNLSNNNLSGAIPASLE---KLS 58
            T +G    L++L +  N L  P   S    L SL+ L+LS N++SGA            
Sbjct: 119 LTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCG 178

Query: 59  YLENLNLSFNKLEGEIP 75
            L++L +S NK+ G++ 
Sbjct: 179 ELKHLAISGNKISGDVD 195

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 83.0 bits (206), Expect = 5e-17
 Identities = 26/76 (34%), Positives = 38/76 (50%), Gaps = 3/76 (3%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPA--SLEKLSY 59
           + + +  L  LE LFL  + + G +   F    SL  L+LS N+LSG +    SL   S 
Sbjct: 69  VSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSG 127

Query: 60  LENLNLSFNKLEGEIP 75
           L+ LN+S N L+    
Sbjct: 128 LKFLNVSSNTLDFPGK 143

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 82.6 bits (205), Expect = 6e-17
 Identities = 27/77 (35%), Positives = 35/77 (45%), Gaps = 4/77 (5%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPD--SFGDLISLKFLNLSNNNLSGAIPASLE-KLS 58
           +        +L  L L  N L GP+    S G    LKFLN+S+N L      S   KL+
Sbjct: 93  VS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLN 151

Query: 59  YLENLNLSFNKLEGEIP 75
            LE L+LS N + G   
Sbjct: 152 SLEVLDLSANSISGANV 168

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 80.3 bits (199), Expect = 4e-16
 Identities = 14/76 (18%), Positives = 27/76 (35%), Gaps = 2/76 (2%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQ--GPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSY 59
               I      +      N L+  G   +    L +    N+++    G    + +    
Sbjct: 574 RYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGS 633

Query: 60  LENLNLSFNKLEGEIP 75
           +  L++S+N L G IP
Sbjct: 634 MMFLDMSYNMLSGYIP 649

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 71.1 bits (175), Expect = 3e-13
 Identities = 19/97 (19%), Positives = 30/97 (30%), Gaps = 22/97 (22%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSF--------------------GDLISLKFLNL 41
           IP E+G  ++L +L L  N   G IP +                      +    K  + 
Sbjct: 530 IPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHG 589

Query: 42  SNN--NLSGAIPASLEKLSYLENLNLSFNKLEGEIPR 76
           + N     G     L +LS     N++     G    
Sbjct: 590 AGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSP 626

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 66.9 bits (164), Expect = 6e-12
 Identities = 17/68 (25%), Positives = 31/68 (45%), Gaps = 1/68 (1%)

Query: 17  LGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR 76
              N     +  S   L  L+ L LSN++++G++    +  + L +L+LS N L G +  
Sbjct: 60  KPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTT 118

Query: 77  GGPFRNFS 84
                + S
Sbjct: 119 LTSLGSCS 126

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 47.6 bits (114), Expect = 6e-06
 Identities = 13/47 (27%), Positives = 25/47 (53%), Gaps = 3/47 (6%)

Query: 39  LNLSNNNLS---GAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRN 82
           ++LS+  L+    A+ +SL  L+ LE+L LS + + G +       +
Sbjct: 55  IDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSAS 101

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  144 bits (365), Expect = 8e-40
 Identities = 61/294 (20%), Positives = 123/294 (41%), Gaps = 37/294 (12%)

Query: 181 IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKV 234
           +G G FG V   R        G +VAVK    + G   +     E E+++++ H N++K 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88

Query: 235 ISTCSNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
              C+ +      L++E++P GSL++Y+  +   +++ Q+L   + +   ++YL    S 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 145

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREGR 351
             +H DL   NVL++      + DF + K + T ++    +    + + + APE   + +
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK 205

Query: 352 VSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED 410
                DV+SFG+ L E  T     ++ +      +            M V          
Sbjct: 206 FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGP------THGQMTV-------TRL 252

Query: 411 IHFVAK-------EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLR 457
           ++ + +         C   V+ L  +C    P  R + + ++       ++LL+
Sbjct: 253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF----EALLK 302

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  143 bits (363), Expect = 1e-39
 Identities = 71/290 (24%), Positives = 128/290 (44%), Gaps = 29/290 (10%)

Query: 181 IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVI 235
           +G+G FGSV   R        G  VAVK         L+ F+ E E++KS++H N++K  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 236 STCSNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
             C +   +   L++EY+P+GSL  Y+      +D  + L     +   +EYL    +  
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREGRV 352
            IH DL   N+L+++     + DF + K+L   ++    +    + I + APE   E + 
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF 194

Query: 353 STNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIH 412
           S   DV+SFG++L E FT  + +       M +         +    +          I 
Sbjct: 195 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG-QMIVFHL----------IE 243

Query: 413 FVAK-------EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL 455
            +         + C   ++ +  EC   +  QR + R++  ++ +IRD++
Sbjct: 244 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  143 bits (363), Expect = 3e-39
 Identities = 71/290 (24%), Positives = 127/290 (43%), Gaps = 29/290 (10%)

Query: 181 IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVI 235
           +G+G FGSV   R        G  VAVK         L+ F+ E E++KS++H N++K  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108

Query: 236 STCSNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
             C +   +   L++EY+P+GSL  Y+      +D  + L     +   +EYL    +  
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 165

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREGRV 352
            IH DL   N+L+++     + DF + K+L   ++    +    + I + APE   E + 
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF 225

Query: 353 STNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIH 412
           S   DV+SFG++L E FT  + +       M +         +    +          I 
Sbjct: 226 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG-QMIVFHL----------IE 274

Query: 413 FVAK-------EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL 455
            +         + C   ++ +  EC   +  QR + R++  ++ +IRD +
Sbjct: 275 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  141 bits (357), Expect = 5e-39
 Identities = 70/287 (24%), Positives = 118/287 (41%), Gaps = 46/287 (16%)

Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           IG G FG V+     +  +VA+K    +   + + F  E E+M  + H  L+++   C  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74

Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL---HFGYSAPIIHC 297
           +    LV E+M HG L  Y+ +   +      L + +DV   + YL           IH 
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV------IHR 128

Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 357
           DL   N L+ +N V  +SDF + + +  +DQ  + T T   + + +PE     R S+  D
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 187

Query: 358 VYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAK 416
           V+SFG+++ E F+ GK P     N                            E +  ++ 
Sbjct: 188 VWSFGVLMWEVFSEGKIPYENRSN---------------------------SEVVEDIST 220

Query: 417 -------EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL 456
                      + V+ +   C  E PE R     ++ +L +I +S L
Sbjct: 221 GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  140 bits (356), Expect = 4e-38
 Identities = 68/321 (21%), Positives = 117/321 (36%), Gaps = 62/321 (19%)

Query: 155 PSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKARLGDGME-----VAVKVFNLQC 209
           P+ A  R     E  +         ++G G FG+VYK       E     VA+K      
Sbjct: 4   PNQALLRILKETEFKKI-------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 56

Query: 210 G-RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILD 268
             +A K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      + 
Sbjct: 57  SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIG 115

Query: 269 IFQRLNIMIDVASALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG 325
               LN  + +A  + YL           +H DL   NVL+       ++DF +AKLL  
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169

Query: 326 EDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMT 384
           E++          I +MA E       +   DV+S+G+ + E  T G KP          
Sbjct: 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP---------- 219

Query: 385 LKHWVNDWLPISTMEVVGANLLSQEDIHFVAK-------EQCVSCVFNLAMECTVESPEQ 437
                  +  I   E+             + K         C   V+ +  +C +   + 
Sbjct: 220 -------YDGIPASEI----------SSILEKGERLPQPPICTIDVYMIMRKCWMIDADS 262

Query: 438 RINAREIVAKLLKIRDSLLRN 458
           R   RE++ +       + R+
Sbjct: 263 RPKFRELIIEF----SKMARD 279

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  139 bits (352), Expect = 5e-38
 Identities = 69/289 (23%), Positives = 112/289 (38%), Gaps = 38/289 (13%)

Query: 181 IGRGGFGSVYKARL----GDGMEVAVKVFN---LQCGRALKGFDVECEMMKSIRHRNLIK 233
           +G G FG V +       G  + VAVK      L    A+  F  E   M S+ HRNLI+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL---HFGY 290
           +         K +V E  P GSL   +        +       + VA  + YL    F  
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF-- 142

Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ-TLATIGYMAPEYGRE 349
               IH DL   N+LL    +  + DF + + L   D      +       + APE  + 
Sbjct: 143 ----IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198

Query: 350 GRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ 408
              S   D + FG+ L E FT G++P                 W+ ++  +++  + + +
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEP-----------------WIGLNGSQIL--HKIDK 239

Query: 409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLR 457
           E       E C   ++N+ ++C    PE R     +   LL+ + + +R
Sbjct: 240 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR 288

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  139 bits (353), Expect = 6e-38
 Identities = 72/292 (24%), Positives = 123/292 (42%), Gaps = 43/292 (14%)

Query: 180 LIGRGGFGSVYKA---RLGDGMEVAVKVFNLQCGR---ALKGFDVECEMMKSIRHRNLIK 233
           ++G GG   V+ A   R     +VAVKV      R       F  E +   ++ H  ++ 
Sbjct: 19  ILGFGGMSEVHLARDLRDHR--DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 234 VISTCSNEEFKA----LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFG 289
           V  T   E        +V+EY+   +L   +  +   +   + + ++ D   AL + H  
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSH-- 133

Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-LATIGYMAPEYGR 348
               IIH D+KP+N+++       + DF IA+ +     S+TQT   + T  Y++PE  R
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192

Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE----MTLKHWVNDWLPISTMEVVGAN 404
              V    DVYS G +L E  TG+ P    F G+    +  +H   D +P S        
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPPSAR----HE 244

Query: 405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQR-INAREIVAKLLKIRDSL 455
            LS +             +  + ++   ++PE R   A E+ A L+++ +  
Sbjct: 245 GLSAD-------------LDAVVLKALAKNPENRYQTAAEMRADLVRVHNGE 283

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  143 bits (363), Expect = 6e-38
 Identities = 68/276 (24%), Positives = 119/276 (43%), Gaps = 28/276 (10%)

Query: 179 NLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
           + +G G +G VY+       + VAVK    +    ++ F  E  +MK I+H NL++++  
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
           C+ E    ++ E+M +G+L  Y+   N   +     L +   ++SA+EYL        IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 341

Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 356
            +L   N L+ +N +  ++DF +++L+T  D           I + APE     + S   
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400

Query: 357 DVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVA 415
           DV++FG++L E  T G  P   I   +                E++      ++D     
Sbjct: 401 DVWAFGVLLWEIATYGMSPYPGIDLSQ--------------VYELL------EKDYRMER 440

Query: 416 KEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
            E C   V+ L   C   +P  R +  EI      +
Sbjct: 441 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  139 bits (353), Expect = 8e-38
 Identities = 66/290 (22%), Positives = 111/290 (38%), Gaps = 32/290 (11%)

Query: 181 IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVI 235
           +G+G FGSV   R        G  VAVK          + F  E +++K++    ++K  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90

Query: 236 STCSNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
                   ++  LV+EY+P G L  ++      LD  + L     +   +EYL    S  
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 147

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREGRV 352
            +H DL   N+L++      ++DF +AKLL   +D  + +    + I + APE   +   
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 207

Query: 353 STNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDI 411
           S   DV+SFG++L E FT   K                     +  M            +
Sbjct: 208 SRQSDVWSFGVVLYELFTYCDKS-------------CSPSAEFLRMMGCERDVPALSRLL 254

Query: 412 HFVAK-------EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS 454
             + +         C + V  L   C   SP+ R +   +  +L  +   
Sbjct: 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  139 bits (351), Expect = 1e-37
 Identities = 66/291 (22%), Positives = 117/291 (40%), Gaps = 35/291 (12%)

Query: 181 IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKV 234
           +G G FG V          G G  VAVK      G +   G+  E ++++++ H ++IK 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 235 ISTCSNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
              C +    +  LV+EY+P GSL  Y+   +  + + Q L     +   + YLH   + 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQ 153

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREGR 351
             IH DL   NVLLD++ +  + DF +AK +  G +    +    + + + APE  +E +
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 213

Query: 352 VSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED 410
                DV+SFG+ L E  T      +        +       +    M V          
Sbjct: 214 FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG------IAQGQMTV-------LRL 260

Query: 411 IHFVAK-------EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS 454
              + +       ++C + V++L   C       R     ++  L  + + 
Sbjct: 261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  141 bits (358), Expect = 1e-37
 Identities = 69/275 (25%), Positives = 122/275 (44%), Gaps = 28/275 (10%)

Query: 179 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTC 238
             +G+G FG V+         VA+K        + + F  E ++MK +RH  L+++ +  
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 239 SNEEFKALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
           S E    +V EYM  GSL  ++       L + Q +++   +AS + Y+        +H 
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304

Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 357
           DL+ +N+L+ +N+V  ++DF +A+L+   + +  Q      I + APE    GR +   D
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSD 363

Query: 358 VYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAK 416
           V+SFGI+L E  T G+ P   + N E               ++ V      +        
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNRE--------------VLDQV------ERGYRMPCP 403

Query: 417 EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
            +C   + +L  +C  + PE+R     + A L   
Sbjct: 404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  138 bits (350), Expect = 1e-37
 Identities = 68/302 (22%), Positives = 120/302 (39%), Gaps = 60/302 (19%)

Query: 181 IGRGGFGSVYKARL----GDGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRNLIKV 234
           +G G FGSV +  L    G  ++VAVK   L     R ++ F  E   MK   H N+I++
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101

Query: 235 ISTCSNEEFKA-----LVLEYMPHGSLEKY-----MYSSNYILDIFQRLNIMIDVASALE 284
           +  C     +      ++L +M +G L  Y     + +    + +   L  M+D+A  +E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161

Query: 285 YL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGY 341
           YL   +F      +H DL   N +L D+M   ++DF ++K +   D           + +
Sbjct: 162 YLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215

Query: 342 MAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEV 400
           +A E   +   ++  DV++FG+ + E  T G  P   + N EM                 
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM----------------- 258

Query: 401 VGANLLSQEDIHFVAK-------EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD 453
                       ++         E C+  ++ +   C    P  R     +  +L K+ +
Sbjct: 259 ----------YDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308

Query: 454 SL 455
           SL
Sbjct: 309 SL 310

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  137 bits (348), Expect = 1e-37
 Identities = 59/285 (20%), Positives = 118/285 (41%), Gaps = 46/285 (16%)

Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90

Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL---HFGYSAPIIHC 297
           +    ++ EYM +G L  Y+    +     Q L +  DV  A+EYL    F      +H 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF------LHR 144

Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 357
           DL   N L++D  V  +SDF +++ +  +D+  +   +   + +  PE     + S+  D
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 203

Query: 358 VYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAK 416
           +++FG+++ E ++ GK P     N                            E    +A+
Sbjct: 204 IWAFGVLMWEIYSLGKMPYERFTN---------------------------SETAEHIAQ 236

Query: 417 -------EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS 454
                        V+ +   C  E  ++R   + +++ +L + D 
Sbjct: 237 GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  137 bits (347), Expect = 1e-37
 Identities = 68/284 (23%), Positives = 122/284 (42%), Gaps = 46/284 (16%)

Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           +G G FG V   +     +VAVK+   +   +   F  E + M  + H  L+K    CS 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74

Query: 241 EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL---HFGYSAPIIHC 297
           E    +V EY+ +G L  Y+ S    L+  Q L +  DV   + +L    F      IH 
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF------IHR 128

Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 357
           DL   N L+D ++   +SDF + + +  +DQ ++   T   + + APE     + S+  D
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSD 187

Query: 358 VYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAK 416
           V++FGI++ E F+ GK P    ++               +  EV          +  V++
Sbjct: 188 VWAFGILMWEVFSLGKMP----YDL-------------YTNSEV----------VLKVSQ 220

Query: 417 -------EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD 453
                        ++ +   C  E PE+R   +++++ +  +R+
Sbjct: 221 GHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  143 bits (361), Expect = 2e-37
 Identities = 69/275 (25%), Positives = 122/275 (44%), Gaps = 28/275 (10%)

Query: 179 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTC 238
             +G+G FG V+         VA+K        + + F  E ++MK +RH  L+++ +  
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 239 SNEEFKALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
           S E    +V EYM  GSL  ++       L + Q +++   +AS + Y+        +H 
Sbjct: 332 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 387

Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 357
           DL+ +N+L+ +N+V  ++DF +A+L+   + +  Q      I + APE    GR +   D
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSD 446

Query: 358 VYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAK 416
           V+SFGI+L E  T G+ P   + N E               ++ V      +        
Sbjct: 447 VWSFGILLTELTTKGRVPYPGMVNRE--------------VLDQV------ERGYRMPCP 486

Query: 417 EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
            +C   + +L  +C  + PE+R     + A L   
Sbjct: 487 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  137 bits (348), Expect = 2e-37
 Identities = 67/313 (21%), Positives = 125/313 (39%), Gaps = 52/313 (16%)

Query: 164 SHLELCRATDGFSENNLIGRGGFGSVYKARLGDG----MEVAVKVFNLQCG-RALKGFDV 218
             + +         + +IG+G FG VY     D     ++ A+K  +     + ++ F  
Sbjct: 12  KDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLR 71

Query: 219 ECEMMKSIRHRNLIKVISTCSNEE-FKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMI 277
           E  +M+ + H N++ +I      E    ++L YM HG L +++ S      +   ++  +
Sbjct: 72  EGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL 131

Query: 278 DVASALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED--QSMTQ 332
            VA  +EYL    F      +H DL   N +LD++    ++DF +A+ +   +       
Sbjct: 132 QVARGMEYLAEQKF------VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQH 185

Query: 333 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVND 391
                 + + A E  +  R +T  DV+SFG++L E  T G  P   I   ++        
Sbjct: 186 RHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL-------- 237

Query: 392 WLPISTMEVVGANLLSQEDIHFVAK-------EQCVSCVFNLAMECTVESPEQRINAREI 444
                               HF+A+       E C   ++ +  +C    P  R   R +
Sbjct: 238 -------------------THFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVL 278

Query: 445 VAKLLKIRDSLLR 457
           V ++ +I  +LL 
Sbjct: 279 VGEVEQIVSALLG 291

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  137 bits (348), Expect = 2e-37
 Identities = 67/296 (22%), Positives = 121/296 (40%), Gaps = 52/296 (17%)

Query: 179 NLIGRGGFGSVYKARL----GDGMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIK 233
            +IGRG FG VY   L    G  +  AVK  N       +  F  E  +MK   H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 234 VISTCSNEEFKAL-VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL---HFG 289
           ++  C   E   L VL YM HG L  ++ +  +   +   +   + VA  ++YL    F 
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF- 149

Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED--QSMTQTQTLATIGYMAPEYG 347
                +H DL   N +LD+     ++DF +A+ +  ++      +T     + +MA E  
Sbjct: 150 -----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204

Query: 348 REGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL 406
           +  + +T  DV+SFG++L E  T G  P  ++   ++                       
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI----------------------- 241

Query: 407 SQEDIHFVAK-------EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL 455
                 ++ +       E C   ++ + ++C     E R +  E+V+++  I  + 
Sbjct: 242 ----TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  138 bits (349), Expect = 2e-37
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 22/218 (10%)

Query: 180 LIGRGGFGSVYKA---RLGDGMEVAVKVFNLQCGR---ALKGFDVECEMMKSIRHRNLIK 233
           L+GRGG G VY+A          VA+K+ +               E      ++  +++ 
Sbjct: 41  LVGRGGMGDVYEAEDTVRER--IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
           +      +    + +  +    L   +      L   + + I+  + SAL+  H   +A 
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAH---AAG 154

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-LATIGYMAPEYGREGRV 352
             H D+KP N+L+  +  A+L DF IA   T  D+ +TQ    + T+ YMAPE   E   
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPERFSESHA 212

Query: 353 STNGDVYSFGIMLMETFTGKKPTNEIFNGE---MTLKH 387
           +   D+Y+   +L E  TG  P    + G+   +   H
Sbjct: 213 TYRADIYALTCVLYECLTGSPP----YQGDQLSVMGAH 246

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  138 bits (349), Expect = 3e-37
 Identities = 60/292 (20%), Positives = 118/292 (40%), Gaps = 49/292 (16%)

Query: 181 IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKV 234
           +G G FG+V+K           + V +KV   + G ++ +        + S+ H +++++
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80

Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI 294
           +  C     + LV +Y+P GSL  ++      L     LN  + +A  + YL       +
Sbjct: 81  LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGM 136

Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVST 354
           +H +L   NVLL       ++DF +A LL  +D+ +  ++    I +MA E    G+ + 
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTH 196

Query: 355 NGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF 413
             DV+S+G+ + E  T G +P                 +  +   EV             
Sbjct: 197 QSDVWSYGVTVWELMTFGAEP-----------------YAGLRLAEV----------PDL 229

Query: 414 VAK-------EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRN 458
           + K       + C   V+ + ++C +     R   +E+  +       + R+
Sbjct: 230 LEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEF----TRMARD 277

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  136 bits (345), Expect = 5e-37
 Identities = 65/284 (22%), Positives = 114/284 (40%), Gaps = 43/284 (15%)

Query: 178 NNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL--QCGRALKGFDVECEMMKSIRHRNLIK- 233
           +  IGRG F +VYK       +EVA              + F  E EM+K ++H N+++ 
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 234 ---VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY 290
                ST   ++   LV E M  G+L+ Y+     ++ I    +    +   L++LH   
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLH-TR 148

Query: 291 SAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIG---YMAPEY 346
           + PIIH DLK  N+ +        + D  +A L          +   A IG   +MAPE 
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL-------KRASFAKAVIGTPEFMAPEM 201

Query: 347 GREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL 406
             E     + DVY+FG+ ++E  T + P +E       +   V   +  ++ +     + 
Sbjct: 202 YEEK-YDESVDVYAFGMCMLEMATSEYPYSE-CQNAAQIYRRVTSGVKPASFD----KVA 255

Query: 407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK 450
             E    +               C  ++ ++R + ++    LL 
Sbjct: 256 IPEVKEIIEG-------------CIRQNKDERYSIKD----LLN 282

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  138 bits (350), Expect = 6e-37
 Identities = 67/298 (22%), Positives = 123/298 (41%), Gaps = 52/298 (17%)

Query: 179 NLIGRGGFGSVYKARL----GDGMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIK 233
            +IGRG FG VY   L    G  +  AVK  N       +  F  E  +MK   H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 234 VISTCSNEEFKAL-VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL---HFG 289
           ++  C   E   L VL YM HG L  ++ +  +   +   +   + VA  +++L    F 
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF- 213

Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT--IGYMAPEYG 347
                +H DL   N +LD+     ++DF +A+ +  ++      +T A   + +MA E  
Sbjct: 214 -----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268

Query: 348 REGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL 406
           +  + +T  DV+SFG++L E  T G  P  ++   ++                       
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI----------------------- 305

Query: 407 SQEDIHFVAK-------EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLR 457
                 ++ +       E C   ++ + ++C     E R +  E+V+++  I  + + 
Sbjct: 306 ----TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  139 bits (353), Expect = 9e-37
 Identities = 67/282 (23%), Positives = 124/282 (43%), Gaps = 42/282 (14%)

Query: 179 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTC 238
             +G G FG V+ A      +VAVK        +++ F  E  +MK+++H  L+K+ +  
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 239 SNEEFKALVLEYMPHGSLEKYMYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
           + E    ++ E+M  GSL  ++ S       + + ++    +A  + ++        IH 
Sbjct: 253 TKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHR 308

Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 357
           DL+ +N+L+  ++V  ++DF +A+++  +++   +      I + APE    G  +   D
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367

Query: 358 VYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAK 416
           V+SFGI+LME  T G+ P    + G             +S  EV          I  + +
Sbjct: 368 VWSFGILLMEIVTYGRIP----YPG-------------MSNPEV----------IRALER 400

Query: 417 -------EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
                  E C   ++N+ M C    PE+R     I + L   
Sbjct: 401 GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  136 bits (344), Expect = 1e-36
 Identities = 67/303 (22%), Positives = 127/303 (41%), Gaps = 61/303 (20%)

Query: 181 IGRGGFGSVYKARL----GDGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRNLIKV 234
           +G+G FGSV +A+L    G  ++VAVK+          ++ F  E   MK   H ++ K+
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90

Query: 235 ISTCSNEEFKA------LVLEYMPHGSLEKYMYSS-----NYILDIFQRLNIMIDVASAL 283
           +        K       ++L +M HG L  ++ +S      + L +   +  M+D+A  +
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150

Query: 284 EYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIG 340
           EYL   +F      IH DL   N +L ++M   ++DF +++ +   D       +   + 
Sbjct: 151 EYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204

Query: 341 YMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTME 399
           ++A E   +   + + DV++FG+ + E  T G+ P   I N E+                
Sbjct: 205 WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI---------------- 248

Query: 400 VVGANLLSQEDIHFVAK-------EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR 452
                       +++          +C+  V++L  +C    P+QR +   +  +L  I 
Sbjct: 249 -----------YNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297

Query: 453 DSL 455
             L
Sbjct: 298 GHL 300

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  134 bits (339), Expect = 3e-36
 Identities = 70/281 (24%), Positives = 117/281 (41%), Gaps = 42/281 (14%)

Query: 181 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           +G G +G VY+       + VAVK    +    ++ F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79

Query: 240 NEEFKALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            E    ++ E+M +G+L  Y+   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136

Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
           L   N L+ +N +  ++DF +++L+T  D           I + APE     + S   DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195

Query: 359 YSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAK- 416
           ++FG++L E  T G  P    + G             I   +V             + K 
Sbjct: 196 WAFGVLLWEIATYGMSP----YPG-------------IDLSQV----------YELLEKD 228

Query: 417 ------EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
                 E C   V+ L   C   +P  R +  EI      +
Sbjct: 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  137 bits (347), Expect = 5e-36
 Identities = 80/286 (27%), Positives = 122/286 (42%), Gaps = 48/286 (16%)

Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           IG+G FG V       G +VAVK   ++     + F  E  +M  +RH NL++++     
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257

Query: 241 EEFKA-LVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
           E+    +V EYM  GSL  Y+ S    +L     L   +DV  A+EYL        +H D
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 314

Query: 299 LKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 358
           L   NVL+ ++ VA +SDF + K     + S TQ      + + APE  RE + ST  DV
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 369

Query: 359 YSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAK- 416
           +SFGI+L E ++ G+ P    +               I   +V          +  V K 
Sbjct: 370 WSFGILLWEIYSFGRVP----YPR-------------IPLKDV----------VPRVEKG 402

Query: 417 ------EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL 456
                 + C   V+++   C       R    ++  +L  IR   L
Sbjct: 403 YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHEL 448

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  135 bits (342), Expect = 6e-36
 Identities = 67/295 (22%), Positives = 128/295 (43%), Gaps = 54/295 (18%)

Query: 181 IGRGGFGSVYKARL----GDGMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKVI 235
           +G G FG V   RL       + VA+K   +    +  + F  E  +M    H N+I++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112

Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL---HFGYSA 292
              +  +   +V EYM +GSL+ ++   +    + Q + ++  +AS ++YL    +    
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY---- 168

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT-GEDQSMTQTQTLATIGYMAPEYGREGR 351
             +H DL   N+L++ N+V  +SDF + ++L    + + T       I + +PE     +
Sbjct: 169 --VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226

Query: 352 VSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED 410
            ++  DV+S+GI+L E  + G++P                 +  +S  +V          
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERP-----------------YWEMSNQDV---------- 259

Query: 411 IHFVAK-------EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRN 458
           I  V +         C + ++ L ++C  +    R    +IV+ L    D L+RN
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL----DKLIRN 310

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  134 bits (339), Expect = 7e-36
 Identities = 58/230 (25%), Positives = 94/230 (40%), Gaps = 24/230 (10%)

Query: 155 PSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKARLGDGME-----VAVKVFNLQC 209
           P+ A  R     E  +         ++G G FG+VYK       E     VA+K      
Sbjct: 4   PNQALLRILKETEFKKI-------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 56

Query: 210 G-RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILD 268
             +A K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      + 
Sbjct: 57  SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIG 115

Query: 269 IFQRLNIMIDVASALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG 325
               LN  + +A  + YL           +H DL   NVL+       ++DF +AKLL  
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169

Query: 326 EDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 374
           E++          I +MA E       +   DV+S+G+ + E  T G KP
Sbjct: 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  134 bits (339), Expect = 7e-36
 Identities = 72/295 (24%), Positives = 124/295 (42%), Gaps = 54/295 (18%)

Query: 181 IGRGGFGSVYKARL----GDGMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKVI 235
           IG G  G V   RL       + VA+K        R  + F  E  +M    H N+I++ 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116

Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL---HFGYSA 292
              +      +V EYM +GSL+ ++ + +    I Q + ++  V + + YL    +    
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY---- 172

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG-EDQSMTQTQTLATIGYMAPEYGREGR 351
             +H DL   NVL+D N+V  +SDF ++++L    D + T T     I + APE      
Sbjct: 173 --VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230

Query: 352 VSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED 410
            S+  DV+SFG+++ E    G++P    +               ++  +V          
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERP----YWN-------------MTNRDV---------- 263

Query: 411 IHFVAK-------EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRN 458
           I  V +         C   +  L ++C  +   QR    +IV+ L    D+L+R+
Sbjct: 264 ISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL----DALIRS 314

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  136 bits (344), Expect = 1e-35
 Identities = 49/210 (23%), Positives = 96/210 (45%), Gaps = 17/210 (8%)

Query: 175 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMK-SIRHRNLIK 233
           F   +++G G  G++    + D  +VAVK    +C       D E ++++ S  H N+I+
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIR 82

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
              T  + +F+ + +E     +L++Y+   ++     + + ++    S L +LH   S  
Sbjct: 83  YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLN 138

Query: 294 IIHCDLKPSNVLL-----DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEY- 346
           I+H DLKP N+L+        + A +SDF + K L     S ++   +  T G++APE  
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198

Query: 347 --GREGRVSTNGDVYSFGIMLMETFTGKKP 374
               +   +   D++S G +     +    
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  133 bits (336), Expect = 1e-35
 Identities = 59/281 (20%), Positives = 113/281 (40%), Gaps = 39/281 (13%)

Query: 179 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNL--IKV 234
             IG GG   V++         A+K  NL+    + L  +  E   +  ++  +   I++
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI 294
                 +++  +V+E   +  L  ++      +D ++R +   ++  A+  +H      I
Sbjct: 94  YDYEITDQYIYMVMECG-NIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH---QHGI 148

Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE--------- 345
           +H DLKP+N L+ D M+  L DF IA  +  +  S+ +   + T+ YM PE         
Sbjct: 149 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 207

Query: 346 --YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA 403
                + ++S   DV+S G +L     GK P  +I N    L   ++    I   ++   
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP-- 265

Query: 404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREI 444
               ++    +               C    P+QRI+  E+
Sbjct: 266 ---EKDLQDVLKC-------------CLKRDPKQRISIPEL 290

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  132 bits (334), Expect = 2e-35
 Identities = 63/295 (21%), Positives = 120/295 (40%), Gaps = 50/295 (16%)

Query: 181 IGRGGFGSVYKARL---GDGMEVAVKVFNLQCGRALKG-FDVECEMMKSIRHRNLIKVIS 236
           +G G FGSV +         ++VA+KV      +A       E ++M  + +  ++++I 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL---HFGYSAP 293
            C  E    LV+E    G L K++      + +     ++  V+  ++YL   +F     
Sbjct: 78  VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----- 131

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS-MTQTQTLATIGYMAPEYGREGRV 352
            +H DL   NVLL +   A +SDF ++K L  +D     ++     + + APE     + 
Sbjct: 132 -VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190

Query: 353 STNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDI 411
           S+  DV+S+G+ + E  + G+KP                 +  +   EV          +
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKP-----------------YKKMKGPEV----------M 223

Query: 412 HFVAK-------EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNV 459
            F+ +        +C   ++ L  +C +   E R +   +  ++     SL   V
Sbjct: 224 AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  133 bits (336), Expect = 2e-35
 Identities = 61/303 (20%), Positives = 122/303 (40%), Gaps = 54/303 (17%)

Query: 181 IGRGGFGSVYKARL------GDGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIK 233
           +G+G FG VY+              VA+K  N     R    F  E  +MK     ++++
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKY---------MYSSNYILDIFQRLNIMIDVASALE 284
           ++   S  +   +++E M  G L+ Y                  + + + +  ++A  + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152

Query: 285 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
           YL+   +   +H DL   N ++ ++    + DF + + +   D      + L  + +M+P
Sbjct: 153 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209

Query: 345 EYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA 403
           E  ++G  +T  DV+SFG++L E  T  ++P    + G             +S  +V   
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP----YQG-------------LSNEQV--- 249

Query: 404 NLLSQEDIHFVAK-------EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL 456
                  + FV +       + C   +F L   C   +P+ R +  EI++ + +  +   
Sbjct: 250 -------LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 302

Query: 457 RNV 459
           R V
Sbjct: 303 REV 305

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  132 bits (334), Expect = 2e-35
 Identities = 80/306 (26%), Positives = 128/306 (41%), Gaps = 65/306 (21%)

Query: 181 IGRGGFGSVYKARL------GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKV 234
           +G G FG V+ A         D M VAVK        A K F  E E++ +++H +++K 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 235 ISTCSNEEFKALVLEYMPHGSLEKY---------------MYSSNYILDIFQRLNIMIDV 279
              C + +   +V EYM HG L K+                  +   L + Q L+I   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 280 ASALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 336
           AS + YL   HF      +H DL   N L+  N++  + DF +++ +   D       T+
Sbjct: 143 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196

Query: 337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPI 395
             I +M PE     + +T  DV+SFG++L E FT GK+P                 W  +
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP-----------------WFQL 239

Query: 396 STMEVVGANLLSQEDIHFVAK-------EQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
           S  EV          I  + +         C   V+++ + C    P+QR+N +EI   L
Sbjct: 240 SNTEV----------IECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKIL 289

Query: 449 LKIRDS 454
             +  +
Sbjct: 290 HALGKA 295

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  133 bits (336), Expect = 2e-35
 Identities = 67/289 (23%), Positives = 126/289 (43%), Gaps = 51/289 (17%)

Query: 181 IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKV 234
           IG G FG VYK  L        + VA+K        +    F  E  +M    H N+I++
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111

Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL---HFGYS 291
               S  +   ++ EYM +G+L+K++   +    + Q + ++  +A+ ++YL   ++   
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY--- 168

Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ-TLATIGYMAPEYGREG 350
              +H DL   N+L++ N+V  +SDF ++++L  + ++   T      I + APE     
Sbjct: 169 ---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225

Query: 351 RVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
           + ++  DV+SFGI++ E  T G++P    +          N                  E
Sbjct: 226 KFTSASDVWSFGIVMWEVMTYGERP----YWE------LSN-----------------HE 258

Query: 410 DIHFVAK-------EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
            +  +           C S ++ L M+C  +   +R    +IV+ L K+
Sbjct: 259 VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  133 bits (336), Expect = 3e-35
 Identities = 59/281 (20%), Positives = 113/281 (40%), Gaps = 39/281 (13%)

Query: 179 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNL--IKV 234
             IG GG   V++         A+K  NL+    + L  +  E   +  ++  +   I++
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI 294
                 +++  +V+E   +  L  ++      +D ++R +   ++  A+  +H      I
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH---QHGI 129

Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE--------- 345
           +H DLKP+N L+ D M+  L DF IA  +  +  S+ +   + T+ YM PE         
Sbjct: 130 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188

Query: 346 --YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA 403
                + ++S   DV+S G +L     GK P  +I N    L   ++    I   ++   
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP-- 246

Query: 404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREI 444
               ++    +               C    P+QRI+  E+
Sbjct: 247 ---EKDLQDVLKC-------------CLKRDPKQRISIPEL 271

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  134 bits (338), Expect = 3e-35
 Identities = 58/281 (20%), Positives = 112/281 (39%), Gaps = 39/281 (13%)

Query: 179 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNL--IKV 234
             IG GG   V++         A+K  NL+    + L  +  E   +  ++  +   I++
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI 294
                 +++  +V+E   +  L  ++      +D ++R +   ++  A+  +H      I
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH---QHGI 176

Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE--------- 345
           +H DLKP+N L+ D M+  L DF IA  +  +  S+ +   +  + YM PE         
Sbjct: 177 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSR 235

Query: 346 --YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA 403
                + ++S   DV+S G +L     GK P  +I N    L   ++    I   ++   
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP-- 293

Query: 404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREI 444
               ++    +               C    P+QRI+  E+
Sbjct: 294 ---EKDLQDVLKC-------------CLKRDPKQRISIPEL 318

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  131 bits (331), Expect = 3e-35
 Identities = 78/286 (27%), Positives = 121/286 (42%), Gaps = 48/286 (16%)

Query: 179 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTC 238
             IG+G FG V       G +VAVK   ++     + F  E  +M  +RH NL++++   
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 239 SNEEFKA-LVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
             E+    +V EYM  GSL  Y+ S    +L     L   +DV  A+EYL        +H
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 140

Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 356
            DL   NVL+ ++ VA +SDF + K     + S TQ      + + APE  RE + ST  
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 195

Query: 357 DVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVA 415
           DV+SFGI+L E ++ G+ P    +               I   +V          +  V 
Sbjct: 196 DVWSFGILLWEIYSFGRVP----YPR-------------IPLKDV----------VPRVE 228

Query: 416 K-------EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS 454
           K       + C   V+ +   C       R +  ++  +L  I+  
Sbjct: 229 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  131 bits (331), Expect = 4e-35
 Identities = 54/196 (27%), Positives = 100/196 (51%), Gaps = 8/196 (4%)

Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           +G G FG V+        +VAVK    Q   +   F  E  +MK ++H+ L+++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79

Query: 241 EEFKALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 299
           E    ++ EYM +GSL  ++ + +   L I + L++   +A  + ++        IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135

Query: 300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVY 359
           + +N+L+ D +   ++DF +A+L+  +++   +      I + APE    G  +   DV+
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194

Query: 360 SFGIMLMETFT-GKKP 374
           SFGI+L E  T G+ P
Sbjct: 195 SFGILLTEIVTHGRIP 210

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  131 bits (331), Expect = 4e-35
 Identities = 63/287 (21%), Positives = 112/287 (39%), Gaps = 51/287 (17%)

Query: 181 IGRGGFGSVYKARL----GDGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVI 235
           +G G FG VY+       G+ + VAVK     C     + F  E  +MK++ H +++K+I
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL---HFGYSA 292
                E    +++E  P+G L  Y+  +   L +   +   + +  A+ YL   +     
Sbjct: 80  GIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC---- 134

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV 352
             +H D+   N+L+       L DF +++ +  ED       T   I +M+PE     R 
Sbjct: 135 --VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS-VTRLPIKWMSPESINFRRF 191

Query: 353 STNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDI 411
           +T  DV+ F + + E  + GK+P                 +  +   +V          I
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQP-----------------FFWLENKDV----------I 224

Query: 412 HFVAK-------EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
             + K       + C   ++ L   C    P  R    E+V  L  +
Sbjct: 225 GVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  130 bits (330), Expect = 6e-35
 Identities = 66/295 (22%), Positives = 117/295 (39%), Gaps = 58/295 (19%)

Query: 181 IGRGGFGSVYKARL---GDGMEVAVKVFNLQCG----RALKGFDVECEMMKSIRHRNLIK 233
           +G G FG+V K           VAVK+  L+              E  +M+ + +  +++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKI--LKNEANDPALKDELLAEANVMQQLDNPYIVR 82

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL---HFGY 290
           +I  C  E +  LV+E    G L KY+  + + +     + ++  V+  ++YL   +F  
Sbjct: 83  MIGICEAESWM-LVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESNF-- 138

Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGR 348
               +H DL   NVLL     A +SDF ++K L   D++  + QT     + + APE   
Sbjct: 139 ----VHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYAPECIN 193

Query: 349 EGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS 407
             + S+  DV+SFG+++ E F+ G+KP                 +  +   EV       
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKP-----------------YRGMKGSEV------- 229

Query: 408 QEDIHFVAK-------EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL 455
                 + K         C   +++L   C     E R     +  +L      +
Sbjct: 230 ---TAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  130 bits (329), Expect = 8e-35
 Identities = 60/290 (20%), Positives = 108/290 (37%), Gaps = 51/290 (17%)

Query: 181 IGRGGFGSVYKARL----GDGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVI 235
           IG G FG V++          + VA+K           + F  E   M+   H +++K+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL---HFGYSA 292
              +      +++E    G L  ++    Y LD+   +     +++AL YL    F    
Sbjct: 83  GVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF---- 137

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV 352
             +H D+   NVL+  N    L DF +++ +  +      ++    I +MAPE     R 
Sbjct: 138 --VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRRF 194

Query: 353 STNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDI 411
           ++  DV+ FG+ + E    G KP   + N                            + I
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKPFQGVKN---------------------------NDVI 227

Query: 412 HFVAK-------EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS 454
             +           C   +++L  +C    P +R    E+ A+L  I + 
Sbjct: 228 GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  136 bits (343), Expect = 1e-34
 Identities = 62/295 (21%), Positives = 120/295 (40%), Gaps = 50/295 (16%)

Query: 181 IGRGGFGSVYKARL---GDGMEVAVKVFNLQCGRALKG-FDVECEMMKSIRHRNLIKVIS 236
           +G G FGSV +         ++VA+KV      +A       E ++M  + +  ++++I 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL---HFGYSAP 293
            C  E    LV+E    G L K++      + +     ++  V+  ++YL   +F     
Sbjct: 404 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----- 457

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS-MTQTQTLATIGYMAPEYGREGRV 352
            +H +L   NVLL +   A +SDF ++K L  +D     ++     + + APE     + 
Sbjct: 458 -VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516

Query: 353 STNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDI 411
           S+  DV+S+G+ + E  + G+KP                 +  +   EV          +
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKP-----------------YKKMKGPEV----------M 549

Query: 412 HFVAK-------EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNV 459
            F+ +        +C   ++ L  +C +   E R +   +  ++     SL   V
Sbjct: 550 AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 604

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  131 bits (331), Expect = 1e-34
 Identities = 65/294 (22%), Positives = 116/294 (39%), Gaps = 46/294 (15%)

Query: 181 IGRGGFGSVYKARL------GDGMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIK 233
           +G G FG VY+ ++         ++VAVK     C  +    F +E  ++    H+N+++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSS------NYILDIFQRLNIMIDVASALEYL- 286
            I        + +++E M  G L+ ++  +         L +   L++  D+A   +YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157

Query: 287 --HFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGY 341
             HF      IH D+   N LL       VA + DF +A+ +            +  + +
Sbjct: 158 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211

Query: 342 MAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEV 400
           M PE   EG  ++  D +SFG++L E F+ G  P     N E+ L+             V
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-LEF------------V 258

Query: 401 VGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS 454
                +          + C   V+ +  +C    PE R N   I+ ++      
Sbjct: 259 TSGGRMDP-------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  135 bits (341), Expect = 2e-34
 Identities = 44/213 (20%), Positives = 83/213 (38%), Gaps = 30/213 (14%)

Query: 180 LIGRGGFGSVYKA---RLGDGMEVAVKVFNLQCGR-ALKGFDVECEMMKSIRHRNLIKVI 235
            I  GG G +Y A    + +G  V +K         A      E + +  + H +++++ 
Sbjct: 87  CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 236 STCSNEEFKA-----LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY 290
           +   + +        +V+EY+   SL++        L + + +  ++++  AL YLH   
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH--- 199

Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT-LATIGYMAPEYGRE 349
           S  +++ DLKP N++L +  +  L D             +        T G+ APE  R 
Sbjct: 200 SIGLVYNDLKPENIMLTEEQLK-LIDLGAVS-------RINSFGYLYGTPGFQAPEIVR- 250

Query: 350 GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
              +   D+Y+ G  L              NG 
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDLPT----RNGR 279

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  130 bits (329), Expect = 4e-34
 Identities = 66/294 (22%), Positives = 116/294 (39%), Gaps = 46/294 (15%)

Query: 181 IGRGGFGSVYKARL------GDGMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIK 233
           +G G FG VY+ ++         ++VAVK     C  +    F +E  ++    H+N+++
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSS------NYILDIFQRLNIMIDVASALEYL- 286
            I        + ++LE M  G L+ ++  +         L +   L++  D+A   +YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198

Query: 287 --HFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGY 341
             HF      IH D+   N LL       VA + DF +A+ +            +  + +
Sbjct: 199 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252

Query: 342 MAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEV 400
           M PE   EG  ++  D +SFG++L E F+ G  P     N E+ L+             V
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-LEF------------V 299

Query: 401 VGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS 454
                +          + C   V+ +  +C    PE R N   I+ ++      
Sbjct: 300 TSGGRMDP-------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  129 bits (326), Expect = 5e-34
 Identities = 48/201 (23%), Positives = 77/201 (38%), Gaps = 14/201 (6%)

Query: 179 NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
             +GRG FG V++ +    G + AVK   L+  R       E      +    ++ +   
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118

Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
                +  + +E +  GSL + +      L   + L  +      LEYLH   +  I+H 
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILHG 174

Query: 298 DLKPSNVLLDDN-MVAHLSDFSIAKLLTGEDQSMTQTQTLATIG---YMAPEYGREGRVS 353
           D+K  NVLL  +   A L DF  A  L  +    +        G   +MAPE        
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234

Query: 354 TNGDVYSFGIMLMETFTGKKP 374
              D++S   M++    G  P
Sbjct: 235 AKVDIWSSCCMMLHMLNGCHP 255

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  133 bits (336), Expect = 9e-34
 Identities = 60/290 (20%), Positives = 107/290 (36%), Gaps = 51/290 (17%)

Query: 181 IGRGGFGSVYKARL----GDGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVI 235
           IG G FG V++          M VA+K           + F  E   M+   H +++K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457

Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL---HFGYSA 292
              +      +++E    G L  ++    + LD+   +     +++AL YL    F    
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF---- 512

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV 352
             +H D+   NVL+  N    L DF +++ +         ++    I +MAPE     R 
Sbjct: 513 --VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFRRF 569

Query: 353 STNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDI 411
           ++  DV+ FG+ + E    G KP   + N                            + I
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKPFQGVKN---------------------------NDVI 602

Query: 412 HFVAK-------EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS 454
             +           C   +++L  +C    P +R    E+ A+L  I + 
Sbjct: 603 GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  128 bits (324), Expect = 9e-34
 Identities = 73/305 (23%), Positives = 124/305 (40%), Gaps = 64/305 (20%)

Query: 181 IGRGGFGSVYKARL------GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKV 234
           +G G FG V+ A         D M VAVK        A + F  E E++  ++H+++++ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 235 ISTCSNEEFKALVLEYMPHGSLEKY--------------MYSSNYILDIFQRLNIMIDVA 280
              C+      +V EYM HG L ++                 +   L + Q L +   VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168

Query: 281 SALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA 337
           + + YL   HF      +H DL   N L+   +V  + DF +++ +   D      +T+ 
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222

Query: 338 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPIS 396
            I +M PE     + +T  DV+SFG++L E FT GK+P                 W  +S
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP-----------------WYQLS 265

Query: 397 TMEVVGANLLSQEDIHFVAK-------EQCVSCVFNLAMECTVESPEQRINAREIVAKLL 449
             E           I  + +         C   V+ +   C    P+QR + +++ A+L 
Sbjct: 266 NTEA----------IDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQ 315

Query: 450 KIRDS 454
            +  +
Sbjct: 316 ALAQA 320

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  127 bits (321), Expect = 1e-33
 Identities = 73/287 (25%), Positives = 120/287 (41%), Gaps = 53/287 (18%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTC 238
           ++G+G +G VY  R L + + +A+K    +  R  +    E  + K ++H+N+++ + + 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 239 SNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL--NIMIDVASALEYLHFGYSAPIIH 296
           S   F  + +E +P GSL   + S    L   ++        +   L+YLH      I+H
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 145

Query: 297 CDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPE---YGREGR 351
            D+K  NVL++  + V  +SDF  +K L G       T+T   T+ YMAPE    G  G 
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAG---INPCTETFTGTLQYMAPEIIDKGPRGY 202

Query: 352 VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN------- 404
                D++S G  ++E  TGK P             +     P + M  VG         
Sbjct: 203 -GKAADIWSLGCTIIEMATGKPP-------------FYELGEPQAAMFKVGMFKVHPEIP 248

Query: 405 -LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK 450
             +S E   F+ K             C    P++R  A +    LL 
Sbjct: 249 ESMSAEAKAFILK-------------CFEPDPDKRACAND----LLV 278

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  127 bits (321), Expect = 2e-33
 Identities = 62/294 (21%), Positives = 105/294 (35%), Gaps = 45/294 (15%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTC 238
            +G GGF  V     L DG   A+K       +  +    E +M +   H N++++++ C
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 239 SNEEFKA----LVLEYMPHGSLEKYMY---SSNYILDIFQRLNIMIDVASALEYLHFGYS 291
             E        L+L +   G+L   +         L   Q L +++ +   LE +H   +
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152

Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-------TIGYMAP 344
               H DLKP+N+LL D     L D           +   Q  TL        TI Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212

Query: 345 E----YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVND--WLPISTM 398
           E          +    DV+S G +L     G+ P + +F    ++   V +   +P S  
Sbjct: 213 ELFSVQSHCV-IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPR 271

Query: 399 EVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR 452
                   S      +                    P QR +   ++++L  ++
Sbjct: 272 -------HSSALWQLLNS-------------MMTVDPHQRPHIPLLLSQLEALQ 305

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  126 bits (318), Expect = 3e-33
 Identities = 48/215 (22%), Positives = 87/215 (40%), Gaps = 33/215 (15%)

Query: 181 IGRGGFGSVYKARL--------GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLI 232
           +G+G F  ++K               EV +KV +       + F     MM  + H++L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYL---HFG 289
                C   +   LV E++  GSL+ Y+  +   ++I  +L +   +A+A+ +L      
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL- 134

Query: 290 YSAPIIHCDLKPSNVLLD--------DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGY 341
                IH ++   N+LL         +     LSD  I+  +    + + Q      I +
Sbjct: 135 -----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV--LPKDILQ----ERIPW 183

Query: 342 MAPEYGREGRV-STNGDVYSFGIMLMETFT-GKKP 374
           + PE     +  +   D +SFG  L E  + G KP
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  124 bits (314), Expect = 9e-33
 Identities = 57/229 (24%), Positives = 91/229 (39%), Gaps = 28/229 (12%)

Query: 170 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRH 228
           R    F E  LIG GGFG V+KA+   DG    +K       +A +    E + +  + H
Sbjct: 8   RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDH 63

Query: 229 RNLIK--------------VISTCSNEEFKAL--VLEYMPHGSLEKYM-YSSNYILDIFQ 271
            N++                    S  + K L   +E+   G+LE+++       LD   
Sbjct: 64  VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123

Query: 272 RLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT 331
            L +   +   ++Y+H   S  +I+ DLKPSN+ L D     + DF +   L  + +   
Sbjct: 124 ALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR 180

Query: 332 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFN 380
              TL    YM+PE           D+Y+ G++L E         E   
Sbjct: 181 SKGTLR---YMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK 226

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  124 bits (314), Expect = 1e-32
 Identities = 63/310 (20%), Positives = 124/310 (40%), Gaps = 74/310 (23%)

Query: 181 IGRGGFGSVYKARL------GDGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIK 233
           +G   FG VYK  L           VA+K    +  G   + F  E  +   ++H N++ 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKY---------------MYSSNYILDIFQRLNIMID 278
           ++   + ++  +++  Y  HG L ++                 +    L+    ++++  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136

Query: 279 VASALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 335
           +A+ +EYL   H       +H DL   NVL+ D +   +SD  + + +   D       +
Sbjct: 137 IAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190

Query: 336 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP----TNEIFNGEMTLKHWVN 390
           L  I +MAPE    G+ S + D++S+G++L E F+ G +P    +N+             
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------------- 237

Query: 391 DWLPISTMEVVGANLLSQEDIHFVAK-------EQCVSCVFNLAMECTVESPEQRINARE 443
                   +V          +  +         + C + V+ L +EC  E P +R   ++
Sbjct: 238 --------DV----------VEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKD 279

Query: 444 IVAKLLKIRD 453
           I ++L    +
Sbjct: 280 IHSRLRAWGN 289

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  123 bits (310), Expect = 3e-32
 Identities = 52/213 (24%), Positives = 83/213 (38%), Gaps = 16/213 (7%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVIS 236
            IG G +G   K R   DG  +  K  +         +    E  +++ ++H N+++   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 237 TCSNEEFKAL--VLEYMPHGSLEKYMYSSNYILDIF---QRLNIMIDVASALEYLH--FG 289
              +     L  V+EY   G L   +               L +M  +  AL+  H    
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 349
               ++H DLKP+NV LD      L DF +A++L   D S  +T  + T  YM+PE    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKTF-VGTPYYMSPEQMNR 190

Query: 350 GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
              +   D++S G +L E      P    F   
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPP----FTAF 219

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  123 bits (311), Expect = 4e-32
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 12/209 (5%)

Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVK---VFNLQCGRALKGFDVECEMMKSIRH 228
             F     IGRG F  VY+A  L DG+ VA+K   +F+L   +A      E +++K + H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIF---QRLNIMIDVASALEY 285
            N+IK  ++   +    +VLE    G L + +        +          + + SALE+
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
           +H   S  ++H D+KP+NV +    V  L D  + +  + +  +   +    T  YM+PE
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TAAHSLV-GTPYYMSPE 206

Query: 346 YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
              E   +   D++S G +L E    + P
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  124 bits (313), Expect = 5e-32
 Identities = 70/315 (22%), Positives = 120/315 (38%), Gaps = 74/315 (23%)

Query: 181 IGRGGFGSVYKARL------GDGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIK 233
           IG G FG V++AR            VAVK+   +        F  E  +M    + N++K
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKY-----------------------MYSSNYILDIF 270
           ++  C+  +   L+ EYM +G L ++                              L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174

Query: 271 QRLNIMIDVASALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 327
           ++L I   VA+ + YL    F      +H DL   N L+ +NMV  ++DF +++ +   D
Sbjct: 175 EQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

Query: 328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLK 386
                      I +M PE     R +T  DV+++G++L E F+ G +P            
Sbjct: 229 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP------------ 276

Query: 387 HWVNDWLPISTMEVVGANLLSQEDIHFVAK-------EQCVSCVFNLAMECTVESPEQRI 439
                +  ++  EV          I++V         E C   ++NL   C  + P  R 
Sbjct: 277 -----YYGMAHEEV----------IYYVRDGNILACPENCPLELYNLMRLCWSKLPADRP 321

Query: 440 NAREIVAKLLKIRDS 454
           +   I   L ++ + 
Sbjct: 322 SFCSIHRILQRMCER 336

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  124 bits (314), Expect = 6e-32
 Identities = 69/304 (22%), Positives = 119/304 (39%), Gaps = 63/304 (20%)

Query: 181 IGRGGFGSVYKARL--------GDGMEVAVKVFNLQCG-RALKGFDVECEMMKSI-RHRN 230
           +G G FG V  A           + + VAVK+       + L     E EMMK I +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148

Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKY---------------MYSSNYILDIFQRLNI 275
           +I ++  C+ +    +++EY   G+L +Y                      +     ++ 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208

Query: 276 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 335
              +A  +EYL    S   IH DL   NVL+ +N V  ++DF +A+ +   D     T  
Sbjct: 209 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265

Query: 336 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLP 394
              + +MAPE   +   +   DV+SFG+++ E FT G  P                 +  
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-----------------YPG 308

Query: 395 ISTMEVVGANLLSQEDIHFVAK-------EQCVSCVFNLAMECTVESPEQRINAREIVAK 447
           I   E+             + +         C + ++ +  +C    P QR   +++V  
Sbjct: 309 IPVEEL----------FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358

Query: 448 LLKI 451
           L +I
Sbjct: 359 LDRI 362

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  124 bits (312), Expect = 6e-32
 Identities = 44/199 (22%), Positives = 85/199 (42%), Gaps = 9/199 (4%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVIS 236
            IG G FG     +   DG +  +K  N+     +  +    E  ++ +++H N+++   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 237 TCSNEEFKALVLEYMPHGSLEKYM-YSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
           +        +V++Y   G L K +      +    Q L+  + +  AL+++H      I+
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKIL 147

Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 355
           H D+K  N+ L  +    L DF IA++L      + +     T  Y++PE       +  
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVLN-STVELARACI-GTPYYLSPEICENKPYNNK 205

Query: 356 GDVYSFGIMLMETFTGKKP 374
            D+++ G +L E  T K  
Sbjct: 206 SDIWALGCVLYELCTLKHA 224

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  123 bits (310), Expect = 9e-32
 Identities = 69/304 (22%), Positives = 119/304 (39%), Gaps = 63/304 (20%)

Query: 181 IGRGGFGSVYKARL--------GDGMEVAVKVFNLQCG-RALKGFDVECEMMKSI-RHRN 230
           +G G FG V  A           + + VAVK+       + L     E EMMK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102

Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKY---------------MYSSNYILDIFQRLNI 275
           +I ++  C+ +    +++EY   G+L +Y                      +     ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162

Query: 276 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 335
              +A  +EYL    S   IH DL   NVL+ +N V  ++DF +A+ +   D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219

Query: 336 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLP 394
              + +MAPE   +   +   DV+SFG+++ E FT G  P                 +  
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-----------------YPG 262

Query: 395 ISTMEVVGANLLSQEDIHFVAK-------EQCVSCVFNLAMECTVESPEQRINAREIVAK 447
           I   E+             + +         C + ++ +  +C    P QR   +++V  
Sbjct: 263 IPVEEL----------FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312

Query: 448 LLKI 451
           L +I
Sbjct: 313 LDRI 316

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  122 bits (309), Expect = 1e-31
 Identities = 62/312 (19%), Positives = 116/312 (37%), Gaps = 74/312 (23%)

Query: 181 IGRGGFGSVYKARL------GDGMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIK 233
           +G G FG V KA             VAVK+         L+    E  ++K + H ++IK
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKY-----------------------MYSSNYILDIF 270
           +   CS +    L++EY  +GSL  +                        +     L + 
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150

Query: 271 QRLNIMIDVASALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 327
             ++    ++  ++YL           +H DL   N+L+ +     +SDF +++ +  ED
Sbjct: 151 DLISFAWQISQGMQYLAEMKL------VHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204

Query: 328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLK 386
             + ++Q    + +MA E   +   +T  DV+SFG++L E  T G  P   I    +   
Sbjct: 205 SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL--- 261

Query: 387 HWVNDWLPISTMEVVGANLLSQEDIHFVAK-------EQCVSCVFNLAMECTVESPEQRI 439
                                    + +         + C   ++ L ++C  + P++R 
Sbjct: 262 ------------------------FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRP 297

Query: 440 NAREIVAKLLKI 451
              +I   L K+
Sbjct: 298 VFADISKDLEKM 309

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  121 bits (307), Expect = 2e-31
 Identities = 59/297 (19%), Positives = 107/297 (36%), Gaps = 48/297 (16%)

Query: 181 IGRGGFGSVYKARL------GDGMEVAVKVFNLQCG-RALKGFDVECEMMKSI-RHRNLI 232
           +G G FG V +A           M VAVK+          +    E +++  +  H N++
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKY-----------------MYSSNYILDIFQRLNI 275
            ++  C+      ++ EY  +G L  +                 M      LD+   L+ 
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150

Query: 276 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 335
              VA  + +L    S   IH DL   N+LL    +  + DF +A+ +  +   + +   
Sbjct: 151 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207

Query: 336 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLP 394
              + +MAPE       +   DV+S+GI L E F+ G  P   +       K        
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM------- 260

Query: 395 ISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
                +     +          E   + ++++   C    P +R   ++IV  + K 
Sbjct: 261 -----IKEGFRMLS-------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  122 bits (308), Expect = 4e-31
 Identities = 71/297 (23%), Positives = 122/297 (41%), Gaps = 49/297 (16%)

Query: 181 IGRGGFGSVYKARL--------GDGMEVAVKVFNLQC-GRALKGFDVECEMMKSI-RHRN 230
           +G G FG V  A              +VAVK+       + L     E EMMK I +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKY---------------MYSSNYILDIFQRLNI 275
           +I ++  C+ +    +++EY   G+L +Y                ++    L     ++ 
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 276 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 335
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DF +A+ +   D     T  
Sbjct: 197 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253

Query: 336 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLP 394
              + +MAPE   +   +   DV+SFG++L E FT G  P   +   E+  K        
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-FKL------- 305

Query: 395 ISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
                +   + + +          C + ++ +  +C    P QR   +++V  L +I
Sbjct: 306 -----LKEGHRMDK-------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  122 bits (308), Expect = 7e-31
 Identities = 63/329 (19%), Positives = 109/329 (33%), Gaps = 71/329 (21%)

Query: 175 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECE-MMKSIRHRNLIK 233
                ++G G  G+V       G  VAVK   +          +E + + +S  H N+I+
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIR 73

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL------NIMIDVASALEYLH 287
              + + + F  + LE     +L+  + S N   +  +        +++  +AS + +LH
Sbjct: 74  YYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132

Query: 288 FGYSAPIIHCDLKPSNVLLD-------------DNMVAHLSDFSIAKLLTGEDQSMTQTQ 334
              S  IIH DLKP N+L+              +N+   +SDF + K L     S     
Sbjct: 133 ---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189

Query: 335 TLA--TIGYMAPEYGREGRVSTNG-------DVYSFGIMLMETFTGKKP--------TNE 377
                T G+ APE   E              D++S G +     +  K          + 
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249

Query: 378 IFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQ 437
           I  G  +L                    L  E    +++                  P +
Sbjct: 250 IIRGIFSLDEMKCLHDR----------SLIAEATDLISQ-------------MIDHDPLK 286

Query: 438 RINAREIVA----KLLKIRDSLLRNVGDR 462
           R  A +++          +   L  V DR
Sbjct: 287 RPTAMKVLRHPLFWPKSKKLEFLLKVSDR 315

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  120 bits (302), Expect = 8e-31
 Identities = 61/296 (20%), Positives = 110/296 (37%), Gaps = 47/296 (15%)

Query: 181 IGRGGFGSVYKARL------GDGMEVAVKVFNLQC-GRALKGFDVECEMMKSI-RHRNLI 232
           +GRG FG V +A             VAVK+          +    E +++  I  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94

Query: 233 KVISTCSNEEFKALV-LEYMPHGSLEKYMYSS---------------NYILDIFQRLNIM 276
            ++  C+      +V +E+   G+L  Y+ S                   L +   +   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154

Query: 277 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 336
             VA  +E+L    S   IH DL   N+LL +  V  + DF +A+ +  +   + +    
Sbjct: 155 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211

Query: 337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPI 395
             + +MAPE   +   +   DV+SFG++L E F+ G  P   +   E   +         
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR-------- 263

Query: 396 STMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
               +     +          +     ++   ++C    P QR    E+V  L  +
Sbjct: 264 ----LKEGTRMRA-------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  119 bits (301), Expect = 2e-30
 Identities = 58/302 (19%), Positives = 111/302 (36%), Gaps = 58/302 (19%)

Query: 179 NLIGRGGFGSVYKARL------GDGMEVAVKVFNLQC-GRALKGFDVECEMMKSI-RHRN 230
             +G G FG V +A           ++VAVK+          +    E ++M  + +H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKY-------------MYSSNYILDIFQRLNIMI 277
           ++ ++  C++     ++ EY  +G L  +                +N        L+   
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 278 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA 337
            VA  + +L    S   IH D+   NVLL +  VA + DF +A+ +  +   + +     
Sbjct: 172 QVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228

Query: 338 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPIS 396
            + +MAPE   +   +   DV+S+GI+L E F+ G  P    + G +             
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP----YPGILV------------ 272

Query: 397 TMEVVGANLLSQEDIHFVAK-------EQCVSCVFNLAMECTVESPEQRINAREIVAKLL 449
                     + +    V               ++++   C    P  R   ++I + L 
Sbjct: 273 ----------NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 322

Query: 450 KI 451
           + 
Sbjct: 323 EQ 324

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  118 bits (299), Expect = 2e-30
 Identities = 50/229 (21%), Positives = 83/229 (36%), Gaps = 28/229 (12%)

Query: 170 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL------QCGRALKGFDVECEM 222
                F   + +G G +G V+K R   DG   AVK             R L     E   
Sbjct: 54  FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLA----EVGS 109

Query: 223 MKSI-RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVAS 281
            + + +H   +++           L  E     SL+++  +    L   Q    + D   
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLL 168

Query: 282 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIG 340
           AL +LH   S  ++H D+KP+N+ L       L DF +   L     +    +       
Sbjct: 169 ALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG----TAGAGEVQEGDPR 221

Query: 341 YMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP------TNEIFNGEM 383
           YMAPE  +     T  DV+S G+ ++E     +         ++  G +
Sbjct: 222 YMAPELLQGSY-GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYL 269

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  118 bits (298), Expect = 4e-30
 Identities = 73/310 (23%), Positives = 129/310 (41%), Gaps = 69/310 (22%)

Query: 179 NLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCG---RALKGFDVECEMMKSI-RHRNL 231
           ++IG G FG V KAR+   G  M+ A+K   ++        + F  E E++  +  H N+
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKR--MKEYASKDDHRDFAGELEVLCKLGHHPNI 88

Query: 232 IKVISTCSNEEFKALVLEYMPHGSLEKY---------------MYSSNYILDIFQRLNIM 276
           I ++  C +  +  L +EY PHG+L  +                 S+   L   Q L+  
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148

Query: 277 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 336
            DVA  ++YL        IH DL   N+L+ +N VA ++DF +++   G++  + +T   
Sbjct: 149 ADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGR 202

Query: 337 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPI 395
             + +MA E       +TN DV+S+G++L E  + G  P   +   E+            
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------------ 250

Query: 396 STMEVVGANLLSQEDIHFVAK-------EQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
                             + +         C   V++L  +C  E P +R +  +I+  L
Sbjct: 251 ---------------YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 295

Query: 449 LKIRDSLLRN 458
               + +L  
Sbjct: 296 ----NRMLEE 301

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  117 bits (295), Expect = 8e-30
 Identities = 53/221 (23%), Positives = 100/221 (45%), Gaps = 26/221 (11%)

Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFN-LQCGRALKGFDVECEMMKSIRHRN 230
             +  ++++G+G   +V++ R    G   A+KVFN +   R +     E E++K + H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 231 LIK---VISTCSNEEFKALVLEYMPHGSLEKYMYS--SNYILDIFQRLNIMIDVASALEY 285
           ++K   +    +      L++E+ P GSL   +    + Y L   + L ++ DV   + +
Sbjct: 69  IVKLFAIEEETTTRHK-VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 286 LHFGYSAPIIHCDLKPSNVLL----DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGY 341
           L       I+H ++KP N++     D   V  L+DF  A+ L  ++Q ++      T  Y
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL---YGTEEY 181

Query: 342 MAPE-YGREGRVSTNG-------DVYSFGIMLMETFTGKKP 374
           + P+ Y R      +        D++S G+      TG  P
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  119 bits (299), Expect = 9e-30
 Identities = 36/274 (13%), Positives = 77/274 (28%), Gaps = 49/274 (17%)

Query: 146 KRPSNDANMPSIATWRTFSHLELCRATDG----FSENNLIGRGGFGSVYKAR-LGDGMEV 200
              S   ++ S + W T     +               ++G+    +  +A     G   
Sbjct: 47  YMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESF 106

Query: 201 AVKVFNLQCG----------------------------RALKGFDVECEMMKSIRHRNLI 232
            V V                                  +    F    +++K  + + +I
Sbjct: 107 EVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMI 166

Query: 233 KVISTCSNEEFKALVLEYM-PHGSLEKYM------YSSNYILDIFQRLNIMIDVASALEY 285
           +V     +    +    Y     +L+ +        S++  L    RL + + V   L  
Sbjct: 167 RVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 226

Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
           LH      ++H  L+P +++LD      L+ F       G        +  A     A  
Sbjct: 227 LH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD-GASAVSPIGRGFAPPETTAER 282

Query: 346 -----YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
                      ++   D ++ G+ +   +    P
Sbjct: 283 MLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  117 bits (296), Expect = 1e-29
 Identities = 61/302 (20%), Positives = 104/302 (34%), Gaps = 53/302 (17%)

Query: 181 IGRGGFGSVYKARL------GDGMEVAVKVFNLQCG-RALKGFDVECEMMKSI-RHRNLI 232
           +G G FG V  A        G  ++VAVK+   +      +    E +MM  +  H N++
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112

Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKY----------------------MYSSNYILDIF 270
            ++  C+      L+ EY  +G L  Y                            +L   
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172

Query: 271 QRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 330
             L     VA  +E+L        +H DL   NVL+    V  + DF +A+ +  +   +
Sbjct: 173 DLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229

Query: 331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWV 389
            +      + +MAPE   EG  +   DV+S+GI+L E F+ G  P   I       K   
Sbjct: 230 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKL-- 287

Query: 390 NDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLL 449
                     +     + Q              ++ +   C      +R +   + + L 
Sbjct: 288 ----------IQNGFKMDQ-------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330

Query: 450 KI 451
             
Sbjct: 331 CQ 332

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  117 bits (294), Expect = 2e-29
 Identities = 35/346 (10%), Positives = 76/346 (21%), Gaps = 61/346 (17%)

Query: 142 RQKGKRPSNDANMPSIATWRTFSHLELCRATDGFSEN----NLIGRGGFGSVYKAR-LGD 196
            +  K P+      +   W   +   +                +  G    V+  R +  
Sbjct: 27  EEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVER 86

Query: 197 GMEVAVKVFN---LQCGRALKGFDVECEMMKSIRHRNLI--------------------- 232
             + A+KVF          L+           +   +                       
Sbjct: 87  LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146

Query: 233 KVISTCSNEEFKA-----LVLEYM-----PHGSLEKYMYSSNYILDIFQRLNIMIDVASA 282
                   ++  A     L++           S   ++Y       I     +   +   
Sbjct: 147 PFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRL 206

Query: 283 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
              L    S  ++H    P N+ +  +    L D S    + G     +       + Y 
Sbjct: 207 AANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV-GTRGPASSV----PVTYA 258

Query: 343 APEY--GREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEV 400
             E+        +   + +  G+ +   +    P    F               +     
Sbjct: 259 PREFLNASTATFTHALNAWQLGLSIYRVWCLFLP----FGLVTPGIKGSWKRPSLRVPGT 314

Query: 401 VGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVA 446
                 S   +    K         L          +R+   E + 
Sbjct: 315 DSLAFGSCTPLPDFVKT--------LIGRFLNFDRRRRLLPLEAME 352

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  116 bits (293), Expect = 3e-29
 Identities = 41/237 (17%), Positives = 75/237 (31%), Gaps = 26/237 (10%)

Query: 172 TDGFSENNLIGRGGFGSVYKARLGD------GMEVAVKVFNLQCGRALKGFDVECEMMKS 225
           +     ++L+G G F  VY+A  GD        +  +KV                E +K 
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123

Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSL----EKYMYSSNYILDIFQRLNIMIDVAS 281
                 +K  S    +    LV E   +G+L      Y  +   ++     ++  + +  
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183

Query: 282 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH-----------LSDFSIAKLLTGEDQSM 330
            +E +H      IIH D+KP N +L +  +             L D   +  +    +  
Sbjct: 184 MIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240

Query: 331 TQTQTLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLK 386
             T    T G+   E     +      D +     +     G     +   GE   +
Sbjct: 241 IFTAKCETSGFQCVEM-LSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPE 296

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  115 bits (290), Expect = 3e-29
 Identities = 61/315 (19%), Positives = 106/315 (33%), Gaps = 76/315 (24%)

Query: 170 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRH 228
           R    F E  ++G+G FG V KAR   D    A+K         L     E  ++ S+ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNH 61

Query: 229 RNLIK-------------VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNI 275
           + +++              ++    +    + +EY  +G+L   ++S N      +   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121

Query: 276 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 335
              +  AL Y+H   S  IIH DLKP N+ +D++    + DF +AK +      +     
Sbjct: 122 FRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 336 LAT---------IG---YMAPE-------YGREGRVSTNGDVYSFGIMLME----TFTGK 372
                       IG   Y+A E       Y  +       D+YS GI+  E      TG 
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEK------IDMYSLGIIFFEMIYPFSTGM 232

Query: 373 ---KPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAME 429
                  ++ +  +              +E     ++                       
Sbjct: 233 ERVNILKKLRSVSIEFPPD--FDDNKMKVE---KKIIRL--------------------- 266

Query: 430 CTVESPEQRINAREI 444
                P +R  AR +
Sbjct: 267 LIDHDPNKRPGARTL 281

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  116 bits (292), Expect = 7e-29
 Identities = 53/214 (24%), Positives = 97/214 (45%), Gaps = 26/214 (12%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFN-LQCGRALKGFDVECEMMKSIRHRNLIK---V 234
           ++G+G   +V++ R    G   A+KVFN +   R +     E E++K + H+N++K   +
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYS--SNYILDIFQRLNIMIDVASALEYLHFGYSA 292
               +      L++E+ P GSL   +    + Y L   + L ++ DV   + +L      
Sbjct: 76  EEETTTRHK-VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---EN 131

Query: 293 PIIHCDLKPSNVLL----DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE-YG 347
            I+H ++KP N++     D   V  L+DF  A+ L  ++Q ++      T  Y+ P+ Y 
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL---YGTEEYLHPDMYE 188

Query: 348 REGRVSTNG-------DVYSFGIMLMETFTGKKP 374
           R      +        D++S G+      TG  P
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  119 bits (298), Expect = 9e-29
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 19/220 (8%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQ-CGRALKGFDVECEMMKSIRHRNLIK---VI 235
           +G GGFG V +      G +VA+K    +   +  + + +E ++MK + H N++    V 
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81

Query: 236 STCSN---EEFKALVLEYMPHGSLEKYM--YSSNYILDIFQRLNIMIDVASALEYLHFGY 290
                    +   L +EY   G L KY+  + +   L       ++ D++SAL YLH   
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH--- 138

Query: 291 SAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYG 347
              IIH DLKP N++L      ++  + D   AK L  +   +     + T+ Y+APE  
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEF-VGTLQYLAPELL 195

Query: 348 REGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKH 387
            + + +   D +SFG +  E  TG +P    +        
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK 235

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  113 bits (284), Expect = 2e-28
 Identities = 48/224 (21%), Positives = 91/224 (40%), Gaps = 29/224 (12%)

Query: 170 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCGRALKGFDVECEMMKSIR 227
           R    F     +GRGGFG V++A+   D    A+K   L     A +    E + +  + 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61

Query: 228 HRNLIKVISTCSNEEFKA------------LVLEYMPHGSLEKYM--YSSNYILDIFQRL 273
           H  +++  +    +                + ++     +L+ +M    +    +    L
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 274 NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 333
           +I + +A A+E+LH   S  ++H DLKPSN+    + V  + DF +   +  +++  T  
Sbjct: 122 HIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 334 QTLATIG----------YMAPEYGREGRVSTNGDVYSFGIMLME 367
             +              YM+PE       S   D++S G++L E
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  113 bits (284), Expect = 4e-28
 Identities = 64/300 (21%), Positives = 109/300 (36%), Gaps = 50/300 (16%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIR-HRNLIKVIST 237
           ++  GGF  VY+A+ +G G E A+K          +    E   MK +  H N+++  S 
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 238 CS-------NEEFKALVLEYMPHGSLEKYM--YSSNYILDIFQRLNIMIDVASALEYLHF 288
            S         + + L+L  +  G L +++    S   L     L I      A++++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153

Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA----------T 338
               PIIH DLK  N+LL +     L DF  A  ++         Q  A          T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 339 IGYMAPE----YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLP 394
             Y  PE    Y     +    D+++ G +L      + P    F     L+        
Sbjct: 214 PMYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQHP----FEDGAKLR-------- 260

Query: 395 ISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS 454
                +V               +   +   +L       +PE+R++  E+V +L +I  +
Sbjct: 261 -----IVNGK------YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  110 bits (277), Expect = 2e-27
 Identities = 69/306 (22%), Positives = 122/306 (39%), Gaps = 62/306 (20%)

Query: 167 ELCRATD---GFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEM 222
            + R  D    +     +G G FG VYKA+    G   A KV   +    L+ + VE E+
Sbjct: 10  HVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEI 69

Query: 223 MKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASA 282
           + +  H  ++K++    ++    +++E+ P G+++  M   +  L   Q   +   +  A
Sbjct: 70  LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEA 129

Query: 283 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIG-- 340
           L +LH   S  IIH DLK  NVL+       L+DF ++       +++ +  +   IG  
Sbjct: 130 LNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL---KTLQKRDSF--IGTP 181

Query: 341 -YMAPE-----YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEI------F----NGEMT 384
            +MAPE       ++       D++S GI L+E    + P +E+           +   T
Sbjct: 182 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT 241

Query: 385 LKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREI 444
           L    + W              S E   F+                  ++PE R +A + 
Sbjct: 242 LLTP-SKW--------------SVEFRDFLKI-------------ALDKNPETRPSAAQ- 272

Query: 445 VAKLLK 450
              LL+
Sbjct: 273 ---LLE 275

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  109 bits (275), Expect = 4e-27
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 10/202 (4%)

Query: 175 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
           ++    IG+G  G+VY A  +  G EVA++  NLQ     +    E  +M+  ++ N++ 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
            + +    +   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQ 136

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRV 352
           +IH D+K  N+LL  +    L+DF     +T      ++  T+  T  +MAPE       
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT---PEQSKRSTMVGTPYWMAPEVVTRKAY 193

Query: 353 STNGDVYSFGIMLMETFTGKKP 374
               D++S GIM +E   G+ P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  109 bits (275), Expect = 5e-27
 Identities = 79/290 (27%), Positives = 117/290 (40%), Gaps = 56/290 (19%)

Query: 175 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
           F     +G G +GSVYKA     G  VA+K   ++    L+    E  +M+     +++K
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVK 88

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
              +        +V+EY   GS+   +   N  L   +   I+      LEYLH      
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMR 145

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIG---YMAPEYGREG 350
            IH D+K  N+LL+    A L+DF +A  LT    +M +  T+  IG   +MAPE  +E 
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLT---DTMAKRNTV--IGTPFWMAPEVIQEI 200

Query: 351 RVSTNGDVYSFGIMLMETFTGKKPTNEI------F----NGEMTLKHWVNDWLPISTMEV 400
             +   D++S GI  +E   GK P  +I      F    N   T +              
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFR-------------- 246

Query: 401 VGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK 450
               L S     FV +             C V+SPEQR  A +    LL+
Sbjct: 247 -KPELWSDNFTDFVKQ-------------CLVKSPEQRATATQ----LLQ 278

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  110 bits (277), Expect = 6e-27
 Identities = 39/261 (14%), Positives = 83/261 (31%), Gaps = 59/261 (22%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFNL----------------QCGRALKG------- 215
           ++G+    +  +A     G    V V                      R L+G       
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 216 -----FDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM-PHGSLEKY------MYSS 263
                F    +++K  + + +I+V     +    +    Y     +L+ +        S+
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 264 NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 323
           +  L    RL + + V   L  LH      ++H  L+P +++LD      L+ F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254

Query: 324 TGEDQSMTQTQTLATIGYMAPEY-----------GREGRVSTNGDVYSFGIMLMETFTGK 372
              D +   +    + G+  PE             R   ++ + D ++ G+++   +   
Sbjct: 255 --RDGARVVSSV--SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

Query: 373 KP---TNEIFNGEMTLKHWVN 390
            P      +   E   +   N
Sbjct: 311 LPITKDAALGGSEWIFRSCKN 331

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  109 bits (274), Expect = 6e-27
 Identities = 55/204 (26%), Positives = 99/204 (48%), Gaps = 14/204 (6%)

Query: 175 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
                 IG G  G V  AR    G +VAVK+ +L+  +  +    E  +M+  +H N+++
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
           +  +    E   +++E++  G+L   +  S   L+  Q   +   V  AL YLH   +  
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH---AQG 161

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIG---YMAPEYGREG 350
           +IH D+K  ++LL  +    LSDF     ++   + + + ++L  +G   +MAPE     
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQIS---KDVPKRKSL--VGTPYWMAPEVISRS 216

Query: 351 RVSTNGDVYSFGIMLMETFTGKKP 374
             +T  D++S GIM++E   G+ P
Sbjct: 217 LYATEVDIWSLGIMVIEMVDGEPP 240

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  108 bits (271), Expect = 8e-27
 Identities = 55/231 (23%), Positives = 95/231 (41%), Gaps = 35/231 (15%)

Query: 179 NLIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRALKGFDVECEMMKSIRHRNLIKV 234
             +G+G FG+VY AR       +A+KV     L+          E E+   +RH N++++
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI 294
                +     L+LEY P G++ + +   +   +       + ++A+AL Y H   S  +
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCH---SKRV 130

Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-ATIGYMAPE------YG 347
           IH D+KP N+LL       ++DF  +           +   L  T+ Y+ PE      + 
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHAPSS-----RRTDLCGTLDYLPPEMIEGRMHD 185

Query: 348 REGRVSTNGDVYSFGIMLMETFTGKKPTNE---------IFNGEMTLKHWV 389
            +       D++S G++  E   GK P            I   E T   +V
Sbjct: 186 EK------VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 230

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  107 bits (270), Expect = 1e-26
 Identities = 54/232 (23%), Positives = 105/232 (45%), Gaps = 32/232 (13%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRALKGFDVECEMMKSIRHRNLIKVI 235
           L+G+G F  VY+A  +  G+EVA+K+ +   +     ++    E ++   ++H +++++ 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
           +   +  +  LVLE   +G + +Y+ +        +  + M  + + + YLH   S  I+
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGIL 134

Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-ATIGYMAPE------YGR 348
           H DL  SN+LL  NM   ++DF +A  L    +      TL  T  Y++PE      +G 
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH---YTLCGTPNYISPEIATRSAHGL 191

Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKPTNE---------IFNGEMTLKHWVND 391
           E       DV+S G M      G+ P +          +   +  +  +++ 
Sbjct: 192 E------SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSI 237

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  106 bits (267), Expect = 4e-26
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)

Query: 175 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCGRALKGFDVECEMMKSIRHRNLI 232
           F++   IG+G FG V+K         VA+K+ +L +    ++    E  ++       + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
           K   +   +    +++EY+  GS    +      LD  Q   I+ ++   L+YLH   S 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SE 138

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIG---YMAPEYGRE 349
             IH D+K +NVLL ++    L+DF +A  LT    +  +  T   +G   +MAPE  ++
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT---DTQIKRNTF--VGTPFWMAPEVIKQ 193

Query: 350 GRVSTNGDVYSFGIMLMETFTGKKP 374
               +  D++S GI  +E   G+ P
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPP 218

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  107 bits (269), Expect = 5e-26
 Identities = 45/233 (19%), Positives = 85/233 (36%), Gaps = 39/233 (16%)

Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFN-----------------LQCGRALKGFDVECEMM 223
           + +G F  +      D    A+K +                  +        F  E +++
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL-------NIM 276
             I++   +      +N +   ++ EYM + S+ K+      +   +           I+
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 277 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 336
             V ++  Y+H      I H D+KPSN+L+D N    LSDF  ++ +  +       +  
Sbjct: 158 KSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK-----IKGS 210

Query: 337 A-TIGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLK 386
             T  +M PE             D++S GI L   F    P    F+ +++L 
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP----FSLKISLV 259

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  107 bits (268), Expect = 8e-26
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 9/204 (4%)

Query: 173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRA-LKGFDVECEMMKSIRHRN 230
           D F + + +G G  G V+K      G+ +A K+ +L+   A       E +++       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92

Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY 290
           ++       ++   ++ +E+M  GSL++ +      +       + I V   L YL   +
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREKH 151

Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 350
              I+H D+KPSN+L++      L DF ++  L     SM  +  + T  YM+PE  +  
Sbjct: 152 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQGT 205

Query: 351 RVSTNGDVYSFGIMLMETFTGKKP 374
             S   D++S G+ L+E   G+ P
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYP 229

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  104 bits (263), Expect = 2e-25
 Identities = 43/209 (20%), Positives = 82/209 (39%), Gaps = 30/209 (14%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRALKGFDVECEMMKSIRHRNLIKVI 235
            +G+GGF   ++          A K+     L      +   +E  + +S+ H++++   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
               + +F  +VLE     SL +       + +   R   +  +    +YLH      +I
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVI 137

Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI-G---YMAPE------ 345
           H DLK  N+ L++++   + DF +A  +          +    + G   Y+APE      
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKV------EYDGERKKVLCGTPNYIAPEVLSKKG 191

Query: 346 YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           +  E       DV+S G ++     GK P
Sbjct: 192 HSFE------VDVWSIGCIMYTLLVGKPP 214

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  104 bits (262), Expect = 2e-25
 Identities = 55/300 (18%), Positives = 107/300 (35%), Gaps = 55/300 (18%)

Query: 170 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCG------RALKGFDVECEM 222
           R T  F E   IG G FGSV+K     DG   A+K              AL+    E   
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALR----EVYA 63

Query: 223 MKSI-RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIF---QRLNIMID 278
              + +H ++++  S  + ++   +  EY   GSL   +  +  I+  F   +  ++++ 
Sbjct: 64  HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 123

Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ---------- 328
           V   L Y+H   S  ++H D+KPSN+ +    + + +     +     ++          
Sbjct: 124 VGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180

Query: 329 --SMTQTQTLA-TIGYMAPEYGREGRVSTN-GDVYSFGIMLMETFTGKKPTNEIFNGEMT 384
              ++  Q       ++A E  +E        D+++  + ++     +       NG+  
Sbjct: 181 VTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR---NGDQW 237

Query: 385 LKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREI 444
            +        I  +       LSQE    +                    PE+R +A  +
Sbjct: 238 HEIRQGRLPRIPQV-------LSQEFTELLKV-------------MIHPDPERRPSAMAL 277

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  105 bits (264), Expect = 2e-25
 Identities = 70/283 (24%), Positives = 104/283 (36%), Gaps = 40/283 (14%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRA-LKGFDVECE-MMKSIRHRNLIKVIST 237
           IGRG +GSV K      G  +AVK           K   ++ + +M+S     +++    
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89

Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLN------IMIDVASALEYLHFGYS 291
              E    + +E M   S +K+         +   +       I +    AL +L     
Sbjct: 90  LFREGDCWICMELMS-TSFDKFY--KYVYSVLDDVIPEEILGKITLATVKALNHLKENLK 146

Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE----YG 347
             IIH D+KPSN+LLD +    L DF I+  L     S+ +T+      YMAPE      
Sbjct: 147 --IIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDAGCRPYMAPERIDPSA 201

Query: 348 REGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS 407
                    DV+S GI L E  TG+ P  +  +    L   V    P   +        S
Sbjct: 202 SRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP--QLSNSEEREFS 259

Query: 408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK 450
              I+FV               C  +   +R   +E    LLK
Sbjct: 260 PSFINFVNL-------------CLTKDESKRPKYKE----LLK 285

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  105 bits (263), Expect = 2e-25
 Identities = 62/242 (25%), Positives = 100/242 (41%), Gaps = 29/242 (11%)

Query: 153 NMPSIATWRTFSHLELCRATD---GFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ 208
           +M S +  R+   ++L    D    F    L+G G +G VYK R +  G   A+KV ++ 
Sbjct: 1   SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60

Query: 209 CGRALKGFDVECEMMKSI-RHRNLIK------VISTCSNEEFKALVLEYMPHGSL-EKYM 260
            G   +    E  M+K    HRN+          +    ++   LV+E+   GS+ +   
Sbjct: 61  -GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119

Query: 261 YSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA 320
            +    L       I  ++   L +LH      +IH D+K  NVLL +N    L DF ++
Sbjct: 120 NTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176

Query: 321 KLLTGEDQSMTQTQTLATIG---YMAPEYGREGRVSTNG-----DVYSFGIMLMETFTGK 372
             L    +++ +  T   IG   +MAPE                D++S GI  +E   G 
Sbjct: 177 AQLD---RTVGRRNTF--IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231

Query: 373 KP 374
            P
Sbjct: 232 PP 233

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  104 bits (262), Expect = 2e-25
 Identities = 67/299 (22%), Positives = 115/299 (38%), Gaps = 47/299 (15%)

Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCGRALKGFDVECEMMKSIRHRN 230
           D +    +IG G    V  A       +VA+K  NL +C  ++     E + M    H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 231 LIKVISTCSNEEFKALVLEYMPHGSL-------EKYMYSSNYILDIFQRLNIMIDVASAL 283
           ++   ++   ++   LV++ +  GS+              + +LD      I+ +V   L
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIG--- 340
           EYLH       IH D+K  N+LL ++    ++DF ++  L               +G   
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 341 YMAPEYGREGRV-STNGDVYSFGIMLMETFTGKKPTNE------IFNGEMTLKHWVND-- 391
           +MAPE   + R      D++SFGI  +E  TG  P ++      +    +TL+   ND  
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM---LTLQ---NDPP 245

Query: 392 WLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK 450
            L     +        +     ++              C  + PE+R  A E    LL+
Sbjct: 246 SLETGVQDKEMLKKYGKSFRKMISL-------------CLQKDPEKRPTAAE----LLR 287

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  105 bits (263), Expect = 3e-25
 Identities = 43/209 (20%), Positives = 82/209 (39%), Gaps = 30/209 (14%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRALKGFDVECEMMKSIRHRNLIKVI 235
            +G+GGF   ++          A K+     L      +   +E  + +S+ H++++   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
               + +F  +VLE     SL +       + +   R   +  +    +YLH      +I
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVI 163

Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI-G---YMAPE------ 345
           H DLK  N+ L++++   + DF +A  +          +    + G   Y+APE      
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKV------EYDGERKKVLCGTPNYIAPEVLSKKG 217

Query: 346 YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           +  E       DV+S G ++     GK P
Sbjct: 218 HSFE------VDVWSIGCIMYTLLVGKPP 240

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  106 bits (265), Expect = 3e-25
 Identities = 44/207 (21%), Positives = 82/207 (39%), Gaps = 16/207 (7%)

Query: 181 IGRG--GFGSVYKAR-LGDGMEVAVKVFNL--QCGRALKGFDVECEMMKSIRHRNLIKVI 235
           IG+G     +V  AR    G  V V+  NL       +     E  + K   H N++   
Sbjct: 33  IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92

Query: 236 STCSNEEFKALVLEYMPHGSLEKYM-YSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI 294
           +T   +    +V  +M +GS +  +       ++      I+  V  AL+Y+H       
Sbjct: 93  ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGY 149

Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLL--TGEDQSMTQTQTLATIG---YMAPEYGRE 349
           +H  +K S++L+  +   +LS       +   G+ Q +       ++    +++PE  ++
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209

Query: 350 GRVSTNG--DVYSFGIMLMETFTGKKP 374
                +   D+YS GI   E   G  P
Sbjct: 210 NLQGYDAKSDIYSVGITACELANGHVP 236

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  102 bits (257), Expect = 8e-25
 Identities = 52/236 (22%), Positives = 97/236 (41%), Gaps = 47/236 (19%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRALKGFDVECEMMKSIRHRNLIKVI 235
            +G+G FG+VY AR   +   +A+KV     L+          E E+   +RH N++++ 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLN------IMIDVASALEYLHFG 289
           +   + +   L+LE+ P G L K +           R +       M ++A AL Y H  
Sbjct: 81  NYFHDRKRIYLMLEFAPRGELYKELQKH-------GRFDEQRSATFMEELADALHYCH-- 131

Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-ATIGYMAPE--- 345
               +IH D+KP N+L+       ++DF  +           + +T+  T+ Y+ PE   
Sbjct: 132 -ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-----RRRTMCGTLDYLPPEMIE 185

Query: 346 ---YGREGRVSTNGDVYSFGIMLMETFTGKKPTNE---------IFNGEMTLKHWV 389
              +  +       D++  G++  E   G  P +          I N ++    ++
Sbjct: 186 GKTHDEK------VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFL 235

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  102 bits (257), Expect = 9e-25
 Identities = 65/283 (22%), Positives = 113/283 (39%), Gaps = 44/283 (15%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRA-LKGFDVECEM-MKSIRHRNLIKVIST 237
           +GRG +G V K R +  G  +AVK           K   ++ ++ M+++     +     
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLN------IMIDVASALEYLHFGYS 291
              E    + +E M   SL+K+      ++D  Q +       I + +  ALE+LH   S
Sbjct: 75  LFREGDVWICMELMD-TSLDKFY---KQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 130

Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE----YG 347
             +IH D+KPSNVL++      + DF I+  L      + +        YMAPE      
Sbjct: 131 --VIHRDVKPSNVLINALGQVKMCDFGISGYLV---DDVAKDIDAGCKPYMAPERINPEL 185

Query: 348 REGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS 407
            +   S   D++S GI ++E    + P +        LK  V +  P        A+  S
Sbjct: 186 NQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP-----ADKFS 240

Query: 408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK 450
            E + F ++             C  ++ ++R    E    L++
Sbjct: 241 AEFVDFTSQ-------------CLKKNSKERPTYPE----LMQ 266

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  104 bits (260), Expect = 3e-24
 Identities = 56/264 (21%), Positives = 98/264 (37%), Gaps = 48/264 (18%)

Query: 142 RQKGKRPSNDANMPSIATWRTFSHLELCRATDGFSEN----NLIGRGGFGSVYKAR-LGD 196
                  S   N+      +    + +       SE       +G G +G V   R    
Sbjct: 2   HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61

Query: 197 GMEVAVKVFNLQCGRALKGFDV-----ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 251
            +E A+K+       ++          E  ++K + H N++K+     ++    LV+E  
Sbjct: 62  HVERAIKIIRK---TSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECY 118

Query: 252 PHGSL-----EKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL 306
             G L      +  ++      I +       V S + YLH      I+H DLKP N+LL
Sbjct: 119 KGGELFDEIIHRMKFNEVDAAVIIK------QVLSGVTYLH---KHNIVHRDLKPENLLL 169

Query: 307 ---DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE-----YGREGRVSTNGDV 358
              + + +  + DF ++ +     + M   + L T  Y+APE     Y  +       DV
Sbjct: 170 ESKEKDALIKIVDFGLSAVF-ENQKKM--KERLGTAYYIAPEVLRKKYDEK------CDV 220

Query: 359 YSFGIMLMETFTGKKPTNEIFNGE 382
           +S G++L     G  P    F G+
Sbjct: 221 WSIGVILFILLAGYPP----FGGQ 240

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  101 bits (253), Expect = 5e-24
 Identities = 52/202 (25%), Positives = 83/202 (41%), Gaps = 14/202 (6%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRA-LKGFDVECE-MMKSIRHRNLIKVIST 237
           +G G  G V+K R    G  +AVK       +   K   ++ + ++KS     +++   T
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92

Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
                   + +E M     EK        +       + + +  AL YL   +   +IH 
Sbjct: 93  FITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHR 149

Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE-----YGREGRV 352
           D+KPSN+LLD+     L DF I+  L        + ++     YMAPE        +   
Sbjct: 150 DVKPSNILLDERGQIKLCDFGISGRLV---DDKAKDRSAGCAAYMAPERIDPPDPTKPDY 206

Query: 353 STNGDVYSFGIMLMETFTGKKP 374
               DV+S GI L+E  TG+ P
Sbjct: 207 DIRADVWSLGISLVELATGQFP 228

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  103 bits (258), Expect = 5e-24
 Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 50/210 (23%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-----ECEMMKSIRHRNLIKV 234
           +G+G F  V +   +  G E A  + N    + L   D      E  + + ++H N++++
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINT---KKLSARDHQKLEREARICRLLKHPNIVRL 75

Query: 235 ISTCSNEEFKALVLEYMPHGSL-----EKYMYS----SNYILDIFQRLNIMIDVASALEY 285
             + S E    L+ + +  G L      +  YS    S+ I  I            A+ +
Sbjct: 76  HDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL----------EAVLH 125

Query: 286 LHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGY 341
            H      ++H +LKP N+LL          L+DF +A  + GE Q+       A T GY
Sbjct: 126 CH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF---GFAGTPGY 179

Query: 342 MAPE------YGREGRVSTNGDVYSFGIML 365
           ++PE      YG+        D+++ G++L
Sbjct: 180 LSPEVLRKDPYGKP------VDLWACGVIL 203

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  101 bits (254), Expect = 5e-24
 Identities = 59/210 (28%), Positives = 88/210 (41%), Gaps = 23/210 (10%)

Query: 175 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFD---VECEMMKSIRHRN 230
           FS+   IG G FG+VY AR + +   VA+K  +    ++ + +     E   ++ +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY 290
            I+       E    LV+EY   GS    +      L   +   +       L YLH   
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH--- 171

Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIG---YMAPE-- 345
           S  +IH D+K  N+LL +  +  L DF  A         M    +   +G   +MAPE  
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSA-------SIMAPANSF--VGTPYWMAPEVI 222

Query: 346 -YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
               EG+     DV+S GI  +E    K P
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  100 bits (250), Expect = 8e-24
 Identities = 59/228 (25%), Positives = 95/228 (41%), Gaps = 50/228 (21%)

Query: 170 RATDGFSEN----NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV------ 218
            +T GF EN     ++GRG    V +        E AVK+ ++  G +    +V      
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 219 ---ECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMPHGSL-----EKYMYSSNYILDI 269
              E ++++ +  H N+I++  T     F  LV + M  G L     EK   S      I
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 129

Query: 270 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS 329
            +       +   +  LH      I+H DLKP N+LLDD+M   L+DF  +  L    + 
Sbjct: 130 MR------ALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEK 179

Query: 330 MTQTQTLATIGYMAPE------------YGREGRVSTNGDVYSFGIML 365
           +   +   T  Y+APE            YG+E       D++S G+++
Sbjct: 180 L--REVCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIM 219

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  100 bits (251), Expect = 1e-23
 Identities = 51/213 (23%), Positives = 86/213 (40%), Gaps = 49/213 (23%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-----ECEMMKSIRHRNLIKV 234
           IG+G F  V +      G + AVK+ ++    +  G        E  +   ++H +++++
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 235 ISTCSNEEFKALVLEYMPHGSL---------EKYMYS----SNYILDIFQRLNIMIDVAS 281
           + T S++    +V E+M    L           ++YS    S+Y+  I            
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL----------E 141

Query: 282 ALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT 338
           AL Y H      IIH D+KP  VLL   +++    L  F +A  L            + T
Sbjct: 142 ALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGRVGT 196

Query: 339 IGYMAPE------YGREGRVSTNGDVYSFGIML 365
             +MAPE      YG+        DV+  G++L
Sbjct: 197 PHFMAPEVVKREPYGKP------VDVWGCGVIL 223

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  100 bits (252), Expect = 3e-23
 Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 39/219 (17%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRALKGFDVECEMMKSIRHRNLIKVIS 236
           +G+G FG V   +    G E AVKV +   ++     +    E +++K + H N++K+  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 237 TCSNEEFKALVLEYMPHGSL-----EKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
              ++ +  LV E    G L      +  +S      I ++      V S + Y+H    
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ------VLSGITYMH---K 144

Query: 292 APIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE--- 345
             I+H DLKP N+LL     +    + DF ++       + M     + T  Y+APE   
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-ASKKM--KDKIGTAYYIAPEVLH 201

Query: 346 --YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
             Y  +       DV+S G++L    +G  P    FNG 
Sbjct: 202 GTYDEK------CDVWSTGVILYILLSGCPP----FNGA 230

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  100 bits (251), Expect = 6e-23
 Identities = 57/221 (25%), Positives = 93/221 (42%), Gaps = 44/221 (19%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-----ECEMMKSIRHRNLIKV 234
           +G+G FG V K +      E AVKV N     + K  D      E E++K + H N++K+
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINK---ASAKNKDTSTILREVELLKKLDHPNIMKL 86

Query: 235 ISTCSNEEFKALVLEYMPHGSL-----EKYMYSSNYILDIFQRLNIMIDVASALEYLHFG 289
                +     +V E    G L     ++  +S +          I+  V S + Y+H  
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR------IIKQVFSGITYMH-- 138

Query: 290 YSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE- 345
               I+H DLKP N+LL   + +    + DF ++     ++  M     + T  Y+APE 
Sbjct: 139 -KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKM--KDRIGTAYYIAPEV 194

Query: 346 ----YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
               Y  +       DV+S G++L    +G  P    F G+
Sbjct: 195 LRGTYDEK------CDVWSAGVILYILLSGTPP----FYGK 225

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 98.5 bits (246), Expect = 8e-23
 Identities = 49/209 (23%), Positives = 87/209 (41%), Gaps = 49/209 (23%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-----ECEMMKSIRHRNLIKV 234
           +G+G F  V +      G+E A K+ N    + L   D      E  + + ++H N++++
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINT---KKLSARDFQKLEREARICRKLQHPNIVRL 93

Query: 235 ISTCSNEEFKALVLEYMPHGSL-----EKYMYS----SNYILDIFQRLNIMIDVASALEY 285
             +   E F  LV + +  G L      +  YS    S+ I  I            ++ Y
Sbjct: 94  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----------ESIAY 143

Query: 286 LHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
            H   S  I+H +LKP N+LL          L+DF +A  +  + ++        T GY+
Sbjct: 144 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAW--HGFAGTPGYL 197

Query: 343 APE------YGREGRVSTNGDVYSFGIML 365
           +PE      Y +        D+++ G++L
Sbjct: 198 SPEVLKKDPYSKP------VDIWACGVIL 220

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 96.9 bits (242), Expect = 1e-22
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 40/204 (19%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-----ECEMMKSIRHRNLIKV 234
           +G+G FG V K +      E AVKV N     + K  D      E E++K + H N++K+
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINK---ASAKNKDTSTILREVELLKKLDHPNIMKL 86

Query: 235 ISTCSNEEFKALVLEYMPHGSL-----EKYMYSSNYILDIFQRLNIMIDVASALEYLHFG 289
                +     +V E    G L     ++  +S +    I +       V S + Y+H  
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK------QVFSGITYMH-- 138

Query: 290 YSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE- 345
               I+H DLKP N+LL   + +    + DF ++     ++  M     + T  Y+APE 
Sbjct: 139 -KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKM--KDRIGTAYYIAPEV 194

Query: 346 ----YGREGRVSTNGDVYSFGIML 365
               Y  +       DV+S G++L
Sbjct: 195 LRGTYDEK------CDVWSAGVIL 212

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 97.7 bits (244), Expect = 1e-22
 Identities = 49/228 (21%), Positives = 88/228 (38%), Gaps = 58/228 (25%)

Query: 167 ELCRATDGFSEN----NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECE 221
           +L R +  F++       IG G +    +       ME AVK+ +          + E E
Sbjct: 12  QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK---SKRDPTE-EIE 67

Query: 222 -MMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL------- 273
            +++  +H N+I +     + ++  +V E M  G L               ++       
Sbjct: 68  ILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL-------------LDKILRQKFFS 114

Query: 274 -----NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL----DDNMVAHLSDFSIAKLLT 324
                 ++  +   +EYLH   +  ++H DLKPSN+L      +     + DF  AK L 
Sbjct: 115 EREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171

Query: 325 GEDQSMTQTQTLA-TIGYMAPE------YGREGRVSTNGDVYSFGIML 365
            E+  +    T   T  ++APE      Y          D++S G++L
Sbjct: 172 AENGLLM---TPCYTANFVAPEVLERQGYDAA--C----DIWSLGVLL 210

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 96.9 bits (242), Expect = 1e-22
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 44/206 (21%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTC 238
           ++G G F  V+  +    G   A+K             + E  ++K I+H N++ +    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 239 SNEEFKALVLEYMPHGSL-----EKYMYS----SNYILDIFQRLNIMIDVASALEYLHFG 289
            +     LV++ +  G L     E+ +Y+    S  I  +           SA++YLH  
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVL----------SAVKYLH-- 123

Query: 290 YSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPE 345
               I+H DLKP N+L    ++N    ++DF ++K+   ++  M+   T   T GY+APE
Sbjct: 124 -ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMS---TACGTPGYVAPE 177

Query: 346 ------YGREGRVSTNGDVYSFGIML 365
                 Y +        D +S G++ 
Sbjct: 178 VLAQKPYSKA------VDCWSIGVIT 197

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 96.1 bits (240), Expect = 2e-22
 Identities = 49/209 (23%), Positives = 87/209 (41%), Gaps = 49/209 (23%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-----ECEMMKSIRHRNLIKV 234
           +G+G F  V +      G+E A K+ N    + L   D      E  + + ++H N++++
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINT---KKLSARDFQKLEREARICRKLQHPNIVRL 70

Query: 235 ISTCSNEEFKALVLEYMPHGSL-----EKYMYS----SNYILDIFQRLNIMIDVASALEY 285
             +   E F  LV + +  G L      +  YS    S+ I  I            ++ Y
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----------ESIAY 120

Query: 286 LHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
            H   S  I+H +LKP N+LL          L+DF +A  +  + ++        T GY+
Sbjct: 121 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAW--HGFAGTPGYL 174

Query: 343 APE------YGREGRVSTNGDVYSFGIML 365
           +PE      Y +        D+++ G++L
Sbjct: 175 SPEVLKKDPYSKP------VDIWACGVIL 197

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 97.1 bits (242), Expect = 3e-22
 Identities = 48/236 (20%), Positives = 86/236 (36%), Gaps = 25/236 (10%)

Query: 143 QKGKRPSNDANMPSIATWRTFSHLELCRATDGFSEN----NLIGRGGFGSVYKAR-LGDG 197
           +      ND +      W+ +    +        +       +G G FG V++      G
Sbjct: 17  KYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATG 76

Query: 198 MEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL- 256
                K  N            E  +M  + H  LI +     ++    L+LE++  G L 
Sbjct: 77  RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF 136

Query: 257 -----EKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV 311
                E Y  S   +      +N M      L+++H      I+H D+KP N++ +    
Sbjct: 137 DRIAAEDYKMSEAEV------INYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKA 187

Query: 312 AHL--SDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 365
           + +   DF +A  L   D+ +    T AT  + APE      V    D+++ G++ 
Sbjct: 188 SSVKIIDFGLATKL-NPDEIV--KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 96.2 bits (240), Expect = 3e-22
 Identities = 49/208 (23%), Positives = 81/208 (38%), Gaps = 50/208 (24%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIR-HRNLIKVISTC 238
           +G G F    K          AVK+ +    R       E   +K    H N++K+    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVF 75

Query: 239 SNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL------------NIMIDVASALEYL 286
            ++    LV+E +  G L             F+R+             IM  + SA+ ++
Sbjct: 76  HDQLHTFLVMELLNGGEL-------------FERIKKKKHFSETEASYIMRKLVSAVSHM 122

Query: 287 HFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           H      ++H DLKP N+L    +DN+   + DF  A+L   ++Q +       T+ Y A
Sbjct: 123 H---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCFTLHYAA 177

Query: 344 PE------YGREGRVSTNGDVYSFGIML 365
           PE      Y          D++S G++L
Sbjct: 178 PELLNQNGYDES------CDLWSLGVIL 199

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 95.7 bits (239), Expect = 4e-22
 Identities = 64/276 (23%), Positives = 107/276 (38%), Gaps = 45/276 (16%)

Query: 169 CRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDV----ECEMMK 224
               + + +   +G G +G VYKA+   G  VA+K   L      +G       E  ++K
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAED--EGIPSTAIREISLLK 74

Query: 225 SIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALE 284
            + H N++ +I    +E    LV E+M    L+K +  +   L   Q    +  +   + 
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133

Query: 285 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
           + H      I+H DLKP N+L++ +    L+DF +A+      +S   T  + T+ Y AP
Sbjct: 134 HCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAP 188

Query: 345 E--YGREGRVSTNGDVYSFGIMLMETFTGK--------------------KPTNEIFNGE 382
           +   G + + ST+ D++S G +  E  TGK                     P    +   
Sbjct: 189 DVLMGSK-KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247

Query: 383 MTLKHWVNDWLP----------ISTMEVVGANLLSQ 408
             L  W                I      G +LLS 
Sbjct: 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSN 283

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 95.0 bits (237), Expect = 5e-22
 Identities = 58/240 (24%), Positives = 97/240 (40%), Gaps = 53/240 (22%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFN--------------------LQCGRALKGFDV 218
            IG+G +G V  A    D    A+KV +                       G  ++    
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 219 ------ECEMMKSIRHRNLIK---VISTCSNEEFKALVLEYMPHGSLEKYM----YSSNY 265
                 E  ++K + H N++K   V+   + +    +V E +  G + +       S + 
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLKPLSEDQ 138

Query: 266 ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG 325
               FQ      D+   +EYLH      IIH D+KPSN+L+ ++    ++DF ++    G
Sbjct: 139 ARFYFQ------DLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189

Query: 326 EDQSMTQTQTLATIGYMAPEYGREGRVSTNG---DVYSFGIMLMETFTGKKPTNEIFNGE 382
            D ++    T+ T  +MAPE   E R   +G   DV++ G+ L     G+ P    F  E
Sbjct: 190 SD-ALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP----FMDE 243

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 94.5 bits (236), Expect = 6e-22
 Identities = 53/209 (25%), Positives = 99/209 (47%), Gaps = 19/209 (9%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV----ECEMMKSIRHRNLIKVI 235
           IG G +G+V+KA+       VA+K   L      +G       E  ++K ++H+N++++ 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDD--EGVPSSALREICLLKELKHKNIVRLH 67

Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
               +++   LV E+     L+KY  S N  LD     + +  +   L + H   S  ++
Sbjct: 68  DVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVL 123

Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE--YGREGRVS 353
           H DLKP N+L++ N    L++F +A+      +    +  + T+ Y  P+  +G +   S
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAK-LYS 180

Query: 354 TNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
           T+ D++S G +  E     +P   +F G 
Sbjct: 181 TSIDMWSAGCIFAELANAGRP---LFPGN 206

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 95.0 bits (237), Expect = 7e-22
 Identities = 60/231 (25%), Positives = 89/231 (38%), Gaps = 52/231 (22%)

Query: 171 ATDGFSEN---------NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVEC 220
           +TD FS           +++G G    V     L    E AVK+   Q G        E 
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61

Query: 221 EMMKSIR-HRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL------ 273
           EM+   + HRN++++I     E+   LV E M  GS+                +      
Sbjct: 62  EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI-------------LSHIHKRRHF 108

Query: 274 ------NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLT 324
                  ++ DVASAL++LH   +  I H DLKP N+L    +      + DF +   + 
Sbjct: 109 NELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165

Query: 325 -GEDQSMTQTQTLATI----GYMAPEYGREGRVSTNG-----DVYSFGIML 365
              D S   T  L T      YMAPE         +      D++S G++L
Sbjct: 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 93.8 bits (234), Expect = 8e-22
 Identities = 55/199 (27%), Positives = 81/199 (40%), Gaps = 32/199 (16%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS 239
           IGRG +G V  A   G  +  A K         +  F  E E+MKS+ H N+I++  T  
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76

Query: 240 NEEFKALVLEYMPHGSL-----EKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI 294
           +     LV+E    G L      K ++  +    I +      DV SA+ Y H      +
Sbjct: 77  DNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK------DVLSAVAYCH---KLNV 127

Query: 295 IHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE-----Y 346
            H DLKP N L      +    L DF +A       + M     + T  Y++P+     Y
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-KPGKMM--RTKVGTPYYVSPQVLEGLY 184

Query: 347 GREGRVSTNGDVYSFGIML 365
           G E       D +S G+M+
Sbjct: 185 GPE------CDEWSAGVMM 197

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 94.0 bits (234), Expect = 9e-22
 Identities = 29/201 (14%), Positives = 57/201 (28%), Gaps = 43/201 (21%)

Query: 180 LIGRGGFGSVYKA---RLGDGMEVAVKVFNLQCGRA---LKGFDVECEMMKSIRHRNLIK 233
             G       ++A    L    +VA+   + Q       L+        +  I    + +
Sbjct: 38  FHGGVPPLQFWQALDTALDR--QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
           V+          +V E++  GSL++   +S         +  M  +A+A +  H    A 
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAG 149

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVS 353
           +      PS V +  +    L+                          M     ++    
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPDANPQD---- 183

Query: 354 TNGDVYSFGIMLMETFTGKKP 374
              D+   G  L      + P
Sbjct: 184 ---DIRGIGASLYALLVNRWP 201

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 96.3 bits (240), Expect = 1e-21
 Identities = 52/231 (22%), Positives = 92/231 (39%), Gaps = 49/231 (21%)

Query: 179 NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-------------ECEMMK 224
             +G G +G V   +      E A+KV         +  D              E  ++K
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 225 SIRHRNLIKVISTCSNEEFKALVLEYMPHGSL-----EKYMYSSNYILDIFQRLNIMIDV 279
           S+ H N+IK+     ++++  LV E+   G L      ++ +      +I ++      +
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ------I 155

Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 336
            S + YLH      I+H D+KP N+LL   +  +   + DF ++     +D  +     L
Sbjct: 156 LSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF-SKDYKL--RDRL 209

Query: 337 ATIGYMAPE-----YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
            T  Y+APE     Y  +       DV+S G+++     G  P    F G+
Sbjct: 210 GTAYYIAPEVLKKKYNEK------CDVWSCGVIMYILLCGYPP----FGGQ 250

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 53/232 (22%), Positives = 85/232 (36%), Gaps = 29/232 (12%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFN----LQCGRALKGFDVECEMMKSIRHRNLIKV 234
           L+G G +G V +          AVK+       +          E ++++ +RH+N+I++
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 235 ISTCSNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
           +    NEE +   +V+EY   G  E           + Q       +   LEYLH   S 
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQ 128

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI----GYMAPE--Y 346
            I+H D+KP N+LL       +S   +A+ L           T  T      +  PE   
Sbjct: 129 GIVHKDIKPGNLLLTTGGTLKISALGVAEAL----HPFAADDTCRTSQGSPAFQPPEIAN 184

Query: 347 GREGRVSTNGDVYSFGIMLMETFTGKKPTNE---------IFNGEMTLKHWV 389
           G +       D++S G+ L    TG  P            I  G   +    
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDC 236

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 60/212 (28%), Positives = 90/212 (42%), Gaps = 47/212 (22%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRALKGFDV-----ECEMMKSIRHRNL 231
           +G G  G V  A       +VA+K+ +      G A +         E E++K + H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 232 IKVISTCSNEEFKALVLEYMPHGSL-----EKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           IK+ +    E++  +VLE M  G L                  F        +  A++YL
Sbjct: 78  IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY------QMLLAVQYL 130

Query: 287 HFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYM 342
           H      IIH DLKP NVLL   +++ +  ++DF  +K+L GE   M    TL  T  Y+
Sbjct: 131 H---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMR---TLCGTPTYL 183

Query: 343 APE---------YGREGRVSTNGDVYSFGIML 365
           APE         Y R   V    D +S G++L
Sbjct: 184 APEVLVSVGTAGYNRA--V----DCWSLGVIL 209

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 95.1 bits (237), Expect = 2e-21
 Identities = 59/212 (27%), Positives = 90/212 (42%), Gaps = 47/212 (22%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRALKGFDV-----ECEMMKSIRHRNL 231
           +G G  G V  A       +VA+++ +      G A +         E E++K + H  +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 232 IKVISTCSNEEFKALVLEYMPHGSL-----EKYMYSSNYILDIFQRLNIMIDVASALEYL 286
           IK+ +    E++  +VLE M  G L                  F        +  A++YL
Sbjct: 203 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY------QMLLAVQYL 255

Query: 287 HFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYM 342
           H      IIH DLKP NVLL   +++ +  ++DF  +K+L GE   M    TL  T  Y+
Sbjct: 256 H---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMR---TLCGTPTYL 308

Query: 343 APE---------YGREGRVSTNGDVYSFGIML 365
           APE         Y R   V    D +S G++L
Sbjct: 309 APEVLVSVGTAGYNRA--V----DCWSLGVIL 334

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 94.0 bits (234), Expect = 3e-21
 Identities = 62/256 (24%), Positives = 99/256 (38%), Gaps = 51/256 (19%)

Query: 142 RQKGKRPSNDANMPSIATWRTFSHLELCRATDGFSEN----NLIGRGGFGSVYKAR-LGD 196
           ++               +      L    A   F +     ++IGRG    V +      
Sbjct: 59  KKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRAT 118

Query: 197 GMEVAVKVFNL--------QCGRALKGFDVECEMMKSIR-HRNLIKVISTCSNEEFKALV 247
           G E AVK+  +        Q     +    E  +++ +  H ++I +I +  +  F  LV
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178

Query: 248 LEYMPHGSL-----EKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPS 302
            + M  G L     EK   S      I +       +  A+ +LH   +  I+H DLKP 
Sbjct: 179 FDLMRKGELFDYLTEKVALSEKETRSIMR------SLLEAVSFLH---ANNIVHRDLKPE 229

Query: 303 NVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPE------------YGRE 349
           N+LLDDNM   LSDF  +  L    + +     L  T GY+APE            YG+E
Sbjct: 230 NILLDDNMQIRLSDFGFSCHL-EPGEKLR---ELCGTPGYLAPEILKCSMDETHPGYGKE 285

Query: 350 GRVSTNGDVYSFGIML 365
                  D+++ G++L
Sbjct: 286 ------VDLWACGVIL 295

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 93.4 bits (233), Expect = 3e-21
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 19/225 (8%)

Query: 166 LELCRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALK-GFDV----E 219
           L++      + + + +G G F +VYKAR       VA+K   L      K G +     E
Sbjct: 3   LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62

Query: 220 CEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV 279
            ++++ + H N+I ++    ++   +LV ++M    LE  +  ++ +L        M+  
Sbjct: 63  IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMT 121

Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
              LEYLH      I+H DLKP+N+LLD+N V  L+DF +AK     +++   T  + T 
Sbjct: 122 LQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTR 176

Query: 340 GYMAPE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
            Y APE  +G         D+++ G +L E      P      G+
Sbjct: 177 WYRAPELLFGAR-MYGVGVDMWAVGCILAELLLR-VP---FLPGD 216

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 93.5 bits (233), Expect = 4e-21
 Identities = 58/265 (21%), Positives = 97/265 (36%), Gaps = 56/265 (21%)

Query: 181 IGRGGFGSVYKARLGDGMEVAVK-------------VFN--LQCGRALKGFDVECEMMKS 225
           I  G +G+V      +G+ VA+K             + +    C R L+    E  ++  
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR----EIRLLNH 85

Query: 226 IRHRNLIK---VISTCSNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVA 280
             H N++    +             LV E M    L + ++    ++        M  + 
Sbjct: 86  FHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHIL 144

Query: 281 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIG 340
             L  LH    A ++H DL P N+LL DN    + DF++A+     D +   T  +    
Sbjct: 145 LGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR-EDTADANK--THYVTHRW 198

Query: 341 YMAPE-------YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWL 393
           Y APE       +      +   D++S G ++ E F  K     +F G      + N   
Sbjct: 199 YRAPELVMQFKGF------TKLVDMWSAGCVMAEMFNRK----ALFRG----STFYNQLN 244

Query: 394 PISTMEVVGANLLSQEDIHFVAKEQ 418
            I  +EVVG      ED+   +   
Sbjct: 245 KI--VEVVGT--PKIEDVVMFSSPS 265

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 93.0 bits (231), Expect = 6e-21
 Identities = 56/253 (22%), Positives = 84/253 (33%), Gaps = 58/253 (22%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-----ECEMMKSIRHRNLIKV 234
           IG+G +G V  A         A+K+ N    R +   DV     E  +MK + H N+ ++
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL--------------------- 273
                +E++  LV+E    G L   +            +                     
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 274 ------------------NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHL- 314
                             NIM  + SAL YLH   +  I H D+KP N L   N    + 
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210

Query: 315 -SDFSIAKLLTGEDQSMTQ--TQTLATIGYMAPE--YGREGRVSTNGDVYSFGIMLMETF 369
             DF ++K     +       T    T  ++APE             D +S G++L    
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270

Query: 370 TGKKPTNEIFNGE 382
            G  P    F G 
Sbjct: 271 MGAVP----FPGV 279

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 91.9 bits (229), Expect = 7e-21
 Identities = 63/299 (21%), Positives = 105/299 (35%), Gaps = 64/299 (21%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV----ECEMMKSIRHRNLIKVI 235
           IG G +G V+K R    G  VA+K F                 E  M+K ++H NL+ ++
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLE--SEDDPVIKKIALREIRMLKQLKHPNLVNLL 68

Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
                +    LV EY  H ++   +      +      +I      A+ + H       I
Sbjct: 69  EVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCI 124

Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE-------YGR 348
           H D+KP N+L+  + V  L DF  A+LLTG          +AT  Y +PE       Y  
Sbjct: 125 HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DDEVATRWYRSPELLVGDTQY-- 180

Query: 349 EGRVSTNGDVYSFGIMLMETFTGK--------------------KPTNEIFNGEMTLKHW 388
                   DV++ G +  E  +G                                T +++
Sbjct: 181 ----GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236

Query: 389 VN----DWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINARE 443
                 D   +  +E+   N +S   +  +  + C      L M+     P +R+   +
Sbjct: 237 SGVKIPDPEDMEPLELKFPN-ISYPALGLL--KGC------LHMD-----PTERLTCEQ 281

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 92.3 bits (230), Expect = 8e-21
 Identities = 64/302 (21%), Positives = 110/302 (36%), Gaps = 46/302 (15%)

Query: 169 CRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV----ECEMM 223
            ++ + +    L+G G +G V K R    G  VA+K F        K        E +++
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLE--SDDDKMVKKIAMREIKLL 78

Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
           K +RH NL+ ++  C  ++   LV E++ H ++   +      LD       +  + + +
Sbjct: 79  KQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGI 137

Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
            + H   S  IIH D+KP N+L+  + V  L DF  A+ L    +       +AT  Y A
Sbjct: 138 GFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--DDEVATRWYRA 192

Query: 344 PE--YGREGRVSTNGDVYSFGIMLMETFTGK--------------------KPTNEIFNG 381
           PE   G + +     DV++ G ++ E F G+                             
Sbjct: 193 PELLVG-DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251

Query: 382 EMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINA 441
                 +    LP             +              V +LA +C    P++R   
Sbjct: 252 FNKNPVFAGVRLPEIKEREPLERRYPKLS----------EVVIDLAKKCLHIDPDKRPFC 301

Query: 442 RE 443
            E
Sbjct: 302 AE 303

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 91.0 bits (227), Expect = 1e-20
 Identities = 49/206 (23%), Positives = 94/206 (45%), Gaps = 15/206 (7%)

Query: 173 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDV----ECEMMKSIRH 228
           + +     IG G +G VYKA+   G   A+K   L+     +G       E  ++K ++H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED--EGIPSTTIREISILKELKH 59

Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
            N++K+      ++   LV E++    L+K +      L+     + ++ + + + Y H 
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH- 117

Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE--Y 346
                ++H DLKP N+L++      ++DF +A+      +    T  + T+ Y AP+   
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAPDVLM 173

Query: 347 GREGRVSTNGDVYSFGIMLMETFTGK 372
           G + + ST  D++S G +  E   G 
Sbjct: 174 GSK-KYSTTIDIWSVGCIFAEMVNGT 198

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 91.5 bits (228), Expect = 1e-20
 Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 19/212 (8%)

Query: 180 LIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVEC-----EMMKSIRHRNLIK 233
           ++G G F +V  AR      E A+K+   +         V       ++M  + H   +K
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN--KVPYVTRERDVMSRLDHPFFVK 94

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
           +  T  ++E     L Y  +G L KY+       +   R     ++ SALEYLH      
Sbjct: 95  LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH---GKG 150

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-ATIGYMAPEYGREGRV 352
           IIH DLKP N+LL+++M   ++DF  AK+L+ E +      +   T  Y++PE   E   
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR-ANSFVGTAQYVSPELLTEKSA 209

Query: 353 STNGDVYSFGIMLMETFTGKKP-----TNEIF 379
             + D+++ G ++ +   G  P        IF
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 241

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 91.1 bits (226), Expect = 2e-20
 Identities = 52/266 (19%), Positives = 95/266 (35%), Gaps = 72/266 (27%)

Query: 181 IGRGGFGSVYKARL------GDGMEVAVKVFNLQ-CGRALKGFDVECEMMKSI-RHRNLI 232
           +GRG FG V +A             VAVK+          +    E +++  I  H N++
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89

Query: 233 KVISTCSNEEFKALV-LEYMPHGSLEKYM----------------------YSSNYILDI 269
            ++  C+      +V +E+   G+L  Y+                      Y     +D+
Sbjct: 90  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 149

Query: 270 FQRLNIMI------------------------------DVASALEYLHFGY--------- 290
            +RL+ +                               D  +    + + +         
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209

Query: 291 -SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 349
            S   IH DL   N+LL +  V  + DF +A+ +  +   + +      + +MAPE   +
Sbjct: 210 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 269

Query: 350 GRVSTNGDVYSFGIMLMETFT-GKKP 374
              +   DV+SFG++L E F+ G  P
Sbjct: 270 RVYTIQSDVWSFGVLLWEIFSLGASP 295

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 90.3 bits (224), Expect = 3e-20
 Identities = 37/171 (21%), Positives = 71/171 (41%), Gaps = 15/171 (8%)

Query: 219 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYI--LDIFQRLNIM 276
           +   M     +N +  +   S + +  + ++     +L+ +M     +   +    L+I 
Sbjct: 111 KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIF 170

Query: 277 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL 336
           I +A A+E+LH   S  ++H DLKPSN+    + V  + DF +   +  +++  T    +
Sbjct: 171 IQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 227

Query: 337 A----------TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNE 377
                      T  YM+PE       S   D++S G++L E         E
Sbjct: 228 PAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME 278

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 47.6 bits (113), Expect = 4e-06
 Identities = 18/96 (18%), Positives = 34/96 (35%), Gaps = 2/96 (2%)

Query: 170 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCGRALKGFDVECEMMKSIR 227
           R    F     +GRGGFG V++A+   D    A+K   L     A +    E + +  + 
Sbjct: 3   RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62

Query: 228 HRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSS 263
           H  +++  +       +    E       ++     
Sbjct: 63  HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWP 98

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 90.9 bits (226), Expect = 3e-20
 Identities = 49/203 (24%), Positives = 87/203 (42%), Gaps = 27/203 (13%)

Query: 175 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV---ECEMMKSIRHRN 230
            S+  ++G G FG V+K      G+++A K+      R +K  +    E  +M  + H N
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIK---TRGMKDKEEVKNEISVMNQLDHAN 147

Query: 231 LIKVISTCSNEEFKALVLEYMPHGSL------EKYMYSSNYILDIFQRLNIMIDVASALE 284
           LI++     ++    LV+EY+  G L      E Y  +    +        M  +   + 
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL------FMKQICEGIR 201

Query: 285 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHL--SDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           ++H  Y   I+H DLKP N+L  +     +   DF +A+      + +       T  ++
Sbjct: 202 HMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRY-KPREKL--KVNFGTPEFL 255

Query: 343 APEYGREGRVSTNGDVYSFGIML 365
           APE      VS   D++S G++ 
Sbjct: 256 APEVVNYDFVSFPTDMWSVGVIA 278

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 90.5 bits (225), Expect = 3e-20
 Identities = 61/248 (24%), Positives = 93/248 (37%), Gaps = 49/248 (19%)

Query: 142 RQKGKRPSNDANMPSIATWRTFSHLELCRATDGFSEN----NLIGRGGFGSVYKAR-LGD 196
                  S  A+           +       D  S+     + +GRG    VY+ +  G 
Sbjct: 18  LYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGT 77

Query: 197 GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 256
               A+KV         K    E  ++  + H N+IK+          +LVLE +  G L
Sbjct: 78  QKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL 135

Query: 257 -----EKYMYS----SNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL- 306
                EK  YS    ++ +  I            A+ YLH      I+H DLKP N+L  
Sbjct: 136 FDRIVEKGYYSERDAADAVKQIL----------EAVAYLH---ENGIVHRDLKPENLLYA 182

Query: 307 --DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPE------YGREGRVSTNGD 357
               +    ++DF ++K++      M    T+  T GY APE      YG E  V    D
Sbjct: 183 TPAPDAPLKIADFGLSKIV-EHQVLMK---TVCGTPGYCAPEILRGCAYGPE--V----D 232

Query: 358 VYSFGIML 365
           ++S GI+ 
Sbjct: 233 MWSVGIIT 240

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 90.0 bits (224), Expect = 4e-20
 Identities = 47/207 (22%), Positives = 94/207 (45%), Gaps = 17/207 (8%)

Query: 173 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDV----ECEMMKSIR 227
           + + + + +G G + +VYK +       VA+K   L+     +G       E  ++K ++
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLE---HEEGAPCTAIREVSLLKDLK 58

Query: 228 HRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLH 287
           H N++ +      E+   LV EY+    L++Y+     I+++      +  +   L Y H
Sbjct: 59  HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117

Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE-- 345
                 ++H DLKP N+L+++     L+DF +A+  +   ++      + T+ Y  P+  
Sbjct: 118 ---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--DNEVVTLWYRPPDIL 172

Query: 346 YGREGRVSTNGDVYSFGIMLMETFTGK 372
            G     ST  D++  G +  E  TG+
Sbjct: 173 LGST-DYSTQIDMWGVGCIFYEMATGR 198

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 90.9 bits (226), Expect = 5e-20
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 44/222 (19%)

Query: 181 IGRGGFGSVYKARLGDGMEVAVK-VFNLQC--GRALKGFDVECEMMKSIRHRNLIK---- 233
           IG G FG V++A+L +  EVA+K V   +    R       E ++M+ ++H N++     
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR-------ELQIMRIVKHPNVVDLKAF 100

Query: 234 VISTCSNEEFKA--LVLEYMPHGSLEKYMYS---SNYILDIFQRLNIMIDVASALEYLHF 288
             S    ++     LVLEY+P  ++ +           + +      M  +  +L Y+H 
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH- 158

Query: 289 GYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE-- 345
             S  I H D+KP N+LLD  + V  L DF  AK+L    +       + +  Y APE  
Sbjct: 159 --SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI-AGEPN--VSYICSRYYRAPELI 213

Query: 346 -----YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
                Y      +TN D++S G ++ E   G +P   +F GE
Sbjct: 214 FGATNY------TTNIDIWSTGCVMAELMQG-QP---LFPGE 245

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 91.8 bits (228), Expect = 5e-20
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 18/212 (8%)

Query: 173 DGFSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFDVECEM-----MKSI 226
           D F +  ++GRGGFG V+  ++    ++ A K   L   R  K    +  M     +  +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKK--LNKKRLKKRKGYQGAMVEKKILAKV 242

Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIF--QRLNIMI-DVASAL 283
             R ++ +      +    LV+  M  G +  ++Y+ +     F   R       + S L
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302

Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYM 342
           E+LH      II+ DLKP NVLLDD+    +SD  +A  L       T+T+  A T G+M
Sbjct: 303 EHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ---TKTKGYAGTPGFM 356

Query: 343 APEYGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           APE         + D ++ G+ L E    + P
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 90.1 bits (224), Expect = 6e-20
 Identities = 65/241 (26%), Positives = 106/241 (43%), Gaps = 65/241 (26%)

Query: 162 TFSHLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFDVEC 220
            F H E+ RA         IG+G FG V   +  D  ++ A+K  N Q  + ++  +V  
Sbjct: 13  NFDHFEILRA---------IGKGSFGKVCIVQKNDTKKMYAMKYMNKQ--KCVERNEVRN 61

Query: 221 -----EMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNI 275
                ++M+ + H  L+ +  +  +EE   +V++ +  G             D+   L  
Sbjct: 62  VFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGG-------------DLRYHLQQ 108

Query: 276 MI------------DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 323
            +            ++  AL+YL    +  IIH D+KP N+LLD++   H++DF+IA +L
Sbjct: 109 NVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165

Query: 324 TGEDQSMTQTQTLA-TIGYMAPE---------YGREGRVSTNGDVYSFGIMLMETFTGKK 373
             E    TQ  T+A T  YMAPE         Y     V    D +S G+   E   G++
Sbjct: 166 PRE----TQITTMAGTKPYMAPEMFSSRKGAGYSFA--V----DWWSLGVTAYELLRGRR 215

Query: 374 P 374
           P
Sbjct: 216 P 216

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 91.6 bits (228), Expect = 7e-20
 Identities = 26/101 (25%), Positives = 40/101 (39%), Gaps = 2/101 (1%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
               + GL +L  L L  N       + F DL  LK ++L  NNL+    +       L+
Sbjct: 528 PIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLK 587

Query: 62  NLNLSFNKLEGEIPR--GGPFRNFSVESFEGNELLCGSPNL 100
           +LNL  N +     +  G  FRN +      N   C   ++
Sbjct: 588 SLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESI 628

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 85.1 bits (211), Expect = 9e-18
 Identities = 24/104 (23%), Positives = 38/104 (36%), Gaps = 6/104 (5%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEK-LSY 59
           +       L  L+ + LG N L       F + +SLK LNL  N ++             
Sbjct: 551 IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRN 610

Query: 60  LENLNLSFNKLEGEIPRGGPFRNFSVES-----FEGNELLCGSP 98
           L  L++ FN  +        F N+  E+        +  LC +P
Sbjct: 611 LTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTP 654

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 84.3 bits (209), Expect = 1e-17
 Identities = 22/84 (26%), Positives = 34/84 (40%), Gaps = 2/84 (2%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
           +         NL  L L  N +Q    + F    +L  L+LS+N LS     +  +L  L
Sbjct: 88  LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENL 147

Query: 61  ENLNLSFNKLEGEIPRGGPFRNFS 84
           + L LS NK++           F+
Sbjct: 148 QELLLSNNKIQALKS--EELDIFA 169

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 83.9 bits (208), Expect = 2e-17
 Identities = 19/76 (25%), Positives = 29/76 (38%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
           + P     L  L+ L L +N L      +F    +L  L+L +N++         K   L
Sbjct: 64  LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNL 123

Query: 61  ENLNLSFNKLEGEIPR 76
             L+LS N L      
Sbjct: 124 ITLDLSHNGLSSTKLG 139

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 83.5 bits (207), Expect = 3e-17
 Identities = 20/84 (23%), Positives = 31/84 (36%), Gaps = 2/84 (2%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
           +          L  L +G+N +    P+    L  LK LNL +N LS     +    + L
Sbjct: 40  LPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNL 99

Query: 61  ENLNLSFNKLEGEIPRGGPFRNFS 84
             L+L  N ++       PF    
Sbjct: 100 TELHLMSNSIQKIKN--NPFVKQK 121

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 79.3 bits (196), Expect = 7e-16
 Identities = 18/85 (21%), Positives = 30/85 (35%), Gaps = 1/85 (1%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIP-DSFGDLISLKFLNLSNNNLSGAIPASLEKLSY 59
           +       L +LE L LG N +   +    +  L ++  + LS N        S   +  
Sbjct: 396 IESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPS 455

Query: 60  LENLNLSFNKLEGEIPRGGPFRNFS 84
           L+ L L    L+       PF+   
Sbjct: 456 LQRLMLRRVALKNVDSSPSPFQPLR 480

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 74.7 bits (184), Expect = 2e-14
 Identities = 21/83 (25%), Positives = 36/83 (43%), Gaps = 4/83 (4%)

Query: 2  IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
          +P ++    N+  L L +N+L+     +F     L  L++  N +S   P   +KL  L+
Sbjct: 19 VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLK 76

Query: 62 NLNLSFNKLEGEIPRGGPFRNFS 84
           LNL  N+L         F   +
Sbjct: 77 VLNLQHNELSQLSD--KTFAFCT 97

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 73.5 bits (181), Expect = 5e-14
 Identities = 24/82 (29%), Positives = 34/82 (41%), Gaps = 8/82 (9%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLS--------GAIPAS 53
            P+    L+NL  L L  N +     D    L  L+ L+L +NNL+        G     
Sbjct: 472 SPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYF 531

Query: 54  LEKLSYLENLNLSFNKLEGEIP 75
           L+ LS+L  LNL  N  +    
Sbjct: 532 LKGLSHLHILNLESNGFDEIPV 553

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 72.3 bits (178), Expect = 1e-13
 Identities = 20/83 (24%), Positives = 29/83 (34%), Gaps = 8/83 (9%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQ--------GPIPDSFGDLISLKFLNLSNNNLSGAIPA 52
           +    + GL+ LE L L +N L         G        L  L  LNL +N        
Sbjct: 495 INDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVE 554

Query: 53  SLEKLSYLENLNLSFNKLEGEIP 75
             + L  L+ ++L  N L     
Sbjct: 555 VFKDLFELKIIDLGLNNLNTLPA 577

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 72.3 bits (178), Expect = 1e-13
 Identities = 21/93 (22%), Positives = 35/93 (37%), Gaps = 9/93 (9%)

Query: 1   VIPTEIGGLKNLEYLFLGYN---------RLQGPIPDSFGDLISLKFLNLSNNNLSGAIP 51
           +    + GL N+ YL L  +          L      SF  L  L+ LN+ +N++ G   
Sbjct: 287 LFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS 346

Query: 52  ASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFS 84
                L  L+ L+LS +           F + +
Sbjct: 347 NMFTGLINLKYLSLSNSFTSLRTLTNETFVSLA 379

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 72.3 bits (178), Expect = 1e-13
 Identities = 16/69 (23%), Positives = 26/69 (37%), Gaps = 1/69 (1%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPAS-LEKLSYLENLNLS 66
               L  L L  N++     D+F  L  L+ L+L  N +   +       L  +  + LS
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLS 438

Query: 67  FNKLEGEIP 75
           +NK      
Sbjct: 439 YNKYLQLTR 447

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 70.8 bits (174), Expect = 3e-13
 Identities = 26/77 (33%), Positives = 32/77 (41%), Gaps = 2/77 (2%)

Query: 1   VIPTEIGGLK--NLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLS 58
              T   GLK  NL  L L YN L     DSF  L  L++  L  NN+      SL  L 
Sbjct: 237 TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLF 296

Query: 59  YLENLNLSFNKLEGEIP 75
            +  LNL  +  +  I 
Sbjct: 297 NVRYLNLKRSFTKQSIS 313

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 24/111 (21%), Positives = 43/111 (38%), Gaps = 13/111 (11%)

Query: 5   EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASL---EKLSYLE 61
           +I    +L+ L L  N+++   P  F  +  L  L L+N  L  ++   L      + + 
Sbjct: 166 DIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIR 225

Query: 62  NLNLSFNKLEGEIP---RGGPFRNFSVESFEGNEL-------LCGSPNLQV 102
           NL+LS ++L         G  + N ++     N L           P L+ 
Sbjct: 226 NLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEY 276

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 59.6 bits (145), Expect = 1e-09
 Identities = 16/65 (24%), Positives = 30/65 (46%), Gaps = 3/65 (4%)

Query: 11 NLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKL 70
          + E     + +L   +PD      ++  LNL++N L     A+  + S L +L++ FN +
Sbjct: 5  SHEVADCSHLKLTQ-VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61

Query: 71 EGEIP 75
              P
Sbjct: 62 SKLEP 66

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 42.3 bits (100), Expect = 3e-04
 Identities = 12/51 (23%), Positives = 23/51 (45%), Gaps = 5/51 (9%)

Query: 34 ISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFS 84
          +S +  + S+  L+  +P  L   + +  LNL+ N+L         F  +S
Sbjct: 4  VSHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPA--ANFTRYS 49

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 89.4 bits (222), Expect = 8e-20
 Identities = 60/241 (24%), Positives = 91/241 (37%), Gaps = 53/241 (21%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFN--------LQCGRALKGFDVECEMMKSIRHRNL 231
           +G G FG V+ A       EV VK                 L    +E  ++  + H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 232 IKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILD-----------IFQRLNIMIDVA 280
           IKV+    N+ F  LV+E    G L+ +     +I             IF++L       
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSG-LDLF----AFIDRHPRLDEPLASYIFRQL------V 140

Query: 281 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIG 340
           SA+ YL       IIH D+K  N+++ ++    L DF  A  L  E   +  T    TI 
Sbjct: 141 SAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYT-FCGTIE 194

Query: 341 YMAPE------Y-GREGRVSTNGDVYSFGIMLMETFTGKKP---TNEIFNGEMTLKHWVN 390
           Y APE      Y G E       +++S G+ L      + P     E     +   + V+
Sbjct: 195 YCAPEVLMGNPYRGPE------LEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVS 248

Query: 391 D 391
            
Sbjct: 249 K 249

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 91.1 bits (226), Expect = 8e-20
 Identities = 47/237 (19%), Positives = 83/237 (35%), Gaps = 25/237 (10%)

Query: 142 RQKGKRPSNDANMPSIATWRTFSHLELCRATDGFSE----NNLIGRGGFGSVYKAR-LGD 196
            +     S++ +      W+ +    +    D   +    +  +G G FG V++      
Sbjct: 122 VRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERAT 181

Query: 197 GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 256
           G   A K          +    E + M  +RH  L+ +     ++    ++ E+M  G L
Sbjct: 182 GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 241

Query: 257 ------EKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM 310
                 E    S +        +  M  V   L ++H       +H DLKP N++     
Sbjct: 242 FEKVADEHNKMSEDEA------VEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKR 292

Query: 311 VAHL--SDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 365
              L   DF +   L    QS+    T  T  + APE      V    D++S G++ 
Sbjct: 293 SNELKLIDFGLTAHLD-PKQSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 88.0 bits (219), Expect = 1e-19
 Identities = 52/201 (25%), Positives = 80/201 (39%), Gaps = 28/201 (13%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCGRALKGFDV-----ECEMMKSIRHRNLIK 233
           +G G F  V K R  G G E A K     +   + +G        E  +++ IRH N+I 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 234 VISTCSNEEFKALVLEYMPHGSL-----EKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
           +     N+    L+LE +  G L     EK   + +           +  +   + YLH 
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ------FLKQILDGVHYLH- 125

Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAH----LSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
             S  I H DLKP N++L D  V +    L DF IA  +              T  ++AP
Sbjct: 126 --SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI-EAGNEF--KNIFGTPEFVAP 180

Query: 345 EYGREGRVSTNGDVYSFGIML 365
           E      +    D++S G++ 
Sbjct: 181 EIVNYEPLGLEADMWSIGVIT 201

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 25/198 (12%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFN-LQCGRALKGFDVECEMMKSIRHRNLIKVISTC 238
           +G G FG V+       G+E  +K  N  +    ++  + E E++KS+ H N+IK+    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89

Query: 239 SNEEFKALVLEYMPHGSLEKYMYSSNYILDIF---QRLNIMIDVASALEYLHFGYSAPII 295
            +     +V+E    G L + + S+              +M  + +AL Y H   S  ++
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVV 146

Query: 296 HCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE-----YG 347
           H DLKP N+L      +    + DF +A+L    D+    T    T  YMAPE       
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELF-KSDEHS--TNAAGTALYMAPEVFKRDVT 203

Query: 348 REGRVSTNGDVYSFGIML 365
            +       D++S G+++
Sbjct: 204 FK------CDIWSAGVVM 215

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 89.2 bits (222), Expect = 1e-19
 Identities = 56/231 (24%), Positives = 103/231 (44%), Gaps = 28/231 (12%)

Query: 169 CRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV----ECEMM 223
           C     + +   IG+G FG V+KAR    G +VA+K   ++     +GF +    E +++
Sbjct: 13  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME--NEKEGFPITALREIKIL 70

Query: 224 KSIRHRNLIKVISTCSNEEFKA--------LVLEYMPHGSLEKYMYSSNYILDIFQRLNI 275
           + ++H N++ +I  C  +            LV ++  H  L   + +      + +   +
Sbjct: 71  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV 129

Query: 276 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ--T 333
           M  + + L Y+H      I+H D+K +NVL+  + V  L+DF +A+  +    S     T
Sbjct: 130 MQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186

Query: 334 QTLATIGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
             + T+ Y  PE   G E       D++  G ++ E +T + P   I  G 
Sbjct: 187 NRVVTLWYRPPELLLG-ERDYGPPIDLWGAGCIMAEMWT-RSP---IMQGN 232

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 58/244 (23%), Positives = 93/244 (38%), Gaps = 47/244 (19%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCGRALKGFDVECEMMKSIRHRNLIK---V 234
            +G G +G V  A        VAVK+ ++ +     +    E  + K + H N++K    
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILD-----------IFQRLNIMIDVASAL 283
                N ++  L LEY   G L       + I              F +L       + +
Sbjct: 74  RRE-GNIQY--LFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQL------MAGV 118

Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
            YLH      I H D+KP N+LLD+     +SDF +A +    ++     +   T+ Y+A
Sbjct: 119 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 344 PE--YGRE--GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVN------DWL 393
           PE    RE         DV+S GI+L     G+ P ++  +       W         W 
Sbjct: 176 PELLKRREFHAEPV---DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 232

Query: 394 PIST 397
            I +
Sbjct: 233 KIDS 236

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 46/201 (22%), Positives = 75/201 (37%), Gaps = 28/201 (13%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCGRALKGFDV-----ECEMMKSIRHRNLIK 233
           +G G F  V K R    G+E A K     Q   + +G        E  +++ + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 234 VISTCSNEEFKALVLEYMPHGSL-----EKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
           +     N     L+LE +  G L     +K   S             +  +   + YLH 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS------FIKQILDGVNYLH- 132

Query: 289 GYSAPIIHCDLKPSNVLL----DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
             +  I H DLKP N++L           L DF +A  +  +           T  ++AP
Sbjct: 133 --TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEF--KNIFGTPEFVAP 187

Query: 345 EYGREGRVSTNGDVYSFGIML 365
           E      +    D++S G++ 
Sbjct: 188 EIVNYEPLGLEADMWSIGVIT 208

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 67/260 (25%), Positives = 110/260 (42%), Gaps = 41/260 (15%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVK----VFN--LQCGRALKGFDVECEMMKSIRHRNLIK 233
           +G G +GSV  A     G+ VAVK     F   +   R  +    E  ++K ++H N+I 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 92

Query: 234 V----ISTCSNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLH 287
           +        S EEF    LV   M    L   +       D  Q   ++  +   L+Y+H
Sbjct: 93  LLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQ--FLIYQILRGLKYIH 149

Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE-Y 346
              SA IIH DLKPSN+ ++++    + DF +A+        M  T  +AT  Y APE  
Sbjct: 150 ---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEM--TGYVATRWYRAPEIM 201

Query: 347 GREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL 406
                 +   D++S G ++ E  TG+     +F G       ++    I  + +VG    
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGR----TLFPG----TDHIDQLKLI--LRLVGT--P 249

Query: 407 SQEDIHFVAKEQCVSCVFNL 426
             E +  ++ E   + + +L
Sbjct: 250 GAELLKKISSESARNYIQSL 269

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 66/334 (19%), Positives = 116/334 (34%), Gaps = 59/334 (17%)

Query: 145 GKRPSNDANMPSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVK 203
                            + S      + D +     +G G +G VYKA        VA+K
Sbjct: 6   HHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK 65

Query: 204 VFNLQCGRALKGFDV----ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKY 259
              L      +G       E  ++K ++HRN+I++ S   +     L+ EY  +  L+KY
Sbjct: 66  RIRL--EHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKY 122

Query: 260 MYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH-----L 314
           M   N  + +    + +  + + + + H   S   +H DLKP N+LL  +  +      +
Sbjct: 123 M-DKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKI 178

Query: 315 SDFSIAKLLTGEDQSMTQTQTLATIGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTGK 372
            DF +A+      +    T  + T+ Y  PE   G     ST+ D++S   +  E     
Sbjct: 179 GDFGLARAFGIPIRQF--THEIITLWYRPPEILLGSR-HYSTSVDIWSIACIWAEMLMKT 235

Query: 373 --------------------KPTNEIFNGEMTLKHWVND---WLPISTMEVVGANLLSQE 409
                                P +  + G   L  W      +   +   V+   LL  E
Sbjct: 236 PLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVL-GALLDDE 294

Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINARE 443
            +             +L        P +RI+A+ 
Sbjct: 295 GL-------------DLLTAMLEMDPVKRISAKN 315

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 88.2 bits (219), Expect = 3e-19
 Identities = 45/204 (22%), Positives = 73/204 (35%), Gaps = 34/204 (16%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV---------ECEMMKSIRHRN 230
           +G G F  V K R    G+E A K       R  +             E  +++ + H N
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIK---KRQSRASRRGVCREEIEREVSILRQVLHPN 76

Query: 231 LIKVISTCSNEEFKALVLEYMPHGSL-----EKYMYSSNYILDIFQRLNIMIDVASALEY 285
           +I +     N     L+LE +  G L     +K   S             +  +   + Y
Sbjct: 77  IITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS------FIKQILDGVNY 130

Query: 286 LHFGYSAPIIHCDLKPSNVLL----DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGY 341
           LH   +  I H DLKP N++L           L DF +A  +  +           T  +
Sbjct: 131 LH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEF--KNIFGTPEF 184

Query: 342 MAPEYGREGRVSTNGDVYSFGIML 365
           +APE      +    D++S G++ 
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVIT 208

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 89.3 bits (222), Expect = 3e-19
 Identities = 24/97 (24%), Positives = 43/97 (44%), Gaps = 2/97 (2%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
            +P     L+NL +L L   +L+   P +F  L SL+ LN+S+NN         + L+ L
Sbjct: 461 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL 520

Query: 61  ENLNLSFNKLEGEIPR--GGPFRNFSVESFEGNELLC 95
           + L+ S N +     +       + +  +   N+  C
Sbjct: 521 QVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 87.0 bits (216), Expect = 2e-18
 Identities = 20/84 (23%), Positives = 33/84 (39%), Gaps = 1/84 (1%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
           +       L +L  L L  N +Q     +F  L SL+ L     NL+      +  L  L
Sbjct: 67  IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126

Query: 61  ENLNLSFNKLEGEIPRGGPFRNFS 84
           + LN++ N ++        F N +
Sbjct: 127 KELNVAHNLIQS-FKLPEYFSNLT 149

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 84.7 bits (210), Expect = 1e-17
 Identities = 15/82 (18%), Positives = 25/82 (30%), Gaps = 2/82 (2%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
           +          L+ L L    +Q     ++  L  L  L L+ N +      +   LS L
Sbjct: 43  LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSL 102

Query: 61  ENLNLSFNKLEGEIPRGGPFRN 82
           + L      L        P  +
Sbjct: 103 QKLVAVETNLASLEN--FPIGH 122

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 80.1 bits (198), Expect = 4e-16
 Identities = 20/78 (25%), Positives = 33/78 (42%), Gaps = 2/78 (2%)

Query: 1   VIPTEI-GGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAI-PASLEKLS 58
           +    +   L+NL YL + +   +      F  L SL+ L ++ N+      P    +L 
Sbjct: 411 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 470

Query: 59  YLENLNLSFNKLEGEIPR 76
            L  L+LS  +LE   P 
Sbjct: 471 NLTFLDLSQCQLEQLSPT 488

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 78.9 bits (195), Expect = 8e-16
 Identities = 29/132 (21%), Positives = 48/132 (36%), Gaps = 9/132 (6%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQG-PIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSY 59
           +    IG LK L+ L + +N +Q   +P+ F +L +L+ L+LS+N +       L  L  
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174

Query: 60  LEN----LNLSFNKLEGEIPRGGPFRNFSVESFE--GNELLCGSPNLQVPPCKTSNHHTL 113
           +      L+LS N +    P  G F+   +       N          +        H L
Sbjct: 175 MPLLNLSLDLSLNPMNFIQP--GAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRL 232

Query: 114 WKNSLLLRIVLP 125
                     L 
Sbjct: 233 VLGEFRNEGNLE 244

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 78.5 bits (194), Expect = 1e-15
 Identities = 21/83 (25%), Positives = 35/83 (42%), Gaps = 4/83 (4%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           IP  +    + + L L +N L+     SF     L+ L+LS   +      + + LS+L 
Sbjct: 22  IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79

Query: 62  NLNLSFNKLEGEIPRGGPFRNFS 84
            L L+ N ++      G F   S
Sbjct: 80  TLILTGNPIQSLAL--GAFSGLS 100

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 75.5 bits (186), Expect = 1e-14
 Identities = 17/77 (22%), Positives = 29/77 (37%), Gaps = 2/77 (2%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPAS-LEKLSY 59
                  G  +L+YL L +N +   +  +F  L  L+ L+  ++NL      S    L  
Sbjct: 364 CCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422

Query: 60  LENLNLSFNKLEGEIPR 76
           L  L++S          
Sbjct: 423 LIYLDISHTHTRVAFNG 439

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 64.3 bits (157), Expect = 3e-11
 Identities = 17/91 (18%), Positives = 30/91 (32%), Gaps = 5/91 (5%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLI-SLKFLNLSNNNLSGAIPAS--LEKL 57
           +       L +L+ L    N +             SL FLNL+ N+ +        L+ +
Sbjct: 509 LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWI 568

Query: 58  SYLENLNLSFNKLEGEIPRGGPFRNFSVESF 88
                L +   ++E   P     +   V S 
Sbjct: 569 KDQRQLLVEVERMECATP--SDKQGMPVLSL 597

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 28/109 (25%), Positives = 39/109 (35%), Gaps = 10/109 (9%)

Query: 4   TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLS--GAIPASLEKLSYLE 61
            +   LK      L +   +G    S  DL SL+FL+LS N LS  G    S    + L+
Sbjct: 317 GQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK 376

Query: 62  NLNLSFNKLEGEIPRGGPFRNFSVESFEGNEL--------LCGSPNLQV 102
            L+LSFN +                 F+ + L             NL  
Sbjct: 377 YLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 53.9 bits (130), Expect = 7e-08
 Identities = 12/73 (16%), Positives = 20/73 (27%), Gaps = 2/73 (2%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           I      L N+    L    ++     S+      + L L N          L+ L  L 
Sbjct: 274 IIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKFGQFPTLKLKSLKRLT 331

Query: 62  NLNLSFNKLEGEI 74
             +        E+
Sbjct: 332 FTSNKGGNAFSEV 344

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 53.9 bits (130), Expect = 7e-08
 Identities = 18/106 (16%), Positives = 32/106 (30%), Gaps = 4/106 (3%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRL---QGPIPDSFGDLISLKFLNLSNNNLSGAIPAS-LEK 56
              + + GL NL         L      I D F  L ++   +L +  +      S    
Sbjct: 246 FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFG 305

Query: 57  LSYLENLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQV 102
             +LE +N  F +      +      F+             P+L+ 
Sbjct: 306 WQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEF 351

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 48.1 bits (115), Expect = 4e-06
 Identities = 15/77 (19%), Positives = 20/77 (25%), Gaps = 7/77 (9%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIP-DSFGDLISLKFLNLSNN------NLSGAIPASL 54
           I         L  L L  N     +       L  L+   L         NL     ++L
Sbjct: 192 IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSAL 251

Query: 55  EKLSYLENLNLSFNKLE 71
           E L  L         L+
Sbjct: 252 EGLCNLTIEEFRLAYLD 268

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 89.6 bits (222), Expect = 3e-19
 Identities = 50/211 (23%), Positives = 90/211 (42%), Gaps = 22/211 (10%)

Query: 175 FSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFDVEC--------EMMKS 225
           FS + +IGRGGFG VY  R  D  ++ A+K   L   R                  ++ +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGETLALNERIMLSLVST 248

Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
                ++ +       +  + +L+ M  G L  ++       +   R     ++   LE+
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEH 307

Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAP 344
           +H   +  +++ DLKP+N+LLD++    +SD  +A   + +     +      T GYMAP
Sbjct: 308 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPHASVGTHGYMAP 359

Query: 345 E-YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           E   +     ++ D +S G ML +   G  P
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 87.7 bits (218), Expect = 4e-19
 Identities = 56/233 (24%), Positives = 93/233 (39%), Gaps = 41/233 (17%)

Query: 172 TDGFSENNLIGRGGFGSVYKARLGD-GMEVAVK-VFN--LQCGRALKGFDVECEMMKSIR 227
            D F    + G+G FG+V   +    GM VA+K V        R L+      + +  + 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ----IMQDLAVLH 77

Query: 228 HRNLIK---VISTCSNEEFK----ALVLEYMP---HGSLEKYMYSSNYILDIFQRLNIMI 277
           H N+++      T    + +     +V+EY+P   H     Y         I  ++  + 
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV-FLF 136

Query: 278 DVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTL 336
            +  ++  LH   S  + H D+KP NVL++  +    L DF  AK L    +       +
Sbjct: 137 QLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL-SPSEPN--VAYI 192

Query: 337 ATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
            +  Y APE       Y      +T  D++S G +  E   G +P   IF G+
Sbjct: 193 CSRYYRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLG-EP---IFRGD 235

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 87.8 bits (218), Expect = 4e-19
 Identities = 63/250 (25%), Positives = 101/250 (40%), Gaps = 45/250 (18%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVK----VFNLQ--CGRALKGFDVECEMMKSIRHRNLIK 233
           IG G  G V  A        VA+K     F  Q    RA +    E  +MK + H+N+I 
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNIIG 88

Query: 234 V----ISTCSNEEFKA--LVLEYMP---HGSLEKYMYSSNYILDIFQRLNIMIDVASALE 284
           +        S EEF+   +V+E M       ++  +        ++Q L         ++
Sbjct: 89  LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-------GIK 141

Query: 285 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
           +LH   SA IIH DLKPSN+++  +    + DF +A+       S   T  + T  Y AP
Sbjct: 142 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAP 195

Query: 345 EYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN 404
           E         N D++S G ++ E   G      +F G       ++ W  +  +E +G  
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMIKGGV----LFPG----TDHIDQWNKV--IEQLGT- 244

Query: 405 LLSQEDIHFV 414
               E +  +
Sbjct: 245 -PCPEFMKKL 253

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 86.9 bits (216), Expect = 4e-19
 Identities = 46/201 (22%), Positives = 78/201 (38%), Gaps = 28/201 (13%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFN-LQCGRALKGFDV-----ECEMMKSIRHRNLIK 233
           +G G F  V K R    G++ A K     +   + +G        E  ++K I+H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 234 VISTCSNEEFKALVLEYMPHGSL-----EKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
           +     N+    L+LE +  G L     EK   +     +       +  + + + YLH 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE------FLKQILNGVYYLH- 131

Query: 289 GYSAPIIHCDLKPSNVLL----DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
             S  I H DLKP N++L           + DF +A  +              T  ++AP
Sbjct: 132 --SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNEF--KNIFGTPEFVAP 186

Query: 345 EYGREGRVSTNGDVYSFGIML 365
           E      +    D++S G++ 
Sbjct: 187 EIVNYEPLGLEADMWSIGVIT 207

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 86.9 bits (216), Expect = 4e-19
 Identities = 39/196 (19%), Positives = 75/196 (38%), Gaps = 26/196 (13%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV--ECEMMKSIRHRNLIKVIST 237
           +GRG FG V++            K       +      V  E  ++   RHRN++ +  +
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHRNILHLHES 69

Query: 238 CSNEEFKALVLEYMPHGSL------EKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
             + E   ++ E++    +        +  +   I+        +  V  AL++LH    
Sbjct: 70  FESMEELVMIFEFISGLDIFERINTSAFELNEREIVS------YVHQVCEALQFLHSHN- 122

Query: 292 APIIHCDLKPSNVLLDDNMVAHL--SDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 349
             I H D++P N++      + +   +F  A+ L     +           Y APE  + 
Sbjct: 123 --IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNF--RLLFTAPEYYAPEVHQH 177

Query: 350 GRVSTNGDVYSFGIML 365
             VST  D++S G ++
Sbjct: 178 DVVSTATDMWSLGTLV 193

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 87.8 bits (218), Expect = 6e-19
 Identities = 67/223 (30%), Positives = 103/223 (46%), Gaps = 45/223 (20%)

Query: 181 IGRGGFGSVYKARLGD-GMEVAVK-VFNLQ--CGRALKGFDVECEMMKSIRHRNLIK--- 233
           IG G FG VY+A+L D G  VA+K V   +    R       E ++M+ + H N+++   
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRY 114

Query: 234 -VISTCSNEEFKAL--VLEYMP---HGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLH 287
              S+   ++   L  VL+Y+P   +     Y  +   +  I+ +L  M  +  +L Y+H
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIH 173

Query: 288 FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE- 345
              S  I H D+KP N+LLD D  V  L DF  AK L    +       + +  Y APE 
Sbjct: 174 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPN--VSYICSRYYRAPEL 227

Query: 346 ------YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
                 Y      +++ DV+S G +L E   G +P   IF G+
Sbjct: 228 IFGATDY------TSSIDVWSAGCVLAELLLG-QP---IFPGD 260

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 86.2 bits (214), Expect = 8e-19
 Identities = 58/244 (23%), Positives = 93/244 (38%), Gaps = 47/244 (19%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCGRALKGFDVECEMMKSIRHRNLIK---V 234
            +G G +G V  A        VAVK+ ++ +     +    E  + K + H N++K    
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILD-----------IFQRLNIMIDVASAL 283
                N ++  L LEY   G L       + I              F +L       + +
Sbjct: 74  RRE-GNIQY--LFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQL------MAGV 118

Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
            YLH      I H D+KP N+LLD+     +SDF +A +    ++     +   T+ Y+A
Sbjct: 119 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 344 PE--YGRE--GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVN------DWL 393
           PE    RE         DV+S GI+L     G+ P ++  +       W         W 
Sbjct: 176 PELLKRREFHAEPV---DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 232

Query: 394 PIST 397
            I +
Sbjct: 233 KIDS 236

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 86.6 bits (215), Expect = 1e-18
 Identities = 67/265 (25%), Positives = 122/265 (46%), Gaps = 47/265 (17%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVK---VFN--LQCGRALKGFDVECEMMKSIRHRNLIK- 233
           IG G +G V  A    + + VA+K    F     C R L+    E +++   RH N+I  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90

Query: 234 --VISTCSNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFG 289
             +I   + E+ K   +V + M    L K + +  ++ +       +  +   L+Y+H  
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICY-FLYQILRGLKYIH-- 145

Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ-TQTLATIGYMAPE--- 345
            SA ++H DLKPSN+LL+      + DF +A++   +       T+ +AT  Y APE   
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204

Query: 346 ----YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVV 401
               Y      + + D++S G +L E  + +     IF G    KH+++    I  + ++
Sbjct: 205 NSKGY------TKSIDIWSVGCILAEMLSNR----PIFPG----KHYLDQLNHI--LGIL 248

Query: 402 GANLLSQEDIHFVAKEQCVSCVFNL 426
           G+   SQED++ +   +  + + +L
Sbjct: 249 GS--PSQEDLNCIINLKARNYLLSL 271

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 41/213 (19%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-----ECEMMKSIRHRNLIK- 233
           IG+G F  V  AR +  G EVA+K+ +      L    +     E  +MK + H N++K 
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIID---KTQLNPTSLQKLFREVRIMKILNHPNIVKL 79

Query: 234 --VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILD-----IFQRLNIMIDVASALEYL 286
             VI T     +  L++EY   G +  Y+ +   + +      F+++       SA++Y 
Sbjct: 80  FEVIET-EKTLY--LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI------VSAVQYC 130

Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI----GYM 342
           H      I+H DLK  N+LLD +M   ++DF       G     T    L        Y 
Sbjct: 131 H---QKRIVHRDLKAENLLLDADMNIKIADF-------GFSNEFTVGGKLDAFCGAPPYA 180

Query: 343 APE-YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           APE +  +       DV+S G++L    +G  P
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 63/272 (23%), Positives = 109/272 (40%), Gaps = 48/272 (17%)

Query: 172 TDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVK----VFN--LQCGRALKGFDVECEMMK 224
              +     +G G +GSV  A     G +VA+K     F   +   RA +    E  ++K
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLK 78

Query: 225 SIRHRNLIK----VISTCSNEEFKA--LVLEYMP---HGSLEKYMYSSNYILDIFQRLNI 275
            ++H N+I          S   F    LV+ +M       +            ++Q L  
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLK- 137

Query: 276 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 335
                  L+Y+H   SA ++H DLKP N+ ++++    + DF +A+     D  M  T  
Sbjct: 138 ------GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEM--TGY 183

Query: 336 LATIGYMAPE-YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLP 394
           + T  Y APE        +   D++S G ++ E  TGK     +F G    K +++    
Sbjct: 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK----TLFKG----KDYLDQLTQ 235

Query: 395 ISTMEVVGANLLSQEDIHFVAKEQCVSCVFNL 426
           I  ++V G      E +  +  +   S + +L
Sbjct: 236 I--LKVTGV--PGTEFVQKLNDKAAKSYIQSL 263

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 84.6 bits (210), Expect = 1e-18
 Identities = 64/237 (27%), Positives = 104/237 (43%), Gaps = 45/237 (18%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRALKGFDVECEMMKSIRHRNLIK-- 233
            +G G FG V        G +VAVK+ N   ++    +     E + +K  RH ++IK  
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77

Query: 234 -VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYI-----LDIFQRLNIMIDVASALEYLH 287
            VIST   + F  +V+EY+  G L  Y+     +       +FQ++       SA++Y H
Sbjct: 78  QVIST-PTDFF--MVMEYVSGGELFDYICKHGRVEEMEARRLFQQI------LSAVDYCH 128

Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI----GYMA 343
                 ++H DLKP NVLLD +M A ++DF ++ +       M+  + L T      Y A
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM-------MSDGEFLRTSCGSPNYAA 178

Query: 344 PE-YGREGRVSTNGDVYSFGIMLMETFTGKKPTNE---------IFNGEMTLKHWVN 390
           PE            D++S G++L     G  P ++         I  G   +  ++N
Sbjct: 179 PEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLN 235

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 87.5 bits (217), Expect = 1e-18
 Identities = 54/242 (22%), Positives = 99/242 (40%), Gaps = 22/242 (9%)

Query: 144 KGKRPSNDANMPSIATWRTFSHLELCRAT-DGFSENNLIGRGGFGSVYKARLGDGMEV-A 201
                ++  +      +  +  LE    T + F +  ++G+GGFG V   ++    ++ A
Sbjct: 154 SVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYA 213

Query: 202 VKVFNLQCGRALKGFDVECEM-----MKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 256
            K   L+  R  K       +     ++ +  R ++ +      ++   LVL  M  G L
Sbjct: 214 CKK--LEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDL 271

Query: 257 EKYMYSSNYILDIFQRLNIMI---DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH 313
               +  +     F     +    ++   LE LH      I++ DLKP N+LLDD+    
Sbjct: 272 --KFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIR 326

Query: 314 LSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGK 372
           +SD  +A  +          +    T+GYMAPE  +  R + + D ++ G +L E   G+
Sbjct: 327 ISDLGLAVHVPEGQ----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

Query: 373 KP 374
            P
Sbjct: 383 SP 384

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 85.5 bits (212), Expect = 1e-18
 Identities = 58/232 (25%), Positives = 90/232 (38%), Gaps = 37/232 (15%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFN----LQCGRALKGFDV--ECEMMKSIRHR--N 230
           L+G GGFGSVY    + D + VA+K          G    G  V  E  ++K +      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 231 LIKVISTCSNEEFKALVLEY-MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFG 289
           +I+++      +   L+LE   P   L  ++ +    L      +    V  A+ + H  
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCH-- 166

Query: 290 YSAPIIHCDLKPSNVLLDDN-MVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEY- 346
            +  ++H D+K  N+L+D N     L DF    LL       T       T  Y  PE+ 
Sbjct: 167 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-----TVYTDFDGTRVYSPPEWI 220

Query: 347 ------GREGRVSTNGDVYSFGIMLMETFTGKKP---TNEIFNGEMTLKHWV 389
                 GR         V+S GI+L +   G  P     EI  G++  +  V
Sbjct: 221 RYHRYHGRS------AAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 266

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 86.4 bits (214), Expect = 2e-18
 Identities = 52/246 (21%), Positives = 94/246 (38%), Gaps = 50/246 (20%)

Query: 167 ELCRATDGFS-ENNLIGRGGFGSVYKAR---LGDGMEVAVKVFNLQCGRALKGFDVE--C 220
           E  R  D F  E   +GRG +G VYKA+     D  + A+K           G  +    
Sbjct: 14  ERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT------GISMSACR 67

Query: 221 EM--MKSIRHRNLIKVISTCSNEEFKA--LVLEYMPHGSLEKYM--------YSSNYILD 268
           E+  ++ ++H N+I +     +   +   L+ +Y  H  L   +              L 
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLP 126

Query: 269 IFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH----LSDFSIAKLLT 324
                +++  +   + YLH   +  ++H DLKP+N+L+           ++D   A+L  
Sbjct: 127 RGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183

Query: 325 GEDQSMTQ-TQTLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTGKKPTN 376
              + +      + T  Y APE       Y      +   D+++ G +  E  T  +P  
Sbjct: 184 SPLKPLADLDPVVVTFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLT-SEP-- 234

Query: 377 EIFNGE 382
            IF+  
Sbjct: 235 -IFHCR 239

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 84.2 bits (209), Expect = 3e-18
 Identities = 64/298 (21%), Positives = 116/298 (38%), Gaps = 55/298 (18%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV----ECEMMKSIRHRNLIKVI 235
           +G G + +VYK      G+ VA+K   L    + +G       E  +MK ++H N++++ 
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLD---SEEGTPSTAIREISLMKELKHENIVRLY 69

Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYI-----LDIFQRLNIMIDVASALEYLHFGY 290
                E    LV E+M +  L+KYM S         L++         +   L + H   
Sbjct: 70  DVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK 128

Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE--YGR 348
              I+H DLKP N+L++      L DF +A+       +   +  + T+ Y AP+   G 
Sbjct: 129 ---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEVVTLWYRAPDVLMGS 183

Query: 349 EGRVSTNGDVYSFGIMLMETFTGK--------------------KPTNEIFNGEMTLKHW 388
               ST+ D++S G +L E  TGK                     P   ++     L  +
Sbjct: 184 R-TYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY 242

Query: 389 VND---WLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINARE 443
             +     P    +V+  +     D + +          +        +P+ R++A++
Sbjct: 243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLM----------DFLHGLLQLNPDMRLSAKQ 290

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 84.7 bits (210), Expect = 4e-18
 Identities = 67/267 (25%), Positives = 114/267 (42%), Gaps = 55/267 (20%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVK----VFN--LQCGRALKGFDVECEMMKSIRHRNLIK 233
           +G G +G+V  A     G +VA+K     F   L   RA +    E  ++K +RH N+I 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMRHENVIG 88

Query: 234 VI----STCSNEEFKA--LVLEYMPHGSLEKYMYSSN-------YILDIFQRLNIMIDVA 280
           ++       + ++F    LV+ +M    L K M           ++  ++Q L       
Sbjct: 89  LLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFL--VYQMLK------ 139

Query: 281 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIG 340
             L Y+H   +A IIH DLKP N+ ++++    + DF +A+     D  M  T  + T  
Sbjct: 140 -GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEM--TGYVVTRW 190

Query: 341 YMAPEY-GREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTME 399
           Y APE      R +   D++S G ++ E  TGK     +F G       ++    I  M+
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK----TLFKG----SDHLDQLKEI--MK 240

Query: 400 VVGANLLSQEDIHFVAKEQCVSCVFNL 426
           V G      E +  +  ++  + +  L
Sbjct: 241 VTGT--PPAEFVQRLQSDEAKNYMKGL 265

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 83.8 bits (208), Expect = 4e-18
 Identities = 43/209 (20%), Positives = 74/209 (35%), Gaps = 46/209 (22%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV-----ECEMMKSIRHR-NLIK 233
           +GRG F  V +      G E A K       R            E  +++  +    +I 
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKK---RRRGQDCRAEILHEIAVLELAKSCPRVIN 93

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRL--------------NIMIDV 279
           +     N     L+LEY   G +             F                  ++  +
Sbjct: 94  LHEVYENTSEIILILEYAAGGEI-------------FSLCLPELAEMVSENDVIRLIKQI 140

Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH---LSDFSIAKLLTGEDQSMTQTQTL 336
              + YLH      I+H DLKP N+LL          + DF +++ + G    +   + +
Sbjct: 141 LEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACEL--REIM 194

Query: 337 ATIGYMAPEYGREGRVSTNGDVYSFGIML 365
            T  Y+APE      ++T  D+++ GI+ 
Sbjct: 195 GTPEYLAPEILNYDPITTATDMWNIGIIA 223

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 85.3 bits (211), Expect = 5e-18
 Identities = 64/256 (25%), Positives = 108/256 (42%), Gaps = 39/256 (15%)

Query: 172 TDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVK----VFN--LQCGRALKGFDVECEMMK 224
              +     IG G  G V  A        VA+K     F       RA +    E  +MK
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR----ELVLMK 116

Query: 225 SIRHRNLIKVI----STCSNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMID 278
            + H+N+I ++       + EEF+   LV+E M   +L + +      LD  +   ++  
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME---LDHERMSYLLYQ 172

Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT 338
           +   +++LH   SA IIH DLKPSN+++  +    + DF +A+   G    M  T  + T
Sbjct: 173 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMM--TPYVVT 226

Query: 339 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTM 398
             Y APE         N D++S G ++ E    K     +F G    + +++ W  +  +
Sbjct: 227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPG----RDYIDQWNKV--I 276

Query: 399 EVVGANLLSQEDIHFV 414
           E +G      E +  +
Sbjct: 277 EQLGT--PCPEFMKKL 290

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 83.5 bits (207), Expect = 6e-18
 Identities = 57/234 (24%), Positives = 90/234 (38%), Gaps = 39/234 (16%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFN----LQCGRALKGFDV--ECEMMKSIR----H 228
           L+G+GGFG+V+    L D ++VA+KV      L             E  ++  +     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 229 RNLIKVISTCSNEEFKALVLEY-MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLH 287
             +I+++     +E   LVLE  +P   L  Y+     + +   R      V +A+++ H
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAIQHCH 156

Query: 288 FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPE 345
              S  ++H D+K  N+L+D     A L DF    LL               T  Y  PE
Sbjct: 157 ---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD-----EPYTDFDGTRVYSPPE 208

Query: 346 Y-------GREGRVSTNGDVYSFGIMLMETFTGKKP---TNEIFNGEMTLKHWV 389
           +                  V+S GI+L +   G  P     EI   E+     V
Sbjct: 209 WISRHQYHALP------ATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHV 256

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 83.4 bits (207), Expect = 7e-18
 Identities = 61/231 (26%), Positives = 102/231 (44%), Gaps = 32/231 (13%)

Query: 169 CRATDGFSENNLIGRGGFGSVYKAR--LGDGMEVAVKVFNLQCGRALKGFDV----ECEM 222
           CRA   +     IG G +G V+KAR     G  VA+K   +Q G   +G  +    E  +
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAV 64

Query: 223 MKSIR---HRN---LIKVISTCSNEEFKA--LVLEYMPHGSLEKYMYSSNYI-LDIFQRL 273
           ++ +    H N   L  V +    +      LV E++    L  Y+       +      
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK 123

Query: 274 NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 333
           ++M  +   L++LH   S  ++H DLKP N+L+  +    L+DF +A++ + +   M  T
Sbjct: 124 DMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALT 177

Query: 334 QTLATIGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
             + T+ Y APE         +T  D++S G +  E F  +KP   +F G 
Sbjct: 178 SVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFR-RKP---LFRGS 222

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 83.8 bits (208), Expect = 7e-18
 Identities = 66/272 (24%), Positives = 114/272 (41%), Gaps = 53/272 (19%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVK---VFN--LQCGRALKGFDVECEMMKSIRHRNLIK- 233
           +G G +G V  A     G  VA+K    F+  L   R L+    E +++K  +H N+I  
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKILKHFKHENIITI 74

Query: 234 --VISTCSNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFG 289
             +    S E F    ++ E M    L + + S+  + D   +   +     A++ LH  
Sbjct: 75  FNIQRPDSFENFNEVYIIQELMQ-TDLHRVI-STQMLSDDHIQY-FIYQTLRAVKVLH-- 129

Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ--------TQTLATIGY 341
             + +IH DLKPSN+L++ N    + DF +A+++       ++         + +AT  Y
Sbjct: 130 -GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188

Query: 342 MAPE-------YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLP 394
            APE       Y      S   DV+S G +L E F  +     IF G    + + +  L 
Sbjct: 189 RAPEVMLTSAKY------SRAMDVWSCGCILAELFLRRP----IFPG----RDYRHQLLL 234

Query: 395 ISTMEVVGANLLSQEDIHFVAKEQCVSCVFNL 426
           I    ++G    S  D+  +   +    + +L
Sbjct: 235 I--FGIIGTP-HSDNDLRCIESPRAREYIKSL 263

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 83.5 bits (207), Expect = 7e-18
 Identities = 44/214 (20%), Positives = 81/214 (37%), Gaps = 58/214 (27%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECE---MMKSIRHRNLIKVI 235
           ++G G  G V +      G + A+K+                E     ++    +++ ++
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVCIL 88

Query: 236 STCSNEEFKA----LVLEYMPHGSLEKYMYSSNYILD-IFQRLN----------IMIDVA 280
               N         +++E M  G L             I +R +          IM D+ 
Sbjct: 89  DVYENMHHGKRCLLIIMECMEGGEL----------FSRIQERGDQAFTEREAAEIMRDIG 138

Query: 281 SALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA 337
           +A+++LH   S  I H D+KP N+L    + + V  L+DF  AK       ++       
Sbjct: 139 TAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNAL--QTPCY 191

Query: 338 TIGYMAPE------YGREGRVSTNGDVYSFGIML 365
           T  Y+APE      Y +        D++S G+++
Sbjct: 192 TPYYVAPEVLGPEKYDKS------CDMWSLGVIM 219

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 84.8 bits (210), Expect = 8e-18
 Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 45/237 (18%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRALKGFDVECEMMKSIRHRNLIK-- 233
            +G G FG V   +    G +VAVK+ N   ++    +     E + +K  RH ++IK  
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 234 -VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYI-----LDIFQRLNIMIDVASALEYLH 287
            VIST  ++ F  +V+EY+  G L  Y+  +  +       +FQ++       S ++Y H
Sbjct: 83  QVIST-PSDIF--MVMEYVSGGELFDYICKNGRLDEKESRRLFQQI------LSGVDYCH 133

Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI----GYMA 343
                 ++H DLKP NVLLD +M A ++DF ++ +       M+  + L T      Y A
Sbjct: 134 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM-------MSDGEFLRTSCGSPNYAA 183

Query: 344 PE-YGREGRVSTNGDVYSFGIMLMETFTGKKPTNE---------IFNGEMTLKHWVN 390
           PE            D++S G++L     G  P ++         I +G      ++N
Sbjct: 184 PEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLN 240

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 84.0 bits (208), Expect = 9e-18
 Identities = 45/213 (21%), Positives = 78/213 (36%), Gaps = 57/213 (26%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECE---MMKSIRHRNLIKVIS 236
           +G G  G V +        + A+K+                E     ++ +  ++++++ 
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 122

Query: 237 TCSNEEFKA----LVLEYMPHGSLEKYMYSSNYILD-IFQRLN----------IMIDVAS 281
              N         +V+E +  G L             I  R +          IM  +  
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGEL----------FSRIQDRGDQAFTEREASEIMKSIGE 172

Query: 282 ALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT 338
           A++YLH   S  I H D+KP N+L      N +  L+DF  AK  T  +   T      T
Sbjct: 173 AIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYT 226

Query: 339 IGYMAPE------YGREGRVSTNGDVYSFGIML 365
             Y+APE      Y +        D++S G+++
Sbjct: 227 PYYVAPEVLGPEKYDKS------CDMWSLGVIM 253

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 82.6 bits (205), Expect = 9e-18
 Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 26/221 (11%)

Query: 169 CRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGR-ALKGFDV----ECEM 222
             AT  +     IG G +G+VYKAR    G  VA+K   +  G     G  +    E  +
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64

Query: 223 MKSIR---HRN---LIKVISTCSNEEFKA--LVLEYMPHGSLEKYMYSSNYI-LDIFQRL 273
           ++ +    H N   L+ V +T   +      LV E++    L  Y+  +    L      
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123

Query: 274 NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQT 333
           ++M      L++LH   +  I+H DLKP N+L+       L+DF +A++ + +   M  T
Sbjct: 124 DLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALT 177

Query: 334 QTLATIGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTGK 372
             + T+ Y APE         +T  D++S G +  E F  K
Sbjct: 178 PVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRK 216

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 84.0 bits (208), Expect = 1e-17
 Identities = 45/218 (20%), Positives = 85/218 (38%), Gaps = 41/218 (18%)

Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFDVEC-----EMMKSIRHRNLIK 233
           +IGRG FG V   +L +  +V A+K+  L     LK  +  C     +++ +   + +  
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKI--LNKWEMLKRAETACFREERDVLVNGDSKWITT 138

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMID----------VASAL 283
           +     ++    LV++Y   G L   +           +    +           +  A+
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLL----------SKFEDRLPEEMARFYLAEMVIAI 188

Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAH--LSDFSIAKLLTGEDQSMTQTQTLATIGY 341
           + +H       +H D+KP N+L+D N   H  L+DF     L  +    +    + T  Y
Sbjct: 189 DSVH---QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSV-AVGTPDY 242

Query: 342 MAPEYGREGRVSTNG-----DVYSFGIMLMETFTGKKP 374
           ++PE  +             D +S G+ + E   G+ P
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 84.0 bits (208), Expect = 1e-17
 Identities = 57/221 (25%), Positives = 88/221 (39%), Gaps = 50/221 (22%)

Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFDVEC-----EMMKSIRHRNLIK 233
           +IGRG FG V   R     +V A+K+ +      +K  D        ++M       +++
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKF--EMIKRSDSAFFWEERDIMAFANSPWVVQ 133

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVA--------SALEY 285
           +     ++ +  +V+EYMP G L   M             ++    A         AL+ 
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVNLM----------SNYDVPEKWARFYTAEVVLALDA 183

Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAH--LSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           +H   S   IH D+KP N+LLD +   H  L+DF     +  E      T  + T  Y++
Sbjct: 184 IH---SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYIS 237

Query: 344 PE----------YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           PE          YGRE       D +S G+ L E   G  P
Sbjct: 238 PEVLKSQGGDGYYGRE--C----DWWSVGVFLYEMLVGDTP 272

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 81.5 bits (202), Expect = 3e-17
 Identities = 58/265 (21%), Positives = 107/265 (40%), Gaps = 56/265 (21%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVK--VFN--LQCGRALKGFDVECEMMKSIRHRNLIKVI 235
           +G GG G V+ A        VA+K  V         AL+    E ++++ + H N++KV 
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKIIRRLDHDNIVKVF 74

Query: 236 ------------STCSNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVAS 281
                          S  E  +  +V EYM    L   +     + +  +    M  +  
Sbjct: 75  EILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHAR--LFMYQLLR 131

Query: 282 ALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQ-TQTLATI 339
            L+Y+H   SA ++H DLKP+N+ ++ +++V  + DF +A+++          ++ L T 
Sbjct: 132 GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188

Query: 340 GYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDW 392
            Y +P        Y      +   D+++ G +  E  TGK     +F G     H +   
Sbjct: 189 WYRSPRLLLSPNNY------TKAIDMWAAGCIFAEMLTGK----TLFAG----AHELEQM 234

Query: 393 LPISTMEVVGANLLSQEDIHFVAKE 417
             I  +E +    + +ED   +   
Sbjct: 235 QLI--LESIPV--VHEEDRQELLSV 255

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 82.9 bits (205), Expect = 3e-17
 Identities = 41/187 (21%), Positives = 82/187 (43%), Gaps = 21/187 (11%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVK----VFN--LQCGRALKGFDVECEMMKSIRHRNLIK 233
           IG G +G V +A    +   VA+K    VF   + C R L+    E  ++  + H +++K
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR----EIAILNRLNHDHVVK 116

Query: 234 ---VISTCSNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
              ++     E+F    +VLE       +K   +  Y+ ++  +  ++ ++   ++Y+H 
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT-LLYNLLVGVKYVH- 173

Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             SA I+H DLKP+N L++ +    + DF +A+ +   +   +Q         M      
Sbjct: 174 --SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231

Query: 349 EGRVSTN 355
             +    
Sbjct: 232 HTKNLKR 238

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 83.2 bits (206), Expect = 3e-17
 Identities = 19/75 (25%), Positives = 36/75 (48%), Gaps = 3/75 (4%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQ-GPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
              +    + ++ +++GYN L+  P+  S   +  L  L    N L G +P +      L
Sbjct: 297 ALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKL 355

Query: 61  ENLNLSFNKLEGEIP 75
            +LNL++N++   IP
Sbjct: 356 ASLNLAYNQITE-IP 369

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 82.4 bits (204), Expect = 6e-17
 Identities = 15/90 (16%), Positives = 29/90 (32%), Gaps = 8/90 (8%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSG-------AIPASL 54
           +        N+  + L  N++     + F     L  +NL  N L+            + 
Sbjct: 425 LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENF 484

Query: 55  EKLSYLENLNLSFNKLEGEIPRGGPFRNFS 84
           +    L +++L FNKL   +          
Sbjct: 485 KNTYLLTSIDLRFNKLTK-LSDDFRATTLP 513

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 80.1 bits (198), Expect = 4e-16
 Identities = 12/80 (15%), Positives = 25/80 (31%), Gaps = 9/80 (11%)

Query: 2   IPTEIGGLKNLEYLFLG------YNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLE 55
            PT+      L+   +        NR     P+      SL  L + +N++   +   + 
Sbjct: 528 FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI- 585

Query: 56  KLSYLENLNLSFNKLEGEIP 75
               +  L++  N       
Sbjct: 586 -TPNISVLDIKDNPNISIDL 604

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 79.3 bits (196), Expect = 7e-16
 Identities = 11/90 (12%), Positives = 28/90 (31%), Gaps = 19/90 (21%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGP-------------------IPDSFGDLISLKFLNLS 42
           +   +  L  L   ++G +                            + +L  L  + + 
Sbjct: 198 VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVY 257

Query: 43  NNNLSGAIPASLEKLSYLENLNLSFNKLEG 72
           N      +P  L+ L  ++ +N++ N+   
Sbjct: 258 NCPNLTKLPTFLKALPEMQLINVACNRGIS 287

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 78.5 bits (194), Expect = 1e-15
 Identities = 17/103 (16%), Positives = 34/103 (33%), Gaps = 12/103 (11%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLE--KLSY 59
                G    L  L L YN++     +  G    ++ L+ ++N L   IP   +   +S 
Sbjct: 345 KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSV 403

Query: 60  LENLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQV 102
           +  ++ S+N++         F                  N+  
Sbjct: 404 MSAIDFSYNEIGSVDG--KNFDPLDPT-------PFKGINVSS 437

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 78.2 bits (193), Expect = 1e-15
 Identities = 16/121 (13%), Positives = 30/121 (24%), Gaps = 8/121 (6%)

Query: 5   EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSG----AIPASLEKLSYL 60
            +     +  L L      G +PD+ G L  L+ L L ++          P  +      
Sbjct: 76  SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135

Query: 61  ENLNLSFNKLEGEIPRGGPFRNFS---VESFEGNELLCGSPNLQVPPCKTSNHHTLWKNS 117
           E         +       P  +FS    +    +                        N+
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR-ITLKDTQIGQLSNN 194

Query: 118 L 118
           +
Sbjct: 195 I 195

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 76.6 bits (189), Expect = 4e-15
 Identities = 21/108 (19%), Positives = 37/108 (34%), Gaps = 16/108 (14%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQG-------PIPDSFGDLISLKFLNLSNNNLSGAIPASL 54
              +   +  +  +   YN +         P+  +    I++  +NLSNN +S       
Sbjct: 394 NIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELF 453

Query: 55  EKLSYLENLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQV 102
              S L ++NL  N L   IP+            + NE    +  L  
Sbjct: 454 STGSPLSSINLMGNMLTE-IPKN--------SLKDENENFKNTYLLTS 492

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 75.8 bits (187), Expect = 8e-15
 Identities = 10/84 (11%), Positives = 26/84 (30%), Gaps = 9/84 (10%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNL--------SGAIPA 52
               +   LK+L  + +        +P     L  ++ +N++ N               A
Sbjct: 240 TEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALA 299

Query: 53  SLEKLSYLENLNLSFNKL-EGEIP 75
                  ++ + + +N L    + 
Sbjct: 300 DAPVGEKIQIIYIGYNNLKTFPVE 323

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 73.5 bits (181), Expect = 5e-14
 Identities = 16/86 (18%), Positives = 27/86 (31%), Gaps = 11/86 (12%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQG-------PIPDSFGDLISLKFLNLSNNNLSGAIPAS 53
                      L  + L  N L            ++F +   L  ++L  N L+  +   
Sbjct: 448 FPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDD 506

Query: 54  LE--KLSYLENLNLSFNKLEGEIPRG 77
                L YL  ++LS+N      P  
Sbjct: 507 FRATTLPYLVGIDLSYNSFSK-FPTQ 531

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 72.0 bits (177), Expect = 1e-13
 Identities = 15/83 (18%), Positives = 32/83 (38%), Gaps = 9/83 (10%)

Query: 2   IPTEIGG-LKNLEYLFLGYNRLQG-PIPDSFGDLISLKFLNLSNNNLSG-------AIPA 52
           IP    G  + +E L   +N+L+  P       +  +  ++ S N +          +  
Sbjct: 368 IPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDP 427

Query: 53  SLEKLSYLENLNLSFNKLEGEIP 75
           +  K   + ++NLS N++     
Sbjct: 428 TPFKGINVSSINLSNNQISKFPK 450

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 13/82 (15%), Positives = 26/82 (31%), Gaps = 6/82 (7%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGP----IPDSFGDLISLKFLNLSNNNLSGAIPASLEK 56
            +P  IG L  LE L LG +  +       P      +S +       +          +
Sbjct: 96  RVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPR 155

Query: 57  LSY--LENLNLSFNKLEGEIPR 76
             +  L    ++ +  +  I +
Sbjct: 156 EDFSDLIKDCINSDPQQKSIKK 177

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 8/93 (8%), Positives = 21/93 (22%), Gaps = 20/93 (21%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAI----------- 50
           I            +    N +   +  +   L  L+   + N+                 
Sbjct: 175 IKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSE 233

Query: 51  --------PASLEKLSYLENLNLSFNKLEGEIP 75
                       + L  L ++ +       ++P
Sbjct: 234 YAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLP 266

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 81.3 bits (201), Expect = 6e-17
 Identities = 59/213 (27%), Positives = 82/213 (38%), Gaps = 58/213 (27%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV------ECEMMKSIRHRNLI 232
            IG G FG     R       VAVK          +G  +      E    +S+RH N++
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVKYIE-------RGAAIDENVQREIINHRSLRHPNIV 79

Query: 233 K---VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILD-----------IFQRLNIMID 278
           +   VI T       A+++EY   G L         I +            FQ+L     
Sbjct: 80  RFKEVILT---PTHLAIIMEYASGGEL------YERICNAGRFSEDEARFFFQQL----- 125

Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHL--SDFSIAKLLTGEDQSMTQTQTL 336
             S + Y H   S  I H DLK  N LLD +    L   DF  +K      Q  +   T 
Sbjct: 126 -LSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 181

Query: 337 ATIGYMAPE--YGRE--GRVSTNGDVYSFGIML 365
           A   Y+APE    +E  G+++   DV+S G+ L
Sbjct: 182 A---YIAPEVLLRQEYDGKIA---DVWSCGVTL 208

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 82.2 bits (203), Expect = 9e-17
 Identities = 17/111 (15%), Positives = 35/111 (31%), Gaps = 19/111 (17%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGP-------------------IPDSFGDLISLKFLNLS 42
           I   I  L  L+ ++   +                           S+ +L  L  + L 
Sbjct: 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELY 499

Query: 43  NNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSVESFEGNEL 93
           N      +P  L  L  L++LN++ N+          +   + +   G ++
Sbjct: 500 NCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 78.8 bits (194), Expect = 1e-15
 Identities = 17/111 (15%), Positives = 36/111 (32%), Gaps = 12/111 (10%)

Query: 2   IPTEIGGLKNLEYL------FLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLE 55
            PT+      L+            NR+    P       SL  L + +N++   +   L 
Sbjct: 768 FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL- 825

Query: 56  KLSYLENLNLSFNKL-EGEIPRGGPFRNFSVESFEGN--ELLCGSPNLQVP 103
               L  L+++ N     ++    P+    +     +  + + G   L + 
Sbjct: 826 -TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALGIE 875

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 74.5 bits (183), Expect = 3e-14
 Identities = 19/85 (22%), Positives = 32/85 (37%), Gaps = 13/85 (15%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGP---------IPDSFGDLISLKFLNLSNNNLSGAIPA 52
           +P  +  L  L+ L +  NR             + D       ++   +  NNL    PA
Sbjct: 507 LPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPA 565

Query: 53  S--LEKLSYLENLNLSFNKLEGEIP 75
           S  L+K+  L  L+   NK+   + 
Sbjct: 566 SASLQKMVKLGLLDCVHNKVR-HLE 589

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 73.4 bits (180), Expect = 6e-14
 Identities = 16/84 (19%), Positives = 28/84 (33%), Gaps = 10/84 (11%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDS--FGDLISLKFLNLSNNNLSGAIPASLEKLSY 59
                     L  + L +N+L   + D      L  L  +++S N  S   P      S 
Sbjct: 720 KDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQ 777

Query: 60  LE------NLNLSFNKLEGEIPRG 77
           L+        +   N++  + P G
Sbjct: 778 LKAFGIRHQRDAEGNRILRQWPTG 801

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 73.0 bits (179), Expect = 7e-14
 Identities = 16/90 (17%), Positives = 29/90 (32%), Gaps = 8/90 (8%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLS-------GAIPASL 54
              +     N   + L YN +Q    + F     +  + LSNN ++            + 
Sbjct: 665 CSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNY 724

Query: 55  EKLSYLENLNLSFNKLEGEIPRGGPFRNFS 84
           +    L  ++L FNKL   +          
Sbjct: 725 KNTYLLTTIDLRFNKLT-SLSDDFRATTLP 753

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 69.5 bits (170), Expect = 1e-12
 Identities = 17/83 (20%), Positives = 33/83 (39%), Gaps = 3/83 (3%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIP--ASLEKLSY 59
                G    L  L L YN+++    D       ++ L  S+N L   IP   + + +  
Sbjct: 587 HLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYV 645

Query: 60  LENLNLSFNKLEGEIPRGGPFRN 82
           + +++ S+NK+  E        +
Sbjct: 646 MGSVDFSYNKIGSEGRNISCSMD 668

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 69.1 bits (169), Expect = 1e-12
 Identities = 14/84 (16%), Positives = 28/84 (33%), Gaps = 11/84 (13%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQ-------GPIPDSFGDLISLKFLNLSNNNLSGAIPAS 53
                      +  + L  N +         P   ++ +   L  ++L  N L+  +   
Sbjct: 688 FPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDD 746

Query: 54  LE--KLSYLENLNLSFNKLEGEIP 75
                L YL N+++S+N      P
Sbjct: 747 FRATTLPYLSNMDVSYNCFS-SFP 769

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 67.6 bits (165), Expect = 4e-12
 Identities = 12/76 (15%), Positives = 25/76 (32%), Gaps = 6/76 (7%)

Query: 5   EIGGLKNLEYLFLGYNRLQGPIPDSFGDL-----ISLKFLNLSNNNLSGAIPASLEKLSY 59
               +  +  +   YN++     +    +     I+   + LS N +           S 
Sbjct: 639 NAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSP 698

Query: 60  LENLNLSFNKLEGEIP 75
           +  + LS N +   IP
Sbjct: 699 ISTIILSNNLMT-SIP 713

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 64.1 bits (156), Expect = 5e-11
 Identities = 14/122 (11%), Positives = 42/122 (34%), Gaps = 5/122 (4%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
               ++     +  L L     +G +PD+ G L  LK L+   ++ + +     ++    
Sbjct: 314 QPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTP 373

Query: 61  ENLNLSFNKLEGEIPR--GGPFRNFSVESFEGNELLCGSPNLQVPPCKTSNHHTLWKNSL 118
           +      +++     +      +  ++     + +     N ++ P K  +  +L    +
Sbjct: 374 DMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR---NPEMKPIKKDSRISLKDTQI 430

Query: 119 LL 120
             
Sbjct: 431 GN 432

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 64.1 bits (156), Expect = 5e-11
 Identities = 14/105 (13%), Positives = 32/105 (30%), Gaps = 2/105 (1%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAI-PASLEKLSY 59
            +P  IG L  L+ L  G +           + ++        + +        L+    
Sbjct: 338 RVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQR 397

Query: 60  LENLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPP 104
           L   +L  + +    P   P +  S  S +  ++   +  +    
Sbjct: 398 LNLSDLLQDAIN-RNPEMKPIKKDSRISLKDTQIGNLTNRITFIS 441

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 55.3 bits (133), Expect = 3e-08
 Identities = 11/104 (10%), Positives = 35/104 (33%), Gaps = 3/104 (2%)

Query: 18  GYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG 77
             +           +   +  L+L+     G +P ++ +L+ L+ L+   +       R 
Sbjct: 307 ELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETV-SGRL 365

Query: 78  GPFRNFSVESFE--GNELLCGSPNLQVPPCKTSNHHTLWKNSLL 119
                 + +  E   + +      + +   +  N   L ++++ 
Sbjct: 366 FGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAIN 409

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 48.7 bits (116), Expect = 3e-06
 Identities = 10/74 (13%), Positives = 26/74 (35%), Gaps = 2/74 (2%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
               +     L+        ++    DS   L   +  NL+N      I  ++++L+ L+
Sbjct: 394 YDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNR--ITFISKAIQRLTKLQ 451

Query: 62  NLNLSFNKLEGEIP 75
            +  + +    +  
Sbjct: 452 IIYFANSPFTYDNI 465

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 51/219 (23%), Positives = 92/219 (42%), Gaps = 36/219 (16%)

Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFDVEC-----EMMKSIRHRNLIK 233
            +G G FG V   +  +     A+K+ + Q    LK   +E       +++++    L+K
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK--QIEHTLNEKRILQAVNFPFLVK 105

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
           +  +  +     +V+EY+  G +  ++       +   R      +    EYLH   S  
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVLTFEYLH---SLD 161

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-ATIGYMAPE------Y 346
           +I+ DLKP N+L+D      ++DF  AK + G      +T TL  T   +APE      Y
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEALAPEIILSKGY 215

Query: 347 GREGRVSTNGDVYSFGIMLMETFTGKKP-----TNEIFN 380
            +   V    D ++ G+++ E   G  P       +I+ 
Sbjct: 216 NKA--V----DWWALGVLIYEMAAGYPPFFADQPIQIYE 248

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 56/303 (18%), Positives = 109/303 (35%), Gaps = 74/303 (24%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVK----VFN--LQCGRALKGFDVECEMMKSIRHRNLIK 233
           IGRG +G VY A        VA+K    +F   + C R L+    E  ++  ++   +I+
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR----EITILNRLKSDYIIR 89

Query: 234 ---VISTCSNEEFKA--LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
              +I      +F    +VLE      L+K   +  ++ +   +  I+ ++     ++H 
Sbjct: 90  LYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKT-ILYNLLLGENFIH- 146

Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ---------------- 332
              + IIH DLKP+N LL+ +    + DF +A+ +  E  +                   
Sbjct: 147 --ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204

Query: 333 ----TQTLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTGKKPTNE---- 377
               T  + T  Y APE       Y      + + D++S G +  E     +        
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENY------TKSIDIWSTGCIFAELLNMLQSHINDPTN 258

Query: 378 ---IFNGEMTLKHWVNDWLPIST-----------MEVVGANLLSQEDIHFVAKEQCVSCV 423
              +F G        +                    ++G    +++D+  + K + +  +
Sbjct: 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGT--PTEDDLKNINKPEVIKYI 316

Query: 424 FNL 426
              
Sbjct: 317 KLF 319

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 58/241 (24%), Positives = 99/241 (41%), Gaps = 54/241 (22%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRALKGFDVECEMMKSIRHRNLIK-- 233
            +G G FG V  A       +VA+K  +   L+        + E   +K +RH ++IK  
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75

Query: 234 -VISTCSNEEFKALVLEY---------MPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
            VI+T   +    +V+EY         +    + +      +    FQ++        A+
Sbjct: 76  DVITT-PTDIV--MVIEYAGGELFDYIVEKKRMTEDE-GRRF----FQQI------ICAI 121

Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI---- 339
           EY H      I+H DLKP N+LLDDN+   ++DF ++ +       MT    L T     
Sbjct: 122 EYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNI-------MTDGNFLKTSCGSP 171

Query: 340 GYMAPE-YGREGRVSTNGDVYSFGIMLMETFTGKKPTNE---------IFNGEMTLKHWV 389
            Y APE    +       DV+S GI+L     G+ P ++         + +    +  ++
Sbjct: 172 NYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFL 231

Query: 390 N 390
           +
Sbjct: 232 S 232

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 48/221 (21%), Positives = 86/221 (38%), Gaps = 28/221 (12%)

Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFDVECEM-----MKSIRHRNLIK 233
           +IGRG F  V   ++    +V A+K+  +     LK  +V C       + +   R + +
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKI--MNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
           +     +E +  LV+EY   G L   +      +        + ++  A++ +H      
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLG 182

Query: 294 IIHCDLKPSNVLLDDNMVAH--LSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGR 351
            +H D+KP N+LLD     H  L+DF     L  +    +    + T  Y++PE  +   
Sbjct: 183 YVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLV-AVGTPDYLSPEILQAVG 239

Query: 352 VSTNGDVY-------SFGIMLMETFTGKKP-----TNEIFN 380
                  Y       + G+   E F G+ P     T E + 
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG 280

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 78.0 bits (193), Expect = 5e-16
 Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 58/230 (25%)

Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFDVEC-----EMMKSIRHRNLIK 233
            +G G FG V+  R        A+KV  L+    ++   VE       M+  + H  +I+
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKV--LKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSN---------YILDIFQRLNIMIDVASALE 284
           +  T  + +   ++++Y+  G L   +  S          Y  ++            ALE
Sbjct: 71  MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV----------CLALE 120

Query: 285 YLHFGYSAPIIHCDLKPSNVLLDDNMVAH--LSDFSIAKLLTGEDQSMTQTQTL-ATIGY 341
           YLH   S  II+ DLKP N+LLD N   H  ++DF  AK +         T TL  T  Y
Sbjct: 121 YLH---SKDIIYRDLKPENILLDKN--GHIKITDFGFAKYVP------DVTYTLCGTPDY 169

Query: 342 MAPE------YGREGRVSTNGDVYSFGIMLMETFTGKKP-----TNEIFN 380
           +APE      Y +   +    D +SFGI++ E   G  P     T + + 
Sbjct: 170 IAPEVVSTKPYNKS--I----DWWSFGILIYEMLAGYTPFYDSNTMKTYE 213

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 78.2 bits (193), Expect = 5e-16
 Identities = 54/252 (21%), Positives = 95/252 (37%), Gaps = 71/252 (28%)

Query: 181 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVI---- 235
           +G G FG V +    + G   A+K          +    E ++MK + H N+IK++    
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVNIIKLVDYFY 70

Query: 236 ----------------------------------STCSNEEFKALVLEYMP---HGSLEK 258
                                                S  ++  +++EY+P   H  L+ 
Sbjct: 71  TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKS 130

Query: 259 YMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDF 317
           ++ S   I      +  +  +  A+ ++H   S  I H D+KP N+L++  +    L DF
Sbjct: 131 FIRSGRSIPMNLISI-YIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDF 186

Query: 318 SIAKLLTGEDQSMTQTQTLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFT 370
             AK L    +       + +  Y APE       Y      + + D++S G +  E   
Sbjct: 187 GSAKKLI-PSEPS--VAYICSRFYRAPELMLGATEY------TPSIDLWSIGCVFGELIL 237

Query: 371 GKKPTNEIFNGE 382
           G KP   +F+GE
Sbjct: 238 G-KP---LFSGE 245

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 79.3 bits (196), Expect = 6e-16
 Identities = 22/84 (26%), Positives = 34/84 (40%), Gaps = 1/84 (1%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
           +      GL +L  L L  N +Q   P SF  L SL+ L      L+      + +L  L
Sbjct: 71  IEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITL 130

Query: 61  ENLNLSFNKLEGEIPRGGPFRNFS 84
           + LN++ N +         F N +
Sbjct: 131 KKLNVAHNFIHS-CKLPAYFSNLT 153

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 75.5 bits (186), Expect = 1e-14
 Identities = 21/75 (28%), Positives = 33/75 (44%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
            +        NL +L L   +L+      F  L  L+ LN+S+NNL     +   +L  L
Sbjct: 464 TLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSL 523

Query: 61  ENLNLSFNKLEGEIP 75
             L+ SFN++E    
Sbjct: 524 STLDCSFNRIETSKG 538

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 21/113 (18%), Positives = 33/113 (29%), Gaps = 13/113 (11%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
           +          L++L L    ++     ++  L  L  L L+ N +    P S   L+ L
Sbjct: 47  LKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSL 106

Query: 61  ENLNLSFNKLEGEIPRGGPFRNFS-----------VESFEGNELLCGSPNLQV 102
           ENL     KL        P                + S +         NL  
Sbjct: 107 ENLVAVETKLASLES--FPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVH 157

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 73.1 bits (180), Expect = 5e-14
 Identities = 16/78 (20%), Positives = 31/78 (39%), Gaps = 1/78 (1%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDS-FGDLISLKFLNLSNNNLSGAIPASLEKLSY 59
           ++     GL+ L++L   ++ L+     S F  L  L +L++S  N           L+ 
Sbjct: 390 IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTS 449

Query: 60  LENLNLSFNKLEGEIPRG 77
           L  L ++ N  +      
Sbjct: 450 LNTLKMAGNSFKDNTLSN 467

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 19/83 (22%), Positives = 31/83 (37%), Gaps = 3/83 (3%)

Query: 3   PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPAS-LEKLSYLE 61
            +    L+ L YL + Y   +      F  L SL  L ++ N+      ++     + L 
Sbjct: 417 FSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLT 476

Query: 62  NLNLSFNKLEGEIPRGGPFRNFS 84
            L+LS  +LE      G F    
Sbjct: 477 FLDLSKCQLEQISW--GVFDTLH 497

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 69.3 bits (170), Expect = 1e-12
 Identities = 20/83 (24%), Positives = 38/83 (45%), Gaps = 4/83 (4%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           +P +I    + + + L +N L+     SF +   L++L+LS   +      +   L +L 
Sbjct: 26  VPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLS 83

Query: 62  NLNLSFNKLEGEIPRGGPFRNFS 84
           NL L+ N ++   P  G F   +
Sbjct: 84  NLILTGNPIQSFSP--GSFSGLT 104

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 19/85 (22%), Positives = 30/85 (35%), Gaps = 3/85 (3%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIP-DSFGDLISLKFLNLSNNNLSGAIPASLEKLSY 59
                  GL +L  L +  N  +     + F +  +L FL+LS   L        + L  
Sbjct: 439 DFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHR 498

Query: 60  LENLNLSFNKLEGEIPRGGPFRNFS 84
           L+ LN+S N L         +    
Sbjct: 499 LQLLNMSHNNLLFLDS--SHYNQLY 521

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 67.7 bits (166), Expect = 3e-12
 Identities = 23/126 (18%), Positives = 44/126 (34%), Gaps = 9/126 (7%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQG-PIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSY 59
           +    IG L  L+ L + +N +    +P  F +L +L  ++LS N +       L+ L  
Sbjct: 119 LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRE 178

Query: 60  L----ENLNLSFNKLEGEIPRGGPFRNFSVES--FEGNELLCGSPNLQVPPCKTSNHHTL 113
                 +L++S N ++        F+   +      GN          +      + H L
Sbjct: 179 NPQVNLSLDMSLNPIDFIQD--QAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236

Query: 114 WKNSLL 119
                 
Sbjct: 237 ILGEFK 242

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 63.9 bits (156), Expect = 4e-11
 Identities = 23/83 (27%), Positives = 37/83 (44%), Gaps = 4/83 (4%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDL--ISLKFLNLSNNNLSGAIPASLEKLSY 59
           I  +   L +L YL L  N L      S+ DL   SL+ L+LS N     + A+   L  
Sbjct: 342 ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEE 400

Query: 60  LENLNLSFNKLEGEIPRGGPFRN 82
           L++L+   + L+  +     F +
Sbjct: 401 LQHLDFQHSTLKR-VTEFSAFLS 422

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 23/67 (34%), Positives = 30/67 (44%), Gaps = 4/67 (5%)

Query: 7   GGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSY--LENLN 64
             L  L+ L L  N+    I      L SL +L+LS N LS +   S   L    L +L+
Sbjct: 325 LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLD 382

Query: 65  LSFNKLE 71
           LSFN   
Sbjct: 383 LSFNGAI 389

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 51.6 bits (124), Expect = 4e-07
 Identities = 13/101 (12%), Positives = 29/101 (28%), Gaps = 9/101 (8%)

Query: 1   VIPTEIGGLKNLEYL------FLGYNRLQGPIPDSFGDLISLKF--LNLSNNNLSGAIPA 52
           ++ T +  L  L         F     L+   P     L  +      L+  N       
Sbjct: 220 IMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIV 279

Query: 53  SLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSVESFEGNEL 93
               L+ +  ++L+   ++  +        +   S    +L
Sbjct: 280 KFHCLANVSAMSLAGVSIK-YLEDVPKHFKWQSLSIIRCQL 319

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 50.8 bits (122), Expect = 6e-07
 Identities = 12/78 (15%), Positives = 25/78 (32%), Gaps = 5/78 (6%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
               +   L N+  + L    ++             + L++    L    P     L +L
Sbjct: 276 DDIVKFHCLANVSAMSLAGVSIKYLEDVPK--HFKWQSLSIIRCQLKQ-FPTL--DLPFL 330

Query: 61  ENLNLSFNKLEGEIPRGG 78
           ++L L+ NK      +  
Sbjct: 331 KSLTLTMNKGSISFKKVA 348

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 47.7 bits (114), Expect = 6e-06
 Identities = 21/99 (21%), Positives = 29/99 (29%), Gaps = 28/99 (28%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGP---------------------------IPDSFGDLI 34
           +P     L NL ++ L YN +Q                             I D     I
Sbjct: 145 LPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI 204

Query: 35  SLKFLNLSNNNLSGAIPA-SLEKLSYLENLNLSFNKLEG 72
            L  L L  N  S  I    L+ L+ L    L   + + 
Sbjct: 205 KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKD 243

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 77.4 bits (190), Expect = 3e-15
 Identities = 59/229 (25%), Positives = 95/229 (41%), Gaps = 52/229 (22%)

Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFDVECEMM------KSIRHRNLI 232
           ++G+G FG V  +      E+ AVK+  L+    ++  DVEC M+         +   L 
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405

Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSN---------YILDIFQRLNIMIDVASAL 283
           ++ S     +    V+EY+  G L  ++             Y  +I          A  L
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI----------AIGL 455

Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYM 342
            +L    S  II+ DLK  NV+LD      ++DF + K    +      T+T   T  Y+
Sbjct: 456 FFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGTPDYI 509

Query: 343 APE------YGREGRVSTNGDVYSFGIMLMETFTGKKP-----TNEIFN 380
           APE      YG+   V    D ++FG++L E   G+ P      +E+F 
Sbjct: 510 APEIIAYQPYGKS--V----DWWAFGVLLYEMLAGQAPFEGEDEDELFQ 552

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 77.0 bits (190), Expect = 3e-15
 Identities = 22/82 (26%), Positives = 35/82 (42%), Gaps = 1/82 (1%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAI-PASLEKLSYL 60
           +P+ + GL  L+ L L  N+ +     S  +  SL  L++  N     +    LE L  L
Sbjct: 293 LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENL 352

Query: 61  ENLNLSFNKLEGEIPRGGPFRN 82
             L+LS + +E         RN
Sbjct: 353 RELDLSHDDIETSDCCNLQLRN 374

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 76.6 bits (189), Expect = 4e-15
 Identities = 18/82 (21%), Positives = 28/82 (34%), Gaps = 2/82 (2%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
           +  T    L NL +L L   ++     D+F     L  L L+ N L      +L     L
Sbjct: 48  IQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKAL 107

Query: 61  ENLNLSFNKLEGEIPRGGPFRN 82
           ++L      +        P  N
Sbjct: 108 KHLFFIQTGISSIDF--IPLHN 127

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 74.7 bits (184), Expect = 2e-14
 Identities = 15/84 (17%), Positives = 22/84 (26%), Gaps = 2/84 (2%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
           +          L+ L L  N L      +     +LK L      +S      L     L
Sbjct: 72  IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131

Query: 61  ENLNLSFNKLEGEIPRGGPFRNFS 84
           E+L L  N +              
Sbjct: 132 ESLYLGSNHISSIKL--PKGFPTE 153

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 74.7 bits (184), Expect = 2e-14
 Identities = 14/75 (18%), Positives = 28/75 (37%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
           +  T + G K L++LF     +         +  +L+ L L +N++S            L
Sbjct: 96  MAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKL 155

Query: 61  ENLNLSFNKLEGEIP 75
           + L+   N +     
Sbjct: 156 KVLDFQNNAIHYLSK 170

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 72.0 bits (177), Expect = 1e-13
 Identities = 18/77 (23%), Positives = 26/77 (33%), Gaps = 1/77 (1%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
           +          L+ L L    L   +P     L +LK L LS N        S      L
Sbjct: 269 ISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSL 327

Query: 61  ENLNLSFNKLEGEIPRG 77
            +L++  N    E+  G
Sbjct: 328 THLSIKGNTKRLELGTG 344

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 72.0 bits (177), Expect = 1e-13
 Identities = 24/101 (23%), Positives = 35/101 (34%), Gaps = 2/101 (1%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
           +    +   K LE L+LG N +             LK L+  NN +       +  L   
Sbjct: 120 IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQA 179

Query: 61  EN--LNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPN 99
            N  LNL+ N + G  P       F   +F G + L     
Sbjct: 180 TNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFK 220

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 70.8 bits (174), Expect = 3e-13
 Identities = 19/78 (24%), Positives = 30/78 (38%), Gaps = 3/78 (3%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPI---PDSFGDLISLKFLNLSNNNLSGAIPASLEKL 57
                  GL  L++L L  N          +S   L  L+ L LS  +LS     +   L
Sbjct: 440 SSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSL 499

Query: 58  SYLENLNLSFNKLEGEIP 75
             + +++LS N+L     
Sbjct: 500 KMMNHVDLSHNRLTSSSI 517

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 70.4 bits (173), Expect = 4e-13
 Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 3/86 (3%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQ--GPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLS 58
           +    +  L+NL  L L ++ ++          +L  L+ LNLS N        + ++  
Sbjct: 341 LGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECP 400

Query: 59  YLENLNLSFNKLEGEIPRGGPFRNFS 84
            LE L+L+F +L+       PF+N  
Sbjct: 401 QLELLDLAFTRLKV-KDAQSPFQNLH 425

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 70.0 bits (172), Expect = 5e-13
 Identities = 18/83 (21%), Positives = 30/83 (36%), Gaps = 4/83 (4%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           IP  +    + E L   +N L      +F  LI+L FL+L+   +      + +    L+
Sbjct: 27  IPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLD 84

Query: 62  NLNLSFNKLEGEIPRGGPFRNFS 84
            L L+ N L              
Sbjct: 85  TLVLTANPLIFMAE--TALSGPK 105

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 70.0 bits (172), Expect = 5e-13
 Identities = 23/85 (27%), Positives = 32/85 (37%), Gaps = 5/85 (5%)

Query: 3   PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAI---PASLEKLSY 59
            +    L  L+ L L ++ L       F  L +L+ LNL  N+          SL+ L  
Sbjct: 418 QSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGR 477

Query: 60  LENLNLSFNKLEGEIPRGGPFRNFS 84
           LE L LSF  L         F +  
Sbjct: 478 LEILVLSFCDLSSIDQ--HAFTSLK 500

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 70.0 bits (172), Expect = 6e-13
 Identities = 19/73 (26%), Positives = 33/73 (45%), Gaps = 1/73 (1%)

Query: 3   PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLEN 62
              +  L  LE L L +  L      +F  L  +  ++LS+N L+ +   +L  L  +  
Sbjct: 469 TNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY- 527

Query: 63  LNLSFNKLEGEIP 75
           LNL+ N +   +P
Sbjct: 528 LNLASNHISIILP 540

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 69.7 bits (171), Expect = 7e-13
 Identities = 22/86 (25%), Positives = 34/86 (39%), Gaps = 2/86 (2%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDS-FGDLISLKFLNLSNNNLSGAIPASLEKLSY 59
           +          LE L L + RL+     S F +L  LK LNLS++ L  +     + L  
Sbjct: 391 LKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPA 450

Query: 60  LENLNLSFNKLEGEIPRG-GPFRNFS 84
           L++LNL  N       +     +   
Sbjct: 451 LQHLNLQGNHFPKGNIQKTNSLQTLG 476

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 67.7 bits (166), Expect = 3e-12
 Identities = 21/74 (28%), Positives = 34/74 (45%), Gaps = 3/74 (4%)

Query: 11  NLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKL 70
           ++E + L  +       ++F     L+ L+L+  +LS  +P+ L  LS L+ L LS NK 
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKF 313

Query: 71  EGEIPRGGPFRNFS 84
           E          NF 
Sbjct: 314 ENLCQ--ISASNFP 325

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 66.6 bits (163), Expect = 6e-12
 Identities = 25/102 (24%), Positives = 47/102 (46%), Gaps = 6/102 (5%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
           +       LK + ++ L +NRL     ++   L  + +LNL++N++S  +P+ L  LS  
Sbjct: 491 IDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQ 549

Query: 61  ENLNLSFNKLEGEIPRGGPFRNFSVES----FEGNELLCGSP 98
             +NL  N L+        F  +  E+     +  + LC +P
Sbjct: 550 RTINLRQNPLDC-TCSNIYFLEWYKENMQKLEDTEDTLCENP 590

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 66.2 bits (162), Expect = 9e-12
 Identities = 18/78 (23%), Positives = 37/78 (47%), Gaps = 3/78 (3%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPI-PDSFGDLISLKFLNLSNNNL--SGAIPASLEKL 57
           +         +L +L +  N  +  +      +L +L+ L+LS++++  S      L  L
Sbjct: 316 LCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNL 375

Query: 58  SYLENLNLSFNKLEGEIP 75
           S+L++LNLS+N+      
Sbjct: 376 SHLQSLNLSYNEPLSLKT 393

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 16/79 (20%), Positives = 30/79 (37%), Gaps = 5/79 (6%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDL--ISLKFLNLSNNNLSGAIPASLEKLSYLENLNL 65
            +++L          +   P  F  L  +S++ +NL  +        +    S L+ L+L
Sbjct: 226 TIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDL 285

Query: 66  SFNKLEGEIPRGGPFRNFS 84
           +   L  E+P G      S
Sbjct: 286 TATHLS-ELPSG--LVGLS 301

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 46.9 bits (112), Expect = 9e-06
 Identities = 12/100 (12%), Positives = 30/100 (30%), Gaps = 8/100 (8%)

Query: 1   VIPTEIGGLKNLE--YLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIP-----AS 53
           +   ++  L+      L L  N + G I     D    + LN         I      ++
Sbjct: 168 LSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNST 226

Query: 54  LEKLSYLENLNLSFNKLEGEIPRGGPFRNFSVESFEGNEL 93
           ++ L      ++    +   +  G    +    + + +  
Sbjct: 227 IQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYF 266

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 75.7 bits (187), Expect = 3e-15
 Identities = 53/228 (23%), Positives = 89/228 (39%), Gaps = 51/228 (22%)

Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFDVECEMM-----KSIRHRNLIK 233
           L+G+G FG V   R        A+K+  L+    +   +V   +      ++ RH  L  
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSN---------YILDIFQRLNIMIDVASALE 284
           +       +    V+EY   G L  ++             Y  +I           SALE
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI----------VSALE 119

Query: 285 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-ATIGYMA 343
           YLH   S  +++ D+K  N++LD +    ++DF + K    +  +    +T   T  Y+A
Sbjct: 120 YLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLA 173

Query: 344 PE------YGREGRVSTNGDVYSFGIMLMETFTGKKP-----TNEIFN 380
           PE      YGR   V    D +  G+++ E   G+ P        +F 
Sbjct: 174 PEVLEDNDYGRA--V----DWWGLGVVMYEMMCGRLPFYNQDHERLFE 215

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 75.9 bits (187), Expect = 5e-15
 Identities = 51/228 (22%), Positives = 92/228 (40%), Gaps = 50/228 (21%)

Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFDVECEM-----MKSIRHRNLIK 233
           L+G+G FG V   +        A+K+  L+    +   +V   +     +++ RH  L  
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKI--LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSN---------YILDIFQRLNIMIDVASALE 284
           +  +    +    V+EY   G L  ++             Y  +I           SAL+
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI----------VSALD 262

Query: 285 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-ATIGYMA 343
           YLH   +  +++ DLK  N++LD +    ++DF + K    +  +    +T   T  Y+A
Sbjct: 263 YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTPEYLA 317

Query: 344 PE------YGREGRVSTNGDVYSFGIMLMETFTGKKP-----TNEIFN 380
           PE      YGR   V    D +  G+++ E   G+ P       ++F 
Sbjct: 318 PEVLEDNDYGRA--V----DWWGLGVVMYEMMCGRLPFYNQDHEKLFE 359

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 74.6 bits (184), Expect = 8e-15
 Identities = 67/231 (29%), Positives = 96/231 (41%), Gaps = 56/231 (24%)

Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFDVECEMM------KSIRHRNLI 232
           +IG+G FG V  AR        AVKV  LQ    LK  + +  M       K+++H  L+
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102

Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSN---------YILDIFQRLNIMIDVASAL 283
            +  +    +    VL+Y+  G L  ++             Y  +I          ASAL
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI----------ASAL 152

Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAH--LSDFSIAKLLTGEDQSMTQTQTL-ATIG 340
            YLH   S  I++ DLKP N+LLD     H  L+DF + K     + +   T T   T  
Sbjct: 153 GYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNST---TSTFCGTPE 204

Query: 341 YMAPE------YGREGRVSTNGDVYSFGIMLMETFTGKKP-----TNEIFN 380
           Y+APE      Y R   V    D +  G +L E   G  P     T E+++
Sbjct: 205 YLAPEVLHKQPYDRT--V----DWWCLGAVLYEMLYGLPPFYSRNTAEMYD 249

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 74.7 bits (184), Expect = 1e-14
 Identities = 62/289 (21%), Positives = 114/289 (39%), Gaps = 78/289 (26%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVK-VFN-----LQCGRALKGFDVECEMMKSIR-HRNLI 232
           +G+G +G V+K+     G  VAVK +F+         R  +    E  ++  +  H N++
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR----EIMILTELSGHENIV 72

Query: 233 KVISTCSNEEFKA--LVLEYMPHGSLEKYMYSSN-------YILDIFQRLNIMIDVASAL 283
            +++    +  +   LV +YM    L   + ++        Y+  ++Q +         +
Sbjct: 73  NLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYV--VYQLIK-------VI 122

Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ----------- 332
           +YLH   S  ++H D+KPSN+LL+      ++DF +++      +               
Sbjct: 123 KYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179

Query: 333 --------TQTLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTGKKPTNE 377
                   T  +AT  Y APE       Y      +   D++S G +L E   G KP   
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKY------TKGIDMWSLGCILGEILCG-KP--- 229

Query: 378 IFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNL 426
           IF G       +N    I  + V+     S ED+  +      + + +L
Sbjct: 230 IFPG----SSTMNQLERI--IGVIDF--PSNEDVESIQSPFAKTMIESL 270

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 73.8 bits (182), Expect = 1e-14
 Identities = 61/225 (27%), Positives = 97/225 (43%), Gaps = 44/225 (19%)

Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFDVECEMM------KSIRHRNLI 232
           ++G+G FG V+ A      +  A+K   L+    L   DVEC M+       +  H  L 
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81

Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSN---------YILDIFQRLNIMIDVASAL 283
            +  T   +E    V+EY+  G L  ++ S +         Y  +I             L
Sbjct: 82  HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI----------ILGL 131

Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAH--LSDFSIAKLLTGEDQSMTQTQTL-ATIG 340
           ++LH   S  I++ DLK  N+LLD +   H  ++DF + K     D     T T   T  
Sbjct: 132 QFLH---SKGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAK---TNTFCGTPD 183

Query: 341 YMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP-----TNEIFN 380
           Y+APE     + + + D +SFG++L E   G+ P       E+F+
Sbjct: 184 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 59/229 (25%), Positives = 95/229 (41%), Gaps = 52/229 (22%)

Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFDVECEMM------KSIRHRNLI 232
           ++G+G FG V  +      E+ AVK+  L+    ++  DVEC M+         +   L 
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84

Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSN---------YILDIFQRLNIMIDVASAL 283
           ++ S     +    V+EY+  G L  ++             Y  +I          A  L
Sbjct: 85  QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI----------AIGL 134

Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-ATIGYM 342
            +L    S  II+ DLK  NV+LD      ++DF + K    +      T+T   T  Y+
Sbjct: 135 FFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGTPDYI 188

Query: 343 APE------YGREGRVSTNGDVYSFGIMLMETFTGKKP-----TNEIFN 380
           APE      YG+   V    D ++FG++L E   G+ P      +E+F 
Sbjct: 189 APEIIAYQPYGKS--V----DWWAFGVLLYEMLAGQAPFEGEDEDELFQ 231

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 52/229 (22%)

Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFDVECEMM------KSIRHRNLI 232
           ++G+G FG V  AR+ +  ++ AVKV  L+    L+  DVEC M        +  H  L 
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 87

Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSN---------YILDIFQRLNIMIDVASAL 283
           ++       +    V+E++  G L  ++  S          Y  +I           SAL
Sbjct: 88  QLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEI----------ISAL 137

Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-ATIGYM 342
            +LH      II+ DLK  NVLLD      L+DF + K       +   T T   T  Y+
Sbjct: 138 MFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDYI 191

Query: 343 APE------YGREGRVSTNGDVYSFGIMLMETFTGKKP-----TNEIFN 380
           APE      YG    V    D ++ G++L E   G  P      +++F 
Sbjct: 192 APEILQEMLYGPA--V----DWWAMGVLLYEMLCGHAPFEAENEDDLFE 234

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 72.7 bits (179), Expect = 3e-14
 Identities = 48/218 (22%), Positives = 97/218 (44%), Gaps = 42/218 (19%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCGRALKGFDVECEMMKSIR-HRNLIKVIST 237
           +GRG +  V++A  + +  +V VK+    +  +  +    E ++++++R   N+I +   
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR----EIKILENLRGGPNIITLADI 99

Query: 238 -CSNEEFK-ALVLEYMPHGSLEKYMYS-SNYILD--IFQRLNIMIDVASALEYLHFGYSA 292
                    ALV E++ +   ++   + ++Y +   +++ L        AL+Y H   S 
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK-------ALDYCH---SM 149

Query: 293 PIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE------ 345
            I+H D+KP NV++D ++    L D+ +A+      Q       +A+  +  PE      
Sbjct: 150 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEY--NVRVASRYFKGPELLVDYQ 206

Query: 346 -YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
            Y        + D++S G ML      K+P    F+G 
Sbjct: 207 MY------DYSLDMWSLGCMLASMIFRKEP---FFHGH 235

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 71.5 bits (176), Expect = 6e-14
 Identities = 22/75 (29%), Positives = 32/75 (42%), Gaps = 2/75 (2%)

Query: 2   IPTEIGGLKNLEYLFL-GYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
           +   I  L  LE L L G   L+   P  FG    LK L L + +    +P  + +L+ L
Sbjct: 221 LGPAIHHLPKLEELDLRGCTALRN-YPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQL 279

Query: 61  ENLNLSFNKLEGEIP 75
           E L+L        +P
Sbjct: 280 EKLDLRGCVNLSRLP 294

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 71.1 bits (175), Expect = 1e-13
 Identities = 19/83 (22%), Positives = 33/83 (39%), Gaps = 11/83 (13%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASL------- 54
           +P  +     LE L L  N L+  +P S   L  L+ L++        +P  L       
Sbjct: 119 LPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASG 177

Query: 55  --EKLSYLENLNLSFNKLEGEIP 75
             + L  L++L L +  +   +P
Sbjct: 178 EHQGLVNLQSLRLEWTGIR-SLP 199

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 24/75 (32%), Positives = 37/75 (49%), Gaps = 4/75 (5%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
              E  GL NL+ L L +  ++  +P S  +L +LK L + N+ LS A+  ++  L  LE
Sbjct: 175 ASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLE 232

Query: 62  NLNLS-FNKLEGEIP 75
            L+L     L    P
Sbjct: 233 ELDLRGCTALR-NYP 246

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 66.5 bits (163), Expect = 3e-12
 Identities = 14/71 (19%), Positives = 26/71 (36%), Gaps = 2/71 (2%)

Query: 2   IPTEIGGLKNLEYLFL-GYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
            P   GG   L+ L L   + L   +P     L  L+ L+L        +P+ + +L   
Sbjct: 245 YPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPAN 303

Query: 61  ENLNLSFNKLE 71
             + +  +   
Sbjct: 304 CIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 63.8 bits (156), Expect = 2e-11
 Identities = 16/76 (21%), Positives = 28/76 (36%), Gaps = 5/76 (6%)

Query: 2   IPTEIGGLK--NLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSY 59
               +          L L    L    PD    L  L+ + +    L   +P ++++ + 
Sbjct: 71  TADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAG 128

Query: 60  LENLNLSFNKLEGEIP 75
           LE L L+ N L   +P
Sbjct: 129 LETLTLARNPLR-ALP 143

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 54.6 bits (132), Expect = 3e-08
 Identities = 14/75 (18%), Positives = 24/75 (32%), Gaps = 5/75 (6%)

Query: 3   PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLIS--LKFLNLSNNNLSGAIPASLEKLSYL 60
                   N +        L+    D   D        L L +  L    P    +LS+L
Sbjct: 49  AWRQANSNNPQIETRTGRALKA-TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHL 106

Query: 61  ENLNLSFNKLEGEIP 75
           +++ +    L  E+P
Sbjct: 107 QHMTIDAAGLM-ELP 120

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 11/56 (19%), Positives = 19/56 (33%), Gaps = 3/56 (5%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNN---NLSGAIPASL 54
           +P +I  L  LE L L        +P     L +   + +  +    L    P + 
Sbjct: 269 LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 71.2 bits (175), Expect = 6e-14
 Identities = 37/171 (21%), Positives = 62/171 (36%), Gaps = 48/171 (28%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECE---MMKSIRHRNLIKVIS 236
           +G G  G V +        + A+K+                E     ++ +  ++++++ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 78

Query: 237 TCSNEEFKA----LVLEYMPHGSLEKYMYSSNYILDIFQRL--------------NIMID 278
              N         +V+E +  G L             F R+               IM  
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGEL-------------FSRIQDRGDQAFTEREASEIMKS 125

Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGE 326
           +  A++YLH   S  I H D+KP N+L      N +  L+DF  AK  TGE
Sbjct: 126 IGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE 173

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 71.5 bits (176), Expect = 8e-14
 Identities = 56/218 (25%), Positives = 84/218 (38%), Gaps = 47/218 (21%)

Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFDVECEMM------KSIRHRNLI 232
           +IGRG +  V   RL     + A+KV  ++        D++          ++  H  L+
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73

Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSN---------YILDIFQRLNIMIDVASAL 283
            + S    E     V+EY+  G L  +M             Y  +I          + AL
Sbjct: 74  GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI----------SLAL 123

Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-ATIGYM 342
            YLH      II+ DLK  NVLLD      L+D+ + K           T T   T  Y+
Sbjct: 124 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYI 177

Query: 343 APE------YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           APE      YG    V    D ++ G+++ E   G+ P
Sbjct: 178 APEILRGEDYGFS--V----DWWALGVLMFEMMAGRSP 209

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 55/218 (25%), Positives = 84/218 (38%), Gaps = 47/218 (21%)

Query: 180 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKGFDVECEMM------KSIRHRNLI 232
           +IGRG +  V   RL     + A++V  ++        D++          ++  H  L+
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116

Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSN---------YILDIFQRLNIMIDVASAL 283
            + S    E     V+EY+  G L  +M             Y  +I          + AL
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI----------SLAL 166

Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL-ATIGYM 342
            YLH      II+ DLK  NVLLD      L+D+ + K           T T   T  Y+
Sbjct: 167 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYI 220

Query: 343 APE------YGREGRVSTNGDVYSFGIMLMETFTGKKP 374
           APE      YG    V    D ++ G+++ E   G+ P
Sbjct: 221 APEILRGEDYGFS--V----DWWALGVLMFEMMAGRSP 252

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 20/84 (23%), Positives = 33/84 (39%), Gaps = 1/84 (1%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
           +       L +L  L L  N +Q     +F  L SL+ L     NL+      +  L  L
Sbjct: 67  IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126

Query: 61  ENLNLSFNKLEGEIPRGGPFRNFS 84
           + LN++ N ++        F N +
Sbjct: 127 KELNVAHNLIQ-SFKLPEYFSNLT 149

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 18/77 (23%), Positives = 34/77 (44%), Gaps = 1/77 (1%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQG-PIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
           + +   GL+ LE+L   ++ L+       F  L +L +L++S+ +   A       LS L
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447

Query: 61  ENLNLSFNKLEGEIPRG 77
           E L ++ N  +      
Sbjct: 448 EVLKMAGNSFQENFLPD 464

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 68.2 bits (167), Expect = 2e-12
 Identities = 18/71 (25%), Positives = 31/71 (43%), Gaps = 2/71 (2%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPA-SLEKLSYLENLNLS 66
            L+NL YL + +   +      F  L SL+ L ++ N+           +L  L  L+LS
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478

Query: 67  FNKLEGEIPRG 77
             +LE ++   
Sbjct: 479 QCQLE-QLSPT 488

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 67.4 bits (165), Expect = 3e-12
 Identities = 15/82 (18%), Positives = 25/82 (30%), Gaps = 2/82 (2%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
           +          L+ L L    +Q     ++  L  L  L L+ N +      +   LS L
Sbjct: 43  LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSL 102

Query: 61  ENLNLSFNKLEGEIPRGGPFRN 82
           + L      L        P  +
Sbjct: 103 QKLVAVETNLASLEN--FPIGH 122

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 67.0 bits (164), Expect = 5e-12
 Identities = 22/83 (26%), Positives = 39/83 (46%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
            +P     L+NL +L L   +L+   P +F  L SL+ LN+++N L        ++L+ L
Sbjct: 461 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSL 520

Query: 61  ENLNLSFNKLEGEIPRGGPFRNF 83
           + + L  N  +   PR      +
Sbjct: 521 QKIWLHTNPWDCSCPRIDYLSRW 543

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 66.3 bits (162), Expect = 8e-12
 Identities = 22/77 (28%), Positives = 37/77 (48%), Gaps = 4/77 (5%)

Query: 8   GLKNLEYLFLGYNRLQ--GPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNL 65
            L +LE+L L  N L   G    S     SLK+L+LS N +   + ++   L  LE+L+ 
Sbjct: 345 DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDF 403

Query: 66  SFNKLEGEIPRGGPFRN 82
             + L+ ++     F +
Sbjct: 404 QHSNLK-QMSEFSVFLS 419

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 25/92 (27%), Positives = 43/92 (46%), Gaps = 7/92 (7%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQ-GPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSY 59
           +    IG LK L+ L + +N +Q   +P+ F +L +L+ L+LS+N +       L  L  
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174

Query: 60  LEN----LNLSFNKLEGEIPRGGPFRNFSVES 87
           +      L+LS N +   I   G F+   +  
Sbjct: 175 MPLLNLSLDLSLNPMN-FIQP-GAFKEIRLHK 204

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 61.7 bits (150), Expect = 3e-10
 Identities = 19/76 (25%), Positives = 34/76 (44%), Gaps = 3/76 (3%)

Query: 2  IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
          IP  +    + + L L +N L+     SF     L+ L+LS   +      + + LS+L 
Sbjct: 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79

Query: 62 NLNLSFNKLEGEIPRG 77
           L L+ N ++  +  G
Sbjct: 80 TLILTGNPIQ-SLALG 94

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 17/72 (23%), Positives = 29/72 (40%), Gaps = 2/72 (2%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPAS-LEKLSY 59
                  G  +L+YL L +N +   +  +F  L  L+ L+  ++NL      S    L  
Sbjct: 364 CCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422

Query: 60  LENLNLSFNKLE 71
           L  L++S     
Sbjct: 423 LIYLDISHTHTR 434

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 25/72 (34%), Positives = 35/72 (48%), Gaps = 5/72 (6%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLS--GAIPASLEKLSYLENLNL 65
            LK+L+ L    N+       S  DL SL+FL+LS N LS  G    S    + L+ L+L
Sbjct: 323 KLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380

Query: 66  SFNKLEGEIPRG 77
           SFN +   +   
Sbjct: 381 SFNGVI-TMSSN 391

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 69.9 bits (172), Expect = 3e-13
 Identities = 55/237 (23%), Positives = 91/237 (38%), Gaps = 65/237 (27%)

Query: 180 LIGRGGFGSVYKARL----GDGMEVAVKVFN----LQCGRALKGFDVECEMM-----KSI 226
           ++G+GG+G V++ R       G   A+KV      ++        D           + +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR-----NAKDTAHTKAERNILEEV 78

Query: 227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSN---------YILDIFQRLNIMI 277
           +H  ++ +I          L+LEY+  G L   +             Y+ +I        
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI-------- 130

Query: 278 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH--LSDFSIAKLLTGEDQSMTQTQT 335
             + AL +LH      II+ DLKP N++L+     H  L+DF + K    +      T T
Sbjct: 131 --SMALGHLH---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTV---THT 180

Query: 336 LA-TIGYMAPE------YGREGRVSTNGDVYSFGIMLMETFTGKKP-----TNEIFN 380
              TI YMAPE      + R   V    D +S G ++ +  TG  P       +  +
Sbjct: 181 FCGTIEYMAPEILMRSGHNRA--V----DWWSLGALMYDMLTGAPPFTGENRKKTID 231

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 69.1 bits (170), Expect = 4e-13
 Identities = 56/232 (24%), Positives = 96/232 (41%), Gaps = 57/232 (24%)

Query: 180 LIGRGGFGSVYKARLGDGMEV----AVKVFNLQCGRALKGFDVECEM----MKSIRHRNL 231
           ++G+G FG V+  +   G +     A+KV  L+         V  +M    +  + H  +
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKV--LKKATLKVRDRVRTKMERDILVEVNHPFI 88

Query: 232 IKVISTCSNEEFKALVLEYMPHGSLEKYMYSSN---------YILDIFQRLNIMIDVASA 282
           +K+      E    L+L+++  G L   +             Y+ ++          A A
Sbjct: 89  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL----------ALA 138

Query: 283 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH--LSDFSIAKLLTGEDQSMTQTQTL-ATI 339
           L++LH   S  II+ DLKP N+LLD+    H  L+DF ++K     ++      +   T+
Sbjct: 139 LDHLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKK---AYSFCGTV 190

Query: 340 GYMAPE------YGREGRVSTNGDVYSFGIMLMETFTGKKP-----TNEIFN 380
            YMAPE      + +        D +SFG+++ E  TG  P       E   
Sbjct: 191 EYMAPEVVNRRGHTQS--A----DWWSFGVLMFEMLTGTLPFQGKDRKETMT 236

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 68.5 bits (168), Expect = 1e-12
 Identities = 23/109 (21%), Positives = 40/109 (36%), Gaps = 7/109 (6%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           +      +  L+ L L +N L   +  +      L+ L L +N++   +  S      L+
Sbjct: 287 LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLK 342

Query: 62  NLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPP--CKTS 108
           NL LS N  +        FRN +  + +  +  C           CK S
Sbjct: 343 NLTLSHNDWD-CNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKES 390

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 20/72 (27%), Positives = 33/72 (45%), Gaps = 2/72 (2%)

Query: 6   IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNL 65
           +     L  + L YN L+  +   F  +  L+ L +SNN L  A+    + +  L+ L+L
Sbjct: 244 LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDL 302

Query: 66  SFNKLEGEIPRG 77
           S N L   + R 
Sbjct: 303 SHNHLL-HVERN 313

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 60.8 bits (148), Expect = 3e-10
 Identities = 16/77 (20%), Positives = 32/77 (41%), Gaps = 2/77 (2%)

Query: 2   IPTEI-GGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
           +P  +    + +E L L   +++     +F    +++ L +  N +    P   + +  L
Sbjct: 60  LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLL 119

Query: 61  ENLNLSFNKLEGEIPRG 77
             L L  N L   +PRG
Sbjct: 120 TVLVLERNDLS-SLPRG 135

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 60.8 bits (148), Expect = 3e-10
 Identities = 23/96 (23%), Positives = 37/96 (38%), Gaps = 4/96 (4%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
            +  L  L L  N L       F +   L  L++SNNNL      + +  + L+NL LS 
Sbjct: 115 NVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSS 174

Query: 68  NKLEGEIPRGGPFRNFSVESFEGNEL--LCGSPNLQ 101
           N+L   +       +    +   N L  L     ++
Sbjct: 175 NRLT-HVDLSL-IPSLFHANVSYNLLSTLAIPIAVE 208

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 57.7 bits (140), Expect = 3e-09
 Identities = 9/69 (13%), Positives = 25/69 (36%), Gaps = 1/69 (1%)

Query: 9   LKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN 68
           L N + +    + ++            ++ LNL++  +      +      ++ L + FN
Sbjct: 44  LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFN 103

Query: 69  KLEGEIPRG 77
            +   +P  
Sbjct: 104 AIR-YLPPH 111

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 51.2 bits (123), Expect = 3e-07
 Identities = 18/74 (24%), Positives = 32/74 (43%), Gaps = 6/74 (8%)

Query: 4   TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 63
           + +     +E L   +N +   +       + L  L L +NNL+    A L     L  +
Sbjct: 199 STLAIPIAVEELDASHNSINV-VRG--PVNVELTILKLQHNNLTD--TAWLLNYPGLVEV 253

Query: 64  NLSFNKLEGEIPRG 77
           +LS+N+LE +I   
Sbjct: 254 DLSYNELE-KIMYH 266

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 50.8 bits (122), Expect = 4e-07
 Identities = 13/66 (19%), Positives = 30/66 (45%), Gaps = 8/66 (12%)

Query: 5   EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLN 64
           ++  + +L +  + YN L      +    I+++ L+ S+N+++  +   +     L  L 
Sbjct: 181 DLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILK 232

Query: 65  LSFNKL 70
           L  N L
Sbjct: 233 LQHNNL 238

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 45.4 bits (108), Expect = 3e-05
 Identities = 13/76 (17%), Positives = 26/76 (34%), Gaps = 1/76 (1%)

Query: 2  IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
          I + +        + +               L + K +   N+ +     A L+    +E
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72

Query: 62 NLNLSFNKLEGEIPRG 77
           LNL+  ++E EI   
Sbjct: 73 LLNLNDLQIE-EIDTY 87

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 47/253 (18%), Positives = 94/253 (37%), Gaps = 50/253 (19%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGF----DVECEMMKSIR------- 227
            +G G F +V+ A+ + +   VA+K+      R  K +    + E ++++ +        
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIV-----RGDKVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 228 -HRNLIKVISTCSNEEFKA-------LVLEYMPHGSLEKYMYSSNYI---LDIFQRLNIM 276
                  ++    +   K        +V E +   +L   +    +    L   ++  I 
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ--IS 137

Query: 277 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH------LSDFSIAKLLTGEDQSM 330
             +   L+Y+H      IIH D+KP NVL++            ++D   A      D+  
Sbjct: 138 KQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDEHY 192

Query: 331 TQT-QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWV 389
           T + QT     Y +PE           D++S   ++ E  TG      +F  +    +  
Sbjct: 193 TNSIQTRE---YRSPEVLLGAPWGCGADIWSTACLIFELITGDF----LFEPDEGHSYTK 245

Query: 390 NDWLPISTMEVVG 402
           +D      +E++G
Sbjct: 246 DDDHIAQIIELLG 258

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 23/109 (21%), Positives = 39/109 (35%), Gaps = 12/109 (11%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           +  ++     L+ L L  N+L   +   F     + +++L NN L   I  +L     LE
Sbjct: 184 VKGQVV-FAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240

Query: 62  NLNLSFNKLEGEIPRGGPFRNFSVESFEGN---------ELLCGSPNLQ 101
           + +L  N       R    +N  V++             E  C  P L 
Sbjct: 241 HFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLG 289

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 65.8 bits (161), Expect = 5e-12
 Identities = 21/83 (25%), Positives = 31/83 (37%), Gaps = 4/83 (4%)

Query: 2  IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
          I          +   +  + L+  +        ++K L+LS N LS    A L   + LE
Sbjct: 2  IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 62 NLNLSFNKLEGEIPRGGPFRNFS 84
           LNLS N L  E        + S
Sbjct: 62 LLNLSSNVLY-ETL---DLESLS 80

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 65.0 bits (159), Expect = 7e-12
 Identities = 22/77 (28%), Positives = 32/77 (41%), Gaps = 4/77 (5%)

Query: 2  IPTEIG-GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
              +     N++ L L  N L             L+ LNLS+N L       LE LS L
Sbjct: 25 ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLSTL 82

Query: 61 ENLNLSFNKLEGEIPRG 77
            L+L+ N ++ E+  G
Sbjct: 83 RTLDLNNNYVQ-ELLVG 98

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 65.0 bits (159), Expect = 9e-12
 Identities = 17/76 (22%), Positives = 32/76 (42%), Gaps = 4/76 (5%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQG-PIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSY 59
           +   + G    ++YL L  N +      +      +L+ LNL  N +   +   +   + 
Sbjct: 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAK 192

Query: 60  LENLNLSFNKLEGEIP 75
           L+ L+LS NKL   + 
Sbjct: 193 LKTLDLSSNKLA-FMG 207

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 62.3 bits (152), Expect = 6e-11
 Identities = 16/77 (20%), Positives = 30/77 (38%), Gaps = 8/77 (10%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
           +   ++     LE L L  N L   +      L +L+ L+L+NN +       L     +
Sbjct: 49  ISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSI 101

Query: 61  ENLNLSFNKLEGEIPRG 77
           E L+ + N +   +   
Sbjct: 102 ETLHAANNNIS-RVSCS 117

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 15/108 (13%), Positives = 35/108 (32%), Gaps = 10/108 (9%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSG-AIPASLEKLSYL 60
           +       +  + ++L  N++        G    +++L+L  N +              L
Sbjct: 114 VSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171

Query: 61  ENLNLSFNKLEGEIPRGGPFRNFSVESFEGNEL------LCGSPNLQV 102
           E+LNL +N +  ++     F          N+L         +  +  
Sbjct: 172 EHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTW 218

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 59.6 bits (145), Expect = 6e-10
 Identities = 12/79 (15%), Positives = 29/79 (36%), Gaps = 4/79 (5%)

Query: 4   TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 63
            E+    ++E L    N +   +          K + L+NN ++          S ++ L
Sbjct: 93  QELLVGPSIETLHAANNNISR-VS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYL 149

Query: 64  NLSFNKLEGEIPRGGPFRN 82
           +L  N+++  +       +
Sbjct: 150 DLKLNEID-TVNFAELAAS 167

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 20/95 (21%), Positives = 32/95 (33%), Gaps = 11/95 (11%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
           GL NL  L L +N +      S  +   L+ L+L+NN L   +P  L    Y++ + L  
Sbjct: 214 GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHN 272

Query: 68  NKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQV 102
           N +                 F          +   
Sbjct: 273 NNI----------SAIGSNDFCPPGYNTKKASYSG 297

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 58.9 bits (143), Expect = 9e-10
 Identities = 18/72 (25%), Positives = 35/72 (48%), Gaps = 6/72 (8%)

Query: 8   GLKNLEYLFLGYNRLQ-GPIPD-SFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNL 65
           GL  +  + LG N L+   I + +F  +  L ++ +++ N++  IP  L     L  L+L
Sbjct: 143 GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHL 199

Query: 66  SFNKLEGEIPRG 77
             NK+  ++   
Sbjct: 200 DGNKIT-KVDAA 210

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 18/77 (23%), Positives = 30/77 (38%), Gaps = 8/77 (10%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSG------AIPASLEKLSYLE 61
              +L  L L  N+L   +P    D   ++ + L NNN+S         P    K +   
Sbjct: 238 NTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYS 296

Query: 62  NLNLSFNKLE-GEIPRG 77
            ++L  N ++  EI   
Sbjct: 297 GVSLFSNPVQYWEIQPS 313

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 56.9 bits (138), Expect = 5e-09
 Identities = 24/78 (30%), Positives = 37/78 (47%), Gaps = 3/78 (3%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           +P ++    +   L L  N++       F +L +L  L L NN +S   P +   L  LE
Sbjct: 46  VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 103

Query: 62  NLNLSFNKLEGEIPRGGP 79
            L LS N+L+ E+P   P
Sbjct: 104 RLYLSKNQLK-ELPEKMP 120

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 56.2 bits (136), Expect = 8e-09
 Identities = 20/70 (28%), Positives = 34/70 (48%), Gaps = 4/70 (5%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
            LKNL  L L  N++    P +F  L+ L+ L LS N L   +P  +     L+ L +  
Sbjct: 74  NLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHE 130

Query: 68  NKLEGEIPRG 77
           N++  ++ + 
Sbjct: 131 NEIT-KVRKS 139

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 50.4 bits (121), Expect = 5e-07
 Identities = 17/71 (23%), Positives = 31/71 (43%), Gaps = 4/71 (5%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
            L  LE L+L  N+L+  +P+      +L+ L +  N ++    +    L+ +  + L  
Sbjct: 98  PLVKLERLYLSKNQLKE-LPE--KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT 154

Query: 68  NKL-EGEIPRG 77
           N L    I  G
Sbjct: 155 NPLKSSGIENG 165

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 49.6 bits (119), Expect = 8e-07
 Identities = 11/76 (14%), Positives = 26/76 (34%), Gaps = 8/76 (10%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQG------PIPDSFGDLISLKFLNLSNNNLSGAI--PAS 53
           +P  +   K ++ ++L  N +          P       S   ++L +N +      P++
Sbjct: 255 VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPST 314

Query: 54  LEKLSYLENLNLSFNK 69
              +     + L   K
Sbjct: 315 FRCVYVRAAVQLGNYK 330

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 67.2 bits (165), Expect = 2e-12
 Identities = 18/69 (26%), Positives = 33/69 (47%), Gaps = 2/69 (2%)

Query: 3   PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLEN 62
            + +  L  L  LFL  N+L     +  G L +L  L LS N+++   P  L  LS +++
Sbjct: 280 ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDS 337

Query: 63  LNLSFNKLE 71
            + +   ++
Sbjct: 338 ADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 66.4 bits (163), Expect = 4e-12
 Identities = 15/74 (20%), Positives = 30/74 (40%), Gaps = 4/74 (5%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
             + +  +  L YL +  ++++   P    +L  L  L+L+ N +    P  L  L+ L 
Sbjct: 147 DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLH 202

Query: 62  NLNLSFNKLEGEIP 75
                 N++    P
Sbjct: 203 YFTAYVNQITDITP 216

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 65.6 bits (161), Expect = 7e-12
 Identities = 15/71 (21%), Positives = 32/71 (45%), Gaps = 3/71 (4%)

Query: 5   EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLN 64
            +  L  +  L LG N           ++  L +L ++ + +    P  +  L+ L +L+
Sbjct: 127 PLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLS 183

Query: 65  LSFNKLEGEIP 75
           L++N++E   P
Sbjct: 184 LNYNQIEDISP 194

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 64.9 bits (159), Expect = 1e-11
 Identities = 19/71 (26%), Positives = 29/71 (40%), Gaps = 2/71 (2%)

Query: 5   EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLN 64
            +  L  L+ L +G N++         +L  L  L L+NN L       +  L+ L  L 
Sbjct: 260 AVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLF 317

Query: 65  LSFNKLEGEIP 75
           LS N +    P
Sbjct: 318 LSQNHITDIRP 328

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 64.5 bits (158), Expect = 2e-11
 Identities = 16/69 (23%), Positives = 29/69 (42%), Gaps = 4/69 (5%)

Query: 4   TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 63
           + +  L +L Y     N++    P    ++  L  L + NN ++   P  L  LS L  L
Sbjct: 193 SPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWL 248

Query: 64  NLSFNKLEG 72
            +  N++  
Sbjct: 249 EIGTNQISD 257

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 63.3 bits (155), Expect = 4e-11
 Identities = 18/72 (25%), Positives = 36/72 (50%), Gaps = 4/72 (5%)

Query: 4   TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 63
           + +  L  L  L++G N++      +  +L +L+ L L+ +N+S   P  L  L+ + +L
Sbjct: 82  SPLSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP--LANLTKMYSL 137

Query: 64  NLSFNKLEGEIP 75
           NL  N    ++ 
Sbjct: 138 NLGANHNLSDLS 149

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 62.9 bits (154), Expect = 4e-11
 Identities = 16/74 (21%), Positives = 32/74 (43%), Gaps = 3/74 (4%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
             + +  L NL  L+L  + +    P    +L  +  LNL  N+      + L  ++ L 
Sbjct: 102 DISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLN 158

Query: 62  NLNLSFNKLEGEIP 75
            L ++ +K++   P
Sbjct: 159 YLTVTESKVKDVTP 172

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 62.2 bits (152), Expect = 8e-11
 Identities = 20/72 (27%), Positives = 34/72 (47%), Gaps = 4/72 (5%)

Query: 4   TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 63
             I  L NLEYL L  N++    P    +L+ L  L +  N ++    ++L+ L+ L  L
Sbjct: 60  QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLREL 115

Query: 64  NLSFNKLEGEIP 75
            L+ + +    P
Sbjct: 116 YLNEDNISDISP 127

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 62.2 bits (152), Expect = 1e-10
 Identities = 19/72 (26%), Positives = 32/72 (44%), Gaps = 4/72 (5%)

Query: 4   TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 63
           T I  L +L  L L YN+++   P     L SL +     N ++   P  +  ++ L +L
Sbjct: 171 TPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSL 226

Query: 64  NLSFNKLEGEIP 75
            +  NK+    P
Sbjct: 227 KIGNNKITDLSP 238

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 61.8 bits (151), Expect = 1e-10
 Identities = 25/91 (27%), Positives = 42/91 (46%), Gaps = 5/91 (5%)

Query: 4   TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 63
           + +  L  L +L +G N++     ++  DL  LK LN+ +N +S    + L  LS L +L
Sbjct: 237 SPLANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSL 292

Query: 64  NLSFNKLEGEIPRG-GPFRNFSVESFEGNEL 93
            L+ N+L  E     G   N +      N +
Sbjct: 293 FLNNNQLGNEDMEVIGGLTNLTTLFLSQNHI 323

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 54.5 bits (132), Expect = 2e-08
 Identities = 15/72 (20%), Positives = 28/72 (38%), Gaps = 4/72 (5%)

Query: 4  TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 63
               L       L    +   +     +L S+  L ++   ++  I   +E L+ LE L
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS-IQG-IEYLTNLEYL 71

Query: 64 NLSFNKLEGEIP 75
          NL+ N++    P
Sbjct: 72 NLNGNQITDISP 83

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 54.5 bits (132), Expect = 3e-08
 Identities = 16/69 (23%), Positives = 30/69 (43%), Gaps = 4/69 (5%)

Query: 3   PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLEN 62
                 L+++  L +   ++          L +L++LNL+ N ++   P  L  L  L N
Sbjct: 37  VVTQEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTN 92

Query: 63  LNLSFNKLE 71
           L +  NK+ 
Sbjct: 93  LYIGTNKIT 101

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 46.8 bits (112), Expect = 8e-06
 Identities = 13/47 (27%), Positives = 18/47 (38%), Gaps = 2/47 (4%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLS 47
                IGGL NL  LFL  N +    P     L  +   + +N  + 
Sbjct: 302 EDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 65.0 bits (159), Expect = 2e-12
 Identities = 17/67 (25%), Positives = 31/67 (46%)

Query: 4   TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 63
             I GL NLE L +    +      +   L SL  L++S++    +I   +  L  + ++
Sbjct: 82  NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSI 141

Query: 64  NLSFNKL 70
           +LS+N  
Sbjct: 142 DLSYNGA 148

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 61.5 bits (150), Expect = 3e-11
 Identities = 16/68 (23%), Positives = 30/68 (44%), Gaps = 1/68 (1%)

Query: 3   PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLEN 62
              + GL +L  L + ++     I      L  +  ++LS N     I   L+ L  L++
Sbjct: 105 IPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKS 163

Query: 63  LNLSFNKL 70
           LN+ F+ +
Sbjct: 164 LNIQFDGV 171

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 59.2 bits (144), Expect = 2e-10
 Identities = 14/72 (19%), Positives = 29/72 (40%), Gaps = 2/72 (2%)

Query: 4   TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 63
           T I    N++ L +         P     L +L+ L +   +++     +L  L+ L  L
Sbjct: 60  TGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117

Query: 64  NLSFNKLEGEIP 75
           ++S +  +  I 
Sbjct: 118 DISHSAHDDSIL 129

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 54.6 bits (132), Expect = 7e-09
 Identities = 17/73 (23%), Positives = 26/73 (35%), Gaps = 3/73 (4%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
            I T+I  L  +  + L YN     I      L  LK LN+  + +       +E    L
Sbjct: 127 SILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKL 183

Query: 61  ENLNLSFNKLEGE 73
             L      + G+
Sbjct: 184 NQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 40.7 bits (96), Expect = 3e-04
 Identities = 10/63 (15%), Positives = 24/63 (38%), Gaps = 5/63 (7%)

Query: 9  LKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN 68
           K      LG +        +   + SL ++ L+N N++      +E    +++L ++  
Sbjct: 22 FKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNI 76

Query: 69 KLE 71
             
Sbjct: 77 HAT 79

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 25/80 (31%), Positives = 39/80 (48%), Gaps = 1/80 (1%)

Query: 3   PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLEN 62
             ++    NL+ L L  +R+     D+F  L SL+ L+LS+N+LS    +    LS L+ 
Sbjct: 43  HGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKY 102

Query: 63  LNLSFNKLEGEIPRGGPFRN 82
           LNL  N  +  +     F N
Sbjct: 103 LNLMGNPYQ-TLGVTSLFPN 121

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 20/94 (21%), Positives = 32/94 (34%), Gaps = 5/94 (5%)

Query: 6   IGGLKNLEYLFLGYNRLQG-PIPDSFGDLISLKFLNLSNNNLSGAIPA-SLEKLSYLENL 63
            G L +L+YL L  N  Q   +   F +L +L+ L + N      I       L+ L  L
Sbjct: 94  FGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNEL 153

Query: 64  NLSFNKLEGEIPRG--GPFRNFSVESFEGNELLC 95
            +    L            R+    +   +E   
Sbjct: 154 EIKALSLR-NYQSQSLKSIRDIHHLTLHLSESAF 186

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 22/100 (22%), Positives = 35/100 (35%), Gaps = 5/100 (5%)

Query: 3   PTEIGGLKNLEYLFLGYNRLQ--GPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
               G   +L+ L L  N L+      +    L +L  L++S N     +P S +    +
Sbjct: 354 SACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKM 412

Query: 61  ENLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNL 100
             LNLS   +   +      +   V     N L   S  L
Sbjct: 413 RFLNLSSTGIR-VVKTCI-PQTLEVLDVSNNNLDSFSLFL 450

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 60.9 bits (148), Expect = 4e-10
 Identities = 31/103 (30%), Positives = 43/103 (41%), Gaps = 19/103 (18%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLS---GAIPASLEKL------- 57
            LKNL  L +  N    P+PDS      ++FLNLS+  +      IP +LE L       
Sbjct: 385 TLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNL 443

Query: 58  -------SYLENLNLSFNKLEGEIPRGGPFRNFSVESFEGNEL 93
                    L+ L +S NKL+  +P    F    V     N+L
Sbjct: 444 DSFSLFLPRLQELYISRNKLK-TLPDASLFPVLLVMKISRNQL 485

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 18/85 (21%), Positives = 30/85 (35%), Gaps = 3/85 (3%)

Query: 3   PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAI---PASLEKLSY 59
            T    L+ ++ + +  +++          L SL+FL+LS N +        A       
Sbjct: 303 STVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPS 362

Query: 60  LENLNLSFNKLEGEIPRGGPFRNFS 84
           L+ L LS N L      G       
Sbjct: 363 LQTLVLSQNHLRSMQKTGEILLTLK 387

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 18/114 (15%), Positives = 32/114 (28%), Gaps = 5/114 (4%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
           GL +L  L +    L+     S   +  +  L L  +  +  +    + LS +  L L  
Sbjct: 146 GLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRD 205

Query: 68  NKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCKTSNHHTLWKNSLLLR 121
             L         F    V+               +     +    L +  L L 
Sbjct: 206 TNLARF-----QFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELS 254

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 20/143 (13%), Positives = 43/143 (30%), Gaps = 5/143 (3%)

Query: 2   IPTEIGGLKNLEYLFLG-YNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
           + +    L NL+ L +G            F  L SL  L +   +L      SL+ +  +
Sbjct: 115 VTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDI 174

Query: 61  ENLNLSFNKLEGEIPRG--GPFRNFSVESFEGNELLCGSPNLQVPPCKTSNHHTLWKNSL 118
            +L L  ++    +         +           L       +P  + S+         
Sbjct: 175 HHLTLHLSESA-FLLEIFADILSSVRYLELRDTN-LARFQFSPLPVDEVSSPMKKLAFRG 232

Query: 119 LLRIVLPLSAIFMIVVILLILRY 141
            +      + +  ++  +L L  
Sbjct: 233 SVLTDESFNELLKLLRYILELSE 255

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 17/81 (20%), Positives = 34/81 (41%), Gaps = 4/81 (4%)

Query: 2  IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
          IP+ +     ++ L L +N++            +L+ L L ++ ++     +   L  LE
Sbjct: 20 IPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLE 77

Query: 62 NLNLSFNKLEGEIPRGGPFRN 82
          +L+LS N L   +     F  
Sbjct: 78 HLDLSDNHLS-SLSS-SWFGP 96

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 12/62 (19%), Positives = 25/62 (40%)

Query: 9   LKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN 68
              +  L +    L   +   +  L  +K + + N+ +     +  + L  LE L+LS N
Sbjct: 285 TVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSEN 344

Query: 69  KL 70
            +
Sbjct: 345 LM 346

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 50.5 bits (121), Expect = 7e-07
 Identities = 14/63 (22%), Positives = 26/63 (41%), Gaps = 2/63 (3%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
            L  L+ L++  N+L+     S      L  + +S N L        ++L+ L+ + L  
Sbjct: 449 FLPRLQELYISRNKLKTLPDASL--FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHT 506

Query: 68  NKL 70
           N  
Sbjct: 507 NPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 6/73 (8%), Positives = 22/73 (30%), Gaps = 1/73 (1%)

Query: 5   EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLN 64
           E              +           + ++++ L++    L   +      L  ++ + 
Sbjct: 257 EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRIT 316

Query: 65  LSFNKLEGEIPRG 77
           +  +K+   +P  
Sbjct: 317 VENSKVF-LVPCS 328

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 67.2 bits (164), Expect = 3e-12
 Identities = 20/117 (17%), Positives = 37/117 (31%), Gaps = 4/117 (3%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           +  ++     L+ L L  N+L   +   F     + +++L NN L   I  +L     LE
Sbjct: 184 VKGQVV-FAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240

Query: 62  NLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCKTSNHHTLWKNSL 118
           + +L  N       R    +N  V++      +          C             
Sbjct: 241 HFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT-VKKLTGQNEEECTVPTLGHYGAYCC 296

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 22/77 (28%), Positives = 33/77 (42%), Gaps = 3/77 (3%)

Query: 1  VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
           + +      N++ L L  N L             L+ LNLS+N L       LE LS L
Sbjct: 25 ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLSTL 82

Query: 61 ENLNLSFNKLEGEIPRG 77
            L+L+ N ++ E+  G
Sbjct: 83 RTLDLNNNYVQ-ELLVG 98

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 19/71 (26%), Positives = 28/71 (39%)

Query: 2  IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
          I          +   +  + L+  +        ++K L+LS N LS    A L   + LE
Sbjct: 2  IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 62 NLNLSFNKLEG 72
           LNLS N L  
Sbjct: 62 LLNLSSNVLYE 72

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 63.7 bits (155), Expect = 5e-11
 Identities = 17/76 (22%), Positives = 32/76 (42%), Gaps = 4/76 (5%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQG-PIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSY 59
           +   + G    ++YL L  N +      +      +L+ LNL  N +   +   +   + 
Sbjct: 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAK 192

Query: 60  LENLNLSFNKLEGEIP 75
           L+ L+LS NKL   + 
Sbjct: 193 LKTLDLSSNKLA-FMG 207

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 59.9 bits (145), Expect = 7e-10
 Identities = 13/79 (16%), Positives = 30/79 (37%), Gaps = 4/79 (5%)

Query: 4   TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 63
            E+    ++E L    N +   +  S       K + L+NN ++          S ++ L
Sbjct: 93  QELLVGPSIETLHAANNNISR-VSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYL 149

Query: 64  NLSFNKLEGEIPRGGPFRN 82
           +L  N+++  +       +
Sbjct: 150 DLKLNEID-TVNFAELAAS 167

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 15/108 (13%), Positives = 35/108 (32%), Gaps = 10/108 (9%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSG-AIPASLEKLSYL 60
           +       +  + ++L  N++        G    +++L+L  N +              L
Sbjct: 114 VSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171

Query: 61  ENLNLSFNKLEGEIPRGGPFRNFSVESFEGNEL------LCGSPNLQV 102
           E+LNL +N +  ++     F          N+L         +  +  
Sbjct: 172 EHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTW 218

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 17/73 (23%), Positives = 31/73 (42%), Gaps = 9/73 (12%)

Query: 5   EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLN 64
           ++  L  L  L L  N +Q           S++ L+ +NNN+S  +  S       +N+ 
Sbjct: 75  DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIY 126

Query: 65  LSFNKLEGEIPRG 77
           L+ NK+   +   
Sbjct: 127 LANNKIT-MLRDL 138

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 41.0 bits (96), Expect = 7e-04
 Identities = 5/67 (7%), Positives = 16/67 (23%), Gaps = 1/67 (1%)

Query: 9   LKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN 68
            K    L    +  +  +     +    + ++         I     +      L     
Sbjct: 312 RKEHALLSGQGSETER-LECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKK 370

Query: 69  KLEGEIP 75
            L+ ++ 
Sbjct: 371 ALDEQVS 377

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 66.2 bits (162), Expect = 5e-12
 Identities = 57/222 (25%), Positives = 89/222 (40%), Gaps = 48/222 (21%)

Query: 180 LIGRGGFGSVYKARLGDGMEV----AVKVFN----LQCGRALKGFDVECEMM-----KSI 226
           ++G G +G V+  R   G +     A+KV      +Q     K    E         + I
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ-----KAKTTEHTRTERQVLEHI 115

Query: 227 RHRN-LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSN---------YILDIFQRLNIM 276
           R    L+ +      E    L+L+Y+  G L  ++             Y+ +I       
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI------- 168

Query: 277 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH--LSDFSIAKLLTGEDQSMTQTQ 334
                ALE+LH      II+ D+K  N+LLD N   H  L+DF ++K    ++       
Sbjct: 169 ---VLALEHLH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYD- 219

Query: 335 TLATIGYMAPEYGREGRVSTNGDV--YSFGIMLMETFTGKKP 374
              TI YMAP+  R G    +  V  +S G+++ E  TG  P
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 65.9 bits (161), Expect = 7e-12
 Identities = 27/90 (30%), Positives = 36/90 (40%), Gaps = 3/90 (3%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
            L  LE L +  N      P SF  L SLK L + N+ +S     + + L+ L  LNL+ 
Sbjct: 216 PLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAH 275

Query: 68  NKLEGEIPRG--GPFRNFSVESFEGNELLC 95
           N L   +P     P R         N   C
Sbjct: 276 NNLS-SLPHDLFTPLRYLVELHLHHNPWNC 304

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 23/75 (30%), Positives = 37/75 (49%), Gaps = 4/75 (5%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
           GL NL+YL LG   ++  +P+    L+ L+ L +S N+     P S   LS L+ L +  
Sbjct: 194 GLFNLKYLNLGMCNIKD-MPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMN 251

Query: 68  NKLEGEIPRGGPFRN 82
           +++   I R   F  
Sbjct: 252 SQVS-LIER-NAFDG 264

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 25/76 (32%), Positives = 35/76 (46%), Gaps = 5/76 (6%)

Query: 8   GLKNLEYLFLG-YNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLS 66
            + +L  L LG   +L+     +F  L +LK+LNL   N+   +P  L  L  LE L +S
Sbjct: 169 RVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMS 226

Query: 67  FNKLEGEIPRGGPFRN 82
            N    EI   G F  
Sbjct: 227 GNHFP-EIRP-GSFHG 240

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 57.4 bits (139), Expect = 4e-09
 Identities = 25/70 (35%), Positives = 33/70 (47%), Gaps = 1/70 (1%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
            L +LE L LG N ++     +F  L SL  L L +N L+     + E LS L  L L  
Sbjct: 97  HLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRN 156

Query: 68  NKLEGEIPRG 77
           N +E  IP  
Sbjct: 157 NPIE-SIPSY 165

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 22/71 (30%), Positives = 30/71 (42%), Gaps = 2/71 (2%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLS- 66
           GL +L  L L  N L      +F  L  L+ L L NN +      +  ++  L  L+L  
Sbjct: 121 GLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGE 180

Query: 67  FNKLEGEIPRG 77
             KLE  I  G
Sbjct: 181 LKKLE-YISEG 190

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 24/76 (31%), Positives = 32/76 (42%), Gaps = 3/76 (3%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           +P  I    N  YL L  N +Q    D+F  L  L+ L L  N++      +   L+ L 
Sbjct: 69  VPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLN 126

Query: 62  NLNLSFNKLEGEIPRG 77
            L L  N L   IP G
Sbjct: 127 TLELFDNWLT-VIPSG 141

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 18/71 (25%), Positives = 31/71 (43%), Gaps = 2/71 (2%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPA-SLEKLSYLENLNLS 66
            L+NL YL + +   +      F  L SL+ L ++ N+           +L  L  L+LS
Sbjct: 124 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 183

Query: 67  FNKLEGEIPRG 77
             +LE ++   
Sbjct: 184 QCQLE-QLSPT 193

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 21/77 (27%), Positives = 35/77 (45%), Gaps = 4/77 (5%)

Query: 8   GLKNLEYLFLGYNRL--QGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNL 65
            L  L  L L  N L  +G    S     SLK+L+LS N +   + ++   L  LE+L+ 
Sbjct: 50  KLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDF 108

Query: 66  SFNKLEGEIPRGGPFRN 82
             + L+ ++     F +
Sbjct: 109 QHSNLK-QMSEFSVFLS 124

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 23/91 (25%), Positives = 41/91 (45%), Gaps = 4/91 (4%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
            L+NL +L L   +L+   P +F  L SL+ LN+S+NN         + L+ L+ L+ S 
Sbjct: 173 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 232

Query: 68  NKLEGEIPRG---GPFRNFSVESFEGNELLC 95
           N +     +        + +  +   N+  C
Sbjct: 233 NHIM-TSKKQELQHFPSSLAFLNLTQNDFAC 262

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 18/77 (23%), Positives = 34/77 (44%), Gaps = 1/77 (1%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQG-PIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
           + +   GL+ LE+L   ++ L+       F  L +L +L++S+ +   A       LS L
Sbjct: 93  MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 152

Query: 61  ENLNLSFNKLEGEIPRG 77
           E L ++ N  +      
Sbjct: 153 EVLKMAGNSFQENFLPD 169

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 25/78 (32%), Positives = 35/78 (44%), Gaps = 5/78 (6%)

Query: 2  IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLS--GAIPASLEKLSY 59
          +PT I    +   L L  N+LQ      F  L  L  L+LS+N LS  G    S    + 
Sbjct: 22 VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTS 79

Query: 60 LENLNLSFNKLEGEIPRG 77
          L+ L+LSFN +   +   
Sbjct: 80 LKYLDLSFNGVI-TMSSN 96

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 26/76 (34%), Positives = 37/76 (48%), Gaps = 3/76 (3%)

Query: 8   GLKNLEYLFLGYNRLQGPI-PDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLS 66
           GL +LE L +  N  Q    PD F +L +L FL+LS   L    P +   LS L+ LN+S
Sbjct: 148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMS 207

Query: 67  FNKLEGEIPRGGPFRN 82
            N     +    P++ 
Sbjct: 208 HNNFF-SLDT-FPYKC 221

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 22/81 (27%), Positives = 39/81 (48%), Gaps = 1/81 (1%)

Query: 3   PTEIGGLKNLEYLFLGYNRLQGPI-PDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
            +    L+ L+ L LG       I  ++F +L +L+ L+L ++ +    P + + L +L 
Sbjct: 41  ASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLF 100

Query: 62  NLNLSFNKLEGEIPRGGPFRN 82
            L L F  L   + + G FRN
Sbjct: 101 ELRLYFCGLSDAVLKDGYFRN 121

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 63.3 bits (154), Expect = 8e-11
 Identities = 19/64 (29%), Positives = 32/64 (50%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
           GL NL+ L L YN L      +F  L  + +++L  N+++     + + L  L+ L+L  
Sbjct: 312 GLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRD 371

Query: 68  NKLE 71
           N L 
Sbjct: 372 NALT 375

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 61.4 bits (149), Expect = 4e-10
 Identities = 23/98 (23%), Positives = 40/98 (40%), Gaps = 5/98 (5%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
            LK+L+ L L YN++     ++F  L +L+ LNLS N L     ++   L  +  ++L  
Sbjct: 288 TLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQK 347

Query: 68  NKLEGEIPRG--GPFRNFSVESFEGNEL--LCGSPNLQ 101
           N +   I                  N L  +   P++ 
Sbjct: 348 NHIA-IIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIP 384

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 60.6 bits (147), Expect = 6e-10
 Identities = 29/98 (29%), Positives = 43/98 (43%), Gaps = 6/98 (6%)

Query: 7   GGLKNLEYLFLGYNRLQGPI-----PDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
               +LE LFLG N LQ         D F  L  L+ L L++N L+   P     L+ L 
Sbjct: 448 SENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALR 507

Query: 62  NLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPN 99
            L+L+ N+L   +       N  +     N+LL  +P+
Sbjct: 508 GLSLNSNRLT-VLSHNDLPANLEILDISRNQLLAPNPD 544

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 59.8 bits (145), Expect = 9e-10
 Identities = 17/71 (23%), Positives = 27/71 (38%), Gaps = 2/71 (2%)

Query: 8  GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAI-PASLEKLSYLENLNLS 66
           L   E L L +N ++     SF  L  L+ L L +      I   +   L  L  L+L 
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81

Query: 67 FNKLEGEIPRG 77
           +K+   +   
Sbjct: 82 SSKIY-FLHPD 91

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 32/140 (22%), Positives = 48/140 (34%), Gaps = 10/140 (7%)

Query: 3   PTEIGGLKNLEYLFLGYNRLQG-PIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLS--Y 59
                 LK L  L L  N+++   +  SFG L SLK ++ S+N +       LE L    
Sbjct: 116 DGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKT 175

Query: 60  LENLNLSFNKLEGEIPRG-----GPFRNFSVESFE--GNELLCGSPNLQVPPCKTSNHHT 112
           L   +L+ N L   +         PFRN  +E  +  GN                S   +
Sbjct: 176 LSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFS 235

Query: 113 LWKNSLLLRIVLPLSAIFMI 132
           L     ++        I   
Sbjct: 236 LILAHHIMGAGFGFHNIKDP 255

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 58.3 bits (141), Expect = 3e-09
 Identities = 28/93 (30%), Positives = 45/93 (48%), Gaps = 4/93 (4%)

Query: 3   PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLEN 62
                GL +L+ L+L +N L    P  F  L +L+ L+L++N L+      L   + LE 
Sbjct: 473 WDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEI 530

Query: 63  LNLSFNKLEGEIPRGGPFRNFSVESFEGNELLC 95
           L++S N+L    P    F + SV     N+ +C
Sbjct: 531 LDISRNQL--LAPNPDVFVSLSVLDITHNKFIC 561

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 22/76 (28%), Positives = 32/76 (42%), Gaps = 7/76 (9%)

Query: 8   GLKNLEYLFLGYNRLQG-PIPDSFGDLISLKFLNLSNNNLSGAIPASLEK-----LSYLE 61
            + +L+ L L  NR        +  +  SL+ L L  N L  A    L       LS+L+
Sbjct: 424 RVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQ 483

Query: 62  NLNLSFNKLEGEIPRG 77
            L L+ N L   +P G
Sbjct: 484 VLYLNHNYLN-SLPPG 498

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 18/61 (29%), Positives = 29/61 (47%)

Query: 11  NLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKL 70
           ++ +L L +  +       F  L  LK LNL+ N ++     +   L  L+ LNLS+N L
Sbjct: 267 SVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326

Query: 71  E 71
            
Sbjct: 327 G 327

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 16/71 (22%), Positives = 34/71 (47%), Gaps = 2/71 (2%)

Query: 3   PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDL--ISLKFLNLSNNNLSGAIPASLEKLSYL 60
              +    ++     G++ ++ P  ++F  L   S++ L+LS+  +        E L  L
Sbjct: 233 AFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDL 292

Query: 61  ENLNLSFNKLE 71
           + LNL++NK+ 
Sbjct: 293 KVLNLAYNKIN 303

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 51.3 bits (123), Expect = 5e-07
 Identities = 17/82 (20%), Positives = 31/82 (37%), Gaps = 8/82 (9%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDL--ISLKFLNLSNNNLSGAIPASLEKLS- 58
           +    G L +L+ +    N++          L   +L F +L+ N+L   +     K   
Sbjct: 140 LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199

Query: 59  -----YLENLNLSFNKLEGEIP 75
                 LE L++S N    +I 
Sbjct: 200 PFRNMVLEILDVSGNGWTVDIT 221

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 45.2 bits (107), Expect = 4e-05
 Identities = 17/76 (22%), Positives = 27/76 (35%), Gaps = 2/76 (2%)

Query: 11  NLEYLFLGYNRLQG-PIPDSFGDLISLKFLNLSNNNLSG-AIPASLEKLSYLENLNLSFN 68
               + L  NRL+   I      +  L+ L L+ N  S  +   +  +   LE L L  N
Sbjct: 402 TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGEN 461

Query: 69  KLEGEIPRGGPFRNFS 84
            L+        +  F 
Sbjct: 462 MLQLAWETELCWDVFE 477

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 24/122 (19%), Positives = 44/122 (36%), Gaps = 7/122 (5%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           +      +  L+ L L +N L   +  +      L+ L L +N++   +  S      L+
Sbjct: 293 LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLK 348

Query: 62  NLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPP--CKTSNHHTLWKNSLL 119
           NL LS N  +        FRN +  + +  +  C           CK S+   L +    
Sbjct: 349 NLTLSHNDWD-CNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQY 407

Query: 120 LR 121
           + 
Sbjct: 408 IA 409

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 20/72 (27%), Positives = 33/72 (45%), Gaps = 2/72 (2%)

Query: 6   IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNL 65
           +     L  + L YN L+  +   F  +  L+ L +SNN L  A+    + +  L+ L+L
Sbjct: 250 LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDL 308

Query: 66  SFNKLEGEIPRG 77
           S N L   + R 
Sbjct: 309 SHNHLL-HVERN 319

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 61.5 bits (149), Expect = 3e-10
 Identities = 16/77 (20%), Positives = 32/77 (41%), Gaps = 2/77 (2%)

Query: 2   IPTEI-GGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
           +P  +    + +E L L   +++     +F    +++ L +  N +    P   + +  L
Sbjct: 66  LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLL 125

Query: 61  ENLNLSFNKLEGEIPRG 77
             L L  N L   +PRG
Sbjct: 126 TVLVLERNDLS-SLPRG 141

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 60.7 bits (147), Expect = 5e-10
 Identities = 23/96 (23%), Positives = 37/96 (38%), Gaps = 4/96 (4%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
            +  L  L L  N L       F +   L  L++SNNNL      + +  + L+NL LS 
Sbjct: 121 NVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSS 180

Query: 68  NKLEGEIPRGGPFRNFSVESFEGNEL--LCGSPNLQ 101
           N+L   +       +    +   N L  L     ++
Sbjct: 181 NRLT-HVDLSL-IPSLFHANVSYNLLSTLAIPIAVE 214

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 58.0 bits (140), Expect = 3e-09
 Identities = 9/69 (13%), Positives = 25/69 (36%), Gaps = 1/69 (1%)

Query: 9   LKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN 68
           L N + +    + ++            ++ LNL++  +      +      ++ L + FN
Sbjct: 50  LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFN 109

Query: 69  KLEGEIPRG 77
            +   +P  
Sbjct: 110 AIR-YLPPH 117

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 50.7 bits (121), Expect = 7e-07
 Identities = 17/74 (22%), Positives = 31/74 (41%), Gaps = 6/74 (8%)

Query: 4   TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 63
           + +     +E L   +N +   +       + L  L L +NNL+      L     L  +
Sbjct: 205 STLAIPIAVEELDASHNSINV-VRG--PVNVELTILKLQHNNLT-DTAW-LLNYPGLVEV 259

Query: 64  NLSFNKLEGEIPRG 77
           +LS+N+LE +I   
Sbjct: 260 DLSYNELE-KIMYH 272

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 13/66 (19%), Positives = 30/66 (45%), Gaps = 8/66 (12%)

Query: 5   EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLN 64
           ++  + +L +  + YN L      +    I+++ L+ S+N+++  +   +     L  L 
Sbjct: 187 DLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILK 238

Query: 65  LSFNKL 70
           L  N L
Sbjct: 239 LQHNNL 244

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 14/71 (19%), Positives = 28/71 (39%), Gaps = 3/71 (4%)

Query: 9  LKNLEYLFLGYNRLQGPIPDSFGD--LISLKFLNLSNNNLSGAIPASLEKLSYLENLNLS 66
            +  +  +  +     +   F D  L + K +   N+ +     A L+    +E LNL+
Sbjct: 24 QYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLN 83

Query: 67 FNKLEGEIPRG 77
            ++E EI   
Sbjct: 84 DLQIE-EIDTY 93

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 21/70 (30%), Positives = 33/70 (47%), Gaps = 1/70 (1%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
            L NL  L L +N L     ++F  + +L++L+LS+N+L          L  LE L L  
Sbjct: 62  RLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYN 121

Query: 68  NKLEGEIPRG 77
           N +   + R 
Sbjct: 122 NHIV-VVDRN 130

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 62.6 bits (152), Expect = 7e-11
 Identities = 22/78 (28%), Positives = 37/78 (47%), Gaps = 4/78 (5%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPA-SLEKLSYLENLNLS 66
            + NL YL L  N L       F DL +L+ L L NN++   +   + E ++ L+ L LS
Sbjct: 86  PVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLS 144

Query: 67  FNKLEGEIPRGGPFRNFS 84
            N++    P     ++ +
Sbjct: 145 QNQIS-RFPVEL-IKDGN 160

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 56.8 bits (137), Expect = 5e-09
 Identities = 29/96 (30%), Positives = 41/96 (42%), Gaps = 10/96 (10%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPA----SLEKLSYLENL 63
            L+ LE L L  N +     ++F D+  L+ L LS N +S   P        KL  L  L
Sbjct: 110 DLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLL 168

Query: 64  NLSFNKLEGEIPRGG----PFRNFSVESFEGNELLC 95
           +LS NKL+ ++P       P    +      N L C
Sbjct: 169 DLSSNKLK-KLPLTDLQKLPAWVKNGLYLHNNPLEC 203

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 19/78 (24%), Positives = 33/78 (42%), Gaps = 6/78 (7%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPD-SFGDLISLKFLNLSNNNLSGAIPA-SLEKLSY 59
           +P  +        L L +N L     + +   L +L  L LS+N+L+  I + +   +  
Sbjct: 33  VPQSL--PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPN 89

Query: 60  LENLNLSFNKLEGEIPRG 77
           L  L+LS N L   +   
Sbjct: 90  LRYLDLSSNHLH-TLDEF 106

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 62.4 bits (152), Expect = 2e-11
 Identities = 23/71 (32%), Positives = 34/71 (47%), Gaps = 3/71 (4%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYLENLNLS 66
             K L  + L  N++    PD+F  L SL  L L  N ++  +P SL E L  L+ L L+
Sbjct: 54  PYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLN 112

Query: 67  FNKLEGEIPRG 77
            NK+   +   
Sbjct: 113 ANKIN-CLRVD 122

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 55.4 bits (134), Expect = 5e-09
 Identities = 22/71 (30%), Positives = 36/71 (50%), Gaps = 3/71 (4%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPA-SLEKLSYLENLNLS 66
           GL++L  L L  N++       F  L SL+ L L+ N ++  +   + + L  L  L+L 
Sbjct: 78  GLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLY 136

Query: 67  FNKLEGEIPRG 77
            NKL+  I +G
Sbjct: 137 DNKLQ-TIAKG 146

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 50.8 bits (122), Expect = 2e-07
 Identities = 19/77 (24%), Positives = 36/77 (46%), Gaps = 9/77 (11%)

Query: 2  IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPA-SLEKLSYL 60
          +P        +  + L  N ++   P +F     L+ ++LSNN +S  +   + + L  L
Sbjct: 30 LPE------TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSL 82

Query: 61 ENLNLSFNKLEGEIPRG 77
           +L L  NK+  E+P+ 
Sbjct: 83 NSLVLYGNKIT-ELPKS 98

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 48.9 bits (117), Expect = 7e-07
 Identities = 18/61 (29%), Positives = 32/61 (52%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
           GL +L+ L L  N++     D+F DL +L  L+L +N L      +   L  ++ ++L+ 
Sbjct: 102 GLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQ 161

Query: 68  N 68
           N
Sbjct: 162 N 162

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 21/82 (25%), Positives = 34/82 (41%), Gaps = 3/82 (3%)

Query: 3   PTEIGGLKNLEYLFLGYNRLQGPIP-DSFGDLISLKFLNLSNNNLSGAIPAS-LEKLSYL 60
            T    L++L++L +        I  ++F  L SL  L L  N     +       L+ L
Sbjct: 47  ETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANL 105

Query: 61  ENLNLSFNKLEGEIPRGGPFRN 82
           E L L+   L+G +  G  F+ 
Sbjct: 106 EVLTLTQCNLDGAVLSGNFFKP 127

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 24/71 (33%), Positives = 35/71 (49%), Gaps = 3/71 (4%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPA-SLEKLSYLENLNLS 66
           GL +L  L L  N L       F +L  L+ L+LS N++  A+   S   L  L+ L L 
Sbjct: 321 GLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALD 379

Query: 67  FNKLEGEIPRG 77
            N+L+  +P G
Sbjct: 380 TNQLK-SVPDG 389

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 30/91 (32%), Positives = 41/91 (45%), Gaps = 5/91 (5%)

Query: 8   GLKNLEYLFLGYNRLQGPI--PDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYLENLN 64
           GL NLE L L    L G +   + F  L SL+ L L +NN+    PAS    +     L+
Sbjct: 101 GLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLD 160

Query: 65  LSFNKLEGEIPRGGPFRNFSVESFEGNELLC 95
           L+FNK++  I       NF  + F    L  
Sbjct: 161 LTFNKVK-SICEED-LLNFQGKHFTLLRLSS 189

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 22/70 (31%), Positives = 30/70 (42%), Gaps = 1/70 (1%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
              +LE L L  N +     ++F  L  L  LNLS N L        E L  LE L+LS+
Sbjct: 297 HFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSY 356

Query: 68  NKLEGEIPRG 77
           N +   +   
Sbjct: 357 NHIR-ALGDQ 365

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 18/77 (23%), Positives = 30/77 (38%), Gaps = 8/77 (10%)

Query: 2  IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPA-SLEKLSYL 60
          +P       ++ Y+ L  N +      SF  L  L+FL +        I   +   LS L
Sbjct: 28 LPA------HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81

Query: 61 ENLNLSFNKLEGEIPRG 77
            L L +N+   ++  G
Sbjct: 82 IILKLDYNQFL-QLETG 97

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 20/61 (32%), Positives = 28/61 (45%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
            L  LE L L YN ++     SF  L +LK L L  N L        ++L+ L+ + L  
Sbjct: 345 NLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHT 404

Query: 68  N 68
           N
Sbjct: 405 N 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 17/68 (25%), Positives = 30/68 (44%), Gaps = 3/68 (4%)

Query: 11  NLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPA-SLEKLSYLENLNLSFNK 69
            ++   L  +++   +   F     L+ L L+ N ++  I   +   L++L  LNLS N 
Sbjct: 276 GVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNF 334

Query: 70  LEGEIPRG 77
           L G I   
Sbjct: 335 L-GSIDSR 341

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 27/90 (30%), Positives = 35/90 (38%), Gaps = 3/90 (3%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
            L NL +LFL  NR+      +F  L SL  L L  N ++   P +   L  L  L L  
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210

Query: 68  NKLEGEIPRG--GPFRNFSVESFEGNELLC 95
           N L   +P     P R         N  +C
Sbjct: 211 NNLS-ALPTEALAPLRALQYLRLNDNPWVC 239

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 23/71 (32%), Positives = 33/71 (46%), Gaps = 3/71 (4%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPA-SLEKLSYLENLNLS 66
           GL  L  L L    LQ   P  F  L +L++L L +N L  A+P  +   L  L +L L 
Sbjct: 103 GLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLH 161

Query: 67  FNKLEGEIPRG 77
            N++   +P  
Sbjct: 162 GNRIS-SVPER 171

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 24/71 (33%), Positives = 35/71 (49%), Gaps = 3/71 (4%)

Query: 8   GLKNLEYLFLGYNRLQGPIPD-SFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLS 66
           GL  L+YL+L  N LQ  +PD +F DL +L  L L  N +S     +   L  L+ L L 
Sbjct: 127 GLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185

Query: 67  FNKLEGEIPRG 77
            N++   +   
Sbjct: 186 QNRVA-HVHPH 195

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 55.8 bits (135), Expect = 7e-09
 Identities = 22/72 (30%), Positives = 31/72 (43%), Gaps = 4/72 (5%)

Query: 8   GLKNLEYLFLGYN-RLQGPIPDSFGDLISLKFLNLSNNNLSGAIPA-SLEKLSYLENLNL 65
           GL  LE L L  N +L+   P +F  L  L  L+L    L   +       L+ L+ L L
Sbjct: 78  GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYL 136

Query: 66  SFNKLEGEIPRG 77
             N L+  +P  
Sbjct: 137 QDNALQ-ALPDD 147

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 53.8 bits (130), Expect = 3e-08
 Identities = 21/76 (27%), Positives = 32/76 (42%), Gaps = 2/76 (2%)

Query: 2  IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
          +P  I      + +FL  NR+      SF    +L  L L +N L+    A+   L+ LE
Sbjct: 26 VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 62 NLNLSFNKLEGEIPRG 77
           L+LS N     +   
Sbjct: 84 QLDLSDNAQLRSVDPA 99

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 24/97 (24%), Positives = 39/97 (40%), Gaps = 4/97 (4%)

Query: 2   IPTE-IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
           +P   +  L  L +L L YN +         +L+ L+ + L    L+   P +   L+YL
Sbjct: 239 VPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYL 298

Query: 61  ENLNLSFNKLEGEIPRG--GPFRNFSVESFEGNELLC 95
             LN+S N+L   +         N      + N L C
Sbjct: 299 RVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLAC 334

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 20/70 (28%), Positives = 30/70 (42%), Gaps = 1/70 (1%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
            L NL  L L  NRL+      F  L +L  L++S N +   +    + L  L++L +  
Sbjct: 78  NLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGD 137

Query: 68  NKLEGEIPRG 77
           N L   I   
Sbjct: 138 NDLV-YISHR 146

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 20/84 (23%), Positives = 34/84 (40%), Gaps = 2/84 (2%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
            +        NL  L + +  L      +   L+ L+FLNLS N +S    + L +L  L
Sbjct: 215 TMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRL 274

Query: 61  ENLNLSFNKLEGEIPRGGPFRNFS 84
           + + L   +L   +     FR  +
Sbjct: 275 QEIQLVGGQLA-VVEP-YAFRGLN 296

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 22/70 (31%), Positives = 32/70 (45%), Gaps = 1/70 (1%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
           GL NL  L +  N++   +   F DL +LK L + +N+L      +   L+ LE L L  
Sbjct: 102 GLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEK 161

Query: 68  NKLEGEIPRG 77
             L   IP  
Sbjct: 162 CNLT-SIPTE 170

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 20/70 (28%), Positives = 31/70 (44%), Gaps = 1/70 (1%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
              +LE L L  N +    P +F +L +L+ L L +N L          LS L  L++S 
Sbjct: 54  SFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISE 113

Query: 68  NKLEGEIPRG 77
           NK+   +   
Sbjct: 114 NKIV-ILLDY 122

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 15/70 (21%), Positives = 26/70 (37%), Gaps = 1/70 (1%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
            L  L  L L +  +      SF  L  LK L +S+      +  +      L +L+++ 
Sbjct: 174 HLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITH 233

Query: 68  NKLEGEIPRG 77
             L   +P  
Sbjct: 234 CNLT-AVPYL 242

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 18/78 (23%), Positives = 35/78 (44%), Gaps = 4/78 (5%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPA-SLEKLSYLENLNLS 66
            L  L+ L + +      +  +    ++L  L++++ NL+ A+P  ++  L YL  LNLS
Sbjct: 198 RLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLS 256

Query: 67  FNKLEGEIPRGGPFRNFS 84
           +N +   I          
Sbjct: 257 YNPIS-TIEG-SMLHELL 272

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 57.4 bits (139), Expect = 5e-09
 Identities = 23/71 (32%), Positives = 31/71 (43%), Gaps = 3/71 (4%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPA-SLEKLSYLENLNLS 66
            L NL+ L +G N L      +F  L SL+ L L   NL+ +IP  +L  L  L  L L 
Sbjct: 126 DLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLR 184

Query: 67  FNKLEGEIPRG 77
              +   I   
Sbjct: 185 HLNIN-AIRDY 194

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 55.1 bits (133), Expect = 3e-08
 Identities = 24/77 (31%), Positives = 33/77 (42%), Gaps = 3/77 (3%)

Query: 1  VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
           +P  I        L LG NR++    D F     L+ L L+ N +S   P +   L  L
Sbjct: 25 AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82

Query: 61 ENLNLSFNKLEGEIPRG 77
            L L  N+L+  IP G
Sbjct: 83 RTLGLRSNRLK-LIPLG 98

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 63.4 bits (153), Expect = 4e-11
 Identities = 36/208 (17%), Positives = 58/208 (27%), Gaps = 57/208 (27%)

Query: 162 TFSHLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKV--------FNLQCGRAL 213
            FSH   C  T+       IG G FG V++    D   VA+K+         N    +  
Sbjct: 12  PFSH---CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTF 67

Query: 214 KGFDVECEMMKSIRHRNLIKVISTCSNEEFKA---------------------------- 245
           +    E  + K +   +      T       +                            
Sbjct: 68  EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAND 127

Query: 246 -----------LVLEYMPHG-SLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
                      +VLE+   G  LE+       +  +    +I+  + ++L          
Sbjct: 128 RPDFFKDDQLFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASLR-- 182

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAK 321
             H DL   NVLL    +  L      K
Sbjct: 183 FEHRDLHWGNVLLKKTSLKKLHYTLNGK 210

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 63.4 bits (155), Expect = 5e-11
 Identities = 20/115 (17%), Positives = 42/115 (36%), Gaps = 11/115 (9%)

Query: 4   TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 63
           + +  L  L+ LF   N++      S  +L ++ +L+  +N +S   P  L  L+ +  L
Sbjct: 325 SPVSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQL 380

Query: 64  NLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCKTSNHHTLWKNSL 118
            L+               N S+ +   N          + P   S+  +  +  +
Sbjct: 381 GLNDQAWTNAPV--NYKANVSIPNTVKNVT-----GALIAPATISDGGSYTEPDI 428

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 63.4 bits (155), Expect = 6e-11
 Identities = 21/73 (28%), Positives = 35/73 (47%), Gaps = 4/73 (5%)

Query: 3   PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLEN 62
            + +  L NLE L    N++    P   G L +L  L+L+ N L      +L  L+ L +
Sbjct: 192 ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTD 247

Query: 63  LNLSFNKLEGEIP 75
           L+L+ N++    P
Sbjct: 248 LDLANNQISNLAP 260

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 63.1 bits (154), Expect = 7e-11
 Identities = 21/69 (30%), Positives = 33/69 (47%), Gaps = 4/69 (5%)

Query: 4   TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 63
           + + GL  L  L L  N+L+   P    +L +L +L L  NN+S   P  +  L+ L+ L
Sbjct: 281 SPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL 336

Query: 64  NLSFNKLEG 72
               NK+  
Sbjct: 337 FFYNNKVSD 345

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 24/72 (33%), Positives = 36/72 (50%), Gaps = 4/72 (5%)

Query: 4   TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 63
           T +G L NL+ L L  N+L+     +   L +L  L+L+NN +S   P  L  L+ L  L
Sbjct: 215 TPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 270

Query: 64  NLSFNKLEGEIP 75
            L  N++    P
Sbjct: 271 KLGANQISNISP 282

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 19/70 (27%), Positives = 33/70 (47%), Gaps = 4/70 (5%)

Query: 3   PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLEN 62
              +  L  LE L +  N++          L +L+ L  +NN +S   P  L  L+ L+ 
Sbjct: 170 LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDE 225

Query: 63  LNLSFNKLEG 72
           L+L+ N+L+ 
Sbjct: 226 LSLNGNQLKD 235

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 16/73 (21%), Positives = 30/73 (41%), Gaps = 4/73 (5%)

Query: 3   PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLEN 62
                 L  +  L      ++    D    L +L  +N SNN L+   P  L+ L+ L +
Sbjct: 39  TVSQTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVD 94

Query: 63  LNLSFNKLEGEIP 75
           + ++ N++    P
Sbjct: 95  ILMNNNQIADITP 107

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 57.3 bits (139), Expect = 4e-09
 Identities = 21/73 (28%), Positives = 40/73 (54%), Gaps = 5/73 (6%)

Query: 3   PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLEN 62
            + + GL +L+ L  G N++    P    +L +L+ L++S+N +S    + L KL+ LE+
Sbjct: 149 ISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLES 203

Query: 63  LNLSFNKLEGEIP 75
           L  + N++    P
Sbjct: 204 LIATNNQISDITP 216

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 56.9 bits (138), Expect = 6e-09
 Identities = 21/72 (29%), Positives = 35/72 (48%), Gaps = 5/72 (6%)

Query: 4   TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 63
           T +  L NL  L L  N++    P    +L +L  L LS+N +S    ++L  L+ L+ L
Sbjct: 106 TPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQL 161

Query: 64  NLSFNKLEGEIP 75
           +   N++    P
Sbjct: 162 SFG-NQVTDLKP 172

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 56.1 bits (136), Expect = 1e-08
 Identities = 19/67 (28%), Positives = 27/67 (40%), Gaps = 5/67 (7%)

Query: 6   IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNL 65
           +  L NL  L L  N +          L SL+ L+  N          L  L+ LE L++
Sbjct: 130 LKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDI 184

Query: 66  SFNKLEG 72
           S NK+  
Sbjct: 185 SSNKVSD 191

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 14/70 (20%), Positives = 22/70 (31%), Gaps = 4/70 (5%)

Query: 6  IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNL 65
             L       LG   +   +     DL  +  L      +       +E L+ L  +N 
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINF 75

Query: 66 SFNKLEGEIP 75
          S N+L    P
Sbjct: 76 SNNQLTDITP 85

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 53.0 bits (128), Expect = 1e-07
 Identities = 12/68 (17%), Positives = 26/68 (38%), Gaps = 2/68 (2%)

Query: 3   PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLEN 62
            + +  L N+ +L  G+N++    P    +L  +  L L++   + A       +S    
Sbjct: 346 VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNT 403

Query: 63  LNLSFNKL 70
           +      L
Sbjct: 404 VKNVTGAL 411

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 47.7 bits (114), Expect = 6e-06
 Identities = 8/68 (11%), Positives = 20/68 (29%), Gaps = 2/68 (2%)

Query: 4   TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 63
           T +  L  +  L L          +   ++     +      L    PA++         
Sbjct: 369 TPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEP 426

Query: 64  NLSFNKLE 71
           ++++N   
Sbjct: 427 DITWNLPS 434

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 62.4 bits (152), Expect = 6e-11
 Identities = 29/149 (19%), Positives = 57/149 (38%), Gaps = 15/149 (10%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLI-KVISTC 238
           IG G FG +++   L +  +VA+K    +          E    K +     I  V    
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75

Query: 239 SNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
                  LV++ +   SLE  +        +         + + ++ +H      +++ D
Sbjct: 76  QEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 131

Query: 299 LKPSNVLL------DDNMVAHLSDFSIAK 321
           +KP N L+      + NM+ ++ DF + K
Sbjct: 132 IKPDNFLIGRPNSKNANMI-YVVDFGMVK 159

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 63.2 bits (154), Expect = 6e-11
 Identities = 24/96 (25%), Positives = 37/96 (38%), Gaps = 4/96 (4%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           IP  +  L  L+ L L  N L    P SF  L+ L+ L +  + +      + + L  L 
Sbjct: 200 IPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLV 258

Query: 62  NLNLSFNKLEGEIPRG--GPFRNFSVESFEGNELLC 95
            +NL+ N L   +P     P  +        N   C
Sbjct: 259 EINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPWNC 293

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 60.1 bits (146), Expect = 5e-10
 Identities = 24/71 (33%), Positives = 35/71 (49%), Gaps = 3/71 (4%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPA-SLEKLSYLENLNLS 66
            L++LE L L  N ++     +F  L +L  L L +N L+  IP  +   LS L+ L L 
Sbjct: 86  HLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLR 144

Query: 67  FNKLEGEIPRG 77
            N +E  IP  
Sbjct: 145 NNPIE-SIPSY 154

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 22/69 (31%), Positives = 32/69 (46%), Gaps = 2/69 (2%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPA-SLEKLSYLENLNLS 66
            L  L+ L+L  N ++     +F  + SL+ L+L        I   + E LS L  LNL+
Sbjct: 134 YLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLA 193

Query: 67  FNKLEGEIP 75
              L  EIP
Sbjct: 194 MCNLR-EIP 201

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 56.3 bits (136), Expect = 9e-09
 Identities = 25/72 (34%), Positives = 33/72 (45%), Gaps = 4/72 (5%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYLENLNLS 66
           GL NL  L L  NRL      +F  L  LK L L NN +  +IP+    ++  L  L+L 
Sbjct: 110 GLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLG 168

Query: 67  -FNKLEGEIPRG 77
              +L   I  G
Sbjct: 169 ELKRLS-YISEG 179

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 24/76 (31%), Positives = 34/76 (44%), Gaps = 3/76 (3%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           +P  I    N   L L  N++Q    +SF  L  L+ L LS N++      +   L+ L 
Sbjct: 58  VPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLN 115

Query: 62  NLNLSFNKLEGEIPRG 77
            L L  N+L   IP G
Sbjct: 116 TLELFDNRLT-TIPNG 130

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 62.4 bits (152), Expect = 7e-11
 Identities = 40/150 (26%), Positives = 67/150 (44%), Gaps = 17/150 (11%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLI-KVISTC 238
           IG G FG +   + L     VA+K+  ++          E    K +   + I +V    
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDGIPQVYYFG 74

Query: 239 SNEEFKALVLEYMPHG-SLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
              ++ A+VLE +  G SLE      +    +   L I I + S +EY+H   S  +I+ 
Sbjct: 75  PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYR 129

Query: 298 DLKPSNVLL------DDNMVAHLSDFSIAK 321
           D+KP N L+         ++ H+ DF++AK
Sbjct: 130 DVKPENFLIGRPGNKTQQVI-HIIDFALAK 158

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 26/76 (34%), Positives = 36/76 (47%), Gaps = 3/76 (3%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYLENLNLS 66
              NL+ L L  N +     DSF  L SL+ L+LS N LS  + +S  + LS L  LNL 
Sbjct: 74  RCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLL 132

Query: 67  FNKLEGEIPRGGPFRN 82
            N  +  +     F +
Sbjct: 133 GNPYK-TLGETSLFSH 147

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 53.2 bits (128), Expect = 8e-08
 Identities = 18/81 (22%), Positives = 30/81 (37%), Gaps = 5/81 (6%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
           GL  LE L +  + LQ   P S   + ++  L L        +   ++  S +E L L  
Sbjct: 172 GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRD 231

Query: 68  NKLEG----EIPRGGPFRNFS 84
             L+     E+   G   +  
Sbjct: 232 TDLDTFHFSELST-GETNSLI 251

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 53.2 bits (128), Expect = 8e-08
 Identities = 24/134 (17%), Positives = 49/134 (36%), Gaps = 4/134 (2%)

Query: 8   GLKNLEYLFLGYNRLQGPIPD-SFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLS 66
            L  L+ L +G       I    F  L  L+ L +  ++L    P SL+ +  + +L L 
Sbjct: 147 HLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILH 206

Query: 67  FNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCKTSNHHTLWKNSLLLRIVLPL 126
             +    +         SVE  E  +    + +        +N  +L K      + +  
Sbjct: 207 MKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETN--SLIKKFTFRNVKITD 263

Query: 127 SAIFMIVVILLILR 140
            ++F ++ +L  + 
Sbjct: 264 ESLFQVMKLLNQIS 277

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 20/77 (25%), Positives = 37/77 (48%), Gaps = 5/77 (6%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPA-SLEKLSYL 60
           IP+ +   + ++ L L  NR+           ++L+ L L++N ++  I   S   L  L
Sbjct: 46  IPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSL 102

Query: 61  ENLNLSFNKLEGEIPRG 77
           E+L+LS+N L   +   
Sbjct: 103 EHLDLSYNYLS-NLSSS 118

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 50.1 bits (120), Expect = 7e-07
 Identities = 15/78 (19%), Positives = 31/78 (39%), Gaps = 10/78 (12%)

Query: 8   GLKNLEYLFLGYNRLQGP--------IPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSY 59
              ++E L L    L             +S     + + + +++ +L   +   L ++S 
Sbjct: 220 VTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISG 278

Query: 60  LENLNLSFNKLEGEIPRG 77
           L  L  S N+L+  +P G
Sbjct: 279 LLELEFSRNQLKS-VPDG 295

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 11/64 (17%), Positives = 21/64 (32%), Gaps = 3/64 (4%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPAS-LEKLSYLENLNLS 66
                  + +    L   +      +  L  L  S N L   +P    ++L+ L+ + L 
Sbjct: 252 KKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLH 309

Query: 67  FNKL 70
            N  
Sbjct: 310 TNPW 313

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 60.9 bits (148), Expect = 1e-10
 Identities = 27/71 (38%), Positives = 37/71 (52%), Gaps = 3/71 (4%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYLENLNLS 66
           GL  L+ L+L  N L+   P        L+ L+L+NNNL+  +PA L   L  L+ L L 
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQ 180

Query: 67  FNKLEGEIPRG 77
            N L   IP+G
Sbjct: 181 ENSLYT-IPKG 190

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 24/77 (31%), Positives = 33/77 (42%), Gaps = 3/77 (3%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYL 60
           +P     L  L  L + +NRL      +   L  L+ L L  N L   +P  L      L
Sbjct: 92  LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKL 150

Query: 61  ENLNLSFNKLEGEIPRG 77
           E L+L+ N L  E+P G
Sbjct: 151 EKLSLANNNLT-ELPAG 166

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 56.7 bits (137), Expect = 4e-09
 Identities = 22/70 (31%), Positives = 32/70 (45%), Gaps = 4/70 (5%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
               L  L L    L   +    G L  L  L+LS+N L  ++P   + L  L  L++SF
Sbjct: 53  PYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSF 109

Query: 68  NKLEGEIPRG 77
           N+L   +P G
Sbjct: 110 NRLT-SLPLG 118

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 55.9 bits (135), Expect = 7e-09
 Identities = 24/72 (33%), Positives = 37/72 (51%), Gaps = 4/72 (5%)

Query: 7   GGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYLENLNL 65
           G L  L  L L +N+LQ  +P     L +L  L++S N L+ ++P      L  L+ L L
Sbjct: 74  GTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYL 131

Query: 66  SFNKLEGEIPRG 77
             N+L+  +P G
Sbjct: 132 KGNELK-TLPPG 142

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 50.1 bits (120), Expect = 6e-07
 Identities = 18/69 (26%), Positives = 27/69 (39%), Gaps = 4/69 (5%)

Query: 2  IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
          +P ++   K+   L L  N L      +      L  LNL    L+  +      L  L 
Sbjct: 25 LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVLG 80

Query: 62 NLNLSFNKL 70
           L+LS N+L
Sbjct: 81 TLDLSHNQL 89

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 62.2 bits (151), Expect = 2e-10
 Identities = 23/82 (28%), Positives = 39/82 (47%), Gaps = 4/82 (4%)

Query: 3   PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLEN 62
             +I  L  L  L L +NR++      F     L++L++S+N L   I      ++ L +
Sbjct: 69  MPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRH 125

Query: 63  LNLSFNKLEGEIPRGGPFRNFS 84
           L+LSFN  +  +P    F N +
Sbjct: 126 LDLSFNDFD-VLPVCKEFGNLT 146

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 57.2 bits (138), Expect = 5e-09
 Identities = 21/78 (26%), Positives = 37/78 (47%), Gaps = 5/78 (6%)

Query: 7   GGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLS 66
              +++  L L  N L G +         +K L+L NN +  +IP  +  L  L+ LN++
Sbjct: 425 AWAESILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIM-SIPKDVTHLQALQELNVA 481

Query: 67  FNKLEGEIPRGGPFRNFS 84
            N+L+  +P  G F   +
Sbjct: 482 SNQLK-SVPD-GVFDRLT 497

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 17/77 (22%), Positives = 32/77 (41%), Gaps = 5/77 (6%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYL 60
           +P ++      + L L  N +          L  L+ L LS+N +  ++   +      L
Sbjct: 46  VPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDL 102

Query: 61  ENLNLSFNKLEGEIPRG 77
           E L++S N+L+  I   
Sbjct: 103 EYLDVSHNRLQ-NISCC 118

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 17/59 (28%), Positives = 32/59 (54%), Gaps = 3/59 (5%)

Query: 11  NLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIP-ASLEKLSYLENLNLSFN 68
            ++ L L  NR+   IP     L +L+ LN+++N L  ++P    ++L+ L+ + L  N
Sbjct: 451 KVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 45.6 bits (108), Expect = 3e-05
 Identities = 10/64 (15%), Positives = 16/64 (25%), Gaps = 1/64 (1%)

Query: 7   GGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLS 66
               +  +L    N     +      L  L+ L L  N L             + +L   
Sbjct: 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETL 408

Query: 67  FNKL 70
              L
Sbjct: 409 DVSL 412

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 12/64 (18%), Positives = 20/64 (31%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
               +    L  +              S  FLN + N  + ++      L  L+ L L  
Sbjct: 327 VFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQR 386

Query: 68  NKLE 71
           N L+
Sbjct: 387 NGLK 390

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 42.2 bits (99), Expect = 3e-04
 Identities = 20/81 (24%), Positives = 29/81 (35%), Gaps = 5/81 (6%)

Query: 3   PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNL----SGAIPASLEKLS 58
                 LK L+ L L  N L+           ++  L   + +L    S A   +     
Sbjct: 370 FQGCSTLKRLQTLILQRNGLKN-FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAE 428

Query: 59  YLENLNLSFNKLEGEIPRGGP 79
            +  LNLS N L G + R  P
Sbjct: 429 SILVLNLSSNMLTGSVFRCLP 449

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 38/220 (17%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGF----DVECEMMKSIRHR----- 229
           +IG+G FG V KA        VA+K+      R  K F      E  +++ +R +     
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMV-----RNEKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 230 -NLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYI---LDIFQRLNIMIDVASALEY 285
            N+I ++   +      +  E +   +L + +  + +    L + ++      +   L+ 
Sbjct: 159 MNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRK--FAHSILQCLDA 215

Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAH--LSDFSIAKLLTGEDQSMTQT-QTLATIGYM 342
           LH      IIHCDLKP N+LL     +   + DF  +     E Q +    Q+     Y 
Sbjct: 216 LH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYTYIQSRF---YR 266

Query: 343 APEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
           APE     R     D++S G +L E  TG      +  GE
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLTGY----PLLPGE 302

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 24/77 (31%), Positives = 42/77 (54%), Gaps = 8/77 (10%)

Query: 7   GGLKNLEYLFLGYNRLQG-PIPDSFGDLISLKFLNLSNNNLSGAIPA----SLEKLSYLE 61
           G LK L+ L + +N +Q   +P+ F +L +L+ L+LS+N +  +I       L ++  L 
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLN 179

Query: 62  -NLNLSFNKLEGEIPRG 77
            +L+LS N +   I  G
Sbjct: 180 LSLDLSLNPMN-FIQPG 195

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 56.5 bits (137), Expect = 4e-09
 Identities = 20/76 (26%), Positives = 32/76 (42%), Gaps = 3/76 (3%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYLENLNLS 66
            L +L  L L  N +Q     +F  L SL+ L     NL+ ++       L  L+ LN++
Sbjct: 74  SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVA 132

Query: 67  FNKLEGEIPRGGPFRN 82
            N ++        F N
Sbjct: 133 HNLIQ-SFKLPEYFSN 147

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 54.2 bits (131), Expect = 2e-08
 Identities = 15/76 (19%), Positives = 26/76 (34%), Gaps = 4/76 (5%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYLENLNLS 66
               L+ L L    +Q     ++  L  L  L L+ N +  ++       LS L+ L   
Sbjct: 50  SFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAV 108

Query: 67  FNKLEGEIPRGGPFRN 82
              L   +    P  +
Sbjct: 109 ETNLA-SLE-NFPIGH 122

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 53.4 bits (129), Expect = 4e-08
 Identities = 20/77 (25%), Positives = 34/77 (44%), Gaps = 5/77 (6%)

Query: 2  IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYL 60
          IP  +    + + L L +N L+     SF     L+ L+LS   +   I     + LS+L
Sbjct: 22 IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHL 78

Query: 61 ENLNLSFNKLEGEIPRG 77
            L L+ N ++  +  G
Sbjct: 79 STLILTGNPIQ-SLALG 94

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 41.5 bits (98), Expect = 4e-04
 Identities = 16/65 (24%), Positives = 26/65 (40%), Gaps = 5/65 (7%)

Query: 8   GLKNLEY----LFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 63
            L  +      L L  N +    P +F ++  LK L L  N L        ++L+ L+ +
Sbjct: 171 VLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLKELALDTNQLKSVPDGIFDRLTSLQKI 229

Query: 64  NLSFN 68
            L  N
Sbjct: 230 WLHTN 234

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 60.1 bits (146), Expect = 3e-10
 Identities = 36/146 (24%), Positives = 66/146 (45%), Gaps = 11/146 (7%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLI-KVISTC 238
           IG G FG +Y    +  G EVA+K+  ++         +E ++ K ++    I  +    
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGIPTIRWCG 74

Query: 239 SNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
           +  ++  +V+E +   SLE      +    +   L +   + S +EY+H   S   IH D
Sbjct: 75  AEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRD 130

Query: 299 LKPSNVLL---DDNMVAHLSDFSIAK 321
           +KP N L+       + ++ DF +AK
Sbjct: 131 VKPDNFLMGLGKKGNLVYIIDFGLAK 156

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 60.1 bits (145), Expect = 4e-10
 Identities = 23/97 (23%), Positives = 37/97 (38%), Gaps = 5/97 (5%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPD-SFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
               + G +NL  L++   +    +       L  L+ L +  + L    P +      L
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82

Query: 61  ENLNLSFNKLEGEIPRGGPFRNFSVES--FEGNELLC 95
             LNLSFN LE  +      +  S++     GN L C
Sbjct: 83  SRLNLSFNALE-SLSW-KTVQGLSLQELVLSGNPLHC 117

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 60.9 bits (147), Expect = 4e-10
 Identities = 23/91 (25%), Positives = 40/91 (43%), Gaps = 5/91 (5%)

Query: 5   EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLN 64
            +  L  + +L L +NRL+  +P +   L  L+ L  S+N L   +   +  L  L+ L 
Sbjct: 458 HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELL 514

Query: 65  LSFNKLEG--EIPRGGPFRNFSVESFEGNEL 93
           L  N+L+    I          + + +GN L
Sbjct: 515 LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 50.9 bits (121), Expect = 5e-07
 Identities = 20/69 (28%), Positives = 30/69 (43%), Gaps = 3/69 (4%)

Query: 3   PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLEN 62
                   ++  L L +  L   +      L+ +  L+LS+N L  A+P +L  L  LE 
Sbjct: 434 SVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEV 490

Query: 63  LNLSFNKLE 71
           L  S N LE
Sbjct: 491 LQASDNALE 499

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 49.8 bits (118), Expect = 1e-06
 Identities = 23/70 (32%), Positives = 29/70 (41%), Gaps = 3/70 (4%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSG-AIPASLEKLSYL 60
           +P  +  L+ LE L    N L+    D   +L  L+ L L NN L   A    L     L
Sbjct: 478 LPPALAALRCLEVLQASDNALE--NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL 535

Query: 61  ENLNLSFNKL 70
             LNL  N L
Sbjct: 536 VLLNLQGNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 42.1 bits (98), Expect = 3e-04
 Identities = 15/60 (25%), Positives = 20/60 (33%), Gaps = 1/60 (1%)

Query: 5   EIGGLKNLEYLFLGYNRLQG-PIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 63
            +  L  L+ L L  NRLQ             L  LNL  N+L             L ++
Sbjct: 503 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 562

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 59.9 bits (145), Expect = 8e-10
 Identities = 22/77 (28%), Positives = 37/77 (48%), Gaps = 5/77 (6%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
             K+L  L +  N L   I         +K L+L +N +  +IP  + KL  L+ LN++ 
Sbjct: 397 WTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVAS 453

Query: 68  NKLEGEIPRGGPFRNFS 84
           N+L+  +P  G F   +
Sbjct: 454 NQLK-SVPD-GIFDRLT 468

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 56.4 bits (136), Expect = 9e-09
 Identities = 16/69 (23%), Positives = 29/69 (42%), Gaps = 2/69 (2%)

Query: 2  IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
          +P ++   +    L +  N +          L  L+ L +S+N +     +  +    LE
Sbjct: 15 VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELE 72

Query: 62 NLNLSFNKL 70
           L+LS NKL
Sbjct: 73 YLDLSHNKL 81

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 54.5 bits (131), Expect = 5e-08
 Identities = 19/71 (26%), Positives = 33/71 (46%), Gaps = 4/71 (5%)

Query: 8   GLKNLEYLFLGYNRLQ-GPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLS 66
            +K+L+ L +  N +             SL  LN+S+N L+  I   L     ++ L+L 
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLH 429

Query: 67  FNKLEGEIPRG 77
            NK++  IP+ 
Sbjct: 430 SNKIK-SIPKQ 439

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 16/73 (21%), Positives = 30/73 (41%), Gaps = 2/73 (2%)

Query: 7   GGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLS--GAIPASLEKLSYLENLN 64
             +    +L    N L   + ++ G L  L+ L L  N L     I     ++  L+ L+
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLD 380

Query: 65  LSFNKLEGEIPRG 77
           +S N +  +  +G
Sbjct: 381 ISQNSVSYDEKKG 393

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 13/77 (16%), Positives = 24/77 (31%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
              N+       +  +         +     L+ SNN L+  +  +   L+ LE L L  
Sbjct: 298 IFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQM 357

Query: 68  NKLEGEIPRGGPFRNFS 84
           N+L+             
Sbjct: 358 NQLKELSKIAEMTTQMK 374

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 51.8 bits (124), Expect = 3e-07
 Identities = 24/82 (29%), Positives = 36/82 (43%), Gaps = 3/82 (3%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQ--GPIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKL 57
            +    G L  LE L L  N+L+    I +    + SL+ L++S N++S           
Sbjct: 339 TVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWT 398

Query: 58  SYLENLNLSFNKLEGEIPRGGP 79
             L +LN+S N L   I R  P
Sbjct: 399 KSLLSLNMSSNILTDTIFRCLP 420

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 47.6 bits (113), Expect = 6e-06
 Identities = 15/60 (25%), Positives = 30/60 (50%), Gaps = 1/60 (1%)

Query: 9   LKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN 68
              ++ L L  N+++  IP     L +L+ LN+++N L        ++L+ L+ + L  N
Sbjct: 420 PPRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 57.4 bits (139), Expect = 1e-09
 Identities = 20/71 (28%), Positives = 32/71 (45%), Gaps = 3/71 (4%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPA-SLEKLSYLENLNLS 66
           G   +  + L  NRL+      F  L SLK L L +N ++  +   S   LS +  L+L 
Sbjct: 79  GASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLY 137

Query: 67  FNKLEGEIPRG 77
            N++   +  G
Sbjct: 138 DNQIT-TVAPG 147

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 56.6 bits (137), Expect = 2e-09
 Identities = 12/71 (16%), Positives = 27/71 (38%), Gaps = 3/71 (4%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYLENLNLS 66
            L  L  +    N++      +F     +  + L++N L   +   + + L  L+ L L 
Sbjct: 55  KLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLR 113

Query: 67  FNKLEGEIPRG 77
            N++   +   
Sbjct: 114 SNRIT-CVGND 123

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 49.3 bits (118), Expect = 6e-07
 Identities = 19/77 (24%), Positives = 30/77 (38%), Gaps = 4/77 (5%)

Query: 2  IPTEIGGLKNLEYLFLGYNRLQG-PIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
          IP  I   +    L L  N          F  L  L+ +N SNN ++     + E  S +
Sbjct: 26 IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV 83

Query: 61 ENLNLSFNKLEGEIPRG 77
            + L+ N+LE  +   
Sbjct: 84 NEILLTSNRLE-NVQHK 99

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 47.0 bits (112), Expect = 3e-06
 Identities = 22/61 (36%), Positives = 34/61 (55%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
           GL++L+ L L  NR+     DSF  L S++ L+L +N ++   P + + L  L  LNL  
Sbjct: 103 GLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLA 162

Query: 68  N 68
           N
Sbjct: 163 N 163

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 35/146 (23%), Positives = 65/146 (44%), Gaps = 11/146 (7%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLI-KVISTC 238
           IG G FG +Y    +    EVA+K+ N++          E ++ + ++    I  V    
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LLYESKIYRILQGGTGIPNVRWFG 72

Query: 239 SNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
              ++  LV++ +   SLE      +  L +   L +   + + +E++H   S   +H D
Sbjct: 73  VEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRD 128

Query: 299 LKPSNVLLDDNMVAH---LSDFSIAK 321
           +KP N L+     A+   + DF +AK
Sbjct: 129 IKPDNFLMGLGRRANQVYIIDFGLAK 154

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 33/166 (19%), Positives = 63/166 (37%), Gaps = 31/166 (18%)

Query: 181 IGRGGFGSVYKAR---------LGDGMEVAVKV-------FNLQ--CGRALKGFDVECEM 222
             R   G +Y+A               + ++K+       FN Q    RA K   V    
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 223 -MKSIRHRNLIKVISTCSNE-EFKALVLEYMPHG-SLEKYM-YSSNYILDIFQRLNIMID 278
            + S     +   +    ++ +++ LVL  +  G SL+  +  S  ++L     L +   
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167

Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAK 321
           +  ALE+LH       +H ++   N+ +   D + V  L+ +  A 
Sbjct: 168 LLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 55.8 bits (135), Expect = 2e-09
 Identities = 24/77 (31%), Positives = 35/77 (45%), Gaps = 3/77 (3%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYL 60
           +P E+   K+L  + L  NR+      SF ++  L  L LS N L   IP    + L  L
Sbjct: 46  VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSL 104

Query: 61  ENLNLSFNKLEGEIPRG 77
             L+L  N +   +P G
Sbjct: 105 RLLSLHGNDIS-VVPEG 120

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 58.4 bits (141), Expect = 3e-09
 Identities = 14/74 (18%), Positives = 26/74 (35%), Gaps = 7/74 (9%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           +P  +    ++  L +  N L   +P        L+ L +S N L+ ++P     L  L 
Sbjct: 55  LPDCLP--AHITTLVIPDNNLTS-LPALPP---ELRTLEVSGNQLT-SLPVLPPGLLELS 107

Query: 62  NLNLSFNKLEGEIP 75
             +     L     
Sbjct: 108 IFSNPLTHLPALPS 121

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 15/74 (20%), Positives = 28/74 (37%), Gaps = 4/74 (5%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           +P        L  L +  N+L   +P+S   L S   +NL  N LS     +L +++   
Sbjct: 256 LPMLPS---GLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLSERTLQALREITSAP 311

Query: 62  NLNLSFNKLEGEIP 75
             +    + +    
Sbjct: 312 GYSGPIIRFDMAGA 325

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 51.4 bits (123), Expect = 4e-07
 Identities = 16/74 (21%), Positives = 27/74 (36%), Gaps = 8/74 (10%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           +P     L  L       N+L   +P        L+ L++S+N L+ ++P    +L  L 
Sbjct: 156 LPALPSELCKLW---AYNNQLTS-LPMLPS---GLQELSVSDNQLA-SLPTLPSELYKLW 207

Query: 62  NLNLSFNKLEGEIP 75
             N     L     
Sbjct: 208 AYNNRLTSLPALPS 221

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 19/88 (21%), Positives = 31/88 (35%), Gaps = 20/88 (22%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLI--------------SLKFLNLSNNNLS 47
           +P    GL  L         L   +P     L                L+ L++S+N L+
Sbjct: 96  LPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQLA 154

Query: 48  GAIPASLEKLSYLENLNLSFNKLEGEIP 75
            ++PA   +   L  L    N+L   +P
Sbjct: 155 -SLPALPSE---LCKLWAYNNQLT-SLP 177

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 20/92 (21%), Positives = 35/92 (38%), Gaps = 26/92 (28%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLI-----------------SLKFLNLSNN 44
           +P        L+ L +  N+L   +P    +L                   LK L +S N
Sbjct: 176 LPMLPS---GLQELSVSDNQLAS-LPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGN 231

Query: 45  NLSGAIPASLEKLSYLENLNLSFNKLEGEIPR 76
            L+ ++P    +L   + L +S N+L   +P 
Sbjct: 232 RLT-SLPVLPSEL---KELMVSGNRLT-SLPM 258

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 47.6 bits (113), Expect = 7e-06
 Identities = 17/67 (25%), Positives = 30/67 (44%), Gaps = 8/67 (11%)

Query: 9  LKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN 68
                L +G + L   +PD       +  L + +NNL+ ++PA   +   L  L +S N
Sbjct: 39 NNGNAVLNVGESGLTT-LPDCLPA--HITTLVIPDNNLT-SLPALPPE---LRTLEVSGN 91

Query: 69 KLEGEIP 75
          +L   +P
Sbjct: 92 QLT-SLP 97

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 37/167 (22%), Positives = 69/167 (41%), Gaps = 31/167 (18%)

Query: 180 LIGRGGFGSVYKAR------LGDGMEVAVKVFNLQCG------RALKGFDVECEMMKSIR 227
            IG+GGFG +Y A       +G      VKV     G      +  +      ++ K IR
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 228 HRNLIKV---------ISTCSNEEFKALVLEYMPHG-SLEKYMYSSNYILDIFQRLNIMI 277
            R L  +         +   + + ++ ++++    G  L+K   ++         L + +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSL 159

Query: 278 DVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAK 321
            +   LEY+H       +H D+K SN+LL   + + V +L D+ +A 
Sbjct: 160 RILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 21/73 (28%), Positives = 30/73 (41%), Gaps = 4/73 (5%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQG-PIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSY 59
           V          L+ L L +N L+      S      L  LNLS   L   +P  L   + 
Sbjct: 219 VCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAK 275

Query: 60  LENLNLSFNKLEG 72
           L  L+LS+N+L+ 
Sbjct: 276 LSVLDLSYNRLDR 288

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 56.1 bits (135), Expect = 6e-09
 Identities = 18/85 (21%), Positives = 24/85 (28%), Gaps = 7/85 (8%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIP----DSFGDLISLKFLNLSNNN---LSGAIPAS 53
               ++     L  L L  N   G              +L+ L L N      SG   A 
Sbjct: 164 FSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSAL 223

Query: 54  LEKLSYLENLNLSFNKLEGEIPRGG 78
                 L+ L+LS N L        
Sbjct: 224 AAARVQLQGLDLSHNSLRDAAGAPS 248

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 15/79 (18%), Positives = 23/79 (29%), Gaps = 6/79 (7%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLI-----SLKFLNLSNNNLSGAIPASLEK 56
            P       +L  L L              +L       LK L+++  +        +  
Sbjct: 113 PPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRV 171

Query: 57  LSYLENLNLSFNKLEGEIP 75
              L  L+LS N   GE  
Sbjct: 172 FPALSTLDLSDNPELGERG 190

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 18/78 (23%), Positives = 31/78 (39%), Gaps = 10/78 (12%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPAS-------LEKLSYL 60
            L  L  L L  N+L   +P    DL  L+ + L  NN++  +  +         K +Y 
Sbjct: 239 FLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYY 296

Query: 61  ENLNLSFNKLE-GEIPRG 77
             ++L  N +   E+   
Sbjct: 297 NGISLFNNPVPYWEVQPA 314

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 56.9 bits (138), Expect = 4e-09
 Identities = 20/71 (28%), Positives = 29/71 (40%), Gaps = 1/71 (1%)

Query: 7   GGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLS 66
              + L  L L +N++Q    +       L  L L +N +      SL  L  L  L+L 
Sbjct: 190 DLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLD 249

Query: 67  FNKLEGEIPRG 77
            NKL   +P G
Sbjct: 250 NNKLS-RVPAG 259

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 56.2 bits (136), Expect = 8e-09
 Identities = 22/70 (31%), Positives = 37/70 (52%), Gaps = 4/70 (5%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
           GL++L  L L  N++      +F  L  L+ L +S N+L   IP +L   S L  L +  
Sbjct: 76  GLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHD 132

Query: 68  NKLEGEIPRG 77
           N++  ++P+G
Sbjct: 133 NRIR-KVPKG 141

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 25/78 (32%), Positives = 32/78 (41%), Gaps = 3/78 (3%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           +P EI    +   L L  N +     D F  L  L  L L NN +S     +   L  L+
Sbjct: 48  VPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQ 105

Query: 62  NLNLSFNKLEGEIPRGGP 79
            L +S N L  EIP   P
Sbjct: 106 KLYISKNHLV-EIPPNLP 122

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 20/71 (28%), Positives = 32/71 (45%), Gaps = 5/71 (7%)

Query: 8   GLKNLEYLFLGYNRLQ-GPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLS 66
           GL+N+  + +G N L+         D + L +L +S   L+  IP  L     L  L+L 
Sbjct: 145 GLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLD 201

Query: 67  FNKLEGEIPRG 77
            NK++  I   
Sbjct: 202 HNKIQ-AIELE 211

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 50.0 bits (120), Expect = 6e-07
 Identities = 17/79 (21%), Positives = 28/79 (35%), Gaps = 3/79 (3%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
            L+ L+ L++  N L   IP       SL  L + +N +          L  +  + +  
Sbjct: 100 PLRKLQKLYISKNHLVE-IPP--NLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGG 156

Query: 68  NKLEGEIPRGGPFRNFSVE 86
           N LE      G F    + 
Sbjct: 157 NPLENSGFEPGAFDGLKLN 175

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 55.4 bits (134), Expect = 9e-09
 Identities = 22/71 (30%), Positives = 37/71 (52%), Gaps = 3/71 (4%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYLENLNLS 66
            L  L  L+L  N+LQ      F +L +L+ L +++N L  A+P  + ++L  L  L L 
Sbjct: 59  RLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLD 117

Query: 67  FNKLEGEIPRG 77
            N+L+  +P  
Sbjct: 118 RNQLK-SLPPR 127

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 30/71 (42%), Positives = 37/71 (52%), Gaps = 3/71 (4%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYLENLNLS 66
            L  L YL LGYN LQ      F  L SLK L L NN L   +P    +KL+ L+ L L 
Sbjct: 131 SLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLD 189

Query: 67  FNKLEGEIPRG 77
            N+L+  +P G
Sbjct: 190 NNQLK-RVPEG 199

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 26/78 (33%), Positives = 41/78 (52%), Gaps = 4/78 (5%)

Query: 2   IPTEI-GGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSY 59
           +P  +   L NL  L L  N+L+   P  F  L  L +L+L  N L  ++P  + +KL+ 
Sbjct: 100 LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTS 158

Query: 60  LENLNLSFNKLEGEIPRG 77
           L+ L L  N+L+  +P G
Sbjct: 159 LKELRLYNNQLK-RVPEG 175

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 50.4 bits (121), Expect = 4e-07
 Identities = 24/77 (31%), Positives = 39/77 (50%), Gaps = 9/77 (11%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYL 60
           IP       + + L L  N+L      +F  L  L+ L L++N L   +PA + ++L  L
Sbjct: 35  IPA------DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNL 87

Query: 61  ENLNLSFNKLEGEIPRG 77
           E L ++ NKL+  +P G
Sbjct: 88  ETLWVTDNKLQ-ALPIG 103

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 20/61 (32%), Positives = 28/61 (45%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
            L +L+ L L  N+L+     +F  L  LK L L NN L      + + L  L+ L L  
Sbjct: 155 KLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQE 214

Query: 68  N 68
           N
Sbjct: 215 N 215

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 23/115 (20%), Positives = 42/115 (36%), Gaps = 19/115 (16%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLI-------------SLKFLNLSNNNLSG 48
           +P E   +K+    +  ++  +   P   G+                   L L+N  LS 
Sbjct: 26  MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS- 84

Query: 49  AIPASLEKLSYLENLNLSFNKLEGEIPRG-GPFRNFSVESFEGNELLCGSPNLQV 102
           ++P       +LE+L  S N L  E+P      ++  V++     L    P L+ 
Sbjct: 85  SLPEL---PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEY 135

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 55.0 bits (133), Expect = 3e-08
 Identities = 19/74 (25%), Positives = 34/74 (45%), Gaps = 5/74 (6%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
              E+  L  L  ++   N L+  +PD      SL+ LN+ +N L+  +P   + L++L+
Sbjct: 229 ELPELQNLPFLTTIYADNNLLKT-LPDLPP---SLEALNVRDNYLT-DLPELPQSLTFLD 283

Query: 62  NLNLSFNKLEGEIP 75
                F+ L    P
Sbjct: 284 VSENIFSGLSELPP 297

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 54.2 bits (131), Expect = 5e-08
 Identities = 19/89 (21%), Positives = 30/89 (33%), Gaps = 20/89 (22%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIP---------------DSFGDLISLKFLNLSNNNL 46
           +P     LK+L         L    P                   +   LK +++ NN+L
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSL 165

Query: 47  SGAIPASLEKLSYLENLNLSFNKLEGEIP 75
              +P        LE +    N+LE E+P
Sbjct: 166 K-KLPDLPPS---LEFIAAGNNQLE-ELP 189

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 53.8 bits (130), Expect = 5e-08
 Identities = 14/74 (18%), Positives = 22/74 (29%), Gaps = 3/74 (4%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           +        +LE +  G N L+        +L  L  +   NN L   +P     L  L 
Sbjct: 207 LKKLPDLPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALN 263

Query: 62  NLNLSFNKLEGEIP 75
             +     L     
Sbjct: 264 VRDNYLTDLPELPQ 277

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 51.5 bits (124), Expect = 3e-07
 Identities = 17/65 (26%), Positives = 30/65 (46%), Gaps = 6/65 (9%)

Query: 7   GGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLS 66
               +LE++  G N+L+  +P+   +L  L  +   NN+L   +P        LE++   
Sbjct: 170 DLPPSLEFIAAGNNQLEE-LPE-LQNLPFLTAIYADNNSLK-KLPDLPLS---LESIVAG 223

Query: 67  FNKLE 71
            N LE
Sbjct: 224 NNILE 228

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 48.8 bits (117), Expect = 2e-06
 Identities = 18/70 (25%), Positives = 31/70 (44%), Gaps = 9/70 (12%)

Query: 6   IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNL 65
                +LE L +  N+L   +P        L+ L  S N+L+  +P   +    L+ L++
Sbjct: 313 CDLPPSLEELNVSNNKLIE-LPALPP---RLERLIASFNHLA-EVPELPQN---LKQLHV 364

Query: 66  SFNKLEGEIP 75
            +N L  E P
Sbjct: 365 EYNPLR-EFP 373

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 48.1 bits (115), Expect = 4e-06
 Identities = 25/67 (37%), Positives = 33/67 (49%), Gaps = 9/67 (13%)

Query: 9   LKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN 68
             NL YL    N ++  + D      SL+ LN+SNN L   +PA   +   LE L  SFN
Sbjct: 296 PPNLYYLNASSNEIRS-LCDL---PPSLEELNVSNNKLI-ELPALPPR---LERLIASFN 347

Query: 69  KLEGEIP 75
            L  E+P
Sbjct: 348 HLA-EVP 353

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 20/90 (22%), Positives = 31/90 (34%), Gaps = 25/90 (27%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSY-- 59
           +P        LE L   +N L   +P+      +LK L++  N L    P   E +    
Sbjct: 332 LPALPP---RLERLIASFNHLAE-VPELPQ---NLKQLHVEYNPLR-EFPDIPESVEDLR 383

Query: 60  --------------LENLNLSFNKLEGEIP 75
                         L+ L++  N L  E P
Sbjct: 384 MNSHLAEVPELPQNLKQLHVETNPLR-EFP 412

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 41.9 bits (99), Expect = 3e-04
 Identities = 12/62 (19%), Positives = 25/62 (40%), Gaps = 4/62 (6%)

Query: 9   LKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN 68
            +NL+ L +  N L+   PD      S++ L +++  +      + E    LE+     +
Sbjct: 395 PQNLKQLHVETNPLRE-FPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHH 450

Query: 69  KL 70
             
Sbjct: 451 HH 452

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 32/165 (19%), Positives = 64/165 (38%), Gaps = 30/165 (18%)

Query: 180 LIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCGRA------------LKGFDVECEMMKS- 225
            IG GGFG +Y A       + A  V  ++                +   D   + ++  
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 226 -IRHRNLIKVI----STCSNEEFKALVLEYMPHG-SLEKYMYSSNYILDIFQRLNIMIDV 279
            + +  +        +      ++ +V+E +  G  L+K     N        L + I +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKI-SGQNGTFKKSTVLQLGIRM 160

Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAK 321
              LEY+H       +H D+K +N+LL   + + V +L+D+ ++ 
Sbjct: 161 LDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 16/68 (23%), Positives = 33/68 (48%), Gaps = 4/68 (5%)

Query: 4   TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 63
           + I GL++++ L L   ++    P     L +L+ L L  N ++   P  L  L+ L+ L
Sbjct: 101 SAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYL 156

Query: 64  NLSFNKLE 71
           ++   ++ 
Sbjct: 157 SIGNAQVS 164

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 18/68 (26%), Positives = 31/68 (45%), Gaps = 4/68 (5%)

Query: 4   TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 63
             +  L  +  L L  N L+     +   L S+K L+L++  ++   P  L  LS L+ L
Sbjct: 79  APLKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVL 134

Query: 64  NLSFNKLE 71
            L  N++ 
Sbjct: 135 YLDLNQIT 142

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 50.8 bits (122), Expect = 3e-07
 Identities = 19/68 (27%), Positives = 32/68 (47%), Gaps = 4/68 (5%)

Query: 4   TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 63
           + + GL NL+YL +G  ++    P    +L  L  L   +N +S   P  L  L  L  +
Sbjct: 145 SPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEV 200

Query: 64  NLSFNKLE 71
           +L  N++ 
Sbjct: 201 HLKNNQIS 208

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 12/64 (18%), Positives = 25/64 (39%), Gaps = 4/64 (6%)

Query: 8  GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
           L N   +  G + +   +     DL  +  L+     ++  I   ++ L+ L  L L  
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72

Query: 68 NKLE 71
          N++ 
Sbjct: 73 NQIT 76

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 47.0 bits (112), Expect = 6e-06
 Identities = 16/69 (23%), Positives = 26/69 (37%), Gaps = 4/69 (5%)

Query: 3  PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLEN 62
                L  +  L      +   I      L +L  L L +N ++   P  L+ L+ +  
Sbjct: 34 TVTQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITE 89

Query: 63 LNLSFNKLE 71
          L LS N L+
Sbjct: 90 LELSGNPLK 98

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 48/209 (22%), Positives = 88/209 (42%), Gaps = 26/209 (12%)

Query: 178 NNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGF----DVECEMMKSIRHR--- 229
           ++LIG+G FG V KA    +   VA+K+      +  K F     +E  +++ +      
Sbjct: 59  DSLIGKGSFGQVVKAYDRVEQEWVAIKII-----KNKKAFLNQAQIEVRLLELMNKHDTE 113

Query: 230 ---NLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEY 285
               ++ +           LV E +   +L   + ++N+  + +         + +AL +
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172

Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAH--LSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
           L       IIHCDLKP N+LL +   +   + DF  +       Q +   Q + +  Y +
Sbjct: 173 LA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS---CQLGQRI--YQYIQSRFYRS 226

Query: 344 PEYGREGRVSTNGDVYSFGIMLMETFTGK 372
           PE           D++S G +L+E  TG+
Sbjct: 227 PEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 54.3 bits (130), Expect = 4e-08
 Identities = 22/66 (33%), Positives = 33/66 (50%), Gaps = 4/66 (6%)

Query: 6   IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNL 65
           +  L  LE L+LG N++          L  L  L+L +N +S  +P  L  L+ L+NL L
Sbjct: 127 LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYL 182

Query: 66  SFNKLE 71
           S N + 
Sbjct: 183 SKNHIS 188

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 26/68 (38%), Positives = 37/68 (54%), Gaps = 4/68 (5%)

Query: 4   TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 63
             +  LKNL +LFL  N+++  +  S  DL  LK L+L +N +S  I   L  L  LE+L
Sbjct: 81  KPLTNLKNLGWLFLDENKIKD-L-SSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESL 136

Query: 64  NLSFNKLE 71
            L  NK+ 
Sbjct: 137 YLGNNKIT 144

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 49.7 bits (118), Expect = 1e-06
 Identities = 21/68 (30%), Positives = 33/68 (48%), Gaps = 4/68 (5%)

Query: 4   TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 63
             I  L N+  LFL  N+L   I     +L +L +L L  N +   +  SL+ L  L++L
Sbjct: 59  QGIQYLPNVTKLFLNGNKLTD-IKP-LTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSL 114

Query: 64  NLSFNKLE 71
           +L  N + 
Sbjct: 115 SLEHNGIS 122

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 10/64 (15%), Positives = 25/64 (39%), Gaps = 4/64 (6%)

Query: 8  GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
                   L    +   +     +L S+  +  +N+++  ++   ++ L  +  L L+ 
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNG 74

Query: 68 NKLE 71
          NKL 
Sbjct: 75 NKLT 78

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 46.3 bits (109), Expect = 2e-05
 Identities = 14/66 (21%), Positives = 27/66 (40%), Gaps = 4/66 (6%)

Query: 6   IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNL 65
              L +++ +    + ++         L ++  L L+ N L+   P  L  L  L  L L
Sbjct: 39  QNELNSIDQIIANNSDIK--SVQGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFL 94

Query: 66  SFNKLE 71
             NK++
Sbjct: 95  DENKIK 100

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 41.6 bits (97), Expect = 4e-04
 Identities = 12/67 (17%), Positives = 21/67 (31%), Gaps = 2/67 (2%)

Query: 4   TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 63
             + GL  L+ L+L  N +      +   L +L  L L +             L     +
Sbjct: 169 VPLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 226

Query: 64  NLSFNKL 70
             +   L
Sbjct: 227 KNTDGSL 233

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 51.9 bits (125), Expect = 5e-08
 Identities = 20/71 (28%), Positives = 32/71 (45%), Gaps = 3/71 (4%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYLENLNLS 66
            L +L  L L  N+L G  P++F     ++ L L  N +   I   +   L  L+ LNL 
Sbjct: 52  RLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLY 110

Query: 67  FNKLEGEIPRG 77
            N++   +  G
Sbjct: 111 DNQISC-VMPG 120

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 24/78 (30%), Positives = 32/78 (41%), Gaps = 10/78 (12%)

Query: 2  IPTEIGGLKNLEYLFLGYNRLQGPIPD-SFGDLISLKFLNLSNNNLSGAIPASL-EKLSY 59
          IP       +   L L  N L     D  FG L  L  L L  N L+  I  +  E  S+
Sbjct: 27 IPL------HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASH 79

Query: 60 LENLNLSFNKLEGEIPRG 77
          ++ L L  NK++ EI   
Sbjct: 80 IQELQLGENKIK-EISNK 96

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 41.9 bits (99), Expect = 1e-04
 Identities = 23/61 (37%), Positives = 35/61 (57%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
           G  +++ L LG N+++      F  L  LK LNL +N +S  +P S E L+ L +LNL+ 
Sbjct: 76  GASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLAS 135

Query: 68  N 68
           N
Sbjct: 136 N 136

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 54.2 bits (130), Expect = 5e-08
 Identities = 15/67 (22%), Positives = 26/67 (38%), Gaps = 8/67 (11%)

Query: 9   LKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN 68
           +     L L    L   +PD+      +  L ++ N L  ++P        LE L+   N
Sbjct: 58  INQFSELQLNRLNLSS-LPDNLPP--QITVLEITQNALI-SLPELPAS---LEYLDACDN 110

Query: 69  KLEGEIP 75
           +L   +P
Sbjct: 111 RLS-TLP 116

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 53.8 bits (129), Expect = 7e-08
 Identities = 17/74 (22%), Positives = 34/74 (45%), Gaps = 11/74 (14%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           +P  +     +  L +  N L   +P+      SL++L+  +N LS  +P     L   +
Sbjct: 74  LPDNLP--PQITVLEITQNALI-SLPELPA---SLEYLDACDNRLS-TLPELPASL---K 123

Query: 62  NLNLSFNKLEGEIP 75
           +L++  N+L   +P
Sbjct: 124 HLDVDNNQLT-MLP 136

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 53.8 bits (129), Expect = 7e-08
 Identities = 14/84 (16%), Positives = 27/84 (32%), Gaps = 5/84 (5%)

Query: 2   IPTEIGGLKNLE----YLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKL 57
           +P       + E    +     NR+   IP++   L     + L +N LS  I  SL + 
Sbjct: 195 LPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253

Query: 58  SYLENLNLSFNKLEGEIPRGGPFR 81
           +   + +           +     
Sbjct: 254 TAQPDYHGPRIYFSMSDGQQNTLH 277

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 23/76 (30%), Positives = 36/76 (47%), Gaps = 12/76 (15%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           +P        LEY+    N+L   +P+      SL+ L++ NN L+  +P   E L   E
Sbjct: 135 LPELPA---LLEYINADNNQLTM-LPELPT---SLEVLSVRNNQLT-FLPELPESL---E 183

Query: 62  NLNLSFNKLEGEIPRG 77
            L++S N LE  +P  
Sbjct: 184 ALDVSTNLLE-SLPAV 198

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 50.4 bits (120), Expect = 9e-07
 Identities = 19/74 (25%), Positives = 35/74 (47%), Gaps = 12/74 (16%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           +P     LK+L+   +  N+L   +P+       L+++N  NN L+  +P     L   E
Sbjct: 115 LPELPASLKHLD---VDNNQLTM-LPELPA---LLEYINADNNQLT-MLPELPTSL---E 163

Query: 62  NLNLSFNKLEGEIP 75
            L++  N+L   +P
Sbjct: 164 VLSVRNNQLT-FLP 176

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 12/74 (16%), Positives = 25/74 (33%), Gaps = 6/74 (8%)

Query: 2  IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
            +     +         N     + +    +     L L+  NLS ++P +L     + 
Sbjct: 29 YFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNLS-SLPDNL--PPQIT 83

Query: 62 NLNLSFNKLEGEIP 75
           L ++ N L   +P
Sbjct: 84 VLEITQNALI-SLP 96

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 53.1 bits (128), Expect = 7e-08
 Identities = 53/237 (22%), Positives = 87/237 (36%), Gaps = 66/237 (27%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGF----DVECEMMKSIRHR----- 229
            +G G FG V   + + +    AVKV      R +K +     +E +++K I++      
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVV-----RNIKKYTRSAKIEADILKKIQNDDINNN 96

Query: 230 NLIKVIST-------CSNEEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVAS 281
           N++K           C       L+ E +   SL + +  +NY    I       I++  
Sbjct: 97  NIVKYHGKFMYYDHMC-------LIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILK 148

Query: 282 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ------------- 328
           AL YL       + H DLKP N+LLDD                 + Q             
Sbjct: 149 ALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205

Query: 329 ---SMTQTQTLATI----GYMAPE------YGREGRVSTNGDVYSFGIMLMETFTGK 372
              +  ++    +I     Y APE      +        + D++SFG +L E +TG 
Sbjct: 206 FGCATFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFGCVLAELYTGS 256

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 51.6 bits (124), Expect = 9e-08
 Identities = 27/76 (35%), Positives = 42/76 (55%), Gaps = 3/76 (3%)

Query: 3   PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYLE 61
           P     L NL+ L+LG N+L       F  L  L  L+L  N L+  +P+++ ++L +L+
Sbjct: 57  PGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLK 115

Query: 62  NLNLSFNKLEGEIPRG 77
            L +  NKL  E+PRG
Sbjct: 116 ELFMCCNKLT-ELPRG 130

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 51.2 bits (123), Expect = 1e-07
 Identities = 25/69 (36%), Positives = 37/69 (53%), Gaps = 2/69 (2%)

Query: 9   LKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN 68
           L  L  L LG N+L       F  L+ LK L +  N L+  +P  +E+L++L +L L  N
Sbjct: 87  LTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQN 145

Query: 69  KLEGEIPRG 77
           +L+  IP G
Sbjct: 146 QLKS-IPHG 153

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 43.9 bits (104), Expect = 4e-05
 Identities = 25/71 (35%), Positives = 37/71 (52%), Gaps = 8/71 (11%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYL 60
           IPT      N + L+L  N++    P  F  LI+LK L L +N L  A+P  + + L+ L
Sbjct: 38  IPT------NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQL 90

Query: 61  ENLNLSFNKLE 71
             L+L  N+L 
Sbjct: 91  TVLDLGTNQLT 101

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 53.7 bits (128), Expect = 1e-07
 Identities = 79/470 (16%), Positives = 143/470 (30%), Gaps = 121/470 (25%)

Query: 39  LNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSP 98
           LNL N N    +   L+KL Y  + N +      +       R  S+++ E   LL   P
Sbjct: 187 LNLKNCNSPETVLEMLQKLLYQIDPNWT---SRSDHSSNIKLRIHSIQA-ELRRLLKSKP 242

Query: 99  NLQVPPCKTSNHHTLWKNSLL-LRIVLPLSAI--FMIVV-ILLILRYRQKGKRPSNDANM 154
                          ++N LL L  V    A   F +   ILL  R             +
Sbjct: 243 ---------------YENCLLVLLNVQNAKAWNAFNLSCKILLTTR----------FKQV 277

Query: 155 PSIATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC---GR 211
               +  T +H+ L   +   + +    +         R  D     +     +      
Sbjct: 278 TDFLSAATTTHISLDHHSMTLTPDE--VKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAE 335

Query: 212 ALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQ 271
           +++      +  K +    L  +I +  N      VLE  P  +  + M+     L +F 
Sbjct: 336 SIRDGLATWDNWKHVNCDKLTTIIESSLN------VLE--P--AEYRKMFDR---LSVFP 382

Query: 272 R-LNIMIDVASAL-------------EYLH-----------FGYSAPIIHCDLKPSNVLL 306
              +I   + S +               LH              S P I+ +LK     L
Sbjct: 383 PSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVK---L 439

Query: 307 DDNMVAH---LSDFSIAKLLTGEDQSMTQTQT--LATIGYMAPEYGREGRVSTNGDVY-S 360
           ++    H   +  ++I K    +D           + IG+         R++    V+  
Sbjct: 440 ENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLD 499

Query: 361 FGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCV 420
           F       F  +K           ++H    W    ++     N L    + F     C 
Sbjct: 500 FR------FLEQK-----------IRHDSTAWNASGSI----LNTLQ--QLKFYKPYICD 536

Query: 421 SCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNVGDRCIRQSILN 470
           +              E+ +NA  I+  L KI ++L+ +     + +  L 
Sbjct: 537 ND----------PKYERLVNA--ILDFLPKIEENLICS-KYTDLLRIALM 573

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 41.8 bits (97), Expect = 5e-04
 Identities = 44/317 (13%), Positives = 84/317 (26%), Gaps = 127/317 (40%)

Query: 38  FLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGS 97
           + +++ + L+  I +SL  L   E   +              F   SV  F         
Sbjct: 347 WKHVNCDKLTTIIESSLNVLEPAEYRKM--------------FDRLSV--FP-------- 382

Query: 98  PNLQVPPCKTSNHHTLWKN----------------SLLLR-----------IVLPLSAIF 130
           P+  +P    S    +W +                SL+ +           I L L    
Sbjct: 383 PSAHIPTILLS---LIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKL 439

Query: 131 MIVVIL---LILRYRQKGKRPSNDANMPSIAT-WRTFS----HLELCRATDGFSENNLIG 182
                L   ++  Y       S+D   P +   +  +S    HL+     +  +      
Sbjct: 440 ENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYF--YSHIGHHLKNIEHPERMTL----- 492

Query: 183 RGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEE 242
              F  V+               +         F     + + IRH          +   
Sbjct: 493 ---FRMVF--------------LDF-------RF-----LEQKIRH--------DSTAWN 515

Query: 243 FKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF--GYSAPII---HC 297
               +L  +    L+ Y     YI D   +   +++       L F       +I   + 
Sbjct: 516 ASGSILNTL--QQLKFY---KPYICDNDPKYERLVN-----AILDFLPKIEENLICSKYT 565

Query: 298 DL------KPSNVLLDD 308
           DL           + ++
Sbjct: 566 DLLRIALMAEDEAIFEE 582

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 22/66 (33%), Positives = 33/66 (50%), Gaps = 4/66 (6%)

Query: 6   IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNL 65
           +  L  LE L+LG N++          L  L  L+L +N +S  +P  L  L+ L+NL L
Sbjct: 130 LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYL 185

Query: 66  SFNKLE 71
           S N + 
Sbjct: 186 SKNHIS 191

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 26/68 (38%), Positives = 36/68 (52%), Gaps = 4/68 (5%)

Query: 4   TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 63
             +  LKNL +LFL  N+++     S  DL  LK L+L +N +S  I   L  L  LE+L
Sbjct: 84  KPLANLKNLGWLFLDENKVK--DLSSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESL 139

Query: 64  NLSFNKLE 71
            L  NK+ 
Sbjct: 140 YLGNNKIT 147

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 10/64 (15%), Positives = 23/64 (35%), Gaps = 4/64 (6%)

Query: 8  GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
                   L    +   +     +L S+  +  +N+++       ++ L  +  L L+ 
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77

Query: 68 NKLE 71
          NKL 
Sbjct: 78 NKLT 81

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 20/66 (30%), Positives = 31/66 (46%), Gaps = 4/66 (6%)

Query: 6   IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNL 65
           I  L N+  LFL  N+L    P    +L +L +L L  N +       L+ L  L++L+L
Sbjct: 64  IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSL 119

Query: 66  SFNKLE 71
             N + 
Sbjct: 120 EHNGIS 125

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 14/66 (21%), Positives = 28/66 (42%), Gaps = 4/66 (6%)

Query: 6   IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNL 65
              L +++ +    + ++  +      L ++  L L+ N L+   P  L  L  L  L L
Sbjct: 42  QNELNSIDQIIANNSDIKS-V-QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFL 97

Query: 66  SFNKLE 71
             NK++
Sbjct: 98  DENKVK 103

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 27/76 (35%), Positives = 40/76 (52%), Gaps = 3/76 (3%)

Query: 3   PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYLE 61
                GL  L +L L YN+LQ      F DL  L  L L+NN L+ ++P  + + L+ L+
Sbjct: 52  DATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLD 110

Query: 62  NLNLSFNKLEGEIPRG 77
            L L  N+L+  +P G
Sbjct: 111 KLYLGGNQLK-SLPSG 125

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 49.7 bits (119), Expect = 5e-07
 Identities = 28/71 (39%), Positives = 41/71 (57%), Gaps = 3/71 (4%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYLENLNLS 66
            L  L+ L+LG N+L+      F  L  LK L L+ N L  +IPA   +KL+ L+ L+LS
Sbjct: 105 HLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLS 163

Query: 67  FNKLEGEIPRG 77
            N+L+  +P G
Sbjct: 164 TNQLQS-VPHG 173

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 21/70 (30%), Positives = 30/70 (42%), Gaps = 8/70 (11%)

Query: 2  IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYL 60
          IP       + E L L    L      +F  L  L +LNL  N L   + A + + L+ L
Sbjct: 33 IPA------DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTEL 85

Query: 61 ENLNLSFNKL 70
            L L+ N+L
Sbjct: 86 GTLGLANNQL 95

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 40/226 (17%), Positives = 79/226 (34%), Gaps = 48/226 (21%)

Query: 180 LIGRGGFGSVYKA--RLGDGMEVAVKVFNLQCGRALKGF----DVECEMMKSIRHR---N 230
            +G G FG V +         +VA+K+      R +  +     +E  ++K I+ +   N
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKII-----RNVGKYREAARLEINVLKKIKEKDKEN 80

Query: 231 LIKVISTCSNEEFKA---LVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYL 286
               +       F     +  E +   +  +++  +N+    +    ++   +  AL +L
Sbjct: 81  KFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFL 139

Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ----------SMTQTQTL 336
           H      + H DLKP N+L  ++    L +   +                  +    +  
Sbjct: 140 H---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH 196

Query: 337 ATI----GYMAPE------YGREGRVSTNGDVYSFGIMLMETFTGK 372
            TI     Y  PE      +      +   DV+S G +L E + G 
Sbjct: 197 TTIVATRHYRPPEVILELGW------AQPCDVWSIGCILFEYYRGF 236

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 49.2 bits (118), Expect = 3e-07
 Identities = 28/77 (36%), Positives = 42/77 (54%), Gaps = 9/77 (11%)

Query: 2  IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYL 60
          IPT        + L+L  N++    P  F  L  L  L+L NN L+  +PA + +KL+ L
Sbjct: 28 IPT------TTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQL 80

Query: 61 ENLNLSFNKLEGEIPRG 77
            L+L+ N+L+  IPRG
Sbjct: 81 TQLSLNDNQLKS-IPRG 96

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 48.8 bits (117), Expect = 4e-07
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 9/77 (11%)

Query: 2  IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYL 60
          IPT      + + L+L  N++    P  F  L++L+ L  ++N L+ AIP  + +KL+ L
Sbjct: 31 IPT------DKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQL 83

Query: 61 ENLNLSFNKLEGEIPRG 77
            L+L+ N L+  IPRG
Sbjct: 84 TQLDLNDNHLKS-IPRG 99

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 49.3 bits (118), Expect = 5e-07
 Identities = 26/70 (37%), Positives = 39/70 (55%), Gaps = 3/70 (4%)

Query: 9   LKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYLENLNLSF 67
           L +L YL L  N+LQ      F  L  LK L L+ N L  ++P  + +KL+ L++L L  
Sbjct: 75  LTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQ 133

Query: 68  NKLEGEIPRG 77
           N+L+  +P G
Sbjct: 134 NQLKS-VPDG 142

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 42.7 bits (101), Expect = 8e-05
 Identities = 28/77 (36%), Positives = 38/77 (49%), Gaps = 5/77 (6%)

Query: 2  IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYL 60
          +PT I       YL L  N L+      F +L SL  L L  N L  ++P  +  KL+ L
Sbjct: 22 VPTGIPA--QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSL 78

Query: 61 ENLNLSFNKLEGEIPRG 77
            LNLS N+L+  +P G
Sbjct: 79 TYLNLSTNQLQ-SLPNG 94

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 50.0 bits (120), Expect = 5e-07
 Identities = 27/70 (38%), Positives = 41/70 (58%), Gaps = 3/70 (4%)

Query: 9   LKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYLENLNLSF 67
           L NL YL L +N+LQ      F  L +L  L+LS N L  ++P  + +KL+ L++L L  
Sbjct: 132 LTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQ 190

Query: 68  NKLEGEIPRG 77
           N+L+  +P G
Sbjct: 191 NQLKS-VPDG 199

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 26/64 (40%), Positives = 35/64 (54%), Gaps = 2/64 (3%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYLENLNLS 66
            L NL YL L  N+LQ      F  L +LK L L  N L  ++P  + +KL+ L  LNL+
Sbjct: 83  ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLA 141

Query: 67  FNKL 70
            N+L
Sbjct: 142 HNQL 145

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 24/67 (35%), Positives = 39/67 (58%), Gaps = 4/67 (5%)

Query: 6   IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYLENLN 64
           I  L N+ YL LG N+L   I  +  +L +L +L L+ N L  ++P  + +KL+ L+ L 
Sbjct: 59  IQYLPNVRYLALGGNKLH-DIS-ALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELV 115

Query: 65  LSFNKLE 71
           L  N+L+
Sbjct: 116 LVENQLQ 122

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 48.8 bits (117), Expect = 5e-07
 Identities = 25/77 (32%), Positives = 37/77 (48%), Gaps = 9/77 (11%)

Query: 2  IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYL 60
          IP+      +   L L  N+LQ      F  L  L  L+LS N +  ++P  + +KL+ L
Sbjct: 26 IPS------SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKL 78

Query: 61 ENLNLSFNKLEGEIPRG 77
            L L  NKL+  +P G
Sbjct: 79 TILYLHENKLQ-SLPNG 94

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 50.8 bits (122), Expect = 5e-07
 Identities = 17/68 (25%), Positives = 26/68 (38%), Gaps = 6/68 (8%)

Query: 4   TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 63
           T I  L  L  L    N +   +        +L +L   +N L+  +   +  L+ L  L
Sbjct: 58  TGIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYL 111

Query: 64  NLSFNKLE 71
           N   NKL 
Sbjct: 112 NCDTNKLT 119

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 15/69 (21%), Positives = 25/69 (36%), Gaps = 6/69 (8%)

Query: 3   PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLEN 62
             ++     L  L   +N++             L  LN   NN++  +   L +   L  
Sbjct: 163 KLDVTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTF 216

Query: 63  LNLSFNKLE 71
           L+ S NKL 
Sbjct: 217 LDCSSNKLT 225

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 18/67 (26%), Positives = 27/67 (40%), Gaps = 6/67 (8%)

Query: 5   EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLN 64
           ++    NL YL    N+L   +      L  L +LN   N L+  +  S  +   L  LN
Sbjct: 80  DLSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLT-KLDVS--QNPLLTYLN 133

Query: 65  LSFNKLE 71
            + N L 
Sbjct: 134 CARNTLT 140

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 48.1 bits (115), Expect = 4e-06
 Identities = 13/66 (19%), Positives = 24/66 (36%), Gaps = 5/66 (7%)

Query: 5   EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLN 64
           ++     L YL+L    L   +         LK L+  N ++      S+ K+  L N  
Sbjct: 313 DLSQNPKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNF 367

Query: 65  LSFNKL 70
            +  + 
Sbjct: 368 EAEGQT 373

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 47.0 bits (112), Expect = 8e-06
 Identities = 11/67 (16%), Positives = 21/67 (31%), Gaps = 5/67 (7%)

Query: 5   EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLN 64
           ++     L  L    N+    +         L  L+ S N ++      + +   L  LN
Sbjct: 143 DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLN 197

Query: 65  LSFNKLE 71
              N + 
Sbjct: 198 CDTNNIT 204

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 45.4 bits (108), Expect = 3e-05
 Identities = 14/66 (21%), Positives = 23/66 (34%), Gaps = 5/66 (7%)

Query: 6  IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNL 65
             L  L  L    + +          L  L  L  ++NN++  +   L + + L  L  
Sbjct: 38 EEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLAC 92

Query: 66 SFNKLE 71
            NKL 
Sbjct: 93 DSNKLT 98

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 44.7 bits (106), Expect = 4e-05
 Identities = 13/62 (20%), Positives = 25/62 (40%), Gaps = 2/62 (3%)

Query: 10 KNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNK 69
           N          +Q     S   L +L  L+  N++++  +   +EKL+ L  L  + N 
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNN 75

Query: 70 LE 71
          + 
Sbjct: 76 IT 77

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 43.9 bits (104), Expect = 8e-05
 Identities = 16/70 (22%), Positives = 26/70 (37%), Gaps = 6/70 (8%)

Query: 6   IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNL 65
           +  L  L YL    N+L             L +LN + N L+  I   +   + L  L+ 
Sbjct: 102 VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDC 155

Query: 66  SFNKLEGEIP 75
             NK   ++ 
Sbjct: 156 HLNKKITKLD 165

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 10/66 (15%), Positives = 20/66 (30%), Gaps = 5/66 (7%)

Query: 5   EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLN 64
           ++     L Y      R    +         L  L+     ++  +   L +   L  L 
Sbjct: 270 DLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLY 324

Query: 65  LSFNKL 70
           L+  +L
Sbjct: 325 LNNTEL 330

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 13/87 (14%), Positives = 23/87 (26%), Gaps = 24/87 (27%)

Query: 5   EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPAS----------- 53
           ++  L  L Y     N L   +  S   L  L  L+    +L   I  +           
Sbjct: 228 DVTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLL-EIDLTHNTQLIYFQAE 283

Query: 54  ---------LEKLSYLENLNLSFNKLE 71
                    +   + L  L+     + 
Sbjct: 284 GCRKIKELDVTHNTQLYLLDCQAAGIT 310

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 49.3 bits (118), Expect = 5e-07
 Identities = 28/91 (30%), Positives = 41/91 (45%), Gaps = 11/91 (12%)

Query: 6   IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNN---LSGAIPASLEKLSYLEN 62
           + G++NL  L LG N ++  I +      +L+ L +S N    LSG     +EKL  L  
Sbjct: 66  LSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIASLSG-----IEKLVNLRV 119

Query: 63  LNLSFNKLE--GEIPRGGPFRNFSVESFEGN 91
           L +S NK+   GEI +             GN
Sbjct: 120 LYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 46.6 bits (111), Expect = 4e-06
 Identities = 17/70 (24%), Positives = 32/70 (45%), Gaps = 3/70 (4%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           +   +  LK  ++L L  N ++  I  S   + +L+ L+L  N +   I         LE
Sbjct: 40  MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96

Query: 62  NLNLSFNKLE 71
            L +S+N++ 
Sbjct: 97  ELWISYNQIA 106

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 42.0 bits (99), Expect = 1e-04
 Identities = 16/63 (25%), Positives = 29/63 (46%), Gaps = 4/63 (6%)

Query: 9  LKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN 68
           + +E L      ++  +  +   L + K L LS NN+   I +SL  +  L  L+L  N
Sbjct: 25 AEKVE-LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRN 80

Query: 69 KLE 71
           ++
Sbjct: 81 LIK 83

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 49.6 bits (119), Expect = 6e-07
 Identities = 17/73 (23%), Positives = 27/73 (36%), Gaps = 4/73 (5%)

Query: 8   GLKNLEYLFLGYNR-LQGPIPDSFGDLISLKFLNLSNNNLSGAIPA--SLEKLSYLENLN 64
            L  + ++ +   R L    PD+  +L  LKFL + N  L    P    +        L 
Sbjct: 78  NLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILE 136

Query: 65  LSFNKLEGEIPRG 77
           ++ N     IP  
Sbjct: 137 ITDNPYMTSIPVN 149

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 48.5 bits (116), Expect = 1e-06
 Identities = 15/77 (19%), Positives = 30/77 (38%), Gaps = 3/77 (3%)

Query: 8   GLKNLEYLFLGYN-RLQGPIPDSFGDLISLKFLNLSNNNLSGAIPAS-LEKLSYLENLNL 65
            L N+  +++  +  LQ     SF +L  +  + + N      I    L++L  L+ L +
Sbjct: 53  NLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGI 112

Query: 66  SFNKLEGEIPRGGPFRN 82
               L+   P      +
Sbjct: 113 FNTGLK-MFPDLTKVYS 128

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 10/68 (14%), Positives = 27/68 (39%), Gaps = 1/68 (1%)

Query: 11 NLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPA-SLEKLSYLENLNLSFNK 69
          + + L L    L+     +F +L ++  + +S +     + + S   LS + ++ +   +
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91

Query: 70 LEGEIPRG 77
              I   
Sbjct: 92 NLTYIDPD 99

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 41.1 bits (97), Expect = 3e-04
 Identities = 15/78 (19%), Positives = 26/78 (33%), Gaps = 6/78 (7%)

Query: 8   GLKN-LEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPA-SLEKL-SYLENLN 64
           GL N    L L  N     +     +   L  + L+ N     I   +   + S    L+
Sbjct: 153 GLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLD 211

Query: 65  LSFNKLEGEIPRGGPFRN 82
           +S   +   +P  G   +
Sbjct: 212 VSQTSVT-ALPSKG-LEH 227

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 49.6 bits (119), Expect = 6e-07
 Identities = 22/66 (33%), Positives = 29/66 (43%), Gaps = 5/66 (7%)

Query: 6   IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNL 65
           +  L  LE L +  NRL+     +      L  L L NN L      SL  L  LE L++
Sbjct: 81  LKDLTKLEELSVNRNRLKNL---NGIPSACLSRLFLDNNELRD--TDSLIHLKNLEILSI 135

Query: 66  SFNKLE 71
             NKL+
Sbjct: 136 RNNKLK 141

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 46.2 bits (110), Expect = 8e-06
 Identities = 17/66 (25%), Positives = 32/66 (48%), Gaps = 4/66 (6%)

Query: 6  IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNL 65
             L  ++      + +Q           +LK L+LS+N +S   P  L+ L+ LE L++
Sbjct: 37 QKELSGVQNFNGDNSNIQ--SLAGMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSV 92

Query: 66 SFNKLE 71
          + N+L+
Sbjct: 93 NRNRLK 98

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 14/68 (20%), Positives = 28/68 (41%), Gaps = 4/68 (5%)

Query: 4  TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 63
              GL N     LG   +   +     +L  ++  N  N+N+       ++  + L+ L
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSLAG--MQFFTNLKEL 68

Query: 64 NLSFNKLE 71
          +LS N++ 
Sbjct: 69 HLSHNQIS 76

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 17/66 (25%), Positives = 28/66 (42%), Gaps = 5/66 (7%)

Query: 6   IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNL 65
           +    NL+ L L +N++    P    DL  L+ L+++ N L       +     L  L L
Sbjct: 59  MQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNG--IPSAC-LSRLFL 113

Query: 66  SFNKLE 71
             N+L 
Sbjct: 114 DNNELR 119

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 50.0 bits (120), Expect = 8e-07
 Identities = 39/226 (17%), Positives = 79/226 (34%), Gaps = 48/226 (21%)

Query: 180 LIGRGGFGSVYKA--RLGDGMEVAVKVFNLQCGRALKGF----DVECEMMKSIRHR---N 230
            +G G FG V +       G  VAVK+      + +  +      E ++++ +      +
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIV-----KNVDRYCEAARSEIQVLEHLNTTDPNS 75

Query: 231 LIKVISTCSNEEFKA---LVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYL 286
             + +      E      +V E +   S   ++  + ++   +     +   +  ++ +L
Sbjct: 76  TFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL 134

Query: 287 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS----------MTQTQTL 336
           H   S  + H DLKP N+L   +      +  I +                      +  
Sbjct: 135 H---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH 191

Query: 337 ATI----GYMAPE------YGREGRVSTNGDVYSFGIMLMETFTGK 372
           +T+     Y APE      +      S   DV+S G +L+E + G 
Sbjct: 192 STLVSTRHYRAPEVILALGW------SQPCDVWSIGCILIEYYLGF 231

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 67/359 (18%), Positives = 112/359 (31%), Gaps = 107/359 (29%)

Query: 181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIR-----HRNLIKV 234
           +G G F +V+ +  +     VA+KV            D E  ++KS+R       N   V
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD-EIRLLKSVRNSDPNDPNREMV 103

Query: 235 ISTCSNEEFKA-------LVLEYMPHGSLEKYMYSSNYI---LDIFQRLNIMIDVASALE 284
           +    + +          +V E + H  L K++  SNY    L   ++  I+  V   L+
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKK--IIQQVLQGLD 160

Query: 285 YLHFGYSAPIIHCDLKPSNVLL-------------------------------------- 306
           YLH      IIH D+KP N+LL                                      
Sbjct: 161 YLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218

Query: 307 -----------DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 355
                       + +   ++D   A  +        QT+      Y + E       +T 
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTP 273

Query: 356 GDVYSFGIMLMETFTGKK---------------------------PTNEIFNGEMTLKHW 388
            D++S   M  E  TG                             P   I  G+ + + +
Sbjct: 274 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFF 333

Query: 389 VND--WLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIV 445
                   I+ ++  G   +  E   +  +E      F L M   +  PE+R  A E +
Sbjct: 334 TKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPM-LELI-PEKRATAAECL 390

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 16/72 (22%), Positives = 28/72 (38%), Gaps = 3/72 (4%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPA-SLEKLSY-LENLNL 65
            L NL+YL +    ++          +    L++ +N     I   S   LS+    L L
Sbjct: 102 NLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWL 161

Query: 66  SFNKLEGEIPRG 77
           + N ++ EI   
Sbjct: 162 NKNGIQ-EIHNS 172

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 47.1 bits (112), Expect = 7e-06
 Identities = 17/80 (21%), Positives = 30/80 (37%), Gaps = 9/80 (11%)

Query: 2  IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPAS----LEKL 57
          IP+++   +N   L     +L+     +F     L+ + +S N++   I A     L KL
Sbjct: 24 IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 81

Query: 58 SYLENLNLSFNKLEGEIPRG 77
            +       N L   I   
Sbjct: 82 HEIRIEK--ANNLL-YINPE 98

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 46.7 bits (111), Expect = 8e-06
 Identities = 14/77 (18%), Positives = 22/77 (28%), Gaps = 6/77 (7%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
           G +  E      N L+    D F        L++S   +       LE L  L   +   
Sbjct: 176 GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 235

Query: 68  NKLEGEIPRGGPFRNFS 84
            K   ++P         
Sbjct: 236 LK---KLP---TLEKLV 246

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 46.7 bits (111), Expect = 9e-06
 Identities = 20/82 (24%), Positives = 33/82 (40%), Gaps = 4/82 (4%)

Query: 8   GLKNLEYLFL-GYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPA-SLEKLSYLENLNL 65
            L  L  + +   N L    P++F +L +L++L +SN  +   +P            L++
Sbjct: 77  NLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDI 135

Query: 66  SFNKLEGEIPRGGPFRNFSVES 87
             N     I R   F   S ES
Sbjct: 136 QDNINIHTIER-NSFVGLSFES 156

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 13/61 (21%), Positives = 23/61 (37%), Gaps = 4/61 (6%)

Query: 8   GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
           G      L +   R+         +L  L+  +  N      +P +LEKL  L   +L++
Sbjct: 200 GASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLP-TLEKLVALMEASLTY 255

Query: 68  N 68
            
Sbjct: 256 P 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 15/72 (20%), Positives = 24/72 (33%), Gaps = 2/72 (2%)

Query: 11  NLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKL 70
               L+L  N +Q     +F      +     NNNL           S    L++S  ++
Sbjct: 155 ESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRI 214

Query: 71  EGEIPRGGPFRN 82
              +P  G   N
Sbjct: 215 H-SLPSYG-LEN 224

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 47.3 bits (111), Expect = 5e-06
 Identities = 15/74 (20%), Positives = 35/74 (47%), Gaps = 7/74 (9%)

Query: 7   GGLKNLEYLFLGYNRLQGPIPDSFGD---LISLKFLNLSNNNLSG----AIPASLEKLSY 59
               NL++L +     Q  + + F +   L  L+ +++S   L+      +   ++K+ +
Sbjct: 249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKH 308

Query: 60  LENLNLSFNKLEGE 73
           L+ +N+ +N L  E
Sbjct: 309 LKFINMKYNYLSDE 322

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.7 bits (106), Expect = 1e-05
 Identities = 26/70 (37%), Positives = 32/70 (45%), Gaps = 2/70 (2%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
           I        NLE+L L    L      +   L  LK L LS N + G +    EKL  L 
Sbjct: 41  IEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLT 98

Query: 62  NLNLSFNKLE 71
           +LNLS NKL+
Sbjct: 99  HLNLSGNKLK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 40.9 bits (96), Expect = 3e-04
 Identities = 19/65 (29%), Positives = 31/65 (47%), Gaps = 3/65 (4%)

Query: 9  LKNLEYLFLGYNRLQ-GPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
             +  L L   +   G I     + ++L+FL+L N  L     ++L KL  L+ L LS 
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSE 80

Query: 68 NKLEG 72
          N++ G
Sbjct: 81 NRIFG 85

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.0 bits (107), Expect = 1e-05
 Identities = 18/87 (20%), Positives = 34/87 (39%), Gaps = 4/87 (4%)

Query: 9   LKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN 68
           L   + +    N ++  + D F  L  LK L ++NN +        + L  L  L L+ N
Sbjct: 41  LDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNN 98

Query: 69  KLE--GEIPRGGPFRNFSVESFEGNEL 93
            L   G++      ++ +      N +
Sbjct: 99  SLVELGDLDPLASLKSLTYLCILRNPV 125

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.9 bits (104), Expect = 2e-05
 Identities = 23/63 (36%), Positives = 32/63 (50%), Gaps = 2/63 (3%)

Query: 9   LKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN 68
            + LE+L      L   I +    L  LK L LS+N +SG +    EK   L +LNLS N
Sbjct: 41  FEELEFLSTINVGLTS-IAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGN 98

Query: 69  KLE 71
           K++
Sbjct: 99  KIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 41.2 bits (97), Expect = 2e-04
 Identities = 19/68 (27%), Positives = 34/68 (50%), Gaps = 3/68 (4%)

Query: 9  LKNLEYLFLGYNRLQ-GPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
            +++ L L  +R   G +     +   L+FL+  N  L+    A+L KL+ L+ L LS 
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSD 73

Query: 68 NKLEGEIP 75
          N++ G + 
Sbjct: 74 NRVSGGLE 81

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 13/73 (17%), Positives = 27/73 (36%), Gaps = 9/73 (12%)

Query: 10  KNLEYLFLGYNRL-----QGPIPDSFGDLISLKFLNLSNNNLSG----AIPASLEKLSYL 60
           + L  + +  N +     +  + +       LK L+L +N  +     A+  +L+    L
Sbjct: 187 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNL 246

Query: 61  ENLNLSFNKLEGE 73
             L L+   L   
Sbjct: 247 RELGLNDCLLSAR 259

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	470
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.8
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.72
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.48
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.46
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.46
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.45
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.42
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.41
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.38
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.37
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.36
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.36
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.33
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.29
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.29
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.28
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.28
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.27
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.26
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.25
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.25
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.24
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.24
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.23
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.23
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.22
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.22
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.22
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.22
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.18
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.17
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.16
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.16
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.16
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.14
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.14
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.14
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.13
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.12
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.12
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.11
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.11
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.1
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.1
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.09
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.09
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.09
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.08
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.08
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.08
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.07
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.04
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.04
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.04
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.01
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.01
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	98.99
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	98.99
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	98.99
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	98.99
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	98.98
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	98.97
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.97
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	98.96
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	98.96
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	98.95
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	98.95
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	98.94
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	98.94
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	98.94
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	98.94
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	98.93
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	98.93
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	98.93
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	98.92
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	98.92
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	98.92
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	98.92
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	98.91
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	98.91
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	98.9
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	98.9
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	98.9
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	98.9
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	98.9
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	98.89
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	98.88
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	98.88
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	98.88
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	98.88
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	98.88
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	98.88
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	98.88
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	98.88
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	98.88
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	98.87
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	98.87
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	98.86
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	98.86
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	98.85
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	98.84
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	98.83
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	98.82
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	98.81
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	98.8
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	98.8
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	98.79
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	98.79
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	98.79
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	98.79
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	98.76
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	98.76
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	98.75
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	98.74
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	98.73
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	98.73
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.72
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	98.72
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	98.71
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	98.7
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.6
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	98.58
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	98.57
1o6v_A	466	Internalin A; bacterial infection, extracellular r	98.57
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	98.57
1o6v_A	466	Internalin A; bacterial infection, extracellular r	98.57
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.56
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	98.55
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.55
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	98.52
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	98.5
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.49
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.47
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	98.45
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.42
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	98.4
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	98.38
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	98.36
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	98.35
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	98.34
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	98.31
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	98.29
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	98.24
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.23
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	98.23
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.18
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	98.16
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.08
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.03
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.86
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	97.83
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	97.79
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	97.75
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	97.73
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.71
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	97.67
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	97.67
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.66
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.65
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	97.62
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	97.62
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.52
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.5
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.49
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.48
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.47
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.37
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.37
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.26
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.25
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	97.21
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	97.11
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.04
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.94
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.85
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	96.8
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	96.79
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	96.7
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	96.55
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.49
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	96.44
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	96.36
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	95.54
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.38
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	95.35
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	95.19
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	95.06
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	94.82
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	94.64
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	93.62
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	93.3
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	91.73
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	90.69
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	89.46
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	88.89
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	85.09
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	83.38
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	82.53

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.6e-58  Score=436.58  Aligned_cols=259  Identities=28%  Similarity=0.465  Sum_probs=217.6

Q ss_pred             CCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  246 (470)
                      ++|.+.+.||+|+||+||+|++.      ++..||||+++.......+.|.+|+++|++++|||||+++++|.+++..++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            46788899999999999999863      478899999987666677889999999999999999999999999999999


Q ss_pred             EEecCCCCChHHhhhcCC------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEE
Q 040392          247 VLEYMPHGSLEKYMYSSN------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHL  314 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl  314 (470)
                      |||||++|+|.+++...+            ..+++.++..++.|+++||+|||   +++|+||||||+|||+++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence            999999999999997542            46899999999999999999999   899999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhc
Q 040392          315 SDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWL  393 (470)
Q Consensus       315 ~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~  393 (470)
                      +|||+|+...............||+.|+|||++.+..++.++|||||||++|||+| |+.||......+  +...+....
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~~i~~~~  247 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIECITQGR  247 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHHHHHTC
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHcCC
Confidence            99999987654443334445679999999999999999999999999999999999 899998754322  111111110


Q ss_pred             CCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          394 PISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                                        ....+..|+.++.+|+.+||+.||++|||+.||.+.|+++...
T Consensus       248 ------------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          248 ------------------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             ------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence                              0112345678899999999999999999999999999998643

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.5e-57  Score=429.86  Aligned_cols=263  Identities=27%  Similarity=0.435  Sum_probs=209.3

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      .+++.+.+.||+|+||+||+|++.+  .||||+++..  ..+..+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            4577888999999999999998753  5999998643  33456789999999999999999999999865 45789999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      ||++|+|.+++...+..+++.++..++.|+++||+|||   +++|+||||||+|||+++++.+||+|||+|+........
T Consensus       112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence            99999999999877778999999999999999999999   899999999999999999999999999999876543333


Q ss_pred             ccccccccCccccCccccCC---CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccccc
Q 040392          330 MTQTQTLATIGYMAPEYGRE---GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL  406 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (470)
                      ......+||+.|||||++.+   +.++.++|||||||++|||+||+.||.+..... .+...+......       +.. 
T Consensus       189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-~~~~~~~~~~~~-------p~~-  259 (307)
T 3omv_A          189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-QIIFMVGRGYAS-------PDL-  259 (307)
T ss_dssp             -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHTTCCC-------CCS-
T ss_pred             eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-HHHHHHhcCCCC-------CCc-
Confidence            34455689999999999853   458999999999999999999999998643322 111111111110       000 


Q ss_pred             CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHH
Q 040392          407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL  455 (470)
Q Consensus       407 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~  455 (470)
                            ...+..|+.++.+|+.+||+.||++||||.||+++|+.++.++
T Consensus       260 ------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          260 ------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             ------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             ------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence                  0112356788999999999999999999999999999886543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.7e-57  Score=437.11  Aligned_cols=258  Identities=27%  Similarity=0.461  Sum_probs=209.7

Q ss_pred             CCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  246 (470)
                      ++|.+.+.||+|+||+||+|++.      +++.||||+++.......+.|.+|+++|++++|||||+++++|.+....++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45667789999999999999864      478899999987666677889999999999999999999999999999999


Q ss_pred             EEecCCCCChHHhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCe
Q 040392          247 VLEYMPHGSLEKYMYSSN--------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA  312 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~  312 (470)
                      |||||++|+|.+++....              ..+++.+++.++.|+++||+|||   +++|+||||||+|||+++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence            999999999999997542              35899999999999999999999   8999999999999999999999


Q ss_pred             EEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhh
Q 040392          313 HLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVND  391 (470)
Q Consensus       313 kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~  391 (470)
                      ||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+| |+.||......+  ....+..
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~~i~~  275 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE--AIDCITQ  275 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH--HHHHHHH
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH--HHHHHHc
Confidence            9999999987755444444456679999999999999999999999999999999999 899998643321  1111111


Q ss_pred             hcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          392 WLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                      ..                  +...+..|+.++.+|+.+||+.||++||||.||+++|+.+..
T Consensus       276 g~------------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          276 GR------------------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             TC------------------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CC------------------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            10                  011234567889999999999999999999999999999864

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.7e-57  Score=432.15  Aligned_cols=256  Identities=24%  Similarity=0.428  Sum_probs=213.5

Q ss_pred             CCCCCCeecccCceEEEEEEeC------CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeE
Q 040392          174 GFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  246 (470)
                      ++++.+.||+|+||+||+|++.      +++.||||+++... ....+.|.+|+.++++++|||||+++|+|.+++..++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            4566789999999999999863      46889999997543 3345679999999999999999999999999999999


Q ss_pred             EEecCCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC
Q 040392          247 VLEYMPHGSLEKYMYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV  311 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~  311 (470)
                      |||||++|+|.+++....               ..+++..+.+++.|||+||+|||   +++|+||||||+|||+++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCC
Confidence            999999999999996532               35899999999999999999999   899999999999999999999


Q ss_pred             eEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhh
Q 040392          312 AHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVN  390 (470)
Q Consensus       312 ~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~  390 (470)
                      +||+|||+|+.....+.........||+.|+|||++.++.++.++|||||||++|||+| |+.||.+....  .+...+.
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~--~~~~~i~  261 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVVEMIR  261 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH--HHHHHHH
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH
Confidence            99999999987654444444455679999999999999999999999999999999999 89999875332  2222221


Q ss_pred             hhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHH
Q 040392          391 DWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR  452 (470)
Q Consensus       391 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~  452 (470)
                      ...                  ..+.+..|+.++.+|+.+||+.||++||||.||+++|+.+.
T Consensus       262 ~~~------------------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          262 NRQ------------------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             TTC------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             cCC------------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence            110                  01123467888999999999999999999999999998753

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=7e-55  Score=419.90  Aligned_cols=250  Identities=24%  Similarity=0.292  Sum_probs=211.5

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      +.|+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|+.++|||||++++++.+.+..|+|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            45888999999999999999864 69999999998766666777899999999999999999999999999999999999


Q ss_pred             CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccc
Q 040392          252 PHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  331 (470)
Q Consensus       252 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  331 (470)
                      ++|+|.+++...  .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+....  ..
T Consensus       154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~  226 (346)
T 4fih_A          154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PR  226 (346)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CC
T ss_pred             CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC--Cc
Confidence            999999999764  4899999999999999999999   9999999999999999999999999999998764322  22


Q ss_pred             ccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhh
Q 040392          332 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDI  411 (470)
Q Consensus       332 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  411 (470)
                      ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||......  .....+....+...              
T Consensus       227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~i~~~~~~~~--------------  290 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLPPRL--------------  290 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSSCCCC--------------
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHcCCCCCC--------------
Confidence            34578999999999999999999999999999999999999999763221  11111111111110              


Q ss_pred             hhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          412 HFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       412 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                        .....++.++.+|+.+||..||++|||+.|+++|
T Consensus       291 --~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          291 --KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             --SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence              1123346778999999999999999999999875

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.4e-54  Score=416.51  Aligned_cols=255  Identities=24%  Similarity=0.294  Sum_probs=209.2

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      +.|++.+.||+|+||.||+|++. +|+.||||+++.+..     ..+|+.+++.++|||||++++++.+++..|+|||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            45777889999999999999864 699999999975422     246999999999999999999999999999999999


Q ss_pred             CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-CeEEeeeccccccCCCCCc-
Q 040392          252 PHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-VAHLSDFSIAKLLTGEDQS-  329 (470)
Q Consensus       252 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~-  329 (470)
                      +||+|.+++...+ .+++..+..++.||+.||+|||   +++|+||||||+|||++.++ ++||+|||+|+.+...... 
T Consensus       133 ~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          133 EGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             TTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            9999999997654 6899999999999999999999   99999999999999999988 6999999999877543221 


Q ss_pred             --ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          330 --MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       330 --~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                        ......+||+.|||||++.+..++.++|||||||++|||+||+.||......+... .......+  .          
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~i~~~~~~--~----------  275 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL-KIASEPPP--I----------  275 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH-HHHHSCCG--G----------
T ss_pred             ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH-HHHcCCCC--c----------
Confidence              12234579999999999999999999999999999999999999998754433221 11110000  0          


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                           ...+..++.++.+++.+||+.||++|||+.|++++|.+....
T Consensus       276 -----~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~  317 (336)
T 4g3f_A          276 -----REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE  317 (336)
T ss_dssp             -----GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence                 011234577899999999999999999999999999887654

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.3e-55  Score=422.04  Aligned_cols=251  Identities=20%  Similarity=0.321  Sum_probs=204.1

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      .++|++++.||+|+||+||+|+. .+|+.||||++...  .....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            46899999999999999999976 46999999999754  2345667889999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          249 EYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||+||+|.+++...+ ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+..  
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--  177 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--  177 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH--
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecC--
Confidence            9999999999997654 45789999999999999999999   99999999999999999999999999999986532  


Q ss_pred             CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                      ........+||+.|+|||++.+..|+.++|||||||++|||+||+.||......+ .+........+             
T Consensus       178 ~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i~~~~~~-------------  243 (350)
T 4b9d_A          178 TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-LVLKIISGSFP-------------  243 (350)
T ss_dssp             HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTCCC-------------
T ss_pred             CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHHHHcCCCC-------------
Confidence            1122345679999999999999999999999999999999999999997632221 11111111110             


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                            ..+..++.++.+|+.+||+.||++|||+.|+++|
T Consensus       244 ------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          244 ------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  0112346778999999999999999999999875

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=7.2e-55  Score=423.57  Aligned_cols=267  Identities=23%  Similarity=0.371  Sum_probs=219.7

Q ss_pred             HHHHHhhCCCCCCCeecccCceEEEEEEeCC------CcEEEEEEeeccc-chhhhhHHHHHHHHhcCCC-CcceeEEee
Q 040392          166 LELCRATDGFSENNLIGRGGFGSVYKARLGD------GMEVAVKVFNLQC-GRALKGFDVECEMMKSIRH-RNLIKVIST  237 (470)
Q Consensus       166 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~nIv~~~~~  237 (470)
                      ...+...++|++.+.||+|+||+||+|++..      ++.||||.+.... ....+.+.+|+++|++++| ||||+++|+
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            3344556789999999999999999997532      4689999997553 3345678999999999976 899999999


Q ss_pred             eccC-CeeeEEEecCCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCC
Q 040392          238 CSNE-EFKALVLEYMPHGSLEKYMYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKP  301 (470)
Q Consensus       238 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp  301 (470)
                      |.+. ...++|||||++|+|.++++...               ..+++..+..++.|||+||+|||   +++|+||||||
T Consensus       137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~  213 (353)
T 4ase_A          137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAA  213 (353)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred             EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCc
Confidence            8664 56899999999999999997532               35899999999999999999999   99999999999


Q ss_pred             CCeeeCCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccc
Q 040392          302 SNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFN  380 (470)
Q Consensus       302 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~  380 (470)
                      +|||+++++.+||+|||+|+.+.............||+.|||||++.+..++.++|||||||++|||+| |+.||.....
T Consensus       214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~  293 (353)
T 4ase_A          214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  293 (353)
T ss_dssp             GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999997765544445556789999999999999999999999999999999998 9999987543


Q ss_pred             CcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          381 GEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                      .+. +...+....                  +...+..++.++.+++.+||+.||++|||+.||+++|+++..+
T Consensus       294 ~~~-~~~~i~~g~------------------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          294 DEE-FCRRLKEGT------------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             SHH-HHHHHHHTC------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHH-HHHHHHcCC------------------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            322 222221111                  1112344577899999999999999999999999999998754

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.5e-55  Score=415.85  Aligned_cols=251  Identities=25%  Similarity=0.364  Sum_probs=211.5

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc---cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++.+.   .....+.+.+|+++++.++|||||++++++.+.+..|+|
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            35799999999999999999975 46999999999754   233456788999999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||++||+|.+++.+.+ .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+....
T Consensus       111 mEy~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             EecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            99999999999997654 6899999999999999999999   9999999999999999999999999999999876544


Q ss_pred             CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                      ........+||+.|+|||++.+..|+.++||||+||++|||++|+.||......+ .+........              
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-~~~~i~~~~~--------------  251 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL-IFAKIIKLEY--------------  251 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCC--------------
T ss_pred             CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCC--------------
Confidence            4444556789999999999999999999999999999999999999997632211 1111111100              


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                            ..+..++.++.+|+.+||..||++|||+.|++.+
T Consensus       252 ------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~  285 (311)
T 4aw0_A          252 ------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  285 (311)
T ss_dssp             ------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred             ------CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence                  0112346678999999999999999999997543

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.6e-54  Score=413.29  Aligned_cols=276  Identities=22%  Similarity=0.299  Sum_probs=201.8

Q ss_pred             CCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCC----eeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEE----FKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~----~~~lv~  248 (470)
                      .+|.+.+.||+|+||+||+|++ +|+.||||+++..... ...+..|+..+..++|||||++++++.+++    ..++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            3567778999999999999998 5899999999754322 122334666667889999999999997653    578999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeeecCCCCCCeeeCCCCCeEEeeecccccc
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFG-----YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  323 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-----~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~  323 (470)
                      ||+++|+|.++++..  .+++..+.+++.|+++||+|||+.     ...+|+||||||+|||++.++++||+|||+|+..
T Consensus        81 Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             cCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            999999999999765  489999999999999999999932     1239999999999999999999999999999876


Q ss_pred             CCCCCc--ccccccccCccccCccccCCC------CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCC
Q 040392          324 TGEDQS--MTQTQTLATIGYMAPEYGREG------RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPI  395 (470)
Q Consensus       324 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~------~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  395 (470)
                      ......  ......+||+.|+|||++.+.      .++.++|||||||++|||+||+.||......+.....+.......
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~  238 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence            543322  222345799999999998754      467899999999999999999888765433332221111000000


Q ss_pred             c-ccc-cccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          396 S-TME-VVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       396 ~-~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                      . ... +....+ ............++..+.+|+.+||+.||++||||.||++.|+++.+
T Consensus       239 ~~~~~~~~~~~~-rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          239 EEMRKVVCEQKL-RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             HHHHHHHTTSCC-CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHhcccC-CCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            0 000 000010 00001111223456789999999999999999999999999999864

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=8.8e-54  Score=404.26  Aligned_cols=245  Identities=24%  Similarity=0.374  Sum_probs=197.6

Q ss_pred             CCCCeecccCceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeecc----CCeeeEEE
Q 040392          176 SENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSN----EEFKALVL  248 (470)
Q Consensus       176 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~----~~~~~lv~  248 (470)
                      .+.+.||+|+||+||+|.+. ++..||+|++...  .....+.+.+|++++++++|||||++++++.+    ....++||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            55678999999999999764 6899999998654  23345678999999999999999999999864    35679999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeeC-CCCCeEEeeeccccccCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP--IIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--i~H~dlkp~Nill~-~~~~~kl~Dfg~a~~~~~  325 (470)
                      |||++|+|.+++.+.. .+++..+..++.||+.||+|||   +++  |+||||||+|||++ .++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            9999999999997654 6899999999999999999999   777  99999999999997 489999999999985432


Q ss_pred             CCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          326 EDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       326 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                          ......+||+.|+|||++.+ .++.++|||||||++|||+||+.||.+..+... +...+......          
T Consensus       185 ----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~-~~~~i~~~~~~----------  248 (290)
T 3fpq_A          185 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-IYRRVTSGVKP----------  248 (290)
T ss_dssp             ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-HHHHHTTTCCC----------
T ss_pred             ----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH-HHHHHHcCCCC----------
Confidence                12335689999999998865 699999999999999999999999975432211 11111110000          


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                             ...+..++.++.+|+.+||+.||++|||+.|+++|
T Consensus       249 -------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          249 -------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             -------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                   01122335678999999999999999999999875

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.3e-53  Score=421.13  Aligned_cols=250  Identities=24%  Similarity=0.292  Sum_probs=211.7

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      +.|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|+.++|||||++++++.+.+..|+|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56999999999999999999864 69999999998766666778899999999999999999999999999999999999


Q ss_pred             CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccc
Q 040392          252 PHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  331 (470)
Q Consensus       252 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  331 (470)
                      +||+|.+++...  .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+....  ..
T Consensus       231 ~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~~  303 (423)
T 4fie_A          231 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PR  303 (423)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--CC
T ss_pred             CCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC--cc
Confidence            999999999754  4899999999999999999999   9999999999999999999999999999998764332  22


Q ss_pred             ccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhh
Q 040392          332 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDI  411 (470)
Q Consensus       332 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  411 (470)
                      ....+||+.|||||++.+..|+.++|||||||++|||++|+.||......  .....+....+...              
T Consensus       304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~i~~~~~~~~--------------  367 (423)
T 4fie_A          304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLPPRL--------------  367 (423)
T ss_dssp             BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCCCCC--------------
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHcCCCCCC--------------
Confidence            34568999999999999999999999999999999999999999763221  11111211111110              


Q ss_pred             hhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          412 HFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       412 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                        .....++.++.+|+.+||..||++|||+.|+++|
T Consensus       368 --~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          368 --KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             --SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence              0112346778999999999999999999999885

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.3e-53  Score=399.58  Aligned_cols=246  Identities=23%  Similarity=0.350  Sum_probs=192.4

Q ss_pred             CCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++....   ......+.+|+++++.++||||+++++++.+++..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            6899999999999999999985 469999999997542   234567889999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||+ +|+|.+++.+.+ .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+.....  
T Consensus        93 Ey~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--  165 (275)
T ss_dssp             ECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             eCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCC--
Confidence            999 679999997654 6899999999999999999999   999999999999999999999999999999865432  


Q ss_pred             cccccccccCccccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                       ......+||+.|+|||++.+..+ +.++||||+||++|||+||+.||......  .+...+.....             
T Consensus       166 -~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~--~~~~~i~~~~~-------------  229 (275)
T 3hyh_A          166 -NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP--VLFKNISNGVY-------------  229 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCC-------------
T ss_pred             -CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHcCCC-------------
Confidence             22334689999999999988776 57999999999999999999999763221  11111111000             


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                            ..+..++.++.+|+.+||+.||++|||+.|+++|
T Consensus       230 ------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          230 ------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             ------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             ------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                  0112346678999999999999999999999885

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=8.4e-54  Score=406.35  Aligned_cols=248  Identities=25%  Similarity=0.315  Sum_probs=198.7

Q ss_pred             CCCCCCCeecccCceEEEEEEeC----CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  246 (470)
                      ++|++.+.||+|+||+||+|+..    +++.||||+++...  ......+.+|++++++++|||||++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999752    47899999987542  2334567889999999999999999999999999999


Q ss_pred             EEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCC
Q 040392          247 VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      ||||++||+|.+++.+.+ .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus       104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            999999999999997654 6899999999999999999999   999999999999999999999999999999865332


Q ss_pred             CCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccccc
Q 040392          327 DQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL  406 (470)
Q Consensus       327 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (470)
                      .  ......+||+.|+|||++.+..++.++||||+||++|||+||+.||......+ .+........             
T Consensus       180 ~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i~~~~~-------------  243 (304)
T 3ubd_A          180 E--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE-TMTMILKAKL-------------  243 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCC-------------
T ss_pred             C--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH-HHHHHHcCCC-------------
Confidence            2  22345689999999999999999999999999999999999999997632221 1111111100             


Q ss_pred             CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCH-----HHHHHH
Q 040392          407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINA-----REIVAK  447 (470)
Q Consensus       407 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~el~~~  447 (470)
                             ..+..++.++.+|+.+||+.||++|||+     +|+++|
T Consensus       244 -------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          244 -------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             -------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence                   0122346778999999999999999985     677654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=6.8e-52  Score=394.68  Aligned_cols=250  Identities=23%  Similarity=0.385  Sum_probs=188.7

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccc-hhhhhHHHHHHHHhcCCCCcceeEEeeeccCC--------
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKVISTCSNEE--------  242 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--------  242 (470)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|++++++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            45889999999999999999864 699999999875433 34567889999999999999999999986443        


Q ss_pred             ----eeeEEEecCCCCChHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEee
Q 040392          243 ----FKALVLEYMPHGSLEKYMYSSN--YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSD  316 (470)
Q Consensus       243 ----~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~D  316 (470)
                          +.|+||||+++|+|.+++....  ...++..+..++.|+++||+|||   +++|+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence                4689999999999999997654  23456778899999999999999   99999999999999999999999999


Q ss_pred             eccccccCCCCCc----------ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhh
Q 040392          317 FSIAKLLTGEDQS----------MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLK  386 (470)
Q Consensus       317 fg~a~~~~~~~~~----------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~  386 (470)
                      ||+|+.+......          ......+||+.|+|||++.+..|+.++|||||||++|||++   ||....+.   ..
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~---~~  235 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER---VR  235 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH---HH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH---HH
Confidence            9999876433221          12234579999999999999999999999999999999996   77542111   11


Q ss_pred             HHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          387 HWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      . .........               .......+.++.+|+.+||+.||++|||+.|+++|
T Consensus       236 ~-~~~~~~~~~---------------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          236 T-LTDVRNLKF---------------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             H-HHHHHTTCC---------------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             H-HHHHhcCCC---------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1 111000000               00112224456789999999999999999999874

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.2e-49  Score=387.84  Aligned_cols=270  Identities=24%  Similarity=0.264  Sum_probs=202.9

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeecc------CC
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSN------EE  242 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~------~~  242 (470)
                      .++|++.+.||+|+||+||+|+. .+|+.||||+++...  ....+.+.+|+++|+.++|||||++++++..      ..
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            36799999999999999999976 469999999996442  2345667889999999999999999998753      36


Q ss_pred             eeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccc
Q 040392          243 FKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL  322 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~  322 (470)
                      ..|+|||||+ |+|.+++...+ .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARG  207 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence            7899999996 68999997654 6899999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCC--CcccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc--c
Q 040392          323 LTGED--QSMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS--T  397 (470)
Q Consensus       323 ~~~~~--~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~  397 (470)
                      +....  ........+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+ .+...........  .
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~-~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH-QLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCCGGG
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhcCCCChHH
Confidence            64322  12233457899999999998775 46999999999999999999999997632211 1111111110000  0


Q ss_pred             cccccc--------cccCchh-hhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          398 MEVVGA--------NLLSQED-IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       398 ~~~~~~--------~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ......        ....... .........+.++.+|+.+||..||++|||+.|+++|
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            000000        0000000 0000112346778999999999999999999999885

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.2e-48  Score=382.29  Aligned_cols=269  Identities=20%  Similarity=0.275  Sum_probs=200.9

Q ss_pred             HhhCCCCCCCeecccCceEEEEEEeC----CCcEEEEEEeecccchhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCee
Q 040392          170 RATDGFSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQCGRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFK  244 (470)
Q Consensus       170 ~~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~  244 (470)
                      ...++|++.+.||+|+||+||+|+.+    +++.||+|.+....  ....+.+|+++++.+ .||||+++++++.+.++.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            35678999999999999999999742    47889999986442  334577899999998 699999999999999999


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-CCeEEeeecccccc
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN-MVAHLSDFSIAKLL  323 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~a~~~  323 (470)
                      ++||||+++|+|.+++.    .+++.++..++.|++.||+|||   +++|+||||||+|||++.+ +.+||+|||+|+..
T Consensus        96 ~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~  168 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT  168 (361)
T ss_dssp             EEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence            99999999999999984    4889999999999999999999   9999999999999999876 79999999999865


Q ss_pred             CCCCCc--------------------------ccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCC
Q 040392          324 TGEDQS--------------------------MTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTN  376 (470)
Q Consensus       324 ~~~~~~--------------------------~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~  376 (470)
                      ......                          ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~  248 (361)
T 4f9c_A          169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY  248 (361)
T ss_dssp             TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence            432111                          112345799999999998775 58999999999999999999999996


Q ss_pred             ccccCcchhhHHhhhh-----------c----------CCc-ccc---------cccccccC---chhhhhHhhhhhHHH
Q 040392          377 EIFNGEMTLKHWVNDW-----------L----------PIS-TME---------VVGANLLS---QEDIHFVAKEQCVSC  422 (470)
Q Consensus       377 ~~~~~~~~~~~~~~~~-----------~----------~~~-~~~---------~~~~~~~~---~~~~~~~~~~~~~~~  422 (470)
                      ...+....+.......           .          +.. ...         ...+....   ............+.+
T Consensus       249 ~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~  328 (361)
T 4f9c_A          249 KASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE  328 (361)
T ss_dssp             CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred             CCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence            5433222211111000           0          000 000         00000000   000001111234677


Q ss_pred             HHHHHhhccCCCccCCCCHHHHHHH
Q 040392          423 VFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       423 l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      +.+|+.+||+.||++|||++|+++|
T Consensus       329 a~DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          329 AYDLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHHHCcCChhHCcCHHHHhcC
Confidence            8999999999999999999999875

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.2e-48  Score=401.41  Aligned_cols=253  Identities=19%  Similarity=0.262  Sum_probs=212.0

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      .++|++.+.||+|+||.||+|... +|+.||+|++........+.+.+|+++|+.++||||+++++++.+....++||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            468999999999999999999764 6999999999766555667788999999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC--CCeEEeeeccccccCCCCC
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN--MVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~--~~~kl~Dfg~a~~~~~~~~  328 (470)
                      |+||+|.+++......+++..+..++.||+.||+|||   +++|+||||||+|||++.+  +.+||+|||+|+.+...  
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~--  310 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--  310 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC--
Confidence            9999999999776677999999999999999999999   9999999999999999854  89999999999977432  


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                       ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....+. +..........             
T Consensus       311 -~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~-~~~i~~~~~~~-------------  375 (573)
T 3uto_A          311 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-LRNVKSCDWNM-------------  375 (573)
T ss_dssp             -SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHTTCCCC-------------
T ss_pred             -CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-HHHHHhCCCCC-------------
Confidence             223446799999999999999999999999999999999999999976432211 11111100000             


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                         .......++.++.+|+.+||..||.+|||+.|+++|
T Consensus       376 ---~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          376 ---DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             ---CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               001112346778999999999999999999999985

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=5.9e-47  Score=366.67  Aligned_cols=278  Identities=33%  Similarity=0.537  Sum_probs=229.2

Q ss_pred             HHHHhhCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeE
Q 040392          167 ELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       167 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  246 (470)
                      ++...+++|+..+.||+|+||.||+|++.+++.||||++........+.+.+|+++++.++||||+++++++.+.+..++
T Consensus        33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  112 (321)
T 2qkw_B           33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL  112 (321)
T ss_dssp             CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred             HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            34456789999999999999999999988899999999877666667788999999999999999999999999999999


Q ss_pred             EEecCCCCChHHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecccccc
Q 040392          247 VLEYMPHGSLEKYMYSSN---YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  323 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~  323 (470)
                      ||||+++|+|.+++....   ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++...
T Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  189 (321)
T 2qkw_B          113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKG  189 (321)
T ss_dssp             EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred             EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence            999999999999997654   35899999999999999999999   899999999999999999999999999999865


Q ss_pred             CCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCc-chhhHHhhhhc-CCcccccc
Q 040392          324 TGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE-MTLKHWVNDWL-PISTMEVV  401 (470)
Q Consensus       324 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~-~~~~~~~~  401 (470)
                      .............||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ .....|..... ........
T Consensus       190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (321)
T 2qkw_B          190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV  269 (321)
T ss_dssp             SSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSS
T ss_pred             ccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhc
Confidence            43333333344568999999999988899999999999999999999999998654432 22333432222 11222333


Q ss_pred             cccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          402 GANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                      ++.....      .+..++..+.+++.+||+.||++|||+.|++++|+.+..
T Consensus       270 ~~~~~~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          270 DPNLADK------IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             SSSCTTC------SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             Chhhccc------cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            3322221      123457889999999999999999999999999998863

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.7e-47  Score=392.44  Aligned_cols=250  Identities=21%  Similarity=0.303  Sum_probs=201.5

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhH---HHHHHHHhcCCCCcceeEEeeeccCCee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGF---DVECEMMKSIRHRNLIKVISTCSNEEFK  244 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~nIv~~~~~~~~~~~~  244 (470)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++.+..   .......   ..++.+++.++|||||++++++.+.+..
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            367999999999999999999764 69999999997532   1122222   3346777788999999999999999999


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccC
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~  324 (470)
                      |+||||++||+|.+++...+ .+++..+..++.||+.||+|||   +++|+||||||+|||++.+|++||+|||+|+.+.
T Consensus       268 ylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            99999999999999997654 6899999999999999999999   9999999999999999999999999999998764


Q ss_pred             CCCCcccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccc
Q 040392          325 GEDQSMTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA  403 (470)
Q Consensus       325 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (470)
                      ...    ....+||+.|+|||++.. ..|+.++|+||+||++|||++|+.||........  ...........       
T Consensus       344 ~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~--~~i~~~i~~~~-------  410 (689)
T 3v5w_A          344 KKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTMA-------  410 (689)
T ss_dssp             SCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH--HHHHHHHHHCC-------
T ss_pred             CCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhhcCCC-------
Confidence            322    234689999999999864 5799999999999999999999999976432221  11111000000       


Q ss_pred             cccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCC-----HHHHHHH
Q 040392          404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRIN-----AREIVAK  447 (470)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~el~~~  447 (470)
                               ...+..++.++.+|+.+||+.||.+|++     +.||++|
T Consensus       411 ---------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          411 ---------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             ---------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence                     0012234677899999999999999998     7888765

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4.7e-47  Score=368.11  Aligned_cols=284  Identities=36%  Similarity=0.546  Sum_probs=232.3

Q ss_pred             ccccccCHHHHHHhhCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccc-hhhhhHHHHHHHHhcCCCCcceeEEe
Q 040392          158 ATWRTFSHLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKVIS  236 (470)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~  236 (470)
                      .....++..++....++|++.+.||+|+||.||+|+..+|+.||||++..... .....+.+|+++++.++||||+++++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            34566788899999999999999999999999999988899999999875432 23446889999999999999999999


Q ss_pred             eeccCCeeeEEEecCCCCChHHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCC---CeeecCCCCCCeeeCCCC
Q 040392          237 TCSNEEFKALVLEYMPHGSLEKYMYSSN---YILDIFQRLNIMIDVASALEYLHFGYSA---PIIHCDLKPSNVLLDDNM  310 (470)
Q Consensus       237 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~---~i~H~dlkp~Nill~~~~  310 (470)
                      ++......++||||+++|+|.+++....   ..+++..+..++.|++.||+|||   +.   +|+||||||+||+++.++
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~ivH~Dlkp~Nil~~~~~  171 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH---DHCDPKIIHRDVKAANILLDEEF  171 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHH---HSSSSCEECCCCSGGGEEECTTC
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCeEeCCCchhhEEECCCC
Confidence            9999999999999999999999997644   34899999999999999999999   66   999999999999999999


Q ss_pred             CeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcc---ccCcchhhH
Q 040392          311 VAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEI---FNGEMTLKH  387 (470)
Q Consensus       311 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~---~~~~~~~~~  387 (470)
                      .+||+|||++....... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||...   .........
T Consensus       172 ~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  250 (326)
T 3uim_A          172 EAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD  250 (326)
T ss_dssp             CEEECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHH
T ss_pred             CEEeccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHH
Confidence            99999999998764322 22333456999999999998888999999999999999999999999732   223344555


Q ss_pred             HhhhhcCCc-ccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          388 WVNDWLPIS-TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       388 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                      |+....... .....+......      .+...+..+.+++.+||+.||++|||+.|++++|++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          251 WVKGLLKEKKLEALVDVDLQGN------YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             HHTTTTSSCCSTTSSCTTCTTS------CCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HHHHHhhchhhhhhcChhhccc------cCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            655444433 223333222221      2234577899999999999999999999999999864

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.6e-46  Score=360.32  Aligned_cols=266  Identities=24%  Similarity=0.359  Sum_probs=220.5

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      .++|.+.+.||+|+||.||+|... +++.||+|.+........+.+.+|+++++.++||||+++++++.+....++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            467888999999999999999864 6899999998766666778899999999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      +++|+|.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++..........
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            9999999999887778999999999999999999999   9999999999999999999999999999998764332211


Q ss_pred             ------------cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccc
Q 040392          331 ------------TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTM  398 (470)
Q Consensus       331 ------------~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  398 (470)
                                  ......||+.|+|||.+.+..++.++||||||+++|||++|..|+...............        
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~--------  237 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR--------  237 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH--------
T ss_pred             cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh--------
Confidence                        111457999999999999999999999999999999999999998764332221110000        


Q ss_pred             ccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHhhh
Q 040392          399 EVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRN  458 (470)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~~~  458 (470)
                                .......+..++.++.+++.+||+.||++|||+.|+++.|++++..+...
T Consensus       238 ----------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~  287 (310)
T 3s95_A          238 ----------GFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH  287 (310)
T ss_dssp             ----------HHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHC
T ss_pred             ----------ccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCc
Confidence                      00111112345667899999999999999999999999999998776543

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.2e-46  Score=362.80  Aligned_cols=276  Identities=22%  Similarity=0.296  Sum_probs=211.4

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCC----eeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEE----FKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~----~~~lv  247 (470)
                      .++|++.+.||+|+||.||+|++. ++.||||++.... ........|+.++++++||||+++++++....    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            467999999999999999999885 8999999996543 23344556899999999999999999987643    46899


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC----------CeeecCCCCCCeeeCCCCCeEEeee
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA----------PIIHCDLKPSNVLLDDNMVAHLSDF  317 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~----------~i~H~dlkp~Nill~~~~~~kl~Df  317 (470)
                      |||+++|+|.+++....  +++..+..++.|++.||+|||   +.          +|+||||||+||+++.++.+||+||
T Consensus       101 ~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A          101 TAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             EECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EecCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence            99999999999997644  899999999999999999999   88          9999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccCccccCccccCC-----CCCCCccchhhHHHHHHHHHhCCCCCCccccCcc-hhhHHhhh
Q 040392          318 SIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE-----GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEM-TLKHWVND  391 (470)
Q Consensus       318 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~-~~~~~~~~  391 (470)
                      |+++...............||+.|+|||++.+     ..++.++||||||+++|||++|+.||....+... .+......
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  255 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ  255 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred             CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence            99987755444334445679999999999876     3566789999999999999999999986433211 11110000


Q ss_pred             hcCCc-ccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          392 WLPIS-TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       392 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                      ..... ......................++.++.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            00000 0000000000111111122334577799999999999999999999999999999753

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=9.3e-46  Score=354.22  Aligned_cols=251  Identities=25%  Similarity=0.339  Sum_probs=210.3

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46799999999999999999975 56899999999866655667788999999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      +++|+|.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......  .
T Consensus        99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  171 (297)
T 3fxz_A           99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S  171 (297)
T ss_dssp             CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--C
T ss_pred             CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc--c
Confidence            9999999999765  4899999999999999999999   8999999999999999999999999999998764322  2


Q ss_pred             cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchh
Q 040392          331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED  410 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (470)
                      ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .........+.               
T Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~---------------  235 (297)
T 3fxz_A          172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTPE---------------  235 (297)
T ss_dssp             CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHHCSCC---------------
T ss_pred             ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCCC---------------
Confidence            23446799999999999999999999999999999999999999976422211 11111100000               


Q ss_pred             hhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          411 IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       411 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                        ...+..++..+.+++.+||+.||++|||+.|++++
T Consensus       236 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          236 --LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             --CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence              01123446778999999999999999999999875

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.7e-46  Score=366.59  Aligned_cols=261  Identities=27%  Similarity=0.441  Sum_probs=216.0

Q ss_pred             hCCCCCCCeecccCceEEEEEEe--------CCCcEEEEEEeeccc-chhhhhHHHHHHHHhcC-CCCcceeEEeeeccC
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL--------GDGMEVAVKVFNLQC-GRALKGFDVECEMMKSI-RHRNLIKVISTCSNE  241 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~  241 (470)
                      .++|.+.+.||+|+||.||+|++        .++..||||++.... ....+.+.+|+++++.+ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            46788999999999999999975        235679999997553 34456788999999999 899999999999999


Q ss_pred             CeeeEEEecCCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 040392          242 EFKALVLEYMPHGSLEKYMYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL  306 (470)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill  306 (470)
                      +..++||||+++|+|.+++....               ..+++..+..++.|++.||+|||   +++|+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence            99999999999999999997653               34789999999999999999999   8999999999999999


Q ss_pred             CCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchh
Q 040392          307 DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTL  385 (470)
Q Consensus       307 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~  385 (470)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+  +
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--~  314 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--L  314 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--H
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--H
Confidence            9999999999999987654443333444567889999999999999999999999999999999 999997643221  1


Q ss_pred             hHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHH
Q 040392          386 KHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL  455 (470)
Q Consensus       386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~  455 (470)
                      ...+.....                  ...+..++.++.+++.+||+.||++||++.|++++|+++....
T Consensus       315 ~~~~~~~~~------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~  366 (370)
T 2psq_A          315 FKLLKEGHR------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  366 (370)
T ss_dssp             HHHHHTTCC------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHhcCCC------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            111111100                  0112345678999999999999999999999999999997543

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.4e-46  Score=372.01  Aligned_cols=260  Identities=29%  Similarity=0.445  Sum_probs=215.3

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      .++|.+.+.||+|+||.||+|++. +++.||||++.... ......+.+|+++++.++||||+++++++...+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            467888999999999999999876 68999999987543 3345678889999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      |+++|+|.+++...+..+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++........
T Consensus       193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~  269 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA  269 (377)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence            99999999999877667899999999999999999999   999999999999999999999999999999865332211


Q ss_pred             ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                      .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+  ....+.....              
T Consensus       270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~--~~~~~~~~~~--------------  333 (377)
T 3cbl_A          270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ--TREFVEKGGR--------------  333 (377)
T ss_dssp             CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH--HHHHHHTTCC--------------
T ss_pred             ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC--------------
Confidence            11222345778999999988889999999999999999998 999987643321  1222111110              


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                          ...+..++.++.+++.+||+.||++|||+.++++.|+++.+.
T Consensus       334 ----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          334 ----LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence                111234577899999999999999999999999999999754

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2e-44  Score=346.53  Aligned_cols=282  Identities=29%  Similarity=0.475  Sum_probs=227.1

Q ss_pred             cccccCHHHHHHhhCCCCCC------CeecccCceEEEEEEeCCCcEEEEEEeeccc----chhhhhHHHHHHHHhcCCC
Q 040392          159 TWRTFSHLELCRATDGFSEN------NLIGRGGFGSVYKARLGDGMEVAVKVFNLQC----GRALKGFDVECEMMKSIRH  228 (470)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~------~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h  228 (470)
                      ....|+..++..++++|...      +.||+|+||.||+|+. +++.||+|++....    ....+.+.+|+++++.++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            34568889999999998877      8999999999999987 68899999986432    3345678899999999999


Q ss_pred             CcceeEEeeeccCCeeeEEEecCCCCChHHhhhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 040392          229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSS--NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL  306 (470)
Q Consensus       229 ~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill  306 (470)
                      |||+++++++.+.+..++||||+++|+|.+++...  ...+++..+..++.|++.||.|||   +.+++||||||+||++
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEE
Confidence            99999999999999999999999999999998643  346899999999999999999999   8999999999999999


Q ss_pred             CCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhh
Q 040392          307 DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLK  386 (470)
Q Consensus       307 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~  386 (470)
                      +.++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|+|++|..||........ ..
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~  244 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-LL  244 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB-TT
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH-HH
Confidence            9999999999999987654333333345678999999998865 589999999999999999999999987544322 22


Q ss_pred             HHhhhhcC--CcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          387 HWVNDWLP--ISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       387 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                      .+......  .......+..+..       .+..++..+.+++.+||+.||.+|||+.+++++|+++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          245 DIKEEIEDEEKTIEDYIDKKMND-------ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HHHHHHHTTSCCHHHHSCSSCSC-------CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHHhhhhhhhhhhhccccccc-------cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            22221111  1112222222211       123457789999999999999999999999999999864

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6.9e-46  Score=357.04  Aligned_cols=261  Identities=27%  Similarity=0.388  Sum_probs=205.6

Q ss_pred             HhhCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          170 RATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       170 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      ...++|++.+.||+|+||.||+|+. +|+.||||++....  ....+.+.+|++++++++||||+++++++......++|
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV  112 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence            3456788999999999999999987 58899999986543  33456788999999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeeCCCCCeEEeeecccccc
Q 040392          248 LEYMPHGSLEKYMYSSN--YILDIFQRLNIMIDVASALEYLHFGYSAP--IIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  323 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~  323 (470)
                      |||+++|+|.+++....  ..+++..++.++.|++.||+|||   +.+  |+||||||+||+++.++.+||+|||+++..
T Consensus       113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  189 (309)
T 3p86_A          113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK  189 (309)
T ss_dssp             EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred             EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence            99999999999997654  23899999999999999999999   888  999999999999999999999999999754


Q ss_pred             CCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccc
Q 040392          324 TGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA  403 (470)
Q Consensus       324 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (470)
                      ...  ........||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.  ...+.....  .      
T Consensus       190 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~--~~~~~~~~~--~------  257 (309)
T 3p86_A          190 AST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV--VAAVGFKCK--R------  257 (309)
T ss_dssp             --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH--HHHHHHSCC--C------
T ss_pred             ccc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhcCC--C------
Confidence            322  2223346789999999999999999999999999999999999999976432211  111110000  0      


Q ss_pred             cccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHH
Q 040392          404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL  455 (470)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~  455 (470)
                               ...+..++.++.+++.+||+.||++|||+.|+++.|+.+..+.
T Consensus       258 ---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          258 ---------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             ---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence                     0112334677899999999999999999999999999987543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=358.03  Aligned_cols=260  Identities=27%  Similarity=0.439  Sum_probs=212.7

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC----CCcEEEEEEeecc-cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQ-CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  246 (470)
                      .++|.+.+.||+|+||.||+|.+.    .+..||||++... .....+.+.+|+++++.++||||+++++++.+....++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            356888899999999999999874    3556999999754 33445678899999999999999999999999999999


Q ss_pred             EEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCC
Q 040392          247 VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      ||||+++|+|.+++......+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus       128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD  204 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred             EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence            99999999999999877678999999999999999999999   899999999999999999999999999999876443


Q ss_pred             CC-cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCccccccccc
Q 040392          327 DQ-SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN  404 (470)
Q Consensus       327 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (470)
                      .. ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+  ....+.....          
T Consensus       205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~~~~~----------  272 (325)
T 3kul_A          205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD--VISSVEEGYR----------  272 (325)
T ss_dssp             --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHTTCC----------
T ss_pred             ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHHcCCC----------
Confidence            22 222233456788999999988899999999999999999999 999997643321  1111111100          


Q ss_pred             ccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                              ...+..++.++.+++.+||..||++|||+.|+++.|+++..+
T Consensus       273 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~  314 (325)
T 3kul_A          273 --------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS  314 (325)
T ss_dssp             --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             --------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence                    011234577799999999999999999999999999999754

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.8e-45  Score=345.74  Aligned_cols=257  Identities=26%  Similarity=0.422  Sum_probs=213.9

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      .++|++.+.||+|+||.||+|++.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+....++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            357888999999999999999998899999999975432 3456889999999999999999999999999999999999


Q ss_pred             CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccc
Q 040392          252 PHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  331 (470)
Q Consensus       252 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  331 (470)
                      ++++|.+++......+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++....... ...
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~  163 (269)
T 4hcu_A           88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS  163 (269)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHS
T ss_pred             CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccc-ccc
Confidence            999999999877777999999999999999999999   9999999999999999999999999999998654221 122


Q ss_pred             ccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCchh
Q 040392          332 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED  410 (470)
Q Consensus       332 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (470)
                      .....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......+  ....+......               
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~--~~~~~~~~~~~---------------  226 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDISTGFRL---------------  226 (269)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTTCCC---------------
T ss_pred             ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHhcCccC---------------
Confidence            233456788999999988899999999999999999999 999987643221  11111110000               


Q ss_pred             hhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          411 IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       411 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                         ..+..++.++.+++.+||+.||++||++.|++++|+++.+
T Consensus       227 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          227 ---YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence               0112235668899999999999999999999999999875

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.9e-45  Score=361.53  Aligned_cols=271  Identities=23%  Similarity=0.383  Sum_probs=219.3

Q ss_pred             ccCHHHHHHhhCCCCCCCeecccCceEEEEEEe------CCCcEEEEEEeeccc-chhhhhHHHHHHHHhcC-CCCccee
Q 040392          162 TFSHLELCRATDGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQC-GRALKGFDVECEMMKSI-RHRNLIK  233 (470)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~  233 (470)
                      .+.........++|++.+.||+|+||.||+|++      .+++.||||++.... ....+.+.+|+++++++ +||||++
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            344555666778999999999999999999973      346889999997543 33456788999999999 7899999


Q ss_pred             EEeeeccCC-eeeEEEecCCCCChHHhhhcCCC-----------------------------------------------
Q 040392          234 VISTCSNEE-FKALVLEYMPHGSLEKYMYSSNY-----------------------------------------------  265 (470)
Q Consensus       234 ~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------  265 (470)
                      +++++.+.+ ..++||||+++|+|.+++.....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            999987754 48899999999999999976532                                               


Q ss_pred             ------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          266 ------------------ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       266 ------------------~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                                        .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                              1889999999999999999999   8999999999999999999999999999998765444


Q ss_pred             CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCccccccccccc
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL  406 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (470)
                      .........+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+.... .+.......          
T Consensus       248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-~~~~~~~~~----------  316 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR-RLKEGTRMR----------  316 (359)
T ss_dssp             TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH-HHHHTCCCC----------
T ss_pred             cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHH-HHHcCCCCC----------
Confidence            4444455678999999999988899999999999999999998 9999976443322111 111111100          


Q ss_pred             CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       407 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                              .+..++.++.+++.+||+.||++|||+.|++++|+++..+
T Consensus       317 --------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          317 --------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence                    1122466789999999999999999999999999999754

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.8e-46  Score=354.76  Aligned_cols=276  Identities=25%  Similarity=0.409  Sum_probs=211.8

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-----CCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeecc--CCee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-----GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN--EEFK  244 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~  244 (470)
                      .++|++.+.||+|+||.||+|++     .+++.||||++........+.+.+|+++++.++||||+++++++..  ....
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            46788999999999999999974     3688999999987666667788999999999999999999999854  3567


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccC
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~  324 (470)
                      ++||||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  165 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred             EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence            8999999999999999887767999999999999999999999   8999999999999999999999999999998764


Q ss_pred             CCCCc-ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcc-ccccc
Q 040392          325 GEDQS-MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIST-MEVVG  402 (470)
Q Consensus       325 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  402 (470)
                      ..... .......++..|+|||.+.+..++.++||||||+++|||++|..|+......   ...+......... .....
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH---HHHHHCTTCCTHHHHHHHH
T ss_pred             CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH---HHhhhcCccccchhHHHHH
Confidence            33221 2223445777899999999889999999999999999999999998753211   0000000000000 00000


Q ss_pred             ccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHH
Q 040392          403 ANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL  455 (470)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~  455 (470)
                      ..+  ........+..++.++.+++.+||+.||++|||+.|+++.|+++.+++
T Consensus       243 ~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          243 ELL--KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             HHH--HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHH--hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            000  000011123456788999999999999999999999999999998654

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.4e-45  Score=345.94  Aligned_cols=257  Identities=25%  Similarity=0.410  Sum_probs=214.0

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      .++|++.+.||+|+||.||+|+..++..||+|++..... ..+.+.+|+++++.++||||+++++++.+....++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            467889999999999999999998888999999975432 3456889999999999999999999999999999999999


Q ss_pred             CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccc
Q 040392          252 PHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  331 (470)
Q Consensus       252 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  331 (470)
                      ++++|.+++......+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++....... ...
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~  161 (268)
T 3sxs_A           86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-YVS  161 (268)
T ss_dssp             TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-EEE
T ss_pred             CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhh-hhc
Confidence            999999999877667999999999999999999999   8999999999999999999999999999998764332 222


Q ss_pred             ccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCchh
Q 040392          332 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED  410 (470)
Q Consensus       332 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (470)
                      .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.. ....... ..               
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~~~~~~~-~~---------------  224 (268)
T 3sxs_A          162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV-LKVSQGH-RL---------------  224 (268)
T ss_dssp             CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHTTC-CC---------------
T ss_pred             ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH-HHHHcCC-CC---------------
Confidence            234456778999999988889999999999999999999 99999764332211 1110000 00               


Q ss_pred             hhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          411 IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       411 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                         ..+..++.++.+++.+||+.||++|||+.|++++|+++++
T Consensus       225 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          225 ---YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             ---CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             ---CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence               0012235668899999999999999999999999999864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.4e-45  Score=354.50  Aligned_cols=254  Identities=23%  Similarity=0.334  Sum_probs=208.6

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      .++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999865 78999999986543 2334678899999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      |+++|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++..+......
T Consensus        86 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           86 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            99999999999654 35899999999999999999999   999999999999999999999999999999866433333


Q ss_pred             ccccccccCccccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          330 MTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                      .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||............|........            
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~------------  229 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN------------  229 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTST------------
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCC------------
Confidence            33345679999999999987765 77899999999999999999999875444333333322211100            


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                            ....++.++.+|+.+||+.||++|||+.|++++
T Consensus       230 ------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          230 ------PWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             ------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ------ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence                  012346678899999999999999999999876

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=6.1e-45  Score=353.06  Aligned_cols=248  Identities=25%  Similarity=0.321  Sum_probs=207.0

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++...  .....+.+.+|+++++.++||||+++++++......++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            56899999999999999999986 57999999999754  2344567889999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||+++|+|.+++...+ .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++......  
T Consensus        94 e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--  167 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--  167 (328)
T ss_dssp             CCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--
T ss_pred             ECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC--
Confidence            9999999999997654 5899999999999999999999   899999999999999999999999999999866432  


Q ss_pred             cccccccccCccccCccccCCCCCC-CccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVS-TNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                       ......+||+.|+|||++.+..++ .++||||+||++|||++|+.||......+  +...+.   ....          
T Consensus       168 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~i~---~~~~----------  231 (328)
T 3fe3_A          168 -GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE--LRERVL---RGKY----------  231 (328)
T ss_dssp             -CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH---HCCC----------
T ss_pred             -CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH--HHHHHH---hCCC----------
Confidence             223456799999999999887765 78999999999999999999997642211  111111   0000          


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                            ..+..++.++.+++.+||..||.+|||+.|+++|
T Consensus       232 ------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          232 ------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             ------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             ------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                  0112235678899999999999999999999876

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3e-45  Score=361.66  Aligned_cols=260  Identities=25%  Similarity=0.470  Sum_probs=203.3

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC----CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  246 (470)
                      .++|.+.+.||+|+||.||+|+..    ++..||||+++... ....+.+.+|++++++++||||+++++++.+....++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            357999999999999999999764    57789999987542 3445678899999999999999999999999999999


Q ss_pred             EEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCC
Q 040392          247 VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      ||||+++|+|.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence            99999999999999877778999999999999999999999   899999999999999999999999999999876432


Q ss_pred             CCc-ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCccccccccc
Q 040392          327 DQS-MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN  404 (470)
Q Consensus       327 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (470)
                      ... .......++..|+|||++.+..++.++||||||+++|||++ |+.||......+  ....+....           
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~--~~~~i~~~~-----------  267 (373)
T 2qol_A          201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--VIKAVDEGY-----------  267 (373)
T ss_dssp             -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--HHHHHHTTE-----------
T ss_pred             CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCC-----------
Confidence            211 11222345778999999998899999999999999999998 999997643221  111111100           


Q ss_pred             ccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                             ....+..++.++.+++.+||+.||++||++.|+++.|+++...
T Consensus       268 -------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          268 -------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             -------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence                   0011224567799999999999999999999999999999754

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.3e-44  Score=348.38  Aligned_cols=261  Identities=24%  Similarity=0.307  Sum_probs=213.8

Q ss_pred             ccCHHHHHHhhCC----------CCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCc
Q 040392          162 TFSHLELCRATDG----------FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRN  230 (470)
Q Consensus       162 ~~~~~~~~~~~~~----------~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  230 (470)
                      .++..++..+++.          |...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+++.++|||
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  103 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN  103 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence            3556666665543          566778999999999999876 79999999998766666677889999999999999


Q ss_pred             ceeEEeeeccCCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC
Q 040392          231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM  310 (470)
Q Consensus       231 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~  310 (470)
                      |+++++++...+..++||||+++++|.+++...  .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++
T Consensus       104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~  178 (321)
T 2c30_A          104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDG  178 (321)
T ss_dssp             BCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTC
T ss_pred             cceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCC
Confidence            999999999999999999999999999998653  5899999999999999999999   89999999999999999999


Q ss_pred             CeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhh
Q 040392          311 VAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVN  390 (470)
Q Consensus       311 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~  390 (470)
                      .+||+|||++.......  .......||+.|+|||++.+..++.++||||||+++|||++|+.||......  .....+.
T Consensus       179 ~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~--~~~~~~~  254 (321)
T 2c30_A          179 RVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMKRLR  254 (321)
T ss_dssp             CEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHH
T ss_pred             cEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHh
Confidence            99999999998764322  1233467999999999999999999999999999999999999999753221  1111111


Q ss_pred             hhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          391 DWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       391 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ...+..        .        .....++.++.+++.+||+.||++|||+.|++++
T Consensus       255 ~~~~~~--------~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          255 DSPPPK--------L--------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             HSSCCC--------C--------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cCCCCC--------c--------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            111110        0        0112346678999999999999999999999986

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=4.2e-45  Score=347.13  Aligned_cols=257  Identities=23%  Similarity=0.419  Sum_probs=210.9

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      .++|++.+.||+|+||.||+|++.++..||+|++..... ..+.+.+|+++++.++||||+++++++.+....++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            567889999999999999999998888999999975432 3456889999999999999999999999999999999999


Q ss_pred             CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccc
Q 040392          252 PHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  331 (470)
Q Consensus       252 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  331 (470)
                      ++++|.+++......+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++....... ...
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~  177 (283)
T 3gen_A          102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTS  177 (283)
T ss_dssp             TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HHS
T ss_pred             CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccc-ccc
Confidence            999999999876667999999999999999999999   8999999999999999999999999999998654221 122


Q ss_pred             ccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCchh
Q 040392          332 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED  410 (470)
Q Consensus       332 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (470)
                      .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.  ...+......               
T Consensus       178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~--~~~~~~~~~~---------------  240 (283)
T 3gen_A          178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--AEHIAQGLRL---------------  240 (283)
T ss_dssp             TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--HHHHHTTCCC---------------
T ss_pred             ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH--HHHHhcccCC---------------
Confidence            223456788999999998889999999999999999998 9999976433211  1111110000               


Q ss_pred             hhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          411 IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       411 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                         ..+..++..+.+++.+||+.||++|||+.|++++|+++.+
T Consensus       241 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~  280 (283)
T 3gen_A          241 ---YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD  280 (283)
T ss_dssp             ---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence               0112235668899999999999999999999999999864

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.2e-44  Score=343.99  Aligned_cols=265  Identities=25%  Similarity=0.374  Sum_probs=205.7

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhc--CCCCcceeEEeeecc----CCeee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKS--IRHRNLIKVISTCSN----EEFKA  245 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~~~~~~~~----~~~~~  245 (470)
                      .++|++.+.||+|+||.||+|+. +++.||||++...   ....+..|.+++..  ++||||+++++++..    ....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            56899999999999999999988 6899999998643   33445567777666  799999999998643    35678


Q ss_pred             EEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeeecCCCCCCeeeCCCCCeEEeeeccc
Q 040392          246 LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY-----SAPIIHCDLKPSNVLLDDNMVAHLSDFSIA  320 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~-----~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a  320 (470)
                      +||||+++|+|.+++...  .+++..++.++.|++.||+|||...     +.+|+||||||+||+++.++.+||+|||++
T Consensus        83 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  160 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA  160 (301)
T ss_dssp             EEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence            999999999999999543  5899999999999999999999322     578999999999999999999999999999


Q ss_pred             cccCCCCCcc--cccccccCccccCccccCCC------CCCCccchhhHHHHHHHHHhC----------CCCCCccccCc
Q 040392          321 KLLTGEDQSM--TQTQTLATIGYMAPEYGREG------RVSTNGDVYSFGIMLMETFTG----------KKPTNEIFNGE  382 (470)
Q Consensus       321 ~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~------~~~~~~DvwslGv~l~el~tg----------~~p~~~~~~~~  382 (470)
                      ..........  ......||+.|+|||++.+.      .++.++||||||+++|||++|          +.||.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~  240 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND  240 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence            8664332221  12334799999999998876      456799999999999999999          77776654443


Q ss_pred             chhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          383 MTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                      ..................         .........++.++.+++.+||+.||++|||+.|+++.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          241 PSFEDMRKVVCVDQQRPN---------IPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCHHHHHHHHTTSCCCCC---------CCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cchhhhhHHHhccCCCCC---------CChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            333332222111110000         001112234578899999999999999999999999999986

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.1e-44  Score=345.92  Aligned_cols=269  Identities=23%  Similarity=0.294  Sum_probs=208.4

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ..++|++.+.||+|+||+||+|+..+|+.||+|++....  ......+.+|+++++.++||||+++++++.+....++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            357899999999999999999999889999999986542  223466788999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||+++ +|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++......  
T Consensus        99 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--  172 (311)
T 3niz_A           99 EFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP--  172 (311)
T ss_dssp             ECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC--
T ss_pred             cCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCC--
Confidence            99985 898888877777999999999999999999999   899999999999999999999999999999876422  


Q ss_pred             cccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCC---ccccccc--
Q 040392          329 SMTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPI---STMEVVG--  402 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~--  402 (470)
                      ........+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+. +..........   ......+  
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ-LPKIFSILGTPNPREWPQVQELP  251 (311)
T ss_dssp             CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH-HHHHHHHHCCCCTTTSGGGTTSH
T ss_pred             cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHHCCCChHHhhhhhccc
Confidence            222334568999999998876 5689999999999999999999999986544322 22221111100   0000000  


Q ss_pred             ------ccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          403 ------ANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       403 ------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                            ..... ..........++.++.+|+.+||+.||++|||+.|+++|
T Consensus       252 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          252 LWKQRTFQVFE-KKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             HHHSCCCCCCC-CCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhhccccccc-CCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                  00000 000111223446778999999999999999999999874

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-45  Score=358.33  Aligned_cols=265  Identities=26%  Similarity=0.421  Sum_probs=214.6

Q ss_pred             HhhCCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCC
Q 040392          170 RATDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEE  242 (470)
Q Consensus       170 ~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  242 (470)
                      ...++|++.+.||+|+||.||+|+..      +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            34578999999999999999999864      35889999997553 334567889999999999999999999999999


Q ss_pred             eeeEEEecCCCCChHHhhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC
Q 040392          243 FKALVLEYMPHGSLEKYMYSSN-----------------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL  299 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dl  299 (470)
                      ..++||||+++|+|.+++....                       ..+++..++.++.|+++||.|||   +.+|+||||
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dl  200 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDL  200 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCC
Confidence            9999999999999999997642                       46899999999999999999999   899999999


Q ss_pred             CCCCeeeCCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q 040392          300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEI  378 (470)
Q Consensus       300 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~  378 (470)
                      ||+||+++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            99999999999999999999987643332233344568899999999988889999999999999999999 99999764


Q ss_pred             ccCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHhh
Q 040392          379 FNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLR  457 (470)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~~  457 (470)
                      ...+  ....+...   ...               ..+..++.++.+++.+||+.||++||++.+++++|+++.++...
T Consensus       281 ~~~~--~~~~~~~~---~~~---------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~  339 (343)
T 1luf_A          281 AHEE--VIYYVRDG---NIL---------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEG  339 (343)
T ss_dssp             CHHH--HHHHHHTT---CCC---------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC----
T ss_pred             ChHH--HHHHHhCC---CcC---------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhh
Confidence            3221  11111110   000               01224467799999999999999999999999999999766544

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-44  Score=357.06  Aligned_cols=264  Identities=27%  Similarity=0.419  Sum_probs=217.3

Q ss_pred             hCCCCCCCeecccCceEEEEEEe--------CCCcEEEEEEeeccc-chhhhhHHHHHHHHhcC-CCCcceeEEeeeccC
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL--------GDGMEVAVKVFNLQC-GRALKGFDVECEMMKSI-RHRNLIKVISTCSNE  241 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~  241 (470)
                      .++|.+.+.||+|+||.||+|+.        .++..||||++.... ......+.+|+++++.+ +||||+++++++...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            46788999999999999999975        234679999997553 34456788999999999 899999999999999


Q ss_pred             CeeeEEEecCCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 040392          242 EFKALVLEYMPHGSLEKYMYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL  306 (470)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill  306 (470)
                      +..++||||+++|+|.+++....               ..+++..++.++.|++.||+|||   +.+|+||||||+||++
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEE
Confidence            99999999999999999997654               35899999999999999999999   8999999999999999


Q ss_pred             CCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchh
Q 040392          307 DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTL  385 (470)
Q Consensus       307 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~  385 (470)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..||......  .+
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~--~~  302 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--EL  302 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HH
Confidence            9999999999999987654443344445567889999999999999999999999999999999 99998764322  11


Q ss_pred             hHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHhhh
Q 040392          386 KHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRN  458 (470)
Q Consensus       386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~~~  458 (470)
                      ...+......                  ..+..++.++.+++.+||+.||++|||+.|++++|+++.......
T Consensus       303 ~~~~~~~~~~------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~  357 (382)
T 3tt0_A          303 FKLLKEGHRM------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ  357 (382)
T ss_dssp             HHHHHTTCCC------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred             HHHHHcCCCC------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence            1111111100                  011234677999999999999999999999999999997654433

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-44  Score=349.92  Aligned_cols=253  Identities=20%  Similarity=0.296  Sum_probs=209.8

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      .++|.+.+.||+|+||.||+|... +++.||+|.+... ......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            468999999999999999999865 5889999998644 33445678899999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC--CCCeEEeeeccccccCCCCC
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD--NMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      +++|+|.+++......+++..+..++.|++.||.|||   +.+|+||||||+||+++.  ++.+||+|||++....... 
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-  158 (321)
T 1tki_A           83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-  158 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence            9999999999877667999999999999999999999   899999999999999987  7899999999998764322 


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                        ......+|+.|+|||++.+..++.++||||||+++|+|++|..||......+ ............             
T Consensus       159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~-------------  222 (321)
T 1tki_A          159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIENIMNAEYTF-------------  222 (321)
T ss_dssp             --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCCCC-------------
T ss_pred             --ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-HHHHHHcCCCCC-------------
Confidence              2334578999999999998889999999999999999999999997643221 111111111000             


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                         .......++.++.+++.+||..||++|||+.|+++|-
T Consensus       223 ---~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp  259 (321)
T 1tki_A          223 ---DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             ---CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             ---ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence               0111224467789999999999999999999999863

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=6e-45  Score=353.49  Aligned_cols=258  Identities=25%  Similarity=0.405  Sum_probs=205.6

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcE----EEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGME----VAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKA  245 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  245 (470)
                      .++|++.+.||+|+||.||+|++. +++.    ||+|.+.... ....+.+.+|+.+++.++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            356889999999999999999854 4443    5888775432 345567889999999999999999999998765 67


Q ss_pred             EEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC
Q 040392          246 LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  325 (470)
                      +|+||+++|+|.+++......+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            899999999999999887778999999999999999999999   89999999999999999999999999999987755


Q ss_pred             CCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCccccccccc
Q 040392          326 EDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN  404 (470)
Q Consensus       326 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (470)
                      ...........+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+  +...+......         
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~~~~~---------  238 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGERL---------  238 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTCCC---------
T ss_pred             CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--HHHHHHcCCCC---------
Confidence            444444445567889999999999999999999999999999999 999997643322  22222111100         


Q ss_pred             ccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                               ..+..++.++.+++.+||+.||++||++.|++++|+++..
T Consensus       239 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          239 ---------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             ---------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             ---------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                     0122346678999999999999999999999999999864

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.7e-44  Score=347.81  Aligned_cols=262  Identities=22%  Similarity=0.373  Sum_probs=216.7

Q ss_pred             hCCCCCCCeecccCceEEEEEEe------CCCcEEEEEEeecccc-hhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQCG-RALKGFDVECEMMKSI-RHRNLIKVISTCSNEEF  243 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~  243 (470)
                      .++|.+.+.||+|+||.||+|++      .+++.||+|++..... ...+.+.+|+++++++ +||||+++++++...+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            46789999999999999999974      3478899999975532 3456788999999999 89999999999999999


Q ss_pred             eeEEEecCCCCChHHhhhcCCC-----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 040392          244 KALVLEYMPHGSLEKYMYSSNY-----------------ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL  306 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill  306 (470)
                      .++||||+++|+|.+++.....                 .+++..++.++.|+++||.|||   +.+++||||||+||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEE
Confidence            9999999999999999976543                 4899999999999999999999   8999999999999999


Q ss_pred             CCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchh
Q 040392          307 DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTL  385 (470)
Q Consensus       307 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~  385 (470)
                      +.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ .
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~  257 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-F  257 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-H
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-H
Confidence            9999999999999987754443333444567889999999988899999999999999999999 9999976543321 1


Q ss_pred             hHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHH
Q 040392          386 KHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL  455 (470)
Q Consensus       386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~  455 (470)
                      ...+......                  ..+..++.++.+++.+||+.||.+|||+.|++++|+++....
T Consensus       258 ~~~~~~~~~~------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  309 (313)
T 1t46_A          258 YKMIKEGFRM------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (313)
T ss_dssp             HHHHHHTCCC------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HHHhccCCCC------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence            2211111110                  011234667899999999999999999999999999987653

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-44  Score=352.82  Aligned_cols=264  Identities=23%  Similarity=0.361  Sum_probs=213.2

Q ss_pred             hhCCCCCCCeecccCceEEEEEEe------CCCcEEEEEEeecc-cchhhhhHHHHHHHHhcC-CCCcceeEEeeeccCC
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQ-CGRALKGFDVECEMMKSI-RHRNLIKVISTCSNEE  242 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~  242 (470)
                      ..++|.+.+.||+|+||.||+|+.      .++..||+|++... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            457889999999999999999985      24668999999754 234556788999999999 8999999999999999


Q ss_pred             eeeEEEecCCCCChHHhhhcCCC----------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 040392          243 FKALVLEYMPHGSLEKYMYSSNY----------------------ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK  300 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~----------------------~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlk  300 (470)
                      ..++||||+++|+|.+++.....                      .+++..++.++.|++.||+|||   +.+|+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence            99999999999999999976542                      3789999999999999999999   8999999999


Q ss_pred             CCCeeeCCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccc
Q 040392          301 PSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIF  379 (470)
Q Consensus       301 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~  379 (470)
                      |+||+++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |..||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999999999987654443334445567889999999988899999999999999999998 999997754


Q ss_pred             cCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHh
Q 040392          380 NGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL  456 (470)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~  456 (470)
                      ... .....+......                  ..+..++.++.+++.+||+.||.+|||+.|++++|+.+.....
T Consensus       280 ~~~-~~~~~~~~~~~~------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  337 (344)
T 1rjb_A          280 VDA-NFYKLIQNGFKM------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE  337 (344)
T ss_dssp             CSH-HHHHHHHTTCCC------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred             cHH-HHHHHHhcCCCC------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence            332 222222211110                  0112346678999999999999999999999999999875543

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.3e-44  Score=348.74  Aligned_cols=259  Identities=25%  Similarity=0.403  Sum_probs=214.8

Q ss_pred             hCCCCCCCeecccCceEEEEEEe------CCCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFK  244 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  244 (470)
                      .++|.+.+.||+|+||.||+|..      .++..||+|++.... ....+.+.+|+++++.++||||+++++++.+....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            56788999999999999999975      345889999997543 34456788999999999999999999999999999


Q ss_pred             eEEEecCCCCChHHhhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCC
Q 040392          245 ALVLEYMPHGSLEKYMYSSN-----------------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKP  301 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp  301 (470)
                      ++||||+++|+|.+++....                       ..+++..++.++.|+++||.|||   +.+|+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccch
Confidence            99999999999999997643                       23789999999999999999999   89999999999


Q ss_pred             CCeeeCCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccc
Q 040392          302 SNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFN  380 (470)
Q Consensus       302 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~  380 (470)
                      +||+++.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987654443334445567889999999988889999999999999999999 9999976433


Q ss_pred             CcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          381 GEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                      .+  +...+......                  ..+..++.++.+++.+||+.||++||++.|++++|+++..
T Consensus       259 ~~--~~~~~~~~~~~------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          259 ER--LFNLLKTGHRM------------------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             GG--HHHHHHTTCCC------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HH--HHHHhhcCCcC------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            22  11111111100                  0112346778999999999999999999999999999864

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4.9e-44  Score=347.72  Aligned_cols=249  Identities=22%  Similarity=0.291  Sum_probs=206.6

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++...   .......+..|+++++.++||||+++++++...+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            467899999999999999999865 6899999999754   233456678899999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||+++|+|.+++...+ .+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++......
T Consensus        84 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence            99999999999987544 6899999999999999999999   8999999999999999999999999999998643221


Q ss_pred             CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                        ......+||+.|+|||++.+..++.++|+||||+++|||++|+.||......+  +...+..   ...          
T Consensus       160 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~i~~---~~~----------  222 (337)
T 1o6l_A          160 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFELILM---EEI----------  222 (337)
T ss_dssp             --CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH---CCC----------
T ss_pred             --CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH--HHHHHHc---CCC----------
Confidence              22345679999999999999999999999999999999999999997532211  1111100   000          


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCC-----CHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRI-----NAREIVAK  447 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~el~~~  447 (470)
                            ..+..++.++.+++.+||+.||++||     ++.|+++|
T Consensus       223 ------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          223 ------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence                  01123466789999999999999999     89999876

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4.3e-44  Score=342.20  Aligned_cols=260  Identities=25%  Similarity=0.434  Sum_probs=207.9

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      .++|++.+.||+|+||.||+|+.. +++.||+|.+....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            467999999999999999999754 68999999985432   33456788999999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||+++++|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus        90 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            99999999999997654 6899999999999999999999   8999999999999999999999999999998654322


Q ss_pred             CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                       ........||+.|+|||.+.+..++.++||||||+++|||++|+.||............ .....+             
T Consensus       166 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~-~~~~~~-------------  230 (294)
T 4eqm_A          166 -LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH-IQDSVP-------------  230 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH-HSSCCC-------------
T ss_pred             -ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-hhccCC-------------
Confidence             12223456899999999999999999999999999999999999999764322111111 000000             


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCC-CHHHHHHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRI-NAREIVAKLLKIR  452 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~el~~~L~~i~  452 (470)
                        .........++..+.+++.+||..||++|| +++++.+.|+++.
T Consensus       231 --~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          231 --NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             --CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             --CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence              011111234577899999999999999999 8999999998875

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=356.94  Aligned_cols=260  Identities=23%  Similarity=0.389  Sum_probs=212.3

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecc-cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQ-CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFK  244 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  244 (470)
                      .++|++.+.||+|+||.||+|++.      ++..||||++... .......+..|+.+++.++||||+++++++......
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            357888999999999999999843      4678999998644 334455688899999999999999999999999999


Q ss_pred             eEEEecCCCCChHHhhhcCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC---CeEEe
Q 040392          245 ALVLEYMPHGSLEKYMYSSN------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM---VAHLS  315 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~---~~kl~  315 (470)
                      ++||||+++|+|.+++....      ..+++..++.++.|++.||+|||   +++|+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999997643      45899999999999999999999   99999999999999999555   59999


Q ss_pred             eeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcC
Q 040392          316 DFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLP  394 (470)
Q Consensus       316 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  394 (470)
                      |||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||......  .....+.....
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--~~~~~i~~~~~  304 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVLEFVTSGGR  304 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHTTCC
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC
Confidence            9999986543333333345668999999999988899999999999999999998 99998764322  11111111110


Q ss_pred             CcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          395 ISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                      .                  ..+..++..+.+++.+||+.||++||++.|++++|+.+...
T Consensus       305 ~------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          305 M------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             C------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             C------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence            0                  01223466789999999999999999999999999998754

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.1e-44  Score=351.42  Aligned_cols=252  Identities=22%  Similarity=0.317  Sum_probs=207.2

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccch------hhhhHHHHHHHHhcCCCCcceeEEeeeccCCee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGR------ALKGFDVECEMMKSIRHRNLIKVISTCSNEEFK  244 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  244 (470)
                      .+.|++.+.||+|+||.||+|+.. +|+.||+|++......      ..+.+.+|+.+++.++||||+++++++.+....
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            567999999999999999999865 6899999999754322      245688999999999999999999999999999


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC----CeEEeeeccc
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM----VAHLSDFSIA  320 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~----~~kl~Dfg~a  320 (470)
                      ++||||+++|+|.+++... ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++    .+||+|||++
T Consensus        91 ~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            9999999999999999654 46899999999999999999999   89999999999999998877    7999999999


Q ss_pred             cccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccc
Q 040392          321 KLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEV  400 (470)
Q Consensus       321 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (470)
                      .......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+ .+.....    ...   
T Consensus       167 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~-~~~~i~~----~~~---  235 (361)
T 2yab_A          167 HEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANITA----VSY---  235 (361)
T ss_dssp             EECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHT----TCC---
T ss_pred             eEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHh----cCC---
Confidence            8764322   2234579999999999999899999999999999999999999997632221 1111110    000   


Q ss_pred             ccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          401 VGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                            .   ........++.++.+++.+||..||++|||+.|+++|
T Consensus       236 ------~---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          236 ------D---FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             ------C---CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ------C---CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                  0   0011123446778999999999999999999999864

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.5e-44  Score=342.95  Aligned_cols=259  Identities=27%  Similarity=0.430  Sum_probs=198.4

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      .++|++.+.||+|+||.||+|+..  ..||+|++....  ....+.+.+|+++++.++||||+++++++. ....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEEE
Confidence            567999999999999999999874  359999986543  345577889999999999999999999764 456789999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      |+++++|.+++......+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++.........
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  176 (289)
T 3og7_A          100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS  176 (289)
T ss_dssp             CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred             ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence            99999999999877778999999999999999999999   899999999999999999999999999999865433333


Q ss_pred             ccccccccCccccCccccC---CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhh-cCCcccccccccc
Q 040392          330 MTQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDW-LPISTMEVVGANL  405 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  405 (470)
                      .......||+.|+|||.+.   +..++.++||||||+++|||++|+.||......+. ....+... .......      
T Consensus       177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~------  249 (289)
T 3og7_A          177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIEMVGRGSLSPDLSK------  249 (289)
T ss_dssp             -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH-HHHHHHHTSCCCCTTS------
T ss_pred             ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH-HHHHhcccccCcchhh------
Confidence            3334567899999999886   56688899999999999999999999986443322 22222111 1110000      


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR  452 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~  452 (470)
                               ....++.++.+++.+||+.||++|||+.|+++.|+++.
T Consensus       250 ---------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          250 ---------VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             ---------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ---------ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence                     01234677999999999999999999999999999874

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-43  Score=342.65  Aligned_cols=270  Identities=24%  Similarity=0.365  Sum_probs=207.3

Q ss_pred             HHHHhhCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcC--CCCcceeEEeeeccC---
Q 040392          167 ELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSI--RHRNLIKVISTCSNE---  241 (470)
Q Consensus       167 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~nIv~~~~~~~~~---  241 (470)
                      ......++|++.+.||+|+||.||+|+.. ++.||||++...   ....+..|.+++..+  +||||+++++++...   
T Consensus        31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~  106 (337)
T 3mdy_A           31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS  106 (337)
T ss_dssp             HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred             cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence            33445678999999999999999999885 899999998643   223344566666554  899999999998776   


Q ss_pred             -CeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--------CeeecCCCCCCeeeCCCCCe
Q 040392          242 -EFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA--------PIIHCDLKPSNVLLDDNMVA  312 (470)
Q Consensus       242 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~--------~i~H~dlkp~Nill~~~~~~  312 (470)
                       ...++||||+++|+|.+++...  .+++..++.++.|++.||+|||   +.        +|+||||||+||+++.++.+
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  181 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTC  181 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             CCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCE
Confidence             6889999999999999999665  4899999999999999999999   77        99999999999999999999


Q ss_pred             EEeeeccccccCCCCCc--ccccccccCccccCccccCCCCCCCc------cchhhHHHHHHHHHhC----------CCC
Q 040392          313 HLSDFSIAKLLTGEDQS--MTQTQTLATIGYMAPEYGREGRVSTN------GDVYSFGIMLMETFTG----------KKP  374 (470)
Q Consensus       313 kl~Dfg~a~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~------~DvwslGv~l~el~tg----------~~p  374 (470)
                      ||+|||++..+......  .......||+.|+|||++.+...+.+      +||||||+++|||++|          +.|
T Consensus       182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p  261 (337)
T 3mdy_A          182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP  261 (337)
T ss_dssp             EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence            99999999766433222  11234579999999999987766665      9999999999999999          555


Q ss_pred             CCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          375 TNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                      |............+.........         ............++.++.+++.+||+.||++|||+.|++++|+++.++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  332 (337)
T 3mdy_A          262 YHDLVPSDPSYEDMREIVCIKKL---------RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES  332 (337)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSCC---------CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HhhhcCCCCchhhhHHHHhhhcc---------CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence            55443333222222211111110         111111122346788899999999999999999999999999999754

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.3e-43  Score=337.52  Aligned_cols=253  Identities=26%  Similarity=0.434  Sum_probs=207.0

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccch-------hhhhHHHHHHHHhcCCCCcceeEEeeeccCCe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGR-------ALKGFDVECEMMKSIRHRNLIKVISTCSNEEF  243 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  243 (470)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++......       ..+.+.+|+++++.++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            46789999999999999999986 47899999998644321       1267889999999999999999999997765 


Q ss_pred             eeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeeCCCCC-----eEEee
Q 040392          244 KALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP--IIHCDLKPSNVLLDDNMV-----AHLSD  316 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--i~H~dlkp~Nill~~~~~-----~kl~D  316 (470)
                       ++||||+++|+|.+++......+++..+..++.|++.||+|||   +.+  ++||||||+||+++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             6999999999999999877778999999999999999999999   888  999999999999988776     99999


Q ss_pred             eccccccCCCCCcccccccccCccccCccccC--CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcC
Q 040392          317 FSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR--EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLP  394 (470)
Q Consensus       317 fg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  394 (470)
                      ||++.....     ......+|+.|+|||.+.  ...++.++||||||+++|||++|+.||...................
T Consensus       173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  247 (287)
T 4f0f_A          173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL  247 (287)
T ss_dssp             CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred             CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence            999974432     233467899999999984  4557899999999999999999999998754443322222111100


Q ss_pred             CcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          395 ISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                      .                 ...+..++.++.+++.+||+.||++|||+.|+++.|+++
T Consensus       248 ~-----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          248 R-----------------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             C-----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             C-----------------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            0                 001233467799999999999999999999999999864

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=6.2e-44  Score=346.84  Aligned_cols=264  Identities=19%  Similarity=0.194  Sum_probs=215.2

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCeeeEEEe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++....  ....+..|+++++.+ +||||+++++++......++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            46799999999999999999985 578999999987542  345688999999999 89999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC-----eEEeeeccccccC
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV-----AHLSDFSIAKLLT  324 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~-----~kl~Dfg~a~~~~  324 (470)
                      |+ +++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.     +||+|||++..+.
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            99 89999999876678999999999999999999999   899999999999999999887     9999999998764


Q ss_pred             CCCCcc-----cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcch--hhHHhhhhcCCcc
Q 040392          325 GEDQSM-----TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMT--LKHWVNDWLPIST  397 (470)
Q Consensus       325 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~  397 (470)
                      ......     ......||+.|+|||++.+..++.++||||||+++|||++|+.||.........  +........+.. 
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~-  240 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP-  240 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC-
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC-
Confidence            432211     124567999999999999999999999999999999999999999875332211  111100000000 


Q ss_pred             cccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHhh
Q 040392          398 MEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLR  457 (470)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~~  457 (470)
                                    .......++ ++.+++..||+.||.+||++.+|.+.|+++..+...
T Consensus       241 --------------~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~  285 (330)
T 2izr_A          241 --------------IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY  285 (330)
T ss_dssp             --------------HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             --------------HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence                          000112245 899999999999999999999999999998876544

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.6e-43  Score=338.60  Aligned_cols=266  Identities=14%  Similarity=0.127  Sum_probs=217.7

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCeeeEEEe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++...  .....+.+|+++++.+ +|+|++++++++......++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            46799999999999999999985 57999999998643  3445688899999999 79999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC-----eEEeeeccccccC
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV-----AHLSDFSIAKLLT  324 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~-----~kl~Dfg~a~~~~  324 (470)
                      |+ +++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.     +||+|||++....
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~  162 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  162 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence            99 89999999877767999999999999999999999   999999999999999987776     9999999998765


Q ss_pred             CCCCc-----ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcch--hhHHhhhhcCCcc
Q 040392          325 GEDQS-----MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMT--LKHWVNDWLPIST  397 (470)
Q Consensus       325 ~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~  397 (470)
                      .....     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........  +........... 
T Consensus       163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-  241 (298)
T 1csn_A          163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP-  241 (298)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC-
T ss_pred             cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc-
Confidence            43221     1234567999999999999999999999999999999999999999874332211  111000000000 


Q ss_pred             cccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHhhh
Q 040392          398 MEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRN  458 (470)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~~~  458 (470)
                                    .......++.++.+++.+||+.||++||++.+|++.|+++..+....
T Consensus       242 --------------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~  288 (298)
T 1csn_A          242 --------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT  288 (298)
T ss_dssp             --------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             --------------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence                          00111245778999999999999999999999999999998766543

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1e-44  Score=351.52  Aligned_cols=258  Identities=22%  Similarity=0.379  Sum_probs=208.0

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcE----EEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGME----VAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKA  245 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  245 (470)
                      .++|++.+.||+|+||.||+|.+. +++.    ||+|.+.... ......+.+|+.+++.++||||+++++++. ....+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            357888999999999999999854 4443    7888775432 344566788999999999999999999986 45678


Q ss_pred             EEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC
Q 040392          246 LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  325 (470)
                      +||||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            999999999999999877667899999999999999999999   89999999999999999999999999999998765


Q ss_pred             CCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCccccccccc
Q 040392          326 EDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN  404 (470)
Q Consensus       326 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (470)
                      ...........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+  ....+.......        
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~~~--------  237 (325)
T 3kex_A          168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--VPDLLEKGERLA--------  237 (325)
T ss_dssp             CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--HHHHHHTTCBCC--------
T ss_pred             ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--HHHHHHcCCCCC--------
Confidence            544444455678889999999998899999999999999999999 999998643322  222221111100        


Q ss_pred             ccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                                .+..++.++.+++.+||..||++||++.|++++|+++..
T Consensus       238 ----------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          238 ----------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             ----------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             ----------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                      011234457899999999999999999999999999864

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=4.3e-44  Score=362.27  Aligned_cols=252  Identities=30%  Similarity=0.454  Sum_probs=209.4

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCC-eeeEEEec
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEE-FKALVLEY  250 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~~~lv~e~  250 (470)
                      .++|++.+.||+|+||.||+|.+. |+.||||+++...  ..+.+.+|++++++++||||+++++++.+.. ..++||||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            467888899999999999999885 7899999997543  4567899999999999999999999986654 78999999


Q ss_pred             CCCCChHHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          251 MPHGSLEKYMYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      +++|+|.+++..... .+++..+..++.|++.||+|||   +++++||||||+|||++.++.+||+|||+++.....   
T Consensus       269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---  342 (450)
T 1k9a_A          269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  342 (450)
T ss_dssp             CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence            999999999987653 4689999999999999999999   899999999999999999999999999999854321   


Q ss_pred             ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                        .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.  ...+....               
T Consensus       343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--~~~i~~~~---------------  403 (450)
T 1k9a_A          343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPRVEKGY---------------  403 (450)
T ss_dssp             ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH--HHHHHTTC---------------
T ss_pred             --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHcCC---------------
Confidence              122357889999999999999999999999999999998 9999986543321  11111110               


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                         +...+..++.++.+++.+||+.||++|||+.++++.|+++...
T Consensus       404 ---~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          404 ---KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ---CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence               0112345678899999999999999999999999999998743

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=5e-45  Score=365.92  Aligned_cols=261  Identities=19%  Similarity=0.243  Sum_probs=210.5

Q ss_pred             HHHHhhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCC
Q 040392          167 ELCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEE  242 (470)
Q Consensus       167 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  242 (470)
                      ++....++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+..|..++..++||||+++++++.+..
T Consensus        68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~  147 (437)
T 4aw2_A           68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN  147 (437)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred             cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence            34455688999999999999999999875 47899999997532   233455889999999999999999999999999


Q ss_pred             eeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccc
Q 040392          243 FKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL  322 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~  322 (470)
                      ..++||||+++|+|.+++......+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla~~  224 (437)
T 4aw2_A          148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLK  224 (437)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence            999999999999999999876667999999999999999999999   99999999999999999999999999999986


Q ss_pred             cCCCCCcccccccccCccccCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcc
Q 040392          323 LTGEDQSMTQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIST  397 (470)
Q Consensus       323 ~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  397 (470)
                      ..... .......+||+.|+|||++.     ...++.++|||||||++|||++|+.||......+. .............
T Consensus       225 ~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-~~~i~~~~~~~~~  302 (437)
T 4aw2_A          225 LMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YGKIMNHKERFQF  302 (437)
T ss_dssp             CCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTHHHHCCC
T ss_pred             cccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH-HHhhhhccccccC
Confidence            64322 22334467999999999986     56789999999999999999999999976432211 1111110000000


Q ss_pred             cccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccC--CCCHHHHHHH
Q 040392          398 MEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQ--RINAREIVAK  447 (470)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~el~~~  447 (470)
                           +..          ...++.++.+|+.+||..+|++  ||++.|+++|
T Consensus       303 -----p~~----------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          303 -----PTQ----------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             -----CSS----------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             -----Ccc----------cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence                 000          0123667899999999999888  9999999876

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.8e-44  Score=341.53  Aligned_cols=268  Identities=21%  Similarity=0.280  Sum_probs=204.3

Q ss_pred             CCCCCCCeecccCceEEEEEEeCCCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          173 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      ++|++.+.||+|+||.||+|+..+|+.||+|++....  ......+.+|+++++.++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            5788999999999999999998889999999986543  22346678899999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      +++ +|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......  .
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--R  155 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc--c
Confidence            975 999999877677999999999999999999999   8999999999999999999999999999998664221  2


Q ss_pred             cccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc--------ccccc
Q 040392          331 TQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS--------TMEVV  401 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~  401 (470)
                      ......+|+.|+|||++.+. .++.++||||||+++|||++|+.||......+. +...........        .....
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHHCCCChhhchhhhccccc
Confidence            22345689999999998764 589999999999999999999999976433221 111111100000        00000


Q ss_pred             cccccCchh-hhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          402 GANLLSQED-IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       402 ~~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ++....... ........++.++.+++.+||+.||++|||+.|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            100000000 0001112346778999999999999999999999875

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3e-44  Score=348.90  Aligned_cols=247  Identities=26%  Similarity=0.388  Sum_probs=204.1

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      .++|.+.+.||+|+||.||+|.. .+++.||+|++....   ......+.+|+++++.++||||+++++++......++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            46799999999999999999986 578999999987542   22345688999999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||+ +|+|.+++.... .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus        88 ~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             ECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             EECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            9999 679999886654 5899999999999999999999   8999999999999999999999999999998654322


Q ss_pred             CcccccccccCccccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccccc
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL  406 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (470)
                         .....+||+.|+|||++.+..+ +.++||||||+++|+|++|+.||......+..              ..+.... 
T Consensus       163 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~--------------~~i~~~~-  224 (336)
T 3h4j_B          163 ---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF--------------KKVNSCV-  224 (336)
T ss_dssp             ---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB--------------CCCCSSC-
T ss_pred             ---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH--------------HHHHcCC-
Confidence               2234579999999999988776 68999999999999999999999764322110              0000000 


Q ss_pred             CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       407 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                            ...+..++.++.+++.+||+.||.+|||+.|++++
T Consensus       225 ------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          225 ------YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             ------CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             ------CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                  01122346678999999999999999999999876

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.2e-44  Score=336.43  Aligned_cols=257  Identities=26%  Similarity=0.420  Sum_probs=213.2

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      .++|++.+.||+|+||.||+|...+++.||+|++..... ..+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            357888999999999999999998899999999975432 3357889999999999999999999999999999999999


Q ss_pred             CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccc
Q 040392          252 PHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  331 (470)
Q Consensus       252 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  331 (470)
                      ++++|.+++......+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++...... ....
T Consensus        86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-~~~~  161 (267)
T 3t9t_A           86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTS  161 (267)
T ss_dssp             TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-HHHS
T ss_pred             CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccc-cccc
Confidence            999999999887777899999999999999999999   899999999999999999999999999999865321 1112


Q ss_pred             ccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCchh
Q 040392          332 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED  410 (470)
Q Consensus       332 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (470)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+  ....+......               
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~i~~~~~~---------------  224 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDISTGFRL---------------  224 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTTCCC---------------
T ss_pred             cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH--HHHHHhcCCcC---------------
Confidence            223456788999999988889999999999999999999 899987632221  11111110000               


Q ss_pred             hhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          411 IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       411 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                         ..+..++..+.+++.+||+.||++||++.|++++|+++.+
T Consensus       225 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          225 ---YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence               0012235678899999999999999999999999999975

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.4e-44  Score=354.55  Aligned_cols=273  Identities=15%  Similarity=0.179  Sum_probs=210.9

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCC------CcEEEEEEeecccchh-----------hhhHHHHHHHHhcCCCCcceeE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGD------GMEVAVKVFNLQCGRA-----------LKGFDVECEMMKSIRHRNLIKV  234 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~nIv~~  234 (470)
                      .++|++.+.||+|+||.||+|.+.+      ++.||||++.......           ...+..|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4589999999999999999998754      4789999987543211           1123346667778899999999


Q ss_pred             EeeeccC----CeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC--C
Q 040392          235 ISTCSNE----EFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD--D  308 (470)
Q Consensus       235 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~--~  308 (470)
                      ++++...    ...++||||+ +++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+|||++  .
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESSC
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecCC
Confidence            9998664    5679999999 99999999887678999999999999999999999   89999999999999998  8


Q ss_pred             CCCeEEeeeccccccCCCCCc-----ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcc
Q 040392          309 NMVAHLSDFSIAKLLTGEDQS-----MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEM  383 (470)
Q Consensus       309 ~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~  383 (470)
                      ++.+||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~  269 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK  269 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence            999999999999876432211     111344599999999999999999999999999999999999999986433322


Q ss_pred             hhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHhhh
Q 040392          384 TLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRN  458 (470)
Q Consensus       384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~~~  458 (470)
                      . ..+.............+..+         ....++.++.+++..||..||++||++.++++.|+++.......
T Consensus       270 ~-~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~  334 (364)
T 3op5_A          270 Y-VRDSKIRYRENIASLMDKCF---------PAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK  334 (364)
T ss_dssp             H-HHHHHHHHHHCHHHHHHHHS---------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             H-HHHHHHHhhhhHHHHHHHhc---------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence            1 11111111111111111111         11344778999999999999999999999999999998765433

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=8.5e-44  Score=339.76  Aligned_cols=269  Identities=22%  Similarity=0.262  Sum_probs=206.0

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++....  ......+.+|+++++.++||||+++++++.+....++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57889999999999999999865 68999999997543  2334677889999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      |+++ ++.+.+......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++......  .
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--V  155 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC--C
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc--c
Confidence            9975 777777666677999999999999999999999   899999999999999999999999999999876422  2


Q ss_pred             ccccccccCccccCccccCCCC-CCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccc------cccc
Q 040392          330 MTQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTM------EVVG  402 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~  402 (470)
                      .......+|+.|+|||++.+.. ++.++||||||+++|||++|..||....+....+.............      ...+
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence            2234457899999999987765 89999999999999999999888654333222222222211110000      0000


Q ss_pred             cc---ccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          403 AN---LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       403 ~~---~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ..   ..............++.++.+++.+||+.||++|||+.|+++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            00   0000000001112346778999999999999999999999875

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=4.4e-44  Score=346.72  Aligned_cols=261  Identities=25%  Similarity=0.456  Sum_probs=197.1

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeCCC----cEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCee
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLGDG----MEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFK  244 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  244 (470)
                      ..++|++.+.||+|+||.||+|+....    ..||||++...  .....+.+.+|+++++.++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            356799999999999999999986543    27999998754  344567789999999999999999999999776554


Q ss_pred             ------eEEEecCCCCChHHhhhcCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeE
Q 040392          245 ------ALVLEYMPHGSLEKYMYSSN-----YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH  313 (470)
Q Consensus       245 ------~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~k  313 (470)
                            ++||||+++|+|.+++....     ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEE
Confidence                  89999999999999986432     25899999999999999999999   89999999999999999999999


Q ss_pred             EeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhh
Q 040392          314 LSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDW  392 (470)
Q Consensus       314 l~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~  392 (470)
                      |+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.  ...+...
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~~~~~~~  255 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI--YNYLIGG  255 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHHHHTT
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH--HHHHhcC
Confidence            999999987654443334445567889999999998899999999999999999999 9999986433221  1111110


Q ss_pred             cCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          393 LPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                      ..                  ...+..++.++.+++.+||+.||++|||+.++++.|+++...
T Consensus       256 ~~------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          256 NR------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             CC------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CC------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            00                  001123467789999999999999999999999999998753

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.8e-44  Score=341.11  Aligned_cols=259  Identities=23%  Similarity=0.380  Sum_probs=201.4

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCC----CcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGD----GMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  246 (470)
                      .++|++.+.||+|+||.||+|....    +..||+|...... ....+.+.+|+.+++.++||||+++++++.+ +..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-CccEE
Confidence            4678899999999999999997643    4579999986532 3345678899999999999999999999854 56789


Q ss_pred             EEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCC
Q 040392          247 VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      ||||+++|+|.+++......+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  169 (281)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence            99999999999999877777999999999999999999999   899999999999999999999999999999876432


Q ss_pred             CCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          327 DQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       327 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      . ........+++.|+|||.+.+..++.++||||||+++|||++ |..||......+  ....+......          
T Consensus       170 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~~~~i~~~~~~----------  236 (281)
T 1mp8_A          170 T-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIENGERL----------  236 (281)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTCCC----------
T ss_pred             c-ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--HHHHHHcCCCC----------
Confidence            2 122233456789999999988889999999999999999997 999997643322  11111111000          


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL  455 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~  455 (470)
                              ..+..++.++.+++.+||+.||++|||+.|++++|+++..+.
T Consensus       237 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          237 --------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             --------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                    012345677899999999999999999999999999997543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=343.36  Aligned_cols=274  Identities=20%  Similarity=0.289  Sum_probs=210.9

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCC--eeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEE--FKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--~~~lv  247 (470)
                      .++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++.++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            357899999999999999999865 58999999987543 334566788999999999999999999987654  77999


Q ss_pred             EecCCCCChHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee----CCCCCeEEeeecccc
Q 040392          248 LEYMPHGSLEKYMYSSN--YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL----DDNMVAHLSDFSIAK  321 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill----~~~~~~kl~Dfg~a~  321 (470)
                      |||+++|+|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+||++    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            99999999999997654  23899999999999999999999   8999999999999999    888899999999998


Q ss_pred             ccCCCCCcccccccccCccccCccccC--------CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchh---hHHhh
Q 040392          322 LLTGEDQSMTQTQTLATIGYMAPEYGR--------EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTL---KHWVN  390 (470)
Q Consensus       322 ~~~~~~~~~~~~~~~~t~~y~aPE~~~--------~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~---~~~~~  390 (470)
                      ......   ......||+.|+|||++.        +..++.++||||||+++|||++|+.||..........   .....
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             ecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            764332   223456899999999875        5678999999999999999999999997544332211   11111


Q ss_pred             hhcCCccccccccc--cc---CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          391 DWLPISTMEVVGAN--LL---SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       391 ~~~~~~~~~~~~~~--~~---~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                      ...+..........  ..   .............+..+.+++.+||+.||++|||+.|++++..+-
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            11111110000000  00   000011112245577899999999999999999999999998865

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=6.6e-44  Score=344.19  Aligned_cols=270  Identities=23%  Similarity=0.373  Sum_probs=218.1

Q ss_pred             CHHHHHHhhCCCCCCCeecccCceEEEEEEe------CCCcEEEEEEeecccc-hhhhhHHHHHHHHhcC-CCCcceeEE
Q 040392          164 SHLELCRATDGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQCG-RALKGFDVECEMMKSI-RHRNLIKVI  235 (470)
Q Consensus       164 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~  235 (470)
                      .........++|++.+.||+|+||.||+|++      .+++.||||++..... .....+.+|+++++.+ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            3444555668899999999999999999974      3568899999975432 3456788999999999 699999999


Q ss_pred             eeeccCC-eeeEEEecCCCCChHHhhhcCCCC---------------CCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC
Q 040392          236 STCSNEE-FKALVLEYMPHGSLEKYMYSSNYI---------------LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL  299 (470)
Q Consensus       236 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~---------------~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dl  299 (470)
                      +++...+ ..++||||+++|+|.+++......               +++..+..++.|++.||.|||   +.+|+||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccC
Confidence            9987654 589999999999999999765432               789999999999999999999   899999999


Q ss_pred             CCCCeeeCCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q 040392          300 KPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEI  378 (470)
Q Consensus       300 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~  378 (470)
                      ||+||+++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999999999987654444344445668899999999988899999999999999999998 99999764


Q ss_pred             ccCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHH
Q 040392          379 FNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL  455 (470)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~  455 (470)
                      ...+..... +.......                  .+..++.++.+++.+||+.||.+|||+.|++++|+++..+.
T Consensus       255 ~~~~~~~~~-~~~~~~~~------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          255 KIDEEFCRR-LKEGTRMR------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             CCSHHHHHH-HHHTCCCC------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             chhHHHHHH-hccCccCC------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            433221111 11111000                  11223567899999999999999999999999999997543

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=6.6e-45  Score=368.75  Aligned_cols=260  Identities=25%  Similarity=0.426  Sum_probs=213.6

Q ss_pred             HHhhCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          169 CRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       169 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ....++|.+.+.||+|+||.||+|.+.++..||||+++... ...+.+.+|+++++.++||||+++++++. .+..++||
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~  261 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT  261 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence            33456788899999999999999999889999999997543 34677899999999999999999999987 55678999


Q ss_pred             ecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          249 EYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      ||+++|+|.+++.... ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus       262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~  338 (454)
T 1qcf_A          262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  338 (454)
T ss_dssp             CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred             eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence            9999999999997543 35788999999999999999999   8999999999999999999999999999998764211


Q ss_pred             CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCccccccccccc
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL  406 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (470)
                       ........++..|+|||.+....++.++||||||+++|||++ |+.||......+  ....+.....            
T Consensus       339 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~~~------------  403 (454)
T 1qcf_A          339 -YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRALERGYR------------  403 (454)
T ss_dssp             -HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHHHTCC------------
T ss_pred             -eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC------------
Confidence             111223446788999999988899999999999999999999 999997643321  1111111100            


Q ss_pred             CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       407 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                            ...+..++.++.+++.+||+.||++|||+.+|++.|+++..+
T Consensus       404 ------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          404 ------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             ------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence                  111234677899999999999999999999999999988643

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.1e-44  Score=344.93  Aligned_cols=252  Identities=21%  Similarity=0.307  Sum_probs=206.6

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccch------hhhhHHHHHHHHhcCCCCcceeEEeeeccCCee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGR------ALKGFDVECEMMKSIRHRNLIKVISTCSNEEFK  244 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  244 (470)
                      .++|.+.+.||+|+||.||+|+.. +|+.||+|++......      ..+.+.+|+.+++.++||||+++++++.+....
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            356889999999999999999865 6899999998754321      346688999999999999999999999999999


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC----CeEEeeeccc
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM----VAHLSDFSIA  320 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~----~~kl~Dfg~a  320 (470)
                      ++||||+++|+|.+++... ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++    .+||+|||++
T Consensus        90 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            9999999999999999654 46899999999999999999999   89999999999999999887    8999999999


Q ss_pred             cccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccc
Q 040392          321 KLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEV  400 (470)
Q Consensus       321 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (470)
                      .......   ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+ .+.........      
T Consensus       166 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~~------  235 (326)
T 2y0a_A          166 HKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANVSAVNYE------  235 (326)
T ss_dssp             EECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHTCCC------
T ss_pred             eECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHHhcCCC------
Confidence            8764322   2234569999999999998899999999999999999999999997532211 11111000000      


Q ss_pred             ccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          401 VGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                                ........++..+.+++.+||..||++|||+.|+++|
T Consensus       236 ----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          236 ----------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             ----------CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ----------cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                      0011123446778999999999999999999999985

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.1e-43  Score=334.89  Aligned_cols=252  Identities=24%  Similarity=0.383  Sum_probs=206.8

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccC--CeeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNE--EFKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~~lv  247 (470)
                      .++|.+.+.||+|+||.||+|++. ++.||+|++....  ....+.+.+|+.+++.++||||+++++++.+.  ...++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            357889999999999999999985 8999999987543  34456788999999999999999999999876  788999


Q ss_pred             EecCCCCChHHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeeCCCCCeEEeeeccccccC
Q 040392          248 LEYMPHGSLEKYMYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSAP--IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~  324 (470)
                      |||+++|+|.+++..... .+++..+..++.|++.||+|||   +.+  ++||||||+||+++.++.++|+|||++....
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            999999999999977553 5899999999999999999999   888  9999999999999999999999999876432


Q ss_pred             CCCCcccccccccCccccCccccCCCCCCC---ccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccc
Q 040392          325 GEDQSMTQTQTLATIGYMAPEYGREGRVST---NGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVV  401 (470)
Q Consensus       325 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~---~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (470)
                      .       ....+|+.|+|||.+.+..++.   ++||||||+++|||++|+.||......+.... ........      
T Consensus       165 ~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~~~~~------  230 (271)
T 3kmu_A          165 S-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK-VALEGLRP------  230 (271)
T ss_dssp             C-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHH-HHHSCCCC------
T ss_pred             c-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHH-HHhcCCCC------
Confidence            2       2346899999999988765544   79999999999999999999976433221111 11110000      


Q ss_pred             cccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          402 GANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                                  ..+..++.++.+++.+||+.||++|||+.|+++.|+++.+
T Consensus       231 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          231 ------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             ------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                        0112346778999999999999999999999999999863

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=5.9e-44  Score=353.39  Aligned_cols=253  Identities=20%  Similarity=0.286  Sum_probs=209.5

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      .++|++.+.||+|+||.||+|... +|+.||+|++..........+.+|+++++.++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            467999999999999999999764 6899999999766555566788999999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC--CCCeEEeeeccccccCCCCC
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD--NMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      +++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.  ++.+||+|||++....... 
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~-  205 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-  205 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence            9999999999877667999999999999999999999   899999999999999974  5789999999998764322 


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+.........      .+..    
T Consensus       206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-~~~~i~~~~~~------~~~~----  272 (387)
T 1kob_A          206 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNVKRCDWE------FDED----  272 (387)
T ss_dssp             --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHCCCC------CCSS----
T ss_pred             --ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCC------CCcc----
Confidence              2234579999999999999999999999999999999999999997632211 11111110000      0000    


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                            ....++.++.+++.+||+.||++|||+.|++++
T Consensus       273 ------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          273 ------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             ------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                  012346678999999999999999999999986

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=5.7e-44  Score=337.02  Aligned_cols=251  Identities=27%  Similarity=0.432  Sum_probs=195.9

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeeccc----chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC----GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      .++|++.+.||+|+||.||+|.+. ++.||||++....    ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            467888999999999999999985 8999999986542    23356788899999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC---eeecCCCCCCeeeCC--------CCCeEEee
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP---IIHCDLKPSNVLLDD--------NMVAHLSD  316 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~---i~H~dlkp~Nill~~--------~~~~kl~D  316 (470)
                      |||+++++|.+++..  ..+++..+..++.|++.||.|||   +.+   ++||||||+||+++.        ++.+||+|
T Consensus        85 ~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           85 MEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             EECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            999999999999954  35899999999999999999999   777   999999999999986        77899999


Q ss_pred             eccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc
Q 040392          317 FSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS  396 (470)
Q Consensus       317 fg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  396 (470)
                      ||++.......    .....+|+.|+|||.+.+..++.++||||||+++|+|++|+.||............ ......  
T Consensus       160 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~--  232 (271)
T 3dtc_A          160 FGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV-AMNKLA--  232 (271)
T ss_dssp             CCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH-HTSCCC--
T ss_pred             CCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh-hcCCCC--
Confidence            99998654322    22456899999999998888999999999999999999999999764322111110 000000  


Q ss_pred             ccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          397 TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       397 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                                      ...+..++.++.+++.+||+.||++|||+.|++++|+++
T Consensus       233 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          233 ----------------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             ----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ----------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                            001233467799999999999999999999999999864

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=6.1e-44  Score=347.25  Aligned_cols=267  Identities=22%  Similarity=0.364  Sum_probs=216.5

Q ss_pred             HHhhCCCCCCCeecccCceEEEEEEeCC------CcEEEEEEeeccc-chhhhhHHHHHHHHhcC-CCCcceeEEeeecc
Q 040392          169 CRATDGFSENNLIGRGGFGSVYKARLGD------GMEVAVKVFNLQC-GRALKGFDVECEMMKSI-RHRNLIKVISTCSN  240 (470)
Q Consensus       169 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~  240 (470)
                      ....++|.+.+.||+|+||.||+|....      +..||+|.+.... ....+.+.+|+++++.+ +||||+++++++..
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            3445789999999999999999998642      2479999987543 33456788999999999 89999999999999


Q ss_pred             CCeeeEEEecCCCCChHHhhhcC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC
Q 040392          241 EEFKALVLEYMPHGSLEKYMYSS-------------NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD  307 (470)
Q Consensus       241 ~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~  307 (470)
                      .+..++||||+++|+|.+++...             ...+++..++.++.|++.||+|||   +.+|+||||||+||+++
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLT  198 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEE
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEEC
Confidence            99999999999999999998653             235789999999999999999999   89999999999999999


Q ss_pred             CCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhh
Q 040392          308 DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLK  386 (470)
Q Consensus       308 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~  386 (470)
                      .++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |..||....... ...
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~~  277 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-KFY  277 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-HHH
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-HHH
Confidence            999999999999987654433333344567889999999988889999999999999999999 999987643322 122


Q ss_pred             HHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHhh
Q 040392          387 HWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLR  457 (470)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~~  457 (470)
                      ..+.......                  .+..++.++.+++.+||+.||.+|||+.|++++|+++.....+
T Consensus       278 ~~~~~~~~~~------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~  330 (333)
T 2i1m_A          278 KLVKDGYQMA------------------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRR  330 (333)
T ss_dssp             HHHHHTCCCC------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHhcCCCCC------------------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhhc
Confidence            2221111100                  1122356789999999999999999999999999998765443

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.3e-44  Score=350.79  Aligned_cols=253  Identities=21%  Similarity=0.315  Sum_probs=204.8

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-----chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-----GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKA  245 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  245 (470)
                      .++|++.+.||+|+||.||+|... +|+.||||++....     ....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            356899999999999999999764 68999999986432     123567889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC---eEEeeecc
Q 040392          246 LVLEYMPHGSLEKYMYSS---NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV---AHLSDFSI  319 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~---~kl~Dfg~  319 (470)
                      +||||+++|+|.+++...   ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999998887543   245899999999999999999999   899999999999999987655   99999999


Q ss_pred             ccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccc
Q 040392          320 AKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTME  399 (470)
Q Consensus       320 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  399 (470)
                      +.......  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....  ............     
T Consensus       180 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~i~~~~~~-----  250 (351)
T 3c0i_A          180 AIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGIIKGKYK-----  250 (351)
T ss_dssp             CEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHHHHHHHTCCC-----
T ss_pred             eeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHHHHHHcCCCC-----
Confidence            98764322  223345799999999999998999999999999999999999999976321  111111110000     


Q ss_pred             cccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          400 VVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                                 ........++.++.+++.+||..||++|||+.|+++|
T Consensus       251 -----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          251 -----------MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             -----------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -----------CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                       0001112346778999999999999999999999875

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.1e-43  Score=343.71  Aligned_cols=262  Identities=27%  Similarity=0.439  Sum_probs=214.3

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC--------CCcEEEEEEeeccc-chhhhhHHHHHHHHhcC-CCCcceeEEeeeccC
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG--------DGMEVAVKVFNLQC-GRALKGFDVECEMMKSI-RHRNLIKVISTCSNE  241 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~  241 (470)
                      .++|++.+.||+|+||.||+|++.        ++..||+|++.... ......+.+|+++++.+ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            467899999999999999999863        46789999997543 34456788999999999 899999999999999


Q ss_pred             CeeeEEEecCCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 040392          242 EFKALVLEYMPHGSLEKYMYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL  306 (470)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill  306 (470)
                      +..++||||+++|+|.+++....               ..+++..++.++.|++.||.|||   +.+|+||||||+||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence            99999999999999999997654               24789999999999999999999   8999999999999999


Q ss_pred             CCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchh
Q 040392          307 DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTL  385 (470)
Q Consensus       307 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~  385 (470)
                      +.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|||++ |+.||......+  +
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~  268 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--L  268 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--H
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH--H
Confidence            9999999999999987654433333344567889999999988889999999999999999999 999987643221  1


Q ss_pred             hHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHh
Q 040392          386 KHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL  456 (470)
Q Consensus       386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~  456 (470)
                      ...+......                  ..+..++.++.+++.+||+.||.+||++.|++++|+++.....
T Consensus       269 ~~~~~~~~~~------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          269 FKLLKEGHRM------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             HHHHHHTCCC------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHHhcCCCC------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence            1111111100                  0112346778999999999999999999999999999976543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=9.5e-44  Score=346.27  Aligned_cols=281  Identities=26%  Similarity=0.340  Sum_probs=202.2

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHH--HhcCCCCcceeEEeee-----ccCCee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEM--MKSIRHRNLIKVISTC-----SNEEFK  244 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~nIv~~~~~~-----~~~~~~  244 (470)
                      .++|++.+.||+|+||.||+|+. +++.||||++....   ...+..|.++  +..++||||+++++.+     ......
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            46899999999999999999987 68999999997442   2333444444  4558999999999754     233467


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC---------CeeecCCCCCCeeeCCCCCeEEe
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA---------PIIHCDLKPSNVLLDDNMVAHLS  315 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~---------~i~H~dlkp~Nill~~~~~~kl~  315 (470)
                      ++||||+++|+|.+++....  .++..+..++.|++.||+|||   +.         +|+||||||+|||++.++.+||+
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~  162 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS  162 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred             EEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEe
Confidence            89999999999999997655  488899999999999999999   77         99999999999999999999999


Q ss_pred             eeccccccCCCCC------cccccccccCccccCccccCC-------CCCCCccchhhHHHHHHHHHhCCCCCCccccCc
Q 040392          316 DFSIAKLLTGEDQ------SMTQTQTLATIGYMAPEYGRE-------GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE  382 (470)
Q Consensus       316 Dfg~a~~~~~~~~------~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~  382 (470)
                      |||++..+.....      ........||+.|+|||++.+       ..++.++||||||+++|||++|+.||.......
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~  242 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP  242 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred             eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence            9999987643221      122234569999999999876       456788999999999999999987765432221


Q ss_pred             chhhHHhhhhcCCcccc-----cccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHhh
Q 040392          383 MTLKHWVNDWLPISTME-----VVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLR  457 (470)
Q Consensus       383 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~~  457 (470)
                      .....+..........+     ...................++.++.+++.+||+.||++|||+.|+++.|+++...+.+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~  322 (336)
T 3g2f_A          243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER  322 (336)
T ss_dssp             CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC
T ss_pred             HHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHh
Confidence            11111100000000000     0000000000011111233577899999999999999999999999999999887766


Q ss_pred             hccC
Q 040392          458 NVGD  461 (470)
Q Consensus       458 ~~~~  461 (470)
                      ..+.
T Consensus       323 ~~~~  326 (336)
T 3g2f_A          323 NKSV  326 (336)
T ss_dssp             ----
T ss_pred             cccC
Confidence            6543

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=5.8e-44  Score=349.43  Aligned_cols=250  Identities=24%  Similarity=0.303  Sum_probs=200.9

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCeee
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CGRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFKA  245 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~  245 (470)
                      ..++|++.+.||+|+||.||+|+.. +|+.||+|++...   .......+..|.++++.+ +||||+++++++.+.+..+
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            3578999999999999999999865 5899999999754   223455677899999988 6999999999999999999


Q ss_pred             EEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC
Q 040392          246 LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  325 (470)
                      +||||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       101 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence            9999999999999997654 5899999999999999999999   89999999999999999999999999999985432


Q ss_pred             CCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          326 EDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       326 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      .  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ..........            
T Consensus       177 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~~~~------------  241 (353)
T 3txo_A          177 N--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-LFEAILNDEV------------  241 (353)
T ss_dssp             -----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCC------------
T ss_pred             C--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCC------------
Confidence            1  223345679999999999988889999999999999999999999997643221 1111111000            


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCH------HHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINA------REIVAK  447 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~------~el~~~  447 (470)
                              ..+..++.++.+++.+||+.||++||++      .|+++|
T Consensus       242 --------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          242 --------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             --------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             --------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence                    0012235668899999999999999998      777764

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.4e-44  Score=343.24  Aligned_cols=262  Identities=23%  Similarity=0.414  Sum_probs=209.2

Q ss_pred             CCCCCCCeecccCceEEEEEEe-----CCCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccC--Cee
Q 040392          173 DGFSENNLIGRGGFGSVYKARL-----GDGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNE--EFK  244 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~  244 (470)
                      +.|++.+.||+|+||.||+|++     .+++.||+|++.... ......+.+|+++++.++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4588889999999999999983     368999999987543 33456788999999999999999999999776  668


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccC
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~  324 (470)
                      ++||||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  177 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence            9999999999999999777777999999999999999999999   9999999999999999999999999999998765


Q ss_pred             CCCCc-ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccC----------cchhhHHhhhhc
Q 040392          325 GEDQS-MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNG----------EMTLKHWVNDWL  393 (470)
Q Consensus       325 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~----------~~~~~~~~~~~~  393 (470)
                      ..... .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+......          ............
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (302)
T 4e5w_A          178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK  257 (302)
T ss_dssp             TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred             CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence            43322 2233456888899999998888999999999999999999999986542110          000011100000


Q ss_pred             CCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHH
Q 040392          394 PISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR  452 (470)
Q Consensus       394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~  452 (470)
                      ..               .....+..++.++.+++.+||+.||++|||+.|+++.|+++.
T Consensus       258 ~~---------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          258 EG---------------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             TT---------------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cc---------------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            00               001112345678999999999999999999999999999874

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.5e-43  Score=351.92  Aligned_cols=272  Identities=18%  Similarity=0.253  Sum_probs=207.2

Q ss_pred             hCCCCCCCeeccc--CceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeE
Q 040392          172 TDGFSENNLIGRG--GFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       172 ~~~~~~~~~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  246 (470)
                      .++|++.+.||+|  +||.||+|+.. +|+.||||++....  ....+.+.+|+++++.++||||+++++++.+....++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4679999999999  99999999865 69999999997553  3345677889999999999999999999999999999


Q ss_pred             EEecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC
Q 040392          247 VLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  325 (470)
                      ||||+++|+|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||.+.....
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            999999999999997652 56899999999999999999999   89999999999999999999999999999865432


Q ss_pred             CCC-----cccccccccCccccCccccCC--CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcc-
Q 040392          326 EDQ-----SMTQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIST-  397 (470)
Q Consensus       326 ~~~-----~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-  397 (470)
                      ...     ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||............+.. ..+... 
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~  259 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG-TVPCLLD  259 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC-CCCcccc
Confidence            211     112223478999999999987  57999999999999999999999999865433322111110 000000 


Q ss_pred             ----------------------cc---cccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          398 ----------------------ME---VVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       398 ----------------------~~---~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                                            ..   ...+............+..++.++.+|+.+||+.||++|||+.|+++|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                                  00   000000000001111234457789999999999999999999999976

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.9e-43  Score=337.68  Aligned_cols=255  Identities=27%  Similarity=0.391  Sum_probs=201.0

Q ss_pred             CCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCC
Q 040392          173 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP  252 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~  252 (470)
                      ++|++.+.||+|+||.||+|++. ++.||+|.+...  ...+.+.+|++++++++||||+++++++.+.  .++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTTT--TEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--cEEEEEcCC
Confidence            56888899999999999999884 789999998643  3456788999999999999999999998743  689999999


Q ss_pred             CCChHHhhhcCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC-eEEeeeccccccCCCCCc
Q 040392          253 HGSLEKYMYSSNY--ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV-AHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       253 ~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~-~kl~Dfg~a~~~~~~~~~  329 (470)
                      +|+|.+++.....  .+++..++.++.|+++||+|||+...++|+||||||+||+++.++. +||+|||++......   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            9999999976552  4788999999999999999999322289999999999999998886 799999999755321   


Q ss_pred             ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCch
Q 040392          330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE  409 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (470)
                        .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....................              
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------  223 (307)
T 2eva_A          160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP--------------  223 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC--------------
T ss_pred             --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC--------------
Confidence              2234589999999999999999999999999999999999999976433322111111110000              


Q ss_pred             hhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHH
Q 040392          410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL  455 (470)
Q Consensus       410 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~  455 (470)
                          .....++..+.+++.+||+.||++|||+.|+++.|+++...+
T Consensus       224 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  265 (307)
T 2eva_A          224 ----PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF  265 (307)
T ss_dssp             ----CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred             ----CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence                011234667899999999999999999999999999987544

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.9e-44  Score=348.37  Aligned_cols=253  Identities=23%  Similarity=0.374  Sum_probs=198.8

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCC--CcceeEEeeeccCCeeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRH--RNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~~~~~lv  247 (470)
                      .++|++.+.||+|+||.||+|...+++.||||++....  ....+.+.+|+++++.++|  +||+++++++......++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            45689999999999999999998889999999987542  3345678899999999986  9999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      ||+ .+++|.+++.... .+++..+..++.|++.||.|||   +.+|+||||||+|||++ ++.+||+|||++.......
T Consensus        88 ~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           88 MEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             ECC-CSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             EeC-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            994 5789999997654 6899999999999999999999   89999999999999997 6789999999998765443


Q ss_pred             CcccccccccCccccCccccCC-----------CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc
Q 040392          328 QSMTQTQTLATIGYMAPEYGRE-----------GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS  396 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~-----------~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  396 (470)
                      .........||+.|+|||++.+           ..++.++||||||+++|||++|+.||....+....+...........
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  241 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE  241 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC
Confidence            3333445679999999998854           67889999999999999999999999764332222221111111000


Q ss_pred             ccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          397 TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       397 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                                        .+...+.++.+++.+||+.||++|||+.|++++-
T Consensus       242 ------------------~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          242 ------------------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             ------------------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             ------------------CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence                              0112245688999999999999999999998763

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.6e-44  Score=341.64  Aligned_cols=253  Identities=23%  Similarity=0.360  Sum_probs=205.8

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCC-C-------cEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGD-G-------MEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEF  243 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  243 (470)
                      .++|.+.+.||+|+||.||+|.... +       ..||+|++........+.+.+|+++++.++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            4578889999999999999997542 3       5799999976666667788999999999999999999999999999


Q ss_pred             eeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC--------eEEe
Q 040392          244 KALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV--------AHLS  315 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~--------~kl~  315 (470)
                      .++||||+++|+|.+++......+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.        +||+
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeec
Confidence            99999999999999999877766999999999999999999999   999999999999999998887        9999


Q ss_pred             eeccccccCCCCCcccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcC
Q 040392          316 DFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLP  394 (470)
Q Consensus       316 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  394 (470)
                      |||++.....      .....+|+.|+|||.+.+ ..++.++||||||+++|||++|..|+........... .......
T Consensus       164 Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~-~~~~~~~  236 (289)
T 4fvq_A          164 DPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ-FYEDRHQ  236 (289)
T ss_dssp             CCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-HHHTTCC
T ss_pred             cCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH-HhhccCC
Confidence            9999875422      123457889999999887 6789999999999999999996555443222211111 1111000


Q ss_pred             CcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          395 ISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                        .                  +...+.++.+++.+||+.||++|||+.|++++|+++..+
T Consensus       237 --~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          237 --L------------------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             --C------------------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             --C------------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence              0                  011134478999999999999999999999999998754

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=8.2e-44  Score=358.30  Aligned_cols=254  Identities=20%  Similarity=0.290  Sum_probs=206.2

Q ss_pred             hhCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      ..++|++.+.||+|+||.||+|.. .+|+.||+|++....  ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            456799999999999999999975 468999999987543  23456688999999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC---CCCCeEEeeeccccccC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~a~~~~  324 (470)
                      |||+++|+|.+.+.... .+++..+..++.|++.||.|||   +.+|+||||||+||+++   .++.+||+|||++....
T Consensus        89 ~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           89 FDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             ECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            99999999999997654 5899999999999999999999   89999999999999998   56889999999998764


Q ss_pred             CCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccc
Q 040392          325 GEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN  404 (470)
Q Consensus       325 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (470)
                      ...  .......||+.|+|||++.+..++.++||||+||++|+|++|..||......+ .............     .  
T Consensus       165 ~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~~~~~-----~--  234 (444)
T 3soa_A          165 GEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR-LYQQIKAGAYDFP-----S--  234 (444)
T ss_dssp             TTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTCCCCC-----T--
T ss_pred             CCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHhCCCCCC-----c--
Confidence            322  22234679999999999999899999999999999999999999997633221 1111111110000     0  


Q ss_pred             ccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                               .....++.++.+++.+||+.||++|||+.|+++|
T Consensus       235 ---------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          235 ---------PEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             ---------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ---------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                     0012346678999999999999999999999885

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.2e-43  Score=337.89  Aligned_cols=250  Identities=25%  Similarity=0.331  Sum_probs=197.5

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccc--------------------------hhhhhHHHHHHHHh
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCG--------------------------RALKGFDVECEMMK  224 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~  224 (470)
                      .++|++.+.||+|+||.||+|+. .+++.||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            46899999999999999999976 4689999999865421                          12356889999999


Q ss_pred             cCCCCcceeEEeeecc--CCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCC
Q 040392          225 SIRHRNLIKVISTCSN--EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPS  302 (470)
Q Consensus       225 ~l~h~nIv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~  302 (470)
                      .++||||+++++++.+  ....++||||+++++|.+++..  ..+++..+..++.|++.||+|||   +.+|+||||||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~  166 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPS  166 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHH
Confidence            9999999999999876  5688999999999999887643  35899999999999999999999   899999999999


Q ss_pred             CeeeCCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCC---CCCccchhhHHHHHHHHHhCCCCCCccc
Q 040392          303 NVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGR---VSTNGDVYSFGIMLMETFTGKKPTNEIF  379 (470)
Q Consensus       303 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---~~~~~DvwslGv~l~el~tg~~p~~~~~  379 (470)
                      ||+++.++.+||+|||++.......  .......||+.|+|||.+.+..   ++.++||||||+++|||++|+.||....
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            9999999999999999998764322  2233457999999999987765   4788999999999999999999997532


Q ss_pred             cCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          380 NGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ..  .....+...   .. ..             .....++.++.+++.+||+.||++||++.|+++|
T Consensus       245 ~~--~~~~~~~~~---~~-~~-------------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          245 IM--CLHSKIKSQ---AL-EF-------------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             HH--HHHHHHHHC---CC-CC-------------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             HH--HHHHHHhcc---cC-CC-------------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            11  111111100   00 00             0012336678999999999999999999999865

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.6e-43  Score=333.38  Aligned_cols=254  Identities=23%  Similarity=0.330  Sum_probs=209.8

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      .++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            457889999999999999999865 68999999987543 3345678899999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      |+++++|.+++... ..+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||.+.........
T Consensus        86 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           86 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             ecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence            99999999999654 46899999999999999999999   899999999999999999999999999999865433322


Q ss_pred             ccccccccCccccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          330 MTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                      .......+++.|+|||.+.+..+ +.++||||||+++|||++|+.||............|.......             
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------  228 (276)
T 2yex_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL-------------  228 (276)
T ss_dssp             CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTS-------------
T ss_pred             hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccccc-------------
Confidence            23345678999999999987665 7789999999999999999999987554433333333211100             


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                           .....++..+.+++.+||+.||++|||+.|++++
T Consensus       229 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          229 -----NPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             -----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -----CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence                 0012346678899999999999999999999875

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.2e-43  Score=348.79  Aligned_cols=252  Identities=21%  Similarity=0.335  Sum_probs=206.1

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      .++|++.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|+++++.++||||+++++++.+....++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            567999999999999999999764 68999999997542  334567889999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC---CeEEeeeccccccCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM---VAHLSDFSIAKLLTG  325 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~---~~kl~Dfg~a~~~~~  325 (470)
                      ||+++|+|.+++.... .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++   .+||+|||++.....
T Consensus       108 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~  183 (362)
T 2bdw_A          108 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  183 (362)
T ss_dssp             CCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence            9999999999986544 6899999999999999999999   89999999999999998654   599999999987643


Q ss_pred             CCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          326 EDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       326 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      ..   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......  .+...+......    ..    
T Consensus       184 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~--~~~~~i~~~~~~----~~----  250 (362)
T 2bdw_A          184 SE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQIKAGAYD----YP----  250 (362)
T ss_dssp             CC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCCC----CC----
T ss_pred             Cc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhCCCC----CC----
Confidence            22   223467999999999999989999999999999999999999999763321  111111110000    00    


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                             ......++.++.+++.+||+.||++||++.|++++
T Consensus       251 -------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          251 -------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             -------TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             -------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                   00112346778999999999999999999999876

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=344.06  Aligned_cols=259  Identities=25%  Similarity=0.401  Sum_probs=204.1

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcE----EEEEEeecc-cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGME----VAVKVFNLQ-CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKA  245 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  245 (470)
                      .++|++.+.||+|+||.||+|.+. +++.    ||+|.+... .....+.+.+|+.+++.++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            467999999999999999999854 4544    577776433 3345677889999999999999999999998765 67


Q ss_pred             EEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC
Q 040392          246 LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  325 (470)
                      +|+||+++|+|.+++......+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++.....
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            899999999999999887778999999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCccccccccc
Q 040392          326 EDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN  404 (470)
Q Consensus       326 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (470)
                      ...........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+  +...+......         
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~~~~~~---------  238 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGERL---------  238 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTCCC---------
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCCCC---------
Confidence            444444445567889999999999999999999999999999999 999998643332  22221111100         


Q ss_pred             ccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                               ..+..++.++.+++.+||+.||++||++.|+++.|+++...
T Consensus       239 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          239 ---------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             ---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             ---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence                     01223466789999999999999999999999999998743

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-43  Score=334.09  Aligned_cols=263  Identities=23%  Similarity=0.391  Sum_probs=215.0

Q ss_pred             CCCCCCC-eecccCceEEEEEEeC---CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          173 DGFSENN-LIGRGGFGSVYKARLG---DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       173 ~~~~~~~-~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      ++|.+.+ .||+|+||.||+|.+.   ++..||+|++.... ....+.+.+|+++++.++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4566666 8999999999999753   57889999997643 34567788999999999999999999999 45568999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||+++++|.+++......+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++.......
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  164 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  164 (287)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence            9999999999999877777999999999999999999999   8999999999999999999999999999998764332


Q ss_pred             Cc-ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          328 QS-MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       328 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      .. .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+  ....+......          
T Consensus       165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~i~~~~~~----------  232 (287)
T 1u59_A          165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIEQGKRM----------  232 (287)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHHHHTTCCC----------
T ss_pred             ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHhcCCcC----------
Confidence            22 22233456889999999988889999999999999999998 999997643321  12221111000          


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHhhhc
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNV  459 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~~~~  459 (470)
                              ..+..++.++.+++.+||+.||++||++.|++++|+++..+.....
T Consensus       233 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~  278 (287)
T 1u59_A          233 --------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV  278 (287)
T ss_dssp             --------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred             --------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence                    0112446779999999999999999999999999999987766554

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-43  Score=338.96  Aligned_cols=246  Identities=26%  Similarity=0.317  Sum_probs=205.2

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++....   ....+.+.+|..+++.++||||+++++++.+....++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            367899999999999999999865 69999999997542   23455677899999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..... 
T Consensus        85 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-  159 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  159 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             EeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence            99999999999997654 6899999999999999999999   999999999999999999999999999999865321 


Q ss_pred             CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                          ....+||+.|+|||++.+..++.++|+||||+++|||++|+.||......+ ...........             
T Consensus       160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~-------------  221 (318)
T 1fot_A          160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-TYEKILNAELR-------------  221 (318)
T ss_dssp             ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHCCCC-------------
T ss_pred             ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCC-------------
Confidence                234579999999999999999999999999999999999999997632211 11111110000             


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCC-----CHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRI-----NAREIVAK  447 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~el~~~  447 (470)
                             .+..++.++.+++.+||..||++||     ++.|+++|
T Consensus       222 -------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          222 -------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             -------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence                   0122356789999999999999999     89998865

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=9.4e-44  Score=352.15  Aligned_cols=254  Identities=22%  Similarity=0.281  Sum_probs=202.7

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCeeeE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~l  246 (470)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+..|..++.++ +||||+++++++.+....++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            467999999999999999999865 57899999997542   33455678899999887 89999999999999999999


Q ss_pred             EEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCC
Q 040392          247 VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      ||||+++|+|..++...+ .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       131 V~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            999999999999997654 6899999999999999999999   999999999999999999999999999999853222


Q ss_pred             CCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcch---hhHHh-hhhcCCccccccc
Q 040392          327 DQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMT---LKHWV-NDWLPISTMEVVG  402 (470)
Q Consensus       327 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~---~~~~~-~~~~~~~~~~~~~  402 (470)
                        .......+||+.|+|||++.+..++.++|+|||||++|||++|+.||......+..   ...++ .......      
T Consensus       207 --~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~------  278 (396)
T 4dc2_A          207 --GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------  278 (396)
T ss_dssp             --TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC------
T ss_pred             --CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc------
Confidence              22334567999999999999999999999999999999999999999643221110   00110 0000000      


Q ss_pred             ccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCH------HHHHHH
Q 040392          403 ANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINA------REIVAK  447 (470)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~------~el~~~  447 (470)
                                ...+..++.++.+|+.+||+.||++||++      .|+++|
T Consensus       279 ----------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          279 ----------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             ----------CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             ----------cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence                      00122346678999999999999999996      566654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5.8e-43  Score=345.31  Aligned_cols=250  Identities=25%  Similarity=0.332  Sum_probs=203.6

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      .++|++.+.||+|+||.||+|... +++.||+|++....   ......+.+|+++++.++||||+++++++.+....++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            367899999999999999999765 58899999986542   23456778899999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||+++|+|.+++... ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++..+... 
T Consensus        94 ~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-  168 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-  168 (384)
T ss_dssp             ECCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred             EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence            9999999999999764 46899999999999999999999   999999999999999999999999999999876432 


Q ss_pred             CcccccccccCccccCccccCC---CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccc
Q 040392          328 QSMTQTQTLATIGYMAPEYGRE---GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN  404 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (470)
                        .......||+.|+|||++.+   ..++.++|||||||++|||++|+.||.......  ............        
T Consensus       169 --~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~~~~~~~~~~--------  236 (384)
T 4fr4_A          169 --TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--SKEIVHTFETTV--------  236 (384)
T ss_dssp             --CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--HHHHHHHHHHCC--------
T ss_pred             --CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHhhcc--------
Confidence              22345679999999999864   458999999999999999999999997533221  111111110000        


Q ss_pred             ccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCC-HHHHHH
Q 040392          405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRIN-AREIVA  446 (470)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-~~el~~  446 (470)
                              ...+..++.++.+++.+||+.||++||+ +.++++
T Consensus       237 --------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          237 --------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             --------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                    0011234677899999999999999998 666664

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.3e-42  Score=339.00  Aligned_cols=274  Identities=22%  Similarity=0.349  Sum_probs=214.7

Q ss_pred             HHHHHhhCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhc--CCCCcceeEEeeeccCC-
Q 040392          166 LELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKS--IRHRNLIKVISTCSNEE-  242 (470)
Q Consensus       166 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~~~~~~~~~~-  242 (470)
                      .......++|.+.+.||+|+||.||+|+. +|+.||||++...   ....+..|.+++..  ++||||+++++++.... 
T Consensus        35 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~  110 (342)
T 1b6c_B           35 LVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNG  110 (342)
T ss_dssp             HHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred             eecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence            33445567899999999999999999988 5899999998643   34556778888887  78999999999998765 


Q ss_pred             ---eeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeeecCCCCCCeeeCCCCCeEE
Q 040392          243 ---FKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY-----SAPIIHCDLKPSNVLLDDNMVAHL  314 (470)
Q Consensus       243 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~-----~~~i~H~dlkp~Nill~~~~~~kl  314 (470)
                         ..++||||+++|+|.+++...  .+++..++.++.|++.||.|||...     +.+|+||||||+||+++.++.+||
T Consensus       111 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL  188 (342)
T 1b6c_B          111 TWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  188 (342)
T ss_dssp             SCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEE
T ss_pred             ccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEE
Confidence               789999999999999999764  4899999999999999999999321     468999999999999999999999


Q ss_pred             eeeccccccCCCCCcc--cccccccCccccCccccCCC------CCCCccchhhHHHHHHHHHhC----------CCCCC
Q 040392          315 SDFSIAKLLTGEDQSM--TQTQTLATIGYMAPEYGREG------RVSTNGDVYSFGIMLMETFTG----------KKPTN  376 (470)
Q Consensus       315 ~Dfg~a~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~------~~~~~~DvwslGv~l~el~tg----------~~p~~  376 (470)
                      +|||++..........  ......+|+.|+|||++.+.      .++.++||||||+++|||++|          ..||.
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~  268 (342)
T 1b6c_B          189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  268 (342)
T ss_dssp             CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence            9999998765433221  22345799999999998765      234789999999999999999          77887


Q ss_pred             ccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          377 EIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                      ...........+.............         ........++..+.+++.+||+.||++|||+.|++++|+++..+
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          269 DLVPSDPSVEEMRKVVCEQKLRPNI---------PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCC---------CGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ccCcCcccHHHHHHHHHHHHhCCCC---------cccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence            6544433333333322211111000         00112234577899999999999999999999999999999754

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4e-43  Score=339.17  Aligned_cols=269  Identities=25%  Similarity=0.326  Sum_probs=192.5

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      .++|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+++++.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            468999999999999999999764 68999999997543 2334667889999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccC
Q 040392          250 YMPHGSLEKYMYSSN-----YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~  324 (470)
                      |++ |+|.+++....     ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 59999886532     35889999999999999999999   8999999999999999999999999999998764


Q ss_pred             CCCCcccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhc-C-Cccc---
Q 040392          325 GEDQSMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWL-P-ISTM---  398 (470)
Q Consensus       325 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~-~~~~---  398 (470)
                      ...  .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+ .+........ + ....   
T Consensus       160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCTTTCGGG
T ss_pred             CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhHhhhh
Confidence            221  122345689999999998764 68999999999999999999999997643321 1111111100 0 0000   


Q ss_pred             ---ccccccccC--c----hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          399 ---EVVGANLLS--Q----EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       399 ---~~~~~~~~~--~----~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                         ....+....  .    .......+..++.++.+++.+||+.||++|||+.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence               000000000  0    000111122456789999999999999999999999875

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4.9e-44  Score=346.17  Aligned_cols=265  Identities=22%  Similarity=0.386  Sum_probs=215.1

Q ss_pred             HHHHHhhCCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeee
Q 040392          166 LELCRATDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTC  238 (470)
Q Consensus       166 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~  238 (470)
                      .+.....++|++.+.||+|+||.||+|.+.      +++.||+|.+.... ......+.+|+++++.++||||+++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            344455678999999999999999999754      37889999987543 23455688999999999999999999999


Q ss_pred             ccCCeeeEEEecCCCCChHHhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC
Q 040392          239 SNEEFKALVLEYMPHGSLEKYMYSSN---------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN  309 (470)
Q Consensus       239 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~  309 (470)
                      .+....++||||+++|+|.+++....         ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.+
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED  174 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTT
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCC
Confidence            99999999999999999999997532         35689999999999999999999   8999999999999999999


Q ss_pred             CCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHH
Q 040392          310 MVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHW  388 (470)
Q Consensus       310 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~  388 (470)
                      +.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+  ....
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~  252 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--VLRF  252 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--HHHH
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH--HHHH
Confidence            9999999999986643333333344567889999999988889999999999999999999 899987643221  1111


Q ss_pred             hhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          389 VNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       389 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                      +..   ....               ..+..++..+.+++.+||+.||++|||+.|++++|+++..
T Consensus       253 ~~~---~~~~---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          253 VME---GGLL---------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHT---TCCC---------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHc---CCcC---------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            110   0000               0112346778999999999999999999999999988754

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=4.2e-44  Score=347.58  Aligned_cols=275  Identities=24%  Similarity=0.338  Sum_probs=214.0

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-----CCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeec--cCCee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-----GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS--NEEFK  244 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~--~~~~~  244 (470)
                      .++|++.+.||+|+||.||+|++     .+++.||||++........+.+.+|+++++.++||||+++++++.  +....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            35788999999999999999984     368899999998766666777899999999999999999999875  45678


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccC
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~  324 (470)
                      ++||||+++++|.+++......+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            8999999999999999876667999999999999999999999   8999999999999999999999999999998764


Q ss_pred             CCCCc-ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcC-Cccccccc
Q 040392          325 GEDQS-MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLP-ISTMEVVG  402 (470)
Q Consensus       325 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  402 (470)
                      ..... .......+|..|+|||.+.+..++.++||||||+++|+|++|+.||............+...... ....+...
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE  258 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred             cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence            33222 22334568888999999988889999999999999999999999987532211000000000000 00000000


Q ss_pred             ccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHH
Q 040392          403 ANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL  455 (470)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~  455 (470)
                      ..      .....+..++.++.+++.+||+.||++|||+.|++++|+++....
T Consensus       259 ~~------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          259 EG------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             TT------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             cc------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            00      001112345778999999999999999999999999999986543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=335.33  Aligned_cols=250  Identities=23%  Similarity=0.384  Sum_probs=187.0

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      .++|++.+.||+|+||.||+|+. .+|+.||+|++....   ....+.+.+|+++++.++||||+++++++.+....++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            46799999999999999999986 579999999996542   22346788899999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||+++++|.+++......+++..+..++.|+++||.|||   +.+++|+||||+||+++.++.+||+|||++.......
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            9999999999999877677999999999999999999999   8999999999999999999999999999998664222


Q ss_pred             CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                        .......+|+.|+|||.+.+..++.++||||||+++|||++|+.||......+. ...    ...        ...  
T Consensus       167 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~----~~~--------~~~--  229 (278)
T 3cok_A          167 --EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-LNK----VVL--------ADY--  229 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------CCS--------SCC--
T ss_pred             --CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-HHH----Hhh--------ccc--
Confidence              122335689999999999988899999999999999999999999976432211 000    000        000  


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                            ..+..++.++.+++.+||+.||++|||+.|++++
T Consensus       230 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          230 ------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             ------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ------CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence                  0112346678999999999999999999999875

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=344.51  Aligned_cols=273  Identities=26%  Similarity=0.425  Sum_probs=215.7

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-----CCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCC--ee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-----GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEE--FK  244 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--~~  244 (470)
                      .++|++.+.||+|+||.||+|++     .+++.||+|++........+.+.+|+++++.++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            35688899999999999999984     368999999998766666778999999999999999999999986543  77


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccC
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~  324 (470)
                      ++||||+++++|.+++......+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++....
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            8999999999999999887777999999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCCc-ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCC-----ccc
Q 040392          325 GEDQS-MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPI-----STM  398 (470)
Q Consensus       325 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-----~~~  398 (470)
                      ..... .......++..|+|||.+.+..++.++||||||+++|||++|..||......   ...........     ...
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH---HHHHHCTTCCTHHHHHHHH
T ss_pred             ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH---HHHhhccccchhhhHHHHH
Confidence            43221 1123345777899999998888999999999999999999999987642110   00000000000     000


Q ss_pred             ccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHh
Q 040392          399 EVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL  456 (470)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~  456 (470)
                      +.+...      .....+..++.++.+++.+||+.||++|||+.|+++.|+++.+++.
T Consensus       274 ~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~  325 (326)
T 2w1i_A          274 ELLKNN------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA  325 (326)
T ss_dssp             HHHHTT------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHhhcC------CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            000000      0011123457789999999999999999999999999999988764

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.8e-43  Score=340.91  Aligned_cols=262  Identities=25%  Similarity=0.430  Sum_probs=200.8

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC----CCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCC--
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEE--  242 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--  242 (470)
                      ..++|.+.+.||+|+||.||+|+..    ++..||+|++...  .....+.+.+|+++++.++||||+++++++.+..  
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            4567888899999999999999753    3458999998654  2344567889999999999999999999987654  


Q ss_pred             ---eeeEEEecCCCCChHHhhhc-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEE
Q 040392          243 ---FKALVLEYMPHGSLEKYMYS-----SNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHL  314 (470)
Q Consensus       243 ---~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl  314 (470)
                         ..++||||+++|+|.+++..     ....+++..++.++.|+++||.|||   +.+|+||||||+||+++.++.+||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEE
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEE
Confidence               35899999999999999843     2356899999999999999999999   999999999999999999999999


Q ss_pred             eeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhc
Q 040392          315 SDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWL  393 (470)
Q Consensus       315 ~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~  393 (470)
                      +|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||......+  ....+....
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~~~  266 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE--MYDYLLHGH  266 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHHHHTTC
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH--HHHHHHcCC
Confidence            99999987654433333344567889999999999899999999999999999999 888987643322  111111100


Q ss_pred             CCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHH
Q 040392          394 PISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL  455 (470)
Q Consensus       394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~  455 (470)
                      ..                  ..+..++.++.+++.+||..||++||++.+++++|+++..++
T Consensus       267 ~~------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          267 RL------------------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             CC------------------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CC------------------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            00                  011234677999999999999999999999999999998654

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=6.9e-44  Score=364.77  Aligned_cols=256  Identities=26%  Similarity=0.427  Sum_probs=213.3

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCC-CcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      .++|.+.+.||+|+||.||+|.+.. +..||||.+.... ...+.+.+|++++++++||||+++++++......++||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            4568888999999999999998764 8899999997543 3456789999999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          251 MPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       251 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      +++|+|.+++.... ..+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++...... .
T Consensus       298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~  373 (495)
T 1opk_A          298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-Y  373 (495)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-E
T ss_pred             cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-e
Confidence            99999999997643 56899999999999999999999   8999999999999999999999999999998764322 2


Q ss_pred             ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |..||......+  ....+.....              
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~--------------  437 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLEKDYR--------------  437 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHHHHTTCC--------------
T ss_pred             eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC--------------
Confidence            22233456789999999988889999999999999999999 999987643321  1121111110              


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR  452 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~  452 (470)
                          ...+..++.++.+|+.+||+.||++|||+.++++.|+++.
T Consensus       438 ----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          438 ----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence                1112345778999999999999999999999999999874

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.4e-43  Score=336.50  Aligned_cols=262  Identities=26%  Similarity=0.434  Sum_probs=207.2

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCC----CcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeee-ccCCeee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGD----GMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTC-SNEEFKA  245 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~-~~~~~~~  245 (470)
                      ..+|++.+.||+|+||.||+|+..+    +..+|+|.+.... ....+.+.+|+.++++++||||+++++++ ......+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            4568888999999999999998543    2358999986533 34556788999999999999999999985 4556789


Q ss_pred             EEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC
Q 040392          246 LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  325 (470)
                      +||||+++|+|.+++......+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.....
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            999999999999999877777899999999999999999999   89999999999999999999999999999986643


Q ss_pred             CCC--cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCccccccc
Q 040392          326 EDQ--SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVG  402 (470)
Q Consensus       326 ~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (470)
                      ...  ........+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+  ...........       
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~-------  251 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLLQGRRL-------  251 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--HHHHHHTTCCC-------
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--HHHHHhcCCCC-------
Confidence            221  122334567889999999988899999999999999999999 555555432221  11111110000       


Q ss_pred             ccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHh
Q 040392          403 ANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL  456 (470)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~  456 (470)
                                 ..+..++..+.+++.+||+.||++|||+.|+++.|+++...+.
T Consensus       252 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          252 -----------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             -----------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence                       0112346678999999999999999999999999999976543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1e-43  Score=343.53  Aligned_cols=273  Identities=23%  Similarity=0.382  Sum_probs=212.0

Q ss_pred             CCCCCeecccCceEEEEEEeC-----CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeecc--CCeeeE
Q 040392          175 FSENNLIGRGGFGSVYKARLG-----DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSN--EEFKAL  246 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~~l  246 (470)
                      |++.+.||+|+||.||++.+.     +++.||||++.... ......+.+|+++++.++||||+++++++.+  ....++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            388899999999999988642     68899999997553 3446678899999999999999999999976  467899


Q ss_pred             EEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCC
Q 040392          247 VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      ||||+++|+|.+++....  +++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus       113 v~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             EECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             EEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            999999999999997654  899999999999999999999   899999999999999999999999999999877543


Q ss_pred             CCc-ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcC-Cccccccccc
Q 040392          327 DQS-MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLP-ISTMEVVGAN  404 (470)
Q Consensus       327 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  404 (470)
                      ... .......+|..|+|||.+.+..++.++||||||+++|||++|+.||............+...... ....+.....
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG  267 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred             ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence            222 22334567888999999998889999999999999999999999987532211100000000000 0000000000


Q ss_pred             ccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHhhh
Q 040392          405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRN  458 (470)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~~~  458 (470)
                            .....+..++.++.+++.+||+.||++|||+.|+++.|+++.+++...
T Consensus       268 ------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~  315 (318)
T 3lxp_A          268 ------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ  315 (318)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred             ------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence                  001112345778999999999999999999999999999998877643

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=349.96  Aligned_cols=247  Identities=22%  Similarity=0.331  Sum_probs=200.4

Q ss_pred             CCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCCCCh
Q 040392          178 NNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL  256 (470)
Q Consensus       178 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L  256 (470)
                      .+.||+|+||.||+|.. .+|+.||+|++........+.+.+|+++++.++||||+++++++.+.+..++||||+++|+|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            56799999999999976 46899999999876555667889999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee--CCCCCeEEeeeccccccCCCCCcccccc
Q 040392          257 EKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL--DDNMVAHLSDFSIAKLLTGEDQSMTQTQ  334 (470)
Q Consensus       257 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  334 (470)
                      .+++......+++..+..++.|++.||+|||   +.+|+||||||+|||+  +.++.+||+|||++..+....   ....
T Consensus       174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~~~  247 (373)
T 2x4f_A          174 FDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKV  247 (373)
T ss_dssp             HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BCCC
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---cccc
Confidence            9999777667899999999999999999999   8999999999999999  677899999999998764332   2233


Q ss_pred             cccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhH
Q 040392          335 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFV  414 (470)
Q Consensus       335 ~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  414 (470)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+...........                ..
T Consensus       248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~~~----------------~~  310 (373)
T 2x4f_A          248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE-TLNNILACRWDLE----------------DE  310 (373)
T ss_dssp             CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCCCSC----------------SG
T ss_pred             ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCCCC----------------hh
Confidence            569999999999998899999999999999999999999997643221 1122111110000                00


Q ss_pred             hhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          415 AKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       415 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ....++.++.+|+.+||+.||++||++.|++++
T Consensus       311 ~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          311 EFQDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            112346778999999999999999999999984

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.2e-43  Score=350.40  Aligned_cols=251  Identities=23%  Similarity=0.377  Sum_probs=198.8

Q ss_pred             CCCCCCCeecccCceEEEEEEeCCCcEEEEEEeeccc--chhhhhHHHHHHHHhcCC--CCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIR--HRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ++|++.+.||+|+||.||+|...+++.||||++....  ....+.+.+|+++++.++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            4599999999999999999998889999999987542  345577889999999997  599999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      | +.+++|.+++.... .+++..+..++.||+.||.|||   +.+|+||||||+|||++ ++.+||+|||+++.+.....
T Consensus       136 E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             E-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred             e-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence            9 56789999997655 6889999999999999999999   99999999999999995 58999999999987654333


Q ss_pred             cccccccccCccccCccccCC-----------CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcc
Q 040392          329 SMTQTQTLATIGYMAPEYGRE-----------GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIST  397 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~-----------~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  397 (470)
                      ........||+.|+|||++.+           ..++.++|||||||++|||++|+.||....+....+...+....... 
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~-  288 (390)
T 2zmd_A          210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE-  288 (390)
T ss_dssp             ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC-
T ss_pred             cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC-
Confidence            333445679999999998864           36889999999999999999999999764332111111111110000 


Q ss_pred             cccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          398 MEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                                       .+...+.++.+++.+||+.||++||++.|++++
T Consensus       289 -----------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          289 -----------------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             -----------------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -----------------CCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence                             011124568899999999999999999999876

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.3e-43  Score=333.76  Aligned_cols=259  Identities=24%  Similarity=0.402  Sum_probs=208.4

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCC----CcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGD----GMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  246 (470)
                      .++|.+.+.||+|+||.||+|.+.+    +..||+|.+.... ....+.+.+|+++++.++||||+++++++.+. ..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence            4678899999999999999997532    3469999987552 34567788999999999999999999998754 4589


Q ss_pred             EEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCC
Q 040392          247 VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      ||||+++++|.+++......+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus        90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  166 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE  166 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred             EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence            99999999999999877777999999999999999999999   999999999999999999999999999999866432


Q ss_pred             CCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          327 DQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       327 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      . ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+  ....+......          
T Consensus       167 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~~~~~~~~~----------  233 (281)
T 3cc6_A          167 D-YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIGVLEKGDRL----------  233 (281)
T ss_dssp             -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHHHHHHTCCC----------
T ss_pred             c-ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHHHHhcCCCC----------
Confidence            2 122234457889999999988889999999999999999998 999997543322  11111111000          


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL  455 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~  455 (470)
                              ..+..++..+.+++.+||+.||++||++.|++++|+++....
T Consensus       234 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  275 (281)
T 3cc6_A          234 --------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME  275 (281)
T ss_dssp             --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             --------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence                    011234667899999999999999999999999999987543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-44  Score=351.81  Aligned_cols=261  Identities=26%  Similarity=0.438  Sum_probs=200.5

Q ss_pred             CCCCCCeecccCceEEEEEEeC--CC--cEEEEEEeecc-cchhhhhHHHHHHHHhcCCCCcceeEEeeec-cCCeeeEE
Q 040392          174 GFSENNLIGRGGFGSVYKARLG--DG--MEVAVKVFNLQ-CGRALKGFDVECEMMKSIRHRNLIKVISTCS-NEEFKALV  247 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~--~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~-~~~~~~lv  247 (470)
                      .|.+.+.||+|+||.||+|++.  ++  ..||+|.+... .....+.+.+|+.++++++||||+++++++. ..+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            3566789999999999999753  22  46899998643 3345677889999999999999999999865 45678899


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||+++|+|.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            9999999999999877777899999999999999999999   8999999999999999999999999999998664322


Q ss_pred             Cc--ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCccccccccc
Q 040392          328 QS--MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN  404 (470)
Q Consensus       328 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (470)
                      ..  .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+.  ...+.....          
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~--~~~~~~~~~----------  314 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLLQGRR----------  314 (373)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH--HHHHHTTCC----------
T ss_pred             cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH--HHHHHcCCC----------
Confidence            21  12234457889999999998899999999999999999999 6777765433221  111111100          


Q ss_pred             ccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHhh
Q 040392          405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLR  457 (470)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~~  457 (470)
                              ...+..++..+.+++.+||+.||++||++.|+++.|+++..++..
T Consensus       315 --------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~  359 (373)
T 3c1x_A          315 --------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  359 (373)
T ss_dssp             --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             --------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence                    011234567799999999999999999999999999999866543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.8e-43  Score=343.70  Aligned_cols=252  Identities=22%  Similarity=0.304  Sum_probs=192.0

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++....  ..+.+.+|++++++++||||+++++++......++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            3567999999999999999999875 58899999987543  34567789999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCCeEEeeeccccccCCC
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~a~~~~~~  326 (470)
                      |+++|+|.+++.... .+++..+..++.|++.||.|||   +.+|+||||||+||+++.   ++.+||+|||++......
T Consensus       129 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          129 LVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             CCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             eCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            999999999996544 5899999999999999999999   899999999999999975   889999999999865322


Q ss_pred             CCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccccc
Q 040392          327 DQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL  406 (470)
Q Consensus       327 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (470)
                         .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.............     ..    
T Consensus       205 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~-----~~----  272 (349)
T 2w4o_A          205 ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYF-----IS----  272 (349)
T ss_dssp             -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCC-----CT----
T ss_pred             ---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCcc-----CC----
Confidence               122345689999999999998999999999999999999999999976433222222211111000     00    


Q ss_pred             CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       407 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                             .....++.++.+++.+||+.||++|||+.|++++
T Consensus       273 -------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          273 -------PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             -------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -------chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                   0012346678999999999999999999999875

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.7e-43  Score=343.58  Aligned_cols=251  Identities=23%  Similarity=0.353  Sum_probs=198.0

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCC-------
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEE-------  242 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-------  242 (470)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            457889999999999999999875 79999999997543 335577889999999999999999999875432       


Q ss_pred             --------------------------------------------------eeeEEEecCCCCChHHhhhcCC--CCCCHH
Q 040392          243 --------------------------------------------------FKALVLEYMPHGSLEKYMYSSN--YILDIF  270 (470)
Q Consensus       243 --------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~--~~~~~~  270 (470)
                                                                        ..++||||+++|+|.+++....  ...++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              3789999999999999997654  345666


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc----------ccccccccCcc
Q 040392          271 QRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS----------MTQTQTLATIG  340 (470)
Q Consensus       271 ~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~~~t~~  340 (470)
                      .++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            78999999999999999   899999999999999999999999999999876543211          12234579999


Q ss_pred             ccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhH
Q 040392          341 YMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCV  420 (470)
Q Consensus       341 y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  420 (470)
                      |+|||.+.+..++.++||||||+++|||++|..|+....       ..........         .      .......+
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-------~~~~~~~~~~---------~------~~~~~~~~  299 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-------RIITDVRNLK---------F------PLLFTQKY  299 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-------HHHHHHHTTC---------C------CHHHHHHC
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-------HHHHHhhccC---------C------CcccccCC
Confidence            999999999999999999999999999999877643210       0000000000         0      01112335


Q ss_pred             HHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          421 SCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       421 ~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      .++.+++.+||+.||++|||+.|++++
T Consensus       300 ~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          300 PQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             hhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence            567899999999999999999999875

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=6.3e-44  Score=355.25  Aligned_cols=258  Identities=23%  Similarity=0.279  Sum_probs=208.4

Q ss_pred             HHHHhhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCC
Q 040392          167 ELCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEE  242 (470)
Q Consensus       167 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  242 (470)
                      ++....++|++.+.||+|+||.||+|+.. +++.||+|++...   .......+.+|+.+++.++||||+++++++.+..
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~  142 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  142 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            34445678999999999999999999865 5889999998653   1233456888999999999999999999999999


Q ss_pred             eeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccc
Q 040392          243 FKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL  322 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~  322 (470)
                      ..++||||+++|+|.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~  217 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  217 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence            999999999999999999764  4889999999999999999999   89999999999999999999999999999987


Q ss_pred             cCCCCCcccccccccCccccCccccCCCC----CCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccc
Q 040392          323 LTGEDQSMTQTQTLATIGYMAPEYGREGR----VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTM  398 (470)
Q Consensus       323 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  398 (470)
                      ..... .......+||+.|+|||++.+..    ++.++|||||||++|||++|+.||......+ ............   
T Consensus       218 ~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~~~~---  292 (410)
T 3v8s_A          218 MNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKIMNHKNSL---  292 (410)
T ss_dssp             CCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTHHHHC---
T ss_pred             eccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh-HHHHHHhccccc---
Confidence            64322 22233567999999999987655    7899999999999999999999997532211 111111100000   


Q ss_pred             ccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccC--CCCHHHHHHH
Q 040392          399 EVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQ--RINAREIVAK  447 (470)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~el~~~  447 (470)
                                   ..+....++.++.+|+.+||+.+|.+  ||++.||++|
T Consensus       293 -------------~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          293 -------------TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             -------------CCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             -------------cCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence                         00011134677899999999999998  9999999986

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.2e-43  Score=344.94  Aligned_cols=253  Identities=23%  Similarity=0.268  Sum_probs=196.1

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|+.+++.++||||+++++++......++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            568999999999999999999865 78999999997543 2345678899999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC--eEEeeeccccccCCCCC
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV--AHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~a~~~~~~~~  328 (470)
                      +++|+|.+++...+ .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.  +||+|||+++....   
T Consensus        98 ~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~---  170 (361)
T 3uc3_A           98 ASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---  170 (361)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc---
Confidence            99999999996544 5899999999999999999999   999999999999999987765  99999999874322   


Q ss_pred             cccccccccCccccCccccCCCCCCCc-cchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTN-GDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                      ........||+.|+|||++.+..++.+ +||||||+++|+|++|+.||........ ..............         
T Consensus       171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~~~~~~~~~~---------  240 (361)
T 3uc3_A          171 HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQRILSVKYS---------  240 (361)
T ss_dssp             ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHHHHHHTTCCC---------
T ss_pred             cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHHHHHhcCCCC---------
Confidence            122234579999999999988777655 8999999999999999999986543322 22222211111100         


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                           ......++.++.+|+.+||+.||++|||+.|+++|
T Consensus       241 -----~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          241 -----IPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             -----CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             -----CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence                 00011235678899999999999999999999987

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.8e-43  Score=334.73  Aligned_cols=261  Identities=24%  Similarity=0.397  Sum_probs=208.6

Q ss_pred             CCCCCCeecccCceEEEEEEeC-C---CcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCee-eEE
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-D---GMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFK-ALV  247 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~-~lv  247 (470)
                      .|...+.||+|+||.||+|.+. +   +..||+|.+.... ....+.+.+|+++++.++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            4556689999999999999743 2   2379999986543 34557788999999999999999999999766554 899


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||+.+|+|.+++......+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.......
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            9999999999999887777899999999999999999999   8999999999999999999999999999998654322


Q ss_pred             C--cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          328 Q--SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       328 ~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      .  ........+++.|+|||.+.+..++.++||||||+++|+|++|..|+....+.. .....+......          
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~----------  247 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF-DLTHFLAQGRRL----------  247 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG-GHHHHHHTTCCC----------
T ss_pred             ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH-HHHHHhhcCCCC----------
Confidence            1  122234567889999999999999999999999999999999666654322221 222222111110          


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHh
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL  456 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~  456 (470)
                              ..+..++..+.+++.+||+.||.+|||+.|+++.|+++..++.
T Consensus       248 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          248 --------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             --------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence                    0112346678999999999999999999999999999987654

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=6.4e-44  Score=361.19  Aligned_cols=258  Identities=27%  Similarity=0.448  Sum_probs=207.1

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      ..++|++.+.||+|+||.||+|.+.++..||||++.... ...+.+.+|++++++++||||+++++++.+ +..++||||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            356788889999999999999999888899999997543 234678899999999999999999999876 667899999


Q ss_pred             CCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          251 MPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       251 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      +++|+|.+++.... ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++...... .
T Consensus       260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~  335 (452)
T 1fmk_A          260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y  335 (452)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-e
Confidence            99999999997532 45899999999999999999999   8999999999999999999999999999998764322 1


Q ss_pred             ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+  ....+....               
T Consensus       336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~~---------------  398 (452)
T 1fmk_A          336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGY---------------  398 (452)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTC---------------
T ss_pred             ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCC---------------
Confidence            22233456789999999988899999999999999999999 999997643321  111111100               


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                         +...+..++..+.+++.+||+.||++|||+.++++.|+++..+
T Consensus       399 ---~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          399 ---RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             ---CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence               0111234577899999999999999999999999999988643

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.2e-43  Score=339.74  Aligned_cols=261  Identities=22%  Similarity=0.290  Sum_probs=208.3

Q ss_pred             hhCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeec----cCCeee
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS----NEEFKA  245 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~----~~~~~~  245 (470)
                      ..++|++.+.||+|+||.||+|+. .+++.||+|++........+.+.+|+++++.++||||+++++++.    .....+
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            346799999999999999999986 579999999987666666778899999999999999999999986    345778


Q ss_pred             EEEecCCCCChHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccc
Q 040392          246 LVLEYMPHGSLEKYMYS---SNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL  322 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~  322 (470)
                      +||||+++|+|.+++..   ....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++..
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            99999999999999876   3467899999999999999999999   89999999999999999999999999999875


Q ss_pred             cCCCCCc-------ccccccccCccccCccccCCCC---CCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhh
Q 040392          323 LTGEDQS-------MTQTQTLATIGYMAPEYGREGR---VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDW  392 (470)
Q Consensus       323 ~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~---~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  392 (470)
                      .......       .......||+.|+|||.+.+..   ++.++||||||+++|||++|+.||.................
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  263 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ  263 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc
Confidence            4321111       0112345799999999987654   68999999999999999999999975332222222111110


Q ss_pred             cCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHH
Q 040392          393 LPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR  452 (470)
Q Consensus       393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~  452 (470)
                      ..                  ......++.++.+++.+||+.||.+||++.|++++|+++.
T Consensus       264 ~~------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          264 LS------------------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             --------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             CC------------------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence            00                  0011234667899999999999999999999999999886

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=9.2e-44  Score=346.76  Aligned_cols=250  Identities=25%  Similarity=0.333  Sum_probs=204.2

Q ss_pred             HhhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCee
Q 040392          170 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFK  244 (470)
Q Consensus       170 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~  244 (470)
                      ...++|.+.+.||+|+||.||+|+.+ +|+.||+|+++...   ......+..|..++..+ +||||+++++++.+.+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            34678999999999999999999865 68999999997542   23445677899999876 899999999999999999


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccC
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~  324 (470)
                      ++||||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        94 ~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            99999999999999997644 5899999999999999999999   8999999999999999999999999999998543


Q ss_pred             CCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccc
Q 040392          325 GEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN  404 (470)
Q Consensus       325 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (470)
                      ...  ......+||+.|+|||++.+..++.++|+|||||++|||++|+.||......+  +...+....+          
T Consensus       170 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~i~~~~~----------  235 (345)
T 1xjd_A          170 LGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LFHSIRMDNP----------  235 (345)
T ss_dssp             CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCC----------
T ss_pred             cCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHhCCC----------
Confidence            221  22345679999999999999999999999999999999999999997633211  1111111000          


Q ss_pred             ccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHH-HHHH
Q 040392          405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAR-EIVA  446 (470)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-el~~  446 (470)
                               ..+..++.++.+++.+||..||++||++. |+++
T Consensus       236 ---------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          236 ---------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             ---------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ---------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence                     00122366789999999999999999997 6654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.4e-43  Score=342.12  Aligned_cols=249  Identities=23%  Similarity=0.320  Sum_probs=196.1

Q ss_pred             hCCCCCCCeecccCceEEEEEEe----CCCcEEEEEEeeccc----chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL----GDGMEVAVKVFNLQC----GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEF  243 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~  243 (470)
                      .++|++.+.||+|+||.||+|+.    .+|+.||+|++....    ......+..|+++++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46799999999999999999986    478999999987542    2344567789999999999999999999999999


Q ss_pred             eeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecccccc
Q 040392          244 KALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  323 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~  323 (470)
                      .++||||+++|+|.+++.... .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             EEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            999999999999999997654 5889999999999999999999   899999999999999999999999999998754


Q ss_pred             CCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccc
Q 040392          324 TGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA  403 (470)
Q Consensus       324 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (470)
                      ....  .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ..........          
T Consensus       172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~----------  238 (327)
T 3a62_A          172 IHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK-TIDKILKCKL----------  238 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTCC----------
T ss_pred             ccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCC----------
Confidence            3221  12234578999999999999899999999999999999999999997643221 1111111000          


Q ss_pred             cccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCC-----CHHHHHHH
Q 040392          404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRI-----NAREIVAK  447 (470)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~el~~~  447 (470)
                                ..+..++.++.+++.+||..||++||     ++.|+++|
T Consensus       239 ----------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          239 ----------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             ----------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             ----------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence                      00123366789999999999999999     78888775

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.2e-43  Score=336.45  Aligned_cols=258  Identities=25%  Similarity=0.429  Sum_probs=211.2

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      .++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+++++.++||||+++++++.. +..++||||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~   89 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence            46788899999999999999998888899999987543 345678899999999999999999999874 4578999999


Q ss_pred             CCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          252 PHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       252 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      ++++|.+++.... ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++....... ..
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  165 (279)
T 1qpc_A           90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YT  165 (279)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EE
T ss_pred             CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-cc
Confidence            9999999996543 25899999999999999999999   9999999999999999999999999999998764322 12


Q ss_pred             cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCch
Q 040392          331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE  409 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (470)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+  ....+.....               
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~~~~---------------  228 (279)
T 1qpc_A          166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQNLERGYR---------------  228 (279)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTCC---------------
T ss_pred             cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH--HHHHHhcccC---------------
Confidence            2233456788999999988889999999999999999999 999987643221  1111111000               


Q ss_pred             hhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHH
Q 040392          410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL  455 (470)
Q Consensus       410 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~  455 (470)
                         ...+..++.++.+++.+||+.||++|||+.++++.|+++..+.
T Consensus       229 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          229 ---MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ---CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence               0011234677899999999999999999999999999987654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.5e-43  Score=344.68  Aligned_cols=246  Identities=20%  Similarity=0.246  Sum_probs=205.8

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++....   ....+.+.+|+++++.++||||+++++++.+....++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            357899999999999999999865 68999999987542   23456678899999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..... 
T Consensus       120 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-  194 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             EECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence            99999999999997654 5899999999999999999999   999999999999999999999999999999876432 


Q ss_pred             CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                          ....+||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ..........              
T Consensus       195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~i~~~~~--------------  255 (350)
T 1rdq_E          195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-IYEKIVSGKV--------------  255 (350)
T ss_dssp             ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCC--------------
T ss_pred             ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH-HHHHHHcCCC--------------
Confidence                234579999999999999999999999999999999999999997632211 1111111100              


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCC-----HHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRIN-----AREIVAK  447 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~el~~~  447 (470)
                            ..+..++.++.+++.+||+.||++||+     +.|+++|
T Consensus       256 ------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          256 ------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             ------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence                  011234667899999999999999998     8888775

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-43  Score=342.60  Aligned_cols=259  Identities=27%  Similarity=0.479  Sum_probs=205.2

Q ss_pred             CCCCCCCeecccCceEEEEEEeCC-----CcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLGD-----GMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  246 (470)
                      ++|...+.||+|+||.||+|....     +..||+|.+.... ......+.+|+++++.++||||+++++++......++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            467778999999999999997542     3469999987543 3345578899999999999999999999999999999


Q ss_pred             EEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCC
Q 040392          247 VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      ||||+++|+|.+++......+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus       124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  200 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  200 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence            99999999999999877778999999999999999999999   899999999999999999999999999999876432


Q ss_pred             CC-cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCccccccccc
Q 040392          327 DQ-SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN  404 (470)
Q Consensus       327 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (470)
                      .. ........+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+  ....+.....          
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~~~~~~~~~----------  268 (333)
T 1mqb_A          201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMKAINDGFR----------  268 (333)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTTCC----------
T ss_pred             cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHHCCCc----------
Confidence            21 112223446788999999988899999999999999999999 999997643221  1111111000          


Q ss_pred             ccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                              ...+..++.++.+++.+||+.||++||++.|++++|+++...
T Consensus       269 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          269 --------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             --------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             --------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                    001123467789999999999999999999999999998754

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.5e-42  Score=334.03  Aligned_cols=262  Identities=23%  Similarity=0.338  Sum_probs=202.0

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc---cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++...   .......+.+|+++++.++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            45799999999999999999975 57999999998743   234456788899999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccC
Q 040392          248 LEYMPHGSLEKYMYS---SNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~  324 (470)
                      |||+++++|.+++..   ....+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999999864   3456899999999999999999999   8999999999999999999999999999987654


Q ss_pred             CCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccc
Q 040392          325 GEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN  404 (470)
Q Consensus       325 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (470)
                      ...  .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.............+...   ....     
T Consensus       188 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~-----  257 (310)
T 2wqm_A          188 SKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC---DYPP-----  257 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT---CSCC-----
T ss_pred             CCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc---cCCC-----
Confidence            322  122345689999999999998999999999999999999999999875432221221111110   0000     


Q ss_pred             ccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHH
Q 040392          405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL  455 (470)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~  455 (470)
                      .         ....++.++.+++.+||+.||++|||+.++++.|+++...-
T Consensus       258 ~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~  299 (310)
T 2wqm_A          258 L---------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT  299 (310)
T ss_dssp             C---------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             C---------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence            0         01234667899999999999999999999999999998654

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.4e-43  Score=338.36  Aligned_cols=270  Identities=21%  Similarity=0.251  Sum_probs=202.2

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeE
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  246 (470)
                      ..++|++.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+.+++.++||||+++++++...+..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3578999999999999999999865 68899999986542   2234678889999999999999999999999999999


Q ss_pred             EEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCC
Q 040392          247 VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      ||||+++++|.+++.... .+++..+..++.|++.||.|||   +.+|+|+||||+||+++.++.+||+|||++......
T Consensus       112 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             EEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            999999999999997654 5899999999999999999999   899999999999999999999999999998765432


Q ss_pred             CCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccccc
Q 040392          327 DQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL  406 (470)
Q Consensus       327 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (470)
                      . ........+++.|+|||.+.+..++.++||||||+++|||++|+.||......  .+...+....+.           
T Consensus       188 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~-----------  253 (309)
T 2h34_A          188 K-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAIPR-----------  253 (309)
T ss_dssp             ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCCCC-----------
T ss_pred             c-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCCCC-----------
Confidence            2 12223456899999999999999999999999999999999999999763221  111111111000           


Q ss_pred             CchhhhhHhhhhhHHHHHHHHhhccCCCccCCC-CHHHHHHHHHHHHHHHhhhccCch
Q 040392          407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRI-NAREIVAKLLKIRDSLLRNVGDRC  463 (470)
Q Consensus       407 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~el~~~L~~i~~~~~~~~~~~~  463 (470)
                           ....+..++.++.+++.+||+.||++|| ++.++++.|+++..........+.
T Consensus       254 -----~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~~~~~~  306 (309)
T 2h34_A          254 -----PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDRATDI  306 (309)
T ss_dssp             -----GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----------
T ss_pred             -----ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcccchhhh
Confidence                 0011233466789999999999999999 999999999998655544444333

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.7e-43  Score=339.41  Aligned_cols=245  Identities=22%  Similarity=0.219  Sum_probs=195.6

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++....  .........|+..+..+ +||||+++++++.+....++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            57999999999999999999876 79999999986432  22333444455555544 8999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||+ +++|.+++...+..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++......  
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~--  210 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA--  210 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccC--
Confidence            999 66999999887778999999999999999999999   899999999999999999999999999998865432  


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                       .......||+.|+|||++.+ .++.++||||||+++|||++|..|+....    ..........               
T Consensus       211 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----~~~~~~~~~~---------------  269 (311)
T 3p1a_A          211 -GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----GWQQLRQGYL---------------  269 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----HHHHHTTTCC---------------
T ss_pred             -CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHHHhccCC---------------
Confidence             22334568999999998876 79999999999999999999977654321    1111111000               


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                         ....+..++.++.+++.+||+.||++|||+.|++++
T Consensus       270 ---~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          270 ---PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             ---CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ---CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence               011223457789999999999999999999999874

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.2e-42  Score=332.11  Aligned_cols=266  Identities=19%  Similarity=0.225  Sum_probs=210.4

Q ss_pred             hhCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeee-ccCCeeeEEE
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTC-SNEEFKALVL  248 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~-~~~~~~~lv~  248 (470)
                      ..++|++.+.||+|+||.||+|+. .+++.||||++....  ....+..|+++++.++|++++..+.++ ......++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999985 578999999875432  335688899999999988877766655 6677889999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---CCCCCeEEeeeccccccCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~a~~~~~  325 (470)
                      ||+ +++|.+++......+++..+..++.|++.||.|||   +.+|+||||||+||++   +.++.+||+|||++.....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence            999 89999999876677999999999999999999999   9999999999999999   7899999999999987654


Q ss_pred             CCCc-----ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcc--hhhHHhhhhcCCccc
Q 040392          326 EDQS-----MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEM--TLKHWVNDWLPISTM  398 (470)
Q Consensus       326 ~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~  398 (470)
                      ....     .......+|+.|+|||.+.+..++.++||||||+++|||++|+.||........  .+........+..  
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--  238 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--  238 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC--
T ss_pred             cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch--
Confidence            3221     122356789999999999999999999999999999999999999986543221  1111111100000  


Q ss_pred             ccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHhh
Q 040392          399 EVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLR  457 (470)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~~  457 (470)
                                   .......++.++.+++..||+.||++||++.++++.|+++..+...
T Consensus       239 -------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~  284 (296)
T 4hgt_A          239 -------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             -------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred             -------------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence                         0011133467899999999999999999999999999999876553

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.8e-43  Score=341.24  Aligned_cols=267  Identities=22%  Similarity=0.295  Sum_probs=199.8

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccc-hhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+++++.++||||+++++++......++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57889999999999999999865 689999999865432 2223455699999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      ++ |+|.+++......+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++......  ..
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~  155 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--TK  155 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCC--cc
Confidence            97 5999999887778999999999999999999999   999999999999999999999999999999765322  22


Q ss_pred             cccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC--
Q 040392          331 TQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS--  407 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  407 (470)
                      ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+ ....... ................  
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~-~~~~~~~~~~~~~~~~~~  233 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-QLHFIFR-ILGTPTEETWPGILSNEE  233 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHH-HHCCCCTTTSTTGGGCHH
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-HhCCCChHhchhhhcchh
Confidence            2234568999999998876 568999999999999999999999997643221 1111111 1110000000000000  


Q ss_pred             ---------chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          408 ---------QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       408 ---------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                               ...........++.++.+|+.+||+.||++|||+.|+++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                     0000111223456778999999999999999999999874

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.8e-43  Score=349.88  Aligned_cols=260  Identities=22%  Similarity=0.292  Sum_probs=208.9

Q ss_pred             HHHHhhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCC
Q 040392          167 ELCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEE  242 (470)
Q Consensus       167 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  242 (470)
                      +.....++|++.+.||+|+||.||+|+.. +|+.||+|++...   .......+..|..++..++||||+++++++.+.+
T Consensus        55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~  134 (412)
T 2vd5_A           55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN  134 (412)
T ss_dssp             HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred             hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence            33445688999999999999999999864 6999999999753   2234566889999999999999999999999999


Q ss_pred             eeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccc
Q 040392          243 FKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL  322 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~  322 (470)
                      ..++||||+++|+|.+++...+..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++++||+|||+++.
T Consensus       135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla~~  211 (412)
T 2vd5_A          135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLK  211 (412)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhhee
Confidence            999999999999999999876667899999999999999999999   89999999999999999999999999999987


Q ss_pred             cCCCCCcccccccccCccccCccccC-------CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCC
Q 040392          323 LTGEDQSMTQTQTLATIGYMAPEYGR-------EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPI  395 (470)
Q Consensus       323 ~~~~~~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  395 (470)
                      ..... .......+||+.|+|||++.       ...++.++|+|||||++|||++|+.||......+. ....+......
T Consensus       212 ~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~i~~~~~~~  289 (412)
T 2vd5_A          212 LRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET-YGKIVHYKEHL  289 (412)
T ss_dssp             CCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTHHHHC
T ss_pred             ccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH-HHHHHhcccCc
Confidence            64322 22223467999999999886       45689999999999999999999999976432211 11111100000


Q ss_pred             cccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCC---CCHHHHHHH
Q 040392          396 STMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQR---INAREIVAK  447 (470)
Q Consensus       396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---ps~~el~~~  447 (470)
                      ..     +          ..+..++.++.+++.+||. +|++|   |++.|+++|
T Consensus       290 ~~-----p----------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          290 SL-----P----------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             CC-----C--------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             CC-----C----------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            00     0          0012346778999999999 99998   589998875

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=9e-44  Score=342.77  Aligned_cols=259  Identities=24%  Similarity=0.379  Sum_probs=198.0

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCC----e
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEE----F  243 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~----~  243 (470)
                      .++|++.+.||+|+||.||+|+. .+++.||||++....   ......+.+|+++++.++||||+++++++....    .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46899999999999999999985 578999999997542   233457888999999999999999999986554    3


Q ss_pred             eeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecccccc
Q 040392          244 KALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  323 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~  323 (470)
                      .++||||+++++|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++..+
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             cEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            489999999999999997654 6899999999999999999999   899999999999999999999999999999866


Q ss_pred             CCCCCc-ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccc
Q 040392          324 TGEDQS-MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVG  402 (470)
Q Consensus       324 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (470)
                      ...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+... ......          
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~-~~~~~~----------  235 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY-QHVRED----------  235 (311)
T ss_dssp             ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHCC----------
T ss_pred             cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHhcCC----------
Confidence            433222 22234568999999999999999999999999999999999999997643221111 111100          


Q ss_pred             ccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHH-HHHHHH
Q 040392          403 ANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIV-AKLLKI  451 (470)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~-~~L~~i  451 (470)
                            ..........++.++.+++.+||+.||++||++.+++ ..|.++
T Consensus       236 ------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          236 ------PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             ------CCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ------CCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence                  0000111234577899999999999999999666555 445444

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=9.8e-44  Score=347.56  Aligned_cols=266  Identities=17%  Similarity=0.201  Sum_probs=203.4

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC----CCcEEEEEEeecccch-----------hhhhHHHHHHHHhcCCCCcceeEEe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQCGR-----------ALKGFDVECEMMKSIRHRNLIKVIS  236 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~nIv~~~~  236 (470)
                      .++|.+.+.||+|+||.||+|...    ++..+|+|+.......           ....+..|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            467999999999999999999875    5788999998754321           1223567888999999999999999


Q ss_pred             eecc----CCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC--
Q 040392          237 TCSN----EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM--  310 (470)
Q Consensus       237 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~--  310 (470)
                      ++..    ....++||||+ +++|.+++.... .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++  
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTT
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCC
Confidence            9877    67889999999 999999997655 7899999999999999999999   89999999999999998887  


Q ss_pred             CeEEeeeccccccCCCCC-----cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchh
Q 040392          311 VAHLSDFSIAKLLTGEDQ-----SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTL  385 (470)
Q Consensus       311 ~~kl~Dfg~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~  385 (470)
                      .+||+|||+++.+.....     ........||+.|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            999999999987643211     112244579999999999999899999999999999999999999997543332222


Q ss_pred             hHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHH
Q 040392          386 KHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR  452 (470)
Q Consensus       386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~  452 (470)
                      .......... .         ............++.++.+++.+||+.||++||++.++++.|+++.
T Consensus       271 ~~~~~~~~~~-~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          271 QTAKTNLLDE-L---------PQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             HHHHHHHHHT-T---------THHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             HHHHHhhccc-c---------cHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            2211111100 0         0000000011145778999999999999999999999999999875

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=9.1e-43  Score=340.15  Aligned_cols=254  Identities=22%  Similarity=0.282  Sum_probs=203.6

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCeeeE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~l  246 (470)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+..|..+++.+ +||||+++++++.+....++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            357889999999999999999865 58899999997542   23455678899999988 89999999999999999999


Q ss_pred             EEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCC
Q 040392          247 VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      ||||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        88 v~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            999999999999997654 6899999999999999999999   899999999999999999999999999999854322


Q ss_pred             CCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcc---hhhHHh-hhhcCCccccccc
Q 040392          327 DQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEM---TLKHWV-NDWLPISTMEVVG  402 (470)
Q Consensus       327 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~---~~~~~~-~~~~~~~~~~~~~  402 (470)
                      .  ......+||+.|+|||++.+..++.++|+|||||++|||++|+.||........   ...... .......      
T Consensus       164 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~------  235 (345)
T 3a8x_A          164 G--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------  235 (345)
T ss_dssp             T--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC------
T ss_pred             C--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC------
Confidence            1  223456799999999999999999999999999999999999999975321110   000000 0000000      


Q ss_pred             ccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCH------HHHHHH
Q 040392          403 ANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINA------REIVAK  447 (470)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~------~el~~~  447 (470)
                                ...+..++.++.+++.+||+.||++||++      .|+++|
T Consensus       236 ----------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          236 ----------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             ----------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             ----------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence                      00112346678999999999999999996      666654

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=6.9e-43  Score=344.23  Aligned_cols=253  Identities=16%  Similarity=0.141  Sum_probs=207.4

Q ss_pred             hhCCCCCCCeecccCceEEEEEE------eCCCcEEEEEEeecccchhhhhHHHHHHHHhcCC---CCcceeEEeeeccC
Q 040392          171 ATDGFSENNLIGRGGFGSVYKAR------LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIR---HRNLIKVISTCSNE  241 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~  241 (470)
                      ..++|.+.+.||+|+||.||+|.      ..+++.||+|++....   ...+..|+++++.++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            35678999999999999999993      4568899999987543   345677888888886   99999999999999


Q ss_pred             CeeeEEEecCCCCChHHhhhc----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---------
Q 040392          242 EFKALVLEYMPHGSLEKYMYS----SNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD---------  308 (470)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~---------  308 (470)
                      +..++||||+++|+|.+++..    ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccc
Confidence            999999999999999999975    3456999999999999999999999   999999999999999998         


Q ss_pred             --CCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhh
Q 040392          309 --NMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLK  386 (470)
Q Consensus       309 --~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~  386 (470)
                        ++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.....+.....
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~  296 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPE  296 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEEC
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCceeec
Confidence              899999999999765433333444566799999999999999999999999999999999999999875433221100


Q ss_pred             HHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCC-CCHHHHHHHHHHHHHH
Q 040392          387 HWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQR-INAREIVAKLLKIRDS  454 (470)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-ps~~el~~~L~~i~~~  454 (470)
                                      ......         ..+..+.+++..|++.+|.+| |+++++.+.|+++..+
T Consensus       297 ----------------~~~~~~---------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          297 ----------------GLFRRL---------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             ----------------SCCTTC---------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ----------------hhcccc---------CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence                            000000         114557789999999999999 5788888889888655

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.1e-43  Score=335.05  Aligned_cols=259  Identities=26%  Similarity=0.423  Sum_probs=215.0

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      ..++|++.+.||+|+||.||+|.+. ++..||+|.+... ....+.+.+|+++++.++||||+++++++.+....++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            3567889999999999999999875 4889999998754 3345678899999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          250 YMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      |+++++|.+++.... ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++....... 
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  165 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-  165 (288)
T ss_dssp             CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-
T ss_pred             cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc-
Confidence            999999999997644 45899999999999999999999   8999999999999999999999999999998765332 


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                      ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......  ....+......            
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--~~~~~~~~~~~------------  231 (288)
T 3kfa_A          166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLEKDYRM------------  231 (288)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHHHHTTCCC------------
T ss_pred             cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHhccCCC------------
Confidence            223334557889999999988899999999999999999999 999987643221  11111111100            


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                            ..+..++.++.+++.+||..||++|||+.|+++.|+++...
T Consensus       232 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          232 ------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence                  11123467789999999999999999999999999998654

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=5.4e-43  Score=331.87  Aligned_cols=248  Identities=25%  Similarity=0.365  Sum_probs=202.2

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      .++|++.+.||+|+||.||+|... ++..||+|++....   ......+.+|+.+++.++||||+++++++.+....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            467999999999999999999765 57899999986432   22345678899999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||+++|+|.+++.... .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++.....  
T Consensus        88 ~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~--  161 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--  161 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCc--
Confidence            99999999999997654 5899999999999999999999   99999999999999999999999999999865432  


Q ss_pred             CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                        .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||......+. ... +... .             
T Consensus       162 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~-~~~~-~-------------  223 (279)
T 3fdn_A          162 --SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-YKR-ISRV-E-------------  223 (279)
T ss_dssp             --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHH-HHHT-C-------------
T ss_pred             --ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH-HHH-HHhC-C-------------
Confidence              122345789999999999999999999999999999999999999975322111 111 1000 0             


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                           ...+..++..+.+++.+||+.||++||++.|+++|-
T Consensus       224 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~  259 (279)
T 3fdn_A          224 -----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP  259 (279)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred             -----CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence                 001122356788999999999999999999999873

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-43  Score=346.00  Aligned_cols=267  Identities=13%  Similarity=0.146  Sum_probs=211.0

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCC---------CcEEEEEEeecccchhhhhHHHHHHHHhcCCCCccee---------
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGD---------GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK---------  233 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~---------  233 (470)
                      .++|++.+.||+|+||.||+|+...         ++.||+|++...     ..+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3679999999999999999998753         789999998743     46888999999999999988         


Q ss_pred             ------EEeeecc-CCeeeEEEecCCCCChHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCee
Q 040392          234 ------VISTCSN-EEFKALVLEYMPHGSLEKYMYSS-NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVL  305 (470)
Q Consensus       234 ------~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nil  305 (470)
                            +++++.. ....++||||+ +++|.+++... ...+++..+..++.|++.||.|||   +.+|+||||||+||+
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEE
Confidence                  5666654 67889999999 99999999865 356899999999999999999999   899999999999999


Q ss_pred             eCCCC--CeEEeeeccccccCCCCCc-----ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcc
Q 040392          306 LDDNM--VAHLSDFSIAKLLTGEDQS-----MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEI  378 (470)
Q Consensus       306 l~~~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~  378 (470)
                      ++.++  .+||+|||+++.+......     .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  9999999999866432211     1223457999999999999989999999999999999999999999875


Q ss_pred             ccCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHhh
Q 040392          379 FNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLR  457 (470)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~~  457 (470)
                      ......+........... ....+...         ....++.++.+++.+||+.||++||++.++++.|+++..+...
T Consensus       272 ~~~~~~~~~~~~~~~~~~-~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~  340 (352)
T 2jii_A          272 LPNTEDIMKQKQKFVDKP-GPFVGPCG---------HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV  340 (352)
T ss_dssp             TTCHHHHHHHHHHHHHSC-CCEECTTS---------CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             CcCHHHHHHHHHhccCCh-hhhhhhcc---------ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence            433333333322211110 00000000         0112366789999999999999999999999999999876553

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.2e-43  Score=343.22  Aligned_cols=250  Identities=21%  Similarity=0.255  Sum_probs=204.8

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCeee
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFKA  245 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~  245 (470)
                      ..++|++.+.||+|+||.||+|+.. +|+.||+|++....   ......+..|..++..+ +||||+++++++.+.+..+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3578999999999999999999875 47899999997542   23455677899999988 7999999999999999999


Q ss_pred             EEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC
Q 040392          246 LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  325 (470)
                      +||||+++|+|.+++...+ .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        98 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            9999999999999997654 5899999999999999999999   89999999999999999999999999999985432


Q ss_pred             CCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          326 EDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       326 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      .  .......+||+.|+|||++.+..++.++|+|||||++|||++|+.||......+ ..........            
T Consensus       174 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~~~~------------  238 (353)
T 2i0e_A          174 D--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-LFQSIMEHNV------------  238 (353)
T ss_dssp             T--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCC------------
T ss_pred             C--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH-HHHHHHhCCC------------
Confidence            2  122345679999999999999999999999999999999999999997632211 1111111000            


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCC-----HHHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRIN-----AREIVAK  447 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~el~~~  447 (470)
                              ..+..++.++.+++.+||..||++||+     +.|+++|
T Consensus       239 --------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          239 --------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             --------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             --------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                    001234667899999999999999995     5777765

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=9.5e-43  Score=329.79  Aligned_cols=251  Identities=24%  Similarity=0.290  Sum_probs=206.9

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      .++|++.+.||+|+||.||+|... ++..||+|.+........+.+.+|+++++.++||||+++++++.+....++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            467899999999999999999865 4789999999876566677889999999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---CCCCCeEEeeeccccccCCCC
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      +++++|.+++.... .+++..+..++.|++.||+|||   +.+++||||||+||++   +.++.+||+|||++.......
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           88 CTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             CCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence            99999999987654 5899999999999999999999   9999999999999999   888999999999998764322


Q ss_pred             CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                         ......+|+.|+|||.+.+. ++.++||||||+++|||++|+.||......+. ...........            
T Consensus       164 ---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~------------  226 (277)
T 3f3z_A          164 ---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV-MLKIREGTFTF------------  226 (277)
T ss_dssp             ---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCCC------------
T ss_pred             ---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhCCCCC------------
Confidence               22345689999999988654 89999999999999999999999976432211 11111100000            


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                       .   ......++.++.+++.+||+.||++||++.|++++
T Consensus       227 -~---~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          227 -P---EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             -C---HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             -C---chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0   00112346778999999999999999999999875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.7e-42  Score=329.76  Aligned_cols=265  Identities=19%  Similarity=0.226  Sum_probs=213.0

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeee-ccCCeeeEEEe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTC-SNEEFKALVLE  249 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~-~~~~~~~lv~e  249 (470)
                      .++|++.+.||+|+||.||+|+. .+|+.||+|++....  ....+..|+.+++.++|++++..+.++ ......++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            57899999999999999999986 579999999986543  335688899999999988876666555 56678899999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---CCCCCeEEeeeccccccCCC
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      |+ +++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||++   +.++.+||+|||++......
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99 88999999866677999999999999999999999   9999999999999999   48899999999999876543


Q ss_pred             CCc-----ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCc--chhhHHhhhhcCCcccc
Q 040392          327 DQS-----MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE--MTLKHWVNDWLPISTME  399 (470)
Q Consensus       327 ~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~  399 (470)
                      ...     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......  ..+...........   
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---  238 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP---  238 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC---
T ss_pred             ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc---
Confidence            321     12245679999999999999999999999999999999999999998643321  11111111110000   


Q ss_pred             cccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHhh
Q 040392          400 VVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLR  457 (470)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~~  457 (470)
                                  .......++.++.+++.+||+.||++||++.++++.|+++......
T Consensus       239 ------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  284 (296)
T 3uzp_A          239 ------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             ------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             ------------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence                        0011134577899999999999999999999999999999766544

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.3e-43  Score=341.74  Aligned_cols=261  Identities=23%  Similarity=0.302  Sum_probs=203.5

Q ss_pred             HHHHhhCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc-----cchhhhhHHHHHHHHhcCCCCcceeEEeeecc
Q 040392          167 ELCRATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ-----CGRALKGFDVECEMMKSIRHRNLIKVISTCSN  240 (470)
Q Consensus       167 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  240 (470)
                      .+....++|++.+.||+|+||.||+|.. .++..||+|++...     .....+.+.+|+++++.++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            3455678899999999999999999976 46889999998644     23455678899999999999999999999999


Q ss_pred             CCeeeEEEecCCCCChHHhhhcC---------------------------------------CCCCCHHHHHHHHHHHHH
Q 040392          241 EEFKALVLEYMPHGSLEKYMYSS---------------------------------------NYILDIFQRLNIMIDVAS  281 (470)
Q Consensus       241 ~~~~~lv~e~~~~g~L~~~l~~~---------------------------------------~~~~~~~~~~~i~~~i~~  281 (470)
                      ....++||||+++|+|.+++...                                       ...+++..+..++.|++.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            99999999999999999998521                                       112356778889999999


Q ss_pred             HHHHHhcCCCCCeeecCCCCCCeeeCCCC--CeEEeeeccccccCCCCC--cccccccccCccccCccccCC--CCCCCc
Q 040392          282 ALEYLHFGYSAPIIHCDLKPSNVLLDDNM--VAHLSDFSIAKLLTGEDQ--SMTQTQTLATIGYMAPEYGRE--GRVSTN  355 (470)
Q Consensus       282 ~L~~LH~~~~~~i~H~dlkp~Nill~~~~--~~kl~Dfg~a~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~--~~~~~~  355 (470)
                      ||+|||   +.+|+||||||+||+++.++  .+||+|||++..+.....  ........||+.|+|||.+.+  ..++.+
T Consensus       180 ~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            999999   89999999999999998776  899999999986543221  122345679999999999865  678999


Q ss_pred             cchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCc
Q 040392          356 GDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESP  435 (470)
Q Consensus       356 ~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP  435 (470)
                      +||||||+++|||++|+.||......+ .............                ......++.++.+++.+||+.||
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~----------------~~~~~~~~~~~~~li~~~l~~~p  319 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDAD-TISQVLNKKLCFE----------------NPNYNVLSPLARDLLSNLLNRNV  319 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCTT----------------SGGGGGSCHHHHHHHHHHSCSCT
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHhcccccC----------------CcccccCCHHHHHHHHHHcCCCh
Confidence            999999999999999999997643322 1111111110000                01112346778999999999999


Q ss_pred             cCCCCHHHHHHH
Q 040392          436 EQRINAREIVAK  447 (470)
Q Consensus       436 ~~Rps~~el~~~  447 (470)
                      ++||++.|++++
T Consensus       320 ~~Rps~~~~l~h  331 (345)
T 3hko_A          320 DERFDAMRALQH  331 (345)
T ss_dssp             TTSCCHHHHHHS
T ss_pred             hHCCCHHHHhcC
Confidence            999999999875

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.1e-42  Score=336.60  Aligned_cols=252  Identities=22%  Similarity=0.318  Sum_probs=206.5

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccch------hhhhHHHHHHHHhcCCCCcceeEEeeeccCCee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGR------ALKGFDVECEMMKSIRHRNLIKVISTCSNEEFK  244 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  244 (470)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++......      ..+.+.+|+++++.++||||+++++++.+....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            456899999999999999999865 6899999998754321      345688999999999999999999999999999


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC----CeEEeeeccc
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM----VAHLSDFSIA  320 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~----~~kl~Dfg~a  320 (470)
                      ++||||+++++|.+++... ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++    .+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            9999999999999999754 46899999999999999999999   89999999999999999888    7999999999


Q ss_pred             cccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccc
Q 040392          321 KLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEV  400 (470)
Q Consensus       321 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (470)
                      .......   ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......+ .+.....    ...   
T Consensus       167 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~----~~~---  235 (321)
T 2a2a_A          167 HEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANITS----VSY---  235 (321)
T ss_dssp             EECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHT----TCC---
T ss_pred             eecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHh----ccc---
Confidence            8764322   2234568999999999999999999999999999999999999997632211 1111100    000   


Q ss_pred             ccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          401 VGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                            .   ........++..+.+++.+||..||++|||+.|++++
T Consensus       236 ------~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          236 ------D---FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             ------C---CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             ------c---cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                  0   0001123346778999999999999999999999975

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=8.4e-43  Score=338.40  Aligned_cols=262  Identities=23%  Similarity=0.378  Sum_probs=208.7

Q ss_pred             hCCCCCCCeecccCceEEEEEEe------CCCcEEEEEEeecc-cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQ-CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFK  244 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  244 (470)
                      .++|++.+.||+|+||.||+|++      .++..||||.+... .......+.+|+.+++.++||||+++++++......
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            46899999999999999999974      35778999998644 234556788899999999999999999999999999


Q ss_pred             eEEEecCCCCChHHhhhcCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCCeEEe
Q 040392          245 ALVLEYMPHGSLEKYMYSSN------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD---NMVAHLS  315 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~  315 (470)
                      ++||||+++|+|.+++....      ..+++..++.++.|++.||.|||   +.+++||||||+||+++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            99999999999999997654      35889999999999999999999   899999999999999984   4569999


Q ss_pred             eeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcC
Q 040392          316 DFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLP  394 (470)
Q Consensus       316 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  394 (470)
                      |||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||......  .....+.....
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~~~~  263 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVLEFVTSGGR  263 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHTTCC
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--HHHHHHhcCCC
Confidence            9999986644333333345568899999999988889999999999999999998 99998764221  11121111100


Q ss_pred             CcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHh
Q 040392          395 ISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL  456 (470)
Q Consensus       395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~  456 (470)
                      .                  ..+..++..+.+++.+||+.||.+||++.|++++|+.+.....
T Consensus       264 ~------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~  307 (327)
T 2yfx_A          264 M------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  307 (327)
T ss_dssp             C------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             C------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence            0                  0112346678999999999999999999999999999875443

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=8.6e-43  Score=331.27  Aligned_cols=252  Identities=20%  Similarity=0.339  Sum_probs=206.0

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      .++|++.+.||+|+||.||+|... +++.||+|++....  ......+.+|+++++.++||||+++++++.+....++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            578999999999999999999764 58999999987543  334567888999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC---eEEeeeccccccCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV---AHLSDFSIAKLLTG  325 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~---~kl~Dfg~a~~~~~  325 (470)
                      ||+++++|.+++.... .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.   +||+|||++.....
T Consensus        85 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            9999999998886654 5899999999999999999999   899999999999999986665   99999999976643


Q ss_pred             CCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          326 EDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       326 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      ..   ......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||......+ .............         
T Consensus       161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~---------  227 (284)
T 3kk8_A          161 SE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYP---------  227 (284)
T ss_dssp             SC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCCC---------
T ss_pred             Cc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-HHHHHHhccccCC---------
Confidence            22   2234568999999999999999999999999999999999999997633221 1111111100000         


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                             ......++.++.+++.+||+.||++|||+.|++++
T Consensus       228 -------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          228 -------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             -------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             -------chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                   00012346678999999999999999999999985

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.7e-43  Score=366.98  Aligned_cols=256  Identities=23%  Similarity=0.391  Sum_probs=206.7

Q ss_pred             eecccCceEEEEEEeC---CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCCCC
Q 040392          180 LIGRGGFGSVYKARLG---DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGS  255 (470)
Q Consensus       180 ~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~  255 (470)
                      .||+|+||.||+|.+.   ++..||||+++... ....+.+.+|+++++.++||||+++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999753   46779999997543 3356778999999999999999999999976 56899999999999


Q ss_pred             hHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc-ccccc
Q 040392          256 LEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS-MTQTQ  334 (470)
Q Consensus       256 L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~  334 (470)
                      |.+++......+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.+...... .....
T Consensus       422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~  498 (613)
T 2ozo_A          422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA  498 (613)
T ss_dssp             HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred             HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence            99999877777999999999999999999999   899999999999999999999999999999876432221 12223


Q ss_pred             cccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhh
Q 040392          335 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF  413 (470)
Q Consensus       335 ~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  413 (470)
                      ..+++.|+|||++.+..++.++|||||||++|||++ |+.||......+  ....+.....                  .
T Consensus       499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i~~~~~------------------~  558 (613)
T 2ozo_A          499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIEQGKR------------------M  558 (613)
T ss_dssp             ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--HHHHHHTTCC------------------C
T ss_pred             CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCCC------------------C
Confidence            346789999999998899999999999999999998 999998754322  2222211110                  1


Q ss_pred             HhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHhhhc
Q 040392          414 VAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNV  459 (470)
Q Consensus       414 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~~~~  459 (470)
                      ..+..++.++.+++..||+.||++||++.++++.|+.+..+.....
T Consensus       559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~  604 (613)
T 2ozo_A          559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV  604 (613)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSC
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcccc
Confidence            1123467889999999999999999999999999999987665444

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=334.12  Aligned_cols=265  Identities=22%  Similarity=0.275  Sum_probs=200.8

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|++....  ....+.+.+|+++++.++||||+++++++......++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            67899999999999999999875 58999999986443  2235667789999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      |+++++|.+++... ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.......  
T Consensus        83 ~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  156 (311)
T 4agu_A           83 YCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS--  156 (311)
T ss_dssp             CCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             eCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc--
Confidence            99999998887644 46899999999999999999999   8999999999999999999999999999998764322  


Q ss_pred             ccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhh-----------cCCc-
Q 040392          330 MTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDW-----------LPIS-  396 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~-----------~~~~-  396 (470)
                      .......+|..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+. ........           .... 
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  235 (311)
T 4agu_A          157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ-LYLIRKTLGDLIPRHQQVFSTNQY  235 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred             cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhcccccccccccccccc
Confidence            22234568999999998876 5689999999999999999999999976433211 11110000           0000 


Q ss_pred             --ccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          397 --TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       397 --~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                        .....++.....   .......++.++.+++.+||+.||++|||+.|+++|
T Consensus       236 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          236 FSGVKIPDPEDMEP---LELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             GTTCCCCCCSSCCC---HHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccCcCCCccccch---hhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence              000001000000   011112456778999999999999999999999976

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.5e-43  Score=348.07  Aligned_cols=276  Identities=20%  Similarity=0.275  Sum_probs=211.3

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCC--eeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEE--FKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--~~~lv  247 (470)
                      .++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++....  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            357899999999999999999865 58999999997543 334566788999999999999999999987654  77999


Q ss_pred             EecCCCCChHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee----CCCCCeEEeeecccc
Q 040392          248 LEYMPHGSLEKYMYSSN--YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL----DDNMVAHLSDFSIAK  321 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill----~~~~~~kl~Dfg~a~  321 (470)
                      |||+++|+|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+||++    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            99999999999997644  23899999999999999999999   8999999999999999    788889999999998


Q ss_pred             ccCCCCCcccccccccCccccCccccCC--------CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhh---HHhh
Q 040392          322 LLTGEDQSMTQTQTLATIGYMAPEYGRE--------GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLK---HWVN  390 (470)
Q Consensus       322 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~---~~~~  390 (470)
                      .....   .......||+.|+|||++.+        ..++.++||||||+++|||++|+.||...........   ....
T Consensus       165 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          165 ELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             ECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             EccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            76432   22234569999999998764        4678899999999999999999999976443322211   1111


Q ss_pred             hhcCCcccccccccc-----cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          391 DWLPISTMEVVGANL-----LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       391 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                      ...+...........     ..............+..+.+++.+||+.||++||++.|+++.+.++..
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            111111100000000     000000111224457789999999999999999999999999988764

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-42  Score=332.98  Aligned_cols=269  Identities=23%  Similarity=0.300  Sum_probs=202.0

Q ss_pred             hhCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccc-----hhhhhHHHHHHHHhcCC---CCcceeEEeeeccC
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCG-----RALKGFDVECEMMKSIR---HRNLIKVISTCSNE  241 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~  241 (470)
                      ..++|++.+.||+|+||+||+|+. .+++.||+|++.....     .....+.+|+++++.++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            467899999999999999999985 5689999999864321     12345667888877775   99999999998765


Q ss_pred             C-----eeeEEEecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEe
Q 040392          242 E-----FKALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLS  315 (470)
Q Consensus       242 ~-----~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~  315 (470)
                      .     ..++||||++ |+|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence            4     5789999997 59999997655 34899999999999999999999   8999999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCC
Q 040392          316 DFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPI  395 (470)
Q Consensus       316 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  395 (470)
                      |||++......   .......+|+.|+|||++.+..++.++||||||+++|||++|+.||......+ .+..........
T Consensus       163 Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~  238 (308)
T 3g33_A          163 DFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLP  238 (308)
T ss_dssp             SCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred             eCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence            99999865432   22344678999999999999999999999999999999999999997643321 111111111000


Q ss_pred             cccccc-----cccccC--chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          396 STMEVV-----GANLLS--QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       396 ~~~~~~-----~~~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ......     ......  ...........++.++.+++.+||+.||++|||+.|+++|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            000000     000000  0000011123456788999999999999999999999875

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.9e-42  Score=350.72  Aligned_cols=248  Identities=24%  Similarity=0.343  Sum_probs=205.8

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      .++|.+.+.||+|+||.||+|+.. +|+.||||++....   ......+.+|+++++.++||||+++++++......++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            367899999999999999999865 79999999997542   22345788999999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||+++|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus        95 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           95 MEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             EECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            9999999999999654 46899999999999999999999   9999999999999999999999999999998764322


Q ss_pred             CcccccccccCccccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccccc
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL  406 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (470)
                         .....+||+.|+|||++.+..+ +.++||||||+++|||++|+.||.......  +...+.   ....         
T Consensus       171 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~--~~~~i~---~~~~---------  233 (476)
T 2y94_A          171 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT--LFKKIC---DGIF---------  233 (476)
T ss_dssp             ---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH--HHHHHH---TTCC---------
T ss_pred             ---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH--HHHHHh---cCCc---------
Confidence               2234579999999999988765 689999999999999999999997632211  111111   0000         


Q ss_pred             CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       407 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                             ..+..++.++.+++.+||+.||++|||+.|+++|
T Consensus       234 -------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          234 -------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             -------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             -------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence                   0112235678899999999999999999999985

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=8.9e-43  Score=340.77  Aligned_cols=247  Identities=27%  Similarity=0.352  Sum_probs=202.5

Q ss_pred             CCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      +.|...+.||+|+||.||+|+. .+|+.||||++....   ....+.+.+|+++++.++||||+++++++......++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4588889999999999999985 578999999987542   234467889999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||++ |+|.+++......+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||++......  
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  207 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence            9997 6898888766677999999999999999999999   899999999999999999999999999999765321  


Q ss_pred             cccccccccCccccCccccC---CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          329 SMTQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                          ....||+.|+|||++.   ...++.++||||||+++|||++|+.||....... .+........+         ..
T Consensus       208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~---------~~  273 (348)
T 1u5q_A          208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESP---------AL  273 (348)
T ss_dssp             ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCC---------CC
T ss_pred             ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCC---------CC
Confidence                2356899999999874   5678999999999999999999999987542211 11111111000         00


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                               .+..++..+.+++.+||+.||++|||+.|++++.
T Consensus       274 ---------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~  307 (348)
T 1u5q_A          274 ---------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  307 (348)
T ss_dssp             ---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             ---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence                     0122356788999999999999999999998764

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=9.5e-43  Score=337.58  Aligned_cols=249  Identities=20%  Similarity=0.257  Sum_probs=181.4

Q ss_pred             CCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCC-CCcceeEEeeeccCCeeeEEEecCCCCC
Q 040392          178 NNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIR-HRNLIKVISTCSNEEFKALVLEYMPHGS  255 (470)
Q Consensus       178 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e~~~~g~  255 (470)
                      .+.||+|+||.||+|... +++.||||++...   ....+.+|+.+++.+. ||||+++++++.+....++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999999864 6899999999743   3456778999999997 9999999999999999999999999999


Q ss_pred             hHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC---CeEEeeeccccccCCCCCcccc
Q 040392          256 LEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM---VAHLSDFSIAKLLTGEDQSMTQ  332 (470)
Q Consensus       256 L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~---~~kl~Dfg~a~~~~~~~~~~~~  332 (470)
                      |.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++   .+||+|||++.......  ...
T Consensus        93 L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~  166 (325)
T 3kn6_A           93 LFERIKKK-KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPL  166 (325)
T ss_dssp             HHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred             HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--Ccc
Confidence            99999765 46899999999999999999999   99999999999999997665   89999999998654322  223


Q ss_pred             cccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCc--chhhHHhhhhcCCcccccccccccCchh
Q 040392          333 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE--MTLKHWVNDWLPISTMEVVGANLLSQED  410 (470)
Q Consensus       333 ~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (470)
                      ....+|+.|+|||++.+..++.++||||||+++|||++|+.||.......  ...............            .
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~------------~  234 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF------------S  234 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC------------C
T ss_pred             cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC------------C
Confidence            34568999999999999999999999999999999999999998643211  111111111111100            0


Q ss_pred             hhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          411 IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       411 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ........++.++.+|+.+||+.||++|||+.|++++
T Consensus       235 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            0011123457789999999999999999999998854

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.8e-43  Score=345.99  Aligned_cols=269  Identities=22%  Similarity=0.313  Sum_probs=194.9

Q ss_pred             hhCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc--cchhhhhHHHHHHHHhcCC-CCcceeEEeeeccC--Cee
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIR-HRNLIKVISTCSNE--EFK  244 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~--~~~  244 (470)
                      ..++|++.+.||+|+||.||+|.. .+|+.||||++...  .......+.+|+.+++.+. ||||+++++++...  ...
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            467899999999999999999975 46899999998543  3345566778999999997 99999999998644  478


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccC
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~  324 (470)
                      ++||||++ |+|.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus        87 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV  160 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred             EEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence            99999997 5999999764  5889999999999999999999   9999999999999999999999999999998653


Q ss_pred             CCC-------------------CcccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcch
Q 040392          325 GED-------------------QSMTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMT  384 (470)
Q Consensus       325 ~~~-------------------~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~  384 (470)
                      ...                   ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~  239 (388)
T 3oz6_A          161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN-Q  239 (388)
T ss_dssp             SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-H
T ss_pred             ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH-H
Confidence            211                   1112234579999999999876 678999999999999999999999997643211 1


Q ss_pred             hhHHhhhhcCCccccccc----------------------ccccCch------hhhhHhhhhhHHHHHHHHhhccCCCcc
Q 040392          385 LKHWVNDWLPISTMEVVG----------------------ANLLSQE------DIHFVAKEQCVSCVFNLAMECTVESPE  436 (470)
Q Consensus       385 ~~~~~~~~~~~~~~~~~~----------------------~~~~~~~------~~~~~~~~~~~~~l~~l~~~cl~~dP~  436 (470)
                      +..... .......+...                      .......      ......+..++.++.+|+.+||+.||+
T Consensus       240 ~~~i~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~  318 (388)
T 3oz6_A          240 LERIIG-VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN  318 (388)
T ss_dssp             HHHHHH-HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHH-hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence            111111 11000000000                      0000000      000001124567899999999999999


Q ss_pred             CCCCHHHHHHH
Q 040392          437 QRINAREIVAK  447 (470)
Q Consensus       437 ~Rps~~el~~~  447 (470)
                      +|||+.|+++|
T Consensus       319 ~R~t~~e~l~H  329 (388)
T 3oz6_A          319 KRISANDALKH  329 (388)
T ss_dssp             GSCCHHHHTTS
T ss_pred             cCCCHHHHhCC
Confidence            99999999987

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=6.3e-43  Score=339.27  Aligned_cols=262  Identities=28%  Similarity=0.455  Sum_probs=208.3

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcE--EEEEEeecc-cchhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCeeeEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGME--VAVKVFNLQ-CGRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      ++|++.+.||+|+||.||+|+.. ++..  +|+|.+... .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            67899999999999999999754 5664  499988643 234556788999999999 899999999999999999999


Q ss_pred             EecCCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCe
Q 040392          248 LEYMPHGSLEKYMYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA  312 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~  312 (470)
                      |||+++|+|.+++....               ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence            99999999999997653               46899999999999999999999   9999999999999999999999


Q ss_pred             EEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhh
Q 040392          313 HLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVND  391 (470)
Q Consensus       313 kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~  391 (470)
                      ||+|||++.....   ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+  ....+..
T Consensus       182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~~~~~~  256 (327)
T 1fvr_A          182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKLPQ  256 (327)
T ss_dssp             EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHGGG
T ss_pred             EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH--HHHHhhc
Confidence            9999999874321   122233457889999999988889999999999999999998 999997643221  1111110


Q ss_pred             hcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHhhhcc
Q 040392          392 WLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNVG  460 (470)
Q Consensus       392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~~~~~  460 (470)
                      ...                  ...+..++.++.+++.+||..||++|||+.|++++|+++.........
T Consensus       257 ~~~------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~  307 (327)
T 1fvr_A          257 GYR------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVN  307 (327)
T ss_dssp             TCC------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBC
T ss_pred             CCC------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCccc
Confidence            000                  001123467789999999999999999999999999999865444333

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=6.9e-43  Score=339.94  Aligned_cols=243  Identities=25%  Similarity=0.318  Sum_probs=203.8

Q ss_pred             hhCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccc--------hhhhhHHHHHHHHhcCCCCcceeEEeeeccC
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCG--------RALKGFDVECEMMKSIRHRNLIKVISTCSNE  241 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~  241 (470)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++.....        .....+..|+++++.++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            456899999999999999999975 4689999999875421        2345677899999999999999999999999


Q ss_pred             CeeeEEEecCCCC-ChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccc
Q 040392          242 EFKALVLEYMPHG-SLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA  320 (470)
Q Consensus       242 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a  320 (470)
                      ...++||||+.+| +|.+++.... .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence            9999999999777 9999996554 5899999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCCcccccccccCccccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccc
Q 040392          321 KLLTGEDQSMTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTME  399 (470)
Q Consensus       321 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  399 (470)
                      .......   ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.......       .         
T Consensus       178 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~---------  238 (335)
T 3dls_A          178 AYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-------E---------  238 (335)
T ss_dssp             EECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-------T---------
T ss_pred             eECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-------h---------
Confidence            8764332   2234568999999999988776 789999999999999999999997532110       0         


Q ss_pred             cccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          400 VVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                         ....        .+..++.++.+++.+||+.||++|||+.|++++
T Consensus       239 ---~~~~--------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          239 ---AAIH--------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ---TCCC--------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ---hccC--------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               0000        011236678999999999999999999999987

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=5.1e-43  Score=331.89  Aligned_cols=252  Identities=30%  Similarity=0.444  Sum_probs=200.7

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccC-CeeeEEEec
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNE-EFKALVLEY  250 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-~~~~lv~e~  250 (470)
                      .++|++.+.||+|+||.||+|+.. |+.||+|++...  ...+.+.+|+++++.++||||+++++++.+. ...++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            467899999999999999999884 899999998743  2456788999999999999999999987544 578999999


Q ss_pred             CCCCChHHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          251 MPHGSLEKYMYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      +++++|.+++..... .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++......   
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---  170 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  170 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence            999999999976542 3788999999999999999999   899999999999999999999999999998755322   


Q ss_pred             ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                        .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+  ....+.....              
T Consensus       171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~~~~~~~--------------  232 (278)
T 1byg_A          171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKGYK--------------  232 (278)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHHHTTTCC--------------
T ss_pred             --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHhcCCC--------------
Confidence              123357889999999988889999999999999999998 999987643221  1111111000              


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                          ...+..++..+.+++.+||+.||++||++.|+++.|++++..
T Consensus       233 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          233 ----MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence                011223467789999999999999999999999999999754

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=7.7e-43  Score=336.89  Aligned_cols=269  Identities=22%  Similarity=0.266  Sum_probs=200.2

Q ss_pred             hCCCCCC-CeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCeeeEEE
Q 040392          172 TDGFSEN-NLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       172 ~~~~~~~-~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      .+.|++. +.||+|+||.||+|.. .+++.||||++..........+.+|++++.++ +||||+++++++.+.+..++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            4567774 7899999999999985 46899999999766555667788999999985 7999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC---eEEeeeccccccCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV---AHLSDFSIAKLLTG  325 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~---~kl~Dfg~a~~~~~  325 (470)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.   +||+|||++.....
T Consensus        91 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             EcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            9999999999997654 5899999999999999999999   899999999999999998776   99999999876532


Q ss_pred             CCC-----cccccccccCccccCccccCC-----CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhh-hhcC
Q 040392          326 EDQ-----SMTQTQTLATIGYMAPEYGRE-----GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVN-DWLP  394 (470)
Q Consensus       326 ~~~-----~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~-~~~~  394 (470)
                      ...     ........||+.|+|||++.+     ..++.++||||||+++|||++|+.||.........+..... ....
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  246 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ  246 (316)
T ss_dssp             ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred             CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence            211     111223468999999999864     45889999999999999999999999865432211000000 0000


Q ss_pred             CcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          395 ISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ....+.+........   ......++.++.+++.+||+.||++|||+.|+++|
T Consensus       247 ~~~~~~i~~~~~~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          247 NMLFESIQEGKYEFP---DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHHHHCCCCCC---HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHhccCcccC---chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            000000000000000   01112346779999999999999999999999985

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.3e-43  Score=354.18  Aligned_cols=249  Identities=22%  Similarity=0.280  Sum_probs=196.5

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc---cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++...   .......+..|+++++.++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            46799999999999999999975 46899999999754   233445677899999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCCeeeCCCCCeEEeeeccccccCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      |||+++|+|.+++.... .+++..+..++.|++.||+|||   + .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       227 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            99999999999997654 6899999999999999999999   7 89999999999999999999999999999754322


Q ss_pred             CCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccccc
Q 040392          327 DQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL  406 (470)
Q Consensus       327 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (470)
                        ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+  +...+...   ..         
T Consensus       303 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~i~~~---~~---------  366 (446)
T 4ejn_A          303 --GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELILME---EI---------  366 (446)
T ss_dssp             ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHC---CC---------
T ss_pred             --CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--HHHHHHhC---CC---------
Confidence              222345679999999999999999999999999999999999999997632211  11111100   00         


Q ss_pred             CchhhhhHhhhhhHHHHHHHHhhccCCCccCCC-----CHHHHHHH
Q 040392          407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRI-----NAREIVAK  447 (470)
Q Consensus       407 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~el~~~  447 (470)
                             ..+..++.++.+++.+||+.||.+||     ++.|+++|
T Consensus       367 -------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          367 -------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence                   00122366789999999999999999     99999875

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-42  Score=329.92  Aligned_cols=251  Identities=25%  Similarity=0.350  Sum_probs=198.9

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      .++|.+.+.||+|+||.||+|+.. ++..||+|++.... ....+.+.+|+++++.++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            457899999999999999999764 68999999987553 3345678899999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---CCCCCeEEeeecccccc
Q 040392          250 YMPHGSLEKYMYSS---NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLL  323 (470)
Q Consensus       250 ~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~a~~~  323 (470)
                      |+++|+|.+++...   ...+++..+..++.|++.||+|||   +.+|+||||||+||++   +.++.+||+|||++...
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999988543   356899999999999999999999   8999999999999999   55688999999999765


Q ss_pred             CCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccc
Q 040392          324 TGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA  403 (470)
Q Consensus       324 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (470)
                      ...   .......+|+.|+|||.+. ..++.++||||||+++|||++|+.||......+.  ........+....     
T Consensus       178 ~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~--~~~~~~~~~~~~~-----  246 (285)
T 3is5_A          178 KSD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV--QQKATYKEPNYAV-----  246 (285)
T ss_dssp             ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHCCCCCCC-----
T ss_pred             CCc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH--HhhhccCCccccc-----
Confidence            432   2223456899999999875 5689999999999999999999999976432211  1111110000000     


Q ss_pred             cccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                                 .....+.++.+++.+||+.||++|||+.|++++
T Consensus       247 -----------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          247 -----------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             -------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             -----------ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                       001125668899999999999999999999864

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3e-42  Score=328.88  Aligned_cols=262  Identities=23%  Similarity=0.364  Sum_probs=209.2

Q ss_pred             hCCCCCCC-eecccCceEEEEEEe---CCCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeee
Q 040392          172 TDGFSENN-LIGRGGFGSVYKARL---GDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKA  245 (470)
Q Consensus       172 ~~~~~~~~-~ig~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  245 (470)
                      .++|.+.+ .||+|+||.||+|.+   .+++.||||++....  ....+.+.+|+++++.++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            45677777 999999999999954   246889999987542  23356788999999999999999999999 556778


Q ss_pred             EEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC
Q 040392          246 LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  325 (470)
                      +||||+++++|.+++.... .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.....
T Consensus        94 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            9999999999999997654 5899999999999999999999   89999999999999999999999999999987644


Q ss_pred             CCCc-ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccc
Q 040392          326 EDQS-MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA  403 (470)
Q Consensus       326 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (470)
                      .... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......  .....+......        
T Consensus       170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~--------  239 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGERM--------  239 (291)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCCC--------
T ss_pred             CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCCC--------
Confidence            3322 12223446788999999988889999999999999999999 99999764322  112221111100        


Q ss_pred             cccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHhhh
Q 040392          404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRN  458 (470)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~~~  458 (470)
                                ..+..++.++.+++.+||+.||++||++.++++.|+++..+....
T Consensus       240 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~  284 (291)
T 1xbb_A          240 ----------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE  284 (291)
T ss_dssp             ----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred             ----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhc
Confidence                      011234677999999999999999999999999999998765443

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=6.4e-42  Score=326.35  Aligned_cols=247  Identities=23%  Similarity=0.372  Sum_probs=198.4

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeecc----CCeeeE
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSN----EEFKAL  246 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~----~~~~~l  246 (470)
                      .|.+.+.||+|+||.||+|... ++..||+|.+...  .....+.+.+|+.+++.++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            4677789999999999999764 6889999998754  23456678899999999999999999998754    456899


Q ss_pred             EEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeeC-CCCCeEEeeecccccc
Q 040392          247 VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP--IIHCDLKPSNVLLD-DNMVAHLSDFSIAKLL  323 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--i~H~dlkp~Nill~-~~~~~kl~Dfg~a~~~  323 (470)
                      ||||+++|+|.+++.... .+++..+..++.|++.||.|||   +.+  ++||||||+||+++ .++.+||+|||++...
T Consensus       107 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            999999999999997643 5899999999999999999999   888  99999999999997 8899999999999754


Q ss_pred             CCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccc
Q 040392          324 TGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA  403 (470)
Q Consensus       324 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (470)
                      ...    ......+|+.|+|||.+. +.++.++||||||+++|+|++|+.||..................+.        
T Consensus       183 ~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------  249 (290)
T 1t4h_A          183 RAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA--------  249 (290)
T ss_dssp             CTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG--------
T ss_pred             ccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCcc--------
Confidence            322    223456899999999886 4589999999999999999999999976433222111111100000        


Q ss_pred             cccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                                ..+...+.++.+++.+||+.||.+|||+.|++++
T Consensus       250 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          250 ----------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             ----------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ----------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                      0112235678999999999999999999999875

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3e-42  Score=327.37  Aligned_cols=257  Identities=23%  Similarity=0.323  Sum_probs=206.0

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccc------hhhhhHHHHHHHHhcCCCCcceeEEeeeccCCee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG------RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFK  244 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  244 (470)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++.....      ...+.+.+|+++++.++||||+++++++.+....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            356889999999999999999875 689999999875422      1356788999999999999999999999999999


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC----CeEEeeeccc
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM----VAHLSDFSIA  320 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~----~~kl~Dfg~a  320 (470)
                      ++||||+++++|.+++.... .+++..+..++.|++.||.|||   +.+++|+||||+||+++.++    .+||+|||++
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            99999999999999996543 6899999999999999999999   89999999999999998877    8999999999


Q ss_pred             cccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccc
Q 040392          321 KLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEV  400 (470)
Q Consensus       321 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (470)
                      .......   ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||......+ ...........      
T Consensus       160 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~------  229 (283)
T 3bhy_A          160 HKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-TLTNISAVNYD------  229 (283)
T ss_dssp             EECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTTCCC------
T ss_pred             eeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-HHHHhHhcccC------
Confidence            8764322   2234568999999999998899999999999999999999999997643211 11111000000      


Q ss_pred             ccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH--HHHHH
Q 040392          401 VGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK--LLKIR  452 (470)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~--L~~i~  452 (470)
                                ........++..+.+++.+||..||++||++.|++++  ++++.
T Consensus       230 ----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          230 ----------FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             ----------CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             ----------CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence                      0011123346778999999999999999999999984  45554

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.5e-42  Score=339.60  Aligned_cols=274  Identities=24%  Similarity=0.266  Sum_probs=207.9

Q ss_pred             cCHHHHHHhhCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcCC-----CCcceeEEe
Q 040392          163 FSHLELCRATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIR-----HRNLIKVIS  236 (470)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~nIv~~~~  236 (470)
                      ++..+.....++|.+.+.||+|+||.||+|+. .+++.||||++... ......+..|+.+++.++     ||||+++++
T Consensus        25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~  103 (360)
T 3llt_A           25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHG  103 (360)
T ss_dssp             CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred             eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence            34444445578999999999999999999986 46899999998632 334456777999999986     999999999


Q ss_pred             eeccCCeeeEEEecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-------
Q 040392          237 TCSNEEFKALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-------  308 (470)
Q Consensus       237 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~-------  308 (470)
                      ++...+..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.       
T Consensus       104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~  179 (360)
T 3llt_A          104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSL  179 (360)
T ss_dssp             EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEE
T ss_pred             eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccccc
Confidence            999999999999999 889999997655 45899999999999999999999   999999999999999975       


Q ss_pred             ------------------CCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh
Q 040392          309 ------------------NMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT  370 (470)
Q Consensus       309 ------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t  370 (470)
                                        ++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~  254 (360)
T 3llt_A          180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT  254 (360)
T ss_dssp             EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred             cchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence                              889999999999865322     234568999999999999999999999999999999999


Q ss_pred             CCCCCCccccCcchhhHHhhhhcCCc-----------ccccccccc--------cC-chhhh------hHhhhhhHHHHH
Q 040392          371 GKKPTNEIFNGEMTLKHWVNDWLPIS-----------TMEVVGANL--------LS-QEDIH------FVAKEQCVSCVF  424 (470)
Q Consensus       371 g~~p~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~--------~~-~~~~~------~~~~~~~~~~l~  424 (470)
                      |+.||......+ .+........+..           .....+...        .. .....      ...+...+..+.
T Consensus       255 g~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~  333 (360)
T 3llt_A          255 GSLLFRTHEHME-HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFC  333 (360)
T ss_dssp             SSCSCCCSSHHH-HHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHH
T ss_pred             CCCCCCCCcHHH-HHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHH
Confidence            999997643221 1111111000000           000000000        00 00000      000111236788


Q ss_pred             HHHhhccCCCccCCCCHHHHHHH
Q 040392          425 NLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       425 ~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      +|+.+||+.||++|||+.|+++|
T Consensus       334 ~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          334 DFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHhcCChhhCCCHHHHhcC
Confidence            99999999999999999999864

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.7e-43  Score=363.69  Aligned_cols=258  Identities=27%  Similarity=0.446  Sum_probs=211.3

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      ..++|++.+.||+|+||.||+|++.++..||||+++... ...+.+.+|+++++.++||||+++++++.+ +..++||||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            356788889999999999999999888899999997543 234678999999999999999999999876 667899999


Q ss_pred             CCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          251 MPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       251 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      +++|+|.+++.... ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...... .
T Consensus       343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~  418 (535)
T 2h8h_A          343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y  418 (535)
T ss_dssp             CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-H
T ss_pred             hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-e
Confidence            99999999997532 45899999999999999999999   8999999999999999999999999999998653211 1


Q ss_pred             ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+  ....+.....              
T Consensus       419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--~~~~i~~~~~--------------  482 (535)
T 2h8h_A          419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGYR--------------  482 (535)
T ss_dssp             HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--HHHHHHTTCC--------------
T ss_pred             ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC--------------
Confidence            11223456788999999988899999999999999999999 999997643321  1111111100              


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                          ...+..++.++.+|+.+||+.||++|||+.+|++.|+++..+
T Consensus       483 ----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          483 ----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence                011234577899999999999999999999999999988643

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.5e-42  Score=336.00  Aligned_cols=256  Identities=23%  Similarity=0.281  Sum_probs=190.6

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCC-CCcceeEEeee--------ccC
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIR-HRNLIKVISTC--------SNE  241 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~--------~~~  241 (470)
                      ..+|++.+.||+|+||.||+|++. +++.||+|++..........+.+|+.+++++. ||||+++++++        ...
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            457899999999999999999864 68999999987666666777889999999996 99999999998        344


Q ss_pred             CeeeEEEecCCCCChHHhhhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeeCCCCCeEEeee
Q 040392          242 EFKALVLEYMPHGSLEKYMYS--SNYILDIFQRLNIMIDVASALEYLHFGYSAP--IIHCDLKPSNVLLDDNMVAHLSDF  317 (470)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--i~H~dlkp~Nill~~~~~~kl~Df  317 (470)
                      ...++||||+. |+|.+++..  ....+++..++.++.|++.||.|||   +.+  |+||||||+||+++.++.+||+||
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecC
Confidence            56789999996 699998865  3456899999999999999999999   888  999999999999999999999999


Q ss_pred             ccccccCCCCCcc----------cccccccCccccCcccc---CCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcch
Q 040392          318 SIAKLLTGEDQSM----------TQTQTLATIGYMAPEYG---REGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMT  384 (470)
Q Consensus       318 g~a~~~~~~~~~~----------~~~~~~~t~~y~aPE~~---~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~  384 (470)
                      |++..........          ......+|+.|+|||++   .+..++.++||||||+++|||++|+.||........ 
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-  261 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI-  261 (337)
T ss_dssp             TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh-
Confidence            9998764322211          11134589999999998   566789999999999999999999999975322110 


Q ss_pred             hhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          385 LKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       385 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                          .......                  .....++..+.+++.+||+.||++||++.|++++|+++...
T Consensus       262 ----~~~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~  309 (337)
T 3ll6_A          262 ----VNGKYSI------------------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA  309 (337)
T ss_dssp             --------CCC------------------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----hcCcccC------------------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                0000000                  00112234477999999999999999999999999999754

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.5e-42  Score=333.12  Aligned_cols=251  Identities=20%  Similarity=0.310  Sum_probs=203.3

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      .++|.+.+.||+|+||.||+|+.. +|+.||+|++..........+.+|+++++.++||||+++++++.+....++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            457889999999999999999865 6899999999865444556788999999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---CCCCCeEEeeeccccccCCCC
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      +++++|.+++.... .+++..+..++.|++.||.|||   +.+++|+||||+||++   +.++.+||+|||++.....  
T Consensus        88 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~--  161 (304)
T 2jam_A           88 VSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--  161 (304)
T ss_dssp             CCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC--
T ss_pred             CCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC--
Confidence            99999999986554 5899999999999999999999   8999999999999999   7889999999999875432  


Q ss_pred             CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                        .......+|+.|+|||.+.+..++.++||||||+++|||++|+.||......+ .............           
T Consensus       162 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~-----------  227 (304)
T 2jam_A          162 --GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-LFEKIKEGYYEFE-----------  227 (304)
T ss_dssp             --BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHCCCCCC-----------
T ss_pred             --CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHcCCCCCC-----------
Confidence              12234568999999999999999999999999999999999999997643211 1111111100000           


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                           ......++.++.+++.+||..||++||++.|++++
T Consensus       228 -----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          228 -----SPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             -----TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             -----ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                 00112346778999999999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.1e-42  Score=327.21  Aligned_cols=250  Identities=25%  Similarity=0.383  Sum_probs=205.3

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeecc----------
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN----------  240 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~----------  240 (470)
                      .++|++.+.||+|+||.||+|... +++.||+|.+....    ..+.+|+++++.++||||+++++++..          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            457889999999999999999875 79999999987543    356789999999999999999998754          


Q ss_pred             ------CCeeeEEEecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeE
Q 040392          241 ------EEFKALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH  313 (470)
Q Consensus       241 ------~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~k  313 (470)
                            ....++||||+++|+|.+++.... ..+++..+..++.|++.||.|||   +.+|+|+||||+||+++.++.+|
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~k  162 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVK  162 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEE
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCEE
Confidence                  445789999999999999997543 56899999999999999999999   89999999999999999999999


Q ss_pred             EeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhc
Q 040392          314 LSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWL  393 (470)
Q Consensus       314 l~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  393 (470)
                      |+|||++.......   ......+++.|+|||.+.+..++.++||||||+++|||++|..|+....       .+.....
T Consensus       163 l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-------~~~~~~~  232 (284)
T 2a19_B          163 IGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-------KFFTDLR  232 (284)
T ss_dssp             ECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-------HHHHHHH
T ss_pred             ECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-------HHHHHhh
Confidence            99999998764332   2234568999999999998889999999999999999999998864311       1111110


Q ss_pred             CCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHh
Q 040392          394 PISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL  456 (470)
Q Consensus       394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~  456 (470)
                      ....                  +..++.++.+++.+||+.||++||++.|++++|+.+..+..
T Consensus       233 ~~~~------------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          233 DGII------------------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             TTCC------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             cccc------------------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence            0000                  11235568899999999999999999999999999975543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-42  Score=337.78  Aligned_cols=271  Identities=23%  Similarity=0.262  Sum_probs=201.7

Q ss_pred             HHhhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccc-----hhhhhHHHHHHHHhcCCCCcceeEEeeeccCC
Q 040392          169 CRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-----RALKGFDVECEMMKSIRHRNLIKVISTCSNEE  242 (470)
Q Consensus       169 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  242 (470)
                      ....++|++.+.||+|+||.||+|+.. +|+.||||++.....     .....+.+|+++++.++||||+++++++....
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            344678999999999999999999865 589999999864321     12356788999999999999999999999999


Q ss_pred             eeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccc
Q 040392          243 FKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL  322 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~  322 (470)
                      ..++||||+++ +|.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++..
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            99999999986 899999877777899999999999999999999   89999999999999999999999999999987


Q ss_pred             cCCCCCcccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc---cc
Q 040392          323 LTGEDQSMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS---TM  398 (470)
Q Consensus       323 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~  398 (470)
                      .....  .......+|+.|+|||.+.+. .++.++||||||+++|||++|..||......+ .+...........   ..
T Consensus       162 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~  238 (346)
T 1ua2_A          162 FGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQWP  238 (346)
T ss_dssp             TTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTSS
T ss_pred             ccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHcCCCChhhhh
Confidence            64322  223345789999999998764 48899999999999999999999987643221 1111111110000   00


Q ss_pred             ---ccccc---cccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          399 ---EVVGA---NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       399 ---~~~~~---~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                         ...+.   ...... ........++.++.+++.+||+.||++|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          239 DMCSLPDYVTFKSFPGI-PLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             STTSSTTCCCCCCCCCC-CHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhccCcccccccccCCC-ChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence               00000   000000 0001113446789999999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.1e-42  Score=333.60  Aligned_cols=253  Identities=24%  Similarity=0.330  Sum_probs=202.4

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      .++|++.+.||+|+||.||+|... +++.||+|++..........+..|+++++.++||||+++++++...+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            467999999999999999999875 5899999999766666677888999999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      +++++|.+++......+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++......  ..
T Consensus        98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~  172 (302)
T 2j7t_A           98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQ  172 (302)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--HH
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--cc
Confidence            9999999999876667999999999999999999999   899999999999999999999999999987543111  11


Q ss_pred             cccccccCccccCcccc-----CCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          331 TQTQTLATIGYMAPEYG-----REGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~-----~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      ......+|+.|+|||.+     .+..++.++||||||+++|+|++|+.||....... ..........+.          
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~----------  241 (302)
T 2j7t_A          173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSDPPT----------  241 (302)
T ss_dssp             C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCCC----------
T ss_pred             ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHhccCCcc----------
Confidence            12235689999999987     46678999999999999999999999997643221 111111110000          


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                             ...+..++.++.+++.+||+.||++|||+.|++++
T Consensus       242 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          242 -------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             -------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             -------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                   01123346678999999999999999999999874

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=5.8e-42  Score=327.26  Aligned_cols=252  Identities=24%  Similarity=0.371  Sum_probs=200.8

Q ss_pred             CCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      ++|.....||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            4456667999999999999985 468899999998766666778899999999999999999999999999999999999


Q ss_pred             CCCChHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCCeEEeeeccccccCCCCC
Q 040392          252 PHGSLEKYMYSSN--YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-NMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       252 ~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ++++|.+++....  ...++..+..++.|++.||.|||   +.+++|+||||+||+++. ++.+||+|||++....... 
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-  177 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-  177 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence            9999999997653  34578889999999999999999   899999999999999987 8999999999998764321 


Q ss_pred             cccccccccCccccCccccCCCC--CCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccccc
Q 040392          329 SMTQTQTLATIGYMAPEYGREGR--VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL  406 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (470)
                       .......+++.|+|||.+.+..  ++.++||||||+++|+|++|+.||...................        +   
T Consensus       178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------~---  245 (295)
T 2clq_A          178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH--------P---  245 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCC--------C---
T ss_pred             -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccc--------c---
Confidence             1223456899999999987643  7899999999999999999999997543222111110000000        0   


Q ss_pred             CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       407 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                             ..+..++.++.+++.+||+.||++||++.|++++
T Consensus       246 -------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          246 -------EIPESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             -------CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             -------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                   0112346678999999999999999999999864

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.4e-42  Score=338.10  Aligned_cols=275  Identities=20%  Similarity=0.234  Sum_probs=203.5

Q ss_pred             HHHHHHhhCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccch-----------hhhhHHHHHHHHhcCCCCccee
Q 040392          165 HLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGR-----------ALKGFDVECEMMKSIRHRNLIK  233 (470)
Q Consensus       165 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~nIv~  233 (470)
                      ..++....++|.+.+.||+|+||.||+|...+|+.||||++......           ..+.+.+|+++++.++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            34667778999999999999999999999888999999998543211           2367889999999999999999


Q ss_pred             EEeeec-----cCCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC
Q 040392          234 VISTCS-----NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD  308 (470)
Q Consensus       234 ~~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~  308 (470)
                      +++++.     .....++||||++ |+|.+++......+++..+..++.|++.||.|||   +.+|+||||||+||+++.
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~  169 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLAD  169 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECT
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEcC
Confidence            999983     3446799999997 5999998877778999999999999999999999   899999999999999999


Q ss_pred             CCCeEEeeeccccccCCCCCcccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhH
Q 040392          309 NMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKH  387 (470)
Q Consensus       309 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~  387 (470)
                      ++.+||+|||++......   .......+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+ .+..
T Consensus       170 ~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~  245 (362)
T 3pg1_A          170 NNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-QLNK  245 (362)
T ss_dssp             TCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHH
T ss_pred             CCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH-HHHH
Confidence            999999999999754322   22334578999999998876 678999999999999999999999997643211 1111


Q ss_pred             HhhhhcCCccc-----------ccccccccC-chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          388 WVNDWLPISTM-----------EVVGANLLS-QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       388 ~~~~~~~~~~~-----------~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ...........           ......... ...........++..+.+++.+||+.||++|||+.|+++|
T Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            11111000000           000000000 0001112223446778999999999999999999999975

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=7.5e-42  Score=342.64  Aligned_cols=254  Identities=24%  Similarity=0.286  Sum_probs=195.3

Q ss_pred             HhhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--------chhhhhHHHHHHHHhcCCCCcceeEEeeecc
Q 040392          170 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--------GRALKGFDVECEMMKSIRHRNLIKVISTCSN  240 (470)
Q Consensus       170 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  240 (470)
                      ...++|.+.+.||+|+||.||+|... +++.||||++....        ......+.+|++++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            34678999999999999999999754 58999999987542        1223467889999999999999999999865


Q ss_pred             CCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC---CeEEeee
Q 040392          241 EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM---VAHLSDF  317 (470)
Q Consensus       241 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~---~~kl~Df  317 (470)
                       +..++||||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++   .+||+||
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DF  286 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF  286 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred             -CceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeec
Confidence             45789999999999999986544 6899999999999999999999   89999999999999997544   5999999


Q ss_pred             ccccccCCCCCcccccccccCccccCccccCC---CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcC
Q 040392          318 SIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE---GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLP  394 (470)
Q Consensus       318 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  394 (470)
                      |+++.....   .......||+.|+|||++.+   ..++.++||||||+++|+|++|+.||........ +...+.....
T Consensus       287 G~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~~i~~~~~  362 (419)
T 3i6u_A          287 GHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKDQITSGKY  362 (419)
T ss_dssp             STTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-HHHHHHTTCC
T ss_pred             ccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-HHHHHhcCCC
Confidence            999875422   22234679999999999853   5688899999999999999999999976433322 2221111100


Q ss_pred             CcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          395 ISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      .               ........++.++.+++.+||+.||++||++.|+++|
T Consensus       363 ~---------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          363 N---------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             C---------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             C---------------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            0               0011123346778999999999999999999999986

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.6e-42  Score=348.90  Aligned_cols=262  Identities=22%  Similarity=0.225  Sum_probs=196.1

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccC------C
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNE------E  242 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~------~  242 (470)
                      .++|++.+.||+|+||.||+|... +++.||||++...  .....+.+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            578999999999999999999754 6899999999754  334466788999999999999999999998554      4


Q ss_pred             eeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccc
Q 040392          243 FKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL  322 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~  322 (470)
                      ..++||||+++ +|.+.+..   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence            56999999976 56666643   3889999999999999999999   89999999999999999999999999999986


Q ss_pred             cCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCC-------
Q 040392          323 LTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPI-------  395 (470)
Q Consensus       323 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------  395 (470)
                      ....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+ .+...+......       
T Consensus       214 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~-~~~~i~~~lg~p~~~~~~~  289 (464)
T 3ttj_A          214 AGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMKK  289 (464)
T ss_dssp             ---C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCHHHHTT
T ss_pred             cCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHH
Confidence            5422   22345679999999999999999999999999999999999999997643211 111111100000       


Q ss_pred             ---------------c---ccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          396 ---------------S---TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       396 ---------------~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                                     .   ............   ........+.++.+|+.+||+.||++|||+.|+++|
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPA---DSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCC---SSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cchhhhhHhhcccccCCCChHHhCccccccc---ccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                           0   000000000000   001112236678999999999999999999999986

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5.2e-42  Score=352.31  Aligned_cols=251  Identities=24%  Similarity=0.368  Sum_probs=207.4

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++....   ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            466889999999999999999864 69999999996542   23345678899999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCC
Q 040392          248 LEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      |||+++|+|.+++.... ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++......
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999999987654 35899999999999999999999   899999999999999999999999999999876432


Q ss_pred             CCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcc--hhhHHhhhhcCCccccccccc
Q 040392          327 DQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEM--TLKHWVNDWLPISTMEVVGAN  404 (470)
Q Consensus       327 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  404 (470)
                      .   .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........  .+...+... +..        
T Consensus       340 ~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-~~~--------  407 (576)
T 2acx_A          340 Q---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-PEE--------  407 (576)
T ss_dssp             C---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-CCC--------
T ss_pred             c---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-ccc--------
Confidence            2   22345799999999999998999999999999999999999999986433211  111111110 000        


Q ss_pred             ccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCC-----CHHHHHHH
Q 040392          405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRI-----NAREIVAK  447 (470)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~el~~~  447 (470)
                                .+..++.++.+|+.+||+.||++||     ++.|+++|
T Consensus       408 ----------~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          408 ----------YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             ----------CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             ----------CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence                      0123366789999999999999999     78999876

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4.6e-42  Score=345.68  Aligned_cols=201  Identities=24%  Similarity=0.338  Sum_probs=168.0

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccC-----Ce
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNE-----EF  243 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-----~~  243 (470)
                      .++|++.+.||+|+||.||+|+.. +++.||||++...  .....+.+.+|+++++.++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            578999999999999999999764 5889999999653  233456788999999999999999999998765     57


Q ss_pred             eeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecccccc
Q 040392          244 KALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  323 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~  323 (470)
                      .++||||++ |+|.+++... ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence            899999996 5999999654 46899999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCCCc--------------------ccccccccCccccCcccc-CCCCCCCccchhhHHHHHHHHHhCCCCCCc
Q 040392          324 TGEDQS--------------------MTQTQTLATIGYMAPEYG-REGRVSTNGDVYSFGIMLMETFTGKKPTNE  377 (470)
Q Consensus       324 ~~~~~~--------------------~~~~~~~~t~~y~aPE~~-~~~~~~~~~DvwslGv~l~el~tg~~p~~~  377 (470)
                      ......                    ......+||+.|+|||++ ....++.++|||||||++|||++|..||..
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~  254 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN  254 (432)
T ss_dssp             -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence            433211                    123556899999999985 566799999999999999999987666543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.1e-42  Score=335.85  Aligned_cols=271  Identities=23%  Similarity=0.278  Sum_probs=198.0

Q ss_pred             HHhhCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeee
Q 040392          169 CRATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKA  245 (470)
Q Consensus       169 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  245 (470)
                      ....++|++.+.||+|+||.||+|.. .+++.||||++....  ......+.+|+++++.++||||+++++++.+....+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            34567899999999999999999975 468999999986543  223456678999999999999999999999999999


Q ss_pred             EEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee-----CCCCCeEEeeeccc
Q 040392          246 LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL-----DDNMVAHLSDFSIA  320 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill-----~~~~~~kl~Dfg~a  320 (470)
                      +||||+++ +|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||++     +.++.+||+|||++
T Consensus       110 lv~e~~~~-~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          110 LIFEYAEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EEEECCSE-EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EEEecCCC-CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            99999975 9999997654 5899999999999999999999   8999999999999999     45556999999999


Q ss_pred             cccCCCCCcccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhh-cCCc-c
Q 040392          321 KLLTGEDQSMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDW-LPIS-T  397 (470)
Q Consensus       321 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~-~  397 (470)
                      ......  ........+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+ .+....... .+.. .
T Consensus       185 ~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~  261 (329)
T 3gbz_A          185 RAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID-QLFKIFEVLGLPDDTT  261 (329)
T ss_dssp             HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTT
T ss_pred             cccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH-HHHHHHHHhCCCchhh
Confidence            876422  1223345689999999998774 48999999999999999999999997643221 111111110 0000 0


Q ss_pred             -ccc-----cccc--ccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          398 -MEV-----VGAN--LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       398 -~~~-----~~~~--~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                       ...     ....  ...........+..++.++.+|+.+||+.||++|||+.|+++|
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence             000     0000  0011112222334457789999999999999999999999874

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.2e-42  Score=330.22  Aligned_cols=252  Identities=28%  Similarity=0.367  Sum_probs=203.0

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      ..++|++.+.||+|+||.||+|... +|+.||+|.+....  ....+.+|+.+++.++||||+++++++......++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            4567999999999999999999865 58999999987542  34668889999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      |+++++|.+++......+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++.......  
T Consensus       105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--  179 (314)
T 3com_A          105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM--  179 (314)
T ss_dssp             CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--
Confidence            99999999999766667899999999999999999999   8999999999999999999999999999998664321  


Q ss_pred             ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCch
Q 040392          330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE  409 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (470)
                      .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||........  ........+..             
T Consensus       180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~-------------  244 (314)
T 3com_A          180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA--IFMIPTNPPPT-------------  244 (314)
T ss_dssp             SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHSCCCC-------------
T ss_pred             cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHhcCCCcc-------------
Confidence            223345689999999999998999999999999999999999999976432111  11111000000             


Q ss_pred             hhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       410 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                         ...+..++..+.+++.+||..||.+|||+.|++++
T Consensus       245 ---~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          245 ---FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             ---CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ---cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence               00122346678999999999999999999999874

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.4e-42  Score=340.24  Aligned_cols=246  Identities=26%  Similarity=0.306  Sum_probs=192.9

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHH-HhcCCCCcceeEEeeeccCCeeeE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEM-MKSIRHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~nIv~~~~~~~~~~~~~l  246 (470)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|++....   ......+..|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            467999999999999999999865 58899999997543   2233445566666 577899999999999999999999


Q ss_pred             EEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCC
Q 040392          247 VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      ||||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       117 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            999999999999997644 5789999999999999999999   999999999999999999999999999999864322


Q ss_pred             CCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccccc
Q 040392          327 DQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL  406 (470)
Q Consensus       327 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (470)
                        .......+||+.|+|||++.+..++.++|+|||||++|||++|+.||......+ ..........  .          
T Consensus       193 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~~~~--~----------  257 (373)
T 2r5t_A          193 --NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-MYDNILNKPL--Q----------  257 (373)
T ss_dssp             --CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-HHHHHHHSCC--C----------
T ss_pred             --CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHhccc--C----------
Confidence              122345679999999999999999999999999999999999999997632221 1111111000  0          


Q ss_pred             CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHH
Q 040392          407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREI  444 (470)
Q Consensus       407 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el  444 (470)
                              .+..++.++.+++.+||+.||++||++.+.
T Consensus       258 --------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~  287 (373)
T 2r5t_A          258 --------LKPNITNSARHLLEGLLQKDRTKRLGAKDD  287 (373)
T ss_dssp             --------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred             --------CCCCCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence                    012235678899999999999999998533

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.1e-41  Score=339.30  Aligned_cols=251  Identities=22%  Similarity=0.272  Sum_probs=193.0

Q ss_pred             hCCCCCC-CeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHh-cCCCCcceeEEeeecc----CCee
Q 040392          172 TDGFSEN-NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMK-SIRHRNLIKVISTCSN----EEFK  244 (470)
Q Consensus       172 ~~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~nIv~~~~~~~~----~~~~  244 (470)
                      .++|.+. +.||+|+||.||+|... +|+.||||++..     ...+.+|+.++. ..+||||+++++++..    ....
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            3556665 68999999999999765 689999999863     234667888874 4589999999998865    5678


Q ss_pred             eEEEecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCCeEEeeeccc
Q 040392          245 ALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFSIA  320 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~a  320 (470)
                      ++||||+++|+|.+++.... ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.   ++.+||+|||++
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence            99999999999999997654 46899999999999999999999   899999999999999997   789999999999


Q ss_pred             cccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcch--hhHHhhhhcCCccc
Q 040392          321 KLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMT--LKHWVNDWLPISTM  398 (470)
Q Consensus       321 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~  398 (470)
                      +.....   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ....+....    .
T Consensus       212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~----~  284 (400)
T 1nxk_A          212 KETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ----Y  284 (400)
T ss_dssp             EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTC----C
T ss_pred             cccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCc----c
Confidence            865422   2223467899999999999999999999999999999999999999764332211  111111000    0


Q ss_pred             ccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          399 EVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                      ....           .....++.++.+|+.+||+.||++|||+.|+++|-
T Consensus       285 ~~~~-----------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          285 EFPN-----------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  323 (400)
T ss_dssp             CCCT-----------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             cCCC-----------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            0000           00123467789999999999999999999999874

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.9e-42  Score=326.87  Aligned_cols=247  Identities=23%  Similarity=0.337  Sum_probs=204.9

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+++++.++||||+++++++.+....++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            367899999999999999999865 57899999986432   22345688899999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||+++|+|.+++.... .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++...... 
T Consensus        93 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-  167 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-  167 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred             EEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence            99999999999997654 5899999999999999999999   999999999999999999999999999998765322 


Q ss_pred             CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                         ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||......+. ......    ...          
T Consensus       168 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~----~~~----------  229 (284)
T 2vgo_A          168 ---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET-HRRIVN----VDL----------  229 (284)
T ss_dssp             ---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHT----TCC----------
T ss_pred             ---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH-HHHHhc----ccc----------
Confidence               22345689999999999999999999999999999999999999976332111 111100    000          


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                            ..+..++.++.+++.+||+.||.+||++.|++++
T Consensus       230 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          230 ------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             ------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             ------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence                  0012235678899999999999999999999975

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.9e-42  Score=337.47  Aligned_cols=253  Identities=22%  Similarity=0.314  Sum_probs=200.6

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCeeeEEE
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ..++|++.+.||+|+||.||+|... +|+.||+|++....    ....+|++++.++ +||||+++++++.+....++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            3567999999999999999999865 68999999997543    2345688888887 7999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC----CCeEEeeeccccccC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN----MVAHLSDFSIAKLLT  324 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~----~~~kl~Dfg~a~~~~  324 (470)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||++..+    +.+||+|||++....
T Consensus        96 E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           96 ELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             CCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             eCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            9999999999997654 6899999999999999999999   8999999999999998433    359999999998764


Q ss_pred             CCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccc
Q 040392          325 GEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN  404 (470)
Q Consensus       325 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (470)
                      ...  .......+|+.|+|||++.+..++.++|||||||++|||++|+.||.......  ............. ..    
T Consensus       172 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~i~~~~~-~~----  242 (342)
T 2qr7_A          172 AEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT--PEEILARIGSGKF-SL----  242 (342)
T ss_dssp             CTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC--HHHHHHHHHHCCC-CC----
T ss_pred             CCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC--HHHHHHHHccCCc-cc----
Confidence            332  22234578999999999988789999999999999999999999997532211  1111111100000 00    


Q ss_pred             ccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                       ..      .....++.++.+++.+||..||++||++.|+++|
T Consensus       243 -~~------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          243 -SG------GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             -CS------TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             -Cc------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence             00      0012346778999999999999999999999875

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.4e-42  Score=328.97  Aligned_cols=249  Identities=19%  Similarity=0.279  Sum_probs=206.1

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      .++|.+.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            467889999999999999999865 58899999986542   23456788899999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||+++++|.+++.... .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.......
T Consensus        94 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             EECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            99999999999886544 6899999999999999999999   8999999999999999999999999999998764222


Q ss_pred             CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                        .......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||......+. .......    ..          
T Consensus       170 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~----~~----------  232 (294)
T 2rku_A          170 --ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-YLRIKKN----EY----------  232 (294)
T ss_dssp             --CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTT----CC----------
T ss_pred             --cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHhhc----cC----------
Confidence              222345689999999999988899999999999999999999999976432211 1111000    00          


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                            ..+..++..+.+++.+||+.||++|||+.|++++
T Consensus       233 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          233 ------SIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                  0012235668899999999999999999999986

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.3e-42  Score=331.20  Aligned_cols=260  Identities=25%  Similarity=0.398  Sum_probs=200.8

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC--CCc--EEEEEEeecc---cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG--DGM--EVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFK  244 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  244 (470)
                      .++|++.+.||+|+||.||+|++.  +++  .||+|++...   .....+.+.+|+++++.++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            357899999999999999999753  333  6899998654   2345677889999999999999999999998765 7


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccC
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~  324 (470)
                      ++||||+++++|.+++......+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++....
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            8999999999999999876667899999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCCc-ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCccccccc
Q 040392          325 GEDQS-MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVG  402 (470)
Q Consensus       325 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (470)
                      ..... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+  ....+..   ...     
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~---~~~-----  242 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--ILHKIDK---EGE-----  242 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHT---SCC-----
T ss_pred             ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH--HHHHHHc---cCC-----
Confidence            43322 22234557888999999988889999999999999999999 999997643221  1111110   000     


Q ss_pred             ccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          403 ANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                               ....+..++.++.+++.+||..||++||++.+++++|+++...
T Consensus       243 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          243 ---------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             ---------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence                     0001123467799999999999999999999999999998643

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=5.9e-42  Score=332.76  Aligned_cols=263  Identities=20%  Similarity=0.277  Sum_probs=201.7

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcCC-CCcceeEEeeecc--CCeeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIR-HRNLIKVISTCSN--EEFKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~--~~~~~lv  247 (470)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++...   ..+.+.+|+++++.++ ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            36789999999999999999975 57899999998743   3456888999999997 9999999999987  6678999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-CeEEeeeccccccCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-VAHLSDFSIAKLLTGE  326 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~  326 (470)
                      |||+++++|.+++.    .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++ .+||+|||++......
T Consensus       112 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             EECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             EeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            99999999999985    3788999999999999999999   99999999999999999776 8999999999876433


Q ss_pred             CCcccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccc----
Q 040392          327 DQSMTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVV----  401 (470)
Q Consensus       327 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----  401 (470)
                      .   ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.........+.............+..    
T Consensus       185 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          185 Q---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             C---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             C---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence            2   2234568999999999877 6689999999999999999999999965433222221111100000000000    


Q ss_pred             -----------cccccC--chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          402 -----------GANLLS--QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       402 -----------~~~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                                 ......  ...........++.++.+|+.+||+.||++|||+.|+++|
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                       000000  0000011122357789999999999999999999999875

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.1e-42  Score=336.36  Aligned_cols=265  Identities=18%  Similarity=0.261  Sum_probs=207.1

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchh-----------------hhhHHHHHHHHhcCCCCcceeE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRA-----------------LKGFDVECEMMKSIRHRNLIKV  234 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~nIv~~  234 (470)
                      .++|.+.+.||+|+||.||+|.. +|+.||+|++.......                 .+.+.+|+++++.++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999998 89999999987542211                 1778899999999999999999


Q ss_pred             EeeeccCCeeeEEEecCCCCChHHh------hhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCCeee
Q 040392          235 ISTCSNEEFKALVLEYMPHGSLEKY------MYSS-NYILDIFQRLNIMIDVASALEYLHFGYS-APIIHCDLKPSNVLL  306 (470)
Q Consensus       235 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~i~H~dlkp~Nill  306 (470)
                      ++++.+.+..++||||+++|+|.++      +... ...+++..+..++.|++.||.|||   + .+++||||||+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEE
Confidence            9999999999999999999999998      6542 467899999999999999999999   7 999999999999999


Q ss_pred             CCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCC-CCCC-ccchhhHHHHHHHHHhCCCCCCccccCcch
Q 040392          307 DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-RVST-NGDVYSFGIMLMETFTGKKPTNEIFNGEMT  384 (470)
Q Consensus       307 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~-~~DvwslGv~l~el~tg~~p~~~~~~~~~~  384 (470)
                      +.++.+||+|||.+......    ......++..|+|||.+.+. .++. ++||||||+++|||++|+.||.........
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  261 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL  261 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred             cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence            99999999999999875432    33446789999999999877 5666 999999999999999999999864432222


Q ss_pred             hhHHhhhhcCCcc--cccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          385 LKHWVNDWLPIST--MEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       385 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      .............  ..... ....  .........++.++.+++.+||+.||++||++.|++++
T Consensus       262 ~~~i~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          262 FNNIRTKNIEYPLDRNHFLY-PLTN--KKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             HHHHTSCCCCCCCSSSSSTT-TTCC----------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHhccCcCCccchhhhhc-cccc--cccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            2111111111000  00000 0000  00011123457789999999999999999999999984

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.1e-42  Score=328.35  Aligned_cols=251  Identities=23%  Similarity=0.277  Sum_probs=189.7

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccc--hhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      .++|++.+.||+|+||.||+|+. .+|+.||+|++.....  .....+.++...++.++||||+++++++.+.+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            46789999999999999999986 4789999999865422  22333445566688889999999999999999999999


Q ss_pred             ecCCCCChHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCCeeeCCCCCeEEeeeccccccC
Q 040392          249 EYMPHGSLEKYMYS---SNYILDIFQRLNIMIDVASALEYLHFGYSA-PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       249 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~  324 (470)
                      ||+++ +|.+++..   ....+++..+..++.|++.||+|||   +. +++||||||+||+++.++.+||+|||++....
T Consensus        86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99974 88777754   4457899999999999999999999   87 99999999999999999999999999998654


Q ss_pred             CCCCcccccccccCccccCcccc----CCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccc
Q 040392          325 GEDQSMTQTQTLATIGYMAPEYG----REGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEV  400 (470)
Q Consensus       325 ~~~~~~~~~~~~~t~~y~aPE~~----~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (470)
                      ...   ......+|+.|+|||.+    .+..++.++||||||+++|||++|+.||.........+........+..    
T Consensus       162 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----  234 (290)
T 3fme_A          162 DDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL----  234 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC----
T ss_pred             ccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc----
Confidence            322   22334689999999995    5667899999999999999999999999764333222222222111100    


Q ss_pred             ccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          401 VGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                                    ....++.++.+++.+||+.||++|||+.|+++|
T Consensus       235 --------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          235 --------------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             --------------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             --------------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence                          012336678999999999999999999999984

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.7e-42  Score=332.12  Aligned_cols=264  Identities=23%  Similarity=0.313  Sum_probs=188.8

Q ss_pred             HhhCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          170 RATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       170 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      ...++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            3457899999999999999999975 468999999986442 33456778899999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhc-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccc
Q 040392          248 LEYMPHGSLEKYMYS-------SNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA  320 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~-------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a  320 (470)
                      |||+++++|.+++..       ....+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            999999999999864       2356899999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCC---cccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc
Q 040392          321 KLLTGEDQ---SMTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS  396 (470)
Q Consensus       321 ~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  396 (470)
                      ........   ........+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||........... ......+..
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~  247 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML-TLQNDPPSL  247 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH-HHTSSCCCT
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH-HhccCCCcc
Confidence            76543211   112234568999999998865 5689999999999999999999999986543321111 111111100


Q ss_pred             ccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          397 TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       397 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      .....+..          ....++.++.+++.+||+.||++||++.|++++
T Consensus       248 ~~~~~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          248 ETGVQDKE----------MLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             TC-----C----------CCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ccccccch----------hhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            00000000          112346678999999999999999999999974

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=6.1e-43  Score=346.07  Aligned_cols=248  Identities=16%  Similarity=0.213  Sum_probs=192.5

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc---cchhhhhHHHHH---HHHhcCCCCcceeEE-------ee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ---CGRALKGFDVEC---EMMKSIRHRNLIKVI-------ST  237 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~nIv~~~-------~~  237 (470)
                      .++|.+.+.||+|+||.||+|+. .+|+.||||++...   .....+.+.+|+   ++++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46688899999999999999985 56999999999743   334567788999   455556899999998       55


Q ss_pred             eccCC-----------------eeeEEEecCCCCChHHhhhcCCC------CCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 040392          238 CSNEE-----------------FKALVLEYMPHGSLEKYMYSSNY------ILDIFQRLNIMIDVASALEYLHFGYSAPI  294 (470)
Q Consensus       238 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~i~~~i~~~L~~LH~~~~~~i  294 (470)
                      +...+                 ..++||||+ +|+|.+++.....      .+++..++.++.|++.||+|||   +.+|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            54442                 378999999 6799999976432      2235788899999999999999   8999


Q ss_pred             eecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCC-----------CCCCccchhhHHH
Q 040392          295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-----------RVSTNGDVYSFGI  363 (470)
Q Consensus       295 ~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----------~~~~~~DvwslGv  363 (470)
                      +||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999985321     2234557 999999999877           7999999999999


Q ss_pred             HHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHH
Q 040392          364 MLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINARE  443 (470)
Q Consensus       364 ~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e  443 (470)
                      ++|||++|+.||......... . +           .. .           ....++.++.+++.+||+.||++||++.|
T Consensus       302 il~elltg~~Pf~~~~~~~~~-~-~-----------~~-~-----------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e  356 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGGS-E-W-----------IF-R-----------SCKNIPQPVRALLEGFLRYPKEDRLLPLQ  356 (377)
T ss_dssp             HHHHHHHSSCCC------CCS-G-G-----------GG-S-----------SCCCCCHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred             HHHHHHHCCCCCcccccccch-h-h-----------hh-h-----------hccCCCHHHHHHHHHHcCCCchhCCCHHH
Confidence            999999999999764322110 0 0           00 0           00233667899999999999999999999


Q ss_pred             HHH--HHHHHHHH
Q 040392          444 IVA--KLLKIRDS  454 (470)
Q Consensus       444 l~~--~L~~i~~~  454 (470)
                      +++  .++++.+.
T Consensus       357 ~l~hp~f~~~~~~  369 (377)
T 3byv_A          357 AMETPEYEQLRTE  369 (377)
T ss_dssp             HHTSHHHHHHHHH
T ss_pred             HhhChHHHHHHHH
Confidence            997  45555443

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.3e-42  Score=339.83  Aligned_cols=265  Identities=20%  Similarity=0.315  Sum_probs=205.3

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      .++|++.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            357899999999999999999865 68999999997653 3345678899999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA-PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      |+++++|.+++.... .+++..+..++.|++.||.|||   +. +|+||||||+||+++.++.+||+|||++......  
T Consensus       112 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  185 (360)
T ss_dssp             CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence            999999999997654 5899999999999999999999   75 8999999999999999999999999998755321  


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhc---------------
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWL---------------  393 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---------------  393 (470)
                        ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+...  ......               
T Consensus       186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL--MFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHH--HHC------------------
T ss_pred             --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HhcccccccCCCCCCCcccCC
Confidence              1234578999999999999999999999999999999999999997643221110  000000               


Q ss_pred             ------------CCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          394 ------------PISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       394 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                                  +....+..+......  ........++.++.+|+.+||+.||++|||+.|+++|-
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  326 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA  326 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSC--CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred             CcccccccCCCCcccchhhhhHHhccC--CCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence                        000000000000000  00001123466799999999999999999999999863

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.9e-42  Score=335.23  Aligned_cols=268  Identities=24%  Similarity=0.317  Sum_probs=202.0

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++....  ....+.+.+|+++++.++||||+++++++.+....++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            467899999999999999999865 58999999986443  223455778999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||+++++|.++.... ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++....... 
T Consensus       104 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  178 (331)
T 4aaa_A          104 EFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-  178 (331)
T ss_dssp             ECCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             ecCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-
Confidence            999998888876543 46899999999999999999999   8999999999999999999999999999997654322 


Q ss_pred             cccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcC-----------Cc
Q 040392          329 SMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLP-----------IS  396 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-----------~~  396 (470)
                       .......+|+.|+|||.+.+. .++.++||||||+++|+|++|+.||......+. +.........           ..
T Consensus       179 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  256 (331)
T 4aaa_A          179 -EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ-LYHIMMCLGNLIPRHQELFNKNP  256 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHHHHHCG
T ss_pred             -cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhhhHhhhcc
Confidence             222345689999999998775 689999999999999999999999976433211 1111110000           00


Q ss_pred             -ccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          397 -TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       397 -~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                       ......+..... .........++.++.+++.+||+.||++|||+.|++++
T Consensus       257 ~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          257 VFAGVRLPEIKER-EPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             GGTTCCCCCCSSC-CCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ccccccCcccccc-chhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence             000000001000 01111123457789999999999999999999999976

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.1e-41  Score=349.15  Aligned_cols=253  Identities=23%  Similarity=0.321  Sum_probs=205.8

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ++|.+.+.||+|+||.||+|+.. +|+.||+|++....   ......+..|+++++.++||||+++++++......++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            57888899999999999999875 69999999997542   233456788999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC
Q 040392          249 EYMPHGSLEKYMYSSN---YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  325 (470)
                      ||+++|+|.+++....   ..+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+..
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            9999999999987543   46899999999999999999999   89999999999999999999999999999987643


Q ss_pred             CCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          326 EDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       326 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      ...  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .............        
T Consensus       342 ~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~-~~~~~~~i~~~~~--------  410 (543)
T 3c4z_A          342 GQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRVLEQAV--------  410 (543)
T ss_dssp             TCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC-HHHHHHHHHHCCC--------
T ss_pred             CCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh-HHHHHHHHhhccc--------
Confidence            221  22345799999999999999999999999999999999999999986432211 1111111110000        


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCH-----HHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINA-----REIVAK  447 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~el~~~  447 (470)
                              ..+..++.++.+++.+||+.||++||++     .++++|
T Consensus       411 --------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          411 --------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             --------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             --------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence                    0112346778999999999999999965     667653

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=6.2e-42  Score=347.64  Aligned_cols=195  Identities=24%  Similarity=0.334  Sum_probs=154.4

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeecc-----CCe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSN-----EEF  243 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-----~~~  243 (470)
                      .++|++.+.||+|+||.||+|+.. +++.||||++...  .....+.+.+|+++++.++||||+++++++..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            478999999999999999999754 6899999998643  23345678899999999999999999999843     357


Q ss_pred             eeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecccccc
Q 040392          244 KALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  323 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~  323 (470)
                      .++||||+. |+|.+++... ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       132 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEEeccc-cchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            899999984 6999998654 46899999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCCCc-------------------------ccccccccCccccCcccc-CCCCCCCccchhhHHHHHHHHHhC
Q 040392          324 TGEDQS-------------------------MTQTQTLATIGYMAPEYG-REGRVSTNGDVYSFGIMLMETFTG  371 (470)
Q Consensus       324 ~~~~~~-------------------------~~~~~~~~t~~y~aPE~~-~~~~~~~~~DvwslGv~l~el~tg  371 (470)
                      ......                         ......+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            422111                         123445789999999975 566799999999999999999994

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.4e-41  Score=326.21  Aligned_cols=250  Identities=24%  Similarity=0.366  Sum_probs=207.8

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      .+.|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            35688999999999999999975 468999999997553 3456778899999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      |+++++|.+++..  ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++.......  
T Consensus       101 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--  173 (303)
T 3a7i_A          101 YLGGGSALDLLEP--GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--  173 (303)
T ss_dssp             CCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--
T ss_pred             eCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccc--
Confidence            9999999999965  35899999999999999999999   8999999999999999999999999999998764322  


Q ss_pred             ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCch
Q 040392          330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE  409 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (470)
                      .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||......+  ....+....+..             
T Consensus       174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~-------------  238 (303)
T 3a7i_A          174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK--VLFLIPKNNPPT-------------  238 (303)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSCCCC-------------
T ss_pred             cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH--HHHHhhcCCCCC-------------
Confidence            22334578999999999999999999999999999999999999997643221  111111111100             


Q ss_pred             hhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       410 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                           .+..++..+.+++.+||+.||++|||+.|++++.
T Consensus       239 -----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          239 -----LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             -----CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             -----CccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence                 0123356789999999999999999999999864

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.7e-42  Score=334.97  Aligned_cols=249  Identities=19%  Similarity=0.276  Sum_probs=206.1

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      .++|.+.+.||+|+||.||++... +++.||+|++....   ....+.+..|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            467899999999999999999865 58899999987542   23456788899999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||+++++|.+++.... .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus       120 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            99999999999986543 6899999999999999999999   8999999999999999999999999999998764222


Q ss_pred             CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                        .......+|..|+|||++.+..++.++||||||+++|||++|+.||......+. .........              
T Consensus       196 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~--------------  258 (335)
T 2owb_A          196 --ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-YLRIKKNEY--------------  258 (335)
T ss_dssp             --CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHTCC--------------
T ss_pred             --ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHhcCCC--------------
Confidence              222345689999999999988899999999999999999999999976322111 111111000              


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                            ..+..++.++.+++.+||+.||++||++.|++++
T Consensus       259 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          259 ------SIPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  0012235668899999999999999999999875

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=4.5e-42  Score=351.15  Aligned_cols=251  Identities=23%  Similarity=0.327  Sum_probs=203.7

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      .++|++.+.||+|+||+||+|+.. +++.||||++....  ......+.+|+++++.++||||+++++++.+....++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            467999999999999999999865 68999999986432  334567889999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC---CCCCeEEeeeccccccCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~a~~~~~  325 (470)
                      ||+++|+|.+.+.... .+++..+..++.|++.||.|||   +.+|+||||||+||+++   .++.+||+|||++.....
T Consensus       101 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            9999999999886654 6899999999999999999999   99999999999999995   566899999999986643


Q ss_pred             CCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          326 EDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       326 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      .   .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||......+ .+...........         
T Consensus       177 ~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~---------  242 (486)
T 3mwu_A          177 N---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRVETGKYAFD---------  242 (486)
T ss_dssp             C-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCSC---------
T ss_pred             C---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCC---------
Confidence            2   22334579999999999875 58999999999999999999999997643221 1111111100000         


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                             ......++.++.+++.+||+.||++|||+.|+++|
T Consensus       243 -------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          243 -------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             -------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             -------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                   01123346778999999999999999999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.5e-41  Score=332.96  Aligned_cols=271  Identities=21%  Similarity=0.282  Sum_probs=203.9

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeecc--------
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSN--------  240 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--------  240 (470)
                      .++|++.+.||+|+||.||+|+. .+|+.||+|++....  ......+.+|+++++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            46799999999999999999986 578999999986543  2234567789999999999999999999876        


Q ss_pred             CCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccc
Q 040392          241 EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA  320 (470)
Q Consensus       241 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a  320 (470)
                      ....++||||+++ +|.+.+......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            3467899999975 888888777677999999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCC--cccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhh--cCC
Q 040392          321 KLLTGEDQ--SMTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDW--LPI  395 (470)
Q Consensus       321 ~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~  395 (470)
                      ..+.....  ........+|+.|+|||++.+ ..++.++||||||+++|||++|+.||....... .........  .+.
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~  250 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQLCGSITP  250 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCT
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCh
Confidence            87643221  222344678999999998876 458999999999999999999999998643221 111111100  000


Q ss_pred             cc-cccccccc------c---CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          396 ST-MEVVGANL------L---SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       396 ~~-~~~~~~~~------~---~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      .. ........      .   .............+..+.+|+.+||+.||++|||+.|+++|
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            00 00000000      0   00000111111225668899999999999999999999986

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=8e-42  Score=336.40  Aligned_cols=255  Identities=25%  Similarity=0.359  Sum_probs=205.8

Q ss_pred             HHhhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccc--------hhhhhHHHHHHHHhcC-CCCcceeEEeee
Q 040392          169 CRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--------RALKGFDVECEMMKSI-RHRNLIKVISTC  238 (470)
Q Consensus       169 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~nIv~~~~~~  238 (470)
                      ....++|++.+.||+|+||.||+|+.. +|+.||||++.....        ...+.+..|+.+++.+ +||||+++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            344567999999999999999999875 799999999875431        1245677899999999 799999999999


Q ss_pred             ccCCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeec
Q 040392          239 SNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFS  318 (470)
Q Consensus       239 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  318 (470)
                      ......++||||+++++|.+++... ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||
T Consensus       170 ~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~DfG  245 (365)
T 2y7j_A          170 ESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFG  245 (365)
T ss_dssp             EBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             eeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEecC
Confidence            9999999999999999999999754 36899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccCccccCccccCC------CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhh
Q 040392          319 IAKLLTGEDQSMTQTQTLATIGYMAPEYGRE------GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDW  392 (470)
Q Consensus       319 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  392 (470)
                      ++..+....   ......||+.|+|||++.+      ..++.++||||||+++|||++|+.||......  .....+...
T Consensus       246 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~~i~~~  320 (365)
T 2y7j_A          246 FSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI--LMLRMIMEG  320 (365)
T ss_dssp             TCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHT
T ss_pred             cccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhC
Confidence            998765322   2234679999999998753      35889999999999999999999999753221  111111110


Q ss_pred             cCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          393 LPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ..            .   ........++.++.+++.+||+.||++||++.|++++
T Consensus       321 ~~------------~---~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          321 QY------------Q---FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             CC------------C---CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CC------------C---CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            00            0   0011112346678999999999999999999999875

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=7e-42  Score=323.60  Aligned_cols=248  Identities=25%  Similarity=0.363  Sum_probs=197.2

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++....   ......+.+|+++++.++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            467999999999999999999875 79999999987542   23355788899999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||+++++|.+++.... .+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++.......
T Consensus        90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            99999999999997654 5899999999999999999999   8999999999999999999999999999998664322


Q ss_pred             CcccccccccCccccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccccc
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL  406 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (470)
                         ......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||......  .....+.....            
T Consensus       166 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~------------  228 (276)
T 2h6d_A          166 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--TLFKKIRGGVF------------  228 (276)
T ss_dssp             --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCC------------
T ss_pred             ---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--HHHHHhhcCcc------------
Confidence               2234568999999999987765 68999999999999999999999753221  11111111000            


Q ss_pred             CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       407 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                             ..+..++.++.+++.+||+.||++|||+.|++++
T Consensus       229 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          229 -------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                   0012235678899999999999999999999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.4e-42  Score=361.39  Aligned_cols=252  Identities=24%  Similarity=0.375  Sum_probs=201.7

Q ss_pred             CeecccCceEEEEEEe---CCCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCC
Q 040392          179 NLIGRGGFGSVYKARL---GDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH  253 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~  253 (470)
                      +.||+|+||.||+|.+   .+++.||||+++...  ....+.+.+|+++++.++||||+++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999964   246789999997543  2345678999999999999999999999965 457899999999


Q ss_pred             CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC-cccc
Q 040392          254 GSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ-SMTQ  332 (470)
Q Consensus       254 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~  332 (470)
                      |+|.+++... ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+..... ....
T Consensus       454 g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          454 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            9999999654 46899999999999999999999   89999999999999999999999999999987654322 1222


Q ss_pred             cccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhh
Q 040392          333 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDI  411 (470)
Q Consensus       333 ~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  411 (470)
                      ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+  ....+.....                 
T Consensus       530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i~~~~~-----------------  590 (635)
T 4fl3_A          530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEKGER-----------------  590 (635)
T ss_dssp             -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTCC-----------------
T ss_pred             cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC-----------------
Confidence            33456789999999998899999999999999999998 999997643321  1111111110                 


Q ss_pred             hhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHH
Q 040392          412 HFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL  455 (470)
Q Consensus       412 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~  455 (470)
                       ...+..++.++.+++..||+.||++||++.+|++.|+++..++
T Consensus       591 -~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l  633 (635)
T 4fl3_A          591 -MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  633 (635)
T ss_dssp             -CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             -CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence             0112345778999999999999999999999999999987554

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.7e-42  Score=326.92  Aligned_cols=253  Identities=21%  Similarity=0.288  Sum_probs=203.5

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeee--ccCCeeeE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTC--SNEEFKAL  246 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~--~~~~~~~l  246 (470)
                      .++|++.+.||+|+||.||+|+.. +++.||+|.+....  ....+.+.+|+++++.++||||+++++++  ......++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            467899999999999999999865 68999999997542  33456788999999999999999999987  44678899


Q ss_pred             EEecCCCCChHHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eeecCCCCCCeeeCCCCCeEEeeec
Q 040392          247 VLEYMPHGSLEKYMYSSN---YILDIFQRLNIMIDVASALEYLHFGYSAP-----IIHCDLKPSNVLLDDNMVAHLSDFS  318 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-----i~H~dlkp~Nill~~~~~~kl~Dfg  318 (470)
                      ||||+++++|.+++....   ..+++..++.++.|++.||+|||   +.+     ++||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            999999999999997532   35899999999999999999999   777     9999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccc
Q 040392          319 IAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTM  398 (470)
Q Consensus       319 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  398 (470)
                      ++.......  .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||......  .+...+......   
T Consensus       162 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~i~~~~~~---  234 (279)
T 2w5a_A          162 LARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAGKIREGKFR---  234 (279)
T ss_dssp             HHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCCC---
T ss_pred             hheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH--HHHHHHhhcccc---
Confidence            998654321  1223456899999999998888999999999999999999999999764321  111111111000   


Q ss_pred             ccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHH
Q 040392          399 EVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLL  449 (470)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~  449 (470)
                                     ..+..++.++.+++.+||+.||++||++.|+++++.
T Consensus       235 ---------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          235 ---------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             ---------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             ---------------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence                           011234677899999999999999999999998764

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.9e-42  Score=336.14  Aligned_cols=255  Identities=23%  Similarity=0.312  Sum_probs=203.5

Q ss_pred             hCCCCCCCeecccCceEEEEEEe----CCCcEEEEEEeeccc----chhhhhHHHHHHHHhcC-CCCcceeEEeeeccCC
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL----GDGMEVAVKVFNLQC----GRALKGFDVECEMMKSI-RHRNLIKVISTCSNEE  242 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~  242 (470)
                      .++|++.+.||+|+||.||+|+.    .+++.||||+++...    ......+..|+++++.+ .||||+++++++....
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            36799999999999999999986    368999999986432    23345567799999999 6999999999999999


Q ss_pred             eeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccc
Q 040392          243 FKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL  322 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~  322 (470)
                      ..++||||+++|+|.+++.... .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            9999999999999999997654 5899999999999999999999   89999999999999999999999999999986


Q ss_pred             cCCCCCcccccccccCccccCccccCC--CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccc
Q 040392          323 LTGEDQSMTQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEV  400 (470)
Q Consensus       323 ~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (470)
                      ..... ........||+.|+|||++.+  ..++.++||||||+++|||++|+.||........ ............    
T Consensus       209 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~----  282 (355)
T 1vzo_A          209 FVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILKSE----  282 (355)
T ss_dssp             CCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHHCC----
T ss_pred             cccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HHHHHHHHhccC----
Confidence            53221 222334579999999999885  3478999999999999999999999975432221 111111110000    


Q ss_pred             ccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCC-----CHHHHHHHH
Q 040392          401 VGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRI-----NAREIVAKL  448 (470)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~el~~~L  448 (470)
                                  ...+..++..+.+++.+||..||++||     ++.|++++.
T Consensus       283 ------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          283 ------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             ------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             ------------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                        001123466788999999999999999     999999875

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.4e-41  Score=323.10  Aligned_cols=244  Identities=19%  Similarity=0.275  Sum_probs=199.0

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCeeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      .++|++.+.||+|+||.||+|... +++.||+|++...  .......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            467899999999999999999875 7999999998754  233456678899999999 899999999999999999999


Q ss_pred             EecCCCCChHHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC---------------
Q 040392          248 LEYMPHGSLEKYMYSSN---YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN---------------  309 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~---------------  309 (470)
                      |||+++++|.+++....   ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.+               
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            99999999999997642   46899999999999999999999   8999999999999999844               


Q ss_pred             ----CCeEEeeeccccccCCCCCcccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcch
Q 040392          310 ----MVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMT  384 (470)
Q Consensus       310 ----~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~  384 (470)
                          ..+||+|||.+.......      ...+|+.|+|||.+.+. .++.++||||||+++|+|++|..|+...    ..
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~  236 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQ  236 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HH
T ss_pred             cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hH
Confidence                489999999998764322      23589999999998765 5678999999999999999998776432    11


Q ss_pred             hhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          385 LKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       385 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      .........+                   ..+..++.++.+++.+||+.||++|||+.|++++
T Consensus       237 ~~~~~~~~~~-------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          237 WHEIRQGRLP-------------------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             HHHHHTTCCC-------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             HHHHHcCCCC-------------------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence            1111111110                   0112346678999999999999999999999875

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.9e-42  Score=352.56  Aligned_cols=250  Identities=24%  Similarity=0.360  Sum_probs=205.9

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++....   ......+.+|+++++.++||||+++++++.+....++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            457899999999999999999865 78999999986542   33456788999999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---CCCCCeEEeeeccccccC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~a~~~~  324 (470)
                      |||+.+|+|.+++.... .+++..+..++.|++.||.|||   +.+|+||||||+||++   +.++.+||+|||++..+.
T Consensus       105 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             ECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            99999999999986554 6899999999999999999999   8999999999999999   567899999999998764


Q ss_pred             CCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhh-cCCcccccccc
Q 040392          325 GEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDW-LPISTMEVVGA  403 (470)
Q Consensus       325 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  403 (470)
                      ...   ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||......+  ....+... ...        
T Consensus       181 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~~~~~~--------  246 (484)
T 3nyv_A          181 ASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD--ILKKVEKGKYTF--------  246 (484)
T ss_dssp             CCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCCCC--------
T ss_pred             ccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHcCCCCC--------
Confidence            322   2334579999999999865 68999999999999999999999997643221  11111110 000        


Q ss_pred             cccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                              .......++.++.+++.+||+.||++|||+.|+++|
T Consensus       247 --------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          247 --------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             --------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence                    001112346778999999999999999999999975

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=5.2e-41  Score=340.75  Aligned_cols=263  Identities=18%  Similarity=0.205  Sum_probs=212.6

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcCCC-CcceeEEeeeccCCeeeEEEe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRH-RNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      .++|.+.+.||+|+||.||+|+. .+++.||||++....  ....+..|+++++.++| ++|..+..++...+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            47899999999999999999985 569999999876543  33468889999999987 556666666777888899999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---CCCCCeEEeeeccccccCCC
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      |+ +++|.+++......+++..++.++.||+.||+|||   +.+|+||||||+|||+   +.++.+||+|||+++.+...
T Consensus        84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99 88999999876778999999999999999999999   8999999999999999   68899999999999876543


Q ss_pred             CCc-----ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcch--hhHHhhhhcCCcccc
Q 040392          327 DQS-----MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMT--LKHWVNDWLPISTME  399 (470)
Q Consensus       327 ~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~  399 (470)
                      ...     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........  +...........   
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~---  236 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS---  236 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC---
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc---
Confidence            321     1223567999999999999999999999999999999999999999875433211  111111100000   


Q ss_pred             cccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHH
Q 040392          400 VVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL  455 (470)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~  455 (470)
                                  .......++.++.+++..||+.||++||++.+|++.|+++....
T Consensus       237 ------------~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          237 ------------IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             ------------HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             ------------HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence                        01112345778999999999999999999999999999997643

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.4e-41  Score=335.41  Aligned_cols=272  Identities=24%  Similarity=0.291  Sum_probs=201.7

Q ss_pred             HHhhCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeecc-------
Q 040392          169 CRATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN-------  240 (470)
Q Consensus       169 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-------  240 (470)
                      ....++|++.+.||+|+||.||+|+. .+|+.||||++.....    ...+|+++++.++||||+++++++..       
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            34567899999999999999999975 5799999999864322    23369999999999999999999833       


Q ss_pred             -------------------------------CCeeeEEEecCCCCChHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHH
Q 040392          241 -------------------------------EEFKALVLEYMPHGSLEKYMYS---SNYILDIFQRLNIMIDVASALEYL  286 (470)
Q Consensus       241 -------------------------------~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~L  286 (470)
                                                     ....++||||++ |+|.+.+..   ....+++..+..++.|+++||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           345789999998 488777653   345789999999999999999999


Q ss_pred             hcCCCCCeeecCCCCCCeeeC-CCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCC-CCCCccchhhHHHH
Q 040392          287 HFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIM  364 (470)
Q Consensus       287 H~~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~  364 (470)
                      |   +.+|+||||||+||+++ .++.+||+|||+++......   ......+|+.|+|||.+.+. .++.++||||+||+
T Consensus       158 H---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 H---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             H---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             H---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9   99999999999999997 68999999999998764332   22345689999999988765 48999999999999


Q ss_pred             HHHHHhCCCCCCccccCcchhhHHhhhhcCCc----------ccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCC
Q 040392          365 LMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS----------TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVES  434 (470)
Q Consensus       365 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d  434 (470)
                      +|||++|+.||......+ .+...+.......          ..+..-+. ..........+..++.++.+|+.+||+.|
T Consensus       232 l~ell~g~~pf~~~~~~~-~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~d  309 (383)
T 3eb0_A          232 FGELILGKPLFSGETSID-QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPT-LKAKDWRKILPEGTPSLAIDLLEQILRYE  309 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHHHCTTC--CCCCC-CCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred             HHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHHHhCcccccccCCc-cCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence            999999999998643221 1111111110000          00000000 01111222233446778999999999999


Q ss_pred             ccCCCCHHHHHHH--HHHHHH
Q 040392          435 PEQRINAREIVAK--LLKIRD  453 (470)
Q Consensus       435 P~~Rps~~el~~~--L~~i~~  453 (470)
                      |++|||+.|+++|  ++++++
T Consensus       310 P~~R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          310 PDLRINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             GGGSCCHHHHHTSGGGHHHHH
T ss_pred             hhhCCCHHHHhcCHHHHHHHh
Confidence            9999999999964  455544

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=7.3e-42  Score=350.23  Aligned_cols=255  Identities=22%  Similarity=0.338  Sum_probs=201.8

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      .++|++.+.||+|+||.||+|+.. ++..||+|++....  ......+.+|+++++.++||||+++++++.+....++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            456999999999999999999865 68999999987542  334567889999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCCeEEeeeccccccCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~a~~~~~  325 (470)
                      ||+++|+|.+++.... .+++..+..++.|++.||.|||   +.+|+||||||+||+++.   ++.+||+|||++.....
T Consensus       116 e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~  191 (494)
T 3lij_A          116 ECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN  191 (494)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence            9999999999886554 5899999999999999999999   899999999999999976   44599999999987643


Q ss_pred             CCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          326 EDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       326 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      ..   ......||+.|+|||++. ..++.++||||+||++|+|++|+.||......+. +...........         
T Consensus       192 ~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~---------  257 (494)
T 3lij_A          192 QK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI-LRKVEKGKYTFD---------  257 (494)
T ss_dssp             TB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCCCCC---------
T ss_pred             Cc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCCCC---------
Confidence            22   233467999999999886 5699999999999999999999999986433211 111111100000         


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH--HHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK--LLKI  451 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~--L~~i  451 (470)
                             ......++.++.+++.+||+.||.+|||+.|+++|  ++++
T Consensus       258 -------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          258 -------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             -------SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             -------chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence                   00112346678999999999999999999999976  4444

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.6e-41  Score=348.60  Aligned_cols=252  Identities=22%  Similarity=0.329  Sum_probs=202.8

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccc-------------hhhhhHHHHHHHHhcCCCCcceeEEe
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-------------RALKGFDVECEMMKSIRHRNLIKVIS  236 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~nIv~~~~  236 (470)
                      ..++|.+.+.||+|+||+||+|+.. +++.||+|++.....             ...+.+.+|+++++.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4578999999999999999999865 588999999865421             23456888999999999999999999


Q ss_pred             eeccCCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC---CeE
Q 040392          237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM---VAH  313 (470)
Q Consensus       237 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~---~~k  313 (470)
                      ++.+....++||||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++   .+|
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEE
Confidence            9999999999999999999999986654 5899999999999999999999   89999999999999998776   699


Q ss_pred             EeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhc
Q 040392          314 LSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWL  393 (470)
Q Consensus       314 l~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  393 (470)
                      |+|||++......   .......||+.|+|||++. +.++.++||||+||++|+|++|..||......+  +...+... 
T Consensus       190 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~~-  262 (504)
T 3q5i_A          190 IVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD--IIKKVEKG-  262 (504)
T ss_dssp             ECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHC-
T ss_pred             EEECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHcC-
Confidence            9999999876432   2233457999999999987 468999999999999999999999998643221  11111110 


Q ss_pred             CCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          394 PISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                        ..            .........++.++.+++.+||+.||.+|||+.|+++|
T Consensus       263 --~~------------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          263 --KY------------YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             --CC------------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --CC------------CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence              00            00011123456779999999999999999999999875

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.1e-41  Score=328.49  Aligned_cols=255  Identities=23%  Similarity=0.366  Sum_probs=198.9

Q ss_pred             HhhCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeeccc--chhhhhHHHHHHHHhcCC--CCcceeEEeeeccCCeee
Q 040392          170 RATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIR--HRNLIKVISTCSNEEFKA  245 (470)
Q Consensus       170 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~nIv~~~~~~~~~~~~~  245 (470)
                      ...++|++.+.||+|+||.||+|...+++.||+|++....  ......+.+|++++++++  |+||+++++++......+
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~  104 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  104 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence            3456799999999999999999998889999999986542  345577889999999997  599999999999999999


Q ss_pred             EEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC
Q 040392          246 LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  325 (470)
                      +||| +.+++|.+++.... .+++..+..++.|+++||.|||   +.+++||||||+||+++ ++.+||+|||++.....
T Consensus       105 lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~  178 (313)
T 3cek_A          105 MVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  178 (313)
T ss_dssp             EEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC---
T ss_pred             EEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEE-CCeEEEeeccccccccC
Confidence            9999 55789999997654 6899999999999999999999   89999999999999996 48999999999987654


Q ss_pred             CCCcccccccccCccccCccccCC-----------CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcC
Q 040392          326 EDQSMTQTQTLATIGYMAPEYGRE-----------GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLP  394 (470)
Q Consensus       326 ~~~~~~~~~~~~t~~y~aPE~~~~-----------~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  394 (470)
                      ...........|++.|+|||.+.+           ..++.++||||||+++|||++|+.||.........+.........
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  258 (313)
T 3cek_A          179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE  258 (313)
T ss_dssp             -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred             ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccc
Confidence            333333345578999999999865           468889999999999999999999997643322222211111100


Q ss_pred             CcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          395 ISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                      ..                  .+..++.++.+++.+||+.||++||++.|++++-
T Consensus       259 ~~------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~  294 (313)
T 3cek_A          259 IE------------------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  294 (313)
T ss_dssp             CC------------------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             cC------------------CcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence            00                  0112255688999999999999999999999863

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.1e-42  Score=336.52  Aligned_cols=264  Identities=25%  Similarity=0.288  Sum_probs=195.8

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCC------
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEE------  242 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~------  242 (470)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++...  .....+.+.+|+++++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46799999999999999999986 46999999998543  2334567889999999999999999999987653      


Q ss_pred             eeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccc
Q 040392          243 FKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL  322 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~  322 (470)
                      ..++||||+ +++|.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence            458999999 78999999763  5899999999999999999999   99999999999999999999999999999986


Q ss_pred             cCCCCCcccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCC--cccc
Q 040392          323 LTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPI--STME  399 (470)
Q Consensus       323 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~  399 (470)
                      ....     .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||....... .+..........  ....
T Consensus       178 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~~~~~~~~  251 (367)
T 1cm8_A          178 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVTGTPPAEFVQ  251 (367)
T ss_dssp             CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHH
T ss_pred             cccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHH
Confidence            5322     234578999999998876 679999999999999999999999997643211 111111100000  0000


Q ss_pred             cccc--------cccCc-hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          400 VVGA--------NLLSQ-EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       400 ~~~~--------~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      .+..        .+... ...........+.++.+|+.+||..||++|||+.|+++|
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            0000        00000 000000112346778999999999999999999999985

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.5e-42  Score=340.95  Aligned_cols=261  Identities=12%  Similarity=0.118  Sum_probs=185.9

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccc---hhhhhHHHHHHHHhcC--CCCcceeEEe-------ee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG---RALKGFDVECEMMKSI--RHRNLIKVIS-------TC  238 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~nIv~~~~-------~~  238 (470)
                      ..+|...+.||+|+||.||+|++. +|+.||||++.....   ...+.+.+|+.+++.+  +||||++++.       ++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345888999999999999999865 789999999976432   3455667785544444  6999888553       33


Q ss_pred             ccC-----------------CeeeEEEecCCCCChHHhhhcCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCee
Q 040392          239 SNE-----------------EFKALVLEYMPHGSLEKYMYSSNYILDIFQR------LNIMIDVASALEYLHFGYSAPII  295 (470)
Q Consensus       239 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~------~~i~~~i~~~L~~LH~~~~~~i~  295 (470)
                      ...                 ...++||||++ |+|.+++...+..+++..+      ..++.|++.||+|||   +.+|+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCc
Confidence            221                 34799999998 8999999875544555566      778899999999999   99999


Q ss_pred             ecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCC--CCCCCccchhhHHHHHHHHHhCCC
Q 040392          296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTGKK  373 (470)
Q Consensus       296 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~tg~~  373 (470)
                      ||||||+|||++.++.+||+|||+++....     ......+|+.|+|||++.+  ..++.++|||||||++|||++|+.
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            999999999999999999999999986532     1113457799999999987  679999999999999999999999


Q ss_pred             CCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH--HHHH
Q 040392          374 PTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK--LLKI  451 (470)
Q Consensus       374 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~--L~~i  451 (470)
                      ||.........  .|...    ......      ...........++.++.+++.+||+.||++|||+.|+++|  ++++
T Consensus       292 Pf~~~~~~~~~--~~~~~----~~~~~~------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  359 (371)
T 3q60_A          292 PFGLVTPGIKG--SWKRP----SLRVPG------TDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL  359 (371)
T ss_dssp             STTBCCTTCTT--CCCBC----CTTSCC------CCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred             CCCCcCccccc--chhhh----hhhhcc------ccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence            99875332111  00000    000000      0000111112447789999999999999999999999863  4444


Q ss_pred             HH
Q 040392          452 RD  453 (470)
Q Consensus       452 ~~  453 (470)
                      ..
T Consensus       360 ~~  361 (371)
T 3q60_A          360 QN  361 (371)
T ss_dssp             HH
T ss_pred             HH
Confidence            43

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.5e-41  Score=324.59  Aligned_cols=251  Identities=22%  Similarity=0.306  Sum_probs=200.3

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc----chhhhhHHHHHHHHhcCCCCcceeEEeee--ccCCee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC----GRALKGFDVECEMMKSIRHRNLIKVISTC--SNEEFK  244 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~--~~~~~~  244 (470)
                      .++|.+.+.||+|+||.||+|... +++.||+|++....    ......+.+|+++++.++||||+++++++  .+....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            478999999999999999999864 68999999986542    23456788999999999999999999998  455688


Q ss_pred             eEEEecCCCCChHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecccccc
Q 040392          245 ALVLEYMPHGSLEKYMYSS-NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  323 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~  323 (470)
                      ++||||++++ |.+++... ...+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++...
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999876 77776543 356899999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCCCcccccccccCccccCccccCCCC--CCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccc
Q 040392          324 TGEDQSMTQTQTLATIGYMAPEYGREGR--VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVV  401 (470)
Q Consensus       324 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (470)
                      .............+|+.|+|||++.+..  ++.++||||||+++|||++|+.||......  .....+...   .     
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~i~~~---~-----  229 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY--KLFENIGKG---S-----  229 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHC---C-----
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHHhcC---C-----
Confidence            5433333444567899999999987644  477999999999999999999999753211  111111100   0     


Q ss_pred             cccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          402 GANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                                 ...+..++..+.+++.+||+.||++|||+.|++++
T Consensus       230 -----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          230 -----------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             -----------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -----------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                       00112346678899999999999999999999976

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.4e-41  Score=329.88  Aligned_cols=256  Identities=20%  Similarity=0.237  Sum_probs=203.3

Q ss_pred             HHhhCCCCCC-CeecccCceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCC-CCcceeEEeeeccCCe
Q 040392          169 CRATDGFSEN-NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIR-HRNLIKVISTCSNEEF  243 (470)
Q Consensus       169 ~~~~~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~  243 (470)
                      ....++|.+. +.||+|+||.||+|... +++.||+|++....  ......+.+|+.+++.+. ||||+++++++.+...
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            3445667777 88999999999999765 68999999987542  233567888999999995 6999999999999999


Q ss_pred             eeEEEecCCCCChHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCCeEEeeecc
Q 040392          244 KALVLEYMPHGSLEKYMYSS-NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFSI  319 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~  319 (470)
                      .++||||+++|+|.+++... ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.   ++.+||+|||+
T Consensus       104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~  180 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM  180 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred             EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence            99999999999999998654 356899999999999999999999   899999999999999988   78999999999


Q ss_pred             ccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccc
Q 040392          320 AKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTME  399 (470)
Q Consensus       320 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  399 (470)
                      +.......   ......+|+.|+|||++.+..++.++||||||+++|||++|+.||......+. ............   
T Consensus       181 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~---  253 (327)
T 3lm5_A          181 SRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET-YLNISQVNVDYS---  253 (327)
T ss_dssp             CEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCCCCC---
T ss_pred             ccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-HHHHHhcccccC---
Confidence            98764322   22345799999999999999999999999999999999999999976432211 111111000000   


Q ss_pred             cccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          400 VVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                                   ......++..+.+++.+||+.||++|||+.|++++
T Consensus       254 -------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          254 -------------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             -------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             -------------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence                         00112346678999999999999999999999876

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.8e-42  Score=331.32  Aligned_cols=256  Identities=23%  Similarity=0.332  Sum_probs=199.0

Q ss_pred             HHHHhhCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcC-CCCcceeEEeeecc----
Q 040392          167 ELCRATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSI-RHRNLIKVISTCSN----  240 (470)
Q Consensus       167 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~----  240 (470)
                      ++....++|++.+.||+|+||.||+|+. .+|+.||+|++.... .....+.+|+.+++++ +||||+++++++..    
T Consensus        18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   96 (326)
T 2x7f_A           18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   96 (326)
T ss_dssp             CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred             hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence            3344578899999999999999999986 468999999987543 3456788899999999 79999999999865    


Q ss_pred             --CCeeeEEEecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeee
Q 040392          241 --EEFKALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF  317 (470)
Q Consensus       241 --~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  317 (470)
                        ....++||||+++|+|.+++.... ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+||
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Df  173 (326)
T 2x7f_A           97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDF  173 (326)
T ss_dssp             CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred             cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeC
Confidence              467899999999999999997643 46899999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccCccccCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhh
Q 040392          318 SIAKLLTGEDQSMTQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDW  392 (470)
Q Consensus       318 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  392 (470)
                      |++......  ........+++.|+|||++.     +..++.++||||||+++|+|++|+.||........  ...+...
T Consensus       174 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~  249 (326)
T 2x7f_A          174 GVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA--LFLIPRN  249 (326)
T ss_dssp             TTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHS
T ss_pred             cCceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH--HHHhhcC
Confidence            998765322  11223456899999999986     56689999999999999999999999975432111  1111110


Q ss_pred             cCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          393 LPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ..        +..         ....++..+.+++.+||..||++||++.|++++
T Consensus       250 ~~--------~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          250 PA--------PRL---------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             CC--------CCC---------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             cc--------ccC---------CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            00        000         012235678999999999999999999999885

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.6e-41  Score=331.86  Aligned_cols=262  Identities=22%  Similarity=0.219  Sum_probs=193.4

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCC------
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEE------  242 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~------  242 (470)
                      .++|++.+.||+|+||.||+|... +++.||||++...  .....+.+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            468999999999999999999754 6899999998753  2334566788999999999999999999987654      


Q ss_pred             eeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccc
Q 040392          243 FKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL  322 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~  322 (470)
                      ..++||||+++ +|.+++..   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++..
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             ceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence            77999999975 78888852   4789999999999999999999   89999999999999999999999999999986


Q ss_pred             cCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCC-------
Q 040392          323 LTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPI-------  395 (470)
Q Consensus       323 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------  395 (470)
                      ....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+...+......       
T Consensus       177 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~  252 (371)
T 2xrw_A          177 AGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEFMKK  252 (371)
T ss_dssp             ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHC-CCCCCHHHHTT
T ss_pred             cccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHH
Confidence            5322   22334578999999999999899999999999999999999999997643211 111111000000       


Q ss_pred             ------------c------ccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          396 ------------S------TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       396 ------------~------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                                  .      ...........   .........+.++.+|+.+||..||++|||+.|+++|
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFP---ADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             SCHHHHHHHHSSCCCCCCCHHHHSCGGGSC---CSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             hhhHHHHHHhhCccccccchhhhcccccCc---ccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                        0      00000000000   0001122346789999999999999999999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.4e-42  Score=333.78  Aligned_cols=263  Identities=22%  Similarity=0.313  Sum_probs=203.0

Q ss_pred             HhhCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          170 RATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       170 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      ...++|++.+.||+|+||.||+|+..+  .+|+|++....  ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  107 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII  107 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence            345789999999999999999998853  49999986542  33456677899999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||+++++|.+++......+++..+..++.|++.||+|||   +.+++||||||+||+++ ++.+||+|||++.......
T Consensus       108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~  183 (319)
T 2y4i_B          108 TSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ  183 (319)
T ss_dssp             CBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred             eecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence            9999999999999877767899999999999999999999   89999999999999998 6899999999987543211


Q ss_pred             ---CcccccccccCccccCccccCC---------CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCC
Q 040392          328 ---QSMTQTQTLATIGYMAPEYGRE---------GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPI  395 (470)
Q Consensus       328 ---~~~~~~~~~~t~~y~aPE~~~~---------~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  395 (470)
                         .........|++.|+|||.+.+         ..++.++||||||+++|||++|+.||........  ...+......
T Consensus       184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~~~  261 (319)
T 2y4i_B          184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI--IWQMGTGMKP  261 (319)
T ss_dssp             ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH--HHHHHTTCCC
T ss_pred             ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHhccCCCC
Confidence               1122234468999999998864         3478899999999999999999999976432211  1111110000


Q ss_pred             cccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHhh
Q 040392          396 STMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLR  457 (470)
Q Consensus       396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~~  457 (470)
                              ...         ...++.++.+++.+||..||++|||+.++++.|+++.....+
T Consensus       262 --------~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~  306 (319)
T 2y4i_B          262 --------NLS---------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR  306 (319)
T ss_dssp             --------CCC---------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred             --------CCC---------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence                    000         012345688999999999999999999999999999765433

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.8e-41  Score=325.27  Aligned_cols=252  Identities=24%  Similarity=0.293  Sum_probs=198.6

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--------chhhhhHHHHHHHHhcCCCCcceeEEeeeccCC
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--------GRALKGFDVECEMMKSIRHRNLIKVISTCSNEE  242 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~  242 (470)
                      .++|.+.+.||+|+||.||+|... +++.||||++....        ......+.+|+++++.++||||+++++++....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            467999999999999999999764 58899999986432        123446788999999999999999999987665


Q ss_pred             eeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC---eEEeeecc
Q 040392          243 FKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV---AHLSDFSI  319 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~---~kl~Dfg~  319 (470)
                       .++||||+++++|.+++... ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.   +||+|||+
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGH  163 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred             -eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence             78999999999999998654 46899999999999999999999   899999999999999987664   99999999


Q ss_pred             ccccCCCCCcccccccccCccccCcccc---CCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc
Q 040392          320 AKLLTGEDQSMTQTQTLATIGYMAPEYG---REGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS  396 (470)
Q Consensus       320 a~~~~~~~~~~~~~~~~~t~~y~aPE~~---~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  396 (470)
                      +......   .......||+.|+|||++   ....++.++||||||+++|+|++|+.||........ +...+...... 
T Consensus       164 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~-  238 (322)
T 2ycf_A          164 SKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKDQITSGKYN-  238 (322)
T ss_dssp             CEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-HHHHHHHTCCC-
T ss_pred             ceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-HHHHHHhCccc-
Confidence            9865321   122345689999999986   356789999999999999999999999976433322 22211111000 


Q ss_pred             ccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          397 TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       397 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                                    ........++.++.+++.+||+.||++||++.|++++
T Consensus       239 --------------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          239 --------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             --------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             --------------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence                          0001123346778999999999999999999999864

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.6e-41  Score=323.29  Aligned_cols=253  Identities=24%  Similarity=0.331  Sum_probs=204.4

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---------chhhhhHHHHHHHHhcCC-CCcceeEEeeec
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---------GRALKGFDVECEMMKSIR-HRNLIKVISTCS  239 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~  239 (470)
                      ..++|++.+.||+|+||.||+|... +|+.||||++....         ....+.+.+|+++++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3578999999999999999999865 68999999987542         123456778999999996 999999999999


Q ss_pred             cCCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecc
Q 040392          240 NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSI  319 (470)
Q Consensus       240 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  319 (470)
                      .....++||||+++++|.+++... ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||+
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccc
Confidence            999999999999999999999764 36899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccCccccCccccC------CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhc
Q 040392          320 AKLLTGEDQSMTQTQTLATIGYMAPEYGR------EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWL  393 (470)
Q Consensus       320 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~------~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  393 (470)
                      +.......   ......+++.|+|||++.      ...++.++||||||+++|||++|+.||......+ ..........
T Consensus       171 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~  246 (298)
T 1phk_A          171 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLRMIMSGNY  246 (298)
T ss_dssp             CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCC
T ss_pred             hhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH-HHHHHhcCCc
Confidence            98764322   223456899999999874      4568899999999999999999999987532211 1111111000


Q ss_pred             CCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          394 PISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ...                ......++.++.+++.+||+.||++|||+.|++++
T Consensus       247 ~~~----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          247 QFG----------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             CCC----------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             ccC----------------cccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence            000                00112346779999999999999999999999863

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.4e-41  Score=357.32  Aligned_cols=250  Identities=21%  Similarity=0.253  Sum_probs=205.8

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCeee
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CGRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFKA  245 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~  245 (470)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++...   .......+..|..++..+ +||+|+++++++.+.+..+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            4568999999999999999999864 5889999999754   233456677899999988 6999999999999999999


Q ss_pred             EEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC
Q 040392          246 LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  325 (470)
                      +||||+++|+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       419 lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            9999999999999997654 5899999999999999999999   99999999999999999999999999999986432


Q ss_pred             CCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          326 EDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       326 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      ..  ......+||+.|+|||++.+..++.++||||||+++|||++|+.||......+  +..   .......        
T Consensus       495 ~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~--~~~---~i~~~~~--------  559 (674)
T 3pfq_A          495 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--LFQ---SIMEHNV--------  559 (674)
T ss_dssp             TT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH---HHHSSCC--------
T ss_pred             CC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH--HHH---HHHhCCC--------
Confidence            22  22345679999999999999999999999999999999999999997643221  111   1111100        


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCH-----HHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINA-----REIVAK  447 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~el~~~  447 (470)
                              ..+..++.++.+|+.+||+.||++||++     .||++|
T Consensus       560 --------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          560 --------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             --------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             --------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence                    0112346778999999999999999997     777654

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.3e-41  Score=326.79  Aligned_cols=268  Identities=21%  Similarity=0.283  Sum_probs=197.1

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeec-----------
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCS-----------  239 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~-----------  239 (470)
                      .++|.+.+.||+|+||.||+|... +++.||+|++........+.+.+|+++++.++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            467999999999999999999875 48999999998766666778899999999999999999998873           


Q ss_pred             ---cCCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCCCeEEe
Q 040392          240 ---NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLS  315 (470)
Q Consensus       240 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~-~~~~~kl~  315 (470)
                         +....++||||++ |+|.+++..  ..+++..+..++.|++.||+|||   +.+++||||||+||+++ .++.+||+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEc
Confidence               3467899999997 599999964  35889999999999999999999   89999999999999997 57799999


Q ss_pred             eeccccccCCCCC-cccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhc
Q 040392          316 DFSIAKLLTGEDQ-SMTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWL  393 (470)
Q Consensus       316 Dfg~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  393 (470)
                      |||++........ ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+ ........ .
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~~-~  241 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-QMQLILES-I  241 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHH-S
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHh-c
Confidence            9999986643211 122234567899999998765 678999999999999999999999998643221 11111111 0


Q ss_pred             CCccc-----------ccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          394 PISTM-----------EVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       394 ~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      +....           ....................++.++.+++.+||+.||++|||+.|++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            00000           0000000000000011123457789999999999999999999999875

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4.1e-41  Score=331.43  Aligned_cols=268  Identities=22%  Similarity=0.249  Sum_probs=202.6

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccC-----Cee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNE-----EFK  244 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-----~~~  244 (470)
                      .++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+++++.++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            568999999999999999999764 68899999987433 33456788999999999999999999998654     467


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccC
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~  324 (470)
                      ++||||++ |+|.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus       106 ~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  179 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence            99999997 5999998664  4899999999999999999999   9999999999999999999999999999998664


Q ss_pred             CCCC-cccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccc
Q 040392          325 GEDQ-SMTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVG  402 (470)
Q Consensus       325 ~~~~-~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (470)
                      .... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+ .+........... .+...
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~-~~~~~  257 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGILGSPS-QEDLN  257 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHHHHCSCC-HHHHH
T ss_pred             CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHHHhCCCC-HHHHH
Confidence            3221 112234579999999998654 458999999999999999999999997643222 1111111100000 00000


Q ss_pred             c-----------cc-cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          403 A-----------NL-LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       403 ~-----------~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      .           .. .............++.++.+|+.+||+.||++|||+.|+++|
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0           00 000000011112346778999999999999999999999875

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.9e-41  Score=357.09  Aligned_cols=259  Identities=23%  Similarity=0.382  Sum_probs=207.7

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeCC----CcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeee
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLGD----GMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKA  245 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  245 (470)
                      ..++|++.+.||+|+||.||+|.+..    +..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+ +..+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceE
Confidence            34567788899999999999998642    4679999986543 3345678899999999999999999999854 5678


Q ss_pred             EEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC
Q 040392          246 LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  325 (470)
                      +||||+++|+|.+++......+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  543 (656)
T ss_dssp             EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred             EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence            999999999999999877777999999999999999999999   89999999999999999999999999999987643


Q ss_pred             CCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCccccccccc
Q 040392          326 EDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN  404 (470)
Q Consensus       326 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (470)
                      .. ........+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+  ....+......         
T Consensus       544 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~~~i~~~~~~---------  611 (656)
T 2j0j_A          544 ST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIENGERL---------  611 (656)
T ss_dssp             -----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHHTCCC---------
T ss_pred             Cc-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHcCCCC---------
Confidence            22 222234457789999999988899999999999999999997 999987643221  11111111000         


Q ss_pred             ccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                               ..+..++..+.+++.+||..||++||++.|+++.|+++.+.
T Consensus       612 ---------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          612 ---------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence                     11234567899999999999999999999999999998654

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.8e-41  Score=336.22  Aligned_cols=266  Identities=21%  Similarity=0.224  Sum_probs=200.5

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcCC--------CCcceeEEeeec---
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIR--------HRNLIKVISTCS---  239 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~nIv~~~~~~~---  239 (470)
                      .++|++.+.||+|+||.||+|+. .+++.||||++... ....+.+.+|+++++.++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            46799999999999999999975 46889999998643 334566788999999985        788999999987   


Q ss_pred             -cCCeeeEEEecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCCeeeCCCC------
Q 040392          240 -NEEFKALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSA-PIIHCDLKPSNVLLDDNM------  310 (470)
Q Consensus       240 -~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~i~H~dlkp~Nill~~~~------  310 (470)
                       .....++||||+ +++|.+++.... ..+++..+..++.|++.||+|||   ++ +|+||||||+|||++.++      
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhh
Confidence             567889999999 556666655443 56899999999999999999999   87 999999999999999776      


Q ss_pred             -------------------------------------------CeEEeeeccccccCCCCCcccccccccCccccCcccc
Q 040392          311 -------------------------------------------VAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYG  347 (470)
Q Consensus       311 -------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~  347 (470)
                                                                 .+||+|||++......     .....||+.|+|||++
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHH
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhh
Confidence                                                       8999999999865422     2345689999999999


Q ss_pred             CCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcch-----hhHHhhhhcCCc---------ccccc----------cc
Q 040392          348 REGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMT-----LKHWVNDWLPIS---------TMEVV----------GA  403 (470)
Q Consensus       348 ~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~-----~~~~~~~~~~~~---------~~~~~----------~~  403 (470)
                      .+..++.++|||||||++|||++|+.||......+..     +...........         .....          +.
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            9989999999999999999999999999864432211     000000000000         00000          00


Q ss_pred             cccC---chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          404 NLLS---QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       404 ~~~~---~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ....   ........+...+.++.+|+.+||+.||++|||+.|+++|
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence            0000   0000011123457789999999999999999999999875

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=8.2e-41  Score=336.02  Aligned_cols=265  Identities=20%  Similarity=0.251  Sum_probs=202.0

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcC------CCCcceeEEeeeccCCee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSI------RHRNLIKVISTCSNEEFK  244 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~nIv~~~~~~~~~~~~  244 (470)
                      ..+|++.+.||+|+||.||+|... +++.||||++... ......+..|+++++.+      .|+||+++++++......
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            467999999999999999999764 5899999999743 23345667788888777      577999999999999999


Q ss_pred             eEEEecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC--eEEeeecccc
Q 040392          245 ALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV--AHLSDFSIAK  321 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~a~  321 (470)
                      ++||||+. ++|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.  +||+|||++.
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            99999996 59999987655 45899999999999999999999   899999999999999999887  9999999997


Q ss_pred             ccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhc-CCc-c--
Q 040392          322 LLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWL-PIS-T--  397 (470)
Q Consensus       322 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~-~--  397 (470)
                      .....     .....+|+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+........ +.. .  
T Consensus       251 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~-~l~~i~~~~~~p~~~~~~  324 (429)
T 3kvw_A          251 YEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD-QLACMIELLGMPSQKLLD  324 (429)
T ss_dssp             ETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHH
T ss_pred             ecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCCHHHHH
Confidence            64322     223578999999999999999999999999999999999999997643221 1111111000 000 0  


Q ss_pred             -----ccccccc---------------------------cc---CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHH
Q 040392          398 -----MEVVGAN---------------------------LL---SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAR  442 (470)
Q Consensus       398 -----~~~~~~~---------------------------~~---~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~  442 (470)
                           ...++..                           ..   .........+...+.++.+|+.+||+.||++|||+.
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~  404 (429)
T 3kvw_A          325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG  404 (429)
T ss_dssp             TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence                 0000000                           00   000001111123356789999999999999999999


Q ss_pred             HHHHH
Q 040392          443 EIVAK  447 (470)
Q Consensus       443 el~~~  447 (470)
                      |+++|
T Consensus       405 e~L~H  409 (429)
T 3kvw_A          405 QALRH  409 (429)
T ss_dssp             HHHTS
T ss_pred             HHhCC
Confidence            99985

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.5e-41  Score=322.06  Aligned_cols=253  Identities=24%  Similarity=0.341  Sum_probs=194.2

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeecc----------
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN----------  240 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~----------  240 (470)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|+++++.++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            467899999999999999999864 7999999998643 3445678899999999999999999998754          


Q ss_pred             ---CCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeee
Q 040392          241 ---EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF  317 (470)
Q Consensus       241 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  317 (470)
                         ....++||||+++|+|.+++......+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+||
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~df  160 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDF  160 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeC
Confidence               45778999999999999999877777889999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCC------------cccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcch
Q 040392          318 SIAKLLTGEDQ------------SMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMT  384 (470)
Q Consensus       318 g~a~~~~~~~~------------~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~  384 (470)
                      |++........            ........+|+.|+|||.+.+. .++.++||||||+++|||++   ||.......  
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~--  235 (303)
T 1zy4_A          161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV--  235 (303)
T ss_dssp             CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH--
T ss_pred             cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH--
Confidence            99986542210            1122345689999999998764 68999999999999999998   554321111  


Q ss_pred             hhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          385 LKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       385 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                        ........... . ..+.          .+..++..+.+++.+||+.||.+|||+.|++++
T Consensus       236 --~~~~~~~~~~~-~-~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          236 --NILKKLRSVSI-E-FPPD----------FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             --HHHHHHHSTTC-C-CCTT----------CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             --HHHHhcccccc-c-cCcc----------ccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence              11111100000 0 0000          112335668899999999999999999999975

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.2e-40  Score=322.76  Aligned_cols=269  Identities=23%  Similarity=0.311  Sum_probs=203.4

Q ss_pred             hhCCCCCCCeecccCceEEEEEEe--CCCcEEEEEEeecccc--hhhhhHHHHHHHHhcC---CCCcceeEEeeec----
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARL--GDGMEVAVKVFNLQCG--RALKGFDVECEMMKSI---RHRNLIKVISTCS----  239 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~~~~~~~----  239 (470)
                      ..++|++.+.||+|+||.||+|+.  .+|+.||+|++.....  .....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            457899999999999999999987  4688999999865432  2334567788877766   8999999999986    


Q ss_pred             -cCCeeeEEEecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeee
Q 040392          240 -NEEFKALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF  317 (470)
Q Consensus       240 -~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  317 (470)
                       .....++||||++ |+|.+++.... ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecC
Confidence             5667899999998 59999997654 45899999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcc
Q 040392          318 SIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIST  397 (470)
Q Consensus       318 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  397 (470)
                      |++.....   ........+|..|+|||.+.+..++.++||||||+++|||++|+.||....... .+............
T Consensus       165 g~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~  240 (326)
T 1blx_A          165 GLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGE  240 (326)
T ss_dssp             CSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCG
T ss_pred             cccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCCc
Confidence            99976532   222344678999999999999899999999999999999999999998643221 11111111000000


Q ss_pred             ccc------ccccccC-chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          398 MEV------VGANLLS-QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       398 ~~~------~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ...      ....... ...........++..+.+++.+||+.||++||++.|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            000      0000000 0000011123456778999999999999999999999864

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.8e-41  Score=333.77  Aligned_cols=263  Identities=24%  Similarity=0.272  Sum_probs=184.8

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccC------C
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNE------E  242 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~------~  242 (470)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++...  .....+.+.+|+++++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            57899999999999999999975 46899999998643  233456778899999999999999999998653      5


Q ss_pred             eeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccc
Q 040392          243 FKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL  322 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~  322 (470)
                      ..++|+|++ +++|.+++..  ..+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred             eEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence            678999999 6799998865  35899999999999999999999   99999999999999999999999999999986


Q ss_pred             cCCCCCcccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccc
Q 040392          323 LTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVV  401 (470)
Q Consensus       323 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (470)
                      ....     .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+....... .....+..
T Consensus       182 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~-g~p~~~~~  254 (367)
T 2fst_X          182 TADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLV-GTPGAELL  254 (367)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHH-CSCCHHHH
T ss_pred             cccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHh-CCCCHHHH
Confidence            5321     234578999999999876 67899999999999999999999999764321 1111111110 00000000


Q ss_pred             c-----------ccccCchhh-hhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          402 G-----------ANLLSQEDI-HFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       402 ~-----------~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      .           ..+...... ........+.++.+|+.+||..||++|||+.|+++|
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            0           000000000 000112346778999999999999999999999986

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=6.6e-41  Score=328.46  Aligned_cols=269  Identities=22%  Similarity=0.254  Sum_probs=201.0

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccC-----Cee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNE-----EFK  244 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-----~~~  244 (470)
                      .++|.+.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+++++.++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            568999999999999999999865 68999999986433 33455678899999999999999999987654     678


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccC
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~  324 (470)
                      ++||||++ |+|.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus        90 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            99999997 5999998764  5899999999999999999999   8999999999999999999999999999998764


Q ss_pred             CCCCcc--------cccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhc-C
Q 040392          325 GEDQSM--------TQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWL-P  394 (470)
Q Consensus       325 ~~~~~~--------~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~  394 (470)
                      ......        ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... .+........ +
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~  242 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH-QLLLIFGIIGTP  242 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred             cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCC
Confidence            322111        1223468999999998654 678999999999999999999999998643211 1111111000 0


Q ss_pred             C--ccccccc-c-------ccc-CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          395 I--STMEVVG-A-------NLL-SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       395 ~--~~~~~~~-~-------~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      .  ....... .       .+. ............++.++.+++.+||+.||++|||+.|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0  0000000 0       000 00000011123457789999999999999999999999875

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=8.7e-41  Score=332.33  Aligned_cols=264  Identities=25%  Similarity=0.299  Sum_probs=195.8

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccC------Ceee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNE------EFKA  245 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~------~~~~  245 (470)
                      ..+|.+.+.||+|+||.||+|+...+..||+|++.....    ...+|+++++.++||||+++++++...      ...+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            356899999999999999999987777799998864322    223699999999999999999998433      3478


Q ss_pred             EEEecCCCCChHHhh--hcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCCCeEEeeeccccc
Q 040392          246 LVLEYMPHGSLEKYM--YSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKL  322 (470)
Q Consensus       246 lv~e~~~~g~L~~~l--~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~a~~  322 (470)
                      +||||++++.+....  ......+++..+..++.|+++||+|||   +.+|+||||||+||+++ .++.+||+|||+++.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            999999875433322  123456899999999999999999999   89999999999999998 799999999999987


Q ss_pred             cCCCCCcccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc-----
Q 040392          323 LTGEDQSMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS-----  396 (470)
Q Consensus       323 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-----  396 (470)
                      .....   ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+...+.......     
T Consensus       192 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~~~~~  267 (394)
T 4e7w_A          192 LIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEIIKVLGTPSREQIK  267 (394)
T ss_dssp             CCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHH
T ss_pred             ccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHH
Confidence            64322   22345689999999988764 5899999999999999999999999864321 11111111100000     


Q ss_pred             -----ccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          397 -----TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       397 -----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                           ..+..-+. ..........+..++.++.+|+.+||+.||++|||+.|+++|
T Consensus       268 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          268 TMNPNYMEHKFPQ-IRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHCGGGSSSCCCC-CCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hhChhhhhhcccc-ccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence                 00000000 000111111223356789999999999999999999999986

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=8.1e-41  Score=318.28  Aligned_cols=251  Identities=23%  Similarity=0.319  Sum_probs=203.3

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++....  ......+.+|++++++++||||+++++++.+....++|
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            4568999999999999999999875 68999999986543  23456788999999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC---CCeEEeeeccccccC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN---MVAHLSDFSIAKLLT  324 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~---~~~kl~Dfg~a~~~~  324 (470)
                      |||+++++|.+++.... .+++..+..++.|++.||.|||   +.+++|+||||+||+++.+   +.+||+|||++....
T Consensus       100 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A          100 GELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            99999999999886554 5899999999999999999999   8999999999999999754   479999999998664


Q ss_pred             CCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhh-cCCcccccccc
Q 040392          325 GEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDW-LPISTMEVVGA  403 (470)
Q Consensus       325 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  403 (470)
                      ...   ......+++.|+|||.+.+ .++.++||||||+++|+|++|+.||......  .....+... ....       
T Consensus       176 ~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~-------  242 (287)
T 2wei_A          176 QNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILKRVETGKYAFD-------  242 (287)
T ss_dssp             CCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCCCC-------
T ss_pred             CCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHcCCCCCC-------
Confidence            322   1223458899999998875 4899999999999999999999999764221  111111110 0000       


Q ss_pred             cccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                               ......++.++.+++.+||+.||++|||+.|++++
T Consensus       243 ---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          243 ---------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             ---------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ---------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence                     01112346778999999999999999999999985

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=7.6e-41  Score=330.27  Aligned_cols=263  Identities=21%  Similarity=0.246  Sum_probs=198.0

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCee----
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFK----  244 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~----  244 (470)
                      .++|.+.+.||+|+||.||+|... +|+.||||++....  ....+.+.+|+.+++.++||||+++++++......    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468999999999999999999754 68999999987542  33456788899999999999999999999876654    


Q ss_pred             --eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccc
Q 040392          245 --ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL  322 (470)
Q Consensus       245 --~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~  322 (470)
                        ++||||+. ++|.+++.   ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       121 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             eEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence              89999997 58888874   24899999999999999999999   89999999999999999999999999999986


Q ss_pred             cCCCCCcccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc--ccc
Q 040392          323 LTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS--TME  399 (470)
Q Consensus       323 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~  399 (470)
                      ....     .....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+ .+...........  ...
T Consensus       194 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~  267 (371)
T 4exu_A          194 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTEFVQ  267 (371)
T ss_dssp             -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCHHHHT
T ss_pred             cccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCcHHHHH
Confidence            5322     234568999999999877 679999999999999999999999997643211 1111111000000  000


Q ss_pred             cccc--------ccc-CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          400 VVGA--------NLL-SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       400 ~~~~--------~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ....        ... ............++.++.+|+.+||+.||++|||+.|++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            0000        000 00000011123457789999999999999999999999876

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.1e-40  Score=332.25  Aligned_cols=262  Identities=24%  Similarity=0.303  Sum_probs=194.8

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeecc------CCeee
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN------EEFKA  245 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~------~~~~~  245 (470)
                      .+|++.+.||+|+||.||+|++. +|+.||||++....    ....+|+++++.++||||+++++++..      ..+.+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            46888999999999999999875 58999999986432    223469999999999999999998743      23467


Q ss_pred             EEEecCCCCChHHhhh---cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-CCeEEeeecccc
Q 040392          246 LVLEYMPHGSLEKYMY---SSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN-MVAHLSDFSIAK  321 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~a~  321 (470)
                      +||||+++ +|.+.+.   .....+++..+..++.|+++||+|||   +.+|+||||||+|||++.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999986 6666654   23457899999999999999999999   9999999999999999965 578999999998


Q ss_pred             ccCCCCCcccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCC-----
Q 040392          322 LLTGEDQSMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPI-----  395 (470)
Q Consensus       322 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-----  395 (470)
                      .+.....   .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+...+......     
T Consensus       206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTREQI  281 (420)
T ss_dssp             ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCHHHH
T ss_pred             hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence            7643222   2345789999999998764 7999999999999999999999999764321 1222222111000     


Q ss_pred             -----cccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          396 -----STMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       396 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                           ...+...+... ........+...+.++.+|+.+||..||++||++.|+++|
T Consensus       282 ~~~~~~~~~~~~p~~~-~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIK-AHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHHCSCCCCCCCCCCC-CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HhhChhhhhhccCccC-CCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence                 00000000000 0000111122346789999999999999999999999875

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.5e-40  Score=323.36  Aligned_cols=275  Identities=20%  Similarity=0.260  Sum_probs=192.9

Q ss_pred             HHHHHhhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCC--
Q 040392          166 LELCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEE--  242 (470)
Q Consensus       166 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--  242 (470)
                      .......++|++.+.||+|+||.||+|+.. +|+.||||++... .........|++.++.++||||+++++++....  
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            455667789999999999999999999864 6899999998643 233455677888889999999999999985432  


Q ss_pred             -----eeeEEEecCCCCChHHhhh---cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCCeE
Q 040392          243 -----FKALVLEYMPHGSLEKYMY---SSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-NMVAH  313 (470)
Q Consensus       243 -----~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~-~~~~k  313 (470)
                           ..++||||+++ +|.+.+.   .....+++..+..++.|++.||.|||. ++.+|+||||||+||+++. ++.+|
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCcEE
Confidence                 37899999986 5554443   244568899999999999999999993 3689999999999999996 89999


Q ss_pred             EeeeccccccCCCCCcccccccccCccccCccccCCCC-CCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhh
Q 040392          314 LSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDW  392 (470)
Q Consensus       314 l~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  392 (470)
                      |+|||++.......   ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||...... ..+.......
T Consensus       173 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~~~~~~  248 (360)
T 3e3p_A          173 LCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA-GQLHEIVRVL  248 (360)
T ss_dssp             ECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHH
T ss_pred             EeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH-HHHHHHHHHc
Confidence            99999998764322   223456899999999886654 899999999999999999999999864322 1222222111


Q ss_pred             c-----------CCc-ccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          393 L-----------PIS-TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       393 ~-----------~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      .           +.. .....+.................+.++.+|+.+||+.||++|||+.|+++|
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            0           000 000000000000000011112247789999999999999999999999976

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.6e-40  Score=323.44  Aligned_cols=265  Identities=20%  Similarity=0.273  Sum_probs=203.1

Q ss_pred             hCCCCCCCeecccCceEEEEEEe--CCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCc------ceeEEeeeccCCe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL--GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRN------LIKVISTCSNEEF  243 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~~~~~~~~~~~  243 (470)
                      .++|++.+.||+|+||.||+|..  .+++.||||++... ....+.+..|+++++.++|++      ++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            46899999999999999999976  36889999998643 334566788999999887654      9999999999999


Q ss_pred             eeEEEecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC--------------
Q 040392          244 KALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD--------------  308 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~--------------  308 (470)
                      .++||||+ +++|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.              
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence            99999999 889999997655 36889999999999999999999   899999999999999987              


Q ss_pred             -----CCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcc
Q 040392          309 -----NMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEM  383 (470)
Q Consensus       309 -----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~  383 (470)
                           ++.+||+|||++......     .....+|+.|+|||++.+..++.++||||||+++|||++|+.||......+ 
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-  241 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE-  241 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH-
T ss_pred             cccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH-
Confidence                 678999999999864322     234568999999999999899999999999999999999999997643221 


Q ss_pred             hhhHHhhhhcCCc--ccc------ccc-ccc----c-----------CchhhhhHhhhhhHHHHHHHHhhccCCCccCCC
Q 040392          384 TLKHWVNDWLPIS--TME------VVG-ANL----L-----------SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRI  439 (470)
Q Consensus       384 ~~~~~~~~~~~~~--~~~------~~~-~~~----~-----------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp  439 (470)
                      ..........+..  ...      ... ...    .           ............++.++.+++.+||+.||++||
T Consensus       242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence            1111111000000  000      000 000    0           000000011223467899999999999999999


Q ss_pred             CHHHHHHH
Q 040392          440 NAREIVAK  447 (470)
Q Consensus       440 s~~el~~~  447 (470)
                      |+.|++++
T Consensus       322 t~~ell~h  329 (339)
T 1z57_A          322 TLREALKH  329 (339)
T ss_dssp             CHHHHTTS
T ss_pred             CHHHHhcC
Confidence            99999875

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.7e-40  Score=322.19  Aligned_cols=254  Identities=25%  Similarity=0.305  Sum_probs=179.5

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHH-HHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKGFDVECE-MMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      .++|.+.+.||+|+||.||+|... +|+.||||++.... ......+..|.. +++.++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            467899999999999999999874 68999999997543 223344555555 777889999999999999999999999


Q ss_pred             ecCCCCChHHhhhc----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCCeeeCCCCCeEEeeecccccc
Q 040392          249 EYMPHGSLEKYMYS----SNYILDIFQRLNIMIDVASALEYLHFGYSA-PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  323 (470)
Q Consensus       249 e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~  323 (470)
                      ||+++ +|.+++..    ....+++..+..++.|++.||.|||   +. +++||||||+||+++.++.+||+|||++...
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99985 88777753    2456899999999999999999999   77 9999999999999999999999999999865


Q ss_pred             CCCCCcccccccccCccccCcccc----CCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccc
Q 040392          324 TGEDQSMTQTQTLATIGYMAPEYG----REGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTME  399 (470)
Q Consensus       324 ~~~~~~~~~~~~~~t~~y~aPE~~----~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  399 (470)
                      ....   ......||+.|+|||.+    .+..++.++||||||+++|||++|+.||.........+....    ...   
T Consensus       177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~----~~~---  246 (327)
T 3aln_A          177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV----KGD---  246 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC----CSC---
T ss_pred             cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh----cCC---
Confidence            4321   22334689999999998    456689999999999999999999999976322111111000    000   


Q ss_pred             cccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          400 VVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                        .+.+..      .....++.++.+++.+||+.||++||++.|++++
T Consensus       247 --~~~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          247 --PPQLSN------SEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             --CCCCCC------CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             --CCCCCC------cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence              000000      0112346678999999999999999999999875

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.8e-40  Score=329.20  Aligned_cols=269  Identities=21%  Similarity=0.278  Sum_probs=183.6

Q ss_pred             CCCCC-CCeecccCceEEEEEEeC---CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeee--ccCCeeeE
Q 040392          173 DGFSE-NNLIGRGGFGSVYKARLG---DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTC--SNEEFKAL  246 (470)
Q Consensus       173 ~~~~~-~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~--~~~~~~~l  246 (470)
                      +.|++ .++||+|+||.||+|+..   +++.||+|++....  ....+.+|+++++.++||||+++++++  ......++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            34655 458999999999999865   57889999986432  234678899999999999999999998  45778899


Q ss_pred             EEecCCCCChHHhhhcCC--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee----CCCCCeEE
Q 040392          247 VLEYMPHGSLEKYMYSSN--------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL----DDNMVAHL  314 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill----~~~~~~kl  314 (470)
                      ||||+++ +|.+++....        ..+++..+..++.|++.||.|||   +.+|+||||||+|||+    +.++.+||
T Consensus        98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence            9999975 8888775321        24899999999999999999999   8999999999999999    77899999


Q ss_pred             eeeccccccCCCCC-cccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCc--------ch
Q 040392          315 SDFSIAKLLTGEDQ-SMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE--------MT  384 (470)
Q Consensus       315 ~Dfg~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~--------~~  384 (470)
                      +|||+++....... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||.......        ..
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  253 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ  253 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence            99999987643221 1223456789999999998874 58999999999999999999999997533210        01


Q ss_pred             hhHHhhhhc-CC-cccccc-------------cccccCc-hhhhh--HhhhhhHHHHHHHHhhccCCCccCCCCHHHHHH
Q 040392          385 LKHWVNDWL-PI-STMEVV-------------GANLLSQ-EDIHF--VAKEQCVSCVFNLAMECTVESPEQRINAREIVA  446 (470)
Q Consensus       385 ~~~~~~~~~-~~-~~~~~~-------------~~~~~~~-~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~  446 (470)
                      +........ +. .....+             ....... .....  ......+.++.+|+.+||..||++|||+.|+++
T Consensus       254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111111000 00 000000             0000000 00000  000111456889999999999999999999998


Q ss_pred             H
Q 040392          447 K  447 (470)
Q Consensus       447 ~  447 (470)
                      |
T Consensus       334 h  334 (405)
T 3rgf_A          334 D  334 (405)
T ss_dssp             S
T ss_pred             C
Confidence            6

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.7e-40  Score=323.33  Aligned_cols=253  Identities=19%  Similarity=0.246  Sum_probs=174.8

Q ss_pred             hCCCCCCC-eecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeecc----CCeee
Q 040392          172 TDGFSENN-LIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN----EEFKA  245 (470)
Q Consensus       172 ~~~~~~~~-~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~----~~~~~  245 (470)
                      .++|.+.+ .||+|+||.||+|+.. +|+.||||++....    .........++.++||||+++++++..    ....+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            56788855 6999999999999865 69999999986431    122233344667799999999999865    45688


Q ss_pred             EEEecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCCeEEeeecccc
Q 040392          246 LVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFSIAK  321 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~a~  321 (470)
                      +||||+++|+|.+++.... ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.   ++.+||+|||++.
T Consensus       103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~  179 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK  179 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence            9999999999999997654 46899999999999999999999   899999999999999976   4559999999998


Q ss_pred             ccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccc
Q 040392          322 LLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVV  401 (470)
Q Consensus       322 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (470)
                      .....    ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||........... ..... ......  
T Consensus       180 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~-~~~~~~--  251 (336)
T 3fhr_A          180 ETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG-MKRRI-RLGQYG--  251 (336)
T ss_dssp             EC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------C--
T ss_pred             ecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh-HHHhh-hccccc--
Confidence            65422    22345689999999999888899999999999999999999999976433221100 00000 000000  


Q ss_pred             cccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHH
Q 040392          402 GANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL  448 (470)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L  448 (470)
                               ........++.++.+++.+||+.||++|||+.|++++-
T Consensus       252 ---------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  289 (336)
T 3fhr_A          252 ---------FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP  289 (336)
T ss_dssp             ---------CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             ---------cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence                     00001123467789999999999999999999999853

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.8e-40  Score=319.09  Aligned_cols=252  Identities=22%  Similarity=0.277  Sum_probs=184.5

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccc--hhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      .++|++.+.||+|+||.||+|... +|+.||||++.....  ...+.+..+..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            467888999999999999999875 689999999975432  22333445566788889999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA-PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      ||+ ++.+..+.......+++..+..++.|++.||.|||   ++ +++|+||||+||+++.++.+||+|||++.......
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence            999 55666666555567899999999999999999999   75 99999999999999999999999999997654322


Q ss_pred             CcccccccccCccccCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccc
Q 040392          328 QSMTQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVG  402 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (470)
                         ......+++.|+|||.+.     ...++.++||||||+++|||++|+.||.........+........+. .     
T Consensus       180 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~-----  250 (318)
T 2dyl_A          180 ---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL-L-----  250 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC-C-----
T ss_pred             ---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC-C-----
Confidence               223456899999999984     45688999999999999999999999976433222222111111000 0     


Q ss_pred             ccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          403 ANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                                 .....++.++.+++.+||+.||.+||++.|++++
T Consensus       251 -----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          251 -----------PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             -----------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             -----------CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                       0011236678999999999999999999999985

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.5e-40  Score=333.06  Aligned_cols=251  Identities=23%  Similarity=0.346  Sum_probs=187.5

Q ss_pred             CCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCeeeEEEecCC
Q 040392          174 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMP  252 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~  252 (470)
                      .|...+.||+|+||+||.+...+|+.||||++...   ..+.+..|+++++.+ +||||+++++++.+....++||||++
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            34556889999999998776678999999998643   234567899999876 89999999999999999999999996


Q ss_pred             CCChHHhhhcCCCC------CCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCC-------------CCeE
Q 040392          253 HGSLEKYMYSSNYI------LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN-------------MVAH  313 (470)
Q Consensus       253 ~g~L~~~l~~~~~~------~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~-------------~~~k  313 (470)
                       |+|.+++......      .++..+..++.|++.||+|||   +.+|+||||||+||+++.+             +.+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             6999999765421      123345789999999999999   8999999999999999654             4899


Q ss_pred             EeeeccccccCCCCCc--ccccccccCccccCccccCC-------CCCCCccchhhHHHHHHHHHh-CCCCCCccccCcc
Q 040392          314 LSDFSIAKLLTGEDQS--MTQTQTLATIGYMAPEYGRE-------GRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEM  383 (470)
Q Consensus       314 l~Dfg~a~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~  383 (470)
                      |+|||++.........  .......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||......+.
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~  248 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES  248 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH
Confidence            9999999876543221  12234579999999999865       568999999999999999999 9999976433221


Q ss_pred             hhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          384 TLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                         ............             ....+..++.++.+++.+||+.||.+|||+.|+++|
T Consensus       249 ---~i~~~~~~~~~~-------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          249 ---NIIRGIFSLDEM-------------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             ---HHHHTCCCCCCC-------------TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---HHhcCCCCcccc-------------cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence               111111110000             001123446789999999999999999999999874

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2e-40  Score=332.97  Aligned_cols=250  Identities=22%  Similarity=0.371  Sum_probs=189.6

Q ss_pred             CCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCeeeEEEecC
Q 040392          173 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      .+|...+.||+|+||+||.....+++.||||++....   ...+.+|+++++.+ +||||+++++++.+....++||||+
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~  100 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC  100 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence            4588889999999999766556689999999986432   23456799999999 7999999999999999999999999


Q ss_pred             CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-----CCCeEEeeeccccccCCC
Q 040392          252 PHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-----NMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       252 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~-----~~~~kl~Dfg~a~~~~~~  326 (470)
                      + |+|.+++........+..+..++.|++.||.|||   +.+|+||||||+||+++.     ...+||+|||+++.....
T Consensus       101 ~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~  176 (432)
T 3p23_A          101 A-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG  176 (432)
T ss_dssp             S-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred             C-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence            6 5999999877655666677899999999999999   899999999999999953     336889999999876433


Q ss_pred             CC-cccccccccCccccCccccC---CCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccc
Q 040392          327 DQ-SMTQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVV  401 (470)
Q Consensus       327 ~~-~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (470)
                      .. ........||+.|+|||++.   ...++.++|||||||++|||++ |..||........  ...    .........
T Consensus       177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~--~~~----~~~~~~~~~  250 (432)
T 3p23_A          177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA--NIL----LGACSLDCL  250 (432)
T ss_dssp             ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH--HHH----TTCCCCTTS
T ss_pred             CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH--HHH----hccCCcccc
Confidence            21 12334467999999999987   4567889999999999999999 9999865322111  110    000000000


Q ss_pred             cccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          402 GANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                           .       .+...+..+.+|+.+||+.||++|||+.|+++|
T Consensus       251 -----~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          251 -----H-------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             -----C-------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -----C-------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence                 0       011235567899999999999999999999954

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.7e-40  Score=324.24  Aligned_cols=263  Identities=21%  Similarity=0.253  Sum_probs=196.5

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCe-----
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEF-----  243 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~-----  243 (470)
                      .++|.+.+.||+|+||.||+|... +|+.||||++....  ....+.+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            467999999999999999999864 68999999986542  2335677889999999999999999999977653     


Q ss_pred             -eeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccc
Q 040392          244 -KALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL  322 (470)
Q Consensus       244 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~  322 (470)
                       .++||||++ ++|.+++..   .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++..
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             eEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence             489999997 589888743   4899999999999999999999   89999999999999999999999999999976


Q ss_pred             cCCCCCcccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhc-CCc-ccc
Q 040392          323 LTGEDQSMTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWL-PIS-TME  399 (470)
Q Consensus       323 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~-~~~  399 (470)
                      ....     .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+ .+........ +.. ...
T Consensus       176 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~  249 (353)
T 3coi_A          176 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTEFVQ  249 (353)
T ss_dssp             -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHHHHCBCCHHHHT
T ss_pred             CCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHH
Confidence            4321     234568999999998876 678999999999999999999999997643211 1111111000 000 000


Q ss_pred             cccc--------cccCc-hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          400 VVGA--------NLLSQ-EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       400 ~~~~--------~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ....        .+... ..........++.++.+++.+||+.||++|||+.|+++|
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            0000        00000 000000112346789999999999999999999999875

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.7e-40  Score=326.54  Aligned_cols=266  Identities=16%  Similarity=0.214  Sum_probs=198.4

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcCC-----------CCcceeEEeeec
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIR-----------HRNLIKVISTCS  239 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~~~~~~~  239 (470)
                      .++|.+.+.||+|+||.||+|+. .+++.||||++... ......+..|++++++++           |+||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            46799999999999999999986 56899999998743 234456778999998886           899999999987


Q ss_pred             cCC----eeeEEEecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCCeeeC------
Q 040392          240 NEE----FKALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSA-PIIHCDLKPSNVLLD------  307 (470)
Q Consensus       240 ~~~----~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~i~H~dlkp~Nill~------  307 (470)
                      ...    ..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||   ++ +|+||||||+||+++      
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCc
Confidence            543    789999999 889999997643 45899999999999999999999   87 999999999999994      


Q ss_pred             CCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcc----
Q 040392          308 DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEM----  383 (470)
Q Consensus       308 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~----  383 (470)
                      ..+.+||+|||++......     .....+|+.|+|||++.+..++.++||||||+++|||++|+.||........    
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence            4558999999999865422     2335689999999999998999999999999999999999999986432110    


Q ss_pred             -hhhHHhhhhcC-----------------C-ccccccccccc-C---chhhhhHhhhhhHHHHHHHHhhccCCCccCCCC
Q 040392          384 -TLKHWVNDWLP-----------------I-STMEVVGANLL-S---QEDIHFVAKEQCVSCVFNLAMECTVESPEQRIN  440 (470)
Q Consensus       384 -~~~~~~~~~~~-----------------~-~~~~~~~~~~~-~---~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps  440 (470)
                       .+.........                 . .....+..... .   ........+..++.++.+|+.+||+.||++|||
T Consensus       248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  327 (373)
T 1q8y_A          248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  327 (373)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence             11111110000                 0 00000000000 0   000011123456788999999999999999999


Q ss_pred             HHHHHHH
Q 040392          441 AREIVAK  447 (470)
Q Consensus       441 ~~el~~~  447 (470)
                      +.|+++|
T Consensus       328 ~~ell~h  334 (373)
T 1q8y_A          328 AGGLVNH  334 (373)
T ss_dssp             HHHHHTC
T ss_pred             HHHHhhC
Confidence            9999885

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.4e-39  Score=322.46  Aligned_cols=200  Identities=25%  Similarity=0.320  Sum_probs=170.6

Q ss_pred             hhCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCC-CC-----cceeEEeeeccCCe
Q 040392          171 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIR-HR-----NLIKVISTCSNEEF  243 (470)
Q Consensus       171 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----nIv~~~~~~~~~~~  243 (470)
                      ..++|++.+.||+|+||.||+|... +++.||||++... ......+..|+++++.++ |+     +|+++++++...+.
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            4578999999999999999999765 6889999999743 233456677888888875 44     49999999999999


Q ss_pred             eeEEEecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC--CCCCeEEeeeccc
Q 040392          244 KALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD--DNMVAHLSDFSIA  320 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~--~~~~~kl~Dfg~a  320 (470)
                      .++||||++ |+|.+++.... ..+++..+..++.|++.||.|||. ...+|+||||||+|||++  .++.+||+|||++
T Consensus       131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            999999996 59999997664 468999999999999999999992 146899999999999994  5788999999999


Q ss_pred             cccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcc
Q 040392          321 KLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEI  378 (470)
Q Consensus       321 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~  378 (470)
                      ......     .....+|+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       209 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          209 CQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             EETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            876422     23457899999999999999999999999999999999999999864

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2e-39  Score=317.82  Aligned_cols=265  Identities=22%  Similarity=0.277  Sum_probs=199.8

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CC-cEEEEEEeecccchhhhhHHHHHHHHhcCCCCc------ceeEEeeeccCCe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DG-MEVAVKVFNLQCGRALKGFDVECEMMKSIRHRN------LIKVISTCSNEEF  243 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~~~~~~~~~~~  243 (470)
                      .++|++.+.||+|+||.||+|... ++ +.||+|++... ......+..|+++++.++|++      ++.+++++.....
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            468999999999999999999864 34 68999998643 334566788999999998766      8999999999999


Q ss_pred             eeEEEecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee----------------
Q 040392          244 KALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL----------------  306 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill----------------  306 (470)
                      .++||||+ +++|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+||++                
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccccc
Confidence            99999999 567777765544 56899999999999999999999   9999999999999999                


Q ss_pred             ---CCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcc
Q 040392          307 ---DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEM  383 (470)
Q Consensus       307 ---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~  383 (470)
                         +.++.+||+|||++......     .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ 
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-  246 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE-  246 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-
T ss_pred             ccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence               56789999999999864322     233568999999999999999999999999999999999999998643321 


Q ss_pred             hhhHHhhhhcCCc--cc-------ccccccc-cCch--------------hhhhHhhhhhHHHHHHHHhhccCCCccCCC
Q 040392          384 TLKHWVNDWLPIS--TM-------EVVGANL-LSQE--------------DIHFVAKEQCVSCVFNLAMECTVESPEQRI  439 (470)
Q Consensus       384 ~~~~~~~~~~~~~--~~-------~~~~~~~-~~~~--------------~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp  439 (470)
                      .+........+..  ..       ....... ....              ..........+.++.+|+.+||+.||++||
T Consensus       247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence            1111111000000  00       0000000 0000              000011122356789999999999999999


Q ss_pred             CHHHHHHH
Q 040392          440 NAREIVAK  447 (470)
Q Consensus       440 s~~el~~~  447 (470)
                      |+.|+++|
T Consensus       327 t~~e~l~h  334 (355)
T 2eu9_A          327 TLAEALLH  334 (355)
T ss_dssp             CHHHHTTS
T ss_pred             CHHHHhcC
Confidence            99999864

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-40  Score=319.89  Aligned_cols=245  Identities=24%  Similarity=0.324  Sum_probs=191.8

Q ss_pred             HHHhhCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccc------hhhhhHHHHHHHHhcC----CCCcceeEEe
Q 040392          168 LCRATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCG------RALKGFDVECEMMKSI----RHRNLIKVIS  236 (470)
Q Consensus       168 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~nIv~~~~  236 (470)
                      .....++|++.+.||+|+||.||+|+. .+++.||||++.....      .....+..|+.++.++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            344567899999999999999999975 4689999999865432      2334556789999888    8999999999


Q ss_pred             eeccCCeeeEEEec-CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCCCeEE
Q 040392          237 TCSNEEFKALVLEY-MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHL  314 (470)
Q Consensus       237 ~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~-~~~~~kl  314 (470)
                      ++...+..++|||+ +.+++|.+++.... .+++..+..++.|++.||+|||   +.+++||||||+||+++ .++.+||
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl  181 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKL  181 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEE
Confidence            99999999999999 78999999997654 5899999999999999999999   89999999999999999 8999999


Q ss_pred             eeeccccccCCCCCcccccccccCccccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhc
Q 040392          315 SDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWL  393 (470)
Q Consensus       315 ~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  393 (470)
                      +|||++.......    .....++..|+|||++.+..+ +.++||||||+++|||++|+.||....       .......
T Consensus       182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~  250 (312)
T 2iwi_A          182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------EILEAEL  250 (312)
T ss_dssp             CCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHTCC
T ss_pred             EEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------HHhhhcc
Confidence            9999998764322    234568999999998876665 458999999999999999999986521       1100000


Q ss_pred             CCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          394 PISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                                          ..+..++.++.+++.+||+.||++|||+.|++++
T Consensus       251 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          251 --------------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             --------------------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             --------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                                0012235678899999999999999999999975

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.5e-40  Score=321.59  Aligned_cols=244  Identities=23%  Similarity=0.305  Sum_probs=200.4

Q ss_pred             HHhhCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccc------hhhhhHHHHHHHHhcCC--CCcceeEEeeec
Q 040392          169 CRATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCG------RALKGFDVECEMMKSIR--HRNLIKVISTCS  239 (470)
Q Consensus       169 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~nIv~~~~~~~  239 (470)
                      ....++|++.+.||+|+||.||+|.. .+++.||||++.....      .....+..|+.+++.++  |+||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            34467899999999999999999975 4689999999975432      12355678999999996  599999999999


Q ss_pred             cCCeeeEEEecCCC-CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC-CCCCeEEeee
Q 040392          240 NEEFKALVLEYMPH-GSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDF  317 (470)
Q Consensus       240 ~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~-~~~~~kl~Df  317 (470)
                      ..+..++|||++.+ ++|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++ .++.+||+||
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Df  194 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDF  194 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence            99999999999976 89999997644 6899999999999999999999   89999999999999999 7899999999


Q ss_pred             ccccccCCCCCcccccccccCccccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc
Q 040392          318 SIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS  396 (470)
Q Consensus       318 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  396 (470)
                      |++......    ......+|+.|+|||++.+..+ +.++||||||+++|||++|+.||.....       ......   
T Consensus       195 g~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------~~~~~~---  260 (320)
T 3a99_A          195 GSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------IIRGQV---  260 (320)
T ss_dssp             TTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HHHCCC---
T ss_pred             ccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------hhcccc---
Confidence            999876432    2234568999999998876665 6889999999999999999999865211       100000   


Q ss_pred             ccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          397 TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       397 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                               .        .+..++.++.+++.+||+.||++|||+.|++++
T Consensus       261 ---------~--------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          261 ---------F--------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             ---------C--------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---------c--------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                     0        012236678899999999999999999999875

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2e-39  Score=336.47  Aligned_cols=271  Identities=23%  Similarity=0.298  Sum_probs=201.2

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc-cchhhhhHHHHHHHHhcCCCCcceeEEeeecc------CCe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ-CGRALKGFDVECEMMKSIRHRNLIKVISTCSN------EEF  243 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~------~~~  243 (470)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+..|+++++.++||||+++++++..      ...
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            47899999999999999999976 46899999998654 33446678899999999999999999999765      677


Q ss_pred             eeEEEecCCCCChHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC---eEEeeec
Q 040392          244 KALVLEYMPHGSLEKYMYSSN--YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV---AHLSDFS  318 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~---~kl~Dfg  318 (470)
                      .++||||+++|+|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            899999999999999997644  25888899999999999999999   899999999999999997765   9999999


Q ss_pred             cccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc--
Q 040392          319 IAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS--  396 (470)
Q Consensus       319 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--  396 (470)
                      ++.......   ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||......    ..|........  
T Consensus       170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~----~~~~~~i~~~~~~  242 (676)
T 3qa8_A          170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP----VQWHGKVREKSNE  242 (676)
T ss_dssp             CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH----HHSSTTCC-----
T ss_pred             ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch----hhhhhhhhcccch
Confidence            998764322   223467899999999999999999999999999999999999999753211    11211110000  


Q ss_pred             ---ccccccccccC--chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHH-----HHHHHHHH
Q 040392          397 ---TMEVVGANLLS--QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREI-----VAKLLKIR  452 (470)
Q Consensus       397 ---~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el-----~~~L~~i~  452 (470)
                         ..+........  ............+..+.+++..||..||++|||+.|+     .+.+..+.
T Consensus       243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL  308 (676)
T 3qa8_A          243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL  308 (676)
T ss_dssp             -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred             hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence               00000000000  0000001123357889999999999999999999984     44444443

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.4e-38  Score=302.57  Aligned_cols=233  Identities=14%  Similarity=0.052  Sum_probs=186.6

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      .++|++.+.||+|+||.||+|+.. +++.||||++....   ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            467999999999999999999875 48999999997553   23346788999999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||+++++|.+++...   .....+.+++.|++.||+|||   +.+|+||||||+||+++.++.+||+++|.        
T Consensus       110 ~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~~--------  175 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPAT--------  175 (286)
T ss_dssp             EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCCC--------
T ss_pred             EEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEeccc--------
Confidence            9999999999999543   356678899999999999999   99999999999999999999999985542        


Q ss_pred             CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                                    ++       .++.++||||||+++|||++|+.||......+.....              ......
T Consensus       176 --------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~--------------~~~~~~  220 (286)
T 3uqc_A          176 --------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA--------------ERDTAG  220 (286)
T ss_dssp             --------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC--------------CBCTTS
T ss_pred             --------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH--------------HHHhcc
Confidence                          22       3678999999999999999999999864332210000              000000


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                      ...........++.++.+++.+||+.||++| |+.|+++.|+++...
T Consensus       221 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          221 QPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             CBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             CCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence            0000111223457789999999999999999 999999999998643

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4.2e-38  Score=301.37  Aligned_cols=231  Identities=20%  Similarity=0.290  Sum_probs=181.0

Q ss_pred             hCCCCCC-CeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHH-hcCCCCcceeEEeeecc----CCee
Q 040392          172 TDGFSEN-NLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMM-KSIRHRNLIKVISTCSN----EEFK  244 (470)
Q Consensus       172 ~~~~~~~-~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~nIv~~~~~~~~----~~~~  244 (470)
                      .++|.+. +.||+|+||.||+|.. .+++.||+|++..     ...+.+|+.++ +.++||||+++++++..    ....
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            4567776 7899999999999976 4689999999863     23566788887 66689999999999876    6778


Q ss_pred             eEEEecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCCeEEeeeccc
Q 040392          245 ALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFSIA  320 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~a  320 (470)
                      ++||||+++|+|.+++.... ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.   ++.+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            99999999999999997754 46899999999999999999999   999999999999999998   789999999998


Q ss_pred             cccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccc
Q 040392          321 KLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEV  400 (470)
Q Consensus       321 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (470)
                      ....                        +..++.++||||||+++|||++|+.||..........          .....
T Consensus       168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~----------~~~~~  213 (299)
T 3m2w_A          168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP----------GMKTR  213 (299)
T ss_dssp             EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C----------CSCCS
T ss_pred             cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH----------HHHHH
Confidence            7542                        2346779999999999999999999997643221100          00000


Q ss_pred             ccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          401 VGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ..   .............++.++.+++.+||+.||++|||+.|+++|
T Consensus       214 ~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          214 IR---MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             SC---TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             Hh---hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            00   000001111223457789999999999999999999999986

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.6e-38  Score=337.53  Aligned_cols=242  Identities=21%  Similarity=0.306  Sum_probs=195.1

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC--CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCe-----
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEF-----  243 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~-----  243 (470)
                      .++|++.+.||+|+||.||+|.+.  +|+.||||++.... ......+..|+++++.++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            478999999999999999999875  58999999986442 3445678889999999999999999999976654     


Q ss_pred             eeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecccccc
Q 040392          244 KALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  323 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~  323 (470)
                      .++||||+++++|.+++..   .+++..+..++.|++.||.|||   +.+|+||||||+||+++.+ .+||+|||+++..
T Consensus       159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence            6999999999999988754   5899999999999999999999   8999999999999999985 9999999999876


Q ss_pred             CCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccc
Q 040392          324 TGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA  403 (470)
Q Consensus       324 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (470)
                      ...      ....||+.|+|||++.+. ++.++||||||+++|+|++|..||........                    
T Consensus       232 ~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--------------------  284 (681)
T 2pzi_A          232 NSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------------------  284 (681)
T ss_dssp             TCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC--------------------
T ss_pred             ccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc--------------------
Confidence            432      345699999999988664 48899999999999999999888764221110                    


Q ss_pred             cccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCC-CHHHHHHHHHHHHHH
Q 040392          404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRI-NAREIVAKLLKIRDS  454 (470)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~el~~~L~~i~~~  454 (470)
                        ...     ......+..+.+++.+||+.||++|| +++++...|..+...
T Consensus       285 --~~~-----~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  329 (681)
T 2pzi_A          285 --PED-----DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE  329 (681)
T ss_dssp             --CTT-----CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred             --ccc-----ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence              000     00112245688999999999999999 567777777776543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-38  Score=318.69  Aligned_cols=248  Identities=16%  Similarity=0.178  Sum_probs=184.4

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCC-Cccee-------------
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRH-RNLIK-------------  233 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~nIv~-------------  233 (470)
                      ...|...+.||+|+||.||+|++ .+|+.||||++....   ....+.+.+|+.+++.++| +|...             
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            34567778999999999999985 469999999987332   2346778899999999987 32211             


Q ss_pred             --------EEeeecc-----CCeeeEEEecCCCCChHHhhh------cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 040392          234 --------VISTCSN-----EEFKALVLEYMPHGSLEKYMY------SSNYILDIFQRLNIMIDVASALEYLHFGYSAPI  294 (470)
Q Consensus       234 --------~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i  294 (470)
                              +..++..     ....+++|+++ +++|.+++.      .....+++..++.++.|+++||+|||   +++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence                    1111111     12356777766 679999984      22445778899999999999999999   9999


Q ss_pred             eecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccccccccCccccCcccc----------CCCCCCCccchhhHHHH
Q 040392          295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYG----------REGRVSTNGDVYSFGIM  364 (470)
Q Consensus       295 ~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~----------~~~~~~~~~DvwslGv~  364 (470)
                      +||||||+|||++.++.+||+|||+++.....     .....| +.|+|||++          .+..++.++|||||||+
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            99999999999999999999999998764321     334567 999999998          56668899999999999


Q ss_pred             HHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHH
Q 040392          365 LMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREI  444 (470)
Q Consensus       365 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el  444 (470)
                      +|||++|+.||......+.. .            ....            ....++.++.+++.+||+.||++||++.|+
T Consensus       307 l~elltg~~Pf~~~~~~~~~-~------------~~~~------------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~  361 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGGS-E------------WIFR------------SCKNIPQPVRALLEGFLRYPKEDRLLPLQA  361 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSCS-G------------GGGS------------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHCCCCCCCcchhhhH-H------------HHHh------------hcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            99999999999764322110 0            0000            001235678999999999999999999998


Q ss_pred             HHH--HHHHHHH
Q 040392          445 VAK--LLKIRDS  454 (470)
Q Consensus       445 ~~~--L~~i~~~  454 (470)
                      +++  ++++...
T Consensus       362 l~~~~~~~~~~~  373 (413)
T 3dzo_A          362 METPEYEQLRTE  373 (413)
T ss_dssp             TTSHHHHHHHHH
T ss_pred             HhCHHHHHHHHH
Confidence            765  5555443

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=8.1e-38  Score=304.45  Aligned_cols=245  Identities=17%  Similarity=0.196  Sum_probs=183.4

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeeccc--------chhhhhHHHHHHHHhcCC---------CCcceeE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--------GRALKGFDVECEMMKSIR---------HRNLIKV  234 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~nIv~~  234 (470)
                      .++|++.+.||+|+||.||+|+. +|+.||||++....        ....+.+.+|+++++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            45788999999999999999988 68999999997542        123367888999998886         6666555


Q ss_pred             Eee-----------------ecc-------------CCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 040392          235 IST-----------------CSN-------------EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALE  284 (470)
Q Consensus       235 ~~~-----------------~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~  284 (470)
                      .+.                 +.+             ....++||||+++|++.+.+..  ..+++..+..++.|++.||+
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence            554                 333             6789999999999977666644  45799999999999999999


Q ss_pred             HHhcCCCCCeeecCCCCCCeeeCCCC--------------------CeEEeeeccccccCCCCCcccccccccCccccCc
Q 040392          285 YLHFGYSAPIIHCDLKPSNVLLDDNM--------------------VAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP  344 (470)
Q Consensus       285 ~LH~~~~~~i~H~dlkp~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP  344 (470)
                      |||+  +.+|+||||||+|||++.++                    .+||+|||+|+....       ....||+.|+||
T Consensus       176 ~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aP  246 (336)
T 2vuw_A          176 VAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDE  246 (336)
T ss_dssp             HHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCS
T ss_pred             HHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccCh
Confidence            9993  37899999999999999887                    999999999987642       134799999999


Q ss_pred             cccCCCCCCCccchhhHHHH-HHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHH
Q 040392          345 EYGREGRVSTNGDVYSFGIM-LMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCV  423 (470)
Q Consensus       345 E~~~~~~~~~~~DvwslGv~-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  423 (470)
                      |++.+.. +.++||||+|++ .+++++|..||...        .|...... .   ........ ..........++.++
T Consensus       247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~--------~~~~~~~~-~---~~~~~~~~-~~~~~~~~~~~s~~~  312 (336)
T 2vuw_A          247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV--------LWLHYLTD-K---MLKQMTFK-TKCNTPAMKQIKRKI  312 (336)
T ss_dssp             GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH--------HHHHHHHH-H---HHHTCCCS-SCCCSHHHHHHHHHH
T ss_pred             hhhcCCC-ccceehhhhhCCCCcccccccCCCcch--------hhhhHHHH-h---hhhhhccC-cccchhhhhhcCHHH
Confidence            9998766 889999998777 77788899987541        11100000 0   00000000 000011234568889


Q ss_pred             HHHHhhccCCCccCCCCHHHHH-HH
Q 040392          424 FNLAMECTVESPEQRINAREIV-AK  447 (470)
Q Consensus       424 ~~l~~~cl~~dP~~Rps~~el~-~~  447 (470)
                      .+|+.+||+.|     |+.|++ +|
T Consensus       313 ~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          313 QEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHGGGSS-----SHHHHHHHC
T ss_pred             HHHHHHHhccC-----CHHHHHhcC
Confidence            99999999977     999988 54

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=1.1e-30  Score=270.27  Aligned_cols=184  Identities=19%  Similarity=0.107  Sum_probs=130.0

Q ss_pred             ecccCceEEEEEE-eCCCcEEEEEEeeccc----------chhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCeeeEEE
Q 040392          181 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC----------GRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       181 ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      .+.|+.|.+..++ .-.|+.+|+|++....          ....+.+.+|+++|+++ .|+||++++++++++...||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            4556666665553 2348889999986541          23345688999999999 6999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||++|++|.+++...+ .++..   +|+.||+.||+|+|   ++||+||||||+|||++.++.+||+|||+|+...... 
T Consensus       322 Eyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~-  393 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC-  393 (569)
T ss_dssp             ECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----
T ss_pred             ecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC-
Confidence            9999999999997654 45553   58999999999999   9999999999999999999999999999998764322 


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP  374 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p  374 (470)
                       ......+||+.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus       394 -~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          394 -SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             -ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence             23345679999999999875 567789999999998887665544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=2.5e-27  Score=243.73  Aligned_cols=186  Identities=16%  Similarity=0.165  Sum_probs=144.5

Q ss_pred             CCCCeecccCceEEEEEEeCCCcEEEEEEeecccc--------hhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          176 SENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCG--------RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       176 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      ...+.||+|+||.||+|.. .++.+++|.......        ...+.+.+|++++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3457899999999999955 578899998643321        1234578999999999999999555555566677999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||+++++|.+++..         +..++.|+++||+|||   +++|+||||||+|||++.  .+||+|||+++......
T Consensus       418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~  483 (540)
T 3en9_A          418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE  483 (540)
T ss_dssp             EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred             EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence            999999999999965         5589999999999999   999999999999999998  99999999998764321


Q ss_pred             Ccc-----cccccccCccccCccccCC--CCCCCccchhhHHHHHHHHHhCCCCCC
Q 040392          328 QSM-----TQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTGKKPTN  376 (470)
Q Consensus       328 ~~~-----~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~tg~~p~~  376 (470)
                      ...     ......||+.|+|||++..  ..|+...|+|+..+-..+-+.++.+|.
T Consensus       484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            111     1235679999999999876  567888999999999998888777653

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=1.6e-24  Score=204.59  Aligned_cols=149  Identities=17%  Similarity=0.125  Sum_probs=118.2

Q ss_pred             HHhhCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccc------------------hhhhhHHHHHHHHhcCCCCc
Q 040392          169 CRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCG------------------RALKGFDVECEMMKSIRHRN  230 (470)
Q Consensus       169 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~n  230 (470)
                      ......|.+.+.||+|+||.||+|...+|+.||+|+++....                  .....+.+|+++++.++|  
T Consensus        86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~--  163 (282)
T 1zar_A           86 VRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG--  163 (282)
T ss_dssp             HHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT--
T ss_pred             HhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC--
Confidence            334455667799999999999999887799999999864321                  134567889999999994  


Q ss_pred             ceeEEeeeccCCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC
Q 040392          231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM  310 (470)
Q Consensus       231 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~  310 (470)
                       +++.+++.. +..++||||+++|+|.+ +..       .....++.|++.||.|||   +.+|+||||||+|||++ ++
T Consensus       164 -~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~  229 (282)
T 1zar_A          164 -LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EE  229 (282)
T ss_dssp             -SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TT
T ss_pred             -CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CC
Confidence             555554433 45689999999999988 421       134579999999999999   99999999999999999 99


Q ss_pred             CeEEeeeccccccCCCCCcccccccccCccccCccccC
Q 040392          311 VAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR  348 (470)
Q Consensus       311 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~  348 (470)
                      .+||+|||+|+..               ..+.|||++.
T Consensus       230 ~vkl~DFG~a~~~---------------~~~~a~e~l~  252 (282)
T 1zar_A          230 GIWIIDFPQSVEV---------------GEEGWREILE  252 (282)
T ss_dssp             EEEECCCTTCEET---------------TSTTHHHHHH
T ss_pred             cEEEEECCCCeEC---------------CCCCHHHHHH
Confidence            9999999998732               3467888764

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.80  E-value=2.9e-20  Score=173.33  Aligned_cols=137  Identities=20%  Similarity=0.243  Sum_probs=106.0

Q ss_pred             CCCCCeecccCceEEEEEEe-CCCcE--EEEEEeecccch------------------------hhhhHHHHHHHHhcCC
Q 040392          175 FSENNLIGRGGFGSVYKARL-GDGME--VAVKVFNLQCGR------------------------ALKGFDVECEMMKSIR  227 (470)
Q Consensus       175 ~~~~~~ig~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  227 (470)
                      |.+.+.||+|+||.||+|.. .+|+.  ||||+++.....                        ....+..|++++..+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56778999999999999987 67989  999997543111                        1125778999999998


Q ss_pred             CCcc--eeEEeeeccCCeeeEEEecCCC-C----ChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 040392          228 HRNL--IKVISTCSNEEFKALVLEYMPH-G----SLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK  300 (470)
Q Consensus       228 h~nI--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlk  300 (470)
                      |+++  ..++.+    ...++||||+.+ |    +|.++...    .++..+..++.|++.||.|||.  ..+|+|||||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlk  198 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ--EAELVHADLS  198 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCC
Confidence            8754  444443    346899999942 3    67666532    2244667899999999999994  5789999999


Q ss_pred             CCCeeeCCCCCeEEeeecccccc
Q 040392          301 PSNVLLDDNMVAHLSDFSIAKLL  323 (470)
Q Consensus       301 p~Nill~~~~~~kl~Dfg~a~~~  323 (470)
                      |+|||++.  .++|+|||+|...
T Consensus       199 p~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          199 EYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TTSEEESS--SEEECCCTTCEET
T ss_pred             HHHEEEcC--cEEEEECcccccC
Confidence            99999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.72  E-value=3.4e-18  Score=165.74  Aligned_cols=137  Identities=16%  Similarity=0.204  Sum_probs=98.9

Q ss_pred             CCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccc--------------hhhhhH--------HHHHHHHhcCCCCc
Q 040392          173 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCG--------------RALKGF--------DVECEMMKSIRHRN  230 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~~--------~~E~~~l~~l~h~n  230 (470)
                      .-|.+.+.||+|++|.||+|...+|+.||||+++....              ......        ..|...+.++.+.+
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            34888999999999999999998999999999753210              001111        23445555553333


Q ss_pred             c--eeEEeeeccCCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC
Q 040392          231 L--IKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD  308 (470)
Q Consensus       231 I--v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~  308 (470)
                      +  ...+++    ...++||||++|++|.++...       .....++.|++.+|.|||   ..+|+||||||.|||+++
T Consensus       175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~  240 (397)
T 4gyi_A          175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIRE  240 (397)
T ss_dssp             CSCCCEEEE----ETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEE
T ss_pred             CCCCeeeec----cCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeC
Confidence            2  122222    123699999999888766421       124568899999999999   899999999999999987


Q ss_pred             CC----------CeEEeeecccccc
Q 040392          309 NM----------VAHLSDFSIAKLL  323 (470)
Q Consensus       309 ~~----------~~kl~Dfg~a~~~  323 (470)
                      ++          .+.|+||+-+...
T Consensus       241 dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          241 EKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCCcccccccccceEEEEeCCcccC
Confidence            76          3899999987654

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.48  E-value=4.1e-14  Score=152.12  Aligned_cols=108  Identities=44%  Similarity=0.761  Sum_probs=96.3

Q ss_pred             CCCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCC
Q 040392            1 VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPF   80 (470)
Q Consensus         1 ~~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l   80 (470)
                      ++|.+|++|++|+.|+|++|+++|.+|..|+++++|+.|||++|+++|.+|..+..+++|+.||+++|+++|.+|..+.+
T Consensus       647 ~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~  726 (768)
T 3rgz_A          647 YIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQF  726 (768)
T ss_dssp             CCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSG
T ss_pred             cCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhh
Confidence            37889999999999999999999999999999999999999999999999999999999999999999999999998889


Q ss_pred             CCCccccccCCccccCCCCCCCCCCCCCCCC
Q 040392           81 RNFSVESFEGNELLCGSPNLQVPPCKTSNHH  111 (470)
Q Consensus        81 ~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~  111 (470)
                      .++....+.+|+.+|+.|   .++|+.....
T Consensus       727 ~~~~~~~~~gN~~Lcg~~---l~~C~~~~~~  754 (768)
T 3rgz_A          727 ETFPPAKFLNNPGLCGYP---LPRCDPSNAD  754 (768)
T ss_dssp             GGSCGGGGCSCTEEESTT---SCCCCSCC--
T ss_pred             ccCCHHHhcCCchhcCCC---CcCCCCCccC
Confidence            999999999999999988   3478765554

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.46  E-value=1.4e-13  Score=121.98  Aligned_cols=94  Identities=27%  Similarity=0.319  Sum_probs=71.8

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPF   80 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l   80 (470)
                      +|..|.++++|+.|+|++|.|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|.|+..++. +..+
T Consensus        46 ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l  125 (193)
T 2wfh_A           46 VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDL  125 (193)
T ss_dssp             CCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTC
T ss_pred             hHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcC
Confidence            566777778888888888888866666777788888888888888866666777788888888888888766654 4567


Q ss_pred             CCCccccccCCcccc
Q 040392           81 RNFSVESFEGNELLC   95 (470)
Q Consensus        81 ~~l~~l~~~~n~~~~   95 (470)
                      ++|+.+++++|++.|
T Consensus       126 ~~L~~L~L~~N~~~C  140 (193)
T 2wfh_A          126 SALSHLAIGANPLYC  140 (193)
T ss_dssp             TTCCEEECCSSCEEC
T ss_pred             ccccEEEeCCCCeec
Confidence            778888888888776

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.46  E-value=2e-13  Score=118.80  Aligned_cols=93  Identities=23%  Similarity=0.342  Sum_probs=83.6

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPF   80 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l   80 (470)
                      +|..+.  ++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++.++. +..+
T Consensus        27 iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l  104 (174)
T 2r9u_A           27 VPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNL  104 (174)
T ss_dssp             CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred             cCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccc
Confidence            566664  8999999999999988899999999999999999999966666678999999999999999988876 6789


Q ss_pred             CCCccccccCCccccC
Q 040392           81 RNFSVESFEGNELLCG   96 (470)
Q Consensus        81 ~~l~~l~~~~n~~~~~   96 (470)
                      ++|+.|++++|++.|.
T Consensus       105 ~~L~~L~L~~N~~~c~  120 (174)
T 2r9u_A          105 KSLTHIYLYNNPWDCE  120 (174)
T ss_dssp             TTCSEEECCSSCBCTT
T ss_pred             cCCCEEEeCCCCcccc
Confidence            9999999999999874

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.45  E-value=2.3e-13  Score=117.97  Aligned_cols=93  Identities=26%  Similarity=0.320  Sum_probs=84.0

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPF   80 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l   80 (470)
                      +|..+.  ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++.++. +..+
T Consensus        24 ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l  101 (170)
T 3g39_A           24 VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNL  101 (170)
T ss_dssp             CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred             cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCC
Confidence            566553  8899999999999988889999999999999999999977777789999999999999999988876 5789


Q ss_pred             CCCccccccCCccccC
Q 040392           81 RNFSVESFEGNELLCG   96 (470)
Q Consensus        81 ~~l~~l~~~~n~~~~~   96 (470)
                      ++|+.|++++|++.|.
T Consensus       102 ~~L~~L~L~~N~~~c~  117 (170)
T 3g39_A          102 KSLTHIWLLNNPWDCA  117 (170)
T ss_dssp             TTCCEEECCSSCBCTT
T ss_pred             CCCCEEEeCCCCCCCC
Confidence            9999999999999874

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.42  E-value=5.4e-13  Score=124.24  Aligned_cols=146  Identities=15%  Similarity=0.082  Sum_probs=115.1

Q ss_pred             HHhhCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCC-CCcceeEEeeeccCCeeeEE
Q 040392          169 CRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIR-HRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       169 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv  247 (470)
                      ....+.|.....++.|+.+.||++... ++.+++|+...........+..|+++++.+. +.++.++++++...+..++|
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            344567888888898999999999764 7899999986532233456889999999884 67788999999888899999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY-------------------------------------  290 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~-------------------------------------  290 (470)
                      |||++|.+|.+...      +......++.+++++|..||...                                     
T Consensus        89 ~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           89 MSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             EECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             EEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            99999999987642      11233468889999999999510                                     


Q ss_pred             -------------------CCCeeecCCCCCCeeeCCCCCeEEeeecccc
Q 040392          291 -------------------SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK  321 (470)
Q Consensus       291 -------------------~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~  321 (470)
                                         ...++|+|++|.||+++++..+.|+||+.+.
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                               1458999999999999876667899998775

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.41  E-value=3.6e-13  Score=119.30  Aligned_cols=90  Identities=24%  Similarity=0.322  Sum_probs=66.8

Q ss_pred             cCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCCCCCc
Q 040392            6 IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPFRNFS   84 (470)
Q Consensus         6 ~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~   84 (470)
                      |+++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|++++|+|++.++. +..+++|+
T Consensus        50 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  129 (192)
T 1w8a_A           50 FGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLT  129 (192)
T ss_dssp             GGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCC
T ss_pred             cccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCC
Confidence            66777777777777777777677777777777777777777766666677777777777777777766554 45677777


Q ss_pred             cccccCCcccc
Q 040392           85 VESFEGNELLC   95 (470)
Q Consensus        85 ~l~~~~n~~~~   95 (470)
                      .+++++|++.|
T Consensus       130 ~L~L~~N~l~c  140 (192)
T 1w8a_A          130 SLNLASNPFNC  140 (192)
T ss_dssp             EEECTTCCBCC
T ss_pred             EEEeCCCCccC
Confidence            77777777765

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.38  E-value=1.2e-12  Score=118.60  Aligned_cols=89  Identities=16%  Similarity=0.132  Sum_probs=53.4

Q ss_pred             cCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCCCCCc
Q 040392            6 IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPFRNFS   84 (470)
Q Consensus         6 ~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~   84 (470)
                      |.++++|+.|+|++|+|++..|..|.++++|+.|+|++|.|++..+..|..+++|+.|+|++|.|++.++. +..+++|+
T Consensus        53 ~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  132 (220)
T 2v70_A           53 FKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVR  132 (220)
T ss_dssp             GGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCS
T ss_pred             hccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCC
Confidence            45666666666666666655555566666666666666666655555566666666666666666655433 34556666


Q ss_pred             cccccCCccc
Q 040392           85 VESFEGNELL   94 (470)
Q Consensus        85 ~l~~~~n~~~   94 (470)
                      .|++++|.+.
T Consensus       133 ~L~L~~N~l~  142 (220)
T 2v70_A          133 LLSLYDNQIT  142 (220)
T ss_dssp             EEECTTSCCC
T ss_pred             EEECCCCcCC
Confidence            6666666554

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.37  E-value=1.4e-12  Score=118.13  Aligned_cols=90  Identities=27%  Similarity=0.247  Sum_probs=58.1

Q ss_pred             ccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCCCCC
Q 040392            5 EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPFRNF   83 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l   83 (470)
                      .|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|.|++..+..|..+++|+.|+|++|.|++.++. +..+++|
T Consensus        51 ~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  130 (220)
T 2v9t_B           51 AFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNL  130 (220)
T ss_dssp             SSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred             HhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCC
Confidence            566666777777777777666666666677777777777777644444456666666777776666655443 3556666


Q ss_pred             ccccccCCccc
Q 040392           84 SVESFEGNELL   94 (470)
Q Consensus        84 ~~l~~~~n~~~   94 (470)
                      +.|++++|.+.
T Consensus       131 ~~L~L~~N~l~  141 (220)
T 2v9t_B          131 NLLSLYDNKLQ  141 (220)
T ss_dssp             CEEECCSSCCS
T ss_pred             CEEECCCCcCC
Confidence            66666666654

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.36  E-value=1e-12  Score=127.67  Aligned_cols=93  Identities=26%  Similarity=0.288  Sum_probs=85.5

Q ss_pred             CCcccCCCCCCcEeeCcC-CcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCC
Q 040392            2 IPTEIGGLKNLEYLFLGY-NRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPF   80 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~-n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l   80 (470)
                      +|. |+.+++|+.|+|++ |+|++..|..|.+|++|+.|+|++|+|++..|..|..|++|+.|+|++|+|++.++.....
T Consensus        24 ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  102 (347)
T 2ifg_A           24 LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQG  102 (347)
T ss_dssp             TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCS
T ss_pred             cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHccc
Confidence            788 99999999999996 9999887788999999999999999999988889999999999999999999888876554


Q ss_pred             CCCccccccCCcccc
Q 040392           81 RNFSVESFEGNELLC   95 (470)
Q Consensus        81 ~~l~~l~~~~n~~~~   95 (470)
                      .+|+.|++.+|++.|
T Consensus       103 ~~L~~l~l~~N~~~c  117 (347)
T 2ifg_A          103 LSLQELVLSGNPLHC  117 (347)
T ss_dssp             CCCCEEECCSSCCCC
T ss_pred             CCceEEEeeCCCccC
Confidence            459999999999987

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.36  E-value=8e-13  Score=126.48  Aligned_cols=96  Identities=39%  Similarity=0.649  Sum_probs=88.3

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFR   81 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~   81 (470)
                      +|..|.++++|+.|+|++|.+++.+|. +..+++|+.|+|++|+|++.+|..+..+++|+.|++++|.|++.+|....++
T Consensus       213 ~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~  291 (313)
T 1ogq_A          213 ASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQ  291 (313)
T ss_dssp             CGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGG
T ss_pred             CCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCcccc
Confidence            567788999999999999999966554 8889999999999999999999999999999999999999999999888999


Q ss_pred             CCccccccCCccccCCC
Q 040392           82 NFSVESFEGNELLCGSP   98 (470)
Q Consensus        82 ~l~~l~~~~n~~~~~~~   98 (470)
                      +|+.+++.+|+.+|+.|
T Consensus       292 ~L~~l~l~~N~~lc~~p  308 (313)
T 1ogq_A          292 RFDVSAYANNKCLCGSP  308 (313)
T ss_dssp             GSCGGGTCSSSEEESTT
T ss_pred             ccChHHhcCCCCccCCC
Confidence            99999999999999987

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.33  E-value=4.7e-12  Score=110.43  Aligned_cols=84  Identities=26%  Similarity=0.254  Sum_probs=43.7

Q ss_pred             CCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCC-CCCCCCccccc
Q 040392           10 KNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GPFRNFSVESF   88 (470)
Q Consensus        10 ~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~~   88 (470)
                      ++|+.|+|++|++++..+..|.++++|+.|+|++|.|++..+..+..+++|+.|++++|.|++.++.. ..+++|+.|++
T Consensus        28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l  107 (177)
T 2o6r_A           28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL  107 (177)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence            45555555555555444444455555555555555555433344455555555555555555444432 44555555555


Q ss_pred             cCCcc
Q 040392           89 EGNEL   93 (470)
Q Consensus        89 ~~n~~   93 (470)
                      ++|.+
T Consensus       108 ~~N~l  112 (177)
T 2o6r_A          108 DTNQL  112 (177)
T ss_dssp             CSSCC
T ss_pred             cCCcc
Confidence            55554

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.29  E-value=7.7e-12  Score=116.02  Aligned_cols=136  Identities=15%  Similarity=0.095  Sum_probs=101.1

Q ss_pred             CCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCc--ceeEEeeeccCCeeeEEEecC
Q 040392          174 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRN--LIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~~~~~~~~~~~~~lv~e~~  251 (470)
                      .+.+....+.|..+.||++...+|..+++|+....   ....+..|+++++.+.+.+  +.+++++....+..++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            34443333456679999998777888999997543   3356788999999886544  566888888778889999999


Q ss_pred             CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------
Q 040392          252 PHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY-----------------------------------------  290 (470)
Q Consensus       252 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~-----------------------------------------  290 (470)
                      +|.+|.  ...    .+   ...++.++++.|..||...                                         
T Consensus        98 ~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (264)
T 1nd4_A           98 PGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA  168 (264)
T ss_dssp             SSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred             CCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence            998884  211    12   2357788888888888421                                         


Q ss_pred             --------------CCCeeecCCCCCCeeeCCCCCeEEeeecccc
Q 040392          291 --------------SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK  321 (470)
Q Consensus       291 --------------~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~  321 (470)
                                    ...++|+|++|.||++++++.+.|+||+.+.
T Consensus       169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                          0129999999999999887777899999875

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.29  E-value=8.3e-12  Score=113.71  Aligned_cols=92  Identities=27%  Similarity=0.336  Sum_probs=73.4

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCC
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRN   82 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~   82 (470)
                      |..|.++++|+.|+|++|+|+...+..|.++++|+.|+|++|+|++..+..|..+++|+.|++++|.|+..+..+..+++
T Consensus        57 ~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~  136 (229)
T 3e6j_A           57 PGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTH  136 (229)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTT
T ss_pred             HHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCcccccCcccccCCC
Confidence            56678888888888888888855556678888888888888888866666678888888888888888866666677888


Q ss_pred             CccccccCCccc
Q 040392           83 FSVESFEGNELL   94 (470)
Q Consensus        83 l~~l~~~~n~~~   94 (470)
                      |+.|++++|.+.
T Consensus       137 L~~L~L~~N~l~  148 (229)
T 3e6j_A          137 LTHLALDQNQLK  148 (229)
T ss_dssp             CSEEECCSSCCC
T ss_pred             CCEEECCCCcCC
Confidence            888888888775

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.28  E-value=1.2e-13  Score=140.56  Aligned_cols=90  Identities=23%  Similarity=0.191  Sum_probs=61.7

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCcccc-CCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCC
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPDSFG-DLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFR   81 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~~~~-~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~   81 (470)
                      |..|+++++|+.|+|++|.+++.+|..+. ++++|+.|+|++|.|++. |. +..+++|+.|+|++|.|++.++.+..++
T Consensus       137 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~l~  214 (487)
T 3oja_A          137 DLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAA  214 (487)
T ss_dssp             GBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGT
T ss_pred             chhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCCCCCCCHhHcCCC
Confidence            44566677777777777777766666664 567777777777777743 22 3357777777777777777666666777


Q ss_pred             CCccccccCCccc
Q 040392           82 NFSVESFEGNELL   94 (470)
Q Consensus        82 ~l~~l~~~~n~~~   94 (470)
                      +|+.|++++|.+.
T Consensus       215 ~L~~L~Ls~N~l~  227 (487)
T 3oja_A          215 GVTWISLRNNKLV  227 (487)
T ss_dssp             TCSEEECTTSCCC
T ss_pred             CccEEEecCCcCc
Confidence            7777777777764

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.28  E-value=1.4e-11  Score=110.42  Aligned_cols=90  Identities=30%  Similarity=0.359  Sum_probs=68.1

Q ss_pred             ccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCCCCC
Q 040392            5 EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPFRNF   83 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l   83 (470)
                      .|.++++|+.|+|++|++++..+..|.++++|++|+|++|+|++..+..+..+++|+.|++++|.|++.++. +..+++|
T Consensus        47 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  126 (208)
T 2o6s_A           47 VFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQL  126 (208)
T ss_dssp             TTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred             hhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcC
Confidence            467788888888888888866555677788888888888888855555677788888888888888766665 3667788


Q ss_pred             ccccccCCccc
Q 040392           84 SVESFEGNELL   94 (470)
Q Consensus        84 ~~l~~~~n~~~   94 (470)
                      +.|++++|.+.
T Consensus       127 ~~L~l~~N~l~  137 (208)
T 2o6s_A          127 KDLRLYQNQLK  137 (208)
T ss_dssp             CEEECCSSCCS
T ss_pred             CEEECCCCccc
Confidence            88888888764

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.27  E-value=4.9e-12  Score=135.96  Aligned_cols=99  Identities=31%  Similarity=0.494  Sum_probs=92.2

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPF   80 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l   80 (470)
                      +|..++++++|+.|||++|+++|.+|..++++++|+.|+|++|+++|.+|..++.+++|+.|||++|+++|.+|. +..+
T Consensus       624 ~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l  703 (768)
T 3rgz_A          624 TSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSAL  703 (768)
T ss_dssp             CCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGC
T ss_pred             CchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCC
Confidence            467888999999999999999999999999999999999999999999999999999999999999999988876 4789


Q ss_pred             CCCccccccCCccccCCCCC
Q 040392           81 RNFSVESFEGNELLCGSPNL  100 (470)
Q Consensus        81 ~~l~~l~~~~n~~~~~~~~~  100 (470)
                      ++|+.+++++|++....|..
T Consensus       704 ~~L~~L~ls~N~l~g~iP~~  723 (768)
T 3rgz_A          704 TMLTEIDLSNNNLSGPIPEM  723 (768)
T ss_dssp             CCCSEEECCSSEEEEECCSS
T ss_pred             CCCCEEECcCCcccccCCCc
Confidence            99999999999998777743

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.26  E-value=1.6e-11  Score=113.48  Aligned_cols=92  Identities=25%  Similarity=0.265  Sum_probs=72.4

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCCC
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPFR   81 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~   81 (470)
                      |..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|++++|.|++.++. +..++
T Consensus        76 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  155 (251)
T 3m19_A           76 AGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLT  155 (251)
T ss_dssp             TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred             HhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCc
Confidence            44577888888888888888866667778888888888888888866556677888888888888888876664 56778


Q ss_pred             CCccccccCCccc
Q 040392           82 NFSVESFEGNELL   94 (470)
Q Consensus        82 ~l~~l~~~~n~~~   94 (470)
                      +|+.|++++|.+.
T Consensus       156 ~L~~L~L~~N~l~  168 (251)
T 3m19_A          156 NLQTLSLSTNQLQ  168 (251)
T ss_dssp             TCCEEECCSSCCS
T ss_pred             CCCEEECCCCcCC
Confidence            8888888888775

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.25  E-value=1.9e-11  Score=111.38  Aligned_cols=91  Identities=26%  Similarity=0.295  Sum_probs=66.0

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCC-CCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GPF   80 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l   80 (470)
                      +|..+.  ++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.|++.++.. ..+
T Consensus        34 ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l  111 (229)
T 3e6j_A           34 VPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRL  111 (229)
T ss_dssp             CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred             cCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcc
Confidence            444443  67778888888888777777777888888888888887544455677788888888888877666653 567


Q ss_pred             CCCccccccCCccc
Q 040392           81 RNFSVESFEGNELL   94 (470)
Q Consensus        81 ~~l~~l~~~~n~~~   94 (470)
                      ++|+.|++++|.+.
T Consensus       112 ~~L~~L~Ls~N~l~  125 (229)
T 3e6j_A          112 VHLKELFMCCNKLT  125 (229)
T ss_dssp             TTCCEEECCSSCCC
T ss_pred             hhhCeEeccCCccc
Confidence            77888888877765

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.25  E-value=7.1e-12  Score=105.91  Aligned_cols=91  Identities=26%  Similarity=0.235  Sum_probs=74.4

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccC--CCCCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEI--PRGGP   79 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~--~~~~~   79 (470)
                      +|..+.++++|+.|+|++|.+++.  ..+.++++|+.|+|++|.|++.+|..+..+++|+.|++++|.|++.+  ..+..
T Consensus        34 ~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~  111 (149)
T 2je0_A           34 LEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKK  111 (149)
T ss_dssp             CCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGG
T ss_pred             HHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhh
Confidence            566778888888888888888855  67888888888888888888768877777888888888888888643  55677


Q ss_pred             CCCCccccccCCccc
Q 040392           80 FRNFSVESFEGNELL   94 (470)
Q Consensus        80 l~~l~~l~~~~n~~~   94 (470)
                      +++|+.|++++|++.
T Consensus       112 l~~L~~L~l~~N~l~  126 (149)
T 2je0_A          112 LENLKSLDLFNCEVT  126 (149)
T ss_dssp             CTTCCEEECTTCGGG
T ss_pred             CCCCCEEeCcCCccc
Confidence            888888888888874

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.24  E-value=1.7e-11  Score=110.91  Aligned_cols=93  Identities=27%  Similarity=0.363  Sum_probs=47.5

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCCC
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPFR   81 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~   81 (470)
                      |..|.++++|+.|+|++|+|+...+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|.|++.++. +..++
T Consensus        73 ~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  152 (220)
T 2v9t_B           73 PDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR  152 (220)
T ss_dssp             TTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCT
T ss_pred             HHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCC
Confidence            34455555555555555555533333344555555555555555544445555555555555555555544443 23445


Q ss_pred             CCccccccCCcccc
Q 040392           82 NFSVESFEGNELLC   95 (470)
Q Consensus        82 ~l~~l~~~~n~~~~   95 (470)
                      +|+.+++++|++.|
T Consensus       153 ~L~~L~L~~N~~~c  166 (220)
T 2v9t_B          153 AIQTMHLAQNPFIC  166 (220)
T ss_dssp             TCCEEECCSSCEEC
T ss_pred             CCCEEEeCCCCcCC
Confidence            55555555555544

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.24  E-value=2.9e-11  Score=113.11  Aligned_cols=90  Identities=29%  Similarity=0.354  Sum_probs=64.5

Q ss_pred             ccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCC-CCCCCC
Q 040392            5 EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GPFRNF   83 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l   83 (470)
                      .|+++++|+.|+|++|++++..|..|.++++|+.|+|++|.+++..+..+..+++|+.|++++|.|++.++.. ..+++|
T Consensus       104 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  183 (272)
T 3rfs_A          104 VFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQL  183 (272)
T ss_dssp             TTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred             HhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccC
Confidence            4567777777777777777666666777777777777777777655556677777777777777777665553 566777


Q ss_pred             ccccccCCccc
Q 040392           84 SVESFEGNELL   94 (470)
Q Consensus        84 ~~l~~~~n~~~   94 (470)
                      +.|++++|.+.
T Consensus       184 ~~L~L~~N~l~  194 (272)
T 3rfs_A          184 KDLRLYQNQLK  194 (272)
T ss_dssp             CEEECCSSCCS
T ss_pred             CEEECCCCcCC
Confidence            77777777764

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.23  E-value=1.8e-11  Score=110.72  Aligned_cols=94  Identities=24%  Similarity=0.260  Sum_probs=78.4

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCCC
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPFR   81 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~   81 (470)
                      |..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|.|++.++. +..++
T Consensus        74 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  153 (220)
T 2v70_A           74 EGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLH  153 (220)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCT
T ss_pred             HHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCC
Confidence            34688888899999999998877777788888999999999998877788888888999999999988877554 56788


Q ss_pred             CCccccccCCccccC
Q 040392           82 NFSVESFEGNELLCG   96 (470)
Q Consensus        82 ~l~~l~~~~n~~~~~   96 (470)
                      +|+.|++++|++.|.
T Consensus       154 ~L~~L~L~~N~l~c~  168 (220)
T 2v70_A          154 SLSTLNLLANPFNCN  168 (220)
T ss_dssp             TCCEEECCSCCEECS
T ss_pred             CCCEEEecCcCCcCC
Confidence            888889999988773

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.23  E-value=3.2e-11  Score=106.65  Aligned_cols=91  Identities=26%  Similarity=0.458  Sum_probs=81.9

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPF   80 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l   80 (470)
                      +|..+.  ++|+.|+|++|+|+ .+|..|.++++|+.|+|++|.|++..+..|..+++|+.|+|++|.|++.++. +..+
T Consensus        25 ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l  101 (193)
T 2wfh_A           25 LPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGL  101 (193)
T ss_dssp             CCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTC
T ss_pred             CCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCC
Confidence            565553  68999999999999 7889999999999999999999987778899999999999999999988775 5789


Q ss_pred             CCCccccccCCcccc
Q 040392           81 RNFSVESFEGNELLC   95 (470)
Q Consensus        81 ~~l~~l~~~~n~~~~   95 (470)
                      ++|+.|++++|.+..
T Consensus       102 ~~L~~L~L~~N~l~~  116 (193)
T 2wfh_A          102 KSLRLLSLHGNDISV  116 (193)
T ss_dssp             TTCCEEECCSSCCCB
T ss_pred             CCCCEEECCCCCCCe
Confidence            999999999999864

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.22  E-value=2.8e-11  Score=114.35  Aligned_cols=93  Identities=26%  Similarity=0.235  Sum_probs=81.0

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCC-CCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GPF   80 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l   80 (470)
                      +|..+.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|++++|+|++.++.. ..+
T Consensus        92 l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l  171 (290)
T 1p9a_G           92 LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGL  171 (290)
T ss_dssp             CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTC
T ss_pred             CchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCc
Confidence            6778888999999999999999777788999999999999999999776677888999999999999999777665 568


Q ss_pred             CCCccccccCCccc
Q 040392           81 RNFSVESFEGNELL   94 (470)
Q Consensus        81 ~~l~~l~~~~n~~~   94 (470)
                      ++|+.|++++|++.
T Consensus       172 ~~L~~L~L~~N~l~  185 (290)
T 1p9a_G          172 ENLDTLLLQENSLY  185 (290)
T ss_dssp             TTCCEEECCSSCCC
T ss_pred             CCCCEEECCCCcCC
Confidence            89999999999885

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.22  E-value=1.4e-11  Score=129.24  Aligned_cols=94  Identities=27%  Similarity=0.405  Sum_probs=85.4

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCC-CCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GPF   80 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l   80 (470)
                      +|..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.||+++|+|++.++.. ..+
T Consensus       486 ~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l  565 (635)
T 4g8a_A          486 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF  565 (635)
T ss_dssp             ECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCC
T ss_pred             CchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhh
Confidence            4678899999999999999999888999999999999999999999888888999999999999999999887764 455


Q ss_pred             -CCCccccccCCcccc
Q 040392           81 -RNFSVESFEGNELLC   95 (470)
Q Consensus        81 -~~l~~l~~~~n~~~~   95 (470)
                       ++|+.|++++|++.|
T Consensus       566 ~~~L~~L~L~~Np~~C  581 (635)
T 4g8a_A          566 PSSLAFLNLTQNDFAC  581 (635)
T ss_dssp             CTTCCEEECTTCCBCC
T ss_pred             hCcCCEEEeeCCCCcc
Confidence             689999999999988

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.22  E-value=1.1e-11  Score=106.97  Aligned_cols=91  Identities=30%  Similarity=0.242  Sum_probs=74.4

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccC--CCCCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEI--PRGGP   79 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~--~~~~~   79 (470)
                      +|..+.++++|+.|+|++|.+++.  ..+..+++|+.|+|++|.+++.+|..+..+++|+.|++++|.|++.+  ..+..
T Consensus        41 i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~  118 (168)
T 2ell_A           41 IEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKK  118 (168)
T ss_dssp             CSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSS
T ss_pred             HHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhc
Confidence            566778888888888888888855  77888888888888888888767777777888888888888888654  45677


Q ss_pred             CCCCccccccCCccc
Q 040392           80 FRNFSVESFEGNELL   94 (470)
Q Consensus        80 l~~l~~l~~~~n~~~   94 (470)
                      +++|+.|++++|++.
T Consensus       119 l~~L~~L~l~~N~l~  133 (168)
T 2ell_A          119 LECLKSLDLFNCEVT  133 (168)
T ss_dssp             CSCCCEEECCSSGGG
T ss_pred             CCCCCEEEeeCCcCc
Confidence            888888888888874

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.22  E-value=2.2e-11  Score=107.63  Aligned_cols=95  Identities=28%  Similarity=0.351  Sum_probs=83.0

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCc-cccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPD-SFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGP   79 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~-~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~   79 (470)
                      +|..+..  +|+.|+|++|+|++..+. .|.++++|+.|+|++|+|++..|..|..+++|+.|++++|.|++.++. +..
T Consensus        23 ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  100 (192)
T 1w8a_A           23 IPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLG  100 (192)
T ss_dssp             CCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTT
T ss_pred             CccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcC
Confidence            5665544  899999999999966554 489999999999999999988899999999999999999999988876 578


Q ss_pred             CCCCccccccCCccccCCC
Q 040392           80 FRNFSVESFEGNELLCGSP   98 (470)
Q Consensus        80 l~~l~~l~~~~n~~~~~~~   98 (470)
                      +++|+.|++++|.+....|
T Consensus       101 l~~L~~L~L~~N~l~~~~~  119 (192)
T 1w8a_A          101 LHQLKTLNLYDNQISCVMP  119 (192)
T ss_dssp             CTTCCEEECCSSCCCEECT
T ss_pred             CCCCCEEECCCCcCCeeCH
Confidence            9999999999999865444

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.18  E-value=7.5e-11  Score=108.88  Aligned_cols=93  Identities=28%  Similarity=0.359  Sum_probs=81.5

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCC-CCCC
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GPFR   81 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~   81 (470)
                      |..|.++++|+.|+|++|.|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|++++|.|++.++.. ..++
T Consensus        52 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  131 (251)
T 3m19_A           52 DATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLT  131 (251)
T ss_dssp             TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred             HhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCC
Confidence            456888999999999999999888888899999999999999999777778889999999999999999777764 6789


Q ss_pred             CCccccccCCcccc
Q 040392           82 NFSVESFEGNELLC   95 (470)
Q Consensus        82 ~l~~l~~~~n~~~~   95 (470)
                      +|+.|++++|.+..
T Consensus       132 ~L~~L~Ls~N~l~~  145 (251)
T 3m19_A          132 KLKELRLNTNQLQS  145 (251)
T ss_dssp             TCCEEECCSSCCCC
T ss_pred             cccEEECcCCcCCc
Confidence            99999999998753

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.17  E-value=7e-11  Score=110.38  Aligned_cols=90  Identities=27%  Similarity=0.324  Sum_probs=64.5

Q ss_pred             ccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCCCCC
Q 040392            5 EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPFRNF   83 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l   83 (470)
                      .|.++++|+.|+|++|.+++..|..|.++++|+.|+|++|.|++..+..+..+++|+.|++++|.|++.++. +..+++|
T Consensus       104 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  183 (270)
T 2o6q_A          104 VFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTEL  183 (270)
T ss_dssp             TTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTC
T ss_pred             HcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCc
Confidence            456777778888888877766666677777777777777777755555567777777777777777765554 3566777


Q ss_pred             ccccccCCccc
Q 040392           84 SVESFEGNELL   94 (470)
Q Consensus        84 ~~l~~~~n~~~   94 (470)
                      +.|++++|++.
T Consensus       184 ~~L~L~~N~l~  194 (270)
T 2o6q_A          184 KTLKLDNNQLK  194 (270)
T ss_dssp             CEEECCSSCCS
T ss_pred             CEEECCCCcCC
Confidence            77777777664

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.16  E-value=7.9e-11  Score=111.22  Aligned_cols=87  Identities=31%  Similarity=0.279  Sum_probs=69.4

Q ss_pred             CCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCC-CCCCCCcc
Q 040392            7 GGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GPFRNFSV   85 (470)
Q Consensus         7 ~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~   85 (470)
                      +.+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..|..|..+++|+.|++++|+|++.++.. ..+++|+.
T Consensus        74 ~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  152 (290)
T 1p9a_G           74 GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEK  152 (290)
T ss_dssp             SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred             CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCE
Confidence            56788888888888888 67777888888888888888888666677888888888888888888766654 56788888


Q ss_pred             ccccCCccc
Q 040392           86 ESFEGNELL   94 (470)
Q Consensus        86 l~~~~n~~~   94 (470)
                      |++++|++.
T Consensus       153 L~L~~N~l~  161 (290)
T 1p9a_G          153 LSLANNNLT  161 (290)
T ss_dssp             EECTTSCCS
T ss_pred             EECCCCcCC
Confidence            888888875

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.16  E-value=1.2e-10  Score=104.16  Aligned_cols=85  Identities=28%  Similarity=0.290  Sum_probs=51.8

Q ss_pred             CCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCC-CCCCCCccccc
Q 040392           10 KNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GPFRNFSVESF   88 (470)
Q Consensus        10 ~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~~   88 (470)
                      ++|++|+|++|++++..+..|.++++|+.|+|++|+|++..+..|..+++|+.|++++|.|++.++.. ..+++|+.|++
T Consensus        28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  107 (208)
T 2o6s_A           28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELAL  107 (208)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEc
Confidence            45666666666666554445566666666666666666444444566666666666666666555442 45666666666


Q ss_pred             cCCccc
Q 040392           89 EGNELL   94 (470)
Q Consensus        89 ~~n~~~   94 (470)
                      ++|.+.
T Consensus       108 ~~N~l~  113 (208)
T 2o6s_A          108 NTNQLQ  113 (208)
T ss_dssp             CSSCCC
T ss_pred             CCCcCc
Confidence            666654

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.16  E-value=5e-11  Score=120.02  Aligned_cols=92  Identities=27%  Similarity=0.256  Sum_probs=51.9

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCC-CCCCCC
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIP-RGGPFR   81 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~-~~~~l~   81 (470)
                      |..|+++++|+.|+|++|++++..|..|.++++|+.|+|++|.+++..|..+..+++|+.|++++|.|++.++ .+..++
T Consensus       292 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  371 (455)
T 3v47_A          292 KSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLP  371 (455)
T ss_dssp             TTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCT
T ss_pred             hhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccc
Confidence            4455556666666666666665555555556666666666666655445555555556666666655554433 234555


Q ss_pred             CCccccccCCccc
Q 040392           82 NFSVESFEGNELL   94 (470)
Q Consensus        82 ~l~~l~~~~n~~~   94 (470)
                      +|+.|++++|++.
T Consensus       372 ~L~~L~L~~N~l~  384 (455)
T 3v47_A          372 NLKELALDTNQLK  384 (455)
T ss_dssp             TCCEEECCSSCCS
T ss_pred             cccEEECCCCccc
Confidence            5555555555553

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.14  E-value=7.5e-11  Score=113.47  Aligned_cols=93  Identities=19%  Similarity=0.171  Sum_probs=47.3

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPF   80 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l   80 (470)
                      +|.+|+++++|+.|+|++|.++ .+|+.+..+++|+.|+|++|.+.+.+|..+..+++|+.|++++|.+.+.+|. +..+
T Consensus       198 lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l  276 (328)
T 4fcg_A          198 LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRL  276 (328)
T ss_dssp             CCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGC
T ss_pred             chHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcC
Confidence            3444555555555555555555 2344455555555555555555555555555555555555555544443332 3445


Q ss_pred             CCCccccccCCcccc
Q 040392           81 RNFSVESFEGNELLC   95 (470)
Q Consensus        81 ~~l~~l~~~~n~~~~   95 (470)
                      ++|+.|++++|++..
T Consensus       277 ~~L~~L~L~~n~~~~  291 (328)
T 4fcg_A          277 TQLEKLDLRGCVNLS  291 (328)
T ss_dssp             TTCCEEECTTCTTCC
T ss_pred             CCCCEEeCCCCCchh
Confidence            555555555555443

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.14  E-value=5.8e-11  Score=122.58  Aligned_cols=91  Identities=25%  Similarity=0.322  Sum_probs=81.5

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCcccccc--CCCCCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGE--IPRGGP   79 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~--~~~~~~   79 (470)
                      +|. |++|++|+.|+|++|+|+ .+|..|+++++|+.|+|++|+|++ +| .+..+++|+.|+|++|.|++.  +..+..
T Consensus       456 lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~  531 (567)
T 1dce_A          456 LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVS  531 (567)
T ss_dssp             CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGG
T ss_pred             CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhc
Confidence            565 889999999999999999 889999999999999999999995 77 799999999999999999988  556788


Q ss_pred             CCCCccccccCCccccC
Q 040392           80 FRNFSVESFEGNELLCG   96 (470)
Q Consensus        80 l~~l~~l~~~~n~~~~~   96 (470)
                      +++|+.|++++|++...
T Consensus       532 l~~L~~L~L~~N~l~~~  548 (567)
T 1dce_A          532 CPRLVLLNLQGNSLCQE  548 (567)
T ss_dssp             CTTCCEEECTTSGGGGS
T ss_pred             CCCCCEEEecCCcCCCC
Confidence            99999999999998543

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.14  E-value=2e-11  Score=116.76  Aligned_cols=97  Identities=35%  Similarity=0.678  Sum_probs=82.7

Q ss_pred             CCcccCCCCCCcEeeCcC-CcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCC
Q 040392            2 IPTEIGGLKNLEYLFLGY-NRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGP   79 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~-n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~   79 (470)
                      +|..|.++++|+.|+|++ |.+++.+|..|.++++|++|+|++|.+++.+|..+..+++|+.|++++|.|++.+|. +..
T Consensus        68 ~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  147 (313)
T 1ogq_A           68 IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS  147 (313)
T ss_dssp             CCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGG
T ss_pred             cChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhc
Confidence            678888999999999994 888888899999999999999999999888888899999999999999999865554 577


Q ss_pred             CCCCccccccCCccccCCC
Q 040392           80 FRNFSVESFEGNELLCGSP   98 (470)
Q Consensus        80 l~~l~~l~~~~n~~~~~~~   98 (470)
                      +++|+.|++++|.+....|
T Consensus       148 l~~L~~L~L~~N~l~~~~p  166 (313)
T 1ogq_A          148 LPNLVGITFDGNRISGAIP  166 (313)
T ss_dssp             CTTCCEEECCSSCCEEECC
T ss_pred             CCCCCeEECcCCcccCcCC
Confidence            8899999999998764433

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.13  E-value=1.6e-10  Score=112.58  Aligned_cols=142  Identities=13%  Similarity=0.167  Sum_probs=106.5

Q ss_pred             CCCeecccCceEEEEEEeCCCcEEEEEEee--ccc-chhhhhHHHHHHHHhcCC--CCcceeEEeeeccC---CeeeEEE
Q 040392          177 ENNLIGRGGFGSVYKARLGDGMEVAVKVFN--LQC-GRALKGFDVECEMMKSIR--HRNLIKVISTCSNE---EFKALVL  248 (470)
Q Consensus       177 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~nIv~~~~~~~~~---~~~~lv~  248 (470)
                      ..+.|+.|.++.||+.... +..+++|+..  ... ......+..|+++++.+.  +..+.+++.++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            3567899999999999875 4678888765  321 123457788999999987  45678899988766   4578999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------------------
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY--------------------------------------  290 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~--------------------------------------  290 (470)
                      ||++|.++.+..   -..++...+..++.++++.|..||...                                      
T Consensus       121 e~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (359)
T 3dxp_A          121 EFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM  197 (359)
T ss_dssp             ECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred             EecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence            999998874422   123678888899999999999999520                                      


Q ss_pred             -----------------CCCeeecCCCCCCeeeCCCCC--eEEeeeccccc
Q 040392          291 -----------------SAPIIHCDLKPSNVLLDDNMV--AHLSDFSIAKL  322 (470)
Q Consensus       291 -----------------~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~a~~  322 (470)
                                       ...++|||+++.||+++.++.  +.|+||+.+..
T Consensus       198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                             256999999999999997753  68999998864

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.12  E-value=2.3e-10  Score=99.54  Aligned_cols=94  Identities=23%  Similarity=0.257  Sum_probs=83.7

Q ss_pred             cccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCC-CCCCC
Q 040392            4 TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GPFRN   82 (470)
Q Consensus         4 ~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~   82 (470)
                      ..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..+..+..+++|+.|++++|.|++.++.. ..+++
T Consensus        46 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~  125 (177)
T 2o6r_A           46 GVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTS  125 (177)
T ss_dssp             TTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTT
T ss_pred             HHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcc
Confidence            35689999999999999999776677899999999999999999777777899999999999999999877765 67999


Q ss_pred             CccccccCCccccCC
Q 040392           83 FSVESFEGNELLCGS   97 (470)
Q Consensus        83 l~~l~~~~n~~~~~~   97 (470)
                      |+.+++++|++.|..
T Consensus       126 L~~L~l~~N~~~~~~  140 (177)
T 2o6r_A          126 LQKIWLHTNPWDCSC  140 (177)
T ss_dssp             CCEEECCSSCBCCCH
T ss_pred             cCEEEecCCCeeccC
Confidence            999999999997743

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.12  E-value=6.8e-11  Score=125.80  Aligned_cols=91  Identities=29%  Similarity=0.322  Sum_probs=61.9

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFR   81 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~   81 (470)
                      +|..+++|++|+.|+|++|.|+ .+|..|.+|++|+.|+|++|.|+ .+|..|..|++|+.|+|++|.|+..+..+..++
T Consensus       239 l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~  316 (727)
T 4b8c_D          239 ISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVTTLPWEFGNLC  316 (727)
T ss_dssp             CCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCCCCCSSTTSCT
T ss_pred             CChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCCccChhhhcCC
Confidence            4556666677777777777776 66666667777777777777777 666667777777777777777765555566667


Q ss_pred             CCccccccCCccc
Q 040392           82 NFSVESFEGNELL   94 (470)
Q Consensus        82 ~l~~l~~~~n~~~   94 (470)
                      +|+.|++++|++.
T Consensus       317 ~L~~L~L~~N~l~  329 (727)
T 4b8c_D          317 NLQFLGVEGNPLE  329 (727)
T ss_dssp             TCCCEECTTSCCC
T ss_pred             CccEEeCCCCccC
Confidence            7777777777653

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.11  E-value=1.2e-10  Score=110.85  Aligned_cols=93  Identities=29%  Similarity=0.371  Sum_probs=54.5

Q ss_pred             CcccCCCCCCcEeeCcCCcCCC-CCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCC-CCCCC
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQG-PIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIP-RGGPF   80 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~-~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~-~~~~l   80 (470)
                      |..|.++++|+.|+|++|.+++ .+|..+..+++|+.|+|++|.+++..|..+..+++|+.|++++|.+++.++ .+..+
T Consensus       143 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  222 (306)
T 2z66_A          143 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL  222 (306)
T ss_dssp             TTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTC
T ss_pred             hhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCc
Confidence            3445556666666666666654 345556666666666666666665555556666666666666666654443 23455


Q ss_pred             CCCccccccCCcccc
Q 040392           81 RNFSVESFEGNELLC   95 (470)
Q Consensus        81 ~~l~~l~~~~n~~~~   95 (470)
                      ++|+.|++++|++..
T Consensus       223 ~~L~~L~L~~N~l~~  237 (306)
T 2z66_A          223 NSLQVLDYSLNHIMT  237 (306)
T ss_dssp             TTCCEEECTTSCCCB
T ss_pred             ccCCEeECCCCCCcc
Confidence            566666666666543

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.11  E-value=2.4e-10  Score=106.85  Aligned_cols=90  Identities=31%  Similarity=0.349  Sum_probs=69.1

Q ss_pred             ccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCC-CCCCCC
Q 040392            5 EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GPFRNF   83 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l   83 (470)
                      .+.++++|++|+|++|.+++..|..|.++++|+.|+|++|++++..+..+..+++|+.|++++|.|++.++.. ..+++|
T Consensus        80 ~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  159 (272)
T 3rfs_A           80 ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNL  159 (272)
T ss_dssp             GGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred             hhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccC
Confidence            5677788888888888888666666777888888888888888666666777888888888888887666654 567788


Q ss_pred             ccccccCCccc
Q 040392           84 SVESFEGNELL   94 (470)
Q Consensus        84 ~~l~~~~n~~~   94 (470)
                      +.|++++|.+.
T Consensus       160 ~~L~l~~n~l~  170 (272)
T 3rfs_A          160 TELDLSYNQLQ  170 (272)
T ss_dssp             CEEECCSSCCC
T ss_pred             CEEECCCCCcC
Confidence            88888888765

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.10  E-value=6.7e-11  Score=111.38  Aligned_cols=92  Identities=29%  Similarity=0.336  Sum_probs=71.4

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCC-CCCCCC
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIP-RGGPFR   81 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~-~~~~l~   81 (470)
                      |..|.++++|+.|+|++|.+++..+..|.++++|+.|+|++|+|++..+..+..+++|+.|++++|.+++..+ .+..++
T Consensus       122 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~  201 (285)
T 1ozn_A          122 PGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG  201 (285)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT
T ss_pred             HhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcc
Confidence            5567788888888888888886666667888888888888888885555568888888888888888877644 446677


Q ss_pred             CCccccccCCccc
Q 040392           82 NFSVESFEGNELL   94 (470)
Q Consensus        82 ~l~~l~~~~n~~~   94 (470)
                      +|+.|++++|.+.
T Consensus       202 ~L~~L~l~~n~l~  214 (285)
T 1ozn_A          202 RLMTLYLFANNLS  214 (285)
T ss_dssp             TCCEEECCSSCCS
T ss_pred             cccEeeCCCCcCC
Confidence            8888888888764

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.10  E-value=7.3e-11  Score=101.79  Aligned_cols=91  Identities=24%  Similarity=0.173  Sum_probs=80.8

Q ss_pred             cccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCc-ccccCCCCCCceecCCccccccCC----CCC
Q 040392            4 TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIP-ASLEKLSYLENLNLSFNKLEGEIP----RGG   78 (470)
Q Consensus         4 ~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~-~~~~~l~~L~~l~l~~N~l~~~~~----~~~   78 (470)
                      ..|.++++|++|+|++|++++.+|..+.++++|+.|+|++|.|++..+ ..+..+++|+.|++++|.+++.++    .+.
T Consensus        65 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~  144 (168)
T 2ell_A           65 SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFK  144 (168)
T ss_dssp             SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHT
T ss_pred             hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHH
Confidence            467889999999999999998788888889999999999999995322 789999999999999999997776    467


Q ss_pred             CCCCCccccccCCccc
Q 040392           79 PFRNFSVESFEGNELL   94 (470)
Q Consensus        79 ~l~~l~~l~~~~n~~~   94 (470)
                      .+++|+.|++.+|.+.
T Consensus       145 ~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A          145 LLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             TCSSCCEETTEETTSC
T ss_pred             hCccCcEecCCCCChh
Confidence            8999999999999874

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.09  E-value=6.9e-11  Score=104.88  Aligned_cols=88  Identities=20%  Similarity=0.299  Sum_probs=44.5

Q ss_pred             ccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCcc-ccccCCCCCCCCCC
Q 040392            5 EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNK-LEGEIPRGGPFRNF   83 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~-l~~~~~~~~~l~~l   83 (470)
                      .+.++++|+.|+|++|.+++..|..+..+++|+.|+|++|.+++..|..+..+++|+.|++++|. ++ .++.+..+++|
T Consensus        83 ~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~~l~~l~~L  161 (197)
T 4ezg_A           83 PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIMPLKTLPEL  161 (197)
T ss_dssp             GGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCGGGGGCSSC
T ss_pred             hhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccHhhcCCCCC
Confidence            44445555555555555554444455555555555555555554444445555555555555554 33 23334445555


Q ss_pred             ccccccCCcc
Q 040392           84 SVESFEGNEL   93 (470)
Q Consensus        84 ~~l~~~~n~~   93 (470)
                      +.|++++|++
T Consensus       162 ~~L~l~~n~i  171 (197)
T 4ezg_A          162 KSLNIQFDGV  171 (197)
T ss_dssp             CEEECTTBCC
T ss_pred             CEEECCCCCC
Confidence            5555555544

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.09  E-value=5.7e-11  Score=114.32  Aligned_cols=92  Identities=22%  Similarity=0.313  Sum_probs=57.5

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccC---------CCCCCceecCCccccc
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEK---------LSYLENLNLSFNKLEG   72 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~---------l~~L~~l~l~~N~l~~   72 (470)
                      +|..|+++++|++|+|++|.++ .+|..+.++++|+.|+|++|.+.+.+|..+..         +++|+.|++++|.|+.
T Consensus       119 lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~  197 (328)
T 4fcg_A          119 LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS  197 (328)
T ss_dssp             CCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCCC
T ss_pred             hhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcCc
Confidence            5666667777777777777776 66666666777777777666666566655443         6666666666666654


Q ss_pred             cCCCCCCCCCCccccccCCccc
Q 040392           73 EIPRGGPFRNFSVESFEGNELL   94 (470)
Q Consensus        73 ~~~~~~~l~~l~~l~~~~n~~~   94 (470)
                      .+..+..+++|+.|++++|.+.
T Consensus       198 lp~~l~~l~~L~~L~L~~N~l~  219 (328)
T 4fcg_A          198 LPASIANLQNLKSLKIRNSPLS  219 (328)
T ss_dssp             CCGGGGGCTTCCEEEEESSCCC
T ss_pred             chHhhcCCCCCCEEEccCCCCC
Confidence            4444455556666666665553

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.09  E-value=1.3e-10  Score=116.56  Aligned_cols=90  Identities=23%  Similarity=0.261  Sum_probs=50.6

Q ss_pred             cCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCC-CCCCCCc
Q 040392            6 IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GPFRNFS   84 (470)
Q Consensus         6 ~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~   84 (470)
                      +.++++|+.|+|++|.|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++.++.. ..+++|+
T Consensus       203 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  282 (440)
T 3zyj_A          203 LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLE  282 (440)
T ss_dssp             CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCC
T ss_pred             cCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCC
Confidence            344455555555555555444555555555555555555555555555555666666666666665544433 4455666


Q ss_pred             cccccCCcccc
Q 040392           85 VESFEGNELLC   95 (470)
Q Consensus        85 ~l~~~~n~~~~   95 (470)
                      .|++++|++.|
T Consensus       283 ~L~L~~Np~~C  293 (440)
T 3zyj_A          283 RIHLHHNPWNC  293 (440)
T ss_dssp             EEECCSSCEEC
T ss_pred             EEEcCCCCccC
Confidence            66666666655

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.08  E-value=1.3e-10  Score=121.82  Aligned_cols=92  Identities=17%  Similarity=0.112  Sum_probs=67.9

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCCC
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPFR   81 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~   81 (470)
                      |.+|.+|++|++|+|++|+|++..|.+|.++++|++|+|++|+|++..+..|..+++|+.|++++|.|++.++. +..++
T Consensus        69 ~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~  148 (635)
T 4g8a_A           69 SYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLK  148 (635)
T ss_dssp             TTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCT
T ss_pred             HHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCc
Confidence            34677777888888888887766666777788888888888887755556677788888888888877766554 46777


Q ss_pred             CCccccccCCccc
Q 040392           82 NFSVESFEGNELL   94 (470)
Q Consensus        82 ~l~~l~~~~n~~~   94 (470)
                      +|+.|++++|.+.
T Consensus       149 ~L~~L~Ls~N~l~  161 (635)
T 4g8a_A          149 TLKELNVAHNLIQ  161 (635)
T ss_dssp             TCCEEECCSSCCC
T ss_pred             ccCeeccccCccc
Confidence            7777777777764

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.08  E-value=1.1e-10  Score=113.76  Aligned_cols=91  Identities=23%  Similarity=0.158  Sum_probs=73.6

Q ss_pred             ccC-CCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCCCC
Q 040392            5 EIG-GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPFRN   82 (470)
Q Consensus         5 ~~~-~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~   82 (470)
                      .+. ++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.|++..+. +..+++
T Consensus        58 ~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~  137 (361)
T 2xot_A           58 WTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQ  137 (361)
T ss_dssp             SSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTT
T ss_pred             hhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCccc
Confidence            455 788888999999988877667788888889999988888866666788888888888888888866543 467888


Q ss_pred             CccccccCCcccc
Q 040392           83 FSVESFEGNELLC   95 (470)
Q Consensus        83 l~~l~~~~n~~~~   95 (470)
                      |+.|++++|.+..
T Consensus       138 L~~L~L~~N~l~~  150 (361)
T 2xot_A          138 LQKLYLSQNQISR  150 (361)
T ss_dssp             CCEEECCSSCCCS
T ss_pred             CCEEECCCCcCCe
Confidence            8888888888753

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.08  E-value=9.4e-11  Score=104.02  Aligned_cols=89  Identities=19%  Similarity=0.251  Sum_probs=79.2

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCc-CCCCCcccccCCCCCCceecCCccccccCCCCCCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNN-LSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPF   80 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~-i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l   80 (470)
                      .|..|+++++|+.|+|++|++++..|..+..+++|+.|+|++|. ++ .+| .+..+++|+.|++++|.|++ ++.+..+
T Consensus       104 ~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~~l~~l  180 (197)
T 4ezg_A          104 KIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YRGIEDF  180 (197)
T ss_dssp             GSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CTTGGGC
T ss_pred             cChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hHHhccC
Confidence            47788999999999999999998788999999999999999998 76 666 69999999999999999996 4477889


Q ss_pred             CCCccccccCCcc
Q 040392           81 RNFSVESFEGNEL   93 (470)
Q Consensus        81 ~~l~~l~~~~n~~   93 (470)
                      ++|+.|++.+|++
T Consensus       181 ~~L~~L~l~~N~i  193 (197)
T 4ezg_A          181 PKLNQLYAFSQTI  193 (197)
T ss_dssp             SSCCEEEECBC--
T ss_pred             CCCCEEEeeCccc
Confidence            9999999999997

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.07  E-value=1.2e-10  Score=121.59  Aligned_cols=94  Identities=26%  Similarity=0.288  Sum_probs=56.3

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCC-
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFR-   81 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~-   81 (470)
                      |..|+++++|+.|+|++|++++..|..+.++++|+.|+|++|++++..|..+..+++|+.|++++|+|+..++.+..++ 
T Consensus       466 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~  545 (606)
T 3vq2_A          466 SNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPK  545 (606)
T ss_dssp             CSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCT
T ss_pred             HHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcc
Confidence            4455566666666666666665555556666666666666666665555666666666666666666664444444443 


Q ss_pred             CCccccccCCccccC
Q 040392           82 NFSVESFEGNELLCG   96 (470)
Q Consensus        82 ~l~~l~~~~n~~~~~   96 (470)
                      +|+.+++++|++.|.
T Consensus       546 ~L~~l~l~~N~~~c~  560 (606)
T 3vq2_A          546 SLAFFNLTNNSVACI  560 (606)
T ss_dssp             TCCEEECCSCCCCCS
T ss_pred             cCcEEEccCCCcccC
Confidence            466666666666553

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.05  E-value=2.2e-10  Score=115.37  Aligned_cols=88  Identities=30%  Similarity=0.276  Sum_probs=40.9

Q ss_pred             CCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCC-CCCCCCccc
Q 040392            8 GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GPFRNFSVE   86 (470)
Q Consensus         8 ~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l   86 (470)
                      .+++|+.|+|++|.+++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|.|++.++.. ..+++|+.|
T Consensus       216 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  295 (452)
T 3zyi_A          216 PLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVEL  295 (452)
T ss_dssp             TCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEE
T ss_pred             ccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEE
Confidence            3344444444444444444444444444444444444444444444444455555555555544433332 334455555


Q ss_pred             cccCCcccc
Q 040392           87 SFEGNELLC   95 (470)
Q Consensus        87 ~~~~n~~~~   95 (470)
                      ++++|++.|
T Consensus       296 ~L~~Np~~C  304 (452)
T 3zyi_A          296 HLHHNPWNC  304 (452)
T ss_dssp             ECCSSCEEC
T ss_pred             EccCCCcCC
Confidence            555555544

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.04  E-value=1.8e-10  Score=100.25  Aligned_cols=83  Identities=14%  Similarity=0.135  Sum_probs=38.3

Q ss_pred             CCCCCCcEeeCcCCcCCCCCCccccCCC-CCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCC-CCCCCCc
Q 040392            7 GGLKNLEYLFLGYNRLQGPIPDSFGDLI-SLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GPFRNFS   84 (470)
Q Consensus         7 ~~l~~l~~l~l~~n~l~~~~p~~~~~l~-~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~   84 (470)
                      .++.+|+.|+|++|+++ .+|. +..+. +|+.|+|++|.|++.  ..+..+++|+.|++++|.|++.++.. ..+++|+
T Consensus        16 ~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~   91 (176)
T 1a9n_A           16 TNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   91 (176)
T ss_dssp             ECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             CCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence            34445555555555555 2222 22222 455555555555532  33444555555555555554443333 3444555


Q ss_pred             cccccCCcc
Q 040392           85 VESFEGNEL   93 (470)
Q Consensus        85 ~l~~~~n~~   93 (470)
                      .|++++|.+
T Consensus        92 ~L~L~~N~i  100 (176)
T 1a9n_A           92 ELILTNNSL  100 (176)
T ss_dssp             EEECCSCCC
T ss_pred             EEECCCCcC
Confidence            555555544

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.04  E-value=1.1e-10  Score=126.72  Aligned_cols=90  Identities=31%  Similarity=0.415  Sum_probs=76.3

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCC
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRN   82 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~   82 (470)
                      |..|.++++|+.|+|++|+|++.+|..|.++++|+.|+|++|+|++..|..+.  ++|+.|++++|+|++.+|..  +.+
T Consensus       473 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~  548 (844)
T 3j0a_A          473 WDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVS  548 (844)
T ss_dssp             SSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSS
T ss_pred             hhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH--hCC
Confidence            34577889999999999999988888889999999999999999966555554  88999999999999888764  568


Q ss_pred             CccccccCCccccC
Q 040392           83 FSVESFEGNELLCG   96 (470)
Q Consensus        83 l~~l~~~~n~~~~~   96 (470)
                      |+.+++++|++.|.
T Consensus       549 L~~l~l~~Np~~C~  562 (844)
T 3j0a_A          549 LSVLDITHNKFICE  562 (844)
T ss_dssp             CCEEEEEEECCCCS
T ss_pred             cCEEEecCCCcccc
Confidence            99999999999884

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.04  E-value=6.9e-10  Score=103.56  Aligned_cols=91  Identities=27%  Similarity=0.325  Sum_probs=76.2

Q ss_pred             ccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCCCCC
Q 040392            5 EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPFRNF   83 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l   83 (470)
                      .|.++++|+.|+|++|.+++..+..|.++++|+.|+|++|.+++..+..|..+++|+.|++++|.|++.++. +..+++|
T Consensus        80 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L  159 (270)
T 2o6q_A           80 IFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSL  159 (270)
T ss_dssp             TTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred             hhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCccc
Confidence            357789999999999999876666778899999999999999977777788899999999999999877665 4678899


Q ss_pred             ccccccCCcccc
Q 040392           84 SVESFEGNELLC   95 (470)
Q Consensus        84 ~~l~~~~n~~~~   95 (470)
                      +.|++++|.+..
T Consensus       160 ~~L~L~~n~l~~  171 (270)
T 2o6q_A          160 KELRLYNNQLKR  171 (270)
T ss_dssp             CEEECCSSCCSC
T ss_pred             ceeEecCCcCcE
Confidence            999999988754

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.04  E-value=5e-10  Score=105.35  Aligned_cols=92  Identities=27%  Similarity=0.251  Sum_probs=75.2

Q ss_pred             CcccCCCCCCcEeeCcCCc-CCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCC
Q 040392            3 PTEIGGLKNLEYLFLGYNR-LQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPF   80 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~-l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l   80 (470)
                      |..|.++++|+.|+|++|. ++...|..+..+++|+.|+|++|.+++..|..+..+++|+.|++++|.+++.++. +..+
T Consensus        73 ~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l  152 (285)
T 1ozn_A           73 AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDL  152 (285)
T ss_dssp             TTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred             HhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccC
Confidence            5678888888888888887 7766677888888888888888888877777888888888888888888876665 4678


Q ss_pred             CCCccccccCCccc
Q 040392           81 RNFSVESFEGNELL   94 (470)
Q Consensus        81 ~~l~~l~~~~n~~~   94 (470)
                      ++|+.|++++|.+.
T Consensus       153 ~~L~~L~l~~n~l~  166 (285)
T 1ozn_A          153 GNLTHLFLHGNRIS  166 (285)
T ss_dssp             TTCCEEECCSSCCC
T ss_pred             CCccEEECCCCccc
Confidence            88888888888774

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.01  E-value=1.2e-10  Score=98.22  Aligned_cols=87  Identities=22%  Similarity=0.160  Sum_probs=75.8

Q ss_pred             cccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCC-CcccccCCCCCCceecCCccccccCC----CCC
Q 040392            4 TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGA-IPASLEKLSYLENLNLSFNKLEGEIP----RGG   78 (470)
Q Consensus         4 ~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~-~~~~~~~l~~L~~l~l~~N~l~~~~~----~~~   78 (470)
                      ..++++++|+.|+|++|.+++.+|..+..+++|+.|+|++|.|++. .+..+..+++|+.|++++|.+++.++    .+.
T Consensus        58 ~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~  137 (149)
T 2je0_A           58 ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFK  137 (149)
T ss_dssp             TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHH
T ss_pred             hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHH
Confidence            4678899999999999999987888888899999999999999953 34789999999999999999997766    356


Q ss_pred             CCCCCccccccC
Q 040392           79 PFRNFSVESFEG   90 (470)
Q Consensus        79 ~l~~l~~l~~~~   90 (470)
                      .+++|+.|++++
T Consensus       138 ~l~~L~~L~l~d  149 (149)
T 2je0_A          138 LLPQLTYLDGYD  149 (149)
T ss_dssp             HCTTCCEETTBC
T ss_pred             HCCCcccccCCC
Confidence            788999888753

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.01  E-value=3.8e-10  Score=110.03  Aligned_cols=92  Identities=22%  Similarity=0.164  Sum_probs=70.7

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCcccc-CCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFG-DLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGP   79 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~-~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~   79 (470)
                      +|..+.  +.++.|+|++|+|++..+..+. ++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++.++. +..
T Consensus        33 iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  110 (361)
T 2xot_A           33 VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSD  110 (361)
T ss_dssp             CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTT
T ss_pred             cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCC
Confidence            454443  3578888888888866666676 788888888888888866667788888888888888888866664 467


Q ss_pred             CCCCccccccCCcccc
Q 040392           80 FRNFSVESFEGNELLC   95 (470)
Q Consensus        80 l~~l~~l~~~~n~~~~   95 (470)
                      +++|+.|++++|.+..
T Consensus       111 l~~L~~L~L~~N~i~~  126 (361)
T 2xot_A          111 LQALEVLLLYNNHIVV  126 (361)
T ss_dssp             CTTCCEEECCSSCCCE
T ss_pred             CcCCCEEECCCCcccE
Confidence            8888888888888754

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=98.99  E-value=4.1e-10  Score=116.58  Aligned_cols=92  Identities=29%  Similarity=0.386  Sum_probs=44.7

Q ss_pred             ccCCCCCCcEeeCcCCcCC-CCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCCCC
Q 040392            5 EIGGLKNLEYLFLGYNRLQ-GPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPFRN   82 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~l~-~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~   82 (470)
                      .|.++++|+.|+|++|.++ +.+|..+..+++|+.|+|++|++++..|..+..+++|+.|++++|.|++.++. +..+++
T Consensus       440 ~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~  519 (570)
T 2z63_A          440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTS  519 (570)
T ss_dssp             TTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTT
T ss_pred             hhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccC
Confidence            3444444444444444444 23444444455555555555555544444455555555555555555544433 244455


Q ss_pred             CccccccCCccccC
Q 040392           83 FSVESFEGNELLCG   96 (470)
Q Consensus        83 l~~l~~~~n~~~~~   96 (470)
                      |+.+++++|++.|.
T Consensus       520 L~~L~l~~N~~~~~  533 (570)
T 2z63_A          520 LQKIWLHTNPWDCS  533 (570)
T ss_dssp             CCEEECCSSCBCCC
T ss_pred             CcEEEecCCcccCC
Confidence            55555555555443

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=98.99  E-value=6.4e-10  Score=104.09  Aligned_cols=85  Identities=20%  Similarity=0.116  Sum_probs=56.1

Q ss_pred             CCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCCCCCccccc
Q 040392           10 KNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPFRNFSVESF   88 (470)
Q Consensus        10 ~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~   88 (470)
                      ++|+.|+|++|++++..+..|.++++|+.|+|++|.+++..+..+..+++|+.|++++|.|++.++. +..+++|+.|++
T Consensus        28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l  107 (276)
T 2z62_A           28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  107 (276)
T ss_dssp             TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence            4567777777777755555666677777777777777655555666777777777777777655543 456667777777


Q ss_pred             cCCccc
Q 040392           89 EGNELL   94 (470)
Q Consensus        89 ~~n~~~   94 (470)
                      ++|.+.
T Consensus       108 ~~n~l~  113 (276)
T 2z62_A          108 VETNLA  113 (276)
T ss_dssp             TTSCCC
T ss_pred             CCCCcc
Confidence            766653

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=98.99  E-value=6e-10  Score=112.03  Aligned_cols=96  Identities=25%  Similarity=0.230  Sum_probs=84.0

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCC-CCCC
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GPFR   81 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~   81 (470)
                      |..|.++++|+.|+|++|.+++..|..|.++++|+.|+|++|+|++..|..+..+++|+.|++++|.|++.++.. ..++
T Consensus       316 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  395 (455)
T 3v47_A          316 DNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLT  395 (455)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCT
T ss_pred             hhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCC
Confidence            667888999999999999998777888899999999999999999777888999999999999999999777654 6788


Q ss_pred             CCccccccCCccccCCC
Q 040392           82 NFSVESFEGNELLCGSP   98 (470)
Q Consensus        82 ~l~~l~~~~n~~~~~~~   98 (470)
                      +|+.+++++|++.|.-|
T Consensus       396 ~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          396 SLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             TCCEEECCSSCBCCCTT
T ss_pred             cccEEEccCCCcccCCC
Confidence            99999999999988655

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=98.99  E-value=4.3e-10  Score=106.91  Aligned_cols=90  Identities=24%  Similarity=0.322  Sum_probs=62.7

Q ss_pred             ccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCC-CCcccccCCCCCCceecCCccccccCCC-CCCCCC
Q 040392            5 EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSG-AIPASLEKLSYLENLNLSFNKLEGEIPR-GGPFRN   82 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~-~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~   82 (470)
                      .+.++++|+.|+|++|.+++..|..+.++++|+.|+|++|.+++ .+|..+..+++|+.|++++|.|++.++. +..+++
T Consensus       121 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~  200 (306)
T 2z66_A          121 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS  200 (306)
T ss_dssp             TTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred             hhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCC
Confidence            56667777777777777776666667777777777777777765 4666677777777777777777765443 456677


Q ss_pred             CccccccCCccc
Q 040392           83 FSVESFEGNELL   94 (470)
Q Consensus        83 l~~l~~~~n~~~   94 (470)
                      |+.|++++|.+.
T Consensus       201 L~~L~L~~N~l~  212 (306)
T 2z66_A          201 LQVLNMSHNNFF  212 (306)
T ss_dssp             CCEEECTTSCCS
T ss_pred             CCEEECCCCccC
Confidence            777777777664

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=98.98  E-value=1.8e-10  Score=100.12  Aligned_cols=88  Identities=19%  Similarity=0.140  Sum_probs=74.8

Q ss_pred             cCCCC-CCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCC--CCCCCCC
Q 040392            6 IGGLK-NLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIP--RGGPFRN   82 (470)
Q Consensus         6 ~~~l~-~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~--~~~~l~~   82 (470)
                      +..+. +|+.|+|++|.|++.  +.+..+++|+.|+|++|.|++..+..+..+++|+.|++++|.|+..++  .+..+++
T Consensus        37 ~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~  114 (176)
T 1a9n_A           37 LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKS  114 (176)
T ss_dssp             GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTT
T ss_pred             hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCCcchhhHhhhcCCC
Confidence            44444 999999999999965  689999999999999999995544556899999999999999986554  5678999


Q ss_pred             CccccccCCcccc
Q 040392           83 FSVESFEGNELLC   95 (470)
Q Consensus        83 l~~l~~~~n~~~~   95 (470)
                      |+.+++++|++..
T Consensus       115 L~~L~l~~N~i~~  127 (176)
T 1a9n_A          115 LTYLCILRNPVTN  127 (176)
T ss_dssp             CCEEECCSSGGGG
T ss_pred             CCEEEecCCCCCC
Confidence            9999999999853

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=98.97  E-value=1.1e-09  Score=94.67  Aligned_cols=74  Identities=24%  Similarity=0.264  Sum_probs=66.7

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR   76 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~   76 (470)
                      |..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.++...+.
T Consensus        47 ~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~  120 (170)
T 3g39_A           47 PGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACSD  120 (170)
T ss_dssp             TTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred             hhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence            67789999999999999999977777789999999999999999976667799999999999999999876653

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.97  E-value=2.4e-10  Score=108.67  Aligned_cols=187  Identities=18%  Similarity=0.173  Sum_probs=121.9

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCC-CCc--ceeEEeeeccCC---eeeEEEecC
Q 040392          178 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIR-HRN--LIKVISTCSNEE---FKALVLEYM  251 (470)
Q Consensus       178 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--Iv~~~~~~~~~~---~~~lv~e~~  251 (470)
                      .+.++.|....||++.    ..+++|.....  .....+..|+++++.+. +..  +.+++.......   ..++|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4678999999999873    46889986432  34567888999998873 332  455665554333   457899999


Q ss_pred             CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 040392          252 PHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFG------------------------------------------  289 (470)
Q Consensus       252 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~------------------------------------------  289 (470)
                      +|.++.+...   ..++..++..++.++++.+..||..                                          
T Consensus        99 ~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A           99 KGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             CCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            9988865332   2356777788888888888888841                                          


Q ss_pred             -------------CCCCeeecCCCCCCeeeCC--CCCeEEeeeccccccCCCCCcccccc-------------cccCccc
Q 040392          290 -------------YSAPIIHCDLKPSNVLLDD--NMVAHLSDFSIAKLLTGEDQSMTQTQ-------------TLATIGY  341 (470)
Q Consensus       290 -------------~~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~-------------~~~t~~y  341 (470)
                                   ....++|+|++|.||++++  +..+.++||+.+..-.+ ........             .....+.
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~-~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~  254 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP-DNDFISLMEDDEEYGMEFVSKILNHYKH  254 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT-THHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh-HHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence                         0135899999999999998  56689999998864321 00000000             0000011


Q ss_pred             cC-ccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 040392          342 MA-PEYGREGRVSTNGDVYSFGIMLMETFTGKKPTN  376 (470)
Q Consensus       342 ~a-PE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~  376 (470)
                      .. |+...  ......+.|++|.++|.+.+|..+|-
T Consensus       255 ~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          255 KDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             SCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             CCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            11 12111  11123689999999999999987753

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=98.96  E-value=7.8e-10  Score=103.48  Aligned_cols=93  Identities=17%  Similarity=0.120  Sum_probs=81.5

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCC-CCCCCC
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIP-RGGPFR   81 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~-~~~~l~   81 (470)
                      +..|.++++|+.|+|++|++++..+..|.++++|++|+|++|.+++..+..+..+++|+.|++++|.+++..+ .+..++
T Consensus        45 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~  124 (276)
T 2z62_A           45 SYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLK  124 (276)
T ss_dssp             TTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCT
T ss_pred             HhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCC
Confidence            3478889999999999999997777789999999999999999997777889999999999999999987666 467889


Q ss_pred             CCccccccCCcccc
Q 040392           82 NFSVESFEGNELLC   95 (470)
Q Consensus        82 ~l~~l~~~~n~~~~   95 (470)
                      +|+.|++++|.+..
T Consensus       125 ~L~~L~l~~n~l~~  138 (276)
T 2z62_A          125 TLKELNVAHNLIQS  138 (276)
T ss_dssp             TCCEEECCSSCCCC
T ss_pred             CCCEEECcCCccce
Confidence            99999999998753

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=98.96  E-value=1.7e-10  Score=121.20  Aligned_cols=93  Identities=15%  Similarity=0.268  Sum_probs=70.2

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCC-----------------CCcccc--CCCCCCEEeccCCcCCCCCcccccCCCCCCc
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGP-----------------IPDSFG--DLISLKFLNLSNNNLSGAIPASLEKLSYLEN   62 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~-----------------~p~~~~--~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~   62 (470)
                      +|.+|+++++|+.|+|++|.++|.                 +|+.++  ++++|++|+|++|.++|.+|..+..+++|+.
T Consensus       198 ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~  277 (636)
T 4eco_A          198 VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQL  277 (636)
T ss_dssp             ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCE
T ss_pred             CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCE
Confidence            577788888888888888888864                 777777  8888888888888888788888888888888


Q ss_pred             eecCCcc-ccc-cCC-CCCCC------CCCccccccCCccc
Q 040392           63 LNLSFNK-LEG-EIP-RGGPF------RNFSVESFEGNELL   94 (470)
Q Consensus        63 l~l~~N~-l~~-~~~-~~~~l------~~l~~l~~~~n~~~   94 (470)
                      |++++|. +++ .+| .++.+      ++|+.|++++|.+.
T Consensus       278 L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~  318 (636)
T 4eco_A          278 INVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK  318 (636)
T ss_dssp             EECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS
T ss_pred             EECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC
Confidence            8888887 776 333 23333      77777777777765

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.95  E-value=1.5e-09  Score=113.08  Aligned_cols=89  Identities=17%  Similarity=0.137  Sum_probs=56.0

Q ss_pred             cCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCC-CCCCCCc
Q 040392            6 IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GPFRNFS   84 (470)
Q Consensus         6 ~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~   84 (470)
                      |.++++|+.|+|++|.+++..|..|.++++|+.|+|++|.|++..|..|..+++|+.|++++|.|++.++.. ..+++|+
T Consensus        71 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~  150 (597)
T 3oja_B           71 LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT  150 (597)
T ss_dssp             HHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             HccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCC
Confidence            345666666666666666555556666666666666666666555555666666666666666666555543 5566666


Q ss_pred             cccccCCccc
Q 040392           85 VESFEGNELL   94 (470)
Q Consensus        85 ~l~~~~n~~~   94 (470)
                      .|++++|.+.
T Consensus       151 ~L~Ls~N~l~  160 (597)
T 3oja_B          151 TLSMSNNNLE  160 (597)
T ss_dssp             EEECCSSCCC
T ss_pred             EEEeeCCcCC
Confidence            6666666654

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=98.95  E-value=1.5e-09  Score=94.08  Aligned_cols=75  Identities=25%  Similarity=0.335  Sum_probs=66.1

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCC
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG   77 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~   77 (470)
                      |..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.+....+.+
T Consensus        50 ~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~~~  124 (174)
T 2r9u_A           50 PGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDCECRDI  124 (174)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBCTTBGGG
T ss_pred             HHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeCCCCcccccccH
Confidence            678899999999999999999766666799999999999999999665566999999999999999998766543

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=98.94  E-value=1e-09  Score=106.60  Aligned_cols=87  Identities=28%  Similarity=0.197  Sum_probs=41.3

Q ss_pred             ccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCC--CCCCCCC
Q 040392            5 EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIP--RGGPFRN   82 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~--~~~~l~~   82 (470)
                      .|.++++|+.|+|++|++++..|..|.++++|++|+|++|+|++..+..+..+++|+.|++++|.+++.+.  .+..+++
T Consensus        71 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~  150 (353)
T 2z80_A           71 DLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTK  150 (353)
T ss_dssp             TTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTT
T ss_pred             HhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCC
Confidence            34445555555555555554444445555555555555555553222234445555555555555543333  2344455


Q ss_pred             CccccccCC
Q 040392           83 FSVESFEGN   91 (470)
Q Consensus        83 l~~l~~~~n   91 (470)
                      |+.|++++|
T Consensus       151 L~~L~l~~n  159 (353)
T 2z80_A          151 LQILRVGNM  159 (353)
T ss_dssp             CCEEEEEES
T ss_pred             CcEEECCCC
Confidence            555555544

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=98.94  E-value=6e-10  Score=112.86  Aligned_cols=91  Identities=25%  Similarity=0.331  Sum_probs=70.1

Q ss_pred             ccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCC-CCCCCC
Q 040392            5 EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GPFRNF   83 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l   83 (470)
                      .|.++++|+.|+|++|.+++..+..|.++++|+.|+|++|++++..|..|..+++|+.|++++|.|++.++.. ..+++|
T Consensus       243 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  322 (477)
T 2id5_A          243 AVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNL  322 (477)
T ss_dssp             HHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGC
T ss_pred             HhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCccc
Confidence            4567778888888888887666667777888888888888888777777888888888888888887666543 567788


Q ss_pred             ccccccCCcccc
Q 040392           84 SVESFEGNELLC   95 (470)
Q Consensus        84 ~~l~~~~n~~~~   95 (470)
                      +.|++++|++.|
T Consensus       323 ~~L~l~~N~l~c  334 (477)
T 2id5_A          323 ETLILDSNPLAC  334 (477)
T ss_dssp             CEEECCSSCEEC
T ss_pred             CEEEccCCCccC
Confidence            888888888876

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=98.94  E-value=9.7e-10  Score=113.30  Aligned_cols=93  Identities=27%  Similarity=0.242  Sum_probs=69.5

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccc--cCCCCCCC
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEG--EIPRGGPF   80 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~--~~~~~~~l   80 (470)
                      |..|.++++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..+..+++|+.|++++|.+++  .++.+..+
T Consensus        43 ~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l  122 (549)
T 2z81_A           43 HGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNL  122 (549)
T ss_dssp             SSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTC
T ss_pred             hhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhcc
Confidence            5567778888888888888887767778888888888888888886666667788888888888888774  23455677


Q ss_pred             CCCccccccCCcccc
Q 040392           81 RNFSVESFEGNELLC   95 (470)
Q Consensus        81 ~~l~~l~~~~n~~~~   95 (470)
                      ++|+.|++++|....
T Consensus       123 ~~L~~L~L~~n~~~~  137 (549)
T 2z81_A          123 TNLQTLRIGNVETFS  137 (549)
T ss_dssp             TTCCEEEEEESSSCC
T ss_pred             CCccEEECCCCcccc
Confidence            778888887776433

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=98.94  E-value=2.2e-09  Score=105.77  Aligned_cols=90  Identities=17%  Similarity=0.128  Sum_probs=65.3

Q ss_pred             cCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCC-CCCCCCc
Q 040392            6 IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GPFRNFS   84 (470)
Q Consensus         6 ~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~   84 (470)
                      |.++++|+.|+|++|.+++..|..|.++++|+.|+|++|.+++..|..+..+++|+.|++++|.|+..++.. ..+++|+
T Consensus        65 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~  144 (390)
T 3o6n_A           65 LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT  144 (390)
T ss_dssp             HHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             hcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCc
Confidence            456777777777777777666667777777777777777777666666777777777777777777655554 5677777


Q ss_pred             cccccCCcccc
Q 040392           85 VESFEGNELLC   95 (470)
Q Consensus        85 ~l~~~~n~~~~   95 (470)
                      .|++++|.+..
T Consensus       145 ~L~L~~n~l~~  155 (390)
T 3o6n_A          145 TLSMSNNNLER  155 (390)
T ss_dssp             EEECCSSCCCB
T ss_pred             EEECCCCccCc
Confidence            77777777643

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=98.93  E-value=4.3e-10  Score=107.36  Aligned_cols=86  Identities=23%  Similarity=0.210  Sum_probs=73.9

Q ss_pred             CCCCCcEeeCcCCcCCCCCCccc--cCCCCCCEEeccCCcCCCCCcccccCC-----CCCCceecCCccccccCC-CCCC
Q 040392            8 GLKNLEYLFLGYNRLQGPIPDSF--GDLISLKFLNLSNNNLSGAIPASLEKL-----SYLENLNLSFNKLEGEIP-RGGP   79 (470)
Q Consensus         8 ~l~~l~~l~l~~n~l~~~~p~~~--~~l~~L~~l~l~~n~i~~~~~~~~~~l-----~~L~~l~l~~N~l~~~~~-~~~~   79 (470)
                      ++++|+.|+|++|++++.+|..+  ..+++|+.|+|++|+|++. |..+..+     ++|+.|++++|.|++.++ .+..
T Consensus        93 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~  171 (312)
T 1wwl_A           93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRV  171 (312)
T ss_dssp             TTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCC
T ss_pred             CcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhcc
Confidence            78899999999999998888876  8899999999999999966 7777777     899999999999987774 4578


Q ss_pred             CCCCccccccCCccc
Q 040392           80 FRNFSVESFEGNELL   94 (470)
Q Consensus        80 l~~l~~l~~~~n~~~   94 (470)
                      +++|+.|++++|.+.
T Consensus       172 l~~L~~L~Ls~N~l~  186 (312)
T 1wwl_A          172 FPALSTLDLSDNPEL  186 (312)
T ss_dssp             CSSCCEEECCSCTTC
T ss_pred             CCCCCEEECCCCCcC
Confidence            899999999999853

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=98.93  E-value=1.5e-09  Score=113.27  Aligned_cols=90  Identities=21%  Similarity=0.198  Sum_probs=53.2

Q ss_pred             ccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCC-CCCCCCCC
Q 040392            5 EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIP-RGGPFRNF   83 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~-~~~~l~~l   83 (470)
                      .|.++++|+.|+|++|.+++..|..|.++++|++|+|++|.|++..|..|..+++|+.|++++|.+++.++ .+..+++|
T Consensus        51 ~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  130 (606)
T 3vq2_A           51 SFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITL  130 (606)
T ss_dssp             TTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTC
T ss_pred             hccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCC
Confidence            55566666666666666665555556666666666666666665555666666666666666666654442 34555556


Q ss_pred             ccccccCCccc
Q 040392           84 SVESFEGNELL   94 (470)
Q Consensus        84 ~~l~~~~n~~~   94 (470)
                      +.|++++|.+.
T Consensus       131 ~~L~L~~n~l~  141 (606)
T 3vq2_A          131 KKLNVAHNFIH  141 (606)
T ss_dssp             CEEECCSSCCC
T ss_pred             CEEeCCCCccc
Confidence            66666655553

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=98.93  E-value=1.5e-09  Score=112.05  Aligned_cols=85  Identities=27%  Similarity=0.220  Sum_probs=75.7

Q ss_pred             CCCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCC-cccccCCCCCCceecCCccccccCCCCC-
Q 040392            1 VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAI-PASLEKLSYLENLNLSFNKLEGEIPRGG-   78 (470)
Q Consensus         1 ~~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~-~~~~~~l~~L~~l~l~~N~l~~~~~~~~-   78 (470)
                      .+|..|++|++|+.|+|++|+|++ +| .++++++|+.|+|++|+|++.. |..+..+++|+.|+|++|.|++.++... 
T Consensus       477 ~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~  554 (567)
T 1dce_A          477 ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQER  554 (567)
T ss_dssp             CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTH
T ss_pred             ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHH
Confidence            378999999999999999999996 66 8999999999999999999776 9999999999999999999998887653 


Q ss_pred             ---CCCCCcccc
Q 040392           79 ---PFRNFSVES   87 (470)
Q Consensus        79 ---~l~~l~~l~   87 (470)
                         .+++|+.|+
T Consensus       555 l~~~lp~L~~L~  566 (567)
T 1dce_A          555 LAEMLPSVSSIL  566 (567)
T ss_dssp             HHHHCTTCSEEE
T ss_pred             HHHHCcccCccC
Confidence               267777764

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=98.92  E-value=2e-09  Score=108.31  Aligned_cols=85  Identities=24%  Similarity=0.172  Sum_probs=57.3

Q ss_pred             CCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCCCCCccccc
Q 040392           10 KNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPFRNFSVESF   88 (470)
Q Consensus        10 ~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~   88 (470)
                      ++|+.|+|++|+|++..|..|.++++|+.|+|++|.|++..|..|..+++|+.|+|++|.|++.++. +..+++|+.|++
T Consensus        75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  154 (452)
T 3zyi_A           75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL  154 (452)
T ss_dssp             TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred             CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence            4667777777777766666677777777777777777766666666777777777777777655554 355667777777


Q ss_pred             cCCccc
Q 040392           89 EGNELL   94 (470)
Q Consensus        89 ~~n~~~   94 (470)
                      ++|.+.
T Consensus       155 ~~N~l~  160 (452)
T 3zyi_A          155 RNNPIE  160 (452)
T ss_dssp             CSCCCC
T ss_pred             CCCCcc
Confidence            776654

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=98.92  E-value=1.9e-09  Score=113.28  Aligned_cols=81  Identities=23%  Similarity=0.262  Sum_probs=37.5

Q ss_pred             CCcEeeCcCCcCCCCCCcccc--CCCCCCEEeccCCcCCCCCcccccCCCCCCceec------CCccccccCC-CCCCCC
Q 040392           11 NLEYLFLGYNRLQGPIPDSFG--DLISLKFLNLSNNNLSGAIPASLEKLSYLENLNL------SFNKLEGEIP-RGGPFR   81 (470)
Q Consensus        11 ~l~~l~l~~n~l~~~~p~~~~--~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l------~~N~l~~~~~-~~~~l~   81 (470)
                      +|+.|+|++|+++ .+|..+.  .+++|+.|+|++|+|++ +|..+..+++|+.|++      ++|.+.+.+| .+..++
T Consensus       489 ~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~  566 (636)
T 4eco_A          489 LLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCP  566 (636)
T ss_dssp             GCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCS
T ss_pred             CccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCC
Confidence            4555555555554 3444443  44555555555555553 4444444555555544      2233333333 223444


Q ss_pred             CCccccccCCcc
Q 040392           82 NFSVESFEGNEL   93 (470)
Q Consensus        82 ~l~~l~~~~n~~   93 (470)
                      +|+.|++++|.+
T Consensus       567 ~L~~L~Ls~N~l  578 (636)
T 4eco_A          567 SLTQLQIGSNDI  578 (636)
T ss_dssp             SCCEEECCSSCC
T ss_pred             CCCEEECCCCcC
Confidence            444555554444

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=98.92  E-value=8.8e-10  Score=117.24  Aligned_cols=90  Identities=23%  Similarity=0.160  Sum_probs=80.1

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCC
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRN   82 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~   82 (470)
                      |+.|..+++|+.|+|++|.+. .+|..+.++++|+.|+|++|.|+ .+|..|..|++|+.|+|++|.|+..+..+..|++
T Consensus       217 ~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~  294 (727)
T 4b8c_D          217 KDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQ  294 (727)
T ss_dssp             -----CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTT
T ss_pred             hhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCccChhhcCCCC
Confidence            667889999999999999999 78888889999999999999999 8999999999999999999999977667789999


Q ss_pred             CccccccCCccc
Q 040392           83 FSVESFEGNELL   94 (470)
Q Consensus        83 l~~l~~~~n~~~   94 (470)
                      |+.|++++|.+.
T Consensus       295 L~~L~L~~N~l~  306 (727)
T 4b8c_D          295 LKYFYFFDNMVT  306 (727)
T ss_dssp             CSEEECCSSCCC
T ss_pred             CCEEECCCCCCC
Confidence            999999999885

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=98.92  E-value=2.1e-09  Score=103.30  Aligned_cols=85  Identities=26%  Similarity=0.198  Sum_probs=55.8

Q ss_pred             CCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCCcccccc
Q 040392           10 KNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSVESFE   89 (470)
Q Consensus        10 ~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~   89 (470)
                      ++|+.|+|++|.+++..|..+.++++|+.|+|++|.+++..+..+..+++|+.|++++|.|+..+..+..+++|+.|+++
T Consensus       192 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~  271 (330)
T 1xku_A          192 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLH  271 (330)
T ss_dssp             TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECC
T ss_pred             ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccCChhhccCCCcCEEECC
Confidence            45555555555665555566666777777777777777555556667777777777777776555556666777777777


Q ss_pred             CCccc
Q 040392           90 GNELL   94 (470)
Q Consensus        90 ~n~~~   94 (470)
                      +|++.
T Consensus       272 ~N~i~  276 (330)
T 1xku_A          272 NNNIS  276 (330)
T ss_dssp             SSCCC
T ss_pred             CCcCC
Confidence            77764

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=98.91  E-value=1.5e-09  Score=113.31  Aligned_cols=93  Identities=18%  Similarity=0.090  Sum_probs=71.7

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCcccccc-CCCCCCCC
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGE-IPRGGPFR   81 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~-~~~~~~l~   81 (470)
                      |..|+++++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|..+++|+.|++++|.|++. +..+..++
T Consensus        50 ~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~  129 (606)
T 3t6q_A           50 NTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQK  129 (606)
T ss_dssp             TTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCT
T ss_pred             hhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCC
Confidence            56777888888888888888877777788888888888888888877777788888888888888888764 23456777


Q ss_pred             CCccccccCCcccc
Q 040392           82 NFSVESFEGNELLC   95 (470)
Q Consensus        82 ~l~~l~~~~n~~~~   95 (470)
                      +|+.|++++|.+..
T Consensus       130 ~L~~L~L~~n~l~~  143 (606)
T 3t6q_A          130 TLESLYLGSNHISS  143 (606)
T ss_dssp             TCCEEECCSSCCCC
T ss_pred             cccEEECCCCcccc
Confidence            78888888877754

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=98.91  E-value=1.7e-09  Score=109.47  Aligned_cols=90  Identities=27%  Similarity=0.275  Sum_probs=49.5

Q ss_pred             cccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCCCC
Q 040392            4 TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPFRN   82 (470)
Q Consensus         4 ~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~   82 (470)
                      ..|.++++|+.|+|++|.+++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|++++|.+++.++. +..+++
T Consensus        50 ~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~  129 (477)
T 2id5_A           50 DEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYN  129 (477)
T ss_dssp             TTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred             hHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHcccccc
Confidence            4455555555555555555555555555555555555555555533334455555555555555555544332 344555


Q ss_pred             CccccccCCcc
Q 040392           83 FSVESFEGNEL   93 (470)
Q Consensus        83 l~~l~~~~n~~   93 (470)
                      |+.|++++|.+
T Consensus       130 L~~L~l~~n~l  140 (477)
T 2id5_A          130 LKSLEVGDNDL  140 (477)
T ss_dssp             CCEEEECCTTC
T ss_pred             CCEEECCCCcc
Confidence            55555555554

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=98.90  E-value=1.4e-09  Score=111.28  Aligned_cols=90  Identities=21%  Similarity=0.183  Sum_probs=72.8

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFR   81 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~   81 (470)
                      +|..+.  ++|+.|+|++|.+++..|..|.++++|++|+|++|+|++..|..|..+++|+.|++++|.|+..++.  .++
T Consensus        15 ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~--~l~   90 (520)
T 2z7x_B           15 VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH--PTV   90 (520)
T ss_dssp             CCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECC--CCC
T ss_pred             cccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCcc--ccC
Confidence            566665  7888888888888877777888888888888888888877788888888888888888888854443  788


Q ss_pred             CCccccccCCcccc
Q 040392           82 NFSVESFEGNELLC   95 (470)
Q Consensus        82 ~l~~l~~~~n~~~~   95 (470)
                      +|+.|++++|.+..
T Consensus        91 ~L~~L~L~~N~l~~  104 (520)
T 2z7x_B           91 NLKHLDLSFNAFDA  104 (520)
T ss_dssp             CCSEEECCSSCCSS
T ss_pred             CccEEeccCCcccc
Confidence            88888888888754

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=98.90  E-value=2.8e-09  Score=106.82  Aligned_cols=84  Identities=24%  Similarity=0.175  Sum_probs=41.2

Q ss_pred             CCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCCCCCccccc
Q 040392           10 KNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPFRNFSVESF   88 (470)
Q Consensus        10 ~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~   88 (470)
                      ++++.|+|++|++++..+..|.++++|+.|+|++|.|++..+..|..+++|+.|+|++|.|++.++. +..+++|+.|++
T Consensus        64 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  143 (440)
T 3zyj_A           64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWL  143 (440)
T ss_dssp             TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEEC
T ss_pred             CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeC
Confidence            3445555555555544444455555555555555555544444455555555555555555443332 244455555555


Q ss_pred             cCCcc
Q 040392           89 EGNEL   93 (470)
Q Consensus        89 ~~n~~   93 (470)
                      ++|.+
T Consensus       144 ~~N~i  148 (440)
T 3zyj_A          144 RNNPI  148 (440)
T ss_dssp             CSCCC
T ss_pred             CCCcc
Confidence            55544

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=98.90  E-value=6.4e-10  Score=106.13  Aligned_cols=91  Identities=20%  Similarity=0.175  Sum_probs=71.1

Q ss_pred             CCccc--CCCCCCcEeeCcCCcCCCCCCccccCC-----CCCCEEeccCCcCCCCCcccccCCCCCCceecCCcccccc-
Q 040392            2 IPTEI--GGLKNLEYLFLGYNRLQGPIPDSFGDL-----ISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGE-   73 (470)
Q Consensus         2 ~p~~~--~~l~~l~~l~l~~n~l~~~~p~~~~~l-----~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~-   73 (470)
                      +|..+  .++++|+.|+|++|++++. |..+..+     ++|++|+|++|+|++..|..+..+++|+.|++++|++.+. 
T Consensus       111 ~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  189 (312)
T 1wwl_A          111 APPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER  189 (312)
T ss_dssp             CCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHH
T ss_pred             hHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcch
Confidence            46655  7888888888888888866 7777766     8888888888888877778888888888888888887654 


Q ss_pred             --CCCC--CCCCCCccccccCCcc
Q 040392           74 --IPRG--GPFRNFSVESFEGNEL   93 (470)
Q Consensus        74 --~~~~--~~l~~l~~l~~~~n~~   93 (470)
                        ++..  ..+++|+.|++++|.+
T Consensus       190 ~~~~~~~~~~l~~L~~L~L~~N~l  213 (312)
T 1wwl_A          190 GLISALCPLKFPTLQVLALRNAGM  213 (312)
T ss_dssp             HHHHHSCTTSCTTCCEEECTTSCC
T ss_pred             HHHHHHHhccCCCCCEEECCCCcC
Confidence              3333  6778888888888876

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=98.90  E-value=1.9e-09  Score=103.67  Aligned_cols=87  Identities=23%  Similarity=0.165  Sum_probs=71.7

Q ss_pred             CCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCCcccccc
Q 040392           10 KNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSVESFE   89 (470)
Q Consensus        10 ~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~   89 (470)
                      ++|+.|+|++|.+++..|..+.++++|+.|+|++|.|++..+..+..+++|+.|++++|.|+..+..+..+++|+.|+++
T Consensus       193 ~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~  272 (332)
T 2ft3_A          193 ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLH  272 (332)
T ss_dssp             SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBCCTTGGGCTTCCEEECC
T ss_pred             CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeecChhhhcCccCCEEECC
Confidence            57888888888888777778888888888888888888777778888888888999988888666667788888888888


Q ss_pred             CCccccC
Q 040392           90 GNELLCG   96 (470)
Q Consensus        90 ~n~~~~~   96 (470)
                      +|++..-
T Consensus       273 ~N~l~~~  279 (332)
T 2ft3_A          273 TNNITKV  279 (332)
T ss_dssp             SSCCCBC
T ss_pred             CCCCCcc
Confidence            8887543

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=98.90  E-value=1.7e-09  Score=106.59  Aligned_cols=92  Identities=21%  Similarity=0.238  Sum_probs=71.7

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCCC
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPFR   81 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~   81 (470)
                      |..|.++++|+.|+|++|.+++..|..|.++++|+.|+|++|.+++..+..|..+++|+.|++++|.+++.++. +..++
T Consensus        86 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~  165 (390)
T 3o6n_A           86 TYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATT  165 (390)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCT
T ss_pred             hhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCC
Confidence            34677888888888888888877777788888888888888888843334467888888888888888876654 56778


Q ss_pred             CCccccccCCccc
Q 040392           82 NFSVESFEGNELL   94 (470)
Q Consensus        82 ~l~~l~~~~n~~~   94 (470)
                      +|+.|++++|.+.
T Consensus       166 ~L~~L~l~~n~l~  178 (390)
T 3o6n_A          166 SLQNLQLSSNRLT  178 (390)
T ss_dssp             TCCEEECCSSCCS
T ss_pred             CCCEEECCCCcCC
Confidence            8888888888764

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.89  E-value=1.6e-09  Score=112.98  Aligned_cols=93  Identities=20%  Similarity=0.231  Sum_probs=82.1

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCCC
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPFR   81 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~   81 (470)
                      |..|+++++|+.|+|++|.+++..|..|+++++|+.|+|++|.|++..+..|..+++|+.|++++|.|++.++. +..++
T Consensus        92 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  171 (597)
T 3oja_B           92 TYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATT  171 (597)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCT
T ss_pred             hHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCC
Confidence            45889999999999999999988888889999999999999999955556678999999999999999987775 57899


Q ss_pred             CCccccccCCcccc
Q 040392           82 NFSVESFEGNELLC   95 (470)
Q Consensus        82 ~l~~l~~~~n~~~~   95 (470)
                      +|+.|++++|.+..
T Consensus       172 ~L~~L~L~~N~l~~  185 (597)
T 3oja_B          172 SLQNLQLSSNRLTH  185 (597)
T ss_dssp             TCCEEECTTSCCSB
T ss_pred             cCcEEECcCCCCCC
Confidence            99999999998753

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=98.88  E-value=2.6e-09  Score=102.72  Aligned_cols=92  Identities=24%  Similarity=0.291  Sum_probs=81.7

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCC----
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGG----   78 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~----   78 (470)
                      |..|.++++|+.|+|++|.+++..+..+..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|.|++.++...    
T Consensus       209 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~  287 (330)
T 1xku_A          209 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG  287 (330)
T ss_dssp             TGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSS
T ss_pred             HHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcc
Confidence            567899999999999999999887778999999999999999999 889999999999999999999997666532    


Q ss_pred             ---CCCCCccccccCCcccc
Q 040392           79 ---PFRNFSVESFEGNELLC   95 (470)
Q Consensus        79 ---~l~~l~~l~~~~n~~~~   95 (470)
                         ....++.+++.+|++.+
T Consensus       288 ~~~~~~~l~~l~l~~N~~~~  307 (330)
T 1xku_A          288 YNTKKASYSGVSLFSNPVQY  307 (330)
T ss_dssp             CCTTSCCCSEEECCSSSSCG
T ss_pred             cccccccccceEeecCcccc
Confidence               24678899999999865

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=98.88  E-value=3.5e-10  Score=121.83  Aligned_cols=93  Identities=18%  Similarity=0.217  Sum_probs=70.3

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCC-----------------CCCcccc--CCCCCCEEeccCCcCCCCCcccccCCCCCCc
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQG-----------------PIPDSFG--DLISLKFLNLSNNNLSGAIPASLEKLSYLEN   62 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~-----------------~~p~~~~--~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~   62 (470)
                      +|.+|++|++|+.|+|++|+|++                 .+|+.++  ++++|+.|+|++|.+.+.+|..+..+++|+.
T Consensus       440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~  519 (876)
T 4ecn_A          440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS  519 (876)
T ss_dssp             ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCE
T ss_pred             hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCE
Confidence            57778888888888888888887                 2777776  8888888888888888888888888888888


Q ss_pred             eecCCcc-ccc-cCCC-C-------CCCCCCccccccCCccc
Q 040392           63 LNLSFNK-LEG-EIPR-G-------GPFRNFSVESFEGNELL   94 (470)
Q Consensus        63 l~l~~N~-l~~-~~~~-~-------~~l~~l~~l~~~~n~~~   94 (470)
                      |++++|. |++ .+|. +       ..+++|+.|++++|.+.
T Consensus       520 L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~  561 (876)
T 4ecn_A          520 LNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE  561 (876)
T ss_dssp             EECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred             EECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence            8888887 776 3332 2       23447777777777765

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=98.88  E-value=2.5e-09  Score=110.70  Aligned_cols=90  Identities=20%  Similarity=0.175  Sum_probs=71.7

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFR   81 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~   81 (470)
                      +|.++.  ++|+.|+|++|.+++..|..|.++++|++|+|++|+|++..|+.|..+++|+.|++++|.|+..++.  .++
T Consensus        46 ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~--~l~  121 (562)
T 3a79_B           46 VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCC--PMA  121 (562)
T ss_dssp             CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEECSC--CCT
T ss_pred             CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccCcc--ccc
Confidence            455554  7888888888888877777888888888888888888877788888888888888888888854444  788


Q ss_pred             CCccccccCCcccc
Q 040392           82 NFSVESFEGNELLC   95 (470)
Q Consensus        82 ~l~~l~~~~n~~~~   95 (470)
                      +|+.|++++|.+..
T Consensus       122 ~L~~L~Ls~N~l~~  135 (562)
T 3a79_B          122 SLRHLDLSFNDFDV  135 (562)
T ss_dssp             TCSEEECCSSCCSB
T ss_pred             cCCEEECCCCCccc
Confidence            88888888888743

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=98.88  E-value=1.4e-09  Score=105.68  Aligned_cols=91  Identities=24%  Similarity=0.318  Sum_probs=80.9

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPF   80 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l   80 (470)
                      +|.++.  ++|+.|+|++|++++..+..|.++++|+.|+|++|.|++..|..|..+++|+.|++++|.|++.++. +..+
T Consensus        46 iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l  123 (353)
T 2z80_A           46 IPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPL  123 (353)
T ss_dssp             CCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTC
T ss_pred             cccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCC
Confidence            565554  5899999999999977666899999999999999999987788899999999999999999977665 5789


Q ss_pred             CCCccccccCCccc
Q 040392           81 RNFSVESFEGNELL   94 (470)
Q Consensus        81 ~~l~~l~~~~n~~~   94 (470)
                      ++|+.|++++|++.
T Consensus       124 ~~L~~L~L~~n~l~  137 (353)
T 2z80_A          124 SSLTFLNLLGNPYK  137 (353)
T ss_dssp             TTCSEEECTTCCCS
T ss_pred             ccCCEEECCCCCCc
Confidence            99999999999985

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=98.88  E-value=1.4e-09  Score=99.50  Aligned_cols=86  Identities=21%  Similarity=0.264  Sum_probs=53.3

Q ss_pred             ccCCCCCCcEeeCcCCc-CCCCCCccccCCCCCCEEeccC-CcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCC
Q 040392            5 EIGGLKNLEYLFLGYNR-LQGPIPDSFGDLISLKFLNLSN-NNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRN   82 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~-l~~~~p~~~~~l~~L~~l~l~~-n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~   82 (470)
                      .|.++++|+.|+|++|. ++...+..|.++++|++|+|++ |+|++..+..|..+++|+.|++++|.+++. |.+..+.+
T Consensus        50 ~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~l-p~~~~l~~  128 (239)
T 2xwt_C           50 AFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMF-PDLTKVYS  128 (239)
T ss_dssp             TTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCSC-CCCTTCCB
T ss_pred             HccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCccc-cccccccc
Confidence            45666666666666665 6644444566666666666666 666644445566666666666666666653 33555555


Q ss_pred             Cc---cccccCC
Q 040392           83 FS---VESFEGN   91 (470)
Q Consensus        83 l~---~l~~~~n   91 (470)
                      |+   .+++++|
T Consensus       129 L~~L~~L~l~~N  140 (239)
T 2xwt_C          129 TDIFFILEITDN  140 (239)
T ss_dssp             CCSEEEEEEESC
T ss_pred             cccccEEECCCC
Confidence            55   6666666

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.88  E-value=1.4e-09  Score=110.42  Aligned_cols=91  Identities=25%  Similarity=0.215  Sum_probs=80.2

Q ss_pred             CcccC-CCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCC
Q 040392            3 PTEIG-GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFR   81 (470)
Q Consensus         3 p~~~~-~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~   81 (470)
                      |..+. ++++|+.|+|++|.|++.  +.+..+++|+.|+|++|.|++ +|..+..+++|+.|++++|.|++.++.+..++
T Consensus       161 ~~~l~~~l~~L~~L~Ls~N~l~~~--~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~  237 (487)
T 3oja_A          161 FAELAASSDTLEHLNLQYNFIYDV--KGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVLIEKALRFSQ  237 (487)
T ss_dssp             GGGGGGGTTTCCEEECTTSCCCEE--ECCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCEECTTCCCCT
T ss_pred             hHHHhhhCCcccEEecCCCccccc--cccccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcccchhhccCC
Confidence            55665 799999999999999966  335569999999999999995 55569999999999999999998888888899


Q ss_pred             CCccccccCCccccC
Q 040392           82 NFSVESFEGNELLCG   96 (470)
Q Consensus        82 ~l~~l~~~~n~~~~~   96 (470)
                      +|+.+++++|++.|+
T Consensus       238 ~L~~L~l~~N~l~c~  252 (487)
T 3oja_A          238 NLEHFDLRGNGFHCG  252 (487)
T ss_dssp             TCCEEECTTCCBCHH
T ss_pred             CCCEEEcCCCCCcCc
Confidence            999999999999874

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=98.88  E-value=1.3e-09  Score=112.40  Aligned_cols=92  Identities=22%  Similarity=0.271  Sum_probs=84.1

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPF   80 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l   80 (470)
                      +|.++.  ++|+.|+|++|++++..|..|.++++|++|+|++|+|++..|..|..+++|+.|++++|.+++.++. +..+
T Consensus        20 ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l   97 (549)
T 2z81_A           20 IPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPL   97 (549)
T ss_dssp             CCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTC
T ss_pred             ccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccC
Confidence            566654  7999999999999988889999999999999999999988888999999999999999999988876 6889


Q ss_pred             CCCccccccCCcccc
Q 040392           81 RNFSVESFEGNELLC   95 (470)
Q Consensus        81 ~~l~~l~~~~n~~~~   95 (470)
                      ++|+.|++++|.+..
T Consensus        98 ~~L~~L~Ls~n~l~~  112 (549)
T 2z81_A           98 SSLKYLNLMGNPYQT  112 (549)
T ss_dssp             TTCCEEECTTCCCSS
T ss_pred             CCCcEEECCCCcccc
Confidence            999999999999854

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=98.88  E-value=2e-09  Score=102.51  Aligned_cols=86  Identities=23%  Similarity=0.205  Sum_probs=62.7

Q ss_pred             cCCCCCCcEeeCcCCcCCCCCCc----cccCCCCCCEEeccCCcCCCCCcccccCC---CCCCceecCCccccccCCCCC
Q 040392            6 IGGLKNLEYLFLGYNRLQGPIPD----SFGDLISLKFLNLSNNNLSGAIPASLEKL---SYLENLNLSFNKLEGEIPRGG   78 (470)
Q Consensus         6 ~~~l~~l~~l~l~~n~l~~~~p~----~~~~l~~L~~l~l~~n~i~~~~~~~~~~l---~~L~~l~l~~N~l~~~~~~~~   78 (470)
                      ++++++|+.|+|++|+++ .+|.    .+.++++|++|+|++|+|++..|..+..+   ++|+.|++++|.|+..+..+.
T Consensus       193 ~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~  271 (310)
T 4glp_A          193 PHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQVPKGLP  271 (310)
T ss_dssp             TTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCSCCSCCC
T ss_pred             hhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCchhhhhc
Confidence            367788888888888887 3343    24667888888888888887667666666   588888888888885444432


Q ss_pred             CCCCCccccccCCccc
Q 040392           79 PFRNFSVESFEGNELL   94 (470)
Q Consensus        79 ~l~~l~~l~~~~n~~~   94 (470)
                        ++|+.|++++|++.
T Consensus       272 --~~L~~L~Ls~N~l~  285 (310)
T 4glp_A          272 --AKLRVLDLSSNRLN  285 (310)
T ss_dssp             --SCCSCEECCSCCCC
T ss_pred             --CCCCEEECCCCcCC
Confidence              67888888888775

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=98.88  E-value=3.1e-09  Score=109.95  Aligned_cols=90  Identities=22%  Similarity=0.202  Sum_probs=67.1

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCc-cccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCC
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPD-SFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFR   81 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~-~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~   81 (470)
                      |..|.++++|+.|+|++|++++.+|. .+..+++|+.|+|++|+|++..|..+.  ++|+.|++++|+|+..++.+..++
T Consensus       396 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~ip~~~~~l~  473 (562)
T 3a79_B          396 ALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQ  473 (562)
T ss_dssp             HHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCCCCTTTTSSC
T ss_pred             hhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCcccChhhcCCC
Confidence            35678889999999999999874555 477788888888888888766655443  577777777777776666666777


Q ss_pred             CCccccccCCccc
Q 040392           82 NFSVESFEGNELL   94 (470)
Q Consensus        82 ~l~~l~~~~n~~~   94 (470)
                      +|+.|++++|.+.
T Consensus       474 ~L~~L~L~~N~l~  486 (562)
T 3a79_B          474 ALQELNVASNQLK  486 (562)
T ss_dssp             CCSEEECCSSCCC
T ss_pred             CCCEEECCCCCCC
Confidence            7777777777765

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=98.87  E-value=3e-09  Score=108.87  Aligned_cols=90  Identities=21%  Similarity=0.143  Sum_probs=56.7

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCcc-ccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCC
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPDS-FGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFR   81 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~~-~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~   81 (470)
                      |..+.++++|+.|+|++|.+++.+|.. +..+++|+.|+|++|++++..|..+.  ++|+.|++++|.|+..++.+..++
T Consensus       367 ~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~~ip~~~~~l~  444 (520)
T 2z7x_B          367 AEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIKSIPKQVVKLE  444 (520)
T ss_dssp             HHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCCCCCGGGGGCT
T ss_pred             hHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCcccccchhhhcCC
Confidence            345677788888888888887645543 66666677777766666655554442  566666666666664444445566


Q ss_pred             CCccccccCCccc
Q 040392           82 NFSVESFEGNELL   94 (470)
Q Consensus        82 ~l~~l~~~~n~~~   94 (470)
                      +|+.|++++|++.
T Consensus       445 ~L~~L~L~~N~l~  457 (520)
T 2z7x_B          445 ALQELNVASNQLK  457 (520)
T ss_dssp             TCCEEECCSSCCC
T ss_pred             CCCEEECCCCcCC
Confidence            6666666666554

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=98.87  E-value=5.8e-10  Score=120.11  Aligned_cols=96  Identities=21%  Similarity=0.208  Sum_probs=83.1

Q ss_pred             CCcccC--CCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCc-CCC-CCcccccCCC-------CCCceecCCccc
Q 040392            2 IPTEIG--GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNN-LSG-AIPASLEKLS-------YLENLNLSFNKL   70 (470)
Q Consensus         2 ~p~~~~--~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~-i~~-~~~~~~~~l~-------~L~~l~l~~N~l   70 (470)
                      +|.+++  +|++|+.|+|++|++.+.+|..|.++++|+.|+|++|+ ++| .+|..+..++       +|+.|++++|.|
T Consensus       481 iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L  560 (876)
T 4ecn_A          481 ENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL  560 (876)
T ss_dssp             TTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCC
T ss_pred             CChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcC
Confidence            788888  99999999999999999999999999999999999998 998 7887666655       999999999999


Q ss_pred             cccCC--CCCCCCCCccccccCCccccCCC
Q 040392           71 EGEIP--RGGPFRNFSVESFEGNELLCGSP   98 (470)
Q Consensus        71 ~~~~~--~~~~l~~l~~l~~~~n~~~~~~~   98 (470)
                      +..+.  .+..+++|+.|++++|.+. ..|
T Consensus       561 ~~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp  589 (876)
T 4ecn_A          561 EEFPASASLQKMVKLGLLDCVHNKVR-HLE  589 (876)
T ss_dssp             CBCCCHHHHTTCTTCCEEECTTSCCC-BCC
T ss_pred             CccCChhhhhcCCCCCEEECCCCCcc-cch
Confidence            94444  3688999999999999886 444

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=98.86  E-value=3.3e-09  Score=110.69  Aligned_cols=94  Identities=22%  Similarity=0.251  Sum_probs=84.3

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccc-cCCCCCCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEG-EIPRGGPF   80 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~-~~~~~~~l   80 (470)
                      .|+.|.++++|+.|+|++|++++..|..|.++++|++|+|++|.|++..|..+..+++|+.|++++|.+++ .++....+
T Consensus        73 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  152 (606)
T 3t6q_A           73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPT  152 (606)
T ss_dssp             CTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCC
T ss_pred             ChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCC
Confidence            47789999999999999999998889999999999999999999997667889999999999999999987 44666669


Q ss_pred             CCCccccccCCcccc
Q 040392           81 RNFSVESFEGNELLC   95 (470)
Q Consensus        81 ~~l~~l~~~~n~~~~   95 (470)
                      ++|+.|++++|.+..
T Consensus       153 ~~L~~L~L~~n~l~~  167 (606)
T 3t6q_A          153 EKLKVLDFQNNAIHY  167 (606)
T ss_dssp             TTCCEEECCSSCCCE
T ss_pred             cccCEEEcccCcccc
Confidence            999999999998743

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=98.86  E-value=4.5e-09  Score=101.09  Aligned_cols=92  Identities=25%  Similarity=0.191  Sum_probs=81.2

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCC----
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGG----   78 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~----   78 (470)
                      |..|.++++|+.|+|++|++++..|..+..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|.|++..+...    
T Consensus       210 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~  288 (332)
T 2ft3_A          210 LEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVG  288 (332)
T ss_dssp             TTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSS
T ss_pred             HHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccc
Confidence            467889999999999999999888888999999999999999999 899899999999999999999997665431    


Q ss_pred             ---CCCCCccccccCCcccc
Q 040392           79 ---PFRNFSVESFEGNELLC   95 (470)
Q Consensus        79 ---~l~~l~~l~~~~n~~~~   95 (470)
                         ...+|+.+++.+|++.+
T Consensus       289 ~~~~~~~l~~L~l~~N~~~~  308 (332)
T 2ft3_A          289 FGVKRAYYNGISLFNNPVPY  308 (332)
T ss_dssp             CCSSSCCBSEEECCSSSSCG
T ss_pred             cccccccccceEeecCcccc
Confidence               14678899999999863

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=98.85  E-value=2.7e-09  Score=115.87  Aligned_cols=91  Identities=27%  Similarity=0.318  Sum_probs=48.5

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCccc--ccCCCCCCceecCCccccccCC--CCC
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPAS--LEKLSYLENLNLSFNKLEGEIP--RGG   78 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~--~~~l~~L~~l~l~~N~l~~~~~--~~~   78 (470)
                      |..|.+|++|+.|+|++|.+++..|..|.++++|++|+|++|.+++..|..  +..+++|+.|++++|.+++..+  .+.
T Consensus        66 ~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~  145 (844)
T 3j0a_A           66 KEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFG  145 (844)
T ss_dssp             TTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGG
T ss_pred             HHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHh
Confidence            344555555555555555555555555555555555555555555444433  5555555555555555554332  234


Q ss_pred             CCCCCccccccCCcc
Q 040392           79 PFRNFSVESFEGNEL   93 (470)
Q Consensus        79 ~l~~l~~l~~~~n~~   93 (470)
                      .+++|+.|++++|.+
T Consensus       146 ~L~~L~~L~Ls~N~i  160 (844)
T 3j0a_A          146 KLNSLKSIDFSSNQI  160 (844)
T ss_dssp             TCSSCCEEEEESSCC
T ss_pred             hCCCCCEEECCCCcC
Confidence            555555555555544

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=98.84  E-value=2.7e-09  Score=102.02  Aligned_cols=90  Identities=23%  Similarity=0.202  Sum_probs=66.9

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCccc-cCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCC
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPDSF-GDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFR   81 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~~~-~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~   81 (470)
                      |..++++++|+.|+|++|.+++..|..+ ..+++|+.|+|++|.|++ +|. ...+++|+.|++++|.|++.++.+..++
T Consensus       137 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~  214 (317)
T 3o53_A          137 DLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKG-QVVFAKLKTLDLSSNKLAFMGPEFQSAA  214 (317)
T ss_dssp             GBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE-EEC-CCCCTTCCEEECCSSCCCEECGGGGGGT
T ss_pred             chhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcc-ccc-ccccccCCEEECCCCcCCcchhhhcccC
Confidence            4466778888888888888886666666 367888888888888874 333 3347788888888888877767667777


Q ss_pred             CCccccccCCccc
Q 040392           82 NFSVESFEGNELL   94 (470)
Q Consensus        82 ~l~~l~~~~n~~~   94 (470)
                      +|+.|++++|.+.
T Consensus       215 ~L~~L~L~~N~l~  227 (317)
T 3o53_A          215 GVTWISLRNNKLV  227 (317)
T ss_dssp             TCSEEECTTSCCC
T ss_pred             cccEEECcCCccc
Confidence            8888888888775

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=98.83  E-value=4.2e-09  Score=108.96  Aligned_cols=91  Identities=18%  Similarity=0.120  Sum_probs=59.9

Q ss_pred             cccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCC-CCCCCCC
Q 040392            4 TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIP-RGGPFRN   82 (470)
Q Consensus         4 ~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~-~~~~l~~   82 (470)
                      ..|.++++|+.|+|++|++++..|..|.++++|++|+|++|.+++..|..|..+++|+.|++++|.+++.++ .+..+++
T Consensus        46 ~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~  125 (570)
T 2z63_A           46 YSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT  125 (570)
T ss_dssp             TTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTT
T ss_pred             hHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCcccccccc
Confidence            356666777777777777765555666667777777777777765555666667777777777776665444 2456666


Q ss_pred             CccccccCCccc
Q 040392           83 FSVESFEGNELL   94 (470)
Q Consensus        83 l~~l~~~~n~~~   94 (470)
                      |+.|++++|.+.
T Consensus       126 L~~L~L~~n~l~  137 (570)
T 2z63_A          126 LKELNVAHNLIQ  137 (570)
T ss_dssp             CCEEECCSSCCC
T ss_pred             ccEEecCCCccc
Confidence            777777666653

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=98.82  E-value=6.4e-09  Score=96.55  Aligned_cols=82  Identities=24%  Similarity=0.270  Sum_probs=46.5

Q ss_pred             cCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCCcc
Q 040392            6 IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSV   85 (470)
Q Consensus         6 ~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~   85 (470)
                      +..+++|+.|++++|.++ .+| .+..+++|+.|+|++|+|++ ++. +..+++|+.|++++|.|++.++ ... .+|+.
T Consensus        37 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~l~~-~~~-~~L~~  110 (263)
T 1xeu_A           37 QKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKNLNG-IPS-ACLSR  110 (263)
T ss_dssp             HHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSCCTT-CCC-SSCCE
T ss_pred             hhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCCcCc-ccc-CcccE
Confidence            345566666666666666 333 45566666666666666663 333 6666666666666666664322 222 55666


Q ss_pred             ccccCCcc
Q 040392           86 ESFEGNEL   93 (470)
Q Consensus        86 l~~~~n~~   93 (470)
                      |++++|.+
T Consensus       111 L~L~~N~l  118 (263)
T 1xeu_A          111 LFLDNNEL  118 (263)
T ss_dssp             EECCSSCC
T ss_pred             EEccCCcc
Confidence            66666655

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=98.81  E-value=7.4e-09  Score=97.65  Aligned_cols=84  Identities=35%  Similarity=0.457  Sum_probs=60.2

Q ss_pred             cCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCCcc
Q 040392            6 IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSV   85 (470)
Q Consensus         6 ~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~   85 (470)
                      +.++++|+.|+|++|.+++.  +.+..+++|+.|+|++|+|++ + +.+..+++|+.|++++|.|++. +.+..+++|+.
T Consensus        86 l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~  160 (291)
T 1h6t_A           86 LANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDT  160 (291)
T ss_dssp             GTTCTTCCEEECCSSCCCCG--GGGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSE
T ss_pred             cccCCCCCEEECCCCcCCCC--hhhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCE
Confidence            66777788888888887742  347777778888888887774 3 3467777777777777777754 55666777777


Q ss_pred             ccccCCccc
Q 040392           86 ESFEGNELL   94 (470)
Q Consensus        86 l~~~~n~~~   94 (470)
                      |++++|.+.
T Consensus       161 L~L~~N~l~  169 (291)
T 1h6t_A          161 LSLEDNQIS  169 (291)
T ss_dssp             EECCSSCCC
T ss_pred             EEccCCccc
Confidence            777777764

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=98.80  E-value=5.1e-09  Score=98.80  Aligned_cols=85  Identities=24%  Similarity=0.315  Sum_probs=62.5

Q ss_pred             ccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCCc
Q 040392            5 EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFS   84 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~   84 (470)
                      .+.++++|+.|+|++|++++.  +.+..+++|+.|+|++|++++.  ..+..+++|+.|++++|.|++.++ +..+++|+
T Consensus       107 ~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~  181 (291)
T 1h6t_A          107 SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQ  181 (291)
T ss_dssp             GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCC
T ss_pred             hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh-hcCCCccC
Confidence            467778888888888888753  4677777888888888887743  457777778888888887776555 66777777


Q ss_pred             cccccCCccc
Q 040392           85 VESFEGNELL   94 (470)
Q Consensus        85 ~l~~~~n~~~   94 (470)
                      .|++++|.+.
T Consensus       182 ~L~L~~N~i~  191 (291)
T 1h6t_A          182 NLYLSKNHIS  191 (291)
T ss_dssp             EEECCSSCCC
T ss_pred             EEECCCCcCC
Confidence            7777777763

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=98.80  E-value=7.5e-09  Score=109.57  Aligned_cols=90  Identities=23%  Similarity=0.217  Sum_probs=58.7

Q ss_pred             ccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCCCCC
Q 040392            5 EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPFRNF   83 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l   83 (470)
                      .|.++++|+.|+|++|.+++..|..|.++++|+.|+|++|.+++..+..|..+++|+.|++++|.+++.++. +..+++|
T Consensus        44 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  123 (680)
T 1ziw_A           44 NFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNL  123 (680)
T ss_dssp             GGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTC
T ss_pred             HHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCC
Confidence            466667777777777777766666666677777777777777643334566677777777777766655543 4566666


Q ss_pred             ccccccCCccc
Q 040392           84 SVESFEGNELL   94 (470)
Q Consensus        84 ~~l~~~~n~~~   94 (470)
                      +.|++++|.+.
T Consensus       124 ~~L~Ls~n~l~  134 (680)
T 1ziw_A          124 ITLDLSHNGLS  134 (680)
T ss_dssp             CEEECCSSCCS
T ss_pred             CEEECCCCccc
Confidence            66666666654

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=98.79  E-value=5.4e-09  Score=99.57  Aligned_cols=85  Identities=15%  Similarity=0.061  Sum_probs=61.6

Q ss_pred             CCCCcEeeCcCCcCCCCCCccc--cCCCCCCEEeccCCcCCCCCc----ccccCCCCCCceecCCccccccCCC-CCCCC
Q 040392            9 LKNLEYLFLGYNRLQGPIPDSF--GDLISLKFLNLSNNNLSGAIP----ASLEKLSYLENLNLSFNKLEGEIPR-GGPFR   81 (470)
Q Consensus         9 l~~l~~l~l~~n~l~~~~p~~~--~~l~~L~~l~l~~n~i~~~~~----~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~   81 (470)
                      +++|+.|+|++|.+++..|..+  ..+++|++|+|++|.+++..+    ..+..+++|+.|++++|.|++.++. +..++
T Consensus        90 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~  169 (310)
T 4glp_A           90 YSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFP  169 (310)
T ss_dssp             HSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCT
T ss_pred             cCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCC
Confidence            4567888888888877777776  777788888888888776544    3344677888888888887766653 45677


Q ss_pred             CCccccccCCcc
Q 040392           82 NFSVESFEGNEL   93 (470)
Q Consensus        82 ~l~~l~~~~n~~   93 (470)
                      +|+.|++++|++
T Consensus       170 ~L~~L~Ls~N~l  181 (310)
T 4glp_A          170 ALTSLDLSDNPG  181 (310)
T ss_dssp             TCCEEECCSCTT
T ss_pred             CCCEEECCCCCC
Confidence            788888888775

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=98.79  E-value=3.1e-09  Score=97.13  Aligned_cols=89  Identities=20%  Similarity=0.167  Sum_probs=77.9

Q ss_pred             cccCCCCCCcEeeCcC-CcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCC---ceecCCc-cccccCCC-C
Q 040392            4 TEIGGLKNLEYLFLGY-NRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE---NLNLSFN-KLEGEIPR-G   77 (470)
Q Consensus         4 ~~~~~l~~l~~l~l~~-n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~---~l~l~~N-~l~~~~~~-~   77 (470)
                      ..|.++++|+.|+|++ |++++..+..|.++++|+.|+|++|++++ +|. +..+++|+   .|++++| .+++.++. +
T Consensus        74 ~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~  151 (239)
T 2xwt_C           74 HSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAF  151 (239)
T ss_dssp             TTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTT
T ss_pred             hHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccc
Confidence            4678999999999998 99997766789999999999999999995 776 88899998   9999999 89877765 5


Q ss_pred             CCCCCCc-cccccCCccc
Q 040392           78 GPFRNFS-VESFEGNELL   94 (470)
Q Consensus        78 ~~l~~l~-~l~~~~n~~~   94 (470)
                      ..+++|+ .+++++|.+.
T Consensus       152 ~~l~~L~~~L~l~~n~l~  169 (239)
T 2xwt_C          152 QGLCNETLTLKLYNNGFT  169 (239)
T ss_dssp             TTTBSSEEEEECCSCCCC
T ss_pred             cchhcceeEEEcCCCCCc
Confidence            7789999 9999999885

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=98.79  E-value=5.3e-09  Score=101.14  Aligned_cols=86  Identities=30%  Similarity=0.415  Sum_probs=57.6

Q ss_pred             cCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCCCCCc
Q 040392            6 IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPFRNFS   84 (470)
Q Consensus         6 ~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~   84 (470)
                      +..+++|+.|+|++|.+++.  +.+..+++|+.|++++|.+++ + +.+..+++|+.|++++|.+++..+. +..+++|+
T Consensus       239 ~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~  314 (347)
T 4fmz_A          239 LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD-I-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLT  314 (347)
T ss_dssp             GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCS
T ss_pred             hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCC-C-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCC
Confidence            56677777777777777743  456677777777777777774 3 3466777777777777777655443 35567777


Q ss_pred             cccccCCcccc
Q 040392           85 VESFEGNELLC   95 (470)
Q Consensus        85 ~l~~~~n~~~~   95 (470)
                      .|++++|++..
T Consensus       315 ~L~L~~n~l~~  325 (347)
T 4fmz_A          315 TLFLSQNHITD  325 (347)
T ss_dssp             EEECCSSSCCC
T ss_pred             EEEccCCcccc
Confidence            77777777644

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=98.79  E-value=7.8e-09  Score=109.43  Aligned_cols=92  Identities=23%  Similarity=0.179  Sum_probs=75.6

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCCC
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPFR   81 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~   81 (470)
                      |..|+++++|+.|+|++|.+++..+..|.++++|++|+|++|.+++..|..|..+++|+.|++++|.+++.++. +..++
T Consensus        66 ~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~  145 (680)
T 1ziw_A           66 PELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLE  145 (680)
T ss_dssp             TTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCT
T ss_pred             HHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccc
Confidence            56678888999999999998855555788899999999999999876667888899999999999988876655 46788


Q ss_pred             CCccccccCCccc
Q 040392           82 NFSVESFEGNELL   94 (470)
Q Consensus        82 ~l~~l~~~~n~~~   94 (470)
                      +|+.|++++|.+.
T Consensus       146 ~L~~L~L~~n~l~  158 (680)
T 1ziw_A          146 NLQELLLSNNKIQ  158 (680)
T ss_dssp             TCCEEECCSSCCC
T ss_pred             cCCEEEccCCccc
Confidence            8888888888764

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=98.76  E-value=5.7e-11  Score=105.51  Aligned_cols=89  Identities=22%  Similarity=0.283  Sum_probs=72.9

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFR   81 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~   81 (470)
                      +|..|.++++|+.|+|++|.+++ +| .+.++++|+.|+|++|.|+ .+|..+..+++|+.|++++|.|++. +.+..++
T Consensus        40 l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~l-~~~~~l~  115 (198)
T 1ds9_A           40 MDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL-SGIEKLV  115 (198)
T ss_dssp             CHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCCH-HHHHHHH
T ss_pred             hhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCcC-CccccCC
Confidence            34478888999999999999985 66 8888999999999999998 7787777788899999999988864 4566677


Q ss_pred             CCccccccCCccc
Q 040392           82 NFSVESFEGNELL   94 (470)
Q Consensus        82 ~l~~l~~~~n~~~   94 (470)
                      +|+.|++++|++.
T Consensus       116 ~L~~L~l~~N~i~  128 (198)
T 1ds9_A          116 NLRVLYMSNNKIT  128 (198)
T ss_dssp             HSSEEEESEEECC
T ss_pred             CCCEEECCCCcCC
Confidence            8888888888763

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=98.76  E-value=1.4e-08  Score=96.54  Aligned_cols=84  Identities=21%  Similarity=0.265  Sum_probs=55.5

Q ss_pred             ccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCCc
Q 040392            5 EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFS   84 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~   84 (470)
                      .+..+++|+.|+|++|.+++. ++ +..+++|+.|+|++|.+++ ++ .+..+++|+.|++++|.|++.. .+..+++|+
T Consensus        58 ~~~~l~~L~~L~L~~n~i~~~-~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~~~-~l~~l~~L~  132 (308)
T 1h6u_A           58 GVQYLNNLIGLELKDNQITDL-AP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDVT-PLAGLSNLQ  132 (308)
T ss_dssp             TGGGCTTCCEEECCSSCCCCC-GG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCCG-GGTTCTTCC
T ss_pred             hhhccCCCCEEEccCCcCCCC-hh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCCch-hhcCCCCCC
Confidence            456667777777777777743 33 6677777777777777763 33 4666777777777777776433 356667777


Q ss_pred             cccccCCcc
Q 040392           85 VESFEGNEL   93 (470)
Q Consensus        85 ~l~~~~n~~   93 (470)
                      .|++++|.+
T Consensus       133 ~L~l~~n~l  141 (308)
T 1h6u_A          133 VLYLDLNQI  141 (308)
T ss_dssp             EEECCSSCC
T ss_pred             EEECCCCcc
Confidence            777777765

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=98.75  E-value=1.4e-08  Score=94.21  Aligned_cols=84  Identities=32%  Similarity=0.355  Sum_probs=54.8

Q ss_pred             cCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCCcc
Q 040392            6 IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSV   85 (470)
Q Consensus         6 ~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~   85 (470)
                      +.++++|+.|+|++|++++ +|. +.. ++|+.|+|++|+|++ ++ .+..+++|+.|++++|+|++. +.+..+++|+.
T Consensus        81 l~~l~~L~~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~~l~~l~~L~~  154 (263)
T 1xeu_A           81 LKDLTKLEELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-VMLGFLSKLEV  154 (263)
T ss_dssp             GTTCSSCCEEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-GGGGGCTTCCE
T ss_pred             hccCCCCCEEECCCCccCC-cCc-ccc-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-hHHccCCCCCE
Confidence            7778888888888888875 333 222 667777777777763 33 366667777777777776643 34556666666


Q ss_pred             ccccCCcccc
Q 040392           86 ESFEGNELLC   95 (470)
Q Consensus        86 l~~~~n~~~~   95 (470)
                      |++++|++..
T Consensus       155 L~L~~N~i~~  164 (263)
T 1xeu_A          155 LDLHGNEITN  164 (263)
T ss_dssp             EECTTSCCCB
T ss_pred             EECCCCcCcc
Confidence            6666666643

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=98.74  E-value=1.3e-08  Score=105.75  Aligned_cols=84  Identities=24%  Similarity=0.327  Sum_probs=54.2

Q ss_pred             ccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCCc
Q 040392            5 EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFS   84 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~   84 (470)
                      .+.+|++|+.|+|++|+|++.  +.+..+++|+.|+|++|.|++.  ..+..|++|+.|+|++|.|++.++ +..+++|+
T Consensus       104 ~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~  178 (605)
T 1m9s_A          104 SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQ  178 (605)
T ss_dssp             TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCC
T ss_pred             hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh-hccCCCCC
Confidence            566677777777777777643  3466666777777777766643  446666666666666666665555 55666666


Q ss_pred             cccccCCcc
Q 040392           85 VESFEGNEL   93 (470)
Q Consensus        85 ~l~~~~n~~   93 (470)
                      .|++++|++
T Consensus       179 ~L~Ls~N~i  187 (605)
T 1m9s_A          179 NLYLSKNHI  187 (605)
T ss_dssp             EEECCSSCC
T ss_pred             EEECcCCCC
Confidence            666666655

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=98.73  E-value=1.8e-08  Score=95.78  Aligned_cols=84  Identities=24%  Similarity=0.325  Sum_probs=66.7

Q ss_pred             cCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCCcc
Q 040392            6 IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSV   85 (470)
Q Consensus         6 ~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~   85 (470)
                      +.++++|+.|+|++|.+++.  +.+..+++|+.|+|++|.+++ ++. +..+++|+.|++++|.+++..+ +..+++|+.
T Consensus        81 ~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~  155 (308)
T 1h6u_A           81 LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP-LAGLTNLQY  155 (308)
T ss_dssp             GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCE
T ss_pred             HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc-ccCCCCccE
Confidence            77888888888888888854  468888888888888888884 443 7888888888888888886554 677788888


Q ss_pred             ccccCCccc
Q 040392           86 ESFEGNELL   94 (470)
Q Consensus        86 l~~~~n~~~   94 (470)
                      |++++|.+.
T Consensus       156 L~l~~n~l~  164 (308)
T 1h6u_A          156 LSIGNAQVS  164 (308)
T ss_dssp             EECCSSCCC
T ss_pred             EEccCCcCC
Confidence            888888764

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=98.73  E-value=1.7e-08  Score=104.75  Aligned_cols=84  Identities=35%  Similarity=0.455  Sum_probs=56.1

Q ss_pred             cCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCCcc
Q 040392            6 IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSV   85 (470)
Q Consensus         6 ~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~   85 (470)
                      +.+|++|+.|+|++|.|++.  +.+..+++|+.|+|++|.|++ + +.+..|++|+.|+|++|.|++. +.+..+++|+.
T Consensus        83 l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~  157 (605)
T 1m9s_A           83 LTNLKNLGWLFLDENKIKDL--SSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDT  157 (605)
T ss_dssp             GGGCTTCCEEECCSSCCCCC--TTSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSE
T ss_pred             hccCCCCCEEECcCCCCCCC--hhhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc-hhhcccCCCCE
Confidence            56677777777777777642  256667777777777777773 3 3466677777777777777644 55566677777


Q ss_pred             ccccCCccc
Q 040392           86 ESFEGNELL   94 (470)
Q Consensus        86 l~~~~n~~~   94 (470)
                      |++++|.+.
T Consensus       158 L~Ls~N~l~  166 (605)
T 1m9s_A          158 LSLEDNQIS  166 (605)
T ss_dssp             EECCSSCCC
T ss_pred             EECcCCcCC
Confidence            777777664

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=98.72  E-value=5e-09  Score=100.15  Aligned_cols=84  Identities=20%  Similarity=0.213  Sum_probs=44.9

Q ss_pred             CCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCccccc-CCCCCCceecCCccccccCCCCCCCCCCcccc
Q 040392            9 LKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLE-KLSYLENLNLSFNKLEGEIPRGGPFRNFSVES   87 (470)
Q Consensus         9 l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~-~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~   87 (470)
                      +++|+.|+|++|++++..|..+..+++|+.|+|++|.|++..+..+. .+++|+.|++++|.|++. +....+++|+.|+
T Consensus       119 ~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~l~~L~~L~  197 (317)
T 3o53_A          119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQVVFAKLKTLD  197 (317)
T ss_dssp             CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCCCCTTCCEEE
T ss_pred             cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-ccccccccCCEEE
Confidence            45555555555555544444555555555555555555544444442 455555555555555533 2233355555555


Q ss_pred             ccCCcc
Q 040392           88 FEGNEL   93 (470)
Q Consensus        88 ~~~n~~   93 (470)
                      +++|.+
T Consensus       198 Ls~N~l  203 (317)
T 3o53_A          198 LSSNKL  203 (317)
T ss_dssp             CCSSCC
T ss_pred             CCCCcC
Confidence            555554

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=98.71  E-value=1.7e-08  Score=97.70  Aligned_cols=81  Identities=20%  Similarity=0.092  Sum_probs=72.8

Q ss_pred             cEeeCcCC-cCCCCCCccccCCCCCCEEeccC-CcCCCCCcccccCCCCCCceecCCccccccCCCC-CCCCCCcccccc
Q 040392           13 EYLFLGYN-RLQGPIPDSFGDLISLKFLNLSN-NNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GPFRNFSVESFE   89 (470)
Q Consensus        13 ~~l~l~~n-~l~~~~p~~~~~l~~L~~l~l~~-n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~~~   89 (470)
                      ..++++++ +|+ .+|. +..+++|+.|+|++ |.|++..+..|..|++|+.|+|++|+|++.++.. ..|++|+.|+++
T Consensus        11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~   88 (347)
T 2ifg_A           11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (347)
T ss_dssp             SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence            35799998 999 5788 99999999999996 9999777789999999999999999999988865 789999999999


Q ss_pred             CCcccc
Q 040392           90 GNELLC   95 (470)
Q Consensus        90 ~n~~~~   95 (470)
                      +|.+..
T Consensus        89 ~N~l~~   94 (347)
T 2ifg_A           89 FNALES   94 (347)
T ss_dssp             SSCCSC
T ss_pred             CCccce
Confidence            999853

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=98.70  E-value=1.4e-10  Score=102.94  Aligned_cols=93  Identities=26%  Similarity=0.283  Sum_probs=80.6

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCC--CCCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIP--RGGP   79 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~--~~~~   79 (470)
                      +| .+.++++|+.|+|++|.++ .+|..+..+++|+.|+|++|+|++ +| .+..+++|+.|++++|.|++..+  .+..
T Consensus        63 l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~  138 (198)
T 1ds9_A           63 IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAA  138 (198)
T ss_dssp             CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTT
T ss_pred             cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhc
Confidence            45 7788999999999999999 778888888999999999999995 66 68899999999999999986443  5678


Q ss_pred             CCCCccccccCCccccCCC
Q 040392           80 FRNFSVESFEGNELLCGSP   98 (470)
Q Consensus        80 l~~l~~l~~~~n~~~~~~~   98 (470)
                      +++|+.+++++|++.+..|
T Consensus       139 l~~L~~L~l~~N~l~~~~~  157 (198)
T 1ds9_A          139 LDKLEDLLLAGNPLYNDYK  157 (198)
T ss_dssp             TTTCSEEEECSCHHHHHHH
T ss_pred             CCCCCEEEecCCccccccc
Confidence            9999999999999866433

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=98.58  E-value=1.1e-07  Score=91.85  Aligned_cols=83  Identities=25%  Similarity=0.357  Sum_probs=54.5

Q ss_pred             cCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCCcc
Q 040392            6 IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSV   85 (470)
Q Consensus         6 ~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~   85 (470)
                      +..+++|+.|+|++|++++. |. +..+++|++|+|++|.++ .+| .+..+++|+.|++++|.+++..+ +..+++|+.
T Consensus        62 ~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~-~~~-~~~~l~~L~~L~l~~n~i~~~~~-~~~l~~L~~  136 (347)
T 4fmz_A           62 IEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKIT-DIS-ALQNLTNLRELYLNEDNISDISP-LANLTKMYS  136 (347)
T ss_dssp             GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECTTSCCCCCGG-GTTCTTCCE
T ss_pred             hhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCccc-Cch-HHcCCCcCCEEECcCCcccCchh-hccCCceeE
Confidence            56667777777777777643 33 666777777777777776 343 46677777777777777764443 566667777


Q ss_pred             ccccCCcc
Q 040392           86 ESFEGNEL   93 (470)
Q Consensus        86 l~~~~n~~   93 (470)
                      +++++|..
T Consensus       137 L~l~~n~~  144 (347)
T 4fmz_A          137 LNLGANHN  144 (347)
T ss_dssp             EECTTCTT
T ss_pred             EECCCCCC
Confidence            77776654

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=98.57  E-value=3.8e-08  Score=95.39  Aligned_cols=92  Identities=17%  Similarity=0.170  Sum_probs=76.3

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCc-ccccCCCCCCc-eecCCccccccCCCC-C
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIP-ASLEKLSYLEN-LNLSFNKLEGEIPRG-G   78 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~-~~~~~l~~L~~-l~l~~N~l~~~~~~~-~   78 (470)
                      +|.+|  .++++.|+|++|+|+...+..|.++++|++|+|++|++.+.+| ..|.++++|.. +.+++|+|+..++.. .
T Consensus        24 iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~  101 (350)
T 4ay9_X           24 IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQ  101 (350)
T ss_dssp             CCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBC
T ss_pred             cCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhh
Confidence            67666  3689999999999995555679999999999999999976666 56788998865 677789999877764 7


Q ss_pred             CCCCCccccccCCcccc
Q 040392           79 PFRNFSVESFEGNELLC   95 (470)
Q Consensus        79 ~l~~l~~l~~~~n~~~~   95 (470)
                      .+++|+.+++++|.+..
T Consensus       102 ~l~~L~~L~l~~n~l~~  118 (350)
T 4ay9_X          102 NLPNLQYLLISNTGIKH  118 (350)
T ss_dssp             CCTTCCEEEEEEECCSS
T ss_pred             hcccccccccccccccc
Confidence            79999999999999854

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=98.57  E-value=6.2e-08  Score=97.68  Aligned_cols=84  Identities=29%  Similarity=0.347  Sum_probs=49.1

Q ss_pred             cCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCCcc
Q 040392            6 IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSV   85 (470)
Q Consensus         6 ~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~   85 (470)
                      +..+++|+.|+|++|++++..|  +..+++|+.|+|++|++++..|  +..+++|+.|++++|.+++. +.+..+++|+.
T Consensus       283 ~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~  357 (466)
T 1o6v_A          283 LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV-SSLANLTNINW  357 (466)
T ss_dssp             GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC-GGGTTCTTCCE
T ss_pred             ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc-hhhccCCCCCE
Confidence            5566666666666666664432  5566666666666666664443  55566666666666665543 34455555555


Q ss_pred             ccccCCccc
Q 040392           86 ESFEGNELL   94 (470)
Q Consensus        86 l~~~~n~~~   94 (470)
                      |++++|++.
T Consensus       358 L~l~~n~l~  366 (466)
T 1o6v_A          358 LSAGHNQIS  366 (466)
T ss_dssp             EECCSSCCC
T ss_pred             EeCCCCccC
Confidence            555555553

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=98.57  E-value=1.2e-07  Score=95.31  Aligned_cols=80  Identities=23%  Similarity=0.218  Sum_probs=38.4

Q ss_pred             cCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCCcc
Q 040392            6 IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSV   85 (470)
Q Consensus         6 ~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~   85 (470)
                      |+++++|+.|+|++|++++. |  +..+++|+.|+|++|.|++ +|  +..+++|+.|++++|.|++. + +..+++|+.
T Consensus        60 l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L~~N~l~~l-~-~~~l~~L~~  131 (457)
T 3bz5_A           60 IEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLTKL-D-VSQNPLLTY  131 (457)
T ss_dssp             GGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEECCSSCCSCC-C-CTTCTTCCE
T ss_pred             hcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEECCCCcCCee-c-CCCCCcCCE
Confidence            44445555555555555432 2  4445555555555555553 22  44455555555555555432 2 444455555


Q ss_pred             ccccCCcc
Q 040392           86 ESFEGNEL   93 (470)
Q Consensus        86 l~~~~n~~   93 (470)
                      |++++|.+
T Consensus       132 L~l~~N~l  139 (457)
T 3bz5_A          132 LNCARNTL  139 (457)
T ss_dssp             EECTTSCC
T ss_pred             EECCCCcc
Confidence            55555544

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=98.57  E-value=5.9e-08  Score=97.87  Aligned_cols=85  Identities=21%  Similarity=0.252  Sum_probs=71.5

Q ss_pred             ccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCCc
Q 040392            5 EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFS   84 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~   84 (470)
                      .+..+++|+.|+|++|.+++. |+ +.++++|+.|+|++|.+++.. . +..+++|+.|++++|.+++.++ +..+++|+
T Consensus        63 ~~~~l~~L~~L~Ls~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~-~-~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~  137 (466)
T 1o6v_A           63 GVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIADIT-P-LANLTNLTGLTLFNNQITDIDP-LKNLTNLN  137 (466)
T ss_dssp             TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCG-G-GTTCTTCCEEECCSSCCCCCGG-GTTCTTCS
T ss_pred             chhhhcCCCEEECCCCccCCc-hh-hhccccCCEEECCCCccccCh-h-hcCCCCCCEEECCCCCCCCChH-HcCCCCCC
Confidence            467889999999999999955 44 889999999999999999544 4 8899999999999999986654 77889999


Q ss_pred             cccccCCccc
Q 040392           85 VESFEGNELL   94 (470)
Q Consensus        85 ~l~~~~n~~~   94 (470)
                      .|++++|.+.
T Consensus       138 ~L~l~~n~l~  147 (466)
T 1o6v_A          138 RLELSSNTIS  147 (466)
T ss_dssp             EEEEEEEEEC
T ss_pred             EEECCCCccC
Confidence            9999988864

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.56  E-value=3.3e-07  Score=85.16  Aligned_cols=135  Identities=15%  Similarity=0.062  Sum_probs=98.2

Q ss_pred             CeecccCce-EEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCC-CCcceeEEeeeccCCeeeEEEecCCCCC
Q 040392          179 NLIGRGGFG-SVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIR-HRNLIKVISTCSNEEFKALVLEYMPHGS  255 (470)
Q Consensus       179 ~~ig~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e~~~~g~  255 (470)
                      +.+..|..| .||+.... ++..+++|+-...   ....+..|...++.+. +-.+.++++++.+.+..++|||+++|.+
T Consensus        30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred             EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence            345556655 69998754 4678999986532   3456778999988884 4447788999988889999999999988


Q ss_pred             hHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------------
Q 040392          256 LEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY---------------------------------------------  290 (470)
Q Consensus       256 L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~---------------------------------------------  290 (470)
                      +.+.....     ......+..+++..|..||...                                             
T Consensus       107 ~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          107 AFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             ccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            87665321     1233456667777777777310                                             


Q ss_pred             ----------CCCeeecCCCCCCeeeCCCCCeEEeeecccc
Q 040392          291 ----------SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK  321 (470)
Q Consensus       291 ----------~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~  321 (470)
                                ...++|+|+.+.||+++.++.+-|+||+.+.
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                      1237999999999999988777899999875

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=98.55  E-value=4e-08  Score=101.03  Aligned_cols=76  Identities=29%  Similarity=0.258  Sum_probs=50.5

Q ss_pred             CCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCC----
Q 040392            8 GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNF----   83 (470)
Q Consensus         8 ~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l----   83 (470)
                      .+++|+.|+|++|+|++ +|.   .+++|+.|+|++|+|++ +|. +.  ++|+.|++++|.|+..+. +..  +|    
T Consensus       138 ~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~lp~-~~~--~L~~~~  206 (571)
T 3cvr_A          138 LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLESLPA-VPV--RNHHSE  206 (571)
T ss_dssp             CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCSSCCC-CC---------
T ss_pred             cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCCchhh-HHH--hhhccc
Confidence            46677777777777774 454   46777788888887774 665 54  777777777777774443 322  55    


Q ss_pred             ---ccccccCCccc
Q 040392           84 ---SVESFEGNELL   94 (470)
Q Consensus        84 ---~~l~~~~n~~~   94 (470)
                         +.|++++|.+.
T Consensus       207 ~~L~~L~Ls~N~l~  220 (571)
T 3cvr_A          207 ETEIFFRCRENRIT  220 (571)
T ss_dssp             -CCEEEECCSSCCC
T ss_pred             ccceEEecCCCcce
Confidence               77777777764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.55  E-value=4.1e-07  Score=86.30  Aligned_cols=136  Identities=13%  Similarity=0.122  Sum_probs=95.2

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCC---cceeEEeeec-cCCeeeEEEecCCC
Q 040392          178 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHR---NLIKVISTCS-NEEFKALVLEYMPH  253 (470)
Q Consensus       178 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~~~~~~~-~~~~~~lv~e~~~~  253 (470)
                      .+.++.|....||+.    |..+++|...  .......+..|.++++.+.+.   .+.+++.++. ..+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            456888999999998    5678888853  223456788899999999642   3567777763 45567899999999


Q ss_pred             CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 040392          254 GSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFG--------------------------------------------  289 (470)
Q Consensus       254 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~--------------------------------------------  289 (470)
                      .++.+....   .++......++.++++.|..||..                                            
T Consensus        98 ~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           98 QILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             EECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             eECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            888653211   234445555555555555555521                                            


Q ss_pred             -------------CCCCeeecCCCCCCeeeCC---CCC-eEEeeeccccc
Q 040392          290 -------------YSAPIIHCDLKPSNVLLDD---NMV-AHLSDFSIAKL  322 (470)
Q Consensus       290 -------------~~~~i~H~dlkp~Nill~~---~~~-~kl~Dfg~a~~  322 (470)
                                   ....++|+|+++.||+++.   ++. +.|+||+.+..
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                         1335799999999999987   455 48999998753

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=98.52  E-value=9.8e-08  Score=95.91  Aligned_cols=86  Identities=20%  Similarity=0.171  Sum_probs=76.1

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCC
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRN   82 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~   82 (470)
                      +..++++++|+.|+|++|.+++. | .+..+++|+.|+|++|.|++ +|  +..+++|+.|++++|.|++. + +..+++
T Consensus        35 ~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~-~~~l~~  107 (457)
T 3bz5_A           35 TISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D-VTPLTK  107 (457)
T ss_dssp             EEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C-CTTCTT
T ss_pred             ccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e-cCCCCc
Confidence            34567899999999999999965 5 79999999999999999996 44  89999999999999999975 3 788999


Q ss_pred             CccccccCCcccc
Q 040392           83 FSVESFEGNELLC   95 (470)
Q Consensus        83 l~~l~~~~n~~~~   95 (470)
                      |+.|++++|.+..
T Consensus       108 L~~L~L~~N~l~~  120 (457)
T 3bz5_A          108 LTYLNCDTNKLTK  120 (457)
T ss_dssp             CCEEECCSSCCSC
T ss_pred             CCEEECCCCcCCe
Confidence            9999999998753

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=98.50  E-value=2.1e-07  Score=95.65  Aligned_cols=73  Identities=25%  Similarity=0.285  Sum_probs=34.5

Q ss_pred             CCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCCcccccc
Q 040392           10 KNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSVESFE   89 (470)
Q Consensus        10 ~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~   89 (470)
                      ++|+.|+|++|+|+ .+|   ..+++|+.|+|++|.|++ +|. +..  +|+.|++++|.|++.++   .+++|+.|+++
T Consensus        80 ~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls  148 (571)
T 3cvr_A           80 PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTMLPE---LPALLEYINAD  148 (571)
T ss_dssp             TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSCCCC---CCTTCCEEECC
T ss_pred             CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCCCCC---cCccccEEeCC
Confidence            44555555555555 344   234555555555555553 443 332  45555555555544222   34444444444


Q ss_pred             CCcc
Q 040392           90 GNEL   93 (470)
Q Consensus        90 ~n~~   93 (470)
                      +|.+
T Consensus       149 ~N~l  152 (571)
T 3cvr_A          149 NNQL  152 (571)
T ss_dssp             SSCC
T ss_pred             CCcc
Confidence            4443

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.49  E-value=3.5e-07  Score=88.74  Aligned_cols=80  Identities=8%  Similarity=-0.030  Sum_probs=57.4

Q ss_pred             Cee-cccCceEEEEEEeC-------CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCC-C--CcceeEEeeeccC---
Q 040392          179 NLI-GRGGFGSVYKARLG-------DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIR-H--RNLIKVISTCSNE---  241 (470)
Q Consensus       179 ~~i-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~nIv~~~~~~~~~---  241 (470)
                      +.| +.|....+|+....       ++..+++|......   ......+..|+.+++.+. +  -.+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            567 88989999998754       26789999865432   112356788999998884 3  3577888887655   


Q ss_pred             CeeeEEEecCCCCChHH
Q 040392          242 EFKALVLEYMPHGSLEK  258 (470)
Q Consensus       242 ~~~~lv~e~~~~g~L~~  258 (470)
                      +..++||||++|.++.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            35689999999877653

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.47  E-value=6.1e-08  Score=89.32  Aligned_cols=66  Identities=33%  Similarity=0.352  Sum_probs=35.3

Q ss_pred             CCCCCcEeeCcCCcCCC--CCCccccCCCCCCEEeccCCcCCCCCcccccCCC--CCCceecCCccccccCC
Q 040392            8 GLKNLEYLFLGYNRLQG--PIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLS--YLENLNLSFNKLEGEIP   75 (470)
Q Consensus         8 ~l~~l~~l~l~~n~l~~--~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~--~L~~l~l~~N~l~~~~~   75 (470)
                      ++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..+..++  +|+.|+|++|.+.+.++
T Consensus       168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~  237 (267)
T 3rw6_A          168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR  237 (267)
T ss_dssp             HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred             hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence            35566666666666664  2234444566666666666666632  2233333  56666666666654433

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=98.45  E-value=8.7e-09  Score=101.28  Aligned_cols=88  Identities=18%  Similarity=0.203  Sum_probs=47.8

Q ss_pred             cCCCCCCcEeeCcCCcCC--C---CCCccccCCCCCCEEeccCCcCC----CCCcccccCCCCCCceecCCcccccc---
Q 040392            6 IGGLKNLEYLFLGYNRLQ--G---PIPDSFGDLISLKFLNLSNNNLS----GAIPASLEKLSYLENLNLSFNKLEGE---   73 (470)
Q Consensus         6 ~~~l~~l~~l~l~~n~l~--~---~~p~~~~~l~~L~~l~l~~n~i~----~~~~~~~~~l~~L~~l~l~~N~l~~~---   73 (470)
                      +.++++|+.|+|++|+++  |   ..|..+..+++|+.|+|++|.|+    +.+|..+..+++|+.|+|++|.|++.   
T Consensus       183 l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~  262 (386)
T 2ca6_A          183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA  262 (386)
T ss_dssp             HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHH
T ss_pred             HHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHH
Confidence            445556666666666655  1   22225555666666666666663    34555556666666666666665533   


Q ss_pred             -C-CCC--CCCCCCccccccCCcc
Q 040392           74 -I-PRG--GPFRNFSVESFEGNEL   93 (470)
Q Consensus        74 -~-~~~--~~l~~l~~l~~~~n~~   93 (470)
                       + ..+  ..+++|+.|++++|.+
T Consensus       263 ~l~~~l~~~~~~~L~~L~L~~n~i  286 (386)
T 2ca6_A          263 AVVDAFSKLENIGLQTLRLQYNEI  286 (386)
T ss_dssp             HHHHHHHTCSSCCCCEEECCSSCC
T ss_pred             HHHHHHhhccCCCeEEEECcCCcC
Confidence             1 111  2255566666666655

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=98.40  E-value=2.5e-08  Score=95.86  Aligned_cols=81  Identities=17%  Similarity=0.173  Sum_probs=41.6

Q ss_pred             CCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCC-CcccccCCCCCCceecCCccccccCC-CCCCCCCCcccc
Q 040392           10 KNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGA-IPASLEKLSYLENLNLSFNKLEGEIP-RGGPFRNFSVES   87 (470)
Q Consensus        10 ~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~-~~~~~~~l~~L~~l~l~~N~l~~~~~-~~~~l~~l~~l~   87 (470)
                      ++++.|++++|.+++.++. +..+++|+.|+|++|.+++. +|..+..+++|+.|++++|.+++..+ .+..+++|+.|+
T Consensus        70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~  148 (336)
T 2ast_B           70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN  148 (336)
T ss_dssp             TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred             ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence            4555555555555544333 33455555555555555533 44455555555555555555543222 223455555555


Q ss_pred             ccCC
Q 040392           88 FEGN   91 (470)
Q Consensus        88 ~~~n   91 (470)
                      +++|
T Consensus       149 L~~~  152 (336)
T 2ast_B          149 LSGC  152 (336)
T ss_dssp             CTTC
T ss_pred             CCCC
Confidence            5555

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=98.38  E-value=4.6e-08  Score=95.24  Aligned_cols=92  Identities=23%  Similarity=0.146  Sum_probs=73.8

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCC----ccccCCC-CCCEEeccCCcCCCCCcccccCC-----CCCCceecCCccccc
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIP----DSFGDLI-SLKFLNLSNNNLSGAIPASLEKL-----SYLENLNLSFNKLEG   72 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p----~~~~~l~-~L~~l~l~~n~i~~~~~~~~~~l-----~~L~~l~l~~N~l~~   72 (470)
                      |..+...++|+.|+|++|.+++..+    ..+.+++ +|+.|+|++|.|++..+..+..+     ++|+.|++++|.|++
T Consensus        15 ~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~   94 (362)
T 3goz_A           15 EEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSY   94 (362)
T ss_dssp             HHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGG
T ss_pred             HHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCCh
Confidence            3344556679999999999997666    6788888 89999999999997777777665     899999999999986


Q ss_pred             cCCC-----CCCC-CCCccccccCCccc
Q 040392           73 EIPR-----GGPF-RNFSVESFEGNELL   94 (470)
Q Consensus        73 ~~~~-----~~~l-~~l~~l~~~~n~~~   94 (470)
                      ..+.     +..+ ++|+.|++++|.+.
T Consensus        95 ~~~~~l~~~l~~~~~~L~~L~Ls~N~l~  122 (362)
T 3goz_A           95 KSSDELVKTLAAIPFTITVLDLGWNDFS  122 (362)
T ss_dssp             SCHHHHHHHHHTSCTTCCEEECCSSCGG
T ss_pred             HHHHHHHHHHHhCCCCccEEECcCCcCC
Confidence            6554     2344 78999999999874

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=98.36  E-value=5.3e-07  Score=93.76  Aligned_cols=54  Identities=30%  Similarity=0.174  Sum_probs=32.1

Q ss_pred             CCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCCccccccCCccc
Q 040392           34 ISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSVESFEGNELL   94 (470)
Q Consensus        34 ~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n~~~   94 (470)
                      ++|+.|+|++|.|++ +|   ..+++|+.|++++|.|+..++   .+++|+.|++++|.+.
T Consensus       221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~lp~---~~~~L~~L~Ls~N~L~  274 (622)
T 3g06_A          221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTSLPM---LPSGLLSLSVYRNQLT  274 (622)
T ss_dssp             TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCC
T ss_pred             CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCcCCc---ccccCcEEeCCCCCCC
Confidence            556666666666663 44   344666666666666664333   4556666666666654

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=98.35  E-value=7.1e-07  Score=92.82  Aligned_cols=79  Identities=23%  Similarity=0.240  Sum_probs=52.9

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFR   81 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~   81 (470)
                      +|..+.  ++|+.|+|++|+|+ .+|.   .+++|+.|+|++|+|+ .+|.   .+++|+.|++++|.|++.++   .++
T Consensus        55 lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~l~~---~l~  121 (622)
T 3g06_A           55 LPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTHLPA---LPS  121 (622)
T ss_dssp             CCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCCCCC---CCT
T ss_pred             cChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCCCCC---CCC
Confidence            455554  67788888888877 4554   4677778888888877 4554   56777777777777775444   345


Q ss_pred             CCccccccCCcc
Q 040392           82 NFSVESFEGNEL   93 (470)
Q Consensus        82 ~l~~l~~~~n~~   93 (470)
                      +|+.|++++|.+
T Consensus       122 ~L~~L~L~~N~l  133 (622)
T 3g06_A          122 GLCKLWIFGNQL  133 (622)
T ss_dssp             TCCEEECCSSCC
T ss_pred             CcCEEECCCCCC
Confidence            566666666654

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=98.34  E-value=1.1e-06  Score=88.24  Aligned_cols=77  Identities=27%  Similarity=0.370  Sum_probs=36.3

Q ss_pred             CCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCCcccccc
Q 040392           10 KNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSVESFE   89 (470)
Q Consensus        10 ~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~   89 (470)
                      ++|+.|+|++|++++ +| .+.++++|++|++++|++++ +|..+   ++|+.|++++|.+++ +|.+..+++|+.++++
T Consensus       131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~~~~~l~~L~~L~l~  203 (454)
T 1jl5_A          131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LPELQNLPFLTAIYAD  203 (454)
T ss_dssp             TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CCCCTTCTTCCEEECC
T ss_pred             CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-CccccCCCCCCEEECC
Confidence            355555555555553 34 35555555555555555552 33321   244444555444443 2234444444444444


Q ss_pred             CCcc
Q 040392           90 GNEL   93 (470)
Q Consensus        90 ~n~~   93 (470)
                      +|.+
T Consensus       204 ~N~l  207 (454)
T 1jl5_A          204 NNSL  207 (454)
T ss_dssp             SSCC
T ss_pred             CCcC
Confidence            4443

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=98.31  E-value=1.2e-06  Score=87.80  Aligned_cols=77  Identities=25%  Similarity=0.338  Sum_probs=52.0

Q ss_pred             CCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCCcccccc
Q 040392           10 KNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSVESFE   89 (470)
Q Consensus        10 ~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~   89 (470)
                      ++|+.|++++|++++ +|..   .++|++|+|++|++++ +| .+..+++|+.|++++|.+++.+..   ..+|+.|+++
T Consensus       111 ~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~lp~~---~~~L~~L~L~  181 (454)
T 1jl5_A          111 QSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKKLPDL---PPSLEFIAAG  181 (454)
T ss_dssp             TTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSCCCCC---CTTCCEEECC
T ss_pred             CCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcccCCC---cccccEEECc
Confidence            456666666666653 2221   1578888888888884 66 488888888888888888764332   3578888888


Q ss_pred             CCcccc
Q 040392           90 GNELLC   95 (470)
Q Consensus        90 ~n~~~~   95 (470)
                      +|.+..
T Consensus       182 ~n~l~~  187 (454)
T 1jl5_A          182 NNQLEE  187 (454)
T ss_dssp             SSCCSS
T ss_pred             CCcCCc
Confidence            887643

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=98.29  E-value=3.2e-08  Score=95.14  Aligned_cols=91  Identities=18%  Similarity=0.059  Sum_probs=76.1

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCC-CCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCc-cccc--cCCCCC
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGP-IPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN-KLEG--EIPRGG   78 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~-~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N-~l~~--~~~~~~   78 (470)
                      +..+.++++|+.|+|++|.+++. +|..+..+++|+.|+|++|.+++..+..+..+++|+.|++++| .+++  ....+.
T Consensus        86 ~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~  165 (336)
T 2ast_B           86 LAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLS  165 (336)
T ss_dssp             CCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHH
T ss_pred             chhhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHh
Confidence            34466789999999999998865 7788899999999999999999888888999999999999999 6774  233346


Q ss_pred             CCCCCccccccCC-cc
Q 040392           79 PFRNFSVESFEGN-EL   93 (470)
Q Consensus        79 ~l~~l~~l~~~~n-~~   93 (470)
                      .+++|+.|++++| .+
T Consensus       166 ~~~~L~~L~l~~~~~l  181 (336)
T 2ast_B          166 SCSRLDELNLSWCFDF  181 (336)
T ss_dssp             HCTTCCEEECCCCTTC
T ss_pred             cCCCCCEEcCCCCCCc
Confidence            7889999999998 65

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=98.24  E-value=1.1e-07  Score=93.37  Aligned_cols=92  Identities=16%  Similarity=0.132  Sum_probs=72.6

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCC----ccccCCCCCCEEeccCC---cCCCCCcccc-------cCCCCCCceecCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIP----DSFGDLISLKFLNLSNN---NLSGAIPASL-------EKLSYLENLNLSF   67 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p----~~~~~l~~L~~l~l~~n---~i~~~~~~~~-------~~l~~L~~l~l~~   67 (470)
                      ++..+..+++|+.|+|++|.+++..+    ..+..+++|+.|+|++|   ++++.+|..+       ..+++|+.|+|++
T Consensus        24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~  103 (386)
T 2ca6_A           24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD  103 (386)
T ss_dssp             TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred             HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence            45567788999999999999986533    44778999999999996   4555566555       6899999999999


Q ss_pred             ccccc-----cCCCCCCCCCCccccccCCcc
Q 040392           68 NKLEG-----EIPRGGPFRNFSVESFEGNEL   93 (470)
Q Consensus        68 N~l~~-----~~~~~~~l~~l~~l~~~~n~~   93 (470)
                      |.|++     .+..+..+++|+.|++++|.+
T Consensus       104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l  134 (386)
T 2ca6_A          104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGL  134 (386)
T ss_dssp             CCCCTTTHHHHHHHHHHCTTCCEEECCSSCC
T ss_pred             CcCCHHHHHHHHHHHHhCCCCCEEECcCCCC
Confidence            99986     233346788999999999987

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.23  E-value=6.6e-08  Score=89.08  Aligned_cols=85  Identities=27%  Similarity=0.244  Sum_probs=63.5

Q ss_pred             CCCCCcE--eeCcCCcCCCCCCc----cccCCCCCCEEeccCCcCCC--CCcccccCCCCCCceecCCccccccCCCCCC
Q 040392            8 GLKNLEY--LFLGYNRLQGPIPD----SFGDLISLKFLNLSNNNLSG--AIPASLEKLSYLENLNLSFNKLEGEIPRGGP   79 (470)
Q Consensus         8 ~l~~l~~--l~l~~n~l~~~~p~----~~~~l~~L~~l~l~~n~i~~--~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~   79 (470)
                      ..+.|..  ++++.|... .++.    ...++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++. ..+..
T Consensus       139 ~dp~L~~~~l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~-~~l~~  216 (267)
T 3rw6_A          139 SDPDLVAQNIDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE-RELDK  216 (267)
T ss_dssp             GCHHHHHTTCCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG-GGGGG
T ss_pred             CCcchhhcCccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc-hhhhh
Confidence            3344444  677778543 3332    22568999999999999997  4557778999999999999999964 33444


Q ss_pred             CC--CCccccccCCccc
Q 040392           80 FR--NFSVESFEGNELL   94 (470)
Q Consensus        80 l~--~l~~l~~~~n~~~   94 (470)
                      ++  +|+.|++.+|++.
T Consensus       217 l~~l~L~~L~L~~Npl~  233 (267)
T 3rw6_A          217 IKGLKLEELWLDGNSLC  233 (267)
T ss_dssp             GTTSCCSEEECTTSTTG
T ss_pred             cccCCcceEEccCCcCc
Confidence            44  8999999999974

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=98.23  E-value=1.1e-06  Score=84.96  Aligned_cols=91  Identities=21%  Similarity=0.144  Sum_probs=71.9

Q ss_pred             CC-cccCCCCCCcEeeCcCCcCCCCCC-ccccCCCCCCE-EeccCCcCCCCCcccccCCCCCCceecCCccccccCCCC-
Q 040392            2 IP-TEIGGLKNLEYLFLGYNRLQGPIP-DSFGDLISLKF-LNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-   77 (470)
Q Consensus         2 ~p-~~~~~l~~l~~l~l~~n~l~~~~p-~~~~~l~~L~~-l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-   77 (470)
                      +| +.|.+|++|+.|+|++|++.+.+| ..|.++++|.. +++++|+|++..|+.|..+++|+.|++++|.|+..++.. 
T Consensus        45 i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~  124 (350)
T 4ay9_X           45 IQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHK  124 (350)
T ss_dssp             ECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTT
T ss_pred             cCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhh
Confidence            44 468999999999999999876555 46889998865 667789999777889999999999999999999666543 


Q ss_pred             CCCCCCccccccCCc
Q 040392           78 GPFRNFSVESFEGNE   92 (470)
Q Consensus        78 ~~l~~l~~l~~~~n~   92 (470)
                      ....++..+++.++.
T Consensus       125 ~~~~~l~~l~l~~~~  139 (350)
T 4ay9_X          125 IHSLQKVLLDIQDNI  139 (350)
T ss_dssp             CCBSSCEEEEEESCT
T ss_pred             cccchhhhhhhcccc
Confidence            344556677775543

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.18  E-value=8.2e-06  Score=80.25  Aligned_cols=75  Identities=15%  Similarity=0.124  Sum_probs=49.8

Q ss_pred             CCeecccCceEEEEEEeC-CCcEEEEEEeecccc-------hhhhhHHHHHHHHhcCCC--C-cceeEEeeeccCCeeeE
Q 040392          178 NNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-------RALKGFDVECEMMKSIRH--R-NLIKVISTCSNEEFKAL  246 (470)
Q Consensus       178 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-nIv~~~~~~~~~~~~~l  246 (470)
                      .+.||.|..+.||+++.. +++.++||.......       .....+..|.++++.+..  + .+.+++.+.  .+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence            467999999999999754 468899998653211       123456779999887742  3 344566543  344579


Q ss_pred             EEecCCCC
Q 040392          247 VLEYMPHG  254 (470)
Q Consensus       247 v~e~~~~g  254 (470)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=98.16  E-value=1.7e-07  Score=91.20  Aligned_cols=91  Identities=21%  Similarity=0.204  Sum_probs=73.2

Q ss_pred             cccCCCC-CCcEeeCcCCcCCCCCCccccCC-----CCCCEEeccCCcCCCCCcccc----cCC-CCCCceecCCccccc
Q 040392            4 TEIGGLK-NLEYLFLGYNRLQGPIPDSFGDL-----ISLKFLNLSNNNLSGAIPASL----EKL-SYLENLNLSFNKLEG   72 (470)
Q Consensus         4 ~~~~~l~-~l~~l~l~~n~l~~~~p~~~~~l-----~~L~~l~l~~n~i~~~~~~~~----~~l-~~L~~l~l~~N~l~~   72 (470)
                      ..+.+++ +|+.|+|++|.+++..+..+..+     ++|+.|+|++|.|++..+..+    ..+ ++|+.|++++|.|++
T Consensus        44 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~  123 (362)
T 3goz_A           44 QAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSS  123 (362)
T ss_dssp             HHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGG
T ss_pred             HHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCc
Confidence            3456777 89999999999998777777775     999999999999997766644    444 899999999999986


Q ss_pred             cCCCC-----CC-CCCCccccccCCccc
Q 040392           73 EIPRG-----GP-FRNFSVESFEGNELL   94 (470)
Q Consensus        73 ~~~~~-----~~-l~~l~~l~~~~n~~~   94 (470)
                      .....     .. .++|+.|++++|.+.
T Consensus       124 ~~~~~l~~~l~~~~~~L~~L~Ls~N~l~  151 (362)
T 3goz_A          124 KSSSEFKQAFSNLPASITSLNLRGNDLG  151 (362)
T ss_dssp             SCHHHHHHHHTTSCTTCCEEECTTSCGG
T ss_pred             HHHHHHHHHHHhCCCceeEEEccCCcCC
Confidence            55431     23 368999999999884

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.08  E-value=1.6e-05  Score=76.18  Aligned_cols=138  Identities=16%  Similarity=0.165  Sum_probs=78.7

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCC--CcceeEEee------eccCCeeeEEEec
Q 040392          179 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRH--RNLIKVIST------CSNEEFKALVLEY  250 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~~~~~------~~~~~~~~lv~e~  250 (470)
                      +.|+.|..+.||++...+| .+++|+....    ...+..|..+++.|..  -.+.+++..      ....+..+++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4566678899999987655 5899988642    1233345555555531  123344431      1235667899999


Q ss_pred             CCCCChH-----H---------hhhc--CCC-----------CCCHHHH-------------------------------
Q 040392          251 MPHGSLE-----K---------YMYS--SNY-----------ILDIFQR-------------------------------  272 (470)
Q Consensus       251 ~~~g~L~-----~---------~l~~--~~~-----------~~~~~~~-------------------------------  272 (470)
                      ++|.++.     +         .++.  ...           ...|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542     0         1111  000           0122110                               


Q ss_pred             HHHHHHHHHHHHHHhc----------CCCCCeeecCCCCCCeeeCCCCCeEEeeecccc
Q 040392          273 LNIMIDVASALEYLHF----------GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK  321 (470)
Q Consensus       273 ~~i~~~i~~~L~~LH~----------~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~  321 (470)
                      ..+...+..++.+|+.          .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            0111223345566652          125789999999999999888899999999774

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.03  E-value=3.1e-05  Score=72.44  Aligned_cols=79  Identities=15%  Similarity=0.106  Sum_probs=58.4

Q ss_pred             CCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCC-C--CcceeEEeeeccCCeeeEEEec
Q 040392          174 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIR-H--RNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      ....++.+|.|..+.||+.+..+|+.|++|+...........+..|+..|+.|. .  -.+.+++++.    ..++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence            344467899999999999999999999999876544444456788999998884 2  2355666653    23689999


Q ss_pred             CCCCCh
Q 040392          251 MPHGSL  256 (470)
Q Consensus       251 ~~~g~L  256 (470)
                      ++++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987643

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.86  E-value=0.00013  Score=68.83  Aligned_cols=136  Identities=13%  Similarity=0.090  Sum_probs=91.4

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCC---CCcceeEEeeeccCCeeeEEEecCCCC
Q 040392          178 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIR---HRNLIKVISTCSNEEFKALVLEYMPHG  254 (470)
Q Consensus       178 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~~lv~e~~~~g  254 (470)
                      .+.|+.|....+|+... ++..+++|+....   ....+..|++.|+.|.   ...+.+++.++...+..++||||+++.
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            46789999999999986 5778999987633   3456788999888884   366888998888778899999999987


Q ss_pred             ChHH-----------hhhcCCC---------------------CCCHHHHH---HHH----------------HHHHHH-
Q 040392          255 SLEK-----------YMYSSNY---------------------ILDIFQRL---NIM----------------IDVASA-  282 (470)
Q Consensus       255 ~L~~-----------~l~~~~~---------------------~~~~~~~~---~i~----------------~~i~~~-  282 (470)
                      .+..           .++....                     .-+|....   ++.                ..++.. 
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            6421           1121110                     11343221   111                111111 


Q ss_pred             HHHHh-cCCCCCeeecCCCCCCeeeCCCCCeEEeeec
Q 040392          283 LEYLH-FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFS  318 (470)
Q Consensus       283 L~~LH-~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  318 (470)
                      ...|. ......++|+|+.+.|++++.++ +.|.|+.
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            22342 12246799999999999999887 8899974

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=97.83  E-value=1.1e-06  Score=88.16  Aligned_cols=92  Identities=20%  Similarity=0.131  Sum_probs=60.1

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCccccC-----CCCCCEEeccCCcCCCC----CcccccCCCCCCceecCCcccccc
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPDSFGD-----LISLKFLNLSNNNLSGA----IPASLEKLSYLENLNLSFNKLEGE   73 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~-----l~~L~~l~l~~n~i~~~----~~~~~~~l~~L~~l~l~~N~l~~~   73 (470)
                      +..+.++++|+.|+|++|.+++..+..+..     .++|+.|+|++|.+++.    ++..+..+++|+.|++++|.|++.
T Consensus       277 ~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~  356 (461)
T 1z7x_W          277 CRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA  356 (461)
T ss_dssp             HHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHH
T ss_pred             HHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccc
Confidence            445566788888888888876443333322     25788888888887754    455666778888888888877643


Q ss_pred             CCC-CC-----CCCCCccccccCCccc
Q 040392           74 IPR-GG-----PFRNFSVESFEGNELL   94 (470)
Q Consensus        74 ~~~-~~-----~l~~l~~l~~~~n~~~   94 (470)
                      .+. +.     ..++|+.|++++|.+.
T Consensus       357 ~~~~l~~~l~~~~~~L~~L~L~~n~i~  383 (461)
T 1z7x_W          357 GVRELCQGLGQPGSVLRVLWLADCDVS  383 (461)
T ss_dssp             HHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred             cHHHHHHHHcCCCCceEEEECCCCCCC
Confidence            221 11     2557777777777763

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=97.79  E-value=1.4e-06  Score=87.41  Aligned_cols=87  Identities=20%  Similarity=0.122  Sum_probs=47.0

Q ss_pred             CCCCCCcEeeCcCCcCCC----CCCccccCCCCCCEEeccCCcCCCCCcccc-cCCC----CCCceecCCccccc-----
Q 040392            7 GGLKNLEYLFLGYNRLQG----PIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLS----YLENLNLSFNKLEG-----   72 (470)
Q Consensus         7 ~~l~~l~~l~l~~n~l~~----~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~-~~l~----~L~~l~l~~N~l~~-----   72 (470)
                      ..+++|+.|+|++|.+++    .++..+..+++|+.|+|++|.+++..+..+ ..++    +|+.|++++|.|+.     
T Consensus        25 ~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~  104 (461)
T 1z7x_W           25 PLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGV  104 (461)
T ss_dssp             HHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHH
T ss_pred             hhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHH
Confidence            445666666666666653    234455556666666666666654322222 2233    46666666666652     


Q ss_pred             cCCCCCCCCCCccccccCCcc
Q 040392           73 EIPRGGPFRNFSVESFEGNEL   93 (470)
Q Consensus        73 ~~~~~~~l~~l~~l~~~~n~~   93 (470)
                      .+..+..+++|+.|++++|.+
T Consensus       105 l~~~l~~~~~L~~L~Ls~n~i  125 (461)
T 1z7x_W          105 LSSTLRTLPTLQELHLSDNLL  125 (461)
T ss_dssp             HHHHTTSCTTCCEEECCSSBC
T ss_pred             HHHHHccCCceeEEECCCCcC
Confidence            122334556666666666654

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=97.75  E-value=2.5e-05  Score=74.57  Aligned_cols=85  Identities=15%  Similarity=0.032  Sum_probs=72.1

Q ss_pred             CCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCC-ceecCCccccccCCC-CCCCCCCccc
Q 040392            9 LKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE-NLNLSFNKLEGEIPR-GGPFRNFSVE   86 (470)
Q Consensus         9 l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~-~l~l~~N~l~~~~~~-~~~l~~l~~l   86 (470)
                      +++|+.|+|++|+++.+.+..|.++.+|+.|+|++| ++...+..|..|++|+ .|++++ .++...+. ...+.+|+.+
T Consensus       225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l  302 (329)
T 3sb4_A          225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV  302 (329)
T ss_dssp             CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred             cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence            789999999999999666667999999999999998 8766678899999999 999999 66644443 4678999999


Q ss_pred             cccCCcccc
Q 040392           87 SFEGNELLC   95 (470)
Q Consensus        87 ~~~~n~~~~   95 (470)
                      ++.+|.+..
T Consensus       303 ~l~~n~i~~  311 (329)
T 3sb4_A          303 LATGDKITT  311 (329)
T ss_dssp             EECSSCCCE
T ss_pred             EeCCCccCc
Confidence            998888743

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=97.73  E-value=2.2e-06  Score=83.53  Aligned_cols=62  Identities=23%  Similarity=0.331  Sum_probs=28.0

Q ss_pred             CCCcEeeCcCCcCCC----CCCccccCCCCCCEEeccCCcCCCC----CcccccCCCCCCceecCCcccc
Q 040392           10 KNLEYLFLGYNRLQG----PIPDSFGDLISLKFLNLSNNNLSGA----IPASLEKLSYLENLNLSFNKLE   71 (470)
Q Consensus        10 ~~l~~l~l~~n~l~~----~~p~~~~~l~~L~~l~l~~n~i~~~----~~~~~~~l~~L~~l~l~~N~l~   71 (470)
                      ++|+.|+|++|.|+.    .++..+..+++|++|+|++|.|++.    ++..+..+++|+.|+|++|.|+
T Consensus       155 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~  224 (372)
T 3un9_A          155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG  224 (372)
T ss_dssp             CCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCC
T ss_pred             CccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCC
Confidence            445555555555432    1222334444555555555555421    1233444445555555555554

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.71  E-value=0.00012  Score=72.36  Aligned_cols=78  Identities=13%  Similarity=0.122  Sum_probs=47.9

Q ss_pred             CCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccccccc--cCccccCccccCCC---CCCCccchhhHHHHH
Q 040392          291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTL--ATIGYMAPEYGREG---RVSTNGDVYSFGIML  365 (470)
Q Consensus       291 ~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~--~t~~y~aPE~~~~~---~~~~~~DvwslGv~l  365 (470)
                      ...++|||++|.||+++.++ ++++||+.+..-.+   ...-....  -...|++|+.....   ......++.+....+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p---~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPM---GFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT  306 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECH---HHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCch---HHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence            67899999999999998876 99999998864211   10000111  11345566544311   112234556777788


Q ss_pred             HHHHhCC
Q 040392          366 METFTGK  372 (470)
Q Consensus       366 ~el~tg~  372 (470)
                      |+.+++.
T Consensus       307 ~~~y~~~  313 (420)
T 2pyw_A          307 WNLFNKR  313 (420)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            8777654

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=97.67  E-value=4.1e-05  Score=73.10  Aligned_cols=83  Identities=14%  Similarity=-0.052  Sum_probs=70.4

Q ss_pred             cccCCCCCCcEeeCcCCcCCCCCCccccCCCCCC-EEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCC-CCCC
Q 040392            4 TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLK-FLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GPFR   81 (470)
Q Consensus         4 ~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~-~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~   81 (470)
                      ..|.++++|+.|+|++| ++.+.+.+|.++.+|+ .++|++ .++..-+.+|..|++|+.|++++|.++...+.. ..++
T Consensus       244 ~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~  321 (329)
T 3sb4_A          244 FTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGV  321 (329)
T ss_dssp             TTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTC
T ss_pred             hhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCc
Confidence            35889999999999998 7766677899999999 999999 777566789999999999999999998666644 5678


Q ss_pred             CCccccc
Q 040392           82 NFSVESF   88 (470)
Q Consensus        82 ~l~~l~~   88 (470)
                      +|+.++.
T Consensus       322 ~L~~ly~  328 (329)
T 3sb4_A          322 PSKLIYK  328 (329)
T ss_dssp             CCCEEEC
T ss_pred             chhhhcc
Confidence            8887764

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=97.67  E-value=6.1e-06  Score=71.88  Aligned_cols=88  Identities=14%  Similarity=0.133  Sum_probs=67.1

Q ss_pred             cCCCCCCcEeeCcCC-cCCCC----CCccccCCCCCCEEeccCCcCCCC----CcccccCCCCCCceecCCcccccc---
Q 040392            6 IGGLKNLEYLFLGYN-RLQGP----IPDSFGDLISLKFLNLSNNNLSGA----IPASLEKLSYLENLNLSFNKLEGE---   73 (470)
Q Consensus         6 ~~~l~~l~~l~l~~n-~l~~~----~p~~~~~l~~L~~l~l~~n~i~~~----~~~~~~~l~~L~~l~l~~N~l~~~---   73 (470)
                      +.+.++|+.|+|++| .|...    +...+...++|++|+|++|.|+..    +...+...++|+.|+|++|.|+..   
T Consensus        32 l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~  111 (185)
T 1io0_A           32 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL  111 (185)
T ss_dssp             HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred             HhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHH
Confidence            456789999999999 88732    345566778999999999999742    334566678999999999998742   


Q ss_pred             --CCCCCCCCCCccccc--cCCcc
Q 040392           74 --IPRGGPFRNFSVESF--EGNEL   93 (470)
Q Consensus        74 --~~~~~~l~~l~~l~~--~~n~~   93 (470)
                        ...+...++|+.|++  ++|.+
T Consensus       112 ~l~~~L~~n~~L~~L~L~~~~N~i  135 (185)
T 1io0_A          112 ALVEALQSNTSLIELRIDNQSQPL  135 (185)
T ss_dssp             HHHHGGGGCSSCCEEECCCCSSCC
T ss_pred             HHHHHHHhCCCceEEEecCCCCCC
Confidence              233455678999999  77887

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.66  E-value=0.00014  Score=69.02  Aligned_cols=157  Identities=15%  Similarity=0.154  Sum_probs=87.4

Q ss_pred             ccCHHHHHHhhCCCCCC-----CeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCc--ceeE
Q 040392          162 TFSHLELCRATDGFSEN-----NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRN--LIKV  234 (470)
Q Consensus       162 ~~~~~~~~~~~~~~~~~-----~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~~  234 (470)
                      ..+..++......|...     +.|+.|....+|+....+| .+++|.....  .....+..|..+++.+....  +.++
T Consensus         6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~   82 (322)
T 2ppq_A            6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP   82 (322)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence            34555666656666552     3466788899999987655 6889988642  12334556777777764222  3333


Q ss_pred             Eeee------ccCCeeeEEEecCCCCChHH----h----------hhcC--C--CC----C---CHHHHHH---------
Q 040392          235 ISTC------SNEEFKALVLEYMPHGSLEK----Y----------MYSS--N--YI----L---DIFQRLN---------  274 (470)
Q Consensus       235 ~~~~------~~~~~~~lv~e~~~~g~L~~----~----------l~~~--~--~~----~---~~~~~~~---------  274 (470)
                      +...      ...+..+++++|++|..+..    .          ++..  .  ..    .   .|.....         
T Consensus        83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  162 (322)
T 2ppq_A           83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  162 (322)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence            3221      12355689999999865321    0          1110  0  00    0   1111000         


Q ss_pred             ---HHHHHHHHHHHHhc----CCCCCeeecCCCCCCeeeCCCCCeEEeeecccc
Q 040392          275 ---IMIDVASALEYLHF----GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK  321 (470)
Q Consensus       275 ---i~~~i~~~L~~LH~----~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~  321 (470)
                         +...+.+.+++++.    ....+++|+|+++.||+++++..+.++||+.+.
T Consensus       163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence               00113344445442    123579999999999999987666899998775

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.65  E-value=0.00021  Score=67.18  Aligned_cols=71  Identities=10%  Similarity=0.053  Sum_probs=46.4

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcc-eeEEeeeccCCeeeEEEecC-CCCC
Q 040392          178 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNL-IKVISTCSNEEFKALVLEYM-PHGS  255 (470)
Q Consensus       178 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv~e~~-~~g~  255 (470)
                      .+.|+.|....+|+.     ..+++|+...... .......|+.+++.+...++ .+++++..  +..++++||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCcc
Confidence            678999999999999     5688998764322 22334568888877743222 46666543  3346899999 6654


Q ss_pred             h
Q 040392          256 L  256 (470)
Q Consensus       256 L  256 (470)
                      +
T Consensus        95 l   95 (301)
T 3dxq_A           95 M   95 (301)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=97.62  E-value=3.8e-06  Score=81.80  Aligned_cols=84  Identities=18%  Similarity=0.107  Sum_probs=49.0

Q ss_pred             CCCcEeeCcCCcCCCCCCccc-cCCCCCCEEeccCCcCCCCCcccc-----cCCCCCCceecCCcccccc-----CCCCC
Q 040392           10 KNLEYLFLGYNRLQGPIPDSF-GDLISLKFLNLSNNNLSGAIPASL-----EKLSYLENLNLSFNKLEGE-----IPRGG   78 (470)
Q Consensus        10 ~~l~~l~l~~n~l~~~~p~~~-~~l~~L~~l~l~~n~i~~~~~~~~-----~~l~~L~~l~l~~N~l~~~-----~~~~~   78 (470)
                      ++|+.|+|++|.++......+ ..+++|+.|+|++|.|++.....+     ...++|+.|+|++|.|+..     ...+.
T Consensus       101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~  180 (372)
T 3un9_A          101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA  180 (372)
T ss_dssp             SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred             CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence            577777777777763222222 234567777777777764332322     2456677777777776531     11113


Q ss_pred             CCCCCccccccCCcc
Q 040392           79 PFRNFSVESFEGNEL   93 (470)
Q Consensus        79 ~l~~l~~l~~~~n~~   93 (470)
                      .+++|+.|++++|.+
T Consensus       181 ~~~~L~~L~Ls~N~l  195 (372)
T 3un9_A          181 GNTSVTHLSLLHTGL  195 (372)
T ss_dssp             TCSSCCEEECTTSSC
T ss_pred             cCCCcCEEeCCCCCC
Confidence            456677777777765

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=97.62  E-value=4.6e-06  Score=72.68  Aligned_cols=89  Identities=15%  Similarity=0.127  Sum_probs=68.9

Q ss_pred             ccCCCCCCcEeeCcCCcCCCC----CCccccCCCCCCEEeccCCcCCCC----CcccccCCCCCCceec--CCccccccC
Q 040392            5 EIGGLKNLEYLFLGYNRLQGP----IPDSFGDLISLKFLNLSNNNLSGA----IPASLEKLSYLENLNL--SFNKLEGEI   74 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~l~~~----~p~~~~~l~~L~~l~l~~n~i~~~----~~~~~~~l~~L~~l~l--~~N~l~~~~   74 (470)
                      .+...++|+.|+|++|.|...    +...+...++|++|+|++|.|++.    +...+...++|+.|+|  ++|.|+..-
T Consensus        60 ~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g  139 (185)
T 1io0_A           60 ALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNV  139 (185)
T ss_dssp             HHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHH
T ss_pred             HHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHH
Confidence            345678999999999999742    334555668999999999999853    4567788899999999  889997421


Q ss_pred             -----CCCCCCCCCccccccCCcc
Q 040392           75 -----PRGGPFRNFSVESFEGNEL   93 (470)
Q Consensus        75 -----~~~~~l~~l~~l~~~~n~~   93 (470)
                           ..+...++|+.|++++|.+
T Consensus       140 ~~~l~~~L~~n~~L~~L~L~~n~i  163 (185)
T 1io0_A          140 EMEIANMLEKNTTLLKFGYHFTQQ  163 (185)
T ss_dssp             HHHHHHHHHHCSSCCEEECCCSSH
T ss_pred             HHHHHHHHHhCCCcCEEeccCCCC
Confidence                 1224457899999999887

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.52  E-value=0.00067  Score=64.68  Aligned_cols=139  Identities=12%  Similarity=0.078  Sum_probs=74.7

Q ss_pred             CeecccCceE-EEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCC--CcceeEEeeeccCCeeeEEEecCCCCC
Q 040392          179 NLIGRGGFGS-VYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRH--RNLIKVISTCSNEEFKALVLEYMPHGS  255 (470)
Q Consensus       179 ~~ig~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~~~~~lv~e~~~~g~  255 (470)
                      +.|+.|.... +|+....+|..+++|......   ...+..|+.+++.+..  -.+.+++.+....+  +++||++.+.+
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            4565555544 677766447788888654321   1344567777776642  23566776644433  68999997766


Q ss_pred             hHHhhhcCC-------------------------CCCCHHHHH-------H-H------------HHHHHHHHHHHh---
Q 040392          256 LEKYMYSSN-------------------------YILDIFQRL-------N-I------------MIDVASALEYLH---  287 (470)
Q Consensus       256 L~~~l~~~~-------------------------~~~~~~~~~-------~-i------------~~~i~~~L~~LH---  287 (470)
                      +.+++....                         ...+.....       . +            ...+...+..+.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            654432110                         011111100       0 0            001111222221   


Q ss_pred             cCCCCCeeecCCCCCCeeeCCC----CCeEEeeeccccc
Q 040392          288 FGYSAPIIHCDLKPSNVLLDDN----MVAHLSDFSIAKL  322 (470)
Q Consensus       288 ~~~~~~i~H~dlkp~Nill~~~----~~~kl~Dfg~a~~  322 (470)
                      ......++|||+.+.||+++.+    +.+.++||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            1124679999999999999875    6899999998764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.50  E-value=0.00045  Score=68.85  Aligned_cols=74  Identities=14%  Similarity=0.162  Sum_probs=49.5

Q ss_pred             CCeecccCceEEEEEEeCC-CcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcc-eeEEeeeccCCeeeEEEecCCCCC
Q 040392          178 NNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNL-IKVISTCSNEEFKALVLEYMPHGS  255 (470)
Q Consensus       178 ~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv~e~~~~g~  255 (470)
                      .+.|+.|-...+|++...+ +..+++|+...... ..-....|..+++.|...++ .++++.+..    .+||||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence            3578889999999998765 57899998754322 22223579999998864444 567777642    35999998754


Q ss_pred             h
Q 040392          256 L  256 (470)
Q Consensus       256 L  256 (470)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.49  E-value=0.00072  Score=59.22  Aligned_cols=102  Identities=13%  Similarity=0.058  Sum_probs=69.3

Q ss_pred             ChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccccc
Q 040392          255 SLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQ  334 (470)
Q Consensus       255 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  334 (470)
                      +|.+.+...+.++++.+++.++.|.+.+|.-+-.  .+.-..+=+.|..|++..+|.|.+.+ +.+.             
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------   97 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------   97 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc-------------
Confidence            7999999999999999999999999999887721  11111223457889999999988764 1110             


Q ss_pred             cccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q 040392          335 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP  374 (470)
Q Consensus       335 ~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p  374 (470)
                       .....+.|||... ...+.+.-|||+|+++|..+--..|
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence             1122466888763 3456788999999999999985554

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.48  E-value=0.00028  Score=69.86  Aligned_cols=73  Identities=21%  Similarity=0.254  Sum_probs=50.2

Q ss_pred             CCeecccCceEEEEEEeCC--------CcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcc-eeEEeeeccCCeeeEEE
Q 040392          178 NNLIGRGGFGSVYKARLGD--------GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNL-IKVISTCSNEEFKALVL  248 (470)
Q Consensus       178 ~~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv~  248 (470)
                      .+.|+.|....+|++...+        +..+++|+.....  ....+..|..+++.+...++ .++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            3568889999999998753        5789999884321  11345578888888853333 567776653    3899


Q ss_pred             ecCCCCCh
Q 040392          249 EYMPHGSL  256 (470)
Q Consensus       249 e~~~~g~L  256 (470)
                      ||++|.++
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986444

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.47  E-value=0.00029  Score=68.33  Aligned_cols=139  Identities=13%  Similarity=0.153  Sum_probs=82.4

Q ss_pred             CCeecccCceEEEEEEeC--------CCcEEEEEEeecccchhhhhHHHHHHHHhcCC-CCcceeEEeeeccCCeeeEEE
Q 040392          178 NNLIGRGGFGSVYKARLG--------DGMEVAVKVFNLQCGRALKGFDVECEMMKSIR-HRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       178 ~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      .+.|..|-...+|++...        ++..+++|+.... ........+|.++++.+. +.-..++++++.+    .+||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            356777888999999875        2578999986432 223445668999988874 2223667777654    2899


Q ss_pred             ecCCCCChHHh-----------------hhcCC----CCCC--HHHHHHHHHHHHH-------------------HHHH-
Q 040392          249 EYMPHGSLEKY-----------------MYSSN----YILD--IFQRLNIMIDVAS-------------------ALEY-  285 (470)
Q Consensus       249 e~~~~g~L~~~-----------------l~~~~----~~~~--~~~~~~i~~~i~~-------------------~L~~-  285 (470)
                      ||++|.+|..-                 ++...    ....  +.+..++..++..                   .+.+ 
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99998655311                 01111    1112  2344444433321                   1222 


Q ss_pred             ---Hhc-CCCCCeeecCCCCCCeeeCCC----CCeEEeeecccc
Q 040392          286 ---LHF-GYSAPIIHCDLKPSNVLLDDN----MVAHLSDFSIAK  321 (470)
Q Consensus       286 ---LH~-~~~~~i~H~dlkp~Nill~~~----~~~kl~Dfg~a~  321 (470)
                         |.. .....++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence               221 123469999999999999876    789999998875

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.37  E-value=0.0011  Score=62.91  Aligned_cols=156  Identities=13%  Similarity=0.097  Sum_probs=87.0

Q ss_pred             ccCHHHHHHhhCCCCC-----CCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCC--cceeE
Q 040392          162 TFSHLELCRATDGFSE-----NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHR--NLIKV  234 (470)
Q Consensus       162 ~~~~~~~~~~~~~~~~-----~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~~  234 (470)
                      ..+...+......|..     ...++ |....||++...+|+.+++|...... .....+..|..+++.+...  .++++
T Consensus        10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~   87 (328)
T 1zyl_A           10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAP   87 (328)
T ss_dssp             CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred             CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecce
Confidence            3444444444443432     34566 88889999987778889999986331 1234566688887777422  23444


Q ss_pred             Eee-----eccCCeeeEEEecCCCCChH-----Hh---------hhc----C----CCCCCHHHH---------------
Q 040392          235 IST-----CSNEEFKALVLEYMPHGSLE-----KY---------MYS----S----NYILDIFQR---------------  272 (470)
Q Consensus       235 ~~~-----~~~~~~~~lv~e~~~~g~L~-----~~---------l~~----~----~~~~~~~~~---------------  272 (470)
                      +..     ....+..+++|||++|.++.     .+         ++.    .    ....++...               
T Consensus        88 ~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  167 (328)
T 1zyl_A           88 VAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP  167 (328)
T ss_dssp             CCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred             eecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCC
Confidence            443     11234567899999875432     11         110    0    011121110               


Q ss_pred             -------HHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeeCCCCCeEEeeecccc
Q 040392          273 -------LNIMIDVASALEYLHF-GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK  321 (470)
Q Consensus       273 -------~~i~~~i~~~L~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~  321 (470)
                             ...+..++..+.-+-. .....++|||+++.||+++ + .+.++||+.+.
T Consensus       168 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          168 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence                   0111122222222211 1245689999999999999 4 89999998775

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.37  E-value=2.5e-05  Score=66.74  Aligned_cols=92  Identities=12%  Similarity=0.031  Sum_probs=67.0

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCc-CCCCCcccccCC----CCCCceecCCcc-ccc-cC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNN-LSGAIPASLEKL----SYLENLNLSFNK-LEG-EI   74 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~-i~~~~~~~~~~l----~~L~~l~l~~N~-l~~-~~   74 (470)
                      +|.....-.+|+.|||+++.++..--..+.++++|+.|+|++|. |++.-=..+..+    ++|+.|+|+++. |+. -+
T Consensus        53 LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl  132 (176)
T 3e4g_A           53 LPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGI  132 (176)
T ss_dssp             SCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHH
T ss_pred             CCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHH
Confidence            45443333479999999999886544667899999999999996 774333445554    479999999975 763 22


Q ss_pred             CCCCCCCCCccccccCCcc
Q 040392           75 PRGGPFRNFSVESFEGNEL   93 (470)
Q Consensus        75 ~~~~~l~~l~~l~~~~n~~   93 (470)
                      ..+..+++|+.|++++.+-
T Consensus       133 ~~L~~~~~L~~L~L~~c~~  151 (176)
T 3e4g_A          133 IALHHFRNLKYLFLSDLPG  151 (176)
T ss_dssp             HHGGGCTTCCEEEEESCTT
T ss_pred             HHHhcCCCCCEEECCCCCC
Confidence            3345689999999987653

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.26  E-value=0.00059  Score=66.14  Aligned_cols=73  Identities=15%  Similarity=0.217  Sum_probs=45.6

Q ss_pred             CeecccCceEEEEEEeCC---------CcEEEEEEeecccchhhhhHHHHHHHHhcCCCCc-ceeEEeeeccCCeeeEEE
Q 040392          179 NLIGRGGFGSVYKARLGD---------GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRN-LIKVISTCSNEEFKALVL  248 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~~lv~  248 (470)
                      +.|+.|....+|+....+         +..+++|+...... .......|.++++.+...+ +.++++...    .++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence            567888889999998754         26899998754322 2223467888888875333 446665542    26899


Q ss_pred             ecCCCCCh
Q 040392          249 EYMPHGSL  256 (470)
Q Consensus       249 e~~~~g~L  256 (470)
                      ||++|.++
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99987543

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.25  E-value=0.00051  Score=55.74  Aligned_cols=57  Identities=26%  Similarity=0.360  Sum_probs=41.6

Q ss_pred             cEeeCcCCcCC-CCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCcccc
Q 040392           13 EYLFLGYNRLQ-GPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLE   71 (470)
Q Consensus        13 ~~l~l~~n~l~-~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~   71 (470)
                      ..++.+++.|+ ..+|..+  ..+|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus        11 ~~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CEEEeCCCCCccccCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            46788888886 3445443  246888899999988555566778888888888888764

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=97.21  E-value=2.3e-05  Score=81.11  Aligned_cols=83  Identities=8%  Similarity=0.006  Sum_probs=60.0

Q ss_pred             CCCCCcEeeCcCCcCCCC----CCccccCCCCCCEEeccCCcCC----CCCcccccCCCCCCceecCCccccccCCCCCC
Q 040392            8 GLKNLEYLFLGYNRLQGP----IPDSFGDLISLKFLNLSNNNLS----GAIPASLEKLSYLENLNLSFNKLEGEIPRGGP   79 (470)
Q Consensus         8 ~l~~l~~l~l~~n~l~~~----~p~~~~~l~~L~~l~l~~n~i~----~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~   79 (470)
                      ++++|+.|+|++|.+++.    ++..+.++++|+.|+|++|.++    +.++..+..+++|+.|++++|.+.+.+..+..
T Consensus       162 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~~~~~~  241 (592)
T 3ogk_B          162 HCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKA  241 (592)
T ss_dssp             HCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGHHHHHH
T ss_pred             hCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHHHHHhh
Confidence            678888888888887755    3344566788888888888887    23445566788888888888888765544456


Q ss_pred             CCCCccccccC
Q 040392           80 FRNFSVESFEG   90 (470)
Q Consensus        80 l~~l~~l~~~~   90 (470)
                      +++|+.+++.+
T Consensus       242 ~~~L~~L~l~~  252 (592)
T 3ogk_B          242 AANLEEFCGGS  252 (592)
T ss_dssp             CTTCCEEEECB
T ss_pred             hhHHHhhcccc
Confidence            67777777654

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=97.11  E-value=2.7e-05  Score=80.67  Aligned_cols=60  Identities=7%  Similarity=-0.009  Sum_probs=25.4

Q ss_pred             CCCCCEEeccCCcCCCCCcccc-cCCCCCCceecCCccccccCC--CCCCCCCCccccccCCc
Q 040392           33 LISLKFLNLSNNNLSGAIPASL-EKLSYLENLNLSFNKLEGEIP--RGGPFRNFSVESFEGNE   92 (470)
Q Consensus        33 l~~L~~l~l~~n~i~~~~~~~~-~~l~~L~~l~l~~N~l~~~~~--~~~~l~~l~~l~~~~n~   92 (470)
                      +++|+.|+|++|.+++.....+ ..+++|+.|++++|.+++...  ....+++|+.|++++|+
T Consensus       455 ~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~  517 (594)
T 2p1m_B          455 AKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCS  517 (594)
T ss_dssp             CTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSC
T ss_pred             chhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCC
Confidence            4445555555554443222222 334555555555555432111  11234445555554444

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.04  E-value=0.0026  Score=60.79  Aligned_cols=67  Identities=12%  Similarity=0.134  Sum_probs=43.4

Q ss_pred             ccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCC---CCcceeEEee------eccCCeeeEEEecCCC
Q 040392          183 RGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIR---HRNLIKVIST------CSNEEFKALVLEYMPH  253 (470)
Q Consensus       183 ~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~------~~~~~~~~lv~e~~~~  253 (470)
                      .|....||+....+| .+++|+......      ..|..+++.|.   -|.+++++..      ....+..+++|+|++|
T Consensus        33 ~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G  105 (339)
T 3i1a_A           33 ADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA  105 (339)
T ss_dssp             SCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred             CccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence            334689999987777 999998764321      34666666553   2224555433      2234677899999998


Q ss_pred             CCh
Q 040392          254 GSL  256 (470)
Q Consensus       254 g~L  256 (470)
                      ..+
T Consensus       106 ~~~  108 (339)
T 3i1a_A          106 PNG  108 (339)
T ss_dssp             CBT
T ss_pred             CcC
Confidence            755

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.94  E-value=0.001  Score=53.90  Aligned_cols=57  Identities=16%  Similarity=0.275  Sum_probs=46.4

Q ss_pred             CEEeccCCcCC-CCCcccccCCCCCCceecCCccccccCCCC-CCCCCCccccccCCcccc
Q 040392           37 KFLNLSNNNLS-GAIPASLEKLSYLENLNLSFNKLEGEIPRG-GPFRNFSVESFEGNELLC   95 (470)
Q Consensus        37 ~~l~l~~n~i~-~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~~~~n~~~~   95 (470)
                      ..++-+++.++ ..+|..+.  .+|+.|+|++|+|+..++.. ..+++|+.|++.+|++.|
T Consensus        11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~C   69 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRC   69 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred             CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeec
Confidence            47899999997 35664332  47999999999999777765 568899999999999988

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=96.80  E-value=0.00019  Score=74.27  Aligned_cols=85  Identities=14%  Similarity=0.107  Sum_probs=56.9

Q ss_pred             CCCCCcEeeCcCCcCCCCCCcccc-CCCCCCEEeccCC-cCCCC-CcccccCCCCCCceecCCccccccCC----C-CCC
Q 040392            8 GLKNLEYLFLGYNRLQGPIPDSFG-DLISLKFLNLSNN-NLSGA-IPASLEKLSYLENLNLSFNKLEGEIP----R-GGP   79 (470)
Q Consensus         8 ~l~~l~~l~l~~n~l~~~~p~~~~-~l~~L~~l~l~~n-~i~~~-~~~~~~~l~~L~~l~l~~N~l~~~~~----~-~~~   79 (470)
                      .+++|+.|+|++|.+++..+..+. .+++|+.|+|++| .+++. ++..+..+++|+.|++++|.+++..+    . ...
T Consensus       103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~  182 (594)
T 2p1m_B          103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDT  182 (594)
T ss_dssp             HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTT
T ss_pred             hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhc
Confidence            467788888888887765555554 5778888888887 45532 44444578888888888887664322    1 135


Q ss_pred             CCCCccccccCCc
Q 040392           80 FRNFSVESFEGNE   92 (470)
Q Consensus        80 l~~l~~l~~~~n~   92 (470)
                      +++|+.|++++|.
T Consensus       183 ~~~L~~L~l~~~~  195 (594)
T 2p1m_B          183 YTSLVSLNISCLA  195 (594)
T ss_dssp             CCCCCEEECTTCC
T ss_pred             CCcCcEEEecccC
Confidence            6677777777764

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=96.79  E-value=0.0002  Score=69.18  Aligned_cols=15  Identities=27%  Similarity=0.091  Sum_probs=7.5

Q ss_pred             CCCCcEeeCcCCcCC
Q 040392            9 LKNLEYLFLGYNRLQ   23 (470)
Q Consensus         9 l~~l~~l~l~~n~l~   23 (470)
                      +++|+.|+|..|.++
T Consensus       192 ~~~L~~L~L~~~~l~  206 (362)
T 2ra8_A          192 RPNLKSLEIISGGLP  206 (362)
T ss_dssp             CTTCSEEEEECSBCC
T ss_pred             CCCCcEEEEecCCCC
Confidence            345555555555443

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=96.70  E-value=0.002  Score=63.08  Aligned_cols=87  Identities=9%  Similarity=-0.084  Sum_probs=61.2

Q ss_pred             cccCCCCCCcEeeCcCCcCC-----CCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-C
Q 040392            4 TEIGGLKNLEYLFLGYNRLQ-----GPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-G   77 (470)
Q Consensus         4 ~~~~~l~~l~~l~l~~n~l~-----~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~   77 (470)
                      ..|.++++|+.+++.+|.+.     ...+..|.++++|+.++|.+ .++..-...|..|++|+.|++..| ++..... .
T Consensus       265 ~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF  342 (401)
T 4fdw_A          265 RAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAF  342 (401)
T ss_dssp             TTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT-CCEECTTSS
T ss_pred             hHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhC
Confidence            45677888888888887764     24456678888888888884 466455677888888888888665 5433333 2


Q ss_pred             CCCCCCccccccCCcc
Q 040392           78 GPFRNFSVESFEGNEL   93 (470)
Q Consensus        78 ~~l~~l~~l~~~~n~~   93 (470)
                      ..+ +|+.+++.+|..
T Consensus       343 ~~~-~L~~l~l~~n~~  357 (401)
T 4fdw_A          343 NNT-GIKEVKVEGTTP  357 (401)
T ss_dssp             SSS-CCCEEEECCSSC
T ss_pred             CCC-CCCEEEEcCCCC
Confidence            455 888888888765

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=96.55  E-value=0.00052  Score=70.85  Aligned_cols=61  Identities=11%  Similarity=0.018  Sum_probs=47.3

Q ss_pred             cCCCCCCcEeeCcCCcCCCC----CCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCC
Q 040392            6 IGGLKNLEYLFLGYNRLQGP----IPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF   67 (470)
Q Consensus         6 ~~~l~~l~~l~l~~n~l~~~----~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~   67 (470)
                      +.++++|+.|+|++|.+++.    ++..+.++++|+.|+|++|.+.+ +|..+..+++|+.|++++
T Consensus       188 ~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~  252 (592)
T 3ogk_B          188 AQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGS  252 (592)
T ss_dssp             HHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECB
T ss_pred             HhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccc
Confidence            34678999999999998733    33445678999999999998884 667777788888888874

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.49  E-value=0.007  Score=59.50  Aligned_cols=74  Identities=11%  Similarity=0.196  Sum_probs=50.0

Q ss_pred             CCeecccCceEEEEEEeCC--------CcEEEEEEeecccchhhhhHHHHHHHHhcCCCCc-ceeEEeeeccCCeeeEEE
Q 040392          178 NNLIGRGGFGSVYKARLGD--------GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRN-LIKVISTCSNEEFKALVL  248 (470)
Q Consensus       178 ~~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~~lv~  248 (470)
                      .+.+..|-...+|+....+        +..+++|+..... ...-...+|.++++.+.-.+ ..++++.+.    .++||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            3567788889999998753        5789999875432 22334567888888875222 355665443    26899


Q ss_pred             ecCCCCCh
Q 040392          249 EYMPHGSL  256 (470)
Q Consensus       249 e~~~~g~L  256 (470)
                      ||++|.+|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998654

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=96.44  E-value=0.00026  Score=68.34  Aligned_cols=86  Identities=21%  Similarity=0.240  Sum_probs=61.4

Q ss_pred             CCCCCcEeeCcC--CcCCCC-----CCccc--cCCCCCCEEeccCCcCCCCCccccc---CCCCCCceecCCcccccc--
Q 040392            8 GLKNLEYLFLGY--NRLQGP-----IPDSF--GDLISLKFLNLSNNNLSGAIPASLE---KLSYLENLNLSFNKLEGE--   73 (470)
Q Consensus         8 ~l~~l~~l~l~~--n~l~~~-----~p~~~--~~l~~L~~l~l~~n~i~~~~~~~~~---~l~~L~~l~l~~N~l~~~--   73 (470)
                      .+++|+.|+|+.  |...+-     +...+  ..+++|+.|+|.+|.+++..+..+.   .+++|+.|+|+.|.|++.  
T Consensus       217 ~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~  296 (362)
T 2ra8_A          217 DLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGA  296 (362)
T ss_dssp             BCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHH
T ss_pred             cCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHH
Confidence            689999999853  322211     11122  2478999999999999854443333   588999999999999852  


Q ss_pred             ---CCCCCCCCCCccccccCCcc
Q 040392           74 ---IPRGGPFRNFSVESFEGNEL   93 (470)
Q Consensus        74 ---~~~~~~l~~l~~l~~~~n~~   93 (470)
                         ...+..+++|+.|++++|.+
T Consensus       297 ~~L~~~L~~l~~L~~L~L~~n~i  319 (362)
T 2ra8_A          297 RLLLDHVDKIKHLKFINMKYNYL  319 (362)
T ss_dssp             HHHHTTHHHHTTCSEEECCSBBC
T ss_pred             HHHHhhcccCCcceEEECCCCcC
Confidence               22335678999999999986

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=96.36  E-value=0.0053  Score=60.09  Aligned_cols=78  Identities=14%  Similarity=0.104  Sum_probs=40.3

Q ss_pred             CCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCC-CCCCCCcccccc
Q 040392           11 NLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GPFRNFSVESFE   89 (470)
Q Consensus        11 ~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~~~   89 (470)
                      +|+.+.|.+ .++.+-+..|.++.+|+.++|++|+++......|. +.+|+.+.+..| ++...... ..+.+|+.+.+.
T Consensus       158 ~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~  234 (401)
T 4fdw_A          158 TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIP  234 (401)
T ss_dssp             CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECC
T ss_pred             CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecC
Confidence            466666664 44434445566666666666666666622223333 456666666543 43222222 345555555554


Q ss_pred             CC
Q 040392           90 GN   91 (470)
Q Consensus        90 ~n   91 (470)
                      .|
T Consensus       235 ~~  236 (401)
T 4fdw_A          235 EN  236 (401)
T ss_dssp             TT
T ss_pred             CC
Confidence            43

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=95.54  E-value=0.013  Score=57.11  Aligned_cols=86  Identities=12%  Similarity=0.155  Sum_probs=62.5

Q ss_pred             ccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCCCCC
Q 040392            5 EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPFRNF   83 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l   83 (470)
                      .|.++++|+.+.+. +.++.+....|.++.+|+.++|..| ++..-..+|..|.+|+.+.+..+ ++..-.. ...+.+|
T Consensus       283 aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L  359 (394)
T 4gt6_A          283 AFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTAL  359 (394)
T ss_dssp             TTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTC
T ss_pred             ccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCC
Confidence            46678889999986 4455354567888999999999765 55455678889999999998765 5522222 3567888


Q ss_pred             ccccccCCcc
Q 040392           84 SVESFEGNEL   93 (470)
Q Consensus        84 ~~l~~~~n~~   93 (470)
                      +.+++.+|..
T Consensus       360 ~~i~~~~~~~  369 (394)
T 4gt6_A          360 NNIEYSGSRS  369 (394)
T ss_dssp             CEEEESSCHH
T ss_pred             CEEEECCcee
Confidence            8888888764

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.38  E-value=0.018  Score=56.25  Aligned_cols=29  Identities=28%  Similarity=0.406  Sum_probs=24.9

Q ss_pred             CeeecCCCCCCeee------CCCCCeEEeeecccc
Q 040392          293 PIIHCDLKPSNVLL------DDNMVAHLSDFSIAK  321 (470)
Q Consensus       293 ~i~H~dlkp~Nill------~~~~~~kl~Dfg~a~  321 (470)
                      .++|+|+.+.||++      +++..+.++||.+|.
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            36799999999999      456789999998875

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=95.35  E-value=0.002  Score=54.92  Aligned_cols=67  Identities=16%  Similarity=0.163  Sum_probs=51.0

Q ss_pred             ccCCCCCCcEeeCcCCc-CCCCCCccccCC----CCCCEEeccCCc-CCCCCcccccCCCCCCceecCCcc-cc
Q 040392            5 EIGGLKNLEYLFLGYNR-LQGPIPDSFGDL----ISLKFLNLSNNN-LSGAIPASLEKLSYLENLNLSFNK-LE   71 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~-l~~~~p~~~~~l----~~L~~l~l~~n~-i~~~~~~~~~~l~~L~~l~l~~N~-l~   71 (470)
                      .+.++++|+.|+|+++. |++.--..+..+    ++|+.|+|++|. ||+.-=..+..+++|+.|+++++. ++
T Consensus        80 ~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c~~It  153 (176)
T 3e4g_A           80 HMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNLKYLFLSDLPGVK  153 (176)
T ss_dssp             GGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTCCEEEEESCTTCC
T ss_pred             HhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCCCEEECCCCCCCC
Confidence            35789999999999995 764322345554    379999999985 885444567889999999999875 44

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=95.19  E-value=0.0041  Score=53.98  Aligned_cols=84  Identities=14%  Similarity=0.112  Sum_probs=60.9

Q ss_pred             CCCCCcEeeCcCC-cCCCC----CCccccCCCCCCEEeccCCcCCCC----CcccccCCCCCCceecCCccccccC----
Q 040392            8 GLKNLEYLFLGYN-RLQGP----IPDSFGDLISLKFLNLSNNNLSGA----IPASLEKLSYLENLNLSFNKLEGEI----   74 (470)
Q Consensus         8 ~l~~l~~l~l~~n-~l~~~----~p~~~~~l~~L~~l~l~~n~i~~~----~~~~~~~l~~L~~l~l~~N~l~~~~----   74 (470)
                      +-++|+.|+|++| +|...    +-..+..-+.|+.|+|++|.|.+.    +-+.+..-+.|+.|+|+.|.|+..-    
T Consensus        39 ~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~al  118 (197)
T 1pgv_A           39 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL  118 (197)
T ss_dssp             TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred             cCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHH
Confidence            4578999999986 77631    334566678899999999999743    3345567789999999999997321    


Q ss_pred             -CCCCCCCCCccccccCC
Q 040392           75 -PRGGPFRNFSVESFEGN   91 (470)
Q Consensus        75 -~~~~~l~~l~~l~~~~n   91 (470)
                       ..+..-+.|+.|++++|
T Consensus       119 a~aL~~N~tL~~L~L~n~  136 (197)
T 1pgv_A          119 LRSTLVTQSIVEFKADNQ  136 (197)
T ss_dssp             HHHTTTTCCCSEEECCCC
T ss_pred             HHHHhhCCceeEEECCCC
Confidence             12334456889998764

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=95.06  E-value=0.023  Score=55.31  Aligned_cols=83  Identities=16%  Similarity=0.046  Sum_probs=50.9

Q ss_pred             ccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCCCCC
Q 040392            5 EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPFRNF   83 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l   83 (470)
                      .|..+.+|+.+.+.++ ++.+-..+|.++.+|+.++|.++ ++..-..+|.+|.+|+.+++..| ++..... ...+.+|
T Consensus       292 ~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L  368 (394)
T 4fs7_A          292 TFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINL  368 (394)
T ss_dssp             TTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTC
T ss_pred             cccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCC
Confidence            3456677777777654 44344456777777777777644 55344566777777777777766 4422222 2456677


Q ss_pred             ccccccC
Q 040392           84 SVESFEG   90 (470)
Q Consensus        84 ~~l~~~~   90 (470)
                      +.+++..
T Consensus       369 ~~i~lp~  375 (394)
T 4fs7_A          369 KKVELPK  375 (394)
T ss_dssp             CEEEEEG
T ss_pred             CEEEECC
Confidence            7776644

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=94.82  E-value=0.038  Score=53.72  Aligned_cols=84  Identities=6%  Similarity=0.027  Sum_probs=60.2

Q ss_pred             ccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCCCCC
Q 040392            5 EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPFRNF   83 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l   83 (470)
                      .|.++..|+.+.+.++..+ .-...|.++.+|+.+.+. +.++..-...|..|.+|+.+++..| ++..-.. ...+.+|
T Consensus       260 aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L  336 (394)
T 4gt6_A          260 AFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQL  336 (394)
T ss_dssp             TTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTC
T ss_pred             eeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCC
Confidence            5667888999988877655 555678888999999986 4455455577888999999998765 4423232 3567788


Q ss_pred             ccccccCC
Q 040392           84 SVESFEGN   91 (470)
Q Consensus        84 ~~l~~~~n   91 (470)
                      +.+.+..+
T Consensus       337 ~~i~ip~s  344 (394)
T 4gt6_A          337 ERIAIPSS  344 (394)
T ss_dssp             CEEEECTT
T ss_pred             CEEEECcc
Confidence            88887544

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=94.64  E-value=0.056  Score=52.11  Aligned_cols=39  Identities=13%  Similarity=0.112  Sum_probs=19.7

Q ss_pred             cccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCC
Q 040392           29 SFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF   67 (470)
Q Consensus        29 ~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~   67 (470)
                      .|.++.+|+.+.+.++.++..-...|.+|.+|+.+++..
T Consensus       281 aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~  319 (379)
T 4h09_A          281 LCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPT  319 (379)
T ss_dssp             TTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCT
T ss_pred             ccccccccccccccccccceehhhhhcCCCCCCEEEcCc
Confidence            344455555555555555433334455555555555543

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=93.62  E-value=0.051  Score=52.81  Aligned_cols=63  Identities=17%  Similarity=0.125  Sum_probs=52.7

Q ss_pred             cccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCc
Q 040392            4 TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN   68 (470)
Q Consensus         4 ~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N   68 (470)
                      ..|.++++|+.++|.++ ++.+-..+|.++.+|+.++|..| ++..-..+|..|.+|+.+++..|
T Consensus       314 ~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~  376 (394)
T 4fs7_A          314 EAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR  376 (394)
T ss_dssp             TTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred             hhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence            35778999999999865 66455678999999999999887 76466678999999999999766

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=93.30  E-value=0.077  Score=51.09  Aligned_cols=65  Identities=15%  Similarity=0.211  Sum_probs=54.1

Q ss_pred             ccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCcccc
Q 040392            5 EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLE   71 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~   71 (470)
                      .|.++++|+.+.+.++.++.+-...|.++.+|+.+.|.++ ++..-..+|.+|.+|+.+.+..| ++
T Consensus       281 aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~  345 (379)
T 4h09_A          281 LCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-IT  345 (379)
T ss_dssp             TTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CC
T ss_pred             ccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cC
Confidence            5678899999999999988565678999999999999866 66455678999999999999765 44

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=91.73  E-value=0.057  Score=46.73  Aligned_cols=63  Identities=16%  Similarity=0.154  Sum_probs=47.5

Q ss_pred             CCCCCCcEeeCcCCcCCCC----CCccccCCCCCCEEeccCCcCCCC----CcccccCCCCCCceecCCcc
Q 040392            7 GGLKNLEYLFLGYNRLQGP----IPDSFGDLISLKFLNLSNNNLSGA----IPASLEKLSYLENLNLSFNK   69 (470)
Q Consensus         7 ~~l~~l~~l~l~~n~l~~~----~p~~~~~l~~L~~l~l~~n~i~~~----~~~~~~~l~~L~~l~l~~N~   69 (470)
                      ..-++|+.|+|++|+|...    +-..+..-+.|+.|+|++|.|++.    +-+.+..-+.|+.|+|++|.
T Consensus        67 ~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~  137 (197)
T 1pgv_A           67 CNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQR  137 (197)
T ss_dssp             TTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCS
T ss_pred             hhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCc
Confidence            3457899999999999732    333444568899999999999843    22456667889999999763

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=90.69  E-value=0.54  Score=29.40  Aligned_cols=7  Identities=29%  Similarity=0.121  Sum_probs=2.7

Q ss_pred             hHHHHHH
Q 040392          122 IVLPLSA  128 (470)
Q Consensus       122 ~~~~~~~  128 (470)
                      ++.++++
T Consensus        17 VVgGv~~   23 (44)
T 2ks1_B           17 MVGALLL   23 (44)
T ss_dssp             HHHHHHH
T ss_pred             hhHHHHH
Confidence            3333443

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=89.46  E-value=0.51  Score=29.42  Aligned_cols=12  Identities=25%  Similarity=0.476  Sum_probs=5.2

Q ss_pred             HHHHHHhhhccC
Q 040392          134 VILLILRYRQKG  145 (470)
Q Consensus       134 ~~~~~~~~~~~~  145 (470)
                      ++++++|+|+..
T Consensus        30 ~~~~~~RRR~~~   41 (44)
T 2jwa_A           30 VFGILIKRRQQK   41 (44)
T ss_dssp             HHHHHHHHHCSC
T ss_pred             HHHhheehhhhh
Confidence            334444444433

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=88.89  E-value=1.3  Score=38.57  Aligned_cols=122  Identities=9%  Similarity=0.142  Sum_probs=79.8

Q ss_pred             CCCcceeEEeeeccCCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 040392          227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL  306 (470)
Q Consensus       227 ~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill  306 (470)
                      .||+++.. .+-.+.+...+.++.-+  +...+-.-  ...+...+++++..|+....+++   .  -+|--++|+|+++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~i--k~~~~~eKlr~l~ni~~l~~~~~---~--r~tf~L~P~NL~f  112 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNI--KSFTKNEKLRYLLNIKNLEEVNR---T--RYTFVLAPDELFF  112 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGG--GGSCHHHHHHHHHHGGGGGGGGG---S--SEECCCSGGGEEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHH--HhcCHHHHHHHHHHHHHHHHHhc---C--ceEEEEecceEEE
Confidence            58888865 45555565545444433  33222211  24678899999999999886666   2  3688899999999


Q ss_pred             CCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCc
Q 040392          307 DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE  382 (470)
Q Consensus       307 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~  382 (470)
                      +.++.+++.-.|+...+.                   |.     ..+...=.-.+=+++..+++++..|+...++.
T Consensus       113 ~~~~~p~i~~RGik~~l~-------------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l~~G~  164 (215)
T 4ann_A          113 TRDGLPIAKTRGLQNVVD-------------------PL-----PVSEAEFLTRYKALVICAFNEKQSFDALVEGN  164 (215)
T ss_dssp             CTTSCEEESCCEETTTBS-------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHHHHSC
T ss_pred             cCCCCEEEEEccCccCCC-------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHHHcCh
Confidence            999999999887654332                   11     11111123346678888999999888755543

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=85.09  E-value=2  Score=26.72  Aligned_cols=6  Identities=17%  Similarity=0.473  Sum_probs=2.4

Q ss_pred             HHHhhh
Q 040392          137 LILRYR  142 (470)
Q Consensus       137 ~~~~~~  142 (470)
                      +++|+|
T Consensus        32 ~~~RRR   37 (44)
T 2l2t_A           32 VYVRRK   37 (44)
T ss_dssp             HHHHTT
T ss_pred             HHhhhh
Confidence            334433

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=83.38  E-value=0.12  Score=51.48  Aligned_cols=61  Identities=8%  Similarity=0.046  Sum_probs=17.8

Q ss_pred             CCCCeecccCceEEEEEEeCC-CcEEEE------EEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeec
Q 040392          176 SENNLIGRGGFGSVYKARLGD-GMEVAV------KVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCS  239 (470)
Q Consensus       176 ~~~~~ig~G~~g~Vy~~~~~~-~~~vav------K~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~  239 (470)
                      .+.+.||   ||.||+|.+.. ..+||+      |.....  ..+....+..|..+++.++|||+++.+++..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            3445666   99999998754 467888      665432  1233456778899999999999999887653

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=82.53  E-value=6.1  Score=34.45  Aligned_cols=115  Identities=10%  Similarity=0.094  Sum_probs=74.6

Q ss_pred             CCCcceeEEeeeccCCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCeeecCCCCCCee
Q 040392          227 RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALE-YLHFGYSAPIIHCDLKPSNVL  305 (470)
Q Consensus       227 ~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~-~LH~~~~~~i~H~dlkp~Nil  305 (470)
                      .||++  -...-.+++...+.++.-+++.=...+.    ..+...+++++..++.... +++     .-+|--++|+|++
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~----~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~  116 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR----KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLM  116 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH----TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH----hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEE
Confidence            57777  3333355666666666543332222332    4678899999999888766 555     3467889999999


Q ss_pred             eCCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccch-hhHHHHHHHHHhCCCCCCc
Q 040392          306 LDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV-YSFGIMLMETFTGKKPTNE  377 (470)
Q Consensus       306 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv-wslGv~l~el~tg~~p~~~  377 (470)
                      ++.++.+++.-.|+-..+                   +|.-+     + ..|. -.+=+++..++.++..|++
T Consensus       117 f~~~~~p~i~hRGi~~~l-------------------pP~e~-----~-ee~fl~qyKali~all~~K~~Fe~  164 (219)
T 4ano_A          117 FNRALEPFFLHVGVKESL-------------------PPDEW-----D-DERLLREVKATVLALTEGEYRFDE  164 (219)
T ss_dssp             ECTTCCEEESCCEETTTB-------------------SSCSC-----C-HHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred             EeCCCcEEEEEcCCcccC-------------------CCCCC-----C-HHHHHHHHHHHHHHHHcCCCCHHH
Confidence            999999999988865433                   22211     1 1222 2466778888888887765

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	470
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-68
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	8e-60
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	9e-60
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-59
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-58
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	8e-57
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-56
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-56
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-56
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	7e-56
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-55
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-55
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-55
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-54
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-54
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-53
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-52
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-52
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-52
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-52
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-52
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-52
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-52
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-51
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-51
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-51
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-50
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-50
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-50
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-49
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-49
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-49
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-48
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-47
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-44
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-43
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-43
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-42
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-42
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-41
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-40
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-40
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-39
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-39
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-39
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-39
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-39
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	7e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-39
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	9e-39
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-37
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	7e-36
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-35
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-35
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-35
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-33
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-32
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-32
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-30
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	8e-29
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-28
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-20
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-18
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	8e-09
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	0.004
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-11
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	7e-11
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-06
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	8e-06
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-05
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.001
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-09
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-07
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-05
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	0.004
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	6e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	5e-06
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	2e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.001
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	5e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-04
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	6e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	2e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.004
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	3e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	3e-04
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-04
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-04
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	0.001
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	4e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.002
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.004

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (553), Expect = 3e-68
 Identities = 71/282 (25%), Positives = 127/282 (45%), Gaps = 26/282 (9%)

Query: 179 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVIS 236
             IG G FG+VYK +     +VAVK+ N+     + L+ F  E  +++  RH N++  + 
Sbjct: 14  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71

Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
             +     A+V ++    SL  +++      ++ + ++I    A  ++YLH      IIH
Sbjct: 72  YST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIH 127

Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY---GREGRVS 353
            DLK +N+ L +++   + DF +A + +    S    Q   +I +MAPE      +   S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187

Query: 354 TNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHF 413
              DVY+FGI+L E  TG+ P + I N +  +      +L     +V             
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV------------- 234

Query: 414 VAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSL 455
             +  C   +  L  EC  +  ++R    +I+A +  +  SL
Sbjct: 235 --RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 8e-60
 Identities = 62/277 (22%), Positives = 118/277 (42%), Gaps = 26/277 (9%)

Query: 173 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLI 232
           +       +G G FG V+        +VAVK    Q   +   F  E  +MK ++H+ L+
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYI-LDIFQRLNIMIDVASALEYLHFGYS 291
           ++ +  + E    ++ EYM +GSL  ++ + + I L I + L++   +A  + ++     
Sbjct: 72  RLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127

Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGR 351
              IH DL+ +N+L+ D +   ++DF +A+L+  +++   +      I + APE    G 
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGT 186

Query: 352 VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDI 411
            +   DV+SFGI+L E  T  +           +++    +                   
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM----------------- 229

Query: 412 HFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
             V  + C   ++ L   C  E PE R     + + L
Sbjct: 230 --VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  196 bits (498), Expect = 9e-60
 Identities = 65/314 (20%), Positives = 127/314 (40%), Gaps = 43/314 (13%)

Query: 162 TFSHLELCRATDGFSEN---------NLIGRGGFGSVYKARL----GDGMEVAVKVFNLQ 208
            F+  +   A   F++           +IG G FG V    L       + VA+K     
Sbjct: 6   PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65

Query: 209 -CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYIL 267
              +  + F  E  +M    H N+I +    +      ++ E+M +GSL+ ++  ++   
Sbjct: 66  YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF 125

Query: 268 DIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 327
            + Q + ++  +A+ ++YL        +H DL   N+L++ N+V  +SDF +++ L  + 
Sbjct: 126 TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182

Query: 328 QSMTQTQTL---ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMT 384
              T T  L     I + APE  +  + ++  DV+S+GI++ E  +  +        +  
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 242

Query: 385 LKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREI 444
           +     D+     M+                   C S +  L ++C  +    R    +I
Sbjct: 243 INAIEQDYRLPPPMD-------------------CPSALHQLMLDCWQKDRNHRPKFGQI 283

Query: 445 VAKLLKIRDSLLRN 458
           V  L    D ++RN
Sbjct: 284 VNTL----DKMIRN 293

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 1e-59
 Identities = 64/280 (22%), Positives = 115/280 (41%), Gaps = 24/280 (8%)

Query: 175 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKV 234
            +    IG G FG V+     +  +VA+K        + + F  E E+M  + H  L+++
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQL 65

Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI 294
              C  +    LV E+M HG L  Y+ +   +      L + +DV   + YL     A +
Sbjct: 66  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACV 122

Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVST 354
           IH DL   N L+ +N V  +SDF + + +  +  + +   T   + + +PE     R S+
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVFSFSRYSS 181

Query: 355 NGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFV 414
             DV+SFG+++ E F+  K   E  +    ++     +                      
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-------------------Y 222

Query: 415 AKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS 454
                 + V+ +   C  E PE R     ++ +L +I +S
Sbjct: 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 3e-58
 Identities = 56/277 (20%), Positives = 115/277 (41%), Gaps = 24/277 (8%)

Query: 175 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKV 234
            +    +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQL 64

Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI 294
              C+ +    ++ EYM +G L  Y+    +     Q L +  DV  A+EYL        
Sbjct: 65  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQF 121

Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVST 354
           +H DL   N L++D  V  +SDF +++ +  +D+  +   +   + +  PE     + S+
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180

Query: 355 NGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFV 414
             D+++FG+++ E ++  K   E F    T +H                           
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-------------------Y 221

Query: 415 AKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
                   V+ +   C  E  ++R   + +++ +L +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (477), Expect = 8e-57
 Identities = 63/277 (22%), Positives = 115/277 (41%), Gaps = 26/277 (9%)

Query: 173 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLI 232
           +       +G+G FG V+         VA+K        + + F  E ++MK +RH  L+
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75

Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIF-QRLNIMIDVASALEYLHFGYS 291
           ++ +  S E    +V EYM  GSL  ++           Q +++   +AS + Y+     
Sbjct: 76  QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--- 131

Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGR 351
              +H DL+ +N+L+ +N+V  ++DF +A+L+  +++   +      I + APE    GR
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGR 190

Query: 352 VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDI 411
            +   DV+SFGI+L E  T  +           L      +                   
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM----------------- 233

Query: 412 HFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
                 +C   + +L  +C  + PE+R     + A L
Sbjct: 234 --PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 1e-56
 Identities = 63/300 (21%), Positives = 119/300 (39%), Gaps = 31/300 (10%)

Query: 167 ELCRATDGFS-ENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCGRA-LKGFDVECE 221
           +L    D     +  +G G FGSV +         ++VA+KV      +A  +    E +
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 222 MMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVAS 281
           +M  + +  ++++I  C  E    LV+E    G L K++      + +     ++  V+ 
Sbjct: 62  IMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120

Query: 282 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIG 340
            ++YL        +H DL   NVLL +   A +SDF ++K L  +D   T        + 
Sbjct: 121 GMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177

Query: 341 YMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTME 399
           + APE     + S+  DV+S+G+ + E  + G+KP  ++   E+         +      
Sbjct: 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP--- 234

Query: 400 VVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNV 459
                             +C   ++ L  +C +   E R +   +  ++     SL   V
Sbjct: 235 -----------------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 2e-56
 Identities = 64/292 (21%), Positives = 115/292 (39%), Gaps = 22/292 (7%)

Query: 181 IGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN 240
           IG+G FG V++ +   G EVAVK+F+ +  R+    + E      +RH N++  I+  + 
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68

Query: 241 EEFKA----LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLH-----FGYS 291
           +        LV +Y  HGSL  Y+  + Y + +   + + +  AS L +LH         
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126

Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT--QTQTLATIGYMAPEY--- 346
             I H DLK  N+L+  N    ++D  +A        ++       + T  YMAPE    
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186

Query: 347 ---GREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTM-EVVG 402
               +        D+Y+ G++  E            + ++     V     +  M +VV 
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246

Query: 403 ANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS 454
              L     +     + +  +  +  EC   +   R+ A  I   L ++   
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 3e-56
 Identities = 65/287 (22%), Positives = 128/287 (44%), Gaps = 29/287 (10%)

Query: 175 FSENNLIGRGGFGSVYKARLGDG-----MEVAVKVFNLQCG-RALKGFDVECEMMKSIRH 228
            +   +IG G FG VYK  L        + VA+K        +    F  E  +M    H
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68

Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
            N+I++    S  +   ++ EYM +G+L+K++   +    + Q + ++  +A+ ++YL  
Sbjct: 69  HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA- 127

Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-TGEDQSMTQTQTLATIGYMAPEYG 347
             +   +H DL   N+L++ N+V  +SDF ++++L    + + T +     I + APE  
Sbjct: 128 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185

Query: 348 REGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS 407
              + ++  DV+SFGI++ E  T  +      +    +K   + +   + M+        
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD-------- 237

Query: 408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS 454
                      C S ++ L M+C  +   +R    +IV+ L K+  +
Sbjct: 238 -----------CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 7e-56
 Identities = 73/276 (26%), Positives = 113/276 (40%), Gaps = 32/276 (11%)

Query: 179 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTC 238
             IG+G FG V       G +VAVK          + F  E  +M  +RH NL++++   
Sbjct: 13  QTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVI 69

Query: 239 SNEEFK-ALVLEYMPHGSLEKYMYSSNY-ILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
             E+    +V EYM  GSL  Y+ S    +L     L   +DV  A+EYL        +H
Sbjct: 70  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 126

Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 356
            DL   NVL+ ++ VA +SDF + K       S TQ      + + APE  RE + ST  
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAPEALREKKFSTKS 181

Query: 357 DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAK 416
           DV+SFGI+L E ++  +        +  +      +                      A 
Sbjct: 182 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-------------------DAP 222

Query: 417 EQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR 452
           + C   V+ +   C       R +  ++  +L  I+
Sbjct: 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 4e-55
 Identities = 63/304 (20%), Positives = 121/304 (39%), Gaps = 34/304 (11%)

Query: 166 LELCRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKG-FDVECEMM 223
           +EL    D F + + +G G  G V+K      G+ +A K+ +L+   A++     E +++
Sbjct: 1   MEL--KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 58

Query: 224 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
                  ++       ++   ++ +E+M  GSL++ +  +   +       + I V   L
Sbjct: 59  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGL 117

Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
            YL       I+H D+KPSN+L++      L DF ++  L     SM  +    T  YM+
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFV-GTRSYMS 171

Query: 344 PEYGREGRVSTNGDVYSFGIMLMETFTGKKP--------------------TNEIFNGEM 383
           PE  +    S   D++S G+ L+E   G+ P                      E      
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231

Query: 384 TLKHWVNDWLPISTMEVVGANLLSQEDIHFVAK--EQCVSCVF-NLAMECTVESPEQRIN 440
           T    ++ +   S   +    LL         K      S  F +   +C +++P +R +
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291

Query: 441 AREI 444
            +++
Sbjct: 292 LKQL 295

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 4e-55
 Identities = 66/296 (22%), Positives = 118/296 (39%), Gaps = 35/296 (11%)

Query: 179 NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
             +G G FG VYKA+     +  A KV + +    L+ + VE +++ S  H N++K++  
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
              E    +++E+   G+++  M      L   Q   +      AL YLH      IIH 
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHR 134

Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY-----GREGRV 352
           DLK  N+L   +    L+DF ++   T   Q         T  +MAPE       ++   
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEVVMCETSKDRPY 192

Query: 353 STNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIH 412
               DV+S GI L+E    + P +E+    + LK   ++   ++          S     
Sbjct: 193 DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW-----SSNFKD 247

Query: 413 FVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNVGDRCIRQSI 468
           F+ K             C  ++ + R    ++      ++   +    ++ IR+ I
Sbjct: 248 FLKK-------------CLEKNVDARWTTSQL------LQHPFVTVDSNKPIRELI 284

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 5e-55
 Identities = 65/288 (22%), Positives = 119/288 (41%), Gaps = 30/288 (10%)

Query: 178 NNLIGRGGFGSVYKARL----GDGMEVAVKVFNLQCGRA-LKGFDVECEMMKSIRHRNLI 232
           N +IGRG FG VY   L    G  +  AVK  N       +  F  E  +MK   H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 233 KVISTCSNEEFKA-LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
            ++  C   E    +VL YM HG L  ++ +  +   +   +   + VA  +++L     
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS--- 148

Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED--QSMTQTQTLATIGYMAPEYGRE 349
              +H DL   N +LD+     ++DF +A+ +  ++      +T     + +MA E  + 
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208

Query: 350 GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
            + +T  DV+SFG++L E  T   P       ++         L               +
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLL---------------Q 249

Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLR 457
               +  E C   ++ + ++C     E R +  E+V+++  I  + + 
Sbjct: 250 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 2e-54
 Identities = 57/275 (20%), Positives = 103/275 (37%), Gaps = 25/275 (9%)

Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCGRALKGFDVECEMMKSIRHRN 230
           + +     +G G +G V  A        VAVK+ ++ +     +    E  + K + H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY 290
           ++K          + L LEY   G L   +   +  +           + + + YLH   
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH--- 120

Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 350
              I H D+KP N+LLD+     +SDF +A +    ++     +   T+ Y+APE  +  
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180

Query: 351 RVSTNG-DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
                  DV+S GI+L     G+ P ++  +       W      ++  + +        
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI-----DSA 235

Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREI 444
            +  + K               VE+P  RI   +I
Sbjct: 236 PLALLHK-------------ILVENPSARITIPDI 257

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  181 bits (459), Expect = 3e-54
 Identities = 66/281 (23%), Positives = 115/281 (40%), Gaps = 26/281 (9%)

Query: 173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNL 231
              +  + +G G +G VY+       + VAVK         ++ F  E  +MK I+H NL
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 75

Query: 232 IKVISTCSNEEFKALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGY 290
           ++++  C+ E    ++ E+M +G+L  Y+   N   +     L +   ++SA+EYL    
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 132

Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 350
               IH DL   N L+ +N +  ++DF +++L+TG D           I + APE     
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN 191

Query: 351 RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED 410
           + S   DV++FG++L E  T         +     +                     ++D
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------------------EKD 232

Query: 411 IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
                 E C   V+ L   C   +P  R +  EI      +
Sbjct: 233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 1e-53
 Identities = 61/279 (21%), Positives = 112/279 (40%), Gaps = 32/279 (11%)

Query: 177 ENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNL 231
           E+  +G G FG+V K           VAVK+   +            E  +M+ + +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 232 IKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYS 291
           +++I  C  E +  LV+E    G L KY+  + + +     + ++  V+  ++YL     
Sbjct: 71  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEE--- 125

Query: 292 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREG 350
           +  +H DL   NVLL     A +SDF ++K L  ++            + + APE     
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185

Query: 351 RVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
           + S+  DV+SFG+++ E F+ G+KP   +   E+T      + +                
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP------------- 232

Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
                    C   +++L   C     E R     +  +L
Sbjct: 233 -------AGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 1e-52
 Identities = 59/286 (20%), Positives = 97/286 (33%), Gaps = 33/286 (11%)

Query: 170 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSI 226
           RA D +     IG G +G   K R   DG  +  K  +         +    E  +++ +
Sbjct: 2   RAED-YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60

Query: 227 RHRNLIKVISTCSNEEFKAL--VLEYMPHGSLEKYMYS---SNYILDIFQRLNIMIDVAS 281
           +H N+++      +     L  V+EY   G L   +         LD    L +M  +  
Sbjct: 61  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 282 ALEYLH--FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
           AL+  H        ++H DLKP+NV LD      L DF +A++L  +           T 
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG--TP 178

Query: 340 GYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTME 399
            YM+PE       +   D++S G +L E      P       E+  K     +  I    
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP--- 235

Query: 400 VVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIV 445
                             +    +  +           R +  EI+
Sbjct: 236 -----------------YRYSDELNEIITRMLNLKDYHRPSVEEIL 264

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (446), Expect = 2e-52
 Identities = 63/276 (22%), Positives = 114/276 (41%), Gaps = 33/276 (11%)

Query: 178 NNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKV 234
           +  IGRG F +VYK       +EVA      +       + F  E EM+K ++H N+++ 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 235 I----STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY 290
                ST   ++   LV E M  G+L+ Y+     ++ I    +    +   L++LH   
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT-R 131

Query: 291 SAPIIHCDLKPSNVLLDD-NMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 349
           + PIIH DLK  N+ +        + D  +A L             + T  +MAPE   E
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEM-YE 186

Query: 350 GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
            +   + DVY+FG+ ++E  T + P +E  N     +   +   P S  +V    +    
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK--- 243

Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIV 445
                           +   C  ++ ++R + ++++
Sbjct: 244 ---------------EIIEGCIRQNKDERYSIKDLL 264

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  177 bits (449), Expect = 2e-52
 Identities = 64/281 (22%), Positives = 104/281 (37%), Gaps = 36/281 (12%)

Query: 172 TDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL---QCGRALKGFDVECEMMKSIR 227
              FS+   IG G FG+VY AR + +   VA+K  +    Q     +    E   ++ +R
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 228 HRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLH 287
           H N I+       E    LV+EY    + +  +      L   +   +       L YLH
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYLH 132

Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEY- 346
              S  +IH D+K  N+LL +  +  L DF  A ++            + T  +MAPE  
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANSFVGTPYWMAPEVI 183

Query: 347 --GREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN 404
               EG+     DV+S GI  +E    K P   +           N+   + +       
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---- 239

Query: 405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIV 445
             S+   +FV               C  + P+ R  +  ++
Sbjct: 240 --SEYFRNFVDS-------------CLQKIPQDRPTSEVLL 265

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 3e-52
 Identities = 69/280 (24%), Positives = 101/280 (36%), Gaps = 30/280 (10%)

Query: 181 IGRGGFGSVYKARL----GDGMEVAVKVFN---LQCGRALKGFDVECEMMKSIRHRNLIK 233
           +G G FG V +       G  + VAVK      L    A+  F  E   M S+ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 234 VISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
           +         K +V E  P GSL   +        +       + VA  + YL    S  
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131

Query: 294 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT-GEDQSMTQTQTLATIGYMAPEYGREGRV 352
            IH DL   N+LL    +  + DF + + L   +D  + Q        + APE  +    
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191

Query: 353 STNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIH 412
           S   D + FG+ L E FT  +      NG   L                       E   
Sbjct: 192 SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK------------------EGER 233

Query: 413 FVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR 452
               E C   ++N+ ++C    PE R     +   LL+ +
Sbjct: 234 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 4e-52
 Identities = 58/299 (19%), Positives = 104/299 (34%), Gaps = 51/299 (17%)

Query: 180 LIGRGGFGSVYKARL------GDGMEVAVKVFNLQCGRA-LKGFDVECEMMKSI-RHRNL 231
           ++G G FG V  A        G  ++VAVK+   +   +  +    E +MM  +  H N+
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 232 IKVISTCSNEEFKALVLEYMPHGSLEKYMYSSN----------------------YILDI 269
           + ++  C+      L+ EY  +G L  Y+ S                         +L  
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163

Query: 270 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS 329
              L     VA  +E+L        +H DL   NVL+    V  + DF +A+ +  +   
Sbjct: 164 EDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220

Query: 330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWV 389
           + +      + +MAPE   EG  +   DV+S+GI+L E F+           +      +
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 280

Query: 390 NDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
                             Q              ++ +   C      +R +   + + L
Sbjct: 281 ------------------QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 4e-52
 Identities = 60/292 (20%), Positives = 115/292 (39%), Gaps = 30/292 (10%)

Query: 166 LELCRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKV-----FNLQCGRALKGFDVE 219
           L + + T+ F +  ++G G FG+VYK   + +G +V + V           +A K    E
Sbjct: 3   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61

Query: 220 CEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDV 279
             +M S+ + ++ +++  C     + L+ + MP G L  Y+      +     LN  + +
Sbjct: 62  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120

Query: 280 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATI 339
           A  + YL       ++H DL   NVL+       ++DF +AKLL  E++          I
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177

Query: 340 GYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTME 399
            +MA E       +   DV+S+G+ + E  T      +                      
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL----------- 226

Query: 400 VVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
                   ++         C   V+ + ++C +   + R   RE++ +  K+
Sbjct: 227 --------EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  175 bits (444), Expect = 6e-52
 Identities = 65/309 (21%), Positives = 115/309 (37%), Gaps = 52/309 (16%)

Query: 173 DGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQC-GRALKGFDVECEMMKS 225
           +       IG G FG V++AR            VAVK+   +        F  E  +M  
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNY-------------------- 265
             + N++K++  C+  +   L+ EYM +G L +++ S +                     
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 266 ---ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 322
               L   ++L I   VA+ + YL        +H DL   N L+ +NMV  ++DF +++ 
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 323 LTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE 382
           +   D           I +M PE     R +T  DV+++G++L E F+           E
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249

Query: 383 MTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAR 442
             + +  +  +                       E C   ++NL   C  + P  R +  
Sbjct: 250 EVIYYVRDGNIL-------------------ACPENCPLELYNLMRLCWSKLPADRPSFC 290

Query: 443 EIVAKLLKI 451
            I   L ++
Sbjct: 291 SIHRILQRM 299

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 3e-51
 Identities = 66/267 (24%), Positives = 108/267 (40%), Gaps = 26/267 (9%)

Query: 179 NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVIST 237
             IG+G  G+VY A  +  G EVA++  NLQ     +    E  +M+  ++ N++  + +
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 238 CSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 297
               +   +V+EY+  GSL   +  +    D  Q   +  +   ALE+LH   S  +IH 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLH---SNQVIHR 140

Query: 298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 357
           D+K  N+LL  +    L+DF     +T E    +      T  +MAPE           D
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG--TPYWMAPEVVTRKAYGPKVD 198

Query: 358 VYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKE 417
           ++S GIM +E   G+ P               N    +   E      LS     F+ + 
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK-----LSAIFRDFLNR- 252

Query: 418 QCVSCVFNLAMECTVESPEQRINAREI 444
                       C     E+R +A+E+
Sbjct: 253 ------------CLDMDVEKRGSAKEL 267

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 3e-51
 Identities = 57/304 (18%), Positives = 109/304 (35%), Gaps = 46/304 (15%)

Query: 173 DGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQCGRA-LKGFDVECEMMKS 225
           +  S    +G G FG V +A           M VAVK+          +    E +++  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 226 I-RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSS-----------------NYIL 267
           +  H N++ ++  C+      ++ EY  +G L  ++                       L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 268 DIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 327
           D+   L+    VA  + +L    S   IH DL   N+LL    +  + DF +A+ +  + 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKH 387
             + +      + +MAPE       +   DV+S+GI L E F+           +     
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259

Query: 388 WVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK 447
            +                  +E    ++ E   + ++++   C    P +R   ++IV  
Sbjct: 260 MI------------------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301

Query: 448 LLKI 451
           + K 
Sbjct: 302 IEKQ 305

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 4e-51
 Identities = 61/277 (22%), Positives = 113/277 (40%), Gaps = 33/277 (11%)

Query: 173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFN---LQCGRALKGFDVECEMMKSIRH 228
           + F     +G+G FG+VY AR       +A+KV     L+          E E+   +RH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
            N++++     +     L+LEY P G++ + +   +   D  +    + ++A+AL Y H 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH- 123

Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +IH D+KP N+LL       ++DF  +       ++        T+ Y+ PE   
Sbjct: 124 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG----TLDYLPPEMIE 177

Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ 408
                   D++S G++  E   GK P    F      + +      IS +E    + +++
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKR----ISRVEFTFPDFVTE 229

Query: 409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIV 445
                +++                 +P QR   RE++
Sbjct: 230 GARDLISR-------------LLKHNPSQRPMLREVL 253

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 2e-50
 Identities = 65/279 (23%), Positives = 110/279 (39%), Gaps = 29/279 (10%)

Query: 170 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRALKGFDVECEMMKS 225
           +  + F    ++G G F +V  AR L    E A+K+     +     +     E ++M  
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           + H   +K+  T  ++E     L Y  +G L KY+       D         ++ SALEY
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEY 123

Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
           LH      IIH DLKP N+LL+++M   ++DF  AK+L+ E +       + T  Y++PE
Sbjct: 124 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180

Query: 346 YGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL 405
              E     + D+++ G ++ +   G  P    F        +      I  +E      
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQK----IIKLEYDFPEK 232

Query: 406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREI 444
              +    V K               V    +R+   E+
Sbjct: 233 FFPKARDLVEK-------------LLVLDATKRLGCEEM 258

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 2e-50
 Identities = 70/307 (22%), Positives = 126/307 (41%), Gaps = 45/307 (14%)

Query: 173 DGFSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCGR-ALKGFDVECEMMKSI-R 227
           +     ++IG G FG V KAR+   G  M+ A+K       +   + F  E E++  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 228 HRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYI---------------LDIFQR 272
           H N+I ++  C +  +  L +EY PHG+L  ++  S  +               L   Q 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 273 LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 332
           L+   DVA  ++YL        IH DL   N+L+ +N VA ++DF +++   G++  + +
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183

Query: 333 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDW 392
           T     + +MA E       +TN DV+S+G++L E  +               +     +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243

Query: 393 LPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR 452
                                     C   V++L  +C  E P +R +  +I+  L ++ 
Sbjct: 244 RL-------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284

Query: 453 DSLLRNV 459
           +     V
Sbjct: 285 EERKTYV 291

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  172 bits (438), Expect = 2e-50
 Identities = 50/268 (18%), Positives = 93/268 (34%), Gaps = 26/268 (9%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTC 238
            +G G FG V++      G   A K          +    E + M  +RH  L+ +    
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92

Query: 239 SNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            ++    ++ E+M  G L + +   +  +   + +  M  V   L ++H       +H D
Sbjct: 93  EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLD 149

Query: 299 LKPSNVLL--DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 356
           LKP N++     +    L DF +   L  +      T T     + APE      V    
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA---EFAAPEVAEGKPVGYYT 206

Query: 357 DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAK 416
           D++S G++     +G  P     + E        DW    +      + +S++   F+ K
Sbjct: 207 DMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF----SGISEDGKDFIRK 262

Query: 417 EQCVSCVFNLAMECTVESPEQRINAREI 444
                          +  P  R+   + 
Sbjct: 263 -------------LLLADPNTRMTIHQA 277

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 2e-49
 Identities = 58/279 (20%), Positives = 104/279 (37%), Gaps = 29/279 (10%)

Query: 180 LIGRGGFGSVYKARL----GDGMEVAVKVFNLQCGRAL-KGFDVECEMMKSIRHRNLIKV 234
            IG G FG V++          + VA+K        ++ + F  E   M+   H +++K+
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI 294
           I   + E    +++E    G L  ++    Y LD+   +     +++AL YL    S   
Sbjct: 74  IGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRF 129

Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVST 354
           +H D+   NVL+  N    L DF +++ +            L  I +MAPE     R ++
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTS 188

Query: 355 NGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFV 414
             DV+ FG+ + E         +       +    N                        
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP------------------- 229

Query: 415 AKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD 453
               C   +++L  +C    P +R    E+ A+L  I +
Sbjct: 230 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  169 bits (430), Expect = 3e-49
 Identities = 52/268 (19%), Positives = 96/268 (35%), Gaps = 26/268 (9%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTC 238
            +G G FG V++      G     K  N            E  +M  + H  LI +    
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 239 SNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            ++    L+LE++  G L   + + +Y +   + +N M      L+++H      I+H D
Sbjct: 96  EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLD 152

Query: 299 LKPSNVLLD--DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 356
           +KP N++ +        + DF +A  L  ++     T   AT  + APE      V    
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPVGFYT 209

Query: 357 DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAK 416
           D+++ G++     +G  P     + E        DW           + +S E   F+  
Sbjct: 210 DMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA----FSSVSPEAKDFIKN 265

Query: 417 EQCVSCVFNLAMECTVESPEQRINAREI 444
                           + P +R+   + 
Sbjct: 266 -------------LLQKEPRKRLTVHDA 280

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (425), Expect = 4e-49
 Identities = 59/301 (19%), Positives = 121/301 (40%), Gaps = 38/301 (12%)

Query: 175 FSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQCG-RALKGFDVECEMMKSIR 227
            + +  +G+G FG VY+              VA+K  N     R    F  E  +MK   
Sbjct: 22  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81

Query: 228 HRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYI---------LDIFQRLNIMID 278
             ++++++   S  +   +++E M  G L+ Y+ S               + + + +  +
Sbjct: 82  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141

Query: 279 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLAT 338
           +A  + YL+   +   +H DL   N ++ ++    + DF + + +   D      + L  
Sbjct: 142 IADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198

Query: 339 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTM 398
           + +M+PE  ++G  +T  DV+SFG++L E  T  +   +  + E  L+  +   L     
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD--- 255

Query: 399 EVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRN 458
                             + C   +F L   C   +P+ R +  EI++ + +  +   R 
Sbjct: 256 ----------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299

Query: 459 V 459
           V
Sbjct: 300 V 300

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  166 bits (421), Expect = 1e-48
 Identities = 74/292 (25%), Positives = 123/292 (42%), Gaps = 31/292 (10%)

Query: 172 TDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGR---ALKGFDVECEMMKSIR 227
           +D +    ++G GG   V+ AR L    +VAVKV      R       F  E +   ++ 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 228 HRNLIKVISTCSNEEFKA----LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
           H  ++ V  T   E        +V+EY+   +L   +++    +   + + ++ D   AL
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 124

Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLA-TIGYM 342
            + H      IIH D+KP+N+++       + DF IA+ +     S+TQT  +  T  Y+
Sbjct: 125 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181

Query: 343 APEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVG 402
           +PE  R   V    DVYS G +L E  TG+ P        +  +H   D +P S      
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH--- 238

Query: 403 ANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRI-NAREIVAKLLKIRD 453
              LS +    V K                ++PE R   A E+ A L+++ +
Sbjct: 239 -EGLSADLDAVVLK-------------ALAKNPENRYQTAAEMRADLVRVHN 276

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 6e-47
 Identities = 70/304 (23%), Positives = 116/304 (38%), Gaps = 47/304 (15%)

Query: 173 DGFSENNLIGRGGFGSVYKARL--------GDGMEVAVKVFNLQCG-RALKGFDVECEMM 223
           D       +G G FG V  A              +VAVK+       + L     E EMM
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 224 KSI-RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYM---------------YSSNYIL 267
           K I +H+N+I ++  C+ +    +++EY   G+L +Y+               ++    L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 268 DIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED 327
                ++    VA  +EYL    S   IH DL   NVL+ ++ V  ++DF +A+ +   D
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKH 387
                T     + +MAPE   +   +   DV+SFG++L E FT           E   K 
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249

Query: 388 WVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK 447
                                          C + ++ +  +C    P QR   +++V  
Sbjct: 250 LKEGHRM-------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

Query: 448 LLKI 451
           L +I
Sbjct: 291 LDRI 294

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (394), Expect = 2e-44
 Identities = 54/299 (18%), Positives = 119/299 (39%), Gaps = 33/299 (11%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTC 238
            +GRG FG V++            K   ++ G        E  ++   RHRN++ +  + 
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESF 70

Query: 239 SNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
            + E   ++ E++    + + + +S + L+  + ++ +  V  AL++LH   S  I H D
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFD 127

Query: 299 LKPSNVLLD--DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 356
           ++P N++     +    + +F  A+ L   D             Y APE  +   VST  
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT---APEYYAPEVHQHDVVSTAT 184

Query: 357 DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAK 416
           D++S G ++    +G  P    F  E             +  +++   + ++      A 
Sbjct: 185 DMWSLGTLVYVLLSGINP----FLAE-------------TNQQIIENIMNAEYTFDEEAF 227

Query: 417 EQCVSCVFNLAMECTVESPEQRINAREIVA------KLLKIRDSLLRNVGDRCIRQSIL 469
           ++      +      V+  + R+ A E +       K+ ++   ++R +  R    +++
Sbjct: 228 KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLI 286

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 2e-43
 Identities = 59/306 (19%), Positives = 107/306 (34%), Gaps = 45/306 (14%)

Query: 173 DGFSENNLIGRGGFGSVYKAR------LGDGMEVAVKVFNLQCGRA-LKGFDVECEMMKS 225
           D       +GRG FG V +A             VAVK+       +  +    E +++  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 226 IRHRNLIKVISTCSNEEFKAL--VLEYMPHGSLEKYMYSSNY---------------ILD 268
           I H   +  +     +    L  ++E+   G+L  Y+ S                   L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 269 IFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ 328
           +   +     VA  +E+L    S   IH DL   N+LL +  V  + DF +A+ +  +  
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW 388
            + +      + +MAPE   +   +   DV+SFG++L E F+           +      
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249

Query: 389 VNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKL 448
           +                  +E     A +     ++   ++C    P QR    E+V  L
Sbjct: 250 L------------------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291

Query: 449 LKIRDS 454
             +  +
Sbjct: 292 GNLLQA 297

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  150 bits (380), Expect = 7e-43
 Identities = 63/289 (21%), Positives = 107/289 (37%), Gaps = 41/289 (14%)

Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV---------ECEM 222
           + +    ++GRG    V +        E AVK+ ++  G +    +V         E ++
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 223 MKSIR-HRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVAS 281
           ++ +  H N+I++  T     F  LV + M  G L  Y+ +    L   +   IM  +  
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLE 121

Query: 282 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGY 341
            +  LH      I+H DLKP N+LLDD+M   L+DF  +  L   D      +   T  Y
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTPSY 175

Query: 342 MAPEYGREGRVSTNG------DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPI 395
           +APE         +       D++S G+++     G  P    F                
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP----FWHR------------- 218

Query: 396 STMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREI 444
             M ++   +           +     V +L     V  P++R  A E 
Sbjct: 219 KQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  150 bits (380), Expect = 2e-42
 Identities = 63/276 (22%), Positives = 112/276 (40%), Gaps = 34/276 (12%)

Query: 179 NLIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRALKGFDVECEMMKSIRHRNLIKV 234
             +G G FG V+  R   +G   A+KV     +   + ++  + E  M+  + H  +I++
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 235 ISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPI 294
             T  + +   ++++Y+  G L   +  S              +V  ALEYLH   S  I
Sbjct: 70  WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF-PNPVAKFYAAEVCLALEYLH---SKDI 125

Query: 295 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVST 354
           I+ DLKP N+LLD N    ++DF  AK +     ++       T  Y+APE       + 
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG-----TPDYIAPEVVSTKPYNK 180

Query: 355 NGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFV 414
           + D +SFGI++ E   G  P    F    T+K +      I   E+      +++    +
Sbjct: 181 SIDWWSFGILIYEMLAGYTP----FYDSNTMKTYEK----ILNAELRFPPFFNEDVKDLL 232

Query: 415 AKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK 450
           ++                    QR+   +   + +K
Sbjct: 233 SR-------------LITRDLSQRLGNLQNGTEDVK 255

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  149 bits (377), Expect = 5e-42
 Identities = 48/275 (17%), Positives = 96/275 (34%), Gaps = 23/275 (8%)

Query: 172 TDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKG-FDVECEMMKSIRHR 229
            D +   +++G G F  V  A        VA+K    +     +G  + E  ++  I+H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 230 NLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFG 289
           N++ +     +     L+++ +  G L   +    +         ++  V  A++YLH  
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDL 126

Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 349
                           LD++    +SDF ++K+   ED     +    T GY+APE   +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQ 183

Query: 350 GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE 409
              S   D +S G++      G  P    F  E             +  ++    L ++ 
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPP----FYDE-------------NDAKLFEQILKAEY 226

Query: 410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREI 444
           +      +       +       + PE+R    + 
Sbjct: 227 EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 3e-41
 Identities = 60/281 (21%), Positives = 106/281 (37%), Gaps = 38/281 (13%)

Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV----ECEMMKSIR 227
           + F  + ++G+G FG V+ A         A+K             +     +  +  +  
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 228 HRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLH 287
           H  L  +  T   +E    V+EY+  G L  ++ S +   D+ +      ++   L++LH
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH 120

Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYG 347
              S  I++ DLK  N+LLD +    ++DF + K     D          T  Y+APE  
Sbjct: 121 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC--GTPDYIAPEIL 175

Query: 348 REGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE---MTLKHWVNDWLPISTMEVVGAN 404
              + + + D +SFG++L E   G+ P    F+G+           D             
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSP----FHGQDEEELFHSIRMDNPFYP-------R 224

Query: 405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIV 445
            L +E    + K               V  PE+R+  R  +
Sbjct: 225 WLEKEAKDLLVK-------------LFVREPEKRLGVRGDI 252

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 2e-40
 Identities = 50/274 (18%), Positives = 101/274 (36%), Gaps = 32/274 (11%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTC 238
           ++G G  G V +        + A+K+    C +A +  ++     ++ +  ++++++   
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREVEL---HWRASQCPHIVRIVDVY 74

Query: 239 ----SNEEFKALVLEYMPHGSLEKYMYS-SNYILDIFQRLNIMIDVASALEYLHFGYSAP 293
               +  +   +V+E +  G L   +    +      +   IM  +  A++YLH   S  
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SIN 131

Query: 294 IIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 350
           I H D+KP N+L      N +  L+DF  AK  T  +   T      T  Y+APE     
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGPE 188

Query: 351 RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED 410
           +   + D++S G+++     G  P        ++        +          + +S+E 
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 248

Query: 411 IHFVAKEQCVSCVFNLAMECTVESPEQRINAREI 444
              +                    P QR+   E 
Sbjct: 249 KMLIRN-------------LLKTEPTQRMTITEF 269

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 3e-40
 Identities = 67/295 (22%), Positives = 113/295 (38%), Gaps = 24/295 (8%)

Query: 168 LCRATDGFSENNLIGRGGFGSVYKAR--LGDGMEVAVKVFNLQCGRALKGFDVECE---- 221
           LCRA   +     IG G +G V+KAR     G  VA+K   +Q G          E    
Sbjct: 2   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61

Query: 222 -MMKSIRHRNLIKVISTCSNEEFKA-----LVLEYMPHGSLEKYMYSSNYILDIFQRLNI 275
             +++  H N++++   C+           LV E++               +      ++
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121

Query: 276 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT 335
           M  +   L++LH   S  ++H DLKP N+L+  +    L+DF +A++       M  T  
Sbjct: 122 MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSV 175

Query: 336 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPI 395
           + T+ Y APE   +   +T  D++S G +  E F  K       + +   K      LP 
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235

Query: 396 STMEVVGANLLSQEDIHFVAK------EQCVSCVFNLAMECTVESPEQRINAREI 444
                    L  Q      A+              +L ++C   +P +RI+A   
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  142 bits (358), Expect = 1e-39
 Identities = 56/277 (20%), Positives = 114/277 (41%), Gaps = 17/277 (6%)

Query: 179 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVIS 236
             IG G +G VYKA+   G   A+K   L+            E  ++K ++H N++K+  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 237 TCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIH 296
               ++   LV E++    L+K +      L+     + ++ + + + Y H      ++H
Sbjct: 68  VIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123

Query: 297 CDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE-YGREGRVSTN 355
            DLKP N+L++      ++DF +A+           T  + T+ Y AP+      + ST 
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181

Query: 356 GDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW-------VNDWLPISTMEVVGANLLSQ 408
            D++S G +  E   G      +   +  ++ +         +W  ++ +     N    
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241

Query: 409 EDIHFVAKEQCVS-CVFNLAMECTVESPEQRINAREI 444
           E + + +  + +     +L  +     P QRI A++ 
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  144 bits (363), Expect = 2e-39
 Identities = 55/286 (19%), Positives = 109/286 (38%), Gaps = 34/286 (11%)

Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL------QCGRALKGFDVECEMMKS 225
           + FS + +IGRGGFG VY  R    G   A+K  +       Q         +   ++ +
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
                ++ +       +  + +L+ M  G L  ++ S + +           ++   LE+
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEH 122

Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE 345
           +H   +  +++ DLKP+N+LLD++    +SD  +A   + +    +      T GYMAPE
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG----THGYMAPE 175

Query: 346 YGREGR-VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN 404
             ++G    ++ D +S G ML +   G  P  +    +      +   + +   +     
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF--- 232

Query: 405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK 450
             S E    +                      +R+      A+ +K
Sbjct: 233 --SPELRSLLEG-------------LLQRDVNRRLGCLGRGAQEVK 263

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 2e-39
 Identities = 57/289 (19%), Positives = 109/289 (37%), Gaps = 19/289 (6%)

Query: 172 TDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFN-LQCGRALKGFDVECEMMKSIRHR 229
              ++  + IG G +G V  A    + + VA+K  +  +     +    E +++   RH 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 230 NLIKVISTCSNEEFKALVLEYMPHGSLEKYMYS--SNYILDIFQRLNIMIDVASALEYLH 287
           N+I +         + +   Y+    +   +Y       L        +  +   L+Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT-GEDQSMTQTQTLATIGYMAPEY 346
              SA ++H DLKPSN+LL+      + DF +A++     D +   T+ +AT  Y APE 
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 347 GREGRVSTN-GDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL 405
               +  T   D++S G +L E  + +         +           P         NL
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243

Query: 406 LSQEDIHFVAKEQCV----------SCVFNLAMECTVESPEQRINAREI 444
            ++  +  +  +  V          S   +L  +    +P +RI   + 
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  141 bits (357), Expect = 2e-39
 Identities = 53/281 (18%), Positives = 92/281 (32%), Gaps = 27/281 (9%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTC 238
            IG G FG +Y    +  G EVA+K+  ++         +E ++ K ++    I  I  C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 239 SNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
             E    +++  +   SLE      +    +   L +   + S +EY+H   S   IH D
Sbjct: 72  GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRD 128

Query: 299 LKPSNVL---LDDNMVAHLSDFSIAKLLTGED-----QSMTQTQTLATIGYMAPEYGREG 350
           +KP N L        + ++ DF +AK                     T  Y +       
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188

Query: 351 RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED 410
             S   D+ S G +LM    G  P   +       K+       +ST   V       E 
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEF 248

Query: 411 IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI 451
             ++               C     + + +   +      +
Sbjct: 249 ATYLNF-------------CRSLRFDDKPDYSYLRQLFRNL 276

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 3e-39
 Identities = 66/284 (23%), Positives = 112/284 (39%), Gaps = 28/284 (9%)

Query: 179 NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC-----GRALKGFDVECEMMKSIRHRNLI 232
           + +G G F +VYKAR       VA+K   L           +    E ++++ + H N+I
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 233 KVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA 292
            ++    ++   +LV ++M        +  ++ +L        M+     LEYLH     
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119

Query: 293 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRV 352
            I+H DLKP+N+LLD+N V  L+DF +AK       +   T  + T  Y APE     R+
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAPELLFGARM 177

Query: 353 -STNGDVYSFGIMLMETFTGKKP---------TNEIFN--GEMTLKHWVNDWLPISTMEV 400
                D+++ G +L E                   IF   G  T + W +       +  
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237

Query: 401 VGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREI 444
                +    I   A +  +    +L     + +P  RI A + 
Sbjct: 238 KSFPGIPLHHIFSAAGDDLL----DLIQGLFLFNPCARITATQA 277

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 7e-39
 Identities = 64/290 (22%), Positives = 114/290 (39%), Gaps = 31/290 (10%)

Query: 175 FSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIK 233
           +++  +IG G FG VY+A+L   G  VA+K       +  +  + E ++M+ + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77

Query: 234 VISTC------SNEEFKALVLEYMPHGSLE--KYMYSSNYILDIFQRLNIMIDVASALEY 285
           +           +E +  LVL+Y+P       ++   +   L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 286 LHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAP 344
           +H   S  I H D+KP N+LLD D  V  L DF  AK L   + +++    + +  Y AP
Sbjct: 138 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAP 191

Query: 345 -EYGREGRVSTNGDVYSFGIMLMETFTGKKP---------TNEIFNGEMTLKHWVNDWLP 394
                    +++ DV+S G +L E   G+             EI     T        + 
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251

Query: 395 ISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREI 444
            +  E     + +               +  L       +P  R+   E 
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAI-ALCSRLLEYTPTARLTPLEA 300

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 7e-39
 Identities = 56/283 (19%), Positives = 104/283 (36%), Gaps = 35/283 (12%)

Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL------QCGRALKGFDVECEMMKS 225
           D +     +G G F  V K R    G++ A K          + G + +  + E  ++K 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 226 IRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEY 285
           I+H N+I +     N+    L+LE +  G L  ++      L   +    +  + + + Y
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYY 128

Query: 286 LHFGYSAPIIHCDLKPSNVLLDDNMVA----HLSDFSIAKLLTGEDQSMTQTQTLATIGY 341
           LH   S  I H DLKP N++L D  V      + DF +A  +   D          T  +
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 182

Query: 342 MAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVV 401
           +APE      +    D++S G++     +G  P                 +L  +  E +
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP-----------------FLGDTKQETL 225

Query: 402 GANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREI 444
                   +          +   +      V+ P++R+  ++ 
Sbjct: 226 ANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 9e-39
 Identities = 61/284 (21%), Positives = 109/284 (38%), Gaps = 17/284 (5%)

Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHR 229
           + F +   IG G +G VYKAR    G  VA+K   L             E  ++K + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 230 NLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFG 289
           N++K++     E    LV E++     +    S+   + +    + +  +   L + H  
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119

Query: 290 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE-YGR 348
            S  ++H DLKP N+L++      L+DF +A+      ++ T      T+ Y APE    
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLG 176

Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ 408
               ST  D++S G +  E  T +         +   + +     P   +     ++   
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 409 EDIHFVAKEQCVSCVF--------NLAMECTVESPEQRINAREI 444
           +        Q  S V         +L  +     P +RI+A+  
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 3e-37
 Identities = 60/279 (21%), Positives = 93/279 (33%), Gaps = 51/279 (18%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC------GRALKGFDVECEMMKSIR--HRN 230
           L+G GGFGSVY    + D + VA+K                    +E  ++K +      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 231 LIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY 290
           +I+++      +   L+LE            +    L      +    V  A+ + H   
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 127

Query: 291 SAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 349
           +  ++H D+K  N+L+D +     L DF    LL         T    T  Y  PE+ R 
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRY 183

Query: 350 GRVSTNG-DVYSFGIMLMETFTGKKP---TNEIFNGEMTLKHWVNDWLPISTMEVVGANL 405
            R       V+S GI+L +   G  P     EI  G++  +  V                
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV---------------- 227

Query: 406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREI 444
            S E  H +               C    P  R    EI
Sbjct: 228 -SSECQHLIRW-------------CLALRPSDRPTFEEI 252

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 7e-36
 Identities = 53/279 (18%), Positives = 109/279 (39%), Gaps = 19/279 (6%)

Query: 179 NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCG--RALKGFDVECEMMKSIRHRNLIKVI 235
             IG G +G+V+KA+       VA+K   L             E  ++K ++H+N++++ 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 236 STCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPII 295
               +++   LV E+      + +   +  + D     + +  +   L + H      ++
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHS---RNVL 123

Query: 296 HCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPE-YGREGRVST 354
           H DLKP N+L++ N    L++F +A+      +    +  + T+ Y  P+        ST
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYST 181

Query: 355 NGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVN--------DWLPISTMEVVGANLL 406
           + D++S G +  E     +P     + +  LK             W  ++ +       +
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241

Query: 407 SQEDIHFVAKEQCVSCVF-NLAMECTVESPEQRINAREI 444
                  V     ++    +L       +P QRI+A E 
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  131 bits (330), Expect = 2e-35
 Identities = 39/290 (13%), Positives = 88/290 (30%), Gaps = 35/290 (12%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTC 238
            IG G FG +++   L +  +VA+K    +          E    K +     I  +   
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 239 SNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 298
             E    +++  +   SLE  +        +         + + ++ +H      +++ D
Sbjct: 70  GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 126

Query: 299 LKPSNVLLDDNMVAH-----LSDFSIAKLL----TGEDQSMTQTQTLA-TIGYMAPEYGR 348
           +KP N L+      +     + DF + K      T +     + + L+ T  YM+     
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186

Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ 408
               S   D+ + G + M    G                        +  +      + +
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRG--------------SLPWQGLKAATNKQKY--ERIGE 230

Query: 409 EDIHFVAKEQCVSC---VFNLAMECTVESPEQRINAREIVAKLLKIRDSL 455
           +      +E C       +         + +   +   +     K+ + L
Sbjct: 231 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 2e-35
 Identities = 59/282 (20%), Positives = 108/282 (38%), Gaps = 31/282 (10%)

Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRA---LKGFDVECEMMKSIRH 228
           + F    L+G+G FG V   R    G   A+K+   +   A   +     E  ++++ RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L  +       +    V+EY   G L  ++ S   +    +      ++ SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLH- 122

Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +++ D+K  N++LD +    ++DF + K    +  +M       T  Y+APE   
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVLE 178

Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ 408
           +       D +  G+++ E   G+ P     + E   +  + + +            LS 
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHERLFELILMEEIRFP-------RTLSP 230

Query: 409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK 450
           E    +A                 + P+QR+      AK + 
Sbjct: 231 EAKSLLAG-------------LLKKDPKQRLGGGPSDAKEVM 259

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 3e-35
 Identities = 59/302 (19%), Positives = 115/302 (38%), Gaps = 29/302 (9%)

Query: 168 LCRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKGFDVECEMMK 224
            C     + +   IG+G FG V+KAR    G +VA+K   ++            E ++++
Sbjct: 5   FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ 64

Query: 225 SIRHRNLIKVISTCSNEEFKA--------LVLEYMPHGSLEKYMYSSNYILDIFQRLNIM 276
            ++H N++ +I  C  +            LV ++  H      + +      + +   +M
Sbjct: 65  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVM 123

Query: 277 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQT- 335
             + + L Y+H      I+H D+K +NVL+  + V  L+DF +A+  +    S     T 
Sbjct: 124 QMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180

Query: 336 -LATIGYMAPEYGREGR-VSTNGDVYSFGIMLMETFTGKKPTN-----------EIFNGE 382
            + T+ Y  PE     R      D++  G ++ E +T                     G 
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240

Query: 383 MTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAR 442
           +T + W N        ++       ++    +          +L  +  V  P QRI++ 
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300

Query: 443 EI 444
           + 
Sbjct: 301 DA 302

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  126 bits (318), Expect = 2e-33
 Identities = 50/285 (17%), Positives = 100/285 (35%), Gaps = 40/285 (14%)

Query: 173 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRALKGFDVECEMMKSIRH 228
           D F     +G G FG V   +    G   A+K+ +   +   + ++    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHF 288
             L+K+  +  +     +V+EY+  G +  ++                  +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH- 158

Query: 289 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 348
             S  +I+ DLKP N+L+D      ++DF  AK + G   ++       T   +APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG-----TPEALAPEIIL 211

Query: 349 EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE---MTLKHWVNDWLPISTMEVVGANL 405
               +   D ++ G+++ E   G  P    F  +      +  V+  +            
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQIYEKIVSGKVRFP--------- 258

Query: 406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK 450
                          S + +L          +R    +     +K
Sbjct: 259 -----------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIK 292

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 1e-32
 Identities = 61/289 (21%), Positives = 108/289 (37%), Gaps = 33/289 (11%)

Query: 173 DGFSENNLIGRGGFGSVYKARL----GDGMEVAVKVFN----LQCGRALKGFDVECEMMK 224
           + F    ++G G +G V+  R       G   A+KV      +Q  +  +    E ++++
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 225 SIRHR-NLIKVISTCSNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
            IR    L+ +      E    L+L+Y+  G L  ++         F    + I V   +
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIV 139

Query: 284 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMA 343
             L   +   II+ D+K  N+LLD N    L+DF ++K    ++          TI YMA
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMA 198

Query: 344 PEYGREGRVSTNG--DVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVV 401
           P+  R G    +   D +S G+++ E  TG  P    F  +            I   E  
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP----FTVDGEKNSQAEISRRILKSEPP 254

Query: 402 GANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLK 450
               +S      + +               ++ P++R+      A  +K
Sbjct: 255 YPQEMSALAKDLIQR-------------LLMKDPKKRLGCGPRDADEIK 290

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 2e-32
 Identities = 69/303 (22%), Positives = 113/303 (37%), Gaps = 29/303 (9%)

Query: 163 FSHLELCRATDGFSEN----NLIGRGGFGSVYKAR-LGDGMEVAVKVFN--LQCGRALKG 215
           F   E+ +              +G G +G+V  A     G +VA+K      Q     K 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 216 FDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY---MPHGSLEKYMYSSNYILDIFQR 272
              E  ++K +RH N+I ++   + +E      ++   MP    +      +  L   + 
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123

Query: 273 LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ 332
             ++  +   L Y+H   +A IIH DLKP N+ ++++    + DF +A+    E      
Sbjct: 124 QFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----M 175

Query: 333 TQTLATIGYMAPE-YGREGRVSTNGDVYSFGIMLMETFTGKKP---------TNEIFNGE 382
           T  + T  Y APE      R +   D++S G ++ E  TGK             EI    
Sbjct: 176 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235

Query: 383 MTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVF-NLAMECTVESPEQRINA 441
            T        L     +     L   E   F +     S +  NL  +  V   EQR+ A
Sbjct: 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA 295

Query: 442 REI 444
            E 
Sbjct: 296 GEA 298

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  118 bits (297), Expect = 2e-30
 Identities = 55/308 (17%), Positives = 116/308 (37%), Gaps = 36/308 (11%)

Query: 160 WRTFSHLELCRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDV 218
           W   SH+      D +     +GRG +  V++A  + +  +V VK+         K    
Sbjct: 22  WDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKR 78

Query: 219 ECEMMKSIR-HRNLIKVISTCSNEEFK--ALVLEYMPHGSLEKYMYSSNYILDIFQRLNI 275
           E ++++++R   N+I +     +   +  ALV E++ +   ++   +    L  +     
Sbjct: 79  EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFY 134

Query: 276 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQ 334
           M ++  AL+Y H   S  I+H D+KP NV++D ++    L D+ +A+             
Sbjct: 135 MYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY---HPGQEYNV 188

Query: 335 TLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMETFTGKKP-----------------TN 376
            +A+  +  PE   + +    + D++S G ML      K+P                   
Sbjct: 189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 248

Query: 377 EIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPE 436
                +   K+ +      + +    +    +  +H   +        +   +      +
Sbjct: 249 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 308

Query: 437 QRINAREI 444
            R+ ARE 
Sbjct: 309 SRLTAREA 316

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 4e-30
 Identities = 62/304 (20%), Positives = 111/304 (36%), Gaps = 29/304 (9%)

Query: 162 TFSHLELCRATDGFSEN----NLIGRGGFGSVYKAR-LGDGMEVAVKVFN--LQCGRALK 214
           TF   EL +      E     + +G G +GSV  A     G+ VAVK  +   Q     K
Sbjct: 3   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 62

Query: 215 GFDVECEMMKSIRHRNLIKVISTCSNE----EFKALVLEYMPHGSLEKYMYSSNYILDIF 270
               E  ++K ++H N+I ++   +      EF  + L     G+    +      L   
Sbjct: 63  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDD 121

Query: 271 QRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM 330
               ++  +   L+Y+H   SA IIH DLKPSN+ ++++    + DF +A+    E    
Sbjct: 122 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 178

Query: 331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP---------TNEIFNG 381
             T                   +   D++S G ++ E  TG+              I   
Sbjct: 179 VAT----RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234

Query: 382 EMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVF-NLAMECTVESPEQRIN 440
             T    +   +   +      +L     ++F       + +  +L  +  V   ++RI 
Sbjct: 235 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294

Query: 441 AREI 444
           A + 
Sbjct: 295 AAQA 298

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  114 bits (286), Expect = 8e-29
 Identities = 47/240 (19%), Positives = 90/240 (37%), Gaps = 24/240 (10%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTC 238
            +G G F +V+ A+ + +   VA+K+         +  + E ++++ +   +  K  S  
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 239 SNEEFK---------------ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASAL 283
           +N   K                +V E +    L       +  + +     I   +   L
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 284 EYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYM 342
           +Y+H      IIH D+KP NVL++  +   +L    IA L          T ++ T  Y 
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 343 APEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVG 402
           +PE           D++S   ++ E  TG       F  +    +  +D      +E++G
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFL----FEPDEGHSYTKDDDHIAQIIELLG 252

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 7e-28
 Identities = 61/295 (20%), Positives = 110/295 (37%), Gaps = 40/295 (13%)

Query: 180 LIGRGGFGSVYKAR-LGDGMEVAVKVFN--LQCGRALKGFDVECEMMKSIRHRNLIKVIS 236
            IG G  G V  A        VA+K  +   Q     K    E  +MK + H+N+I +++
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 237 TCSNEEFK------ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY 290
             + ++         LV+E M     +          D  +   ++  +   +++LH   
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHLH--- 136

Query: 291 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 350
           SA IIH DLKPSN+++  +    + DF +A+       S   T  + T  Y APE     
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYYRAPEVILGM 193

Query: 351 RVSTNGDVYSFGIMLMETFTGKKP---------TNEIFNG------------EMTLKHWV 389
               N D++S G ++ E    K            N++               + T++++V
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253

Query: 390 NDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREI 444
            +    + +        S         +   S   +L  +  V  P +RI+  + 
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 87.5 bits (216), Expect = 1e-20
 Identities = 28/200 (14%), Positives = 61/200 (30%), Gaps = 25/200 (12%)

Query: 179 NLIGRGGFGSVYKARLGDGMEVAVKVFNL----------QCGRALKGFDVECEMMKSIRH 228
            L+G G   +V+        E  VK   +          +       F V          
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 229 RNLIKVISTCSNEEFKALVLEYMPHGSL-EKYMYSSNYILDIFQRLNIMIDVASALEYLH 287
           R L K+      + +      +  +  L E       Y + +     ++  +   +   +
Sbjct: 66  RALQKLQGLAVPKVY-----AWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120

Query: 288 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYG 347
                 I+H DL   NVL+ +  +  + DF  +  +    +   +      +  +   + 
Sbjct: 121 ---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEV---GEEGWREILERDVRNIITYFS 173

Query: 348 REGRVSTNGDVYSFGIMLME 367
           R  R     D+ S    +++
Sbjct: 174 RTYRTEK--DINSAIDRILQ 191

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 82.9 bits (203), Expect = 4e-18
 Identities = 30/66 (45%), Positives = 43/66 (65%), Gaps = 3/66 (4%)

Query: 40  NLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPN 99
           +L NN + G +P  L +L +L +LN+SFN L GEIP+GG  + F V ++  N+ LCGSP 
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP- 308

Query: 100 LQVPPC 105
             +P C
Sbjct: 309 --LPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 54.8 bits (130), Expect = 8e-09
 Identities = 15/50 (30%), Positives = 21/50 (42%), Gaps = 1/50 (2%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIP 51
           +P  +  LK L  L + +N L G IP   G+L        +NN      P
Sbjct: 260 LPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 37.0 bits (84), Expect = 0.004
 Identities = 29/119 (24%), Positives = 41/119 (34%), Gaps = 3/119 (2%)

Query: 7   GGLKNLEYLFLGYNRLQG--PIPDSFGDLISLKFLNLSNN-NLSGAIPASLEKLSYLENL 63
                +  L L    L    PIP S  +L  L FL +    NL G IP ++ KL+ L  L
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 64  NLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCKTSNHHTLWKNSLLLRI 122
            ++   + G IP         V        L G+    +         T   N +   I
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 61.9 bits (149), Expect = 4e-11
 Identities = 15/64 (23%), Positives = 29/64 (45%), Gaps = 4/64 (6%)

Query: 5   EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLN 64
            +  L  L+ LF   N++      S  +L ++ +L+  +N +S   P  L  L+ +  L 
Sbjct: 324 PVSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLG 379

Query: 65  LSFN 68
           L+  
Sbjct: 380 LNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 61.6 bits (148), Expect = 7e-11
 Identities = 21/67 (31%), Positives = 32/67 (47%), Gaps = 4/67 (5%)

Query: 9   LKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN 68
           LKNL YL L +N +    P     L  L+ L  +NN +S    +SL  L+ +  L+   N
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHN 361

Query: 69  KLEGEIP 75
           ++    P
Sbjct: 362 QISDLTP 368

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.9 bits (110), Expect = 3e-06
 Identities = 9/42 (21%), Positives = 20/42 (47%), Gaps = 2/42 (4%)

Query: 3   PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNN 44
            + +  L N+ +L  G+N++    P    +L  +  L L++ 
Sbjct: 344 VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.8 bits (107), Expect = 8e-06
 Identities = 25/109 (22%), Positives = 43/109 (39%), Gaps = 8/109 (7%)

Query: 10  KNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNK 69
            NL+ L L  N+L+     +   L +L  L+L+NN +S   P  L  L+ L  L L  N+
Sbjct: 219 TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 274

Query: 70  LEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCKTSNHHTLWKNSL 118
           +        P    +  +              +   K   + TL+ N++
Sbjct: 275 ISNIS----PLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNI 319

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.5 bits (101), Expect = 3e-05
 Identities = 14/68 (20%), Positives = 23/68 (33%), Gaps = 4/68 (5%)

Query: 8  GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 67
           L       LG   +   +  +  DL  +  L      +       +E L+ L  +N S 
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 75

Query: 68 NKLEGEIP 75
          N+L    P
Sbjct: 76 NQLTDITP 83

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.8 bits (89), Expect = 0.001
 Identities = 15/60 (25%), Positives = 27/60 (45%), Gaps = 4/60 (6%)

Query: 9  LKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN 68
          L  +  L      ++    D    L +L  +N SNN L+   P  L+ L+ L ++ ++ N
Sbjct: 43 LDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNN 98

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 56.6 bits (135), Expect = 2e-09
 Identities = 21/71 (29%), Positives = 33/71 (46%), Gaps = 2/71 (2%)

Query: 2  IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 61
          +P ++    +   L L  N++       F +L +L  L L NN +S   P +   L  LE
Sbjct: 25 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82

Query: 62 NLNLSFNKLEG 72
           L LS N+L+ 
Sbjct: 83 RLYLSKNQLKE 93

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 50.0 bits (118), Expect = 2e-07
 Identities = 21/118 (17%), Positives = 37/118 (31%), Gaps = 1/118 (0%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
           +   +   LKNL  L L  N++    P +F  L+ L+ L LS N L        + L  L
Sbjct: 46  IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQEL 105

Query: 61  ENLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCKTSNHHTLWKNSL 118
                   K+   +  G              +             K  ++  +   ++
Sbjct: 106 RVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENG-AFQGMKKLSYIRIADTNI 162

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 44.3 bits (103), Expect = 2e-05
 Identities = 28/112 (25%), Positives = 41/112 (36%)

Query: 7   GGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLS 66
           G   +L  L L  N++      S   L +L  L LS N++S     SL    +L  L+L+
Sbjct: 168 GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 227

Query: 67  FNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCKTSNHHTLWKNSL 118
            NKL          +   V     N +     N   PP   +   +    SL
Sbjct: 228 NNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSL 279

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 36.9 bits (84), Expect = 0.004
 Identities = 16/68 (23%), Positives = 28/68 (41%), Gaps = 7/68 (10%)

Query: 10  KNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSG------AIPASLEKLSYLENL 63
            +L  L L  N+L   +P    D   ++ + L NNN+S         P    K +    +
Sbjct: 219 PHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGV 277

Query: 64  NLSFNKLE 71
           +L  N ++
Sbjct: 278 SLFSNPVQ 285

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.6 bits (116), Expect = 4e-07
 Identities = 13/71 (18%), Positives = 25/71 (35%), Gaps = 5/71 (7%)

Query: 11 NLEYLFLGYNRLQ-GPIPDSFGDLISLKFLNLSNNNLSG----AIPASLEKLSYLENLNL 65
          +++ L +    L      +    L   + + L +  L+      I ++L     L  LNL
Sbjct: 3  DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 66 SFNKLEGEIPR 76
            N+L      
Sbjct: 63 RSNELGDVGVH 73

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.5 bits (108), Expect = 5e-06
 Identities = 18/76 (23%), Positives = 26/76 (34%), Gaps = 9/76 (11%)

Query: 10  KNLEYLFLGYNRLQG----PIPDSFGDLISLKFLNLSNNNLSGAIPASL-----EKLSYL 60
             L  L+L    +       +  +     SL+ L+LSNN L  A    L     +    L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 61  ENLNLSFNKLEGEIPR 76
           E L L       E+  
Sbjct: 429 EQLVLYDIYWSEEMED 444

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (94), Expect = 2e-04
 Identities = 12/70 (17%), Positives = 23/70 (32%), Gaps = 9/70 (12%)

Query: 6  IGGLKNLEYLFLGYNRLQG----PIPDSFGDLISLKFLNLSNNNLSGAIPASL-----EK 56
          +  L+  + + L    L       I  +     +L  LNL +N L       +       
Sbjct: 23 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82

Query: 57 LSYLENLNLS 66
             ++ L+L 
Sbjct: 83 SCKIQKLSLQ 92

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 4e-04
 Identities = 11/61 (18%), Positives = 20/61 (32%), Gaps = 5/61 (8%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLI-----SLKFLNLSNNNLSGAIPASLEK 56
           +   +    +L  L L  N L         + +      L+ L L +   S  +   L+ 
Sbjct: 389 LAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQA 448

Query: 57  L 57
           L
Sbjct: 449 L 449

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 47.9 bits (112), Expect = 1e-06
 Identities = 18/67 (26%), Positives = 31/67 (46%), Gaps = 9/67 (13%)

Query: 9   LKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN 68
             +LE L +  N+L   +P        L+ L  S N+L+  +P   + L   + L++ +N
Sbjct: 283 PPSLEELNVSNNKLIE-LPALPP---RLERLIASFNHLA-EVPELPQNL---KQLHVEYN 334

Query: 69  KLEGEIP 75
            L  E P
Sbjct: 335 PLR-EFP 340

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 43.3 bits (100), Expect = 4e-05
 Identities = 14/54 (25%), Positives = 21/54 (38%), Gaps = 5/54 (9%)

Query: 7   GGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
                LE L   +N L   +P+      +LK L++  N L    P   E +  L
Sbjct: 301 ALPPRLERLIASFNHLAE-VPELPQ---NLKQLHVEYNPLRE-FPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 41.0 bits (94), Expect = 2e-04
 Identities = 25/78 (32%), Positives = 31/78 (39%), Gaps = 7/78 (8%)

Query: 16  FLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIP 75
               N     I        SL+ LN+SNN L   +PA   +   LE L  SFN L  E+P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVP 320

Query: 76  RGGPFRNFSVESFEGNEL 93
                +N      E N L
Sbjct: 321 EL--PQNLKQLHVEYNPL 336

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.9 bits (110), Expect = 1e-06
 Identities = 16/61 (26%), Positives = 25/61 (40%), Gaps = 4/61 (6%)

Query: 6   IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNL 65
           +  L  L  L    N++    P     L +L  ++L NN +S   P  L   S L  + L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

Query: 66  S 66
           +
Sbjct: 225 T 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.9 bits (97), Expect = 6e-05
 Identities = 9/39 (23%), Positives = 17/39 (43%), Gaps = 2/39 (5%)

Query: 5   EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSN 43
            +  L NL  + L  N++    P    +  +L  + L+N
Sbjct: 190 PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 43.6 bits (102), Expect = 4e-06
 Identities = 23/95 (24%), Positives = 31/95 (32%), Gaps = 24/95 (25%)

Query: 2   IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISL----------------------KFL 39
           +   +  L  + +L L +NRL+   P +   L  L                      + L
Sbjct: 12  VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDGVANLPRLQEL 70

Query: 40  NLSNNNL-SGAIPASLEKLSYLENLNLSFNKLEGE 73
            L NN L   A    L     L  LNL  N L  E
Sbjct: 71  LLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 38.2 bits (88), Expect = 3e-04
 Identities = 13/53 (24%), Positives = 18/53 (33%), Gaps = 1/53 (1%)

Query: 13  EYLFLGYNRLQG-PIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLN 64
           + L L  NRLQ             L  LNL  N+L             L +++
Sbjct: 68  QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVS 120

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 37.8 bits (87), Expect = 5e-04
 Identities = 17/71 (23%), Positives = 31/71 (43%), Gaps = 2/71 (2%)

Query: 37  KFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCG 96
           + L+L++ +L+  +   LE+L  + +L+LS N+L    P     R   V     N L   
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58

Query: 97  SPNLQVPPCKT 107
                +P  + 
Sbjct: 59  DGVANLPRLQE 69

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 44.8 bits (104), Expect = 5e-06
 Identities = 24/101 (23%), Positives = 40/101 (39%), Gaps = 3/101 (2%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
           +      GL  L+ L L  N++   +P SF  L SL  LNL++N  +           +L
Sbjct: 93  ISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC-NCHLAWFAEWL 151

Query: 61  ENLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQ 101
              +L+        P     R+  ++    +E  C S N +
Sbjct: 152 RKKSLNGGAARCGAPS--KVRDVQIKDLPHSEFKCSSENSE 190

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 40.2 bits (92), Expect = 2e-04
 Identities = 24/80 (30%), Positives = 35/80 (43%)

Query: 19  YNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGG 78
            N+++      F  L  LK LNL +N +S  +P S E L+ L +LNL+ N          
Sbjct: 87  ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW 146

Query: 79  PFRNFSVESFEGNELLCGSP 98
                  +S  G    CG+P
Sbjct: 147 FAEWLRKKSLNGGAARCGAP 166

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.2 bits (100), Expect = 3e-05
 Identities = 10/44 (22%), Positives = 15/44 (34%), Gaps = 2/44 (4%)

Query: 2  IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNN 45
          +P ++   K+   L L  N L      +      L  LNL    
Sbjct: 25 LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.2 bits (87), Expect = 0.001
 Identities = 14/62 (22%), Positives = 22/62 (35%), Gaps = 3/62 (4%)

Query: 5  EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLN 64
          E+  + +   +      L   +P           L+LS N L     A+L   + L  LN
Sbjct: 5  EVSKVASHLEVNCDKRNLTA-LPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 65 LS 66
          L 
Sbjct: 62 LD 63

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.2 bits (97), Expect = 5e-05
 Identities = 9/44 (20%), Positives = 13/44 (29%)

Query: 26  IPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNK 69
             D F        L++S   +       LE L  L   +    K
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.0 bits (94), Expect = 2e-04
 Identities = 6/44 (13%), Positives = 12/44 (27%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNN 44
           +      G      L +   R+         +L  L+  +  N 
Sbjct: 192 LPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.4 bits (98), Expect = 6e-05
 Identities = 13/68 (19%), Positives = 30/68 (44%), Gaps = 2/68 (2%)

Query: 10 KNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSG-AIPASLEKLSYLENLNLSFN 68
          + +       + +  P+ + F     ++ ++LSN+ +    +   L + S L+NL+L   
Sbjct: 23 QGVIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 81

Query: 69 KLEGEIPR 76
          +L   I  
Sbjct: 82 RLSDPIVN 89

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.5 bits (91), Expect = 2e-04
 Identities = 9/88 (10%), Positives = 25/88 (28%), Gaps = 2/88 (2%)

Query: 29  SFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSVESF 88
            + + +  + L+L    +   I      L   + ++ S N++  ++      R       
Sbjct: 13  QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLV 70

Query: 89  EGNELLCGSPNLQVPPCKTSNHHTLWKN 116
             N +      L       +       +
Sbjct: 71  NNNRICRIGEGLDQALPDLTELILTNNS 98

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 35.7 bits (81), Expect = 0.004
 Identities = 15/103 (14%), Positives = 29/103 (28%), Gaps = 3/103 (2%)

Query: 9   LKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN 68
                 L L   ++   I +    L     ++ S+N +          L  L+ L ++ N
Sbjct: 17  AVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLLVNNN 73

Query: 69  KLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCKTSNHH 111
           ++               E    N  L    +L       S  +
Sbjct: 74  RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTY 116

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 41.0 bits (94), Expect = 2e-04
 Identities = 17/71 (23%), Positives = 24/71 (33%), Gaps = 11/71 (15%)

Query: 14  YLFLGYNRLQGPIPDSFGD------LISLKFLNLSNNNLSGAIPASL-----EKLSYLEN 62
            L L    L      +  D       I L+ L L  N +      +L     EK+  L  
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306

Query: 63  LNLSFNKLEGE 73
           L L+ N+   E
Sbjct: 307 LELNGNRFSEE 317

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 40.2 bits (92), Expect = 3e-04
 Identities = 12/109 (11%), Positives = 29/109 (26%), Gaps = 5/109 (4%)

Query: 10  KNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSG----AIPASLEKLSYLENLNL 65
           K+L+   +     +  +     +  S+K + LS N +       +  ++     LE    
Sbjct: 8   KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66

Query: 66  SFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCKTSNHHTLW 114
           S                  +++      L            T+    + 
Sbjct: 67  SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLID 115

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.4 bits (91), Expect = 3e-04
 Identities = 25/100 (25%), Positives = 31/100 (31%), Gaps = 2/100 (2%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQG--PIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLS 58
            +      +  L  L L  NRL     +        +LK LNLS N L         K  
Sbjct: 56  TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGL 115

Query: 59  YLENLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSP 98
            LE L L  N L         + +   E F     L G  
Sbjct: 116 KLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGHE 155

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.6 bits (93), Expect = 3e-04
 Identities = 28/98 (28%), Positives = 39/98 (39%)

Query: 1   VIPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
           V      GL +L+ L L  NR+    P +F DL  L  L L  NNLS     +L  L  L
Sbjct: 168 VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRAL 227

Query: 61  ENLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSP 98
           + L L+ N    +      +          +E+ C  P
Sbjct: 228 QYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLP 265

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.8 bits (91), Expect = 4e-04
 Identities = 22/65 (33%), Positives = 31/65 (47%)

Query: 11  NLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKL 70
            L+YL+L  N LQ    D+F DL +L  L L  N +S     +   L  L+ L L  N++
Sbjct: 130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189

Query: 71  EGEIP 75
               P
Sbjct: 190 AHVHP 194

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.6 bits (88), Expect = 0.001
 Identities = 13/62 (20%), Positives = 23/62 (37%), Gaps = 4/62 (6%)

Query: 11  NLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKL 70
            L+YL L  N        +      L+    S++ +  ++P  L          L+ N L
Sbjct: 226 ALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLPQRLAGRDL---KRLAANDL 281

Query: 71  EG 72
           +G
Sbjct: 282 QG 283

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.6 bits (88), Expect = 4e-04
 Identities = 25/118 (21%), Positives = 39/118 (33%), Gaps = 1/118 (0%)

Query: 2   IPTEIGGLKNLEYLFL-GYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 60
               + G +NL  L++     LQ         L  L+ L +  + L    P +      L
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82

Query: 61  ENLNLSFNKLEGEIPRGGPFRNFSVESFEGNELLCGSPNLQVPPCKTSNHHTLWKNSL 118
             LNLSFN LE    +     +       GN L C      +   +      + +  L
Sbjct: 83  SRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKL 140

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 36.9 bits (84), Expect = 0.002
 Identities = 10/39 (25%), Positives = 17/39 (43%), Gaps = 2/39 (5%)

Query: 5   EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSN 43
            + GL  L+ L+L  N +      +   L +L  L L +
Sbjct: 173 PLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 36.2 bits (82), Expect = 0.004
 Identities = 11/56 (19%), Positives = 19/56 (33%), Gaps = 7/56 (12%)

Query: 8  GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 63
           L       LG   +   +  +  DL  +  L      +      S++ + YL NL
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-----SIDGVEYLNNL 64

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	470
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.89
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.41
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.37
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.33
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.31
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.19
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.16
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.12
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.08
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.08
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.04
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.03
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	98.96
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	98.92
d2ifga3	156	High affinity nerve growth factor receptor, N-term	98.78
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.77
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	98.74
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	98.74
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	98.73
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	98.71
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.67
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	98.6
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	98.56
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.55
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.51
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.47
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.35
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	98.32
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.25
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	98.24
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	98.13
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.04
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.03
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	97.97
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.82
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	97.73
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.29
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.2
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	97.19
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	97.18
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	97.11
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.1
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	96.94
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	96.81
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	96.68
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	96.65
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	95.33
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	93.78
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	92.31

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-55  Score=412.73  Aligned_cols=261  Identities=27%  Similarity=0.423  Sum_probs=209.5

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      .++|.+.+.||+|+||+||+|+++  ..||||+++..  .....+.+.+|++++++++||||+++++++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            467999999999999999999874  35999998644  34556788999999999999999999999865 45789999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      |+++|+|.+++...+..+++..+..++.|+++||+|||   +++|+||||||+|||++.++.+||+|||+|+........
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            99999999999877778999999999999999999999   899999999999999999999999999999876544333


Q ss_pred             ccccccccCccccCccccCC---CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhh-cCCcccccccccc
Q 040392          330 MTQTQTLATIGYMAPEYGRE---GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDW-LPISTMEVVGANL  405 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  405 (470)
                      .......||+.|+|||++.+   ..++.++|||||||++|||+||+.||.+...... +...+... .+...        
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-~~~~~~~~~~~p~~--------  231 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIFMVGRGYLSPDL--------  231 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHHHHTSCCCCG--------
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH-HHHHHhcCCCCCcc--------
Confidence            44455679999999999864   3588999999999999999999999986533221 11111111 11100        


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                             ...+..++.++.+|+.+||+.||++||||.||+++|+.+..+
T Consensus       232 -------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         232 -------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             -------GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -------hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence                   011234577899999999999999999999999999998754

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-55  Score=406.25  Aligned_cols=258  Identities=25%  Similarity=0.395  Sum_probs=205.3

Q ss_pred             CCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCC
Q 040392          173 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP  252 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~  252 (470)
                      ++|++.+.||+|+||+||+|++.+++.||||+++.. ....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            578889999999999999999988999999998754 3345678999999999999999999999999999999999999


Q ss_pred             CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcccc
Q 040392          253 HGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQ  332 (470)
Q Consensus       253 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  332 (470)
                      +|+|.+++......+++..+..++.|+++||+|||   +++|+||||||+|||+++++.+||+|||+++....... ...
T Consensus        84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~  159 (263)
T d1sm2a_          84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSS  159 (263)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCc-eee
Confidence            99999999887778999999999999999999999   89999999999999999999999999999987643322 223


Q ss_pred             cccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhhh
Q 040392          333 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIH  412 (470)
Q Consensus       333 ~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  412 (470)
                      ....||+.|+|||++.+..++.++|||||||++|||+|+..|+...... ..+...+.....                  
T Consensus       160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-~~~~~~i~~~~~------------------  220 (263)
T d1sm2a_         160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTGFR------------------  220 (263)
T ss_dssp             -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-HHHHHHHHHTCC------------------
T ss_pred             cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-HHHHHHHHhcCC------------------
Confidence            3456899999999999999999999999999999999955444332221 112221111111                  


Q ss_pred             hHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          413 FVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       413 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                      ...+..++.++.+++.+||+.||++||||+||+++|+++.++
T Consensus       221 ~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         221 LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence            011234567789999999999999999999999999999653

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=406.20  Aligned_cols=254  Identities=23%  Similarity=0.330  Sum_probs=209.1

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            367999999999999999999864 69999999987543 3345678999999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      |+++|+|.+++... ..+++..+..++.|+++||+|||   +++|+||||||+|||+++++.+||+|||+|+........
T Consensus        84 y~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          84 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             ccCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            99999999999654 46899999999999999999999   999999999999999999999999999999877544444


Q ss_pred             ccccccccCccccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          330 MTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                      ......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||....+.......+.......             
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~-------------  226 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL-------------  226 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS-------------
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-------------
Confidence            44456789999999999988776 5789999999999999999999976544333222221111000             


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                           .....++.++.+|+.+||+.||++|||+.|+++|
T Consensus       227 -----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         227 -----NPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             -----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -----CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                 0112346678899999999999999999999764

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-53  Score=402.19  Aligned_cols=250  Identities=26%  Similarity=0.340  Sum_probs=210.7

Q ss_pred             CCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++........+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            4799999999999999999975 469999999998665556677899999999999999999999999999999999999


Q ss_pred             CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccc
Q 040392          252 PHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  331 (470)
Q Consensus       252 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  331 (470)
                      ++|+|.+++.+.  .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+....  ..
T Consensus       100 ~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~~  172 (293)
T d1yhwa1         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SK  172 (293)
T ss_dssp             TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CC
T ss_pred             CCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccc--cc
Confidence            999999988654  4899999999999999999999   9999999999999999999999999999998764322  23


Q ss_pred             ccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhh
Q 040392          332 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDI  411 (470)
Q Consensus       332 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  411 (470)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+........+.                
T Consensus       173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~~~~----------------  235 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPE----------------  235 (293)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSCC----------------
T ss_pred             ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-HHHHHHhCCCCC----------------
Confidence            345679999999999999999999999999999999999999997533221 111111111000                


Q ss_pred             hhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          412 HFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       412 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                       ...+..++.++.+|+.+||+.||++|||+.|+++|
T Consensus       236 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         236 -LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             -CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             -CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             01123456779999999999999999999999875

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=396.86  Aligned_cols=255  Identities=22%  Similarity=0.422  Sum_probs=216.6

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      .++|++.+.||+|+||+||+|++++++.||||+++... ...+.+.+|++++++++||||++++|++.++...++||||+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            36899999999999999999999889999999997543 34567899999999999999999999999999999999999


Q ss_pred             CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccc
Q 040392          252 PHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  331 (470)
Q Consensus       252 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  331 (470)
                      ++|+|.+++......+++..+.+++.|+++||+|||   +++|+||||||+||++++++.+||+|||+++...... ...
T Consensus        82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~~  157 (258)
T d1k2pa_          82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTS  157 (258)
T ss_dssp             TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-CCC
T ss_pred             CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCC-cee
Confidence            999999998887778999999999999999999999   8999999999999999999999999999998765432 223


Q ss_pred             ccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCchh
Q 040392          332 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED  410 (470)
Q Consensus       332 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (470)
                      .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......+.  ...+....                 
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~--~~~i~~~~-----------------  218 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--AEHIAQGL-----------------  218 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH--HHHHHTTC-----------------
T ss_pred             ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH--HHHHHhCC-----------------
Confidence            344678999999999999999999999999999999998 8999987543321  11111110                 


Q ss_pred             hhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          411 IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       411 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                       +...+..++.++.+|+.+||+.||++|||++|++++|.+|
T Consensus       219 -~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         219 -RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             -CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             -CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence             0111234567799999999999999999999999999653

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-53  Score=402.03  Aligned_cols=252  Identities=24%  Similarity=0.337  Sum_probs=210.9

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      +.|++.+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46888999999999999999864 68999999998777777788999999999999999999999999999999999999


Q ss_pred             CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCccc
Q 040392          252 PHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMT  331 (470)
Q Consensus       252 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  331 (470)
                      ++|+|.+++.+....+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|......  ...
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~  166 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQR  166 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHH
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCC--ccc
Confidence            999999998776667999999999999999999999   999999999999999999999999999999754321  122


Q ss_pred             ccccccCccccCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccccc
Q 040392          332 QTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL  406 (470)
Q Consensus       332 ~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (470)
                      .....||+.|+|||++.     +..++.++|||||||++|||+||+.||......+. +........+            
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-~~~i~~~~~~------------  233 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-LLKIAKSEPP------------  233 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-HHHHHHSCCC------------
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH-HHHHHcCCCC------------
Confidence            33567999999999874     45688999999999999999999999976433221 1111111100            


Q ss_pred             CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       407 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                           ....+..++.++.+|+.+||+.||++|||+.|+++|
T Consensus       234 -----~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         234 -----TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             -----CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             -----CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 001123457789999999999999999999999875

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-53  Score=405.85  Aligned_cols=258  Identities=23%  Similarity=0.424  Sum_probs=203.5

Q ss_pred             CCCCCCCeecccCceEEEEEEeCC-C---cEEEEEEeecc-cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLGD-G---MEVAVKVFNLQ-CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      ++|++.+.||+|+||+||+|++.. +   ..||||.+... .....+.+.+|++++++++|||||++++++.+.+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            457778899999999999998642 3   35899988654 344566789999999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||+++|+|.+++......+++.++..++.|+++||+|||   +++|+||||||+|||++.++.+||+|||+|+.+....
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence            9999999999999887778999999999999999999999   8999999999999999999999999999998765432


Q ss_pred             Ccc---cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccc
Q 040392          328 QSM---TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA  403 (470)
Q Consensus       328 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (470)
                      ...   ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.+....  .+...+....          
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~~~~i~~~~----------  250 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVINAIEQDY----------  250 (299)
T ss_dssp             -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTC----------
T ss_pred             CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC----------
Confidence            221   1223457899999999999999999999999999999998 89999764332  1222221110          


Q ss_pred             cccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                              +...+..++.++.+|+.+||+.||++||||.||++.|+++..
T Consensus       251 --------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         251 --------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             --------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             --------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence                    011123457789999999999999999999999999999864

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-53  Score=396.05  Aligned_cols=246  Identities=25%  Similarity=0.379  Sum_probs=206.9

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++....   ......+.+|+++++.++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57899999999999999999864 68999999986432   334566888999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||+++|+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|......  
T Consensus        86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--  159 (263)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred             eecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCC--
Confidence            9999999999997654 5899999999999999999999   999999999999999999999999999999865432  


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+.....    ..            
T Consensus       160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~----~~------------  220 (263)
T d2j4za1         160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TYKRISR----VE------------  220 (263)
T ss_dssp             --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHT----TC------------
T ss_pred             --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH-HHHHHHc----CC------------
Confidence              2234679999999999999999999999999999999999999997532211 1111111    00            


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                          ...+..++.++.+|+.+||+.||++|||+.|+++|
T Consensus       221 ----~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         221 ----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             ----CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence                00122346778999999999999999999999874

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-53  Score=396.57  Aligned_cols=258  Identities=23%  Similarity=0.400  Sum_probs=211.0

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      .++|++.+.||+|+||.||+|++++++.||||+++... ...+.+.+|++++++++|||||++++++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            35788899999999999999999888999999997543 345678999999999999999999998865 4568999999


Q ss_pred             CCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          252 PHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       252 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      ++|+|.+++.... ..+++..+..++.||++||+|||   +++|+||||||+|||+++++.+||+|||+|+.+.... ..
T Consensus        90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~  165 (272)
T d1qpca_          90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YT  165 (272)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EE
T ss_pred             CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCc-cc
Confidence            9999999875443 35899999999999999999999   8999999999999999999999999999998775322 23


Q ss_pred             cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchh
Q 040392          331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED  410 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (470)
                      ......||+.|+|||++.++.++.++|||||||++|||+||..|+....... .....+.....                
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-~~~~~i~~~~~----------------  228 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERGYR----------------  228 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHTTCC----------------
T ss_pred             cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhcCC----------------
Confidence            3345678999999999998899999999999999999999766654432221 11111111110                


Q ss_pred             hhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          411 IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       411 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                        ...+..++.++.+|+.+||+.||++||||.||++.|+++..+
T Consensus       229 --~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         229 --MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence              111234577899999999999999999999999999998653

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-53  Score=398.83  Aligned_cols=263  Identities=23%  Similarity=0.398  Sum_probs=215.8

Q ss_pred             CCCCCCCe-ecccCceEEEEEEeC---CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          173 DGFSENNL-IGRGGFGSVYKARLG---DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       173 ~~~~~~~~-ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      ++|.+.+. ||+|+||.||+|.+.   ++..||||+++... ....+.+.+|++++++++|||||++++++.. +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            45666664 999999999999753   35679999997543 3456778999999999999999999999865 457899


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||+++|+|.+++...+..+++..+..++.|+++||+|||   +++|+||||||+||+++.++.+||+|||+++.+....
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  163 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  163 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence            9999999999998777778999999999999999999999   8999999999999999999999999999998775433


Q ss_pred             Cc-ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          328 QS-MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       328 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      .. .......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+  +...+....            
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~--~~~~i~~~~------------  229 (285)
T d1u59a_         164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIEQGK------------  229 (285)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHHHHTTC------------
T ss_pred             cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCC------------
Confidence            22 22334568999999999998999999999999999999998 999998754322  222221111            


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHhhhc
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRNV  459 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~~~~  459 (470)
                            +...+..++.++.+|+.+||+.||++|||+.+|++.|+.+..++....
T Consensus       230 ------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~  277 (285)
T d1u59a_         230 ------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV  277 (285)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred             ------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhcc
Confidence                  011234567889999999999999999999999999998876655444

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-52  Score=396.61  Aligned_cols=257  Identities=25%  Similarity=0.392  Sum_probs=213.2

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      .++|++.+.||+|+||+||+|++. +++.||||+++... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            457888899999999999999875 58899999987543 3456789999999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          251 MPHGSLEKYMYSS-NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       251 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      +++|+|.+++... ...+++..+..++.|+++||+|||   +++|+||||||+|||+++++.+||+|||+|+...... .
T Consensus        95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~-~  170 (287)
T d1opja_          95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-Y  170 (287)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS-S
T ss_pred             ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCC-c
Confidence            9999999998754 457899999999999999999999   8999999999999999999999999999998764332 2


Q ss_pred             ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCch
Q 040392          330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE  409 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (470)
                      .......|++.|+|||++.+..++.++|||||||++|||++|..||....+.. .+...+.....               
T Consensus       171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-~~~~~i~~~~~---------------  234 (287)
T d1opja_         171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELLEKDYR---------------  234 (287)
T ss_dssp             EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHHHHHTTCC---------------
T ss_pred             eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-HHHHHHhcCCC---------------
Confidence            33344568899999999999999999999999999999999877765432211 11222211111               


Q ss_pred             hhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHH
Q 040392          410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR  452 (470)
Q Consensus       410 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~  452 (470)
                         ...+..++.++.+|+.+||+.||++|||+.|+++.|+.+.
T Consensus       235 ---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         235 ---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ---CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence               1112345778999999999999999999999999998874

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-52  Score=392.32  Aligned_cols=260  Identities=25%  Similarity=0.439  Sum_probs=205.6

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCC-----cEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDG-----MEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKA  245 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  245 (470)
                      .+.|+..+.||+|+||.||+|.+.+.     ..||||++.... ......+.+|++++++++|||||+++|++.+.+..+
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            35678889999999999999976432     479999986543 334557889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC
Q 040392          246 LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  325 (470)
                      +||||+.+|++.+++......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus        86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence            999999999999999887778999999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCC-cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccc
Q 040392          326 EDQ-SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGAN  404 (470)
Q Consensus       326 ~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (470)
                      ... ........||+.|+|||++.+..++.++|||||||++|||++|..|+....... .+...+....           
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-~~~~~i~~~~-----------  230 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMKAINDGF-----------  230 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHTTC-----------
T ss_pred             CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH-HHHHHHhccC-----------
Confidence            322 223334568999999999999999999999999999999999766654432221 1222211111           


Q ss_pred             ccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          405 LLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       405 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                             +...+..++.++.+|+.+||+.||++||||.||++.|+++.+
T Consensus       231 -------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         231 -------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             -------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -------CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence                   011223457789999999999999999999999999998864

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-53  Score=398.49  Aligned_cols=250  Identities=24%  Similarity=0.364  Sum_probs=205.4

Q ss_pred             CCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5799999999999999999986 469999999987532   334567889999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||+++|+|.+++...+ .+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+|+.+.....
T Consensus        88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            9999999999987654 6899999999999999999999   99999999999999999999999999999988754444


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+  +...+   .....           
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~~~i---~~~~~-----------  227 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL--IFQKI---IKLEY-----------  227 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH---HTTCC-----------
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH--HHHHH---HcCCC-----------
Confidence            444455689999999999999999999999999999999999999997632211  11111   11000           


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                           ..+..++.++.+|+.+||+.||++|||++|++++
T Consensus       228 -----~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         228 -----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             -----CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             -----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence                 0112346678999999999999999999998664

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=404.19  Aligned_cols=256  Identities=23%  Similarity=0.376  Sum_probs=210.2

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCC------CcEEEEEEeecc-cchhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGD------GMEVAVKVFNLQ-CGRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEF  243 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~  243 (470)
                      .++|++.+.||+|+||+||+|++..      ...||+|.+... .......+.+|+.++.++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            3678899999999999999997532      236999998644 334556788999999998 89999999999999999


Q ss_pred             eeEEEecCCCCChHHhhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCC
Q 040392          244 KALVLEYMPHGSLEKYMYSSN----------------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKP  301 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp  301 (470)
                      .++||||+++|+|.+++....                      ..+++..++.++.|+++||+|||   +++|+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCch
Confidence            999999999999999997653                      24788999999999999999999   89999999999


Q ss_pred             CCeeeCCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccc
Q 040392          302 SNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFN  380 (470)
Q Consensus       302 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~  380 (470)
                      +||+++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+| |+.||.+...
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987765544444455678999999999999999999999999999999998 8999986543


Q ss_pred             CcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHH
Q 040392          381 GEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLL  449 (470)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~  449 (470)
                      .+ .+...+.....                  ...+..++.++.+|+.+||+.||++|||++||+++|.
T Consensus       273 ~~-~~~~~~~~~~~------------------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 DA-NFYKLIQNGFK------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SH-HHHHHHHTTCC------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HH-HHHHHHhcCCC------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            32 22222221111                  1123345778999999999999999999999999985

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=391.47  Aligned_cols=254  Identities=21%  Similarity=0.278  Sum_probs=194.2

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeecc--CCeeeE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSN--EEFKAL  246 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~~l  246 (470)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++....  ....+.+.+|++++++++||||+++++++.+  ....++
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            46799999999999999999976 468999999986542  3345668899999999999999999998854  456789


Q ss_pred             EEecCCCCChHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeeecCCCCCCeeeCCCCCeEEeeecccc
Q 040392          247 VLEYMPHGSLEKYMYS---SNYILDIFQRLNIMIDVASALEYLHFGY--SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK  321 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~--~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~  321 (470)
                      ||||+++|+|.+++.+   .+..+++..++.++.|++.||+|||+..  ..+|+||||||+|||++.++.+||+|||+|+
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            9999999999999864   2357899999999999999999999311  1349999999999999999999999999998


Q ss_pred             ccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccc
Q 040392          322 LLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVV  401 (470)
Q Consensus       322 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (470)
                      .+....  .......||+.|+|||++.+..++.++|||||||++|||+||+.||......  .+...+......      
T Consensus       163 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~--~~~~~i~~~~~~------  232 (269)
T d2java1         163 ILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAGKIREGKFR------  232 (269)
T ss_dssp             HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHTCCC------
T ss_pred             ecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH--HHHHHHHcCCCC------
Confidence            764322  2233467999999999999999999999999999999999999999764322  111111111000      


Q ss_pred             cccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          402 GANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                                  ..+..++.++.+|+.+||+.||++|||+.|+++|
T Consensus       233 ------------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         233 ------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             ------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                        0112346779999999999999999999999864

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=385.29  Aligned_cols=245  Identities=24%  Similarity=0.386  Sum_probs=197.1

Q ss_pred             CCCCeecccCceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeecc----CCeeeEEE
Q 040392          176 SENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSN----EEFKALVL  248 (470)
Q Consensus       176 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~----~~~~~lv~  248 (470)
                      +..+.||+|+||+||+|++. +++.||+|.+...  .....+.+.+|++++++++||||+++++++..    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            45568999999999999864 6889999998654  23345678899999999999999999999854    35678999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeeC-CCCCeEEeeeccccccCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAP--IIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--i~H~dlkp~Nill~-~~~~~kl~Dfg~a~~~~~  325 (470)
                      ||+++|+|.+++.+.. .+++..+..++.||++||+|||   +++  |+||||||+|||++ +++.+||+|||+|+....
T Consensus        92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            9999999999997654 6899999999999999999999   777  99999999999996 588999999999986432


Q ss_pred             CCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          326 EDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       326 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      .    ......||+.|+|||++.+ .++.++|||||||++|||++|+.||....+.............+.          
T Consensus       168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~----------  232 (270)
T d1t4ha_         168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA----------  232 (270)
T ss_dssp             T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG----------
T ss_pred             C----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCc----------
Confidence            1    2234679999999998865 699999999999999999999999976433221111111100000          


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                              ..+..++.++.+++.+||+.||++|||+.|+++|
T Consensus       233 --------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         233 --------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             --------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             --------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence                    1122345678999999999999999999999874

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-52  Score=390.41  Aligned_cols=251  Identities=24%  Similarity=0.375  Sum_probs=203.4

Q ss_pred             CeecccCceEEEEEEeC---CCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecCCC
Q 040392          179 NLIGRGGFGSVYKARLG---DGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH  253 (470)
Q Consensus       179 ~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~  253 (470)
                      +.||+|+||+||+|.+.   .++.||||+++..  .....+.+.+|++++++++||||+++++++..+ ..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            47999999999999753   3568999998643  233456789999999999999999999999654 56899999999


Q ss_pred             CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc-ccc
Q 040392          254 GSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS-MTQ  332 (470)
Q Consensus       254 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~  332 (470)
                      |+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.+...... ...
T Consensus        92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            99999997654 6899999999999999999999   899999999999999999999999999999876543322 223


Q ss_pred             cccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCchhh
Q 040392          333 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDI  411 (470)
Q Consensus       333 ~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  411 (470)
                      ....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+....+  +...+....                  
T Consensus       168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~--~~~~i~~~~------------------  227 (277)
T d1xbba_         168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEKGE------------------  227 (277)
T ss_dssp             ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTC------------------
T ss_pred             cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH--HHHHHHcCC------------------
Confidence            34578999999999999999999999999999999998 899998643321  222221110                  


Q ss_pred             hhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          412 HFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       412 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                      +...+..++.++.+|+.+||+.||++|||+.+|++.|+.+..+
T Consensus       228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence            0112244578899999999999999999999999999887544

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-52  Score=401.08  Aligned_cols=268  Identities=19%  Similarity=0.289  Sum_probs=206.5

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      .++|++.+.||+|+||+||+|+. .+|+.||+|+++... ......+.+|+++++.++|||||++++++.+.+..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            57899999999999999999986 468999999997553 3345678899999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSA-PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      |+++|+|.+++.+.+ .+++..+..++.|++.||.|||   ++ +|+||||||+|||++.++.+||+|||+|+.+...  
T Consensus        85 y~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  158 (322)
T ss_dssp             CCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence            999999999997654 5899999999999999999999   64 8999999999999999999999999999866321  


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhh--hhcC---------Cc-
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVN--DWLP---------IS-  396 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~--~~~~---------~~-  396 (470)
                        .....+||+.|+|||++.+..++.++||||+||++|||++|+.||......+........  ....         .. 
T Consensus       159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (322)
T d1s9ja_         159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  236 (322)
T ss_dssp             --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred             --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence              223468999999999999999999999999999999999999999764332211100000  0000         00 


Q ss_pred             -ccccccccccCc-hh-hhh--------HhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          397 -TMEVVGANLLSQ-ED-IHF--------VAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       397 -~~~~~~~~~~~~-~~-~~~--------~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                       .....+...... .. ...        ......+.++.+|+.+||+.||++|||++|+++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence             000000000000 00 000        0001235678999999999999999999999986

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=9.2e-52  Score=400.25  Aligned_cols=253  Identities=19%  Similarity=0.270  Sum_probs=211.5

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            46899999999999999999986 46999999999766555667788999999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC--CCCCeEEeeeccccccCCCCC
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD--DNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~--~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      +++|+|.+++......+++..+..++.||+.||+|||   +++|+||||||+|||++  .++.+||+|||+|+.+.... 
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~-  180 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-  180 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc-
Confidence            9999999999776667999999999999999999999   99999999999999995  46789999999998764322 


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+...........            
T Consensus       181 --~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~~~~~------------  245 (350)
T d1koaa2         181 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-TLRNVKSCDWNMD------------  245 (350)
T ss_dssp             --CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCSC------------
T ss_pred             --ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCC------------
Confidence              2344679999999999999999999999999999999999999997532211 1111111110000            


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                          ......++.++.+|+.+||..||++|||+.|+++|
T Consensus       246 ----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         246 ----DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             ----CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ----cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                01112346778999999999999999999999986

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.6e-52  Score=394.13  Aligned_cols=252  Identities=19%  Similarity=0.265  Sum_probs=192.4

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      .+.|++.+.||+|+||+||+|+.. +|+.||||++.... ......+.+|+++++.++||||+++++++.+++..++|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            467999999999999999999864 68999999987543 2334567789999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC---CCCCeEEeeeccccccCCC
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~a~~~~~~  326 (470)
                      |+++|+|.+++... ..+++..+..++.|++.||+|||   +++|+||||||+||++.   +++.+||+|||+|+.....
T Consensus        88 ~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          88 LVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             CCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             ccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            99999999999754 46899999999999999999999   99999999999999994   5789999999999865422


Q ss_pred             CCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccccc
Q 040392          327 DQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL  406 (470)
Q Consensus       327 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (470)
                         ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+  ....+......           
T Consensus       164 ---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~~~i~~~~~~-----------  227 (307)
T d1a06a_         164 ---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK--LFEQILKAEYE-----------  227 (307)
T ss_dssp             ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHTTCCC-----------
T ss_pred             ---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH--HHHHHhccCCC-----------
Confidence               22234679999999999999999999999999999999999999997643221  11111110000           


Q ss_pred             CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       407 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                          ........++.++.+|+.+||+.||++|||+.|+++|
T Consensus       228 ----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         228 ----FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             ----CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ----CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                0001112346778999999999999999999999985

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.8e-51  Score=398.58  Aligned_cols=253  Identities=20%  Similarity=0.284  Sum_probs=211.8

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++..........+.+|++++++++||||+++++++.+.+..++||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            46799999999999999999986 47999999999866555566788999999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC--CCCCeEEeeeccccccCCCCC
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD--DNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~--~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      +++|+|.+++......+++..+..++.||+.||+|||   +++|+||||||+|||++  .++.+||+|||+|..+.... 
T Consensus       108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~-  183 (352)
T d1koba_         108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-  183 (352)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred             CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence            9999999988777777999999999999999999999   99999999999999997  67899999999998775332 


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                        ......||+.|+|||++.+..++.++||||+||++|||+||+.||.+....+ .+...........      .     
T Consensus       184 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~~~~~------~-----  249 (352)
T d1koba_         184 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNVKRCDWEFD------E-----  249 (352)
T ss_dssp             --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHCCCCCC------S-----
T ss_pred             --ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCC------c-----
Confidence              2344679999999999999999999999999999999999999997643221 1111111110000      0     


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                           .....++.++.+|+.+||+.||++|||+.|+++|
T Consensus       250 -----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         250 -----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             -----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             -----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 0012346778999999999999999999999885

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-51  Score=385.11  Aligned_cols=258  Identities=23%  Similarity=0.384  Sum_probs=202.5

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCC----CcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGD----GMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  246 (470)
                      .++|++.+.||+|+||.||+|++..    +..||||.++... ....+.+.+|++++++++||||+++++++.+ +..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence            3578899999999999999997642    4568999886443 3345678899999999999999999999964 56789


Q ss_pred             EEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCC
Q 040392          247 VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      ||||+++|+|.+++......+++..+..++.|+++||+|||   +++++||||||+||+++.++.+||+|||+|+.....
T Consensus        85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            99999999999998887778999999999999999999999   999999999999999999999999999999876432


Q ss_pred             CCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          327 DQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       327 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      . ........||+.|+|||.+.+..++.++|||||||++|||++ |..||......+.  ...+.....           
T Consensus       162 ~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~--~~~i~~~~~-----------  227 (273)
T d1mp8a_         162 T-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IGRIENGER-----------  227 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHHHHTTCC-----------
T ss_pred             c-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH--HHHHHcCCC-----------
Confidence            2 223344568999999999999999999999999999999998 8889876543321  111111110           


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                             ...+..++.++.+|+.+||+.||++|||+.||+++|+++.+.
T Consensus       228 -------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         228 -------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                   011234577899999999999999999999999999998644

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-51  Score=392.24  Aligned_cols=257  Identities=25%  Similarity=0.406  Sum_probs=208.0

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCc----EEEEEEeecc-cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGM----EVAVKVFNLQ-CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l  246 (470)
                      ++|++.+.||+|+||+||+|.+. +|+    .||+|.+... ..+..+.+.+|++++++++|||||+++++|.++. .++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-eeE
Confidence            46899999999999999999764 444    5888887643 3445677899999999999999999999998754 568


Q ss_pred             EEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCC
Q 040392          247 VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  326 (470)
                      ++||+.+|+|.+++......+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            88999999999999888888999999999999999999999   899999999999999999999999999999987654


Q ss_pred             CCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccc
Q 040392          327 DQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANL  405 (470)
Q Consensus       327 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (470)
                      ..........||+.|+|||++.++.++.++|||||||++|||+| |..||......+  +...+....            
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~~i~~~~------------  230 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGE------------  230 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHHHHHHTC------------
T ss_pred             cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCC------------
Confidence            44444455678999999999999999999999999999999999 788887643332  222222111            


Q ss_pred             cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          406 LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       406 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                            +...+..++.++.+|+.+||+.||++|||+.|++++|.++..
T Consensus       231 ------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         231 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             ------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence                  011234457789999999999999999999999999998864

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-50  Score=384.90  Aligned_cols=252  Identities=21%  Similarity=0.314  Sum_probs=208.0

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccc------hhhhhHHHHHHHHhcCCCCcceeEEeeeccCCee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCG------RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFK  244 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  244 (470)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++.....      ...+.+.+|++++++++||||+++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            46799999999999999999986 4699999999865421      2346788999999999999999999999999999


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC----CeEEeeeccc
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM----VAHLSDFSIA  320 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~----~~kl~Dfg~a  320 (470)
                      ++||||+++|+|.+++...+ .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++    .+|++|||+|
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhh
Confidence            99999999999999997654 6899999999999999999999   99999999999999998777    5999999999


Q ss_pred             cccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccc
Q 040392          321 KLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEV  400 (470)
Q Consensus       321 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (470)
                      .......   ......+|+.|+|||++.+..++.++||||+||++|||++|+.||......+ .+......    .    
T Consensus       165 ~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~~----~----  232 (293)
T d1jksa_         165 HKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANVSAV----N----  232 (293)
T ss_dssp             EECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHTT----C----
T ss_pred             hhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-HHHHHHhc----C----
Confidence            8764322   2334578999999999999999999999999999999999999997632221 11111110    0    


Q ss_pred             ccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          401 VGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                              .......+..++.++.+|+.+||+.||++|||+.|+++|
T Consensus       233 --------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         233 --------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             --------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             --------CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                    000111223457788999999999999999999999875

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.6e-51  Score=388.84  Aligned_cols=262  Identities=26%  Similarity=0.409  Sum_probs=214.2

Q ss_pred             HHHhhCCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccc-hhhhhHHHHHHHHhcCCCCcceeEEeeecc
Q 040392          168 LCRATDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCG-RALKGFDVECEMMKSIRHRNLIKVISTCSN  240 (470)
Q Consensus       168 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~  240 (470)
                      ++...++|++.+.||+|+||+||+|++.      +++.||||+++.... ...+.+.+|+++++.++||||+++++++..
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            3344678999999999999999999853      457899999875533 345678999999999999999999999999


Q ss_pred             CCeeeEEEecCCCCChHHhhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 040392          241 EEFKALVLEYMPHGSLEKYMYSSN-----------------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHC  297 (470)
Q Consensus       241 ~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~  297 (470)
                      ....++||||+++|+|.+++....                       ..+++..++.++.|++.||+|||   +++++||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHr  164 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHR  164 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEee
Confidence            999999999999999999996532                       24788999999999999999999   9999999


Q ss_pred             CCCCCCeeeCCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCC-CCCC
Q 040392          298 DLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGK-KPTN  376 (470)
Q Consensus       298 dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~-~p~~  376 (470)
                      ||||+|||++.++.+||+|||+|+.+.............+++.|+|||.+.+..++.++|||||||++|||++|. .||.
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence            999999999999999999999998765444444445567899999999999999999999999999999999986 4665


Q ss_pred             ccccCcchhhHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHH
Q 040392          377 EIFNGEMTLKHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR  452 (470)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~  452 (470)
                      .....+  ....+.....                  ...+..++.++.+|+.+||+.||++||||.||++.|++|.
T Consensus       245 ~~~~~e--~~~~v~~~~~------------------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         245 GMAHEE--VIYYVRDGNI------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TSCHHH--HHHHHHTTCC------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCHHH--HHHHHHcCCC------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            532221  2222211110                  0112345778999999999999999999999999999874

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-51  Score=384.47  Aligned_cols=257  Identities=25%  Similarity=0.403  Sum_probs=205.6

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEecC
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM  251 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~  251 (470)
                      .++|++.+.||+|+||.||+|++++++.||||+++.. ....+.+.+|+.++++++|||||++++++.+. ..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEecC-CeEEEEEec
Confidence            4679999999999999999999988889999998644 33456799999999999999999999999654 568999999


Q ss_pred             CCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          252 PHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       252 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      ++|+|..++.... ..+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++++||+|||+++..... ...
T Consensus        94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~-~~~  169 (285)
T d1fmka3          94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYT  169 (285)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCC-Cce
Confidence            9999998886543 46899999999999999999999   899999999999999999999999999999876432 223


Q ss_pred             cccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCchh
Q 040392          331 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQED  410 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  410 (470)
                      ......+|+.|+|||++..+.++.++||||||+++|||++|..|+........ +...+.....                
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~-~~~~i~~~~~----------------  232 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQVERGYR----------------  232 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHHHTTCC----------------
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH-HHHHHHhcCC----------------
Confidence            33446789999999999999999999999999999999997776654333221 2222211111                


Q ss_pred             hhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          411 IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       411 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                        ...+..++.++.+++.+||+.||++||++.+|++.|+++..
T Consensus       233 --~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         233 --MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             --CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence              01123457789999999999999999999999999988753

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.4e-51  Score=388.91  Aligned_cols=245  Identities=26%  Similarity=0.335  Sum_probs=201.3

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          174 GFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      .|+..+.||+|+||+||+|+. .+|+.||||++....   ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            488899999999999999975 468899999987543   2345668899999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      |+++|+|..++... ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|.....    
T Consensus        96 ~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----  167 (309)
T d1u5ra_          96 YCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----  167 (309)
T ss_dssp             CCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred             ecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence            99999997666544 46899999999999999999999   99999999999999999999999999999986532    


Q ss_pred             ccccccccCccccCccccCC---CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccccccc
Q 040392          330 MTQTQTLATIGYMAPEYGRE---GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLL  406 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (470)
                        .....||+.|+|||++.+   +.++.++|||||||++|||++|+.||.+....+ .+........+.         . 
T Consensus       168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-~~~~i~~~~~~~---------~-  234 (309)
T d1u5ra_         168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPA---------L-  234 (309)
T ss_dssp             --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCCC---------C-
T ss_pred             --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCCCC---------C-
Confidence              234579999999998864   458999999999999999999999997642221 111111110000         0 


Q ss_pred             CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          407 SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       407 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                              .+..++.++.+|+.+||+.||++|||+.|+++|
T Consensus       235 --------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         235 --------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             --------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             --------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence                    012346678999999999999999999999874

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-51  Score=380.97  Aligned_cols=251  Identities=29%  Similarity=0.440  Sum_probs=201.1

Q ss_pred             hCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeecc-CCeeeEEEec
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN-EEFKALVLEY  250 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~~~~~lv~e~  250 (470)
                      .++|++.+.||+|+||.||+|++ .|+.||||+++..  ...+.+.+|++++++++||||+++++++.+ .+..++||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            45688889999999999999998 4889999999643  345678999999999999999999999854 4567999999


Q ss_pred             CCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          251 MPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       251 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      +++|+|.+++.... ..+++..+++++.||+.||.|||   +.+|+||||||+||+++.++.+|++|||+++.....   
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---  156 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  156 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC---
Confidence            99999999997644 35899999999999999999999   899999999999999999999999999999865322   


Q ss_pred             ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                        .....++..|+|||++.+..++.++||||||+++|||+| |+.||......  .+..++.....              
T Consensus       157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~i~~~~~--------------  218 (262)
T d1byga_         157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYK--------------  218 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTTTCC--------------
T ss_pred             --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCCC--------------
Confidence              233467889999999999999999999999999999998 67777654222  22222221111              


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                          ...+..++.++.+|+.+||+.||++||||.|++++|++++.
T Consensus       219 ----~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         219 ----MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence                11123446779999999999999999999999999999874

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-50  Score=382.15  Aligned_cols=259  Identities=25%  Similarity=0.427  Sum_probs=210.5

Q ss_pred             CCeecccCceEEEEEEeCC----CcEEEEEEeecc-cchhhhhHHHHHHHHhcCCCCcceeEEeeecc-CCeeeEEEecC
Q 040392          178 NNLIGRGGFGSVYKARLGD----GMEVAVKVFNLQ-CGRALKGFDVECEMMKSIRHRNLIKVISTCSN-EEFKALVLEYM  251 (470)
Q Consensus       178 ~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~~~~~lv~e~~  251 (470)
                      .++||+|+||+||+|++.+    ...||||+++.. .....+.+.+|++++++++||||++++|++.+ +...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            4689999999999998643    236899998643 44556789999999999999999999999865 45789999999


Q ss_pred             CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc--
Q 040392          252 PHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS--  329 (470)
Q Consensus       252 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--  329 (470)
                      ++|+|.+++.......++..+..++.|+++||.|||   +.+|+||||||+|||+++++.+||+|||+++........  
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            999999999888778889999999999999999999   999999999999999999999999999999876543222  


Q ss_pred             ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCch
Q 040392          330 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQE  409 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  409 (470)
                      .......||+.|+|||.+.+..++.++||||||+++|||+||+.||....... .+..++.....               
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i~~g~~---------------  252 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQGRR---------------  252 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCC---------------
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHHHHcCCC---------------
Confidence            22334578999999999999999999999999999999999888876533221 12222211110               


Q ss_pred             hhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHhhh
Q 040392          410 DIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLLRN  458 (470)
Q Consensus       410 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~~~  458 (470)
                         ...+..++.++.+|+.+||+.||++||+|.||+++|+++..++.++
T Consensus       253 ---~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~  298 (311)
T d1r0pa_         253 ---LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  298 (311)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred             ---CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence               1112345677999999999999999999999999999998765554

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-50  Score=383.22  Aligned_cols=261  Identities=23%  Similarity=0.378  Sum_probs=202.6

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeeccc-chhhhhHHHHHHHHhcC-CCCcceeEEeeeccC-C
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-GRALKGFDVECEMMKSI-RHRNLIKVISTCSNE-E  242 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~-~  242 (470)
                      .++|++.+.||+|+||.||+|++.      +++.||||+++... ....+.+..|..++.++ +|+||+.+++++.+. .
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            467999999999999999999753      35689999986543 33455677788877776 689999999987654 5


Q ss_pred             eeeEEEecCCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC
Q 040392          243 FKALVLEYMPHGSLEKYMYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD  307 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~  307 (470)
                      ..++||||+++|+|.+++....               ..+++..+..++.|+++||+|||   +++|+||||||+|||++
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeEC
Confidence            6789999999999999996542               34889999999999999999999   99999999999999999


Q ss_pred             CCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCC-CCCCccccCcchhh
Q 040392          308 DNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGK-KPTNEIFNGEMTLK  386 (470)
Q Consensus       308 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~-~p~~~~~~~~~~~~  386 (470)
                      .++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+||. .||......+ .+.
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-~~~  247 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFC  247 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-HHH
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-HHH
Confidence            99999999999998765554444555678999999999999999999999999999999999965 5666543322 222


Q ss_pred             HHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          387 HWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                      ..+......                  ..+..++.++.+++.+||+.||++|||+.|++++|+++..+
T Consensus       248 ~~~~~~~~~------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         248 RRLKEGTRM------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             HHHHHTCCC------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHhcCCCC------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            222211111                  11233467799999999999999999999999999998654

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-50  Score=387.08  Aligned_cols=249  Identities=22%  Similarity=0.290  Sum_probs=208.7

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEE
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      .++|++.+.||+|+||.||+|+. .+|+.||||+++...   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            46799999999999999999986 579999999997542   33456688899999999999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||+++|+|.+++...+ .+++..+..++.|++.||+|||   +++|+||||||+|||++.+|.+||+|||+|+......
T Consensus        84 ~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             eeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence            99999999999987655 5889999999999999999999   9999999999999999999999999999998654322


Q ss_pred             CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                        ......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+  +...+...   .           
T Consensus       160 --~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~~i~~~---~-----------  221 (337)
T d1o6la_         160 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFELILME---E-----------  221 (337)
T ss_dssp             --CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHC---C-----------
T ss_pred             --cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH--HHHHHhcC---C-----------
Confidence              23345689999999999999999999999999999999999999998643221  11111100   0           


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCC-----HHHHHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRIN-----AREIVAK  447 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~el~~~  447 (470)
                           ...+..++.++.+|+.+||++||++||+     +.|+++|
T Consensus       222 -----~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         222 -----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -----CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence                 0012234677899999999999999995     8888875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-50  Score=381.75  Aligned_cols=275  Identities=22%  Similarity=0.297  Sum_probs=202.5

Q ss_pred             CCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHH--HHHHHhcCCCCcceeEEeeeccCC----eeeE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDV--ECEMMKSIRHRNLIKVISTCSNEE----FKAL  246 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~h~nIv~~~~~~~~~~----~~~l  246 (470)
                      .+|...+.||+|+||.||+|++ +|+.||||+++...   ...+..  |+..+..++||||+++++++.+.+    ..++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            4566778999999999999997 58999999986442   223333  555556789999999999996543    5789


Q ss_pred             EEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeeecCCCCCCeeeCCCCCeEEeeecccc
Q 040392          247 VLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFG-----YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK  321 (470)
Q Consensus       247 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-----~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~  321 (470)
                      ||||+++|+|.+++++.  .+++..+.+++.|++.||+|+|..     ..++|+||||||+|||++.++.+||+|||+++
T Consensus        79 v~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            99999999999999765  489999999999999999999932     13699999999999999999999999999998


Q ss_pred             ccCCCCCc--ccccccccCccccCccccCCCC------CCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhc
Q 040392          322 LLTGEDQS--MTQTQTLATIGYMAPEYGREGR------VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWL  393 (470)
Q Consensus       322 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~------~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  393 (470)
                      ........  .......||+.|+|||++.+..      ++.++|||||||++|||+||..||......+...........
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence            77543322  2334567999999999987543      677899999999999999999887654333222111110000


Q ss_pred             CCc-cc-ccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          394 PIS-TM-EVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       394 ~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                      ... .. ...+..... ..........++..+.+|+.+||+.||++|||+.||++.|+++.++
T Consensus       237 ~~~~~~~~~~~~~~~p-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         237 SVEEMRKVVCEQKLRP-NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CHHHHHHHHTTSCCCC-CCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHhccccCC-CCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence            000 00 001111100 0011222334567799999999999999999999999999999754

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.1e-50  Score=382.02  Aligned_cols=245  Identities=25%  Similarity=0.314  Sum_probs=205.9

Q ss_pred             CCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++...   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5789999999999999999986 469999999997542   334567889999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||++||+|..++.... .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.....  
T Consensus        84 E~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             eecCCccccccccccc-cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence            9999999999886655 5788888999999999999999   999999999999999999999999999999876432  


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                         ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+. .........               
T Consensus       158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~~~~---------------  218 (316)
T d1fota_         158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-YEKILNAEL---------------  218 (316)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHCCC---------------
T ss_pred             ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH-HHHHHcCCC---------------
Confidence               2346799999999999999999999999999999999999999976322211 111111000               


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCC-----CHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRI-----NAREIVAK  447 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~el~~~  447 (470)
                           ..+..++.++.+++.+||..||.+|+     |++|+++|
T Consensus       219 -----~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         219 -----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -----CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence                 01123466788999999999999996     89999886

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=379.47  Aligned_cols=256  Identities=26%  Similarity=0.395  Sum_probs=200.3

Q ss_pred             CCCCCCCeecccCceEEEEEEeC--CC--cEEEEEEeecc---cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeee
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG--DG--MEVAVKVFNLQ---CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKA  245 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~  245 (470)
                      ++|++.+.||+|+||.||+|+..  ++  ..||||++...   .....+.+.+|++++++++||||++++|++.++ ..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence            56889999999999999999753  22  47899998654   234456789999999999999999999999764 568


Q ss_pred             EEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC
Q 040392          246 LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  325 (470)
                      +||||+++|++.+++......+++..+..++.|++.||.|||   +++|+||||||+||+++.++.+||+|||+++....
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            999999999999998877777999999999999999999999   89999999999999999999999999999998754


Q ss_pred             CCCc-ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchhhHHhhhhcCCcccccccc
Q 040392          326 EDQS-MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA  403 (470)
Q Consensus       326 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (470)
                      .... .......++..|+|||.+.+..++.++||||||+++|||+| |+.||......+  ...++...   .       
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~--~~~~i~~~---~-------  231 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--ILHKIDKE---G-------  231 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTS---C-------
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH--HHHHHHhC---C-------
Confidence            4332 22334567889999999999999999999999999999998 899997643222  11121111   0       


Q ss_pred             cccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHH
Q 040392          404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKI  451 (470)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i  451 (470)
                             .+...+..++.++.+|+.+||+.||++||||.||.+.|++.
T Consensus       232 -------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         232 -------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                   00111234567799999999999999999999999998875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.5e-50  Score=376.99  Aligned_cols=260  Identities=24%  Similarity=0.365  Sum_probs=203.8

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCC----e
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEE----F  243 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~----~  243 (470)
                      .++|++.+.||+|+||.||+|+. .+|+.||||+++...   ......+.+|+++++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            47799999999999999999975 579999999997543   234567889999999999999999999986543    4


Q ss_pred             eeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecccccc
Q 040392          244 KALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  323 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~  323 (470)
                      .++||||+++|+|.+++...+ .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++..+++|||.+...
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             EEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhh
Confidence            789999999999999886654 6899999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCC-CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccccc
Q 040392          324 TGED-QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVG  402 (470)
Q Consensus       324 ~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (470)
                      .... .........||+.|+|||++.+..++.++|||||||++|||+||+.||......+. ....+......       
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~~~~~~~~~-------  233 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-AYQHVREDPIP-------  233 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHCCCCC-------
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH-HHHHHhcCCCC-------
Confidence            4322 22334456799999999999999999999999999999999999999976332211 11111110000       


Q ss_pred             ccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCC-CHHHHHHHHHHHH
Q 040392          403 ANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRI-NAREIVAKLLKIR  452 (470)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~el~~~L~~i~  452 (470)
                               .......++.++.+++.+||+.||++|| |++++++.|.+++
T Consensus       234 ---------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         234 ---------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             ---------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ---------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence                     0011123467799999999999999999 8999999998875

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-49  Score=380.04  Aligned_cols=262  Identities=21%  Similarity=0.347  Sum_probs=215.8

Q ss_pred             hCCCCCCCeecccCceEEEEEEe------CCCcEEEEEEeeccc-chhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQC-GRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEF  243 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~  243 (470)
                      .++|++.+.||+|+||.||+|++      .+++.||||+++... ......+.+|+.+++++ +|||||++++++.+...
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            46788899999999999999975      346789999997543 33455688999999999 69999999999999999


Q ss_pred             eeEEEecCCCCChHHhhhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 040392          244 KALVLEYMPHGSLEKYMYSSN-----------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL  306 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~-----------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill  306 (470)
                      .++||||+++|+|.+++....                 ..+++..+..++.||++||+|||   +++++||||||+||++
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccccc
Confidence            999999999999999987543                 35889999999999999999999   9999999999999999


Q ss_pred             CCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhh
Q 040392          307 DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLK  386 (470)
Q Consensus       307 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~  386 (470)
                      +.++.+|++|||.++...............||+.|+|||.+.+..++.++|||||||++|||+|+..|+.........+.
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~  258 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY  258 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999999999999987655555555567899999999999999999999999999999999995555443333322333


Q ss_pred             HHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          387 HWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                      ..+.......                  .+..++.++.+|+.+||+.||++||||.||++.|+++...
T Consensus       259 ~~i~~~~~~~------------------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         259 KMIKEGFRML------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             HHHHHTCCCC------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHhcCCCCC------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            3333221111                  1223467799999999999999999999999999887543

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=381.23  Aligned_cols=252  Identities=19%  Similarity=0.278  Sum_probs=208.3

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      .++|++.+.||+|+||+||+|... +|+.||||+++.... ....+.+|+++|+.++||||+++++++.+.+..|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            468999999999999999999865 688999999975532 344578899999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC--CCCeEEeeeccccccCCCCC
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD--NMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      +++|+|.+++...+..+++.++..++.||+.||+|||   +.+|+||||||+|||++.  ...+||+|||++......  
T Consensus        83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~--  157 (321)
T d1tkia_          83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--  157 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccC--
Confidence            9999999999877767999999999999999999999   999999999999999985  458999999999876432  


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                       .......+|+.|+|||...+..++.++||||+||++|+|++|+.||......+ .+.........              
T Consensus       158 -~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-~~~~i~~~~~~--------------  221 (321)
T d1tkia_         158 -DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIENIMNAEYT--------------  221 (321)
T ss_dssp             -CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCCC--------------
T ss_pred             -CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCC--------------
Confidence             22344678999999999999999999999999999999999999997643221 11111110000              


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                        ........++.++.+|+.+||..||++|||+.|+++|
T Consensus       222 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         222 --FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             --CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             --CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              0011122346778999999999999999999999985

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.4e-49  Score=372.88  Aligned_cols=251  Identities=24%  Similarity=0.341  Sum_probs=205.6

Q ss_pred             CCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccc---------hhhhhHHHHHHHHhcCC-CCcceeEEeeeccC
Q 040392          173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCG---------RALKGFDVECEMMKSIR-HRNLIKVISTCSNE  241 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~  241 (470)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++.....         ...+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            6799999999999999999986 4789999999875421         12345778999999997 99999999999999


Q ss_pred             CeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecccc
Q 040392          242 EFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK  321 (470)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~  321 (470)
                      +..++||||+++|+|.+++.... .+++..+..++.||++||+|||   +++|+||||||+||+++.++.+||+|||+++
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             cceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhee
Confidence            99999999999999999997654 6899999999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCCcccccccccCccccCccccCC------CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCC
Q 040392          322 LLTGEDQSMTQTQTLATIGYMAPEYGRE------GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPI  395 (470)
Q Consensus       322 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  395 (470)
                      ......   ......||+.|+|||.+.+      ..++.++||||+||++|||++|+.||......+ ............
T Consensus       159 ~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-~~~~i~~~~~~~  234 (277)
T d1phka_         159 QLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLRMIMSGNYQF  234 (277)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCC
T ss_pred             EccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-HHHHHHhCCCCC
Confidence            764322   2344679999999998753      347889999999999999999999998643221 111111111000


Q ss_pred             cccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          396 STMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                                      .......++.++.+|+.+||+.||++|||+.|+++|
T Consensus       235 ----------------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         235 ----------------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             ----------------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             ----------------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                            001122457789999999999999999999999875

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-49  Score=375.79  Aligned_cols=258  Identities=28%  Similarity=0.428  Sum_probs=209.7

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC--------CCcEEEEEEeecccc-hhhhhHHHHHHHHhcC-CCCcceeEEeeeccC
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG--------DGMEVAVKVFNLQCG-RALKGFDVECEMMKSI-RHRNLIKVISTCSNE  241 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~  241 (470)
                      .++|++.+.||+|+||.||+|+..        ++..||||+++.+.. .....+.+|...+.++ +||||++++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            467888999999999999999742        235799999976543 4457788899988888 799999999999999


Q ss_pred             CeeeEEEecCCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 040392          242 EFKALVLEYMPHGSLEKYMYSSN---------------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL  306 (470)
Q Consensus       242 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill  306 (470)
                      +..++||||+++|+|.+++....               ..+++.+++.++.|++.||+|||   +.+|+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceee
Confidence            99999999999999999997553               35899999999999999999999   9999999999999999


Q ss_pred             CCCCCeEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccCcchh
Q 040392          307 DDNMVAHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTNEIFNGEMTL  385 (470)
Q Consensus       307 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-g~~p~~~~~~~~~~~  385 (470)
                      +.++.+||+|||+++...............+|+.|+|||.+.++.++.++||||||+++|||++ |..||......  ..
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--~~  246 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--EL  246 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH--HH
Confidence            9999999999999987765555455556779999999999999999999999999999999998 78887653322  12


Q ss_pred             hHHhhhhcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHH
Q 040392          386 KHWVNDWLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIR  452 (470)
Q Consensus       386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~  452 (470)
                      ...+......                  ..+..++.++.+|+.+||+.||.+||||.||++.|+++.
T Consensus       247 ~~~i~~~~~~------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         247 FKLLKEGHRM------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             HHHHHTTCCC------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHcCCCC------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence            2222211111                  112334677999999999999999999999999999985

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=8.3e-49  Score=381.74  Aligned_cols=250  Identities=21%  Similarity=0.301  Sum_probs=201.2

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhH---HHHHHHHhcCCCCcceeEEeeeccCCee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGF---DVECEMMKSIRHRNLIKVISTCSNEEFK  244 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~nIv~~~~~~~~~~~~  244 (470)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++....   ......+   ..|+++++.++||||+++++++.+.+..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            468999999999999999999864 69999999986432   1112223   3457778888999999999999999999


Q ss_pred             eEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccC
Q 040392          245 ALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLT  324 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~  324 (470)
                      ++||||+++|+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+.
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            99999999999999997654 5789999999999999999999   9999999999999999999999999999998764


Q ss_pred             CCCCcccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccc
Q 040392          325 GEDQSMTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA  403 (470)
Q Consensus       325 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (470)
                      ..    ......||+.|+|||++.. ..++.++|||||||++|||+||+.||.........  ...........      
T Consensus       159 ~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--~~~~~~~~~~~------  226 (364)
T d1omwa3         159 KK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTLTMAV------  226 (364)
T ss_dssp             SS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH--HHHHHSSSCCC------
T ss_pred             CC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhcccCCC------
Confidence            32    2234579999999999865 56899999999999999999999999864332211  11111111000      


Q ss_pred             cccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCC-----HHHHHHH
Q 040392          404 NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRIN-----AREIVAK  447 (470)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~el~~~  447 (470)
                                ..+..++.++.+|+.+||+.||++|||     ++|+++|
T Consensus       227 ----------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         227 ----------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             ----------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             ----------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence                      011234677899999999999999999     7888875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-49  Score=377.08  Aligned_cols=256  Identities=27%  Similarity=0.451  Sum_probs=205.4

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCc--EEEEEEeecc-cchhhhhHHHHHHHHhcC-CCCcceeEEeeeccCCeeeEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGM--EVAVKVFNLQ-CGRALKGFDVECEMMKSI-RHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      ++|++.+.||+|+||.||+|++. +|.  .||||.+... .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            67888999999999999999764 344  4788887543 344567789999999999 799999999999999999999


Q ss_pred             EecCCCCChHHhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCe
Q 040392          248 LEYMPHGSLEKYMYSS---------------NYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA  312 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~  312 (470)
                      |||+++|+|.++++..               ...+++..+.+++.||++||.|||   +++|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence            9999999999999654               256899999999999999999999   9999999999999999999999


Q ss_pred             EEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCC-CCCccccCcchhhHHhhh
Q 040392          313 HLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKK-PTNEIFNGEMTLKHWVND  391 (470)
Q Consensus       313 kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~-p~~~~~~~~~~~~~~~~~  391 (470)
                      ||+|||+++....   ........||..|+|||.+.+..++.++|||||||++|||++|.. ||......  .+...+..
T Consensus       167 kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~--~~~~~i~~  241 (309)
T d1fvra_         167 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKLPQ  241 (309)
T ss_dssp             EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHGGG
T ss_pred             EEccccccccccc---cccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH--HHHHHHHh
Confidence            9999999975432   222234568999999999999999999999999999999999765 56543221  22222211


Q ss_pred             hcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          392 WLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                      ..                  +...+..++.++.+|+.+||+.||++||||.||+++|+++...
T Consensus       242 ~~------------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         242 GY------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             TC------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             cC------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            10                  1112234577899999999999999999999999999998754

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7e-49  Score=380.24  Aligned_cols=245  Identities=20%  Similarity=0.232  Sum_probs=206.2

Q ss_pred             CCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc---chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~  248 (470)
                      ++|++++.||+|+||.||+|+. .+|+.||||++....   ....+.+.+|+++++.++||||+++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            5799999999999999999986 469999999986432   234566889999999999999999999999999999999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQ  328 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  328 (470)
                      ||+.+|+|.+++...+ .+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+.+...  
T Consensus       121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence            9999999999997654 6899999999999999999999   999999999999999999999999999999876432  


Q ss_pred             cccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccCc
Q 040392          329 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLSQ  408 (470)
Q Consensus       329 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (470)
                         .....||+.|+|||++.+..++.++|||||||++|||+||+.||......  .....+.....              
T Consensus       195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~i~~~~~--------------  255 (350)
T d1rdqe_         195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--QIYEKIVSGKV--------------  255 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCC--------------
T ss_pred             ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH--HHHHHHhcCCC--------------
Confidence               23467999999999999999999999999999999999999999753211  11111111000              


Q ss_pred             hhhhhHhhhhhHHHHHHHHhhccCCCccCCC-----CHHHHHHH
Q 040392          409 EDIHFVAKEQCVSCVFNLAMECTVESPEQRI-----NAREIVAK  447 (470)
Q Consensus       409 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~el~~~  447 (470)
                           ..+..++.++.+++.+||..||.+|+     |+.|+++|
T Consensus       256 -----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         256 -----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             -----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence                 01123467789999999999999994     89999875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-48  Score=377.05  Aligned_cols=252  Identities=21%  Similarity=0.277  Sum_probs=199.4

Q ss_pred             hCCCCCCC-eecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhc-CCCCcceeEEeeecc----CCee
Q 040392          172 TDGFSENN-LIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKS-IRHRNLIKVISTCSN----EEFK  244 (470)
Q Consensus       172 ~~~~~~~~-~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~~~~~~~~----~~~~  244 (470)
                      .++|.+.+ .||+|+||+||+|+. .+++.||||+++.     ...+.+|++++.+ .+||||+++++++.+    ....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            46788765 699999999999976 5799999999863     2456779988655 589999999999864    4678


Q ss_pred             eEEEecCCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC---CCCeEEeeeccc
Q 040392          245 ALVLEYMPHGSLEKYMYSSN-YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFSIA  320 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~a  320 (470)
                      ++|||||+||+|.+++...+ ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.   ++.+||+|||+|
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccccee
Confidence            99999999999999997653 46899999999999999999999   999999999999999975   567999999999


Q ss_pred             cccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCccccc
Q 040392          321 KLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEV  400 (470)
Q Consensus       321 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (470)
                      +......   ......||+.|+|||++.+..++.++|||||||++|+|+||+.||.+....+. ... +......     
T Consensus       162 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~-~~~-~~~~i~~-----  231 (335)
T d2ozaa1         162 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SPG-MKTRIRM-----  231 (335)
T ss_dssp             EECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCS-----
T ss_pred             eeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH-HHH-HHHHHhc-----
Confidence            8765432   23446799999999999999999999999999999999999999976432211 000 0000000     


Q ss_pred             ccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          401 VGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                            ............++.++.+|+.+||+.||++|||+.|+++|
T Consensus       232 ------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         232 ------GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             ------CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ------CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                  00000011123457789999999999999999999999885

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-49  Score=375.28  Aligned_cols=259  Identities=22%  Similarity=0.373  Sum_probs=212.8

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFK  244 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~  244 (470)
                      .++|++.+.||+|+||+||+|.+.      +++.||||+++... .+....+.+|++++++++||||+++++++...+..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            467888899999999999999753      35789999997543 34455688999999999999999999999999999


Q ss_pred             eEEEecCCCCChHHhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEe
Q 040392          245 ALVLEYMPHGSLEKYMYSSN---------YILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLS  315 (470)
Q Consensus       245 ~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~  315 (470)
                      ++||||+++|+|.+++....         ..+++..+.+++.|+++||.|||   +++|+||||||+|||++.++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEe
Confidence            99999999999999986432         34688999999999999999999   8999999999999999999999999


Q ss_pred             eeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCC-CCCCccccCcchhhHHhhhhcC
Q 040392          316 DFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGK-KPTNEIFNGEMTLKHWVNDWLP  394 (470)
Q Consensus       316 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~-~p~~~~~~~~~~~~~~~~~~~~  394 (470)
                      |||+|+.+.............+|+.|+|||.+.+..++.++||||||+++|||+||. .||......+     +......
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~-----~~~~i~~  250 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-----VLRFVME  250 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-----HHHHHHT
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHh
Confidence            999998775544444455567899999999999999999999999999999999985 6665532221     1111111


Q ss_pred             CcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHH
Q 040392          395 ISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRD  453 (470)
Q Consensus       395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~  453 (470)
                      ...               ...+..++..+.+++.+||+.||++|||+.||+++|++..+
T Consensus       251 ~~~---------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         251 GGL---------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             TCC---------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             CCC---------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            110               11123456789999999999999999999999999988743

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-49  Score=377.57  Aligned_cols=247  Identities=25%  Similarity=0.338  Sum_probs=202.8

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHh-cCCCCcceeEEeeeccCCeeeEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKGFDVECEMMK-SIRHRNLIKVISTCSNEEFKALV  247 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~nIv~~~~~~~~~~~~~lv  247 (470)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++...   ....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57899999999999999999764 68999999997542   233445666776655 68999999999999999999999


Q ss_pred             EecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCC
Q 040392          248 LEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGED  327 (470)
Q Consensus       248 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  327 (470)
                      |||+++|+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++..... 
T Consensus        82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~-  156 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-  156 (320)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred             EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhcccc-
Confidence            99999999999997654 5889999999999999999999   899999999999999999999999999999865432 


Q ss_pred             CcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccccccC
Q 040392          328 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGANLLS  407 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (470)
                       ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+  +...+....+             
T Consensus       157 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~--~~~~i~~~~~-------------  220 (320)
T d1xjda_         157 -DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LFHSIRMDNP-------------  220 (320)
T ss_dssp             -TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCC-------------
T ss_pred             -cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH--HHHHHHcCCC-------------
Confidence             233345679999999999999999999999999999999999999997643221  1111111000             


Q ss_pred             chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHH-HHHH
Q 040392          408 QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAR-EIVA  446 (470)
Q Consensus       408 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-el~~  446 (470)
                            ..+..++.++.+|+.+||+.||++||++. |+++
T Consensus       221 ------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         221 ------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence                  01123467789999999999999999995 7765

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-48  Score=370.23  Aligned_cols=269  Identities=23%  Similarity=0.258  Sum_probs=202.9

Q ss_pred             CCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      ++|++++.||+|+||+||+|+. .+|+.||||+++...  ......+.+|++++++++||||+++++++.+....++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            6899999999999999999986 579999999986543  2345678899999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      |+.++.+..........+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||.|+.....  .
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~--~  156 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--V  156 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC--S
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCC--c
Confidence            99765444444444567999999999999999999999   999999999999999999999999999999876432  2


Q ss_pred             ccccccccCccccCccccCCCC-CCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhh-hcCCc-c-ccccc-cc
Q 040392          330 MTQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVND-WLPIS-T-MEVVG-AN  404 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~-~-~~~~~-~~  404 (470)
                      .......||+.|+|||.+.... ++.++||||+||++|+|++|+.||......+ .+...... ..+.. . ..... +.
T Consensus       157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-HHHHHHHhcCCCchhhccccccccc
Confidence            2334467999999999876655 5789999999999999999999997643221 11111110 00000 0 00000 00


Q ss_pred             cc----C-chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          405 LL----S-QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       405 ~~----~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ..    . ............+.++.+|+.+||+.||++|||+.|+++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            00    0 0000011122446778999999999999999999999986

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-48  Score=369.62  Aligned_cols=263  Identities=23%  Similarity=0.259  Sum_probs=196.5

Q ss_pred             CCCeecccCceEEEEEEeC-CCcEEEEEEeecccc-----hhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          177 ENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCG-----RALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       177 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      .+++||+|+||+||+|+.. +|+.||||+++....     ...+.+.+|+++++.++||||+++++++.+++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            3578999999999999864 699999999864422     1245688999999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      +.++++..+. .....+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+......  .
T Consensus        82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--~  155 (299)
T d1ua2a_          82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--R  155 (299)
T ss_dssp             CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--C
T ss_pred             hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCc--c
Confidence            9887766555 44556888999999999999999999   9999999999999999999999999999998664322  2


Q ss_pred             cccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc---c------ccc
Q 040392          331 TQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS---T------MEV  400 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~------~~~  400 (470)
                      .....+||+.|+|||++... .++.++|||||||++|||++|+.||....+.+ .+...........   .      ...
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~~~~~~~~~~~~~~~~~~~~  234 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQWPDMCSLPDY  234 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred             cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-HHHHHHHhcCCCChhhccchhccchh
Confidence            23345799999999988654 57999999999999999999999987543221 1111111100000   0      000


Q ss_pred             ccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          401 VGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ........... .......+.++.+|+.+||+.||++|||+.|+++|
T Consensus       235 ~~~~~~~~~~~-~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         235 VTFKSFPGIPL-HHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             CCCCCCCCCCH-HHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhccCCCCCh-HHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            00000000000 01112346779999999999999999999999875

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3.5e-48  Score=366.52  Aligned_cols=269  Identities=20%  Similarity=0.261  Sum_probs=202.8

Q ss_pred             CCCCCCCeecccCceEEEEEEeCCCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEec
Q 040392          173 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLEY  250 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~  250 (470)
                      ++|++.+.||+|+||+||+|++++|+.||||++....  ....+.+.+|+.++++++||||+++++++...+..+++||+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            6899999999999999999999999999999996543  23356788999999999999999999999999999999999


Q ss_pred             CCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCcc
Q 040392          251 MPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQSM  330 (470)
Q Consensus       251 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  330 (470)
                      +.++.+..+. .....+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+|++|||.+.......  .
T Consensus        82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~--~  155 (286)
T d1ob3a_          82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--R  155 (286)
T ss_dssp             CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCc--c
Confidence            9876665555 44567999999999999999999999   8999999999999999999999999999998764322  2


Q ss_pred             cccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCC-c----ccc--ccc
Q 040392          331 TQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPI-S----TME--VVG  402 (470)
Q Consensus       331 ~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~----~~~--~~~  402 (470)
                      ......+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+....+.....+.....+. .    ...  ..+
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence            23445689999999988754 568999999999999999999999976432221111110000000 0    000  000


Q ss_pred             ccccC-chhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          403 ANLLS-QEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       403 ~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ..... ............+.++.+|+.+||+.||++|||+.|+++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00000 0000011123346778999999999999999999999864

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=365.67  Aligned_cols=271  Identities=22%  Similarity=0.290  Sum_probs=203.7

Q ss_pred             HhhCCCCCCCeecccCceEEEEEEe-CC-CcEEEEEEeeccc--chhhhhHHHHHHHHhcC---CCCcceeEEeeec---
Q 040392          170 RATDGFSENNLIGRGGFGSVYKARL-GD-GMEVAVKVFNLQC--GRALKGFDVECEMMKSI---RHRNLIKVISTCS---  239 (470)
Q Consensus       170 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~nIv~~~~~~~---  239 (470)
                      +..++|++++.||+|+||+||+|+. ++ ++.||||+++...  ......+.+|+.+++.+   +||||+++++++.   
T Consensus         4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~   83 (305)
T d1blxa_           4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   83 (305)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence            3457899999999999999999986 34 5679999986543  22344566788877766   7999999999884   


Q ss_pred             --cCCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeee
Q 040392          240 --NEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF  317 (470)
Q Consensus       240 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  317 (470)
                        .....+++|||++++++..........+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+||
T Consensus        84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecch
Confidence              335778999999988776666666677899999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcc
Q 040392          318 SIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIST  397 (470)
Q Consensus       318 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  397 (470)
                      |+++...   .........||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .+............
T Consensus       161 g~~~~~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~  236 (305)
T d1blxa_         161 GLARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGE  236 (305)
T ss_dssp             CSCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCG
T ss_pred             hhhhhhc---ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCch
Confidence            9987543   2233455779999999999999999999999999999999999999997643221 11111111000000


Q ss_pred             cc------ccccccc-CchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          398 ME------VVGANLL-SQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       398 ~~------~~~~~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ..      ....... .............+..+.+|+.+||+.||++|||+.|+++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            00      0000000 00000011123346778999999999999999999999886

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-48  Score=364.17  Aligned_cols=241  Identities=23%  Similarity=0.309  Sum_probs=197.4

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccc------hhhhhHHHHHHHHhcCC--CCcceeEEeeeccCC
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCG------RALKGFDVECEMMKSIR--HRNLIKVISTCSNEE  242 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~nIv~~~~~~~~~~  242 (470)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++.....      .....+.+|+.++++++  ||||+++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            35799999999999999999986 4789999999875421      12344678999999986  899999999999999


Q ss_pred             eeeEEEecCCC-CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-CCCeEEeeeccc
Q 040392          243 FKALVLEYMPH-GSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-NMVAHLSDFSIA  320 (470)
Q Consensus       243 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~a  320 (470)
                      ..++||||+.+ +++.+++.... .+++..+..++.|++.||+|||   +++|+||||||+|||++. ++.+||+|||+|
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eEEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccc
Confidence            99999999976 57777776544 6899999999999999999999   999999999999999985 479999999999


Q ss_pred             cccCCCCCcccccccccCccccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccc
Q 040392          321 KLLTGEDQSMTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTME  399 (470)
Q Consensus       321 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  399 (470)
                      +.....    ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||....    .+   .....      
T Consensus       159 ~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~i---~~~~~------  221 (273)
T d1xwsa_         159 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----EI---IRGQV------  221 (273)
T ss_dssp             EECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----HH---HHCCC------
T ss_pred             eecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----HH---hhccc------
Confidence            865322    2334679999999999887665 567899999999999999999997521    00   00000      


Q ss_pred             cccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          400 VVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                                    ..+..++.++.+|+.+||+.||++|||++|+++|
T Consensus       222 --------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         222 --------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             --------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                          0012246678999999999999999999999875

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.3e-45  Score=349.33  Aligned_cols=262  Identities=19%  Similarity=0.215  Sum_probs=205.4

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcce-eEEeeeccCCeeeEEEe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLI-KVISTCSNEEFKALVLE  249 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~~~~~~~~~~~~~lv~e  249 (470)
                      .++|++.+.||+|+||.||+|++ .+|+.||||++....  ....+..|+++++.++|+|++ .+.+++.+.+..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            36799999999999999999976 468999999987543  335688899999999877655 45555677788899999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeC---CCCCeEEeeeccccccCCC
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLTGE  326 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~a~~~~~~  326 (470)
                      |+ ++++.+.+......+++..+..++.|++.||+|||   +++|+||||||+||+++   .+..+||+|||+|+.+...
T Consensus        84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          84 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             Ec-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            99 55777777776778999999999999999999999   99999999999999986   4557999999999977543


Q ss_pred             CCc-----ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhh--HHhhhhcCCcccc
Q 040392          327 DQS-----MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLK--HWVNDWLPISTME  399 (470)
Q Consensus       327 ~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~  399 (470)
                      ...     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........  .+.......    
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~----  235 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST----  235 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS----
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC----
Confidence            321     223456799999999999999999999999999999999999999987543322111  111100000    


Q ss_pred             cccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHH
Q 040392          400 VVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDS  454 (470)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~  454 (470)
                                 ........++.++.+++..||+.||++||++.++.+.|+.+..+
T Consensus       236 -----------~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         236 -----------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             -----------CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             -----------ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence                       00111234678899999999999999999999999999887543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4.2e-45  Score=345.93  Aligned_cols=264  Identities=14%  Similarity=0.140  Sum_probs=213.4

Q ss_pred             hCCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCC-CcceeEEeeeccCCeeeEEEe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRH-RNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      .++|++.+.||+|+||+||+|++. +|+.||||++...  .....+.+|++.++.++| +|++.+++++......++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc--cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            467999999999999999999864 6899999988643  234567889999999975 899999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCC-----CCCeEEeeeccccccC
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-----NMVAHLSDFSIAKLLT  324 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~-----~~~~kl~Dfg~a~~~~  324 (470)
                      |+ +++|.+++......++..++..++.|++.||+|||   +.+|+||||||+||+++.     ++.+||+|||+|+.+.
T Consensus        82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            99 67999999887778999999999999999999999   999999999999999974     6789999999998765


Q ss_pred             CCCCc-----ccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhh-HHh-hhhcCCcc
Q 040392          325 GEDQS-----MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLK-HWV-NDWLPIST  397 (470)
Q Consensus       325 ~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~-~~~-~~~~~~~~  397 (470)
                      .....     .......||+.|+|||.+.+..++.++||||||+++|||+||+.||........... ..+ ....... 
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~-  236 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP-  236 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC-
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC-
Confidence            33221     223346799999999999999999999999999999999999999986433321111 111 0000000 


Q ss_pred             cccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHHHHHHHHHHh
Q 040392          398 MEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAKLLKIRDSLL  456 (470)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~L~~i~~~~~  456 (470)
                                    .......++.++.+++..|+..+|++||+++.+.+.|+++..+..
T Consensus       237 --------------~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~  281 (293)
T d1csna_         237 --------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  281 (293)
T ss_dssp             --------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             --------------hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence                          001113457789999999999999999999999999998876543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-45  Score=349.28  Aligned_cols=269  Identities=20%  Similarity=0.229  Sum_probs=206.7

Q ss_pred             CCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeeccCCeeeEEEe
Q 040392          173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSNEEFKALVLE  249 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e  249 (470)
                      ++|++++.||+|+||+||+|++ .+|+.||||+++...  ......+.+|+.+++.++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5799999999999999999986 478999999986543  3346778899999999999999999999999999999999


Q ss_pred             cCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCCCCCc
Q 040392          250 YMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTGEDQS  329 (470)
Q Consensus       250 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  329 (470)
                      ++.+++|..++... ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||.++....... 
T Consensus        82 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-  156 (292)
T d1unla_          82 FCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-  156 (292)
T ss_dssp             CCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred             eccccccccccccc-cccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence            99998888777544 46889999999999999999999   89999999999999999999999999999987643322 


Q ss_pred             ccccccccCccccCccccCCCC-CCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc------cccc--
Q 040392          330 MTQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS------TMEV--  400 (470)
Q Consensus       330 ~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~--  400 (470)
                       ......++..|+|||.+.... ++.++||||+||++|||++|+.||....+....+...........      ....  
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (292)
T d1unla_         157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence             223345788899999887655 689999999999999999999997543332222221111111100      0000  


Q ss_pred             -ccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          401 -VGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       401 -~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                       ...................+.++.+|+.+||+.||.+||||+|+++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             00000001111111223446778999999999999999999999875

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-45  Score=357.46  Aligned_cols=269  Identities=21%  Similarity=0.222  Sum_probs=198.3

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc-chhhhhHHHHHHHHhcCCCCcceeEEeeeccCC----eee
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC-GRALKGFDVECEMMKSIRHRNLIKVISTCSNEE----FKA  245 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~----~~~  245 (470)
                      +++|++++.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|+.++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            46799999999999999999975 579999999997543 344567889999999999999999999986543    234


Q ss_pred             EEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccccCC
Q 040392          246 LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLTG  325 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  325 (470)
                      ++++|+.+|+|.+++...  .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||++.....
T Consensus        87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            555667799999999764  4899999999999999999999   99999999999999999999999999999987643


Q ss_pred             CCC-cccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccccc
Q 040392          326 EDQ-SMTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVVGA  403 (470)
Q Consensus       326 ~~~-~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (470)
                      ... .......+||+.|+|||++.. ..++.++||||+||++|||++|+.||.......... ........... .....
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~-~~~~~~~~~~~-~~~~~  239 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN-HILGILGSPSQ-EDLNC  239 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHHHCSCCH-HHHHT
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHH-HHhhhccCCCh-hhhhh
Confidence            322 222345679999999998854 457899999999999999999999997643221111 11110000000 00000


Q ss_pred             c-----------c-cCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          404 N-----------L-LSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       404 ~-----------~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      .           . ..............+.++.+|+.+||+.||++|||+.|+++|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0           0 000000001112335678999999999999999999999987

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-45  Score=351.09  Aligned_cols=271  Identities=20%  Similarity=0.244  Sum_probs=199.1

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeecc--------
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSN--------  240 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--------  240 (470)
                      .++|++++.||+|+||+||+|+. .+|+.||||++...  .......+.+|+++++.++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            47899999999999999999986 47999999998644  23345668899999999999999999998754        


Q ss_pred             CCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccc
Q 040392          241 EEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA  320 (470)
Q Consensus       241 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a  320 (470)
                      ....++||||+.++.+.... .....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence            34678999999876655444 44557899999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCC--cccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhc--CC
Q 040392          321 KLLTGEDQ--SMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWL--PI  395 (470)
Q Consensus       321 ~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~  395 (470)
                      ........  ........||+.|+|||.+.+. .++.++||||+||++|||++|+.||....+.+ ..........  +.
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~  243 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQLCGSITP  243 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCT
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH-HHHHHHHhcCCCCh
Confidence            86643222  1222345799999999998765 68999999999999999999999997533211 1111111000  00


Q ss_pred             ccccccc-c---------cccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          396 STMEVVG-A---------NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       396 ~~~~~~~-~---------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ......+ .         ................+.++.+|+.+||+.||++|||++|+++|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            0000000 0         00000011111222335678899999999999999999999975

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-45  Score=353.39  Aligned_cols=266  Identities=25%  Similarity=0.323  Sum_probs=196.0

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcceeEEeeecc------CCeeeE
Q 040392          174 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNLIKVISTCSN------EEFKAL  246 (470)
Q Consensus       174 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~------~~~~~l  246 (470)
                      +|+..+.||+|+||+||+|++. +|+.||||++.....    ...+|++++++++||||+++++++..      ..+.++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5788899999999999999864 699999999875422    23469999999999999999998843      345789


Q ss_pred             EEecCCCCChHHhhh--cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-CeEEeeecccccc
Q 040392          247 VLEYMPHGSLEKYMY--SSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-VAHLSDFSIAKLL  323 (470)
Q Consensus       247 v~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~a~~~  323 (470)
                      ||||++++.+..+..  .....+++..+..++.|++.||+|||   +++|+||||||+|||++.++ .+||+|||++...
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            999998764433322  34457899999999999999999999   99999999999999999775 8999999999876


Q ss_pred             CCCCCcccccccccCccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHH-----------hhh
Q 040392          324 TGEDQSMTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHW-----------VND  391 (470)
Q Consensus       324 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~-----------~~~  391 (470)
                      ....   ......||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+...           ...
T Consensus       174 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         174 VRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             CTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHH
T ss_pred             cCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-HHHHHHHHhCCChHHhhhh
Confidence            4332   2234579999999998765 568999999999999999999999997643221 11111           111


Q ss_pred             hcCCcccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH--HHHHH
Q 040392          392 WLPISTMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK--LLKIR  452 (470)
Q Consensus       392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~--L~~i~  452 (470)
                      ..+... ...-+..... ..........+.++.+|+.+||+.||++|||+.|+++|  ++++.
T Consensus       250 ~~~~~~-~~~~~~~~~~-~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         250 MNPNYT-EFKFPQIKAH-PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             HCC----CCCCCCCCCC-CGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hccchh-hccccccccC-chhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence            111000 0000000000 00011112346678999999999999999999999975  55554

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-45  Score=351.18  Aligned_cols=253  Identities=24%  Similarity=0.318  Sum_probs=203.2

Q ss_pred             CCCCCCCeecccCceEEEEEEe----CCCcEEEEEEeecc----cchhhhhHHHHHHHHhcCCC-CcceeEEeeeccCCe
Q 040392          173 DGFSENNLIGRGGFGSVYKARL----GDGMEVAVKVFNLQ----CGRALKGFDVECEMMKSIRH-RNLIKVISTCSNEEF  243 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~~~~  243 (470)
                      ++|++.+.||+|+||+||+|+.    .+|+.||||+++..    .....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            6799999999999999999974    24889999998643    22345667889999999977 899999999999999


Q ss_pred             eeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecccccc
Q 040392          244 KALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  323 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~  323 (470)
                      .+++|||+.+|+|.+++...+ .+++.....++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            999999999999999997665 4678888999999999999999   999999999999999999999999999999876


Q ss_pred             CCCCCcccccccccCccccCccccCCC--CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCcccccc
Q 040392          324 TGEDQSMTQTQTLATIGYMAPEYGREG--RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPISTMEVV  401 (470)
Q Consensus       324 ~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (470)
                      .... ........|++.|+|||.+.+.  .++.++||||+||++|||++|+.||............+ .......     
T Consensus       180 ~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~-~~~~~~~-----  252 (322)
T d1vzoa_         180 VADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS-RRILKSE-----  252 (322)
T ss_dssp             CGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH-HHHHHCC-----
T ss_pred             cccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-HhcccCC-----
Confidence            4322 2223446799999999988754  46889999999999999999999998754433221111 1111000     


Q ss_pred             cccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCC-----HHHHHHH
Q 040392          402 GANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRIN-----AREIVAK  447 (470)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~el~~~  447 (470)
                                 ...+..++.++.+++.+||++||++|||     ++|+++|
T Consensus       253 -----------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         253 -----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             -----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             -----------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence                       0012235778999999999999999994     8899874

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-45  Score=354.80  Aligned_cols=269  Identities=25%  Similarity=0.279  Sum_probs=197.7

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc--cchhhhhHHHHHHHHhcCCCCcceeEEeeeccCC------
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRALKGFDVECEMMKSIRHRNLIKVISTCSNEE------  242 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~------  242 (470)
                      .++|++++.||+|+||+||+|.. .+|+.||||+++..  .....+.+.+|+++|+.++||||+++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            56899999999999999999986 46999999999754  2334567888999999999999999999987654      


Q ss_pred             eeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeeccccc
Q 040392          243 FKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL  322 (470)
Q Consensus       243 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~  322 (470)
                      ..++||||+ +++|..+....  .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+|++|||+|+.
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceec
Confidence            568999999 56788777543  5899999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCCcccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc--ccc
Q 040392          323 LTGEDQSMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS--TME  399 (470)
Q Consensus       323 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~  399 (470)
                      ....     .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||...... ..+...........  ...
T Consensus       171 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~  244 (346)
T d1cm8a_         171 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVTGTPPAEFVQ  244 (346)
T ss_dssp             CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHH
T ss_pred             cCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH-HHHHHHHhccCCCcHHHHh
Confidence            6432     2346799999999988664 5789999999999999999999999764321 11111111110000  000


Q ss_pred             ccc--------ccccCchh-hhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH--HHHHH
Q 040392          400 VVG--------ANLLSQED-IHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK--LLKIR  452 (470)
Q Consensus       400 ~~~--------~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~--L~~i~  452 (470)
                      ...        ..+..... .........+.++.+|+.+||..||++|||+.|+++|  ++++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            000        00000000 0000112345678899999999999999999999987  66554

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.2e-44  Score=349.01  Aligned_cols=262  Identities=20%  Similarity=0.287  Sum_probs=199.0

Q ss_pred             CCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcCC-CCcceeEEeeecc--CCeeeEEE
Q 040392          173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIR-HRNLIKVISTCSN--EEFKALVL  248 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~--~~~~~lv~  248 (470)
                      ++|++++.||+|+||+||+|+. .+|+.||||+++..   ..+.+.+|+++|+.++ ||||+++++++..  ....++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            6799999999999999999986 56899999998643   3456788999999995 9999999999864  45689999


Q ss_pred             ecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCC-CeEEeeeccccccCCCC
Q 040392          249 EYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-VAHLSDFSIAKLLTGED  327 (470)
Q Consensus       249 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~  327 (470)
                      ||+++++|.++.    ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++ .+||+|||+|.......
T Consensus       112 e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         112 EHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             ECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            999999997765    35899999999999999999999   99999999999999998655 69999999998764332


Q ss_pred             CcccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhh------------HHhhhhcC
Q 040392          328 QSMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLK------------HWVNDWLP  394 (470)
Q Consensus       328 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~------------~~~~~~~~  394 (470)
                         ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||....+......            .|......
T Consensus       185 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  261 (328)
T d3bqca1         185 ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  261 (328)
T ss_dssp             ---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             ---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence               23446789999999997765 479999999999999999999999976433211110            11110000


Q ss_pred             Cc---ccccccc--cccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          395 IS---TMEVVGA--NLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       395 ~~---~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                      ..   .......  ...............++.++.+|+.+||..||++|||++|+++|
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00   0000000  00000011111223456789999999999999999999999874

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-44  Score=351.44  Aligned_cols=261  Identities=22%  Similarity=0.225  Sum_probs=191.2

Q ss_pred             CCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeec------cCCe
Q 040392          173 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCS------NEEF  243 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~------~~~~  243 (470)
                      ++|++++.||+|+||+||+|.+. +|+.||||++....  ....+.+.+|+.+++.++||||+++++++.      ...+
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            67999999999999999999865 69999999997542  334556889999999999999999999985      3468


Q ss_pred             eeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecccccc
Q 040392          244 KALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  323 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~  323 (470)
                      .|+||||+.++.+ +.+.   ..+++..+..++.|++.||.|||   +.||+||||||+|||++.++.+|++|||+++..
T Consensus        97 ~~iv~Ey~~~~l~-~~~~---~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          97 VYLVMELMDANLC-QVIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             EEEEEECCSEEHH-HHHT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             eEEEEeccchHHH-Hhhh---cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhcc
Confidence            8999999976544 4443   35789999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHh--------------
Q 040392          324 TGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWV--------------  389 (470)
Q Consensus       324 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~--------------  389 (470)
                      ..   ........+|+.|+|||++.+..+++++||||+||++|||++|+.||....... ......              
T Consensus       170 ~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~-~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         170 GT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHTTS
T ss_pred             cc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH-HHHHHHHhccCCCHHHHHHh
Confidence            32   233345678999999999999999999999999999999999999997532211 111100              


Q ss_pred             --------hhhcCCc---ccccccccccCchhhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          390 --------NDWLPIS---TMEVVGANLLSQEDIHFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       390 --------~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                              .......   ...........   .........+.++.+|+.+||..||++||||+|+++|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFP---ADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSC---CSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhHHHHhhcCcccccccccccccccccc---ccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                    0000000   00000000001   1111233457789999999999999999999999976

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-44  Score=348.16  Aligned_cols=265  Identities=22%  Similarity=0.244  Sum_probs=196.2

Q ss_pred             hCCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc--chhhhhHHHHHHHHhcCCCCcceeEEeeecc-----CCe
Q 040392          172 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKGFDVECEMMKSIRHRNLIKVISTCSN-----EEF  243 (470)
Q Consensus       172 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-----~~~  243 (470)
                      +++|++.+.||+|+||+||+|+. .+|+.||||++....  ....+.+.+|+++++.++||||+++++++..     ...
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            57899999999999999999985 579999999997542  3345567889999999999999999998853     234


Q ss_pred             eeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeecccccc
Q 040392          244 KALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL  323 (470)
Q Consensus       244 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~~~  323 (470)
                      .+++++|+.+|+|.+++...  .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+|++|||++...
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             eEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhccc
Confidence            46677888899999999654  5899999999999999999999   999999999999999999999999999998754


Q ss_pred             CCCCCcccccccccCccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCccccCcchhhHHhhhhcCCc--ccc-
Q 040392          324 TGEDQSMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTNEIFNGEMTLKHWVNDWLPIS--TME-  399 (470)
Q Consensus       324 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~-  399 (470)
                      .     .......|++.|+|||...+. .++.++||||+||++|+|++|+.||........ ............  ... 
T Consensus       172 ~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~-~~~i~~~~~~~~~~~~~~  245 (348)
T d2gfsa1         172 D-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRLVGTPGAELLKK  245 (348)
T ss_dssp             T-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCHHHHTT
T ss_pred             C-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCChHHhhh
Confidence            2     233446789999999986665 468999999999999999999999975322111 111111000000  000 


Q ss_pred             -------cccccccCchhh-hhHhhhhhHHHHHHHHhhccCCCccCCCCHHHHHHH
Q 040392          400 -------VVGANLLSQEDI-HFVAKEQCVSCVFNLAMECTVESPEQRINAREIVAK  447 (470)
Q Consensus       400 -------~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el~~~  447 (470)
                             ............ ........+.++.+|+.+||..||++|||+.|+++|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence                   000000000000 001112346778999999999999999999999985

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.5e-39  Score=315.07  Aligned_cols=267  Identities=15%  Similarity=0.176  Sum_probs=188.1

Q ss_pred             CCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHhcCC-----------CCcceeEEeeecc
Q 040392          173 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKGFDVECEMMKSIR-----------HRNLIKVISTCSN  240 (470)
Q Consensus       173 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~~~~~~~~  240 (470)
                      ++|++++.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++++.+.           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            3599999999999999999986 579999999997542 23456677888888775           5789999888754


Q ss_pred             --CCeeeEEEecCCCCCh--HHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCC-----
Q 040392          241 --EEFKALVLEYMPHGSL--EKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV-----  311 (470)
Q Consensus       241 --~~~~~lv~e~~~~g~L--~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~-----  311 (470)
                        ....+++++++..+..  ..........+++..+..++.|++.||+|||+  ..+|+||||||+|||++.++.     
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccc
Confidence              3455666666655443  22223344678899999999999999999992  389999999999999986653     


Q ss_pred             -eEEeeeccccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccCc-----chh
Q 040392          312 -AHLSDFSIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTNEIFNGE-----MTL  385 (470)
Q Consensus       312 -~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tg~~p~~~~~~~~-----~~~  385 (470)
                       ++++|||.+.....     ......||+.|+|||++.+..++.++||||+||+++||++|+.||.......     ..+
T Consensus       170 ~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         170 QIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             EEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             eeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence             99999999875532     2234679999999999999999999999999999999999999997532211     011


Q ss_pred             hHHhhhh-----------------cCCc-ccccccccccCch----hhhhHhhhhhHHHHHHHHhhccCCCccCCCCHHH
Q 040392          386 KHWVNDW-----------------LPIS-TMEVVGANLLSQE----DIHFVAKEQCVSCVFNLAMECTVESPEQRINARE  443 (470)
Q Consensus       386 ~~~~~~~-----------------~~~~-~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e  443 (470)
                      ...+...                 .... .............    ..........+.++.+|+.+||..||++|||++|
T Consensus       245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence            1111000                 0000 0000000000000    0111122345778999999999999999999999


Q ss_pred             HHHH
Q 040392          444 IVAK  447 (470)
Q Consensus       444 l~~~  447 (470)
                      +++|
T Consensus       325 ~L~H  328 (362)
T d1q8ya_         325 LVNH  328 (362)
T ss_dssp             HHTC
T ss_pred             HhcC
Confidence            9876

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.89  E-value=3.6e-24  Score=188.31  Aligned_cols=168  Identities=16%  Similarity=0.139  Sum_probs=119.0

Q ss_pred             CCCeecccCceEEEEEEeCCCcEEEEEEeecccc------------------hhhhhHHHHHHHHhcCCCCcceeEEeee
Q 040392          177 ENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCG------------------RALKGFDVECEMMKSIRHRNLIKVISTC  238 (470)
Q Consensus       177 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~~  238 (470)
                      +.+.||+|+||+||+|...+|+.||||+++....                  ........|...+.++.|.+++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            4678999999999999988999999998753210                  0112344588899999999999888764


Q ss_pred             ccCCeeeEEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeeCCCCCeEEeeec
Q 040392          239 SNEEFKALVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFS  318 (470)
Q Consensus       239 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  318 (470)
                      .    .+++|||++++.+.+        ++......++.|+++++.|||   +.+|+||||||+|||++++ .++|+|||
T Consensus        84 ~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDFG  147 (191)
T d1zara2          84 G----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDFP  147 (191)
T ss_dssp             T----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCCT
T ss_pred             C----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEECC
Confidence            2    369999998866543        233445679999999999999   8999999999999999965 48999999


Q ss_pred             cccccCCCCCcccccccccCccccCccccCCCCCCCccchhhHHHHH
Q 040392          319 IAKLLTGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML  365 (470)
Q Consensus       319 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslGv~l  365 (470)
                      .|.....+.........+..    -.+ .....|+.++|+||+.--+
T Consensus       148 ~a~~~~~~~~~~~l~rd~~~----~~~-~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         148 QSVEVGEEGWREILERDVRN----IIT-YFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             TCEETTSTTHHHHHHHHHHH----HHH-HHHHHHCCCCCHHHHHHHH
T ss_pred             CcccCCCCCcHHHHHHHHHH----HHH-HHcCCCCCcccHHHHHHHH
Confidence            99765322111000000000    001 1134678899999965443

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.41  E-value=1.1e-13  Score=130.15  Aligned_cols=100  Identities=39%  Similarity=0.698  Sum_probs=92.8

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFR   81 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~   81 (470)
                      +|..++.+++|+.+++++|.+++.+ +.+..+++|+.|+|++|+|+|.+|..+..+++|+.|||++|+|+|.+|..+.++
T Consensus       213 ~~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~  291 (313)
T d1ogqa_         213 ASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQ  291 (313)
T ss_dssp             CGGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGG
T ss_pred             ccccccccccccccccccccccccc-cccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCC
Confidence            5778889999999999999999764 578899999999999999999999999999999999999999999999888999


Q ss_pred             CCccccccCCccccCCCCCCCCCC
Q 040392           82 NFSVESFEGNELLCGSPNLQVPPC  105 (470)
Q Consensus        82 ~l~~l~~~~n~~~~~~~~~~~~~~  105 (470)
                      +|+.+++.+|+.+|+.|   .|+|
T Consensus       292 ~L~~l~l~~N~~l~g~p---lp~c  312 (313)
T d1ogqa_         292 RFDVSAYANNKCLCGSP---LPAC  312 (313)
T ss_dssp             GSCGGGTCSSSEEESTT---SSCC
T ss_pred             CCCHHHhCCCccccCCC---CCCC
Confidence            99999999999999988   5677

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.37  E-value=5.5e-13  Score=111.59  Aligned_cols=94  Identities=26%  Similarity=0.266  Sum_probs=84.2

Q ss_pred             CCcccCCCCCCcEeeCcCC-cCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCC
Q 040392            2 IPTEIGGLKNLEYLFLGYN-RLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPF   80 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n-~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l   80 (470)
                      +|..+..+++|+.|++++| .|+...+.+|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|+..++.....
T Consensus        23 ~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~  102 (156)
T d2ifga3          23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQG  102 (156)
T ss_dssp             TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCS
T ss_pred             CcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcccChhhhcc
Confidence            5778889999999999876 588666678999999999999999999777888999999999999999999888877666


Q ss_pred             CCCccccccCCcccc
Q 040392           81 RNFSVESFEGNELLC   95 (470)
Q Consensus        81 ~~l~~l~~~~n~~~~   95 (470)
                      .+|+.|++++|++.|
T Consensus       103 ~~l~~L~L~~Np~~C  117 (156)
T d2ifga3         103 LSLQELVLSGNPLHC  117 (156)
T ss_dssp             CCCCEEECCSSCCCC
T ss_pred             ccccccccCCCcccC
Confidence            689999999999977

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.33  E-value=1e-12  Score=114.19  Aligned_cols=92  Identities=27%  Similarity=0.346  Sum_probs=54.5

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCC-CCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCC-CC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGP-IPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GP   79 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~-~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~   79 (470)
                      +|.++.  +++++|+|++|+|++. .+..|.++++|+.|+|++|.+++..+..+..+++|+.|++++|+|+..++.. ..
T Consensus        23 iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~  100 (192)
T d1w8aa_          23 IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLG  100 (192)
T ss_dssp             CCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTT
T ss_pred             cCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhC
Confidence            444443  4566666666666542 2344566666666666666666555566666666666666666666555543 45


Q ss_pred             CCCCccccccCCcccc
Q 040392           80 FRNFSVESFEGNELLC   95 (470)
Q Consensus        80 l~~l~~l~~~~n~~~~   95 (470)
                      +++|+.|++++|.+..
T Consensus       101 l~~L~~L~L~~N~l~~  116 (192)
T d1w8aa_         101 LHQLKTLNLYDNQISC  116 (192)
T ss_dssp             CTTCCEEECCSSCCCE
T ss_pred             CCcccccccCCccccc
Confidence            6666666666666543

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.31  E-value=2.5e-12  Score=102.96  Aligned_cols=88  Identities=25%  Similarity=0.321  Sum_probs=77.2

Q ss_pred             ccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCC--CCCCCCC
Q 040392            5 EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIP--RGGPFRN   82 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~--~~~~l~~   82 (470)
                      .++++++|++|+|++|+|+ .+|+.+..+++|+.|++++|+|+ .+| .+..+++|+.|++++|+|+....  .+..+++
T Consensus        15 ~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~   91 (124)
T d1dcea3          15 HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPR   91 (124)
T ss_dssp             CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTT
T ss_pred             ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCccCCCCCchhhcCCCC
Confidence            5889999999999999999 67888999999999999999999 565 48999999999999999985443  3577889


Q ss_pred             CccccccCCcccc
Q 040392           83 FSVESFEGNELLC   95 (470)
Q Consensus        83 l~~l~~~~n~~~~   95 (470)
                      |+.+++++|++..
T Consensus        92 L~~L~l~~N~i~~  104 (124)
T d1dcea3          92 LVLLNLQGNSLCQ  104 (124)
T ss_dssp             CCEEECTTSGGGG
T ss_pred             CCEEECCCCcCCc
Confidence            9999999999854

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.19  E-value=2e-11  Score=105.85  Aligned_cols=94  Identities=23%  Similarity=0.313  Sum_probs=85.9

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCC-CCCC
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GPFR   81 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~   81 (470)
                      +..|.++++|+.|+|++|.+....+..+..+++|+.|+|++|+|+...|..|.++++|+.|+|++|.|++.++.. ..++
T Consensus        47 ~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~  126 (192)
T d1w8aa_          47 DGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLN  126 (192)
T ss_dssp             SCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCT
T ss_pred             ccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCc
Confidence            456788999999999999999888899999999999999999999777788999999999999999999887765 6789


Q ss_pred             CCccccccCCccccC
Q 040392           82 NFSVESFEGNELLCG   96 (470)
Q Consensus        82 ~l~~l~~~~n~~~~~   96 (470)
                      +|+.+++.+|++.|.
T Consensus       127 ~L~~l~L~~N~~~~~  141 (192)
T d1w8aa_         127 SLTSLNLASNPFNCN  141 (192)
T ss_dssp             TCCEEECTTCCBCCS
T ss_pred             ccccccccccccccc
Confidence            999999999999774

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.16  E-value=2.1e-11  Score=97.51  Aligned_cols=79  Identities=28%  Similarity=0.318  Sum_probs=71.1

Q ss_pred             cEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCCccccccCCc
Q 040392           13 EYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSVESFEGNE   92 (470)
Q Consensus        13 ~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n~   92 (470)
                      +.|+|++|+|+ .+| .+..+++|++|++++|+|+ .+|+.+..+++|+.|++++|.|++ ++.+..+++|+.+++++|+
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~~~~~l~~L~~L~l~~N~   76 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNR   76 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSSC
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cCccccccccCeEECCCCc
Confidence            57999999999 554 5899999999999999999 788889999999999999999995 4668899999999999999


Q ss_pred             ccc
Q 040392           93 LLC   95 (470)
Q Consensus        93 ~~~   95 (470)
                      +..
T Consensus        77 i~~   79 (124)
T d1dcea3          77 LQQ   79 (124)
T ss_dssp             CCS
T ss_pred             cCC
Confidence            853

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.12  E-value=8.7e-11  Score=107.24  Aligned_cols=91  Identities=29%  Similarity=0.272  Sum_probs=71.5

Q ss_pred             ccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCCc
Q 040392            5 EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFS   84 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~   84 (470)
                      .+..+.+++.|++++|.++...+..+..+++|+.|++++|+|++..+..|..+++|+.|+|++|+|+..++.+..+++|+
T Consensus       119 ~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~  198 (266)
T d1p9ag_         119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLP  198 (266)
T ss_dssp             TTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCS
T ss_pred             ccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCcccChhHCCCCCCC
Confidence            44566777777777777775555666778888888888888887666778888888888888888886666777888888


Q ss_pred             cccccCCcccc
Q 040392           85 VESFEGNELLC   95 (470)
Q Consensus        85 ~l~~~~n~~~~   95 (470)
                      .|++++|++.|
T Consensus       199 ~L~L~~Np~~C  209 (266)
T d1p9ag_         199 FAFLHGNPWLC  209 (266)
T ss_dssp             EEECCSCCBCC
T ss_pred             EEEecCCCCCC
Confidence            88888888877

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.08  E-value=2.2e-11  Score=114.08  Aligned_cols=97  Identities=35%  Similarity=0.680  Sum_probs=72.6

Q ss_pred             CCcccCCCCCCcEeeCcC-CcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCC-CCCC
Q 040392            2 IPTEIGGLKNLEYLFLGY-NRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIP-RGGP   79 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~-n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~-~~~~   79 (470)
                      +|++|++|++|++|+|++ |+++|.+|+.|++|++|++|+|++|+|++..+..+..+..|+.+++++|.+.+.+| .+..
T Consensus        68 lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~  147 (313)
T d1ogqa_          68 IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS  147 (313)
T ss_dssp             CCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGG
T ss_pred             CChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhcc
Confidence            577778888888888875 77777778788888888888888888877777777777888888888887766554 3467


Q ss_pred             CCCCccccccCCccccCCC
Q 040392           80 FRNFSVESFEGNELLCGSP   98 (470)
Q Consensus        80 l~~l~~l~~~~n~~~~~~~   98 (470)
                      +++++.+++++|.+....|
T Consensus       148 l~~L~~l~l~~n~l~~~ip  166 (313)
T d1ogqa_         148 LPNLVGITFDGNRISGAIP  166 (313)
T ss_dssp             CTTCCEEECCSSCCEEECC
T ss_pred             Ccccceeeccccccccccc
Confidence            7777778887777654444

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.08  E-value=4.1e-11  Score=100.56  Aligned_cols=87  Identities=14%  Similarity=0.094  Sum_probs=66.1

Q ss_pred             ccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCC-CCCCCC
Q 040392            5 EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GPFRNF   83 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l   83 (470)
                      .+.++.+|+.|+|++|+|+ .+|..+..+++|+.|+|++|.|+ .++ .+..+++|+.|++++|.|+..++.. ..+++|
T Consensus        13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L   89 (162)
T d1a9na_          13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   89 (162)
T ss_dssp             EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence            3556777888888888888 55666677888888888888888 553 4778888888888888888666554 457888


Q ss_pred             ccccccCCccc
Q 040392           84 SVESFEGNELL   94 (470)
Q Consensus        84 ~~l~~~~n~~~   94 (470)
                      +.|++++|++.
T Consensus        90 ~~L~L~~N~i~  100 (162)
T d1a9na_          90 TELILTNNSLV  100 (162)
T ss_dssp             CEEECCSCCCC
T ss_pred             ccceecccccc
Confidence            88888888764

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.04  E-value=8.4e-11  Score=108.43  Aligned_cols=92  Identities=28%  Similarity=0.346  Sum_probs=63.4

Q ss_pred             cccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCCCC
Q 040392            4 TEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPFRN   82 (470)
Q Consensus         4 ~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~   82 (470)
                      ..|.++++|+.|+|++|+|++..|..|.++++|+.+++++|++++..|..|..+++|+.||+++|.+.+.++. +..+++
T Consensus       147 ~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~  226 (284)
T d1ozna_         147 DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA  226 (284)
T ss_dssp             TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTT
T ss_pred             hHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccc
Confidence            4456667777777777777766666667777777777777777766667777777777777777777655543 256667


Q ss_pred             CccccccCCcccc
Q 040392           83 FSVESFEGNELLC   95 (470)
Q Consensus        83 l~~l~~~~n~~~~   95 (470)
                      |+.+++++|++.|
T Consensus       227 L~~L~l~~N~l~C  239 (284)
T d1ozna_         227 LQYLRLNDNPWVC  239 (284)
T ss_dssp             CCEEECCSSCEEC
T ss_pred             cCEEEecCCCCCC
Confidence            7777777777766

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.03  E-value=8.1e-11  Score=98.73  Aligned_cols=91  Identities=20%  Similarity=0.140  Sum_probs=76.7

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccC--CCCCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEI--PRGGP   79 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~--~~~~~   79 (470)
                      +|+.+..+++|+.|+|++|+|+ .+ +.|..+++|++|+|++|+|++..+..+..+++|+.|++++|+|+...  ..+..
T Consensus        33 i~~~~~~l~~L~~L~Ls~N~i~-~l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~  110 (162)
T d1a9na_          33 IENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLAS  110 (162)
T ss_dssp             CCCGGGGTTCCSEEECCSSCCC-EE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGG
T ss_pred             cCccccccccCCEEECCCCCCC-cc-CCcccCcchhhhhcccccccCCCccccccccccccceecccccccccccccccc
Confidence            4555677899999999999999 44 45889999999999999999555555678999999999999998533  34577


Q ss_pred             CCCCccccccCCccc
Q 040392           80 FRNFSVESFEGNELL   94 (470)
Q Consensus        80 l~~l~~l~~~~n~~~   94 (470)
                      +++|+.+++++|++.
T Consensus       111 l~~L~~L~l~~N~i~  125 (162)
T d1a9na_         111 LKSLTYLCILRNPVT  125 (162)
T ss_dssp             CTTCCEEECCSSGGG
T ss_pred             ccccchhhcCCCccc
Confidence            899999999999984

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.96  E-value=3.4e-10  Score=103.21  Aligned_cols=89  Identities=25%  Similarity=0.257  Sum_probs=73.2

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFR   81 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~   81 (470)
                      +|.+|.  ++|+.|+|++|+|++..+..|.++++|+.|+|++|+|+ .+|. +..+++|+.|++++|++++.++....++
T Consensus        25 iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~l~  100 (266)
T d1p9ag_          25 LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSHNQLQSLPLLGQTLP  100 (266)
T ss_dssp             CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTCCEEECCSSCCSSCCCCTTTCT
T ss_pred             eCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc-cccccccccccccccccccccccccccc
Confidence            566554  57889999999998666677889999999999999998 5553 5788999999999999987777778888


Q ss_pred             CCccccccCCccc
Q 040392           82 NFSVESFEGNELL   94 (470)
Q Consensus        82 ~l~~l~~~~n~~~   94 (470)
                      +|+.+++++|.+.
T Consensus       101 ~L~~L~l~~~~~~  113 (266)
T d1p9ag_         101 ALTVLDVSFNRLT  113 (266)
T ss_dssp             TCCEEECCSSCCC
T ss_pred             ccccccccccccc
Confidence            9999999888764

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.92  E-value=8.4e-10  Score=102.57  Aligned_cols=92  Identities=24%  Similarity=0.305  Sum_probs=59.1

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCC-----
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-----   77 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-----   77 (470)
                      +..|.+++.++.|++++|.+++..|..+.++++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+......     
T Consensus       188 ~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~  266 (305)
T d1xkua_         188 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG  266 (305)
T ss_dssp             TGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSS
T ss_pred             hhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcc
Confidence            445666667777777777777665666666777777777777776 55666777777777777777776432221     


Q ss_pred             --CCCCCCccccccCCcccc
Q 040392           78 --GPFRNFSVESFEGNELLC   95 (470)
Q Consensus        78 --~~l~~l~~l~~~~n~~~~   95 (470)
                        ..+.+|+.+++.+|++.+
T Consensus       267 ~~~~~~~L~~L~L~~N~~~~  286 (305)
T d1xkua_         267 YNTKKASYSGVSLFSNPVQY  286 (305)
T ss_dssp             CCTTSCCCSEEECCSSSSCG
T ss_pred             hhcccCCCCEEECCCCcCcc
Confidence              234566666777776643

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.78  E-value=1.1e-09  Score=90.91  Aligned_cols=96  Identities=24%  Similarity=0.205  Sum_probs=69.7

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCcccccc--CCCCCCC
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGE--IPRGGPF   80 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~--~~~~~~l   80 (470)
                      ++.|.++++|+.|+|++|+|+.+.|..|..+++|++|+|++|+|+ .+|.......+|+.|+|++|.+.-.  ...+..+
T Consensus        49 ~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~C~C~~~~l~~~  127 (156)
T d2ifga3          49 LRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRW  127 (156)
T ss_dssp             GGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCCCCGGGHHHHHH
T ss_pred             chhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhccccccccccCCCcccCCchHHHHHHH
Confidence            456899999999999999999877888999999999999999999 5655544555799999999998521  1111111


Q ss_pred             CCCccccccCCccccCCCC
Q 040392           81 RNFSVESFEGNELLCGSPN   99 (470)
Q Consensus        81 ~~l~~l~~~~n~~~~~~~~   99 (470)
                      .......+..+.+.|..|.
T Consensus       128 ~~~~~~~~~~~~~~C~~p~  146 (156)
T d2ifga3         128 EEEGLGGVPEQKLQCHGQG  146 (156)
T ss_dssp             HHTTCSSCGGGCCCCSSSS
T ss_pred             HHhccCccCcCCcEECcCh
Confidence            1112223344667776663

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.77  E-value=2e-08  Score=90.76  Aligned_cols=148  Identities=16%  Similarity=0.103  Sum_probs=104.7

Q ss_pred             HHHHhhCCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCC-CCcceeEEeeeccCCeee
Q 040392          167 ELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIR-HRNLIKVISTCSNEEFKA  245 (470)
Q Consensus       167 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~  245 (470)
                      ++......|+..+..+-++.+.||+... ++..+++|+...........+..|...+..+. +-.+.+++.+...++..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            4555566777666555555678999865 56778889886655555666788999888774 444678888888888899


Q ss_pred             EEEecCCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------
Q 040392          246 LVLEYMPHGSLEKYMYSSNYILDIFQRLNIMIDVASALEYLHFGY-----------------------------------  290 (470)
Q Consensus       246 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~-----------------------------------  290 (470)
                      +||++++|.++.+.....      .....++.++++.+..||+..                                   
T Consensus        87 lv~~~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEECCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred             EEEEeccccccccccccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence            999999998886554221      122334555666666666310                                   


Q ss_pred             ---------------------CCCeeecCCCCCCeeeCCCCCeEEeeecccc
Q 040392          291 ---------------------SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK  321 (470)
Q Consensus       291 ---------------------~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~  321 (470)
                                           ...++|+|+.|.||++++++.+.|+||+.+.
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                 1237999999999999987777899998875

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=98.74  E-value=4e-11  Score=104.23  Aligned_cols=88  Identities=23%  Similarity=0.314  Sum_probs=66.3

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCC
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFR   81 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~   81 (470)
                      +|.+|..|++|+.|+|++|+|+ .++ .+.++++|+.|+|++|.|+ .+|..+..+++|+.|++++|.|+. ++.+..++
T Consensus        40 l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~~~~~l~  115 (198)
T d1m9la_          40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LSGIEKLV  115 (198)
T ss_dssp             CHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HHHHHHHH
T ss_pred             hhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-cccccccc
Confidence            3456778889999999999998 443 5888899999999999988 666655556678888888887774 34455666


Q ss_pred             CCccccccCCcc
Q 040392           82 NFSVESFEGNEL   93 (470)
Q Consensus        82 ~l~~l~~~~n~~   93 (470)
                      +|+.|++++|.+
T Consensus       116 ~L~~L~L~~N~i  127 (198)
T d1m9la_         116 NLRVLYMSNNKI  127 (198)
T ss_dssp             HSSEEEESEEEC
T ss_pred             cccccccccchh
Confidence            777777777765

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.74  E-value=8e-09  Score=95.74  Aligned_cols=86  Identities=26%  Similarity=0.187  Sum_probs=77.8

Q ss_pred             CCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCCccccc
Q 040392            9 LKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSVESF   88 (470)
Q Consensus         9 l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~   88 (470)
                      +++|+.|++++|.+++..+..|.+++.++.|++++|.+++..+..+..+++|+.|+|++|.|+..++.+..+++|+.|++
T Consensus       170 ~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~L~~L~L  249 (305)
T d1xkua_         170 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYL  249 (305)
T ss_dssp             CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEEC
T ss_pred             CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccccccccccccCCCEEEC
Confidence            57888999999998888888899999999999999999987788899999999999999999977777888999999999


Q ss_pred             cCCccc
Q 040392           89 EGNELL   94 (470)
Q Consensus        89 ~~n~~~   94 (470)
                      ++|++.
T Consensus       250 s~N~i~  255 (305)
T d1xkua_         250 HNNNIS  255 (305)
T ss_dssp             CSSCCC
T ss_pred             CCCccC
Confidence            999975

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.73  E-value=9.5e-09  Score=94.26  Aligned_cols=93  Identities=25%  Similarity=0.306  Sum_probs=58.8

Q ss_pred             CcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCC-CCCC
Q 040392            3 PTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GPFR   81 (470)
Q Consensus         3 p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~   81 (470)
                      |..|.++++|+.|+|++|.+....+..+....+|+.+++++|.|++..+..|..+++|+.|++++|.|++.++.. ..++
T Consensus        98 ~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~  177 (284)
T d1ozna_          98 PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLH  177 (284)
T ss_dssp             TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT
T ss_pred             chhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhcccc
Confidence            445666677777777777666555555666666677777777766555556666666666777766666554443 4566


Q ss_pred             CCccccccCCcccc
Q 040392           82 NFSVESFEGNELLC   95 (470)
Q Consensus        82 ~l~~l~~~~n~~~~   95 (470)
                      +|+.+++.+|.+..
T Consensus       178 ~L~~l~l~~N~l~~  191 (284)
T d1ozna_         178 SLDRLLLHQNRVAH  191 (284)
T ss_dssp             TCCEEECCSSCCCE
T ss_pred             ccchhhhhhccccc
Confidence            66666666666543

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.71  E-value=6.7e-09  Score=99.25  Aligned_cols=81  Identities=26%  Similarity=0.377  Sum_probs=52.5

Q ss_pred             cCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCCcc
Q 040392            6 IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSV   85 (470)
Q Consensus         6 ~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~   85 (470)
                      +..+++++.|+|++|++++..  .+..+++|+.|+|++|+|+ .++ .+..+++|+.|++++|+|++.+| +..+++|+.
T Consensus       303 ~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~  377 (384)
T d2omza2         303 ISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQ  377 (384)
T ss_dssp             GGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSE
T ss_pred             cchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCE
Confidence            455666677777777776542  2666777777777777776 344 46667777777777777765544 556667777


Q ss_pred             ccccCC
Q 040392           86 ESFEGN   91 (470)
Q Consensus        86 l~~~~n   91 (470)
                      |++++|
T Consensus       378 L~L~~N  383 (384)
T d2omza2         378 LGLNDQ  383 (384)
T ss_dssp             EECCCE
T ss_pred             eeCCCC
Confidence            776665

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.67  E-value=1.9e-08  Score=87.02  Aligned_cols=83  Identities=23%  Similarity=0.297  Sum_probs=44.6

Q ss_pred             cCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCCcc
Q 040392            6 IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSV   85 (470)
Q Consensus         6 ~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~   85 (470)
                      +..|++|++|+|++|++++..  .+.++++|+.|++++|.+. .++. +..+++|+.|++++|.+.. ++.+..+++|+.
T Consensus        58 l~~l~nL~~L~Ls~N~l~~~~--~l~~l~~L~~L~l~~n~~~-~~~~-l~~l~~L~~L~l~~~~~~~-~~~~~~l~~L~~  132 (199)
T d2omxa2          58 VEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIA-DITP-LANLTNLTGLTLFNNQITD-IDPLKNLTNLNR  132 (199)
T ss_dssp             GGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC-CCGG-GTTCTTCSEEECCSSCCCC-CGGGTTCTTCSE
T ss_pred             cccCCCcCcCccccccccCcc--cccCCcccccccccccccc-cccc-ccccccccccccccccccc-ccccchhhhhHH
Confidence            445555666666666655332  2555556666666666555 3332 5555555556665555542 233445555666


Q ss_pred             ccccCCcc
Q 040392           86 ESFEGNEL   93 (470)
Q Consensus        86 l~~~~n~~   93 (470)
                      +++++|.+
T Consensus       133 L~l~~n~l  140 (199)
T d2omxa2         133 LELSSNTI  140 (199)
T ss_dssp             EECCSSCC
T ss_pred             hhhhhhhh
Confidence            66655554

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.60  E-value=2.8e-08  Score=87.81  Aligned_cols=79  Identities=24%  Similarity=0.386  Sum_probs=45.3

Q ss_pred             cCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCCcc
Q 040392            6 IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSV   85 (470)
Q Consensus         6 ~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~   85 (470)
                      +.++++|+.|++++|.+++.  ..+.++++|+.|+|++|++++ +++ +..+++|+.|++++|+|++. +.+..+++|+.
T Consensus       147 ~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt~i-~~l~~l~~L~~  221 (227)
T d1h6ua2         147 LAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISDV-SPLANTSNLFI  221 (227)
T ss_dssp             GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCCBC-GGGTTCTTCCE
T ss_pred             hccccccccccccccccccc--hhhcccccceecccCCCccCC-Chh-hcCCCCCCEEECcCCcCCCC-cccccCCCCCE
Confidence            44556666666666666533  235566666666666666663 332 55666666666666666633 23455666666


Q ss_pred             cccc
Q 040392           86 ESFE   89 (470)
Q Consensus        86 l~~~   89 (470)
                      |+++
T Consensus       222 L~ls  225 (227)
T d1h6ua2         222 VTLT  225 (227)
T ss_dssp             EEEE
T ss_pred             EEee
Confidence            6554

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=98.56  E-value=3.8e-10  Score=97.90  Aligned_cols=91  Identities=25%  Similarity=0.275  Sum_probs=76.2

Q ss_pred             ccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccC--CCCCCCCC
Q 040392            5 EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEI--PRGGPFRN   82 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~--~~~~~l~~   82 (470)
                      .+.+|++|+.|+|++|.|+ .+|..+..+++|+.|++++|+|+ .++ .+..+++|+.|++++|+|+...  ..+..+++
T Consensus        65 ~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~  141 (198)
T d1m9la_          65 SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDK  141 (198)
T ss_dssp             CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTT
T ss_pred             cccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-cccccccccccccccchhccccccccccCCCc
Confidence            4778899999999999999 66766666778999999999999 454 4888999999999999998543  34678999


Q ss_pred             CccccccCCccccCCC
Q 040392           83 FSVESFEGNELLCGSP   98 (470)
Q Consensus        83 l~~l~~~~n~~~~~~~   98 (470)
                      |+.|++++|++....+
T Consensus       142 L~~L~L~~N~l~~~~~  157 (198)
T d1m9la_         142 LEDLLLAGNPLYNDYK  157 (198)
T ss_dssp             CSEEEECSSHHHHHHC
T ss_pred             cceeecCCCccccCcc
Confidence            9999999999865433

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.55  E-value=6e-08  Score=84.54  Aligned_cols=81  Identities=21%  Similarity=0.269  Sum_probs=60.5

Q ss_pred             CCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCCcccc
Q 040392            8 GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSVES   87 (470)
Q Consensus         8 ~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~   87 (470)
                      .|.+|+.|++++|.++..  ..+..+++|+.|+|++|+|++ ++ .+..+++|+.|++++|+|++ ++.+..+++|+.++
T Consensus        44 ~L~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~~l~~l~~L~~L~  118 (210)
T d1h6ta2          44 ELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLS  118 (210)
T ss_dssp             HHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEE
T ss_pred             HhcCccEEECcCCCCCCc--hhHhhCCCCCEEeCCCccccC-cc-ccccCccccccccccccccc-cccccccccccccc
Confidence            366788888888888744  247778888888888888884 43 26778888888888888874 44567778888888


Q ss_pred             ccCCcc
Q 040392           88 FEGNEL   93 (470)
Q Consensus        88 ~~~n~~   93 (470)
                      +.+|.+
T Consensus       119 l~~~~~  124 (210)
T d1h6ta2         119 LEHNGI  124 (210)
T ss_dssp             CTTSCC
T ss_pred             cccccc
Confidence            887765

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.51  E-value=1.2e-07  Score=81.70  Aligned_cols=83  Identities=25%  Similarity=0.417  Sum_probs=42.8

Q ss_pred             cCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCCcc
Q 040392            6 IGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSV   85 (470)
Q Consensus         6 ~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~   85 (470)
                      |+++++|+.|++++|.+.. +| .+.++++|+.|++++|.+.. . ..+..+++|+.|++++|++. .++.+..+++|+.
T Consensus        80 l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~-~-~~~~~l~~L~~L~l~~n~l~-~~~~l~~~~~L~~  154 (199)
T d2omxa2          80 LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLFNNQITD-I-DPLKNLTNLNRLELSSNTIS-DISALSGLTSLQQ  154 (199)
T ss_dssp             GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCC-CCGGGTTCTTCSE
T ss_pred             ccCCccccccccccccccc-cc-cccccccccccccccccccc-c-cccchhhhhHHhhhhhhhhc-ccccccccccccc
Confidence            5566666666666666652 22 35555555555555555552 2 12445555555555555554 2233344444445


Q ss_pred             ccccCCcc
Q 040392           86 ESFEGNEL   93 (470)
Q Consensus        86 l~~~~n~~   93 (470)
                      +++.+|.+
T Consensus       155 L~l~~n~l  162 (199)
T d2omxa2         155 LNFSSNQV  162 (199)
T ss_dssp             EECCSSCC
T ss_pred             cccccccc
Confidence            55444443

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.47  E-value=1e-07  Score=83.08  Aligned_cols=85  Identities=24%  Similarity=0.282  Sum_probs=70.6

Q ss_pred             ccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCCc
Q 040392            5 EIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFS   84 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~   84 (470)
                      .+.++++|+.|++++|.+...  +.+..+++|+.+++++|.+++ . ..+..+++|+.+++++|++++. +.+..+++|+
T Consensus       107 ~l~~l~~L~~L~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~-~-~~~~~l~~L~~l~l~~n~l~~i-~~l~~l~~L~  181 (210)
T d1h6ta2         107 SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITD-I-TVLSRLTKLDTLSLEDNQISDI-VPLAGLTKLQ  181 (210)
T ss_dssp             GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCC-GGGTTCTTCC
T ss_pred             ccccccccccccccccccccc--ccccccccccccccccccccc-c-cccccccccccccccccccccc-ccccCCCCCC
Confidence            578899999999999998733  468889999999999999984 3 3477889999999999999854 4477889999


Q ss_pred             cccccCCccc
Q 040392           85 VESFEGNELL   94 (470)
Q Consensus        85 ~l~~~~n~~~   94 (470)
                      .|++++|++.
T Consensus       182 ~L~Ls~N~i~  191 (210)
T d1h6ta2         182 NLYLSKNHIS  191 (210)
T ss_dssp             EEECCSSCCC
T ss_pred             EEECCCCCCC
Confidence            9999999874

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.35  E-value=7.2e-07  Score=79.74  Aligned_cols=130  Identities=17%  Similarity=0.114  Sum_probs=87.8

Q ss_pred             eecccCc-eEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCC--CCcceeEEeeeccCCeeeEEEecCCCCCh
Q 040392          180 LIGRGGF-GSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIR--HRNLIKVISTCSNEEFKALVLEYMPHGSL  256 (470)
Q Consensus       180 ~ig~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~~~~~~~~~~~~~lv~e~~~~g~L  256 (470)
                      .+..|.. +.||+....++..+++|.....   ....+..|...++.+.  .-.+.+++.+..+++..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4455554 6899999888888999986543   3345777888888774  33467788888888888999999988665


Q ss_pred             HHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc------------------------------------------------
Q 040392          257 EKYMYSSNYILDIFQRLNIMIDVASALEYLHF------------------------------------------------  288 (470)
Q Consensus       257 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~------------------------------------------------  288 (470)
                      .+..      ...   ...+.++.+.|.-||.                                                
T Consensus        94 ~~~~------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          94 LSSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             TTSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             cccc------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence            3321      111   1122233333333331                                                


Q ss_pred             -------CCCCCeeecCCCCCCeeeCCCCCeEEeeecccc
Q 040392          289 -------GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK  321 (470)
Q Consensus       289 -------~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~  321 (470)
                             .....++|+|+.|.||+++++..+-|+||+.+.
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                   012248999999999999988778899998775

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.32  E-value=3.1e-07  Score=87.33  Aligned_cols=82  Identities=21%  Similarity=0.244  Sum_probs=70.5

Q ss_pred             CCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCCcccc
Q 040392            8 GLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSVES   87 (470)
Q Consensus         8 ~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~   87 (470)
                      .+.+|+.|++++|.|+..  +.+..+++|++|+|++|+|+ .+|+ +..+++|+.|++++|.|.+. +.+..+++|+.++
T Consensus        42 ~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~-~l~~-l~~L~~L~~L~L~~n~i~~i-~~l~~l~~L~~L~  116 (384)
T d2omza2          42 DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLT-DITP-LKNLTKLVDILMNNNQIADI-TPLANLTNLTGLT  116 (384)
T ss_dssp             HHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCCC-GGGTTCTTCCEEE
T ss_pred             HhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCC-CCcc-ccCCcccccccccccccccc-ccccccccccccc
Confidence            467899999999999943  56888999999999999999 4553 99999999999999999854 4478899999999


Q ss_pred             ccCCccc
Q 040392           88 FEGNELL   94 (470)
Q Consensus        88 ~~~n~~~   94 (470)
                      +.+|.+.
T Consensus       117 ~~~~~~~  123 (384)
T d2omza2         117 LFNNQIT  123 (384)
T ss_dssp             CCSSCCC
T ss_pred             ccccccc
Confidence            9888764

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.25  E-value=1.4e-07  Score=78.52  Aligned_cols=65  Identities=32%  Similarity=0.216  Sum_probs=35.2

Q ss_pred             CCCCCcEeeCcCCcCCCCC--CccccCCCCCCEEeccCCcCCCCCcc-cccCCCCCCceecCCcccccc
Q 040392            8 GLKNLEYLFLGYNRLQGPI--PDSFGDLISLKFLNLSNNNLSGAIPA-SLEKLSYLENLNLSFNKLEGE   73 (470)
Q Consensus         8 ~l~~l~~l~l~~n~l~~~~--p~~~~~l~~L~~l~l~~n~i~~~~~~-~~~~l~~L~~l~l~~N~l~~~   73 (470)
                      ++++|+.|+|++|+|+..-  +..+..+++|+.|+|++|.|+ .+++ .+....+|+.|++++|.+...
T Consensus        63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~  130 (162)
T d1koha1          63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDT  130 (162)
T ss_dssp             HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSS
T ss_pred             hCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcC
Confidence            4566666666666666331  233445666666666666666 3332 223344566666666666543

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.24  E-value=5.9e-07  Score=79.69  Aligned_cols=91  Identities=18%  Similarity=0.233  Sum_probs=73.7

Q ss_pred             CCcccCCCCCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCC-cccccCCCCCCceecC-CccccccCCCC-C
Q 040392            2 IPTEIGGLKNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAI-PASLEKLSYLENLNLS-FNKLEGEIPRG-G   78 (470)
Q Consensus         2 ~p~~~~~l~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~-~~~~~~l~~L~~l~l~-~N~l~~~~~~~-~   78 (470)
                      +|+++.  +++++|+|++|+|+...+..|.++++|++|+|++|.+.+.+ +..|..++.++.+.+. .|.+....+.. .
T Consensus        23 iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~  100 (242)
T d1xwdc1          23 IPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQ  100 (242)
T ss_dssp             CCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEE
T ss_pred             cCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccc
Confidence            565553  58999999999999555567899999999999999988654 4568899999999876 46777666554 6


Q ss_pred             CCCCCccccccCCccc
Q 040392           79 PFRNFSVESFEGNELL   94 (470)
Q Consensus        79 ~l~~l~~l~~~~n~~~   94 (470)
                      .+++|+.+++.+|.+.
T Consensus       101 ~l~~L~~l~l~~~~l~  116 (242)
T d1xwdc1         101 NLPNLQYLLISNTGIK  116 (242)
T ss_dssp             CCTTCCEEEEESCCCC
T ss_pred             ccccccccccchhhhc
Confidence            7899999999999874

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.13  E-value=2.2e-06  Score=75.18  Aligned_cols=80  Identities=25%  Similarity=0.397  Sum_probs=58.5

Q ss_pred             CCCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCCcccccc
Q 040392           10 KNLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSVESFE   89 (470)
Q Consensus        10 ~~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~   89 (470)
                      +.+..+.++++.+...  ..+.++++|+.|++++|.+++..  .+..+++|+.|++++|++++ ++.+..+++|+.|+++
T Consensus       129 ~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~~l~~l~~L~~L~Ls  203 (227)
T d1h6ua2         129 SNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLK  203 (227)
T ss_dssp             TTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECT
T ss_pred             cchhhhhchhhhhchh--hhhccccccccccccccccccch--hhcccccceecccCCCccCC-ChhhcCCCCCCEEECc
Confidence            3333444444443322  34666788999999999988433  38899999999999999985 4557788999999999


Q ss_pred             CCccc
Q 040392           90 GNELL   94 (470)
Q Consensus        90 ~n~~~   94 (470)
                      +|++.
T Consensus       204 ~N~lt  208 (227)
T d1h6ua2         204 NNQIS  208 (227)
T ss_dssp             TSCCC
T ss_pred             CCcCC
Confidence            99875

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.04  E-value=5.8e-06  Score=77.02  Aligned_cols=53  Identities=26%  Similarity=0.258  Sum_probs=25.1

Q ss_pred             CCcEeeCcCCcCCCCCCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCcccc
Q 040392           11 NLEYLFLGYNRLQGPIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLE   71 (470)
Q Consensus        11 ~l~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~   71 (470)
                      +++.|||++|.|+ .+|+.   +++|++|+|++|+|+ .+|+.+   ++|+.|++++|.++
T Consensus        39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~   91 (353)
T d1jl5a_          39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK   91 (353)
T ss_dssp             TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS
T ss_pred             CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc
Confidence            3455555555555 34432   334555555555555 444332   33444444444443

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.03  E-value=3.9e-06  Score=78.23  Aligned_cols=55  Identities=40%  Similarity=0.397  Sum_probs=33.9

Q ss_pred             CCCCCEEeccCCcCCCCCcccccCCCCCCceecCCccccccCCCCCCCCCCccccccCCccc
Q 040392           33 LISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGPFRNFSVESFEGNELL   94 (470)
Q Consensus        33 l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n~~~   94 (470)
                      +++|++|+|++|+|+ .+|..   +++|+.|++++|+|+. +|.  .+.+|+.|++++|++.
T Consensus       283 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~~-l~~--~~~~L~~L~L~~N~L~  337 (353)
T d1jl5a_         283 PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLAE-VPE--LPQNLKQLHVEYNPLR  337 (353)
T ss_dssp             CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSC-CCC--CCTTCCEEECCSSCCS
T ss_pred             CCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCCc-ccc--ccCCCCEEECcCCcCC
Confidence            456777777777776 55542   4566677777777663 332  2456666777777654

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.97  E-value=1.6e-07  Score=78.06  Aligned_cols=64  Identities=31%  Similarity=0.231  Sum_probs=50.2

Q ss_pred             cCCCCCCEEeccCCcCCCC--CcccccCCCCCCceecCCccccccCCCC--CCCCCCccccccCCcccc
Q 040392           31 GDLISLKFLNLSNNNLSGA--IPASLEKLSYLENLNLSFNKLEGEIPRG--GPFRNFSVESFEGNELLC   95 (470)
Q Consensus        31 ~~l~~L~~l~l~~n~i~~~--~~~~~~~l~~L~~l~l~~N~l~~~~~~~--~~l~~l~~l~~~~n~~~~   95 (470)
                      .++++|++|+|++|+|+..  ++..+..+++|+.|++++|.|+...+ +  ....+|+.+++.+|++.+
T Consensus        62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~-l~~l~~~~L~~L~L~~Npl~~  129 (162)
T d1koha1          62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERE-LDKIKGLKLEELWLDGNSLSD  129 (162)
T ss_dssp             HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGG-HHHHTTCCCSSCCCTTSTTSS
T ss_pred             HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchh-hhhhhccccceeecCCCCcCc
Confidence            4588999999999999943  23456789999999999999995433 2  233468999999999854

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.82  E-value=4.1e-05  Score=72.66  Aligned_cols=76  Identities=16%  Similarity=0.162  Sum_probs=49.8

Q ss_pred             CCeecccCceEEEEEEeCC-CcEEEEEEeeccc-------chhhhhHHHHHHHHhcCC-C--CcceeEEeeeccCCeeeE
Q 040392          178 NNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQC-------GRALKGFDVECEMMKSIR-H--RNLIKVISTCSNEEFKAL  246 (470)
Q Consensus       178 ~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~-h--~nIv~~~~~~~~~~~~~l  246 (470)
                      .+.||.|....||++...+ ++.++||.-.+..       .....+...|.+.++.+. +  ..+.+++.+.  ++..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence            3568999999999998654 6789999754321       112345566888887663 2  3456666654  344578


Q ss_pred             EEecCCCCC
Q 040392          247 VLEYMPHGS  255 (470)
Q Consensus       247 v~e~~~~g~  255 (470)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997654

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.73  E-value=1.4e-05  Score=70.38  Aligned_cols=77  Identities=19%  Similarity=0.082  Sum_probs=41.0

Q ss_pred             CCcEeeCcCCcCCCCCCccccCCCCCCEE-eccCCcCCCCCcccccCCCCCCceecCCccccccCCC-CCCCCCCccccc
Q 040392           11 NLEYLFLGYNRLQGPIPDSFGDLISLKFL-NLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGPFRNFSVESF   88 (470)
Q Consensus        11 ~l~~l~l~~n~l~~~~p~~~~~l~~L~~l-~l~~n~i~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~   88 (470)
                      .+..|++++|+++. ++.......+++.+ ++++|+|+...+..|..+++|+.|++++|+|+..++. +..+++|+.+++
T Consensus       154 ~l~~L~l~~n~l~~-i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~  232 (242)
T d1xwdc1         154 ESVILWLNKNGIQE-IHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST  232 (242)
T ss_dssp             SCEEEECCSSCCCE-ECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred             cceeeecccccccc-cccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence            55666666666663 33333334444333 4566666633234466666777777777766644443 244444444444

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.29  E-value=0.00056  Score=62.79  Aligned_cols=133  Identities=14%  Similarity=0.145  Sum_probs=77.1

Q ss_pred             ceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcc--eeEEe-----eeccCCeeeEEEecCCCCChH-
Q 040392          186 FGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNL--IKVIS-----TCSNEEFKALVLEYMPHGSLE-  257 (470)
Q Consensus       186 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI--v~~~~-----~~~~~~~~~lv~e~~~~g~L~-  257 (470)
                      --.||+++..+|+.|++|+.++. ....+.+..|...+..|....+  +..+.     .+...+..+.++++++|..+. 
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            46899999999999999998754 2244557778888887753222  11111     123356678899999764321 


Q ss_pred             ----Hhh-------------hcC----CCCCCHH----------------------HHHHHHHHHHHHHHHH-hcCCCCC
Q 040392          258 ----KYM-------------YSS----NYILDIF----------------------QRLNIMIDVASALEYL-HFGYSAP  293 (470)
Q Consensus       258 ----~~l-------------~~~----~~~~~~~----------------------~~~~i~~~i~~~L~~L-H~~~~~~  293 (470)
                          .+-             ...    ....+..                      .....+..+...+.-. ......+
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence                110             000    0111111                      1112223333333222 1223467


Q ss_pred             eeecCCCCCCeeeCCCCCeEEeeecccc
Q 040392          294 IIHCDLKPSNVLLDDNMVAHLSDFSIAK  321 (470)
Q Consensus       294 i~H~dlkp~Nill~~~~~~kl~Dfg~a~  321 (470)
                      ++|+|+.+.|||++++  ..++||+-+.
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             eecCCCCcccEEEeCC--ceEEechhcc
Confidence            8999999999999743  4589999876

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.20  E-value=0.0007  Score=63.95  Aligned_cols=73  Identities=19%  Similarity=0.230  Sum_probs=50.1

Q ss_pred             CCeecccCceEEEEEEeCC--------CcEEEEEEeecccchhhhhHHHHHHHHhcCCCCc-ceeEEeeeccCCeeeEEE
Q 040392          178 NNLIGRGGFGSVYKARLGD--------GMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRN-LIKVISTCSNEEFKALVL  248 (470)
Q Consensus       178 ~~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~~lv~  248 (470)
                      ++.|+.|-.-.+|++..++        ...|.+++.. ... ......+|..+++.+.-.+ ..++++++.+    .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            3578889999999998654        3567777765 222 2334567888888885333 3577887754    5899


Q ss_pred             ecCCCCCh
Q 040392          249 EYMPHGSL  256 (470)
Q Consensus       249 e~~~~g~L  256 (470)
                      ||++|.++
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987544

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.19  E-value=1.8e-05  Score=71.66  Aligned_cols=85  Identities=18%  Similarity=0.045  Sum_probs=64.6

Q ss_pred             CCCCCCcEeeCcCCcCCCC-CCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCceecCCc-cccc--cCCCCCCCCC
Q 040392            7 GGLKNLEYLFLGYNRLQGP-IPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN-KLEG--EIPRGGPFRN   82 (470)
Q Consensus         7 ~~l~~l~~l~l~~n~l~~~-~p~~~~~l~~L~~l~l~~n~i~~~~~~~~~~l~~L~~l~l~~N-~l~~--~~~~~~~l~~   82 (470)
                      ....+|++|||+++.++.. ++..+.++++|++|+|++|.+++..+..+..+++|+.|+++++ .++.  ...-...+++
T Consensus        43 ~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~  122 (284)
T d2astb2          43 FSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR  122 (284)
T ss_dssp             CCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTT
T ss_pred             ccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHh
Confidence            4567899999999988743 3445678899999999999998777788889999999999984 5652  1111245788


Q ss_pred             CccccccCC
Q 040392           83 FSVESFEGN   91 (470)
Q Consensus        83 l~~l~~~~n   91 (470)
                      |+.|+++++
T Consensus       123 L~~L~ls~c  131 (284)
T d2astb2         123 LDELNLSWC  131 (284)
T ss_dssp             CCEEECCCC
T ss_pred             ccccccccc
Confidence            899988764

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.18  E-value=1.2e-05  Score=77.43  Aligned_cols=87  Identities=20%  Similarity=0.150  Sum_probs=51.2

Q ss_pred             CCCCCCcEeeCcCCcCCC----CCCccccCCCCCCEEeccCCcCCCC----Cccccc-CCCCCCceecCCcccccc----
Q 040392            7 GGLKNLEYLFLGYNRLQG----PIPDSFGDLISLKFLNLSNNNLSGA----IPASLE-KLSYLENLNLSFNKLEGE----   73 (470)
Q Consensus         7 ~~l~~l~~l~l~~n~l~~----~~p~~~~~l~~L~~l~l~~n~i~~~----~~~~~~-~l~~L~~l~l~~N~l~~~----   73 (470)
                      ..+++++.|+|++|.++.    .+...+..+++|+.|||++|.|+..    +...+. ...+|+.|++++|.|++.    
T Consensus        24 ~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~  103 (460)
T d1z7xw1          24 PLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGV  103 (460)
T ss_dssp             HHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHH
T ss_pred             HhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCcccccccc
Confidence            345677777777777662    2233456677777777777777521    111222 234677777777777532    


Q ss_pred             -CCCCCCCCCCccccccCCcc
Q 040392           74 -IPRGGPFRNFSVESFEGNEL   93 (470)
Q Consensus        74 -~~~~~~l~~l~~l~~~~n~~   93 (470)
                       ...+..+++|+.|++++|.+
T Consensus       104 l~~~l~~~~~L~~L~L~~N~i  124 (460)
T d1z7xw1         104 LSSTLRTLPTLQELHLSDNLL  124 (460)
T ss_dssp             HHHHTTSCTTCCEEECCSSBC
T ss_pred             ccchhhccccccccccccccc
Confidence             11234566777777777765

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=97.11  E-value=2.1e-05  Score=73.32  Aligned_cols=87  Identities=16%  Similarity=0.131  Sum_probs=45.2

Q ss_pred             CCCCCCcEeeCcCCcCCCC-----CCccccCCCCCCEEeccCCcCCCC----CcccccCCCCCCceecCCccccccCC--
Q 040392            7 GGLKNLEYLFLGYNRLQGP-----IPDSFGDLISLKFLNLSNNNLSGA----IPASLEKLSYLENLNLSFNKLEGEIP--   75 (470)
Q Consensus         7 ~~l~~l~~l~l~~n~l~~~-----~p~~~~~l~~L~~l~l~~n~i~~~----~~~~~~~l~~L~~l~l~~N~l~~~~~--   75 (470)
                      ..+++|+.|+|+.|+++..     +...+..+++|+.|+|++|.++..    +...+..+++|+.|++++|.|++.-.  
T Consensus       183 ~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~  262 (344)
T d2ca6a1         183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA  262 (344)
T ss_dssp             HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHH
T ss_pred             hhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHH
Confidence            3455666666666666521     222344556666666666665422    23345556666666666666653100  


Q ss_pred             ---CC--CCCCCCccccccCCcc
Q 040392           76 ---RG--GPFRNFSVESFEGNEL   93 (470)
Q Consensus        76 ---~~--~~l~~l~~l~~~~n~~   93 (470)
                         .+  ....+|+.|++++|++
T Consensus       263 l~~~l~~~~~~~L~~L~ls~N~i  285 (344)
T d2ca6a1         263 VVDAFSKLENIGLQTLRLQYNEI  285 (344)
T ss_dssp             HHHHHHTCSSCCCCEEECCSSCC
T ss_pred             HHHHhhhccCCCCCEEECCCCcC
Confidence               00  1224456666666654

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.10  E-value=0.0013  Score=59.93  Aligned_cols=156  Identities=15%  Similarity=0.099  Sum_probs=84.7

Q ss_pred             cCHHHHHHhhCCCCCCCee-----cccCceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHhcCCCCcc--eeEE
Q 040392          163 FSHLELCRATDGFSENNLI-----GRGGFGSVYKARLGDGMEVAVKVFNLQCGRALKGFDVECEMMKSIRHRNL--IKVI  235 (470)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~i-----g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI--v~~~  235 (470)
                      .+..++.....+|.+.+..     ..|---+.|+.+..+| .+++|++...  ...+.+..|.+++..|...++  ...+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccc
Confidence            4567777778888876544     4566688899988665 4899998643  223445557777777642222  1111


Q ss_pred             ee------eccCCeeeEEEecCCCCChHHh--------------hhc----CC----CCCC------------------H
Q 040392          236 ST------CSNEEFKALVLEYMPHGSLEKY--------------MYS----SN----YILD------------------I  269 (470)
Q Consensus       236 ~~------~~~~~~~~lv~e~~~~g~L~~~--------------l~~----~~----~~~~------------------~  269 (470)
                      ..      .........++.+..+......              ++.    ..    ....                  .
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            11      1123445566666655322110              000    00    0000                  0


Q ss_pred             HHHHHHHHHHHHHHHHHh-cCCCCCeeecCCCCCCeeeCCCCCeEEeeecccc
Q 040392          270 FQRLNIMIDVASALEYLH-FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK  321 (470)
Q Consensus       270 ~~~~~i~~~i~~~L~~LH-~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~a~  321 (470)
                      ......+......+...+ .....++||+|+.+.||+++.+...-+.||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            011122222233333333 1235789999999999999998888999999875

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=96.94  E-value=2.9e-05  Score=72.29  Aligned_cols=86  Identities=17%  Similarity=0.158  Sum_probs=59.9

Q ss_pred             CCCCCcEeeCcCCcCCCC----CCccccCCCCCCEEeccCCcCCCC-----CcccccCCCCCCceecCCcccccc-----
Q 040392            8 GLKNLEYLFLGYNRLQGP----IPDSFGDLISLKFLNLSNNNLSGA-----IPASLEKLSYLENLNLSFNKLEGE-----   73 (470)
Q Consensus         8 ~l~~l~~l~l~~n~l~~~----~p~~~~~l~~L~~l~l~~n~i~~~-----~~~~~~~l~~L~~l~l~~N~l~~~-----   73 (470)
                      ..+.|+.|++++|.++..    +...+...+.|+.|+|++|.|+..     +...+..+++|+.|++++|.|+..     
T Consensus       156 ~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L  235 (344)
T d2ca6a1         156 NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSAL  235 (344)
T ss_dssp             TCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHH
T ss_pred             cCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccc
Confidence            456788888888887632    223345577888888888888632     334566788888888888887532     


Q ss_pred             CCCCCCCCCCccccccCCcc
Q 040392           74 IPRGGPFRNFSVESFEGNEL   93 (470)
Q Consensus        74 ~~~~~~l~~l~~l~~~~n~~   93 (470)
                      ...+..+++|+.|++++|.+
T Consensus       236 ~~~l~~~~~L~~L~Ls~n~i  255 (344)
T d2ca6a1         236 AIALKSWPNLRELGLNDCLL  255 (344)
T ss_dssp             HHHGGGCTTCCEEECTTCCC
T ss_pred             cccccccccchhhhhhcCcc
Confidence            12335677888888888876

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.81  E-value=6.4e-05  Score=72.20  Aligned_cols=84  Identities=20%  Similarity=0.101  Sum_probs=35.5

Q ss_pred             CCCcEeeCcCCcCCCCCCc----cccCCCCCCEEeccCCcCCCC----Cccccc-CCCCCCceecCCcccccc----C-C
Q 040392           10 KNLEYLFLGYNRLQGPIPD----SFGDLISLKFLNLSNNNLSGA----IPASLE-KLSYLENLNLSFNKLEGE----I-P   75 (470)
Q Consensus        10 ~~l~~l~l~~n~l~~~~p~----~~~~l~~L~~l~l~~n~i~~~----~~~~~~-~l~~L~~l~l~~N~l~~~----~-~   75 (470)
                      ..|+.+++++|.++.....    .+...++|++|+|++|.|++.    ++..+. ..+.|+.|+|++|.|+..    + .
T Consensus       312 ~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~  391 (460)
T d1z7xw1         312 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA  391 (460)
T ss_dssp             CCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred             cccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHH
Confidence            3455555555555422111    122234555555555555421    112222 234455555555555421    0 0


Q ss_pred             CCCCCCCCccccccCCcc
Q 040392           76 RGGPFRNFSVESFEGNEL   93 (470)
Q Consensus        76 ~~~~l~~l~~l~~~~n~~   93 (470)
                      .+..+++|+.|++++|++
T Consensus       392 ~l~~~~~L~~L~Ls~N~i  409 (460)
T d1z7xw1         392 TLLANHSLRELDLSNNCL  409 (460)
T ss_dssp             HHHHCCCCCEEECCSSSC
T ss_pred             HHhcCCCCCEEECCCCcC
Confidence            112334555555555554

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.68  E-value=0.00058  Score=61.35  Aligned_cols=83  Identities=22%  Similarity=0.198  Sum_probs=50.7

Q ss_pred             CCCCcEeeCcCC--cCCCC-CCccccCCCCCCEEeccCC-cCCCCCcccccCCCCCCceecCCc-ccccc-CCCCCCCCC
Q 040392            9 LKNLEYLFLGYN--RLQGP-IPDSFGDLISLKFLNLSNN-NLSGAIPASLEKLSYLENLNLSFN-KLEGE-IPRGGPFRN   82 (470)
Q Consensus         9 l~~l~~l~l~~n--~l~~~-~p~~~~~l~~L~~l~l~~n-~i~~~~~~~~~~l~~L~~l~l~~N-~l~~~-~~~~~~l~~   82 (470)
                      .++|+.|+++++  .++.. +...+.++++|++|+|++| .+++.....+..+++|+.|+++++ .|++. +..+..+++
T Consensus       147 ~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~  226 (284)
T d2astb2         147 SETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT  226 (284)
T ss_dssp             CTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTT
T ss_pred             ccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCC
Confidence            367777777754  33321 1122345677778888775 466666666777777788888773 45532 223456677


Q ss_pred             CccccccCC
Q 040392           83 FSVESFEGN   91 (470)
Q Consensus        83 l~~l~~~~n   91 (470)
                      |+.|++.++
T Consensus       227 L~~L~l~~~  235 (284)
T d2astb2         227 LKTLQVFGI  235 (284)
T ss_dssp             CCEEECTTS
T ss_pred             CCEEeeeCC
Confidence            777777654

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=96.65  E-value=0.00025  Score=58.35  Aligned_cols=87  Identities=14%  Similarity=0.101  Sum_probs=64.0

Q ss_pred             CCCCCCcEeeCcCC-cCCCC----CCccccCCCCCCEEeccCCcCCCC----CcccccCCCCCCceecCCcccccc----
Q 040392            7 GGLKNLEYLFLGYN-RLQGP----IPDSFGDLISLKFLNLSNNNLSGA----IPASLEKLSYLENLNLSFNKLEGE----   73 (470)
Q Consensus         7 ~~l~~l~~l~l~~n-~l~~~----~p~~~~~l~~L~~l~l~~n~i~~~----~~~~~~~l~~L~~l~l~~N~l~~~----   73 (470)
                      .+.++|+.|+|+++ .++..    +-..+...++|+.|+|++|.++..    +...+...++|+.|++++|.|+..    
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~   91 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR   91 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred             hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence            35689999999975 46521    223566778999999999999742    334566789999999999999742    


Q ss_pred             -CCCCCCCCCCccccccCCcc
Q 040392           74 -IPRGGPFRNFSVESFEGNEL   93 (470)
Q Consensus        74 -~~~~~~l~~l~~l~~~~n~~   93 (470)
                       ...+...++|+.|++++|.+
T Consensus        92 l~~aL~~n~sL~~L~l~~n~~  112 (167)
T d1pgva_          92 LLRSTLVTQSIVEFKADNQRQ  112 (167)
T ss_dssp             HHHHTTTTCCCSEEECCCCSS
T ss_pred             HHHHHHhCCcCCEEECCCCcC
Confidence             11245567899999988865

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=95.33  E-value=0.0023  Score=52.22  Aligned_cols=67  Identities=15%  Similarity=0.125  Sum_probs=51.9

Q ss_pred             ccCCCCCCcEeeCcCCcCCC----CCCccccCCCCCCEEeccCCcCCCC----CcccccCCCCCCceecCCcccc
Q 040392            5 EIGGLKNLEYLFLGYNRLQG----PIPDSFGDLISLKFLNLSNNNLSGA----IPASLEKLSYLENLNLSFNKLE   71 (470)
Q Consensus         5 ~~~~l~~l~~l~l~~n~l~~----~~p~~~~~l~~L~~l~l~~n~i~~~----~~~~~~~l~~L~~l~l~~N~l~   71 (470)
                      .+.+.++|+.|+|++|.+..    .+...+...+.|+.|+|++|.|++.    +-..+...++|+.|++++|.+.
T Consensus        39 ~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~  113 (167)
T d1pgva_          39 AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQS  113 (167)
T ss_dssp             HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSC
T ss_pred             HHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCC
Confidence            35567889999999999873    2223455678999999999999843    2245777899999999999765

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=93.78  E-value=0.006  Score=49.47  Aligned_cols=87  Identities=14%  Similarity=0.144  Sum_probs=59.7

Q ss_pred             CCCCCCcEeeCcC-CcCCCC----CCccccCCCCCCEEeccCCcCCCC----CcccccCCCCCCceecCCcccccc----
Q 040392            7 GGLKNLEYLFLGY-NRLQGP----IPDSFGDLISLKFLNLSNNNLSGA----IPASLEKLSYLENLNLSFNKLEGE----   73 (470)
Q Consensus         7 ~~l~~l~~l~l~~-n~l~~~----~p~~~~~l~~L~~l~l~~n~i~~~----~~~~~~~l~~L~~l~l~~N~l~~~----   73 (470)
                      .+.++|+.|+|++ |.++..    +-..+...++|+.|+|++|.++..    +-..+...+.|+.+++++|.+...    
T Consensus        14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~   93 (166)
T d1io0a_          14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA   93 (166)
T ss_dssp             TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred             hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence            4678999999998 456521    223456788999999999998743    223456788999999999998632    


Q ss_pred             -CCCCCCCCCCccccc--cCCcc
Q 040392           74 -IPRGGPFRNFSVESF--EGNEL   93 (470)
Q Consensus        74 -~~~~~~l~~l~~l~~--~~n~~   93 (470)
                       ...+...++|+.+++  .+|++
T Consensus        94 l~~~l~~~~~L~~l~L~l~~n~i  116 (166)
T d1io0a_          94 LVEALQSNTSLIELRIDNQSQPL  116 (166)
T ss_dssp             HHHGGGGCSSCCEEECCCCSSCC
T ss_pred             HHHHHHhCccccEEeeccCCCcC
Confidence             123355667776555  34444

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=92.31  E-value=0.0063  Score=49.36  Aligned_cols=88  Identities=15%  Similarity=0.114  Sum_probs=61.2

Q ss_pred             cCCCCCCcEeeCcCCcCCCC----CCccccCCCCCCEEeccCCcCCCC----CcccccCCCCCCceec--CCcccccc--
Q 040392            6 IGGLKNLEYLFLGYNRLQGP----IPDSFGDLISLKFLNLSNNNLSGA----IPASLEKLSYLENLNL--SFNKLEGE--   73 (470)
Q Consensus         6 ~~~l~~l~~l~l~~n~l~~~----~p~~~~~l~~L~~l~l~~n~i~~~----~~~~~~~l~~L~~l~l--~~N~l~~~--   73 (470)
                      +...++|+.|+|++|.++..    +-..+...++|+.+++++|.++..    +-..+...++|+.++|  ++|.+...  
T Consensus        42 l~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~  121 (166)
T d1io0a_          42 LKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVE  121 (166)
T ss_dssp             HTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHH
T ss_pred             HhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHH
Confidence            45778999999999998743    223455678999999999998743    2256778899987555  57777531  


Q ss_pred             ---CCCCCCCCCCccccccCCcc
Q 040392           74 ---IPRGGPFRNFSVESFEGNEL   93 (470)
Q Consensus        74 ---~~~~~~l~~l~~l~~~~n~~   93 (470)
                         ...+...++|+.|++..|..
T Consensus       122 ~~La~~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_         122 MEIANMLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             HHHHHHHHHCSSCCEEECCCSSH
T ss_pred             HHHHHHHHhCCCcCEEeCcCCCC
Confidence               11123567788888765543